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Background: Knowing characteristic adverse events (AEs) and their inci-
dence among patients participating in past acute stroke trials (Stroke.
2014;45:2677–2682) may assist recruitment of patients in future studies.
We aimed to develop an online tool to inform stroke trial safety.
Methods: We identified relevant AEs from patients within the acute trial
database, the Virtual International Stroke Trials Archive (VISTA), using
receiver operating characteristic principles. We modeled the incidence of
these events as a function of patient age, baseline NIHSS score and
co-morbidities using binary logistic regression. Models with R-squared
value greater than five percent, R2 >5%, were deemed powerful enough to
predict expected AE incidences in future trials and were included. The
calculator was developed using both R and Visual Studio development
tools.
Results: Forty-eight of the most common AEs in acute stroke trials were
identified and incorporated into the Adverse Event Stroke Score Calcula-
tor. The calculator, which will be available at www.vistacollaboration.org,
calculates the expected incidence of AEs or groups of AEs per 1000-
patients in a trial cohort and where possible compares these proportions
to the observed incidence (Fig. 1).
Conclusions: The Adverse Event Stroke Score Calculator is an open access
resource to support recruitment and safety interpretation in acute stroke
trials. Prediction of AEs with higher likelihood of occurrence may facili-
tate implementation of preventive clinical measures.
Fig. 1 Results window, comparing the expected and observed incidences
of cardiovascular AEs from a mock dataset. Red bars denote a significant
difference (p < 0.05).
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Background: Appropriate patient selection for endovascular revascular-
ization treatment (ERT) in acute ischemic stroke is important for a good
benefit-risk ratio. Given that recanalization is a major determinant of
good functional outcome, we aimed to identify independent predictors
for recanalization after ERT.
Methods: We did a retrospective analysis of consecutive stroke patients
with distal ICA-, proximal MCA- or T-occlusion who were treated with
ERT from 2006 to 2012. We assessed admission noncontrast CT and CT
angiography for thrombus location, thrombus load (clot burden score,
CBS) and collateral status. Clinical data were extracted from medical
charts. Univariate and multivariate regression analyses were performed to
identify predictors of recanalization (TICI ≥ 2b) after ERT.
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Results: 171 patients were identified (70.9 ± 12.3 years, 103 females). 34
(20%) underwent intravenous thrombolysis before ERT. 50 (29%) had
intraarterial thrombolysis, 54 (32%) mechanical thrombectomy, and 67
(39%) a combination of both; stentretrievers were used in 64 patients
(37.4%). Overall recanalization rate was 66.1% and 9.9% had symptom-
atic intracranial bleeding. In-hospital mortality was 11.7% and 40%
reached good functional outcome at discharge. Univariate analysis
revealed thrombus location, bridging intravenous thrombolysis, com-
bined endovascular approaches, good collateral status, continuous CBS
and dichotomized CBS ≥ 6 vs <6 as predictors for recanalization. In mul-
tivariate regression analysis, bridging intravenous thrombolysis prior to
ERT, and dichotomized CBS ≥ 6 vs <6 were identified as independent
predictors for recanalization.
Conclusion: Bridging intravenous thrombolysis and lower thrombus load
increased the rate of recanalization after ERT for ischemic stroke with
proximal vessel occlusions.
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Background: Outcome after endovascular revascularization treatment
(ERT) in acute ischemic stroke depends on admission NIHSS, age, degree
of recanalization, and time to reperfusion. There is still insufficient knowl-
edge about periprocedural parameters predicting clinical outcome,
however. We aimed to identify clinical and radiological predictors for
favorable outcome after ERT in acute ischemic stroke.
Methods: 171 consecutive stroke patients (70.9 ± 12.3 years, 103 female)
with distal ICA-, proximal MCA- or T-occlusion were treated with acute
ERT within 6 hours after symptom onset from 2006 to 2012. We retro-
spectively assessed clinical data, admission CT and periprocedural param-
eters. We performed univariate and multivariate logistic regression
analyses to predict favorable outcome (mRS ≤ 2) at discharge from
hospital.
Results: ERT consisted in intraarterial thrombolysis (29%), mechanical
thrombectomy (32%) or a combination of both (39%). 64 patients
(37.4%) were treated with stent retrievers and 34 (20%) received intrave-
nous thrombolysis before ERT. Overall recanalization rate (TIMI 2b/3)
was 66.1%. 40% reached good functional outcome at discharge. 9.9% had
symptomatic intracranial bleeding, 11.7% died. Univariate analysis iden-
tified atherosclerotic stroke mechanism, recanalization as positive predic-
tors and more proximal vessel occlusion, increasing passes of
thrombectomy, longer time to treatment, longer intervention time and
higher admission NIHSS as negative predictors for favorable outcome. In
multivariate analysis lower admission NIHSS, shorter onset-to-treatment
time, less device passes, recanalization, and atherosclerotic etiology were
associated with better outcome.
Conclusion: Lower number of passes during thrombectomy is an inde-
pendent predictor for favorable outcome after ERT. Patients requiring
multiple passes and long intervention times may benefit less from this
procedure.
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Introduction: Nitrate-induced headache is common and may signify
vaso-responsive cerebral vasculature. Stroke recurrence was reduced in
patients with dipyridamole headache in the PRoFESS mega-trial. We
assessed the relationship between glyceryl trinitrate (GTN), headache and
outcome in acute stroke.
Methods: ENOS randomized 4011 patients with acute stroke to receive
GTN or control for 7 days. Headache was assessed at day 7, and functional
outcome at day 90. Data are number (%); odds ratio (OR), hazard ratio
(HR) or mean difference (MD); and 95% confidence intervals.
Results: Headache was more common by day 7 in patients randomized to
GTN (360/1996, 18.0%) compared to control (170/2004, 8.5%)
(p < 0.001). Nitrate headache was associated with: younger age, female,
higher diastolic blood pressure, non-TACS diagnosis, absence of dyspha-
sia, and less neurological impairment (p < 0.05). In adjusted analyses,
patients with a GTN headache were less likely to die or deteriorate by day
7 (OR 0.45, 95% CI 0.25–0.82, p = 0.009), die in hospital (OR 0.44, 0.22–
0.88, p = 0.02), or be dead at day 90 (HR 0.64, 0.40–1.02, p = 0.062); had
better scores on the Barthel Index (MD 14.0, 10.2 to 17.7, p = 0.025), mini
mental state examination (p=0.002), Telephone Interview of Cognitive
Status (p = 0.003), and category fluency (animal naming, p = 0.007); no
differences were seen for the modified Rankin Scale or stroke recurrence.
Discussion: Nitrate-induced headache is associated with reduced death or
deterioration, disability and cognitive impairment at day 90.
Abstracts
© 2015 The Authors.
International Journal of Stroke © 2015 World Stroke Organization Vol 10 (Suppl. 2); April 2015; 77–43878
ESOC-0954
01. Clinical Trial Results – Acute Management
Effects of blood pressure and blood pressure lowering
treatment within 24 hours in the third International
Stroke Trial of thrombolytic treatment for acute
ischemic stroke
E Berge1, G Cohen2, R Lindley3, P Sandercock2, J M Wardlaw2,
E C Sandset4, W Whiteley2
1Department of Internal Medicine, Oslo University Hospital,
Oslo, Norway
2Centre for Clinical Brain Sciences, University of Edinburgh,
Edinburgh, United Kingdom
3Discipline of Medicine, University of Sydney and George
Institute for Global Health, Sydney, Australia
4Department of Neurology, Oslo University Hospital, Oslo,
Norway
Background: A high blood pressure (BP) is a common reason for with-
holding thrombolytic treatment. We have studied the impact of BP and BP
lowering treatment in patients included in the Third International Stroke
Trial (IST-3).
Methods: IST-3 randomized 3.035 patients with ischemic stroke to
thrombolytic treatment or control. BP was measured at randomization,
before start, and at 30 minutes, 1 hour and 24 hours after start of treat-
ment, and use of BP lowering treatment during the first 24 hours was
recorded. We characterized BP by mean systolic BP at baseline, systolic BP
variability, and change in systolic BP from baseline to 24 hours.
Results: Higher baseline BP and higher BP variability were associated with
higher numbers of early adverse events, early deaths, and poor functional
outcome at 6 months. A larger fall in BP, and use of BP lowering treatment
were both associated with lower numbers of early adverse events (except
early recurrent ischemic stroke), and with a significantly reduced risk of
poor outcome (p = 0.002 and 0.006, respectively), irrespective of whether
or not the patient received thrombolytic treatment.
Conclusions: Higher baseline BP and higher BP variability seem to be
associated with a poorer prognosis, whereas a larger fall in BP and use of
BP lowering treatment seem to be associated with a better prognosis.
Agents that lower BP or reduce BP variability should be tested further to
determine whether current guidelines for treatment of BP in the hyper-
acute phase of ischemic stroke are too conservative.
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Introduction: Outcome after stroke in older patients is often poor. We
investigated the effect of intra-arterial treatment (IAT) in older patients in
the MR CLEAN study, a randomized controlled trial of IAT versus no IAT
in patients with acute ischemic stroke and a confirmed intracranial occlu-
sion who could be treated within 6 hours from onset of symptoms.
Methods: We compared the effect of treatment in patients aged 80 years or
over versus less than 80 years. We used multivariable ordinal logistic
regression to assess treatment effect and the interaction between age and
treatment. All estimates were adjusted for prespecified prognostic factors;
stroke severity at baseline, time onset symptoms to randomization, dia-
betes mellitus, previous stroke, atrial fibrillation and ICA-T occlusion.
Results: We included 500 patients of which 81 (16%) were 80 years or
older. These patients more often suffered from atrial fibrillation, hyper-
tension and myocardial infarction. The overall treatment effect was sig-
nificant in patients under 80 years (acOR 1.67, 95% CI: 1.78 to 2.36) and
in patients 80 years or over (acOR 3.27, 95% CI: 1.24 to 8.67). We found
no interaction of age with treatment (p = 0.87). The absolute increase in
chance of good outcome (mRS 0–2) ranged from 21% at 20 to 7% at 90
years of age.
Conclusion: Advanced age is not a contra-indication for intra-arterial
treatment, although the absolute treatment effects and chances of good
functional outcome decrease with increasing age.
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Background and Purpose: Minor stroke and TIA with an intracranial
occlusion are associated with neurological deterioration and disability.
Tenecteplase (TNK-tPA) compared to alteplase is easier to administer, has
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a longer half-life, higher fibrin specificity, possibly a lower rate of intrac-
ranial hemorrhage and may be an ideal thrombolytic agent in this
population.
Methods: TEMPO-1 was a multi-center, prospective, uncontrolled, TNK-
tPA dose-escalation, safety and feasibility trial. Patients with an NIHSS ≤ 5
within 12h of symptom onset, intracranial arterial occlusion on CTA and
absence of well-evolved infarction were eligible. Fifty patients were
enrolled; 25 patients at a dose of 0.1 mg/kg, and 25 patients at 0.25 mg/kg.
Primary outcome was the rate of drug related serious adverse events.
Secondary outcomes included recanalization and 90-day neurological
outcome (mRS 0–1).
Results: Median baseline NIHSS was 2.5 (IQR 1) and median age was 71
years (IQR: 22). There were no drug related serious adverse events in tier
1. In tier 2 there was 1 symptomatic ICH (4%, 95% CI: 0.01–20.0). Stroke
progression occurred in 6% of cases. Overall, 66% had excellent func-
tional outcome (mRS 0–1) at 90-days. Recanalization rates were high;
0.1 mg/Kg (39% complete, 17% partial), 0.25 mg/Kg (52% complete, 9%
partial). Complete recanalization was significantly related to excellent
functional outcome (mRS 0–1) at 90-days (RR 1.65: CI95 1.09–2.5,
p = 0.026).
Conclusion: Administration of TNK-tPA in minor stroke with intracra-
nial occlusion is both feasible and safe. A larger randomized controlled
trial is needed to prove that this treatment is efficacious.
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Introduction: Prophylactic carotid endarterectomy (CEA) in patients with
carotid stenosis can prevent long-term stroke. Indication for operation is
currently clinical judgment based on severity of stenosis. The benefit of
the operation could be increased if one could identify high-risk plaque
prior to surgery. Plaque ulceration might be one feature identified on
routine non-invasive imaging. We assessed the association between recent
symptoms and features of high-risk plaque by post-operative histology.
Methods: This is a prospective observational study over a one-year period
in a central London joint neurovascular HASU. Patients with carotid
stenosis were reviewed at a neurovascular MDT and where referred for
CEA. All plaques underwent routine AHA grading including histological
analysis for: calcification, lipid core, thrombus, intra-plaque hemorrhage
and thin fibrous cap ulceration.
Results: 85 patients had histology available for analysis. Average age was
74 years; 73 had recent symptoms and 12 asymptomatic carotid stenosis.
Preoperative imaging included 82 duplex, 64 CTA and 21 MRA. Average
stenosis was 71% (s.d. 14.1), 37 patients had moderate stenosis of
50–70%. Only one patient had a moderate risk plaque (AHA grade IV), 26
(30%) had very high-risk plaques (grade VI) the remainder all being high
risk (grade V). The distribution was similar in symptomatic severe steno-
sis, symptomatic moderate stenosis and asymptomatic stenosis. Ulcer-
ation was more common in symptomatic patients (43% v 8% P = 0.02).
Conclusion: Patients with symptomatic carotid stenosis are more likely to
have plaque ulceration. Current selection criteria for CEA did not identify
those patients more likely to have a high-risk plaque.
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Design: An open-labeled, single-blinded, randomized controlled study.
Subjects: 136 patients with confirmed aSAH.
Objectives: Determination of the effects of SC IL-1Ra.
Methods: Patients were randomized to IL-1Ra or control. 100 mg SC
IL-1Ra in treatment group was first administered within 72 hours of
confirmed ictus and then twice daily for up to 21 days (or discharge).
Plasma inflammatory markers were measured in both groups at baseline,
between day 3–8, 14 and 21 post ictus. Safety was checked at day 30 and
Glasgow Outcome score measured at 6 months. Outcomes were area
under curve (AuC) for plasma IL-6 (primary) and other inflammatory
markers from day 3 to day 8 and clinical outcome.
Results: 123 patients (mean age 52 yrs, 27 male) provided sufficient data
for primary analysis. Median IL-6 at baseline was 7.6 pg/ml and
10.0 pg/ml in controls and treated respectively. By Day 3 corresponding
figures were 8.6 pg/ml and 4.7 pg/ml, dropping to 6.8 pg/ml and
2.8 pg/ml by Day 8. IL-6 AuC was significantly lower in the treated group
(p < 0.0001). Results for secondary outcomes will also be presented.
Conclusions: These are preliminary results. If confirmed, this clinical trial
will provide the anticipated proof of efficacy for the use of SC IL-1Ra to
dampen IL-1 mediated inflammation following SAH. It will inform a
phase III trial of SC IL-1Ra in patients with SAH.
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Introduction: Induced hypertension is often used to treat delayed cerebral
ischemia (DCI) after aneurysmal subarachnoid hemorrhage (aSAH), but
evidence on effectiveness is lacking.
Aim: To investigate the effect of induced hypertension in treatment of
DCI on cerebral perfusion as initial stage in a phase III randomized
clinical trial.
Methods: Patients with an aSAH and occluded aneurysm who developed
clinical signs of DCI were randomized to either induced hypertension or
no induced hypertension. Hypertension was induced with noradrenaline.
Cerebral perfusion was assessed with CT-perfusion as CBF (ml/100 g/s) in
predefined regions on two time points: 1) at time of clinical deterioration
and 2) 24–36 hours after randomization. Mean arterial blood pressure
(MAP) was measured continuously in the hypertension-group and at least
every four hours in the no hypertension-group. CBF was assessed by
observers who were blinded for treatment allocation. Change in CBF was
compared between groups using the Mann-Whitney U test. Informed
consent was asked after admission; randomization was done at time of
clinical deterioration.
Results: The average MAP was 111 (SD 6.73) in the hypertension-group
(n = 12) and 100 (SD 6.28) in the no hypertension-group (n = 12,
P < 0.001). Delta median CBF was -2.01 ml/100 g/s (IQR −11.40 to 19.55)
in the hypertension-group and −4.78 ml/100 g/s (IQR −25.32 to 12.45) in
the no hypertension-group, P = 0.67.
Conclusions: Induced hypertension does not improve CBF as measured
by CT-perfusion. Given the size of change in CBF in both groups, it is
unlikely that a larger number of patients will result in clinically relevant
differences in CBF.
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Background: The superiority of the newer generation of endovascular
devices over previous devices is well established. However it is important
to update evaluations of the technical efficacy of these devices including
quality of recanalization and the number and nature of complications
from the procedure. The current study provides a detailed analysis of the
catheter angiographic outcomes using the Solitaire revascularization
device within the endovascular arm of a multicenter, international, ran-
domized trial.
Methods: The SWIFT PRIME trial is an RCT comparing IVtPA versus
IVtPA + endovascular treatment using the Solitaire FR or Solitaire 2
devices. The trial was put on hold after enrollment of 196 patients over 39
sites by the DSMB. Use of suction either through a balloon guide catheter
or through a distal access catheter in conjunction with the Solitaire device
was recommended. All angiographic images were centrally adjudicated by
a core lab regarding quality of reperfusion (TICI scale), quality of reca-
nalization (AOL scale), and presence of angiographic complications. The
number and size of device deployments was documented. Presence of
intracranial hemorrhage subsequent to the procedure was documented
and whether this was likely due to a complication from the angiographic
procedure was centrally adjudicated by two experts.
Results: Shall be presented at the meeting.
Conclusion: The findings will provide insight into the technical success
and complication rate of Solitaire FR device for endovascular treatment of
stroke in multiple centers in the United States and Europe.
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Background: The importance of speed of treatment of ischemic stroke
‘time is brain’) is well known. Previous data from published RCTs further
suggest the importance of time efficiency of recanalization of the occluded
vessel. Based on the inclusion criteria of the ESCAPE trial, CT to first
reperfusion time has to be possible within 90 minutes. The current study
provides a detailed analysis of time/reperfusion outcome relationship and
workflow within the endovascular arm of the trial.
Methods: The ESCAPE trial is a PROBE design, randomized controlled
trial which was stopped at an interim analysis by the DSMB for efficacy. At
the time of the trial being stopped a total of 315 patients were enrolled.
Patients were randomized 1:1 to standard of care versus standard of
care + fast endovascular recanalization using modern devices such as
stentrievers.
The data will be analyzed for the following work flow time processes:
Onset to ESCAPE treating hospital; door to CT; CT to randomization,
randomization to groin puncture, groin puncture to first reperfusion and
first reperfusion to final reperfusion. 3. Major causes of treatment delay
and proportions of endovascular arm subjects meeting the various work-
flow time processes set out in the trial will be determined.
Results: To be presented at the meeting.
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Background: Early blood pressure lowering treatment seems to be benefi-
cial in patients with acute intracerebral hemorrhage, and possibly in isch-
emic stroke. We used a new method for analysis of vascular events in the
Scandinavian Candesartan Acute Stroke Trial (SCAST).
Methods: SCAST was a randomized- and placebo-controlled trial of can-
desartan within 30 hours of ischemic or hemorrhagic stroke. Of 2029
included, 231 patients (11.4%) had a vascular event (stroke, myocardial
infarction, or vascular death) during the first 6 months. The modified
Rankin Scale (mRS) score at six months was used to categorize vascular
events in order of severity: “no event” (n = 1798), “minor” (mRS 0–2,
n = 53), “moderate” (mRS 3–4, n = 46) and “major event” (mRS 5–6,
n = 132). We used ordinal logistic regression for analysis.
Results: Candesartan had no effect on vascular events (adjusted common
OR 0.94, 95% CI 0.62–1.43, p = 0.77), which is comparable to the result
from the primary analysis using conventional Cox regression (HR 1.09,
0.84–1.41, p = 0.52). The results in subgroups were also comparable to
those in the primary analysis, i.e. the effects were the same in ischemic and
hemorrhagic stroke, and the effect of treatment within 6 hours was not
significantly better than at other time intervals (p-value for interaction
0.15, Fig. 1).
Conclusion: The result of ordinal analysis was comparable to that of the
conventional analysis, that there was no effect of candesartan on vascular
events. Ordinal analysis of vascular events is possible, and can be used in
future trials.
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Endovascular Clinical Trial
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Background: Endovascular treatment of acute ischemic stroke is more
effective with faster treatment of acute stroke. The ESCAPE RCT with 22
global sites, aimed to demonstrate the benefit of endovascular treatment
compared to the current standard of care. A key differentiating feature of
this trial is a focus on fast treatment times for the endovascular arm.
Methodology: An audit and feedback intervention using teleconference
and webinar is used to improve time from CT to reperfusion through the
course of the trial. The intervention is studied using a nested prospective
cohort study within the ESCAPE RCT. The main measures for the
ESCAPE trial are CT to groin puncture (target = 60 min) and CT to first
reperfusion (target = 90 min). Using a supportive coaching approach, the
audit and feedback comprised of a webinar immediately followed by an
emailed letter. Reduction in the measures over time is assessed.
Results: There were 165 endovascular cases enrolled. Audit and feedback
was performed on 16 of the top recruiting sites, and three sites had a
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second cycle performed. Each webinar was 30 minutes in duration. The
mean attendance rate by each site at the webinar was 5.3. The CT to
puncture and CT to reperfusion time showed a linear and steady decline
over the course of the trial. Discussions during the webinar included:
pre-notification and preparing team ahead of patient’s arrival; standard
procedures; and efficient processes for after-hour.
Conclusion: By embedding an audit and feedback approach within an
RCT, improvements over time can be achieved for treatment times.
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large, phase 3 prehospital trial of paramedic delivery
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Background: Enrolling patients in the field is a promising strategy to
facilitate entry of subjects in acute stroke trials within the first hours after
onset. The enrollment yield and reasons for screen failure in prehospital
stroke trials have not been well delineated.
Method: The Field Administration of Stroke Therapy – Magnesium
(FAST-MAG) trial identified patients for enrollment using a two stage
screening process – paramedics in person followed by physician-
investigators by cellphone. Outcomes of consecutive screening calls
from paramedics to enrolling physician-investigators were prospectively
recorded.
Results: From 2005 to 2013, 4,458 phone calls were made by paramedics
to physician-investigators. A total of 1,700 (38.1%) calls resulted in enroll-
ments. Among the 2,758 patients not enrolled, 3,140 reasons for screen
failure were documented. The most common reasons for non-enrollment
were: more than 2 hours from last known well (16.6%), having a prestroke
condition causing disability (15.9%), and absence of a consent provider
(9.5%). Novel barrier to enrollment specific to the prehospital setting were
infrequent, but included: cellphone connection difficulties (3.0%), insuf-
ficient time to complete consent (1.3%), and competent patient being
hard of hearing (1.3%) or severly dysarthric (1.2%). The rate of enroll-
ment of cerebrovascular mimics was low, 3.9%.
Conclusions: In this large, multicenter prehospital trial, nearly two of
every five calls from the field to physician-investigators resulted in trial
enrollments. The most common reasons for non-enrollment were out of
window last known well time, prestroke confounding medical condition,
and absence of a consent provider.
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Pseudoaneurysms in cervical artery dissection: Results
from a multicenter randomized trial – Cervical Artery
Dissection in Stroke Study (CADISS)
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Introduction: Cervical artery dissection is a major cause of ischemic
stroke in patients aged <50. The sub-intimal or sub-adventitial tear results
in intramural hematoma with thrombus and/or pseudo-aneurysm.
Pseudoaneurysms are common, but why they occur in some patients is
unknown. There are limited data on whether they relate to future risk and
whether antiplatelets or anticoagulants are more appropriate treatments
for patients with pseudoaneurysms.
Method: Cervical Artery Dissection in Stroke Study randomized 250
patients with extracranial internal carotid artery (ICA) and vertebral
artery (VA) dissection to antiplatelets or anticoagulants, 97 patients ineli-
gible for randomization were recruited to non-randomized arm. Patients
were randomized to anti-platelets or anti-coagulants for 3 months. Neu-
roimaging was performed using standard clinical dissection protocols at
baseline, vascular imaging was performed at 3 months. All neuroimaging
was centrally reviewed by an experienced consultant neuroradiologist.
Results: Dissection was confirmed radiologically in 267(80%) (198 ran-
domized, 69 non-randomized). 23/267 (8.6%) patients had pseudoaneu-
rysms at baseline. Pseudoaneurysms were present in 13% ICA and 6% VA
dissections. 249 patients had adequate 3 month neuroimaging of whom
36 (14.5%) had pseudo-aneurysms at 3 months. At 3 months, pseudoan-
eurysms seen at baseline had resolved in 12/23 (52%), but in 25 (10%) a
new pseudoaneurysm had occurred. Initial results of CADISS are available
in Feb 2015, we will present a first analysis determining (1) Factors asso-
ciated with pseudoaneurysms and their resolution and effect of
antiplatelets/anticoagulants,(2) Recurrent stroke risk in patients with
pseudoaneurysm and effects of antiplatelets or anticoagulants.
Conclusion: Overall 20% of patients developed pseudoaneurysm at base-
line or 3 months. CADISS will provide new data on factors involved in
their development and how they relate to recurrent stroke.
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Background: High blood pressure is common in acute intracerebral hem-
orrhage (ICH) and independently associated with a poor functional
outcome. We investigated whether glyceryl trinitrate (GTN) altered func-
tional outcome in patients with acute ICH, using data from the ‘Efficacy of
Nitric Oxide in Stroke’ (ENOS) trial.
Methods: ENOS was a partial-factorial randomized patient-masked
blinded end-point trial of transdermal GTN or none given for 7 days in
4011 patients with acute stroke and systolic blood pressure ≥140 mm Hg.
Here we assessed the effect of GTN (n = 310) versus no GTN (n = 319) in
patients with ICH on functional outcome at 90 days according to the
modified Rankin scale (mRS).
Results: Blood pressure at baseline was 172/93 mm Hg and significantly
lower on day 1 in patients assigned to GTN (difference −7.5/–4.2 mm Hg;
both p ≤ 0.05). At 90 days, no difference in mRS was observed between
those receiving GTN versus no GTN (adjusted odds ratio, OR for worse
outcome with GTN 1.04, 95% confidence interval, CI 0.78–1.38;
p = 0.81). In a subgroup of 61 patients treated within 6 hours, GTN
improved functional outcome with a shift in the modified Rankin Scale
(OR 0.22, 95% CI 0.07–0.69; p = 0.0096). There were no significant dif-
ference in the rates of serious adverse events between GTN and no GTN.
Conclusions: In patients with acute intracerebral hemorrhage, treatment
with GTN lowered blood pressure but did not improve functional
outcome. Very early treatment may be beneficial but needs further assess-
ment, as will be done in the forthcoming RIGHT-2 trial.
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ASPIRATION SCREENING IN ACUTE STROKE – IS
MEASUREMENT OF OXYGEN SATURATION HELPFUL?
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Background: Dysphagia is one of the most dangerous symptoms of acute
stroke. Various screening tools have been suggested for the early detection
of this condition. In spite of conflicting results, measurement of oxygen
saturation (SpO2) during clinical swallowing assessment is still recom-
mended by different national guidelines as screening tool with a decline in
SpO2 ≥ 2% usually being regarded as marker of aspiration. This paper
assesses the sensitivity of SpO2 measurement to evaluate the aspiration
risk in acute stroke patients.
Methods: 50 acute stroke patients with moderate to severe dysphagia were
included in this study. In all patients, FEES was performed according to a
standardized protocol. Blinded to the results of FEES SpO2 was monitored
simultaneously. The amount of desaturation during/after swallows with
aspiration was compared to the amount of desaturation during/after swal-
lows without aspiration in each patient. The extent of aspiration and
cough strength were assessed qualitatively.
Results: In each subject one swallow with and one swallow without aspi-
ration was analyzed. Overall, aspiration seen in FEES was related to a
minor decline in SpO2 (mean SpO2 without aspiration = 95.54 (±2.7) %
vs. mean SpO2 with aspiration = 95.28 (±2.7) %). However, a relevant
desaturation ≥2% occurred only in 5 patients during/after aspiration.
There was no correlation between the extent of aspiration or cough
strength and SpO2-levels.
Conclusions: According to this study SpO2-measurement is not a suitable
screening tool to detect aspiration in stroke patients.
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Repeated measures analysis of modified Rankin Scale
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A common method for analysis of modified Rankin Scale (mRS) score at
90 days is to dichotomize it to good vs bad outcome that yields clinically
meaningful summary statistics, relative risks or odds ratios (ORs), but
dichotomization can be inefficient. Other approaches use the full ordinal
scale, such as the shift analysis or proportional odds model (POM). Gen-
erally, these approaches have more power to detect treatment differences,
if they exist. The POM yields a common OR, provided the proportionality
in the odds assumption is met. Also, in addition to 90 days, most trials
assess mRS at discharge and/or 30 days, and in some trials, at periodic
intervals through 12 months. This makes mRS amenable to repeated
measures analysis which may yield even more power to test the treatment
effect. To illustrate, we re-analyzed the ordinal mRS data from NINDS
rt-PA Stroke Study and the NIHSS≥20 subgroup of Interventional Man-
agement of Stroke III Trial. Results from repeated measures analyses and,
as a comparison, single measure analyses, all adjusted for baseline NIHSS
and symptom onset to randomization time, are provided below. Appro-
priate assumptions for the repeated measures analysis will be detailed.
Repeated measures
analysis
Single measure
analysis
OR (95% CI) p-value OR (95% CI) p-value
NINDS t-PA
(3 months)
1.53 (1.18, 1.98) 0.0013 1.43 (1.09, 1.91) 0.0130
NINDS t-PA
(12 months)
1.45 (1.26, 1.88) 0.0041 1.42 (1.06, 1.90) 0.0194
IMS-III
(3 months)
1.57 (0.95, 2.60) 0.0775 1.64 (0.97, 2.77) 0.0661
IMS-III
(12 months)
1.65 (1.00, 2.74) 0.0522 1.67 (0.97, 2.86) 0.0649
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Background: High blood pressure is common in acute ischemic stroke
and associated with a poor outcome. Transdermal glyceryl trinitrate
(GTN), a nitric oxide donor, is a candidate treatment for acute stroke,
especially if given within 6 hours.
Methods: Patients randomized into the large Efficacy of Nitric Oxide in
Stroke (ENOS) trial were included in this subgroup analysis if they had an
ischemic stroke and neuroimaging at both baseline and day 7. Analysis
assessed the effect of GTN on day 7 imaging parameters and on the
modified Rankin Scale (mRS) in subgroups defined by baseline imaging
criteria.
Results: Of 4,011 patients recruited into ENOS, 3,342 had an acute isch-
emic stroke and 837 (GTN 412, no GTN 425) of these had both a baseline
and day 7 scan performed. GTN did not alter outcome and did not affect
neuroimaging parameters at day 7 when adjusted for baseline results. In
pre-specified subgroups, interactions were present between markers of
early ischemic change on baseline scan (hyperdense artery, loss of gray-
white matter, mass effect) and treatment group, suggesting improved
functional outcome with GTN in these patients. In patients randomized
within 6 hours of stroke onset, GTN was associated with less loss of
gray/white matter differentiation (36.7% vs 55.6%, odds ratio 0.20, 95%
confidence intervals 0.04, 0.89) and less periventricular lucencies at 7 days.
Conclusions: Although GTN did not alter imaging outcomes in ENOS,
treatment was associated with less loss of gray/white matter differentia-
tion in patients randomized within 6 hours. This result needs further
prospective assessment.
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Background: The Efficacy of Nitric Oxide in Stroke (ENOS) trial found
no beneficial effect of blood pressure (BP) lowering with transdermal
glyceryl trinitrate (GTN). We aimed to investigate whether early change in
BP after stroke is associated with fewer early adverse events (neurological
deterioration or recurrent stroke) within 7 days and improved functional
outcome at three months.
Methods: ENOS was a multicenter randomized single-blind and
outcome-blinded trial of GTN vs. no GTN in 4,011 patients recruited
within 48 hours of an ischemic or hemorrhagic stroke and with raised
systolic BP (SBP 140–220 mmHg). We categorized patients, independent
of treatment, by change in SBP from baseline to day 1: >15% decrease,
15-5% decrease, 5% decrease to 5% increase (reference), and >5%
increase, and assessed the effect on functional outcome (ordinal regres-
sion) and early adverse events (logistic regression) adjusting for known
baseline predictors.
Results: Across all patients, both moderate (5–15%) and large (>15%)
decreases in SBP were associated with beneficial shifts in the mRS: OR
0.81 (95% CI 0.70–0.90) and OR 0.84 (95% CI 0.71–1.00) respectively. A
moderate decrease in SBP was also associated with a lower risk of early
adverse, OR 0.69 (95% CI 0.52–0.90) (Fig. 1).
Conclusion: A moderate reduction in SBP of 5–15% within the first 3 days
of stroke seems to be associated with fewer early adverse events and better
long-term functional outcome.
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Background: Dizziness is frequent in emergency care. In acute ongoing
dizziness fast differentiation between central vestibular (such as stroke)
and peripheral vestibular disease is essential for correct management.
Telemedicine has become an increasing means to bring special expertise to
rural areas. However, subtle oculomotor disturbances are difficult to
capture with existing videoconference systems but are important for this
patient group.
Aim: To assess correctness of initial telediagnosis compared to final diag-
nosis at discharge.
Methods: The Telemedical Project for integrative Stroke Care (TEMPiS) is
a TeleStroke Unit network with 2 hub and 18 spoke hospitals. Patients are
remotely examined via videoconference. On admission We prospectively
documented all consecutive patients suffering from acute ongoing dizzi-
ness from Sept–Dec 2013. Initially suspected and final etiology, initial
recommendations and retrospective correct workup were analyzed.
Results: 123 patients were included. Out of 55 with initial telemedical
classification of central etiology, 43 (78%) patients finally had a central
vestibular cause. Out of 68 with initial non-central or uncertain etiology,
17 (25%) finally had central vestibular cause. Sensitivity and specificity for
central cause were 72% (43/60) and 81% (51/63) respectively. Stroke Unit
treatment was recommended in 52 of 58 (90%) patients with stroke as
final diagnosis.
Conclusion: In patients with acute ongoing dizziness, accuracy of admis-
sion diagnosis via conventional videoconference based telemedicine con-
sultation is limited.
Development of new devices is needed to reliably identify stroke patients.
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Background: Treatment of post-stroke dysphagia is notoriously difficult
with different neurostimulation strategies having been employed with a
variable degree of success during the last years. Recently, electrical pha-
ryngeal stimulation (EPS) has been shown to improve swallowing func-
tion and in particular decrease airway aspiration in acute stroke patients.
In the present study we used EPS for the treatment of severly dysphagic
tracheotomized stroke patients.
Methods: 30 consecutive stroke patients successfully weaned from the
respirator were included in this study. All patients had severe dysphagia
making decannulation impossible. Patients were randomized (verum :
placebo = 2:1) to receive either EPS or placebo stimulation on three con-
secutive days. Primary endpoint was improvement of swallowing function
enabling decannulation which was assessed by a previously established
fiberoptic endoscopic evaluation of swallowing (FEES)-based algorithm.
Patients having received sham stimulation were offered EPS during
unblinded follow-up if required.
Results: Both groups were well matched for age, stroke severity and stroke
location. Decannulation after study intervention was possible in 75% of
patients of the treatment group and in 20% of patients of the sham group
(p < 0.01). During follow-up 7 still dysphagic patients of the shame group
received unblinded EPS, whereupon in 5 of them (71%) the tracheal tube
could be removed. No adverse events occurred.
Conclusion: EPS can safely be applied to tracheotomized stroke patients.
EPS enhances remission of dysphagia thereby enabling decannulation in
the majority of patients.
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Introduction: Little is known about malignant middle cerebral artery
infarctions (MMI) after intra-arterial treatment (IAT) for ischemic stroke.
A possible explanation for the development of MMI could be the devel-
opment of hyperperfusion syndrome after recanalization following IAT.
We aimed to determine the relation between clinical and radiological
predictors and occurrence of MMI among patients included in the MR
CLEAN study, a randomized controlled trial of IAT versus no IAT in
patients with ischemic stroke.
Methods: All 500 trial patients were included in the analysis. In this sub-
study, primary outcome was occurrence of MMI. Clinical and radiological
variables with a possible association with MMI in univariable analyses
(p < 0.1) were included in multivariable logistic regression analyses to
assess a possible independent association with MMI.
Results: Of 500 patients included in the trial, 65 (13%) had MMI. 51%
(33/65) of the MMI group was allocated to IAT versus 46.0% (200/435) in
the non-MMI group (p = 0.47). In our model, independent predictors of
MMI were age (OR 0.97, 95% CI 0.95–0.99), baseline NIHSS (OR 1.07,
95% CI 1.02–1.13) and ASPECT score 5–10 (0.24, 95% CI 0.10–0.56).
IAT was not associated with a higher risk of MMI (OR 1.37, 95% CI
0.79–2.40).
Conclusion: In the MR CLEAN population independent risk factors for
the occurrence of MMI are severe neurological deficit, low ASPECT score
(0–4) and younger age. Despite our results, IAT should not be withheld in
patients with these risk factors. We will further study these findings and
their implications.
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Background: Animal studies suggest that cooling to temperatures of 35°C
or below improves outcome after ischemic stroke. We assessed the feasi-
bility and safety of surface cooling for 24 hours in awake patients with
acute ischemic stroke.
Methods: This is an international, randomized, open, multi-center, phase
II clinical trial, comparing standard treatment with surface cooling to
35.0, 34.5, or 34.0°C in patients with acute ischemic stroke and a score on
the NIHSS ≥ 6, admitted to a stroke unit. Cooling was started within 4.5
hours after symptom onset and maintained for 24 hours. The primary
outcome was feasibility, defined as successfully having completed the
assigned treatment strategy. Secondary outcomes included safety and
functional outcome (as measured with the modified Rankin scale) at three
months.
Results: 22 patients were included (mean age 63 years; 19 men; median
NIHSS, 13 (IQR, 9). Three of 5 patients randomized to cooling to 35.0°C;
3 of 6 patients randomized to 34.5°C; and none of 5 patients randomized
to 34.0°C successfully completed the assigned treatment (p = 0.11). Pneu-
monia occurred in 8 of 16 cooled patients and in none of 6 controls
(absolute risk increase, 50%; 95% CI, 5–72%).There was no difference in
functional outcome between treatment groups.
Conclusion: In awake patients with acute ischemic stroke, surface cooling
to 35.0°C appears feasible in the majority patients, and cooling to 34.0°C
not. Cooling is associated with an increased risk of pneumonia.
Registered as NTR2616 and supported by the Netherlands Heart Foun-
dation (2010B239)
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Background: In a recent large RCT (PASS), preventive ceftriaxone reduced
infection rate but did not improve functional outcome in 2550 acute
stroke patients. In this sub-study, we investigate differences between phy-
sician vs. expert panel diagnosis, risk factors, and associations with
outcome of post-stroke infections.
Methods: In PASS, post-stroke infection was diagnosed by treating phy-
sician or expert panel, strictly adhering to CDC-criteria. We use multi-
variate analysis to investigate associations of baseline characteristics with
infections and regression analysis to evaluate the effect on outcome.
Results: Infections were diagnosed in 348 of 2538 patients (14%) by phy-
sicians and 129 (5%) by the panel; urinary tract infection (UTI) (7%
physician, 3% panel) and pneumonia (6% physician, 2% panel) were most
common. Advanced age (odds ratio (OR)1.03, 1.01–1.06), severe stroke
(OR1.08, 1.04–1.16) obstructive-pulmonary-disease (OR2.21, 1.26–3.91),
prior medication beta-blocker (OR1.60, 1.08–2.37) and dysphagia
(OR4.10, 2.55–6.58) were associated with clinical diagnosis of pneumo-
nia; age and dysphagia with expert panel diagnosis (OR1.04, 1.00–1.08
and 4.54, 1.99–10.37 respectively). Advanced age (OR1.03, 1.01–1.05),
male sex (OR0.38, 0.27–0.55), hypercholesterolemia (OR0.18, 95%CI
0.05–0.69), stroke severity (OR1.04; 1.02–1.07), bladder catheter (OR3.49,
95%CI 2.38–5.13) and IVT (OR0.54, 0.35–0.82) were associated with
clinical diagnosis of UTI; bladder catheter (OR6.56, 3.80–11.31) with
expert panel diagnosis. Both pneumonia and UTI were independently
associated with unfavorable outcome (OR9.62, 5.08–18.52 and 1.87, 1.24–
2.79, for physician diagnosis; OR6.17, 2.27–16.67, and 3.56, 1.81–6.99 for
expert panel diagnosis).
Conclusions: Definitions of post-stroke infections by physicians and
CDC-criteria differ substantially. Both pneumonia and UTI are strongly
associated with unfavorable outcome.
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Introduction: Hemorrhagic transformation (HT) is usually taken into
account when symptomatic. The aim of our study was to evaluate the link
between all-type hemorrhagic transformation after thrombolysis for isch-
emic stroke and functional outcome at 3 months.
Methods: Our study was performed prospectively between June 2012 and
June 2013 in our stroke unit of Tours. All patients treated with intravenous
thrombolysis were consecutively included. HT were classified according to
ECASS on susceptibility weighted imaging (SWI) on a 3 tesla MRI at 7 ± 3
days after thrombolysis. We evaluated functional outcome at three months
using the modified Rankin scale (mRS). Dependency was defined by
mRS< or = 3.
Results: Over one year 127 patients have received thrombolysis therapy
for ischemic stroke. Among them 91 had a 3T MRI with SWI at 7 days.
Fifty of them had HT (of which 8 were symptomatic). At 3 months, 68%
of those patients were dependant versus 31% of patient without HT
(p = 0.001), OR= 4.6 (1.9–11.4)).
Discussion: All-type HT is significantly associated with dependency at 3
months. The impact of symptomatic HT is well known, but the literature
is very poor on all-type HT. Its innocuity is not so sure and rare studies
have already enlightened the increase risk of dependency. Using 3T MRI
with SWI allow us to increase detection of small hemorrhage, still the
results are significant.
Conclusion: The presence of HT after thrombolysis should be considered,
even when it is not associated with significant neurological deterioration.
It could have an impact on long-term functional outcome.
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Safety of stereotactic intracranial injection of modified
bone marrow-derived mesenchymal stem cells (SB623)
in chronic stroke patients: A Phase 1/2A study
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Background: Currently, there are no clinically effective therapies for
chronic stroke, which is a significant cause of disability.
Methods: We evaluated safety after 12 months of modified bone marrow-
derived mesenchymal stem cells (SB623) transplanted via stereotactic
intracranial injection into patients with stable chronic stroke (6–60
months post-stroke) during a two-year, phase 1/2A, open label, study
(NCT01287936) (N = 18). The study was approved by an institutional
review board, and patients provided written informed consent.
Results: Treatment emergent adverse events (TEAEs) were experienced by
all 17 patients in the safety population. There were no dose-limiting
toxicities or deaths, and no patients withdrew from the study due to
adverse events. The most frequent TEAEs were procedural headache
(88.2%), constipation (23.5%), depression (23.5%), nausea (23.5%),
vomiting (17.6%), and fatigue (17.6%). The intensity of most TEAEs was
mild (17.6%) or moderate (47.1%). No TEAEs were probably or definitely
related to the study treatment. TEAEs definitely related to surgical proce-
dure and possibly related to study treatment were experienced by 42.2%
and 17.6% of patients, respectively. After 12 months there were no signifi-
cant changes or trends in patients’ biochemistry or hematology param-
eters, vital signs, lipids, or cytokines (TNF-α, IL-6, and INF-γ). At
screening, serum antibodies to HLA antigen on donor SB623 cells were
detected in a single patient, however this was not associated with TEAEs.
In addition, SB623 specific antibodies did not develop in patients after
transplantation.
Conclusions: The intracranial injection of SB623 cells in chronic stroke
patients was generally safe and well tolerated after 12 months.
ESOC-0099
02. Clinical Trial Results – Rehabilitation and Recovery
Time spent in physiotherapy sessions during sub-acute
rehabilitation does not predict recovery of walking
ability
C English1, J Bernhardt2, M Crotty3, A Esterman4, S Hillier5
1International Centre for Allied Health Evidence, University of
South Australia, Adelaide, Australia
2Stroke Division, Florey Institute of Neuroscience and Mental
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The Phase 3, randomized controlled CIRCIT trial (n = 283) was predi-
cated on the belief that more therapy time would lead to improved func-
tional recovery and investigated the effectiveness of two alternative
models of augmented physiotherapy (7-day week therapy and group
circuit class therapy) compared to usual care for stroke survivors in
hospital-based rehabilitation. Participants receiving 7-day week and
circuit class therapy received an additional 3 hours, and 22 hours of
physiotherapy time, respectively, compared with usual care. Here we
investigate the contribution of therapy time to improvements on the
primary outcome measure (6 minute walk test [6mWT]). Using linear
regression we found that therapy time alone did not influence 6mWT
change scores (ß = 0.059, p = 0.351). Adding the covariates of age,
admission functional independence measure (FIM) score, Charlson
co-morbidity index and time since stroke increased the predictive value of
the model, but still explained only 12% of the variance in 6mWT change.
Age, FIM score and time since stroke (but not co-morbidities) were all
significant factors within the model, but therapy time remained non-
significant. These results are surprising given the evidence that more
therapy is better. Our previous work suggests that time in physiotherapy
sessions is a poor proxy measure of therapy ‘dose’ as stroke survivors are
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inactive for large proportions of therapy sessions. Alternative metrics for
therapy are required and should include measures of factors known to
promote motor learning, including level of effort, grading of task com-
plexity and amount of practice
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Motorized multidirectional protuberance device for
sitting balance of stroke patients
F Kashoo1, R Baradie2
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Background and Purpose: Trunk control is essential for the efficient and
effective performance of all goal-directed activities while sitting. We tested
the effect of the use of a Multidirectional protuberance chair in addition
to physical therapy in training stroke patients with impaired sitting
balance compared with effect in patients receiving conventional physical
therapy only.
Methods: The study was conducted in King Khalid Hospital from October
2012 to June 2013.The protuberance group consisted of 24 patients who
received protuberance training in addition to conventional physical
therapy. During the 3 weeks training program, the chair generated pro-
tuberance in random directions, intensity of protuberance was adjusted as
per severity of impairment and improvement was documented on various
balance scales and ability to retain balance against time.
Results:
Table 1 Demographic results of protuberance and control groups
Characteristic Protuberance group Control group P
Mean ± SE age, y 58.17 ± 1.80 62.31 ± 3.09 .506
Mean ± SE duration
of disease, wk
11.37 ± 2.06 12.85 ± 3.51 .753
Sex, women/men 10/14 9/4 .884
Side of involvement 11 L, 9 R, 1 bilateral 5 L, 7 R, 1 bilateral .832
Type of stroke 17 thromb,
9 hemorrhagic
6 thromb,
7 hemorrhagic
.745
Table 2 Mean ± SE length of time patients could retain sitting
balance
Time, s
Initial After 3 weeks Discharge
Protuberance group 65.67 ± 10.46 265.04 ± 9.32 293.71 ± 5.12
Control group 68.69 ± 16.83 187.08 ± 15.99 272 ± 17.40
P* .909 <.001 .201
*Differences between protuberance and control groups.
Conclusions: Protuberance-based balance training provides earlier pos-
tural trunk control, is a useful addition to conventional physical therapy in
the rehabilitation of stroke patients with impaired sitting balance.
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Comparing the immediate effect of auditory and
visual mental imagery on reaching and grasping task
among sub-acute stroke patients
F Kashoo1, R Baradie2
1Department Of Physical Therapy and Health Rehabilitation,
Majmaah University, Riyadh, Saudi Arabia
2Department Of Laboratory Science, Majmaah University,
Riyadh, Saudi Arabia
Introduction: Upper-limb hemiparesis is one of the most debilitating
effects of stroke. We are comparing the effects of both type of mental
imagery i.e. visual and auditory on upper limb impairment among stroke.
Study intends to determine the efficacy of auditory and visual mental
imagery to increase upper limb function among sub-acute stroke patients.
Method: The study was done in Yasuda Hospital in India during 2010–
2011.A randomized, controlled, multiple baseline, pre and post test case
series design was applied. The Action Research Arm test and Motor Activ-
ity Log was administered every time before and after the procedure i.e. 2
days a week for 4 weeks.
Results:
Table 1 Quality of movement/week
QOM 1 QOM 2 QOM 3 QOM 4 QOM 1′ QOM 2′ QOM 3′ QOM 4′
p-value .091 .047 .021 .013 .111 .023 .011 .005
Table 2 Amount of use/week
AOU 1 AOU 2 AOU 3 AOU 4 AOU 1′ AOU 2′ AOU 3′ AOU 4′
p-value .399 .042 .015 .002 .259 .015 .002 .002
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Fig. 1 Quality of movement score in 4 weeks
Fig. 2 Amount of use score in 4 weeks
Discussion: The increased use and motor function changes exhibited
more by Mental practice group confirmed our hypothesis that there may
be change in task performance after visual mental imagery and auditory
mental imagery among sub-acute stroke patients, though the changes
were more in visual mental imagery group as compared to auditory
mental imagery.
Conclusion: Our study concludes that visual mental imagery appears to be
a promising rehabilitation protocol for improving affected upper limb
motor function in stroke patients as compared to auditory mental
imagery.
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Dual-mode-noninvasive brain stimulation over the
primary motor cortices in stroke patients
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Noninvasive brain stimulation (NBS) using the repetitive transcranial
magnetic stimulation (rTMS) or the transcranial direct current stimula-
tion (tDCS) were recently adopted for modulating motor function of
stroke patients. We investigated the effect of simultaneous dual-mode
stimulation using rTMS and tDCS over bilateral primary motor cortices
(M1) whether it is more effective than single stimulation using rTMS for
recovery of motor function in subacute stroke patients. Thirty-one sub-
acute stroke patients were recruited in this open-label study. In dual-mode
stimulation group, the 10 Hz rTMS (90% of resting motor threshold,
1,000 pulses) were applied over the ipsilesional M1 for 20 minutes with
simultaneous application of the cathodal tDCS (2 mA) on the contral-
esional M1 for 20 minutes. Single stimulation group underwent 10 Hz
rTMS without tDCS. Ten daily sessions were conducted for 2 weeks. The
total, upper, and lower scores of FMA were measured before, after, and 2
months after the intervention. The scores of total and upper FMA were
significantly improved over time in both dual and single stimulation
group (p < 0.05). However, there were group and time interaction effects
in total FMA (p < 0.05) and upper FMA (p = 0.056). Post-hoc study
showed that the mean changes in total and upper FMA (p < 0.05) scores
were better in the dual stimulation group than the single group after 10
sessions of stimulation. The dual-mode NBS with simultaneous applica-
tion of 10 Hz rTMS and the cathodal tDCS over the bilateral M1s was safe
and superior to 10 Hz rTMS alone for improving motor function in
subacute stroke patients.
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Effects of cerebrolysin on motor recovery in patients
with severe motor impairment after stroke
Y H Kim1, D Y Kim2, Y I Shin3, M H Ko4, W H Chang5, A H Lee5
1Physical and Rehabilitation Medicine Center for Prevention
and Rehabilitation Heart Vascular and Stroke Institute,
Samsung Medical Center Sungkyunkwan University School of
Medicine, Seoul, Korea
2Department and Research Institute of Rehabilitation
Medicine, Yonsei University College of Medicine, Seoul, Korea
3Department of Rehabilitation Medicine, Pusan National
University School of Medicine, Busan, Korea
4Department of Physical Medicine and Rehabilitation,
Research Institute of Clinical Medicine of Chonbuk National
University Biomedical Research Institute of Chonbuk National
University Hospital, Jeonbuk, Korea
5Department of Physical and Rehabilitation Medicine Center
for Prevention and Rehabilitation Heart Vascular and Stroke
Institute, Samsung Medical Center Sungkyunkwan University
School of Medicine, Seoul, Korea
The aims of this study was to evaluate whether Cerebrolysin provide
additional motor recovery of rehabilitation therapy during the subacute
phase of stroke in patients. This study was a phase IV clinical trial
designed as a multicenter, randomized, double-blind, placebo-controlled,
parallel-group study. Seventy stroke patients with the moderate to severe
motor function involvement (Fugl-Meyer assessment (FMA) ≤ 84) were
included at 7 days after stroke onset. Participants were randomly assigned
to one of two groups to receive a 21-day course of either Cerebrolysin or
placebo in addition to the regular rehabilitation therapy. Assessments for
motor function were performed at baseline, immediately after treatment,
2 and 3 months after stroke onset. The plasticity of motor system was
assessed with diffusion tensor imaging (DTI) for white matter integrity,
and with resting state functional magnetic resonance imaging (rsfMRI)
for cortical functional connectivity. None of participants showed severe
adverse effect in each group. Sixty-one patients (Cerebrolysin group: 32)
completed the follow-up process included in the analysis. Both group
demonstrated significant time effect on motor function, however, only the
patients with severe motor impairment (FMA < 50) showed a significant
interaction between time and type of intervention (p < 0.05). Effects of
the Cerebrolysin on white and gray matters were demonstrated in terms of
restricted increments of corticospinal diffusivity by DTI and recovery
of the sensorimotor connectivity by rsfMRI, respectively. Cerebrolysin
treatment demonstrated additional benefit on motor recovery and plastic
changes of CST in patients with severe motor impairment while admin-
istered with conventional rehabilitation therapy during the subacute
phase of stroke.
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Predictors of functional outcomes and quality of life
at 12 months after first-ever stroke in Korea: The
KOSCO study
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This study aimed to analyze the factors influencing the functional status
and quality of life (QOL) of stroke survivors at 12 months after onset to
provide useful information for establishing comprehensive and systematic
care for stroke. This is the interim results of the Korean Stroke Cohort for
Functioning and Rehabilitation (KOSCO) designed as 10 years long-term
follow-up study of stroke patients. The face-to-face assessments were
completed from 1,803 patients (mean age 63.8 ± 13.0, 79.2% ischemic
stroke) at discharge and at 12 months after their stroke onset. Assessments
included Korean Mini-Mental State Examination, Fugl-Meyer Assessment
(FMA), Functional Ambulatory Category (FAC), the American Speech-
Language-Hearing Association National Outcome Measurement System
Swallowing Scale, Korean Version of Frenchay Aphasia Screening Test, and
Geriatric depression scale-short form (GDS-SF). Functional indepen-
dency and quality of life were assessed by Korean modified Barthel index
(K-MBI) and Euro Quality of Life (EQ)-5D. Multiple regression analysis
revealed that age at onset, FMA score, and FAC at discharge were the
significant influencing factors on functional independence measured by
K-MBI score at 12 months. FMA score and GDS-SF at discharge were also
the significant influencing factors on QOL (EQ-5D) at 12 months. Inten-
sive rehabilitation to increase motor function at discharge seemed to be a
good strategy for improving independence and QOL of stroke patients
(Supported by Korea Centers for Disease Control and Prevention (2013E-
11001-01)).
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A feasibility study of an integrated stroke
self-management program: A cluster randomized
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Background: This study tested the feasibility of conducting a cluster ran-
domized controlled trial (RCT) into the effectiveness of a stroke self-
management program (SMP) integrated into post hospital rehabilitation.
The program consisted of a workbook combined with defined strategies
used by clinicians to facilitate self-management.
Methods: Ethics approval (11LO1450). A cluster RCT was utilized with
community stroke rehabilitation teams (CSR) as units of randomization;
both intervention and control sites comprised multiprofessional teams
delivering post hospital rehabilitation. Stroke therapists in the interven-
tion teams only were trained to use the program; impact was tested on
quality of life, mood, self-efficacy, functional capacity and economic
outcome at six weeks and three months and compared to control teams.
Results: Four CSR teams were recruited who received 317 stroke referrals
over 10 months: 138 met trial eligibility criteria and 78 participants were
recruited (24.6%). Demographic and baseline outcome measures were
similar between intervention and control arms. The SMP was feasible;
results favored the intervention clusters, with the exception of SF-12, none
were significantly different between arms. Functional capacity (NEADL)
and self-efficacy (SSEQ) showed most responsiveness to the intervention.
Conclusion: It was feasible to integrate a stroke self-management program
into post hospital community rehabilitation and train therapists to deliver
the program according to pre-determined criteria. The study was com-
pleted with minimal data lost to follow up and the design could be rep-
licated in a definitive trial to test the effectiveness and cost effectiveness of
integrated self-management support post stroke.
Funded by RfPT (NIHR). Registration: ISRCTN – 42534180.
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Pharyngeal hypesthesia in MCA-infarction is related to
overall dysphagia severity
T Marian1, J Schroeder1, P Muhle1, I Suttrup1, S Oelenberg1,
C Hamacher1, T Warnecke1, S Suntrup1, J Minnerup1, R Dziewas1
1Neurology, University Hospital Muenster Germany, Muenster,
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Background: Impairment of the conventional processing of laryngopha-
ryngeal sensory information entails to neurogenic dysphagia. Recently,
several studies indicated a bilateral processing in the primary somatosen-
sory cortex while swallowing execution. In the present study correlations
between anatomical conditions and amount of laryngopharyngeal
sensory impairment, severity of general medical condition and severity of
dysphagia in acute stroke patients have been under examination.
Methods: In this study, we included 45 acute stroke patients with infarc-
tion of the middle cerebral artery and with moderate to severe dysphagia.
In all patients, FEES was performed according to a standardized protocol
within 96 hours after stroke onsets. The laryngopharyngeal sensitivity was
evaluated by touching the tip of the endoscope to the arytenoids, the
posterior pharynx wall and the lateral pharynx walls.
Results: The amount of laryngopharyngeal hypoesthesia is not correlated
with the severity of stroke. Though, the severity of dysphagia is closely
correlated with the amount of the laryngopharyngeal hypoesthesia. There
is no strong lateralization of the sensory laryngopharyngeal deficit. Right
hemispheric strokes determine severe laryngopharyngeal sensory deficits
compared to left hemispheric strokes, pronouncing the left side, specifi-
cally the left arytenoids.
Conclusions: Overall, this study has demonstrated that the amount of
laryngopharyngeal sensory impairment depend on the severity of dyspha-
gia and is independent of the severity of stroke. In addition, our results
maintain a bilateral processing in the primary somatosensory cortex while
swallowing execution with a right hemispheric focus.
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Cerebrolysin and Recovery after Stroke (CARS):
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multicenter, phase ii clinical study
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Background and Purpose: The aim of this early neurorehabilitation trial
was to investigate whether patients randomized to Cerebrolysin showed
improved motor function of the upper extremities over 90 days in com-
parison with patients randomized to placebo.
Methods: This study was designed as a prospective, randomized, double-
blind, placebo-controlled, multicenter and parallel-group study. Patients
were treated with Cerebrolysin (30 ml/day) or placebo (saline) once daily
over 21 days starting the treatment 24–72 hours after stroke onset. In
addition, patients participated in a standardized rehabilitation program
over 21 days starting within 72 hours after stroke onset. Primary endpoint
was the action research arm test (ARAT) score on day 90. Safety assess-
ment was based on adverse events, vital signs and laboratory parameters.
Results: The nonparametric effect size on the ARAT score on Day 90
indicated a large superiority of Cerebrolysin as compared to placebo
(MW = 0.71, 95%CI 0.63–0.79). The multivariate effect size on the global
status, as assessed by twelve different outcome scales, showed a small
superiority (MW 0.60, P < 0.0001). The rate of premature discontinua-
tions was below 5% (3.8%). Cerebrolysin was safe and well tolerated.
Conclusions: Cerebrolysin had a beneficial effect on function and global
outcome in early rehabilitation patients after stroke. The safety aspects of
Cerebrolysin were comparable to placebo, thus suggesting a favorable
benefit-risk ratio. Due to the size of the study the results should be con-
firmed by a high precision, large-scale randomized clinical trial.
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Feasibility of treatment with modafinil to reduce
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Introduction: Poststroke fatigue is common and assumed to negatively
affect rehabilitation and quality of life. The aim of this study was to
investigate the feasibility of a trial when treating stroke patients with the
wakefulness promoting modafinil or placebo and to examine if modafinil
can improve rehabilitation.
Method: This trial was double-blind, randomized and placebo-
controlled. Inclusions ran from October 1 2012 to November 1 2014. The
intervention group was treated with up to 400 mg modafinil and the
control group with placebo for three months. Assessments were done after
1, 3 and 6 months. The primary endpoint was a reduction in the General
Fatigue Score on the questionnaire “Multidimensional Fatigue Inventory-
20” after three months. Inclusion criteria were stroke, written informed
consent and a General Fatigue score of 12 or more. Exclusion criteria were
drug abuse, psychiatric instability or cognitive disabilities. The study was
approved by the Ethic Committee.
Results: We screened 1121 patients. Forty-one fulfilled the in- and exclu-
sion criteria and were included: 7 had an intracerebral hemorrhage and 34
ischemic stroke. Six patients left the study before the three month follow
up. The primary endpoint was achieved in 35 patients. Four patients
stopped medication and three had reduced dosages due to adverse events.
Results from the primary endpoint and the Modified Ranking Scale will
be presented.
Discussion: This study is the first randomized and placebo-controlled trial
of modafinil treatment after stroke. Modafinil has proven effective in
multiple sclerosis and we hope to demonstrate a beneficial effect after
stroke.
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Multiple organ dysfunction syndrome in critically ill
stroke patients and early robot-assisted therapy
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E V Gnedovskaya1, L M Legostaeva1
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Introduction: Multiple organ dysfunction syndrome (MODS) increases
risk of unfavorable outcome and mortality in severe stroke.
Methods: This case-control study included 66 consecutive critically ill
patients (49 males, 17 females, median age 59.3), admitted to the Intensive
Care Unit within 7 days from onset of ischemic or hemorrhagic stroke. We
assessed mortality, MODS and specifically rate of pulmonary embolism
(PE) and acute respiratory disease (ARD) up to Day 21 and used NIHSS
and MODS II scales.
Results: Patients were equally distributed into two groups – Intervention
and Control and received standard stroke therapy vs. standard stroke
therapy plus daily robot-assisted arm and leg therapy (MOTOmed letto 2)
in Intervention group. Groups had similar stroke and MODS severity on
admission (NIHSS: Me = 20[LQ-16,UQ-29] vs. Me = 18[LQ-15,UQ-27],
p > 0.5; MODS II: Me = 2[LQ-1,UQ-4] vs. Me = 2[LQ-1,UQ-4], p > 0.5 in
Intervention and Control group, respectively).
There was no significant difference in rate of MODS and its severity (67
vs. 60%, Me = 1[LQ-1,UQ-2] vs. Me = 0[LQ-0,UQ-1] p > 0.05 in Control
and Intervention group, respectively) on Day 21. The rate of MODS
affecting three and more organ systems was 41% vs. 14% (p = 0.013) in
Control and Intervention group, respectively. Rates of PE, ARD and mor-
tality on Day 21 were significantly higher in the Control vs. Intervention
group (39% vs. 12%, p = 0.014, 88% vs. 64% p = 0.026, and 39% vs. 12%,
p = 0.014, respectively).
Conclusion: Early robot-assisted therapy in severe stroke patients was
associated with significant reduction of serious pulmonary complications
and MODS affecting three and more organ systems and mortality on Day
21.
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Neurophysiological and clinical effects of one session
radial shockwave therapy on post-stroke plantar flexor
spasticity: A single blind clinical study
H Radinmehr1, N Ansari1, S Naghdi1, G Oliaei1, A Tabatabaei1
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Background: Spasticity is a common phenomenon after upper motor
neuron syndrome such as stroke, multiple sclerosis, spinal cord injury, and
cerebral palsy. There are different physiotherapy strategies for controlling
spasticity. This study aimed to investigate the effectiveness of radial shock-
wave therapy (RSWT) on plantarflexor spasticity post stroke.
Methods: The study was a single blind clinical study with three measure-
ments: pre, immediately post and 1 hour after treatment. Twelve patients
with stroke (5 male, 7 female; mean age of 59 years) were included in the
study. All patients received one session of RSWT (2000 shots, frequency 5
Hz, and energy 60 mj). Primary outcome measures were the Hmax/Mmax
ratio and the Modified Modified Ashworth Scale (MMAS). Secondary
outcome measures were the H reflex latency, active range of motion
(AROM), passive range of motion (PROM), passive plantar flexor torque
(PPFT), and the timed up and go test (TUG).
Results: Main effect of Time on Hmax/Mmax ratio was not statistically
significant. The spasticity as evaluated by the MMAS decreased 1 score
posttreatment which persisted for 1 hour after the end of treatment. The
H-reflex latency was significantly improved post treatment(p < 0.05). A
significant main effect of Time was found for the AROM, the PROM, and
the PPFT. The TUG test was improved post treatment (p = 0.02).
Conclusion: One session RSWT may be effective in improving plantar
flexor spasticity in patients with stroke. Further rigorous investigations are
needed.
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The effect of early versus late constraint-induced
movement therapy on motor function: Results from a
randomized controlled trial with 12-month follow-up
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Objective: To compare the effect of constraint-induced movement
therapy (CIMT) applied early after stroke with delayed intervention and
to evaluate the long-term effect.
Methods: Forty-seven informed subjects with mild to moderate stroke
gave their consent to participate in this single-blinded randomized mul-
tisite trial. The participants were randomized to an early (7–28 days post
stroke) or delayed (6 months) intervention group. Both groups received 3
h/d CIMT intervention over 10 consecutive working days. The partici-
pants were tested at 5 occasions: before and after early as well as delayed
intervention and after 12 months. The primary outcome measure was
Wolf Motor Function Test (WMFT), secondary outcome measures were
Nine Hole Peg test (NHPT) and the Fugl-Meyer assessment score (FMA).
Results: Thirty-one subjects completed all five assessments. Compared to
pre-treatment, both groups improved significantly at 12 months
follow-up on WMFT. There were no significant differences between pre 6
months testing and 12 months follow-up in the early intervention group,
while the delayed intervention group reached a plateau at post 6 months
test. No significant differences were found between the groups at any time
point. FMA and NHPT showed corresponding results.
Conclusion: Despite no significant differences between the groups, the
early intervention group showed a faster recovery curve compared to
CIMT applied 6 months later. The small sample size is a limitation of this
study. More research is necessary to determine when it is best to start the
intervention.
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02. Clinical Trial Results – Rehabilitation and Recovery
Home-based reach-to-grasp training for people after
stroke: A feasibility randomized controlled trial
F van Wijck1, P Cunningham2, A Turton2, C Sackley3, C Rodgers4,
S Wolf5, S Jowett6, K Wheatley7, P van Vliet8
1Institute for Applied Health Research and School of Health
and Life Sciences, Glasgow Caledonian University, Glasgow,
United Kingdom
2Department of Allied Health Professions, University of the
West of England, Bristol, United Kingdom
3Physiotherapy, King’s College London, London, United
Kingdom
4Bristol Clinical Trials and Evaluation Unit, University of
Bristol, Bristol, United Kingdom
5Center for Rehabilitation Medicine, Emory University,
Atlanta, USA
6School of Health and Population Sciences, University of
Birmingham, Birmingham, United Kingdom
7School of Cancer Sciences, University of Birmingham,
Birmingham, United Kingdom
8Faculty of Health and Medicine, University of Newcastle,
Newcastle, Australia
Background: Arm rehabilitation after stroke is a top research priority.
Specifically, there is an urgent need for trials on task-specific training to
improve arm function for people discharged home post stroke.
Aim: To determine the feasibility of a Phase III randomized controlled
trial of home-based reach-to-grasp (RtG) training after stroke.
Methods: Design: multicenter, assessor-blinded feasibility RCT.
• Intervention group (RtG): task-specific reach-to-grasp train-
ing. Dose 56 hours: 14 therapist visits over 6-weeks plus 1 hour
self-practice per day.
• Control group (CG): usual care.
• Participants: less than 12 months post-stroke, discharged
home.
• Data collection: recruitment, adherence, treatment fidelity,
acceptability, adverse events. Outcomes: Action Research Arm
Test (ARAT, primary outcome), Wolf Motor Function Test
(WMFT), Motor Activity Log, Stroke Impact Scale. Time points:
pre-randomization and 7, 12 and 24 weeks post-randomization.
Results: 47 participants (RtG = 24, UC = 23) were recruited over 17
months, two withdrew.
94% of scheduled treatment visits were completed. RtG participants per-
formed a median of 157 repetitions per visit plus 52 repetitions of self-
practice per day. 96% participants rated training acceptable, 71% rated 1
hour of independent practice/day acceptable and 83% reported it
improved arm function. There were no serious adverse events.
The ARAT score in the RtG group improved beyond the MCID, whilst it
did not change in the CG (Table 1).
Table 1
ARAT score(0–57) RtG CG
Baseline median (IQR) 8.5 (3.0–24.0) 4 (3.0–14.0)
24 weeks median (IQR) 14.5 (3.5–26.0) 4 (3.0–30.0)
Conclusions: Findings indicate that a Phase III RCT of home-based RtG
training after stroke is warranted and feasible.
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03. Clinical Trial Results – Prevention
Risk and risk factors of perioperative myocardial
infarction after carotid endarterectomy and carotid
angioplasty and stenting: Systematic review and
meta-analysis
M B Boulanger1, L C Cameliere2, L T Trinquart3, K R Rerkasem4,
L B Berger2, P C Courthéoux5, P M R Rothwell6, E T Touzé1
1Neurology, CHU Cote de Nacre, CAEN, France
2Vascular Surgery, CHU Cote de Nacre, CAEN, France
3Centre d’Epidémiologie Clinique, Hôpital Hôtel-Dieu, PARIS,
France
4Surgery, Chiang Mai Univ, Chiang Mai, Thailand
5Neuroradiology, CHU Cote de Nacre, CAEN, France
6Stroke Prevention Research Unit, University of Oxford,
Oxford, United Kingdom
Background: Carotid Angioplasty-Stenting(CAS) is associated with
higher risk of periprocedural stroke and death compared with Endart-
erectomy(CEA). By contrast, the risk of myocardial infarction(MI) was
higher after CEA than after CAS in randomized trials. However, numbers
were small and risk factors are unknown. We aimed to estimate the 30-day
risk of MI after CAS and CEA and to determine subgroups at higher risks.
Methods: We performed a systematic review and a meta-analysis of
studies published from 01/1980 to 06/2014 and collected unpublished
data. We extracted data on 9 predefined risk factors (age, contralateral
carotid occlusion, CAD, diabetes, sex, hypertension, PVD, type stenosis
and clinical presentation).We selected studies with data in at least one
subgroup. We calculated absolute and relative risks and identified differ-
ential effects on risks of MI.
Results: The risk of MI after CEA was 0.87% (95%CI,0.69–1.07) and
0.70%(95%CI,0.54–0.88) after CAS(Pint = 0.07). Risk of MI has not
changed over time in CEA and CAS studies. After CAS, patients with
symptomatic stenosis, restenosis were at higher risk of MI whereas males
were at lower risk. After CEA, age, coronary artery disease, peripheral
artery disease, and restenosis increased the risk of MI. Only the effect of
gender differed between CAS and CEA with males being at lower risk of
MI than females after CAS whereas there was no difference between after
CEA(Pint = 0.01).
Conclusions: The risk of MI is slightly higher after CEA than after CAS.
Risk factors for MI are overall similar in both techniques except that males
are at lower risk of MI after CAS but not after CEA.
ESOC-0967
03. Clinical Trial Results – Prevention
Cilostazol prevents progression of atherosclerosis in
ischemic stroke patients with peripheral arterial
disease: A randomized, double-blind,
placebo-controlled trial
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15Neurology, Taipei Medical University, Taipei, Taiwan
Background: Patients with polyvascular atherosclerotic diseases carry a
high risk of vascular events and death. Dual antiplatelet therapy could
benefit these patients by inhibiting atherosclerotic progression. We aimed
to investigate the effect of combination therapy of cilostazol and aspirin
on subclinical atherosclerosis progression in patients with ischemic stroke
or transient ischemic attack (TIA) who had peripheral arterial disease.
Methods: We conducted an investigator-initiated, randomized, double-
blind, placebo-controlled trial at 16 centers in Taiwan. Participants aged
50 years or older who were taking aspirin (100 mg per day) after a
previous ischemic stroke or TIA, and an ankle-brachial index (ABI) <1.0
were randomly assigned to receive cilostazol 200 mg per day (n = 403) or
placebo (n = 397) for 1 year. The primary end point was changes in ABI,
and the secondary end point was changes in common carotid artery
intima-media thickness. This trial is registered with ClinicalTrials.gov
(NCT01188824).
Findings: Ankle blood pressure significantly increased in the cilostazol
group compared with the placebo group (p < 0.001), but there was no
significant difference in the increase in ABI between the two groups. The
regression in mean left, mean right, and maximum left common carotid
artery intima-media thickness was significantly greater in the cilostazol
group than in the placebo group. There were no significant differences in
vascular events, death, or major hemorrhagic events between the two
groups.
Interpretation: Compared with aspirin alone, aspirin plus cilostazol was
more effective in slowing down atherosclerotic progression, and did not
increases the incidence of hemorrhagic events in this patient population
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03. Clinical Trial Results – Prevention
Acupuncture for cerebral vasospasm after
subarachnoid hemorrhage
S Cho1, D Lee1, J Park1, C Ko1, S Park1
1Department of Cardiology and Neurology College of Korean
Medicine, Kyung Hee University, Seoul, Korea
Subarachnoid hemorrhage (SAH) is a neurological disease with a high
mortality rate. Cerebral vasospasm, one of serious complications, fre-
quently occurs after successful surgery. Nimodipine, a calcium channel
blocker, and hypovolemic-hemodilution-hypertensive (HHH) therapy
are used to prevent delayed cerebral vasospasm after SAH, but these treat-
ments are by no means completely effective.
Acupuncture is known to increase the production and activity of vascular
endothelial cell-derived NO and improve endothelium-dependent vasodi-
lation. Therefore, we conducted a preliminary case study to investigate the
ability of acupuncture to prevent the occurrence of cerebral vasospasm.We
treated 20 patients with SAH after their ruptured aneurysms had been
secured by endovascular coiling or surgical clipping. Prophylactic HHH
therapy and nimodipine were initiated immediately after surgery. Acu-
puncture treatment started within 3 days after aneurysm rupture and was
performed once a day for 2 weeks. The outcomes were compared with those
of an age and severity matched control group without acupuncture.
As a result, delayed ischemic neurological deficit (DIND) occurred in 2
patients (10%), angiographic vasospasm in 5 (25.0%) and none of the
patients died in acupuncture group. In the control group, DIND occurred
in 7 patients (38.9%), angiographic vasospasm in 10 (55.6%) and one
patients died.
The results indicate the possibility of acupuncture treatment in preventing
the occurrence of cerebral vasospasm after SAH. But, this is a preliminary
retrospective case study and rigorous clinical trials such as randomized,
double-blind trials are required. To determine the efficacy and safety of
acupuncture, a randomized, controlled clinical trial is in progress.
ESOC-1177
03. Clinical Trial Results – Prevention
Changes in determinants of health-related behavior
improvement after TIA or ischemic stroke
I Dunca1, D Brouwer-Goossensen2, L van Genugten3, H F Lingsma3,
D W J Dippel2, P J Koudstaal2, H M den Hertog1
1Neurology, Medisch Spectrum Twente, Enschede,
Netherlands
2Neurology, Erasmus University Medical Center, Rotterdam,
Netherlands
3Public Health, Erasmus University Medical Center, Rotterdam,
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Background: Health-related behavior improvement after TIA or minor
stroke may reduce stroke recurrence. We showed that self-efficacy, ie con-
fidence to carry out a certain life style behavior, and fear are important
determinants of intention to change health-related behavior after TIA or
ischemic stroke. In this study, we assessed whether these determinants
vary over time. This may provide insight into the window of opportunity
for managing health related behavior change after TIA or ischemic stroke.
Methods: We prospectively studied 100 patients with TIA or minor isch-
emic stroke. Patients were assessed at baseline, and at 3 months after their
visit to the TIA clinic or admission to the stroke unit. Fear was measured
with an 8-item scale with scores that range from 0 to 32 and higher values
indicating higher levels of fear. Self- efficacy was assessed with a 9-item
scale with scores that range from 1 to 5, with higher values indicating
more confidence to carry out the desired behavior. Changes in fear and
self-efficacy from baseline and corresponding 95% confidence intervals
(CI) were calculated.
Results: At baseline, median self-efficacy was 4 (IQR 3–4), and median
fear 16 (IQR 7–21). Fear was significantly higher at baseline than at 3
months (mean difference 2.0; 95% CI 0.08–3.9). No change in self-efficacy
was found.
Conclusion: Fear significantly decreased over time after TIA or ischemic
stroke. Patients with TIA or ischemic stroke have high self- efficacy scores
for health-related behavior change and these do not vary over time
ESOC-0037
03. Clinical Trial Results – Prevention
Relationship between the plasma level of
homocysteine and intra-/ extracranial artery stenosis
in the patients with ischemic stroke
J Jiang1, Z Hu1, Q Zeng1, Y Qi1, A Zhuang1, Y A N G Wang1
1Neurology, lianyungang City No.2 People’s Hospital,
Lianyungang, China
Objective: To study the relationship between the plasma level of homo-
cysteine and Intra-/Extracranial Artery stenosis in patients with ischemic
stroke.
Methods: The correlation between plasma homocysteine levels and cere-
bral artery stenosis in patients with ischemic stroke were analyzed by
case-control study. The laboratory results including medical history, base-
line clinical information, imaging examination and homocysteine levels of
the patients were collected. The patients were divided into either artery
stenosis group or no-stenosis group according to MRA examination.
Results: A total of 147 patients with ischemic cerebrovascular disease were
enrolled during the study. They were divided into the artery stenosis
group (115 cases) and the non-stenosis group (32 cases) according to
MRA examination results. The proportion of age (65.7 ± 10.59 years vs.
56.33 ± 14.138 years, t = 4.577, p < 0.01), homocysteine levels
(16.56 ± 7.5 mmol/L vs. 11.25 ± 6.3 mmol/L; t = 3.65, p < 0.01),
C-reactive protein (4.24 ± 4.13 mmol/L vs. 3.26 ± 1.6 mmol/L; t = 2.06,
p = 0.041), low density lipoprotein cholesterol (2.87 ± 0.75 mmol/L vs.
2.5 ± 0.76 mmol/L; t = 1.896, p = 0.046), baseline history of diabetes
(38.26% vs. 15.62%; c2 = 5.772, p = 0.016), hypertension (57.4% vs. 25%;
c2 = 10.507, p = 0.01) in the artery stenosis group were significantly
higher than those in the non-stenosis group. But high-density lipoprotein
cholesterol (1.01 ± 0.23 vs. 1.25 ± 0.43; t = −4.26, p = 0.000) is lower than
nonstenosis group. Multivariate logistic regression analysis showed that
age ≥ 60 years (OR 3.374, 95% CI 1.351∼8.426; p = 0.009), HDLC>1.0
(OR 0.166, 95% CI 0.054∼0.511; p = 0.002), homocysteine >15 mmol/L
(OR 2.274, 95% CI 1.147∼8.173); p = 0.025), hypertension (OR 5.782,
95% CI 2.045∼16.345; p = 0.001), history of smoking (OR 3.514, 95% CI
1.200∼10.293; p = 0.022) were the independent risk factors for the artery
stenosis group. The stenosis group were divided into simple extracranial
stenosis group (24 cases),simple intracranial stenosis group (61 cases) and
both stenosis group (30 cases) according to stenosis location. The com-
parison of the clinical data and risk factors among the three groups
showed that hypertension (c2 = 7.024, p = 0.003), LDLC (F = 3.276,
p = 0.042), C-reactive protein (F = 3.645, 0.029) have significant differ-
ences. Multivariate logistic regression analysis showed that age (OR 6.351,
95% CI 2.277∼17.717; p < 0.001), hypertension (OR 3.795, 95% CI
1.261∼11.424; p = 0.018), HDL-C (OR 0.150, 95% CI 0.043∼0.523;
p = 0.003) were the independent risk factors for intracranial artery steno-
sis; hypertension (OR 18.490, 95% CI 3.117∼10.966; p = 0.0010), HDLC
(OR 0.078, 95% CI 0.12∼0.488; p = 0.006), LDLC (OR 6.021, 95% CI
1.212∼29.917; p = 0.028), homocysteine(OR 4.376, 95% CI 1.026∼18.671;
p = 0.046) were the independent risk factors for extracranial artery steno-
sis; hypertension (OR 9.178, 95% CI 2.211∼38.094; p = 0.002), HDLC
(OR 0.089, 95% CI 0.021∼0.385; p = 0.001) homocysteine (4.951, 95% CI
1.378∼17.783; p = 0.014) were the independent risk factors for co-existing
of artery stenosis.
Conclusions: The increased plasma homocysteine levels is only related to
the extracranial artery stenosis in the patients with ischemic stroke.
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03. Clinical Trial Results – Prevention
Early outcome data from the Cardiac Rehabilitation
Adapted for TIA and Stroke (CRAFTS)
randomized-controlled trial
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Background: The impact of comprehensive, lifestyle-modification pro-
grams on adherence to secondary prevention guidelines following TIA/
stroke is uncertain.
Methods: This single-blinded, multi-center, randomized-controlled trial
(ISRCTN90272638) recruited patients ≥3 months after TIA or ≥1 year
after ischemic stroke from a Rapid Access Stroke Prevention Clinic and
Community Stroke Rehabilitation Service. Patients were randomized to
(i) 2-hour didactic risk-factor reduction education class; brief lifestyle
intervention counselling on exercise participation, dietary intake and
smoking cessation; and 16 aerobic-exercise training classes over 8 weeks
(intervention group) or (ii) 2-hour didactic risk-factor reduction class
alone (control group). Primary outcomes included adherence with mod-
erate aerobic exercise (>20 minutes 3 times/week), consumption of 5
portions of fruit and vegetables/day, and smoking cessation. Secondary
outcomes included Cardiovascular Risk Scores (CRS), and cardiovascular
fitness (VO2peak on submaximal testing). An independent, blinded asses-
sor performed baseline (week 1) and follow-up (week 10) objective mea-
surements. Chi-squared tests compared proportional improvement
between groups. Adjusted mean changes in continuous variables were
analyzed by ANCOVA. Analyses were by intention-to-treat.
Results: Seventy-two patients were assigned to ‘intervention’ and 70 to
‘control’ groups. A higher proportion in the intervention group improved
compliance with moderate exercise (P = 0.04), fruit and vegetable con-
sumption (P = 0.026), smoking cessation (P = 0.045), and all three mea-
sures compared with controls (P = 0.005). Cardiovascular fitness
(VO2peak) was more improved in the intervention group than in controls
(P = 0.042), no difference in CRS was noted (P = 0.144).
Discussion: A modified-cardiac rehabilitation program improves initial
adherence to lifestyle guidelines, and may improve cardiovascular fitness
after TIA/ischemic stroke. One-year follow-up data are being analyzed.
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03. Clinical Trial Results – Prevention
Contributing factors for the baseline intima-media
thickness of the carotid artery in Japanese stroke
patients: J-STARS Echo Study
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Background and Purpose: J-STARS is a multicenter, randomized, open-
label, parallel group trial on the secondary stroke prevention, using
pravastatin (10 mg/day) in Japanese patients with noncardioembolic isch-
emic stroke and hypercholesterolemia (Nagai Y, et al: Int J Stroke 2014). As
one of the sub-studies, this study (ClinicalTrials.gov NCT00361530)
aimed to explore pleiotropic effects of statin on the changes of carotid
atherosclerosis, as assessed by ultrasound.
Methods: Of 1589 patients recruited for J-STARS, 804 patients (266
women, 66.4 ± 8.3 years old) underwent ultrasound evaluation. Mean and
maximum intima-media thickness (IMT) of the bilateral common carotid
arteries was automatically measured by the Intimascope® (Softmedical).
Results: Baseline characteristics of patients were similar between 393
patients in pravastatin group and 411 patients in control group. Mean
IMT was 0.84 ± 0.22 mm in pravastatin group and 0.84 ± 0.20 mm in
control group (p=0.57). Max IMT was 1.24 ± 0.45 mm and 1.23 ± 0.38
mm, respectively (p = 0.62). By multiple regression analysis, factors asso-
ciated with mean IMT were men (β 0.050, p = 0.002), age (/10 years)
(0.038, p < 0.001), categories of blood pressure (0.026, p = 0.020), and
mRS at entry (0.020, p = 0.016). Also, factors associated with max IMT
were men (0.075, p = 0.019), age (0.065, p < 0.001), diabetes mellitus
(0.070, p = 0.042), categories of blood pressure (0.045, p = 0.038), and
mRS (0.035, p = 0.045).
Conclusion: In the Japanese stroke patients recruited for J-STARS, base-
line IMT values and their associations with atherosclerotic risk factors
were similar to those reported in prior studies from Western countries,
supporting the rationale of international comparison despite difference in
race and ethnicity.
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03. Clinical Trial Results – Prevention
Feasibility of multidomain preventive lifestyle
intervention in stroke patients. twelve-month findings
from a randomized, multi-center, multi-intervention
study to prevent cognitive decline after ischemic
stroke (ASPIS)
Y Teuschl1, K Matz1, A Dachenhausen1, B Firlinger1, M Keindl1,
J Tuomilehto2, M Brainin1, ASPIS Study Group
1Department for Clinical Medicine and Preventive Medicine,
Danube University Krems, Krems, Austria
2Center for Vascular Prevention, Danube University Krems,
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Background: Cognitive impairment after stroke is a considerable burden
to stroke survivors. Using the data of the 1-year interim analysis of the
ASPIS trial designed to examine whether intensive multi-intervention
lifestyle modifications can prevent cognitive decline at 24 months we
evaluated the effectiveness of such intervention on lifestyle parameters.
Methods: A randomized, multicenter, observer-blind, two-arm parallel
group clinical trial in 202 acute stroke patients. Lifestyle interventions in
the intervention group were individually designed with the target of
increasing regular physical activity, improving healthy diet and adequate
blood pressure control. The control group obtained standard stroke care.
Results: After 12 months the use of reduced-fat milk (p = 0.031), reduced-
fat spreads (p = 0.007) and the consumption of fish (p = 0.021) signifi-
cantly increased in the intervention group compared to baseline, but no
changes were observed in the control group. Furthermore, we created a
low-risk lifestyle summary score including lifestyle indicators (nutrition,
physical exercise, body mass index, non-smoking) and a low-risk lifestyle
and laboratory summary score including additionally fasting glucose,
blood pressure and non-high-density lipoprotein cholesterol. Those
scores indicated a significant improvement in the number of healthy
lifestyle indicators and adequately controlled laboratory parameters
(p < 0.001) in the intervention group compared with the control group.
Conclusions: These interim results of the ASPIS-trial demonstrate the
feasibility of intensified individualized lifestyle interventions in stroke
patients and confirm that multidomain interventions might be more
effective in changing lifestyle habits than standard stroke care.
Registry number: NCT01109836
Funded: Nö Bildungs- und Forschungsgesellschaft LS09-002
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MORPHOLOGICAL CHARACTERISTICS OF INTRACRANIAL
ATHEROSCLEROTIC PLAQUES
L Wang1, S Yu2, D Siu2, Y Soo1, L Wong1, T Leung1
1Medicine & Therapeutics, The Chinese University of Hong
Kong, Shatin N.T., Hong Kong China
2Imaging & Interventional Radiology, The Chinese University
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Background: Intracranial atherosclerosis is a common stroke etiology
with a high risk of recurrence. Studies on morphology of intracranial
plaques may improve our understanding of underlying stroke
mechanism.
Method: We prospectively recruited patients with symptomatic intracra-
nial atherosclerotic stenosis for 3D-rotational angiography within one
month from the index stroke. Morphological parameters included
plaque surface (smooth/irregular/ulcerated), ulcer location (upstream/
downstream), plaque thickness, length, thickness-to-length ratio,
upstream angulation, maximal stenosis distribution (proximal/middle/
distal) and eccentricity.
Results: We prospectively enrolled 87 patients (age 62.2 ± 9.7 yrs, male
66.7%). Plaques were of moderate (stenosis 50–70%; n = 11) to severe
(stenosis >70%; n = 87) stenosis (mean stenosis: 76 ± 10%). We observed
irregular or ulcerated surfaces in 53 plaques (54.1%), and all ulcers (n = 7)
were located at the upstream border. Maximal stenosis was predominantly
at the proximal (20.4%) or distal (48%) region of the plaque. The majority
of plaques were eccentric (87.8%). Surfaces of moderate stenoses were
mostly smooth, significantly higher than that in severe stenoses (81.8% vs.
41.4%) (p = 0.015, Fisher’s Exact Test).
Conclusion: High-grade symptomatic intracranial plaques were fre-
quently eccentric, associated with an irregular or ulcerative surface at the
upstream border. These morphological characteristics may predict plaque
vulnerability.
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04. Prevention (Other than Clinical Trials)
Better stroke preventive effect of calcium channel
blockers is not explained by its effect in macro and
microvascular disease markers
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Background: Recent data challenged the cornerstone statement that only
blood pressure (BP) values are important to stroke prevention, regardless
of drug class, showing that calcium channel blockers (CCB) seem to be
more effective in reducing cerebrovascular events, although the mecha-
nisms remains elusive.
Aim: To find whether CCB use is associated with lower retinal damage,
coronary atherosclerosis, aortic stiffness and carotid artery intima-media
thickness (IMT).
Methods: Two groups, with CCB (n = 77) and without CCB (n = 78),
were selected from a cohort patients at a Hypertension Clinic. Groups
were compared regarding gender, age, BMI, past medical history, HgA1c,
lipids, uric acid, 24-hours MAPA BP, left ventricle dysfunction, retinopa-
thy lesions by fundus photograph, aortic stiffness by pulse wave velocity
(PWV), coronary calcium score (CAC), carotid plaques and IMT by
duplex ultrasound.
Results: CCB patients used more statin (p = 0.004), antiplatelet
(p = 0.011) and combined hypertensive (p < 0.001) drugs and had higher
HgA1c (p = 0.040) and lower BP (systolic p = 0.003; diastolic p = 0.002).
CAC (89.7 vs 88.5 AU, p = 0.566) and PWV (10.9 ± 1.8 vs 11.0 ± 1.8 m/s,
p = 0.815) did not differ between groups. Mean IMT was higher
(0.76 ± 0.13 vs 0.72 ± 0.13 mm, p = 0.048) and retinopathy (61% vs 42%,
p = 0.024) more frequently present with CCB but not after multivariate
adjustment.
Conclusions: In a hypertensive population, retinal disease, carotid, coro-
nary and aortic atherosclerotic pre-clinical biomarkers, were not signifi-
cantly different in CCB users, as compared to non-CCB users. CCB higher
efficacy in stroke prevention may be explained by other factors unrelated
to direct cerebral micro and macrovascular damage.
ESOC-1397
04. Prevention (Other than Clinical Trials)
Antiplatelet agents use before ischemic stroke is
associated with reduced severity of stroke
R Bassil1, Y Mayasi1, K Kane2, B A Husaini3, M Moonis1
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2Behavioral Medicine, University of Massachusetts Medical
School, Worcester, USA
3Center for Health Research, Tennessee State University,
Nashville, USA
Introduction:
– Antiplatelet agents use in acute stroke reduce the risk of recurrent
ischemic stroke
– It is less well known whether antiplatelet agents use before stroke onset
reduces the severity of ischemic stroke
– We used a phase 3 database of Citicoline where sufficient numbers of
patients were on antiplatelet agents and measures of stroke severity were
available (NIHSS at stroke onset)
Methods:
– Outcomes were dichotomized to:
* Severe stroke (NIHSS > 14)
* Mild to moderate stroke (NIHSS ≤ 14)
– Patients were divided into 2 populations:
* On antiplatelet agents before stroke onset
* Not on antiplatelet agents before stroke onset
Analysis:
– Outcomes: NIHSS score at admission
– NIHSS ≤ 14 is a positive outcome
– NIHSS > 14 is a negative outcome
– Univariate analysis was performed using demographic, vascular risk
factors and medications before stroke onset. Univariate predictors with
P < 0.1 were included in the multivariate model
– Multivariate regression analysis was done to determine independent
factors predictive of NIHSS ≤ 14 (Milder stroke)
Conclusions:
– Patients with a history of cardiac disease were 1.516 time more likely to
have a severe stroke (NIHSS > 14) than patients who did not have a
history of cardiac disease (P < 0.05)
– Patients on antiplatelet therapy were 1.466 time more likely to have a
mild to moderate (NIHSS ≤ 14) stroke compared to patients not on anti-
platelet therapy (P < 0.05)
ESOC-0745
04. Prevention (Other than Clinical Trials)
TIA Pathway implementation to improve clinical
management in a second-level hospital: The
experience of Modena in Management of TIA Patient
G Bigliardi1, A Zini1, G Bandiera2, G Pinelli2, R D’Amico3,
S Balduzzi3, P F Nichelli1, F Casoni1
1Neurology, Nuovo Ospedale Civile S.Agostino-Estense,
Modena, Italy
2Emergency Department, Nuovo Ospedale Civile
S.Agostino-Estense, Modena, Italy
3Diagnostic Clinical and Pubblic Health Medicine, University
of Modena and Reggio Emilia, Modena, Italy
Background: Transient ischemic attack (TIA) is considered a medical
emergency and is associated with high risk of stroke in short time. In our
local experience, a protocol for management of TIA was created and
applied until 2008, and results of first two years application were encour-
aging. We evaluated results of last four year-application of protocol, in a
prospective observational cohort study.
Protocol: Patients with suspected TIA is evaluated by Neurologist and
undergone to CT scan. If CT has resulted negative for brain lesions patient
is admitted to Emergency Department (ED) for 24 hours observation and
ABCD2 score is calculated. Blood sample, carotid and transcranial ultra-
sound, ECG and blood pressure monitoring are performed. At the end of
the observation we could have different settings on the basis of presence of
ABCD2 score, cerebrovascular risk factors, and results of investigations.
On the basis of these factors patient could be discharged or hospitalized.
Methods: We prospectively analyzed patients admitted at ED with sus-
pected TIA in the period January 2011-June 2014 and compared to data of
patient with suspected TIA for the year 2007, in particular diagnosis
accuracy, recurrence stroke-TIA, risk factor analysis.
Results: In the period January 2011 to June 2014 we documented an
increased diagnostic accuracy (65–75% vs 43%), a reduction in number
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and percentage of recurrent stroke-TIA (13% vs 29%, p < 0.001) and a
confirmed reduction in hospitalization for patient with TIA (19–31% vs
41%).
Conclusion: These results, after application of multidisciplinary protocol,
may suggest a strategy for improving management of TIA patients.
ESOC-1382
04. Prevention (Other than Clinical Trials)
Medication adherence at six months post-ischemic
stroke – The ASPIRE-S Study
L Brewer1, L Mellon2, P Hall1, F Horgan3, E Dolan4, E Shelley5,
H McGee2, P Kelly6, A Hickey2, D Williams1
1Geriatric and Stroke, Royal College of Surgeons in Ireland,
Dublin, Ireland
2Psychology, Royal College of Surgeons in Ireland, Dublin,
Ireland
3Physiotherapy, Royal College of Surgeons in Ireland, Dublin,
Ireland
4Geriatric Medicine, Connolly Hospital, Dublin, Ireland
5Population Health Sciences, Royal College of Surgeons in
Ireland, Dublin, Ireland
6Neurology, Mater Misericordiae University Hospital, Dublin,
Ireland
Background: Survivors of ischemic stroke (IS) are at high-risk of future
vascular events. Secondary prevention improves long-term outcomes
however medication adherence is essential for therapeutic benefits.
ASPIRE-S (Action on Secondary Prevention Interventions and Rehabili-
tation in Stroke) was a prospective multi-center study that comprehen-
sively assessed patients six months following IS. This included a measure
of self-reported medication adherence.
Methods: Consenting patients admitted with IS to three Dublin hospitals
were recruited over one year, from October 2011. At six months post IS,
assessments were completed. The Medication Adherence Rating Scale cap-
tured self-reported medication adherence.
Results: 302 patients (58% male; mean age 69 years, range 22–95) were
recruited, of whom 256 (85%) were followed-up at six months. Overall,
self-reported adherence was excellent (mean score 24.2/25, range 12 to
25). However, 43% of patients admitted to (sometimes) unintentionally
missing medication dosages. These patients (compared with fully adher-
ent patients) were younger (54% of those vs 23% of those >80 y), on less
medications (57% of those on vs 22% of those on ≥10 medications) and
had better function (51% of those with mRS ≤ 2 vs 23% of those with
mRS >3); p
Conclusion: Overall self-reported medication adherence was excellent.
Older age and polypharmacy may necessitate medication supervision,
resulting in improved adherence. Patients with milder strokes may have
been less concerned about secondary prevention and therefore medica-
tion adherence. Focus must be placed on all patients to explain the
purpose of medications and the importance of adherence to ensure effec-
tive secondary prevention post-stroke.
ESOC-0540
04. Prevention (Other than Clinical Trials)
Self-efficacy and determinants of self-efficacy for
health-related behavior change in patients with TIA or
minor ischemic stroke
D Brouwer- Goossensen1, L van Genugten2, H F Lingsma2,
D W J Dippel1, P J Koudstaal1, H M den Hertog3
1Neurology, Erasmus MC University Medical Center,
Rotterdam, Netherlands
2Public Health, Erasmus MC University Medical Center,
Rotterdam, Netherlands
3Neurology, Medisch Spectrum Twente, Enschede,
Netherlands
Background: Health-related behavior change after TIA or minor stroke
may reduce stroke recurrence. Self-efficacy, i.e. confidence to carry out
behavior necessary to reach a desired goal, is important for achieving
health-related change. Little is known about the role of self-efficacy in
health-related behavior change in patients with ischemic stroke or TIA.
We aimed to assess self-efficacy for health-related behavior change in
patients with TIA or ischemic stroke.
Methods: We prospectively studied 100 patients with TIA or minor isch-
emic stroke. Patients filled in questionnaires on self-efficacy for health-
related behavior change, and sociocognitive determinants including
severity, susceptibility, fear, social support. Self-efficacy was measured
with a 9-item scale with scores that range from 1 to 5. Higher values
indicate more confidence to carry out the behavior necessary to reach the
desired goal. Demographic data, vascular history and risk factors, event
type, cognitive impairment and depression were also collected. We studied
relations between sociocognitive determinants, depression, cognitive
impairment, vascular risk factors and history, and demographic data and
self-efficacy with univariable linear regression.
Results: Median self-efficacy at baseline was 4 (IQR 3.8–4.7). Age (OR
1.04, 95% CI 1.01–1.09), depression (OR 1.09, 95% CI 1.03–1.16), pres-
ence of vascular history (OR 2.42, 95% CI 0.98–6.03), BMI (OR 1.15, 95%
CI 1.01–1.30), and fear (OR 1.06, 95% CI 1.01–1.12) were associated with
low self-efficacy.
Conclusion: Patients with TIA of minor ischemic stroke on average have
high self-efficacy scores for health-related behavior change. Low self-
efficacy scores are associated with higher age, known vascular disease,
depression, higher BMI and increased fear.
ESOC-1566
04. Prevention (Other than Clinical Trials)
Carotid intima-medial thickness, aortic stiffness and
retinal microvascular signs provide evidence for
optimal blood pressure target in hypertensive patients
P Castro1, A Monteiro1, S Penas2, C Ferreira1, L Martins3,
A Campilho3, J Polónia4, E Azevedo1
1Department of Neurology, Centro Hospitalar São João,
Porto, Portugal
2Department of Ophthalmology, Centro Hospitalar São João,
Porto, Portugal
3Institute of Biomedical Engineering, University of Porto,
Porto, Portugal
4Arterial Hypertension Clinic, Hospital Pedro Hispano, Porto,
Portugal
Background: Hypertension is a major modifiable risk factor for ischemic
and hemorrhagic stroke, particularly in the elderly. In this aged group,
recent guidelines changed the systolic blood pressure (BP) control cut-off
from 140 mmHg to 150 mmHg, which could raise concern about stroke
prevention.
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Aim: We aim to find differences in biological markers of heart damage,
aortic stiffness, carotid and retinal microvascular disease that could
support or refute this view.
Methods: Three groups, A, B and C, with Systolic BP < 140 (n = 39),
140–149 (n = 27) and ≥150 (n = 89), respectively, were selected from a
cohort at an Hypertension Clinic. Groups were compared regarding
gender, age, past medical history, BMI, HgA1c, lipid, uric acid, 24-hours
MAPA BP, left ventricle hypertrophy (LVH), aortic stiffness by pulse wave
velocity (PWV), carotid intima-medial thickness (IMT) by duplex
ultrasound and retinopathy microvascular signals (RMS) by fundus
photograph.
Results: Groups did not differ in baseline characteristics except for higher
diastolic BP in C (p < 0.001) and lower HgA1c levels in A (p < 0.001).
PWV (11.6 ± 1.8, 10.1 ± 1.5 and 10.1 ± 1.5, p < 0.001), IMT (0.77 ± 0.13,
0.69 ± 0.11 and 0.70 ± 0.13, p < 0.001), RMS score (2.4 ± 2.7, 1.3 ± 2.3
and 0.9 ± 1.4, p = 0.004), presence of any retinopathy (61, 39 and 39%,
p = 0.024) and of LVH (30, 11 and 11%, p = 0.013) was only higher in
>150 mm Hg group. Groups A and B were similar.
Conclusions: Retinal microvascular signals, left ventricular hypertrophy,
aortic stiffness and carotid intima-medial thickness significantly increased
only at systolic BP levels above 150 mmHg. This provides evidence of
biological plausibility for this BP target for older patients.
ESOC-1148
04. Prevention (Other than Clinical Trials)
Level of heterogeneity between neuroradiologists,
neurosurgeons, neurologists and epidemiologist in the
Unruptured Intracranial Aneurysm Treatment Score
(UIATS)
N Etminan1, R D Brown2, K Beseoglu3, S Juvela4, J Raymond5,
A Morita6, J C Torner7, C Derdeyn8, A Raabe9, J Mocco10, M Korja4,
A Abdulazim3, P Vajcoczy11, D Hänggi3, G J E Rinkel12,
R L Macdonald13, U on behalf of the UIATS investigators14
1Neurosurgery, Heinrich Heine University, Düsseldorf,
Germany
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3Neurosurgery, Heinrich-Heine University, Düsseldorf,
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4Neurosurgery, University of Helsinki, Helsinki, Finland
5Interventional Radiology, CHUM Research Center, Montreal,
Canada
6Neurosurgery, Nippon Medical School, Tokyo, Japan
7Epidemiologiy, University of Iowa, Iowa City, USA
8Interventional Radiology, Washington University School of
Medicine, St. Louis, USA
9Neurosurgery, Inselspital, Bern, Switzerland
10Neurosurgery, Vanderbilt Vanderbilt University Medical
Center, Nashville, USA
11Neurosurgery, Charité University Medical Centre, Berlin,
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12Neurosurgery and Neurology, University Medical Centre
Utrecht, Utrecht, Netherlands
13Neurosurgery, University of Toronto, Toronto, Canada
14Neurology Neurosurgery Interventional Radiology and
Clinical Epidemiology, Research Group, UIATS, Germany
Objective: Unruptured intracranial aneurysms (UIAs) are being identi-
fied with increasing frequency. Recently, a group of experts developed an
UIA treatment score (UIATS) that guides decision making for manage-
ment of UIAs. We assessed heterogeneity between different specialties
regarding their agreement with treatment recommendations based on the
UIATS during its development.
Methods: A multidisciplinary (neurosurgery, NSX; neuroradiology, INR
and neurology/clinical epidemiology, NEU/EPI) group of 69 experts on
UIA management and research was convened to develop and validate the
UIATS model using a Delphi consensus. Thirty selected UIA cases were
used to analyze agreement with UIATS management recommendations
based on a 5-point Likert scale (5 indicating strong agreement) for experts
who were and were not involved in the development of the UIATS. Inter-
rater agreement (IRA) between experts and specialties was assessed with
standardized coefficients of dispersion (vr*) (vr* = 0 indicating excellent
and vr* = 1 poor agreement).
Results: Overall agreement with UIATS treatment recommendations
(mean Likert scores) per reviewer was 4.2 (95%CI: 4.1–4.3) for all experts,
4.3 (95%CI: 4.2–4.4) for NSX, 4.1 (95%CI: 3.9–4.3) for INR and 4.1
(95%CI: 3.9–4.4) for NEU/EPI (p = 0·234). Overall IRA (vr*) for all spe-
cialties was 0.026 (95%CI: 0.019–0.033), without any evidence for hetero-
geneity between the different specialties (p = 0.846).
Conclusions: The UIATS captures an excellent consensus among highly
informed individuals on UIA management, irrespective of their underly-
ing specialty. Clinicians can use the UIATS as a comprehensive mechanism
for indicating how a large group of specialists might manage an individual
UIA patient.
ESOC-0252
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Stroke Riskometer app: A new promising approach for
primary stroke prevention and epidemiological
research on stroke and other major non-communicable
disorders (NCD) across the globe
V Feigin1, B Norrving2, R Krishnamurthi1, S Barker-Collo3,
W Wang4, H U A Fu5, D N M Ibrahim6, R Sahathevan6, G A Roth7,
S Mendis8
1National Institute for Stroke and Applied Neurosciences,
AUT University, Auckland, New Zealand
2Neurology and Clinical Neurosciences, Lund University, Lund,
Sweden
3Psychology, Auckland University, Auckland, New Zealand
4Neuroepidemiology, Beijing Neurosurgical Institute, Beijing,
China
5Health Communication Institute, Fudan University, Shanghai,
China
6Neurology, UKM Medical Center, Kuala Lumpur, Malaysia
7Institute for Health Metrics Evaluation, Washington
University, Seattle, USA
8Non-Communicable Disorders, World Health Organization,
Geneva, Switzerland
There is little awareness in the population about stroke and other
major NCD that share common risk factors (eg, heart attack, dementia,
diabetes mellitus), and their risk factors. This, coupled with underutiliza-
tion of strategies for primary prevention of NCD on an individual
level and the lack of accurate data on the frequency and significance of risk
factors in different populations have been implicated in the ever-
increasing worldwide burden of these NCD. Recent advances in mobile
(smartphone) technologies and their worldwide use (about 1.75 billion
users) offers a unique opportunity to utilize these technologies for
improving health and research capabilities. In recognition of the impor-
tance of e-research NCD initiatives, the United Nations (UN) Economic
and Social Council, the International Telecommunication Union (ITU)
and the World Health Organization (WHO) have recently (June 2013)
launched a new mHealth initiative for improving NCD prevention, treat-
ment and policy enforcement.
To inform and support these UN/ITU/WHO efforts, AUT University in
collaboration with New Zealand Stroke Education (charitable) Trust
recently developed a new, validated version of the Stroke Riskome-
terTM app translated into 12 world’s most spoken languages. Endorsed
by the World Stroke Organization, World Federation of Neurology and
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the International Association on Neurology and Epidemiology the
app allows calculation of not only risk of stroke occurrence and risk
profile-tailored recommendations on stroke prevention but also a partici-
pation in the unprecedented, global smartphone-based research on fre-
quency, distribution and determinants of major NCD – RIBURST study
(Reducing the International Burden of Stroke Using Mobile Technology).
ESOC-1162
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Awareness of stroke risk factors in the general
population and changes of risk factor knowledge by
an educational lecture
K Haas1, M Olma2, J Röther3, M Wagner4, H Faller5, O Busse6,
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Hamburg, Germany
4German Stroke Foundation, Stiftung Deutsche
Schlaganfallhilfe (SDSH), Gütersloh, Germany
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Division of Medical Psychology – Psychotherapy – Medical
Sociology and Rehabilitation Research, University of
Würzburg, Würzburg, Germany
6German Stroke Society, Deutsche Schlaganfall-Gesellschaft
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Introduction: Previous studies showed poor knowledge of stroke risk
factors in the general population. We investigated awareness of stroke risk
factors in the lay public and changes of its short-term knowledge by an
educational lecture.
Method: Hospitals providing Stroke Unit care in Germany were invited to
organize educational lectures for the lay public during the World Stroke
Day 2014. Risk factor awareness among participants was measured before
and after the lecture. Two different lecture formats were used, one with
regular information material and one with material specifically adapted
for lay public needs. Hospitals were randomly assigned to one of these
presentation groups. The study was organized by the German Stroke
Society, the German Stroke Foundation, the Center for Stroke Research
Berlin and the Institute of Clinical Epidemiology Würzburg.
Results: Overall, 2124 persons in 51 regions across Germany participated
in the study. Diabetes and atrial fibrillation were less known as risk factors
for stroke before the lecture (65.0% and 64.9%, respectively), whereas
hypertension and obesity were correctly identified from 95.1% and 88.4%
of the participants. After the lecture the correct short-term knowledge
increased significantly to 84.0% or more for all risk factors. Hierarchical
linear regression showed improvement of risk factor knowledge being
associated with personal experience of vascular diseases and participation
in a lecture specifically adapted for lay public needs.
Conclusion: Educational lectures seem to be beneficial to improve short-
term knowledge of risk factors for stroke, especially if the information
material is specifically adapted to lay public needs.
ESOC-0434
04. Prevention (Other than Clinical Trials)
Neurophysiological monitoring during trans-catheter,
endovascular closure of adults’ patent foramen ovale
(PFO)
M Habeych Sanmiguel1, A J C Smith2, D J Crammond1,
P D Thirumala1, W Anderson2, J R Balzer1
1Neurological Surgery, Center for Clinical Neurophysiology,
Pittsburgh, USA
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Introduction: Trans-catheter endovascular is a non-surgical, minimally
invasive technique to treat PFOs. However, cardio-cerebral embolisms can
occur. Our aims are to describe and assess an intra-procedural neuro-
physiological monitoring (IPNM) protocol to prevent stroke clinically
significant during these procedures.
Materials and Methods: Twenty-one (N = 21) successive patients have
been studied between January of 2010 and July of 2014. Somatosensory
evoked potentials from upper and lower extremities, and bi-hemispheric
electroencephalogram were monitored.
Results: Mean age was 53.9 years (SD: ±16.7), and two thirds of the
patients were females. Average duration of the procedure was 79.9 mins.
All subjects received heparin according to ACT, general anesthesia, and
muscular relaxation. A device was successfully deployed in 90.5% of sub-
jects, and two cases were aborted. Four cases (19.05%) had abnormal
baseline signals, and none presented significant (amplitude reduction 3
50%, latency increase 3 10% of baselines) changes. Although no post-
procedure brain MRI has been done, no subject has shown abnormal
mental status or neurologic deficit.
Conclusions: Preliminary data shows IPNM has a 100% specificity, with
no false positives to detect clinically significant cardio-cerebral embolisms
during the endovascular closure of PFOs. No patient showed neurological
changes, therefore, a false negative rate could not be determined.
ESOC-1409
04. Prevention (Other than Clinical Trials)
Neuroprotection induced by physical activity level
prior to ischemic stroke
K D Hougaard1, R A Blauenfeldt1, G Andersen1
1Neurology, Aarhus University Hospital, Århus C, Denmark
Regular physical activity (PhA) is associated with improved functional
outcome following stroke. We aim to investigate the possible neuropro-
tective effect of prestroke PhA, on final infarct size using 24 hour MRI-
DWI and functional outcome determined on modified Rankin Scale
(mRS) after three months.
Physical Activity Scale for Elderly (PASE) was used to determine PhA.
PASE is a questionnaire which quantifies physical activity over a 7-day
period (range 0 to >400).
102 patients, mean age 64.3 years, 39.2% women with rtPA treated acute
ischemic stroke were included. 24-Hour MRI-DWI (n = 80) and 3-month
mRS (n = 102) were adjusted for baseline acute-DWI lesion and National
Institute of Health Stroke Score (NIHSS), respectively.
Increase of one point in PASE score was associated with decreased final
infarct volume (–0.4% (–0.7%;–0.3%) (SE = 0.002) (p = 0.031), suggest-
ing a dose response relationship. The linear regression analysis included
age, hypertension, atrial fibrillation and type 2 diabetes mellitus and base-
line acute DWI lesion volume. Infarct growth defined as DWI (24
h-baseline), were significantly reduced in patents with the highest PhA
(linear regression, p = 0.036)
PhA was associated with decreased odds for a long-term unfavorable
outcome (mRS 2 to 6), when corrected for baseline NIHSS. −1.1% (SE
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0.0039) (p = 0.005). The association remained significant also after mul-
tiple logistic regression analysis included relevant baseline characteristics
(p = 0.039).
Conclusion: Level of physical activity prior to ischemic stroke may induce
neuroprotection and reduced infarct growth and final infarct in the hyper
acute phase of ischemic stroke (<24 hours) which may contribute to an
improved functional outcome at 3 months.
ESOC-0378
04. Prevention (Other than Clinical Trials)
Statin pretreatment is associated with initial stroke
severity in non-cardioembolic ischemic stroke patients
with dyslipidemia: The Fukuoka Stroke Registry
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Background: Statin pretreatment improves neurological outcomes after
ischemic stroke. However, the effect of statin pretreatment on initial
stroke severity, especially in patients with dyslipidemia, has been remained
controversial. We aimed to evaluate the association between statin pre-
treatment and initial stroke severity in ischemic stroke patients with
dyslipidemia.
Methods: Patients with first-ever ischemic stroke (within 24-hours of
onset) with dyslipidemia who had been functionally independent (modi-
fied Rankin Scales ≤1) before the onset were enrolled in this study
(n = 1,323). Mild stroke severity was defined as NIHSS ≤ 4 on admission.
Multivariable logistic regression models and propensity score (PS)-
matched analysis were used to quantify the association between statin
pretreatment and mild stroke severity.
Results: Of overall patients, 299 (22.6%) were taking statins prior to the
stroke. Mild stroke severity on admission tended to be more frequent in
patients with statin pretreatment than in those without the treatment
(65% vs 60%, p = 0.09). Multivariable analysis showed that statin pre-
treatment was significantly associated with higher probability of mild
stroke severity on admission (odds ratio [OR], 1.75; 95% confidence
interval [CI], 1.26–2.46). In the stroke subtype-stratified analysis, the
association was similar in patients with non-cardioembolic ischemic
stroke in multivariable-adjusted model (OR, 2.00; 95% CI, 1.33–3.05) as
well as in the PS-matched analysis (OR, 2.24; 95% CI, 1.01–4.97). A
similar but non-significant association was observed in patients with car-
dioembolic stroke (multivariable OR, 1.73; 95% CI, 0.90–3.37).
Conclusions: Statin pretreatment was significantly associated with mild
stroke severity on admission within 24-hours of onset in non-
cardioembolic ischemic stroke patients with dyslipidemia.
ESOC-0443
04. Prevention (Other than Clinical Trials)
Modeling likely risk and benefit of long-term
aspirin-based secondary prevention after TIA and
ischemic stroke at older ages: Population-based study
L Li1, O C Geraghty1, Z Mehta1, P M Rothwell1,
on behalf of the Oxford Vascular Study1
1Nuffield Department of Clinical Neurosciences, University of
Oxford, Oxford, United Kingdom
Background: Randomized trials (RCT) of long-term aspirin after TIA and
ischemic stroke were done 20–40 years ago in patients with a mean age of
63 years. Half of patients are now aged ≥75 (20% aged ≥85), when risk of
bleeding is considerably increased. Modeling studies show that benefit
from antiplatelet drugs is unlikely once the ratio of major bleeds:ischemic
events reaches 0.5.
Methods: We studied all bleeding events requiring medical attention
(identified from 10-year face-to-face follow-up and multiple other
sources) and all recurrent ischemic vascular events (stroke, acute coronary
events or sudden cardiac death) in all patients with a first TIA or ischemic
stroke who were treated with antiplatelet drugs in a defined population
(Oxford Vascular Study) from 2002–2012. The ratio of major bleeds
(CURE Trial definition) to ischemic events was stratified by age.
Results: Of 2072 patients on antiplatelet treatment (1961/94.6% aspirin-
based), 1088 (52.5%) were aged ≥75 y. During 8,585 patient-years of
follow-up, there were 117 major bleeds and 392 ischemic events. At age
<75 the bleed: ischemic ratio (0.16, 95% CI 0.10–0.25) was comparable to
that in previous RCTs (0.20, 0.19–0.22). However, the ratio was much
higher (0.42, 0.31–0.57) at age ≥75 (difference – p = 0.0003), particularly
after the acute phase (post-90 days: 0.54, 0.37–0.78) and at age ≥85 (0.64,
0.41–1.00).
Conclusions: The ratio of major bleeds:ischemic events on long-term
follow-up in patients treated with aspirin after TIA and ischemic stroke at
age>75 may not be consistent with overall benefit of long-term treatment.
Trials of gradual withdrawal treatment in older age groups are justified.
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Management of carotid stenosis in the real evolving
world: Single-center experience with a
multidisciplinary team including stroke neurologists
E López-Cancio1, P Pérez2, C Castano3, S Remollo3, L Dorado1,
M Gomis1, M Hernández-Pérez1, N Pérez de la Ossa1, C Guerrero1,
M Millán1, A Dávalos1
1Neurosciences, Hospital Universitari Germans Trias i Pujol,
Badalona, Spain
2Vascular Surgery, Hospital Universitari Germans Trias i Pujol,
Badalona, Spain
3Intervantional Neuroradiology, Hospital Universitari Germans
Trias i Pujol, Badalona, Spain
Background: Carotid stenosis management has evolved in the last decade
and includes endarterectomy (CEA), stenting (CAS) and/or medical treat-
ment (MT). Guidelines recommend decision making after multidisci-
plinary discussion including neurologists. We aimed to present a single-
center experience over 6 years on carotid stenosis management.
Methods: Prospective hospital registry of all patients evaluated in a weekly
multidisciplinary session including stroke neurologists, vascular surgeons
and interventional radiologists. Treatment decision was achieved follow-
ing internal protocols which have been progressively updated according to
international guidelines and clinical trials. Patients were followed-up by a
stroke neurologist.
Results: From January 2008 to December 2014, 465 patients with carotid
stenosis were evaluated. Final decision treatment was 138 CEA, 133 CAS
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and 194 MT. MT alone was more frequently decided in asymptomatic
stenosis, older patients and in those with co-morbidities. Revasculariza-
tion of asymptomatic stenosis decreased over time from 60% in 2008 to
18% in 2014. Time from multidisciplinary session to revascularization
decreased progressively from 30 days in 2008 to 7 days in 2014. Combined
peri-procedural (30 days) stroke/death was 2.3% in CAS and 0% in CEA
in asymptomatic stenosis, and 4.6% in CAS and 5.2% in CEA in symp-
tomatic. Stroke recurrence at 1 year was recorded in 3.2% (2/63) of
patients under MT (both with symptomatic stenosis not suitable for
revascularization), in 2.8% (2/72) in CAS and in 1.5% (1/68) in CEA.
Conclusions: Multidisciplinary decision including stroke neurologists and
continuous evaluation of quality standards lead to an optimal manage-
ment of carotid stenosis. Asymptomatic carotid stenosis has a benign
natural course under optimal MT
ESOC-1006
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Centrally Observed Home Telemetric Monitoring of
Blood Pressure to Manage Intensive Treatment
(COMMIT) Study: Medication changes and control of
BP
N Lovett1, S M Lyons1, B D James1, M Wilson1, F C Cuthbertson1,
L E Silver1, A W R Webb1, U Fischer1, L Tarassenko1, P M Rothwell1
1Stroke Prevention Research Unit, University of Oxford,
Oxford, United Kingdom
Background: Hypertension is a major modifiable risk factor for recurrent
stroke, but rates of control in practice are low. We determined the feasi-
bility of using telemetric home BP-monitoring to improve control after
TIA and stroke.
Methods: We studied consecutive patients with TIA and non-disabling
stroke in a population-based study (Oxford Vascular Study). After pre-
scription of initial antihypertensive medication, patients measured their
BP with a Bluetooth-equipped monitor (t+ Medical, Abingdon, UK) for
1–3 months, depending on control. Measurements transmitted automati-
cally in real time and were checked daily on a secure webpage. If BP was
consistently above (>130/80) or below (<100/60) medication was
adjusted. BP was measured in clinic at 1 and 3 months follow-up.
Results: Among 1000 participants, mean/SD age was 69/13 years
(range = 21–98), with 23% aged ≥80 years. BP-lowering medication was
initiated or increased at the pre-monitoring baseline assessment in 555
patients. Medication was further initiated or adjusted at least once within
the first month of home-monitoring in 558 patients and from 1–3 months
in 393 patients. Mean BP measured on clinic follow-up fell from 141/83 at
entry to 130/74 at 1-month (p < 0.001) and to 127/72 mmHg at 3-months
(p < 0.001).
Conclusion: Telemetric home BP monitoring was feasible in patients with
TIA and non-disabling stroke irrespective of age. Monitoring informed
titration of medication in the majority of patients, and was associated
with good BP control.
ESOC-0392
04. Prevention (Other than Clinical Trials)
Stroke prevention in atrial fibrillation population:
Predictors of anticoagulation control in new warfarin
users
A F Macedo1, J Bell2, C McCarron1, R Conroy3, R Richardson3,
A Scowcroft1, T Sunderland1, N Rotheram3
1Market Access Pricing & Outcomes Research,
Boehringer-Ingelheim, Bracknell, United Kingdom
2Biometrics & Data Management, Boehringer-Ingelheim,
Bracknell, United Kingdom
3Medical Affairs – Cardiovascular, Boehringer-Ingelheim,
Bracknell, United Kingdom
The safety and effectiveness of warfarin therapy depends critically on the
quality of anticoagulation control, often assessed using the percentage
time in therapeutic International Normalized Ratio (INR) range (TTR).
We aim to identify patient characteristics associated with quality of anti-
coagulation control on warfarin, as measured by TTR.
We carried out a population-based retrospective study using data from the
Clinical Practice Research Datalink. This study included one cohort of
patients starting warfarin treatment after a first diagnosis of atrial fibrilla-
tion (AF) between January 2000 and December 2013. We used multivariate
mixed regression and logistic regression models to predict the fully-
adjusted effect of each predictor variable upon TTR.
The study population comprised 29,717 incident AF patients who initi-
ated warfarin. Patient characteristics all together explained only 2% of the
variation in individual’s TTR. Poor anticoagulation control (TTR<70%)
driven by subtherapeutic INRs occurred in younger patients (<45 years)
and in AF patients with repeated hospitalizations. Poor anticoagulation
control driven by sub and/or supratherapeutic INRs was seen in AF
patients who were current smokers and in patients using medications for
pain.
In a real world clinical practice setting there is a high amount of unpre-
dictable inter-individual TTR variability and in some patients good anti-
coagulation control is more challenging to achieve and maintain than in
others. These findings draw attention to the difficulty of achieving high-
quality anticoagulation control with warfarin clinical practice and may
help to identify patients who will require closer monitoring or innovative
management strategies to optimize the outcomes of oral anticoagulant
therapy.
ESOC-1470
04. Prevention (Other than Clinical Trials)
Sonodynamic therapy of neointimal hyperplasia
stenosis in the rabbit carotid artery with repeated
extracorporeal shock waves accompanied by PESDA
microbubbles and protoporphyrin IX administration
H Mehrad1, M Farhoudi2, L Kazemi3
1Department of Medical Physics, Neurosciences Research
Center (NSRC) Tabriz University of Medical Sciences, Tabriz,
Iran
2Department of Neurology, Neurosciences Research Center
(NSRC) Tabriz University of Medical Sciences, Tabriz, Iran
3Department of Biomedical Engineering, Tabriz Branch Islamic
Azad University, Tabriz, Iran
Introduction: In- stent restenosis is related to neointimal hyperplasia.
Sever carotid restenosis after stenting is a risk factor for ischemic stroke
and its related deaths.
Aims: We developed an experimental electrohydraulic shock wave gen-
erator (0–20 kv), and investigated its effectiveness on neointimal hyper-
plasia reduction in the rabbit carotid artery.
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Methods: Briefly, New Zealand white rabbits underwent perivascular
severe cold injury using liquid nitrogen at the right common carotid
artery. After eight weeks, the histopathology results showed progressive
smooth muscle cells proliferation in neointimal layer, resulting in vessel
wall thickening. Then treatment group underwent sonodynamic therapy
with repeated electrohydraulic shock waves accompanied by protopor-
phyrin IX (50 mg/kg) and PESDA microbubbles (100 μl/kg , 2–5 ×105
bubbles/ml) administration. Blood volume flow and blood mean velocity
were measured by color Doppler ultrasonography at the stenotic region.
Moreover, wall mean thickness and percentage of luminal cross-sectional
area of stenosis were measured by B-mode ultrasound and histology.
Results: Results showed a significant reduction in the mean value for
blood mean velocity, wall mean thickness and the percentage of luminal
cross-sectional area of stenosis and a significant increase in the mean value
for blood volume flow in the treatment group compared with the other
groups (P < 0.05).
Conclusion: Cytotoxic effect of protoporphyrin IX and inertial cavitation
effect of PESDA microbubbles, induced by repeated shock waves, can
cause to reduce the smooth muscle cells in neointimal layer and signifi-
cantly dilate the luminal cross-sectional area of stenosis.
ESOC-1473
04. Prevention (Other than Clinical Trials)
Non- invasive treatment of advanced carotid
atherosclerosis using repeated extracorporeal shock
waves accompanied by PESDA microbubbles and high-
dose atorvastatin administration
H Mehrad1, M Farhoudi2, H Jalalian3
1Department of Medical Physics, Neurosciences Research
Center (NSRC) Tabriz University of Medical Sciences, Tabriz,
Iran
2Department of Neurology, Neurosciences Research Center
(NSRC) Tabriz University of Medical Sciences, Tabriz, Iran
3Department of Physics, Tabriz Branch Islamic Azad University,
Tabriz, Iran
Introduction: The management of advanced carotid atherosclerosis with
severe stenosis (>70%) reduces the risk of stroke and its related deaths.
Management options are invasive and include carotid endarterectomy and
carotid artery stenting.
Aims: We developed an experimental electrohydraulic shock wave gen-
erator (0–20 kv), and investigated its effectiveness on stenosis reduction in
the rabbit carotid artery.
Methods: Carotid fibro-lipid plaque with severe stenosis (>70%) and neo-
vascularization was induced at the right common carotid artery of New
Zealand white rabbits. The animals treated by repeated electrohydraulic
shock waves accompanied by PESDA microbubbles (100 μl/kg, 2–5×105
bubbles/ml) and high- dose atorvastatin (5 mg/kg/day) administration.
Blood volume flow and blood mean velocity were measured by color
Doppler ultrasonography at the stenotic region. Moreover, wall mean
thickness and percentage of luminal cross-sectional area of stenosis were
measured by B-mode ultrasound and histology.
Results: Results showed a significant reduction in the mean value for
serum lipid parameters, blood mean velocity, wall mean thickness and the
percentage of luminal cross-sectional area of stenosis and a significant
increase in the mean value for blood volume flow in the treatment group
compared with the other groups (P < 0.05).
Conclusion: Inertial cavitation effect of microbubbles, induced by
repeated shock waves, and lipophilic and
pleiotropic effects of high-dose atorvastatin can cause to destroy the
plaque microvessels, reduce the lesion lipid content and significantly dilate
the luminal cross-sectional area of stenosis.
ESOC-0435
04. Prevention (Other than Clinical Trials)
Should we be screening the Asian population at a
younger age? A review of the University Hospitals of
Leicester NHS Trust Stroke Database
S Oram1, S Dawson2, M Fotherby2, E Goodwin2
1Medical School, University of Leicester, Leicester, United
Kingdom
2Stroke Services, University Hospitals of Leicester NHS Trust,
Leicester, United Kingdom
Leicestershire is renowned for being a multicultural area, with an Asian
population of 35.8% (1). There is currently limited research exploring the
differences in stroke between the Asian and White population. Banerjee et
al demonstrated that, compared to the White population, the London
south Asian stroke population was younger with a larger proportion of
hemorrhages (2). This review was undertaken to determine whether the
Leicestershire population demonstrates the same pattern.
Data from the University Hospitals of Leicester NHS Trust’s stroke data-
base from February 2013 to July 2014 was analyzed. It confirms that in the
Asian population strokes occur at a younger age (graph 1), and there is
higher incidence of vascular risk factors (Table 1), but a difference in
stroke type was not found.
This raises the question of whether these groups are being screened appro-
priately. Should risk factors, such as hypertension, be actively looked for at
an earlier age? Further research is planned, and may prove vital to the
future health care planning of the local stroke service.
Table 1
White Asian
% population of Leicester and Leicestershire 50.5 35.8
Total number of strokes 940 121
% with hypertension 59.36 69.4
% with diabetes 19.89 43.8
Fig. 1
Abstracts
© 2015 The Authors.
International Journal of Stroke © 2015 World Stroke Organization Vol 10 (Suppl. 2); April 2015; 77–438 105
Pooled Analysis and Metanalysis
ESOC-1384
05. Pooled Analysis and Metanalysis
Therapeutic targeting of secondary brain injury – A
systematic review and meta-analysis of previous
clinical trials
T Beez1, H J Steiger1, N Etminan1
1Neurosurgery, Heinrich Heine University, Düsseldorf,
Germany
Objective: The effect of experimental treatments targeting secondary
brain injury following acute cerebral insults, such as ischemic stroke,
aneurysmal subarachnoid (SAH) or intracerebral hemorrhage (ICH),
traumatic brain injury (TBI) and intracranial infections remains unclear.
To address this, we performed a systematic review and meta-analysis of all
clinical trials on sole reduction of secondary brain injury across all entities
noted.
Methods: A systematic review for all randomized, controlled, blinded
clinical trials solely targeting secondary brain injury after aforementioned
entities and with ‘death’ or ‘poor neurological outcome’ as outcome mea-
sures was performed. Effect sizes were analyzed using Cochrane Collabo-
ration Review Manager and expressed as pooled risk ratio (RR) estimates
with 95% confidence intervals (CI).
Results: Out of 3817 studies, ultimately data from 130 studies on 53,393
patients were included. In the pooled analysis, there was no significant
effect of experimental treatment on the incidence of ‘death’ for ischemic
stroke [RR 1.01 (95% CI: 0.93–1.09)], aSAH [RR 0.91 (95% CI:0.83–
1.00)], ICH [RR 0.93 (95% CI:0.82–1.04)], TBI [1.01 (95% CI:0.92–1.11)]
and intracranial infection [RR 0.93 (95% CI:0.84–1.04)]. For those
studies, which allowed pooled analysis for ‘poor outcome’ as an endpoint
due to common definitions, similar results were seen.
Conclusion: The poor effect of experimental treatments in previous clini-
cal trials targeting secondary brain injury on neurological outcome is
likely originated in the strong association of primary brain injury and
functional outcome but also insensitive therapeutic targets or endpoints.
Future treatments may become more efficacious when pathomechanisms
for primary and secondary brain injury are concomitantly targeted.
ESOC-0616
05. Pooled Analysis and Metanalysis
G-CSF for treating stroke: An independent patient data
meta-analysis
T England1, N Sprigg2, A M Alasheev3, A A Belkin3, A Kumar4,
K Prasad4, P M W Bath4
1Division of Medical Sciences & GEM, University of
Nottingham, Nottingham, United Kingdom
2Division of Stroke, University of Nottingham, Nottingham,
United Kingdom
3Russian Academy of Medical Sciences, Institute of Medical
Cell Technologies, Yekaterinburg, Russia
4Department of Neurology, All India Institute of Medical
Sciences, New Delhi, India
Background: Granulocyte colony stimulating factor (G-CSF) may
enhance recovery from stroke through various mechanisms including
reducing apoptosis in the ischemic penumbra if administered early, or
through neurorepair if given later. Several small trials suggest administra-
tion is safe but effects on efficacy are unclear.
Methods: We searched for randomized controlled trials (RCT) assessing
G-CSF for treating hyperacute, subacute or chronic stroke and asked Chief
Investigators to share individual patient data on baseline characteristics,
stroke severity and type, end-of-trial modified Rankin Scale (mRS),
Barthel Index (BI), severity (National Institutes of Health Stroke Scale
NIHSS), serious adverse events and death. Multivariate analyses were
adjusted for age, sex, baseline severity and time-to-treatment. Significance
was taken at p<0.05.
Results: Individual patient data were obtained from 6 of 10 RCTs com-
prising 196 stroke patients (116 G-CSF, 80 placebo), mean age 67.1 (SD
12.9), 92% ischemic, median NIHSS 10 (IQR 5-15), randomized 11 days
(interquartile range IQR 4-238) post ictus. In adjusted and unadjusted
analyses, G-CSF did not alter the odds of a poor outcome: mRS>3, odds
ratio OR 0.83 (95% confidence interval [0.4, 2.1], p = 0.8); BI < 60, OR
0.85 (95%CI [0.4, 1.8], p = 0.7). Time-to-treatment did not influence
effect on outcome. There were more patients with a serious adverse event
in the G-CSF group (29.6% versus 7.5%, p = 0.051) with no significant
difference in all-cause end-of-trial mortality (G-CSF 11.2%, placebo
7.6%, p = 0.4).
Conclusion: G-CSF did not significantly improve stroke outcome in this
individual patient data meta-analysis, and may have increased serious
adverse events.
ESOC-0019
05. Pooled Analysis and Metanalysis
Outcome of stent-retriever thrombectomy in acute
basilar artery occlusion: A clinical registry and
meta-analysis
R Riva1, B Gory1, M Rabilloud2, P E Labeyrie1, N Nighoghossian3,
F Turjman1
1Interventional Neuroradiology, Hôpital Neurologique Pierre
Wertheimer, Bron, France
2Biostatistics, Hospices Civils de Lyon CNRS UMR 5558, Bron,
France
3Stroke Unit, Hôpital Neurologique Pierre Wertheimer, Bron,
France
Background and Purpose: Basilar artery occlusion (BAO) remains one of
the most devastating subtypes of stroke with dismal natural course, car-
rying 90% mortality if not recanalized, even with fibrinolytic therapy.
Recanalization is the most powerful predictor of favorable outcome in
patients with stroke, and may be improved with mechanical thrombec-
tomy (MT) using stent retriever device. However, the benefit in functional
outcome and safety of MT has not been fully examined. The aim of this
study was to determine efficacy and safety profiles of stent retriever MT in
BAO stroke patients.
Methods: We analyzed data retrospectively from our consecutive clinical
series and conducted a systematic review of all previous studies of stent
retrievers MT in BAO stroke patients between November 2010 and April
2014.
Results: From March 2010 to March 2013, 22 patients with acute BAO
were treated with Solitaire stent retriever device in our series. The litera-
ture search identified 15 previous studies involving a total of 312 subjects.
In the meta-analysis, including our series data, the recanalization rate
(TICI score ≥2b) reached 81% (95% CI, 73–87). The rate of symptomatic
intracranial hemorrhage was 4% (95% CI, 2–8), favorable outcome (mRS
≤2 at 3 months) was found in 42% (95% CI, 36–48) and mortality rate was
30% (95% CI, 25–36).
Conclusions: MT with stent retriever is a safe treatment modality for
patients presenting with acute BAO, and might represent a relevant strat-
egy for recanalization therapy, mainly in the presence of contraindications
or resistance to intravenous thrombolysis.
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ESOC-1013
05. Pooled Analysis and Metanalysis
The importance of a multidisciplinary approach to
dysphagia in acute stroke
M Guillan1, J Fernandez-Ferro1, L Martin-Gil1, N Barbero1,
B Garcia-Botran2, R Gutierrez-Fonseca2, J Pardo-Moreno1
1Stroke Unit, Hospital Universitario Rey Juan Carlos, Madrid,
Spain
2Dysphagia Unit, Hospital Universitario Rey Juan Carlos,
Madrid, Spain
Objectives: Acute stroke is the most common cause of oropharyngeal
dysphagia. It affects 37–78% of stroke patients and increases the risk of
aspiration pneumonia (APn). We aim to compare the incidence of APn
before and after the implementation of a protocol for dysphagia screening
(DS).
Material and Methods: The study period extended from September 2013
to June 2014. The protocol was implemented in February 2014. Different
clinical parameters were compared retrospectively between groups
(preDS: up to February 2014; postDS: after February 2014). Patients were
divided in those with little or nule presumptive risk of APn, screened
through the modified water swallowing test; and those with medium or
high presumptive risk of APn, screened by a pre-trained nurse through the
volume-viscosity swallow test (V-VST). This nurse also established the
need for further invasive screening tools (videoendoscopy and/or video-
fluoroscopy) and adapted diet consistencies individually.
Results: 178 patients were included: 78 preDS/100 postDS. Groups were
comparable in age, sex, stroke severity and affected hemisphere. Dyspha-
gia was present in 37.7% preDS and 36% postDS. Prevalence for pneu-
monia was of 32% preDS and 10% postDS (OR = 4.2; p = 0.0002). The
mortality rate was 16.6% preDS and 10% postDS (p = 0.09). No difference
in hospital stay was found. The V-VST showed a reliability 94.4%.
Conclusions: In our series, implementing a dysphagia screening protocol
including a pre-trained nurse for the correct identification and manage-
ment of dysphagia was associated with lower rates of pneumonia after
stroke.
ESOC-0618
05. Pooled Analysis and Metanalysis
Patient reported outcome measures for visual
impairment after stroke: A systematic review
L Hepworth1, F Rowe1, R Harper2, K Jarvis3, T Shipman4,
H Rodgers5
1Health Services Research, University of Liverpool, Liverpool,
United Kingdom
2Manchester Royal Eye Hospital, Central Manchester
University Hospital NHS Foundation Trust, Manchester, United
Kingdom
3School of Health Sciences, University of Liverpool, Liverpool,
United Kingdom
4Directorate of Ophthalmology, Sheffield Teaching Hospitals
NHS Foundation Trust, Sheffield, United Kingdom
5Institute of Neuroscience and Institute for Ageing, Newcastle
University, Newcastle upon Tyne, United Kingdom
Patient reported outcome measures (PROMs) are important tools in iden-
tifying and highlighting the impact of clinical conditions on individuals
daily lives. We sought to identify PROMs for use in research and clinical
practice involving individuals with visual impairment following stroke, to
evaluate their content validity against quality assessment criteria and to
collate key items across vision- and health-related categories to form the
basis for a single stroke/vision PROM.
In order to identify existing PROMs we searched scholarly online
resources and hand searched articles. Data was extracted relating to the
development and validation of the included instruments. The quality of
the development process was assessed using a modified PROM quality
assessment tool. Through clinician and stroke survivor surveys, data was
extracted for key items across a range of vision- and health-related
categories.
Thirty-four vision-specific PROMs were relevant and available to be ana-
lyzed in this review. Quality appraisal identified four highly rated instru-
ments: NEI-VFQ, AI, DLTV and VA-LV-VFQ. All instruments have only
been used with either a limited number of stroke survivors or a sub-
population. Over 600 items were identified across 20 categories, these
were reduced to 100 items following a rating process with clinicians and
stroke survivors input.
No instruments were identified which specifically targeted visual impair-
ment following stroke. Further research is required to refine the 100 items
which a population of stroke survivors with visual impairment considered
to be of most importance. The validation of a combination of instruments
or a new instrument for use with this population is required.
ESOC-0108
05. Pooled Analysis and Metanalysis
Prognostic value of 24-h ABPM in acute ischemic
stroke: A systematic review and meta-analysis
N Kakaletsis1, G Ntaios2, H Milionis3, A B Haidich4, K Makaritsis2,
C Savopoulos1, E Berge5, A I Hatzitolios1
1First Propedeutic Department of Internal Medicine, AHEPA
University Hospital, Thessaloniki, Greece
2Department of Medicine, University of Thessaly, Larissa,
Greece
3Department of Internal Medicine, University Hospital of
Ioannina, Ioannina, Greece
4Department of Hygiene and Epidemiology, Aristotle
University of Thessaloniki, Thessaloniki, Greece
5Department of Internal Medicine, Oslo University Hospital,
Oslo, Norway
Background and Purpose: The association of blood pressure (BP) levels
during the acute phase of ischemic stroke with outcome remains contro-
versial. The objective of this systematic review is to assess the predictive
value of systolic (SBP) and diastolic BP (DBP), measured by ambulatory
blood pressure monitoring (ABPM) methods during the acute phase
of ischemic stroke, compared to the value of casually derived BP
measurement.
Methods: We searched for studies with patients admitted within 24 hours
of stroke onset, and who had ABPM during the first 24 hours of admis-
sion. We identified studies that reported BP in those with good outcome
and in those with poor outcome at end of follow-up, and performed a
meta-analysis of the association between mean BP and BP variability on
outcome.
Results: High SBP and DBP levels derived with ABPM during the first 24
hours were associated with poor short-, medium- and long-term
outcome, but the same was not found for casual BP measurements. An
increase in SBP of 9.1 mmHg (95%CI: 6.6–11.6, p < 0.001; I2 = 9%) and
an increase in DBP of 2.3 mmHg (95%CI: 0.8–3.7, p = 0.002; I2 = 0%)
was associated with poor outcome. A decrease of BP during night was
associated with good outcome. BP variability in the acute phase was not
significantly associated with outcome after stroke.
Conclusions: Higher SBP and DBP levels derived with ABPM in the acute
phase of stroke were associated with poor outcome. The same was not
found for higher casual BP measurements on admission, and it is possible
that ABPM conveys better prognostic information.
Abstracts
© 2015 The Authors.
International Journal of Stroke © 2015 World Stroke Organization Vol 10 (Suppl. 2); April 2015; 77–438 107
ESOC-0067
05. Pooled Analysis and Metanalysis
Young-aged stroke in Korea: Changing patterns of risk
factors and etiologies
H Kim1, J S Kim1, BJ Kim1
1Neurology, Asan Medical Center Seoul, Seoul, Korea
Although the etiologies of young-age stroke may change over time, the
changing patterns of etiologies have been rarely investigated. Acute isch-
emic stroke patients aged between 15 to 44 years were enrolled from 2009
to 2013 in Asan Medical Center. The results were compared with similarly
designed study results from 1994 to 1997.
In results, the proportion of young age stroke (252 of 4581 (5.5%, vs.
9.7%) and that of male patient (64.7%, vs. 75.2%) decreased. While
smoking (57.7% vs. 67.0%) and drinking (32.5% vs. 41.1%) rates were
reduced in male patients, they increased in female patients. The preva-
lence of diabetes and dyslipidemia increased in both genders. The pro-
portion of large artery atherosclerosis declined (1.7%, vs. 25.9%) in men,
while increased in women (13.5%, vs. 5.4%). Other determined etiology
proportion increased (39.3%, vs. 26.8%) and among that, dissection rates
increased (23%, vs. 10.7%). 3-teslor high resolution vessel-wall MRI has
been used since January, 2010.
Compared to the previous study, the proportion of male to female ratio
decreased. While smoking and drinking rates decreased in male, metabolic
risk factors such as diabetes and dyslipidemia increased in both genders,
which explain the increasing proportion of large artery atherosclerotic
disease in female patients. The proportion of strokes associated with
artery dissection increased, which may be due to the use of advanced
diagnostic tools. Our data show that etiologies in young age strokes
change depending on the changing risk factor profiles and extensiveness
of advanced diagnostic work up.
ESOC-0493
05. Pooled Analysis and Metanalysis
Test properties of informant (proxy)-based cognitive
screening tools when used in stroke settings
A McGovern1, N Mishra2, Y Fan3, T Quinn4
1Greater Glasgow and Clyde, NHS, Glasgow, United Kingdom
2Stanford University, Stanford Stroke Center, Stanford, USA
3Department of Neurology, First affiliated hospital of Sun
Yat-sen University, Guangdong, China
4University of Glasgow, Institute of Cardiovascular Sciences,
Glasgow, United Kingdom
Background: Assessing cognition through structured interview with
family or caregiver is frequently employed in stroke. We sought to collate
the evidence on test properties of these informant based assessments.
Method: We performed systematic review of the literature, following best
practice as outlined in Cochrane Diagnostic Test Accuracy guidance. We
created sensitive search terms based on concepts of “stroke”; “informant
assessment” and “dementia/cognition” and searched multiple cross-
disciplinary, international electronic databases. We included studies where
an informant assessment was compared against a reference standard of
dementia/multi-domain cognitive impairment. We assessed potential bias
using QUADAS2 and reporting quality using STARDdem. A priori we
described three potential uses of informant assessments: diagnosis of
pre-stroke dementia; contemporaneous diagnosis of dementia or as prog-
nostic tool assessed against prospective dementia.
Results: From 1830 titles, we assessed 189 abstracts and included 10
studies. All papers used the Informant Questionnaire on Cognitive
Decline in the Elderly (IQCODE). There was substantial heterogeneity
and we did not attempt to pool results (Table 1). No papers scored “low
risk of bias” on all QUADAS-2 items, areas of concern were around patient
flow/loss to follow up and the application of the IQCODE. Reporting
quality was variable, no paper reported all items recommended in
STARDdem.
Conclusions: There is a limited literature on informant cognitive assess-
ments in stroke. We found no papers describing test accuracy of IQCODE
for diagnosis of pre-stroke cognitive decline, albeit the scale is commonly
used for this purpose in trials and clinical practice.
ESOC-1252
05. Pooled Analysis and Metanalysis
Quality of life after acute ischemic stroke: Analysis of
utility data from the Virtual International Stroke Trials
Archive (VISTA)
M Ali1, R Fulton1, T Quinn1, P M Bath2, D L Veenstra3, Y Xu4,
M Brady on behalf of the VISTA Collaboration5
1Institutes of Cardiovascular and Medical Sciences, University
of Glasgow, Glasgow, United Kingdom
2Division of Stroke Medicine, University of Nottingham,
Nottingham, United Kingdom
3Department of Pharmacy, University of Washington, Seattle,
USA
4Genentech Inc., San Francisco, USA
5NMAHP Research Unit, Glasgow Caledonian University,
Glasgow, United Kingdom
Background: Health utility (HU) estimates are used in cost-utility analy-
ses to assess the economic value of interventions. For stroke, HU data have
been generated using modest sample sizes and homogenous populations,
limiting generalizability and clinical application. The ideal would be inter-
national HU data that map across all possible functional outcomes.
Methods: We estimated mean HU values for modified Rankin Scale
(mRS) levels 0–5 at 3 months after stroke, using corresponding EQ-5D
data from the Virtual International Stroke Trials Archive (VISTA). HU
estimates were generated using the time trade-off method and validated
using ordinary least squares regression, adjusting for age and baseline
NIHSS. We generated both country-specific and exemplar HU estimates
to describe expected variability when applying a single value set to an
international trial population.
Results: We analyzed data from 3,858 patients with acute ischemic stroke
(mean age: 68.8 ± 12.6, baseline NIHSS: 12 ± 9). HU estimates progres-
sively worsened with increasing disability. Application of country-specific
value sets revealed little between-country variation in HU values for mRS
of 0–2, but increased variation with poorer mRS. Application of country-
specific value sets to the whole dataset demonstrated similar HU values
and stability for mRS of 0–2, and increased variation at levels 3–5
(Table 1).
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Conclusions: These data can inform cost-utility studies by providing
robust HU estimates for countries typically represented in acute stroke
trials for each level of mRS at a common trial end point.
Table 1 HU generated using country-specific value sets. Utilities displayed
as mean (StdDev)/N.
ESOC-1003
05. Pooled Analysis and Metanalysis
Lipoprotein (A) and ischemic stroke – An updated
meta-analysis
A H Nave1, C S Lange1, C O Leonards1, W Doehner1, M Endres1,
M Ebinger1
1Neurology, Center for Stroke Research Berlin (CSB), Berlin,
Germany
Background and Purpose: Ischemic stroke correlates with traditional car-
diovascular risk factors, but the etiology frequently remains unknown.
Lipoprotein (a) [Lp(a)] presumably has atherogenic and vascular inflam-
matory potential. However, the literature on Lp(a) as a risk factor for
stroke is still controversial.
Methods: A systematic literature search was performed for case control
studies and prospective cohort studies published after June 2006. Associa-
tions between Lp(a) serum levels and ischemic stroke from adjusted odds
ratios (OR) were calculated in random effect meta-analyses. Results were
merged with a previous meta-analysis which included studies prior to
2006. A mixed effect meta-regression was performed to locate sources of
heterogeneity.
Results: 34 potentially relevant articles were identified, 12 of which were
eventually eligible for analyses. A total of 63423 subjects and 4940 stroke
events were included in the meta-analyses. The pooled estimated OR was
1.41 (95% CI, 1.26–1.57, p < 0.01) for case control studies and 1.14 (95%
CI, 0.97–1.34, p = 0.11) for prospective cohort studies, with significant
heterogeneity being present. Subgroup analyses demonstrated a sex-
specific risk difference with an estimated pooled OR of 2.40 (95% CI,
1.69–3.41, p < 0.01) for men and 1.49 (95% CI, 1.09–2.04, p = 0.01) in
women.
Conclusions: This meta-analysis underlines the importance of Lp(a) as a
risk factor in ischemic stroke and highlights Lp(a) as a stronger risk factor
in men compared to women. Sufficiently powered studies with standard-
ized reporting should target subgroups of stroke patients and confirm the
sex-specific risk differences of Lp(a). Future interventional trials are
needed to assess causality of Lp(a) in ischemic stroke.
ESOC-0349
05. Pooled Analysis and Metanalysis
Meta-analysis of the efficacy of neuroprotective drugs
in experimental stroke studies, early phase and phase
iii clinical trials
A Schmidt1, J Wellmann2, N M Bruckmann1, J K Strecker1,
K Diederich1, J Minnerup1
1Department of Neurology, University of Münster, Münster,
Germany
2Institute of Epidemiology and Social Medicine, University of
Münster, Münster, Germany
Background: Many experimental studies have shown beneficial effects of
neuroprotective drugs in animal models of stroke, whereas only a few
clinical trials have yielded positive results. We aimed to determine the
efficacy of neuroprotectants in experimental studies, early phase and
phase III clinical trials by means of a meta-analysis. Moreover, we aimed to
identify study characteristics of experimental studies associated with
correct prediction of subsequent clinical trials.
Methods: We identified phase III clinical trials and corresponding experi-
mental studies and early phase clinical trials of neuroprotective drugs for
ischemic stroke. Two reviewers independently extracted data on infarct
size, neurological outcome and study characteristics (e.g. randomization,
blinded outcome assessment, co-administration of rtPA, and the use of
animals with comorbidities). We determined the overall efficacy of neu-
roprotective drugs in experimental studies, early phase and phase III
clinical trials. Meta-regression analyses will be performed to identify study
characteristics of experimental studies associated with correct prediction
of subsequent clinical trials.
Results: We identified 47 phase III clinical trials, more than 70 corre-
sponding early phase clinical trials, and more than 180 corresponding
experimental studies. Seventy-seven percent of experimental studies
reported a significantly reduced infarct volume or significantly improved
functional outcome in at least one treatment arm. By contrast, there was
only one positive phase III study, which was followed by a larger negative
study.
Conclusion: Our study illustrates the efficacy decline from experimental
studies to phase III clinical trials. Regression analyses shall identify char-
acteristics of experimental studies associated with correct prediction of
subsequent clinical trials.
ESOC-0802
05. Pooled Analysis and Metanalysis
Beta-blockers, pneumonia and outcome after ischemic
stroke: Evidence from VISTA
M Sykora1, P Siarnik2, J Diedler3
1Department of Neurology, St. Johns Hospital Vienna, Vienna,
Austria
2Department of Neurology, University Bratislava, Bratislava,
Slovakia
3Department of Neurology, University Tübingen, Tübingen,
Germany
Background: Beta-blocker therapy (BB) has been suggested to have neu-
roprotective properties and to decrease infectious complications after
stroke. We aimed to examine the effects of pre- and on-stroke BB exposure
on mortality, functional outcome, and pneumonia after ischemic stroke.
Methods: Data including standard demographic and clinical variables as
well as pre-stroke and on-stroke antihypertensive medication, incidence
of pneumonia, functional outcome defined using modified Rankin Scale
(mRS) and mortality at 3 months were extracted from the Virtual Inter-
national Stroke Trials Archive. For statistical analysis multivariable
Poisson regression was used.
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Results: 5212 patients were analyzed. 1155 (22.2%) patients were treated
with BB before stroke onset and 244 (4.7%) patients were newly started
with BB in the acute phase of stroke. Mortality was 17.5%, favorable
outcome (defined as mRS 0–2) occurred in 58.2% and pneumonia in
8.2% of patients. Pre-stroke BB showed no association with mortality.
On-stroke BB was associated with reduced mortality (adjusted RR 0.63, CI
0.42–0.96). Neither pre-stroke BB nor on-stroke BB showed an associa-
tion with functional outcome. Both pre-stroke and on-stroke BB was
associated with reduced frequency of pneumonia (adjusted RR 0.77, CI
0.6–0.98 and RR 0.49, CI 0.25–0.95).
Conclusion: In this large non-randomized comparison, on-stroke BB was
associated with reduced mortality. Pre-stroke and on-stroke BB were
inversely associated with incidence of nosocomial pneumonia. Random-
ized trials investigating the potential of beta-blockade in acute stroke may
be warranted.
ESOC-0241
05. Pooled Analysis and Metanalysis
Diagnostic accuracy of transcranial doppler for brain
death confirmation: Systematic review and
meta-analysis
G Tsivgoulis1, J Chang2, A H Katsanos1, C Zompola1,
M Chondrogianni1, C Liantinioti1, G Papadimitropoulos1,
A W Alexandrov2, M D Malkoff2, A V Alexandrov2
1Second Department of Neurology “Attikon” University
Hospital, School of Medicine University of Athens, Athens,
Greece
2Department of Neurology, University of Tennessee Health
Science Center, Memphis, USA
Background: The latest guidelines from the American Academy of Neu-
rology state that there was insufficient evidence for determining brain
death with ancillary tests. Transcranial Doppler (TCD) is a useful ancillary
test for brain death confirmation because it is safe, non-invasive, and done
at bedside. TCD confirms brain death by evaluating for cerebral circula-
tory arrest (CCA). Case series studies have generally reported good cor-
relations between TCD confirmation of CCA and clinical confirmation of
brain death.
Methods: We conducted a systematic review of the literature from 1987 to
2014 and a diagnostic test accuracy meta-analysis according to PRISMA
guidelines to compare the sensitivity and specificity of TCD confirmation
of CCA, using clinical confirmation of brain death as the gold standard.
Results: We identified 21 eligible studies for a total of 1596 patients.
Pooled sensitivity and specificity estimates from 11 study protocols that
reported data for the calculation of both values were 0.89 (95% CI: 0.86–
0.91) and 0.98 (95% CI: 0.96–0.99) respectively. Between-study differ-
ences in the diagnostic performance of TCD were found for both
sensitivity (I2 = 71.2%; p < 0.001) and specificity (I2 = 76.1%; p < 0.001).
Threshold effect was not significant (Spearman r = −0.173; p = 0.612).
The Area Under the Curve with the corresponding standard error (SE)
was 0.977 ± 0.013, while the Q* ± SE was estimated at 0.933 ± 0.023.
Conclusions: Our findings indicate that TCD is a highly accurate ancillary
test for brain death confirmation. However, TCD evaluates CCA rather
than brainstem function and this limitation should be taken into account
when interpreting the results of this meta-analysis.
ESOC-0242
05. Pooled Analysis and Metanalysis
The diagnostic yield of transesophageal
echocardiography in patients with cryptogenic
cerebral ischemia: A systematic review and
meta-analysis of prospective observational studies
A H Katsanos1, S Giannopoulos1, A Frogoudaki2, A R Vrettou2,
C Liantinioti3, M Chondrogianni3, A Roussopoulou3, K Vadikolias4,
A P Kyritsis1, G Tsivgoulis3
1Department of Neurology, School of Medicine University of
Ioannina, Ioannina, Greece
2Second Department of Cardiology “Attikon” University
Hospital, School of Medicine University of Athens, Athens,
Greece
3Second Department of Neurology “Attikon” University
Hospital, School of Medicine University of Athens, Athens,
Greece
4Department of Neurology, School of Medicine Democritus
University of Thrace, Alexandroupolis, Greece
Background: The diagnostic utility of transesophageal echocardiography
(TEE) in patients with cryptogenic ischemic stroke (IS) or transient isch-
emic attack (TIA) remains controversial.
Methods: We performed a systematic review and meta-analysis to esti-
mate the pooled prevalence (with the corresponding 95% confidence
intervals) of possible cardioembolic causes detected by TEE in prospective
observational studies of patients with cryptogenic IS and/or TIA.
Results: We identified 35 eligible studies, comprising 5772 patients (mean
age = 53.6 years, 56.9% males). The most common finding was ascending
aorta and/or aortic arch atheroma [51.2% (27.4%–74.5%)], followed by
patent foramen ovale (PFO) [43.2% (36.3%–50.4%)]. Complex aortic
plaques and large PFOs were reported in 14% (10.2%–18.9%) and 19.5%
(16.6%–22.8%) of TEE evaluations. Atrial septal aneurysm was discov-
ered in 12.3% (7.9%–18.7%) of the TEE examinations, and was signifi-
cantly more prevalent in conjunction with PFO presence (Risk
Ratio = 2.04, 95% CI: 1.63–2.54, p < 0.001). The prevalence of left atrial
thrombus [3.0% (1.1%–8.3%)] and spontaneous echo contrast [3.8%
(2.3%–6.2%)] during TEE examinations was low. In all analyses, except
for large PFO, significant heterogeneity was found (I2 > 60%). After
dichotomizing available studies, using mean age of 50 years as a cut-off
point, PFO was found to be significantly (p = 0.001) more prevalent in
young patients [59.9% (49.4%–69.5%)], when compared with older
patients [35.2% (26.1%–45.6%)].
Conclusion: Routine TEE in patients with cryptogenic IS/TIA identifies
cardiac findings in a large proportion. However, there is marked inter-
study variation in the definition and prevalence of common findings due
to poor inter-rater reliability.
Abstracts
© 2015 The Authors.
International Journal of Stroke © 2015 World Stroke Organization Vol 10 (Suppl. 2); April 2015; 77–438110
ESOC-0329
05. Pooled Analysis and Metanalysis
Transcranial Doppler versus transthoracic
echocardiography for the detection of patent foramen
ovale in cryptogenic cerebral ischemia: A systematic
review and diagnostic test accuracy meta-analysis
A H Katsanos1, S Giannopoulos1, A Frogoudaki2, A R Vrettou2,
M Chondrogianni3, C Zompola3, C Liantinioti3, K Vadikolias4,
AP Kyritsis1, G Tsivgoulis3
1Department of Neurology, School of Medicine University of
Ioannina, Ioannina, Greece
2Second Department of Cardiology “Attikon” University
Hospital, School of Medicine University of Athens, Athens,
Greece
3Second Department of Neurology “Attikon” University
Hospital, School of Medicine University of Athens, Athens,
Greece
4Department of Neurology, School of Medicine Democritus
University of Thrace, Alexandroupolis, Greece
Introduction: The diagnostic value of transthoracic echocardiography
(TTE) in the detection of patent foramen ovale (PFO) in patients with
cryptogenic ischemic stroke (IS) or transient ischemic attack (TIA) has
never been compared with that of transcranial Doppler (TCD) using a
comprehensive meta-analytical approach.
Methods: We performed a systematic literature review according to
PRISMA guidelines to identify all prospective observational studies of
patients with cryptogenic IS and/or TIA that provided both sensitivity and
specificity measures of TTE, TCD or both compared to the gold standard
of transesophageal echocardiography. We presented data in forest plots
and summary receiver operator curves (SROCs), using the Moses-
Littenberg model.
Results: Our literature search identified 34 eligible studies. Pooled sensi-
tivity was found to be greater in TCD (95%; 95%CI: 93–96%) compared
to TTE (41%; 95%CI: 35–47%), while TTE appeared to have higher
pooled specificity (99%; 95%CI: 98–100%) across studies compared to
TCD (87%; 95% CI: 84–89%). No significant heterogeneity across differ-
ent studies (I2 < 60%) was found only for TCD sensitivity measurements.
In the SROCs plot the overall diagnostic yield – expressed with the area
under the curve ± standard error – of TCD appeared to outweigh that of
TTE (0.971 ± 0.005 vs 0.897 ± 0.048).
Conclusions: TCD appears to be more sensitive but less specific compared
to TTE for the detection of PFO in patients with cryptogenic IS or TIA.
ESOC-1583
05. Pooled Analysis and Metanalysis
Inhibitory non-invasive brain stimulation to
homologous language regions may be a useful adjunct
to speech and language therapy in post-stroke
aphasia. An exploratory meta-analysis
B Otal1, M Olma1, U Grittner1, A Flöel1, I Wellwood1
1Centre for Stroke Research Berlin (CSB),
Charité-Universitätsmedizin Berlin, Berlin, Germany
Background: Chronic communication impairment is common after
stroke, and conventional speech and language therapy (SLT) strategies
have limited effectiveness in post-stroke aphasia. Neurorehabilitation with
non-invasive brain stimulation (NIBS) techniques, particularly repetitive
transcranial magnetic stimulation (rTMS) or transcranial direct current
stimulation (tDCS), may enhance the effects of SLT in selected patients,
but there is limited information to guide research and clinical practice.
Methods: We systematically searched electronic databases (PubMed,
Embase, clinicaltrials.com) to update recent comprehensive systematic
reviews which included randomized controlled trials (RCTs) of cathodal
tDCS (Elsner et al., 2013) and low-frequency rTMS (Ren et al., 2014)
applied over the non-lesioned, non-language dominant hemisphere as an
adjunct to SLT in post stroke aphasia. We included search terms “rTMS”
OR “tDCS”, “aphasia” AND “stroke”. Studies were assessed for quality by
PEDro score and exploratory meta-analysis of the inhibitory NIBS trials
considered combinable was undertaken using a random-effects model in
RevMan software.
Results: Searches identified 9 eligible RCTs (215 participants). All studies
had PEDro score ≥6/10. For the main outcome “accuracy of naming (%)”
in language assessment at the end of intervention, exploratory meta-
analysis showed a significant mean effect size of 0.51 (95% CI = 0.24 to
0.79) with NIBS. We found no significant heterogeneity between trials
(I2 = 0%). No adverse events were reported.
Conclusion: Results suggest improved accuracy of naming with SLT and
NIBS over the unaffected non-language dominant hemisphere in post-
stroke aphasia. Larger multicenter RCTs and homogenous intervention
protocols are required to ascertain these results and the long-term clinical
effects.
ESOC-0494
05. Pooled Analysis and Metanalysis
Interventions for post-stroke fatigue: A systematic
review and meta-analysis
S Wu1, M A Kutlubaev2, H Y Chun1, E Cowey3, A Pollock4,
M R Macleod1, M Dennis1, E C Keane5, M Sharpe6, G E Mead1
1Centre for Clinical Brain Sciences, University of Edinburgh,
Edinburgh, United Kingdom
2Department of Neurology Neurosurgery and Medical
Genetics, Bashkir State Medical University, Ufa, Russia
3Nursing & Health Care School, University of Glasgow,
Glasgow, United Kingdom
4Nursing Midwifery and Allied Health Professions Research
Unit, Glasgow Caledonian University, Glasgow, United
Kingdom
5Department of Medicine for the Elderly, Western General
Hospital, Edinburgh, United Kingdom
6Department of Psychiatry, University of Oxford, Oxford, UK
Introduction: Post-stroke fatigue (PSF) affects more than one third of
stroke survivors. Here we systematically reviewed the efficacy of interven-
tions to treat PSF.
Methods: We searched nine online databases and five trial registers in May
2014. We included randomized controlled trials which investigated the
efficacy of any intervention specifically aimed to treat PSF. The primary
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outcome was fatigue severity after treatment. Two authors independently
applied inclusion criteria and extracted data. We calculated standardized
mean differences (SMDs) and pooled results using a random-effects
model.
Results: We retrieved 6839 citations, considered 29 full texts and included
8 trials (n = 455). Two trials (n = 211) were not included in meta-analysis
as both compared two active interventions without a control. The other
six trials (7 comparisons: 5 pharmacological and 2 non-pharmacological
interventions) provided data suitable for meta-analysis. There was a sta-
tistically significant benefit of interventions treating on PSF (n = 244,
SMD = −1.07, 95% confidence interval −1.93 to −0.21), but with substan-
tial heterogeneity (I2 = 87%). The benefit was not seen in trials with low
risk of bias (trials using allocation concealment: SMD = −0.38, 95% CI
−0.80 to 0.04 or trials using blinded outcome assessment: SMD = −1.10,
95% CI −2.31 to 0.11). Subgroup analysis found a significant benefit of
pharmacological interventions (SMD = −1.23, 95% CI −2.40 to −0.06)
and a trend towards benefit of non-pharmacological interventions
(SMD = −0.68, 95% CI −1.37 to 0.02).
Conclusion: There is no robust evidence to inform the treatment of PSF.
Previous trials were small and heterogeneous, and some had a risk of bias.
Further high quality trials are needed.
ESOC-0530
05. Pooled Analysis and Metanalysis
Safety of intravenous thrombolysis among stroke
patients taking new oral anticoagulants – A case
series and systematic review of reported cases
S Shahjouei1, G Tsivgoulis2, R Bavarsad-Shahripour3,
A V Alexandrov4, R Zand4
1Neurology, Tehran University of Medical Sciences, Tehran,
Iran
2Neurology, University of Athens, Athens, Greece
3Neurology, University of Alabama, Alabama, USA
4Neurology, University of Tennessee Health Science Center,
Memphis, USA
Background and Purpose: Current guidelines do not recommend admin-
istration of intravenous tissue plasminogen activator (IV-tPA) to patients
with acute ischemic stroke (AIS) who take new oral anticoagulants
(NOACs). In this study, we present case series of IV-tPA while on NOACs.
We also performed a systematic review of similar reported cases in the
literature.
Subjects and Methods: We reviewed medical records of consecutive
patients on NOACs who received IV-tPA for symptoms of AIS at four
participating stroke centers in the United States and Europe. We also
performed a systematic review of the literature on this topic. Safety end-
points were post thrombolysis symptomatic intracranial hemorrhage
(sICH) or serious systemic bleeding.
Results: Between October 2010 and October 2014, six patients received
IV-tPA for possible AIS while taking dabigatran. None of the patients had
sICH or other extracranial hemorrhagic complications. Literature review
resulted in a total of 25 cases receiving IV-tPA while on NOACs (dabiga-
tran: 14, rivaroxaban: 10, apixaban: 1). Among them, two patients had
sICH and died. Minor and asymptomatic hemorrhagic complications
were reported in five patients. Pooled analysis indicates a sICH rate of
6.7% (95% CI:0–22.4%). PT, INR and aPTT were 14.82 ± 3.30 [10.7–
22.6], 1.21 ± 0.26 [0.9–20.03], and 32.55 ± 6.18 [20.00–46] seconds
(mean ± SD [range]). The mean interval between the last dose of NOAC
and IV thrombolysis was 12 ± 7.8 [4–28.3] hours.
Conclusions: Administration of IV-tPA in stroke patients receiving
NOACs that occurred inadvertently in our study might be justified in view
of observed safety and considering the severity of stroke and the absence
of coagulopathy by conventional tests.
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06. Hyperacute Management
Pre-hospital fast positive cases identified by Dublin
Fire Brigade ambulance paramedics – Final clinical
diagnosis
A Feeney1, T Barry1, D Hayden1, L Higgins1, E Kavanagh2,
P McMahon2, M O’ Reilly3, S P Teeling4, P J Kelly1, S Murphy1
1Acute Stroke Service, Mater Misericordiae University
Hospital, Dublin, Ireland
2Department of Radiology, Mater Misericordiae University
Hospital, Dublin, Ireland
3Lean Health Academy, Mater Misericordiae University
Hospital, Dublin, Ireland
4Ambulance Service, Dublin Fire Brigade, Dublin, Ireland
Objectives: Ischemic stroke clinical outcomes are improved by earlier
treatment with intravenous thrombolysis. Using Lean Health Care meth-
odology, an existing clinical pathway for initial assessment of suspected
acute stroke was updated aiming to shorten ‘door to needle time’. This
audit examines the final clinical diagnosis of ambulance paramedic
indentified FAST positive patients over a 7 month period following imple-
mentation of the new stroke assessment pathway.
Methods: A retrospective analysis of 177 consecutive pre-notified FAST
positive patients presenting between March and November 2014. Patient
demographics, time of presentation, symptoms, initial imaging and final
diagnosis were recorded.
Results: 177 patients (54.8% Male) were included. 95.5% underwent im-
mediate imaging (NCCT Brain and/or CT Angiogram). 67.8% presented
outside normal working hours. In total, 57.1% had a final diagnosis of
acute stroke. Of 41.2% of patients with non-stroke diagnosis, 28.9% had a
neurological diagnosis, which would have warranted acute neuroimaging.
Conclusion: Nearly 60% of FAST positive patients identified by Ambu-
lance Paramedics had a final diagnosis of acute stroke. Two thirds present
out of hours. A significant proportion of non-stroke patients would still
have needed urgent neuroimaging. The current model of ultra-fast assess-
ment of suspected stroke patients in the Emergency Department has
significant staff training and resource implications.
ESOC-0838
06. Hyperacute Management
Neurointerventional treatment conducted by
interventional radiologists in close cooperation with
diagnostic neuroradiologists (The Stavanger
procedure)
G Behzadi1, L Fjetland1, K D Kurz1, M W Kurz2
1Department of Radiology, Stavanger University Hospital,
Stavanger, Norway
2Department of Neurology, Stavanger University Hospital,
Stavanger, Norway
Purpose: Neurointerventional treatment in acute stroke patients are
usually conducted by neurointerventional radiologists. However, there are
too few of such sub-specialists to provide a well covering service in
Norway. Therefore we have established a neurointerventional treatment
where general interventional radiologists perform the intervention in
close cooperation with diagnostic neuroradiologists (“The Stavanger pro-
cedure”). We present the safety and efficacy of our approach.
Material and Methods: A total of 92 acute stroke patients were treated
with neurointervention. Revascularization rate was rated with the Throm-
bolysis in Myocardial Infarction (TIMI) score. Hemorrhage complica-
tions assessed according to the ECASS 2 criteria. For clinical outcome the
National Institutes of Health Stroke Scale scale (NIHSS) was used, long
term outcome appraised by the modified Rankin scale at 90 days (mRS).
Results: Mean patient age was 67.3 years (range 31–92); the average
NIHSS at hospital admission was 17 (range 2–36). Successful recanaliza-
tion was reached in 82.6% of the patients. Procedure-related complica-
tions were seen in 14% of the patients, and 10.3% suffered a symptomatic
intracerebral hemorrhage. Patients who were successfully recanalized had
a significantly better NIHSS postinterventionally (NIHSS 11.4 vs −20.4,
p < 0.001), and at dismissal (NIHSS 7.1 vs 15.5, p = 0.002), a significantly
better outcome at 90 days (mRS 2.7 vs 5.1, p < 0.001), and a reduced
mortality (18.4% vs 50%, p = 0.01).
Conclusion: Our results show that neurointerventional stroke treatment
can be performed by interventional radiologists working in close coop-
eration with diagnostic neuroradiologists. Patients with successful reca-
nalization profit clinically.
ESOC-0394
06. Hyperacute Management
Obstacles and facilitators in emergency calls about
stroke: Nurses’ skills enable identification of stroke
A Berglund1, K Heikkilä2, K Bohm1, K Schenck-Gustafsson3,
M von Euler1
1Department of Clinical Science and Education
Södersjukhuset, Karolinska Institutet, Stockholm, Sweden
2Department of Health and Caring Sciences, Linneaus
University, Kalmar, Sweden
3Department of Gender Medicine, Karolinska Institutet,
Stockholm, Sweden
Background: Early identification of stroke in the emergency call can be
difficult as the patient may be unable to express their symptoms and the
caller generally is a bystander describing the problem by phone. In a
previous study we found fall or lying position to be the dominating
problem in 2/3 of emergency calls concerning acute stroke but not dis-
patched as such. The aim of this qualitative study was to explore obstacles
and facilitators in the identification of stroke in emergency calls where the
patient was reported to have fallen or being in a lying position.
Methods: Transcribed emergency calls concerning 29 patients with stroke
diagnosis presented with fall or lying position, were analyzed using inter-
pretive phenomenological methodology. The study was approved by the
Regional Ethics Board and consent given by the participants.
Findings: Patient’s ability to express themselves, callers’ knowledge of the
patient and stroke, first call-takers’ and nurses’ authority, nurses’ coaching
strategies and nurses’ expertise skills facilitated or hindered the identifi-
cation of stroke. These aspects/factors were partly adjustable, but some
depended on the situation, as well as callers’ and patients’ abilities. The
theme “nurses” expertise skills” was the only found to alone have a decisive
effect of the identification of stroke.
Conclusion: In emergency calls concerning stroke, The first call-taker’s
and nurses’ action, competence and awareness of obstacles can be
improved and strengthened to increase the identification of stroke in
emergency calls. In difficult cases, the expertise skills of the nurses’ are
crucial for identification of the diagnosis.
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Treatment with exenatide in acute ischemic stroke
(TEXAIS)
C Bladin1, T Robinson2, S Coote3, T Frost3, S Daly2, Z Ross2,
PS Loh2, A Gilligan2
1Eastern Health Clinical School, Monash University/The Florey,
Melbourne, Australia
2Eastern Health Clinical School, Monash University,
Melbourne, Australia
3Eastern Health Clinical School, Box Hill Hospital, Melbourne,
Australia
Background: Post-stroke hyperglycemia (PSH) occurs in up to 50% of
ischemic stroke patients with adverse effects on recanalization, infarct size,
long term outcome. Insulin therapies are difficult, cause hypoglycemia,
with no long term benefit. The diabetic drug Exenatide (Byetta, Astrazen-
eca), a glucagon-like peptide-1 (GLP-1) agonist, may be a safer glucose
lowering therapy with fewer side effects.
Methods: Phase II safety and feasibility open label trial with randomiza-
tion of acute ischemic stroke patients into treatment (exenatide 5μg sub-
cutaneously twice daily commenced within 9 hours of stroke onset) or
control (Standard of Care) groups. Exenatide commenced with inclusion
criteria, regardless of admission glucose level, for 5 days. Primary end-
point was the difference between groups in glycemic control measured by
continuous glucose monitor and finger prick glucose. Secondary end-
points were adverse events, modified Rankin Day 90.
Results: n = 17 pts. No significant differences between treatment and
control groups in mean age, sex, risk factors, diabetes (11% vs 14%),
admission NIHSS. Hyperglycemia (≥7 mmol/L) detected in 44% of all
patients. Blood glucose levels consistently lower (with less variable mean
SD) in the exenatide group – Fig. 1. [small sample size, (p = 0.550)]. No
significant difference in 3 month mRS or adverse events – no symptomatic
hypoglycemia, no vomiting in exenatide group.
Conclusions: Exenatide appears to be a safe and effective therapy for the
minimization of PSH. It potentially can be given safely to most patients
presenting with acute ischemic stroke, regardless of admission glucose
level. No major episodes of hypoglycemia. A larger Phase 2/3 efficacy trial
now planned.
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06. Hyperacute Management
Carotid artery transluminal angioplasty and stenting in
patients with acute ischemic stroke which undergo
intraarterial treatment
C Estevez-Fraga1, L Crespo-Araico1, P Agüero-Rabes1,
P Martinez-Ulloa1, P Perez-Torre1, J C Méndez-Cendón1,
E Fandiño-Benito1, C Matute-Lozano1, A De Felipe-Mimbrera1,
J Masjuan-Vallejo1, A Cruz-Culebras1
1Neurology, Hospital Universitario Ramon y Cajal, Madrid,
Spain
Background: Recanalization treatment is crucial for good functional
outcome of acute ischemic stroke patients with carotid artery occlusion or
severe stenosis. Large vessel occlusion show a very limited response to
systemic thrombolysis and endovascular treatment is increasingly used.
Methods: We prospectively analyzed 11 patients with intracranial vessel
occlusion of the anterior circulation simultaneously presenting with high-
grade cervical internal carotid artery (ICA) stenosis or occlusion who
required ICA stenting during the period 2005–2014 (13,7 % of the
patients treated with endovascular treatment for anterior circulation).
Reperfusion was assessed according to the Thrombolysis in Cerebral
Infarction (TICI) score. Clinical outcome was evaluated at 3 months after
treatment by modified Rankin Scale (mRS)
Results: 10 patients were male (ages ranged from 65 to 74; mean: 61).
Most frequent indications for endovascular treatment were unsuccessful
treatment with intravenous alteplase (55%) and wake-up stroke (27%) .
Median NIHSS score at baseline was 12. Successful revascularization was
achieved in 9 patients (81.8%) 1 patient had asymptomatic stent resteno-
sis during follow-up . Only 1 patient had a non fatal symptomatic intrac-
ranial hemorrhage. mRS functional score at 90 days of assessment was 0–2
in 7 patients (63.6%) and 3–4 (36.3%). Mortality rate during the proce-
dure or follow up was 0%.
Conclusion: Endovascular recanalization of acute cervical carotid artery
occlusion was technically feasible and resulted in high extra- and intrac-
ranial revascularization rates with and security rates
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Evaluation of pre-hospital delay and related factors in
stroke patients in a second-level hospital in La
Mancha (Spain)
R García Ruiz1, J Silva Fernández2, R M García Ruiz3,
M Recio Bermejo1, A García Chiclano1, A Mateu Mateu1,
M C Blanco Valero4, J M Tenias Burillo5, E Botia Paniagua1
1Neurology, La Mancha Centro General Hospital, Alcázar de
San Juan, Spain
2Endocrinology, La Mancha Centro General Hospital, Alcázar
de San Juan, Spain
3Nurse, Denia General Hospital, Denia, Spain
4Neurology, La Mancha Centro General Hospital, Badajoz,
Spain
5Research, La Mancha Centro General Hospital, Alcázar de
San Juan, Spain
Background and Purpose: Stroke is the leading cause of disability and the
second most common cause of death in the world. Acute-stroke care is
attracting increasing attention, mostly due to the advent of thrombolysis.
This study investigated the time elapsed between onset of stroke symp-
toms and arrival at the hospital (‘delay’), and which factors are associated
with a shorter delay.
Methods: An observational study was conducted on a sample of consecu-
tive stroke patients diagnosed by a neurologist in our Emergency Depart-
ment between 15th November 2013 and 14th April 2014. Subarachnoidal
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hemorrhage and in-hospital stroke patients were excluded. Descriptive,
bivariate and multivariate analyses were performed.
Results: 138 patients (52.2% male) were included (mean age 73.97 years).
Median delay was 165 minutes (52.2% arrived in less than 180 min; 12.3%
arrived in the first hour). Quantitative and qualitative results are shown in
Figs 1 and 2 respectively. Bivariate analysis is shown in Figs 1–3. Multi-
variate analysis is shown in Fig 3.
Conclusions: The proportion of patients with a delay of up to 180 min
(52.2%) was similar to other recent studies performed in our country.
However, the fraction of those arriving in the first 60 min was significantly
lower. Independent predictors of early arrival (< 180 min) were education
level (primary or higher), stroke type (Total Anterior Circulation Infarct
patients arriving earlier) and the activation of the so called ‘stroke code’.
Risk factors for stroke other than atrial fibrillation or a family history of
stroke did not predict a faster response after stroke onset.
Fig. 1 Bivariate analysis: demographic and circumstantial variables.
Fig. 2 Bivariate analysis: risk factors
Fig. 3 Bivariate analysis: OCSP subtype and stroke severity
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Background and Purpose: Stroke is the leading cause of disability and the
second most common cause of death in the world. Acute-stroke care is
attracting increasing attention, mostly since the advent of thrombolysis.
This study investigated the time elapsed between onset of stroke symp-
toms and arrival at the hospital (delay), and which factors are associated
with a shorter delay.
Methods: An observational study was conducted on a sample of consecu-
tive stroke patients diagnosed by a neurologist in our Emergency Depart-
ment between 15th November 2013 and 14th April 2014. Subarachnoidal
hemorrhage and in-hospital stroke patients were excluded. Descriptive,
bivariate and multivariate analyses were performed.
Results: 138 patients (52.2% male) were included (mean age 73.97 years).
Median delay was 165 minutes (52.2% arrived in less than 180 minutes;
12.3% arrived in the first hour). Independent predictors of early arrival (<
180 minutes) were education level -those with at least primary education
arrived earlier-, stroke type – Total Anterior Circulation Infarct (TACI)
patients arriving earlier – and the activation of the so called ‘stroke code’.
Conclusions: The proportion of patients with an early arrival (52.2%) was
similar to other recent studies performed in our country. However, the
fraction of those arriving in the first hour was significantly lower. Risk
factors for stroke other than atrial fibrillation or a family history of stroke
did not predict a faster response in either bivariate or multivariate analy-
sis. Independent predictors of early arrival were primary education or
higher, the activation of the ‘stroke code’, and TACIs.
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New prehospital stroke scale: The NIHSS-AS
C García-Cabo Fernández1, P Martínez Camblor2,
A I Pérez Álvarez3, J C Martínez Ramos3, L Benavente Fernández3,
J Pascual Gómez3, S Calleja Puerta3
1Neurology, Hospital Universitario Central de Asturias,
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2Biostadistics, Foundation of Research Support in Asturias,
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Background: Our aim is to develop and validate an abbreviated and prac-
tical prehospital stroke scale to be used by medical emergencies physicians
(MEP) and another non- neurologist physicians to predict the presence of
large vessel occlusion (LVO) in patients with acute stroke.
Methods: The NIHSS-Asturias (NIHSS-AS) was designed based on the
National Institutes of Health Stroke Scale (NIHSS) items with strongest
correlation between neurologists and MEP administration according to
kappa index. Scores on the NIHSS were obtained from a cohort of 235
patients with acute ischemic stroke by neurologists and MEP. The
NIHSS-AS scale was validated retrospectively in the same group of
patients by other neurologists. LVO was diagnosed by CT in the first 4,5
hours.
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Results: The model with the highest degree of correlation included the
following items: Speech, Orientation, Gaze and Arm weakness (area
under the curve 0.73). NIHSS-AS scale ≥4 has sensitivity 0.775, and speci-
ficity 0.642 for detecting LVO.
Conclusions: Shortening the NIHSS could facilitate its use during prehos-
pital evaluations. Other short scales have been designed in order to predict
the patient outcome but the NIHSS- AS scale is a simple triage tool that
can predict LVO in patients with ischemic stroke at prehospital setting by
MEP.
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Background/Aims: Early neurological deterioration (END) occurs in
20–40 % of acute ischemic stroke (AIS) patients and has been associated
with worse outcome. Recent improvements in treatment may have
reduced the prevalence of END and the associated worse outcome. The
primary aim of this study was to assess the association between END and
outcome after AIS. Secondary aims were to assess the association between
early deteriorating episode (EDE) and outcome, and the prevalence of
END and EDE.
Methods: 368 patients with AIS treated in our stroke unit were included
and followed upwith assessments including frequently repeated scoring of
selected Scandinavian stroke scale- (SSS) items until 72 hours. Primary
endpoint was mRS at 12 weeks.
END was defined as 2-point decrease in selected SSS-items between
admission and 72 hours. EDE was defined as similar worsening between
two consecutive assessments within 72 hours.
Results: 14.1%of the patients had END. Adjusted for age and stroke sever-
ity, with ORs were 29.7 (7.4–120.6) for death/dependency and 4.6
(1.6–10.6) for death at 12 weeks, compared to patients without END, and
length of stay in hospital was increased by 6.5 days (p < 0.001). 28.0% of
patients had EDE without END, with ORs of 2.2 (1.1–4.7) for death/
dependency and 1.5 1.5 (0.4–5.7) for death, while hospitalization
increased 1.2 days (p=0.011), compared to stable patients.
Conclusion: Both patients with END and patients with EDE without END
have significantly worse prognosis than stable patients, and unstable
patients with END and EDE are still a challenge in acute stroke care.
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Background: Early neurological deterioration (END) after stroke has been
found to be associated with worse outcome. Most END definitions are
based upon NIHSS. Comparisons between END definitions based upon
different stroke scales are scarce. We have performed an END study where
one of the aims was to compare END definitions based upon NIHSS (2
points increase, ENDNIHSS) and 2 points decrease in selected Scandina-
vian Stroke Scale items (European progressing stroke study (EPSS) defi-
nition, ENDEPSS).
Material andMethods: 368 acute ischemic stroke patients admitted to our
stroke unit were included and followed for 3 months, with NIHSS and SSS
every 24 hours from admission until 72 hours, and modified Rankin Scale
(mRS) at 12 weeks as the primary endpoint. Logistic regression analyses
were performed, adjusted for pre-stroke mRS, initial stroke severity and
age.
Results: 14.1% and 8.4% of all patients fulfilled the ENDEPSS criteria and
the ENDNIHSS (p = 0.001), respectively. For ENDEPSS, the adjusted OR
was 29.9 (7.4–120.1) for death/dependency (defined as mRS≥3), and 4.1
(1.6–10.6) for death, and the corresponding estimates using ENDNIHSS
were 7.4 (2.2–24.6) and 3.1 (1.1–9.0). When both ENDEPSS and END-
NIHSS were entered into the same model, the corresponding odds ratios
were 24.5 (5.2–114.9) and 3.4 (1.2–10.1) for ENDEPSS and 1.6 (0.3–7.9)
and 1.5 (0.5–5.2) for ENDNIHSS.
Conclusion: A higher proportion of patients were found with END
according to the EPSS definition than according to the NIHSS definition.
Still, the association between END and poor outcome was stronger for the
EPSS definition than the NIHSS definition of END.
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Objective: Acute basilar artery occlusion (BAO) is associated with high
mortality rate and poor outcome. We investigated outcomes of acute BAO
patients treated with reperfusion therapy using a single–center registry
(ClinicalTrials.gov: NCT02251665).
Methods: Between October 2011 and March 2014, 27 ischemic stroke
patients with acute BAO were admitted within 24 hours after onset.
Among them, patients treated with reperfusion therapy (intravenous
thrombolysis [IVT] and/or endovascular therapy [EVT]) were included.
We evaluated patient background, recanalization rate, favorable outcome
(modified Rankin Scale ≤2) and mortality at 3 months.
Results: Seventeen patients (13 men, 72 ± 12 years old) were included.
Median baseline NIHSS score was 24 [IQR 10-29]) and median onset-to-
treatment time was 92 minutes [IQR 40–200]. IVT was performed in
eleven patients (65%) and 5 of whom underwent subsequent EVT, and
primary EVT was performed in 6 patients. Successful reperfusion (a
modified Mori grade of 3 on MRA within 24 hours) was achieved in 16
patients (94%). Symptomatic intracranial hemorrhage occurred in none.
The 3-month outcomes were favorable in 9 patients (53%) and fatal in 3
patients (18%). These results seemed to be better than those of BASICS
study; the rate of favorable outcome was 22.2% and the mortality rate was
38.6% in patients treated with IVT and/or intra-arterial therapy.
Conclusion: In our stroke center, clinical results of reperfusion therapy in
acute BAO patients were better than those in the previous report. This
may be due to shorter onset-to-treatment time and novel thrombectomy
devices.
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Introduction: We developed and validated the Cincinnati Prehospital
Stroke Severity Scale (CPSSS) to identify patients with severe strokes and
large vessel occlusion (LVO).
Methods: CPSSS was developed based on regression tree analysis, objec-
tivity, ease in administration by EMS personnel, and cortical signs. We
derived and validated the tool using the NINDS t-PA Stroke Trial and IMS
III Trial cohorts, respectively, to predict severe stroke [NIH stroke scale
(NIHSS) ≥15] and LVO (internal carotid artery, M1, tandem M2, or
basilar artery occlusions by angiography prior to IV t-PA therapy). Stan-
dard test characteristics were determined, and receiver operator curves
were generated and summarized by the area under the curve (AUC).
Results: CPSSS items and scoring are shown in the Table 1. In the deriva-
tion set, CPSSS had an AUC of 0.89; score ≥2 was 89% sensitive and 73%
specific in identifying NIHSS of ≥15. Validation results were similar with
an AUC of 0.83; score ≥ 2 was 92% sensitive, 51% specific for severe stroke.
For 222/303 IMS III subjects with LVO, CPSS had an AUC of 0.67; a score
≥ 2 was 83% sensitive, 40% specific, a positive likelihood ratio of 1.4, and
negative likelihood ratio of 0.4 in predicting LVO.
Conclusion: CPSSS can help identify stroke patients with NIHSS≥15 and
LVO.
Table 1 Cincinnati prehospital stroke severity score
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Background: The first positive Phase III trial of acute mechanical throm-
bectomy, MR CLEAN, was published recently. MR CLEAN had broad
eligibility including an NIHSS≥2, but also allowed for patient selection
using clinical judgment (“gray area principle”). We explore how the
NIHSS distribution would have appeared if the gray principle had not
been used, and compare this to the distribution observed in MR CLEAN.
Methods: We ascertained all ischemic strokes seen in all emergency
departments among the 1.3 million Greater Cincinnati/Northern Ken-
tucky (GCNK) population (known to be representative of the US) in
2005. Relevant data were abstracted from patient charts. We first identified
patients with NIHSS ≥2 and IV rtPA-eligible. We then applied estimated
rates of proximal arterial occlusions (PAOs) from the literature.
Results: Among 1,843 ischemic strokes, 286 (15.5%) had an NIHSS≥2 and
were otherwise IV rtPA-eligible. We estimated that 127/1843 (6.8%)
would also have PAOs and have a median NIHSS of 9–12 (vs 18 in MR
CLEAN) (see Table 1).
NIHSS NIHSS NIHSS NIHSS NIHSS
TOTAL2–4 5–8 9–12 13–16 >=17
GCNKSS Total with NIHSS ≥2 and IV rtPA-Eligible 127 (44%) 56 (20%) 35 (12%) 23 (8%) 45 (16%) 286
Estimated PAO rate by NIHSS from literature
(Heldner et al, Stroke, 2013)
18% 39% 66% 85% 87% –
GCNKSS Subset Expected to Have PAOs 23 (18%) 22 (17%) 23 (18%) 20 (16%) 39 (31%) 127
GCNKSS: MEDIAN NIHSS 9–12, IQR <8 to >18
MR CLEAN: MEDIAN NIHSS 18, IQR 14–22 (FULL RANGE 3–23)
Conclusion: Our findings suggest that MR CLEAN trialists’ clinical judg-
ment may have led to the preferential enrollment of patients with higher
NIHSS than would be expected based on the NIHSS≥2 inclusion alone.
Results from upcoming trials and further data from MR CLEAN will likely
inform optimal endovascular eligibility.
Abstracts
© 2015 The Authors.
International Journal of Stroke © 2015 World Stroke Organization Vol 10 (Suppl. 2); April 2015; 77–438 117
ESOC-0749
06. Hyperacute Management
From clinical trials to bedside: Evaluating the transfer
of scientific insights to the “real-world” stroke care in
Germany by comparison of nation-wide administrative
data
C Krogias1, D Bartig2, M Kitzrow3, R Weber4, J Eyding5
1Neurology St. Josef-Hospital, Ruhr University Bochum,
Bochum, Germany
2Drg Market, Osnabrück, Germany
3Neurology Bergmannsheil, Ruhr University Bochum, Bochum,
Germany
4Neurology, Alfried-Krupp-Krankenhaus, Essen, Germany
5Neurology Knappschaftskrankenhaus, Ruhr University
Bochum, Bochum, Germany
Background: Promising advances in stroke medicine have been reported
recently regarding specialized stroke unit (SU) care, expansion of the time
window of iv thrombolysis (IVT), mechanical thrombectomy (MT), and
decompressive hemicraniectomy (DHC) for malignant brain infarction. It
remains unclear to what extent new evidence of therapeutic procedures is
transferred to the “real-world” of everyday hospital care.
Methods: We analyzed epidemiologic and procedural therapeutic trends
of hospitalized acute stroke patients in Germany by the comparison of
administrative hospital data of the years 2008 (n = 219,359) and 2012
(n = 239,394).
Results: Proportion of specialized SU care rose from 43.4% to 56.9%. Rate
of IVT increased from 5.6% to 10.2%. 32% of IVT therapies in 2012 were
performed in patients over 80 years. Number of MT increased exponen-
tially from 298 to 3906 procedures. Number of DHC did not increase
significantly (2008 = 636; 2011 = 796).
Conclusions: A strong momentum in transferring scientific insights to the
“real-world” stroke care in Germany was documented. Increase of IVT
therapy is largely due to the increase of off-label treatment. Almost every
46 th patient <80 years was treated by MT in 2012. Despite proven benefits
in selected patients, utilization of DHC remained almost stable.
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Most guidelines for administration of IV thrombolysis (IVT) to acute
ischemic stroke patients advice to keep systolic blood pressure (BP) below
180/105 mmHg prior the bolus injection. Less is known about optimal
management of BP thereafter. We assessed temporal changes in post-
thrombolytic systolic BP values and their impact on development of
symptomatic intracerebral hemorrhage (sICH).
The study cohort included 1868 consecutive acute ischemic stroke
patients treated with IVT at the Helsinki University Central Hospital
(1995–2012). sICH was defined according to the ECASS-II, NINDS and
SITS criteria. We evaluated BP at baseline, prior IVT, and at 2, 4, 8, 12, 24,
and 48 hours after thrombolysis.
Prevalence of sICH in the cohort was 5.8% (ECASS-II), 8.9% (NINDS)
and 2.5% (SITS). While systolic BP values at baseline and prior IVT were
similar among patients with and without sICH the difference in BP values
at all other time points (except for 24 hours) was associated with sICH.
The corresponding odds ratios per mmHg increase for development
of sICH were ranged from 1.011 (1.001–1.021) to 1.013 (95% CI
1.003–1.023).
Patients with sICH had significantly higher systolic BP values in the
hyperacute phase (2–12 h) and at a later phase (48 h) after IVT.
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Background: Telestroke has benefited patients with difficult access to
thrombolytic therapy for reasons such as geographic distance or limited
resources.
Methods: Three centers serving a population close to 2 million, a tertiary
referral hospital and two community hospitals with a distance between 16
and 110 km from the first one. The video conferencing and data trans-
mission in standard clinical history, analysis and pictures, are performed
in certified digital network and it runs after issuing the consultation. CT
images were validated in JPEG and DICOM to reduce technical delays.
The professionals involved in the project were invited to participate in a
satisfaction survey.
Outcomes: The CT image showed a Kappa index ≥ 0.7 for early signs of
ischemic stroke, ≥ 0.96 for hemorrhage and ≤0.5 to define acute/ subacute
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hypodensity. Clinical Results: 46 patients were treated between January
2009 and December 2013, age 65.3 (±10.2), 26 women (56.5%), median
door-needle time 82.5 (71.5–108 minutes), fibrinolysis time 160 (130–
191.5), initial NIHSS 14.3 (±5.7) and at discharge 10.0 (±6.3), 40% of
patients with Rankin <3 at 3 months, 4 total bleeding, 1 symptomatic
(intervention with improvement), 17% mortality at 3/6 months and 6.5%
in-hospital (total 3 patients). The survey was completed by 34 out of the
60 professionals (56.7%), 11/14 (80%) neurologists from the referral hos-
pital and the means obtained in each dimension exceeded 7.
Conclusions: Telestroke is a useful and safe tool that facilitates the access
of patients to treatment with intravenous t-PA. The model of assistance is
well accepted by the participating professionals.
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Background: The region currently defined as tissue “at-risk” by CT per-
fusion (CTP) includes areas of benign oligemia. Our aim was to determine
CTP parameters and thresholds that would optimally distinguish regions
of “true at risk” tissue destined to infarct from “false at risk” tissue, i.e.
benign oligemia. This would serve to improve CTP-based decision making
in acute stroke management.
Methods: Among acute stroke patients evaluated by multimodal CT
(NCCT/CTA/CTP) we identified those that had not undergone
endovascular/thrombolytic treatment and had follow-up CT. CTP data
were post-processed with the Brain Perfusion application in Intellispace
Portal (Philips Healthcare). Maps of absolute and relative cerebral blood
flow (CBF), cerebral blood volume, mean-transit-time and time-to-peak
were generated. Relative values were obtained by normalization to the
contralateral hemisphere .Follow-up CT was automatically co-registered
to the CTP maps and the final infarct region was manually outlined. For
each patient and for each perfusion parameter we chose the threshold that
would provide 90% sensitivity in identifying “true at-risk” tissue. At this
threshold the specificity, i.e. portion of “false at risk” tissue correctly
identified as oligemia was documented.
Results: Sixty-six acute stroke patients met selection criteria. Relative CBF
was found to identify “true at-risk” tissue more accurately than other
studied parameters. A rCBF threshold of 0.7, providing a sensitivity of
90%, recognized 40% of the “false at risk” tissue as oligemia.
Conclusion: Appropriately thresholded rCBF maps can differentiate
clinically-irrelevant oligemia from tissue destined to infarct.
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Objectives: To analyze the Stroke Code (SC) operation in Catalonia and to
estimate the number of thrombolytic treatments not given due to SC
dysfunctions.
Methods: Observational prospective multicenter study based on by
region-wide registry data of consecutive stroke admissions from April to
June 2013 in all acute-care public hospitals in Catalonia (n = 40). Medical
history, stroke characteristics and severity, and times from onset to atten-
tion by Emergency Medical Services and hospital admission were regis-
tered. Criteria for SC activation were: onset of symptoms within 8 hours
or unknown/awaking, previous functional independency and no age
limit. Potential candidates to intravenous thrombolysis were patients with
ischemic stroke able to be treated within the 4.5 h time window, NIHSS >4
and no formal contraindications such as current anticoagulant treatment
or recent surgery.
Results: 2000 stroke patients were admitted. SC criteria were met by 1233/
2000 (61.7%) patients and SC protocol was activated in 908 (73.6%) of
them. If SC had been activated in all patients with SC criteria the rate of
thrombolysis would have increased from the current 15.6% to 16.3%
of ischemic stroke patients. Most patients not detected by the SC had
minor stroke, posterior territory stroke or wake-up stroke.
Conclusion: There is room for improvement for the SC in Catalonia,
particularly in the detection of minor, posterior and wake-up strokes.
These findings will help to implement training measures for professionals
involved in the SC system. Nevertheless, current rate of thrombolytic
therapy is close to the theoretical maximum according to our data.
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Objectives: To analyze the impact of a regional educational program for
Emergency Medical Services (EMS) directed to implement the RACE
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scale, previously validated to predict large vessel occlusions on the field
(Stroke 2014).
Methods: A 5 hour online training course was designed, including: 1)
clinical features and treatment options for stroke; 2) Stroke Code (SC)
activation criteria; 3) case-based training on the RACE scale. The course
was offered to all the ambulance companies of Catalonia (7.5million
inhabitants) via the central EMS website (http://cvsem.il3.ub.edu/course),
and was fulfilled by 2850 technicians (82% of technicians in our region).
A questionnaire about stroke knowledge was answered before and 3
months after the training program. SC activations, EMS response times,
and the RACE scale score were continuously registered by the EMS coor-
dination center. We compared 3 months before and after the program.
Results: Increasing knowledge of EMS providers (score from 6.6 to 8.3)
and number of SC activations (from 9.5 to 12.6 per 100.000 inhabitants)
were observed after the program, with no significant variation on the
number of reperfusion therapy administered (215 vs. 177 patients). The
RACE scale was evaluated in 62% of all the SC activations in the post-
training period, concurrently to 2 minutes increase on the time elapsed
from EMS alert to hospital arrival (from 49 min to 51 min; p = 0.01).
Conclusion: An educational program for EMS providers improves their
knowledge about stroke and allows the implementation of the RACE
scale, a fast and easy-to-administer prehospital scale. In addition, the
training program boosted up SC activations.
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Introduction: Since the use of tissue plasminogen activator for acute isch-
emic stroke, stroke care pathways have been developed for patients with a
suspicion of acute stroke.
Methods: The aim of this prospective study is to analyze the differential
diagnosis (DD) of neurovascular diseases in patients included in the
stroke care pathway of Strasbourg university hospital (France). All con-
secutive patients admitted in this pathway within a one-year period were
prospectively enrolled in this study. The stroke code was activated by
calling the 15 number for patients with an acute neurological deficit
within the time window for intravenous thrombolysis. A clinical neuro-
logical evaluation and a brain MRI with 3D-TOF-MRA were performed in
all patients.
Results: There were 1361 consecutive patients admitted for a suspicion of
acute stroke. Sixty-two per cent (n = 840) had a neurovascular diagnosis
including ischemic stroke (n = 529), transient ischemic attack (n = 236),
intracranial hemorrhage (n = 68), cerebral venous thrombosis (n = 3) and
neurovascular medullar pathology (n = 4). DD represented 38% of cases
(n = 521) and the most frequent discharge diagnosis were migraine with
aura (17.2%), psychological disorder (16.7%), peripheral vertigo (11.9%)
and epilepsy (10.6%).
Conclusion: A rate of DD of neurovascular diseases up to 38% confirms
the difficulty to distinguish clinically a stroke from another diagnosis. This
result highlights that cerebral MRI is expected in all patients with acute
neurological symptoms. Stroke care pathway initially developed to select
patients with ischemic stroke for a thrombolysis treatment offers the
advantage to evaluate DD of stroke.
ESOC-0119
06. Hyperacute Management
12-month data on frequency and pattern of stroke
chameleons in Bradford Royal Infirmary, UK
H Ramadan1, C Patterson1, S Maguire1, I Melvin1, I Adamson2,
K Kain3, E Teale4, D Werring5, A Forster4
1Neurology Department, Bradford Teaching Hospitals NHS
Foundation Trust, Bradford, United Kingdom
2Department of Health Sciences, University of York, York,
United Kingdom
3Division of Cardiovascular & Diabetes Research, University of
Leeds, Leeds, United Kingdom
4Academic Unit of Elderly Care and Rehabilitation, University
of Leeds, Leeds, United Kingdom
5Brain Repair & Rehabilitation, UCL Institute of Neurology,
London, United Kingdom
Sometimes patients with a final stroke diagnosis present with symptoms
suggestive of a non-cerebrovascular cause, and have been labeled ‘stroke
chameleons (SC)’ (1,2). Delayed or incorrect stroke diagnoses have impli-
cations for therapy and outcome. Since we are not aware of any systematic
published data on SC incidence, we aimed to determine incidence and
nature of SC in our single center serving a catchment population of
273,327 adult inhabitants.
We prospectively studied consecutive suspected stroke presentations
(aged ≥18 years), from 01/05/2013 to 30/04/2014. A final diagnosis was
made by a stroke specialist, taking into account all available clinical infor-
mation and diagnostic tests.
A total of 916 patients were assessed. 252 (28%) stroke mimics were
diagnosed, leaving 664 (72%) confirmed strokes. 19 of 664 (2.8%) con-
firmed strokes presented initially as SC; a crude incidence rate of 6.95/
100,000 person years. Of SC patients, 58% were female; the mean age was
74 years (range 24 to 93). The commonest presenting symptoms were
acute confusional state, headache and vertigo, initially diagnosed as
delirium, migraine, and acute labyrinthitis respectively. The average delay
from admission to final stroke diagnosis was 5.5 days. The arterial terri-
tories involved were vertebro-basilar (72%), and MCA (28%). The right
cerebral hemisphere was affected in 80%. One ICH also initially presented
as SC.
The crude incidence of SC was 6.95/100,000 person year. The delay from
admission to diagnosis may have resulted in patients not receiving appro-
priate care including thrombolysis. Training of health professionals might
improve recognition of SC in the A&E, warranting further research.
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12-month data on frequency and pattern of stroke
mimic diagnosis in a district general hospital in the UK
H Ramadan1, C Patterson1, S Maguire1, I Melvin1, J Adamson2,
K Kain3, E Teale4, A Forster4
1Neurology, Bradford Teaching Hospitals NHS Foundation
Trust, Bradford, United Kingdom
2Health Sciences, University of York, York, United Kingdom
3Division of Cardiovascular & Diabetes Research, University of
Leeds, Leeds, United Kingdom
4Academic Unit of Elderly Care and Rehabilitation, University
of Leeds, Leeds, United Kingdom
Background: There is considerable variation in the reported incidence of
stroke mimics (SM), depending on the timing, referral source, the service
setting, and lack of a standardized definition. We aimed to determine the
frequency and nature of SM diagnosis in our center (catchment popula-
tion 273,327).
Method: We prospectively studied all consecutive suspected stroke pre-
sentations (aged ≥18 years) from 01/05/2013 to 30/04/2014 referred to the
DGH. A final diagnosis of stroke or SM was made by a stroke specialist.
Results: A total of 916 patients were assessed. 664 (72%) consecutive acute
stroke (Infarction, ICH and SAH) and 252 (28%) SM presentations by 241
patients were diagnosed. Among the 252 SM patients; 55% were female
with mean age 62 years (range 17–98), Brain imaging was carried out in
90% (CT 54%, MRI 36%) of SM patients. Functional neurological disor-
der (FND) (22.2%), migraine (12.3%), seizure (8%) and sepsis (7%)
accounted for 50% of all SM diagnoses. The breakdown of the causes of
SM is shown in Fig. 1.
Conclusions: 28% of patients referred with suspected stroke were eventu-
ally diagnosed as SM; this is in line with other studies. However, in our
cohort the FND and migraine are the first and second commonest causes
of SM as opposed to seizure and syncope in a recent systemic review.
Training of health professionals might improve recognition of SM in the
A&E, warranting further research.
ESOC-0666
06. Hyperacute Management
The role of relatives in help-seeking for patients with
stroke/TIA: Results from Stroke and TIA Awareness and
Response to Symptoms (STARS) study
E Abbey1, N Rugg1, N O O R Sharrack1, A Majid1, K Harkness1,
J Redgrave1
1Neurology, University of Sheffield, Sheffield, United
Kingdom
Background: 999 calls for stroke are usually made by the patients’ spouse
or another relative. However the relatives’ role in early symptom recogni-
tion and in decisions to call for help is unclear.
Method: We interviewed 214 consecutive stroke/TIA patients (and/or
their relatives) presenting to the stroke unit at Royal Hallamshire Hospital,
Sheffield in May to June and Aug to Oct 2014. Our hospital is the sole
provider of hyper-acute stroke services for a catchment population of
approximately 500,000.
Results: 123 (57.5%) patients were with someone else at symptoms onset
e.g. spouse/partner (30.4%) or son/daughter (26.7%). In 47 (22%) cases
the relative noticed the symptoms before the patient did. In 158 (73%) the
first call for medical help was made by a relative, after a median of 30
minutes from symptoms onset. In comparison, when patients made the
first call, they did so after a median 3.3 hours from symptoms onset
(P = 0.02). Relatives who called for help usually rang ‘999 whereas patients
usually rang the GP (P < 0.001). In 66 cases (31%) the relative was solely
responsible for accessing help e.g. because the patient was incapacitated by
the stroke/TIA (59%) or a comorbidity (9.1%) or because the patient
refused to call (21.2%).
Conclusion: Relatives are often first to notice the symptoms of a stroke in
a patient and usually make the first call to medical services for patients
with stroke symptoms. Rapidity of access to stroke care may be improved
if education campaigns (e.g. F.A.S.T.) target the relatives of patients at
high stroke risk.
ESOC-0918
06. Hyperacute Management
Quality of acute stroke care in the 1st stroke unit in
the U.A.E
R Renganathan1, Y Paulucy2, D Somarajan1, A Hassan1,
N Moussa1, K A Siddiqui1
1Department of Neurology, Al Ain Hospital, Al Ain, United
Arab Emirates
2Department of Quality and Safety, Al Ain Hospital, Al Ain,
United Arab Emirates
Objective: The objective of this study was to assess the quality of stroke
care based on STK (Stroke) Measure Set, a standardized performance
measure developed by Joint Commission in collaboration with American
Heart Association/ American Stroke Association (AHA/ASA).
Methods: We prospectively analyzed data from the Stroke registry for a
one-year period starting 01.01.2014. The quality of stroke care in the
stroke unit was measured on the basis of 8 quality indicators STKs
1,2,3,4,5,6,8 and STK 10 from the STK measure set.
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STK set no. Stroke measure
STK-1 Deep vein thrombosis (DVT) prophylaxis
STK-2 Discharged on antithrombotic therapy
STK-3 Patients with atrial fibrillation receiving anticoagulation
therapy
STK-4 Thrombolytic therapy administered
STK-5 Antithrombotic therapy by end of hospital day two
STK-6 Discharged on statin
STK-8 Stroke education
STK-10 Assessed for rehabilitation
Results: 237 stroke patients were admitted of which 84% were ischemic.
Target ranges achieved for STK measure:
STK measure Achieved target range (%)
STK1 87.8
STK2 98.3
STK3 100
STK4 61.1
STK5 98.9
STK6 98.4
STK8 80.2
STK10 95
Expected target ranges were achieved in 6 (STK2,3,4,5,6,10) of 8 STK
measures. The achieved target range would be 100% for STK-4, if the
therapeutic window for thrombolysis is considered to be up to 4.5 hours
instead of 3 hours.
Conclusion: Findings from this study suggest that the quality of care in the
1st Stroke unit in the UAE is high. However, there is room for improve-
ment in documentation of DVT prophylaxis (STK1) and stroke education
(STK8)
ESOC-0613
06. Hyperacute Management
A systematic review of the performance of stroke
recognition instruments in pre-hospital and hospital
settings
M Rudd1, D Buck1, G A Ford2, C I M Price1
1Institute of Neurosciences, Newcastle University, Newcastle
upon Tyne, United Kingdom
2Division of Medical Sciences, Oxford University, Oxford,
United Kingdom
Background: We undertook a systematic review to describe the perfor-
mance of stroke recognition instruments applied prospectively by
clinicians.
Methods: Literature search up to 31/12/2013 by two independent authors.
Figure 1 describes the search adjudication process.
Fig. 1 Study selection process.
Results: Table 1 summarizes 7 included instruments. Study quality and
performance indicators varied widely between studies (Table 2), preclud-
ing formal meta-analysis. Performance varied markedly between studies
of the same instrument particularly specificity, reflecting heterogeneous
setting and design.
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Instrument
Facial
weakness
Arm
weakness
Grip
strength
Speech
problem
Leg
weakness Vision Exclusions
Cincinatti Prehospital Stroke Scale (CPSS) ✓ ✓ ✗ ✓ ✗ ✗ none
Face Arm Speech Test (FAST) ✓ ✓ ✗ ✓ ✗ ✗ glucose <3.5 mmol/l; GCS <7
Los Angeles Prehospital Stroke Scale
(LAPSS)
✓ ✓ ✓ ✗ ✗ ✗ age <45; epilepsy; onset >24 hours;
immobile; glucose <60 or >400 mg/dL
Medic Prehospital Assessment for Code
Stroke (MEDPACS)
✓ ✓ ✗ ✓ ✓ ✓ epilepsy; onset >24 hours; glucose <60 or
>400 mg/dL
Melbourne Ambulance Stroke Scale
(MASS)
✓ ✓ ✓ ✓ ✗ ✗ age <45 yrs; epilepsy; onset >24 hours;
immobility; glucose <60 or >400 mg/dL
Ontario Prehospital Stroke Screening tool
(OPSS)
✓ ✓ ✗ ✓ ✓ ✗ arrival >2 hrs of onset; GCS<10; seizure;
terminally ill; glucose <4 mmol/l
Recognition Of Stroke In the Emergency
Room (ROSIER)
✓ ✓ ✗ ✓ ✓ ✓ glucose <3.5 mmol/l;
Instrument
Number of
studies
Total
patients
Sensitivity
range
Specificity
range
PPV
range
NPV
range
Cincinatti Prehospital Stroke Scale (CPSS) 7 3265 44–95 24–79 40–88 57–96
Face Arm Speech Test (FAST) 7 1529 79–97 13–83 62–89 48–73
Los Angeles Prehospital Stroke Scale (LAPSS) 5 2039 59–91 62–97 79–98 45–98
Medic Prehospital Assessment for Code Stroke (MEDPACS) 1 416 74 33 47 61
Melbourne Ambulance Stroke Scale (MASS) 2 950 83–90 74–85 64–90 74–90
Ontario Prehospital Stroke Screening tool (OPSS) 1 554 89 80 90 88
Recognition Of Stroke In the Emergency Room (ROSIER) 5 1418 83–97 18–83 64–94 33–88
Discussion: A reliable conclusion cannot be drawn about the superiority
of any stroke recognition instrument. Desirable performance characteris-
tics depend upon the intended role of the instrument in the clinical
process and the boundary set for the service population. Differences in the
underlying prevalence of clinical characteristics between cohorts and the
inclusion or exclusion of cases by pre-screening contributed to differences
in sensitivity. Further studies are needed to recommend instruments for
use in specific settings.
ESOC-1538
06. Hyperacute Management
Decompressive craniectomy in malignant medium
cerebral artery infarction
I Sarbochova1, H Magerova1, O Chudomel1, A Tomek1
1Neurology, 2nd Medical School Charles University Prague,
Prague 5, Czech Republic
Decompressive craniectomy (DC) reduces mortality and improves func-
tional outcome in patients with malignant middle cerebral artery
(MMCAI) infarction. Although DC is included in the guidelines, there is
still general uncertainty concerning optimal timing and characteristics of
the suitable patient leading to reluctance to implement it.
Methods: Monocentric retrospective analysis of patients with MMCAI
treated with DC. Clinical outcome was assessed with modified Rankin
Scale (mRS) at 1 and 12 months after stroke, mRS 0-3 was considered as
good outcome.
Results: 14 patients with mean age 60.5 (44–71) years were included.
Mean admission NIHSS score was 17 (9–24), 7 (50%) patients had domi-
nant hemisphere infarction. Etiology was cardioembolic in 5 (36%),
carotid atherosclerosis in 8 (57%) and cryptogenic in one case. 12
patients were treated with recanalization (intravenous thrombolysis,
endovascular). 7(50%) patients had symptomatic hemorrhagic transfor-
mation. Mean time from onset to DC was 52 (12–96) hours. Outcome
assessed at 1 month after DC was poor in all patients – 13 patients had
mRS 5 and 1 died. Final outcome (12 months) was good in 5 (36%), 4
(28%) had severe disability (mRS 4–5) and 5 (36%) patients died.
Conclusion: In agreement with published data one third of our patients
had acceptable outcome. DC outcome should be assessed later than in
other acute stroke trials – optimally at least after 12 months. Poor
outcome was associated with rapid development of swelling and comor-
bidity. We did not observe any influence of hemorrhagic transformation,
age, side of infarction, midline shift or timing of DC.
ESOC-0109
06. Hyperacute Management
The role of mannitol in the management of patients
with severe acute ischemic stroke
K Tziomalos1, S D Bouziana1, M Spanou1, S Kostaki1,
M Papadopoulou1, V Giampatzis1, M Papagianni1, V Dourliou1,
C Savopoulos1, A I Hatzitolios1
1First Propedeutic Department of Internal Medicine, Aristotle
University of Thessaloniki, Thessaloniki, Greece
Background/Aims: Mannitol is frequently administered to patients with
severe acute ischemic stroke, even though no randomized controlled study
evaluated its safety and efficacy. We aimed to evaluate the effects of man-
nitol on the outcome of these patients.
Patients and Methods: We prospectively studied 539 consecutive patients
hospitalized for acute ischemic stroke. Stroke severity was evaluated at
admission with the National Institutes of Health Score Scale (NIHSS). The
outcome was evaluated with dependency rate at discharge (modified
Rankin scale 2-5) and with in-hospital mortality.
Results: Mannitol was administered to 49 patients. These patients had
higher diastolic blood pressure (DBP) and higher serum glucose and
triglyceride levels than patients who did not receive mannitol. Other car-
diovascular risk factors did not differ between the 2 groups. The NIHSS at
admission was higher in patients treated with mannitol (21.7 ± 9.2 vs.
7.0 ± 7.5 in patients who did not receive mannitol; p < 0.001). Among
patients who received mannitol, 46.9% died during hospitalization and all
the rest were dependent at discharge. In binary logistic regression analysis,
independent risk factors for dependency at discharge were age (odds ratio
(OR) 1.12, 95% confidence interval (CI) 1.03–1.22, p < 0.01) and the
NIHSS at admission (OR 1.78, 95% CI 1.47–2.15, p < 0.001). Independent
risk factors for in-hospital mortality were DBP at admission (OR 1.09,
95% CI 1.02–1.18, p < 0.05), NIHSS at admission (OR 1.23, 95% CI
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1.12–1.35, p < 0.001) and treatment with mannitol (OR 6.24, 95% CI
1.12–34.69, p < 0.05).
Conclusions: In patients with acute ischemic stroke, treatment with man-
nitol appears to increase the risk of in-hospital mortality.
ESOC-0383
06. Hyperacute Management
Comparison of outcomes between acute ischemic
stroke and transient ischemic attack: Data from the
‘Triple Antiplatelets for Reducing Dependency after
Ischaemic Stroke’ (TARDIS) trial
L J Woodhouse1, K S Robson1, K Krishnan1, N Sprigg1,
P M W Bath1
1Stroke Division of Clinical Neuroscience, University of
Nottingham, Nottingham, United Kingdom
Background: Patients with TIA are expected to have a better outcome and
return to normal as compared to those with ischemic stroke. We com-
pared baseline characteristics and outcomes for stroke and TIA patients.
Methods: Data from 2078 patients (stroke 1388, TIA 690), with functional
outcome data at day 90, enrolled into the ongoing TARDIS trial were
assessed. TARDIS is comparing short term intensive vs guideline anti-
platelet therapy. Data are number (%) or mean (standard deviation) and
odds ratio (OR) or mean difference (MD) with 95% confidence interval
(CI) relative to stroke.
Results: Overall patients had a mean age of 69 (10) and 63% were male.
Although TIA patients had a better outcome than those with stroke, many
had not returned to normal by day 90. Significant differences were present
for; death OR 0.33, 95% CI (0.12, 0.89), dependency (modified Rankin
Scale) MD −0.73, 95% CI (−0.86, −0.61), disability (Barthel Index) MD
5.56, 95% CI (3.63, 7.49), cognition (TICS-M) MD 2.78, 95% CI (1.50,
4.07), quality of life (EQ-5D) MD 0.10, 95% CI (0.07, 0.12), and mood
(Zung depression scale) MD -3.79, 95% CI (−5.69, −1.89) by day 90. There
was no significant difference in recurrence rates between stroke and TIA
patients.
Conclusion: Although outcome after TIA is better than stroke, many
patients do not make a full recovery. TIA patients may need monitoring of
functional outcome, cognition and mood to ensure that they receive
support where necessary.
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06. Hyperacute Management
Help-seeking behavior and onset-to-alarm time after
stroke
E Zock1, H Kerkhoff1, R P Kleyweg1, T B V van Bavel-Ta2, S Scott3,
N D Kruyt4, P J Nederkoorn5, D van de Beek5
1Neurology, Albert Schweitzer Hospital, Dordrecht,
Netherlands
2Neurology, St. Elisabeth Hospital, Tilburg, Netherlands
3Neurology, Slotervaart Hospital, Amsterdam, Netherlands
4Neurology, Leiden University Medical Centre, Leiden,
Netherlands
5Neurology, Academic Medical Centre, Amsterdam,
Netherlands
Background: Many patients do not seek immediate medical attention
after stroke onset, which may influence treatment and prognosis. Public
campaigns have focused on public knowledge about individual stroke
symptoms aiming to decrease patient’s delay. We explored help-seeking
behavior and evaluated whether knowledge, recognition, interpretation,
socio-demographic and clinical characteristics of stroke were associated
with onset-to-alarm time.
Methods: 161 patients admitted with acute stroke were included from
November 2011 till May 2014. A semi-structured questionnaire was used
to assess knowledge of stroke, recognition and interpretation. Action and
reasons for this action were explored. Associations were evaluated using
parametric and non-parametric test where appropriate.
Results: The median onset-to-alarm time was 30 minutes (IQR 10–150
min). Knowledge about individual stroke symptoms was not associated
with recognition of own stroke symptoms neither with correct interpre-
tation of a stroke situation, or onset-to-alarm time. However, correct
interpretation of the stroke situation was associated with shorter onset-
to-alarm time (15 vs. 45 min; p = 0.003). Clinical characteristics of stroke
associated with a shorter onset-to-alarm-time were higher NIHSS score
(Kruskal Wallis, p = 0.003) and stroke occurring at night (30 vs. 270 min;
p = 0.002). Additional factors associated with shorter onset-to-alarm-
time were transport by ambulance (30 vs. 75 min; p = 0.04) and immedi-
ate calling the emergency telephone number (Kruskal Wallis, p = 0.004).
Conclusion: Help-seeking behavior after stroke is a complex process.
Onset-to-alarm time after stroke is associated with correct interpretation
of the stroke situation by the patient, stroke characteristics and logistics of
stroke care, but not with knowledge about stroke symptoms.
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06. Hyperacute Management
A pilot study proposing a clinical decision algorithm
(CDA), which, aims to improve clinical acumen in the
recognition of patients with stroke or TIA
M Zulafkar1, L Alwis2, R Licenik2, H Kadwani2, S Sethuraman1,
L Sekaran1, J Divine2
1Department of Stroke, Luton & Dunstable Hospital, Luton,
United Kingdom
2Department of Stroke, Northwick Park Hospital, London,
United Kingdom
Background: Recognition of strokes can be challenging for training clini-
cians. We developed a clinical decision algorithm (CDA), which aims to
encourage clinical decision making. It is based on three questions. (1)Is
there a focal neurological deficit? (2)Is it acute onset? (3)If yes, is this due
to a stroke mimic (examples given) Responses would be ‘Yes’ ‘No’ or
‘Unsure’. We undertook prospective pilot studies at two hospitals.
Method: Over two months acute medical and A&E trainees were asked to
use a pro-forma which contains the ROSIER scale, CDA, and an opinion
survey, the eventual diagnosis was sought retrospectively.
Results: Of 40 total cases, 18 (45%) were strokes by CDA (ROSIER also
positive for these) of which 14 were eventually diagnosed with stroke/TIA
(78%). 6 were mimics by CDA, all of which were true mimics, but ROSIER
was positive for stroke in 3 of these. In 17, CDA result was ‘unsure’ (40%).
11 (65%) were mimics eventually. In 8 cases when CDA was ‘unsure’,
ROSIER was positive, these were all mimics. Data from 33 opinion surveys
revealed 29(88%) thought that CDA is user friendly and 25(76%) agree it
improves clinical acumen. 18(56%) prefer CDA than ROSIER.
Conclusion: CDA seems useful for trainees, and has a positive trend
towards more accurate prediction of stroke, the liberty to declare indeci-
siveness may be a reason for this. A majority believes CDA is user friendly
and improves clinical acumen. This pilot paves the path for a larger study
to develop and validate the CDA.
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Thrombolysis
ESOC-1366
07. Thrombolysis
Watching the stroke: Can door-to-needle time be
reduced after a video visualization by the nursing
staff?
R Barbosa1, F Ladeira1, A S Corredoura2, M R Carmo3,
V Fernandes3, F Grenho4, S Calado1, M Monteiro5,
M Viana-Baptista1
1Neurology Department, Hospital Egas Moniz, Lisboa,
Portugal
2Emergency Department Medical Staff, Centro Hospitalar
Lisboa Ociedental, Lisboa, Portugal
3Emergency Department Nursing Staff, Centro Hospitalar
Lisboa Ocidental, Lisboa, Portugal
4Internal Medicine, Centro Hospitalar Lisboa Ocidental,
Lisboa, Portugal
5Emergency Department Medical Staff, Centro Hospitalar
Lisboa Ocidental, Lisboa, Portugal
Background: The benefits of intravenous (IV) thrombolysis with
alteplase (rtPa) are strongly time dependent. According to guidelines, IV
thrombolysis should be administered as soon as possible, preferably up to
60 minutes after patients arrival. To ensure low door-to-needle times
(DNT) close collaboration between many health care professionals is
required and multiple interventions have been adopted with the goal of
reducing DNT.
Methods: During the second semester of 2014 the nursing staff of the
emergency department saw a video everyday for 7 consecutive days every
two months. The video involved neurologists and emergency staff (nurses
and doctors) and highlighted the importance of shorter DNT and
reviewed information about stroke and thrombolysis. Regarding patients
treated with IV rtPA, demographic and clinical data, DNT, and onset-to-
needle time was recorded. The results were compared with the same data
retrieved from de first semester of 2014. From the nursing staff, only the
co-authors knew the purpose of the intervention.
Results: All the nurses have seen the video at least once. Comparing the
intervention period with the previous semester the results were: 51 vs 33
patients treated, 74 vs 75 median patients age, median DNT 60 vs 65
minutes (p = 0.542).
Conclusions: Although the number of patients treated with rtPA have
increased and the median DNT have decreased 5 minutes, the results
weren’t statistically significant. This could be due to the small number of
patients included. However, the results suggest that interventions target-
ing the non-medical staff can be effective in reducing DNT.
ESOC-0884
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Safety and efficacy of mechanical thrombectomy in
acute stroke of anticoagulated patients. An only
hospital experience
L Benavente1, D Larrosa1, C García-Cabo1, P Vega2, A Pérez1,
E Murias2, J Martínez1, E Morales2, P Calleja1
1Neurology, Hospital Universitario Central de Asturias,
Oviedo, Spain
2Radiology, Hospital Universitario Central de Asturias, Oviedo,
Spain
Background: Anticoagulated patients (AP) are excluded from the acute
stroke management with alteplase. They could benefit from mechanical
thrombectomy (MT), which wasn’t undoubtedly proven. There are scarce
data about this results in such patients. Our aim is to analyze the efficacy
and safety of MT in AP in our hospital.
Methods: Prospective observational study comparing 30 AP and 109
N-AP underwent to direct MT without alteplase. Demographic data, clini-
cal severity (NIHSS), efficacy (recanalization TICI ≥ 2b and mRankin ≤2
at 3 months), and security (symptomatic intracranial hemorrhage
(SICH), mortality at 3 months were compared between both groups.
Results: AP were mostly men (63.3%), as N-AP (61.5%). Mean-age were
7a3 in AP and 67.2 in N-AP. Median NIHSS was similar (17 AP; 16 N-AP),
also TICI ≥2b (93.3% AP; 89.9% N-AP). The 3 months m-Rankin ≤2 was
46.7% in AP and 55.2% in N-AP (p = 0.40). SICH was present in 16.7% of
AP and 8.3% of N-AP (p = 0.15). Mortality at 3 months was 6.7% in AP
and 19% in N-AP (p = 0.08).
Conclusions: MT seems to be a treatment for acute ischemic stroke in AP.
It achieve as efficacy as in N-AP with a tendency to suffer from more
SICH, but lower mortality. We hypothesize that cardioembolic clots may
be easier removed than atherothrombotics and that embolic stroke in AP
might be less severe than those in N-AP or might suffer less of other
complications than atherothrombotics.
ESOC-1242
07. Thrombolysis
Off-label thrombolysis: A complex decision requiring a
collegial agreement
B Bouamra1, E Medeiros de Bustos1, F Vuillier1, P Montiel1,
L Bonnet1, T Moulin1
1Neurology, CHRU de Besançon, Besançon, France
A study of medical practice has been based on the hospital stroke registry
of the neurological emergencies network in the French Franche-Comté
region, RUN-FC. The study put into perspective the management of
stroke patients in the acute phase by intravenous thrombolysis in compli-
ance or at variance with the May 2009 recommendations of the French
Health Authority (HAS): “Stroke: early management”.
All patients from the region who received rt-PA treatment in the initial
phase of ischemic stroke were included in the study from 2009 to 2012,
namely 393 patients. 265 thrombolyses satisfied the criteria defined by the
HAS and 115 did not.
Exceeding time limits is the leading cause of protocol deviation. Rankin at
3 months (2,45/3,01) and the mortality rate (12/25%) were significantly
higher in the group at variance with the recommendations, whereas there
is no significant difference with the NINDS study groups (treatment or
placebo). The group at variance with the HAS recommendations can be
split into two subgroups: one where a considered medical decision was
made on the administration of treatment, and one where a medical deci-
sion was made, but without deliberation. The criteria for time limit and
for thrombolysis with a considered medical decision did not unfavorably
modify Rankin at 3 months.
In accordance with results of European studies, this practice is common
and is evidently beneficial for certain patients, subject to a strict prescrip-
tion framework and to collegial and considered medical decisions that
take into account the risk-benefit ratio on a case-by-case basis.
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Usage rate of thrombolysis in an Italian county: Data
from Progetto Nazionale Esiti (PNE) in Umbria
F Corea1, V Caso2, M Zampolini1, F Costantini3, S Mastrocola4,
L Greco5, P Brustenghi1, S Stefanucci6, S Ricci4
1Stroke and Brain Injury Units, Usl Umbria 2, Foligno, Italy
2Stroke Unit, S M M Hospital, Perugia, Italy
3Stroke Unit, SM Hospital, Terni, Italy
4Stroke Unit, Usl Umbria 1, Città di Castello, Italy
5Stroke Unit, Usl Umbria 1, Branca, Italy
6Neurology, Usl Umbria 2, Foligno, Italy
Background: Purpose of the study was to investigate the relationship
between ischemic stroke outcome and rate of thrombolytic therapy
administration in Perugia and Terni counties, Italy.
Methods: Cases outcomes were extrapolated from the PNE database for
all ischemic stroke admitted in Umbria Hospitals, (Jan2011-Nov2012)
in the counties of Perugia and Terni. For ischemic stroke (ICD9
433.x1,434.x1,436) were available both risk adjusted 30 day mortality and
30 day re hospitalization rate. We reviewed the rate of thrombolysis usage
in each hospital doing correlation analysis on outcome measures and lysis
rate.
Results: We found 2272 patients with ischemic stroke included in the PNE
database (men 1178). Among them the majority was admitted in the 2
general hospitals of Perugia and Terni (N: 1226) while the remaining half
in other county hospitals (N: 1046). The rate of lysis in 2011 and 2012 was
5,7% and 5,9%. The overall mean 30 day mortality rate in the main
hospitals of the survey was 10,38% (CI 95%:10.110.6) with a re-admission
rate of 11,2% in 2011 and 11,5% in 2012. According to Pearson correla-
tion analysis (R: 0.609; R: 0.698) we found a negative correlation between
variables, with a tendency for high lysis rate to go with low mortality and
low readmissions. Also the Spearman’s analysis found (p: −0.707;
p: 0.756) a significant (p = 0.004) inverse association between variables
Conclusion: The adjusted 30 day mortality and re admission rate of isch-
emic stroke were inversely
correlated with the annual lysis rate. The lysis rate represents a marker of
good stroke care providing a direct monitoring tool.
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07. Thrombolysis
Association between I.V. thrombolysis volume and
door-to-needle times in acute ischemic stroke
A E D Groot1, P J Nederkoorn1, M Limburg2, M C Visser3,
I N van Schaik1, Y B Roos1, J M Coutinho1,
on behalf of the North-Holland Stroke Research Group4
1Neurology, Academic Medical Center – University of
Amsterdam, Amsterdam, Netherlands
2Neurology, Flevo Ziekenhuis, Almere, Netherlands
3Neurology, VU Medical Centre, Amsterdam, Netherlands
4Netherlands
Background: Concentration of intravenous thrombolysis (IVT) for acute
ischemic stroke (AIS) in high-volume centers is often believed to result in
shorter door-to-needle times (DNTs), but evidence for this assumption is
limited. Our aim was to examine the relation between IVT volume and
DNTs in the Netherlands.
Methods: All hospitals in the province of North-Holland that perform
IVT were invited to participate. We retrospectively identified consecutive
patients treated with IVT between January 2009 and January 2013. Based
on annualized IVT volumes, hospitals were categorized as low-volume
(≤24), medium-volume (25–49) or high-volume (≥50). We compared
median DNTs and onset-to-needle times (ONTs) between centers.
Results: 11/13 hospitals agreed to participate in the study. 1822 of 1962
patients treated with IVT were included (mean age 70.1 years). Reasons
for exclusion were in-hospital stroke (n = 54) or missing DNT (n = 86).
Overall, 80,5% of patients had a DNT<60 minutes. There were 2 low-
volume (101 patients), 5 medium-volume (747 patients) and 4 high-
volume hospitals (974 patients). The DNT was significantly shorter in
high-volume centers (median DNT 30 minutes) compared to medium-
volume (42 min, p < 0.001) and low-volume hospitals (38 min,
p < 0.001). High-volume hospitals also more often achieved a DNT<30
minutes compared to the other two groups (43,8% vs. 17,4% and 26,7%,
p < 0.001). High-volume centers had shorter ONTs than medium-volume
(median 113 vs. 120 min, p = 0.03), but not than low-volume hospitals
(113 vs. 98 min, p = 0.04).
Conclusion: In this Dutch province with overall short DNTs, hospitals
with the largest annual IVT volumes achieved the shortest DNTs.
ESOC-1586
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How to half door-to-needle times: A single center
strategy
J Demeestere1
1Neurology, AZ Groeninge, Kortrijk, Belgium
Introduction: In a time where treatment options for acute stroke are
rapidly expanding and fast delivery of intravenous thrombolysis (IVT) is
significantly associated with a good outcome and recanalization, we are
challenged to reorganize acute stroke care. In our center we implemented
a new acute stroke care pathway over the last year.
Methods: After consultation with emergency physicians, emergency room
(ER) nurses and radiologists we started using a new stroke flowchart for
acute stroke patient care (flowchart). Briefing by emergency physicians
and patient registration is done by telephone before patient arrival. Two
ER nurses, a radiology nurse, the CT scan and neurologist are standby
before arrival. The ER is bypassed and the patient is taken straight to CT
scan whilst blood pressure and blood glucose level is checked. Clinical
investigation with NIH stroke scale is done bedside at CT scan. IVT,
positioned at CT scan, is administered immediately at CT after exclusion
of hemorrhagic stroke. Only after admission of thrombolysis further vas-
cular imaging is done to look for proximal large artery occlusion for which
additional thrombectomy can be done.
Results: By implementing this new acute stroke care pathway we were able
to reduced door-to-needle times by over 50% (Table 1). Median door to
needle times at the end of the implementation period were as low as 22
minutes, compared to 45 minutes before implementing the stroke
pathway.
Discussion: Using several simple measures a reduction of door-to-needle
times of over 50% can be readily achieved.
Table 1 Mean and median door-to-needle times of 2014 in our center.
The stroke pathway was implemented before the start of October.
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Fig. 1 Flowchart of the step-by-step stroke pathway
ESOC-0986
07. Thrombolysis
Is the risk of TPA-related hemorrhage different in
patients with posterior circulation stroke vs. anterior
circulation stroke?
H Erdur1, T Müller1, J F Scheitz1, S Tütüncü1, H J Audebert1,
C H Nolte1
1Department of Neurology, Charité – Campus Benjamin
Franklin, Berlin, Germany
Background: Acute ischemic stroke (AIS) in the posterior circulation
differs in many aspects from AIS in the anterior circulation. We investi-
gated whether the risk of symptomatic intracranial hemorrhage (sICH) or
parenchymal hemorrhage (PH) was associated with affected circulation.
Methods: We included all patients of our local thrombolysis register who
received systemic thrombolytic therapy. Anterior circulation stroke was
defined as stroke in the vascular territory of the middle cerebral artery or
anterior cerebral artery, whereas posterior circulation stroke was defined
as stroke in the territory of the posterior cerebral artery or vertebrobasilar
territory. Patients with concurrent stroke in anterior and posterior circu-
lation were not included into the analysis. The end points were sICH
according to SITS-definition and any PH.
Results: A total of 1277 patients were included. Posterior circulation
stroke was present in 252 (19.7%) patients. Frequencies of sICH and PH
were higher in anterior as compared to posterior circulation stroke but
these differences did not reach statistical significance (sICH: 4.1% (42
patients) vs. 2.4% (6 patients), p = 0.20; PH: 8.7% (89 patients) vs. 5.6%
(14 patients), p = 0.10). After adjustment for known risk factors (age,
stroke severity, blood glucose level, systolic blood pressure, antithrom-
botic therapy, statin therapy) and additional mechanical recanalization in
multiple regression analysis, risks for sICH and PH were similar in pos-
terior and anterior circulation stroke (sICH: OR 0.34, 95% CI 0.10–1.13,
p = 0.08; PH: OR 0.63, 95% CI 0.31–1.26, p = 0.19).
Conclusions: The risk of sICH or PH was similar in patients with poste-
rior circulation stroke compared to anterior circulation stroke.
ESOC-1105
07. Thrombolysis
Hematological, hemorheological, hemostatic changes
and CT-perfusion in ischemic stroke: The effect of IV
thrombolysis
M Gafarova1, M Domashenko1, M Maximova1, M Loskutnikov1,
D Korobkova1, R Konovalov2, A Shabalina3, M Kostyreva3
1Acute Stroke Unit, Research Center of Neurology, Moscow,
Russia
2Radiology, Research Center of Neurology, Moscow, Russia
3Hemostasis and Hemorheology, Research Center of
Neurology, Moscow, Russia
Lack of microcirculation is believed to be one of mechanisms of impaired
brain tissue perfusion in ischemic stroke (IS). The aim of the study was to
evaluate the blood parameters and brain perfusion characteristics in
patients with IS treated with intravenous thrombolysis (IVT) and without
IVT.
Methods: 70 patients with IS (48M, 22W, mean age 61[54;69],
mean admission NIHSS 14.5[11;17]) admitted at first 4,5 hours after
stroke onset were treated with IVT (IVT-group). 63 patients with IS (31M,
32W, mean age 67[58;73], mean admission NIHSS 9[6;13]) were admit-
ted after 4.5 hours after stroke onset (non-IVT group). Neurological
examination, blood tests (evaluation of hemostasis, hematology, kinetics
of erythrocyte aggregation/disaggregation and erythrocyte deformability,
platelet aggregation (PA)), neuroimaging (brain MRI, CT-angiography,
CT-perfusion) were performed at admission (before IVT in IVT-group)
and 24 hours later.
Results: IVT-group had larger NIHSS score at admission (p < 0.001) but
improvement of their neurological deficit was more rapid than in non-
IVT-group. In IVT-group adrenaline-induced PA (ADR-PA) was higher
than in non-IVT-group and this difference had vanished after IVT.
Increased ADR-PA in IVT-group was associated with lack of recanaliza-
tion and neurological improvement. Erythrocyte sedimentation rate had
lowered after IVT (p = 0.015 comparing to non-IVT-group). Negative
correlation of lymphocyte level with NIHSS score and infarct core size was
showed for both groups and positive correlation of leukocyte level with
those parameters was showed only for IVT-group. Hemorheological
parameters were seemed to have no significant differences between
groups.
IVT may influence blood properties in conjunction with infarct size and
neurological deficit.
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Does the recanalizing effect of intravenous
thrombolysis depend on the actual applied dose of
T-PA?
A Garcia Pastor1, F Díaz Otero1, C Funes Molina1,
B Benito Conde1, S Grandes Velasco1, P Sobrino García1,
Y Fernández Bullido1, P Vazquez Alén1, J A Villanueva Osorio1,
A Gil Núñez1
1Neurology Stroke Unit, Hospital General Universitario
Gregorio Marañón, Madrid, Spain
Objectives: To determine if the recanalizing effect of intravenous t-PA
depends on the actual applied dose (AAD).
Methods: We conducted a sub-analysis of a prospective study designed to
assess t-PA misdosing in acute ischemic stroke patients treated with intra-
venous thrombolysis (IVT). T-PA dose was calculated according to esti-
mated patient weight. Patients were weighed during the 24 hours
following treatment with t-PA, and AAD was calculated. Recanalization
rate according to the AAD was analyzed.
Results: AAD could be calculated in 97 of the 108 included patients. Mean
AAD of t-PA was 0,927 mg/Kg (SD:0.081). Vascular status before and
within 24 hours after IVT could be determined in 40 patients. Recanali-
zation occurred in 17 patients (42.5%). AAD in recanalized patients was
0,933 mg/Kg (SD:0.078), and 0,920 mg/Kg (SD: 0.068) in non-recanalized
patients, p = 0.58. Recanalization rate was 66.7% in patients treated with
AAD ≥0,99 mg/Kg and 35.5% for AAD <0,99 mg/Kg (p = 0.09). A higher
rate of cerebral bleeding was observed in the AAD ≥0,99 mg/Kg group
(29.4% vs 16.3%, p = 0.20).
Conclusions: Our results suggest that the AAD of t-PA could affect the
recanalizing effect of IVT. Doses ≥0,99 mg/Kg could have a higher recana-
lizing power, but also an increased risk of hemorrhagic complications.
The optimal dose of t-PA in terms of clinical benefit and safety is
probably different to the dose that provides the best results in terms of
recanalization.
ESOC-1135
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IV thrombolysis in patients dependent on others prior
to stroke
H Gensicke1
1Neurology, University Hospital Basel, Basel, Switzerland
Thrombolysis in Stroke Patients study group (TriSP)
Objective: To compare outcome and complications in stroke patients
treated with IV-thrombolysis (IVT) who were dependent on the help of
others prior to stroke versus independent ones.
Methods: In a multicenter IVT-database, we compared patients with pre-
stroke mRS>2 (‘dependent’) versus those with pre-stroke mRS 0–2 (‘inde-
pendent’) with regard to favorable 3-month outcome (i.e., reaching pre-
stroke mRS or better), death, symptomatic ICH (sICH) and any ICH
(aICH). Unadjusted and adjusted odds ratios with 95%-confidence inter-
vals (OR[95%CI]) were calculated.
Results: Among 7430 IVT-treated patients, 489 (6.6%) dependent
patients were compared with 6941 (93.4%) independent ones. Dementia,
prior stroke, heart failure and osteoarthritis were the most common
causes for pre-existing dependency. Dependent patients were more likely
to die (ORunadjusted 4.55[3.74–5.53]; ORadjusted 2.19[1.70–2.84]) or to
suffer aICHs (ORunadjusted 2.17[1.75–2.70]; ORadjusted 1.56[1.22–
2.01]). sICH occurred equally frequent in both groups (4.5% vs 4.8%).
Favorable outcome was less frequent in dependent (39.5%) than in inde-
pendent (60.4%) patients. However, among survivors the odds for favor-
able outcome were even higher in dependent than in independent
patients, after adjustment for age and stroke severity (ORadjusted
1.56[1.19–2.04]).
Conclusion: IVT-treated stroke patients who were dependent on the help
of others prior to stroke had a higher 3-month mortality than indepen-
dent patients, despite similar sICH rates. The unexpected observation,
that – among survivors – the adjusted odds for reaching at least the
pre-stroke mRS were higher in dependent than previously independent
patients, deserves further research. Nevertheless, withholding IVT in such
patients might not be justified.
ESOC-1146
07. Thrombolysis
Impact of body mass index on outcome in IVT-treated
stroke patients
H Gensicke1
1Neurology, University Hospital Basel, Basel, Switzerland
Thrombolysis in Stroke Patients study group (TriSP)
Objective: To investigate the impact of body mass index (BMI) on func-
tional outcome and complications in stroke patients treated with IV
thrombolysis (IVT).
Methods: In a multicenter IVT-register based observational study, we
studied the association between BMI and poor 3-month outcome (i.e.,
modified Rankin Scale scores 3–6), death and symptomatic intracranial
hemorrhage (sICH) based on criteria of the ECASS-II trial. BMI was used
as (i) continuous and (ii) categorical variable distinguishing underweight
(<18.5 kg/m2), normal weight (18.5–24.9 kg/m2), overweight (25-
29.9 kg/m2) and obesity (≥30 kg/m2). Normal weight (18.5–24.9 kg/m2)
served as the reference group. Univariate and multivariate regression
analyses with adjustments for age and NIHSS were done and odds ratios
with 95%-confidence intervals (OR[95%CI]) were calculated.
Results: Among 1797 IVT-treated patients 55 (3.1%) were underweight
730 (40.6%) normal weight, 717 (39.9%) overweight, and 295 (16.4%)
obese. Compared to normal weight, none of the other BMI-categories was
associated with poor outcome (OR[95%CI]unadjusted: 1.36[0.78–2.35];
0.92[0.74–1.14]; 0.78[0.59–1.04]; death 1.63[0.74–3.59]; 1.02[0.72–1.45];
0.77[0.67–1.27]; or sICH (OR[95%CI]: 1.44[0.42–4.89]; 1.13[0.67–1.90];
0.70[0.32–1.55] in univariate analyses as well as in multivariate analyses.
BMI as continuous variable was neither associated with poor outcome,
death nor sICH in unadjusted (OR[95%CI]: 0.99 (0.97–1.01), 0.98 (0.95–
1.02), 0.98 (0.94–1.04)), or adjusted analyses (OR[95%CI]: 1.01 (0.98–
1.03), 0.99 (0.95–1.05) 1.01 (0.97–1.05)), respectively.
Conclusion: In this largest study to date investigating the prognostic
impact of BMI in IVT-treated stroke patients, BMI was neither associated
with poor 3-month outcome nor with death nor with sICH.
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FABS: A prediction tool for screening of stroke mimics
in the emergency department
N Goyal1, S Male1, G Tsivgoulis1, S Iftikhar1, A Kerro1, J Chang1,
J Metter1, A Alexandrov1, R Zand1
1Neurology, University of Tennessee Health Science Center,
Memphis, USA
Background and Purpose: Around 5–31% of patients presenting with
symptoms of acute ischemic cerebrovascular disease (iCVD) are stroke
mimics (SM). Administration of IV-rtPA to SM is unnecessary and
costly. In this study, we propose a scoring system (FABS) for screening of
SM in the emergency setting.
Methods: We reviewed medical records of consecutive patients who
received IV-rtPA for possible iCVD from January 2011 to December 2014.
The diagnosis of SM was based on patient presentation, hospital course
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and negative neuroimaging studies. FABS score includes six variables:
absence of Facial droop, negative history of Atrial fibrillation, Age < 50,
systolic Blood pressure <150 mmHg at presentation, history of Seizures,
and isolated Sensory symptoms without weakness at presentation. One-
point was given for every variable present. FABS score was calculated for
all iCVD and SMs.
Results: Out of 588 patients, 125 (21.3%) were SMs. Mean age was
61.7 ± 14 [18–95]. 50.5% of patients were male. Median NIHSS at pre-
sentation was 7 ± 6.3 [0–31]. Receiver operating characteristic curve (area
under curve 0.94, CI: 0.92–0.96) indicated that FABS ≥ 3 could identify
patients with SM with 88% sensitivity (95%, CI: 81–93%) and 92% speci-
ficity (95%, CI: 90–95%). Only three (0.6%) patients with iCVD had
FABS-score of 4 or more. FABS ≥ 4 showed a specificity of 99% (95%, CI:
98–99.8%).
Conclusion: FABS-score could be used to identify patients with SM. It can
help clinicians consider alternative diagnosis and advanced imaging
before administration of IV-rtPA.
ESOC-1369
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CT versus MRI in stroke thrombolysis: Evidence from
the Safe Implementations of Treatments In Stroke
(SITS)
C Hametner1, N Ahmed2, L Kellert3, P Ringleb1
1Neurology, University of Heidelberg, Heidelberg, Germany
2Clinical Neuroscience, Karolinska Institutet, Stockholm,
Sweden
3Neurology, Ludwig-Maximilians-University, Munich, Germany
Introduction: Previous literature reports that magnetic-resonance-
imaging-based thrombolysis has an improved safety profile in acute isch-
emic stroke patients. We evaluated this hypothesis.
Methods: We analyzed 35817 patients by type of imaging from the SITS-
registry for whom information on type of imaging, age, sex, National
Institutes of Health Stroke Scale (NIHSS), common cerebrovascular risk
factors, safety outcome (symptomatic intracerebral hemorrhage [SICH]
following SITS definition) and functional outcome (as measured by
modified Rankin Scale on day 90) were available. We also determined the
relationship of imaging type and stroke onset to time-to-treatment
(OTT).
Results: Using a linear mixed effects model (random effects: NIHSS, OTT,
center), MRI significantly prolonged OTT (P < 0.001). In terms of safety,
frequency of SICHSITS was equal between computed tomography [CT]
and magnetic resonance imaging [MRI] (1.6% vs. 1.6%, P = 0.85).
Adjusted binary regression analysis confirmed MRI a non-significant pre-
dictor of SICHSITS (odds ratio [OR] 0.939, 95% confidence interval [CI]
0.845–1.044). Although less MRI- than CT-patients died within 3 months
(10.2% vs. 15.8%, P < 0.001), multivariate analysis (which included an
adjusting variable that indicates high-volume MRI-centers) found the
estimate of MRI (OR 0.831, CI 0.684–1.009) as non-significant. Stratify-
ing for time window, we gained similar results predicting death (<4.5 h:
OR 0.855, CI 0.695–1.053, >4.5 h: OR 0.710, CI 0.407–1.237).
Conclusion: (preliminary) For routine use – this study suggests that MRI
gains no benefit compared to CT in stroke patients treated with intrave-
nous thrombolysis.
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Reduction in door-to-needle thrombolysis times: A lean
approach
D Hayden1, L Higgins1, C Byrne1, S Doyle1, C Roche2, S P Teeling3,
P J Kelly1, S Murphy1
1Stroke, Mater University Hospital, Dublin, Ireland
2Emergency, Mater University Hospital, Dublin, Ireland
3Lean Academy, Mater University Hospital, Dublin, Ireland
Background: Earlier thrombolytic therapy administered in acute ischemic
stroke is associated the better functional outcomes. We aim to reduce
thrombolysis Door-to-needle (DTN) times from a median of 80 minutes
to 60 minutes in line with current international guidelines.
Methods: A Lean project involving stakeholder analysis and a process
time-step-survey was undertaken to identify potential barriers to the
timely provision of thrombolytic therapy. A fully revised ‘Acute Stroke
Thrombolysis Pathway’ was generated to overcome these barriers.
Results: Fifty-three “out-of-hospital” ischemic stroke patients received
thrombolytic therapy over a 9-month period following the introduction
of the revised pathway. Mean age was 69.5 (±15.5), 50.4% were female,
80% pre-notified and 64% afterhours.
The median DTN-time is now 57 minutes (IQR 45–73). The median
Door-to-CT (DTCT) time is 21 mins (IQR 12–29) and the CT-to-Needle
(CTTN) time is now 33 mins (IQR 24–49).
Median DTCT (26.5 vs. 15 mins; P = 0.0005) and DTN times (59.5 vs. 48
mins; P = 0.04), but CTTN times (33 vs. 32; P = 0.9) were significantly
longer in the after-hours period.
Conclusions: The Door-to-Needle Project has dramatically reduced stroke
thrombolysis DTN-times in line with international guidelines over a 24/7
period. During normal working hours the DTN time is now 48 minutes.
Efforts are ongoing to further improve these figures.
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Thrombolysis in Qatar – A 1-year prospective
descriptive study
Y Z Imam1, N Akhtar1, P J Bourke1, S Kamran1, A D’souza1,
M Santos1, S Joseph1, D Deleu1, A Shuaib1
1Stroke Service, Hamad Medical Corporation, Doha, Qatar
Background: Intravenous thrombolysis is currently the only approved
treatment for acute stroke. Limited data is available from the Middle East.
Methods: Prospective data was collected over the year of 2014 for all
thrombolysed patients at Hamad Medical Corporation (the soul provider
of acute stroke care in Qatar). Demographics, stroke-type, stroke severity,
door-to-CT times (DCT), door-to-needle times (DNT) and outcome
were noted.
Results: Out of 892 stroke cases admitted; 51 cases (5.7%) received
thrombolysis. Forty-four (86%) were males. Thirty-three (64.7%) were
above 50 years of age. Arabs were 9(17.6%), Asians 41(80.4%) and 1(2%)
Caucasian. Thirty-nine (76.5%) arrived by ambulance. (vs. 55% for non-
thrombolysed) (p = 0.009)
Strokes subtypes (as per Bamford classification) were: TACI 13(25.5 %),
PACI 27 (53%), LACI 5(9.8%), POCI 6(11.7%) (p < 0.001).
Stroke severity were; mild (NIHSS ≤4) 1(2%), moderate (5–10) 24(47%),
severe (>10) 26(51%) (p < 0.001).
Mean DCT was 22.2 + 16.2 minutes (Range 6–85) and mean DNT was
51.0 + 22.0 minutes (Range 12–113). Symptomatic bleeding occurred in
3(5.8%).
Outcome at discharge were good (mRs: 0–2) 23 (45%), moderate (mRs:
3–4) 23 (45%)and (poor: mRs: 5–6) 5 (10%) and when compared with
non-thrombolysed patient it was significant (p < 0.05).
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Conclusion: Around 6% of strokes are thrombolysed in Qatar. Patients
were more likely to be thrombolysed if they arrive by ambulance, if they
present with cortical strokes and have moderate-severe strokes. DCT and
DTN were within international benchmarks. Incidence of symptomatic
bleeds is low and is comparable to the literature. Outcomes at discharge
are good.
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Influence of treatment during working and
nonworking hours on outcome of acute stroke
patients treated with intravenous thrombolysis
D Jovanovic1, M Bogicevic1, M Stefanovic Budimkic1,
L J Beslac Bumbasirevic1, V Padjen1, P Stanarcevic1, M Ercegovac1,
I Berisavac1
1Clinical Center of Serbia, Neurology Clinic, Belgrade, Serbia
Introduction: The impact of working and nonworking hours might be
relevant to the outcome of stroke patients treated with intravenous
thrombolysis (IVT). The aim of our study was to compare the efficacy of
IVT on outcome of acute ischemic stroke patients after 3 months who
received IVT during working hours with those who received it during
nonworking hours.
Materials and Methods: According to the time of entry into the hospital,
acute stroke patients treated with IVT within 4.5 hours were grouped into
those who were admitted during working hours on weekdays (08:00 to
13:59) and the other who were admitted during nonworking hours
(14:00–07:59 on weekdays and 00–24 on weekends and holidays). Func-
tional outcome of patients were evaluated by modified Rankin score
(mRS).
Results: Out of 333 acute stroke patients treated with IVT, 62 (18.6%)
were admitted during working hours. Univariate analysis showed no sta-
tistically significant differences in outcome after 3 months between the
two groups of patients. Also, multivariate analysis showed no effect of
working and nonworking hours on the excellent functional outcome
(mRS 0–1), good functional outcome (mRS 0–2) or death after three
months of stroke onset, as well as the occurrence of symptomatic intrac-
erebral hemorrhage, after two groups were adjusted for confounders.
Conclusion: The majority of stroke patients were treated with IVT during
nonworking hours. However, there was no impact of nonworking hours
on outcome of stroke patients after 3 months of stroke onset, who were
treated with IVT.
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Comparison of thrombolysis time delays during and
beyond working hours in a telestroke unit network
S Kannookadan1, S Boy2, G Hubert1, R L Haberl1
1Staedtisches Klinikum München, TEMPiS, Munich, Germany
2Department of Neurology, University of Regensburg,
Regensburg, Germany
Introduction: Several publications indicate that quality of in-hospital
treatment varies according to time of admission. Quality seems to be
significantly lower beyond working hours. Effect of intravenous throm-
bolysis in acute stroke patients is time dependent and therefore reduction
of time delays is a quality indicator for acute stroke care.
Aims: Comparison of time delays in patients treated with thrombolysis in
the Telemedical Project for integrative Stroke care (TEMPiS) regarding
time of admission. We hypothesized no significant differences between
working and non-working hours will be found, as amount of staff and
qualification of teleconsultants is constant over time in these settings.
Methods: All stroke patients receiving thrombolysis in the TEMPiS
network were prospectively registered. For analysis we included all throm-
bolysis patients presented for teleconsultation in the years 2011 to 2013
and compared pre-hospital (onset-to-door), in-hospital (door-to-needle)
and overall (onset-to-treatment) time delays depending on admission
within and beyond working hours. Patients with basilar artery occlusion
and in-hospital strokes were excluded.
Results: 781 patients were identified. 45.2% (352) of patients were admit-
ted during and 54.8% (429) beyond working hours. During and beyond
working hours median onset-to-door delay was 65 (IQR 45–104) and 64
(IQR 48–100) minutes (p = 0.909), door-to-needle delay was 45 (IQR
33–62) and 48 (IQR 35–65) minutes (p = 0.069), onset-to-treatment delay
123 (IQR 90–160) and 120 (IQR 95–159) minutes (p = 0.324) respectively.
No significant differences were seen in any of the delays.
Conclusions: Telemedicine for stroke appears to have an equalizing effect
on differences in time delays during and beyond working hours.
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Short- and longterm effect of blood pressure
variability after intravenous thrombolysis
L Kellert1, C Hametner2, P Ringleb2, N Ahmed3
1Neurology, Ludwigs-Maximilians-Universität, München,
Germany
2Neurology, University Hospital Heidelberg, Heidelberg,
Germany
3Clinical Neurosciences, Karolinska Institutet, Solna, Sweden
Introduction: Prognostic importance of blood pressure variability (BPV)
for safety and outcome in patients treated with intravenous thrombolysis
(IVT) is unclear.
Methods: 28.976 patients of the Safe Implementations of Treatments in
Stroke (SITS) registry were analyzed. Blood pressure was measured on
admission, two and 24 hours after IVT. Patients were dichotomized
according to median of standard deviation (SD) of systolic BP (BPVSD).
Successive variation (SV) of systolic BP (BPVSV) was entered as continu-
ous variable in the outcome regressions. Early neurological improvement
(ENI) was defined as 20% improvement of the NIHSS score during first
24 hours. Symptomatic intracerebral hemorrhage (SICH) was observed
according to SITS definition. Excellent outcome was defined by the modi-
fied Rankin Scale (mRS) 0–1 at 3-month and functional independency by
mRS 0–2.
Results: Regression analysis for higher BPVSD showed association to
higher age, female sex, higher baseline NIHSS, higher baseline BP, longer
time to treatment, and higher rates of cardiovascular risk factors. Regard-
ing short-term outcome, BPVSV (OR 0.99, p = 0.005) predicted ENI, and
SICHSITS (BPVSV: OR 1.02, p < 0.001). Similar effect was observed
regarding 3-months excellent outcome (BPVSV: OR 0.99, p = 0.04), good
outcome (BPVSV: OR 0.99, p = 0.001), and mortality (BPVSV: OR 1.01,
p < 0.001) adjusted to age, sex, baseline NIH, baseline BP, and cardiovas-
cular risk factors.
Conclusion: Higher BPV is a relevant negative predictor for favorable
short- and longterm outcome after IVT and is associated with increased
rates of SICH and mortality independently of absolute BP measurements.
A randomized trial addressing the hypothesis of BPV as therapeutic target
in acute stroke is necessary.
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07. Thrombolysis
How safe is systemic intravenous thrombolysis (IVT) in
periprocedural ischemic stroke after left heart
catheterization and percutaneous coronary
intervention?
F Kraus1, G J Hubert1, S Boy2, R L Haberl1
1Neurology, Städtisches Klinikum München-Harlaching,
München, Germany
2Neurology, Universitätsklinik Regensburg, Regensburg,
Germany
Introduction: Ischemic Stroke during or shortly after left heart catheter-
ization or percutaneous coronary intervention is a rare but possibly dev-
astating complication. Although periprocedural stroke is usually detected
fast, intravenous thrombolysis (IVT) may be harmful because of preced-
ing application of heparin and/or high-dose antiplatelet medication.
Aim: To analyze safety of IVT after periprocedural ischemic stroke focus-
ing on occurrence of intracerebral hemorrhage and stroke mortality.
Methods: The Telemedical Project for integrative Stroke Care (TEMPiS) is
a TeleStroke Unit network with 2 hub and 18 spoke hospitals. The TEMPiS
registry includes all consecutive teleconsultation reports of the network.
We retrospectively analyzed all documented strokes that occurred during
or within 48 hours after a cardiac catheterization procedure in the period
between January 2004 and December 2014.
Results: Within an 11 y-period 71 patients with periprocedural stroke
were documented.
One patient (1.4%) was diagnosed ICH in the initial CT scan. Out of the
remaining 70 patients with ischemic stroke, 20 (29%) (18 embolic
infarcts, 2 TIA) received IVT. Of those, one patient (5%) was diagnosed
hemorrhagic transformation in CT scan the following day without clinical
deterioration. All other 19 patients (95%) had no hemorrhagic complica-
tions. Two patients (10%) died, both due to cardiac failure caused by their
underlying heart disease.
Conclusion: Intravenous thrombolysis in periprocedural stroke after
cardiac catheterization appears to be safe despite preceding treatment
with heparin and/or antiplatelet medication.
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Temporal trends in TPA use in a bi-ethnic US
community from 2000 to 2012
J Domino1, J Baek1, W Meurer2, L Morgenstern3, N Garcia3,
L Lisabeth1
1Epidemiology, University of Michigan, Ann Arbor, USA
2Emergency Medicine, University of Michigan Health System,
Ann Arbor, USA
3Stroke Program, University of Michigan Health System, Ann
Arbor, USA
Objective: To explore trends in tissue plasminogen activator (tPA) admin-
istration for acute ischemic stroke (AIS) in a US community with a large
representation of the minority population, Mexican Americans (MA), and
to determine whether trends vary by age, sex, ethnicity and stroke severity.
Methods: Cases of AIS (n = 5,277) were identified from 7 hospitals in a
population-based study (2000-2012). TPA, demographics and severity
(National Institutes of Health Stroke Scale (NIHSS)) were abstracted from
medical records. Trends were modeled using a generalized additive model
with a smoothing spline for time adjusted for age, sex, ethnicity (MA
versus non-Hispanic white (NHW)), and NIHSS; interaction terms were
added to test modification of trends.
Results: Median age was 72 (IQR: 61–81); 56.7% were MA. TPA use was
steady at 2% until 2006 when it rose considerably (Fig. 1). Those with
more severe strokes had larger increases in tPA use than those with lower
severity (p < 0.001). MAs were less likely to receive tPA (RR 0.64
[0.48,0.84]) than NHWs due to emerging ethnic differences in later years.
Conclusions: Rapid increases in tPA use after 2006 were apparent in this
community. Increases in tPA use were larger in higher compared with
lower severity patients. A treatment gap between MAs and NHWs may be
emerging which suggests the potential need to focus professional educa-
tion on stroke treatment in MAs.
ESOC-1402
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How do the outcomes of patients with ischemic stroke
treated with thrombolysis differ from those
untreated? Data from the Scottish Stroke Care Audit
M Turner1, M Dennis2, M Barber3, P Langhorne4, M Macleod1
1Division of Applied Medicine, University of Aberdeen,
Aberdeen, United Kingdom
2Centre for Clinical Brain Sciences, University of Edinburgh,
Edinburgh, United Kingdom
3Department of Medicine, NHS Lanarkshire, Lanarkshire,
United Kingdom
4Institute of Cardiovascular and Medical Sciences, University
of Glasgow, Glasgow, United Kingdom
Background: There is ongoing public debate around the benefits of iv
thrombolysis in ischemic stroke. A Cochrane review of clinical trials and
the SITS registry both report benefits of thrombolysis in terms of
improved outcomes.
Aims and Methods: To compare outcomes in 1239 patients who were
thrombolysed and 11847 not thrombolysed using a national ischemic
stroke cohort (2012–13) corrected for case mix.
Results: Case fatality at 7 days was 8.7% in those thrombolysed compared
to 3.5% for those not treated. After case mix adjustment using the six
simple variables (SSV), mortality was significantly higher at seven days for
thrombolysed patients, but not at 30 days, 90 days or six months. Dis-
charge home or to usual place was no different at 30 or 90 days.
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Death
7 days
n (%)
Death
30 days
n (%)
Death
90 days
n (%)
Death
6 months
n (%)
Home/usual residence
30 days
n (%)
Home/usual residence
90 days
n (%)
Not thrombolysed (n = 11847) 413 (3.5) 1120 (9.5) 1781 (15.0) 2254 (19.0) 7516 (63.4) 8286 (69.9)
Thrombolysed (n = 1239) 108 (8.7) 190 (15.3) 250 (20.2) 278 (22.4) 634 (51.2) 748 (60.4)
Adjusted OR (95%CI) 1.41 (1.11–1.80) 1.07 (0.89–1.30) 0.96 (0.81–1.14) 0.85 (0.72–1.00) 0.90 (0.78–1.04) 0.92 (0.79–1.06)
Conclusions: Similar to clinical trial findings, there is an increased risk of
early death with thrombolysis, but no difference in later mortality. Case
fatality at 30 days is broadly similar to that reported in the SITS registry
(14%). We did not show a benefit in terms of discharge destination at 30
or 90 days: this may reflect the broad comparator population or use of a
surrogate endpoint rather than a specific disability measure.
ESOC-1247
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Call protocol on transient ischemic attack (TIA): A
cohort study in hospital school of Santa House of
Mercy Fernandópolis-SP
M J Medeiros1, V Cortezzi Junior2, J P U Ferreira3, F C R Ferreira4,
P F Sablewski4, F A G Teixeira4, K P I Silva4, L F M Pereira4,
G A G Silva5, J D Almeida4
1Medicine School, University Camilo Castelo Branco, São José
dos Campos, Brazil
2Department of Neurology, School Hospital Santa Casa de
Misericordia de Fernandópolis, Fernandópolis, Brazil
3Intensive Care, São Francisco Hospital, Ribeirão Preto, Brazil
4Medicine School, University Camilo Castelo Branco,
Fernandópolis, Brazil
5Medicine School, University of the Region of Joinville,
Joinville, Brazil
Context: Multicenter studies have shown low rates of antithrombotic use,
low rates of neuroimaging and high subsequent risk of stroke within 90
days after a diagnosis of transient ischemic attack (TIA) given in an
emergency unit
Objectives: Outline the emergency response protocol to transient isch-
emic attack in a given ER.
Design, Target Population and Methods: We conducted a retrospective
cohort study 2010 – 2012 of patients who were discharged with TIA in the
E.R. of a Health Reference Service in the State of São Paulo.
Results and Discussion: A total of 113 patients were analyzed through their
records. The patients had the following characteristics: the mean age was
71.2 years (SD 13.8 years), 56.9% were female, 53.1% had a history of
hypertension, 26.5% had a history of ischemic heart disease, and 17.1%
had a previous stroke. The most frequent neurological deficit was the
unilateral weakness (53.6%), and most deficits lasted more than 60
minutes (71.6%). Antithrombotic drugs were used for 96.7% of patients
at discharge in PS. Neuroimaging was performed in 94.3% of patients,
while in the PS. Our group had a 1.9% stroke rate after 90 days of diag-
nosis of TIA.
Conclusion: This study established that most patients diagnosed with TIA
in the emergency room and imaging studies, receive antithrombotic
agents. Physicians are encouraged to ensure that electrocardiograms are
done routinely involved and Neurology in follow-up care. And more
importantly, there has been a significant improvement in clinical
outcome.
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Previous treatment with angiotensin converting
enzyme inhibitors in patients with ischemic stroke
submitted to intravenous thrombolysis
J Parra1, F Silva1, J Sargento-Freitas1, L Fonseca2, D Ferreira3,
M Pereira1, G Cordeiro1, L Cunha1
1Neurology, Centro Hospitalar e Universitário de Coimbra,
Coimbra, Portugal
2Integrated Master’s in Medicine, Faculdade de Medicina da
Universidade de Coimbra, Coimbra, Portugal
3Internal Medicine, Centro Hospitalar e Universitário de
Coimbra, Coimbra, Portugal
Introduction: Angiotensin converting enzyme inhibitors (ACEi) are one
of the most prescribed classes of antihypertensive drugs. Experimental
studies showed modulation properties of the fibrinolytic system, associ-
ated with reduction of serum concentration of plasminogen activator
inhibitor-1. Clinical relevance of these findings is still unknown.
Objectives: To evaluate the impact of previous treatment with ACEi on
functional outcome of ischemic stroke patients submitted to intravenous
thrombolysis.
Methods: Historical cohort study that included consecutively patients
submitted to intravenous thrombolysis in our Stroke Unit due to ischemic
stroke, between March 1st 2010 and March 31st 2014. Functional outcome
at three months was rated according to modified Rankin Scale (mRS) and
dichotomized into good (mRS ≤2) and poor (mRS >2). We excluded
patients with no information on previous medication, previous mRS>2
and those submitted to intra-arterial thrombolysis. A multivariate logistic
regression was adjusted for age, hypertension, baseline NIHSS and
symptoms-needle time.
Results: We included 399 patients, mean age 73.16 years (SD: 11.36), 212
(53.1%) males, 112 (28.1%) on ACEi therapy. Seventy-eight (70.4%) of
the patients on ACEi vs. 159 (55.0%) of those not on ACEi had poor
outcome, p = 0.01. Previous treatment with ACEi was an independent
predictor of poor outcome (OR: 1.94; 95%CI: 1.12–3.35, p = 0.018).
Patients on ACEi suffered more hemorrhagic transformation (OR: 1.73;
95%CI: 1.05–2.85, p = 0.03). We found no statistically significant differ-
ences on recanalization or symptomatic intracerebral hemorrhage.
Conclusions: In ischemic stroke patients submitted to intravenous throm-
bolysis, previous treatment with ACEi seems to be associated with a worse
functional outcome.
ESOC-1328
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Which steps in EMS operation predict early hospital
arrival and prompt thrombolysis in acute stroke?
T Puolakka1, D Strbian2, M Kuisma1, P J Lindsberg2
1Emergency Medical Services Study Group, Helsinki University
Central Hospital, Helsinki, Finland
2Department of Neurology, Helsinki University Central
Hospital, Helsinki, Finland
Using emergency medical services (EMS) and early prenotification are
associated with early hospital arrival and increased likelihood of
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intravenous thrombolysis in acute stroke. We studied which dispatch and
prehospital management features predict early hospital arrival (<90
minutes) and treatment (<2 hours) after symptom onset.
All stroke patients receiving recanalization therapy during 2010–2011 and
transported by the EMS to the Helsinki University Hospital were recruited
for this prospective, observational study. Individual emergency phone call
tapes, time-stamped prehospital patient-care reports and hospital records
were retrieved and analyzed.
In the sample of 308 eligible patients [55% male, median (interquartile
range) NIHSS 8 (5–14)] the median (IQR) onset-to-call time was 6 (0–16)
in early and 60 (18–104) minutes in late hospital arrival group while other
differences in prehospital time intervals were modest. The stroke code was
used by the emergency medical dispatchers in 206 (67%) and by the
paramedics in 285 (93%) cases. High priority including lights and sirens
was used in 258 (84%) dispatches and 269 (87%) patient transports. In a
backwards logistic regression analysis, the onset-to-call time duration
(p < 0.0001) and ambulance transport using high priority (p < 0.01) were
independently associated with both early arrival and treatment but dis-
patch using high priority was not. Arm weakness was the only symptom in
prehospital examination promoting early treatment (<0.05).
Hesitation to activate the EMS remains as an important problem for acute
stroke care. The importance of early emergency call and high priority
transport to the stroke center should be emphasized in public education
and prehospital guidelines.
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Safety and efficacy of intravenous tissue plasminogen
activator in acute ischemic stroke
S Rajapa1, S Sivakumar1, D Arjundas2
1Neurology, Cerebrovascular and Vasculitis Research
Foundation, Chennai, India
2Neurology, Stroke Unit Vijaya Health Center, Chennai
600026, India
Objective: To evaluate the safety and efficacy of intravenous thrombolysis
using recombinant tissue plasminogen activator (rtPA) in patients with
acute ischemic stroke.
Methods and Materials: This is a prospective, multicenter study from
Chennai, India. 518 patients with acute ischemic stroke were treated with
0.9 mg per kilogram of body weight of rt-PA (Alteplase) within 41/2
hours from the onset of symptoms. The non tPA group was patients who
refused or were ineligible for rtPA. The Primary, Secondary and Tertiary
end points were; Barthel Index (BI) and modified Rankin Scale (mRS) at
90 days, 30-day mortality and early neurological recovery and duration of
in-hospital stay, respectively. Safety parameters included mortality and
incidence of hemorrhage.
Results: Demographics was similar in both groups. There was a significant
difference in Primary outcome in favor of rt-PA treated patients
(P < 0.033). The combined BI and mRS was in favor of rt-PA
patients (P < 0.001) and neurological recovery at 90 days was significantly
better (P ≤ 0.003), Speed of neurological recovery was significantly better
at 7 days, 30 days and In-hospital stay was significantly shorter. There were
no statistically significant differences in the mortality rate at 30 days or in
the overall incidence of intracerebral hemorrhages among both groups.
Large parenchymal hemorrhages was significantly more frequent in the
rt-PA group.
Conclusions: rt-PA in acute ischemic stroke is effective in improving func-
tional and neurological outcome. The safety and efficacy is well proven
and hence, intravenous thrombolysis should be recommended for use in
all eligible acute ischemic stroke patients.
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Blood pressure control in thrombolysed acute ischemic
stroke patients requiring intravenous antihypertensive
treatment at a London hyperacute stroke unit (HASU)
A Sivagnanaratnam1, R I Abdul Hamid1, R Simister1
1Hyperacute Stroke Unit, University College Hospital London,
London, United Kingdom
Introduction: There is uncertainty about optimum early BP management
in ischemic stroke patients being considered for thrombolysis. At our
hospital a protocol for acute lowering of BP prior to administration of
thrombolysis is followed. The aim of our study was to look at the effec-
tiveness of this protocol on BP control over the first 24 hours and impact
on door-to-needle (DTN) times.
Methodology: A retrospective observational study of all patients throm-
bolysed from January 2012 to November 2014 was conducted and the
available notes of all patients requiring acute BP lowering treatment prior
to thrombolysis were studied. The DTN times, medications on admission,
interval BP scores and presence of complications were recorded. Statistical
analysis was performed with SPSS 20.
Results: During the observed period 575 patients received thrombolysis.
Fifty two(9%) patients required BP lowering prior to thrombolysis and
complete case records were available for 36/52 patients. Median DTN was
longer in the group requiring BP lowering (45 minutes versus 35 minutes,
p = 0.10). 47.2% of patients were already on antihypertensive drugs. Pro-
tocol violations were seen in 31% of the studied cases during the first hour
of thrombolysis. Complications were seen in 4/36(two hemorrhage, one
reinfarction and one anaphylaxis) patients. Median BP at 24 hours in the
hypertensive group was 180/90 mmHg.
Conclusion: Over the period of observation 9% of patients treated with
thrombolysis required prior treatment to lower BP. Protocol violations
were seen in 31% of these patients during the first hour of thrombolysis
and treatment was associated with a longer DTN times.
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Interval from onset of stroke to call of emergency
M Sramek1, T Ruzickova1, P Kesnerova2
1Department of Neurology, 2nd Medical School Charles
University Prague, Prague 5, Czech Republic
2Department of Neurology, Regional Hospital, Kladno, Czech
Republic
Background: Time from stroke onset to beginning of treatment with
thrombolysis (onset to treatment time, OTT) is composed of several time
intervals. Concern is focused on the intra-hospital interval (door to needle
time, DNT), but the prehospital intervals also influence the whole OTT.
The very first is the time from onset of stroke symptoms to patient’s
emergency call (onset to call time, OCT). OCT can hypothetically be
reduced by education of the public.
Aim: To determine OCT values and its correlation with OTT. Discover
impact of educating the public on OCT.
Method: In period from 1/2012 to 12/2013 time intervals (OCT, OTT,
DNT) of consecutive patients treated with thrombolysis in single stroke
center were recorded. In the end of 8/2012 an educational article was
published in local press (readers represent about 10% of target popula-
tion). The article focused on recognition of stroke symptoms and the
necessity of urgent call to emergency medical service.
Results: Data of 124 patients were collected, mean age 69 years (27–88), 71
men (57%). Median of OCT was 28,1 min (1–202), OTT 127,5 min
(52–290) and DNT 45 min (15–175). There is a good correlation between
OCT and OTT (R2 0.665), but not between OCT and DNT (R2 0.001). No
significant change in OCT was observed after article publication – median
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before it was 23 min, 3 months after 37 min (p = 0.433) and in whole
period after publication 31 min (p=0,618).
Conclusion: OCT correlates with OTT, single-time educational attempt
had no significant effect on OCT.
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Effect of clinical presentation and stroke etiology on
outcome in acute ischemic stroke with or without
thrombolytic treatment
D Strambo1, S La Gioia1, A Zambon1, L Peruzzotti-Jametti1,
G Giacalone1, G Comi1, M Sessa1, L Roveri1
1Neurology and Neurophysiology, IRCCS Ospedale San
Raffaele, Milano, Italy
Introduction: Despite broad demonstration of benefit from thrombolysis,
better knowledge of prognostics factors could optimize acute stroke
management.
Aim: To assess the predictors of functional outcome in patients with or
without thrombolytic treatment.
Methods: From our stroke database we selected acute ischemic stroke
patients arrived at our ER within 4.5 hours from symptom onset between
March 2005 and April 2013. Clinical presentation and stroke etiology were
categorized using OCSP and TOAST classifications.
Results: Among 386 patients included, 220 (55.7%) received IV throm-
bolysis. The two treatment groups showed similar baseline features except
for lower age (67.9% vs. 71.7%, p .001), lower proportion of diabetes
(13.6% vs. 21.7% p .038) and higher rate of cardioembolic strokes (39.6%
vs. 28.9%, p .001) in the rt-PA treatment group. At logistic regression
analysis independent predictors of outcome were age (OR 0.97 [95%CI
0.95-0.99]), baseline NIHSS (OR 0.87 [95%CI 0.82–0.92]), TACS clinical
presentation (OR 0.29 [95%CI 0.15–0.59]) and thrombolytic treatment.
When interaction terms were added to the model we found no significant
difference in the effect of thrombolytic treatment in the subgroups of
patients classified according to OCSP and TOAST categories.
Conclusions: Despite a general poor prognosis of strokes with TACS clini-
cal presentation, IV thrombolysis significantly improved their chance of
favorable outcome. The beneficial effect of rt-PA treatment was main-
tained across the different stroke etiologies.
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ASTRAL-R score does not reliably predict
non-recanalization after intravenous thrombolysis in
M1-occlusive strokes
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1Neurology, CHUV – University of Lausanne, Lausanne,
Switzerland
2Neurology, Inselspital, Bern, Switzerland
3Neurology, University Hospital Basel, Basel, Switzerland
4Neurology, University Hospital Geneva, Geneva, Switzerland
5Neurology, Universitätsklinikum Carl Gustav Carus, Dresden,
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6Neurology, University Hospital Caen, Caen, France
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Background: Intravenous thrombolysis (IVT) alone for acute ischemic
stroke (AIS) may be insufficient to achieve recanalization in certain
patients. A simple 5-item score (ASTRAL-R) was recently shown to
predict absence of complete and partial recanalization at 24 hours in
patients treated with IVT.
Aim: The study aims to investigate the accuracy of ASTRAL-R score to
predict for absence of recanalization in thrombolysed occlusive strokes of
the M1 segment of middle cerebral artery.
Methods: Data from prospective AIS registries of six academic stroke
centers (Lausanne, Bern, Basel, Geneva, Dresden and Caen) were exam-
ined. Patients with arterial occlusion in M1 on acute non-invasive
imaging, treatment with IVT alone within proven time windows, and
repeat arterial assessment at 24 hours were selected. Performance of
ASTRAL-R-score was assessed by bootstrapping available data and cross
validation.
Results: Of the 347 included patients, 127 (37%) did not achieve partial or
complete recanalization within 24 hours. Both the ASTRAL-R score (OR
0.83, 0.69–0.99) and acute glucose levels on admission (OR 0.86, 0.76–
0.97) [MP1] were identified as independent predictors of absence of reca-
nalization. ASTRAL-R scores of 0, 3 and 6 for M1 occlusions
corresponded to non-recanalization probabilities of 26, 38 and 52%
respectively. The predictive ability of the ASTRAL-R for these patients was
0.57 (95%CI, 0.50–0.63).
Conclusions: The 5-item ASTRAL-R score accuracy to predict non-
recanalization of M1 occlusions after IV thrombolysis was confirmed but
seem insufficient for routine clinical use. Adding selective radiological
parameters such as collateral vessel status, perfusion imaging and throm-
bus length may further improve this score for these patients.
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I.V. thrombolysis and general stroke care in Latin
America – Report from the SIECV-SITS Iberoamerican
Stroke Register
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Background: 56 centers in 15 Latin American (LA) countries aimed to
describe an unselected population of stroke patients, including those
treated with iv thrombolysis (IVT), with baseline data and 3 months
functional outcomes on the modified Rankin Scale (mRS).
Methods: Data for this study were entered into the Safe Implementation
of Treatments in Stroke (SITS) registry September 2009-December 2013.
For patients untreated with IVT, a minimal version of All Patients Proto-
col (APPm) was used, including baseline National Institutes of Health
Stroke Scale (NIHSS) score, other baseline data and 3 m mRS. For IVT
patients, the standard protocol for IVT (IVTs) was used, also including
NIHSS 2 h/24 h, concomitant treatments, imaging. Parts of data were
adjudicated. A Local Coordinator was responsible at each site. Each
country had a National Coordinator.
Results: 5401 patients were entered; of these 301 were treated with IVT
(5.6%). For APPm population, median age was 65 years, 46% were female,
atrial fibrillation 14%, baseline NIHSS 6, functional independence (mRS
0-2) at 3 months 60% and mortality 11%. For IVTs population, median
age 66 years, 45% female, atrial fibrillation 22%, baseline NIHSS 11, mRS
0–2 at 3 m 62% and mortality 11%.
Conclusions: This is the first study to confirm a level of IVT use in LA,
although varying between centers, and lower than in many other coun-
tries. It is also the largest study of a general stroke population in LA. IVT
patients had more severe neurological deficit than the general stroke
population but similar functional outcome at three months.
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Assessment of the feasibility of using wearable
technology as an innovative tool for telestroke
services: Initial results of Google Glass evaluation
S J Warach1, B T King2, K Chandler2, A G Hartman3, T J Milling2
1Neurology, University of Texas Southwestern, Austin TX, USA
2Seton Healthcare, Seton Clinical Research Institute, Austin
TX, USA
3School of Medicine, University of Texas Medical Branch,
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Wearable technologies offer potential Telestroke applications that are
more mobile and less expensive than traditional telemedicine carts.
Several vendors have software for Google Glass that has encrypted video-
streaming to ensure protection of patient privacy.
We evaluated products from two vendors for stability and quality of live
streaming transmission. A brief neurological exam and NIH Stroke Scale
was performed on 17 mock patients by an emergency medicine physician
wearing the Google Glass and viewed remotely by a vascular neurologist.
The users evaluated the device on a standardized set of questions.
Acceptable quality of the live-streaming transmission was achievable. The
vascular neurologist judged the quality to make treatment decisions as
“very confident” or better in 6 of 17 cases (2/9 & 4/8 in vendors 1 and 2,
respectively). Instability of the transmission occurred with either vendor
and led to slow, choppy or freezing video making patient evaluation
inadequate in some cases. The components of the neurologic exam that
yielded the lowest confidence ratings were ‘rapid alternating movement’
(35.3% very confident or better) and ‘pupil reactivity’ (41.2% very confi-
dent or better). Transmission lag time was significantly longer in the
device provided by one of the two vendors (p < 0.005). Heating of the
device battery during video streaming limited its use to brief sessions of
5–10 minutes in both devices.
The quality of video-streaming using Google Glass may be adequate for
remote assessment of patients, but connectivity limitations may affect the
quality, reliability and duration of the assessment.
ESOC-1564
07. Thrombolysis
Assessing the need for routine CT head
post-thrombolysis
G Yeldham1, R Bathula1
1Stroke Unit, Northwick Park Hospital, London, United
Kingdom
Background: A CT scan to rule out hemorrhagic transformation 24 hours
post thrombolysis has been part of routine care since the original NINDS
trial in 1995. Given the radiation exposure associated with CT scans, the
necessity of routine scanning should be reconsidered, particularly in
patients who are improving clinically.
Method: A retrospective study of 739 patients who received thrombolysis
at Northwick Park hospital between March 2012 and February 2014 was
carried out. 28 patients were identified as having hemorrhagic transfor-
mation on the 24 hour CT. An analysis of NIHSS scores within this cohort
was undertaken to assess whether patients would have been scanned if a
new protocol was used, where only patients who were not clinically
improving at 24 hours were scanned. Subsequent management of clini-
cally improving patients was evaluated to see if standard post-
thrombolysis antiplatelet therapy changed as a result of scan findings.
Results: 3.8% (n = 28) of patients were identified as having a hemorrhage
post-thrombolysis on imaging, of which the majority (82%; n = 23) had
either no change, or a deterioration, in their NIHSS. These patients would
have been identified clinically as requiring a CT scan. The remaining
patients (n = 5) were clinically improving at 24 hours and did not have
their management altered as a result of hemorrhagic transformation on
CT.
Conclusions: A CT head scan may not be indicated in all patients post
thrombolysis. Scanning protocols based on the clinical assessment of
patients could reduce radiation exposure whilst maintaining clinical
safety.
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Early intravenous thrombolysis in the elderly after
acute ischemic stroke in a telestroke network – A
retrospective analysis
C Zerna1, T Siepmann1, K Barlinn1, J Kepplinger1, L P Pallesen1,
V Puetz1, U Bodechtel1
1Neurology, University Hospital Dresden, Dresden, Germany
Background: Recent studies showed that the beneficial effects of early
intravenous (IV) thrombolysis on favorable outcomes in acute ischemic
stroke patients are also seen in the elderly. We aimed to assess the appli-
cability of these findings to telestroke.
Methods: We retrospectively analyzed 542 out of 1659 consecutive stroke
patients treated with IV thrombolysis in our telestroke network in East-
Saxony, Germany from 2007 to 2012. Outcome data were symptomatic
intracranial hemorrhage (sICH) by ECASS-2-criteria, favorable outcome
defined as a modified Rankin scale (mRs) of 0-2 at discharge and survival
at discharge.
Results: Thirty-three percent of patients were older than 80 years
(elderly). Baseline characteristics were similar to younger patients except
for higher median NIHSS scores in elderly patients (14 (IQR 10) vs. 11
(11), p-value < 0.01). Being elderly was associated with higher risk of
sICH (p = 0.003), less favorable outcome (p = 0.02) and lower survival
rate (p = 0.01). Using logistic regression analysis earlier onset-to-
treatment time was associated with favorable outcome in not elderly
patients (adjusted odds ratio (OR) 1.18; 95 % CI 1.03–1.34; p = 0.01) and
tended to be associated with favorable outcome in elderly patients
(adjusted OR 1.13; 95 % CI 0.92–1.38; p = 0.25). Age caused no significant
differences in onset-to-door-time (p = 0.25), door-to-treatment-time
(p = 0.06) or onset-to-treatment-time (p = 0.29).
Conclusion: Earlier telestroke mediated thrombolysis tends to benefit
favorable outcome following acute ischemic stroke in the elderly. Age is
not associated with longer delivery times for thrombolysis in telestroke.
ESOC-0776
07. Thrombolysis
Our institutional experience with thrombolysis in
acute ischemic stroke (AIS) in patients with
nonvalvular atrial fibrillation (NVAF)
R Amanovic Curuvija1, D Kosevic2, S Atic3
1Neurology, Hospital for Cerebrovascular Diseases Sveti Sava,
Belgrade, Serbia
2Cardiosurgery, Cardiovascular Institute Dedinje, Belgrade,
Serbia
3Neurology, Hospital for Cerebrovascular Disease Sveti Sava,
Belgrade, Serbia
Background: Non valvular atrial fibrillation (NVAF) is an independent
risk factor for acute ischemic stroke (AIS). Intravenous administration of
recombinant tissue plasminogen activator (rtPA) is known as the best
treatment for AIS. Most ischemic strokes in NVAF patients are due to
cardiogenic embolism of left atrial appendage thrombi. AF patients with
stroke are typically older (averaging approximately 75 years) with large
hemispheric strokes and with higher early mortality compared with isch-
emic stroke patients in sinus rhythm.
Methods: We identified prospectively all patients with AIS due to the
NVAF who were referred to our Institution in six months period in 2014.
We calculated the incidence of administrated rtPA in these patients due to
their gender, sex, medical history, clinical status on admission a previous
oral anticoagulant therapy and outcome.
Results: A total of 199 patients with AIS due to NVAF was admitted to our
hospital and 115(57,7%) were female and 84 (42,3%) male. Mean age was
77,2 years (44–102 years). Among them 7 patients (3,5%) received rtPA.
Only one patient was previously on oral anticoagulation therapy (OAT).
Other 192 patients (96,5% ) received standard therapy for AIS. Among
them 49 (25,5%) patients were previously on OAT. Two patients who
received rtPA died and in the group of 192 patients died 48 pts (25%).
Conclusion: Our institutional experience in patients with AIS due to the
NVAF brings out dilemma – is there more space for thrombolytic therapy
in reducing mortality in this particular group?
ESOC-0074
07. Thrombolysis
White matter lesions double the risk of
post-thrombolytic intracerebral hemorrhage
S Curtze1, E Haapaniemi1, S Melkas1, S Mustanoja1, J Putaala1,
T Sairanen1, G Sibolt1, M Tiainen1, T Tatlisumak1, D Strbian1
1Neurology, Helsinki University Central Hospital, Helsinki,
Finland
Background and Purpose: Cerebral white matter lesions (WMLs), a sur-
rogate for small-vessel disease, are common in stroke patients and may
relate to an increased intracranial bleeding risk following intravenous
thrombolysis (IVT) for acute ischemic stroke. However, major guidelines
lack a statement on WMLs as a possible contraindication.
Objective: We aimed to investigate the risk of symptomatic intra-cerebral
hemorrhage (sICH) in presence of WMLs in a large cohort of IVT-treated
ischemic stroke patients.
Methods: We analyzed 2485 consecutive patients treated with IVT at the
Helsinki University Central Hospital. WMLs were scored according to five
previously published CT visual rating scales from all baseline CT head
scans. The inter-rater agreement was calculated for all four visual rating
scales.
Occurrence of intra-cerebral bleeding after thrombolysis was considered
as symptomatic applying the European Cooperative Acute Stroke Study II
criteria for sICH.
The associations of sICH with nominal, ordinal, and continuous variables
were analyzed in a univariate binary regression model and adjusted in
multivariate binary regression models.
Results: In univariate and multivariate regression analyses, all five tested
visual WML rating scales as continuous variables, or dichotomized at
different cut-off points, were associated with increased risk of sICH: the
odds ratio ranged from 2.22 (95% confidence interval 1.49-3.30) to 2.70
(1.87–3.90).
Conclusions: Relevant WMLs visible on CT are associated with more than
a double risk of sICH in patients treated with IVT for acute ischemic
stroke.
ESOC-0079
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Series of patients of AIS with recurrent occlusion after
recanalization with Solitaire
Dr. Dalai1, Dr. R V Narayana2, Dr. Pati3
1Interventional Neuroradiology, SevenHills Hospital,
Visakhapatnam, India
2Neurology, SevenHills Hospital, Visakhapatnam, India
3Neurology, Rajesh, Visakhapatnam, India
Background: AIS due to large vessel occlusion is increasingly treated with
mechanical thrombectomy device like solitaire. Many studies have
reported the recanalization of large vessels to be better with mechanical
thrombectomy compared to IV rTPA or standard medical management.
Objective: To evaluate the rate of recanalization and re-occlusion of major
vessels after recanalization with mechanical thrombectomy within 24 hrs
of intervention.
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Materials and Methods: we treated 46 patients of AIS with mechanical
thrombectomy from May 2012 to Dec 2014. the recanalization rate was
noted. the patients were re-evaluated within 30 min to 24 hrs post throm-
bectomy for stable recanalization.
Results: We could achieve 86% complete recanalization (TICI 3) by throm-
bectomy with Solitaire. 10% of these patients had re-occlusion of the target
vessel (the one underwent thrombectomy) who had otherwise had com-
plete recanalization with thrombectomy with or without symptom. the
reoccluded vessels had no angiographically proven native vessel disease.
Conclusion: The rate of immediate or delayed re-occlusion after success-
ful recanalization with solitaire thrombectomy in patients with AIS is
significant. it needs to be studied further to prevent such re-occlusion in
such patients.
ESOC-0418
07. Thrombolysis
The influence of stroke team assessment on door to
needle time (DNT)
B Dallol1, A Kenton1
1Neurosciences, University Hospital Coventry and
Warwickshire, Coventry, United Kingdom
Introduction: The West Midlands Regional Stroke Service Specification
states that patients who have been identified for thrombolysis should have
a door to needle time (DNT) of less than 60 minutes and ideally 30
minutes. In this audit we examine the current practice against these
regional standards and also examine the diurnal variation of depending
on the medical team delivering the treatment. Both teams have round the
clock access to an on-call neurology consultant. The Stroke team consists
of Stroke Fellows and Neurology Registrars from 08:30 am until 09:00 pm.
and then medical registrars for the remainder of the time, completing 24
hours cycle
Methods: Data were collected retrospectively over a 12 month period
using a local database and thrombolysis forms which, in turn, were col-
lected in real time by stroke nurses on admission. This included identify-
ing the team involved (stroke teams or medical teams), time of admission,
time of thrombolysis and DTN time. Inpatient referrals were excluded
from this audit.
Results: 131 patients were identified who had received thrombolysis. 106
patients were treated by the stroke team and 25 by the medical team. The
median time for receiving thrombolysis for the stroke team was 55 min
and the mean time was 58.5 min. This was 65 min and 73.2 min respec-
tively for the medical team.
Discussion: Recent studies have shown that shortening DNT improves
outcome. In this audit we found that DTN time was shorter when patients
were assessed by the dedicated stroke team which is consistent with pre-
vious studies.
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Thrombolysed strokes at the Royal Berkshire Hospital:
Their estimated and actual weights and the doses of
alteplase given
R Davidson1, F Jeddi1, E Flossmann2, S Khan2, L Barber2,
S Panchalingam2, C Love2, N Bhupathiraju2, C Canavan2
1Neurorehabilitation, Royal Berkshire Hospital, Reading,
United Kingdom
2Neurology, Royal Berkshire Hospital, Reading, United
Kingdom
Background: NICE have recommended alteplase at for treating acute isch-
emic stroke. The recommended dose is 0.9 mg/kg. Studies have shown
that higher doses may cause increased rates of intracranial hemorrhage.
However, when patients arrive in the Emergency Department weights
often have to be guessed.
Methods: A random sample of 56 patients was taken from all patients
thrombolysed at the Royal Berkshire Hospital over the last 3 years. Their
notes were obtained and their estimated and actual weights looked at as
well as the dose of alteplase given compared with what should have been
given. Outcomes that were looked at from the notes included whether the
patient died within 30 days of a stroke (from all causes), whether the
patient had an intracranial bleed and what the eventual discharge desti-
nation was (used as a proxy for residual disability).
Results: Only 7 patients had their weight estimated exactly. 20 patients
were estimated to be more than they were and 29 patients as less.
Overall 8 patients died within 30 days. 2 patients suffered intracranial
bleeds. 43 patients were discharged home.
There was no statistically significant increase in risk of death or bleed or of
difference in discharge destination in either the overestimation or under-
estimation group.
Conclusion: We found that wrong estimation of weight is a problem.
However there was no evidence it affected the outcomes of intracranial
bleed, death or discharge destination. We recommend the implementation
of a bed with inbuilt scales in the resuscitation department so this
problem can be overcome.
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Intravenous tissue plasminogen activator improves the
outcome in very elderly Korean patients with acute
ischemic stroke
K Hong1, J Lee2, J Choi3, Y Cho1, J Park4, T Park5, K Lee6, J Lee7,
S Lee8, Y Ko8, J Cha9, D Kim9, J Kim10, J U N Lee11, D Kim12,
K Yu13, M Oh13, B Lee13, B Kim14, H Bae14
1Neurology, Ilsan Paik Hospital Inje University, Goyang, Korea
2Biostatistics, Clinical Research Center Asan Medical Center,
Seoul, Korea
3Neurology, Jeju National University Hospital Jeju National
University School of Medicine, Jeju, Korea
4Neurology, Eulji General Hospital Eulji University, Seoul,
Korea
5Neurology, Seoul Medical Center, Seoul, Korea
6Neurology, Soonchunhyang University Hospital, Seoul, Korea
7Biostatistics, Korea University College of Medicine, Seoul,
Korea
8Neurology, Eulji University Hospital Eulji University, Daejeon,
Korea
9Neurology, Dong-A University Hospital, Busan, Korea
10Neurology, Chonnam National University Hospital, Gwangju,
Korea
11Neurology, Yeungnam University Hospital, Daegu, Korea
12Neurology, Dongguk University Ilsan Hospital, Goyang,
Korea
13Neurology, Hallym University Sacred Heart Hospital,
Anyang, Korea
14Neurology, Cerebrovascular Center Seoul National University
Bundang Hospital, Seongnam, Korea
Background: In a recent pooled analysis of randomized clinical trials
(RCTs), intravenous tissue plasminogen activator (TPA) improves the
outcome in patients aged ≥80 years. However, it is uncertain whether the
findings are applicable to clinical practice in Asians.
Methods: From a multicenter stroke registry database of Korea, we iden-
tified acute ischemic stroke patients aged ≥80 years. Using multivariable
analysis and propensity score matching (PSM) analysis, we compared the
discharge mRS outcome between patients treated with intravenous TPA
within 4.5 hours and those without treatment.
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Results: Among 2331 patients who met the eligible criteria, 236 were
treated with intravenous TPA (mean age, 83.5 ± 3.2; median NIHSS, 12.5
[IQR, 8–17]). At discharge, the TPA group versus the no-TPA group had
a favorable shift on the mRS score (multivariable analysis, OR [95% CI],
1.50 [1.16–1.94], p = 0.0020; PSM analysis, 1.49 [1.14–1.95], p = 0.0034)
and was more likely to achieve mRS 0–2 outcome (multivariable analysis,
1.98 [1.34–2.91], p = 0.0005; PSM analysis, 1.69 [1.14–2.51], p = 0.0091).
TPA treatment was associated with more symptomatic hemorrhagic
transformation (multivariable analysis, 5.44 [2.80–10.59], p < 0.0001;
PSM analysis, 4.65 [2.33–9.29], p < 0.0001), but did not increase the mor-
tality at discharge (multivariable analysis, 0.85 [0.50–1.47], p = 0.5672;
PSM analysis, 0.77 [0.44–1.36], p = 0.3673).
Conclusions: In very elderly Korean patients registered in this multicenter
registry, intravenous TPA within 4.5 hours improved the functional
outcome despite an increased risk of symptomatic hemorrhagic transfor-
mation. The findings, consistent with those from pooled analysis of RCTs,
strongly support the use of TPA for this population.
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A new interventional protocol cuts intravenous
thrombolysis door-to-needle time in a tertiary hospital
A M Iglesias Mohedano1, A García Pastor1, A García Arratibel1,
A Sobrino García1, F Diaz Otero1, P Vázquez Alen1,
R Domínguez Rubio1, F Romero Delgado1, A Muñoz González1,
Y Fernández Bullido1, J A Villanueva Osorio1, A Gil Núñez1
1Neurology, Gregorio Marañón General Hospital, Madrid,
Spain
Objective: To determine if a new intravenous thrombolysis (IVT) proto-
col reduces door-to-needle time (DNT) in a tertiary hospital.
Methods: We retrospectively analyzed which factors were associated with
in-hospital delays in treating acute stroke with IVT between 2009 and
2012. According to the obtained information, from February to December
2014, we introduced a series of consecutive interventions aimed to reduce
DNT including personal history review and test request before patient
admission, defined criteria to perform advanced neuroimaging before
IVT only in selected patients and not waiting for coagulation laboratory
results and/or use of point-of-care INR test before initiating IVT.
In-hospital time results were reported monthly to the stroke team.
Patients treated during this period were registered prospectively. We com-
pared DNT and factors associated with in-hospital delays before and after
protocol changes.
Results: 239 patients were included before and 59 patients after interven-
tion. Median (IQR) DNT was 52 minutes (43–70) and 39 (30–51) respec-
tively (25%reduction, p < 0.001). Before the intervention, DNT was
within 60 minutes in 65.4% and reached 86.4% after. During the pre-
intervention period, 2 factors reduced DNT: pre-hospital notification
(beta= −0,26; p < 0.001) and onset-to-door time (“3-hour-effect”)
(beta = −0,15; p = 0.02), while advance neuroimaging before IVT
increased DNT (beta = 0.13; p = 0.03). After intervention, pre-hospital
notification and 3-hour-effect did not affect DNT (beta = −0.13, p = 0.30
and beta = −0.05, p = 0.69), but the effect of advance neuroimaging per-
sisted (beta = 0.35, p = 0.007).
Conclusions: Our interventional protocol reduces DNT effectively. We
overcame the 3-hour-effect and improved our capacity to proceed even
without pre-hospital notification. Advanced neuroimaging before IVT
persisted as a delaying factor of DNT.
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Reducing in-hospital delays in acute stroke patient
care: Analysis of a new interventional protocol in a
tertiary stroke hospital
A Iglesias Mohedano1, A García Pastor1, F Diaz Otero1,
P Vázquez Alen1, R Domínguez Rubio1, F Romero Delgado1,
A Muñoz González1, Y Fernández Bullido1, J A Villanueva Osorio1,
A Gil Núñez1
1Neurology, Gregorio Marañón General Hospital, Madrid,
Spain
Objectives: To analyze the effect of different interventions aimed to reduce
in-hospital delays of acute stroke care.
Methods: we prospectively included all acute stroke potential candidates
for intravenous thrombolysis (IVT) admitted from February to December
2014 in a tertiary care hospital. A series of consecutive interventions were
implemented during this period including personal history review and
CT/blood test request before patient admission (in case of pre-hospital
notification), not repeating electrocardiogram (EKG) if previously per-
formed by the emergency medical services, defined criteria to perform
advanced neuroimaging only in selected patients and not waiting for
coagulation laboratory results and/or use of point-of-care (POC) INR test
before initiating IVT. We analyzed the effect on door-to-CT, CT-to-needle,
and door-to-needle times.
Results: 230 patients were included, median (IQR) door-to-CT was 16
minutes (13–21). 59 (25.7%) patients were treated with IVT, door-to-
needle was 39 (30–51), CT-to-needle: 24 minutes (18–33). Door-to-CT
was significantly reduced with pre-hospital notification and personal
history review + CT/blood test request before patient admission: 15 vs
19(p < 0,001); not performing a new EKG 14.5 vs 19 (p < 0.001) and IVT
treatment: 14 vs 18(p < 0.001). Advance neuroimaging increased CT-to-
needle (21 vs 38.5, p = 0.009) and Door-to-needle time (35 vs 55,
p = 0.003). Not waiting for coagulation laboratory results and/or use of
POC INR test reduced Door-to-needle: 35.5 vs 46.5 (p = 0,05). The whole
protocol could only be applied in 23% of cases. Two patients (3.4%)
treated with IVT were proved to be “stroke mimics”.
Conclusions: Our interventional protocol seems to reduce in-hospital
delays in acute stroke care. However, a better adherence to the protocol
interventions is required in order to improve our results.
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Impact of thrombolysis in acute ischemic stroke
without occlusion: An observational comparative study
B Lapergue1, N Ajili1, J Labreuche2, J P Decroix1, Y Bejot3,
P Michel4, M Sevin5, I Sibon6, S Vergnet6, S Evrard1, A Wang1,
P H Graveleau1, M Mazighi7, F Bourdain1
1Stroke Center – Neurology Division, Foch Hospital University
Of Versailles Saint Quentin En Yvelines, Suresnes, France
2Department of Biostatistics, Lille University Medical Center,
LILLE, France
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Medical School of Dijon, DIJON, France
4Neurology Service, Centre Hospitalier Universitaire Vaudois
and University of Lausanne, Lausanne, Switzerland
5Department of Neurology, Nantes University Hospital,
Nantes, France
6Unité neuro-vasculaire Pole de Neurosciences Cliniques,
Université Bordeaux 2 CHU Bordeaux Pole de Neurosciences
Cliniques, Bordeaux, France
7Department of Neurology, Lariboisiere Hospital Laboratory
of Vascular Translational Science Paris 7 and Sorbonne Paris
Cité Universities., Paris, France
Objective: The impact of intravenous (IV) recombinant tissue plasmino-
gen activator (rtPA) is debated in acute ischemic stroke (AIS) patients
without arterial occlusion. We examined the outcomes of patients with
AIS and no arterial occlusion according to IV-rtPA use.
Methods: In center A, all eligible patients did not receive IV rtPA in cases of
no documented occlusion (controls groups), while in centers B, all eligible
patients were treated with conventional IV rtPA regardless of the arterial
vessel status (cases group). The primary outcome was excellent outcome at
3 months after stroke, as defined by a modified Rankin scale score 0 to 1.
Secondary outcomes included different clinical and safety outcomes.
Results: From January 2011 to June 2014, 139 AIS patients without arte-
rial occlusion documented by angiography in center A and 366 patients in
centers B were thrombolysed. After adjustment for baseline between-
group differences, including admission NIHSS, hypercholesterolemia,
lacunar stroke subtype, we found no significant difference whatever the
clinical outcomes (OR 0.86 (0.51–1.47; p = 0.59). When analysis was
stratified according to lacunar and nonlacunar stroke etiology, we found
no significant heterogeneity in the effect size whatever the clinical efficacy
outcomes. Sensitivity analysis excluding patients with pre-stroke disability
or restricted to balanced groups after propensity score matching, yielded
similar results.
Fig. 1 Clinical efficacy outcomes in non-IV and IV rtPA-treated groups,
overall and according to lacunar stroke subtype.
Conclusions: In an observational comparative cohort of acute stroke
without occlusion, we found no significant effect of IV rtPA on clinical
outcome, independently of lacunar stroke mechanism or not. Further
randomized controlled trails are warranted to address this issue.
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Influence of neurologists’ experience on the outcome
of patients treated by intravenous thrombolysis for
cerebral ischemia
E Tuffal1, S Moulin1, N Dequatre-Ponchelle1, M Bodenant1,
F Dumont1, C Lefebvre1, H Hénon1, S Debette1, C Cordonnier1,
D Leys1
1Neurology, Lille University, Lille, France
Background: Intravenous (i.v.) recombinant tissue plasminogen activator
(rt-PA) should be available on a 24/7 basis in hospitals admitting patients
with stroke. We aimed at evaluating the influence of the number of
patients previously treated with i.v. rt-PA by neurologists on patients’
outcome.
Method: For each patient consecutively treated with i.v. rt-PA for cerebral
ischemia at the Lille University Hospital, we determined the number of
previous treatments with rt-PA administered by the neurologist. We per-
formed logistic regression analyses to determine the influence of the expe-
rience on the outcome evaluated by the modified Rankin scale (mRS) after
3 months, 0–1 meaning independence, and 0–2 meaning absence of
handicap. We compared outcomes of patients treated by the 25% less
experienced neurologists with those of trials.
Results: Forty-five neurologists treated 800 patients. The experience of
the treating neurologist was independently associated with independence
(adjusted odds ratio [adjOR] 1.062 for 10 patients more; 95% confidence
interval [CI] 1.008–1.120), and absence of handicap (adjOR 1.076 for 10
patients more; 95%CI: 1.016-1.140) at 3 months, but not with symptom-
atic intracerebral hemorrhage and death. The proportions of patients
from the 1st quartile who were independent and without handicap at 3
months were 37.9% and 51.1%.
Conclusion: Patients treated by less experienced neurologists, have similar
outcomes than expected from trials, suggesting they benefit from throm-
bolysis. However, the outcome of patients treated by more experienced
neurologists was slightly better. Less experienced neurologists should not
be excluded from rt-PA programs, but their practices should be evaluated
and educational programs organized.
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Stroke nurse practitioners – The solution to
maintaining a short door to needle time?
B Madigan1, G J Taylor2
1Stroke, Royal United Hospitals Bath NHS Foundation Trust,
Bath, United Kingdom
2Department of Health, Bath University, Bath, United
Kingdom
The Royal United Hospital Bath is a 600 bed District General Hospital.
Stroke Thrombolysis is led by the Emergency Department physicians.
From January to March 2014, the role of a Stroke Nurse Practitioner
(SNP) was being piloted with 1 WTE nurse in order to ensure national
stroke targets are being met. The SNP attended all thrombolysis calls in
hours.
Results: The overall DTN time was significantly reduced during the pilot.
However, this was not maintained after the pilot had finished.
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Time
Mean
DTN
95 % CI
for mean
(lower/
upper)
Median
DTN SD n P-value
Pre-pilot (Jan to
Mar 2013)
68.4 51.7; 85.0 60 32.3 17 Pre:during
0.027
During pilot (Jan
to Mar 2014)
47.5 37.7; 57.3 42 19.7 18 During:post
0.021
Post-pilot (Apr
to Jul 2014)
64.8 54.4; 75.2 57.5 25.8 26 Pre:post
0.689
During pilot
with SNP
39.1 33.0; 45.2 37.5 8.6 10
During pilot
without SNP
58 37.1; 78.9 53 25.0 8
Further benefits were the increase in the number of stroke patients who
were scanned within 1 hour of arrival after a nurse-requesting CT policy
was put in place from 1st of February, and the number of stroke patients
having their swallow assessed within 4 hrs.
Conclusion: Stroke Nurse Practitioners can be the answer to maintaining
short door to needle times and improve on national stroke target
performance.
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Repeated intravenous thrombolysis after rapid
recurrent cerebrovascular event
J Metrikat1, M Scheibe1, V Krack1, F Weber1
1Neurology, Military Hospital Ulm, Ulm, Germany
Background: Thrombolytic therapy is the only approved treatment for
acute ischemic stroke. Manufacturer’s instructions do not recommend the
use of alteplase (rtPA) within 3mo of stroke recurrence due to increased
risk of bleeding. Published experience with repeated iv-thrombolysis in
recurrent stroke is rare. We report a case of two rtPA-treatments within
8 hrs in a patient with an ulcerated carotid plaque and early recurrent
stroke.
Method/Case: A 67-year-old man presented with a sudden onset left sided
hemiparesis (NIHSS: 5, mRS: 4); RR150/80 mmHg. He had a history of
prior posterior infarction 2 yrs ago with no remaining deficit. He was
thrombolysed within 110 min after first onset of symptoms with 60 mg
iv-rtPA, according to current guidelines (door-to-needle time (DNT):
35 min). Hemiparesis resolved within 1 hr (NIHSS: 1). 5.5 hrs after first
iv-rtPA treatment was concluded he again developed a left sided hemipa-
resis (NIHSS: 6). A second thrombolysis (60 mg iv-rtPA) was adminis-
tered after informed consent (DNT: 40 min). He fully recovered (NIHSS:
0, mRS: 0).
Results: A male with rapid recurrent cerebrovascular event and an ulcer-
ated carotid plaque fully recovered from his hemiparesis by repeated
iv-rtPA-thrombolysis within <8 hrs time interval. No bleeding was
observed. We did not see any other suitable treatment option after clini-
cally relevant reocclusion had occurred.
Conclusion: Our case adds individual experience with thrombolysis treat-
ment beyond the guidelines in early recurrent arterio-arterial embolic
stroke. Reevaluation of rtPA-exclusion criteria, such as recent ischemic
stroke, should be further evaluated in formal trials, to closely address
bleeding risks and possibly increase the number of patients who may
benefit from repeated thrombolysis.
ESOC-0361
07. Thrombolysis
Clinical outcome of intravenous tissue plasminogen
activator for basilar artery occlusion
M Mikamoto1, K Kamiyama1, H Endo1, K Shindo1, T Osato1,
H Nakamura1
1Department of Neurosurgery, Nakamura Memorial Hospital,
Sapporo, Japan
Background: Benefit of intravenous tissue plasminogen activator (IV-t-
PA) in basilar artery occlusion remains unclear. We evaluated the efficacy
of IV-t-PA for basilar artery occlusion from our experience.
Methods: We retrospectively reviewed 20 patients who received IV-t-PA
treatment for basilar artery occlusion in our hospital during 2006 and
2013. All patients received 0.6 mg/kg alteplase within 4.5 hours from
onset. We analyzed their age, gender, stroke subtype, National institute of
Health Stroke Scale (NIHSS) at admission and discharge, modified
Rankin Scale (mRS) at discharge, occurrence of intracerebral
hemorrhage.
Results: Sixteen patients were treated with IV-t-PA alone and 4 patients
were added mechanical embolectomy with Penumbra system. Mean age
was 73 years (32-90) and 5 patients were female gender. Stroke subtype
was cardiogenic embolism in 16 cases, atherothrombosis in 3 cases and
other causes in 1 case. Recanalization was obtained in 15 patients (75%).
Eight patients (40%) regained independence (mRS of 0–2) at discharge
and their scores in NIHSS at admission were significantly lower than that
of the others. Intracerebral hemorrhage occurred in 2 patients, but both of
them were asymptomatic.
Conclusion: Efficacy of IV-t-PA for basilar artery occlusion may not be
inferior to that for other large vessel occlusion. Our results suggest that
low score in NIHSS at admission is associated with favorable outcome.
ESOC-0325
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Efficacy of intraarterial thrombolysis with tissue
plasminogen activator in acute ischemic stroke.
Uzbekistan results
S Mubarakov1, A Zakhidov1
1Neurology Department, Republic Research Center of
Emergency Medicine, Tashkent, Uzbekistan
Background and Purpose: Intravenous tissue plasminogen activator (tPA)
application within 3 hours after onset of acute ischemic stroke (AIS) is
established therapy. The alternative for thrombolysis in patient admitted
within 3-6 hours after onset is intra-arterial thrombolysis (IAT). The
purpose was to evaluate the efficacy of IAT with tPA in AIS due to middle
cerebral artery (MCA) occlusion.
Methods: Cerebral angiography (CA) and standard Seldinger technique
was applied in IAT. After angiographic detection of MCA occlusion IAT
with tPA in dose 15–25 mg was perform. 10 patients (7 male, 3 female,
aged 48–75 years, average age 64,4 ± 8,6) were investigated. All patients
were selected by National Institute of Neurological Disorders and Stroke
recommendations. National Institutes of Health Stroke Scale (NIHSS),
modified Rankin scale (mRs) were used.
Results: MCA occlusion was detected by CA in all patients. NIHSS average
score at admission was 14.7 ± 3.9, 272 ± 36.5 minutes elapsed from
symptom onset. We obtained the following clinical results: 5
patients (50%) had excellent outcome (mRs score 0 to 1), 3 patients
(30%) a good outcome (mRs score 2), 2 patients (20%) had no changes
(mRs score 3 to 4). In this patient brain ischemic zone was detected on
control CT. In group with excellent and good outcomes 3 patient had
asymptomatic hemorrhagic transformation (HT) with small petechiae
along the margins of infarct zone.
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Conclusions: IATT with tPA performed under CA control can be consid-
ered as effective method in patients with AIS. Thrombolysis-related HT is
a marker of successful recanalization.
ESOC-0326
07. Thrombolysis
Monitoring of thrombolysis efficiency in patients with
acute ischemic stroke
S Mubarakov1, A Zakhidov1, N Dadamyants2
1Neurology Department, Republic Research Center of
Emergency Medicine, Tashkent, Uzbekistan
2Functional Diagnosis Department, Republic Research Center
of Emergency Medicine, Tashkent, Uzbekistan
Background and Purpose: The purpose of this study was to evaluate diag-
nostic opportunities of such ray methods as transcranial dopplerography
(TCDG), traditional cerebral angiography (TCA) and multislice com-
puted tomography angiography (MSCTA) in monitoring of thrombolysis
efficiency in acute ischemic stroke.
Methods: Since 2003 to 2014 we have 50 patients admitted in “therapeutic
window” (3 hours after symptoms onset). 12 patients intravenous throm-
bolysis with actilyse and 38 patients intra-arterial thrombolysis with
streptokinase were performed. Efficiency of thrombolysis (grade of reca-
nalization) was monitored by TCDG, TCA and MSCTA.
Results: In patients with intra-arterial streptokinase administration
TCDG and TCA were performed before and after thrombolysis. In case
with streptokinase the most noninvasive method of monitoring TCDG in
average showed hemodynamically (>75%) significant decrease of linear
blood velocity in middle carotid artery (MCA) before thrombolysis. After
procedure only in 10 of 38 patients TCDG showed full recanalization, in
14 patients – partial recanalization and in 14 patients – no recanalization
sings were revealed. TCA only in 6 patients showed immediate recanali-
zation after intra-arterial streptokinase administration while intra-arte-
rial catheter was not removed. In case of 12 patients with actilyse
intravenous thrombolysis hemodynamically (>75%) significant decrease
of linear blood velocity in MCA before thrombolysis was also detected by
TCDG. MSCTA revealed occlusion of MCA large branch. After throm-
bolysis procedure TCDG showed full in 5 and partial (60–80%) recanali-
zation in 7 patients. MSCTA detected the same recanalization rate.
Conclusions: The gold standard of thrombolysis estimation are TCA and
MSCTA. TCDG showed high sensitivity and specificity in comparison
with TCA and MSCTA.
ESOC-0656
07. Thrombolysis
Very early thrombolysis for acute ischemic stroke:
Native CT is enough, so why wait?
N Nicastro1, H M Müller1, P A Poletti2, A Platon2, R F Sztajzel1
1Neurology, Geneva University Hospital, Geneva, Switzerland
2Radiology, Geneva University Hospital, Geneva, Switzerland
We designed a case-control study by creating two groups of patients with
confirmed acute ischemic stroke. We administered IV bolus directly after
the native CT to patients with suspected stroke, as they were still lying in
the CT. This group, called “very early IVT”, was compared to a control
group, consisting of patients who benefited from IVT after the regular
complete CT.
We assessed door-to-imaging, door-to-needle, symptoms-to-lysis time
and, when available, time from IV lysis to thrombectomy. We also assessed
NIHSS score at admission, at 24 h and modified Rankin score at discharge
from the Neurology Department. The two groups were matched for age,
male/female ratio, initial NIH and site of occlusion. The endpoints were
the time gained with very early thrombolysis, as well as NIH at 24 h and
mRS at discharge improvement. Hemorrhagic complications and mortal-
ity were also assessed.
We enrolled a total of 46 patients in the very early thrombolysis group and
92 patients in the control group. Door-to-lysis time was respectively 47
and 79 minutes (p < 0.001). NIHSS at 24 h were 4.88 vs 7.43 (p < 0.03)
and mRS at discharge 2.13 vs 2.85 (p < 0.056). We noticed favorable
outcome (mRS 0-1) for 43% of patients in the very early IVT group vs
30% in the control group. We found a significantly lower incidence of
acute hemorrhage and mortality in the very early IVT group.
This method has the advantage of being implementable in every center, in
order to treat patients earlier and with a potential reduction of disability
after an acute ischemic stroke.
ESOC-0117
07. Thrombolysis
Validating the DRAGON score in Korean patients with
ischemic stroke
M S Oh1, K H Yu1, S H Ahn1, B C Lee1
1Neurology, Hallym University Sacred Heart Hospital, Anyang
Gyeonggi-do, Korea
Background: The Dense Artery, Rankin Score, Age, Glucose, Onset to
Treatment Time, NIHSS (DRAGON) score predicts functional outcome
in the hyperacute phase of intravenous thrombolysis therapy of ischemic
stroke patients. We assessed the validity of the DRAGON score in Korean
ischemic stroke patients.
Methods: Prospectively collected data of consecutive ischemic stroke
patients who received intravenous r-tPA in Hallym stroke center were
reviewed (n = 185). We assessed the performance of the DRAGON score
with area under the AUC-ROC for both good outcome (mRS, 0–2) and
miserable outcome (mRS, 5–6) at 3 months after stroke onset. We also
compared the AUC-ROC of four prediction scores (DRAGON score,
THRIVE, STROKE-TPI and SPAN -100) in identification of functional
outcome in patients who received intravenous r-tPA.
Results: Among 158 eligible patients, good outcome was found in 94
patients (59.5 %), whereas miserable outcome occurred in 41 patients
(25.9%). The AUC-ROC of the DRAGON score was 0.88 (95% CI 0.75–
0.88) for miserable outcome and 0.86(95 % CI, 0.80–0.91) for good
outcome. Other prediction scores (THRIVE, STROKE-TPI and SPAN-
100) had similar AUC-ROC of functional outcome; AUC-ROC for good
outcome was 0.80(95% CI, 0.73–0.896), 0.84(95% CI 0.78–0.90) and
0.78(95% CI 0.70–0.86) respectively; AUC-ROC for miserable outcome
was 0.81(95% CI 0.74–0.87), 0.90(95% CI 0.84–0.94) and 0.85(95% CI
0.78–0.90) respectively. When compared with four prediction scores, there
was no significant difference of performance between four scores.
Conclusions: The DRAGON score reliably predicts good or miserable
outcome at 3 months after intravenous r-tPA in Korean ischemic stroke
patients.
ESOC-0817
07. Thrombolysis
Improving the selection of patients for stroke code
from the coordinating center urgent phone calls in
Southern Spain. Evaluation and defining strategies
A Palomino1, A Caballero2, I Escudero3, F Moniche3, M D Jiménez3
1Neuroscience, Hospital Universitario Virgen del
Rocío/Instituto de Biomedicina de Sevilla (IBI, Seville, Spain
2Emergency, Company Public Health Emergency of Andalucia,
Seville, Spain
3Neuroscience, Hospital Universitario Virgen del
Rocío/Instituto de Biomedicina de Sevilla (IBI), Seville, Spain
Background: Ischemic stroke is the paradigm prevalent and potentially
serious disease whose prognosis depends on the speed and effectiveness in
the proceedings. The first 90 minutes are critical to identify candidates for
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the treatment of acute and to improve prognosis. Since 1990, deaths
related to stroke increased by 26% annually, so it can be said that we are
experiencing an epidemic.
Methods: The sample analyzed patients are treated at the Coordinator of
Emergency Center from 1 January 2011 to 31 December 2014, attended by
a medicalized equipment and whose diagnosis by ICD-9 is 436. The
telephone screening performed by expert personnel of the Coordinating
Center using standardized questionnaires. The variables analyzed were
age, sex, reason for the call, time of call entry, time of arrival at hospital,
resource assigned code resolution of the case.
Results: The sample is found 2,462 cases with ICD-9 code 436. The
reasons for calling are classified in 14 core reasons. As a second specifica-
tion of the reason for call found inside the trunk neurological disorder to
cause stroke, syncope, unconscious, dizziness and fainting. 852 were iden-
tified as stroke corresponding to 34% of the overall sample. The average
age is 81 years and men 75. Less than 10%, 230 patients, received intra-
venous thrombolytic therapy (available until 22 May 2014).
Conclusions: The telephone screening performed by qualified personnel
with standardized cuestionarios selects 1 in 10 patients with acute isch-
emic stroke who benefit from thrombolytic treatment and 1 in 3 after
diagnosis by prehospital emergency medical team.
ESOC-0253
07. Thrombolysis
Effectiveness and safety of intravenous thrombolysis
in patients receiving intra-arterial recanalization
therapy
H Park1, J Chung1, J Hong2, H Noh3, J Park4, S Lee5, J Cha6,
T Park7, K Lee8, J Lee3, K Hong9, Y Cho9, B Lee10, J Kim11, D Kim12,
J Choi13, W Kim14, J Lee15, J Lee16, H Bae1
1Neurology, Seoul National University Bundang Hospital,
Seongnam, Korea
2Neurology, Keimyung University Dongsan Medical Center,
Daegu, Korea
3Neurology, Yeungnam University Hospital, Daegu, Korea
4Neurology, Eulji General Hospital, Seoul, Korea
5Neurology, Eulji University Hospital, Daejeon, Korea
6Neurology, Dong-A University Hospital, Busan, Korea
7Neurology, Seoul Medical Center, Seoul, Korea
8Neurology, Soonchunhyang University Hospital, Seoul, Korea
9Neurology, Ilsan Paik Hospital Inje University, Goyang, Korea
10Neurology, Hallym University Sacred Heart Hospital,
Anyang, Korea
11Neurology, Chonnam National University Hospital, Gwangju,
Korea
12Neurology, Dongguk University Ilsan Hospital, Goyang,
Korea
13Neurology, Jeju National University Hospital Jeju National
University School of Medicine, Jeju, Korea
14Neurology, Ulsan University College of Medicine, Ulsan,
Korea
15Clinical Research Center, ASAN Medical Center, Seoul, Korea
16Biostatistics, Korea University College of Medicine, Seoul,
Korea
Background: Intravenous thrombolysis (IVT) within 4.5 h of onset is the
standard treatment that should be provided to patients with acute large
artery occlusion and receiving intra-arterial therapy (IAT). However, the
efficacy and safety of preceding IVT are unclear.
Method: From a multicenter stroke registry database of Korea, we iden-
tified patients with acute ischemic stroke who were treated with IAT
within 8 h of onset. The efficacy outcomes were 3-month modified Rankin
Scale score 0–2 and successful recanalization defined as the modified
Thrombolysis in Cerebral Infarction score 2b-3. The safety outcome was
symptomatic hemorrhagic transformation (SHT). The effect of preceding
IVT compared to no IVT was estimated with multivariable logistic regres-
sion analysis as an adjusted odds ratio (OR).
Results: Among the 639 patients (male, 61%; age 69 ± 12 years; NIHSS 15
[11–19]) who met the eligibility criteria, 458 (72%) were treated with
preceding IVT. The adjusted ORs of preceding IVT were 1.25 (95% con-
fidence interval, 0.81–1.94) for functional independence, 1.61 (1.05–2.46)
for successful recanalization, and 0.96 (0.50–1.84) for SHT. There was an
absolute difference of 8.2% in successful recanalization in favor of pre-
ceding IVT (73.4% vs. 65.2%, p = 0.04). There were no significant differ-
ences in functional independence (39.3% vs. 32.0%, p = 0.09) or SHT
(10.0% vs. 10.5%, p = 0.86).
Conclusion: This retrospective registry-based analysis suggests that, in
patients with acute large artery occlusion and treated with IAT within 8 h
of onset, preceding IVT enhanced successful recanalization without addi-
tional risk of intracranial hemorrhage. But the better recanalization was
not translated into better functional outcome.
ESOC-0733
07. Thrombolysis
Long-term prognosis after intravenous thrombolysis in
patients with ischemic stroke
C Machado1, A F Santos1, J N Alves1, C Ferreira2, J Mota3,
L Oliveira4, J Pinho1, C Ferreira1
1Neurology Department, Hospital de Braga, Braga, Portugal
2Psychiatry Department, Hospital de Braga, Braga, Portugal
3Internal Medicine Department, Hospital de Santa Maria
Maior, Barcelos, Portugal
4Internal Medicine Department, Centro Hospitalar de Médio
Ave Unidade de Famalicão, Famalicão, Portugal
Introduction: Intravenous thrombolysis is undisputedly accepted as one
of the interventions in acute ischemic stroke (IS) which significantly
improves short-term prognosis. Little is known about long-term progno-
sis (>12 months).
Aim: Evaluate 5-year prognosis of IS patients submitted to thrombolysis
Methods: Review of a prospective registry of patients with IS submitted to
intravenous thrombolysis between February 2007 and November 2009.
Review of hospitals’ clinical records and telephonic interviews with the
patient/next of kin/caregiver to determine living settings, stroke recur-
rence and functional status at 5 years after IS. Favorable prognosis was
defined as Modified Rankin Scale (mRS) <3.
Results: Long-term prognosis information was retrieved for 105/155
patients. Mean age was 68 years, there was a high prevalence of vascular
risk factors, atrial fibrillation was present in 17.1%, median admission
NIHSS was 13 and median discharge NIHSS was 5. At 5 years, 38 patients
(36.2%) had a favorable prognosis, 10 patients (9.5%) were institutional-
ized or living in next of kin’s household, and 44 patients had died (41.9%).
Recurrent IS occurred in 9 patients. Annual IS recurrence or death inci-
dence was 14.1% / patient year. The only clinical predictors of 5-year IS
recurrence or death were admission NIHSS (HR = 1.12, IC 95% = 1.06–
1.18, p < 0.001) and discharge NIHSS (HR = 1.10, IC 95% = 1.05–1.15,
p < 0.001).
Discussion: Analysis of 5-year prognosis after thrombolysis revealed a
high annual IS recurrence or death incidence. Severity of neurological
deficits on admission and discharge were found to be the only predictors
of long-term prognosis.
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Orolingual angioedema in acute stroke treatment with
recombinant tissue plasminogen activator
L Oliveira1, A F Santos2, J Mota3, L M Afonso4, C Machado2,
J N Alves2, J Pinho2, C Ferreira2
1Internal Medicine Department, Centro Hospitalar do Médio
Ave Unidade Famalicão, Braga, Portugal
2Neurology Department, Hospital de Braga, Braga, Portugal
3Internal Medicine Department, Hospital de Santa Maria
Maior, Barcelos, Portugal
4Internal Medicine Department, Hospital Pedro Hispano
Unidade Local de Saúde de Matosinhos, Matosinhos, Portugal
Introduction: Orolingual angioedema (OA) is a potentially life-
threatening complication of acute stroke treatment with recombinant
tissue plasminogen activator (rtPA), occurring in about 0.2%- 5.1% of
patients. Those with insular involvement and prior use of angiotensin-
converting enzyme inhibitors seem to be especially at risk.
Objectives: To describe the occurrence, clinical presentation and outcome
of OA.
Methods: Analysis of the prospective register of patients who were treated
with systemic rt-PA, between February 2007 and December 2014, in our
department.
Results: From the 564 patients who underwent thrombolysis in the study
period, 24 (4.3%) developed OA, median age 78 years old (IQR = 65–81)
and 83.3% were female. Eighteen (75%) were taking angiotensin-
converting enzyme inhibitors and/or angiotensin receptor antagonists.
One patient had a posterior circulation stroke. Admission median NIHSS
was 17 (IQR = 10–21) and median ASPECTS 8 (IQR = 7–10). OA
occurred during rtPA perfusion in 17 patients (70.8%), was bilateral and
symmetric in 13 (54.2%) and asymmetric, predominantly ipsilateral to
the deficits, in 7 (29.2%). Medical treatment was necessary in 22 patients
(91.7%) and OA resolved spontaneously in 2. Control CT scan at 24h
showed insular involvement in 14 patients (58.3%). At 3 month follow-up
29.2% were independent.
Conclusions: AO occurred most frequently during rtPA perfusion and was
mainly bilateral and symmetric. Prompt treatment resulted in resolution
without complications.
ESOC-0354
07. Thrombolysis
Repeated intravenous treatment with RT-PA in patients
with acute ischemic stroke
M Laible1, E Jenetzki2, M Möhlenbruch3, S Schüler4, P Ringleb1,
T Rizos1
1Department of Neurology, Heidelberg University, Heidelberg,
Germany
2Division of Clinical Epidemiology and Aging Research,
German Cancer Research Center, Heidelberg, Germany
3Department of Neuroradiology, Heidelberg University,
Heidelberg, Germany
4Institute of Medical Biometry and Informatics, Heidelberg
University, Heidelberg, Germany
Background: Growing use of systemic thrombolysis, demographic
changes and higher chances to survive first-ever strokes anticipates an
increasing number of patients with recurrent ischemic strokes (IS).
However, data on repeated thrombolytic treatment are limited.
Methods: Consecutive IS patients repeatedly treated with rt-PA were
included into a prospective single center registry. Basic demographic and
stroke related variables were documented. Intracerebral hemorrhages
(ICH) were assessed on follow-up brain imaging. All anaphylactic reac-
tions were recorded; 3-month clinical outcome was evaluated using the
modified Rankin Scale (mRS).
Results: Within 15 years, 24 patients were included [male 46%; median
age at 1st event: 75 years; median time between treatments: 346 days (IQR
120–932)]. Onset-to-treatment times did not differ between the events
(p = 0.237) and no difference concerning treatment procedures was
present (1st treatment: 79% rt-PA alone, 21% additional thrombectomy;
2nd treatment: 71% rt-PA alone, 29% additional thrombectomy;
p = 0.726). No allergic or anaphylactic reactions were recorded after first,
but one oral angioedema occurred after recurrent treatment. No symp-
tomatic ICH was observed. After the 1st treatment, an mRS ≤2 was present
in 75%; 54% recovered to the status before stroke. In contrast, after 2nd
treatment an mRS of ≤2 was observed in 38% and only 29% recovered to
the status before the respective stroke. An mRS 5–6 (versus 0–4) after 2nd
treatment was associated to atrial fibrillation (p = 0.05) and higher initial
NIHSS values (p = 0.01).
Conclusions: Repeated thrombolysis is feasible and safe. However, the
clinical outcome appears to be less satisfying compared to the results after
the first treatment.
ESOC-0848
07. Thrombolysis
Predictive variables for mortality in patients with
ischemic stroke treated with intravenous thrombolysis
F Romero Delgado1, F Díaz Otero1, A García Pastor1,
P Vázquez Alen1, A M Iglesias Mohedano1, R Domínguez Rubio1,
A Múñoz González1, Y Fernández Bullido1, J A Villanueva Osorio1,
A C Gil Núñez1
1Neurology, Hospital General Universitario Gregorio
Marañon, Madrid, Spain
Objectives: To determine which variables are associated with a higher risk
of mortality in patients treated with intravenous thrombolysis (IVT).
Methods: Descriptive observational study of patients treated with IVT
during 2003-2013. We analyzed: age, sex, hypertension, onset-to-needle
time, door-to-needle time, previous stroke, previous modified Rankin
scale (mRS), baseline glucose levels, NIHSS score and pretreatment sys-
tolic blood pressure (pSBP). We considered early mortality (EM) (1–7
days) and late mortality (LM) (8–90 days). 5 causes of death were con-
sidered: symptomatic intra-cerebral hemorrhage (ICH), cerebral edema
caused by ischemic damage, infections, heart failure (HF) and other.
Results: 412 patients included. 46 died (11,2%): 28 EM (60%) and 18 LM
(40%). Causes of death were: cerebral edema 18 (39,1%), infections 14
(30,4%), ICH 10 (21,7%), HF 2 (4,3%) and other 2 (4,3%). ICH and
cerebral edema were the main causes of death in EM while infections were
more frequently related with LM. Factors associated with mortality were:
age (HR 1,051, 95% CI 1,020–1,084, p = 0,001), hypertension (HR 3,459,
95% CI 1,614–7,415, p = 0,001), previous stroke (HR 3,002, 95% CI
1,400–6,438, p = 0,005), pSBP (HR 1,016, CI 1,004–1,027, p = 0,007),
glucose (HR 1,005, 95% CI 1–1.01, p = 0,046) and baseline NIHSS score
(HR 1,137, 95% CI 1,078–1, p < 0,001). Age, previous stroke and baseline
NIHSS score were retained as independent predictors of mortality after
multivariate analysis.
Conclusions: Mortality is similar to other series recently published.
Advanced age, previous stroke and stroke severity were the main factors
associated with mortality.
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07. Thrombolysis
First description of alteplase’s pharmacokinetics and
activity in acute ischemic stroke (AIS) patients
G Rosenberg1, T Horovitz1
1Clinical Development, D-Pharm Ltd., Rehovot, Israel
Background: Despite increasing use of alteplase in AIS, and despite its
unique administration regimen in this indication, to our knowledge
alteplase’s pharmacokinetic profile hasn’t been described before in this
patient population.
Methods: As a reference in a THR-18 trial (ClinicalTrials.gov
NCT01957774; Approval: the Central Clinical Hospital of Ukrzaliznytsia
Ethics Committee), 0.9 mg/kg alteplase (Actilyse®, Boehringer Ingelheim
GmbH, Germany) was administered i.v. over 60 minutes (10% as a
1-minute initial bolus), without THR-18, to 12 AIS patients, of whom 10
had evaluable data (all Caucasians, age (mean ± SD) 69 ± 7.46 years, 8
females). Total alteplase concentration and activity were determined using
the rtPA Combi Actibind ELISA Kit (Technoclone, Vienna, Austria) in
plasma sampled immediately before administration (time 0), and 5, 10,
30, 62, 75, and 90 minutes after bolus initiation. Non-compartmental
analysis was performed with PK Solver v2.0.
Results: Alteplase’s AUC0-t was 113,325 ± 22,085 ng/mL*min, Cmax:
1,911 ± 288 ng/mL, Tmax: 31 ± 23 minutes and t1⁄2: 7.74 ± 3.02 minutes
(means ± SD). Mean alteplase time-concentration and -activity plots:
There was an excellent linear correlation between alteplase’s activity
and concentrations up to ≈2000 ng/mL (correlation coefficient:
0.984 ± 0.015).
Conclusions: alteplase’s current administration regimen in AIS produces
stable concentrations throughout the 60-minute infusion. Alteplase’s
activity parallels alteplase’s blood concentrations. These data may help in
designing alternative alteplase administration regimens.
ESOC-0657
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First administration of THR-18 to acute ischemic stroke
(AIS) patients treated with alteplase: Safety, imaging
and clinical outcome data from a phase IIA trial
G Rosenberg1, D Lebedynets2, N Ovsyannikova2, V Lebedynets2
1Clinical Development, D-Pharm Ltd., Rehovot, Israel
2Neurology Department #1, Central Clinical Hospital of
Ukrzaliznytsya, Kharkiv, Ukraine
Background: THR-18 is a plasminogen activator inhibitor-1-based
peptide, aimed at reducing alteplase-associated brain bleeding and edema.
Methods: In a double-blind trial (ClinicalTrials.gov NCT01957774;
Approval: Central Clinical Hospital of Ukrzaliznytsia Ethics Committee),
30 i.v. alteplase-treated AIS patients (19 females, age (mean ± SD)
69.7 ± 8.2 years) were randomized to i.v. THR-18 0.18 mg/kg (n = 6),
0.54 mg/kg (n = 12) or placebo (n = 12) as a 1-hour infusion paralleling
alteplase’s. Safety, NIHSS, mRS, non-contrast CT (NCCT, day 2), phar-
macokinetic and pharmacodynamic data were collected through day 30.
Results: The overall rates of adverse events and drug-related adverse
events were similar across the 3 groups; 3 fatalities occurred with THR-18
and 1 with placebo (none considered drug-related). The THR-18
0.54 mg/kg group tended towards greater systolic blood pressure reduc-
tion, peaking ≈7:30 hours after drug initiation (mean ± SD, mmHg):
−19.8 ± 27.2 vs. −9.1 ± 13.4 with placebo, (p = 0.234, ANOVA); these
blood pressure changes did not correlate with clinical outcome. On day 2
NCCT, 1 hemorrhagic infarction and 2 parenchymal hemorrhages type 1
were observed with placebo vs. 0 in both THR-18 groups (p = 0.054,
Fisher exact test). On this NCCT, the prevalence of acute hypodensities
was similar across all groups (range: 75–83%): 40% of the THR-18-treated
subjects with hypodensities developed brain edema vs. 89% in placebo
(p = 0.033, Fisher exact test). Mean baseline NIHSS scores were 9.3, 9.7,
and 11.1 in the 0.18 mg/kg, 0.54 mg/kg and placebo patients, respectively;
33%, 42% and 17% attained a day 30 NIHSS score of 0-1, respectively.
Conclusion: These safety, clinical and imaging results merit further clini-
cal research with THR-18.
ESOC-0720
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Stroke thrombolysis experience in Oradea
M Sabau1, H Borcea2
1Neurology Department, University of Oradea and Clinical
County Hospital of Emergency Oradea, Oradea, Romania
2Emergency Department, Clinical County Emergency Hospital
Oradea, Oradea, Romania
Introduction: Thrombolytic treatment for stroke patients is used in our
hospital only since 2012.
Material and Method: In 2012 we developed our own Algorithm and
Protocol for Thrombolysis treatment and since 2013 we are part of the
Romanian National Program for Thrombolysis Treatment in Stroke
Patients.
Results: There are 78 patients that underwent thrombolysis treatment in
our hospital: 25 in 2012, 30 in 2013 and 23 in 2014. The age distribution
was between 32 and 80 years, with mean age 68 years. The time from the
onset to ED was between 30 and 165 minutes. The time from the onset to
the CT scan was 30 to 180 minute. The time from the onset to blood tests
results was 75 to 225 minute. The time from onset to thrombolysis treat-
ment was 75 to 240 minute. The door to needle time was between 30–135
minutes. At 2 hours 64% of the patients have improved, 7% had the same
NIHSS Score and 29% worsened. At 24 hours, 81% of the patients have
improved and only 19% worsened. There were 18% patients with hem-
orrhagic transformation and 20% deaths – 6,4 % because of the hemor-
rhagic transformation, 7,6% because of the stroke and 6,4% by other
causes.
Discussion and Conclusion: The clinical evolution of our patients moti-
vates us to enhance this kind of treatment. It is necessary to develop
educational programs for the population as well as for pre-hospital
healthcare so that a greater number of stroke patients could benefit from
IV thrombolysis treatment.
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Thrombolysis accelerated the breakdown of unstable
plaque – Uncommon case of neurological deterioration
post-thrombolysis
S Saber1, J Li1, H Elshimy1, G Zachariah1, V Umachandran1
1Stroke Medicine, Broomfield Hospital, Chelmsford, United
Kingdom
Introduction: Early neurological deterioration is relatively common event
with first few days following acute ischemic stroke. We observed unusual
complications in 3 patients following thrombolysis.
Case Report: 84 year old man presented with left arm weakness and
paresthesia. His initial NIHSS score was 6. He was thrombolysed with
Alteplase at 123 minutes from the onset of symptoms. His 1 Hour NIHSS
score improved to 1.
Next day post thrombolysis his clinical condition deteriorated with reduc-
tion of GCS, headache, drowsiness and new onset lateral rectus palsy and
marked increased of NIHSS score to 12 within 24 hours.
MRI scan showed multiple foci of restricted diffusion mostly in the ter-
ritory of middle cerebral artery, multiple infarcts demonstrated in right
parietal and occipital lobe which was highly suggestive of embolic nature.
He was in sinus rhythm, Echocardiogram was normal.
CT angiogram showed mild plaque at carotid bulb extending in to right
proximal internal carotid artery causing 50% stenosis.
Conclusion: We have noticed similar complications in another 2 cases
where thrombolysis accelerated the breakup of an unstable plaque from
carotid artery leading on to shower of emboli. This case study showed
there was no other source of thrombus detected in heart or any other
vasculature in the imaging.
This is likely an uncommon complication of stroke thrombolysis.
ESOC-0416
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Safety and efficacy of IV RT-PA therapy for acute
ischemic stroke presenting with minor symptom
K Shindo1, K Kamiyama1, T Osato1, H Endo1, M Mikamoto1,
K Takahira1, K Fumoto1, T Watanabe1, T Kataoka1, H Sugio1,
T Ogino1, K Honjo1, H Nakamura1
1Neurosurgery, Nakamura Memorial Hospital, Sapporo, Japan
Background: The Japan Stroke Society recommends careful administrat-
ing intravenous recombinant tissue plasminogen activator (IV rt-PA) to
patients with minor stroke symptoms. We explained some of these, which
especially had a major trunk occlusion or stenosis, had poor prognosis.
So we positively administrate IV rt-PA to patients with minor stroke
symptoms.
Purpose and Method: We retrospectively evaluated the safety and efficacy
of IV rt-PA therapy for minor symptomatic stroke. We defined minor
symptom as NIHSS score ≤4. Outcome was assessed using the modified
Rankin scale (mRS) score at discharge and was dichotomized into good
(mRS 0-2) versus poor (mRS 3–6). In addition we evaluated risk of hem-
orrhagic complications.
Result: There were 110 cases who received IV rt-PA therapy between
January 2012 and August 2014 in Nakamura Memorial Hospital. Of those,
21(male 76% [n = 16]) cases were minor symptomatic stroke. The median
NIHSS score was 3. Stroke etiology was identified as: cardiogenic embo-
lism (14 cases), large vessel atherosclerosis (5 cases), small vessel occlusion
(1 case), paradoxical embolism (1 case). Sixteen cases (76.2%) had a major
trunk occlusion or stenosis. There were two asymptomatic hemorrhagic
infarction cases but no symptomatic case. Other hemorrhagic complica-
tion was only one, which didn’t give a disadvantage for a patient. Com-
pared with admission, 19 cases (90.5%) were better condition and no case
became worse condition at discharge. Seventeen cases (81.0%) were good
prognosis.
Conclusion: This retrospective study suggests that administering IV rt-PA
to patients with a minor symptomatic cerebral infarction can lead to
improved clinical outcome with low risk of bleeding.
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07. Thrombolysis
Intravenous thrombolysis is delayed in posterior
circulation strokes: Results from the Austrian Stroke
Unit Registry
P Sommer1, L Seyfang2, J Ferrari3, E Fertl1, W Serles4,
S Greisenegger4
1Neurology, Krankenanstalt Rudolfstiftung, Vienna, Austria
2Klinische Neurowissenschaften und Präventionsmedizin,
Danube University, Krems, Austria
3Neurology, Krankenhaus Barmherzige Brüder, Vienna,
Austria
4Neurology, Medical University of Vienna, Vienna, Austria
Background: Therapeutic effect of recombinant-tissue-activator (rt-PA)
is highly time-dependent. Previous smaller studies reported that rt-PA
treatment was delayed in patients with posterior circulation strokes
(PCS). We analyzed in a large multicenter cohort whether patients with
PCS had prolonged onset-to-door-times (ODT) and door-to-needle-
times (DNT) compared to patients with anterior circulation strokes
(ACS).
Methods: We studied ODT and DNT of patients enrolled into the Aus-
trian Stroke Unit Registry (ASUR) and treated with rt-PA. Classification
into PCS or ACS was based on clinical presentation at onset according to
the Oxfordshire Community Stroke Project. The relationships between
ODT respectively DNT and several explanatory variables were modeled by
multivariate linear regression.
Results: Out of 74.591 patients with acute ischemic stroke enrolled into
the ASUR between 2003 and 2014, 9185 were treated with rt-PA (846 with
PCS and 8.339 with ACS). Univarietly, ODT and DNT were significantly
longer among patients with PCS as compared to patients with ACS: ODT
– median 80 minutes (IQR 52–120) vs. 72 (50–109), p<0.001; DNT – 55
(35–90) vs. 45 (30–68), p < 0.001. After adjustment for confounding,
localization within the posterior circulation was significantly associated
with delay in the DNT (p < 0.001). Patients with PCS lost on average 11
minutes (95% CI 8–15min) before treatment with rt-PA. There was no
significant association of PCS or ACS with ODT after adjustment for
confounding.
Conclusions: We detected a delay in treatment with rt-PA in patients with
PCS. Given the observational character of our study, future studies ana-
lyzing in-hospital stroke protocols specifically for patients with PCS are
needed.
ESOC-0030
07. Thrombolysis
Is there clear indication for routine repeat CT head 24
hours post-thrombolysis in acute stroke?
H Taylor1, G Pinches2
1Surgery, Great Western Hospital NHS Trust, Swindon, United
Kingdom
2Medicine, Cheltenham Hospital, Cheltenham, United
Kingdom
Background: Current practice at North Bristol NHS Trust is to perform a
CT head in acute stroke patients at approximately 24 hours post-
thrombolysis to rule out a significant secondary hemorrhage before
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aspirin administration. Guidelines advise CT head after 24–48 hours1 and
aspirin to be considered after 24 hours2,3.
Method: Retrospective audit of all patients (46) admitted with acute
stroke and thrombolysed with Alteplase, between 24/03/2013 and 11/10/
2013. Data was collected from imaging software and patient notes.
Results: 98% of patients were scanned within 36h and 100% within 48h.
6.8% showed no clinical deterioration in the first 24h but the CT scan
revealed a hemorrhage that altered management. Time of aspirin admin-
istration after thrombolysis ranged from 25–45h with 74% receiving
aspirin within 36h and 100% within 48h. The mean time from CT head to
aspirin administration was 6.9 hours and rose to 9.4 h if scanned outside
of normal working hours.
Key Messages: Overall NBT is doing well at performing repeat CT scans.
We consider a change in management of 6.8% patients as a result of the
CT head to be a significant finding, supporting continued use of the repeat
CT head. There was a significant delay to aspirin administration, espe-
cially out-of-hours.
Referens
1. Avon Gloucestershire Wiltshire & Somerset Stroke Network Acute
Ischaemic Stroke Thrombolysis Guideline V4.0, March 2011.
2. Intercollegiate Stroke Working Party. National clinical guideline for
stroke, 4th edition. London: Royal College of Physicians, 2012.
3. European Stroke Organisation guideline. Guidelines for Management
of Ischaemic Stroke. 2008, updated 2009.
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07. Thrombolysis
Achieving door-to-needle times below 10 minutes in
stroke thrombolysis with favorable outcomes
B Hörmanseder1, G Schustereder1, S Einsiedler1, W Sperl2,
G Huemer3, H Lugmayr4, R Topakian1
1Department of Neurology, Klinikum Wels-Grieskirchen, Wels,
Austria
2Zentrale Akutversorgung, Klinikum Wels-Grieskirchen, Wels,
Austria
3Institute of Anesthesiology and Critical Care Medicine I,
Klinikum Wels-Grieskirchen, Wels, Austria
4Department of Radiology, Klinikum Wels-Grieskirchen, Wels,
Austria
Objective: Because efficacy of IV thrombolysis for acute ischemic stroke
decreases with time elapsed from symptom onset, the in-hospital door-
to-needle time (DNT) should be kept as short as possible. Here we present
all 6 stroke patients in whom we achieved a DNT below 10 minutes.
Methods: All patients were treated according to our local stroke care
protocol which resembles the Helsinki model: 1) ambulance prenotifica-
tion with patient details (including name, date of birth, symptoms, onset
time, comorbidity, medication, weight) alerting the stroke team to meet
the patient on arrival; 2) patients transferred directly from triage onto the
CT table on the ambulance stretcher; and 3) pre-prepared alteplase bolus
delivered in CT immediately after the interpretation of scans by the neu-
rologist without waiting for coagulation results. Early outcome was
assessed at discharge from the stroke unit.
Results: All 6 patients (5 men, 1 woman) were treated in the period
August 2014 to December 2014. Mean age was 72.7 (range 46–93) years,
mean baseline National Institute of Health Stroke Scale (NIHSS) score
was 7.2 (range 2–15), mean DNT was 7 (range 3–9) minutes, and mean
onset-to-treatment time (OTT) was 59.3 (range 48–85) minutes. All
patients had substantial early improvement (complete restitution: n = 3;
NIHSS 1: n = 2; NIHSS 7: n = 1).
Conclusion: In selected stroke patients with a clear-cut clinical scenario
and physician access to full information on patient history and medica-
tion, dedicated acute care can keep the DNT below 10 minutes and the
OTT below 90 minutes improving the odds for favorable outcomes.
ESOC-0839
07. Thrombolysis
Helsinki model in Wels: Stroke thrombolysis
door-to-needle time cut by 20 minutes in 5 months
G Schustereder1, B Hörmanseder1, S Einsiedler1, W Sperl2,
G Huemer3, H Lugmayr4, R Topakian1
1Department of Neurology, Klinikum Wels-Grieskirchen, Wels,
Austria
2Zentrale Akutversorgung, Klinikum Wels-Grieskirchen, Wels,
Austria
3Institute of Anesthesiology and Critical Care Medicine I,
Klinikum Wels-Grieskirchen, Wels, Austria
4Instutute of Radiology, Klinikum Wels-Grieskirchen, Wels,
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Objective: When IV thrombolysis is initiated within 90 minutes of
symptom onset after acute ischemic stroke, the number needed to treat
(NNT) to achieve little or no symptoms is 4.5. As the NNT increases by 1
for every 20 minutes of extra delay, the in-hospital door-to-needle time
(DNT) should be kept as short as possible. We hypothesized that adher-
ence to the Helsinki model could improve the DNT in our large general
hospital.
Methods: The stroke team gradually restructured the stroke care protocol
in cooperation with the ambulance and emergency teams to improve
adherence to key components of the Helsinki model: 1) ambulance preno-
tification with patient details alerting the stroke team to meet the patient
on arrival; 2) patients transferred directly from triage onto the CT table on
the ambulance stretcher; and 3) alteplase delivered in CT immediately
after imaging. We analyzed our prospective stroke registry for effects of
these changes on the DNT over the course of 5 months.
Results: From mid-July to mid-December 2014, 66 stroke patients were
treated with IV thrombolysis. The median (interquartile range) DNT was
reduced from 49.5 (35–95) minutes in the first month of the observation
period to 29 (8.5–64.5) minutes in the fifth month. Longer DNT was
associated with lack of ambulance prenotification, unclear symptom
onset, use of MRI as initial imaging modality, and service out of business
hours.
Conclusion: Adherence to key components of the Helsinki model was
highly efficacious by cutting the DNT by 20 minutes within only 5
months.
ESOC-0175
07. Thrombolysis
Thrombolysis-associated parenchymal hemorrhage is
not associated with CT perfusion volumes
S Tsetsou1, M Amiguet2, A Eskandari1, M Wintermark3, P Michel1
1Neurology, CHUV-Lausanne University, Lausanne, Switzerland
2Institute of Social and Preventive Medicine, CHUV-Lausanne
University, Lausanne, Switzerland
3Radiology, Stanford University and Medical Center, Stanford,
USA
Introduction: Intracerebral hemorrhagic transformation, in particular
parenchymal hemorrhage (PH), remains a feared complication of intra-
venous thrombolysis (IVT) with recombinant plasminogen activator (rt-
PA). Several epidemiological, clinical and radiological risk factors have
been established. We aim to identify parameters based on CT-perfusion
(CTP), which can predict the risk of PH, alone or in combination with
other variables.
Methods: In this observational cohort study, we reviewed the prospective
Acute Stroke Registry Analysis of Lausanne from 2003 to December 2013.
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We selected patients with Acute Ischemic Stroke involving the Middle
Cerebral Artery (MCA) territory who were thrombolysed within 4.5
hours and who had a good quality baseline CTP immediately before or at
the beginning of the IVT. Demographic and clinical data, the Alberta
Stroke Program Early CT Score (ASPECTS) and volumes of penumbral
and infarcted tissue on CTP using a validated threshold model were com-
pared in patients with and without PH.
Results: Of 193 thrombolysed patients with good quality CTP, 24 (12%)
presented a PH transformation (11 PH1, 13 PH2). In univariate analysis,
later IVT within 4.5 hours (OR:1.97 per hour, 95% CI:1.09–3.56), pres-
ence of atrial fibrillation (OR:2.55, 95% CI:1.04–6.23), and a lower
ASPECTS (OR: 0.77 per point, 95% CI: 0.67–0.9) were associated with
PH. CTP volumes of penumbra (OR:1.00, 95% CI:0.99–1.01) and infarct
size (OR:1.00, 95% CI:0.99–1.01 respectively) were similar between the
two groups.
Conclusion: In this small sample of thrombolysed MCA strokes undergo-
ing acute CTP, we confirmed that later treatment, atrial fibrillation and a
lower ASPECTS, but not volumes of thresholded CTP, are correlated with
PH.
ESOC-0371
07. Thrombolysis
The natural history of ischemic stroke not treated with
IV thrombolysis because of mild or rapidly improving
symptoms
J S P van den Berg1, J Janssen1, M A Edens2
1Neurology, Isala, Zwolle, Netherlands
2Department of Innovation and Science, Isala Academy,
Zwolle, Netherlands
Background and Purpose: Intravenous thrombolysis (IVT) is the only reg-
istered treatment for acute ischemic stroke (AIS). However, the number of
patients with an ischemic stroke receiving IVT is small. Common cited
reasons for not treating with IVT are the deficits being too mild or rapidly
improving. The aims of this study were investigating the natural history of
patients not treated with IVT solely because of mild or rapidly improving
symptoms and to assess predictors of an unfavorable outcome.
Methods: Patients with an AIS at the emergency department who were
not treated with IVT solely because of mild or rapidly improving symp-
toms were included. The mRS and NIHSS scores on admission were
registered and follow-up mRS scores were obtained 3 months later. Vari-
ables were obtained to evaluate possible predictors of an unfavorable
outcome.
Results: Eleven of the patients with initial mild or rapidly improving
symptoms did receive IVT after deterioration on the ward, and 8 had an
unfavorable outcome after 3 months. A total of 148 patients with an AIS
did not receive IVT because of mild or improving deficit. The mRS scores
declined in a significant amount of patients, nonetheless 34.5% (95% CI
27.3–42.4%) had an unfavorable mRS score (2–6) after 3 months. In the
multiple model, female sex, higher initial NIHSS score and unfavorable
mRS on admission were significant predictors of unfavorable outcome.
Conclusions: The natural history of patients with ischemic stroke and
mild or rapidly improving symptoms is not always favorable.
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Neurointervention
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08. Neurointervention
Association of radiation dose, contrast volume and
number of microcatheter injections with
post-procedure intracranial hemorrhage following
interventional treatment for acute ischemic stroke
A Barnes1, N Ahmad2, I Natarajan2, S Nayak2, C Jadun2,
J Bankart3, C Roffe4
1Keele University Medical School, Keele University,
Stoke-on-Trent, United Kingdom
2Royal Stoke University Hospital, University Hospitals of North
Midlands, Stoke-on-Trent, United Kingdom
3Department of Primary Care and Health Sciences, Keele
University, Stoke-on-Trent, United Kingdom
4Stroke Research In Stoke, Institute for Science & Technology
in Medicine, Stoke-on-Trent, United Kingdom
Introduction: Intracranial hemorrhage (ICH) after thrombectomy has
been reported to be related to microcatheter delivered angiographic con-
trast in patients undergoing thrombectomy for stroke.
Methods: We examined local registry data to establish whether there was
an association between contrast and radiation exposure and intracranial
hemorrhage within 24 hours in 144 patients who were treated by
mechanical thrombectomy for anterior circulation strokes. Analyses were
conducted in SPSS v.21.
Results: Forty-eight (33%) developed post-operative ICH and 12 (8%)
subarachnoid hemorrhage (SAH); 6 (4%) and 2 (1%) respectively were
clinically significant. On univariable binary logistic analysis there was no
correlation between radiation dose, contrast volume, number of micro-
catheter contrast injections (MCIs) and overall rates of post procedure
ICH or SAH. After adjustment for contrast dose, radiation dose, MCIs,
pre-procedure NIHSS, perfusion TICI score, systolic blood pressure,
intra-arterial alteplase dose, procedure duration, number of thrombec-
tomy attempts to primary lesion and the primary occlusion site, multi-
variable logistic regression analysis showed no association for SAH, but
there was an association between ICH and the number of MCIs.
Adjusted analysis
OR Sig. N (n)
ICH Radiation dose 1.000 0.140 114(33)
Contrast volume 1.000 0.922
MCIs 1.123 0.019
SAH Radiation dose 1.000 0.078 116(11)
Contrast volume 1.013 0.068
MCIs 0.920 0.318
Conclusion: The likelihood of ICH increases with higher number of
MCIs, but not with contrast volume after adjustment for confounding
factors. No such relationship was found for SAH. This needs confirmation
in a clinical study, but might suggest that the number MCIs should be kept
at a minimum.
ESOC-0937
08. Neurointervention
Intravenous thrombolysis and thrombus length are
predictive factors for successful recanalization in acute
ischemic stroke treated by mechanical thrombectomy
D Behme1, A Mpotsaris2, T Liebig2, W Weber3
1Neuroradiology, University Medical Center Göttingen,
Göttingen, Germany
2Radiology and Neuroradiology, University Cologne University
Hospital, Cologne, Germany
3Radiology and Neuroradiology, University Medical Center
Langendreer, Bochum, Germany
Aims: Several factors determine the outcome after acute ischemic stroke
treated by mechanical thrombectomy. Among other factors not receiving
intravenous thrombolysis and an incomplete revascularization were
shown to predict unfavorable outcome at 90 days. Therefore the aim of
this study was to investigate whether intravenous thrombolysis influences
the revascularization efficacy.
Methods: Retrospective analysis of all patients who presented with an
anterior circulation stroke with underlying large artery occlusion and who
received mechanical thrombectomy between 07/12 and 12/13 and at two
German Stroke Centers. Imaging data was graded and evaluated accord-
ing to the mTICI scale and the respective vessel occlusion site definitions.
Outcome measures included NIHSS, mRS, and procedural timings.
Results: We identified 129 patients; 91/129 (71%) did receive intravenous-
thrombolysis prior to mechanical thrombectomy; of these 66/91 (73%)
presented with a middle cerebral artery occlusion and 25/91 (27%) pre-
sented with a Carotid-T occlusion. We could not find significant differ-
ences for baseline NIHSS; time from symptom onset to groin puncture or
age when comparing these patients to those who did not receive intrave-
nous thrombolysis. We found that the rate of successful recanalization
(mTICI ≥ 2b) was significantly higher in those patients with underlying
middle cerebral artery occlusion and intravenous-thrombolysis prior to
mechanical thrombectomy (p = 0.01). Stepwise logistic regression identi-
fied intravenous thrombolysis and thrombus length as predictive factors
for a favorable recanalization result (p = 0,0039/p = 0,0016).
Conclusion: Intravenous-thrombolysis and thrombus length are predic-
tive factors for successful recanalization in acute ischemic stroke with
underlying middle cerebral artery occlusion that might help to avoid futile
treatment in acute ischemic stroke.
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08. Neurointervention
Endovascular rescue interventions in cervical artery
dissection
R Berger1, P Michels1, F Kämmerer2, J Röther1, B Eckert2
1Neurology, Asklepios Clinic Altona, Hamburg, Germany
2Neuroradiology, Asklepios Clinic Altona, Hamburg, Germany
Background: Cervical artery dissections (CAD) are a major cause of
stroke in young adults. Despite the often benign condition, a stenosis,
occlusion or embolization may lead to an acute ischemic stroke. In such
cases, endovascular interventions may be the only treatment option.
Methods: We retrospectively analyzed all patients presenting with a CAD
at our hospital from 2008 to 2014.
Results: We identified 52 patients with CAD treated on our stroke unit
(n = 29 male; n = 23 female; mean age 45.2 years). The affected vessels
were the internal carotid artery (n = 32; 61%), the vertebral artery (n = 17;
33%) and multiple arteries (n = 3; 6%).
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Due to severe progressive symptoms (NIHSS 6–21; mean 13) endovascu-
lar therapy was performed in 8 of 52 patients: in 3 cases a combined
intravenous thrombolysis and endovascular treatment (ET) without
stenting of the CAD, in 3 cases a stenting of the CAD and ET of the
intracranial occlusion, in 1 case extracranial stenting only.
7 procedures were technically successful with clinical significant improve-
ment in 6 patients. 1 patient had a symptomatic intracranial reperfusion
hemorrhage at day 1. In 1 case endovascular access was technically impos-
sible. After acute therapy the NIHSS of the endovascular treated patients
was 2-18, mean 7 (Table 1).
Conclusion: In CAD patients suffering progressive hemodynamic or
embolic stroke, ET should be considered in the acute phase depending on
multimodal CT imaging. We describe the successful combination of intra-
venous and intraarterial thrombolysis as well as endovascular recanaliza-
tion strategies for acute stroke in CAD.
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Trevo XP 3x20 in patients with M2 occlusion selected
with CT perfusion: Preliminary results
A Bernardoni1, A De Vito2, C Azzini2, L Borgatti3, M Borrelli3,
E Fainardi3, O Marcello3, M Padroni4, S Ceruti3, V Tugnoli2,
A Saletti3
1Department of Morphology Surgery and Experimental
Medicine University of Ferrara, Radiology Section, Ferrara,
Italy
2Department of Neuroscience and Rehabilitation Azienda
Ospedaliera Universitaria, Neurology Unit, Ferrara, Italy
3Department of Neuroscience and Rehabilitation Azienda
Ospedaliera Universitaria, Neuroradiology Unit, Ferrara, Italy
4Department of Biological Psychiatric and Psychological
Science University of Ferrara, Neurology Unit, Ferrara, Italy
Background: Stentrievers are increasingly used to recanalize intracranial
artery occlusion in acute ischemic stroke (AIS). However, also small
vessels occlusion can lead to poor prognosis. We report our preliminary
experience in using the Trevo XP 3x20 stent for M2 occlusion.
Methods: Five AIS patients with left M2 occlusion admitted <6 hours
from stroke symptom onset underwent endovascular treatment with
Trevo XP 3x20 (2 pure thrombectomy and 3 rescue therapy). All patients
underwent NCCT, CTA and CTP at onset and at 24 hours. Selection
criteria were NIHSS>6, ASPECTS>7 and large mismatch visually assessed
on CT perfusion (CTP) maps. The difference between final infarct volume
and admission CTP-MTT lesion volume, outlined on admission CTP and
24 hour-NCCT respectively, represented the amount of post-treatment
rescued brain tissue. Recanalization was assessed on 24 hour-CTA accord-
ing to TICI criteria. Good outcome was defined as 3 month-modified
Rankin scale (mRS) ≤2.
Results: Successful recanalization was achieved in 4/5 patients. No infarct
signs on 24 hours-NCCT and a complete rescue ischemic tissue were
found in all recanalizers in whom was sufficient just 1 pass with a
puncture-to-recanalization time ranged from 35 to 70 min. No patients
had procedure-related complications or hemorrhagic transformation at
follow-up CT scans. A good outcome was achieved in all 5 cases.
Conclusions: Our results suggest that thrombectomy using Trevo XP 3x20
stentriever in M2 occlusion is safe and effective. These findings also indi-
cate that CTP seem to be a promising tool for the patient selection.
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Disentangling the entangled vessels: Clinical
presentation of intracranial arteriovenous
malformations
E Campos Costa1, R Silva2, L Neves2, M Rodrigues1
1Neurology, Hospital Garcia de Orta EPE, Almada, Portugal
2Neuroradiology, Hospital Garcia de Orta EPE, Almada,
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Background: Intracranial Arteriovenous Malformations (IAVM) are brain
vascular malformations that present with hemorrhage, seizure, headache,
or focal neurologic deficit.
We aim to describe the clinical presentation of patients with IAVM.
Methods: Retrospective observational study of patients with IAVM diag-
nosed or submitted to endovascular treatment in 4 years. IAVM was
defined as abnormality of intracranial vessels that constitute a connection
between arterial and venous systems without an intervening capillary bed.
Data on demographics, clinical and morphological characteristics, diag-
nostic and therapeutic procedures was collected. We present descriptive
and inferential statistics using chi-square test and Mann-Whitney.
Results: Of 32 patients diagnosed with IAVM (62.5% men, median age 35
years, range 8–83), 26 were embolized. IAVM were located in the frontal
lobe in 10, occipital in 8, parietal in 8, temporal in 6 and cerebellar in 4
patients. According to Spletzer-Martin classification, 4 were grade I, 14
grade II, 6 grade III and 8 grade IV. Ruptured IAVM was seen in 11
patients (34.4%).
Clinical presentation included headache (n = 19), focal neurological defi-
cits (n = 10), seizure (n = 6), intracranial hemorrhage (n = 5) and inci-
dental (n = 1).
A total of 41 embolization procedures were performed, median 1 (range
1–3), and complete exclusion was achieved in 4 (15.4%). Seizure as pre-
sentation (31.3%) was associated with frontal location (p = 0.038).
Conclusion: We had more headache as initial presentation than other
studies, probably because our hospital is a reference neurosurgery center
receiving patients with brain hematomas. Our study suggests, as previ-
ously reported, that seizures mainly occur in frontal lobe IAVM.
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Mechanical thrombectomy in cerebral venous
thrombosis: A systematic review of 185 cases
F M Siddiqui1, S Dandapat1, C Banerjee2, S M Zuurbier3,
M Johnson2, J Stam3, J M Coutinho4
1Neurology, Southern Illinois University School of Medicine,
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2Neurology, UT Southwestern Medical Center, Dallas, USA
3Neurology, Academic Medical Center, Amsterdam,
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Amsterdam, Amsterdam, Netherlands
Background and Purpose: Cerebral venous thrombosis (CVT) is generally
treated with anticoagulation. However, some patients do not respond to
medical therapy and these might benefit from mechanical thrombectomy
(MT). The aim of this study was to gain a better understanding of the
efficacy and safety of MT in patients with CVT, by performing a system-
atic review of the literature.
Methods: We identified studies published between January 1995 and Feb-
ruary 2014 from PubMed and Ovid. We included all cases of CVT in
whom MT was performed with or without intra-sinus thrombolysis
(IST). Good outcome was defined as normal or mild neurological deficits
at discharge (modified Rankin Scale 0–2). Secondary outcome variables
included peri-procedural complications and recanalization rates.
Results: Our study included 42 studies (185 patients). Sixty percent of
patient had a pretreatment intracerebral hemorrhage (ICH) and 47%
were stuporous or comatose. AngioJet was the most commonly used
device (40%). IST was used in 131 patients (71%). Overall, 156 (84%)
patients had a good outcome and 22 (12%) died. 9 (5%) patients had no
recanalization, 38(21%) had partial and 137(74%) had near to complete
recanalization. The major peri-procedural complication was new or
increased ICH (10%). Use of AngioJet was associated with lower rate of
complete recanalization (OR 0.2, 95% CI 0.09–0.4) and lower chance of
good outcome (OR 0.5, 95% CI 0.2–1.0).
Conclusion: Our systematic review suggests that MT is reasonably safe but
controlled studies are required to provide a definitive answer on its effi-
cacy and safety in patients with CVT.
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Acute stroke due to tandem (internal carotid
artery/middle cerebral artery) occlusion: Efficiency and
safety of the association of the three main treatment
modalities
P Desfontaines1, F Delvoye1
1Neurology, CHC Saint-Joseph, Liège, Belgium
Introduction: Stroke caused by acute tandem ICA/MCA occlusion is asso-
ciated with a poor prognosis.
In acute stroke due to large vessels lesion, intravenous thrombolysis (IVT)
leads to poor recanalization rate while endovascular therapy (stenting and
thrombectomy) is a promising treatment. Double antiplatelet therapy
(APT) is then used to prevent reocclusion and distal embolization.
We wanted to evaluate the efficiency and safety of the association of those
treatments in patients with acute stroke due to MCA/ICA tandem lesions.
Method: We reviewed data of five 60-year-old patients with tandem ICA/
MCA stenosis and mean NIHSS of 16 at admission.
Primary end points were safety of the procedure and good clinical
outcome (as defined by mRS = 0–2 at 90 days).
Results: All had IVT followed by endovascular therapy. Stenting was per-
formed on four of five ICA lesions (three stenoses, two occlusions).
Then the five MCA occlusions were treated by mechanical thrombectomy
performed with Solitaire FR2.
Antiplatelet therapy was delayed by 24 hours due to IVT.
Revascularization was achieved for all (TICI2c-3). IVT was efficient at
temporary recanalizing proximal lesion in two individuals.
We observed two reocclusions of carotid stent (one with clinical worsen-
ing) and two asymptomatic intracerebral hemorrhages.
Conclusion: To our knowledge, this is the first series fully related to ICA/
MCA lesions combining those three modalities of treatment.
This association is often effective as IVT temporary reopens ICA occlusion
before endovascular procedure although it delays the APT set up.
A timing question remains in post-procedure APT since reocclusion has
occurred in two people.
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Thrombectomy after intravenous thrombolysis versus
intravenous thrombolysis alone in acute ischemic
stroke: Results of a multicenter prospective
observational with retrospective case control study
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S Van Snick1, K Windhausen3, A Maertens de Noordhout4
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Background: We prospectively developed a protocol of thrombectomy
performed after IV thrombolysis in patients with acute ischemic stroke
and proximal MCA or distal internal carotid artery (ICA) occlusion. We
compared the clinical outcome of those patients with a pooled data of
acute stroke patients treated with iv thrombolysis alone.
Material and Method: Between August 2011 and October 2014, all
patients fulfilling the criteria’s for iv thrombolysis underwent an
angio-CT scan before IV thrombolysis. In 34 consecutive patients with
proximal occlusion and no clinical recovery at the end of iv thrombolysis,
a thrombectomy was performed with the Solitaire FR device. A retrospec-
tive comparison was performed with a pooled data of 84 stroke patients
treated with iv thrombolysis alone before August 2011. A t-test of student
was used for statistical analysis.
Results: The thrombectomy and the thrombolysis cohorts were similar in
term of age, stroke severity and time delay of iv thrombolysis from stroke
onset. Time delay of thrombectomy (recanalization) from stroke onset
was 321 ± 77 min. At 3 months, 67.6 % (n = 23) of the thrombectomy
cohort had a clinical good outcome (mRS </= 2) whereas 35,7% (n = 30)
of the iv thrombolysed cohort had a mRS </= 2 (p < 0.001).
Conclusion: Thrombectomy performed after iv thrombolysis in patients
with proximal MCA occlusion seems to have significant clinical benefit
when compared with patients treated by iv thrombolysis alone. Although
our series is too small to give definite conclusions, it should encourage to
go further in determining the place of thrombectomy in the treatment of
acute ischemic stroke.
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Why carotid stenting and intracranial thrombectomy
for treatment of acute stroke due to tandem
occlusions is associated with a high risk of intracranial
hemorrhage?
C Duwicquet1, C Papagiannaki2, A P Narata2, D Herbreteau2,
R BIBI2, M Annan1, M Gaudron1, O Motica1, B De Toffol1,
S Debiais1
1Neurology, Bretonneau, Tours, France
2Neuroradiology, Bretonneau, Tours, France
Background: Tandem occlusion is a rare but severe presentation of stroke
that involves an occlusion of the internal carotid artery (ICA) with an
ipsilateral intracranial cerebral artery occlusion. Primary stenting of the
ICA combined with intracranial mechanical thrombectomy can be an
effective treatment, but may be associated with a high incidence of symp-
tomatic intracranial hemorrhage (SIH). We described our experience with
such endovascular treatment and discussed factors of SIH.
Methods: Consecutive cases of emergency carotid stenting followed by
mechanical intracranial thrombectomy were retrospectively reviewed
from March 2012 to December 2014. Patients were selected with MRI.
Clinical outcomes were assessed at admission, at discharge and at 90 days.
Morbidity and mortality data were collected and analyzed.
Results: In our stroke unit, 13 patients (mean age of 61,8 [42–86]) were
identified. Mean initial NIHSS score was 12,8. Nine patients (69%)
received IV tPA prior to the procedure. 12/13 treated patients achieved a
TICI score ≥2b. On discharge the mean NIHSS score was 11,4 and 50% of
patients achieved a MRS ≤2 at 90 days. Hemorrhagic transformation
within 48 h occurred in 77% of patients, including SIH in 5/13 patients
(38%). There were 3 stent thrombosis, without clinical relevance. Two
patients died, but neither THS nor stent thrombosis were associated with
mortality.
Conclusion: Primary stenting of the ICA combined with intracranial
mechanical thrombectomy can be performed with a high rate of technical
success but the incidence of SICH poses challenges for clinician. We dis-
cussed, analyzing our experience, and the factors of SIH.
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Hemicraniectomy in ischemic stroke: Important to
consider
A Fazal1, S Dr Keir1
1Stroke Medicine, Western General Hospital NHS Lothian,
Edinburgh, United Kingdom
Aim/ Introduction: In spite of trials demonstrating potential benefit,
hemicraniectomy following severe ischemic stroke remains a controversial
intervention due to the potential for severe disability and concern over
future quality of life. We analyzed the outcomes of patients undergoing
hemicraniectomy at a tertiary stroke and neurosurgical center in
Edinburgh.
Methods: Using ISD/ coding, we retrospectively identified patients who
had undergone hemicraniectomy over the last five years. For outcome, we
analyzed notes and followed-up by phone. Rated functional level using
modified Rankin Scale.
Results: 14 patients underwent hemicraniectomy. The mean age was 51
years (median 49 years), 9 (64%) were female, 5 (36%) were male. 10
patients (71%) had surgery within 48 hours of onset of symptoms, 4
patients (29%) were greater than 48 hours. Time from onset to assess-
ment of outcome was a mean of 25 months (range 0 to 59)
7 patients (50%) had a right middle cerebral artery (MCA) territory
infarct, 4 patients (29%) had a left MCA territory infarct, 3 patients (21%)
had posterior cerebral artery territory infarcts.
mRankin Score- 2 (1, 7%), 3(6, 43%), 4(1, 7%), 5(2, 14%), 6(4, 29%).
Mortality in this series was 29%. 50% had an mRS of less than or equal
to 3.
Conclusion: In this case series, and in keeping with hemicraniectomy trial
data, mortality was lower than would be expected with conservative man-
agement. We also found in this highly selected population that although
there was disability, in half of the population this was at a level that would
allow independence.
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Balloon test occlusion of an ophthalmic artery
aneurysm with subsequent treatment and retinal
preservation with pipeline embolization
J Fraser1, N Timoney1, M Kleinman2, C Fraser2
1Neurological Surgery, University of Kentucky, Lexington, USA
2Ophthalmology, University of Kentucky, Lexington, USA
Treatment of ophthalmic artery aneurysms can be challenging surgically
and endovascularly given their location and issues related to recurrence
and preservation of vision. Flow diversion provides an additional tool for
treating these aneurysms, but some questions remain regarding preserva-
tion of the ophthalmic artery and vision. We present a case of a 27-year-
old female with a growing 5 mm ophthalmic artery aneurysm in which
the ophthalmic artery arose from the dome of the aneurysm. The patient
underwent balloon test occlusion of the periophthalmic internal carotid
artery with intraoperative retinography showing decreased perfusion and
loss of vision with decreased blood pressure. As such, coil embolization of
the aneurysm was deferred. Instead, pipeline embolization was per-
formed, which resulted in no loss of vision and no compromise of retinal
perfusion. Prior to placement of the device, therapeutic levels of dual
anti-platelets were verified with laboratory testing. Six-month followup
angiography demonstrated complete obliteration of the aneurysm. While
others have published clinical experience with flow diversion in ophthal-
mic aneurysms, we present for the first-time, correlative management and
followup with retinal examinations.
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Mechanical thrombectomy versus systemic
thrombolysis in MCA stroke: A distance to
thrombus-based outcome analysis
D Lobsien1, M Gawlitza2, A Schaudinn2, S Schob1, C Hobohm3,
D Fritzsch1, U Quäschling1, K T Hoffmann1, B Friedrich2
1Department of Neuroradiology, University Hospital Leipzig,
Leipzig, Germany
2Department of Diagnostic and Interventional Radiology,
University Hospital Leipzig, Leipzig, Germany
3Department of Neurology, University Hospital Leipzig,
Leipzig, Germany
Background and Purpose: Acute ischemic stroke due to occlusion of the
MCA has a poor outcome. The distance to thrombus from the carotid T
can predict the outcome after intravenous thrombolysis. With a distance
to thrombus <16 mm, fewer than 50% of patients treated with intrave-
nous thrombolysis achieve a favorable outcome. We compared stent
retriever-based endovascular mechanical thrombectomy with additional
intravenous thrombolysis versus intravenous thrombolysis alone.
Materials and Methods: Patients with MCA occlusion proven by com-
puted tomography angiography with a DT <16 mm, treated either with
intravenous thrombolysis alone or with stent retriever-based endovascu-
lar mechanical thrombectomy with additional intravenous thrombolysis,
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were included in the present study. Changes in NIH stroke scale (NIHSS),
the 7d NIHSS and the 90d modified Rankin Scale (mRS) scores were
analyzed by treatment modality.
Results: Of 621 patients, 87 fulfilled all inclusion criteria. Fifty-nine
patients were treated by intravenous thrombolysis and 28 by mechanical
thrombectomy with additional intravenous thrombolysis. Although
patients treated with mechanical thrombectomy with additional intrave-
nous thrombolysis had significantly more severe strokes (NIHSS
17.1 ± 4.5 vs. 14.3 ± 6.1; p = 0.032), both the short- and long-term out-
comes were significantly in favor of this patient group (7d NIHSS:
10.9 ± 6.3 vs. 6.7 ± 6.7; p = 0.008/90d mRS: 4 [2–6] vs. 2 [0.75–2.5];
p = 0.003).
Conclusions: Mechanical thrombectomy with additional intravenous
thrombolysis leads to a significant improvement in clinical outcome com-
pared with intravenous thrombolysis alone in patients with proximal
MCA occlusion with a distance to thrombus <16 mm.
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Mechanical thrombectomy using the new
ERIC-retriever is safe and reveals high rates of
successful vessel recanalization in acute ischemic
stroke
T Kahles1, C Garcia Esperon1, S Zeller1, M Hlavica2, J Añon2,
M Diepers2, K Nedeltchev1, L Remonda2
1Neurology, Kantonsspital Aarau, Aarau, Switzerland
2Neuroradiology, Kantonsspital Aarau, Aarau, Switzerland
Background and Purpose: Mechanical thrombectomy (MT) with new
generation devices such as stent-retrievers are highly effective in acute
ischemic stroke with large vessel occlusion (LVO). The aim of this pilot
study was to determine the safety and feasibility of MT using the new
ERIC-retrieval-device consisting of several interlinked cages.
Methods: Twenty-one consecutive patients suffering from acute ischemic
stroke with LVO who have been treated with ERIC-retriever were included
into this pilot study. Onset to intravenous thrombolysis time ≤4.5 h or
wake-up-stroke with relevant CT-perfusion mismatch and NIHSS ≥4 rep-
resented the main inclusion criteria. We assessed baseline/stroke charac-
teristics, treatment related parameters and outcome.
Results: Mean age was 69 ± 12 years, 62% women. Median NIHSS on
admission was 16 [IQR11–20] and onset to MT time was 7h59m [IQR
6h50m–11h07m]. Eight patients received intravenous thrombolysis, 2
intraarterial urokinase. The new ERIC device was used as the sole retriever
in 14/21 patients (67%) and as a rescue device in 7, with 3 of them
supported by thrombus aspiration. Excellent recanalization was achieved
in 17 patients (81%) with TICI3 in 10/21 and 2b in 7/21, respectively. The
median procedural time was 106 min [IQR 72–166]. No intraprocedural
complications occurred. At 3 months, fair outcome (mRS ≤ 3) was
achieved in 62%, with 54% of them being independent (mRS ≤ 2). Symp-
tomatic intracerebral hemorrhage unrelated to the device developed in 2
patients (mRS at 3 mo 3+6) and mortality at 3 months was 29%.
Conclusion: The new ERIC-retrieval-device is technically safe and effec-
tive in removing thrombi in patients with acute ischemic stroke due to
large vessel occlusion.
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Endovascular embolization of the middle meningeal
artery: Morphological aspect
M Kornieieva1
1Basic Science, The University of Jordan, Amman, Jordan
Introduction: The endovascular embolization of the middle meningeal
artery (MMA) is considered as one of the basic methods of acute bleeding
and posttraumatic aneurism treatment nowadays. The aim of present
research is to correlate the morphological characteristics of the MMA with
the individual shape of skull.
Material and Methods: A total of 50 patients who underwent routine
magnetic resonance angiography examination of the head and neck were
involved into our prospective cohort study. The length and outer diameter
of extracranial, intraosseous, and intracranial segments of the MMA were
measured in patients with dolichocephalic, mesocephalic, and brachyce-
phalic types of the skull construction.
Results: The morphological characteristics of the MMA in different
groups were estimated in order to determine the possibility of using
minimal invasive procedures. The brachycephalic patients had the most
inauspicious anatomical precondition for endovascular intervention on
MMA due to the narrowest lumen of the vessel, high probability of torture
of its extracranial part, and pronounced inflexion at the transmission of
the interosseous segment to the intracranial one.
Conclusion: The morphological characteristics of the MMA have close
correlation with the individual shape of skull. Estimating the shape of the
skull gives valuable information for involved specialists, helping them to
predict probable types of variability of the MMA and to foresee the
possibility of the manipulation and risk of iatrogenic trauma at the early
diagnostic stage.
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“Moving forward following the MR CLEAN trial”:
A retrospective analysis of how our acute stroke
service could be improved by provision of
intra-arterial treatment
B Edge1, K Lawton1, M Poitelea1, S Vundavalli1, B Davies1, I Kane1,
N Gainsborough1
1Stroke Medicine, Brighton & Sussex Universities Hospital NHS
Trust, Brighton, United Kingdom
Introduction: The recent Mr Clean Trial demonstrated favorable func-
tional outcomes following IAT compared to usual care. We conducted a
retrospective observational study to ascertain what proportion of our
patients may benefit from IAT.
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Method: All acute stroke patients with hyperdense changes in the internal
carotid and middle cerebral arteries (MCA) were identified from 2013.
Images and case details were assessed by an interventional neuroradiolo-
gist and stroke physician to determine whether they would be considered
for IAT.
Results: Of 393 patients, 46 patients (35 TACIs and 11 PACIs) had vascu-
lar hyperdensity on non-contrast brain CT corresponding to the terminal
ICA, M1, M1 bifurcation or proximal M2. 22 of the 46 patients may in
retrospect have been radiologically and clinically suitable for consider-
ation of IAT. Of these 22 patients, 12 received IV thrombolysis with a
range of improvement in NIHSS -3 to 20. Of the 10 patients unable to
receive thrombolysis reasons included no clear time of onset, raised INR
and high NIHSS. With the aid of CT perfusion a proportion of these 10
patients could have received IAT. 16 of the 22 patients were admitted
between 9am and 5pm.
A further group of patients without hyperdense changes with would have
benefitted from CT angiogram (CTA) to assess suitability for IAT.
Conclusion: 5.6% of our patients could potentially benefit from IAT. We
are evaluating our service based on this. Increased usage of CTA and/or
perfusion in addition to plain CT is likely to increase this number.
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Percutaneous cerebrovascular intervention vs.
intravenous thrombolytic therapy for acute ischemic
stroke: A systematic review and meta-analysis
H Lindekleiv1, E Berge2, K O’Rourke3, K Bruins Slot2,
J M Wardlaw4
1Department of Community Medicine, University of Tromsø,
Tromsø, Norway
2Department of Internal Medicine, Oslo University Hospital,
Oslo, Norway
3Department of Neurology, Mater Private Hospital, Dublin,
Ireland
4Centre for Clinical Brain Sciences, University of Edinburgh,
Edinburgh, United Kingdom
Purpose: Percutaneous cerebrovascular intervention (intra-arterial reca-
nalization therapy) offers a new approach to the treatment of acute isch-
emic stroke. The purpose of our systematic review and meta-analysis was
to examine whether this intervention is more effective and safer than
intravenous thrombolytic therapy.
Methods: We searched MEDLINE, EMBASE, and the Cochrane Central
Register of Controlled Trials for randomized-controlled trials up to
January 1st 2015 that compared percutaneous cerebrovascular interven-
tion with intravenous thrombolytic treatment in patients with acute isch-
emic stroke. Good functional outcome was defined as a modified Rankin
Scale score of 0 to 2. We searched Clinicaltrials.gov, Current Controlled
Trials, and Stroke Trials Registry for on-going trials. We contacted authors
for additional unpublished data.
Results: We identified four trials with a total of 450 patients. Percutaneous
cerebrovascular intervention was not associated with an improved pro-
portion of patients with good functional outcome (relative risk (RR) 1.01,
95% confidence interval (CI) 0.82 to 1.25, P = 0.92). At the end of
follow-up there was a non-significant increase in the proportion of
patients who died in the percutaneous cerebrovascular intervention group
(RR 1.34, 95% CI 0.84 to 2.14, P = 0.21).
Conclusions: Percutaneous cerebrovascular intervention was not superior
to intravenous thrombolytic treatment for the treatment of acute ischemic
stroke. Endovascular devices are rapidly evolving, and new trials of the
latest generation devices (stent-retrievers) are warranted.
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Spinal radicular artery pseudoaneurysms presenting
with spontaneous spinal subarachnoid hemorrhage –
An unconsidered diagnosis with a benign course?
T J Singh1, S Loo2, D Ghia3
1Interventional Radiology, Neurological Intervention &
Imaging Service of Western Australia (NIISwa), Perth,
Australia
2Neurology, Royal Perth Hospital, Perth, Australia
3School of Medicine and Pharmacology, University of Western
Australia, Perth, Australia
Spinal subarachnoid hemorrhage is rare, representing <1% of all suba-
rachnoid hemorrhage (SAH). Underlying etiologies are trauma (includ-
ing lumbar puncture), vascular lesions (arteriovenous malformations,
arteriovenous fistula, aneurysm), neoplastic lesions, coagulopathy, vascu-
litis (polyarteritis nodosa, systemic lupus erythematosus, Behcet’s
disease), hypertension, and coarctation of the aorta.
Spontaneous subarachnoid hemorrhage of unknown pathogenesis is
diagnosed after underlying causes are ruled out with selective spinal
angiography, computed tomography (CT), magnetic resonance (MR)
imaging or autopsy.
We present two cases of radicular artery pseudoaneurysms, one arising
from the radicular medullary artery (supply to the Anterior Spinal Artery)
and the other, the radiculopial artery (supply to the Posterolateral Spinal
Artery). Each case presented with spontaneous spinal subarachnoid hem-
orrhage. Early spinal angiography disclosed the underlying etiology in
both cases. Both patients were treated conservatively with good outcome.
Follow up spinal angiography showed not only resolution of the pseudoa-
neurysm, but loss of the radicular arteries. Without the prior spinal angio-
gram, follow up angiography would have been reported as normal due to
the significant variations in supply of radicular arteries to the spinal cord.
These patients would then have been mischaracterized as “Spontaneous
SAH of unknown pathogenesis”.
Literature review discloses many cases of spontaneous spinal SAH of
unknown etiology either have no or delayed angiography potentially
missing this diagnosis. This suggests that spinal radicular artery pseudoa-
neurysm causing spinal SAH may be more common than thought. These
two cases suggest that this disease is self-limiting with good prognosis. The
clinical and imaging features of these two cases are presented.
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Possibilities of interventional treatment of patients
after extensive ischemic stroke
I Maksimovich1
1Iterventional Neuroangiology, Clinic of Cardiovascular
Diseases named after Most Holy John Tobolsky, Moscow,
Russia
Introduction: The research investigates the possibility of interventional
restoration of cerebral perfusion in patients after extensive ischemic
stroke.
Methods: We examined 1238 patients aged 29–81 (average age 74) with
various types of atherosclerotic disorders of cerebral vessels: 916 male
(73.99%), 322 female (26.01%).
Of these, 93 patients after extensive ischemic stroke were selected.
Examination plan: CT, MRI, SG, REG, cerebral MUGA, laboratory diag-
nostics, CDR, MMSE, IB.
Test Group: 69 (74.19%) patients. For revascularization of the main
intracranial arteries high-energy lasers were used; for revascularization of
distal intracranial branches and stimulation of angiogenesis low-energy
lasers were used.
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Control Group: 24 (25.81 %) patients underwent therapeutic treatment.
Results:
Test Group:
Cerebral arterial blood flow restoration was achieved in 66 (95.65%)
patients.
In 12-24 months the following positive tendency was observed:
- good clinical outcome – IB90-100 – 14 (20.29%) patients;
- satisfactory clinical outcome – IB75-85 – 27 (39.13%) patients;
- relatively satisfactory clinical outcome – IB60-70 – 28 (40.58%)
patients;
- relatively positive clinical outcome – IB below 60 – was not obtained in
any case.
Control Group:
In 12–24 months the following was observed:
- good clinical outcome was not obtained any case;
- satisfactory clinical outcome was not obtained in any case;
- relatively satisfactory clinical outcome – 4 (16.67%) patients;
- relatively positive clinical outcome – 20 (83.33%) patients.
Conclusion:
Transluminal laser revascularization of cerebral blood vessels is a signifi-
cantly more effective treatment for the effects of extensive ischemic stroke
than the therapeutic treatment.
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Mechanical thrombectomy for acute ischemic stroke
managed in peripheral stroke centers: Timing, safety
and prognosis
P Malissart1, N Gaillard2, S Bouly3, Y Boukriche4, D Sablot2,
T Lalu4, O Eker5, P Machi5, C Riquelme5, M Charif1, X Ayrignac1,
I Mourand1, A Bonafe5, V Costalat5, C Arquizan1
1Neurology, CHU Gui de Chauliac, Montpellier, France
2Neurology, Hôpital Saint Jean, Perpignan, France
3Neurology, CHU Carémeau, Nimes, France
4Neurology, Centre Hospitalier, Béziers, France
5Neuroradiology, CHU Gui de Chauliac, Montpellier, France
Introduction: Endovascular therapy seems to achieve better outcome than
intravenous fibrinolysis in acute ischemic stroke with intracranial occlu-
sion. Our goal was to evaluate the feasibility, efficacy and safety of the
thrombectomy in a regional protocol, comparing patients initially
managed in the referential vascular center with a stroke unit and a neu-
roradiologist department (local patients), and patients managed in
another stroke unit and transferred to the referential center for throm-
bectomy (regional patients).
Methods: From September 2010 to December 2012, consecutive patients
with acute ischemic stroke of the anterior circulation were included if they
had clinical-diffusion mismatch (defined by National Institute of Health
Stroke Scale (NIHSS) ≥ 8 and a DWI-ASPECT score ≥ 5) and large intrac-
ranial artery occlusion. Time window for thrombectomy was 6 hours.
Intravenous fibrinolysis was administered according guidelines. Safety
and clinical outcome at 3 months was compared in local and regional
patients (good outcome was defined as modified Rankin scale (mRs) ≤ 2).
Results: 179 patients were included (93 local, 86 regional). There was no
difference between groups in terms of initial NIHSS (median 18) and
ASPECTS (median 7). Delays for thrombectomy were higher in the
regional group (median: 337 versus 249 minutes, p < 0,001). Predictive
factors of good outcome were low initial NIHSS and age. 44 % of local
patients and 40% of regional patients had good clinical outcome
(p = 0,56).
Conclusion: Despite the increased delay of treatment in regional patients,
our regional organization for thrombectomy with only one neuroradiolo-
gist interventional unit seems to be safe and effective.
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Revascularization of subacute and chronic total
occlusion of the internal carotid artery and VA
O Mansour1
1Stroke and Neurovascular Department, Faculty of Medicine,
Alexandria, Egypt
Background and Purpose: The natural course of symptomatic carotid or
vertebral artery occlusion with hemo-dynamic impairment is poor. Sur-
gical revascularization may improve the outcome; however, its efficacy has
not been established yet. The goal of this study was to characterize the
technical and clinical outcomes protection. following endovascular reca-
nalization of the ICA and Vertebral cerebral circulatory
Materials and Methods: Endovascular recanalization was attempted in 14
patients with symptomatic 11 ICA occlusions and 3 VA occlusions . The
duration of the occlusion ranged from 10 days to 6 months (mean, 2.5
months), and the mean length of the occlusion was 95 mm. Cerebral
hemodynamics ipsilateral to the side of the occlusion were severely
impaired in all patients. The endovascular procedure was performed
under total cerebral circulatory protection, beginning with proximal pro-
tection with a subsequent switch to distal protection (in 11 cases) after
successful guide wire passage.
Results: The occlusion was recanalized successfully in 12 out 14 of
patients (85.7%), resulting in improve-ment of ipsilateral cerebral hemo-
dynamics without symptomatic stroke. Small asymptomatic ischemic
lesions were detected in 3 of 14 patients (21%) on DWI, and 1 patient
developed a mild groin hematoma. Ischemic episodes did not recur
during the mean follow-up period of 19 months. However, 2 patients
experienced asymptomatic reocclusion, which was retreated successfully
without complications due to failure maintenance of antiplatelet and
anticoagulant therapy.
Conclusions: Endovascular revascularization of an ICA occlusion is fea-
sible and well-tolerated inpatients with subacute or chronic total occlu-
sion of the ICA.
Abstracts
© 2015 The Authors.
International Journal of Stroke © 2015 World Stroke Organization Vol 10 (Suppl. 2); April 2015; 77–438154
ESOC-0280
08. Neurointervention
External carotid artery percutaneous angioplasty and
stenting – From an idea to a good alternative for
patients with ischemic events
A C Mergeani1, D Popescu1, O Rusu1, B Dorobat2, A Dimitriade2,
O A Bajenaru1, F Antochi1
1Neurology, University Emergency Hospital, Bucharest,
Romania
2Interventional Neuroradiology, University Emergency
Hospital, Bucharest, Romania
Introduction: In patients with internal carotid artery (ICA) occlusion the
ipsilateral external carotid artery (ECA) may supply the cerebral circula-
tion through collateral vessels. Although endarterectomy for ECA stenosis
has been described in the literature, angioplasty and stenting has rarely
been reported. The aim of our study is to present nine cases with ECA
stenosis and ipsilateral ICA occlusion in whom stenting of ECA was
performed.
Methods: Our study consists of 5 male and 4 female patients aged between
48-73 years who were admitted to our clinic for transient ischemic attack
(five patients) or ischemic stroke (four patients). All the patients had
medical history of arterial hypertension, dyslipidemia and cardiac isch-
emic disease. One male patient had diabetes, another impaired fasting
glucose. All patients underwent Doppler ultrasonography of the cervico-
cerebral arteries that revealed bilateral (four cases) or unilateral ICA
occlusion associated with a hemodynamically significant contralateral
ICA stenosis (five cases), and ECA stenosis ipsilateral to the symptomatic
occluded artery. These findings were confirmed by digital substraction
angiography, with ECA stenosis between 80-99% (eight of the left ECA
and one of the right ECA).
Results: We proceeded to angioplasty and stenting of the ECA with
optimal postangioplasty results and improved intracranial cerebral blood
flow, without periprocedural incidents. The patients were discharged few
days later with double antiplatelet therapy.
Conclusion: We choose to present these cases underlining the importance
of preventing further ischemic events and vascular cognitive impairment
in patients with occluded ICA and ipsilateral ECA stenosis using angio-
plasty and stenting of ECA.
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Monitoring by aggregometry to adjust antiplatelet
therapy in neurointerventional stent applications for
vessel recanalization
S Nagel1, L Sun1, M Möhlenbruch2, C Herweh2, O Müller3,
H A Katus3, P A Ringleb1
1Department of Neurology, University Hospital Heidelberg,
Heidelberg, Germany
2Department of Neuroradiology, University Hospital
Heidelberg, Heidelberg, Germany
3Department of Internal Medicine III, University Hospital
Heidelberg, Heidelberg, Germany
Background: Patients’ responses to oral antiplatelet therapy, necessary for
peri-interventional stent management, vary. We report the incidence of
pharmacological therapy resistance in this cohort and assess whether tai-
lored therapy reduces the risk of complications.
Methods: Between August 1996 and June 2013 patients that underwent a
stent implantation for recanalization were prospectively entered into a
local database. Since 2006 platelet reactivity tests by whole blood
aggregometry were carried out and the cohort was divided into two
groups: without (standard treatment) and with aggregometry. We then
assessed retrospectively the frequency of resistance to therapy and ana-
lyzed whether complications were less frequent in the monitoring group.
Results: A total of 648 patients could be included (78% extracranial, 22%
intracranial). 227 (35%) patients were in the monitoring group and 421
(65%) in the standard group. 91.2% of patients had a good response to
both aspirin and clopidogrel, 0.8% showed no response to both drugs
7.5% patients had a response to only one of the drugs. Only six patients
required an additional drug bolus. During hospital stay there were no
significant differences in complications like TIA (4.4 % vs. 5.2%, p = 0.7),
stroke (12.7% vs. 10.5%, p = 0.36), ICH (3.9% vs. 2.1%, p = 0.2) and death
(0% vs. 1.4%, p = 0.1). Other complications were less frequent in the
monitoring group (17.6% vs. 28%, p = 0.005).
Conclusions: The frequency of pharmacological therapy resistance to
aspirin and clopidogrel resistance was low in this cohort. Except a lower
rate of non-neurological complications, both groups showed no signifi-
cant differences in relevant outcome parameters.
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Carotid artery stenting safety – Protection devices
comparison
O Pavlik1, D Václavík1, D Kucˇera2, J Návratová3, G Solná1
1Stroke Unit and Department of Neurology, Vítkovice
Hospital, Ostrava, Czech Republic
2Vascular Center, Vítkovice Hospital, Ostrava, Czech Republic
3Department of Radiology, Vítkovice Hospital, Ostrava, Czech
Republic
Background: International carotid stenting study proved significantly
more microembolic brain lesions after carotid artery stenting (CAS) com-
pared to carotid endarterectomy and considered cerebral protection
devices (CPD) ineffective. Although microembolic lesions after CAS
usually remain asymptomatic, we assume, that higher number of new
lesions may lead to decline in cognitive functions.
Objectives: To compare safety and efficiency of distal protection
devices (filters) to the proximal protection device (Mo.Ma system) during
CAS and to determine an effect of microembolic lesions after CAS on
cognitive functions.
Methods: 54 patients were randomized into two groups by used CPD
(Filter vs. Mo.Ma group). All patients underwent brain magnetic reso-
nance imaging (MRI) before and after stenting. 32 patients were tested
before and 30 days after stenting with Adenbrook cognitive examina-
tion (ACE) tests.
Results: 31% (n = 17) of all patients had new ischemic lesions on MRI
after CAS, in Filter group (n = 37) it was 35% of patients (n = 13), in
Mo.Ma group (n = 17) it was 24% of patients (n = 4). Only 41%
of all new ischemic lesions were localized only in the territory of inter-
vened artery. Significant decline in ACE test was found only in 1
patient (3%).
Conclusions: New ischemic lesions on MRI after CAS were present in both
groups, but reduction in Mo.Ma group was not significant. Significantly
more lesions were localized outside the territory of intervened artery in
Filter group. We did not prove impact of new lesions on results in ACE
tests.
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Endovascular embolization of arteriovenous
malformations: Report from University Medical Centre
Ljubljana
K Pavsic1, B Zvan1, Z Milosevic2
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University Medical Centre Ljubljana, Ljubljana, Slovenia
2Department of Radiology, University Medical Centre
Ljubljana, Ljubljana, Slovenia
Background: Endovascular embolization is one of the treatment modali-
ties for cerebral AVM. The aim of this study was to analyze embolization-
related complication rate at our department.
Methods: We retrospectively reviewed patients with AVM embolization
from 2009 to 2014. Patients were assigned into two groups according to
clinical presentation: ruptured (R) and unruptured AVM (UR). We ana-
lyzed the obliteration rate, periprocedural complications and clinical
outcome reported as NIHSS and mRS. Study was approved by Slovenian-
National-Medical-Ethics-Committee.
Results: 25 patients with AVM were enlisted (56.0% male, age at treat-
ment 41.7 ± 14.9 years). There were 4 Spetzler–Martin grade I, 9 grade II,
8 grade III, 3 grade IV and 1 grade V. Group R consisted of 9 patients with
initial NIHSS 8.8 and group UR of 16 patients with NIHSS 0.1. Eleven
embolizations were performed in R and 18 in UR group. Complete AVM
obliteration was achieved in 77.8% of R and 62.5% of UR patients. Favor-
able outcomes (mRS ≤ 2) at discharge were observed in 33.3% of R and in
87.5% of UR patients. Clinically significant procedure-related complica-
tions defined as increase of NIHSS≥4 or death occurred in 9.1% of pro-
cedures (11.1% of patients) in R and in 7.1% of procedures (12.5% of
patients) in UR group.
Conclusions: Our findings show that in spite of being a center with few
annual cases of AVM, endovascular embolization was a generally safe
procedure with low complication rates for patients with ruptured and
according to ARUBA also for patients with unruptured AVM.
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Thrombectomy in vertebrobasilar stroke. Futile or
insufficient treatment
B Lara1, P Cardona2, L Cano3, H Quesada3, L Aja4, R Barranco5,
M A De Miquel6, M Ribo7, N Perez de la Osa8, A Escrig9, F Rubio8
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Background: Treatment of vertebrobasilar occlusions with thrombectomy
could restore cerebral flow and improve clinical outcome in acute stroke.
In our experience the treatment alone with intravenous fibrinolysis in
vertebrobasilar strokes present a limited results when they are caused by
large vessel occlusion.
Methods: We review 408 consecutive patients treated with neurointerven-
tional treatments, from April 2010 to September 2014 in our comprehen-
sive stroke center. We analyze patients with acute vertebrobasilar
occlusions. The grade of perfusion pre and postprocedural were measured
by TIMI and TICI score. Clinical results and good outcome were rated
using 3 month-NIHSS and Rankin scale. Successful recanalization (TICI
2b-3), functional and clinical good outcome (mRankin 0–2 and 0–3
respectively) at day 90, mortality and symptomatic hemorrhage were pro-
spectively assessed.
Results: Forty-five patients with acute occlusion of the vertebral or basilar
arteries were treated (mean age 65 years; range 48-80 years, 71 % men).
Twenty patients had a wake-up stroke or progressive brain stem stroke and
median NIHSS was 20. Ninety percent of patients had baseline Rankin
0-1, and pre-procedural TICI 0–1 was 81%. After neurointerventional
treatment the acceptable recanalization rate was achieved in 61% (TICI
2b-3). Clinical results after 3 months showed a functional recovery of 24%
(mRankin 0–2) and good clinical prognosis in 38% (Rankin 0–3). Mor-
tality was 45% (six patients recanalization failed and four presented symp-
tomatic hemorrhage)
Conclusions: It is feasible and reasonably safe to use neurointerventional
treatment in severe strokes associated to acute vertebrobasilar artery
occlusions. However the percentage of functional recovery after follow-up
is very low.
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Focal hemodynamic changes after successful stent
retrievers’ thrombectomy in acute stroke: A sign of
vessel wall injury?
F Perren1, J M Pignat2, V Mendes Pereira3
1Neurology, HUG University Hospital Dept. of Clinical
Neurosciences, Geneva, Switzerland
2Neurology, CHUV University Hospital, Lausanne, Switzerland
3Neuroradiology, Toronto Western Hospital University Health
Network, Toronto Ontario, Canada
Background: Stent retrievers with rapid recanalization and acceptable
safety have revolutionized intracranial endovascular treatment of acute
ischemic stroke. However, animal studies showed that mechanical throm-
bectomy may cause endothelial injury leading to myointimal hyperplasia.
Using transcranial duplex sonography (TDS) monitoring, we observed
post-procedural hemodynamic changes in the treated vessel.
Methods: We studied acute ischemic stroke patients with single
large intracranial artery occlusion in whom mechanical thrombectomy
using stent retrievers was performed. Only those with complete vessel
recanalization (modified TICI 2b or 3) as assessed by post-procedural DSA
and MRA and in whom early control TDS was performed were retained.
Patients treated with intra-arterial thrombolysis or stenting were excluded.
Results: In 28 patients (26 MCA, 2 BA), post acute MRA confirmed com-
plete recanalization without residual stenosis or vasospasm. However, in
24 of them TDS (mean 3.4 days after thrombectomy) showed very seg-
mental acceleration of blood flow velocities in the affected arteries (MCA
PSVmax at least >35%) as compared with the contralateral side at same
depth; BA PSVmax >40% as compared to velocities measured in the same
vessel). None showed clinical deterioration. Follow-up TDS (mean 20
days) showed normalization in 11 /14.
Conclusion: This is the first TDS study showing focal acceleration of
blood flow velocities after stent retrievers’ thrombectomy. Without
residual stenosis, thrombosis or vasospasms, this may be a sign of intimal
injury in humans. Whether this is due to local inflammatory agents,
neothrombosis or myointimal hyperplasia is yet not clear.
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Regional collateral flow evaluation predicts infarction
during stroke endovascular procedures
R Pop1, M Manisor1, V Wolff2, C Marescaux2, R Beaujeux1
1Interventional Neuroradiology, Strasbourg University
Hospitals, Strasbourg, France
2Vascular Neurology, Strasbourg University Hospitals,
Strasbourg, France
Background: We developed a new system for grading of leptomeningeal
collateral flow in angiography. We investigated its diagnostic value for the
prediction of infarction during stroke endovascular procedures.
Material and Method: We evaluated all consecutive patients treated for an
anterior circulation occlusion between 2009 and 2013. Two readers per-
formed a zonal collateral circulation evaluation in 5 cortical regions based
on the vascular anatomy. Regional scores were correlated with the pres-
ence of infarction in the same cortical region on pretreatment and
follow-up imaging. Global collateral scores were correlated with initial
and final infarct volumes and clinical scores.
Results: In 89 patients with 408 cortical zones we found good correlation
between the degree of collateral flow and the absence of infarction in the
same region on pretreatment imaging (AUC of ROC curve 0.82,
p < 0.0001).
In a subgroup of 37 recanalized patients (TICI 3) with 173 cortical
regions, retrograde collateral flow to the proximal M4 segment predicted
the absence of infarction in the same region on follow-up imaging (PPV
88,7% , NPV 83,8%). We found good inter-rater agreement for the pres-
ence of collateral flow to the M4 proximal segment or further – kappa 0.77
(p = 0.05, 95%CI 0.66–0.88).
The number of cortical regions with good collateral flow (0–5) was cor-
related with the initial infarct volume (p = 0.003). All patients with 4-5
cortical regions had infarct volumes ≤70 ml.
Conclusion: Anatomic collateral flow evaluation can provide a real-time
estimation of the size and location of irreversible ischemia during stroke
endovascular procedures.
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Peri-interventional management of sedation and
airway during the endovascular therapy of acute
ischemic stroke: SIESTA (Sedation vs Intubation for
Endovascular Stroke Treatment) – A randomized trial
S Schönenberger1, M Möhlenbruch2, M Bendszus2, W Hacke1,
J Bösel1
1Neurology, University Hospital Heidelberg, Heidelberg,
Germany
2Neuroradiology, University Hospital Heidelberg, Heidelberg,
Germany
Background: Although intravenous thrombolytic therapy within 4.5
hours after onset is still the gold standard in acute stroke treatment, this
therapy leads to recanalization results in only 30 % of patients if large
proximal cerebral arteries are occluded.
Hence, endovascular recanalization methods are increasingly applied. In
addition to the degree of recanalization, the peri-interventional manage-
ment is probably a crucial factor for success. An important and contro-
versially discussed issue the ideal sedation concept and airway
management
According to the available data the widely favored general anesthesia
seems to be disadvantageous with regard to functional outcome compared
to “conscious sedation” in non-intubated state. However, only retrospec-
tive studies have addressed this issue, so far.
Methods: This study is a first prospective, monocentric, randomized par-
allel interventional study comparing non-intubated vs. intubated patients
receiving endovascular treatment (EST) of acute ischemic stroke of ante-
rior circulation (study registered under www.clinicaltrials.gov, NCT
02126085).
Primary endpoint is the improvement of the National Institute of Health
Stroke Scale (NIHSS) after 24 hours. Secondary endpoints include: func-
tional outcome after 3 months as by modified Rankin Scale, duration of
ventilation, mortality, feasibility and safety, i.e. complications during EST.
An inclusion of 50 patients in each arm of the study is intended. Recruit-
ment started in April 2014, 42 patients have been included so far. The
detailed study protocol and preliminary results will be presented.
Conclusion: The aim of this study is the prospective randomized investi-
gation of potential advantages of the non-intubated compared to the
intubated state in patients receiving acute EST.
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Embotrap revascularization device: Initial experience
in 49 patients from two European centers
M Söderman1, P A Brouwer1, T Andersson1, J Thornton2
1Neuroradiology, Karolinska University Hospital, Stockholm,
Sweden
2Radiology, Beaumont hospital, Dublin, Ireland
We here report our initial experience with a novel stent-retriever for
removal of intracranial clots, the Embotrap revascularization device
(Neuravi, Galway, Ireland).
Methods: 83 patients have been treated with the Embotrap device.
Outcome data for the patients in this study was collected from the two
centers with complete follow up of all patients.
42 Patients (17 female/25 male) presenting with acute ischemic stroke in
two European centers underwent intra-arterial therapy using the
Embotrap device. 57% of these patients had received IV tPA prior to
commencing thrombectomy. Baseline NIHSS was 15, and the average clot
length was 12.7 mm. Immediate angiographic results, procedural tech-
niques, and 90 day clinical outcomes are presented.
Results: The Embotrap alone was successful in achieving revasculariza-
tion in 36/42 patients (86%) with a final Thrombolysis in Cerebral Infarc-
tion (TICI) score 2b. 93% of the patients in achieved successful
revascularization (TICI ≥2b).
18/36 (50%) of these patients achieved TICI 2b in one pass with the
Embotrap device, and 77% had a good clinical outcome (mRS 0-2) at 90
days. 25/38 (66%) of the overall series achieved a good clinical outcome.
Four patients still lack 90 days follow up.
The mortality rate was 18%. There were no device related complications.
The average time from 1st deployment of the Embotrap device to proce-
dural completion was 9 mins 30 secs.
Conclusions: The Embotrap device alone provided an 86% recanalization
rate. There were no device related complications. The procedure was fast
with few passes.
77% of the patients had a good clinical outcome.
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Identifying patients at high risk for poor outcome
after endovascular treatment for acute ischemic stroke
M Tinková1, A Tomek2, L Vasina3, H Parobková4
1Military University Hospital Prague, Central Military Hospital,
Prague 6, Czech Republic
2Military University Hospital, 2end Faculty of MedicineCharles
University in Prague and Motol University Hospital, Prague,
Czech Republic
3Neurology, Central Military Hospital – Military University
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4Radiodiagnostic, Central Military Hospital – Military
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Background: The aim of our study was to determine the ability of the
iScore (www.sorcan.ca/iscore) to predict bad clinical outcome after endo-
vascular treatment.
Methods: We retrospectively reviewed patients who underwent endovas-
cular therapy for acute anterior circulation ischemic stroke from January
2009 to December 2013. iScore was calculated using following parameters:
age (years), male (+10), NIHSS 14-22 (+40), NIHSS >22 (+105), nonla-
cunar stroke (+30), atrial fibrillation (+10), heart failure (+10), glucose
>7.5 mmol/l (+15), cancer (+10), renal dialysis (+35), preadmission dis-
ability (+15). Bad clinical outcome was defined as mRS score of 3 to 6.
Patients were categorized into 3 risk groups: low-risk (iScore <139),
medium-risk (iScore 140–179) and high-risk (iScore >180).
Results: 80 patients were included, mean age was 61.6 (18–85) years;
median NIHSS score was 13.5 (range, 2–31). Successful recanalization
TICI 2b-3 was achieved in 61/80 (76.3%) patients. Clinical outcome at 90
days was good (mRS 0–2) in 37 (46.3%). Poor clinical outcome (mRS
3-6) was in 8/28 (28.6%) patients in low-risk group, in 20/34 (58.8%)
patients in medium-risk group and in 15/18 (83.3%) patients in high-risk
group. Odds ratio for bad outcome (mRS 3–6) was in respective groups
following: in high-risk group OR = 6.071 (95% CI 1.59–23.1, p = 0.004),
in medium-risk group OR = 1.429 (95% CI 0.58-3.5, p = 0.43) and in
low-risk OR = 0.194 (95% CI 0.07–0.53, p = 0.001). The iScore correlated
well with clinical outcome expressed as mRS (r = 0.68, p < 0.001).
Conclusion: The iScore may be informatively used to predict clinical
outcome after endovascular therapy.
ESOC-1259
08. Neurointervention
Role of non-contrast CT aspects score in the selection
of patients with ischemic stroke for endovascular
treatment
E Viedma-Guiard1, B Fuentes2, A Ximénez-Carrillo3,
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B Marín6, M Alonso de Leciñana1
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Background: Alberta Stroke Program Early CT Score (ASPECTS) <7 of
baseline noncontrast CT (NCCT) has been considered as an exclusion
criterion for endovascular treatment (EVT). Currently, a controversy
exists regarding the use of this score to select patients. We analyze the
evolution of patients receiving EVT according to ASPECTS.
Methods: Retrospective analysis of the Madrid North East Stroke
Network registry of eligible patients for EVT. Demographics, NIHSS and
radiological data on admission, recanalization rate and complications
were collected. Outcome measures were symptomatic intracranial hem-
orrhage (SICH), functional independence (mRS 0–2) and mortality at
three months.
Results: Included were 152 patients. Age: 68 years (57,5; 76); baseline
NIHSS: 18 (14; 21); onset-to-recanalization time-lapse: 315 minutes (250;
409,5) [median (IQR)]. NCCT-ASPECTS 0 to 4: 4 patients; 5 to 6: 12
patients; 7 to 10: 136 patients. Recanalization rate (TICI 2b/3): 118
(81 %).
For ASPECTS 0 to 4; 5 to 6 and 7 to 10, respectively, functional indepen-
dence rates were 25%, 33% and 62%, mortality rates were 50%, 25% and
7% and SICH rates 0%, 8% and 4%. When recanalization occurred inde-
pendence rates were 50%, 33% and 70%, mortality 50%, 22% and 6% and
SICH 0%, 11%, 4% respectively.
Conclusion: Although higher ASPECTS is associated with higher prob-
ability of good outcome, up to one third of subjects with ASPECTS <7
could benefit from EVT so this score should not be, by itself, an exclusion
criterion.
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Mechanical thrombectomy with a self-expanding
retrievable intracranial stent (SOLITAIRE AB) in acute
ischemic stroke patients: Our initial experiences
A Bajrami1, M Cabalar1, S Senadim1, F Azman1, H Selcuk2,
B Kara2, V Yayla1
1Neurology, Bakirkoy Dr Sadi Konuk Research & Training
Hospital, Istanbul, Turkey
2Neuroradiology, Bakirkoy Dr Sadi Konuk Research & Training
Hospital, Istanbul, Turkey
Introduction: Patients with contraindications for IV thrombolysis may be
considered for endovascular revascularization, particularly when baseline
imaging suggests proximal cerebral vessel occlusion. This retrospective
analysis describes our initial experience with self-expanding retrievable
intracranial stent (Solitaire AB) for thrombectomy in acute ischemic
stroke (AIS) patients.
Material and Methods: AIS patients who underwent endovascular treat-
ment between February 2011 and January 2014 in Neuroradiology Unit
were evaluated. Baseline and outcome data were retrieved from comput-
erized records. National Institute of Health Stroke Scale (NIHSS) and the
modified Rankin Scale (mRS) were used as outcome parameters. Peripro-
cedural complications were recorded.
Results: Age range of 17 patients (11M:7F) was 40–77 years. Baseline
mean NIHS score was 21.1 ± 2.9 (18–26). Occlusion sites were: internal
carotid (n = 4), internal carotid bifurcation (n = 2) and middle cerebral
artery (n = 11). Recanalization was achieved with Solitaire thrombectomy
as the single treatment technique in 12 patients and in combination with
intra-arterial administration of urokinase in the remaining five patients.
Post-procedural intracerebral hemorrhage occurred in only one case
(5.5%), with an all-cause mortality of two (11%) patients. Demographic
data, time to treatment, complications, NIHSS at the beginning and 24th
hour and mRS at discharge were evaluated.
Conclusion: The aim of AIS treatment is early revascularization of
occluded vessels. Mechanical thrombectomy (primary or in combination
with a bridging thrombolysis) by Solitaire stent appears to be safe and is
capable of achieving high rate of canalization. Favorable clinical outcomes
may be obtained in selected patients with proximal vessel occlusions
without or in combination with fibrinolytic treatment.
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Restenosis post-carotid angioplasty (CA) : Associated
factors and predictors
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J Montaner2
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3Interventional Neurorradiology, Hospital Universitario Virgen
del Rocío/Instituto de Biomedicina de Sevilla (IBI, Seville,
Spain
Objectives: We aimed to estimate the frequency and consequences of rest-
enosis and its predictors in a cohort of patients with carotid stenosis
treated by carotid angioplasty( CA).
Methods: All patients with carotid stenosis treated with angioplasty
(n = 1,100)in a single University Hospital were included [from 2002 to
2013]. Follow-up was done prospectively evaluating restenosis by ultra-
sonography, ipsilateral stroke or death. Restenosis was defined as a nar-
rowing of >70% of a previously treated vessel. Predictors of restenosis and
association of restenosis and outcome were determined by Kaplan Meier
Curves. Independent predictors of restenosis were assessed by Cox regres-
sion analysis.
Results: Of the 1,100 patients treated, 8.8% of patients experienced >70%
restenosis during follow up (median 12 (9–32) months). Mean age was 69
years and 79.8% were male. Restenosis during follow up was related to age
older than 70 (p = 0.005), hypertension (p = 0.001), angioplasty without
stent (p < 0.0001), postprocedure stenosis >30% (p < 0.0001), impaired
cerebral vasoreactivity (0.003), and treatment of a previous restenosis
(p < 0.0001). Occurrence of restenosis was strongly associated with ipsi-
lateral stroke during follow-up (p < 0.0001). After Cox regression analysis,
hypertension (HR = 5.9[1.8–18.9], p = 0.003), impaired vasoreactivity
(HR = 1.7[1.06–2.7], p = 0.027) and angioplasty without stent
(HR = 0.34[0.14–0.79], p = 0.12) were independent predictors of >70%
restenosis.
Conclusions: Carotid restenosis after CAS is strongly associated with ipsi-
lateral stroke, especially within the first two years after procedure. In our
sample, hypertension, angioplasty without stent and impaired vasoreac-
tivity work as independent predictors of restenosis.
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Thrombectomy in acute ischemic stroke: Stentriever
experience in Modena hospital
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G Giovannini1, M Gentile1, L Verganti2, F Menetti2, C Moratti2,
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1Stroke Unit- Neurology Clinic – Dept. of Neuroscience,
Nuovo Ospedale Civile Sant’Agostino Estense, Modena, Italy
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Background: Endovascular treatment (ET) in ischemic stroke patients
produces high rate of recanalization and may improve good outcome in
patients with documented large vessel occlusions.
Methods: We analyzed acute ischemic stroke patients admitted at the
Nuovo Ospedale Civile S.Agostino-Estense in Modena in the period 2008-
2014 and underwent to endovascular therapy. All patients were registered
in the Italian Registry of Endovascular Treatment in Acute Stroke. Efficacy
measures were arterial recanalization (TICI 2b-3), and 3-month func-
tional outcome (mRS 0–2) and mortality.
Results: In the period 2008-2014 we treated 236 patients with ET. We
analyzed 212 patients (n = 180 with thrombectomy) with completed
3-month follow-up. Mean age was 71.5 years, male gender 52%, median
baseline NIHSS 17. Bridging and rescue treatments were performed,
respectively, in 3 (1.4%) and 77 (36.3%) patients. Intraarterial drugs were
given to 94 patients (44.3%). In the thrombectomy group 119 patients
(66%) were treated with stentriever (in order of use: Trevo®, Solitaire®,
Mindframe Capture®, Merci®, Revive®, Penumbra Separator 3D®,
Aperio®, Catch®, Eric®). In only 4 cases 2 different stentrievers were used
during the same ET.
The TICI score 2b-3 was reached in 77.3% in stentriever group (versus
65.5% in ‘no stentriever group’). 3-months mortality was 22.1% (vs
17.8%), and mRS 0-2 was 46.1% (vs 37.5%).
Conclusion: Stentrievers in ET may be useful and safe in acute ischemic
patients as demonstrated in recent RCTs.
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Rehabilitation and Recovery
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09. Rehabilitation and Recovery
Effect of neuromuscular magnetic stimulation on the
hemiplegic upper extremity in subacute stroke
patients
S Y Ahn1, H G Lee1, S J Jee1, M K Sohn1
1Rehabilitation Medicine, Daejeon Regional Rehabilitation
Center, Daejeon, Korea
Objects: To investigate effects of neuromuscular magnetic stimulation
(NMMS) on the wrist and hand muscle comparing with neuromuscular
electric stimulation (NMES) in subacute stroke patients.
Subject and Method: Patients with subacute hemiplegic stroke were
recruited to the study, excluded if they have a cognitive dysfunction
(MMSE <20). Participants were randomized into 2 groups, that is a
NMMS group(N = 10) and a NMES group(N = 10). Both group received
15-minute session at least twice a day for 5 days a week for 3 weeks.
NMMS(10 Hz, duration 10 s, 10 min treatment time and 3000 total pulse)
and NMES(a symmetrical, biphasic waveform ; 30 us pulse width; 40 Hz)
was applied to the affected upper extremity in alternating extensor/flexor
muscle contraction. Outcome measurements were done at baseline, after
1 week, and at the end of the treatment period (after 3 weeks). The
primary outcome measure was for hand function: Box and blocks test,
Jebson-Taylor hand function test and 9-hole peg board test. Secondary
outcome measure was for motor performance: Wrist and hand muscle
strength(manual muscle test), grip power, and spasticity.
Results: There were statistically significant improvements in measures of
wrist flexor and hand flexor/extensor strength over the treatment period,
but not significantly different between the groups.
Conclusions: Both stimulations of wrist and hand muscle improves
muscle strength, but there were no significant change between the
stimulations.
ESOC-1312
09. Rehabilitation and Recovery
Information provision after stroke: A qualitative
synthesis of the views and experiences of stroke
survivors and their carers
A Benham1, L Brown1, C McKevitt2, A Forster1
1Bradford Institute for Health Research, Academic Unit of
Elderly Care and Rehabilitation, Bradford, United Kingdom
2Division of Health & Social Care Research, King’s College,
London, United Kingdom
Background: The provision of information is frequently reported as being
an unmet need of stroke survivors and their carers. Optimal strategies to
address this lack of adequate information provision have not yet been
identified and it is currently unclear why information interventions do
not consistently show benefit with these people. In this review, we evalu-
ated qualitative studies of patients’ and carers’ perspectives of information
provision after stroke, to understand how these may inform the develop-
ment of future strategies of information delivery.
Method: An electronic search of relevant databases was conducted, and all
results were screened by title and abstract by two independent reviewers.
Qualitative studies which gathered the perspectives of stroke survivors
and/or their carers about the provision of information after stroke were
included. The studies were summarized, and findings synthesized using
tabulation and thematic analysis.
Results: Eight studies were included in the synthesis, and the following
themes were derived: The adequacy of the information including the
timing of information; access to information, including information con-
sistency; and the delivery of information including specific views on infor-
mation topics, delivery method and format.
Conclusions: The timing and format of information was important to the
participants of the included studies, and the information requirements
and preferences for how it should be delivered varied greatly between
participants. The findings suggest that while information is an important
component of post-stroke care for both the survivor and their carer, a
personalized approach to information provision might be required.
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Driving a car does not make you happy 2–5 years
after stroke
H Bergersen1
1Brain Injury, Sunnaas Rehab. Hospital, Bjørnemyr, Norway
Background: Most adults in Norway hold a driver license. After brain
injury this can be withdrawn. National regulations including satisfactory
mental speed and attention, satisfactory problem solving and intact field
of view are required. Getting back the driver license is a huge goal for
many stroke survivors.
In a Norwegian follow up study of former stroke patients discharged
from specialized rehabilitation, psychiatric problems according to The
General Health Questionnaire (GHQ-30) and Hospital Anxiety and
Depression Scale (HADS) were found in almost 50 % averagely 3 1⁄2 years
after their stroke. Fifty four percent reported driving a car at follow up,
and 43 % had lost their driver license due to the brain injury. There was no
information regarding the last three percent.
Method: Univariate and multiple regression analyses were performed in
100 included persons (35 % women, average age 59 years).
Results: Dependency in toileting during rehabilitation predicted emo-
tional distress (HADS > 10) at follow up. Well-being (GHQ-30 <6) at
follow up was predicted by age > 65 years, independent walking ability,
perceiving proxies as supportive and holding a job (occupation). Well-
being was strongly associated with emotional distress at follow up. There
was no association between the outcome measures and holding a driver
license.
Conclusion: Even if loosing the license to drive a car for many patients
seems to feel like a huge loss, in this study no association were found
between having a driver license and mental health or psychological well-
being in the long run after cerebral stroke.
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Be aware of differences when comparing results of
rehabilitation in different countries
G Berzina1, A Vetra1, K S Sunnerhagen2
1Department of Rehabilitation, Riga Stradins University, Riga,
Latvia
2Institute of Neuroscience and Physiology/Rehabilitation
Medicine, University of Gothenburg, Gothenburg, Sweden
The objective of the study was to describe the diversity between Latvian
and Swedish populations for persons who undergoes in-patient rehabili-
tation after stroke.
Methods: The data of 1117 patients from Latvia and 3723 patients from
Sweden who received post-acute inpatient rehabilitation after stroke was
used for this retrospective cohort study. Basic medical (type of stroke
diagnosis, side of lesion in brain) and sociodemographic information (age
and gender of patients), as well as information on organization of reha-
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bilitation (time since onset of stroke, length of stay, involvement of phys-
iotherapist, occupational therapist, speech therapist and psychologists in
the rehabilitation process) was compared between both populations.
Results: The populations were significantly different in all compared
factors (p < 0.0005). Most substantial differences between Latvian and
Swedish population was in time since onset of stroke at the beginning of
rehabilitation and length of rehabilitation. Average time between stroke
onset and admittance for in-patient rehabilitation was 15 weeks in Latvia
and 5 weeks in Sweden. Length of stay was 15 days, whereas in Sweden 51
days.
Conclusion: Basic medical and sociodemographic characteristics, as well
as organization of rehabilitation are significantly different between
patients after stroke selected for inpatient rehabilitation in Latvia and
Sweden. Therefore, before comparing the results of rehabilitation in dif-
ferent countries for persons after stroke, they have to be adjusted for
diversities in the systems.
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Cardiorespiratory fitness after TIA and minor ischemic
stroke: Baseline data of the MOVEIT study
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R M Van den Berg-Vos3
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6Julius Center for Health Sciences and Primary Care, UMC
Utrecht, Utrecht, Netherlands
Background and Purpose: Cardiorespiratory fitness is reduced in patients
with stroke. It is unclear whether patients with a TIA or minor stroke also
have reduced cardiorespiratory fitness.
Methods: 113 patients with a TIA or minor stroke (64 (SD = 10) years of
age; 49 (IQR 27–86) days post TIA or stroke) were included in a random-
ized controlled trial investigating the effect of physical exercise on cogni-
tion. The peak oxygen consumption (VO2peak) was determined in a
symptom-limited ramp exercise test with gas exchange and noninvasive
hemodynamic measurements. Physical activity level, vascular risk factors,
history of vascular or pulmonary disease and stroke characteristics were
evaluated at inclusion.
Results: Mean VO2peak was 22 ml/kg/min (SD = 6.4), which is the 5th
percentile of age and sex related normative values. Forty-five percent had
a value less than 21 ml/kg/min, which is associated with an increased
mortality. Higher age ((B(95%CI) per 10 years (−2.57(−3.75;−1.40)) and
female sex (−5.84(−8.06;−3.62)) were associated with a lower exercise
capacity. Age- and sex-adjusted linear regression analyses showed that a
history of cardiac ischemic disease or other vascular disease and pulmo-
nary disease were associated with a lower VO2peak. In addition, a lower
level of physical activity, hypertension, smoking and overweight were
associated with a lower VO2peak. Prior TIA or stroke and stroke charac-
teristics were not related to VO2peak.
Conclusions: Patients with a TIA or a minor ischemic stroke have a poor
cardiorespiratory fitness. Our findings suggest that premorbid cardiovas-
cular and pulmonary disease and vascular risk factors, but not stroke-
related factors contribute to a reduced cardiorespiratory fitness.
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Complications in the acute phase after stroke – A ten
years comparison
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1Faculty of Medicine, Norwegian University of Science and
Technology, Trondheim, Norway
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Background: Complications after stroke is associated with poor outcome.
The main aim of this study was to investigate whether the timing and
frequency of complications during the first week after stroke has changed
in patients treated in a stroke unit in 2003 compared to 2013.
Methods: A total of 489 patients in 2003 and 185 patients in 2013 were
included and followed for one week, examining the frequency of 12 pre-
defined complications. Informed consent was given by all patients or a
next of kin.
Results: Baseline characteristics: Mean (SD) age was 77.2 (10.2) and 76.9
(8.5) in 2003 and 2013 respectively, p = 0.455. Severity of stroke, measured
by the Scandinavian Stroke Scale, was 39.4 (16.8) and 37.0 (16.4),
p = 0.011. Complications: 51,1 % experienced one or more complications
in 2003, versus 45,4 % in 2013, p = 0.156. Only 2 of the complications
recorded showed a significant difference between the two cohorts: pro-
gressing stroke 18.4 % in 2003 versus 5.9 % in 2013, p ≤ 0.001, and
myocardial infarction 4.5 % versus 0,5 %, p = 0.012, while the frequency
of recurrent stroke, fever, seizures, non-serious falls, serious falls, chest
infections, urinary tract infections, pressure sores, deep vein thrombosis
and pulmonary embolisms remained unchanged.
Conclusions: Complications are still common in 2013, even though the
frequency of progressing stroke and myocardial infarction has decreased
significantly since 2003.
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The impact of stroke on driving status at six months –
The ASPIRE-S study
L Brewer1, P Hall1, L Mellon2, F Horgan3, E Dolan4, E Shelley5,
H McGee2, R Conroy5, A Hickey2, D Williams1
1Geriatric and Stroke, Royal College of Surgeons in Ireland,
Dublin, Ireland
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Background: Driving is an important activity of daily living. Following
stroke, a patient’s ability to drive safely can be affected in various ways.
ASPIRE-S (Action on Secondary Prevention Interventions and Rehabili-
tation in Stroke), a prospective multi-center study, comprehensively
assessed patients six-months following IS. This included an assessment of
the impact of stroke on driving.
Methods: Consenting patients admitted with IS to three Dublin hospitals
were recruited over one year, from October 2011. At six months post IS, a
comprehensive assessment was completed to review secondary prevention
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and rehabilitation status. Patients completed a questionnaire about their
driving experience post-stroke during this assessment.
Results: 302 patients (58% male; mean age 69 years, range 22-95) con-
sented to participate, of whom 256 (85%) were followed-up at six months.
226 (88%) completed the driving questionnaire. 149 respondents could
drive, of whom 129 patients (86%) were driving pre-stroke. Two-thirds
resumed driving post-stroke, mostly (62%) after one month. Medical
advice was the commonest reason (75%) to cease driving. Other transport
forms utilized post-stroke included ‘getting lifts’ (66%), ‘walking’ (53%)
and ‘public transport’ (47%). Of those driving pre-stroke, almost one-
quarter (23%) reported that driving had become an issue post-stroke.
Conclusion: This multi-center survey shows that many patients lost their
ability to drive post-stroke. This may lead to depression, dependence and
social isolation. Although returning to driving after a stroke is an impor-
tant part of the recovery process, it is not routinely evaluated. Rehabilita-
tion programs post-stroke should incorporate driving assessments to
encourage more stroke survivors to safely resume driving.
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Introduction: Evidence suggests increased frequency and intensity of
therapy leads to better outcomes for stroke patients. National Clinical
Guidelines (UK) recommend forty-five minutes of each active therapy be
provided on at least five days a week if therapy is appropriate and patients
can tolerate it. National Audit data (2014) identified this standard was not
achieved for most patients. Existing research has not explored how thera-
pists manage their practice to deliver this standard, or explained factors
influencing their decision making regarding therapy provision.
Methods: Multi-site case study design in six stroke units, including
process mapping, non-participant observation, documentary analysis and
interviews with therapists, managers, patients and carers.
Results: Preliminary findings from observations in three units identify
five key areas influencing frequency and intensity of therapy: i) Amount
of time spent by therapists in non-patient contact activity. ii) Professional
and organizational factors impacting on times when therapy is or is not
provided. iii) Limited evidence of timetabling or advance planning of
therapy. iv) Variability in frequency and intensity of therapy provided
between units with similar staffing levels. v) Uncertainty amongst thera-
pists within and between units regarding interpretation of the forty-five
minute therapy standard.
Next Stages: Observations in three further stroke units will focus on these
areas; interviews will explore therapists’ perceptions of their work and
their reasoning for their working practices. Findings from this in-depth
work will be explored with therapists not involved in the study through
consensus conferences and will lead to recommendations for therapy
practice in stroke units.
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Not all multidisciplinary stroke teams are the same:
The influence of team type on implementation of a
structured caregiver training intervention
D Clarke1, J Dickerson1, R Hawkins1, A Forster1,
T. on behalf of the TRACS Research Group1
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Introduction: A key component of effective stroke unit care is treatment
provided by a coordinated multidisciplinary team (MDT). The Training
Caregivers After Stroke (TRACS) trial implemented a complex, multicom-
ponent caregiver training intervention in 18 stroke units. The intervention
was to be implemented and delivered by MDT members within usual care.
The results of TRACS reported variability in compliance with the inter-
vention, half of the units had a compliance rate of >60% and half <45%
(range 0% to 93%). Parallel process evaluation undertaken in 6 interven-
tion centers identified differences in how intervention unit teams orga-
nized and managed their work, this included teams working in
interdisciplinary ways, and those with strong and weak multidisciplinary
affiliations.
Methods: Secondary analysis of caregiver training records from 18 stroke
units in England. Observational and interview data from the process
evaluation undertaken in 6 stroke units were compared with compliance
data from the TRACS trial to determine whether team type and function-
ing impacted upon compliance with implementation and delivery of the
intervention.
Results: Teams displaying interdisciplinary characteristics were more
commonly associated with increased intervention compliance and were
observed to display collaborative working patterns which increased
team members’ involvement in and delivery of the caregiver training
intervention.
Conclusions: Multidisciplinary team working in stroke units may have
important limitations in terms of delivering complex interventions which
rely upon collective action and collaborative working. The observed vari-
ability in intervention compliance rates can be partly explained with
reference to the team working types evident in different stroke units.
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A systematic overview of Cochrane reviews of
interventions feasible for stroke survivors and carers
in the community beyond 6 months
T Crocker1, L Brown1, J Hall1, K Grenfell1, J Dickerson1, A Forster2
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Introduction: Long-term outcome after stroke is poor, depression is
prevalent, inactivity common and quality of life often deteriorates. Effec-
tive community-based interventions to improve these outcomes are
required, but there is little information to guide service provision.
Method: We completed a systematic overview of Cochrane reviews to
identify effective interventions that may be relevant to long-term stroke
survivors or their carers. We searched the Cochrane library (May 2014) for
reviews of community interventions for stroke survivors or carers at least
six months post-stroke. Because of this long-term focus, outcomes of
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interest were perceived health status, mood, participation and quality of
life. One reviewer extracted data, which another checked. Quality was
assessed by NICE criteria.
Results: We included 28 reviews (353 studies) of which ten reported per-
ceived health status, nine reported mood, one reported participation and
two reported quality of life. There was limited evidence that information
provision, inspiratory muscle training, fitness training and telerehabilita-
tion can improve perceived health status. There was limited evidence that
information provision and fitness training can improve mood. There was
no evidence of effect on participation. There was very limited evidence
that information provision could improve quality of life. Although other
interventions may improve these outcomes they are rarely assessed.
Conclusion: There is insufficient evidence to establish whether commu-
nity interventions can improve quality of life, participation, mood or
perceived health status of stroke survivors or their carers. Future research
should evaluate the effect of interventions on these outcomes so a more
relevant evidence base can be established.
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Self-report and objective measures of cognitive and
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Background: Cognitive and physical difficulties are common following
stroke and can have a significant impact on the individual’s quality of life.
Following mild strokes, these cognitive and physical difficulties may be
more subtle and it is unclear whether self-report measures are as reliable
as objective measures in these cases. We aimed to determine whether
self-report measures of cognitive and physical functioning are related to
objective measures in patients with mild stroke.
Methods: Patients in the Mild Stroke Study completed measures of cog-
nitive and physical functioning three to four years after a mild ischemic
stroke. Self-reported cognitive and physical functioning were measured
using the Stroke Impact Scale (SIS); objective measures included the
Timed Get Up and Go (TUG) , Nine Hole Peg Test (9-HPT), Adden-
brooke’s Cognitive Examination (ACE-R) and Montreal Cognitive Assess-
ment (MoCA) administered by trained staff.
Results: Ninety seven participants (mean age 70.5, range 45–94) were
assessed. The Mobility and Hand Function domain scores of the SIS
showed strong positive correlations with performance on the TUG
(r = 0.69, p < 0.05) and 9-HPT (right hand; r = 0.22, p < 0.05, left hand;
r = 0.53, p < 0.001). The SIS Memory domain scores did not relate to
performance on the ACE-R (r = 0.17, p = 0.47) or MoCA (r = 0.19,
p = 0.09).
Conclusions: The SIS self-reported measures of physical functioning were
reliable compared with objective measures, but poor correlation on cog-
nitive tests may indicate lack of insight into cognitive difficulties possibly
attributed to “getting older”. Objective measures of cognitive functioning
appear preferable in follow-up of patients with mild stroke.
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Changes in gait characteristics and walking ability
after high-intensity aerobic interval treadmill training
following stroke
A E Dahl1, T Egerton1, J L Helbostad1, B Indredavik1, T Askim1
1Department of Neuroscience, Norwegian University of
Science and Technology, Trondheim, Norway
Introduction: High-intensity treadmill training following stroke has been
shown to improve gait speed and endurance. However, the effect of such
training on walking characteristics is scarcely investigated.
Aim: To assess changes in spatiotemporal gait characteristics and walking
ability after a high-intensity aerobic interval training (AIT) program
shown to improve cardiovascular fitness.
Methods: Single-group, interventional study consisting of 4x4-minute
intervals at 85–95% of peak heart rate, interrupted by 3-minute active
breaks, performed twice per week for 6 weeks, using treadmill with body-
weight support. Spatiotemporal gait characteristics were assessed using an
electronic mat before, immediately after and 6 and 12 weeks after the
intervention. Walking ability was assessed with the self-report Walking
Impairment Questionnaire (WIQ). All participants signed written
informed consent.
Results: Fifteen independent walkers (10 men and five women, mean age
70.0 ± 7.7 years, 3–9 months post stroke), were included. At 12-weeks
follow-up preferred walking speed had increased from 1.18–1.32 m/s
(p = 0.021) and fast walking speed had increased from 1.59–1.77 m/s
(p = 0.020). Step length increased and stance time decreased at both pre-
ferred and fast speeds over the same period (all p < 0.05). Stance time
asymmetry at preferred speed had reduced immediately after training (p
< 0.05), but the improvement was not sustained. Neither step length
asymmetry nor stance time asymmetry improved. Walking duration sub-
scale of WIQ improved (p < 0.05), but there was no improvement in the
total WIQ-score.
Conclusion: Improvement in walking speed, stride length, stance time and
self-reported endurance, but not gait symmetry were maintained 12 weeks
following high-intensity AIT on treadmill with body-weight support.
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The correlations between unstable angina pectoris
(UAP), diabetes mellitus type 2 (DMT2), silent ischemic
strokes at patients with first ever ischemic stroke.
Early neurological rehabilitation
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Background: Patients with unstable angina pectoris (UAP) complicated
with diabetes mellitus and silent strokes are characterized by poorer
outcome in physical rehabilitation with varying risks of early and long-
term rehabilitation events in first ever stroke.
Methods: The study included 215 patients after first ever major ischemic
stroke with severe motor impairment who present on MRI older image
infarcts as define ≥3–15 mm in diameter, UAP, DMT2. The subjects were
evaluated at admission, after 1 month and after 1 year using a standard
neurological exam, CT scan/MRI, blood tests, NIHSS scale, Rankin Modi-
fied Scale (mRS), and MMSE scale.
Results: Mean age was 68.2 ± 3.24 years and 143 (66%) were man. Dia-
betic patients were 74 (34.41%), UAP patients were 78 (36.27%). Abnor-
mal ECG was found in 45 (20.93%) of the patients, including damaged left
ventricular systolic and diastolic functions. In the subjects with DMT2
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after 1 year NIHSS average score was significantly higher compared with
admission score, with 3.68 points on the scale (p < 0.001,CI95%), and the
average mRS score was 3.8 vs.2.9 (p = 0.023,CI95%). At admission the
mean MMSE score was 24.2 points and 19.7 after 1 year. The overall
mortality rate was 17.67 % (n = 38).
Conclusions: The prevalence of UAP and DMT2 is associated with a
reduction in physical outcome for hemiplegia and also after the first year
with severe cognitive impairment. Patients with abnormal ECG, cardiac
enlargement and damage of cardiac function in echocardiography after
first stroke present risk of myocardial infarction and death.
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Introduction: Stroke survivors and their carers experience continuing
problems in the longer-term after stroke with nearly half of all survivors
reporting one or more unmet need up to five years post-stroke. Prevalence
studies commonly report practical and functional needs such as informa-
tion provision, mobility issues and fatigue. However, qualitative research
studies often emphasize social and emotional problems. In order to
achieve a more complete understanding of longer-term unmet needs after
stroke we have completed a large scale needs assessment.
Method: We used multiple methods to identify the longer-term needs of
stroke survivors including interviews with survivors and their families,
focus groups with community stroke services, a review of the unmet needs
literature and analysis of the queries made to the Stroke Association
helpline. The identified needs were then merged based on the categories of
the International Classification of Functioning.
Results: A total of 25 longer-term needs were identified including a range
of emotional, cognitive, physical, practical, social, instrumental, informa-
tion and support needs.
Conclusion: These results indicate that the longer-term needs of stroke
survivors can be complex. Longer-term support interventions for stroke
survivors and their families need to be flexible and generic in order to
address and resolve the individual needs of all survivors.
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Introduction: In 1993 Hanger and Mulley reported the type and frequency
of questions made to the UK Stroke Association helpline in 1990. Since
that time stroke care has been transformed with the introduction of stroke
units and early supported discharge. The purpose of this paper is to
compare the Stroke Association helpline data from 2013 to that reported
in 1990 to explore whether the types of inquiry have changed in line with
the revolution in stroke care over the past two-decades.
Methods: Data on all of the inquiries received by the UK Stroke Associa-
tion helpline between 1st April 2013 and 31st March 2014 were collated
and compared to the data collected by the UK Stroke Association helpline
between May 1990 and September 1990.
Results: In 1990 the most common inquiry was for more information
about stroke (22.5% (429/1,908)) and in 2013 this remained the same,
with 25.4% (2601/10,233) of all callers asking “what is a stroke?”. Specific
medical questions increased from 4.2% (80/1,908) in1990 to 10.5%
(1,074/10,233) in 2013. Queries about support with home care reduced
from 9.4% (180/1,908) in 1990 to 2.6% (257/10,233) in 2013. Questions
concerning recovery and rehabilitation were of similar frequency in 1990
(11.1% (212/1,908)) and in 2013 (13.2% (1354/10,233)).
Conclusion: Despite the developments in the stroke care pathway, many
stroke-survivors and their families still struggle with understanding their
condition and coping at home in the longer-term.
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Application of neurofeedback in patients with frontal
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Background: Conventional neurofeedback (NF) includes voluntary train-
ing and thus is impossible in frontal dysfunction. Infra-low frequency
(ILF) NF implicates subconscious training at the frequencies of default
mode networks, and thus does not require high level of voluntary
cooperation.
Aims: To evaluate the adherence to ILF neurofeedback in patients with
moderate to severe frontal dysfunction
Methods: 15 patients aged 43 ± 25.6 with moderate to severe frontal dys-
function due to acquired brain injury (stroke, TBI) were included. NF was
performed with the use of Cygnet HD ILF system at reward frequencies
between 0.1 and 2.5 mHz at interhemispheric and frontal sites – 10 to 20
30-min sessions 5 days a week. Patients observed therapeutic “game”,
where the amplitude of EEG in the reward frequency was fed back as the
speed of an object (e.g., a rocket) and/or volume of the music, brightness
of images etc.
Results: Compliance to training was high in 14 patients. One patient was
unable to tolerate 30-min session, so two 15-min sessions a day were
performed. In one case due to absence of gaze fixation the feedback was
entirely audial. The only side effects were transient headache (2 cases) and
muscle tension (1 case). An increase in cognitive performance was
observed by the end of the treatment (MoCa scale 17.0 ± 9.6 vs. 11.5 ± 8,
p = 0.002; Frontal Assessment Battery 9.6 ± 8.8 vs. 7.2 ± 6.5, p = 0.075;
Neuromental index 75.0 ± 13.3 vs. 52.9 ± 24.8, p = 0.002).
Conclusions: ILF NF is a viable approach to rehabilitation of frontal
systems functions after stroke and traumatic brain injury.
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Background: Visual problems are common after stroke and affect up to
60% of survivors. The resultant disability impacts on ability to perform
everyday tasks and is present in 25% of survivors at 3 months (Ali, 2014).
Existing interventions fall into three categories:
• Substitution (use of an external device e.g. prisms)
• Compensation (improvement in visual field e.g technological
scanning programs)
• Restitution (restoration of visual field e.g. computerized
therapy)
Methods: We searched the Cochrane Database of Systematic Reviews, the
Cochrane Central Register of Controlled Trials CENTRAL (MEDLINE
and EMBASE) from 2008 to present date. We included all studies which
incorporated one, or a combination of the three types of interventions for
both homonymous hemianopia and unilateral spatial neglect.
Results: 13 studies involving 1122 participants were included. We identi-
fied a lack of robust RCT’s, most studies had small sample sizes (ave
n = 26), lengthy interventions (up to15 weeks) and no or poorly matched
control groups. One large scale observational study (n = 915) excluded
restitution studies and found half (52%) of the participants showed no
recovery. Prisms yielded some improvements but overall sufficient evi-
dence was found to recommend the use of cognitive based and neuroplas-
ticity promoting interventions (eg. The RehaCom “Exploration” task
showed significant (p = .048) improvement).
Conclusion: Further research is needed to prioritize disabilities that arise
from visual impairment and establish acceptability of new technology
which will involve both compensation and restitution intervention types.
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Background: Adherence to rehabilitation programs is considered impor-
tant in the wake of optimizing long-term participation in physical activi-
ties after stroke. The aim of this study was to investigate to what extent
patients were adherent to a long-term follow-up program, applied in a
randomized controlled trial.
Method: A prospective, longitudinal study followed patients for 18 con-
secutive months. The intervention consisted of monthly coaching by a
coordinating physiotherapist, aiming to motivate patients to adhere to at
least 30 minutes of daily physical activity and 45 minutes of weekly exer-
cise. Patients’ self-reports in training diaries, in addition to adherence
reported by the physiotherapist reviewing these, were combined and
assessed as the primary outcome measure. Borg’s scale of perceived exer-
tion and Goal attainment scaling were secondary measures.
Results: Forty-one informed consenting patients with mild to moderate
stroke (mean age 75.2 years (SD 7.7)) were included three months after
onset. Nine patients withdrew during the follow-up period. The overall
median (IQR) amount of daily physical activity and weekly exercise was
30.0 minutes (15.7–48.4) and 90.0 minutes (15.6–173.1), respectively.
There were no statistically significant changes in adherence to physical
activity or exercise from the beginning to the end of the study. Further,
most of the exercise was performed at levels of moderate to high intensity,
while goals were poorly achieved over time.
Conclusion: Except for the nine participants who withdrew the study, our
findings indicate that stroke patients who completed the intervention
demonstrated good adherence to physical activity and exercise over time.
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A mixed methods exploration of the effect and
feasibility of home-based scanning training
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Background: Visual field loss (VFL) persists in 20% of stroke survivors,
reducing ability in activities of daily living (ADL) and quality of life
(QoL). Scanning training is a promising rehabilitation method, with a
range of interventions in use. We aimed to explore the effect and feasibility
of home-based scanning training for rehabilitation of VFL.
Methods: Design: n-of-1 methodology.
Participants: visual field defects, more than 6-months post-stroke, living
at home.
Interventions: Four interventions delivered in randomized order: paper-
based (Rainbow Readers), computer software (VISIOcoach), web-based
(Happy Neuron) and specialized (NeuroVision Training). Intervention
choice reflected training modalities used in UK clinical practice.
Outcomes: Quantitative measures of visual search, reading, ADL and QoL.
Diaries of adherence. Qualitative interviews to explore participant
perspectives.
Analysis: Visual analysis of outcome measure plots. Framework analysis of
interview transcripts.
NHS ethical approval was granted, requiring participant’s signed written
informed consent.
Results: Twelve participants were recruited (6–16 months post-stroke; 6
right-sided, 6 left-sided VFL) and with one dropout due to family circum-
stances. Quantitative measures demonstrated no treatment effect at indi-
vidual patient level. Qualitatively, participants reported benefits due to
improved visual skills and confidence. Intervention use varied from 0 to
300% of recommended timings; enjoyment and levels of cognitive chal-
lenge were key aspects affecting motivation and adherence.
Conclusion: Home-based VFL scanning training can be delivered in a
range of formats: key factors relating to the delivery of acceptable training
have been identified. This evidence can inform continuing intervention
development, with a need for further clinical and cost effectiveness studies
using randomized trial designs.
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Parietofrontal motor pathways and their association
with motor function after stroke
P Koch1, R Schulz1, M Zimerman1, M Wessel1, M Bönstrup1,
G Thomalla2, B Cheng2, C Gerloff1, F C Hummel1
1Neurology, Brain Imaging and NeuroStimulation (BINS)
Laboratory, Hamburg, Germany
2Neurology, Clinical Stroke Imaging Laboratory, Hamburg,
Germany
Corticocortical interactions between the primary motor cortex, the
ventral premotor cortex and posterior parietal motor areas, such as the
anterior and caudal intraparietal sulcus are relevant for skilled voluntary
hand function. It remains unclear to what extent this network contributes
to basic motor functions after stroke. We hypothesized that white matter
integrity of the underlying parietofrontal motor pathways between these
brain regions might relate to residual motor function after stroke. 25
chronic stroke patients were recruited (aged 64 ± 8.8 years, range 46–75,
17 male, one left-handed) and evaluated 34 months after stroke (range
12–169 months).
Based on grip force, pinch force and the Fugl-Meyer assessment of the
upper extremity, a motor function score was estimated applying a factor
analysis with principal component extraction. Using diffusion tensor
imaging and probabilistic tractography we reconstructed probable intra-
hemispheric trajectories between the brain regions of interest in each
patient. White matter integrity was estimated for each individual tract by
means of fractional anisotropy. Generalized linear modeling was used to
relate tract-related fractional anisotropy to the motor function. We found
that the white matter integrity of the fiber tracts connecting the ventral
premotor cortex and the primary motor cortex (p < 0.001) and the ante-
rior intraparietal sulcus and the ventral premotor cortex (p < 0.01) posi-
tively correlated with motor function. Providing first structural
connectivity data for parietofrontal connections in chronic stroke
patients, the present results indicate that both the ventral premotor cortex
and the posterior parietal cortex might play a relevant role in generating
basic residual motor output after stroke.
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Energy cost of overground walking early after stroke
S F Kramer1, L Johnson2, T Cumming3, J Bernhardt3
1The Florey Department of Neuroscience and Mental Health,
Melbourne University, Melbourne, Australia
2Institute of Sport Exercise and Active Living (ISEAL), College
of Sport and Exercise Science Victoria University, Melbourne,
Australia
3Stroke Division, The Florey Institute of Neuroscience and
Mental Health, Melbourne, Australia
Background: Physical impairments post-stroke affect the ability to
perform daily activities, such as walking. Oxygen uptake during walking,
i.e. energy cost (EC), provides an indirect estimate of energy expenditure.
We know little about energy expenditure during walking in acute stroke.
Objectives: To pilot measuring EC levels at <2 weeks post-stroke and
determine test-retest reliability of EC using breath-by-breath analysis.
Methods: Ambulatory acute stroke survivors performed 2 bouts of
6-minute overground walking at a comfortable walking speed, separated
by a 30-minute rest-period. EC was measured in ml/kg/m over 6-minutes
and steady-state (final 3 minutes of each bout) walking. Intra-class and
concordance correlation coefficients were calculated to estimate test-retest
reliability. This study was approved by the local HREC.
Results: 11 participants (men/women 7/4; mean ± SD age 76 ± 14 years
and time since stroke 5 ± 3 days) completed the 1st bout of walking;
average ± SD EC was 0.26 ± 0.14 ml/kg/m over 6 minutes (Fig. 1) and
0.27 ± 0.15 ml/kg/m over steady-state walking. Eight participants com-
pleted both walking bouts; agreement between EC measures was high
(all > 0.9).
Conclusions: We found high variability in EC between the participants
early after stroke, but individual performance was consistent between
tests. We showed that it is feasible to measure EC early after stroke. Future
studies with larger samples can help to identify subgroups of people with
high and low EC.
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Post-stroke checklist adaptation into Swedish
Å Lundgren Nilsson1, R Emma Kjörk1,
P Katharina Stibrant Sunnerhagen1
1Clinical Neuroscience and rehabilitation, Neuroscience and
physiology, Gothenburg, Sweden
The incidence of stroke in Sweden is 300 cases per 100 000 inhabitants a
year. Of these, about 20% will die within the first month and about 1/3 of
the survivors will remain significantly disabled after 6-12 months.
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The post-stroke checklist was developed for follow-up (Philp I, Brainin M,
et al, Global Stroke Community Advisory Panel; J Stroke and Cerebrovas-
cular Disease). Eleven long-term post stroke problem areas were identified
and rated along with stroke secondary prevention; activities of daily
living, mobility, spasticity, pain, incontinence, communication, mood,
cognition, life after stroke, relationship with caregiver. The checklist has
been tried in the UK and in Singapore with positive responses reported. It
is posted on the website of the World stroke organization and the Cana-
dian stroke guidelines advocate its use.
The checklist was translated in to two independent Swedish versions and
then back to English. Focus groups were used with persons with prior
stroke as well as health care personnel for further validation. Some small
modification was made which then needed to be translated back into
English again. The final version is validated in a clinical setting with follow
-up in specialized care as well as in a primary/community care center. Data
from 20 patients from each level of health care (40 in all) with the spe-
cialized setting mainly seeing patients within the first 15 months post
stroke and the primary/community care center mainly seeing patients
more than 12 months post stroke is collected.
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Early rehabilitation after acute stroke in older
patients: Is it safe and effective?
M Masina1, S Malservisi1, C Scampoli2, M Borellini2, M Fabbri2,
G Albertosi2, S Censoni3, C Mignani2, P F Censoni2
1Stroke Care Area Geriatric Ward, Bentivoglio Hospital,
Bentivoglio, Italy
2Stroke Care Area Rehabilitative Ward, Bentivoglio Hospital,
Bentivoglio, Italy
3ASP Citta’ di Bologna, Rehabilitative Service, Bologna, Italy
Early rehabilitation is a critical component of care in stroke unit. Our
protocol provides out of bed sitting and walking within the first 36 h from
admission when allowed by clinical and neurological conditions. Our
retrospective analysis evaluated safety and effectiveness of early rehabili-
tation in patients older than 80 years.
Methods: Data regarding demographic, neurological, clinical and func-
tional status had been prospectively collected in our stroke registry. Out of
410 patients admitted in 24 months, those with unstable or deteriorating
clinical conditions, palliative care, fracture and pre-stroke mRankin
score>3 were excluded. Patients with normal trunk control on admission
(TCT score = 100) were excluded too. The 111 remaining patients with
impaired trunk control were grouped according to age and their data
compared (see Table 1).
<80 y
n44
≥80 y
n67
Age – female 70.4–43% 85.9–61% p<00001
Ischemic 90.1% 88.0% ns
Time to bed sitting (days) 1.43 1.43 ns
Prestroke mRankin 1.20 1.42 ns
NIHSS 8.07 9.35 ns
TCT admission 46.2 37.9 ns
LOS (days) 10.0 11.0 ns
Complications 38.6% 35.8% ns
mRankin (discharge) 3.22 3.80 p.01
TCT (discharge) 65.6 50.7 p.04
TCT <36 (discharge) 22.7% 40.3% p.0001
Barthel Index (discharge) 52.4 38.9 p.015
Conclusion: In older patients with impaired trunk control, early rehabili-
tation in Stroke Unit seems safe but less effective than in younger. Groups
didn’t differ for complications but the older one had a poorer functional
status at discharge. A greater proportion of older patients failed to reach a
TCT score>36 that is predictive of good functional outcome in the fol-
lowing in-patient rehabilitation.
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Consumer involvement in the design and development
of clinical stroke research: Can models of consumer
involvement in the UK be adopted in other countries?
C Moshona1, M Wagner2, C McKevitt3, C D A Wolfe3,
P U Heuschmann4, I Wellwood5
1Cetre for Stroke Research (CSB), Charité-Universitätsmedizin
Berlin, Berlin, Germany
2German Stroke Foundation, Stiftung Deutsche Schlaganfall
Hilfe, Gütersloh, Germany
3Department of Primary Care and Public Health Sciences,
King’s College London, London, United Kingdom
4Institute of Clinical Epidemiology and Biometry (ICE-B), Julius
Maximilian University of Würzburg, Würzburg, Germany
5Institute of Public Health, University of Cambridge,
Cambridge, United Kingdom
Background: Consumer (patient and carer) involvement is an established
component of clinical stroke research with perceived benefits in the UK.
However, this concept remains relatively undeveloped in other European
countries. We set out to establish and evaluate the impact of including
consumer involvement in a comprehensive stroke research center in
Berlin, Germany.
Methods: We adapted an established consumer group model from a
translational research center in King’s College London. Recruitment strat-
egies included: posters, website, purposive sampling from stroke outpa-
tient clinics. Consumer group participants provide informed consent. The
group meets regularly with various stroke researchers to ask and answer
questions about ongoing research and proposals. Consumer involvement
was reviewed using recognized categories (no involvement, ‘consultation’,
‘collaboration’, ‘consumer-led’ activity) in 9 established activities e.g.
setting up project; designing project materials; dissemination of research
findings.
Results: Since January 2012, over 200 consumers (age 29–78) were invited
to the group of which 46 expressed interest and 19 (age 49–78) attend
regularly. As of December 2014, the group has attracted less severely
disabled stroke patients, but includes carers of more disabled patients. To
date involvement only takes the form of consultation, including 4 large
projects and a patient on one study board.
Conclusion: A stroke research consumer group based on a UK model was
successfully established in Berlin, raising consumer involvement levels.
This project is unique in Germany, but how increased consultation
impacts on the quality, quantity or relevance of local clinical stroke
research needs to be established before the model is more widely adopted.
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Activity patterns during hospital stay after stroke
O Norvang1, A Hokstad1, K Taraldsen1, B Indredavik2, T Askim1
1Department of Neuroscience, Norwegian University of
Science and Technology, Trondheim, Norway
2Department of Stroke, St Olavs Hospital, Trondheim, Norway
Background and Aim: Early mobilization and reduced bed rest is recom-
mended after stroke, and activity levels should preferably increase during
the hospital stay. However, few studies have examined how physical activ-
ity changes from day to day while hospitalized. The aim of this study was
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to investigate day-to-day changes in physical activity during the hospital
stay.
Method: Physical activity was assessed by use of triaxial accelerometers,
fixed on their unaffected sides’ thigh for 4 consecutive days. Starting day
was on average day 3 (±2.7) from stroke. Primary outcomes were time in
upright (standing and walking) and number of upright transitions.
Severity of stroke was assessed by use of National Institutes of Health
Stroke Scale (NIHSS) and physical function by using the Short-Physical-
Performance Battery (SPPB).
Result: Thirty-three, consenting, in-hospital stroke patients were
included. Mean age was 76.3 (±10.5) years (51% women). Participants’
severity of the stroke was moderate (NIHSS 8.2 ±6.0), they had a reduced
physical function (SPPB 3.5 ±3.3), and slow walking speeds (0.6 ± 0.35 m/
sec). Time in upright position had a median (interquartile ranch) of 0.44
(0.16–1.41), 0.32 (0.11–0.78), 0.28 (0.12–0.86), and 0.40 (0.09–1.13) on
day 1, day 2, day 3, and day 4, respectively. Number of transitions had a
median (interquartile ranch) of 20 (10.5–48.0), 16 (8.0–29.5), 17 (11.5–
31.5), and 21 (11.50–34.50) one the four days. No significant changes were
found.
Conclusion: Patients undergoing stroke only have small changes in physi-
cal activity, and tends to maintain a low level of activity during their
hospital stay.
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Identifying expressed need for social support in stroke
recovery
I Padberg1, P Knispel2, S Zöllner2, M Sieveking2, A Schneider1,
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in Stroke” (CEHRiS), Charité-Center for Stroke Research Berlin
(CSB), Berlin, Germany
2Stroke Servicepoint, Charité-Center for Stroke Research
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3Managing Director, Charité-Center for Stroke Research Berlin
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4Clinical Epidemiology and Biometry, Universität Würzburg,
Würzburg, Germany
5Department of Public Health and Primary Care, Cambridge
Institute of Public Health, Cambridge, United Kingdom
6Clinical Neuroscience, Charité-Department of Experimental
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Background: Previous studies examining social work interventions often
lack information on content, methods and timing over the different
phases of care (acute hospital, rehabilitation clinic, and ambulant after-
care). We aimed to address this information gap by describing and
quantifying expressed need for social work in people with stroke and their
carers in terms of the timing and the content of social work contact and
how this varied over different phases.
Methods: We evaluated data from a descriptive cross sectional study
(March 2010 to April 2012) of a “Stroke-Servicepoint”, a “drop in” center
for non-medical stroke assistance staffed by trained social workers in
Berlin, Germany, handling enquiries in person, by phone and website.
Results: 257 subjects (patients (28%) and carers (61%)) provided
informed consent. Stroke had occurred within six month in 45% of the all
cases and 56% of patients were 65 years and older. Total interest in support
in one or more subtopics associated with therapeutic options was 55%
and 30% in further medical topics. Interest in some subtopics associated
with long term recovery and outcome such as secondary prevention dif-
fered depending on patients’ location e.g. hospital, rehabilitation clinic or
ambulant setting, while others, such as further therapeutic options did not
show relevant changes with the phases of stroke care.
Conclusion: Expressed need for social work related support after stroke
varied across the course of the disease. Future high quality studies should
characterize social work interventions over all stroke care phases to inform
developments in social work services.
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Methods for modeling stroke outcome data over time
J Potts1, J Belcher2, J Sim1, C Roffe3
1Health Services Research Unit, Keele University,
Stoke-on-Trent, United Kingdom
2Department of Mathematics, Keele University,
Stoke-on-Trent, United Kingdom
3Institute for Science & Technology in Medicine, Keele
University, Stoke-on-Trent, United Kingdom
Introduction: After a stroke, it is important to determine the nature and
duration of the recovery process. We are conducting a longitudinal analy-
sis using data from 8003 patients enrolled in the Stroke Oxygen Study
using the modified Rankin Scale (mRS) at 90, 180, and 365 days, to predict
recovery using statistical modeling techniques.
Challenges: The mRS is a 6-point ordinal scale assessing disability, with
scores ranging from 0 (no disability) to 5 (severely dependent, requiring
24-hour care). A score of 6 is commonly added to include death, but this
may affect the ordinality of the scale, as severe disability may be deemed a
worse outcome than death – hence, treating the scale as ordinal could
provide misleading results. The challenge is to justify the inclusion of
death as a point on the scale and apply appropriate longitudinal methods,
as these subjects would drop out of follow-up assessments.
Methods: A proportional odds model can be used for modeling longitu-
dinal ordinal data, or the ordinal structure could be ignored and a mul-
tinomial model applied, thus comparing the scores to a reference category.
Alternatively, latent class growth analysis could be used to classify patients
into groups with similar recovery profiles. If mRS values are treated as
separate states, death can be accommodated using multi-state models, or
a time-to-event analysis using Cox regression.
Conclusion: Modeling stroke recovery poses significant challenges, espe-
cially when including death into the scale. Issues determining the most
appropriate modeling strategy for these extreme values in the scale will be
discussed.
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Bone mineral density in patients with stroke
V Povoroznyuk1, M Bystrytska1
1Department of Clinical Physiology and Pathology of
Locomotor Apparatus, D.F. Chebotarev Institute of
Gerontology NAMS Ukraine, Kiev, Ukraine
Aim: The aim of this research is to define the bone mineral density in
patients, with stroke.
Methods: We examined 26 women with stroke and 26 healthy women of
appropriate age; 27 men with stroke and 27 healthy men of appropriate
age.
Results: BMD of women after stroke was significantly lower compared
with BMD of women of control group on the level of total body
(Z-score = −0.02 ± 0.21 vs. 0.67 ± 0.21, F = 5.92, p = 0.018) and at the
distal forearm (Z-score = −0.65 ± 0.24 vs. 0.45 ± 0.25, F = 9.7, p = 0.003).
In men with moderate and severe it was obtained significant differences in
BMD at total body (Z-score = −0.35 ± 0.25 vs. 0.59 ± 0.23, F = 7.4,
p = 0.09), lumbar spine (Z-score = −0.48 ± 0.42 vs. 0.68 ± 0.26,
F = 6.0, p = 0.02), total hip (Z-score = −0.16 ± 0.27 vs. 0.51 ± 0.15, F = 5.4,
p = 0.03), distal forearm (Z-score = −0.03 ± 0.33 vs. 0.99 ± 0.30, F = 4.7,
p = 0.04).
Conclusion: BMD in patients with stroke was significantly lower than in
healthy people of the same age. In women the difference was significant at
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the level of the total body and distal forearm. In men, the difference was
significant only in the group of the patients with moderate and severe
paresis.
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What factors inhibit and enable English community
stroke teams from meeting the needs of longer-term
stroke survivors? Findings from a focus group study
A Prashar1, J Dickerson1, A Forster1
1Academic Unit of Elderly Care and Rehabilitation, Institute
of Health Sciences, Bradford, United Kingdom
Introduction: A national survey of community stroke teams revealed that
longer-term support for survivors is variable across England. Most teams
provided a service for up to 12 months, yet less than half commissioned an
annual review. Strategies for developing longer-term stroke care need to
recognize barriers and enablers confronting service providers.
Method: A purposive sample of eight English community stroke teams
selected from the national survey hosted focus group discussions as part of
a wider study into developing and implementing a longer-term stroke
strategy for survivors and their families. Six of the teams provided
support for up to 12 months; one for up to 6 months, and one for up to
3 years. Group discussions were facilitated and audio-recorded, then tran-
scribed and subjected to qualitative thematic analysis.
Results: Several interconnecting themes were identified that inhibited and
enabled support.
Inhibitors included shortage of psychologist input, a target-driven culture
based on managing survivor throughput, limitations of commissioning
processes, weak multi-agency partnerships involving NHS, Social Services
and Voluntary organizations, shortfalls in training within primary care
and in care home settings, poor information provision, inadequate public
transportation, and limited retraining/employment opportunities for
survivors.
Enablers included annual reviews, open door referral systems, inter-
disciplinary team learning and practice across professional boundaries in
clinical settings, innovative in-house training programs, peer support
schemes and the delivery of group self-management programs for
survivors.
Discussion: A number of barriers and enablers were identified. Manage-
rial, operational and cultural shifts in practice are required to produce
longer-term wraparound support for survivors.
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Proportion of patients with acute ischemic stroke who
presented dysphagia in Clínica Alemana Temuco, Chile,
during the period from October 2013 to October 2014
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Background: Hospital- acquired pneumonia (HAP) is often the result or
aspiration of oral secretion and is reported to occur in 3.9%–21.4% of
acute ischemic stroke (AIS) patients overall. Since the presence of dyspha-
gia has been associated with increased risk of pulmonary complications
and mortality. Our national guidelines recommend swallow evaluation be
performed in at-risk patients before any oral intake.
Aim: To determine the proportion of patients with AIS who presented
dysphagia in Clínica Alemana Temuco (CAT) from October 2013 to
October 2014.
Methods: All patients with AIS hospitalized in (CAT) were evaluated. The
variables of age, sex, realization and form of swallowing evaluation.
Dysphagia was considered with a positive swallowing evaluation accord-
ing our national guide (MINSAL, 2013) made by physicians and speech
therapist and a positive nasofibrolaryngoscopy (FEES). All patients signed
informed consent.
Results: Of 73 patients, 11 were excluded for having a TIA. Of the total 62,
22 presented dysphagia (35.5%). Of the patients with dysphagia, 16 were
male (72.8 %), 6 women (27.2 %). The median age: 66.4 years (±14.2).
Only a 48.4% was formally written by the physician in the medical record
the form of swallowing evaluation in the first 24 hours. 4 (6.5%) had an
aspiration pneumonia and none had a nosocomial pneumonia. 1 patient
died (1.6%).
Conclusion: The proportion of dysphagia in AIS in our clinic is similar to
other studies. However we should improve the screenings and diagnostics
protocols especially the formally written evaluation. Because this compli-
cation can be serious.
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Effectiveness of modified constraint induced
movement therapy on the quality and quantity of
upper extremity movement recovery after stroke
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Frontera, Temuco, Chile
3Departamento de Psicología, Universidad de La Frontera,
Temuco, Chile
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Introduction: Constraint-Induced Therapy (CIT) is a therapeutic strategy
that has been show to improve the function of the upper limb affected by
stroke. Although an extensive body of literature supports the positive
impact of CIT on neuroplasticity and the recovery of function, most
research has evaluated an individual mode of delivery. However, evidence
is limited for the application of CIT protocol in a group setting.
Objective: To determine the effectiveness of a modified version of CIT in
a group setting as compared to individual, one-on-one basis on the quan-
tity and quality of movement of the paretic upper limb.
Methods: Forty participants, 6–60 months post stroke, were randomized
into either a group or individual application of CIT. The hemiparetic
upper extremity quantity and quality of movement was evaluated using
the self-reported, Motor Activity Log and each participant’s clinical record
at baseline, pre-treatment and post-treatment. The data were analyzed
through an analysis of variance with a mixed factorial design 2x2. All
patients signed informed consent.
Results: Both groups tended to improve their scores between baseline and
pre-treatment measurement, however, no significant effect was found
between groups for this time period (p > 0.05). Conversely, group differ-
ences were seen between pre and post treatment evaluations (p < 0.05).
Conclusion: This clinical trial provides evidence supporting the applica-
tion of CIT delivered in a group mode for 3 hours, to improve the per-
formance of the paretic upper limb in daily activities. However the
evidence is still limited in relation to this mode CIT version.
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Study design and preliminary results of the study
SMARTS: Studying markers of angiogenesis during
rehabilitation therapy after stroke
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Experimental studies in stroke have shown the importance of angio-
vasculogenesis in functional recovery, but its role during rehabilitation
therapy is unknown. The SMARTS study was designed to identify biologi-
cal markers of angiogenesis (molecular/cellular) associated with recovery
during rehabilitation after stroke. First-ever ischemic strokes enrolled to
intensive neurorehabilitation therapy (>3 h a day/5 days a week) were
included as SMARTS cases. The protocol consisted in a battery of
neurological/functional tests (FMA, FAC, MRC, CAHAI, among others)
performed by an experienced neuro-rehabilitator before therapy (base-
line, 11 ± 4.7 days after stroke) and at one, three and six months together
with a blood extraction to collect serum/plasma and to count endothelial
progenitor cells (EPCs, as CD34+/KDR+ within CD45+ population). Part
of the cohort also underwent an MRI study (baseline/three months). For
non-ischemic controls, blood was collected to obtain serum/plasma and
EPCs counts. The stroke group consisted in 10 men and 3 women, mean
age of 54.5 ± 10.6 years; whereas 6 men and 8 women, mean age of 65 ± 6
years, formed the control group. The number of EPCs was significantly
higher at baseline in strokes vs. controls (p = 0.026) and decreased over
time with less circulating EPCs at 3/6 months vs. baseline (p = 0.068).
Stroke severity (NIHSSS) trended to be associated with the number of
baseline EPCs (p = 0.089). Patients with improved neurological function
(decrease of NIHSSS≥4 points) presented higher levels of EPCs than
patients who did not improve (p = 0.064). In conclusion, the results of the
SMARTS study could contribute to determine the role of angiogenesis in
neurorehabilitation therapy after stroke.
ESOC-0988
09. Rehabilitation and Recovery
Effectiveness of post-stroke rehabilitation in elderly
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Background and Purpose: The stroke impact on the population health is
rising steadily with gradual changes in demographic indicators (length-
ening the life). There is only little data about the benefit from post-stroke
rehabilitation in older population. We aimed to evaluated effectiveness of
early post-stroke rehabilitation in patients older than 75 years as compare
to younger population.
Methods: The study included 1754 consecutive post-stroke patients
admitted to the neurorehabilitation unit in 2006–2013. We evaluated
changes in: the degree of disability using the modified Rankin scale
(mRs), functional state – Barthel index (BI), neurological state – NIH
Stroke Scale (NIHSS), weekly increase in BI and the frequency of
complications.
Results: Our study group consists of: 787 (44.9%) women and 967
(55.1%) men; 315 patients (18%) were over 75. The functional state and
disability at admission (0) and at discharge (1) were worse in group older
than 75 (consecutively: BI_0: 8.9 vs. 10.64; mRs_0: 3.81 vs. 3.56; BI_1: 13.0
vs. 15.11; mRs_1: 3.02 vs. 2.64), even if the neurological state was similar
(NIHSS_0: 7.18 vs. 7,81; NIHSS_1: 5.54 vs. 5.52). Weekly improvement in
BI was similar in both groups (0.67/week vs. 0.78/week). Complication
rates was higher in group older than 75 (80.2% vs. 72.8%).
Conclusions: Rehabilitation in older patients may bring functional
improvement and should be investigated. Older patients should not be a
priori disqualified from post-stroke rehabilitation, even those that have
higher risk of complications during therapy.
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Association between BDNF-196 G>A and BDNF-270
C>T polymorphisms, BDNF concentration, and
cerebrolysin treatment outcome after ischemic stroke
V Shishkova1, L I Zotova1, A Y U Remennik1
1Health, Moscow Centre of Speech Pathology and
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Annual mortality from ischemic stroke (IS) in Russia – one of the highest
in the world. Morbidity and mortality from IS among persons of working
age in Russia increased over the past 10 years, more than 30% IS is the
leading cause of disability in the population , one third of patients under-
going its need assistance , another 20 % cannot walk alone , only one in
five could return to work. The efficacy of rehabilitation in ischemic stroke
patients likely varies because of brain plasticity. One of the main neuro-
trophins in the central nervous system is brain-derived neurotrophic
factor (BDNF).
Objectives: This study aimed to determine allelic and genotypic distribu-
tion of BDNF-196 G>A and -270 C>T polymorphisms, and to assess the
impact of Cerebrolysin treatment on serum BDNF concentrations mea-
sured before rehabilitation and after 4 weeks of rehabilitation.
Methods: 60 patients with hand paresis and 60 with aphasia were ran-
domly assigned to treatment with Cerebrolysin (25 ml/daily) or placebo
group (which received saline infusions).
Results: In patients with aphasia in Cerebrolysin group after the 4 weeks
rehabilitation, BDNF concentration was increased than placebo-treated
patients. A similar difference was observed in patients with hand paresis
after 4 weeks of rehabilitation. No significant differences in serum BDNF
concentration were observed in patients with different BDNF-196 G>A or
-270 C>T genotypes.
The positive dynamics of speech rehabilitation was observed, the regress
of aphasic disturbances being more significant for daily Cerebrolysin
dosage of 25 ml than placebo-treated patients.
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The effect of ankle foot orthosis on postural control in
patients with post-stroke hemiplegia
M K Sohn1, K S Park2, S Y Ahn1
1Rehabilitation Medicine, Chungnam National University
School of Medicine, Daejeon, Korea
2Rehabilitation Medicine, Chungnam National University
Hospital, Daejeon, Korea
Objectives: Ankle foot orthosis (AFO) is a useful orthosis to improve gait
pattern, but lack of study on the static balance in hemiplegic patients. This
study was to investigate the changes of postural control and the effect of
AFO on the static balance in patients with post-stroke hemiplegia.
Materials and Method: Fourteen hemiplegic stroke patients with inde-
pendent ambulation more than 10 m were included. Severe cognitive
impairment, severe visual spatial disturbance and musculoskeletal
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problem unrelated to stroke were excluded. The movement of center of
gravity (COG) during static postural control was measured with Biodex
Balance System SD® (Biodex Medical System, New York, USA) at three
different conditions (barefoot, shoes and AFO) randomly for three times
on same condition. Percent (%) time in quadrant(anterior, posterior, left
and right), overall, anterior-posterior and medio-lateral movement index
were measured.
Results: COG were distributed to the right and posterior quadrant during
static standing for maintaining postural stability in patients with post-
stroke hemiplegia, and this patterns were not changed with shoes or AFO
application. There was tendency of weight shift to the sound side for
maintaining postural stability in hemiplegic patients, but not statistically
significant. Overall, anterior-posterior and medio-lateral movement index
were increased in hemiplegic patients compared to control (p < 0.05), and
decreased by application of AFO (p < 0.05).
Conclusion: The impaired static postural control in patients with post-
stroke hemiplegia was improved with AFO application.
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The effect of shoulder sling on postural control in
hemiplegic stroke patients
M K Sohn1, H K Lee1, K S Park2
1Rehabilitation Medicine, Chungnam National University
School of Medicine, Daejeon, Korea
2Rehabilitation Medicine, Chungnam National University
Hospital, Daejeon, Korea
Purpose: Balance impairment is a common problem caused by multiple
factors in patients with hemiplegia. The shoulder sling commonly used for
hemiplegic shoulder subluxation may affect the postural control. So, this
study investigate the effect of various shoulder slings on balance in
patients with hemiplegia. Subjects andMethods: Twenty-seven hemiplegic
stroke patients were enrolled in this study. The Fugl-Meyer score of upper
arm and Functional ambulation category were measured. Balance test
were performed with simple arm sling and with Bobath sling and without
sling in random serial order. Static and dynamic balance was assessed by
using BALANCE SYSTEM SD (SD950-302, Biodex Medical System Inc,
USA). The summation of distance from the center of the platform to the
reference position for 20 s is measured and a score named the Balance
Index (BI). Static and dynamic balance testing during eye open was
carried out 3 times. Functional balance was evaluated using the Berg
balance test and Trunk impairment scale.
Results: The Fugl-Meyer score of upper arm and Functional ambulation
category were correlated with all balance tests. Static and dynamic overall
BI score was lower with simple arm sling compared with that score with
Bobath sling and without sling, but the difference was not statistically
significant. Likewise, Berg balance score and Trunk impairment scale were
also no significant difference in each comparison.
Conclusion: There was no significant effect of shoulder sling on balance in
hemiplegic stroke patients regardless of sling type.
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Phospholipids in neurorehabilitation ischemic stroke
S Turuspekova1, A Seydanova2, K Musahmetova3
1Of Internship and Residency in Neurology, Kazakh National
Medical University, Almaty, Kazakhstan
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3Of Physiotherapy, City Clinical Hospital ! 1, Almaty,
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Objective: To evaluate effectiveness of ion-reflex phonophoresis session
using hypothalamus phospholipids in rehabilitation of patients with isch-
emic stroke in the early recovery period.
Materials andMethods: 158 patients were supervised with ischemic stroke.
There were use Mini Mental State Examination (MMSE), The Montreal
Cognitive Assessment Scale (MoCA), and Barthel ADL Index. Under obser-
vation were 3 groups: 1st- 65 patients received intramuscular injections of
hypothalamus phospholipids; 2nd- 63 patients who received an extra
ion-reflex phonophoresis sessions using hypothalamus phospholipids by
applying head’s frontooccipital longitudinal galvanization techniques were
conducted; 3rd- 30 patients treated with protocol formed a control group.
Results: Additional use of phospholipids hypothalamus significantly
improves cognitive function and the degree of self-service in both groups,
sessions of ion-reflex phonophoresis hypothalamus phospholipids using
longitudinal methods fronto-occipital head galvanizing can achieve more
significant results. Observed positive dynamics of cognitive functions
according to MoCA test in both groups (23,23 ± 1,3 and 25,75 ± 1,3
points; 20,6 ± 1,1-control). The MMSE was not informative. Barthel index
rose by 4 and 8 points, respectively, in the control without dynamic.
Conclusions: The research’s indicators’ dynamics shows positive impact
of ion-reflex phonophoresis sessions using hypothalamus phospholipids
by applying head’s frontooccipital longitudinal galvanization techniques
in rehabilitation of patients with ischemic stroke in the early recovery
period.
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The rationale for and methods of dose selection in
trials of intensity of physical therapy to enhance
recovery after stroke
P Hartley1, V Pomeroy2, I Wellwood3
1Physiotherapy Department, Cambridge University Hospitals
NHS Foundation Trust, Cambridge, United Kingdom
2School of Health Sciences, University of East Anglia,
Norwich, United Kingdom
3Institute of Public Health, University of Cambridge,
Cambridge, United Kingdom
Background: The optimum therapeutic “dose” of physical therapy to
enhance motor recovery after stroke remains unclear. We aimed to inves-
tigate the rationale for and methods of dose selection reported in ran-
domized controlled trials (RCTs) of intensity of physical therapy after
stroke which were included in recent systematic reviews.
Methods: Narrative review of a convenience sample of primary RCTs
(English language) included in a comprehensive systematic review and
meta-analysis of physical therapy after stroke (Veerbeek et al.2014). Two
reviewers (PH, IW) extracted data on pre-defined methodological fea-
tures including: (1) rationale for dose selection (2) dose components
(length, frequency, duration) and (3) development of intervention. Data
were synthesized for rationale and method of dose selection.
Results: We reviewed 31 RCTs (2518 participants). One was a feasibility
trial. No other studies reported or referred to previous dose selection
investigations (e.g. dose ranging / safety / tolerance).
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29 trials did not report the rationale for dose selection. 2 trials reported
basing dose on available literature. One reported discussions with stroke
survivors to develop the intervention. Most doses were selected by prag-
matic or arbitrary increases over standard care (range from a few hours to
1 year longer “on treatment”) with dose adjusted according to therapists’
judgment of patients’ tolerance or response.
Conclusion: The rationale and methods of dose selection of physical
therapy were poorly described in this sample of trials comparing different
intensities. Future trials of physical therapy to enhance recovery after
stroke should investigate the optimum therapeutic dose before undertak-
ing a subsequent definite trial.
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Early psychosocial risk factors for depression after
stroke
K Werheid1
1Department of Psychology, Humboldt University, Berlin,
Germany
Depression is among the most frequent long-term complications after
stroke, affecting about 30% of stroke survivors. Post-stroke depression is
associated with prolonged recovery, reduced quality of life, and increased
mortality. Longitudinal research on risk factors for post-stroke depression
is complicated by the diversity of stroke-related impairments, and the long
periods in which depression can emerge. We recently proposed a two-
phase pathogenetic model of depression after stroke, with premorbid,
neurobiological and psychosocial factors predicting early-onset
depressiveness, and psychosocial integration predicting late-onset and
persisting depression. The model is currently tested in a prospective
longitudinal study involving 302 patients in two different neurological
rehabilitation clinics. The study involves assessment of demographic neu-
rological, stroke-related, and psychosocial risk factors one, six, and twelve
months after stroke. Results of the baseline and six months follow-up
assessment show that psychosocial factors such as self-efficacy, perceived
social support and self-reported depressive symptoms one month after
stroke strongly impact the risk of later depressive disorders. However,
stroke localization in the left or right hemisphere, cognitive status or
functional impairment did in our rather mildly affected sample not sig-
nificantly influence the future risk of depression. We conclude that psy-
chosocial factors represent important early predictors of later depressive
disorders and should be targeted by prevention programs.
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Time to recovery to pre-intervention functioning and
return-to-work, and long-term life satisfaction after
treatment of unruptured aneurysms
D Backes1, M D I Vergouwen1, I C van der Schaaf2,
J A Nij Bijvank1, B H Verweij1, J M A Visser-Meily3, M W Post3,
A Algra4, G J E Rinkel1
1Neurology and Neurosurgery, University Utrecht, Utrecht,
Netherlands
2Radiology, University Utrecht, Utrecht, Netherlands
3Center of Excellence for Rehabilitation Medicine, University
Utrecht, Utrecht, Netherlands
4Julius Center for Health Sciences and Primary Care &
Neurology and Neurosurgery, University Utrecht, Utrecht,
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Background: The eventual goal of preventive treatment of unruptured
intracranial aneurysms is to increase the number of life years with high life
satisfaction. Insight in the time with reduced functioning, working capac-
ity and life satisfaction after aneurysm treatment is pivotal to balance the
pros and cons of preventive aneurysm occlusion.
Methods: We sent a questionnaire on time-to-recovery to pre-
intervention functioning and return-to-work and life satisfaction to
patients treated for an unruptured aneurysm between 2000 and 2013.
Changes in life satisfaction before treatment, during recovery and at
follow-up were assessed with Wilcoxon signed-rank tests.
Results: The questionnaire was sent to 159 patients of whom 110 (69%)
responded. The mean follow-up time after aneurysm treatment was 6
years (SD 4). Fifty-four patients had endovascular and 56 had microsur-
gical occlusion. Complete recovery to pre-intervention functioning was
reported by 81% (95% CI: 74–88) of patients, with a median time-to-
recovery of 3 months (range 0–48). Complete work recovery was reported
by 78% (95% CI: 66–87) of patients. The proportion of patients with high
life satisfaction reduced from 76% [95% CI: 67–84] before treatment to
52% (95% CI: 43–61) during the period of recovery (p < 0.01), and
restored largely at long-term follow-up (67% [95% CI: 59–76], p = 0.08).
Conclusion: Life satisfaction is significantly reduced during the period of
recovery after treatment of unruptured aneurysms. In the long-term,
approximately one out of five patients reports incomplete recovery. These
treatment effects should be kept in mind when considering preventive
aneurysm treatment. Prospective studies are needed to better compare
these losses in patients treated for unruptured aneurysms with those who
had subarachnoid hemorrhage.
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Acupuncture for post-stroke neurogenic bladder:
A systematic review and meta-analysis of randomized
controlled trials
J Lee1, S Shin2, Y Li3, J Yoo3, E Lee1, S Yim4, H Kim5, H Ahn5
1Stroke Center Korean Medicine Hospital, Kyung Hee
University Medical Center, Seoul, Korea
2College of Korean Medicine, Kyung Hee University, Seoul,
Korea
3Korean Medicine Hospital, Kyung Hee University Medical
Center, Seoul, Korea
4National Rehabilitation Research Institute, National
Rehabilitation Center, Seoul, Korea
5Korean Branch of Cochrane Collaboration, College of
Medicine Korea University, Seoul, Korea
Introduction: This study is aimed to review the randomized controlled
trials (RCTs) systematically to evaluate the effectiveness of acupuncture or
electro-acupuncture for the patients with post-stroke neurogenic bladder.
Methods: After searching Medline, EMBASE and Cochrane Central Reg-
ister, KoreaMed and Oasis in Korean, and China Integrated Knowledge
Resources Database in Chinese, we selected any eligible RCTs with placebo
or conventional control groups. The two investigators assessed the risk of
bias. And the meta-analysis was performed with Maximum Cystometric
Capacity (MCC), Post-void Residual urine (PVR), and Clinical Effective
Rate (CER), using the Reviewer Manager Software 5.3 (Cochrane Col-
laboration, Oxford, UK).
Results: One RCT in English and 12 in Chinese were included. Meta-
analysis showed that acupuncture or electro-acupuncture significantly
increased MCC (weighted mean difference=25.34, 95% CI = 4.56-46.11,
I2 = 38%, n = 312, random effect model) and CER (risk ratio = 1.73, 95%
CI = 1.44-2.08, I2 = 68%, n = 1151, random effect model) of the patients
with post-stroke neurogenic bladder. In sub-analysis, PVR in post-stroke
urinary incontinence patients significantly decreased. Heterogeneity
could be explained by the differences of control groups, acupoints selec-
tion, and the stroke onset between studies.
Conclusions: Acupuncture could be very effective to increase MCC and to
decrease PVR of the patients with neurogenic bladder after stroke, but
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further studies are needed to be designed to figure out the long-term
effects of the acupuncture for the disease.
Fig. 1 Flow chart.
Fig. 2
Fig. 3 AT vs usual care, changes of maximum cystometric capacity.
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Fig. 4 AT vs usual care, changes of post-void residual urine.
Fig. 5 AT vs usual care, clinical effective rate.
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Family-led rehabilitation after stroke in India:
The ATTEND trial
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Background: Western models of stroke rehabilitation are currently unaf-
fordable for the majority of the global stroke population but evidence
from The Completed Stroke Unit and Early Supported Discharge Reha-
bilitation Trials suggest that components of these interventions may be
effective in a low-cost model. We have designed a randomized controlled
trial (RCT) based in India to test this hypothesis.
Methods: The ATTEND trial is a RCT with secure randomization and
blinded outcome assessment. The intervention is protocol-based, with an
emphasis of repetition of task-specific activities, patient-centered goals
and begins in hospital within 7 days of admission (< 1 month of stroke)
and includes post-discharge home visits by the stroke coordinator. The
primary outcome is the modified Rankin Score, six months after random-
ization; secondary outcomes include care giver burden scale, quality of
life.
Results: By 5 January 2015, 482 out of a planned sample size of 1,200 had
been recruited from 13 active sites across India. The average age of
recruited patients is 57.3 years, mean NIHSS 10, caregivers were the
spouse (43%) daughters/daughter-in-law (27%) or sons/sons-in-law
(26%). A quarter of recruited patients had hemorrhagic stroke. At
6-months 53% of participants were independent (mRS0-2).
Conclusions: Recruitment is on target to complete final follow-up in 2016.
The younger age of stroke and a greater prevalence of hemorrhagic stroke
is characteristic of stroke in India. Nearly half the trial participants were
dead or disabled six months after stroke, confirming the poor prognosis
for stroke in India.
Universal Trial Number (UTN): U1111-1138-6707
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Socioeconomic status predicts return to work after
first stroke in younger adults
E Glader1, B Jonsson1, M Eriksson2
1Public Health and Clinical Medicine, Umeå University, Umeå,
Sweden
2Statistics, Umeå University, Umeå, Sweden
Background: Stroke is a leading cause of disabilities among young adults.
This can result in an inability to return to work after stroke. We studied
socioeconomic status and other possible predictors of work return one
year after stroke in a nationwide population in Sweden.
Methods: Employed patients aged 25–55 with first stroke between 2008
and 2011 were included. Data on sequelae and employment were retrieved
from the Swedish national stroke register, Riksstroke, and socioeconomic
data (income, education and country of birth) from Statistics Sweden.
Multiple logistic regression analyses were used to calculate odds ratios for
return to work between pre-specified patient subgroups and to adjust for
confounders.
Results: The study included 2370 stroke patients. Physical and mental
disabilities after stroke were observed to be major independent predictors
for decreased chance of work return, especially if the patient had need of
help with ADL (activities of daily living) (OR 0.02; 95% CI 0.006–0.04),
were depressed (OR 0.46; 95% CI 0.35–0.61) or experienced pain (OR
0.45; 95% CI 0.35–0.594). Highest income tertile (OR 1.40; 95% CI 1.06–
1.86) and ages of 35-44 (OR 1.88; 95 % CI 1.18–3.00) and 45-55 (OR 1.74;
95 % CI 1.14–2.68) were after adjustment for confounders observed to be
predictive factors of work return after stroke.
Conclusion: This study demonstrates that socioeconomic status predicts
return to work in Swedish younger adults within one year after first stroke.
Positive predictors for work return were high income and not belonging
to the youngest age group.
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What is the role of the home environment during
rehabilitation? The experience of STRENGTH (Stroke
Rehabilitation Enhancing and Guiding Transition Home)
L Gustafsson1, P Cornwell2, S Kuys2, J Fleming1
1School of Health and Rehabilitation Sciences, The University
of Queensland, Brisbane, Australia
2Behavioural Basis of Health Program, Griffith Health
Institute & Metro North (Northern) Health Services District,
Gold Coast, Australia
Background: Research has explored the impact of an enriched hospital
environment on activity levels during rehabilitation. Acknowledging the
contrived nature of an enriched hospital environment, it is important to
recognize that the home environment may be an equally important
mediator of client motivation, client-centered goal setting, therapy, and
activity levels. STRENGTH is a model of inpatient rehabilitation that is
enhanced by therapy within the home environment for one day of every
week.
Objective: To explore the impact of STRENGTH on client-centered goal
setting, therapy, and activity levels.
Method: STRENGTH was piloted for six months and semi-structured
interviews were conducted with clients (n = 7), carers (n = 3), and the
therapy team (n = 9). Interviews were completed with clients and carers at
discharge and four to six week follow-up. Therapy staff participated in a
focus group at the conclusion of the pilot. Inductive analysis of each
participant group has been reported previously. This presentation reports
a meta-synthesis of the qualitative results from all participants.
Results: The meta-synthesis identified three key themes: the restricted
nature of the hospital environment, home as a mediator of change to goals
and therapy, and home was central to preparation for discharge.
Discussion: The results support that the home environment is an impor-
tant mediator of the therapeutic alliance and process, and may prove
essential to ensuring client-centered practices within rehabilitation.
Further studies are required to understand the role of the home environ-
ment and evaluate the impact of STRENGTH on key outcomes and activ-
ity levels.
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Fact or fiction? Compression management for
post-stroke edema of the upper limb
L Gustafsson1, K Bower2, K Marshall2, A Slaughter2, A Walter1,
J Cavaye1, E Patterson1, M Hoyle1
1School of Health and Rehabilitation Sciences, The University
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Background: Research evidence supports compression management for
many forms of edema but the effectiveness has not yet been established for
post-stroke edema. The purpose of this program of research was to
address this gap and explore the effectiveness of compression manage-
ment for post-stroke upper limb edema.
Method: Three single case design studies explored the effectiveness of:
1. Low (n = 4) versus high (n = 4) stretch bandaging of the hand.
2. Bandaging of the hand (n = 6) versus hand to axilla (n = 6).
3. Compression gloves (n = 4) to maintain reductions in edema.
Circumferential measurements were taken at five points along the partici-
pants’ hand and arm during baseline and intervention phases. Analysis of
data included visual analysis of graphs for slope trends and calculated
celeration lines.
Results: Post-stroke edema levels fluctuated during all baseline and inter-
vention phases. All studies demonstrated an intervention effect with
increasing edema during baseline phases followed by a decrease during the
bandaging (intervention) phases. There was no difference in effectiveness
between high and low stretch bandaging of the hand. There was a trend to
suggest that bandaging from the hand to the axilla was more effective than
bandaging of the hand alone. A compression glove applied after bandag-
ing did not maintain reductions.
Conclusions: This preliminary evidence supports the clinical application
of compression management for the stroke-affected upper limb. Further
research should seek to understand the mechanism of the edema, refine
the management protocols, and conduct further empirical testing.
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Is serum vascular endothelial growth factor expression
in combination with physiotherapy along with
repetitive transcranial magnetic stimulation plays a
role in acute stroke recovery?
H Sharma1, A Bhasin1, R Sharma1, N Kumar2, R Moganty3,
M V Padma Srivastava1
1Neurology, All India Institute Of Medical Sciences, New
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Background and Objective: Low frequency repetitive transcranial mag-
netic stimulation to the contralateral (M1) along with physical therapy
enhances serum VEGF level in acute ischemic stroke (AIS). This study
aimed to compare serum VEGF levels in AIS using low frequency rTMS
with physiotherapy compared to physiotherapy alone.
Methods: Patients diagnosed with AIS onset within 7–15 days with NIHSS
score 4-20 were recruited. Active group was administered with low fre-
quency (1Hz), 750 pulses, inter train stimulus interval∼45 seconds @
110% resting motor threshold (RMT) given at 10th week for 2 weeks (10
days). Physical therapy was administered to all patients for 12 weeks.
Venous blood sample was collected at baseline, 10th week and 12th week
for serum VEGF along with clinical assessment.
Results: Fifty five subjects were randomized into real group (n = 28) and
sham group (n = 27) with mean age 51.72 ± 13.55. Significant increase in
serum VEGF was observed in real group (P = 0.04) with recovery as mea-
sured on FMA (P = 0.01) (Table 1).
Conclusion: Low frequency rTMS along with physiotherapy elevates
VEGF level in AIS patients causing restoration of neurological function.
Table 1
Time period
(12th week)
Variable Real group
Mean ± S.D.
N = 28
Sham group
Mean ± S.D.
N = 27
P<0.05
NIHSS
(0–42)
2.79 ± 1.41 5.82 ± 2.52 0.001
FMA Upper
(0–66)
57.05 ± 10.23 50.03 ± 15.72 0.01
VEGF (pg/ml) 592.50 ± 190.03 450.93 ± 221.30 0.04
RMT affected hand (%) 57.83 ± 15.51
(n = 18)
68.18 ± 10.25
(n = 17)
0.07
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Daily life consequences, cognitive impairment and
fatigue after transient ischemic attack (TIA)
E Kjörk1, C Blomstrand1, G Carlsson1, A Lundgren-Nilsson1,
C Gustafsson2
1Section of Clinical Neuroscience and Rehabilitation, Institute
of Neuroscience and Physiology, Gothenburg, Sweden
2Internal Medicine, Sahlgrenska University Hospital,
Gothenburg, Sweden
Background: After transient ischemic attack (TIA) fatigue and cognitive
impairment may be present as suggested in several studies, but little is
known about consequences in daily life.
Aims: The aim was to explore performance in daily life, presence of cog-
nitive impairment and fatigue at 1 and 9 months after a TIA event.
Methods: Data regarding cognition, fatigue and activities of daily life was
used from 46 patients, assessed at discharge from hospital and at 1 and 9
months after TIA. The assessments served as a basis for interviews focus-
ing on changes related to the TIA.
Results: Analyzes showed that 16 patients had remaining problems in
complex activities of daily life after 9 months. Mental fatigue was experi-
enced by 11 after one month and by 7 after 9 months. Cognitive impair-
ment was present in 18/44 patients after one month and 7/23 after nine
months. Difficulty with communication in daily life was the most com-
monly reported problem and increased from 7 patients to 14 between the
two time-points. Decrease in performance at work was experienced by
6/15 at 9 months.
Conclusions: A third of the patients discharged after TIA had residual
problems in performance of complex activities in daily life, particularly
concerning communication, within the first 9 months. Some patients
needed to change working-tasks or could not work fulltime, one explana-
tion could be the cognitive impairments and the mental fatigue. The risk
of consequences in daily life and at work indicates the need for systematic
multi-professional evaluation and support after TIA.
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Depression, anxiety, and cognitive functioning after
intracerebral hemorrhage
R J Koivunen1, H Harno1, T Tatlisumak1, J Putaala1
1Department of Neurology, Helsinki University Central
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Background and Purpose: Poststroke depression (PSD) is an important
complication of stroke. We studied long-term PSD after intracerebral
hemorrhage (ICH) at young age, as well as anxiety, and cognitive func-
tioning of the survivors.
Methods: We gathered clinical and imaging data of 336 young ICH patients
between age 16 and 49 treated in the Helsinki University Central Hospital.
After a median follow-up of 9.7 (7.0–12.0) years, we interviewed 130
survivors with structural questionnaires including Beck Depression Inven-
tory II (BDI-II), Hospital Anxiety and Depression Scale (HADS), Pain
Anxiety Symptoms Scale (PASS), Brief Pain Inventory (BPI), and Montreal
Cognitive Assessment (MoCA). Univariate and multivariate analysis was
performed to identify factors associated with PSD (BDI-II score > 13).
Degree of disability was measured by modified Rankin Scale score (mRS).
Results: PSD was present among 30 (23.1%) and anxiety among 52
(40.0%) patients (HADS score >6). Higher degree of disability was asso-
ciated with symptoms of depression (higher BDI-II scores, p = 0.001),
emotional distress (higher HADS scores, p = 0.004), and pain (higher
PASS scores, p=0.008, and higher BPI scores, p = 0.003). The only baseline
factor identified to associate with PSD was hydrocephalus (p = 0.014).
Median PASS score was 9 (IQR 0–25), median BPI score was 5 (0–23), and
median MoCA score was 26 (22-28) hinting to normal or mild cognitive
dysfunction. Antidepressants were used by 9.2%.
Conclusions: One out of four survivors of ICH at young age suffers long-
term PSD. Higher degree of disability predicted occurrence of PSD. Treat-
ment of depression appears as an unmet need in young ICH survivors.
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Walking ability, independence and health-related
quality of life
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Background: Stroke patients, indifferent of disability, have the same pos-
sibility to improve with training, it is argued. The aim of the study was to
follow and register functional improvements in two groups with different
ambulatory ability at baseline for a period of 48 months.
Methods: Stroke patients were recruited and divided into groups accord-
ing to functional ambulatory capacity (FAC) at baseline: FAC 0-2 (n = 36)
and FAC 3-5 (n = 39). During the acute rehabilitation both groups
received functional task-oriented training, followed by regular self- or
therapeutic driven training the first year post stroke and varied exercise
patterns the following months. The participants were tested on admission,
discharge, at three, six, twelve and forty-eight months after the onset of
stroke with Motor Assessment Scale (MAS),Barthel Index (BI), Timed-
Up-and-Go (TUG), Berg Balance Scale (BBS), 6 Minute Walk Test
(6MWT) and Nottingham Health Profile (NHP).
Results: There were significant differences between the groups in MAS,
BI, TUG, BBS and 6MWT. Change scores indicate a greater potential for
rehabilitation in FAC≤2 in relation to FAC≥3, although the functional
capacity was higher in the latter. HRQoL was perceived worse in the
FAC≤2 compared to FAC≥3 in total score, and for sub scores physical
mobility, pain and energy. However there were no significant differences
in perceptions of emotional, sleep and social functions.
Conclusion: The results indicate the importance of maintaining exercise
and training for all persons post stroke. Furthermore, the results underline
the importance of ambulation as a prerequisite for independence and for
HRQoL.
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Post-stroke pain: Is it being under-reported?
H Tawfik1, N Leaver1, A Manoj2
1Medical School, University of Liverpool, Liverpool, United
Kingdom
2Department of Gerontology, Royal Liverpool and Broadgreen
University Hospitals NHS Trust, Liverpool, United Kingdom
Post stroke pain (PSP) refers to a broad range of clinical conditions,
including central post stroke pain (CPSP) and tension type headaches.
The prevalence of PSP is reported at 11-55% following a stroke, with the
average duration of the pain lasting 5.73 years. CPSP can exhibit a latent
period of up to 18 months, meaning that the incidence of PSP is generally
underestimated. Pregabalin and gabapentin are used as first line agents to
manage this pain; however, there is currently no recommendation for
providing preventative treatment.
Our aim was to estimate the prevalence of PSP, and investigate whether it
is under-reported or misdiagnosed. Patients attending the Royal Liverpool
and Broadgreen University Hospital Trust outpatient stroke clinics were
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interviewed after their appointment and completed a modified McGill
Pain Questionnaire.
In total, 100 participants were included. 45 (45.0%) reported having pain
following their stroke; of which, 20 (44.4%) did not report this pain to the
doctor. The main reason for not reporting the pain was that the doctor
didn’t ask about pain, which occurred in nine (45.0%) participants. The
pain presented during the first three months after the stroke in 39 (86.7%)
participants. Nine (20.0%) participants reported the pain as severe, 23
(51.1%) reported the pain to be moderate and 13 (28.9%) reported only
mild pain.
The presence of PSP is common within our trust but is commonly under-
reported due to the lack of diagnostic criteria, because of this PSP should
be included in the stroke follow up proforma.
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Feasibility of cognitive assessment in post-stroke
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Introduction: Cognitive screening using a multi-domain assessment tool
is recommended in stroke rehabilitation guidelines, however there is no
guidance on the preferred instrument. Choice of assessment should be
guided by test properties. We aimed to describe feasibility of commonly
used cognitive assessment tools.
Methods: We approached sequential medically stable stroke-survivors in
two teaching hospital stroke rehabilitation units. Two researchers
administered Folstein’s Mini-Mental State Examination (MMSE); Mon-
treal Cognitive Assessment (MoCA); Addenbrooke’s Cognitive
Examination(ACE-III) and the Informant Questionnaire on Cognitive
Decline in the Elderly(IQCODE). We recorded numbers completing tests;
time to complete tests and where assistance was required.
Results: Over three months recruitment, of n = 55 suitable, n = 34 (62%)
agreed to testing and completed at least part of the cognitive test battery.
Median age 72 years (IQR: 62–84); n = 14(41%) male. Of this group
around half were able to fully complete the assessments with no assistance
(Table 1). Completion time was lowest for MMSE. Partial completion of
tests predominantly related to drawing and writing tasks (ACE-III n = 5;
MMSE n = 6 participants; MoCA n = 9). Only 7 (21%) IQCODE assess-
ments were completed.
Conclusions: Many stroke-survivors in rehabilitation struggle with tradi-
tional multi-domain cognitive assessments, gaining informant based data
is also difficult. Recommendations for universal cognitive assessment
need to be mindful of limited feasibility in a rehabilitation setting.
Assessment
(range, threshold)
Median score
(IQR)
Median time (minutes)
to complete (IQR)
Below threshold for “impairment”
n (%)
Partially completed
n (%recruited)
Fully completed
n (%recruited)
ACE-III
(0–100, 88)
55 (41–70) 21 (15–25) 28 (97%) 29 (85%) 15 (44%)
MoCA
(0–30, 26)
14 (7–16) 10 (8–11) 25 (100%) 25 (76%) 16 (47%)
MMSE
(0–30, 24)
21 (18–25) 5 (5–6) 13 (54%) 23 (68%) 17 (50%)
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Stroke survivors’ experience of stroke rehabilitation:
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J A Luker1, E Lynch2, S Bernhardsson3, L Bennett2, J Bernhardt4
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Background: The voices of patients recovering from stroke are not well
represented in the evidence currently guiding rehabilitation research and
service development.
Objective: To synthesize the best available evidence on the perspectives
and preferences of stroke survivors undertaking physical rehabilitation in
inpatient settings.
Methods: MEDLINE, CINAHL , Embase, and PsycINFO databases were
searched, with no language or time constraints applied. Independent pro-
cesses were used throughout by two or more reviewers, and final decisions
made by consensus. Qualitative studies reporting the experiences of inpa-
tient stroke rehabilitation were selected. The search yielded 3039 records,
95 documents went to full text review. Quality of reporting was assessed
using the COREQ framework. A thematic synthesis approach was used,
where all text reported in studies’ results sections were entered into NVivo
software for coding and analysis.
Results: 31 studies met inclusion criteria and had an acceptable level of
bias. Nine interrelated analytical themes, with descriptive subthemes, were
identified that related to issues of importance to stroke survivors: physical
activity is valued; bored and alone; patient-centered therapy; recreation is
also rehabilitation; dependency and lack of control; fostering autonomy;
power of communication and information; motivation needs nurturing;
fatigue can overwhelm. Negative experiences were reported in all studies
and include disempowerment, boredom, and frustration.
Conclusions: Rehabilitation could be improved by increasing activity
within formal therapy and in free time, fostering patients’ autonomy
through genuinely patient-centered care, and more effective communica-
tion and information. Future stroke rehabilitation research should take
into account the experiences and preferences of stroke survivors.
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Why aren’t all patients with stroke on Australian acute
stroke units considered for rehabilitation?
E Lynch1, J A Luker1, D A Cadilhac2, C E Fryer1, S L Hillier1
1International Centre for Allied Health Evidence, University of
South Australia, Adelaide, Australia
2Department of Medicine, Monash University, Melbourne,
Australia
Background: In 2013, less than half of the patients with stroke in Austra-
lian hospitals were assessed by rehabilitation specialists.
Aims: To explore how clinicians working in acute stroke units (ASU)
determine which patients to refer to rehabilitation services.
Methods: Mixed qualitative methods design. Team meetings were
observed and medical records reviewed over 4 weeks at two Australian
ASUs. Detailed field notes were taken during and after each observed
meeting. Focus groups were also conducted with staff from 8 ASUs in two
states of Australia. Focus groups were audio-taped and transcribed. Data
were coded and content analyzed.
Results: Rehabilitation was mentioned in team meetings for 50/64
patients (78%) during the observation period. Rehabilitation referrals
were organized for 47 patients (94%) for whom rehabilitation was dis-
cussed (74% of the sample); and for no patients when rehabilitation was
not discussed. Factors identified from both the observations and the focus
groups that influenced whether rehabilitation referrals were organized
included the anticipated discharge destination; severity of stroke; staff
expectations of the patient’s recovery trajectory; and if there was advocacy
by families about rehabilitation. Clinicians tended to refer the patients
they considered might be accepted by the rehabilitation service. Staff at
two ASUs expressed concern that referring all patients with stroke-related
deficits to rehabilitation would be unfavorable with rehabilitation
providers.
Conclusions: Decisions made by ASU staff regarding who to refer to reha-
bilitation after stroke are often not solely based on patients rehabilitation
requirements. Further research is underway to clarify how to improve
assessment and referral processes.
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Improving rehabilitation assessment and referral
practices for patients with stroke in Australia. A mixed
methods cluster-randomized implementation trial
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2Department of Medicine, Monash University, Melbourne,
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Background: In 2013, one third of patients with acute stroke in Australian
hospitals were not assessed for ongoing rehabilitation requirements.
Aims: To evaluate the effectiveness of 2 implementation programs for a
clinical decision-making tool, the Assessment for Rehabilitation Tool
(ART), on rehabilitation assessments and access to rehabilitation for
patients with stroke.
Methods: Ten hospitals in 2 Australian states were randomly assigned to
receive either education-only or multi-faceted ART implementation inter-
ventions. Medical records were audited before and after the implemen-
tation period and relevant staff participated in focus groups and
individual interviews. Qualitative data were independently coded by two
researchers, and thematically analyzed.
Results: Data from 705 patients (333 pre-intervention; 372 post-
intervention; median age 77 years; 56% male) showed that proportions of
patients assessed for rehabilitation increased significantly post-ART inter-
ventions (χ2 = 3.81, p = 0.05). Despite a strong association between being
assessed for rehabilitation and accessing rehabilitation (OR 22.13 [CI
11.27–43.47, p = 0.00]), rehabilitation access did not change post-ART
interventions (χ2 = 0.25, p = 0.62). The difference in absolute change in
proportions of patients assessed for rehabilitation was not significantly
affected by intervention type (5% [CI −20% to 10%, p = 0.48]).
Following the ART interventions, health professionals at 7 sites (3 educa-
tion; 4 multi-faceted intervention) reported focusing on patient require-
ments when conducting rehabilitation assessments. Five of these sites
reported that pre-ART, assessments were based on rehabilitation service
availability and admission criteria.
Conclusion: The 2 ART interventions were equally effective in improving
rehabilitation assessment documentation and reported patient-centered
assessment practices, but interventions did not improve access to
rehabilitation.
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Outcome prediction of early recovery period of the
cerebral ischemic hemispheric stroke
S Medvedkova1, O Lisovaya2
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Aim: Of the research was to investigate the predictive value of circulating
vascular endothelial growth factor-1 level for recurrent cardiovascular
events by the cerebral ischemic hemispheric stroke patients.
Methods: 102 cerebral ischemic hemispheric stroke patients of the early
recovery period were included in the study. Follow-up was 12 months.
The circulating peak VEGF-1 level was assessed at baseline. Clinical inter-
views were conducted every 3 months for 1 year after receiving blood
samples.
Results: We found that circulating VEGF-1 levels in patients with one,
two, three and more recurrent cardiovascular events were 373.80 pg/ml
(95% CI=342.90–479.70 pg/ml), 539.96 pg/ml (95% CI = 444.28–
865.56 pg/ml) and 724.66 pg/ml (95% CI = 558.72–890.66 pg/ml) respec-
tively. Peak VEGF-1 level for these subjects were significantly higher than
patients of free events (Me=289.28 pg/ml; 95% CI = 279.71–345.88 pg/
ml) (P = 0.001). The most optimal cutoff-point of circulating peak
VEGF-1 in hypertensive patients was 403.57 pg/ml (sensitivity and speci-
ficity were 78.6% and 70.0%). Area under ROC curve (AUC) was 0.76
(95% CI = 0.602–0.917; P = 0.001). Kaplan-Meier curves revealed an
accumulation of cardiovascular events was superior in patients with peak
VEGF-1 level more 403.57 pg/ml when compared with subjects with
VEGF-1 level less this cutoff point (P = 0.001).
Conclusions: We found that peak vascular endothelial growth factor-1
level was an independent predictor of one-year cumulative cardiovascular
events by the cerebral ischemic hemispheric stroke patients.
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Intra-arterial bone marrow mononuclear cells
(BM-MNCS) transplantation in acute ischemic stroke
(IBIS trial). Protocol of a phase II randomized,
dose-finding, controlled multicenter trial
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Rationale: No neuroprotective or neurorestorative therapies have been
approved for ischemic stroke. Bone marrow mononuclear cell (BM-
MNC) intra-arterial transplantation improves recovery in experimental
models of ischemic stroke.
Aims: This trial aims to test safety and efficacy of intra-arterial injection
of autologous BM-MNC in ischemic stroke patients.
Design: Multicenter prospective phase II, randomized, controlled (non-
treated group as control), assessor-blinded clinical trial. Seventy-six stroke
patients will be enrolled. Patients fulfilling clinical and radiological crite-
ria (e.g. age between 18-80 years, middle cerebral artery ischemic stroke
with a National Institutes of Health Stroke Scale[NIHSS] score of 6–20
within 1–7 days from stroke onset and no lacunar stroke) will be random-
ized to intervention or control group(1:1). Bone marrow harvest and
intra-arterial injection of autologous BM-MNC will be done in the inter-
vention group with two different doses (2x106/kg or 5x106/kg in 1:1
proportion). Patients will be stratified at randomization by NIHSS score.
Patients will be followed-up for 2 years.
Study Outcomes: The primary outcome is the proportion of patients with
modified Rankin Scale scores of 0–2 at 180 days. Secondary outcomes
include NIHSS and Barthel scores at 6 months, infarct volume, mortality,
and seizures.
Discussion: This is the first trial to explore efficacy of different doses of
intra-arterial BM-MNC in moderate-severe acute ischemic stroke
patients. The trial is registered as NCT02178657.
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Physical activity, sedentary behavior and metabolic
control following stroke: A cross-sectional and
longitudinal study
S Moore1, K Hallsworth1, T Ploetz2, G A Ford3, L Rochester3,
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Background: Physical activity and sedentary behavior are key moderators
of cardiovascular disease risk and metabolic control. Despite the impor-
tance of a physically active lifestyle, little is known about the effects of
stroke on physical activity. We assessed physical activity and sedentary
behavior at three time points following stroke compared to a healthy
control group.
Methods: Physical activity and sedentary behavior were objectively mea-
sured using a portable multi-sensor array in 31 stroke participants (73 ± 9
years, National Institute of Health Stroke Scale 2 ± 2, mobile 10 meters
with/without aid) within seven days and at three and six months. Stroke
data were compared with an age, sex and body mass index matched
healthy control group (n = 31).
Results: Within seven days of stroke, total energy expenditure and physi-
cal activity were significantly lower and sedentary time higher in the
stroke group compared to controls (total energy expenditure 1840 ± 354
vs. 2220 ± 489 kcal, physical activity 28 ± 32 vs. 79 ± 46 min/day, steps
3111 ± 2290 vs. 7996 ± 2649, sedentary time 1383 ± 42 vs. 1339 ± 44 min/
day, p < 0.01). At three months physical activity levels had increased
(64 ± 58 min/day) but plateaued by six months (66 ± 68 min/day).
Conclusions: Physical activity levels are reduced immediately post-stroke
and remain below recommended levels for health and well-being at the
three and six month time points. Clinicians should explore methods to
increase physical activity and reduce sedentary behavior in both the acute
and later stages following stroke.
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motivators to physical activity post-stroke
S L Nicholson1, C A Greig2, F Sniehotta3, M Johnston4, S J Lewis1,
M E T McMurdo5, D Johnston4, J Scopes6, G E Mead1
1School of Clinical Sciences and Community Health, University
of Edinburgh, Edinburgh, United Kingdom
2School of Sport Exercise and Rehabilitation Sciences,
University of Birmingham, Birmingham, United Kingdom
3Institute of Health & Society Faculty of Medical Sciences,
Newcatle University, Newcastle, United Kingdom
4Health Psychology, University of Aberdeen, Aberdeen,
United Kingdom
5Department of Ageing and Health, University of Dundee,
Dundee, United Kingdom
6Physiotherapy, Astley Ainslie Hospital, Edinburgh, United
Kingdom
Background: Physical activity after stroke is low. To understand the
reasons for this, we explored stroke survivors’ perceived barriers and
motivators to physical activity, including self-efficacy and the intention to
be physical active.
Methods: Fifty independently mobile stroke survivors [(29/50) 58%
female] were recruited prior to hospital discharge. Participant average age
was 72.4 years (standard deviation: 12.3 years). After completing two
walking tests (6 minute walk test and a short walk) participants rated nine
possible motivators and four possible barriers to physical activity based on
The Mutrie Scale, as having either “no influence”, “some influence” or “a
major influence” on physical activity. To determine the influence of the
walking tests on self-efficacy and intention to increasing walking, partici-
pants were asked to rate their confidence and their intention to increase
walking in the next month on two separate five-point rating scales.
Results: The most common motivating factor was “physical activity is
good for health” [34(68%)]. The most common barrier was “feeling too
tired” [24(48%)]. After the walks, intention and self-efficacy were high.
Self-efficacy was graded as either 4 or 5 (highly confident) on the five-
point scale by 34 (68%) participants, whilst 42 (84%) participants
“strongly agreed” or “agreed” that they intended to increase their walking
in the next month.
Conclusions: Participants felt capable of increasing physical activity after
their stroke but fatigue was perceived as a common barrier to physical
activity. These results need to be incorporated into interventions to
increase physical activity in stroke survivors.
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Effortful swallow with resistive electrical stimulation
training improved pharyngeal propulsion in
post-stroke dysphagia
J Park1, Y Kim2, H Lee3
1Physical Medicine and Rehabilitation, Dongguk University
Ilsan Hospital, Goyang, Korea
2Physical Medicine and Rehabilitation, Myongji Hospital,
Goyang, Korea
3Physical Medicine and Rehabilitation, Ilsan Paik Hospital,
Goyang, Korea
Introduction: To evaluate that effortful swallow combined with surface
electrical stimulation used as a form of resistance training affect on pha-
ryngeal constriction function in post-stroke patients with dysphagia.
Materials and Methods: Nineteen post-stroke dysphagia patients received
20 minutes effortful swallow training with resistive electrical stimulation
during every weekday for 4 weeks. Electrical stimulation was applied on
infrahyoid area as a resistance against hyolaryngeal elevation. Stimulation
intensity was daily adjusted till the patients could endure electrical stimu-
lation and raise their hyolaryngeal complex. Blinded biomechanical mea-
surements of the extent of hyolaryngeal excursion and the pharyngeal
constriction ratio (PCR) before and after training were performed. The
change of the PCR and the relationship between hyolaryngeal elevation
and the PCR were evaluated.
Results: The PCR was significantly decreased after training (p < 0.05).
There was a high inverse correlation between the hyoid elevation and the
PCR (−0.62).
Discussion: Effortful swallow with resistive electrical stimulation training
increased pharyngeal strength. It can be used as a treatment to improve
pharyngeal propulsion in dysphagia patients.
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K Nam1, J Park1
1Physical Medicine and Rehabilitation, Dongguk University
Ilsan Hospital, Goyang, Korea
Purpose: This study examined whether the method ‘increasing fluid bolus
volume’ might be applied as a treatment option for stroke dysphagic
patients.
Methods: Ten stroke patients who had a problem of delayed swallowing
reflex confirmed by video fluoroscopic swallowing study (VFSS) were
enrolled. Each subjects completed two swallows each of 2 mL, 5 mL, and
10 mL of barium liquid thinned with water. Pharyngeal delay time and
penetration-aspiration scale (PAS) were measured and the changes among
different volume swallows were analyzed.
Results: The pharyngeal delay time were shortened significantly when
5 mL and 10 mL thin barium were swallowed compared to 2 mL.
However, there was no significant difference in PAS as bolus volume
increased.
Conclusion: The increased fluid bolus volume reduced pharyngeal delay
time, but did not affect penetration and aspiration status. This method is
not proper as a treatment for stroke dysphagic patients.
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Background: Reducing length of stay (LoS) for stroke patients is viewed as
a good quality marker. However, this might be confounded by stroke
survivors been discharge to a long-term care institutions. We aimed to
determine the discharge destination (DD) for stroke survivors in our
hospital (23 acute stroke beds), which serves a catchment population of
273,327 adult inhabitants.
Method: We prospectively studied consecutive acute stroke presentations
(TIA excluded), aged ≥18 years from 01/05/2013 to 30/04/2014 referred to
our single center.
Results: A total of 664 acute strokes were diagnosed in 652 individuals, of
whom: 18.3% (122) died in hospital; 6.4% (43) were not admitted to
hospital; 0.9% (6) had second stroke during same admission; and in 0.6%
(4) DD was not known. The average LoS among the remaining 495 stroke
survivors was 20.2 (SD 23.7) days; of those 84.6% (419) were discharged
to their own home (OH), 9% (45) went from OH to nursing home (NH),
2% (10) went from OH to residential home (RH), 2.2% (11) and 0.8% (4)
discharged back to their own NH and RH respectively, and 1% (5) went
from RH to NH. The average LoS in those discharged from OH to NH was
>3 times longer (52 days) than those discharged to OH (17 days).
Conclusions: The average LoS among stroke survivors was 20.2 days. 12 %
of patients were discharged to long term care institutions. DD needs to be
considered when LoS is measured.
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The cardiac autonomic nervous system state and
response to different stimuli among stroke patients
and age-matched controls
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Autonomic nervous system instability, reflecting hyper-stimulation of the
sympathetic system, is a common phenomenon among patients post
stroke. Heart rate variability (HRV) refers to beat-to-beat alterations in
the heart rate, measured non-invasively in the assessment of cardiac auto-
nomic control. The purpose of the current study is to describe the
response of the cardiac autonomic nervous system to different physical
and cognitive stimuli, among patients post stroke and age matched
healthy controls.
Study Population: Four patients in the sub-acute stage post first-ever isch-
emic stroke, with preserved cognitive capacity, without severe vision or
hearing impairment, and four age-matched healthy controls.
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Method: HRV recorded in several conditions: (1) rest, (2) a grip task, (3)
a breathing task, (4) cycling, (5) a cognitive task, (6) cycling combined
with a cognitive task. Each condition followed by a rest period.
Results: Mean heart rate values□□were similar in both groups at rest and
throughout the different study conditions. In contrast, the HRV was lower
among individuals post stroke, both at rest and during performance of the
different tasks, except for cycling, alone or combined with a cognitive task
(4, 6), where healthy controls showed a decline in HRV.
Discussion: The findings highlight the fact that the cardiac autonomic
nervous systems, as measured by the HRV, react in an abnormal manner
in the sub-acute period after stroke onset.
Fig. 1 HRV in stroke patients and matched controls in different conditions.
RMSSD = root mean square standard deviation.
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Background and Purpose: Stroke survivors who are in an Acute Stroke
Unit (ASU) have been found to spend the majority of their day inactive
and alone, with little information available regarding cognitive or social
engagement. Since these studies, growing evidence indicates that stroke
survivors should be active as early and frequently as possible. The aim of
this study was to characterize the physical, social and cognitive activity
levels of people with a stroke in a contemporary ASU.
Methods: Thirty adults with stroke admitted to an ASU in Australia were
observed every 10 minutes from 7.30am to 7.30pm across three days
during their first week in the ASU by staff trained in behavioral mapping.
The location, body position, people present, physical, social and cognitive
activity occurring was recorded at each observation.
Results: The mean age of participants was 76 (SD13) years, who were
classified to have a mild (n = 17), moderate (n = 9) or severe (n = 4)
stroke. Participants spent 91% of their time in their room, 65% in supine
position, and were alone 57% of the time. Physical, social, and cognitive
activity was observed in 21%, 28% and 42% of the day, with the severe
group having lowest activity levels across all areas.
Conclusion: Despite growing evidence recommending early activity,
stroke survivors continue to spend the majority of the day inactive in the
first week after stroke. An upcoming study will determine if an enriched
environment can increase activity levels and reduce secondary complica-
tions in an ASU.
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In this study, 35 healthy subjects were asked to perform and to imagine the
same motor task before and after a training period through mental prac-
tice with motor imagery. The protocol was approved by the ULB-Erasme
Ethics Committee and all subjects gave their written informed consent
before participating. The motor task consisted of different repetitive left
ankle movements executed in a predetermined order. The training con-
sisted in five times a week of mental practice comprising 10 blocks of 10
sequences in the kinesthetic imagined condition. Subjects were divided in
2 groups: first group imagined foot movements at regular velocity, second
group imagined fast foot movements. They underwent brain functional
MRI (fMRI) before and after training.
Mental training induced improvement in motor performance and a con-
comitant functional cerebral reorganization. First, time for the imagina-
tion and the execution of the motor sequence before and after mental
training in both group showed that mental training led to a significant
improvement (picture1). Second, mental training induced significant
recruitment with a left-side predominance of the dorsomedial prefrontal,
anterior paracingulate, posterior cingulate and precuneate cortices, left
putamen and left head of the caudate nucleus. Our results also revealed
training-related differences in the attentional network comprising specific
cerebellar (crus I and II) and anterior paracingulate activations during the
post-training task (picture2).
In conclusion, the present fMRI study show that mental practice is an
efficient training method to improve motor performance and the shift of
differential and coupled recruitment of cognitive networks can constitute
neural marker of training effects.
ESOC-0197
09. Rehabilitation and Recovery
Intensive CIMT (Constraint Induced Motor Therapy) in
chronic stroke- feasible in outpatient settings
S S Schwarz1, M P Petra Mitterhauser-Gratzer1, R K Rauch Karin1,
T Y Teuschl Yvonne2, B M Brainin Michael3
1Neurology, University Clinic Tulln, Tulln, Austria
2Clinical Neurosciences, Danube University Krems, Krems,
Austria
3Neurology and Clinical Neurosciences, University Clinic Tulln
and Danube University Krems, Tulln and Krems, Austria
Background: CIMT (Constraint Induced Motor Therapy) is an effective
method in the treatment of post-stroke- patients. Due to cost restrictions
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it is important to test whether this therapy can also be delivered in a day
clinic setting.
Methods: 11 chronic stroke outpatients were treated six hours daily in a
group therapy setting over two weeks. Motor hand function was evaluated
using the WMFT (Wolf Motor Function Test), and MAL (Motor Activity
Log) at therapy onset, after two weeks of therapy, and in a 6-month-
follow-up.
Functionally relevant individual task movements were shaped into
sequential modules for a repetitive training program. The training was
performed by two occupational therapists.
Results: In the Wilcoxon analyses, comparison to baseline scores showed
that 6 out of 7 items of the WMFT improved significantly (lift pencil
p < 0,004, pick up paper clip p < 0,01, flip card p < 0,017, turn key in lock
p < 0,021, fold towel p < 0,003, lift basket p < 0,023) after two weeks of
therapy. In 6 out of 7 test items in the WMFT, there were significant
improvements in the re-evaluation after 6 months (lift pencil p < 0,041,
pick up paper clip p < 0,006, stack checkers p < 0,01, flip cards p < 0,003,
turn key in lock p < 0,003, fold towel p < 0,01). The MAL showed a sig-
nificant improvement after six months. Three patients even reported a
“normal spontaneous use” of their paretic hand and arm.
Shoulder pain or increased spasticity were not reported.
Conclusion: CIMT in chronic stroke patients can be performed in a day
clinic setting and shows impressive and sustainable gains in motor
function.
ESOC-0132
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Efficacy of CIMT with RTMS on upper extremity
recovery in chronic stroke
P Srivastava1, N Kuthiala1, R Sharma1, A Bhasin1, N Kumar2
1Department of Neurology, All India Institute of Medical
Sciences, Delhi, India
2Department of Psychiatry, All India Institute of Medical
Sciences, Delhi, India
Background and Purpose: Constraint-induced movement therapy
(CIMT) has been documented to improve motor function in the upper
extremity following stroke. Repetitive transcranial magnetic stimulation
(rTMS) is a non-invasive and effective therapeutic stimulation to modu-
late cortical excitability of motor area and has the potential to improve
dexterity of affected hand post stroke. The purpose of the study was to
investigate the effect of rTMS with CIMT in chronic stroke patients with
upper extremity motor deficits.
Methods: A randomized controlled study was undertaken with 25 chronic
stroke patients between 3 to 18 months of index event with preserved at
least 10° of wrist extension, 10° of thumb abduction and 10° of any two
digit extension, and NIHSS score of (4–20). Group A (n = 13) was given
CIMT alone and Group B (n = 12) were given rTMS with CIMT. All
patients were subjected to Fugl Meyer Assessment (FMS), Barthel Index
(BI) and Modified Rankin Scales (MRS). Resting motor threshold (RMT)
and motor evoked potentials (MEP) were assessed before and after rTMS.
Results: Significant improvement was seen in patients treated with rTMS
and CIMT on FMS of Upper extremity (p = 0.006) and non-significant
on MRS (p = 0.3) and BI (p = 0.9). Follow up MEP mean was
109.78 ± 157.27 and RMT mean was 80.08 ± 23.24 with no significant
changes between the baseline and follow up MEP and RMT .
Conclusion: rTMS with CIMT resulted in significant improvement on
FMS scale for upper extremity motor deficits.
ESOC-0218
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Repeated sessions of motor skill learning under
dual-TDCS in chronic stroke patients
Y Vandermeeren1, M Yeganeh Doost1, P Laloux1,
P H Desfontaines2, F Evrard3, A Peeters4, S Lefebvre1
1Neurology, Université Catholique de Louvain CHU
Dinant-Godinne UcL, Yvoir, Belgium
2Neurology, Centre Hospitalier Chrétien (C.H.C.) Site
Saint-Joseph, Liège, Belgium
3Neurology, Clinique Saint-Pierre, Ottignies, Belgium
4Neurology, UcL Cliniques Universitaires Saint Luc Unité
neuro-vasculaire, Brussels, Belgium
Background: We previously showed that dual transcranial direct current
stimulation (dual-tDCS) improves motor skill learning and long-term
retention in stroke patients.
Objective: To prospectively follow-up 7 chronic hemiparetic stroke
patients during repeated sessions. Among the 39 patients who participated
in the RCT, 7 individuals spontaneously reported improvements beyond
those formally assessed with the outcome measures; they requested addi-
tional sessions.
Methods: We provided additional sessions of motor skill learning com-
bined with dual-tDCS every 4–8 weeks depending on the patient’s needs
and requests. During the repeated sessions, dual-tDCS (1 mA) was deliv-
ered to both primary motor cortices during 30 minutes.
Results: The baseline characteristics of these 7 patients were similar to
those of the others. They reported lasting benefits of the repeated inter-
vention (“somehow regained more control over the paretic upper limb”,
“spasticity attenuated”, “more benefit from the usual physical/occupational
therapy sessions”). Within-session, the Learning Index (LI) kept improving
during most of the repeated sessions (LI: 23.97% ± 14.45% (mean ± SD);
slope: 0.56 ± 0.65). Between-session, there was also a constant, cumulative
performance improvement (slope: 0.12 ± 0.23).
Conclusion: Beyond the enhancements formally assessed in our previous
RCT, 7/39 patients spontaneously reported enhancement of motor func-
tion in everyday life, exclusively after the real dual-tDCS session (applied
in a randomized, double-blind, sham-controlled, cross-over design). They
benefited from additional, repeated real sessions, suggesting that motor
skill learning combined with dual-tDCS could be applied repetitively. It
would be surprising that the continuous between-sessions enhancements
were driven exclusively by a placebo effect.
ESOC-0145
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Relaxation techniques for stroke survivors: Findings
from a patient and public involvement project in the
UK
S X Wang1, M E Hyland2, K Sutcliffe3, A Christensen4
1Faculty of Health & Social Sciences, Leeds Beckett University,
Leeds West Yorkshire, United Kingdom
2Psychology, Plymouth University, Plymouth, United Kingdom
3A Stroke Survivor, Retired, Leeds, United Kingdom
4Faculty of Health & Social Sciences, Leeds Beckett University,
Leeds, United Kingdom
About 2/3 stroke patients report psychological problems such as depres-
sion, anxiety and poor confidence. Relaxation techniques have been
reported as effective interventions in non-stroke people with anxiety
issues. Little is known whether and how these techniques might work for
stroke survivors.
This project aimed to consult with stroke patients about: 1) the suitability
of relaxation techniques for improving psychological health; 2) determin-
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ing preference in applying them and 3) how they can be tailored to meet
stroke patients’ needs, especially those with aphasia.
Four focus groups were conducted in the UK with 13 stroke survivors
(aphasic = 7, median age = 61 years). Patients watched a 15-minute film of
relaxation techniques and practiced each one (counting, word repetition,
body movement, breathing, positive emotions, thinking of a nice place
and body relaxation). They feedback how these techniques could be tai-
lored to meet their needs, their preferences for different techniques and
reasons for likes and dislikes. They also rated each technique in order of
preference.
The mean rating showed that nice place comes out top, followed by
breathing, and positive emotions. Counting and word repetition were the
least favorable. Correlation analysis suggested that if people like positive
emotions, they also like breathing. A strong relationship also existed
between those who like the nice place and those who like body relaxation.
All top 3 techniques should be selected for use in further studies; however
tailoring is necessary for stroke survivors, e.g., choosing specific wording
for the instructions and a slower pace for aphasic patients.
ESOC-0339
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Investigation of body schema in adults post-stroke
L J Williams1, S L Hillier1, M N McDonnell1, G L Moseley2
1International Centre for Allied Health Evidence Sansom
Institute for Health Research, University of South Australia,
Adelaide, Australia
2Body in Mind Research Group Sansom Institute for Health
Research, University of South Australia, Adelaide, Australia
Background: The mechanisms underpinning unilateral spatial neglect are
not well understood. There is some evidence to suggest that it may be
associated with an impairment of an individual’s body schema. However,
little is known about distortions of body schema in the first two weeks
following stroke, nor any associations with somatosensory deficits.
Methods: Fifteen participants with a hemispheric stroke were assessed
within the first two weeks of their stroke and then again three weeks later.
The primary outcome was body schema, assessed using an online left/
right hand judgment task with the Recognise™ app (noigroup). Second-
ary outcomes included assessing personal neglect with the Vest Test,
spatial neglect with the Bells Test and Line Bisection Task, light touch
sensation of the arm with the Semmes-Weinstein monofilaments and
proprioception with the Distal Proprioception Test. Contralesional and
ipsilesional hand judgment accuracy and reaction time was compared at
both time points to determine if body schema was distorted and if it
changed over time. Associations between somatosensory deficits, unilat-
eral neglect and distorted body schema were explored.
Results: There was no significant difference in body schema between con-
tralesional and ipsilesional sides of the body or from the acute to subacute
period following a stroke. Quantile regression analysis identified a signifi-
cant association with impairment of proprioception and a distorted body
schema (p = 0.03).
Conclusion: A distorted body schema was associated with impaired pro-
prioception in adults post stroke.
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A prospective study of the psychological determinants
of walking among community-based, ambulatory
stroke survivors
A Wright1, C D A Wolfe2, C McKevitt2, I Wellwood3, J Lo4,
D P French5
1Primary Care & Public Health Sciences, King’s College
London, London, United Kingdom
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Biomedical Research Centre based at Guy’s and St Thomas’
NHS Foundation Trust and King’s College London, London,
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3Public Health and Primary Care, University of Cambridge,
Cambridge, United Kingdom
4Public Health and Primary Care, King’s College London,
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Background: Many stroke survivors have low levels of physical activity. In
order to develop a novel physical activity intervention, focused on
walking, for stroke survivors able to walk outdoors following rehabilita-
tion, knowledge of the psychological factors affecting how much stroke
survivors walk is required. Therefore, we tested whether psychological
beliefs, taken from the well-known Theory of Planned Behavior, and
participants’ self-reported use of planning strategies, predicted intentions
for, and actual, walking more.
Methods: Prospective survey. At time 1, 70 South London Stroke Register
participants, able to walk outdoors, completed measures of weekly
walking time, intentions to walk more, attitudes towards walking more,
perceived norms for walking more, perceived behavioral control over
walking more and use of spontaneous planning strategies for walking
more. One week later, weekly time walked was assessed again.
Results: Intentions to walk more were significantly predicted by perceived
positive norms for walking more (β = 0.41, p < 0.001) and higher per-
ceived control over walking more (β = 0.38, p = 0.01) while attitudes’
effect (β = 0.20, p = 0.08) was not significant, R2 = 0.50. Walking more
was not significantly predicted by either intentions (OR = 1.09, p = 0.20)
or perceived control over walking more (OR = 0.99, p = 0.99), contrary to
what was expected. Use of planning strategies also did not significantly
influence whether participants walked more (OR = 0.93, p = 0.33).
Discussion: Greater perceived behavioral control and perceived positive
subjective norms are associated with increased intentions to walk more
and could be targeted by walking interventions for stroke survivors.
However, any intervention will also require additional strategies to turn
this positive motivation into action.
ESOC-0199
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Continuous activity monitoring in cryptogenic stroke
patients with insertable cardiac monitors and the
impact of newly detected atrial fibrillation
P D Ziegler1, J L Koehler1, S Sarkar1, J D Rogers2
1Diagnostics and Monitoring Research, Medtronic, Mounds
View, USA
2Cardiology, Scripps Clinic, La Jolla, USA
Introduction: Comprehensive activity data following cryptogenic stroke
(CS) and the subsequent impact of atrial fibrillation (AF) are limited. We
investigated activity stabilization and AF’s impact on activity among a
large cohort with insertable cardiac monitors (ICM) placed following CS.
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Methods: Patients in the Medtronic Discovery™Link database with ≥12
weeks of data who received an ICM (Reveal LINQ™) following CS were
included. The ICM continuously monitors activity and AF. Activity stabi-
lization was defined as the time required to attain ≥95% of the average
weekly activity between weeks 9–12. For patients with AF detected, activ-
ity was compared between weeks 1, 2, and 4 prior vs. after detection of the
first adjudicated episode.
Results: 1069 patients (age 65.1 ± 13.1, 52% male) were included. Median
activity in the initial week following ICM placement was low (69.0 [IQR
22.3–138.9] minutes/day) but increased over 5 weeks and stabilized
(Fig. 1). Among patients with sufficient data, daily activity did not change
significantly in the week(s) before vs. after initial AF detection (p=NS).
Conclusion: Activity following CS was low but significantly improved
over the initial 5 weeks following ICM placement. The presence of AF did
not impact weekly activity levels, suggesting that most AF was asymptom-
atic. Consequently, ICMs could aid in both monitoring functional recov-
ery as well as identifying asymptomatic AF in CS patients who would
benefit from oral anticoagulation.
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Phenomenology and neuropsychology of delirium in
the 14 days after stroke: A prospective cohort study
A J Barugh1, S D Shenkin1, A M J MacLullich1, G E Mead1
1Edinburgh Delirium Research Group Geriatric Medicine,
University of Edinburgh, Edinburgh, United Kingdom
Background: Delirium affects ∼25% of patients after stroke, has adverse
consequences, and yet is poorly understood. Here we examined the phe-
nomenology and neuropsychology of delirium after acute stroke.
Methods: We consecutively recruited 95 participants (aged >60) hospital-
ized with acute stroke. Diagnosis of delirium was made using DSM-IV
criteria. Features of delirium were assessed by the Confusion Assessment
Method-ICU (CAM-ICU), Delirium Rating Scale-Revised-98 (DRS-R98)
and retrospective Chart-CAM, administered on alternate days over week
one (first assessment median 5 days post-stroke) and at day 14. National
Institutes for Health Stroke Scale (NIHSS) was scored at baseline.
Results: Twenty-six participants (27%) developed delirium.
Characteristic Median (inter-quartile range)
Age, years 83.5 (79–85.3)
NIHSS score 8.5 (5.0–12.8)
Day of delirium onset 5 (4–7)
Duration of delirium, days 2 (1.3–9)
Maximum severity score (DRS-R98) 22 (15.8–25.5)
Delirium subtype, n (%)
Hypoactive
Hyperactive
Mixed
14 (54)
4 (15)
8 (31)
The median time of delirium onset was day 5, and the median duration
was 2 days. The majority (14/26) had a hypoactive delirium. The median
DRS-R98 score was 22 out of 48 and the most common abnormalities
were short and long-term memory deficits (23/26 and 25/26 respectively),
sleep-wake cycle disturbance (22/26) and moderate to severe inattention
(20/26). Fourteen (54%) patients had detectable psychotic features.
Discussion: Delirium affected more than 25% of patients. It was most
often hypoactive. Sleep-wake cycle disturbance and significant memory
and attentional deficits were common. Psychotic features affected more
than 50% of delirious patients. Stroke physicians should be aware of the
high prevalence of the frequently undetected hypoactive subtype of
delirium post-stroke.
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The role of the amygdala in the perception of positive
emotions: An “intensity detector”
L Bonnet1, A Comte2, L Tatu1, J L Millot3, T Moulin1,
E Medeiros de Bustos1
1Neurology, University of Franche-Comté, Besancon, France
2Research in Functional Imaging, Besancon University
Hospital, Besancon, France
3Laboratory of Integrative and Clinical Neuroscience, INSERM,
Besancon, France
Although the development of functional imaging techniques has estab-
lished the implication of the amygdala in the emotional process, its spe-
cific role remains controversial. The aim of this study was to highlight the
sensitivity of the amygdala to emotional intensity (arousal). We conducted
an analysis of the modulation of amygdala activation according to varia-
tion in emotional intensity via an fMRI event-related protocol. Monitor-
ing of electrodermal activity, a marker of psychophysiological emotional
perception and which reflects the activation of the autonomic nervous
system, was carried out concurrently. Eighteen subjects (10 men; aged
from 22 to 29 years) looked at emotionally positive photographs. We
demonstrated that the left and right amygdalae were sensitive to changes
in emotional intensity, activating more in response to stimuli with higher
arousal. Furthermore, electrodermal responses were more frequent for the
most intense stimuli, demonstrating the concomitant activation of the
autonomic nervous system. These results highlight the sensitivity of
the amygdala to the intensity of positive emotions, and in conjunction
with results in the literature on negative emotions, prove the role of the
amygdala in the perception of intensity.
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The AVERT MoCA data: Cognitive assessment in a
large-scale, multi-center stroke trial
T Cumming1, D Lowe1, J Bernhardt1
1Stroke, Florey Institute of Neuroscience and Mental Health,
Melbourne, Australia
Background: The Montreal Cognitive Assessment (MoCA) is now one of
the most widely used cognitive screening tools in stroke. Scoring the
visuospatial/executive items of the MoCA involves subjective judgment.
The aim of this study was to examine scoring accuracy in the context of a
multi-center trial.
Methods: A Very Early Rehabilitation Trial (AVERT) is a Phase III RCT of
early mobilization after stroke that included the MoCA as a 3-month
outcome measure. Once completed, MoCA score sheets were scanned and
sent from the 53 participating hospital sites to a central repository for data
checking. For the 3 visuospatial/executive items (Trail-making, Cube copy,
Clock drawing), we compared the original scoring of the assessors at each
site (trained to administer the MoCA) to blind scoring of the data by a
second, independent and experienced rater.
Results: In a sub-sample of 910 score sheets (originally completed by 99
different assessors), we found reasonable agreement. The match between
original and blind scoring was: Trail-making 97%, Cube 90%, Clock
contour 91%, Clock numbers 87%, Clock hands 72%. For all items except
Clock contour, independent scoring was stricter than original scoring.
Most of the discrepancies were errors in original scoring, rather than
being attributable to gray areas in subjective judgment.
Conclusions: In trials that include the MoCA, researchers should empha-
size the scoring rules to assessors and implement some form of indepen-
dent data checking, especially for the Clock hands item, to maximize
accuracy.
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Metacognition versus global cognition determining
mood symptoms post-stroke
C Donnellan1, M Al Banna2, N Redha2, I Al Sharoqi3, A Al Jishi3,
M Bazhiet4, S Taha4, F Abdulla3
1School of Medicine, Royal College of Surgeons Ireland in
Bahrain AND Trinity College Dublin, Dublin, Ireland
2School of Postgraduate Studies, Royal College of Surgeons
Ireland in Bahrain, Busaiteen, Bahrain
3Neurology, Salmaniya Medical Complex, Salmaniya, Bahrain
4Neurology, Al Jawhara Molecular Medicine, Salmaniya,
Bahrain
Introduction: The association between global cognition and depression
after stroke has been recognized. Although the link between metacogni-
tion and mood has been well established, particularly in other conditions
with psychological comorbidity, there is limited evidence regarding this
association in the area of stroke.
Aims: The aim of the study was to examine correlates and potential
predictors of mood symptoms after stroke including global and metacog-
nition in a Middle Eastern cohort.
Methods: A prospective stroke sample of n = 50 patients have been
recruited to date from the largest Medical Complex in Bahrain. A neuro-
psychological battery of cognitive assessments including measures the
Mini-mental State Examination (MMSE), the Montreal Cognitive Assess-
ment (MOCA) for global cognition and the Meta-cognition Question-
naire 30 (MCQ-30) for meta-cognition. The Hospital Anxiety and
Depression Scale assessed mood symptoms and stroke severity was
measured using the National Institute of Health Stroke Severity Scale
(NIH-SS).
Results: Total MCQ-30 scores highly correlated with anxiety (r = .54,
p < .0001) and depression (r = .47, p = .001). The MCQ-30 subscales cog-
nitive confidence (p < .05), cognitive self-consciousness (p<.05) and
uncontrollability/danger (p < .0001) were the specific domains to be asso-
ciated with anxiety and depression. There were no statistical significant
correlations found for the MMSE or MOCA scores with the MCQ-30.
Metacognition remained a statistically significant correlate with anxiety
(beta = .53, p < .0001) and depression (beta = .52, p < .0001), after con-
trolling for age and stroke severity.
Conclusions: Metacognition appears to be a better estimator of mood
symptoms after stroke in comparison to global cognition.
ESOC-1479
10. Language and Cognition
The relationship between cognitive and emotional
symptoms one week and three months post-stroke
R Grambaite1, B Thommessen1, E Hessen1, T Fladby1
1Department of Neurology, Akershus University Hospital,
Lørenskog, Norway
Background: Cognitive and emotional symptoms are common in stroke
patients. The aim of the present study was to explore the relationship
between emotional and cognitive symptoms one week and three moths
post-stroke.
Method: 36 patients with cortical and 49 patients with lacunar supraten-
torial ischemic infarctions, recruited from a university-hospital based
stroke unit, were followed-up for 3 months (age = 64.4 ± 9.2;
education = 11.0 ± 2.9; men = 68%; Mini Mental State Examina-
tion = 28.4 ± 1.7; the National Institute of Health Stroke Scale-day
2 = 2.7 ± 2.6). All patients were assessed for emotional and cognitive
symptoms one week and three months post-stroke. Emotional symptoms
were evaluated using the Hospital Anxiety and Depression Scale (HADS).
Working memory, processing speed/attention, divided attention, response
inhibition and inhibition/switching were assessed using the following
neuropsychological measures: the Letter-Number Sequencing task, the
Trail Making Test (TMT) A/B and the Color-Word Interference Test.
Correlation analyses were performed in order to test the association
between cognitive and emotional symptoms.
Results: One week post-stroke, higher emotional morbidity (HADS
depression and anxiety subscales) was significantly associated with worse
working memory performance (Pearson’s r = −0.27 for anxiety subscale
and r = −0.30 for depression subscale; p < 0.05). In addition, higher
depressive symptoms (HADS depression subscale) were significantly asso-
ciated with reduced divided attention one week post-stroke (r = 0.22;
p < 0.05).Three months post-stroke, higher depressive symptoms (HADS
depression, but not anxiety subscale) were significantly associated with
worse performance on measures of processing speed/attention, divided
attention and response inhibition/switching (r ≥ 0.23; p < 0.05).
Conclusion: The findings indicate an association between depressive
symptoms and performance on neuropsychological measures of executive
function one week and three months post-stroke.
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Lesions in the left precentral gyrus were associated
with apraxia of speech in patients with acute stroke in
the MCA territory
R Itabashi1, Y Nishio2, Y Kataoka3, Y Yazawa1, E Furui1,
M Matsuda2, E Mori2
1Department of Stroke Neurology, Kohnan Hospital, Sendai,
Japan
2Department of Behavioral Neurology and Cognitive
Neuroscience, Tohoku University Graduate School of
Medicine, Sendai, Japan
3Department of Rehabilitation Medicine, Kohnan Hospital,
Sendai, Japan
Background: Accumulated case reports of pure apraxia of speech (AOS)
suggested that the left precentral gyrus is the responsible lesion, while the
left anterior insula or posterior part of the inferior frontal gyrus has been
implicated in speech articulation in stroke patients. The aim of this study
is to address this issue in consecutive acute stroke patients.
Methods: We retrospectively studied consecutive 2146 ischemic stroke
patients who were admitted within 7 days after onset. According to the
inclusion criteria of first-ever stroke onset, right-handed, isolated non-
lacunar infarcts in the left MCA territory, and evaluation by speech-
language pathologists, consecutive 136 patients were enrolled in this
study. Lesions were delineated on T2-weighted images or fluid-attenuated
inversion recovery images obtained during hospital stay. We generated a
statistic map of lesions contribution related to AOS using voxel-based
lesion symptom mapping (VLSM).
Results: The median interval between onset and speech evaluation was 7
days [5–10, interquartile range]. Of the 136 patients, 22 patients (16 %)
showed AOS including 7 patients with pure AOS. The median time from
onset to imaging was 9 days [7–12.75]. The VLSM analysis revealed areas
associated with AOS in regions centered at the posterior bank of the left
precentral gyrus.
Conclusion: Lesions in the left precentral gyrus are the most likely site
causing AOS in acute stroke patients.
Abstracts
© 2015 The Authors.
International Journal of Stroke © 2015 World Stroke Organization Vol 10 (Suppl. 2); April 2015; 77–438186
ESOC-0590
10. Language and Cognition
Cerebrolysin adjuvant treatment in Broca’s aphasics
following first acute ischemic stroke of the left middle
cerebral artery
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Objective: To assess the efficacy of Cerebrolysin in Broca’s aphasics with
acute ischemic stroke of left middle cerebral artery (MCA).
Methods: Language was evaluated with the Romanian version of the
Western Aphasia Battery (WAB). Inclusion criteria: age 20–75 years,
admission in the hospital within 12 hours from the onset of the symp-
toms, diagnosis of first acute left MCA ischemic stroke, presence of large
artery disease stroke, a NIHSS score of 5–22 points, and a therapeutic time
window within 72 h. 52 patients were treated with Cerebrolysin (Cere-
brolysin group) as an adjunctive treatment. A placebo group, which
received adjunctive saline infusions (104) were matched to the NIHSS and
WAB scores, gender and age of the Cerebrolysin group at baseline. We
assessed spontaneous speech (SS), comprehension (C), repetition (R),
naming (N), and Aphasia Quotient (AQ) scores of the two groups in an
open label design, over 90 days, the mRS scores and mortality.
Results: The two groups had similar age (66 ± 8 versus 65 ± 8 years) and
sex ratio (14/38 versus 30/74). The mean AQ scores and the mean sub-
scores for SS, R, N were similar at baseline and improved in the Cerebroly-
sin group significantly (p < 0.05) over placebo group at all study time
points. The mRS score at 90 days was also lower in the Cerebrolysin group
than in the placebo group. Cerebrolysin and placebo were both tolerated
and safe, and no difference in the mortality rate was seen (3.8% in each
group).
Conclusion: Cerebrolysin is effective for the treatment of such Broca’s
aphasics.
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Blood brain barrier permeability predicts cognition
one year post-lacunar stroke
S D J Makin1, F N Doubal2, K Shuler1, M Valdés Hernández1,
E Sakka1, A K Heye1, M J Thrippleton1, P A A Armitage3,
M S Dennis4, J M Wardlaw1
1Division of Neuroimaging Sciences, University of Edinburgh,
Edinburgh, United Kingdom
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4Centre for Clinical Brain Sciences, University of Edinburgh,
Edinburgh, United Kingdom
Background: Blood brain barrier permeability (BBBP) is linked to lacunar
stroke sub-type, and dementia. Little data exists on the relationship
between BBBP and post-stroke cognition.
Methods: We recruited patients with a lacunar or cortical non-disabling
ischemic stroke. At 1–3 months and 1 year post-stroke we measured
cognition with Addenbrookes Cognitive Examination (ACE-R) and pre-
morbid intelligence quotient (IQ) with the National Adult Reading Test
(NART).We obtained BBBP measurements on white matter hyperinten-
sities (WMH) and normal tissues at 1–3 months from dynamic contrast
enhanced MRI. We used multiple linear regression to investigate the link
between BBBP and ACE-R.
Results: A total of 147 patients (92 lacunar stroke, 109 cortical) had DCE
MRI and cognitive tests at 1–3 months post-stroke and 139 returned for
one year follow-up. In lacunar stroke only patients there was a significant
association between increased BBBP in WMH and lower ACE-R at 1–3
and 12 months post-stroke (adjusted for age, sex, NART, diabetes, and
alcohol) p = 0.03 in lacunar and 0.07 in cortical stroke. The difference
between subtypes was more pronounced at 1 year (p < 0.001 lacunar and
0.45 cortical). There was no other consistent association with BBBP else-
where in the brain, or between BBBP and NART.
Conclusion: In lacunar, but not cortical, stroke increased BBBP in white
matter lesions was associated with post-stroke cognition. The mechanism
of post-stroke cognitive impairment may be different in lacunar stroke,
perhaps due to the involvement of diffuse small vessel disease which may
be mediated by BBBP.
ESOC-0286
10. Language and Cognition
Methodological factors in determining rates of
dementia and cognitive impairment in TIA and stroke:
Applicability of short cognitive tests
S T Pendlebury1, S Klaus1, R Wharton1, P M Rothwell1
1Nuffield Department of Clinical Neurosciences, Stroke
Prevention Research Unit, Oxford, United Kingdom
Introduction: Cognitive assessment is recommended after stroke but there
are few data on the applicability of short cognitive tests to the full spec-
trum of patients. We therefore determined rates and causes of untestabil-
ity in a population-based study of all TIA and stroke.
Methods: Patients with TIA or stroke prospectively recruited (2002–2007)
into the Oxford Vascular Study had ≥1 of mini-mental-state examination
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(MMSE), telephone interview of cognitive status (TICSM), Montreal cog-
nitive assessment (MOCA), and abbreviated mental test score (AMTS)
with follow-up to 5-years.
Results: Among 1097 consecutive assessed survivors (mean age/sd 74.8/
12.1 years, 378 TIA), numbers testable with a short cognitive test at base-
line, 1, 6, 12 and 60 months were 819/1097 (75%), 760/947 (80%), 671/825
(81%), 612/762 (80%) and 381/544 (70%). Untestability was associated
with older age, greater severity of index event and premorbid depen-
dency. Over 90% (343/378) of TIA patients were testable at baseline
compared to only 41% (120/290) of major stroke. Untestability was com-
monly caused by dysphasia (18%) and being too unwell (13%) at baseline
whereas moving out of study area was common at 5 years (26%). Testing
difficulties (eg dysphasia, poor vision) in otherwise testable patients were
more prevalent at baseline (120/819 (15%)) than thereafter: 57/760 (8%),
16/671 (2%), 7/612 (<1%) and 12/381 (3%) at 1, 6, 12 and 60 months.
Conclusions: Requiring completion of a cognitive test excludes those most
at risk of cognitive impairment after TIA and stroke. Future studies
should report data on untestable patients and on those with testing
difficulties.
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New IPAD-based cognitive test for stroke patients
L Willer1, P M Pedersen1, H B Forchhammer2, H K Christensen1
1Neurology, Bispebjerg Hospital, Copenhagen, Denmark
2Neurology, Glostrup Hospital, Copenhagen, Denmark
Introduction: Cognitive testing is important in sub-acute stroke for
research, prognostication and planning. However, the very diverse symp-
toms poses challenges for a test battery suitable for all patients, and the
testing has to be carried out in a limited time as stroke patients are prone
to fatigue.
Method: We developed and validated an iPad-based battery of tests for
aphasia, neglect, episodic memory, attention span, executive function,
working memory, mental speed, anosognosia, manual speed and depres-
sion. Sub-acute stroke patients and age-matched controls were tested
twice within one month.
Results: 44 healthy controls and 51 stroke patients were included. Mean
age 67 years (range 33–90). Mental speed by coding: patients 29.3 and
controls 45.7; mean difference 16.4, 95% CI (10.3–22.4) p〈0.001. Test
re-test reliability in healthy controls by intra-class correlation coefficients
(ICC) 0.925. Mean verbal fluency correct in 1st session: patients 29.2 and
controls 45.3; Mean difference 16.03, 95% CI (10.1–22.0) p < 0.001. Mean
change in patients from 1st to 2nd session: 6.2, 95%CI (1.2–11.2)
p = 0.017. Test-retest reliability in healthy controls by ICC 0.935. Similar
analyses of memory, attention span, and executive function showed sig-
nificant differences between control and patient groups as well as in
patients from 1st to 2nd session.
Conclusion: It is feasible to employ the test battery with the majority of
sub-acute stroke patients. It can be performed in a relatively short time-
span. It is sensitive to the common neuropsychological symptoms and to
the remission of the symptoms.
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Inflammatory biomarkers associated with acute
symptomatic carotid atherosclerosis in the Dublin
Carotid Atherosclerosis and Stroke Study (DUCASS)
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1Neurovascular Unit for Translational and Therapeutics
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3Department of Clinical Chemistry, Mater Misericordiae
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Introduction: In recently-symptomatic carotid stenosis, circulating
inflammatory biomarkers may predict recurrent stroke but may be con-
founded by inflammation secondary to cerebral ischemia. We investigated
the relationship between clinical syndrome (DWI-negative, DWI-positive
TIA, mild stroke) and inflammatory markers in the DUCASS Study.
Methods: DUCASS is a prospective study of biomarkers of recurrent
stroke in consecutive patients with retinal embolism, TIA and mild-
moderate stroke (Rankin <3), with ipsilateral carotid stenosis ≥50%.
Plasma C-reactive protein (CRP), interleukin-6 (IL-6), tumor necrosis
factor-α (TNF-α) and IL-1b were analyzed by mass spectrometry and
ELISA, and compared with non-stroke controls.
Results: 97 patients were included (60.8% retinal embolism/TIA (40.7%
DWI-positive), 39.2% stroke.
In patients with DWI-positive TIA (n = 24) CRP, TNF-α and IL-6 but not
IL-1β (8.96 vs. 1.88, p = 0.002), 4.97 vs. 3.61, p = 0.002) and (7.42 vs. 3.43,
p = 0.002) and for stroke (n = 38), CRP, TNF-α and IL-6 but not IL-1β
(3.58 vs. 1.88, p = 0.03), (6.03 vs. 3.61, p = 0.002) and (6.85 vs. 3.43,
p = 0.0002) were higher in carotid stenosis than controls.
Similar relationships were found in DWI-negative TIA (n = 23) compared
with controls, for CRP and TNF-α, but not IL-6 and IL-1β (0.82 vs.
1.88 mg/ml, p = 0.047) and (4.40 vs. 3.61 pg/ml, p = 0.028).
Conclusion: CRP, TNF-α and IL-6 but not IL1-β were associated with
acute symptomatic carotid atherosclerosis, including CRP and TNF-α in
DWI-negative TIA, suggesting a contribution from plaque inflammation.
Further study is required to determine the prognostic utility of inflam-
matory biomarkers in cranio-cervical atherosclerosis.
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Early ischemic changes on CT are associated with
MMP-3 and TIMP-1 balance after thrombolysis in
patients with acute ischemic stroke
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B Giusti3, P Tonelli1, E Innocenti1, G Pracucci1, A Sereni3, A Sticchi3,
A Nucera4, D Toni5, R Abbate3, D Inzitari1
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3Department of Experimental and Clinical Medicine,
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Background and Purpose: Substantial experimental and clinical evidence
suggest that matrix metalloproteinases (MMPs) and their tissue inhibitors
(TIMPs) play a relevant pathophysiologic role in early phases of acute
ischemic stroke. In acute clinical setting, early ischemic damage on base-
line CT scan is often evaluated by using the Alberta Stroke Program Early
Computed Tomography Score (ASPECTS). We aimed to establish whether
an association between ASPECTS and MMPs and TIMPs exists in patients
treated with i.v. thrombolysis.
Methods: Data were obtained from the MAGIC study. We performed
centralized assessment of ASPECTS dichotomized into two groups (0–7 vs
8–10). Circulating levels of MMPs and TIMPs were taken before and 24
hours after t-PA treatment. Baseline values, delta median values ([24
hours post t-PA – pre t-PA]/pre t-PA), and delta median ratio values
between MMPs and their inhibitors [(MMP/TIMP 24 hours post t-PA –
MMP/TIMP pre t-PA)/(MMP/TIMP 24 hours)] were analyzed among the
two ASPECTS groups. We used multiple logistic regression to study inde-
pendent associations.
Results: 230 patients were assessed for ASPECTS rating and blood bio-
markers levels. After adjustment for major clinical determinants, MMP-3
delta median value showed a trend towards lower ASPECTS (OR = 1.25;
95% CI: 0.97–1.61). Higher MMP-3/TIMP-1 delta median ratio proved to
be independently associated with lower ASPECTS (OR = 1.27; 95% CI:
1.01–1.58).
Conclusions: In patients with acute ischemic stroke treated with intrave-
nous thrombolysis the extent of ischemic changes on baseline CT is asso-
ciated with balance between MMP-3 and TIMP-1. Further studies are
needed to validate this finding.
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Peripheral frequency of CD4+CD28-cells in acute
ischemic stroke: Relationship with stroke subtype and
severity markers
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Background: CD28 null cells have been reported as increased in acute
coronary syndrome. Only two studies analyzed peripheral frequency of
CD28 null cells in acute ischemic stroke but, peripheral frequency of
CD28-cells in each TOAST subtype has never been evaluated. We hypoth-
esized that the CD4+CD28- subset could show a different degree of
peripheral percentage in subjects with acute ischemic stroke in relation to
clinical subtype and severity of istroke.
Objectives: To analyze peripheral frequency of CD4CD28-cells in subjects
with acute ischemic stroke in relation to TOAST diagnostic subtype, rela-
tionship with scores of clinical severity of acute ischemic stroke, and their
predictive role in the diagnosis.
Methods: We enrolled 98 consecutive subjects with ischemic stroke. As
controls we enrolled 66 patients without acute ischemic stroke. Peripheral
frequency of CD4+ and CD28-T cells has been evaluated by a FACS
Calibur flow cytometer.
Results: Subjects with acute ischemic stroke had a significantly higher
peripheral frequency of CD4+ cells and CD4+CD28-cells compared to
controls without acute ischemic stroke. Subjects with cardio-embolic
stroke had a significantly higher peripheral frequency of CD4+cells and
CD28-cells compared to subjects with other TOAST subtypes. We
observed a significant relationship between CD4CD28-cells and Scandi-
navian Stroke Scale and NIHSS scores. ROC curve analysis showed that
CD28-cell percentage was predictive of stroke and LAAS and cardio-
embolic subtype.
Conclusions: These findings suggest a possible role for a T-cell component
also in acute ischemic stroke clinical setting showing a different CD28-
cell peripheral frequency in relation of each TOAST subtype of stroke.
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Delayed administration of perlecan doman V
significantly increases neurogenesis and improves
functional outcome after experimental ischemic stroke
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Stroke, a major cause of morbidity and death, has limited therapeutic
options. In our efforts to develop novel stroke therapies, we have discov-
ered that the domain V (DV) bioactive protein fragment of the brain
vascular matrix proteoglycan perlecan is both neuroprotective and pro-
angiogenic. Furthermore, functional outcome can be significantly
improved in rodents by administering DV 6–24 hours after experimental
transient (distal MCA occlusion) or permanent (photothrombosis)
stroke. Here we studied the potential of delayed DV administration (ini-
tiated 7 days post-stroke) to increase neurogenesis and improve functional
outcome as well as a possible mechanism of action through the alpha 2
integrin receptor. After two doses of DV, 3-month old male C57BL6 mice
subjected to transient distal MCA occlusion had significant functional
improvement as measured by rotor rod. Brain immunohistochemistry 21
days after stroke demonstrated that DV treated mice had significantly
more BrdU (a marker of cell division), doublecortin (DCX, immature
neuron marker), and NeuN (neuronal marker) positive cells in the infarct
area. Furthermore, DV’s neurogenic effects could be blocked by treatment
with alpha 2 function blocking antibody after photothrombosis. These
results suggest that delayed DV treatment after experimental stroke
increases neurogenesis, increases the number of new neurons that reach
stroked brain regions and survive there, and improves functional outcome
through an alpha 2 integrin dependent mechanism. Importantly, as we are
unaware of any other delayed stroke monotherapy that significantly
improves functional outcome after stroke, our data further support the
promise of DV as a novel stroke therapy.
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Prognostic value of SST2 in patients with acute
ischemic stroke – Results of the Linz Stroke Unit (LISU)
study. A prospective cohort study
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Aim: To evaluate whether plasma concentrations of sST2 were indepen-
dently associated with death and disability after stroke.
Concentrations were measured in consecutive patients with acute isch-
emic stroke.
The NIHSS and plasma concentrations of C-reactive protein (CRP) and
amino-terminal pro-B-type natriuretic peptide (NT-proBNP) were also
assessed at baseline. Primary outcome measure was all-cause mortality at
90 days; secondary outcome measure was functional outcome at 90 days.
The median sST2 plasma concentration was 35 U/mL. The median sST2
plasma concentration was higher in decedents than survivors (55 U/mL
vs. 34 U/mL; p < 0.001). A clear threshold effect at an sST2 plasma con-
centration of 35 U/mL was established. Univariate Cox proportional-
hazard regression analysis, using the threshold of 35 U/mL to dichotomize
sST2, revealed a 7.5 fold increased risk of death in stroke patients with
increased sST2 plasma concentrations (risk ratio 7.57, 95% confidence
interval 2.65–21.57; p < 0.001). In multivariate analysis, sST2 remained an
independent predictor of mortality (risk ratio 3.07, 95% confidence inter-
val 1.02–9.20; p = 0.046). With respect to the secondary outcome, median
sST2 plasma concentrations were significantly higher in stroke patients
with unfavorable vs. favorable outcome at 90 days (41 U/mL vs. 32 U/mL;
p < 0.001). After adjustment for NIHSS, CRP and NT-proBNP sST2 lost
its predictive value for unfavorable outcome at 90 days (odds ratio 1.50,
95% confidence interval 0.90–2.51; p = 0.199).
Conclusion: SST2 was an independent predictor of 90-day all-cause mor-
tality but not of 90-day functional outcome. The biomarker sST2 added
prognostic information to the NIHSS with respect to mortality at 90 days.
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Bone structure and density were reduced in
non-paretic but not in paretic hindlimbs in an animal
model of stroke: A pilot investigation
K Borschmann1, S Rewell1, A Ghasem-Zadeh2, R Davey3,
L Churilov1, J Bernhardt1, D Howells1
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Background and Aim: In humans, inactivity after stroke is associated with
accelerated bone loss. The aim of this study was to investigate skeletal
effects of brain infarct, using a proven animal model.
Hypothesis: Post-stroke, skeletal parameters of left and right femurs
would be compromised, but physical activity unaffected, to suggest a
skeletal effect of brain infarct.
Methods: Spontaneously-hypertensive male rats, aged 15 weeks, random-
ized to stroke (right middle cerebral artery occlusion, n = 12) or sham
surgery (n = 8). Impairment testing (stroke behaviors, ladder walk) and
activity monitoring (proportion of time active) were undertaken prior to
cull at four weeks. Trabecular and cortical parameters of distal regions of
both femurs were determined by Micro-CT (10.5 μm resolution). Study
was approved and managed according to Austin Health Animal Ethics
Committee.
Results: Stroke animals displayed impaired left hindlimbs, but activity did
not differ between groups. Non-parametric analyses showed no between-
group differences in trabecular (primary outcome) or cortical parameters
of left femurs. However, between-group differences were observed in
right femurs: stroke animals had lower trabecular connective density
(median 194.1 (IQR 182.9, 230.0) v 206.0 (195.9, 226.2), p = 0.03), corti-
cal bone volume fraction (85.8% (83.6, 86.0) v 88.1 (86.4, 89.1) p = 0.02)
and material density (951.8 mgHA/mm3 (943.3, 958.1) v 973.4(969.2,
981.7), p = 0.01). Stroke impairments were not associated with these
parameters.
Conclusion: Stroke animals had compromised bone parameters of non-
paretic legs, but not paretic legs compared to shams, despite no observed
differences in activity or associations with impairments. Investigation of
limb use and weightbearing symmetry using this model is warranted to
better understand drivers of post-stroke bone loss.
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Introduction: Clinical diagnosis of patients with transient ischemic attack
(TIA) is a difficult endeavor and metabolomics on patient cohorts is often
jeopardized due to intrinsic variability of sampling patients on the clinical
setup. To circumvent this, we used a mice model to identify TIA biomark-
ers and we develop as well an ischemic conditioning (IC) system for
molecular characterization of this phenomenon.
Methods: Mice were submitted to surgery only (SHAM), 7 minutes or 25
minutes occlusion (TIA and Stroke), and plasma was collected at 6, 12, 24
and 48 h after. For IC, mice got 5x2 min occlusion (not on SHAM), let
recover 24 h and a 60 min occlusion (Stroke) was performed. Just before
stroke (basal) and 0, 1, 3, 6, 12 and 24 h post Stroke ischemic cortical brain
tissue and plasma were obtained for mRNA and metabolomics assay.
Results: Multivariate statistics allowed us to separate between different
times on same treatment (except for SHAM) and SHAM vs TIA vs Stroke.
Further, one way ANOVA after Benjamini-Hochberg correction identified
38 metabolites that separate SHAM-TIA-Stroke.
Conclusion: The use of mice model to identify metabolites for clinical
diagnosis of TIA allows the use of very stringent statistics. This allows
proposing candidate biomarkers to distinguish between TIA and Stroke,
providing an excellent platform for biomarker development to be vali-
dated on human cohorts.
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Distinct specificity patterns of anti-beta amyloid
peptide antibodies in hemorrhagic and inflammatory
cerebral amyloid angiopathy and Alzheimer’s disease
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Context: Cerebral amyloid angiopathy is a frequent cause of microvascu-
lar stroke and lobar cerebral hemorrhage (CAA-h). CAA related inflam-
mation (CAA-i) is a rare cause of subacute steroid responsive focal white
matter edema with superficial hemorrhages. Deposits of aggregated
β-amyloid peptide (Aβ) are found in the brain parenchyma and/or vessel
walls of CAA-h, CAA-i and Alzheimer’s disease (AD) patients. Natural
anti-Aβ antibodies are produced spontaneously by both healthy subjects
and patients. We hypothesize that a specific immune reaction induced
against fibrillar Aβ deposits might play a key role in the pathophysiology
of CAA-h and CAA-i.
Objective: To compare concentrations of serum anti-Aβ antibodies and
their specificity against polystyrene-coated monomeric, oligomeric and
fibrillary forms of Aβ, in a cohort of CAA-h, CAA-i, AD and age-matched
healthy controls.
Methods: Purity of in vitro generated monomeric, oligomeric and fibrillar
Aβ was evaluated by cryoTEM. Using these antigenic preparations, indi-
rect ELISAs were performed for measuring the serum levels of anti-Aβ
IgG and IgM specific for the corresponding conformers.
Results: Preliminary studies revealed that CAA-i is associated to lower
levels of anti-Aβ IgG than CAA-h, AD and healthy controls. CAA-i is also
associated to higher ratios of anti-fibrillar Aβ / anti-soluble (monomeric
and oligomeric) Aβ antibodies. This repertoire shift was observed in a
lesser extent in CAA-h.
Conclusion: Results suggest a specific role of anti-Aβ antibodies in CAA-i
and CAA-h, along with the development of an immune response against
fibrillar Aβ deposits.
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Cerebrolysin dose-dependently improves neurological
outcome in male and female rats after acute stroke
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Cerebrolysin is a peptide preparation indicated for the use in stroke,
traumatic brain lesions and dementias including Alzheimers disease. The
current study was conducted with the aim to examine the dose response of
Cerebrolysin on behavior and histology parameters in a clinical relevant
treatment scheme. The present study was carried out as a prospective,
randomized, double-blind, placebo-controlled study of Cerebrolysin in
both male and female ischemic rats. Wistar rats (51 male and 51 female)
were subjected to embolic middle cerebral artery occlusion (MCAO). Rats
were randomized to treatment with Cerebrolysin or saline at 0.8, 2.5, 5.0,
and 7.5 ml/kg with treatment initiated at 4 h after MCAO and continued
daily for 9 consecutive days. An array of behavioral tests to detect soma-
tosensory functions was measured. All rats were sacrificed 28 days after
MCAO and infarct volume was measured. There was a significant
(p < 0.01) dose effect of Cerebrolysin on neurological outcome versus
saline in both genders 28 days after MCAO. Doses ≥ 2.5 ml/kg signifi-
cantly (p < 0.01) improved functional recovery starting 14 days post
stroke. Cerebrolysin at doses of ≥2.5 ml/kg also significantly (p < 0.05)
reduced infarct volume. For the first time a preclinical Cerebrolysin study
with a rigorous double-blind clinical trial design and analyses has been
implemented under good laboratory practice (GLP) conditions. Thus,
preclinical data performed under rigorous conditions of a clinical trial,
strongly support the clinical translation of Cerebrolysin as a treatment for
stroke.
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Assessment L-theanine neuroprotective efficiency
using neurological and behavioural tests in different
terms after focal cerebral ischemia in rats
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Among broad spectrum of neuroprotective drugs new natural origin neu-
roprotective factors start to draw investigator’s attention. L-theanine
(gamma-glutamylethylamide) is the green tea (Camellia sinensis) amino
acid. Present study is aimed to evaluate L-theanine neuroprotective effi-
ciency in experimental brain ischemic damage in rats on late terms (till 4
weeks) of postischemical period using several neurological and behavioral
tests (Garcia Score Test, Modified Sticky-Tape Test, Tongue Protrusion
Test, Open Field Test). Also we compare the sensitivity of noticed tests in
different terms after ischemia to produce optimal postischemical impair-
ment assessment criteria. L-Theanine was administered intraperitoneally
1 mg/kg 30 minutes before middle cerebral artery occlusion in Koidzumi
model of focal transient cerebral ischemia. Tests were managed before and
on the 2, 7, 14, 21, 28 days after the ischemia. According to Garcia Score
Test significant difference in neurological deficiency between control and
experimental groups was revealed only on the second day after ischemia.
Modified Sticky-Tape Test shows significant somatosensory sensitivity
diminution on the second week after ischemia. Significant tongue motion
activity diminution was observed on the first, second and third weeks after
MCA occlusion. Significant difference in behavioral disorders was fixed
only since fourth week after ischemia. Thereby L-theanine introduction
decrease an intensity of neurological deficiency and behavioral disorders
in rats during the whole observed postischemical period. On early terms
after ischemia it’s more appropriate to use neurological tests for func-
tional disorders evaluation, as well as behavioral tests are more sensible on
late terms (3–5 weeks) after ischemia.
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Systemically injected IGF-I is transported to the brain
and exerts neuroprotective effects via central IGF-I
receptors in a rat model for ischemic stroke
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The pleiotropic peptide insulin-like growth factor (IGF)-I is a neuropro-
tective agent in animal models of focal cerebral ischemia, but only a few
studies demonstrated these effects following systemic IGF-I administra-
tion. It remains unknown whether systemic injection of IGF-I exerts its
neuroprotective effects through interaction with IGF-I receptors in the
brain after passage of the blood-brain barrier or more indirectly via
peripheral effects.
To separate the central action component of IGF-I from its systemic
component in stroke, conscious male Wistar Kyoto rats received IGF-I
systemically and the IGF-I receptor antagonist JB-1 centrally in the lateral
cerebral ventricle. Stroke was induced through injection of endothelin-1
in the right hemisphere next to the middle cerebral artery.
Intravenous administration of IGF-I reduced the infarct size with 50%
and central administration of JB-1 reverted the neuroprotective effects of
IGF-I. These results suggest that systemically injected IGF-I exerts neuro-
protective effects via binding to IGF-I receptors in the brain. We also
measured the transport to the brain of systemically administered recom-
binant human IGF-I after induction of ischemic stroke with an ELISA
specifically detecting human IGF-I. Human IGF-I was detected in both
hemispheres. Remarkably, induction of stroke induced transport of sys-
temically injected IGF-I to the left hemisphere in which no opening of the
blood-brain barrier could be detected, indicating that stroke stimulates
IGF-I transport to the brain through a genuine transport mechanism
across the blood-brain barrier. This evidence provides strong arguments
for testing systemic IGF-I administration together with protocols enhanc-
ing transport of IGF-I to the brain.
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Moderate forced exercise improves sensorimotor and
cognitive function following stroke in mice
K Diederich1, D Zaremba1, A Schmidt1, J K Strecker1, J Minnerup1
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Introduction: Stroke is one of the leading causes of death and the most
common cause of adult disability in the western industrial countries.
Whereas thrombolysis with tissue plasminogen activator (tPA) is an
approved neuroprotective therapy, neurorestorative pharmacological
interventions targeting post-acute treatment of stroke are still elusive. The
aim of this study was to investigate neurorehabilitative effects of moderate
forced exercise on functional recovery and on the generation and survival
of neural cells following photothrombotic stroke in mice.
Methods: A total of twenty-four C57BL/6 mice were subjected to photo-
thrombotic cortical ischemia, a subset of twelve animals underwent mod-
erate forced training in motorized running wheels starting at day 3
following ischemia until the end of the experiment on day 28. Extensive
sensorimotor and cognitive testing was applied to quantify the animals’
deficit and recovery process. To birth-date newly generated neurons, the
thymidine analogues 5-Chloro-2′-deoxyuridine (CldU) and iododeoxyu-
ridine (IdU) were administered at days 1 and 2 (CldU) and twice weekly
until day 28 (IdU) after ischemia.
Results: Forced rehabilitative training improved recovery from senso-
rimotor and cognitive deficits following cortical ischemia. Immunohisto-
chemical analysis revealed significantly increased generation and survival
of newly born neurons in both the dentate gyrus and the subventricular
zone.
Conclusion: Moderate forced exercise improved the recovery of senso-
rimotor and cognitive function following stroke and increased both the
generation and survival of neural cells. Effectiveness even after delayed
initiation 48 hours after onset of ischemia opens up promising possibili-
ties for successful rehabilitation following stroke.
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Spreading depolarization in patients with cardiac
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Background: Spreading depolarization (SD) is characterized by massive
ion translocation. Dependent on energy, SD is either preceded by non-
spreading electrical silence (depression) due to neuronal hyperpolariza-
tion, or it causes spreading depression of electrical activity due to a
depolarization block. Nonspreading depression seems to translate into the
initial symptoms of ischemic stroke and spreading depression into
migraine aura. SDs facilitate neuron death when they invade metabolically
compromised tissue while they are innocuous in healthy tissue. SDs are
abundant in patients with aneurismal subarachnoid hemorrhage (aSAH)
and malignant hemispheric stroke (MHS). The sequence of nonspreading
depression followed be SD has however not been observed in patients.
Methods: In 2 aSAH patients, we performed subdural electrocorticogra-
phy (ECoG) of SDs in order to detect delayed cerebral ischemia. Clinical
and research consents were obtained according to our Institutional
Review Board.
Results: In both cases, ECoG electrodes were in place when a medical
decision of the treating intensivists was reached to withdraw life support.
Cardiac failure induced acute cerebral hypoxia-ischemia. Spontaneous
electrical activity was present at baseline and the series of events associated
with death were similar: first, decline in cardiac output developed together
with progressive depression of spontaneous activity. Then, complete
depression of activity was documented to occur synchronously in a non-
spreading manner across the array of the 6 electrodes, spanning 5 cm.
Seventy-five respectively 222 seconds later, terminal SD started to run in
the cortex with amplitudes of 4.7 respectively 9.2 mV.
Conclusion: Similar to animal experiments, cardiac arrest induces non-
spreading depression followed by SD.
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The role of Ghrelin in neuroregeneration following
experimental stroke
U Eisele1, K Diederich1, J K Strecker1, B Geng1, M Hoppen1,
J Minnerup1
1Neurology, University of Münster, Münster, Germany
Introduction: The discovery that Ghrelin receptors are expressed in
the CNS led to the view that ghrelin may affect higher brain functions,
besides its regulatory impact on feeding and metabolism. Ghrelin
exerts multifaceted actions in the CNS and possesses vital functions in
neuroregeneration.
The aim of this study is to investigate effects and the underlying mecha-
nisms of Ghrelin on functional and structural regeneration in the post-
ischemic brain.
Methods: Male adult rats were given a photothrombotic infarct and
divided into the following intervention groups:
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– Photothrombosis and Ghrelin for 28 days (50 μg/kg, i.p.)
– Photothrombosis and NaCl for 28 days (i.p.)
– Photothrombosis and Ghrelin receptor antangonist D-Lys3-GHRP-6
(i.p.)
To birth-date newly generated neurons, the thymidine analogues Chloro-
deoxyuridine (CldU) and Iodo-deoxyuridine (IdU) were administered at
days 1–4 (CldU) and at days 25–27 (IdU) after ischemia. Functional
recovery was assessed using the adhesive tape removal test and the cylinder
test, cognitive function was measured via the water maze test.
To quantify neurogenesis in the dentate gyrus and the subventricular
zone, immunohistochemical co-staining of CldU and NeuN was
performed.
Results: Ghrelin treatment led to increased sensorimotor recovery after
stroke, whereas blocking of the Ghrelin receptor interfered with the recov-
ery. Concordantly, cognitive performance was improved within the
Ghrelin-treated group.
Immunohistochemical analysis revealed an increased survival of newly
born neurons in both the dentate gyrus and the subventricular zone.
Conclusions: The ameliorated functional recovery and its structural cor-
relate, adult neurogenesis, strongly undermines the role of Ghrelin as a
promising agent for the sub-acute treatment of ischemic stroke.
ESOC-0898
11. Experimental/Translational Medicine
Selective intra-arterial verapamil after reperfusion in
experimental ischemic stroke is neuroprotective and
improves motor function
J Fraser1, M Maniskas2, G Bix2
1Department of Neurosurgery, University of Kentucky,
Lexington, USA
2Anatomy & Neurobiology, University of Kentucky, Lexington,
USA
Large vessel ischemic stroke is a major cause of morbidity and mortality.
Despite improving treatments and techniques to promote acute cerebro-
vascular recanalization, progress in clinical outcomes continues to lag. In
this setting, we previously created and optimized a mouse model to study
concurrent large vessel recanalization (1 hour transient middle cerebral
artery occlusion) with intra-arterial drug administration. Using this
model, we aimed to study verapamil, an FDA-approved calcium-channel
blocker already administered to the brain for cerebral vasospasm. Vera-
pamil or saline (n = 10) was given intra-arterially to the common carotid
artery after reperfusion. We noted that mice treated with verapamil had
significantly (p < 0.05) better functional recovery as assessed by the rotor
rod. Mean stroke volumes were also significantly smaller as measured by
TTC and cresyl violet stain. Verapamil treatment also resulted in signifi-
cant reduction in apoptosis by TUNEL stain, and significantly more
mature neurons were noted by NeuN stain. Finally, verapamil treatment
resulted in reduced astrogliosis, as evaluated by GFAP staining. These
results suggest that IA administration of verapamil immediately following
experimental large vessel stroke represents a novel therapeutic approach
that may be directly neuroprotective and improve functional recovery.
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Spreading depolarizations increase delayed brain
injury in a rat model of subarachnoid hemorrhage
A M Hamming1, M J H Wermer1, U Rudrapatna2, C Lanier3,
H J Van Os1, W van den Bergh4, M D Ferrari1, A van der Toorn2,
A M J M van den Maagdenberg5, A M Stowe3, R M Dijkhuizen2
1Neurology, Leiden University Medical Center, Leiden,
Netherlands
2Biomedical MR Imaging and Spectroscopy Group Image
Sciences Institute, University Medical Center Utrecht, Utrecht,
Netherlands
3Department of Neurology and Neurotherapeutics, University
of Texas Southwestern Medical Center, Dallas Texas, USA
4Department of Critical Care, University of Groningen,
Groningen, Netherlands
5Department of Human Genetics, Leiden University Medical
Center, Leiden, Netherlands
Spreading depolarizations (SDs) may contribute to delayed cerebral isch-
emia after subarachnoid hemorrhage (SAH), but their effect on post-SAH
lesion progression has not yet been assessed directly. In a rat SAH model,
we measured brain tissue damage with MRI, before and two days after
cortical KCl (SD group, n = 16) or NaCl application (no-SD group,
n = 15) at day 1 post-SAH. Histology confirmed neuronal damage in areas
of early and delayed injury. Lesion growth was significantly larger in the
SD group (243 ± 233 mm3) than in the no-SD group (30 ± 55 mm3)
(p = 0.001). Our study demonstrates that SDs advance delayed brain
injury after SAH.
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Successive synaptic and membrane failure depend on
depth and duration of hypoxia in an vitro model of
the ischemic penumbra
J Hofmeijer1, S T Pavlidou1, M J A M van Putten1, J le Feber1
1Clinical Neurophysiology, University of Twente, Enschede,
Netherlands
There is limited understanding of the nature of dynamic neuronal pro-
cesses leading to either secondary irreversible damage or recovery in the
ischemic penumbra. We use cultured neuronal networks to study neu-
ronal dynamics during partial hypoxia, focusing on changes of synaptic
transmission and membrane integrity.
Twenty-two cultured networks of rat cortical neurons grown over multi
electrode arrays were exposed to hypoxia of various depth and duration
(pO2 of 160 mmHg lowered to 90 or 30 mmHg, during 6–48 hours).
Synaptic functioning was assessed before, during, and after hypoxia by the
amount of spontaneous network activity and network responses to elec-
trical stimulation. Action potential shapes and direct (non-synaptic)
stimulus responses were used as measures of neuronal integrity.
During pO2 = 30 mmHg, synaptic transmission failed within an hour.
Isolated synaptic failure was reversible after 6–12 hours of hypoxia,
but partly irreversible after 24 hours (Figure 1). Irreversible membrane
failure occurred between 24 and 48 hours (Figure 2), but later with
pO2 = 90 mmHg.
The cascade of neuronal pathophysiological events in the ischemic pen-
umbra includes reversible synaptic failure, irreversible synaptic failure,
and membrane failure, respectively. The timescale of this cascade depends
on remaining perfusion levels.
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Fig. 1 Reversible (a) and partly irreversible (b) decrease of synaptic stimu-
lus response during hypoxia of 6 (a) and 24 (b) hours.
Fig. 2 Irreversible decrease of non-synaptic stimulus response after
hypoxia of 48 hours.
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Magnetic resonance spectroscopy pattern-recognition
techniques to metabolically differentiate brain regions
in a rat stroke model: A biomarker discovery tool
E Jimenez-Xarrie1, M Davila2, A P Candiota2,
R Delgado-Mederos1, C Arús2, J Martí-Fàbregas1
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Introduction: Magnetic resonance spectroscopy (MRS) assesses the meta-
bolic pattern of a brain region. SpectraClassifier is a pattern-recognition
software that uses the metabolites that vary among different regions to
objectively classify them in additional subjects. Our purpose was to deter-
mine those metabolites for normal-tissue, subventricular zones (SVZ) and
infarct in a rat stroke model.
Methods: A total of 164 proton MR spectra were obtained at 7T at an echo
time of 12 ms from Sprague-Dawley rats subjected to 90-minutes MCAO.
MRS was acquired from normal-tissue (n = 48), SVZ (n = 82) and infarct
(at 1 and 7 +/- 1 days post-MCAO; n = 34). Spectra were assigned to the
training set (n = 108) to determine the discriminant features and to the
independent test set (n = 56) to evaluate the classification robustness,
using SpectraClassifier v3.0 (http://gabrmn.uab.es/sc). Statistical analysis
of the individual metabolic changes among regions was performed with
the Kruskall-Wallis test using SPSS.
Results: The training set showed that spectral features coherent with
myoinositol (Myo, 3.62 ppm) and total creatine (TCr, 3.04 ppm) distin-
guished amongst normal-tissue (AUC: 0.90 ± 0.06), SVZ (AUC:
0.92 ± 0.04) and infarct (AUC: 1.00 ± 0.00), with a 83.5 ± 3.6% of cor-
rectly classified cases. The Balanced Error Rate in the independent test set
was 7.2%. When the discriminative spectral features were analyzed indi-
vidually, a diminished TCr allowed the differentiation of the infarct com-
pared to the other brain regions (p < 0.01). Furthermore, Myo was
increased in the SVZ and decreased in the infarct, in relation with the
normal-tissue (p < 0.01).
Conclusion: SpectraClassifier robustly identifies different brain regions
with good accuracy based on metabolite feature analysis.
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p75 neurotrophin receptor and its novel interaction
partner, NIX, are involved in neuronal apoptosis after
intracerebral hemorrhage
J Shen1, X Chen1, Y Song1, H Ni1, M Cao1, Q Ji1, K Ke1
1Neurology, Affiliated Hospital of Nantong University,
Nantong, China
Recently, NIX, a pro-apoptotic BH3-only protein, was found a novel p75
neurotrophin receptor (p75NTR) binding protein by screening a human
fetal brain two-hybrid library in our laboratory. Here, we further study the
interaction of these two proteins and the possible roles for p75NTR and
NIX in intracerebral hemorrhage (ICH)-induced neuronal death.
Co-immunoprecipitation and in vitro binding assays demonstrated a
direct interaction between p75NTR and NIX. Based on this interaction,
NIX protein was stabilized by p75NTR at posttranslational levels. In addi-
tion, p75NTR could work together with NIX to promote apoptosis and
affected NIX-induced JNK-p53-Bax pathway in neuronal PC12 cells. Pre-
vious work indicated that p75NTR and NIX are induced in neurons in
human ICH and rat ICH model, respectively. In this study, we confirmed
that both p75NTR and NIX levels were up-regulated in glutamate treated
primary cortical neurons, a cellular in vitro model for ICH and in rat ICH
model. Also, glutamate exposure increased the association between
p75NTR and NIX and elevated the activation of JNK-p53-Bax pathway
and neuronal apoptosis, all of these observations are similar in rat ICH
model. Importantly, p75NTR and NIX appeared to be involved in cortical
neuronal apoptosis because knockdown of p75NTR or NIX not only
inhibited JNK pathway, but also impaired neuronal apoptosis. Our study
suggests that p75NTR and NIX may play critical roles in ICH-induced
neuronal apoptosis in vitro and in vivo.
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Stem cell therapy in stroke – human dental pulp stem
cells from basic science to a clinical trial
S Koblar1, S Gronthos2, S Shi3
1Medicine, University of Adelaide, Adelaide, Australia
2Medical Science, University of Adelaide, Adelaide, Australia
3Penn Dental Medicine, University of Pennsylvania,
Philadelphia, USA
Stroke is the leading cause of disability in many countries. The global
burden of stroke is estimated at 33 million people who are chronically
disabled post-stroke. There is no clinically proven drug or biological agent
that will enhance neurological recovery as an adjunctive therapy with
rehabilitation. We propose – TOOTH (The Open study Of dental pulp
stem cells (DPSC) Therapy in Humans) Stroke Clinical Trial – to investi-
gate the safety, feasibility and parameters of efficacy of autologous human
adult stem cell therapy in participants with chronic stable disability.
TOOTH will provide the first-in-human evidence of the potential of
human DPSC as an active biological therapy. We will utilize autologous
DPSCs, which are a neural-type of human adult stem cell. We first isolated
human DPSCs from the dental pulp tissue of a human tooth in 2000.
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DPSCs are clinically easy to access and have unique neurogenic potential
due to their neural crest ontogeny. We have published a series of studies
that demonstrated DPSCs differentiate into functional neurons, interact
with the host nervous system inducing neural plasticity, and enhance
neurological recovery following intracerebral injection into a rodent
stroke brain. To date, we do not know which stem cell type will be best for
neural regeneration or repair but one assumption is that neural stem cells
or like cells will have a greater propensity for benefit. This presentation
will demonstrate our path from basic stem cell and neuroscience discovery
to translation into a future clinical trial.
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Development of long-circulating liposomes for
thrombus imaging by CT
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Introduction: Liposomes represent advanced nanodelivery systems
capable loading contrast CT agents as well as targeting of desired tissue
(e.g. thrombus). Targeted CT liposomes represent novel approach for
rapid thrombus imaging. The surface modification by polymer of these
liposomes prolongs their biologic circulation. It also improves selective
thrombus accumulation to enhance contrast over the surrounding tissue.
Aims: The aim of this study was development of post-forming procedure
for preparation of long-circulating liposomes.
Methods: Preformed liposomes prepared by freeze-thaw extrusion
(100 nm) were modified by addition (5 mol %) of micellar lipid polymer
(distearoyl phosphatidyl choline – polyethylene glycol 2000, DSPE-mPEG
2000). Preformed liposomes were composed of distearoyl phosphatidyl
choline and cholesterol (molar ratio, 55/45). The size of micelles, pre-
formed and long-circulating liposomes was monitored by dynamic light
scattering. The formation of micelles was fluorimetrically detected.
Results: Formation of micelles was initiated from 8 μM of DSPE-mPEG
2000. Further, transfer of DSPE-mPEG2000 from micelles to preformed
liposomes was completed during 30 min at 65oC. Corresponding to this
phenomenon, the original liposome size increased from 94 nm to 107 nm.
Micelles had size of 12 nm.
Conclusions: The post-forming was eligible for preparation of long-
circulating liposomes. Using this procedure, only the external liposomal
surface was modified. These liposomes will be further developed for
loading of CT contrast agents as well as for thrombus imaging such as
targeted long-circulating CT liposomes.
Acknowledgements: This work was supported by the following grants:
GAP503/12/G147, MZE0002716202, CZ.1.05/1.1.00/02.0123 and
CZ.1.07/2.3.00/30.0043.
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Activation of the HMGB1-RAGE signaling pathway in
rats during neurogenesis after intracerebral
hemorrhage
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Chengdu, China
Background and Purpose: Following intracerebral hemorrhage (ICH),
high-mobility group box 1 protein (HMGB1) may promote neurogenesis
that supports functional recovery. How HMGB1 regulates or participates
in this process is unclear, as are the pattern recognition receptors and
signaling pathways involved.
Methods: ICH was induced by injection of collagenase in Sprague-Dawley
rats, which were treated 3 days later with saline, with the HMGB1 inhibi-
tor ethyl pyruvate (EP) or with FPS-ZM1, an antagonist of the receptor for
advanced glycation end-products (RAGE). A Sham group was treated with
saline solution instead of collagenase and then treated 3 days later with
saline again or with EP or FPS-ZM1. Expression of the following proteins
was measured by Western blot, immunohistochemistry, or immunofluo-
rescence: HMGB1, RAGE, toll-like receptor (TLR)-2, TLR4, brain-derived
neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9).
Numbers of cells positive for 5-bromo-2-deoxyuridine (BrdU) or
doublecortin (DCX) were determined by immunohistochemistry and
immunofluorescence.
Results: Levels of HMGB1, RAGE, TLR4, TLR2, BDNF, and MMP-9 were
significantly higher 14 days after ICH than at baseline, as were the
numbers of BrdU- or DCX-positive cells. At the same time, HMGB1
moved from the nucleus into the cytoplasm. Administering EP signifi-
cantly reduced all these ICH-induced increases, except the increase in
TLR4 and TLR2. Administering FPS-ZM1 reduced the ICH-induced
increases in the expression of BDNF and MMP-9, and in the numbers of
BrdU- or DCX-positive cells.
Conclusions: These findings suggest that HMGB1 acts via the RAGE sig-
naling pathway to promote neurogenesis in later phases of ICH.
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Matrix metalloproteinase-13 (MMP-13) modulates
neuroprotection and neurorepair after cerebral cortical
ischemia
F Ma1, V Barceló1, A Morancho1, P Martínez-San Segundo1,
M Gabriel-Salazar1, D Giralt1, J Montaner1, A Rosell1
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Background and objective: Neurorepair and neuroprotective therapies for
stroke diseases can be modulated by some proteases of the extracellular
matrix which participate in cell death and neurovascular remodeling. Our
aim was to investigate the dual role of matrix metalloproteinase-13
(MMP-13), a central proteinase in the matrix metalloproteinase activa-
tion, in acute and subacute phases of stroke.
Methods and results: Transient focal cerebral ischemia was induced by
distal middle cerebral artery occlusion (tdMCAo) in MMP-13 knockout
(KO) and wild-type (WT) mice. tdMCAo led to significant smaller infarct
size (p < 0.01) acutely (24 hours after ischemia) and less neurological
deficits in MMP-13 deficient mice, whereas extensive corrected tissue
atrophy (p < 0.01) was seen at 14 days post-ischemia. Immunohistochem-
istry at 14 d post-ischemia showed that ischemia induced neuroblasts
migration from subventricular zone (SVZ) to peri-infarct areas, as
expected. No difference was found in neuroblast density; however, less
newborn proliferating neuroblasts were found in peri-infarct areas in
MMP-13 KO mice (p < 0.01). Regarding angiogenesis, peri-infarct cortical
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vessel density was increased after ischemia in WT (p < 0.01) but not in
MMP-13 KO mice, whereas KO mice presented lower vessel density than
WT (p < 0.05), indicating an MMP-13-dependance for post-stroke angio-
genesis. In agreement with these results, MMP-13 gene-silencing in
endothelial progenitor cells (EPCs, key progenitor populations involved in
endogenous post-stroke angio-vasculogenesis) resulted in deficient abili-
ties to build vascular networks (p < 0.05) in Matrigel®.
Conclusion: MMP-13 plays an important role in both infarct develop-
ment and cortical neurorepair during the recovery phase being critical for
optimal angio-neurogenic responses during stroke recovery.
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glial homeostasis of sensomotor cerebral cortex of
rats under experimental acute hemorrhagic stroke
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Background: M2 is a complex of trophinotropic regulatory oligopeptides
with a molecular weight of 250–500 Da, polypeptides with a molecular
weight up to 7000 Da, and the number of dominating amino acids.
Methods: The experiment was conducted with 3 groups of rats – “A”
(control), “B” and “C” (with the simulated acute HS against the additional
use of calcium gluconate within 10 days in a dose of 10 mg/kg). The rats
of “C” group were injected M2 in a dose of 10 mg/kg every day. For the
analysis of changes in the glial system were used a glial formula and glial
quantitative index.
Results: Quantitative changes of cellular elements of the cerebral cortex of
the experimental rats after modeling of primary acute HS and M2 appli-
cation are given. The rats of group “C” were observed show the ratio of
astrocytes to microgliocytes – 0,693, oligodendrocytes to microgliocytes-
0,573, astrocytes to oligodendrocytes – 1,212. Positive changes were
retraced also among ependymocytes and pyramidal neurons of 3 and 5
layers of the sensomotor zone of the cerebral cortex.
Conclusions: On application of M2 one noted astrocyte restoration to the
lower standard bound, index ratio restoration of the sum of astrocytes to
microgliocytes, an essential ratio decrease in the sum of oligodendrocytes
to microgliocytes and a ratio increase of of the sum of astrocytes to
oligodendrocytes. However, restoration among oligodendrocytes and
microgliocytes was not revealed.
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Brain vascular pericytes (PCs) are a key component of the blood–brain
barrier (BBB)/neurovascular unit. Besides their crucial role in maintain-
ing the BBB, their multipotency has not been considered in the brain
injury such as ischemic stroke. Here using the pericytes derived from the
post-stroke mouse brain and the human brain pericytes cultured under
oxygen glucose deprivation (OGD), we examined whether ischemia-
stimulated PCs (iPC) acquire the stem cell activity and differentiate into
neural and other lineage cells to reconstruct the neurovascular unit.
The iPCs were extracted from post-stroke CB-17 mice as described pre-
viously (Eur J Neurosci 2009;29:1842, Stem Cells Dev 2011;20:2037).
Adhered iPCs were reincubated with floating cultures in neural-
conditioned medium (NCM) (DMEM/F12, EGF, FGF-2, N2) or
endothelial-conditioned medium (ECM) (DMEM, FGF-2, 10% FBS, N2).
In another experiment, primary human brain PCs (hPCs; ACBRI-499,
Cell Systems, Kirkland, WA) were incubated under OGD (1%O2/glucose-
free) using a hypoxia-inducing system (Bionix, SUGIYAMA-GEN, Tokyo,
Japan). Cell clusters formed were subjected to immunohistochemistry or
reverse transcriptase-polymerase chain reaction (RT-PCR) analysis.
The iPCs revealed a complex phenotype of angioblasts, in addition to
their original mesenchymal properties, and multi-differentiated into cells
from both a neural and vascular lineage including endothelial cells. In
addition iPCs cultured under NCM differentiated into functional micro-
glia. These data indicate that under ischemic/hypoxic conditions, PCs can
acquire multipotential stem cell activity and can differentiate into all
components of the BBB/neurovascular unit. Thus, these findings support
the novel concept that iPCs can contribute to CNS repair after stroke.
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Antenatal inflammation attenuates blood-brain barrier
disruption after stroke in young adult mice
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Aim: Maternal infection is associated with increased risk of preterm
birth, lung diseases and neurologic disorders in the offspring. In this
study, we aimed to elucidate the effects of antenatal maternal inflamma-
tion on stroke outcome in young, adult mice.
Methods: Pregnant mice were subjected to antenatal LPS i.p. injection on
day E13 and the offspring underwent transient middle cerebral artery
occlusion (tMCAO) at the age of 12-weeks. Several parameters including
ischemic damage, edema formation, blood-brain barrier (BBB) impair-
ment and behavior were measured 24 h or 72 h after stroke surgery.
Results: Antenatal LPS treatment significantly attenuated BBB disruption
and subsequent edema formation 24 h after tMCAO and this was accom-
panied by an improved neurological status. Three days after tMCAO the
BBB was still less permeable to Evans Blue and the infarcted brain area was
significantly smaller in the offspring from LPS treated mice. Molecular
analysis of the tight junction proteins occludin, claudin-3, claudin-5 and
ZO-1 supported the findings of a tighter BBB after tMCAO in antenatal
LPS-treated mice in comparison to controls.
Conclusion: Antenatal LPS treatment of pregnant mice ameliorates BBB
damage and functional impairment after focal cerebral ischemia in the
(adult) offspring.
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Introduction: The Quality in Acute Stroke Care (QASC) Trial (Lancet
2011) proved supported implementation of clinical protocols to manage
fever, hyperglycaemia and swallowing (FeSS protocols) following acute
stroke decreased death and dependency by 16% (p = 0.002); reduced tem-
peratures (p = 0.001); glucose (p = 0.02); and improved swallowing man-
agement (p =< 0.001).
Aim: This project aimed to implement the QASC FeSS protocols in all 36
Stroke Services in New South Wales (NSW) Australia.
Method: All 36 NSW stroke services were eligible to participate. The
project team mirrored the implementation strategy from the QASC trial
that consisted of barrier identification, reinforcement of multidisciplinary
teamwork, local adaptation and use of site champions. Evaluation was
undertaken in collaboration with the National Stroke Foundation using
their already established national audit data collection tool and processes.
Primary outcome measures: Proportion of patients that received care
according to the FeSS clinical protocols pre to post-implementation.
Results: All 36 (100%) NSW stroke services agreed to participate. One
hundred clinicians attended the one-day educational workshops. All
(n = 36, 100%) sites participated in the medical record audit providing
data for a total of 2144 patients (pre-implementation: n = 1062; post-
implementation: n = 1082). Significantly increased proportions of
patients received care according to the fever (pre: 69%; post: 78%;
P = 0.0031), hyperglycaemia (pre: 23%; post: 34%; P = 0.0085), and swal-
lowing (pre: 42%; post: 51%; P = 0.0331) protocols post-implementation.
Conclusion: While there was further room for improvement in the pro-
portion of patients receiving care according to these protocols, we dem-
onstrated that scale-up and spread of proven interventions to achieve
evidence based clinical practice is possible.
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Cytokine expression in circulating monocytes during
the acute phase of ischemic stroke
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Background: In cerebrovascular diseases complex interactions occur
between the CNS and the peripheral immune system. Circulating mono-
cytes rapidly increase in peripheral blood after stroke and their activity is
related to the prognosis after stroke and the risk of infections.
Aim: We aimed to examine the cytokine expression profile of circulating
monocytes in acute ischemic stroke and its correlation with the patient
outcome.
Methods: We collected blood samples from 21 stroke patients (SP) at 3, 6
and 24 hours after symptom onset and from 20 healthy controls (HC).
From each sample we measured the mRNA levels of IL-10, TNFalpha and
IL-1beta expressed by circulating monocytes.
Results: Compared to HC, in SP the IL-10 expression significantly
increased at 3 h after symptom onset (p < 0.01) and high levels persisted
at 6 h (p < 0.05) and 24 h (p < 0.01). IL-1beta was reduced (p < 0.05)
whereas TNFalpha was increased within the first 24 h after stroke, though
last finding was not statistically significant. High levels of IL-10 expression
during the acute phase were associated with poor outcome at 3 months
(mRS > 2), while association with infections after stroke was not
significant.
Conclusions: Circulating monocytes modify their pattern of cytokine
expression acutely after stroke, mainly resulting in increased IL-10 expres-
sion. High levels of IL-10 showed correlation with 3-month outcome,
suggesting that peripheral immune activation during acute stroke might
have possible clinical implications.
Fig. (a, b, c) IL-10, TNFalpha and IL-1beta gene expression in stroke
patients and healthy controls. Data are expressed as Fold Induction (over
healthy controls in arbitrary units). Statistics: Kruskall–Wallis test followed
by Dunn’s Multiple Comparison Test * = p < 0.05; ** = p < 0.01. (d) IL-10
gene expression at 6 h from symptom onset in patients with good
(mRS <= 2) and poor 3-month outcome (mRS > 2). Data are expressed as
Fold Induction (over first column in arbitrary units). Statistics: Unpaired t
test. * = p < 0.05. IL-10, interleukin-10; TNFalpha, Tumor Nerosis Factor
alpha; IL-1beta, interleukin-1 beta; HC, healthy controls; SP, stroke
patients; AU, arbitrary units; mRS, modified Rankin Scale.
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Orphan receptor Nur77-Deficiency results in impaired
microglial activation and worsens functional outcome
following cerebral ischemia in mice
J K Strecker1, S Hucke1, K Diederich1, A Schmidt1, L Klotz1,
J Minnerup1
1Department of Neurology, University Of Münster, Muenster,
Germany
Introduction: Cerebral ischemia results in a sterile inflammation accom-
panied by activation and recruitment of both resident and hematogenous
immune cells. Nur77, also known as Nerve Growth Factor IB (NGFIB) is
an intracellular transcription factor which regulates the inflammatory
response in macrophages via the Nuclear Factor-κB. The aim of this study
was to investigate a potential influence of Nur77 regarding the activation
of resident microglia and recruitment of hematogenous immune cells
following experimental stroke in mice.
Methods: Nur77-deficient (n = 13) and wildtype mice (n = 12) were sub-
jected to transient middle cerebral ischemia (MCAO, 30 min). Animals
underwent functional tests and were sacrificed 24 h and 72 h after reper-
fusion. Infarct volume, activation of micro- and astroglia, immigration of
immune cells and cell death were analyzed via (immuno-)histological
studies.
Results: Nur77-deficiency resulted in worsened functional outcome
(p < 0.001) and increased infarct volumes 72 h after ischemia/reperfusion
(p < 0.01) compared to the wildtype group. Nur77-deficient mice showed
enlarged astroglial scar formation (p < 0.01) and increased cell death
within the ischemic lesion (p < 0.05). Evaluation of resident and
immigrating immune cells revealed attenuated microglial activation
24 h after MCAO. Seventy-two hours after MCAO a diminished number
of microglia/macrophages (p < 0.05) and neutrophil granulocytes
(p < 0.001) could be observed within the infarcted core.
Conclusion: Nur77-deficient mice developed enlarged infarcts and aggra-
vated functional outcomes, accompanied with increased cell death. Sur-
prisingly, Nur77-deficient mice showed impaired microglia activation and
reduced influx of hematogenous immune cells. These results indicate a
prominent influence of the receptor Nur77 in regulation and activation of
the cellular immune response and development of subsequent brain
injury.
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11. Experimental/Translational Medicine
Adrenomedullin provide protective effects against
aging and ischemic white matter injury in mice brain
T Urabe1, Y Mitome-Mishima2, N Miyamoto1, R Tanaka3,
T Shimosawa4, H Oishi5, H Arai2, N Hattori3
1Department of Neurology, Juntendo University Urayasu
Hospital, Urayasu, Japan
2Department of Neurosurgery, Juntendo University, Tokyo,
Japan
3Department of Neurology, Juntendo University, Tokyo, Japan
4Department of Clinical Laboratory Faculty of Medicine, The
University of Tokyo, Tokyo, Japan
5Department of Neuroendovascular Therapy, Juntendo
University, Tokyo, Japan
Background and Aims: Adrenomedullin, a potent antioxidative peptide,
was originally isolated from pheochromocytoma cells and reduces insulin
resistance by decreasing oxidative stress. White matter damage induced by
aging, hyperglycemia and oxidative stress play a crucial role in cognitive
impairment in post-stroke patients. In this study, we assess whether
adrenomedullin deficiency and aging exacerbate ischemic white matter
injury after prolonged cerebral hypoperfusion.
Methods: All animal procedures were approved by the Animal Care Com-
mittee of Juntendo University. Adrenomedullin knockout heterozygous
(AM+/−), wild-type young/aged mice underwent bilateral common
carotid artery stenosis using microcoils. Measurement of physiological
parameter, such as blood glucose, and immunohistochemistry for
several neuronal and glial markers were analyzed until 28 days after
hypoperfusion.
Results: After hypoperfusion, white matter damage progressed in a time-
dependent manner in AM+/− group compared with the wild-type group.
The number of oligodendrocyte progenitor cells gradually increased after
hypoperfusion, whereas oligodendrocytes decreased following a transient
increase, but the ratio of increase was mild in the AM+/− group (P < 0.05).
Oxidative stress was detected in oligodendrocytes, with a larger increase in
theAM+/− group (P < 0.05). Aged mice showed the same tendency, but
white matter damage was worse, especially in the aged AM+/− group.
Conclusions: This study showed that adrenomedullin downregulation
results in increase in oxidative stress after cerebral hypoperfusion in mice
cerebral white matter. White matter injury was more exacerbated because
of hyperglycemia in aged AM+/− group. The results indicated that
adrenomedullin may be an important target in the control of ischemic
white matter injury.
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11. Experimental/Translational Medicine
Secondary brain injury following intracerebral
haemorrhage (ICH): The neurotoxic effects of
haemoglobin and its degradation products on human
neurons in vitro
K Whitehead1, J Galea1, D Brough2, S Allan2
1Manchester Academic Health Science Centre, Stroke and
Vascular Centre Institute of Cardiovascular Sciences,
Manchester, United Kingdom
2Manchester Academic Health Science Centre, Faculty of Life
Sciences University of Manchester, Manchester, United
Kingdom
Background: ICH is a devastating clinical entity for which current man-
agement is limited. The role of secondary injury, which results in neuro-
logical deficit beyond the effects of acute extravasation of blood into the
brain parenchyma, is being increasingly recognised. Orchestrated by
inflammatory cascades, this noxious insult, resulting in oedema and neu-
rotoxicity, contributes to a “perihaematomal penumbra” that may be ame-
nable to therapeutic intervention. Several toxic stimuli have been
implicated, including haemoglobin and its breakdown products.
Aims: To assess the degree of neurotoxicity of haemoglobin, hemin, bili-
rubin, biliverdin and iron on human neurons in vitro.
Methods: Differentiated human neural stem cells (hNSC) and differenti-
ated SHSY-5Y human neuroblastoma cells were treated at several time
points (2 h, 4 h, 6 h, 10 h) with varying concentrations (0–100 μM) of
haemoglobin, hemin, bilirubin, biliverdin and iron. Cell viability was
determined through the activity of intracellular aminopeptidase and
lactate dehydrogenase release was used to assess cytotoxicity.
Results: After 4 hours, viability of differentiated hNSC reduced with
increasing concentrations of haemoglobin and hemin. Comparable, but
more modest effects were seen with biliverdin and bilirubin. There was a
significant increase in dead:live cell ratio with increasing concentration of
haemoglobin and hemin in differentiated SHSY-5Y cells which was most
pronounced with hemin. This neurotoxicity was maximal at 10 hours.
Conclusion: Focussed therapeutic approaches for limiting neurological
sequelae following ICH are needed. Inhibition of secondary neurotoxic
cascades may be beneficial, and could possibly be achieved through tar-
geted manipulation of haemoglobin metabolism to limit neuronal expo-
sure to noxious mediators; in particular haem.
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Strong improvement of ApoE/LDL-R signals and
amyloidgenesis by telmisartan in post-stroke SHR-SR
T Yamashita1, Y Zhai1, S Kono1, N Hishikawa1, Y Ohta1,
K Deguchi1, K Abe1
1Department of Neurology, Okayama University, Okayama,
Japan
Objective: Telmisartan, an angiotensin receptor blocker (ARB), is
expected to reduce not only the levelof blood pressure (BP) but also
neuroinflammation and neurotoxicity, then weexamined the effects of
telmisartan on both cholesterol transport-relatedproteins (ApoE/LDL-R)
and AD pathology in spontaneously hypertensive rat strokeresistant
(SHR-SR) after transient middle cerebral artery occlusion (tMCAO).
Methods: SHR-SR received tMCAO for 90 min at 12 weeksof age, and
then were divided into 3 experiment groups including a vehicle, low-dose
telmisartan (0.3 mg/kg/day), and high-dose telmisartan (3 mg/kg/day).
Results: Immunohistologicalanalysis showed that ApoE expression of
cortical neurons was strong in thevehicle group at 6, 12 and 18 months of
age, and LDL-R expression of corticalneurons was transiently increased at
6 months of age only on the ipsilateralside. However, telmisartan dramati-
cally suppressed the expression of ApoE/LDL-Rat both doses. Meanwhile,
the numbers of amyloid β (Aβ)-positive neurons andsenile plaque (SP) in
the ipsilateral cerebral cortex progressively increasedwith age until
18 M in the SHR-SR after tMCAO. To our surprise, low-dose/high-
dosetelmisartan significantly reduced the number of Aβ-positive neuron
as well asSP at 6, 12, and 18 M.
Conclusion: These findings suggest that both low and highdoses of telm-
isartan prevented the activation of ApoE/LDL-R in SHR-SR aftertMCAO,
reducing both intracellular Aβ and extracellular SP accumulations
aftertMCAO in SHR-SR, with a further improvement by combined BP
lowering.
ESOC-0833
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Prehospital heart rate variability analysis in acute
stroke patients: Correlation with stroke severity and
short term outcome
L Yperzeele1, R J Van Hooff2, A De Smedt2, R Van Dyck2,
I Hubloue3, J De Keyser2, R Brouns2
1Neurology, Universitair Ziekenhuis Antwerpen, Edegem,
Belgium
2Neurology, Universitair Ziekenhuis Brussel, Jette, Belgium
3Emergency Medicine, Universitair Ziekenhuis Brussel, Jette,
Belgium
Objective: To evaluate prehospital heart rate variability (HRV) as a pre-
dictor of stroke severity and short term clinical outcome.
Methods: HRV was registered during ambulance transportation of acute
ischemic stroke patients using a non-invasive, 2 lead ECG registration
device. Assessment included time domain, frequency domain, nonlinear
and time-frequency analysis.
Results: Patient characteristics are summarized in Table 1. Four patients
were treated with IV rtPA and one patient was treated as part of a clinical
trial comparing IV rtPA with placebo. Disease and outcome characteristics
are summarized in Table 2. No correlation between HRV parameters and
in hospital mortality could be demonstrated. Peak HF was found to cor-
relate significantly (p = 0.037) with the NIHSS score on admission.
Parameters inversely associated with the NIHSS score at 24 hours included
pVLF, aVLF and alpha2 (p = 0.037). Peak HF was positively associated
with the NIHSS score at 24 hours (p = 0.037). Peak VLF was inversely
associated with the mRS score at 90 days (p = 0.044).
Conclusion: The results of this preliminary study indicate that prehospital
HF and VLF are associated with stroke severity and outcome. Further
study is needed to evaluate this effect in a larger population.
Table 1
Study group
(n = 5)
Male gender 3 (60%)
Age (years) (S.D.) 70.6 (18.6)
Arterial hypertension 3 (60%)
Diabetes mellitus 0 (0%)
Cardiac arrhythmia 2 (40%)
Coronary artery disease 1 (20%)
Antihypertensive treatment 3 (60%)
Anti-arrhythmic therapy 1 (20%)
Table 2
Study group
(n = 5)
Disease characteristics
NIHSS admission (S.D.) 15 (4)
NIHSS 24 hours (S.D.) 15 (14)
Outcome characteristics
Survival on discharge 4 (80%)
mRS 90 days (S.D.) 3 (3)
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11. Experimental/Translational Medicine
Effects of anti-LINGO-1 treatment on structural and
functional regeneration after cortical stroke in mice
D Zaremba1, M Hoppen2, B Geng2, J Minnerup2, J K Strecker2,
A Schmidt2, K Diederich2
1Department of Psychology, University of Münster, Münster,
Germany
2Department of Neurology, University of Münster, Münster,
Germany
Stroke is one of the leading causes of death and the most common cause
of adult disability in the western industrial countries. Whereas thromboly-
sis with tissue plasminogen activator (tPA) is an approved neuroprotective
therapy, neurorestorative pharmacological interventions targeting post-
acute treatment of stroke are still elusive. Blocking the function of
Nogo-66 transmembrane protein LINGO-1 has been demonstrated to
enhance axonal sprouting and neuronal survival following various kinds
of brain injury. So far the implications of these results for the structural
and functional regeneration following stroke have not been investigated.
In the present study thirty-eight C57BL/6 mice were subjected to a pho-
tothrombotic cortical ischemia and treated either with a LINGO-1
function-blocking protein (n = 20) or vehicle (n = 18) twice a week for
forty-nine days. Extensive sensorimotor and cognitive testing was used to
quantify the animals’ deficit and recovery process. The impact of anti-
LINGO-1 on structural regeneration was evaluated by poststroke neuro-
genesis in the dentate gyrus (DG) and the subventricular zone (SVZ).
Anti-LINGO-1 treatment improved recovery from sensorimotor deficits
whereas stroke did not have an effect on cognitive performance in this
study. Animals treated with anti-LINGO-1 showed more newborn
neurons in DG and SVZ than vehicle-treated or sham animals. Anti-
LINGO-1 has proven a promising effect on the recovery of sensorimotor
function following stroke. Effectiveness even after delayed application 24
hours after onset of ischemia opens up new possibilities in the treatment
of chronic stroke.
Abstracts
© 2015 The Authors.
International Journal of Stroke © 2015 World Stroke Organization Vol 10 (Suppl. 2); April 2015; 77–438200
Epidemiology of Stroke
ESOC-1375
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Stroke in commercial flights: Beyond ecomomy class
stroke
R Alvarez Velasco1, J Masjuán Vallejo1, I Corral Corral1,
M J González López1, C Estevez Fraga1, L Crespo Araico1,
A De Felipe Mimbrera1, A Alonso Cánovas1
1Neurology, Hospital Ramón y Cajal, Madrid, Spain
Stroke on board has been communicated in retrospective case series,
mainly focused on economy class stroke. Data on the actual incidence,
etiology and prognosis of stroke in commercial flights are lacking.
A prospective registry was designed to include all consecutive patients
referred from an international airport (40 million passengers a year) to
our hospital with a diagnosis of ischemic stroke or TIA and onset of
symptoms during a flight or immediately after landing.
Forty-three patients, 30 ischemic strokes and 11 TIA, were included in a 76
months period (January 2008-April 2014). Estimated incidence of stroke
was 1 stroke in 35000 flights. Etiologies of stroke or TIA were athero-
thrombotic in 16(37%), cardioembolic in 7(16%), economy class stroke
syndrome in 7(16%), arterial dissection in 4(9%), lacunar stroke in
4(9%), and undetermined in 5(12%). Carotid stenosis >70% was found in
13(30%) patients. Although overall prognosis was good and thrombolysis
applied in 44% of the cases, only 33% of patients with stroke onset during
the flight arrived on time window for treatment. Only one patient
prompted a flight diversion.
We found an elevated prevalence of high-grade carotid stenosis among
patients with stroke linked to commercial flights, suggesting carotid
disease might be a risk factor for stroke in this setting. Economy class
stroke syndrome and arterial dissection were also registered as important
stroke etiologies. Onset-to-door times need to be shortened. Implemen-
tation of stroke education programs for the aircrew, and flight diversion
protocols are mandatory.
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Male and female strokes compared
C Dehlendorff1, K Andersen2, T S Olsen3
1Statistics, Danish Cancer Society, Copenhagen, Denmark
2Statistics, Danish Cancer Society, Copenhagen Ø, Denmark
3Stroke Unit, Bispebjerg University Hospital, Copenhagen,
Denmark
Background: Uncertainty remains about whether stroke affects men and
women similarly. We studied differences between men and women in
stroke severity and survival.
Methods: We used the Danish Stroke Register, which contains informa-
tion on all hospital admissions for stroke in Denmark between 2003 and
2012 (N = 79 617), and the Danish Registry of Causes of Death. Informa-
tion was available on age, sex, civil status, stroke severity, stroke subtype,
socioeconomic status and the cardiovascular risk profile. We studied only
deaths due to the index stroke, on the assumption that death reported as
due to stroke on a death certificate was due to the index stroke if death
occurred within the first month after the stroke. Multivariate Cox regres-
sion analysis and multiple imputation for missing information were
applied.
Results: Stroke was the cause of death for 5512 of the 79 617 patients
(6.9%). After the age of 60 years, women had more severe strokes than
men. Up to the mid-60s, no difference in the risk for death from stroke was
seen between the two sexes. For people aged > 65 years, however, the risk
gradually became greater in men than in women and significantly so
(>15%) from the mid-70s (adjusted for age, civil status, stroke severity,
subtype, socioeconomic status and cardiovascular risk factors). Analysis of
deaths within 1 week of the stroke gave similar results.
Conclusions: Stroke affects women and men differently. Elderly women
were affected more severely than elderly men but survived stroke better.
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ESUS: A descriptive analysis in an Italian stroke
registry
V Arnao1, V Caso1, M Acciarresi1, G Agnelli1, A Alberti1,
C D’Amore1, M Venti1, M Paciaroni1
1Vascular Medicine and Stroke Unit, University of Peugia,
Perugia, Italy
Cryptogenic stroke accounts to 25% of ischemic stroke. Most of these
strokes could be embolic, and for these has been proposed the definition
of embolic stroke of undetermined source (ESUS).
Objectives: To evaluate the frequency of ESUS and to explore the potential
association among ESUS and other clinical features.
Methods: This hospital-based study of a consecutive series of stroke
patients from a stroke unit to evaluate the prevalence of ESUS according
to the new proposed criteria was carried out.
Results: A total of 2,217 consecutive patients (1,280 males, 937 females)
were included in this study. According TOAST classification 308 patients
were classified as cryptogenetic stroke (14%). According TOAST classifi-
cation 308 patients were classified as cryptogenetic stroke (14%). Using
ESUS criteria, 183(8%) stroke patients met a clinical definition for ESUS.
Out of these, 69 ESUS stroke patients were women (38%). The most
frequent vascular risk factor was the hypertension (70%) followed by
hyperlipidaemia (29%), smoking (16%) diabetes (9%), and obesity(7%).
Six patients experienced a previous TIA.
Neuroimaging showed in 84% of ESUS patients an anterior stroke, in 13%
a posterior stroke and in 3 % anterior and posterior stroke. According to
NIHSS score, 41% of ESUS were minor stroke, 30% were moderate stroke
and 14% were severe stroke.
Conclusion: An extensive application of new criteria for ESUS is an useful
tool for the physicians for a correct diagnosis of these patients in order to
improve their secondary prevention.
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Increased incidence of subarachnoid hemorrhage
during cold temperatures and influenza epidemics
D Backes1, M D I Vergouwen1, A Algra2, I Vaartjes3, G A Donker4,
G J E Rinkel1
1Neurology and Neurosurgery, University Utrecht, Utrecht,
Netherlands
2Julius Center for Health Sciences and Primary Care and the
Department of Neurology and Neurosurgery, University
Utrecht, Utrecht, Netherlands
3Julius Center for Health Sciences and Primary Care,
University Utrecht, Utrecht, Netherlands
4Netherlands Institute of Health Services Research, NIVEL,
Utrecht, Netherlands
Background: The incidence of aneurysmal subarachnoid hemorrhage
(SAH) peaks in winter. We aimed to investigate if the increased incidence
in winter can be explained by cold temperatures or an increased incidence
of influenza.
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Methods: We linked a nationwide sample of SAH patients registered
between 1995–2010 with weekly temperature and with influenza-like
illness consultation data. With Poisson regression analyses we calculated
incidence density ratios (IDR) with corresponding 95% confidence inter-
vals (CI) for the association between SAH incidence with temperature and
influenza epidemics, and repeated these analyses after adjustment for
study year (aIDR). We used time-window shift analysis to investigate if
there was a delayed effect of influenza epidemics on SAH incidence. In
addition, we linked SAH incidence data from European population-based
studies with daily temperature data from the European Climate
Assessment.
Results: A total of 18,714 SAH events were registered between 1995
and 2010 in the Netherlands. The aIDR for SAH during influenza epi-
demics was 1.061 (95%CI:1.022–1.101) in the univariable and 1.030
(95%CI:0.989–1.074) in the multivariable analysis. This association
declined gradually in the weeks following epidemics. For each °C drop in
mean weekly temperature, the IDR for SAH was 1.005 (95%CI:1.003–
1.008) in the univariable and 1.004 (95%CI:1.002–1.007) in the multi-
variable analysis. In the European population-based studies the IDR of
SAH was 1.098 (95%CI:1.083–1.111) for each °C temperature drop.
Conclusion: There is an increased incidence of SAH during cold tempera-
tures and epidemic influenza. Future studies with individual patient data
are needed to investigate possible causality between temperature, influ-
enza, and SAH.
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Incidence and attack rates of stroke and transient
ischaemic attack in Auckland, New Zealand, in
2011–2012
P A Barber1, R Krishnamurthi2, V Parag3, N E Anderson4, A Ranta5,
D Kilfoyle4, E Wong4, V L Feigin2
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2National Institute for Stroke and Applied Neurosciences,
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3National Institute for Health Innovation, University of
Auckland, Auckland, New Zealand
4Neurology, Auckland City Hospital, Auckland, New Zealand
5Medicine, University of Otago, Wellington, New Zealand
Introduction: There have been few recent population studies reporting the
burden of acute cerebrovascular disease. We aimed to determine the inci-
dence (first ever) and attack rates (incident and recurrent) of stroke and
TIA in an ethnically diverse community.
Methods: The fourth Auckland Regional Community Stroke study
(ARCOS IV) used multiple overlapping case ascertainment methods to
identify all hospitalized and non-hospitalized stroke and TIA events that
occurred in people ≥16 years of age usually resident in Auckland (popu-
lation ≥16 years is 1.12 million), over the 12 months from 1st March 2011.
Results: Two thousand eight hundred twenty-nine people [1464 (52%)
women, mean (standard deviation) age of 71.6 (14.6) years] presented
with stroke (2096 people), TIA (785) or both stroke and TIA (52). 91% of
the stroke patients were admitted to hospital and 82% of the TIA patients
were seen in a hospital setting (emergency department, outpatient clinic
or admitted). By 28 days, 392 (13.9%) of the stroke and TIA patients had
died. There were 40 incident TIAs, 116 strokes and 154 strokes and TIAs
combined, per 100,000 people per year standardized to the WHO world
population. The annual attack rate for TIA was 63, for stroke was 149, and
for stroke and TIA combined was 212, per 100,000 people per year.
Conclusions: This study has described the burden of acute cerebrovascu-
lar disease in a developed country in an age of aggressive primary and
secondary vascular risk factor management. These results may be used to
inform evidence based planning of health care services.
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Phenotype and mortality of renal replacement therapy
recipients with acute stroke: A National Linkage Study
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Background: There is little data describing the epidemiology of stroke in
renal replacement therapy (RRT) patients. We aimed to describe the phe-
notype and mortality outcomes of acute stroke in RRT patients.
Methods: Retrospective linked cohort study using data from the UK Renal
Registry and SINAP (Stroke Improvement National Audit Programme; a
national stroke quality register) of patients admitted with stroke to hos-
pitals in England from April 2010-December 2012. Pseudonymised
person-level data linkage was carried out. Mortality data was obtained
from the national register of deaths in England.
Results: Of 84,330 patients with acute stroke admitted to 96 hospitals and
reported to SINAP, 439 were RRT recipients: 292 (67%) haemodialysis, 41
(9%) peritoneal dialysis and 105 (24%) transplant. The proportion of
stroke due to intracerebral haemorrhage (13% vs 11%) or undetermined
stroke (3% vs 1%) was higher in RRT recipients (p < 0.0001). RRT recipi-
ents were younger (median 69 vs 77 years; p < 0.0001) and were more
likely to have stroke whilst an inpatient (15% vs 5%; p < 0.0001). In
ischemic stroke patients, the distribution of Oxford Community Stroke
Project classification was similar between RRT and non-RRT patients. 30
day mortality was similar for RRT and non – RRT patients (16% vs 13%;
p = 0.11) but 90 day mortality was higher in RRT recipients (24% vs 19%;
p = 0.017).
Conclusion: The phenotype of stroke in RRT recipients reported to the
national stroke quality register of England is broadly similar to other
stroke patients but occurs at younger age and with worse medium term
survival.
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Validation of diagnosis of transient ischemic attack in
the Swedish Stroke Register (RIKSSTROKE) TIA-module
F Buchwald1, J Ström2, B Norrving1, J Petersson1
1Dept of Neurology Skåne University Hospital, Dept of
Cliinical Sciences Neurology Lund University, Malmö/Lund,
Sweden
2Örebro University Hospital, Centre for Health Sciences,
Örebro, Sweden
Introduction: To the Swedish Stroke Register (Riksstroke; RS), a module
for registration of transient ischemic attacks (RS-TIA) was added in 2011.
We report a diagnostic validation study of patients included in RS-TIA.
Methods: During the 1st year 59 out of 74 Swedish hospitals adopted the
TIA-module and included 7745 patients. A time-based TIA-definition
(complete remission of symptoms <24 hours) was used.
For the validation study, a sample of 180 patients (30 patients each from
6 hospitals), with a similar distrubution of age and sex as in the full
RS-TIA, was prepared. Two independent observers assessed the original
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medical records with respect to quality of documentation (completeness
of reporting of clinical symptoms, signs and features) and final diagnosis
(likely TIA, possible TIA, unlikely TIA, ischemic stroke) according to
prespecified criteria.
Results: Out of the 180 patients assessed, the two observers agreed in 138
patients (77 %) that the event was a likely or possible TIA, in 5 patients
(3%) that the event was an ischemic stroke, and in 3 patients (2%) that the
event was unlikely to be due to TIA. Disagreement was present in 34
patients; in 15 patients (8%) on TIA vs ischemic stroke, and in 19 patients
(11%) on TIA or ischemic stroke vs a non-vascular cause.
Conclusion: There was interobserver agreement on diagnosis of TIA in
the majority of patients included in RS-TIA. Diagnostic precision may be
further improved by more careful documentation of symptoms and signs
in medical records, and use of a diagnostic manual.
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Ischaemic preconditioning by recent TIAs and strokes
in 2,730 consecutive stroke patients
P Correia1, I A Meyer1, A Eskandari1, M Amiguet2, L Hirt1,
P Michel1
1Neurology, Centre Hospitalier Universitaire Vaudois
University of Lausanne, Lausanne, Switzerland
2Institute of Social and Preventive Medicine, University of
Lausanne, Lausanne, Switzerland
Background: Preconditioning improves acute ischaemic stroke (AIS)
outcome in animals, and possibly in humans. The influence on AIS of
preceding ischaemic events (PIE) such as TIAs and AIS occurring at
different intervals, sites and for different durations can be studied in
humans.
Methods: Using consecutive AIS from the ASTRAL registry we compared
in univariate analyses patients who never had PIEs (controls) with those
with recent PIEs at different time points (acute within 24 h; subacute 2 to
7 days before event), at various locations (PIE within or outside the
territory of the subsequent AIS) and for different durations (PIE lasting
<24 h vs. >24 h). Endpoints were admission NIHSS, difference between
initial and 24 h-NIHSS (ΔNIHSS), and 3-month modified Rankin score
(mRS) ≤2.
Results: There were 162 acute PIEs (TIA = 126), 83 subacute PIEs
(TIA = 57) and 2’485 control patients. Admission NIHSS after subacute
but not acute PIEs was lower than controls (p < 0.05), which was due to
subacute PIEs occuring in the same territory. ΔNIHSS was higher in
recent PIEs than in controls (p < 0.05), but mRS at 3 months was not
different. Recent TIAs lead to higher ΔNIHSS than recent strokes, but
neither influenced NIHSS nor mRS. Acute and subacute PIEs in the same
territory had comparable ΔNIHSS and mRS.
Conclusions: In patients with AIS, we found short term beneficial effects
of PIE occurring 2–7 days before a stroke, in particular if occurring in the
same territory and if they were of short duration. However, this did not
result in a better 3-month outcome.
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Ethnic differences in stroke outcomes in the state of
Qatar
A D’souza1, A Shuaib1, N Akhtar1, P Bourke1, S Joseph1,
M Santos1, Y Z Imam1, S Kamran1, D Deleu1
1Medicine/Neurology, Hamad General Hospital, Doha, Qatar
Objective: To describe the Ethnic differences in Stroke Outcomes in the
State of Qatar.
Methods: A one year prospective Stroke Registry search was performed
and outcomes with regard to stroke subtype, severity, complications,
length of stay [LOS] and prognosis at 90 days were analyzed and reported
based on ethnicity of the patient population.
Results: Of 894 strokes, 50.7% [454] were South East Asian [SEA], 18%
[162] Qataris, 17.6% [158] Non Qatari Arabs [NQA], 9.8% [88] Far
eastern [FE] and 2.6% [24] Caucasians. Out of 356 [39.8%] patients < 50
years old 65.9% were FE (p < 0.001).
ICH’s were highest in 31/88 [35.2%] FE compared to other groups (SEA
[17%], Q [14.1%], NQA [12%] and 8.3% Caucasian). Small 158/247
[63.9%] and large 41/247 [16.5%] vessel strokes were commoner in SEA
while cardio-embolic strokes 2/13[15.3%] in Caucasians. NIHSS ≥11 at
presentation were seen in FE 20/72 [27.7%] compared to others (SEA
[20.3%], Q [19.8%], NQA [16.4%] and Caucasian [15.7%]). Complica-
tions were highest in the Qatari 26/137[18.9%] and FE 11/76 [14.5%].
Qatari’s 47/158 [29.7%] and FE 21/88[23.8%] had LOS ≥10 days. 90 day
outcome [mRS 5–6] was worst in Qatari’s 24/87[27.5%] versus FE 7/38
[18.4%], SEA 31/196 [15.8%], NQA 11/79 [13.9%] and 1/11 9% in Cau-
casians (p < 0.001).
Conclusions: The FE’s were younger, suffered more intracranial hemor-
rhages, had longer LOS, more severe strokes and complication rates while
Qatari’s were older, suffered ischemic strokes with highest LOS secondary
to complications and poor outcomes. Caucasians were >50 years with
highest cardio-embolic strokes, best outcomes and shortest LOS.
ESOC-0496
12. Epidemiology of Stroke
Population-based incidence study of transient ischemic
attacks according to the tissue-based definition
D Degan1, R Ornello1, C Tiseo1, S Sacco1, A Carolei1
1Department of Neurology, University of L’Aquila, L’Aquila,
Italy
Introduction: As information about the incidence of transient ischemic
attack (TIA), according to the tissue-based definition, is scarce we aimed
to ascertain its epidemiology and the proportional change attributable to
the shift from the time-based to the tissue-based definition.
Materials and methods: Incident TIA cases were ascertained in a prospec-
tive population-based registry including patients residing in the L’Aquila
district, in a two-year period (2011–2012).
Results: Out of 804 screened patients, we found 151 TIA incident cases
according to the tissue-based definition and 30 patients with transient
symptoms and inadequate or not performed brain investigations (acute
neurovascular syndromes [ANS]). Twenty nine further patients with tran-
sient symptoms and with an acute infarction at brain neuroimaging
would have been diagnosed as TIA according to the time-based definition.
The crude annual incidence rate in the 151 TIA patients was 25.3/100,000
(95% CI 21.5–29.6); the rate, standardized to the 2011 Italian population,
was 23.6/100,000 (95% CI 19.1–26.5) and standardized to the European
2011 population was 20.0/100,000 (95% CI 19.9–27.7). Considering the
30 patients with ANS, the crude annual incidence rate increased up to
30.3/100,000 (95% CI 26.1–35.0). If we had included the 29 patients
complying with the time-based definition, the crude annual incidence rate
would have been 35.2/100,000 providing a +16.2% variation in TIA
incidence.
Conclusion: We found a low TIA incidence, only in part attributable to the
change in definition, but mostly attributable to improvement in preven-
tive strategies. The case-ascertainment based upon the tissue-based defi-
nition sounds poorly compatible with the population-based study design.
Abstracts
© 2015 The Authors.
International Journal of Stroke © 2015 World Stroke Organization Vol 10 (Suppl. 2); April 2015; 77–438 203
ESOC-0503
12. Epidemiology of Stroke
Timing and mode of hospital admission for acute
ischemic stroke in the L’Aquila district
D Degan1, C Tiseo1, R Ornello1, B Orlandi1, A Carolei1, S Sacco1
1Department of Neurology, University of L’Aquila, L’Aquila,
Italy
Introduction: The aim of the present study was to analyze the timing and
mode of admission of patients with a first-ever ischemic stroke (FE-IS) in
the L’Aquila district.
Material and methods: All patients with a FE-IS residing in the L’Aquila
district were included in a population-based registry from January 2011
until December 2012.
Results: We identified 634 patients with FE-IS; 624 (49.8% male; mean
age ± SD 75.5 ± 12.9 years) were hospitalized. Considering the time inter-
val between symptom onset and hospital arrival (SO-HA), 207 (33.2%)
patients arrived within 3 hours and 255 (40.9%) within 4.5 hours from
stroke onset. The median time interval from hospital arrival to ward
admission (HA-WA) was 100 minutes (Interquartile Range [IQR]
65–180). We found a correlation of SO-HA and HA-WA with the National
Institutes of Health Stroke Scale (NIHSS) score on admission (r = −0.254;
P < 0.001 and r = −0.177; P < 0.001, respectively). Twenty-six patients
(4.1%) underwent revascularization procedures (20 intravenous throm-
bolyses and 6 endovascular treatments). The median time from Emer-
gency Room (ER) arrival to initiation of rt-PA (“door-to-needle” time)
was 62.5 minutes (IQR 45–82.5). Three hundred and twenty patients
arrived at the ER by 118 ambulance (51.3%), 296 (47.4%) by private
transportation, and 8 (1.3%) were already hospitalized at stroke onset.
Conclusion: The proportion of patients with acute stroke arriving early at
hospital is fair but still need to be implemented by fostering public aware-
ness and recognition of stroke symptoms. Acute stroke services need to be
improved in the district.
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Study presenting the epidemiology of stroke in 50
consecutive stroke patients visiting a private
neurology clinic in South India
H Fatima1, V Sreekanth1
1Neurology, Magna Neurology Clinics, Hyderabad, India
Aim: To study the epidemiology of stroke in stroke patients.
Methods: A cross sectional study was carried out in 50 consecutive stroke
patients visiting a private neurology clinic in South India. Stroke was
confirmed by Magnetic Resonance Imaging (MRI). All patients were
asked to fill a pre-tested questionnaire that contained questions on Socio-
demographics, Dietary Habits, History of Previous Illnesses, Blood Inves-
tigations and Imaging. Subjects were made to sign a written informed
consent as approved by the Institutional Review Board.
Results: Out of 50 patients, 30 {60%} were males (45 years = 25) and 20
{40%} were females (45 years = 19). 43 (86%) patients suffered from
Ischemic Stroke and 7 (14%) from Hemorrhagic Stroke. 3 (6%) patients
had Transient Ischemic Attack preceding Stroke and 4 Patients (8%) pre-
sented with recurrence of Stroke. Hyperhomocysteinemia, Antithrombin
III deficiency, Vasculitis and Oral Contraceptive Pills were causes of Stroke
in patients < 45 years. Different causes of Stroke were elicited. Many
patients had overlapping causes.
Conclusions: Forty-four (88%) patients are aged > 45 years confirming
risk of Stroke with increasing age. Hypertension (60%), Hypertriglyceri-
demia (30%), Diabetes Mellitus (20%), Tobacco (20%) and Alcohol
(16%) remain the main causes of Stroke. Non-Compliance to drugs for
Hypertension is the cause for occurrence of Stroke in 20 (40%) patients
and is an easy to rectify cause.
ESOC-0837
12. Epidemiology of Stroke
Changes in incidence of ischaemic stroke subtypes in
urban Northern Portugal 1998 to 2011: Data from two
population-based studies
R Felgueiras1, R Magalhães2, M C Silva2, M Correia1
1Neurology, Hospital Santo António – Centro Hospitalar do
Porto, Porto, Portugal
2Population Study Department, Instituto Ciências Biomédicas
Abel Salazar, Porto, Portugal
Background: In the last decade, many preventive strategies and stroke
treatments in acute phase have been implemented. The global incidence of
stroke and stroke mortality has declined. In this study, we evaluate the
trend in incidence of ischemic stroke subtypes eleven years apart.
Methods: Data from two prospective population-based studies (1998–
2000 and 2009–2011) were used to estimate changes in ischemic stroke
incidence. All suspected first-ever-in-a-lifetime ischemic stroke were
entered into a stroke registry. Standard definitions and comprehensive
sources of information were used to ascertain all stroke events. The
Oxfordshire classification was used to define ischemic stroke subtypes.
Patients were observed at onset and at three months.
Results: Between 1998 and 2011 the incidence of ischemic stroke
decreased from 2.02 (95% CI, 1.81–2.24) to 1.61 (95% CI, 1.48–1.73).
TACI incidence declined from 0.44 (95% CI, 0.34–0.55) to 0.29 (95% CI,
0.24–0.35) and LACI incidence from 0.79 (95% CI, 0.66–0.92) to 0.43
(95% CI, 0.36–0.49); PACI incidence increased from 0.40 (95% CI 0.31–
0.51) to 0.49 (95% CI 0.42–0.56); POCI incidence remained stable chang-
ing from 0.40 (95% CI 0.31–0.50) to 0.39 (95% CI 0.33–0.46). Age-
specific incidence for TACI and LACI reveals an important decrement in
patients older than 65 and PACI increased in the oldest (>85).
Discussion: There is a trend to less severe strokes, with a decrement in
TACI and an increment in PACI in the oldest patients. LACI significantly
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decreased in the past decade probably related to preventive strategies,
manly blood pressure control. These trends may justify the decline in
stroke mortality.
ESOC-0850
12. Epidemiology of Stroke
Etiological variability after recurrent stroke
C Calle de Miguel1, P Martínez-Sánchez1, E Alba-Suárez1,
F J Díaz de Terán1, J Rodríguez-Pardo1, J Illán-Gala1, J Pérez-Lucas1,
B E Sanz-Cuesta1, B Fuentes1, E Díez-Tejedor1
1NEUROLOGY, UNIVERSITY HOSPITAL LA PAZ, Madrid, Spain
Objective: To analyze the etiology of recurrent ischemic stroke and to
investigate in which cases a different cause was detected in the second
event.
Methods: Observational study of patients with ischemic stroke (2010–
2014). Variables: Baseline/clinical data, prior cerebral infarction (CI) or
transient ischemic attack (TIA). Etiologies of current and previous stroke/
TIA and their concordance were recorded.
Results: A total of 1197 patients were included, 57.1% were male, mean
age 70.5 years. 18.5% (222) had a prior ischemic stroke (CI 58.1%, TIA
34.2% and TIA+CI 7.7%). The cause of the previous stroke was: undeter-
mined / unreported (53.2%), cardioembolic (17.1%), lacunar (13.3%),
atherothrombotic (9.2%) and unusual (3.2%). The concordance between
past and present etiology was analyzed, being the most consistent cardio-
embolic (94.7%), followed by atherothrombotic (74.1%) and unusual
(62.5%), with low agreement in the lacunar (30%) and undetermined
(39.8%) (P < 0.0001). The most frequent cause of recurrence in lacunar
and undetermined / unreported stroke was the cardioembolic cause
(37.5% and 40%, respectively). In 39.8% of prior strokes of undetermined
etiology, a current cause was not identified. The mean time to recurrence
was higher in those who changed etiology respect to those who main-
tained the previous (73.1 vs. 46.3 months, P = 0.003).
Conclusion: The etiologic subtype that most frequently recurs with the
same etiology is the cardioembolic stroke. Current cardioembolic cause is
more frequent in patients with prior lacunar or undetermined/
unreported strokes. In up to one third of patients with stroke of undeter-
mined / unreported cause, no etiology is found after recurrence.
ESOC-0243
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Risk factors for stroke – a study in a tertiary care
hospital of South India
S Gandra1, K Chaithanya2
1Internal Medicine, Narayana Medical College and Hospital,
Nellore, India
2Anesthesia, Narayana Medical College And Hospital, Nellore,
India
Diseases of the cerebral blood vessels are the second most common cause
of death worldwide after ischemic heart disease.they are leading cause of
adult disability in united states and europe becoming more frequent with
increasing age. The incidence of stroke increases exponentially from 30 yrs
of age and etiology varies with age. Advanced age is one of the most
significant risk factor.
These diseases cause ischemia, infarction and intracranial hemorrhage.
Ischemia and infarction constitute 85 to 90 percent of the total cases in
western countries while 10 to 15 percent are intracranial hemorrhages.
Incidence of infarctions is more than hemorrhage.
Aim of the study: To evaluate the risk factors of stroke in our hospital.
Material and methods: One hundred cases of stroke according to WHO
definition admitted into medical wards in Narayana Medical College and
Hospital, Nellore, during a period of 1 year from July 2012 to June 2013.
Appropriate history was taken regarding symptoms and the risk factors.
Meanwhile all the patients were appropriately managed.
Result: The male to female ratio in the present study is 70 is to 30. The
average age was between 25 and 86 years. Hypertension is the most
common risk factor seen in 82 percent cases. Diabetes is present in 40
percent of cases. Smoking history is present in 56 percent. Alcoholism is
present in 30 percent. Dyslipidemias are present in 24 percent; h/o TIA in
12 percent.
Conclusion: Hypertension is the most common risk factor for stroke fol-
lowed by diabetes and smoking.
ESOC-1340
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Siesta-strokes: Clinical characteristics and outcome of
ischemic strokes occurring during day-sleep
J Haba-Rubio1, M Faouzi2, P Michel3
1Center for Investigation and Research of Sleep (CIRS),
University Hospital CHUV, Lausanne, Switzerland
2Institute of Social and Preventive Medicine, University
Hospital CHUV, Lausanne, Switzerland
3Stroke Center Neurology Service Department of Clinical
Neurosciences, University Hospital CHUV, Lausanne,
Switzerland
Objectives: Circadian and sleep-related cardiovascular changes may play a
role in stroke pathogenesis. Several studies have examined acute ischemic
strokes (AIS) occurring during night-sleep, but none has addressed the
question of strokes occurring during day sleep (DS) (“siesta-strokes”).
Methods: We used the Acute STroke Registry and Analysis of Lausanne
(ASTRAL) which records consecutive AIS admitted to a single stroke
center within 24 hours after last proof of good health. Demographics, risk
factors, laboratory variables, stroke pathophysiology, clinical and radio-
logical findings and 3 and 12 months outcomes were compared in a
multivariate approach between patients with known stroke onset while
awake (KO) and DS.
Results: DS occured in 50 of 2’471 consecutive AIS (2.0%). There were no
significant differences in demographic or clinical characteristics. Fewer DS
patients were treated with intravenous thrombolysis or endovascular
treatment (12.0% vs 28.7%, multivariate odds ratio 0.12, 95% confidence
intervals 0.02–0.88), mainly due to late arrival at the hospital (4.9 ± 6.4
hours vs 2.2 ± 3.40, OR 1.06, 95%CI 1.01–1.11). Patients with DS had
more strokes of undetermined localization, mostly lacunar type (21.7% vs
13.8%, OR 2.88, 95%CI 1.25–6.61). Discharge NIHSS and modified
Rankin Scale scores at 3 and 12 months were similar in adjusted analyses.
Conclusion: Day-sleep strokes (“siesta strokes”) occur in about 2% of all
ischemic strokes. They are similar to wake-onset stroke except for the
lower rate of recanalisation treatment, explained by the admission delay.
Exploiting treatment windows up to 6 hours and using advanced imaging
may increase acute treatment rates.
ESOC-0270
12. Epidemiology of Stroke
Autumn weather is associated with increase in
cerebrovascular disease mortality in the subsequent
winter
R McDonagh1, J Harbison1
1Dept. of Medical Gerontology, Trinity Centre for Health
Sciences, Dublin, Ireland
A number of studies have considered the relationship between winter
weather and the rate of stroke deaths, but findings have been inconsistent.
Ireland has a temperate oceanic climate influenced by the North Atlantic
current that means that it infrequently experiences extremes of winter
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weather. In the last decade it has however experienced a number of
extreme winters. We performed a study to determine how weather pat-
terns influenced mortality.
Methods: Seasonal data for Sunshine (% of seasonal average), Rainfall (%
of seasonal average) and Temperature (degrees Centigrade above seasonal
average) were collected for Autumn (September-November) and Winter
(December-February) using official Irish Meteorological Office (Met
Eireann) data since 2002. Data was used from the meteorological station
closest to the main population centre (Casement Aerodrome, Dublin).
National cerebrovascular mortality data was obtained from Central Sta-
tistics Office’s Quarterly Vital Statistics. Excess winter deaths were calcu-
lated by subtracting (nadir) 3rd quarter mortality (July-September) from
subsequent first quarter (January-March) 30-day mortality data. Local
data reports a median onset to death duration for stroke of 20 days.
Results: Data for 12 years were analysed. Mean winter mortality excess
was 25.1% (SD 8.4). Rainfall (123.9%), temperature (+0.57 C), and sun-
shine (104.3%) all exceeded long term averages. Excess winter mortality
did not correlate significantly with winter weather (Rainfall: r = 0.21
p = 0.5, Temperature: r = 0.21, p = 0.5, Sunshine, r = 0.14, p = 0.6). Winter
mortality excess however correlated strongly with the weather in the
preceding autumn (Rainfall: r = 0.13 p = 0.7, Temperature: r = −0.61,
p = 0.03, Sunshine, r = 0.58, p = 0.04).
Conclusion: Winter cerebrovascular disease mortality appears lower fol-
lowing warm, cloudy autumns.
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Association of migraine with ischemic stroke –
multicentre registry study
Y Ishibashi1, Y Terayama1, H Oikawa2
1Neurology and Gerontology, Iwate Medical University,
Morioka Iwate, Japan
2Neurology, Oikawa Clinic, Kitakami Iwate, Japan
Introduction: Migraine with aura is an established risk factor of ischemic
stroke. However, clinical features of ischemic stroke related with migraine
are not clarified.
Purpose: We verify the clinical features of ischemic stroke in patients with
migraine.
Method: One thousand six consecutive patients with acute ischemic
stroke admitted to the 7 hospitals during Apr. 1, 2012 and Mar. 31, 2013
are registered. Clinical characteristics, subtype of ischemic stroke based on
the TOAST, radiological findings and history of migraine diagnosed
through the International Classification of Headache Disorders; 2nd
Edition are registered.
Results: Among 1006 patients with acute ischemic stroke, 20 patients had
migraine headache(2%). Migraine group was younger than non-migraine
group (64.4 ± 16.5 and 74.6 ± 12.0 years respectively). There were no sig-
nificant differences between both group about the prevalence of hyper-
tension, ischemic heart disease, atrial fibrillation, dyslipidemia, diabetes
mellitus, past history of stroke and smoking and alcohol drinking habit.
The prevalence of obesity was higher in migraine group. There were no
significant differences between both group about subtype of ischemic
stroke, stroke lesion, and prevalence of old infarction and microbleeds.
Stenosis in vertebrobasilar artery was more frequent in non-migraine
group. Patent Foramen Ovale(PFO) was more frequent in migraine
group. Clinical severity of stroke on onset was milder in migraine group.
Conclusion: Patients with migraine were younger and had milder symp-
toms of stroke. No differences regarding subtype of ischemic stroke and
stroke lesion were observed.
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Procalcitonin and midregional pro-atrial natriuretic
peptide as markers of silent brain infarcts: The
Northern Manhattan Study
M Katan1, Y P Moon2, J T DeRosa2, S A Torres2,
A von Eckardstein3, K Spanaus3, C B Wright4, R L Sacco5,
M S V Elkind6
1Neurology, University Hospital Zurich, Zurich, Switzerland
2Neurology, Columbia University, New York, USA
3Clinical Chemistry, University Hospital Zurich, Zurich,
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4Neurology, University of Miami, Miami, USA
5Neurology & Public Health Sciences and Human Genetics,
University of Miami, Miami, USA
6Neurology & Epidemiology, Columbia University, New York,
USA
Background: Chronic infections and hemodynamic dysfunction may be
risk factors for silent brain infarcts (SBI). We hypothesized that selected
blood biomarkers of infection (procalcitonin, or PCT), and hemody-
namic stress (midregional pro-atrial natriuretic peptide, or MRproANP)
would be associated with SBI in the multiethnic, urban Northern Man-
hattan Study (NOMAS) cohort.
Methods: The NOMAS cohort was designed to assess risk factors for
incident vascular disease, and a subsample underwent brain MRI
(n = 1178). Our primary endpoint, SBI (n = 172) was defined as a cavita-
tion on the fluid-attenuated inversion recovery sequence of at least 3 mm
and distinct from a vessel due to the lack of signal void on T2 sequence,
and of equal intensity to cerebrospinal fluid. Biomarkers were measured in
a blinded batch analysis. We calculated odds ratios and 95% confidence
intervals (OR, 95% CI) using logistic regression models to estimate the
association of PCT and MRproANP levels with silent brain infarcts after
adjusting for demographic, behavioral, and medical risk factors.
Results: Mean age was 70 (± 9) years; 60% were female. After adjusting for
confounders, those with PCT in the top quartile, compared to the lowest
quartile, were at increased risk of SBI (adjusted OR 2.2, 95% CI 1.3–3.7).
Those with MRproANP levels in the top quartile, compared to the lowest
quartile, were also at increased risk of SBI (adjusted OR 3.1, 95% CI
1.7–5.9).
Conclusion: Higher levels of procalcitonin, a marker of infection, and
MRproANP, a marker for hemodynamic stress, were independently asso-
ciated with silent brain infarcts in this multiethnic, urban cohort.
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Understanding in-hospital stroke management and
outcomes in the Australian Stroke Clinical Registry
(AUSCR)
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2Eastern Clinical School Faculty of Medicine Nursing & Health
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3Faculty of Health Sciences, La Trobe University, Melbourne,
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4Priority Research Centre for Translational Neurosciences
Mental Health Research, University of Newcastle and Hunter
Research Institute, Newcastle, Australia
5Clinical Programs, National Stroke Foundation, Melbourne,
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6Stroke Division, The Florey Institute of Neuroscience and
Mental Health, Melbourne, Australia
7Department of Medicine, Nambour General Hospital,
Sunshine Coast, Australia
8The University of Sydney, The George Institute for Global
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Background and Purpose: The quality of care for people who experience
stroke whilst in hospital for another condition has not been previously
studied in Australia. Our aim was to compare patient characteristics,
quality of care indicators, and outcomes for in-hospital strokes with those
for community-onset strokes.
Methods: We used data from the Australia Clinical Stroke Registry
(AuSCR) obtained from January 2010 to December 2013 (40 hospitals).
Outcomes were compared using multilevel regression models and linked
to the National Death Index. Utility scores were derived from the EQ-5D
health-related quality-of-life (HRQoL) questionnaire assessed in eligible
survivors at 90–180 days.
Results: Among 13,860 registrants, 817 (6%) had the onset of symptoms
whilst in hospital. Patients with an in-hospital stroke were more likely to
be female (51% vs. 46%) and older (median age 78 vs. 76 years, p = 0.015)
compared to community-onset cases. Fewer patients with an in-hospital
stroke received stroke unit care (61% vs. 79%; p < 0.001). After accounting
for patient and hospital characteristics, patients with in-hospital strokes
were less likely to be discharged home (adjusted OR 0.31, 95% CI 0.25–
0.39) and more likely to die within 180 days from onset (aOR 2.02, 95% CI
1.69–2.43) or report worse HRQoL (mean difference utility score −0.11,
95% CI −0.16 to −0.06) compared with community-onset strokes.
Conclusions: Compared to community-onset strokes, patients with an
in-hospital stroke receive less stroke unit care and experience worse out-
comes. These findings suggest an important opportunity for focused
strategies to improve outcomes for patients who experience a stroke whilst
in hospital.
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High carotid intima-media thickness is a predictor for
incident stroke and ischemic heart disease in Japanese
urban cohort: The Suita study
Y Kokubo1, M Watanabe1, A Higashiyama2, Y M Nakao1,
T Kobayashi1, T Watanabe1, Y Miyamoto1
1Preventive Cardiology, National Cerebral and Cardiovascular
Center, Suita, Japan
2Preventive Medicine and Public Health, National Cerebral
and Cardiovascular Center, Suita, Japan
Introduction: Carotid intima-media thickness (IMT) has been increas-
ingly a subclinical marker for the risks of stroke and ischemic heart disease
(IHD). However, few studies have examined the associations between IMT
and stroke and IHD in Asia.
Methods: We studied 5,331 Japanese individuals (mean age 55.3 years) at
the baseline survey. Mean-IMT was defined as the mean of the proximal/
distal IMTs for both common carotid arteries (CCAs) at 10 mm proximal
points to the beginning of the bulb dilations. Adjusted hazard ratios (HRs)
of stroke and IHD were calculated by the Cox proportional hazards
model.
Results: During 8.7-year of follow-up in average, 185 strokes and 125 IHD
events occurred. The adjusted HRs (95% confidence intervals, CIs) in the
fourth quartile (≥0.95 mm) of Mean-IMT for strokes and IHD were 2.5
(1.1–5.5) and 2.9 (1.0–8.7), respectively, compared with the first quartile
(<0.75 mm). The highest quartile of Maximum-IMT of all areas
(≥1.7 mm) and CCA (≥1.15 mm) had 1.9 and 1.7 times increased risk of
stroke, and 2.3 and 2.4 times increased risk of IHD, compared with the
lowest quartiles of all areas (<1.0 mm) and CCA (<0.9 mm), respectively.
The adjusted HRs (95% CIs) for stroke and IHD were 1.3 (1.0–1.7) and
1.6 (1.3–2.0) with 0.1 mm increases in Maximum-IMT of CCA, respec-
tively. The HRs (95% CIs) in subjects with plaques (Maximum-
IMT≥1.4 mm) of CCA and areas were 1.6 (1.1–2.2) and 1.4 (1.0–2.0) for
strokes, and were 2.6 (1.7–3.8) and 2.6 (1.5–4.3) for IHD, respectively.
Conclusion: Carotid IMT, especially Maximum-CCA is strong predictors
of stroke and IHD in Asians.
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Vascular parkinsonism and episodes of stroke: The
Japanese multi-center study of vascular dementia
T Maeda1, K Nagata1
1Department of Neurology, Research Institute for Brain and
Blood Vessels-Akita, Akita, Japan
Background: In the post-stroke state, vascular dementia (VaD) and vas-
cular parkinsonism (VaP) are well-known as deteriorating conditions of
activities and qualities of daily life. We previously reported the clinical
features of VaP in patients with VaD. In this study, we investigated the
relationship between VaP and episodes of stroke.
Methods: We used retrospective database of VaD which included patients
visiting from 2000 to 2005 in 12 Japanese medical centers. Parkinsonism-
related items were analyzed statistically.
Results: In 12 medical centers, 217 patients with VaP were recruited in this
study. Sixty-nine patients (30.8 %) were co-morbid with VaP (male 75.4
%, mean onset age 71.5 y). Patients with stroke were 155 (69.2 %), includ-
ing 45 patients (66.2 %) with VaP and 110 patients (73.8 %) without VaP.
There was no difference between them (p = 0.16). In patients with VaP,
onset of stroke was significantly younger (p = 0.016). When analyzing in
frequencies of cerebral infarction, cerebral hemorrhage and subarachnoi-
dal hemorrhage, there was no difference between patients with and
without VaP (p = 0.08, 0.13, 0.69). Gait disturbance was the most impor-
tant symptom (62.3 %, p < 0.0001) in diagnosing VaP. In gait disturbance,
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freezing was most frequent (p = 0.0004). Postural impairment and no
abnormal involuntary movement were emphasized in the diagnosis.
Conclusion: It is suggested that stroke are common in VaP and the history
of any type of stroke is important. VaP is diagnosed as a clinical syndrome
characterized by freezing gait, postural instability and no abnormal invol-
untary movement.
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Clinical features in transient ischaemic attack (TIA)
and transient ischaemic attack (tia) mimics:
Distinguishing between the two entities
M M Mahmoud1, H Christensen1
1Department of Neurology, Copenhagen University Hospital
Bispebjerg, Copenhagen, Denmark
Background: Transient ischaemic attack (TIA) is defined as a reversible
episode of acute focal neurological deficit of presumed vascular origin.
However, it remains a diagnostic challenge to distinguish a TIA from
non-cerebrovascular conditions that also cause transient focal neurologi-
cal symptoms (TIA mimics). Thus, the aim of this study was to identify
clinical features in patients with TIA and patients with TIA mimics.
Methods: We studied 1339 consecutive patients admitted to our depart-
ment with suspected TIA from February 2010 to December 2013. Clinical
characteristics, radiological findings, and outcome were recorded. The
final diagnosis of TIA or TIA mimic was given after assessment by a stroke
specialist.
Results: Of the 1339 patients, 362 (27.0%) had a minor stroke, 397
(29.7%) suffered from a TIA, while the remaining 580 (43.3%) patients
had a TIA mimic. Age > 60 years (OR 2.10, 95% CI 1.58–2.78), gender
(male, OR 1.6, 95% CI 1.23–2.08), hypertension (OR 2.36, 95% CI 1.75–
3.18) hypercholesterolemia (OR 4.81, 95% CI 3.58–6.45), and atrial fibril-
lation (OR 2.36, 95% CI 1.35–4.15) occurred more likely in patients with
TIA and minor stroke. Among the clinical symptoms, monoparesis (OR
1.90, 95% CI 1.29–2.80) and hemiparesis (OR 1.74, 95% CI 1.23–1.74)
were identified as independent predictors of TIA or minor stroke, whereas
headache (OR 0.59, 95% CI 0.43–0.81) was independently associated with
a TIA mimic.
Conclusion: Clinical variables known as high-risk markers were found to
occur more likely in TIA, while clinical symptoms less suggestive of vas-
cular disease predicted a TIA mimic.
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Stroke and atrial fibrillation: Its incidence in a
retrospective study from 2008 to 2012 in
Fernandópolis region, State of São Paulo, Brazil
M J Medeiros1, F C R Ferreira2, J P U Ferreira3, L B A P Appoloni2,
T T P A Mathias2, O E Santos2, O E Santos2, P F Sablewski2,
M P Ribeiro2, J R L Flores2
1Medicine School, University Camilo Castelo Branco, São José
dos Campos, Brazil
2Medicine School, University Camilo Castelo Branco,
Fernandópolis, Brazil
3Intensive Care, São Francisco Hospital, Ribeirão Preto, Brazil
Context: The relation of cause and effect between atrial fibrillation and
stroke is narrow and represents a growing public health problem.
However few studies have been done to measure the reality of this issue.
Objectives: Track and outline a retrospective study, the incidence of stroke
in the occurrence of atrial fibrillation.
Design, target population and methods: Cohort Study, a retrospective of
adult patients aged 20 years or older who were admitted to a reference
Health Service between 2008 and 2012.
Main outcome: Stroke incidence measured in the study population
111 926 inhabitants; projected number of people in the region of Fernan-
dopolis, Sao Paulo, Brazil.
Results: A total of 923 adults diagnosed with stroke were identified during
the period; of these 461 were diagnosed with atrial fibrillation at the time
of stroke; 47.28% were aged 71 years or more. The incidence of atrial
fibrillation as the main cause for the occurrence of cardioembolic stroke
event was 0.95% (95% confidence interval 0.94% 0.96%). Incidence
increased from 0.1% among adults under 55 years to 9.0% in those aged
80 or more. Among people aged 50 or older, the prevalence of atrial
fibrillation was higher in whites than in blacks (2.2% vs 1.5%, P, 0.001).
Conclusions: Our study confirms that atrial fibrillation is common among
older adults. Atrial fibrillation proved to be a strong risk factor for stroke,
reflecting the growing need for online efforts to meet the challenge of
preventing stroke and the search for rhythm management in patients with
atrial fibrillation.
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Differences in association of body mass index between
stroke subtypes and acute coronary syndrome:
A population-based case : control study
C Mettananda1, L Li1, L M Bull1, E McCulloch1, S J Welch1,
L E Silver1, S Gutnikov1, Z Mehta1, P M Rothwell1
1Nuffield Department of Clinical Neurosciences, University of
Oxford, Oxford, United Kingdom
Background: There is conflicting evidence of an association between
obesity and risk of stroke, and data on stroke subtypes are limited. We
studied the association of pre-morbid body mass index (BMI) and stroke
subtypes versus acute coronary syndrome (ACS).
Methods: We studied BMI in all first-ever TIA/stroke and ACS from
2002–2012 in a population-based cohort (Oxford Vascular Study) com-
pared with a group of matched healthy controls (n = 618) from the same
population using logistic regression adjusted for age, sex and smoking.
Standard BMI categories were used: underweight (≤18.4); normal (18.5–
24.9; reference group); overweight (25.0–29.9); obese (≥30.0).
Results: Among 2025 TIA and strokes (mean age 71.6 years, women
53.8%, mean BMI 26.3) and 1191 ACS (mean age 71.35 years, women
35.4%, mean BMI 26.8), risk of TIA/ischaemic stroke (adjusted
OR = 2.87, 95%CI = 1.13–7.34, p = 0.027), ACS (3.26, 1.12–9.50,
p = 0.031) and particularly intracranial haemorrhage (ICH) (7.60, 2.15–
26.88, p = 0.002) were all increased in under-weight patients versus con-
trols. The negative association was continuous throughout the full range
of BMI for ICH (OR = 0.93, 0.88–0.98/unit, p = 0.008), whereas it flat-
tened out for TIA/ischaemic stroke (BMI > 30: 1.15, 0.88–1.50, p = 0.29)
and revered for ACS (BMI > 30: 1.46,1.05–2.03, p = 0.026). On direct
comparison, BMI > 25 was more common in ACS than TIA/ischaemic
stroke (OR = 1.31, 1.09–1.57, p = 0.004). Results were unchanged after
exclusion of TIA.
Conclusions: Under-weight is a significant risk factor for stroke and ACS.
The negative association with BMI was particularly strong for ICH.
Obesity is a stronger risk factor for ACS than for ischaemic stroke.
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Effects of meteorological conditions on the risk of
stroke events–HEWS–Stroke Study
T Mukai1, N Hosomi1, M Tsunematsu2, Y Sueda3, Y Shimoe4,
T Ohshita5, S Aoki1, M Kakehashi2, M Matsumoto1
1Clinical Neuroscience and Therapeutics, Hiroshima University
Graduate School of Biomedical & Health Sciences, Hiroshima,
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2Health Informatics, Hiroshima University Graduate School of
Biomedical & Health Sciences, Hiroshima, Japan
3Neurology, National Hospital Organization Kure Medical
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4Neurology, Brain Attack Center Ota Memorial Hospital,
Fukuyama, Japan
5Neurology, Suiseikai Kajikawa Hospital, Hiroshima, Japan
Background: Seasonal variation in the incidence of cerebrovascular dis-
eases has been reported in many countries. However, little is known about
the relationship between meteorological change and stroke incidence. We
conducted a multi-center, retrospective and observational study in Hiro-
shima district.
Methods: Clinical data from 3935 stroke patients, admitted between
January 2012 and December 2013 at seven institutes, were collected ret-
rospectively. The subtypes of ischemic stroke were classified according to
the TOAST Classification as lacunar infarction, atherothrombotic stroke,
cardioembolic stroke, and the other. The daily rates of stroke events were
compared to the daily mean thermo-hydrological index (THI), the atmo-
spheric pressure, and the daily changes of these variables for the seven days
preceding a stroke event using Poisson regression analysis.
Results: We divided onset days into five quantiles based on the THI,
atmosphere, and their changes. The frequency of intracranial hemorrhage
was significantly higher on cold days (RR 1.65, 95%CI 1.30–2.09), and a
decline in temperature one day before the onset from two day before (RR
1.32, 95%CI 1.06–1.64). The frequency of atherosclerotic stroke was sig-
nificantly higher when temperature surged one day before the onset from
two day before onset (RR 1.32, 95% CI 1.07–1.61). Atmosphere and
atmosphere change did not show significant influence on the frequency of
stroke onset.
Conclusions: High incidence of intracranial hemorrhage was relevant to
cold day and declined temperature on one day before. Atherothrombotic
stroke was relevant to increased temperature on one day before. It was
suggested that meteorological change may also influence stroke onset
frequency.
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The distribution of modified Rankin scale scores
change according to eligibility criteria in acute
ischaemic stroke trials
V Olavarria1, P M Lavados1
1Internal Medicine, Clinica Alemana Universidad del
Desarrollo Instituto de Neurociencias, Santiago, Chile
Background: Shifts in the distribution of ordinal scales like modified
Rankin scale (mRs) are being increasingly used as outcome measures in
acute ischaemic stroke trials. The assumption is that there is an equal
chance of being in any strata. Distribution across strata is relevant for
sample size calculation and statistical analysis. Eligibility criteria usually
are standard, but could change the distribution of outcomes.
Aims: To assess the distribution of mRs scores across its different strata in
patients with acute ischemic strokes according to usual eligibility criteria
used in stroke trials.
Methods: Usual eligibility criteria in acute stroke trials (NIHSS > 3- < 25
and time from symptom onset < 6 hours) were applied to a prospective
cohort of acute ischemic stroke patients from a single centre. MRs scores
were adjudicated at discharge. Median values were calculated and Wil-
coxon 2 sample test was used to compare strata distribution for each set of
criteria to the crude sample.
Results: From 1548 patients, selection criteria yielded 803 (52%) patients
for NIHSS criteria, 555 (39%) for time and 336 (22%) for both. When
NIHSS were used, distribution was slightly homogeneous (median = 3)
but not significant (p = 0.07) and when time was used, distribution was
homogeneous (median = 3) and significantly different from the crude
distribution (p = 0.002).
Conclusions: Usual eligibility criteria produced 1/5 reduction in potential
selected population and a distribution of mRs scores significantly differ-
ent from the unselected data sample. Distribution of scores from 1 to 5
was homogeneous, and can be analysed with multivariate ordinal logistic
regression assumptions.
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Changes in stroke incidence and case fatality in the
L’Aquila district over two decades
R Ornello1, D Degan1, C Tiseo1, S Sacco1, A Carolei1
1Department of Neurology, University of L’Aquila, L’Aquila,
Italy
Background: Stroke incidence and case fatality in Western countries are
decreasing. We evaluated changes in stroke epidemiology in the district of
L’Aquila.
Methods: All residents in the district with a first-ever stroke (FES) in
2011–2012 were included in a population-based registry. All events were
identified by active monitoring of all inpatients and outpatients health
services and of death certificates. Current results were compared with
those obtained in 1994–1998 and already published.
Results: Eight hundred forty-seven FES (51.4% women; mean age ± SD,
75.4 ± 13.2 years) were included in the registry. The crude annual inci-
dence rate decreased from 293/100,000 in 1994–1998 to 142/100,000 in
2011–2012. After standardization to the 2011 Italian population, the rate
decreased from 323/100,000 to 130/100,000 (incidence rate ratio [IRR]
0.42; 95% CI, 0.34–0.51; P < 0.001). Declines were observed for ischemic
stroke (IS) (from 266/100,000 to 98/100,000; IRR 0.37; 95% CI, 0.29–0.47;
P < 0.001) and intracerebral (ICH) (from 41/100,000 to 23/100,000; IRR
0.54; 95% CI, 0.30–0.92; P = 0.023) but not for subarachnoid hemorrhage
(SAH). We observed a reduction in 1-year case fatality from 1994–1998 to
2011–2012 for all strokes (from 37.9% to 33.1%; relative risk [RR] 0.87;
95% CI, 0.77–0.99; P = 0.031) and IS (from 33.8% to 26.0%; RR 0.77; 95%
CI, 0.65–0.90; P = 0.001) but not for ICH or SAH.
Conclusion: Despite aging of the population, we observed a decreased
stroke incidence and mortality over the last two decades, partly explain-
able by improved stroke preventive strategies and management, but also
by the occurrence of competing diseases causing earlier deaths.
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Increased burden of ischemic stroke in the oldest old
over two decades
R Ornello1, C Tiseo1, D Degan1, A Carolei1, S Sacco1
1Department of Neurology, University of L’Aquila, L’Aquila,
Italy
Background: Aging of Western populations emphasized the relevance of
ischemic stroke (IS) in the elderly. We evaluated demographic changes in
IS patients aged 80 years and over in the past two decades in the district of
L’Aquila.
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Methods: All residents in the district presenting with a first-ever IS in
2011–2012 were included in a population-based registry by active moni-
toring of all inpatients and outpatients health services and of death cer-
tificates. Current results were compared with those obtained in 1994–1998
and already published.
Results: Of 634 first-ever IS included in the registry in 2011–2012, 289
events occurred in patients aged 80 years and over with a 24.4% increase
as compared to 1994–1998 (45.6% vs. 36.6%; P < 0.0001). No changes
were observed in gender and stroke type distribution. Elderly patients
were more frequently hospitalized in 2011–2012 than in 1994–1998
(97.9% vs. 90.9%; P < 0.0001), had more brain neuroimaging studies
(98.3% vs. 79.6%; P < 0.0001), and a shorter mean hospital stay (9.4 ± 5.7
vs. 12.1 ± 9.7 days; P < 0.0001) without relevant changes in hospital mor-
tality (20.4% vs. 23.6%; P = 0.284), despite a decline in 30-day (27.7% vs.
34.6%; P = 0.029) and 1-year (40.1% vs. 51.6%; P = 0.0005) case fatality
rates. Notably, only proportions of arterial hypertension (82.0% vs.
65.0%; P < 0.0001) and atrial fibrillation (43.9% vs. 30.2%; P < 0.0001)
increased in 2011–2012 compared to 1994–1998.
Conclusion: Comparing data of 2011–2012 with those of 1994–1998 we
found a 24.4% increased proportion of IS in the oldest old and greater
proportions of arterial hypertension and atrial fibrillation with decreased
30-day and 1-year case fatality rates.
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Stroke trends in Malmö, Sweden: Incidence and
survival
H Pessah-Rasmussen1, J Julia Ålenius2, E Elisabet Zia2,
G Gunnar Engström2
1Neurology and Rehabilitation Medicine Skåne University
Hospital and Dept of Health Sciences, Lund University,
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2Clinical Sciences Malmö, Lund University, Malmö, Sweden
Background: The overall declining stroke incidence trend in high-income
countries has not been consistent for all age groups. The aim of this study
was to investigate temporal trends in incidence and 2-years survival
between 1993 and 2009, in Malmö (300 000 inhabitants), Sweden.
Methods: Cases with first-ever stroke were retrieved from Malmö Stroke
Register (STROMA). Since 1989, systematic search for suspected or estab-
lished cases of stroke in Malmö citizens over the age of 18 years who were
hospitalized and/or attended the hospital outpatient clinic and/or died
was made. Date of death was retrieved from the Swedish Cause of Death
Register. Age-standardized incidence and incidence for different age
groups was calculated (all/men/women). Time-trends were analysed using
log linear regression i.e. the natural logarithm of the age-standardized
incidence as a linear function over time. Cox proportional hazard regres-
sion (age-and sex adjusted) was used to compare survival over time.
Results: 11019 cases (46% men and 54% women) with a first-ever stroke
were identified between 1993 and 2009. During the study period, the
age-standardized incidence decreased by 2.0% (p < 0.05) for men and by
1.0% (p < 0.05) for women. The decrease was mainly driven by the age-
group 75–84 years. No decreasing trend was observed for younger age
groups. Stroke survival improved for most years observed compared to
1993.
Conclusion: The overall declining stroke incidence and stroke fatality
trend in high-income countries has now been also confirmed in Malmö,
Sweden. The cause of absence of decline in incidence in the younger age
groups needs to be further studied.
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High burden of ischemic stroke in Croatia is largely
due to modifiable risk factors
S Pikija1, V T Trkulja2, B M Malojcic3, S M Mutzenbach4,
J S Sellner4
1Stroke Unit, Salzburger Landeskliniken/Paracelsus Medical
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Background: Incidence and mortality of ischemic stroke in Croatia are
higher than in developed countries.
Methods: Observational prospective cohort study following-up (1–3
years) first-ever ischemic stroke patients indentified in a population-based
incidence study (N = 751) (study 1, S1) and a concurrent case-control
study (215 patients, 125 controls, S2) were conducted in one of Croatia’s
counties (2007–2010).
Results: Atrial fibrillation (AF) was common in patients (36.1% in S1,
40.9% in S2) and mostly (>50%) unrecognized before the stroke. In a
multivariate analysis, odds of stroke increased with tobacco smoking
(OR = 3.95, 95%CI 1.33–10.8), unhealthy diet (OR = 2.12, 1.12–4.01) and
AF (OR = 9.40, 4.01–22.0), and decreased with higher education
(OR = 0.33, 0.11–0.98), moderate alcohol consumption (OR = 0.48, 0.25–
0.93), higher fasting HDL (OR = 0.14, 0.07–0.30) and pre-stroke use of
anticoagulants (OR = 0.09, 0.01–0.59), antihypertensives (OR = 0.52,
0.27–1.00) and statins (OR = 0.29, 0.12–0.69). All patients were managed
in stroke units with neuroimaging within 48 hours in 93.1% (S1) and
100% (S2) patients, acute aspirin in 84.0% (S1) and 100% (S2) patients
and thrombolysis in 1.9% (S1) and 2.8% (S2) patients. Among the acute
phase survivors, 30.9% died over the subsequent 1–3 years; only 15.4% of
those with AF were treated with warfarin at any time between day 15 and
death or end of study and 73.5% received low-dose aspirin; only 44.2% of
those with dyslipidemia were treated with statins.
Conclusion: Acute stroke management and mortality do not seem con-
siderably different from those in developed countries, but post-acute mor-
tality is higher, likely due to inappropriate management of prognostically
infavorable comorbidity.
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Age associations with fast campaign awareness and
recall in patients presenting with stroke/TIA; Results
from Stroke and TIA Awareness and Response to
Symptoms (STARS) Study
N Rugg1, E Abbey1, N O O R Sharrack1, A Majid1, K Harkness2,
J Redgrave1
1Neurology, University of Sheffield, Sheffield, United
Kingdom
2Neurology, Sheffield Teaching Hospitals NHS Trust, Sheffield,
United Kingdom
Background: As the population ages, it is vital that public education cam-
paigns promoting stroke awareness and the need for an emergency
response (e.g. F.A.S.T.) are accessible by the elderly.
Method: We interviewed consecutive patients with stroke/TIA and/or
their relatives (if they had sought medical help on the patients behalf)
presenting to the hyper-acute stroke unit, Sheffield UK in May-June and
Aug-Oct 2014. We assessed knowledge of the F.A.S.T. campaign in relation
to age.
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Results: Two hundred fifty-two participants were interviewed within 72
hours of admission (215 patients, 37 relatives). In age subgroups <65
(n = 66), 66–79 (n = 100), >80 (n = 86), awareness of a stroke media cam-
paign was reported by 92% vs. 85% vs.74% respectively (P trend 0.004)
with campaign awareness in those aged > 80 much lower than in those
<65 OR = 0.26, 0.09–0.72) P = 0.01. Similarly, the ability to name one or
more F.A.S.T. components correctly (i.e. Face/ Arm/ Speech/ Time)
declined with increasing age group; 58% vs. 39% vs. 38% (P trend 0.02)
with lower recall in those aged > 80 vs. those aged <65 (OR 0.43, 0.22–
0.85), P = 0.01). Of those who were aware of the campaign, 159 (79%) had
seen it on the television and television was the most common source of
F.A.S.T. knowledge in all age subgroups. Most participants in each age
group (98%, 97% and 92%) watched television regularly.
Conclusion: Awareness of the media campaign and recall of F.A.S.T.
declined significantly with increasing age. Further research is needed to
establish how stroke media campaigns can be more accessible and memo-
rable for older people.
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Accuracy of iCD-10AM coding for transient ischaemic
attack (TIA)
L M Sanders1, V Sundararajan2, T G Phan1, V K Srikanth1
1Medicine, Monash University, Clayton, Australia
2Medicine, University of Melbourne, East Melbourne,
Australia
Background: Diagnostic coding is often used in stroke research. However,
few data exist regarding the accuracy of Transient Ischaemic Attack (TIA)
codes in Australia.
Aims: To determine the accuracy of ICD-10 Australian Modification
(AM) diagnostic codes assigned to patients with neurologist diagnosed
TIA.
Methods: ICD-10AM codes were identified for patients with suspected
TIA treated at Monash Medical Centre, Australia (2004–2007). Coding
accuracy was assessed against final neurologist diagnosis using the
24-hour criterion (clinical TIA). Assignment of a TIA code of G45.3,
G45.8 or G45.9 to a patient with neurologist confirmed TIA was consid-
ered true positive and TIA mimics were considered false positives.
Results: ICD-10AM codes were available for 336/488 (68.9%; 95% Con-
fidence Interval 64.6%-72.8%) patients. Clinical TIA was confirmed in
209/336 (62.2%; 56.9%-67.2%). Evaluation of ICD-10AM codes for clini-
cal TIA revealed: sensitivity 0.76 (0.69–0.81), specificity 0.43 (0.34–0.51),
Positive Predictive Value 0.68 (0.62–0.74), Negative Predictive Value 0.51
(0.42–0.61). Mean age was slightly higher in those assigned a TIA code
(66.4 +/- 13.7) compared with a non-TIA code (62.3 +/- 15.6; p < 0.02).
Patients with symptoms lasting less than one hour were more likely to be
assigned a TIA code than those with symptoms lasting more than one
hour (p < 0.001).
Discussion: ICD10AM codes are sensitive for clinical TIA, but insuffi-
ciently specific. These data may help to estimate measurement error when
using administrative datasets for TIA research.
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Sensitivity of hospital data coding of acute stroke in a
district general hospital in the UK
L T Sansom1, J Crabtree2, H Ramadan1
1Department of Neurology, Bradford Teaching Hospitals NHS
Foundation Trust, Bradford, United Kingdom
2Clinical Coding Department, Bradford Teaching Hospitals
NHS Foundation Trust, Bradford, United Kingdom
Background: Accurate recording of stroke diagnosis is necessary for
understanding of stroke frequency, demographics and epidemiology and
for hospital trusts to ensure financial reimbursement and target monitor-
ing. Studies of stroke coding using ICD codes reported varying estima-
tions of true stroke incidence. This study aims to assess the sensitivity and
positive predictive value (PPV) of coded stroke diagnosis from a single
acute hospital trust when compared to multiple overlapping stroke inci-
dence data.
Methods: Twelve-month coding data on all patients with a diagnosis of
stroke using ICD-10 codes 160, 161, 162, 163 and 164 was collected. Over
the same period a single physician collected stroke data from multiple
overlapping sources, including; neurology/TIA/stroke clinics, neuroimag-
ing review, coding department and bereavement department data. Data-
sets were compared to assess the accuracy of coding department detection
of acute stroke.
Results: Six hundred sixty-four confirmed stroke cases were identified
using multiple overlapping methods; 502 cases were identified by the
coding department. Sensitivity of coding department data was 75.6%
(95% CI: 72.15–78.82). PPV was 96.3% (95% CI: 94.36–97.79). Seven
patients identified by the coding department were missed by multiple
overlapping methods. 19 patients were incorrectly coded as stroke by the
coding department.
Discussion: The sensitivity of ICD-10 coding for identification of
in-hospital acute stroke is insufficient for accurate prediction of stroke
incidence. Lack of accuracy has wide ranging implications on stroke
service provision and epidemiological knowledge. Multiple overlapping
methods identified multiple issues as to why stroke coding diagnoses were
missed. Improved data capture methods are required to overcome these
issues.
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Women initiatives for stroke in Europe: A new
European task force against stroke in women
P Santalucia on behalf of WISE Group1,
A Pavlovic on behalf of WISE Group2
1Scientific Direction and Emergency Dept., Fondazione IRCCS
Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
2Neurology Clinic, Univerrsity of Belgrade, Belgrade, Serbia
Epidemiological studies have demonstrated that women have a higher
prevalence of stroke over their lifetime than men and worse functional
outcome after stroke. Sex-specific differences contribute to these features.
In Europe, there are significant East-West differences in stroke incidence
and related mortality rates being higher in Central-Eastern Europe where
stroke victims are on average younger compared to Western Europe. In
Western Europe, where women outnumber men in the over 80 age group,
stroke in women is on the rise due to their longer life-expectancy and
related higher prevalence of stroke due to atrial fibrillation.
WISE-Women Initiatives for Stroke in Europe is a European Stroke Orga-
nization (ESO) working group focused on stroke in women to improve
the knowledge on gender differences in stroke in Europe taking into
account the regional discrepancies in stroke care.
WISE includes representatives from most European regions and members
from USA and Brazil who are involved in stroke research in women.
For 2015, main aims of the working group are:
1. Publication of a WISE position paper
2. Review and update of available epidemiological data
3. Identification of weaknesses and strengths from a gender perspective at
scientific, institutional, and public awareness level in supporting stroke
victims
4. Promotion of an observational study on stroke in women
5. Design of a RCT on stroke prevention
During the first ESO Conference in Glasgow the II WISE assembly will
take place in order to define the working group bylaws and the working
strategy for the next 5 years to fight stroke in women.
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Survival of young ischemic stroke patients in Estonia
in 2003–2012
S Schneider1, A Kornejeva1, R Vibo1, J Kõrv1
1Neurology, University of Tartu, Tartu, Estonia
Introduction: Young stroke patients face a long lasting burden of disability
and a worse survival compared to their healthy counterparts.
Aims: The aim of the study was to analyze the survival, its influencing
factors and the time trends in young ischemic stroke patients in
2003–2012.
Methods: We performed a retrospective study of all consecutive patients
aged 15–54 years treated in Tartu University Hospital and North Estonia
Medical Centre from January 2003 to December 2012 with the discharge
diagnosis of ischemic stroke. Stroke was classified according to the NIHS
score, the TOAST and the Bamford criteria. For time trend analysis we
divided the study period into two groups (2003–2007 and 2008–2012).
The survival data were obtained from the Estonian Population Register.
Results: Of the 723 patients, 486 (67%) were men. The survival rate at 28
days, 1 year and 5 years was 0.96 (95% CI 0.94- 0.97), 0.92 (95% CI
0.90–0.94), and 0.85 (95% CI 0.82–0.88), respectively. The survival was
significantly worse for men (P = 0.01) and with the advancing age
(P = 0.04) and stroke severity (P < 0.01). Clinically, total anterior circula-
tion infarction and etiologically, cardioembolic stroke had the lowest sur-
vival rates (P < 0.01). The time trend analysis showed an improved 28-day
survival rate among the whole study population (P < 0.001) and among
men (P < 0.001) in the later period.
Conclusion: We identified several factors that are related to the lower
survival rate in young stroke patients. The improved short-term survival
during the study period is probably due to the improvements in acute
care.
ESOC-1305
12. Epidemiology of Stroke
Incidence of hospitalized stroke in the Czech Republic
from the National Registry of Hospitalized Patients
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Background: Stroke is a leading cause of mortality and morbidity in
Eastern Europe. However detailed stroke incidence data are not available.
Methods: We previously validated the accuracy of coding of stroke diag-
noses in the National Registry of Hospitalized Patients (NRHOSP), a
nationwide registry of prospectively collected data regarding each hospi-
talization in the Czech Republic (CR) since 1992. The accuracy of coding
of the main stroke diagnosis [International Classification of Diseases
Tenth Revision (ICD-10): subarachnoid hemorrhage (I60), intracerebral
hemorrhage (I61) and cerebral infarction (I63)] included in a CR national
registry was high (91%, 91% and 82%, respectively). We calculated the
incidence of hospitalized stroke in the CR using the validated NRHOSP.
We calculated the overall stroke incidence and the incidence rates of the
three main stroke types: cerebral infarction (I63), subarachnoid hemor-
rhage (I60) and intracerebral hemorrhage (I61). The results of the
Validation study assessing the accuracy of coding of stroke diagnoses in
NRHOSP were applied to appropriately adjust the rates from the
NRHOSP data.
Results: The overall incidence of hospitalized stroke in the CR is 240 per
100 000 population. The incidence of hospitalized stroke according to
stroke types I60, I61 and I63 is 8, 29 and 210 cases per 100 000 population,
respectively.
Conclusions: The incidence data of hospitalized stroke in the CR can be
compared to previously reported rates for Central and Eastern Europe.
Future studies will expand beyond hospitalized cases.
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Prevalence and prognosis of intracranial stenosis in
acute ischemic stroke
M H Sorgun1, C Ulukan1, A Rawandi1, M Kuzu1, S Rızayev1,
S Tezcan1, I S Gul1, H Cotur1, V Yilmaz1, C Togay Isıkay1
1Neurology, Ankara University Medical School, Ankara, Turkey
Introduction: Intracranial stenosis (ICS) is common among stroke
patients of Asians, Blacks, and Hispanics ancestry. Furthermore, stroke
patients with ICS have higher recurrence rate of ischemic stroke and death
than those without ICS. This study aimed to determine the prevalence of
ICS in our stroke registry.
Methods: We reviewed the charts of 554 patients who were admitted with
acute ischemic stroke between the dates January 2011 and August 2014.
ICS was defined as any intracranial stenosis >50% on cerebrovascular
imaging. The demographic data, NIHSS scores at admission and mRS in
follow-up period were recorded. We determined etiologic stroke subtypes
using the automated Causative Classification System (CCS).
Results: A total of 64 (11.6%) patients with ICS (42 males [65.6%] and 22
females [34.4%]; mean age 67.3 ± 12.4 [37–98] years) were included in the
study. ICS was more common in men (p = 0.019). Sixty patients (10.8%)
had symptomatic ICS and 41 patients (7.4%) had isolated ICS. DM was
significantly higher in the ICS group compared to others (p = 0.007). The
mean NIHSS score was 5.97 (0–26) at admission and it was significantly
lower than others (p < 0.001). There were 51 (79.7%) patients with large-
artery atherosclerosis and 2 (3.1%) patients with cardioaortic embolism,
according to the CCS. Eleven (17.2%) patients remained undetermined-
unclassifed. The outcome was significantly better than others (p < 0.001).
Recurrent stroke was higher in the ICS group, but was not significantly
(p = 0.49).
Conclusion: ICS was seen in 11.6% of acute ischemic stroke in our regis-
try. Diabetes mellitus appears to be the major risk factor for ICS.
ESOC-0591
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Etiologic subtypes of posterior circulation strokes
I S Gul1, S Tezcan1, A Rawandi1, M Kuzu1, C Ulukan1, S Rızayev1,
V Yilmaz1, H Coturs1, M H Sorgun1, C Togay Isıkay1
1Neurology, Ankara Univesity Medical School, Ankara, Turkey
Introduction: Acute infarcts in posterior circulation (AIPC) has been
reported 17–40% in the previous studies. The most frequent cause of
AIPC was embolism from cardioaortic, vertebrobasilar atherosclerosis or
dissection, followed by large-artery atherosclerosis (LAA), small vessel
disease and other causes. The aim of this study was to determine the
etiologic subtypes of AIPC in our stroke registry.
Methods: We reviewed the charts of 554 patients who were admitted with
acute ischemic stroke between the dates January 2011 and August 2014.
The demographic data, the National Institutes of Health Stroke Scale
(NIHSS) scores at admission and detailed investigations to determine
etiologic focus of stroke were recorded. We determined etiologic stroke
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subtypes using the automated Causative Classification System (CCS). The
modified Rankin Scale (mRS) scores were recorded in follow-up period.
Results: A total of 88 (15.9%) patients with AIPC (47 males [53.4%] and
41 females [46.6%]; mean age, 65.82 ± 14.04 (25–92) years) were included
in the study. The mean NIHSS score was 4.75 (0–26) at admission. Hyper-
lipidemia was significantly higher in AIPC compered to others
(p = 0.004). Otherwise, atrial fibrillation and congestive hearth failure
were significantly lower (p = 0.025, p = 0.004). There were large-artery
atherosclerosis (LAA) (n = 32, 36.4%), cardioaortic embolism (n = 23,
26.1%), small vessel disease (n = 8, 9.1%), other cause (n = 4, 4.5%) and
undetermined causes (n = 21, 23.9%). The large-artery atherosclerosis
was significantly higher in AIPC groups (p = 0.005).
Conclusion: AIPC was found in 15.9% of acute stroke patients in this
registry. LAA was the most common cause of AIPC opposite to previous
studies.
ESOC-1287
12. Epidemiology of Stroke
Patients with symptomatic internal carotid artery
stenosis ineligible for endarterectomy can be stented
with acceptable safety
H Steglich-Arnholm1, M Holtmannspötter2, D W Krieger1
1Department of Neurology, Rigshospitalet, Copenhagen,
Denmark
2Department of Neuroradiology, Rigshospitalet, Copenhagen,
Denmark
Aim: Superiority of carotid artery stenting (CAS) vs. carotid endarterec-
tomy (CEA) is debated. However, some patients are ineligible for CEA
because of high risk of surgery, stroke in progression (SIP) or anatomical
obstacles. This study reports the safety and feasibility of CAS in patients
with symptomatic internal carotid artery (ICA) stenosis ineligible for
CEA.
Method: Retrospective single-center experience of all CAS treated
patients with symptomatic ICA stenosis. Detailed clinical and radiological
information was collected. Patients were deemed ‘stable’ if they were
referred from an out-patient clinic with transient ischemic attacks or
persistent minor symptoms or ‘unstable’ if they were referred from
another hospital with SIP or recent embolic ischemic/hemodynamic
symptoms. Restenosis of more than 60% or recurrent ischemic events
were followed.
Results: Forty-five ICA stenoses were successfully treated in 46 patients.
Three of 48 stenting attempts failed resulting in ICA coiling in 2 cases.
Four of 46 patients (9%) died in-hospital. All of those were unstable
patients. Twenty-four of 45 stents were placed in stable patients. Those
patients experienced recurrent ischemic events in 5 (21%) cases and rest-
enosis in 7 (29%) cases. Unstable stented patients did not experience late
adverse events. Follow-up length, procedural complications, age, sex,
devices used and pre-procedural comorbidity was comparable in the two
patient groups.
Conclusion: CAS in patients ineligible for CEA is feasible and reasonable
safe. Our data suggests that patients stented early after an ischemic event
may face an increased risk for severe procedural complications as opposed
to patients stented in a delayed fashion.
ESOC-1295
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Long term follow-up of carotid artery stenting in
symptomatic patients ineligible for endarterectomy
H Steglich-Arnholm1, M Holtmannspötter2, D W Krieger1
1Department of Neurology, Rigshospitalet, Copenhagen,
Denmark
2Department of Neuroradiology, Rigshospitalet, Copenhagen,
Denmark
Aim: Durability of carotid artery stenting (CAS) has been suggested to be
approximately 95% in large clinical trials. The rate of recurrent ischemic
events in patients ineligible for carotid endarterectomy (CEA) is
unknown. This study assesses the durability of CAS in patients with a
symptomatic internal carotid artery (ICA) stenosis ineligible for CEA.
Method: Retrospective single-center experience of all patients treated
with CAS from 2011 to 2014. Patients were followed with duplex sonog-
raphy in an outpatient clinic for detection of restenosis above 60% or
recurrent ischemic events from the stented ICA.
Results: Forty-six patients were identified. Four patients died within few
weeks after the procedure and 3 patients had unsuccessful stent place-
ment. Thirty-nine patients were included in the analysis. Median age: 65
(range 42–90). Male: 39 (79%). Median follow-up length: 13 months
(range 2–26). No patients died during follow-up. No restenosis was
observed in 32 patients (82%). Thirty-four patients (87%) did not suffer
recurrent ischemic events (Figure). Recurrent ischemic events only
occurred within 6 months while restenosis occurred until 13 months.
Conclusion: The durability of CAS in patients ineligible for CEA is slightly
less than, but comparable to, patients eligible for CEA. This study suggests
a discrepancy between recurrent ischemic events, which cluster within the
first six months, and restenosis, occurring later. Larger trials need to
confirm these findings.
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Are patient selection criteria for randomized
endovascular therapy stroke trials too rigid?
H Steglich-Arnholm1, M Holtmannspötter2, D W Krieger1
1Department of Neurology, Rigshospitalet, Copenhagen,
Denmark
2Department of Neuroradiology, Rigshospitalet, Copenhagen,
Denmark
Aim: Patient enrollment into randomized clinical trials (RCTs) can be a
challenging endeavor. Recent RCTs of endovascular therapy (EVT) in
acute ischemic stroke (AIS) has shown low patient enrollment from mul-
tiple centers. This study assesses all EVT treated patients within one year
for eligibility into five recent stroke trials.
Methods: Retrospective single-center study. All patients with attempted
EVT for anterior circulation AIS were identified. Detailed clinical and
radiological information was collected. Patients were followed for 3
months. Inclusion and exclusion criteria was obtained from online
sources and assessed for the following trials: IMS-III, SWIFT-PRIME,
ESCAPE, PRO-ACT II and MR-CLEAN.
Results: Ninety-nine patients were identified. Median age: 71 (range
33–94). Male: 52 (53%). Median stroke severity: NIHSS 16 (range 5–26).
Eighty-nine patients had three months follow-up. Forty-two (47%)
patients experienced favorable 3-months outcome (mRS 0–2). Patient
eligibility for the RCTs varied from 58% to 100% (58% SWIFT-PRIME,
71% IMS-III, 84% PRO-ACT II, 88% MR-CLEAN, 100% ESCAPE). Age
was the predominant censoring factor (4% to 9% of patients). There were
no significant differences in terms of procedural or late complications and
3-months clinical outcome between eligible an ineligible patients.
However, patients eligible for SWIFT-PRIME had slightly worse outcomes
(P = 0.05).
Conclusion: Patient selection criteria in recent RCTs seem sapient with
high rates of eligibility, and are unlikely to have been the predominant
reason for low enrollment. Since procedural safety and clinical outcomes
were similar in eligible and ineligible patients, exclusion criteria may be
broadened in particular regarding age restriction.
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Being an endovascular stroke trialist is not an ‘eight
to four’ occupation
H Steglich-Arnholm1, M Holtmannspötter2, D W Krieger1
1Department of Neurology, Rigshospitalet, Copenhagen,
Denmark
2Department of Neuroradiology, Rigshospitalet, Copenhagen,
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Aim: Recent randomized clinical trials of endovascular therapy (EVT) in
acute ischemic stroke have shown low patient enrollment from multiple
centers. Patients with acute ischemic stroke may present at any hour of the
day. Sparse resources outside normal working hours combined with late
patient presentation could lead to difficult patient enrollment. This study
aims to assess when patients eligible for recent randomized EVT trials
present.
Methods: Single-center analysis of all anterior circulation stroke patients
treated with endovascular therapy (EVT) within 1 year. On-hours was
defined as the time from 8 AM to 4 PM on weekdays. Inclusion and
exclusion criteria was obtained from online sources and assessed for the
following trials: IMS-III, SWIFT-PRIME, ESCAPE, PRO-ACT II and
MR-CLEAN.
Results: Ninety-nine patients were identified. Median age: 71 (range
33–94 years). Male: 52 (53%). Median stroke severity: NIHSS 16(range
5–26). Patients presented mostly between noon and 4AM evenly
throughout the week (Figure). In total 78 (79%) patients presented off-
hours. The majority of patients eligible for recent EVT trials presented
off-hours (77% PRO-ACT II, 77% SWIFT-PRIME and 77% MR-CLEAN,
79% ESCAPE, 80% IMS III)
Conclusion: Patients predominantly present from noon to 4AM, every
day of the week. Since the majority of EVT trial eligible patients present
outside normal working hours care should be taken to ensure sufficient
resources for EVT off-hours.
ESOC-0422
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Lower income district of Budapest associated with
higher case fatality of younger stroke patients
I Szocs1, I Vastagh1, A Ajtay1, D Bereczki1
1Neurology, Semmelweis University, Budapest, Hungary
Background: Hungary has a single payer health insurance system which
makes access to care universal and offers a potential for uniform quality of
disease-management. On the other hand within Budapest there are
important regional differences regarding socioeconomic status of the
population. Less wealthy socioeconomic conditions were reported by
some studies to be associated with higher incidence and more severe state
in the acute phase of stroke but not with higher 30-day or 1-year case
fatality.
Methods: Based on the national database of the health insurance fund, we
have identified 4779 hospitalized stroke patients dwelling in the least
(district 8, n = 2618) and the most wealthy district (district 12, n = 2161)
of Budapest, respectively, with a first-ever stroke episode between 2002
and 2007. These patients were followed up for case fatality of any causes,
hospital diagnoses, and stroke recurrence until March of 2013.
Results: Global case fatality was higher in the less wealthy district (59% vs.
54%, p = 0.003). A more striking difference was found in the younger
age-groups: 33% of patients aged 41–50 years from district 8, while only
16% of those from district 12 have deceased. Case fatality was higher in all
age groups in the less wealthy district, with largest differences in the
working age groups.
Conclusions: Patients belonging to lower socioeconomic groups of the
same universal healthcare system show strikingly higher stroke fatality. It
would be of outmost importance to identify patient groups in which
improving healthcare management would improve national stroke
statistics.
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Stroke cases in the US Centers For Aids Research
(CFAR) Network of Integrated Clinical Systems (CNICS)
cohort
D L Tirschwell1, F Chow2, K J Becker1, C M Marra1, J R Zunt1,
E Ho1, R Kalani1, A Huffer1, R Nance3, J A C Delaney4,
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M Kitahata3, M Saag5, H M Crane3
1Neurology, University of Washington, Seattle, USA
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4Epidemiology, University of Washington, Seattle, USA
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Introduction: Stroke in HIV-infected patients is increasingly common in
the antiretroviral therapy (ART) era. Potential explanations include aging
of the population, HIV-related inflammation and metabolic side effects of
some antiretroviral medications. The large and well-characterized CNICS
cohort is a tremendous resource for modern studies of CVA in HIV, with
up to ten fold more cases than previous studies.
Methods/results: Each stroke case was adjudicated by two neurologists
using the NHLBI funded Multi-Ethnic Study of Atherosclerosis criteria.
We used descriptive statistics and linear regression. Of 128 stroke events
adjudicated thus far (additional adjudication is ongoing) from patients
enrolled between 1994–2012, 65% of individuals were ages 40–59 and
19% ≤40 years; 28% were female and 63% African-American. Average age
at stroke onset significantly increased with calendar year (0.8 years/
calendar year, p = 0.001). Traditional risk factors included 36% with
treated hypertension, 20% diabetes, 25% on statins, and 51% were
smokers. Non-traditional risk factors included Hepatitis C in 29%, illicit
drug use in 21% and infectious causes in 20%. CD4 count closest to stroke
event was <200 in 32%, 200–349 in 17%, and 350–499 in 12%. Ischemic
strokes were most common (84%), with TOAST subtypes of large vessel
atheroembolic (18%), cardioembolic (24%), small vessel (23%), and
other/unknown (35%). The case-fatality rate was 9%.
Conclusions: The average age at stroke onset in this HIV-infected cohort,
though still young overall, increased in more recent years. Strokes were
largely ischemic and tended to occur in young, male, African-Americans,
with low CD4 counts and other non-traditional risk factors.
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Gender differences in stroke incidence and outcome:
Results from a population-based registry
C Tiseo1, R Ornello1, D Degan1, A Carolei1, S Sacco1
1Neurology, University of L’AQUILA, L’AQUILA, Italy
Background: Gender differences in stroke have been described. This study
evaluates first-ever stroke (FES) incidence, severity, and outcome by
gender.
Methods: Prospective population-based registry including all patients
with FES residing in the L’Aquila district in the years 2011–2012.
Results: We included 847 patients, 51.4% women. Crude annual FES inci-
dence was similar in men (141.8/100,000) and in women (142.2/100,000).
Women were older at stroke onset (78.1 ± 12.7 vs 72.6 ± 13.2 years;
P = 0.002), had more subarachnoid hemorrhages (6.2% vs 2.9%;
P = 0.012), and higher proportion of atrial fibrillation than men, while
hypercholesterolemia and coronary heart disease were more frequent in
men (P < 0.05 in all cases). Stroke severity at onset was worst in women
than in men (median NIHSS score 8 [IQR 3.25–15] vs 6 [IQR 3–12];
P = 0.001) as also disability at discharge (mRS score ≥3, 85% vs 78%;
P = 0.017). Additionally, women had a higher 30-day (29.7%; 95%CI
25.4–34.0 vs 20.9% 95%CI 17.0–24.8) and 1-year case-fatality rate
(38.6%; 95%CI 34.0–43.2 vs 27.2% 95%CI 22.9–31.5) and were more
likely to be discharged to long–term rehabilitation facilities (42.1% vs
30.8%; P = 0.006) than men. The multivariate logistic regression analysis
showed that age and NIHSS scores were independent predictors of 30-day
and 1-year mortality or disability while gender was not.
Conclusions: Incidence of stroke was similar in women and in men but
women had a poorer stroke-related prognosis. The poorer prognosis may
be attributable, at least in part, to the older age and to the greater stroke
severity in women than in men.
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Burden of atrial fibrillation in ischemic stroke: Results
from a population-based registry
C Tiseo1, D Degan1, R Ornello1, F De Santis1, A Carolei1, S Sacco1
1Neurology, University of L’Aquila, L’Aquila, Italy
Background: Atrial fibrillation (AF) is a known risk factor for ischemic
stroke (IS). The study evaluates the current burden of AF in first-ever
ischemic stroke (FEIS) patients.
Methods: Prospective population-based registry (2011–2012) to investi-
gate the prevalence of AF and its influence on prognosis in patients with
FEIS.
Results: Among 634 patients included with FEIS, 200 (122 women; 61%)
had documented AF (31.5%): paroxysmal in 32 (16%), persistent in 4
(2%), and permanent in 164 (82%) patients. AF was newly diagnosed in
41 patients (20.5%). Mean age ± SD at stroke onset was higher in women
than in men (82.7 ± 7.7 vs 79.6 ± 8.5 years; P = 0.009). Fifty patients
(25%) were taking oral anticoagulants at stroke onset (mean INR ± SD:
1.9 ± 0.85). With respect to patients without the arrhythmia, those with
AF were mostly women, aged 80 years and older, and hypertensive
(P < 0.05 in all cases). Patients with AF had greater stroke severity on
admission (median NIHSS score 9 [IQR 4–17] vs 6 [IQR 3–12];
P < 0.001), more disabling strokes at discharge (mRS score ≥3 74.4% vs
52.9%; P < 0.001), and higher 30-day (29.5%; 95%CI 24.0–35.6 vs 18.6%
95%CI 15.6–22.0) and 1-year (40.2%; 95%CI 34.1–46.6 vs 25.2% 95%CI
21.8–29.0) case fatality rate (CFR). AF was an independent predictor of
30-day and 1-year mortality and of disability at discharge.
Conclusions: In patients with AF, strokes were more severe on admission,
more disabling at discharge and with higher 30-day and 1-year CFRs.
More aggressive diagnostic and therapeutic preventive strategies for AF
are needed, mostly in women and in elderly patients.
ESOC-0756
12. Epidemiology of Stroke
Aetiology, severity and outcome of ischaemic
cerebrovascular events in patients with active cancer:
A population-based study
A Tornada1, L Silver2, L Li2, Z Mehta2,
P Rothwell on behalf of the Oxford Vascular Study2
1Department of Medicine, Hospital de Cascais Dr Jose de
Almeida, Lisbon, Portugal
2Nuffield Department of Clinical Neurosciences John Radcliffe
Hospital, University of Oxford, Oxford, United Kingdom
Background: Cancer patients are at increased risk of TIA and ischaemic
stroke, but it is uncertain how the nature and risk of events differs between
those with active cancer and those in remission or without cancer.
Methods: We compared aetiological subtype (TOAST), severity (NIHSS)
and disability (Rankin) of TIA and ischaemic stroke in a population-
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based study (Oxford Vascular Study) in patients with active cancer versus
no cancer or cancer that was in remission/cured.
Results: Of 2433 patients with a first TIA or ischaemic stroke, 324 had
history of prior cancer, of whom 103 had active cancer. Those with active
cancer more often had stroke than TIA (75% vs 62%, p = 0.037) and
tended to have more severe strokes than the inactive/no-cancer group
(NIHSS > 3: 35% vs 25%; p = 0.053). Pre-morbid disability (Rankin
score > 2) was increased in patients with active cancer (p = 0.014), and
remained higher on follow-up (69% vs. 36% at 1-month, 77% vs. 40% at
1-year and 97% vs. 69% at 5-years, all p < 0.0001). All differences
remained after adjustment for age, sex and baseline vascular risk factors.
TOAST subtyping identified non-significantly more ‘other determined’
events in the active cancer group (4.9% vs. 2.1%), including hypercoagu-
lable states and nonatherosclerotic vasculopathies.
Conclusion: Patients with active cancer presenting with TIA/stroke have
more severe events and greater disability on follow-up than patients
without cancer or those in remission or cured.
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Mumbai Stroke Registry: Long term follow up of 456
first ever stroke cases in a population based study
J Vairale1, P M Dalal1, M Bhattacharjee1, K Gawali1
1Research, LKMMTrust Research Centre, Mumbai, India
Background: Non Communicable Diseases pose great health burden and
present enormous challenge for national economies. Stroke is second
leading cause of death and third leading cause of DALYs lost worldwide
Data suggests that 5 million die and 5 million more are left with chronic
disability each year.
Aims: The Study objectives were to determine long-term outcome of 456
stroke patients from Mumbai Stroke registry in terms of disability, mor-
tality and quality of life after stroke.
Methods: The survivors were traced and interviewed by the stroke team
by hot and cold pursuit. Barthel Index, was used to assess activities of daily
living, deaths were verified by death certificates.
Results: Four hundred fifty-six of 156,861 residents from H ward in
Mumbai, suffered first stroke in 2005–06 and were followed up till 2012 at
28, 90 days, one year and 7 years. At the end of the study 15% were lost to
follow up. At 28 days, mortality was 29.8%, 33% at 90 days, 40% at end of
one year and 58.10% at 7 years. Percentage of patients with moderate to
severe disability was 39% at 28 days, 23% at 90 days, 15.3% at 1 year and
8.5% at 7 years respectively. At end of 7 years only 17% were independent
Conclusions: Public awareness, health education on warning symptoms of
TIA, early stroke by optimum use of existing mass media is of utmost
importance in success of stroke campaigns Better rehabilitation services
and training of caregivers will possibly help reducing the burden in stroke
survivors.
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Increased cancer prevalence in stroke patients in the
Netherlands; PSI Stroke Study
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Introduction: Cancer and stroke are the two leading causes of morbidity
and mortality worldwide. We studied stroke and cancer characteristics in
stroke patients with and without a history of cancer.
Methods: Prospective multicenter cohort study of 3184 patients present-
ing with stroke. Biographical and stroke characteristics between the
patients with (n = 357) and without (n = 2827) a history of cancer were
compared. From the subgroup of 357 patients with a history of cancer,
type of cancer and treatment characteristics were collected. Prevalence of
cancer types was compared with the prevalence of the general population
with Standardized Prevalence Ratio (SPR).
Results: Stroke patients with a history of cancer were on average 8 years
older than those without (71 versus 63 years). There were no major
differences in stroke characteristics between these two groups. Overall
prevalence of cancer was higher in stroke patients than in the age and sex
matched general population (SPR 1.2, 95% C.I 1.1–1.4). High SPRs were
observed for cancer of head and neck (SPR 3.1, 95% C.I 2.0–4.2), central
nervous system (SPR 18.7, 95% C.I 10.0–27.3), lower respiratory tract
(SPR 2.3, 95% C.I 1.5–3.2) and urinary tract (SPR 2.2, 95% C.I 1.5–2.9).
Conclusion: The overall prevalence of cancer, specifically that of head and
neck, central nervous system, lower respiratory and urinary tract is higher
in stroke patients than in the age and sex matched general population.
Stroke characteristics were not different between patients with or without
a history of cancer. More attention is needed for stroke prevention in
specific cancer survivors.
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Increased risk of ischaemic stroke with high levels of
coagulation factor VIII activity in combination with
oral contraceptives
D Van Dooren1, F Rosendaal1,2,3, A Algra1,4,5, B Siegerink1,6
1Department of Clinical Epidemiology, Leiden University
Medical Center, Leiden, Netherlands
2Department of Thrombosis and Haemostasis, Leiden
University Medical Center, Leiden, Netherlands
3Einthoven Laboratory for Experimental Vascular Medicine,
Leiden University Medical Center, Leiden, Netherlands
4Julius Center for Health Sciences and Primary Care, Utrecht,
Netherlands
5Department of Neurology and Neurosurgery, Brain Center
Rudolf Magnus, University Medical Center Utrecht, Utrecht,
Netherlands
6Center for Stroke Research Berlin, Charité
Universitätsmedizin, Berlin, Germany
Background: Coagulation factor VIII (FVIII) is a well-established risk
factor for venous thrombotic disease. Its role in the aetiology leading to
ischaemic stroke (IS) is less well studied, especially among young people.
The aim of this study was to determine whether high levels of FVIII
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activity (FVIII:C) increase the risk of IS and how this association is
affected by oral contraceptive use.
Methods: We included young women (aged 18–50), who either experi-
enced an ischaemic stroke between 1990 and 1995 or who were free of this
disease as controls matched on age, year of inclusion and region. Risk
factors, including OC use, were determined by questionnaire. Citrated
plasma samples were stored until the measurement of FVIII:C. Logistic
regression was used to obtain odds ratios (OR) as measures of relative risk.
Levels of FVIII:C were categorized based on the 90th percentile and
quartile cut-offs of the control group. A dummy variable was constructed
to assess the risk for the combination of high FVIII and OC use.
Results: High FVIII:C levels were associated with increased risk of IS (P90
[OR 3.3, 95% Confidence interval 1.9–5.8], Q4 vs Q1 [OR 3.6, 2.0–6.5]).
The combination of OC use and high FVIII:C increased IS risk substan-
tially compared with no OC and low FVIII:C (OR = 15, 6.4–35). Adjust-
ments for levels of von Willebrand Factor (VWF) did not materially
change results.
Conclusion: High levels of FVIII:C increase the risk of IS in young
women. This risk is further increased by oral contraceptives use.
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Concomitant headache in acute ischaemic stroke:
relation with ct angiography and CT perfusion
characteristics
H J A van Os1, I A Mulder1, I C van der Schaaf2,
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Background and purpose: Headache in the acute phase of ischaemic stroke
is a prevalent symptom with a largely unknown pathophysiology. It often
occurs in young patients without cardiovascular risk factors suggesting a
role for vessel wall elasticity. Also, headache often occurs during clot
manipulation and is more prevalent in stroke patients with a migraine
history suggesting activation of the trigeminal system by spreading
depression in the penumbra. We investigated with CT-angiography (CTA)
and CT-perfusion (CTP) whether headache was related to atherosclerosis,
clot burden or penumbra size.
Methods: We included 233 patients with ischaemic stroke from our
Leiden Stroke Cohort and the Dutch Acute Stroke Trial. CT, CTA and CTP
were performed <9 hours of stroke onset. Headache characteristics were
prospectively collected with a semi-structured questionnaire. We assessed
atherosclerosis by measuring signs of calcium in any intracranial artery.
Clot burden score was assessed by CTA and penumbra size by CTP. We
calculated risk ratios (RR) with adjustments for age and sex with multi-
variable regression.
Results: Eighty-eight (38%) of the patients reported headache at stroke
onset. Patients with intracranial atherosclerosis less often had headache
than those without (34% versus 51%; RR: 0.67; 95% CI: 0.48–0.93). In
patients with large clots (37% large versus 49% small; RR: 0.79; 95% CI:
0.48–1.30) or large penumbra volumes (38% large versus 37% small; RR:
1.03; 95% CI: 0.62–1.72) no significant difference in headache occurrence
was found.
Conclusions: Stroke patients with concomitant headache less often have
intracranial atherosclerosis than patients without headache. This finding
supports the theory that vessel wall elasticity plays a role in the develop-
ment of stroke related headache.
ESOC-0953
12. Epidemiology of Stroke
Perioperative spinal cord ischemia: Case series and
comparison with non-perioperative ischemia
P Vanacker1, J B Vulsteke2, A Eskandari3, N Libbrecht2,
K Ramboer4, S Vermeire5, T Deckmyn6, P Cras7, P Michel3
1Neurology, CHUV – University of Lausanne, Lausanne,
Switzerland
2Neurology, Sint-Lucashospital, Bruges, Belgium
3Neurology, CHUV-University of Lausanne, Lausanne,
Switzerland
4Neuroradiology, Sint-Lucashospital, Bruges, Belgium
5Nephrology, Sint-Lucashospital, Bruges, Belgium
6Intensive Care, Sint-Lucashospital, Bruges, Belgium
7Neurology, University Hospital Antwerp, Antwerp, Belgium
Background: Spinal cord infarction is a rare but often devastating disorder
caused by a wide array of pathologic conditions, including perioperative
ischemia during aortic repair or spinal surgery.
Objective: The authors aimed at better understanding causes, presenta-
tion and outcome of perioperative spinal cord ischemia using consecutive
patients from two neurovascular centers.
Methods: Consecutive subjects enrolled in the ASTRAL-E registry (Lau-
sanne, 2003–2014) and ASTRAL-B registry (Bruges, 2014) with acute
vascular myelopathy and spinal cord imaging were selected and catego-
rized according to the perioperative vs. non-perioperative occurrence.
Results: The population existed of 13 men and 12 women (median age
63.8, range 37–86 yr). 4 of the 25 patients (16%) had spinal cord infarc-
tions related to surgery. In two patients, ischemia developed during spinal
surgery, in one after endovascular aortic dissection type B repair and in
one following nephrectomy. The majority of patients (21, 84%), both
perioperative (18/21) as non-perioperative (3/4), had at least one cardio-
vascular risk factor. MRI imaging (of whom 70% with DWI) showed 9
anterior spinal artery patterns, 6 unilateral anterior/posterior spinal pat-
terns, 2 posterior patterns, no central patterns, and 8 patients without
visible ischemic lesions. Most patients (8, 32%) had thoracolumbar
lesions. In general, the prognosis at three months was quite favorable with
one perioperative patient deceased (1/4, 25%) and zero non-perioperative
patients (0/11).
Conclusion: Clinical findings, imaging patterns and long-term prognosis
seem to be similar in patients with perioperative ischemic myelopathy as
in other. A prospective multicenter registry for this disease would be
helpful to better characterize and study it.
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Medical quality registers are useful sources of knowledge about diseases
and the health services. However, there are challenges in obtaining valid
and reliable data. This study aims to assess the reliability in The Norwe-
gian Stroke Register, as well as to identify problem areas and suggest
improvement strategies.
Abstracts
© 2015 The Authors.
International Journal of Stroke © 2015 World Stroke Organization Vol 10 (Suppl. 2); April 2015; 77–438 217
We randomly selected 111 patients having had a stroke in 2012. An expe-
rienced stroke nurse completed the Norwegian Stroke Register paper
forms for all 111 patients by review of the medical records. We then
extracted all registered data on the same patients from the Norwegian
Stroke Register and calculated Kappa statistics with 95% confidence inter-
vals for nominal variables. For two time variables, we calculated the Intra-
class Correlation Coefficient.
Substantial to excellent reliability (kappa > 0.60) was observed for all vari-
ables related to past medical history, functional status, stroke subtype and
discharge destination. Although excellent reliability was observed for time
of stroke onset (kappa > 0.80), this variable was hampered with a substan-
tial amount of missing values. Some variables related to treatment and
examinations in hospital displayed low levels of agreement (kappa <0.20).
This applies to heart rhythm monitoring, swallowing test performed and
mobilized out of bed within 24 hours after admission.
A majority of the variables in The Norwegian Stroke Register have sub-
stantial to excellent reliability. The problem areas seem to be the lack of
completeness in the time variable indicating stroke onset and poor reli-
ability in some variables concerning examinations and treatment received
in hospital.
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Background: Neurological complications, particularly stroke, are rare but
dreaded complications to coronary interventions. As acute reperfusion
treatment of stroke has developed during the last decade immediate iden-
tification and treatment of stroke following coronary intervention is
essential.
Methods: All reported neurological complications registered in the
Swedish Coronary Angiography and Angioplasty Register (SCAAR) on
patients undergoing coronary intervention in Sweden 2003–2011
(n = 340 782) were collected, adjudicated and analyzed regarding medical
management, treatment and follow up.
Results: After review of the 735 reported neurological complications, 586
patients (0.17 %) were adjudicated to have suffered a neurological com-
plication within 24 h of the procedure. The complications were as follows:
54.1 % ischemic stroke, 2.7 % hemorrhagic stroke, 3.8 % stroke UNS (CT
not performed), 24.7 % TIA (CT performed), 7.8 % TIA (CT not per-
formed) 0.7 % subarachnoid bleeding, and 6.1 % other neurological
complications (seizures, confusion, peripheral nerve impairment). In 269
(79%) of the patients with ischemic stroke symptoms were observed
within 3 hours of onset and 14 patients received reperfusion treatment; 11
thrombolysis, one thrombolysis + thrombectomy, and one thrombec-
tomy. Of patients treated with thrombolysis ten had a good outcome and
two suffered haemorrhagic complications.
Conclusion: Stroke as a complication to coronary interventions is rare but
may be devastating. Good medical management to recognize stroke symp-
toms early and performing neuroimaging without delay is imperative as
reperfusion treatment may be considered for ischemic complications and
for patients with haemorrhagic complications medication need to be
modified.
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Introduction: Aneurysmal subarachnoid haemorrhage (aSAH) is associ-
ated with high rates of mortality/morbidity. Infections occurring just after
the haemorrhage are one of the main causes of outcome worsening and
death. Until now, no efficient blood biomarker is available for the early
detection and prevention of this complication. The aim of this study was
to use proteomics strategies to discover biomarkers for infection predic-
tion in aSAH patients.
Material and methods: The plasma proteome of infected (n = 4) and non-
infected (n = 4) patients was compared using the 10-plex tandem mass tag
isobaric labelling quantitative mass spectrometry. Among the differen-
tially expressed proteins SAA was selected for further ELISA verification in
54 infected and 27 no infected patients. The combination of SAA with
clinical parameters was established using PanelomiX.
Results: At the day of infection, proteomic results gave rise to 17 signifi-
cantly regulated proteins. Among those, SAA levels were significantly
higher in infected patients than in no infected ones (ratio:15.86). Further-
more, we found that at the admission to the hospital its levels were
significantly higher in patients that will develop an infection during hos-
pitalisation (p = 0.002) reaching a performance of 75.3% (80% SP, 71.8%
SE). Combining SAA with three clinical parameters (WBC, WFNS, age)
improved its performance to an AUC of 94.4% (100%SP, 83%SE).
Conclusion: Our data suggested that the combination of SAA with clinical
parameters could be an efficient tool for infection determination in aSAH
patients. Their prediction capacity would potentially lead to an earlier
antibiotherapy and improvement of the long-term outcome of these
patients.
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The genetic component of cerebral venous thrombosis (CVT) is largely
unknown and so far has been assessed only by candidate gene studies. To
better understand the genetic basis of CVT, we have established an inter-
national consortium of CVT cases, the Biorepository to Establish the
Aetiology of Sinovenous Thrombosis (BEAST), which currently includes
9 European research centres.
We have analysed exome array data of 374 European individuals with CVT
and 2469 healthy controls from the 1958 Birth cohort part of the WTCCC
(Welcome Trust Case Control Consortium), genotyped using the Illumina
HumanCoreExome BeadChip. After performing PCA (Principal Compo-
nents Analysis) to remove outliers for population stratification, we have
retained for analysis 147 CVT cases and 2152 WTCCC controls. We have
applied rigorous quality control procedures and assessed the association
of the genotyped variants with cerebral venous thrombosis using logistic
regression.
We have identified several potential associated loci on chromosome 2, 6
and 9 at a significant P < 9 x 10–7. Interestingly, the associated locus on
chromosome 6 is located within the human major histocompatibility
complex, while the locus on chromosome 9 is located in and near ABO
gene, suggesting potential implications of these regions in CVT. The locus
on chromosome 2 does not seem to have an obvious role in CVT.
However, these are preliminary results, and further additional analysis on
an increased sample with matched CVT cases and controls followed by
replication will be required to confirm these associations.
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Introduction: Application of acute therapies for ischemic stroke is con-
strained because of diagnosis uncertainty and the dynamic nature of
stroke biology. Developing a blood biomarker stroke clock which
describes the evolution of stroke in an individual would make treating
stroke easier.
Methods: Blood samples were collected from 8 male spontaneously
hypertensive rats at 0, 1, 2, 3, 6 and 24 h post stroke induction by middle
cerebral artery occlusion. RNA was extracted from whole blood stabilized
in PAXgene tubes and mRNA expression was detected by oligonucleotide
Affymetrix microarray.
Results: Using a pairwise comparison model, 2045 genes were identified
to vary significantly over time (p ≤ 10–7). Some of the top20 most
changed genes are already known to be relevant to the ischemic stroke
physiopathology (e.g. Il-1R, Nos2, Prok2). Cluster analysis showed mul-
tiple stereotyped and time dependent profiles of gene expression. Direc-
tion and rate of change of expression for some profiles varied dramatically
during these 24 h. Profiles with potential clinical utility including hyper
acute or acute transient upregulation (with expression peaking from 2 to
6 h after stroke and normalisation by 24 h) were identified. Combining
different genes profiles (e.g. Myo1E, Mrga10 and Prok2) will allow the
construction of a tool capable of determining the stroke onset time.
Conclusion: Gene expression profiles vary acutely in the blood of rats after
stroke and have the potential to allow the construction of a stroke clock
and to have an impact on IS treatment decision making.
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Antiplatelet therapy reduces vascular recurrence in ischemic stroke,
however, there is variability in patient’s response to this treatment.
Genetic studies have described polymorphisms in CYP450 genes associ-
ated with resistance to clopidogrel. However none Epigenome Wide Asso-
ciation studies (EWAs) have been performed to analyze whether
epigenetics is associated with clinical response (new vascular events) to
clopidogrel.
Methods: From a cohort of 1.967 ischemic stroke patients, we selected 21
patients with a new vascular event (myocardial infarction, ischemic stroke
or cardiovascular death) despite correct medication compliance and 21
patients without vascular recurrence during the first year of follow up.
Epigenome was analyzed with the Infinium Human-Methylation Bead-
chip that detects >450.000 methylation sites. The replication cohort com-
prises 190 subjects with complete follow up and vascular recurrence data.
The vascular recurrence was detected by telephone interviews and con-
firmed with a hospital medical record. All pre-processing, correction,
normalization and analysis steps were implemented using R and Ilumina
GenomeStudio software package. Mann-Whitney U-test was used to
analyze the levels of methylation.
Results: After quality filters, 452.449 CpG sites were analyzed. Four gene
regions were found with p-values < 10–06, one site remained significant
in the replication study (p < 0.05). A deep analysis of this region revealed
another methylation site associated with vascular recurrence. These meth-
ylation sites were located in one TNF receptor associated factor gene,
previously linked with atherosclerosis progression and with CD40L
regulation.
Conclusions: We have successfully performed the first pharmacoepigen-
omic study in clopidogrel treated patients suggesting that epigenetics are
involved in vascular recurrence during clopidogrel treatment.
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Introduction and objectives: The identification of changes in the human
brain proteome after an ischemic stroke has allowed the discovery of new
blood biomarkers to predict long-term functional disability. Analysis of
the neurovascular unit components such as neurons and vessels, could
give further insights into stroke pathophysiology.
Methods: Neurons and blood brain barrier units (BBB) from infarcted
and healthy contralateral brain areas of 7 patients who died because of
stroke were isolated by immunofluorescence staining followed by laser
microdissection. Microdissected samples were analyzed through mass
spectrometry using a label-free quantification method of the identified
proteins. Gene ontology and pathways analyses were also conducted. Rep-
lication of interesting candidates was done by immunofluorescence in
new human brain stroke samples.
Results and discussion: A total of 768 proteins in neurons and 1078 pro-
teins in BBB were identified and quantified. When paired infarcted and
contralateral areas were compared, 55 proteins from neurons and 23
proteins from BBB were differentially expressed (p < 0.05, fold-change >2,
and peptide count ≥2), being mainly involved in mitochondrial dysfunc-
tion processes and associated with nervous system development.
Top significant proteins only found in neurons, in BBB or in both neuro-
vascular components were verified in the replication phase.
Conclusions: We were able to describe protein level changes in specific
neurovascular components after stroke. These results highlighted novel
candidates to be further explored as therapeutic targets or biomarkers for
the diagnosis or prognosis of stroke.
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Background: The pathophysiology of sporadic brain arteriovenous mal-
formations (BAVMs) remains largely unknown, and medical treatments
are lacking. We used next-generation RNA-sequencing to identify differ-
ential expression on a transcriptome wide level comparing BAVM tissue
samples to control samples of intracranial arteries to gain insight in the
pathophysiology of BAVMs.
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Methods: Single read (1 x 100 bp) RNA-sequencing was carried out on
12 resected BAVM specimens and 16 intracranial control arteries. Dif-
ferentially expressed genes between BAVMs and controls were identified
by negative binominal regression analysis including age as a covariate
(False Discovery Rate (FDR) corrected p-value < 0.05). We performed
functional pathway analysis, taking potential gene-length bias into
account, to establish enhancement of biological pathways involved in
BAVMs.
Results: Seven hundred thirty-six genes were upregulated in BAVMs
including genes encoding for inflammatory cytokines and secretory prod-
ucts of neutrophils and macrophages. Furthermore, 498 genes were down-
regulated including genes encoding for extracellular matrix and smooth
muscle cell components, and genes of the transforming growth factor b
signaling pathway. Functional pathway analysis showed enrichment of 17
biological pathways, of which protein digestion and absorption remained
statistically significant after FDR correction.
Conclusion: We found evidence for involvement of inflammatory media-
tors and impaired vascular wall integrity in BAVM pathophysiology. The
differentially expressed genes and pathways identified may aid in the
identification of novel therapeutic targets in the future.
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HMOX1 codes for HO1 enzyme, which degrades heme into bilirubin, iron
and carbon monoxide, and maintains normal vascular function e.g. by
acting as an antioxidant and modulator of vascular tone. We have previ-
ously shown HMOX1 is over-expressed in symptomatic carotid stenosis
(CS). HMOX1 promoter contains GTn-repeat suggested to modulate
HMOX1 expression: longer repeats have lower expression and weaker
enzymatic efficacy during oxidative stress. We investigated whether
HMOX1 promoter polymorphism associates with symptomatic CS and
the risk of future thromboembolic events.
HMOX1 was genotyped in 85 CS patients and 964 population controls.
Plaques were collected in endarterectomy and scored macroscopically for
ulceration. Patients were divided into asymptomatic and symptomatic
groups according to whether they had had ipsilateral ischemic symptoms
during their lifetime and followed for a median of 12.7 years for throm-
boembolic events.
HMOX1 was highly polymorphic with 22 alleles which therefore were
classified as long (>GT30), intermediate (GT30) and short (<gt30)
for analysis. Symptomatic patients were more often carriers of
long alleles (23%) than asymptomatic patients (8%, P = 0.135) or
controls (16%, P = 0.149). Patients with ulcerative plaques carried
significantly more often long alleles (35%) than patients with
smooth plaques (9%, P = 0.004) or controls (16%, p = 0.007). In Cog
regression analysis, the lack of a short allele significantly increased the
risk of stroke (OR 4.31, 95%CI 1.11–16.68) and AMI (OR 4.15, 95%CI
1.42–12.17).
Long alleles of HMOX1 promotor polymorphism associate with ulcer-
ative plaque phenotype and future stroke and AMI. HMOX1 genotyping
might prove useful in cardiovascular risk stratification in specific target
groups.
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Introduction: The use of biomarkers might be a complement for ischemic
stroke diagnosis. MALDI Imaging-Mass-Spectrometry is a powerful tech-
nique that allows the protein distribution visualization along a tissue
without labelling. Our aim is to study the distribution of proteins along
mouse brain and to identify new potential biomarkers of brain ischemia.
Methods: We performed a tMCAO (60 min) of C57BL/6J mice (n = 4)
with 24 h of reperfusion (approved by VHIR ethics committee according
Spansih and UE directives). We obtained brain sections for MALDI-TOF
analysis. ROIs were defined on infarct and contralateral regions. The
obtained mass spectra were analyzed by ClinProTools. We used PCA to
select relevant m/z peaks and analyzed their capacity of discrimination by
ROC curve analysis. Each m/z distribution was analyzed by Flex-
Imagin3.0. Subsequent top-down and bottom-up approaches, as well as
MaTIsse and MSImass list databases search, were developed to identify the
protein related to each m/z.
Results: We identified 102 m/z with different abundances between the
infarct and healthy contralateral regions (p < 0.05). We selected 21 m/z by
PCA and obtained their corresponding ion distribution maps . Thirteen
m/z were found increased in the infarct region and 4 m/z showed ROC
curves with AUC > 0.9 (Fig. 1). MaTIsse and MSImass list databases were
used to predict the identity of 11 m/z. We identified 35 proteins by
bottom-up approach that matched the MALDI-identified m/z.
Conclusions: For the first time, we identifed by MALDI-Imaging-Mass-
Spectrometry several m/z peaks with different abundances between
infarct and contralateral regions of mouse brain that might represent
potential biomarkers or therapeutic targets of ischemic stroke.
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Introduction and aim: The etiological classification of patients with tran-
sient ischaemic attack (TIA) could be difficult endeavor. Metabolomics
provides the opportunity to identify new biomarkers and pathogenic
pathways that could improve the diagnostic accuracy. Our aim was to
discover, by using metabolomics, novel candidate biomarkers for the diag-
nosis of the different etiologic subtypes.
Methods: A cohort of 131 consecutive TIA patients <24 hours after symp-
toms onset was chosen. The cause of TIA was classified according to the
Trial of ORG 10172 criteria: large-artery atherosclerosis (LAA, n = 33
[25.2%]), cardioembolism (n = 87 [17.6%]), small-vessel disease (n = 28
[21.4%]), undetermined (n = 47 [35.9%]).
Results: From the metabolome among the different causes, 93 m/z peaks
differed (p < 0.05 by ANOVA Fisher’s LSD) among the patients groups.
Even we developed, by applying multivariate statistics, a partial-least
square discriminant analyses model, its accuracy was low when consider-
ing all the 4 etiological groups (i.e. less than 35%). However, when con-
sidering differentiation between two groups several metabolites showed
ROC curve values higher than 0.7.
Conclusion: The different etiological subtypes among TIA patients
present specific metabolomics profile. This finding could be the first step
for the discovery of new biomarkers that could improve the diagnostic
work-up of stroke patients.
Fig. Tridimensional partial least squares discriminant analysis (PLS-DA)
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Background and purpose: MicroRNAs (miRNAs) are single-stranded,
small noncoding RNAs that regulate gene expression. Because they are
stable in blood, they are being developed as biomarkers for different
diseases. In intracranial aneurysms (IA) a major challenge is to develop
efficient screening methods to prevent future aneurysmal subarachnoid
hemorrhage (aSAH). We compared circulating miRNA expression levels
in plasma of aSAH patients and patients with unruptured IA (UIA) to
healthy controls to explore the usage of miRNAs as potential biomarkers
for individuals at high risk of IA development and its subsequent rupture.
Methods: A total of 370 miRNAs were measured in plasma of 15 aSAH
patients, of whom 11 had an additional UIA, and 15 healthy controls,
using the serum and plasma specific miRNA array MIHS3016 (Qiagen).
Significantly differentially expressed miRNAs (as defined by absolute fold
change (FC) > 1.2 and p < 0.01) were validated using real-time (RT) PCR
in an additional independent set of 15 aSAH patients, 15 patients with
UIA and 15 controls.
Results: The miRNA array analysis showed differential expression of five
miRNAs and three of these five miRNAs were validated in the indepen-
dent set with miRNA-183–5p decreased in all patients (FC = −2.2, p = 1.7
x 10–3), miRNA-200a-3p increased in aSAH patients (FC = 1.8, p = 2.8 x
10–2) and miRNA-let7b-5p decreased in UIA patients (FC = −1.7,
p = 1.27 x 10–3) as compared to controls.
Conclusions: Our results establish three circulating miRNAs as promising
readily accessible blood biomarkers to be used to identify individuals at
high risk of IA development and its subsequent rupture in the future.
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Introduction: There is a genetic aetiology to sporadic ischaemic stroke.
However, the genetics of such stroke in South Asians and Middle Eastern
populations has been poorly investigated, partly as a result of few centres
having access to enough subjects from this ethnic group. This is despite
the fact that those of non-European descent have a high vascular event
rate. The British Repository of DNA In Stroke (BRAINS) is a platform of
several arms for collecting DNA in patients with different cerebrovascular
diseases including TIA, AVMs, ischaemic and haemorrhagic stroke.
Method: We are recruiting DNA from highly characterised ischaemic
stroke patients of South Asian and Middle Eastern ancestry in four coun-
tries: UK, India Sri Lanka and Qatar. Control subjects are also recruited.
We propose to undertake a genome wide association study (GWAS) to
identify susceptibility loci to ischaemic stroke and compare and contrast
them to migrated Asians as well as against a Caucasian stroke population.
Results: In UK, we have recruited over 2393 subjects (98% cases). Total
number of recruitment in India is 2190 subjects. Of these 51% (1119) are
cases. In Sri Lanka 338 cases and 44 controls are recruited. In Qatar 290
cases are recruited to date.
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Conclusion: BRAINS is designed to collect one of the largest repositories
of DNA in ischaemic stroke patients from a South Asian and Middle
Eastern ancestry.
Funding: This study is funded by the British Council/UKIERI, Henry
Smith Charity, Dept of Health & Qatar National Research Fund.
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TXNIP gene associated to diabetes mellitus.
Genome-wide methylation analysis of ischemic stroke
patients
C Soriano Tarraga1, J Jiménez-Conde1, E Giralt-Steinhauer1,
M Mola1, R Vivancos1, A Ois1, A Rodríguez-Campello1,
E Cuadrado-Godia1, J Roquer1
1Department of Neurology Neurovascular Research Group,
IMIM-Hospital del Mar (Institut Hospital del Mar
d’Investigacions Mèdiques), Barcelona, Spain
Background: Ischemic stroke is a heterogeneous multifactorial disorder.
Diabetes mellitus (DM) is a risk factor for stroke. The prevalence of DM
in acute ischemic stroke (IS) ranges from 15% to 44%. Hemoglobin A1c
(HbA1c) screening is a method to diagnose DM (HbA1c levels > = 6.5%).
This serves as a marker for average blood glucose levels over the previous
8 weeks prior to the measurement. Epidemiological data provides evi-
dence for a genetic component to the disease, but its epigenetic involve-
ment is still largely unknown. Epigenetic mechanisms, such as DNA
methylation, change over time and may be associated with aging processes
and with modulation of the risk of various pathologies, such as cardio-
vascular disease, stroke and diabetes mellitus. Our goal was to identify
CpG sites associated with diabetes mellitus and HbA1c levels.
Methods: We perform genome-wide methylation study in whole-blood
DNA from 298 of ischemic stroke patients. HumanMethylation450 Bead-
Chip array was used to measure DNA methylation in 426036 CpG sites.
Results: Our study identified successfully a novel CpG site: cg19693031 in
TXNIP gene, Thioredoxin-interacting protein, (p = 1.02 × 10–18) associ-
ated with DM. The methylation of this CpG site was inversely correlated
to HbA1c, higher levels of HbA1c were associated to hypomethylation.
Moreover, TXNIP has been previously associated with hyperglycemia in
expression studies, being upregulated in most tissues in diabetes.
Conclusions: We identified a potentially novel CpG site in TXNIP gene
associated to diabetes mellitus. Our study extends the evidence of DM
related changes in DNA methylation.
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Cluster of four new NOTCH3 mutations – detailed
search – but all CADASIL?
M R Vosko1, C Brunner1, W Struhal1, J Balzar1, M Guger1, S Bartl1,
D Flöry2, F Laccone3, G Ransmayr1
1Neurology, AKH Linz Medical Faculty Johannes Kepler
University, Linz, Austria
2Radiology, AKH Linz Medical Faculty Johannes Kepler
University, Linz, Austria
3Institute of Medical Genetics, Medical University Vienna,
Vienna, Austria
CADASIL is a rare inherited cerebrovascular disease associated with
mutations in the NOTCH3 gene and represents the most common heredi-
tary stroke disorder.
In the period of 2010–2014 we prospectively screened consecutive stroke
patients (N = 1280) for suspicious CADASIL pattern (recurrent subcorti-
cal strokes, strokes of unknown origin, extensive or untypical white matter
lesions, dementia, migraine headaches, positive familiar history).
Laboratory analysis revealed NOTCH3 Gene Mutations in 11 subjects.
Four of these NOTCH3 mutations are new, not yet published (2x
c.269G>A, 1x c5282G>A, 1x c3664T>G). One new NOTCH3 Mutation
was found in 80 years old female patient and in all (!) her 5 asymptomatic
children (c3664T>G).
We present a detailed description of all these cases with neurolopsycho-
logical pattern as well as magnetic resonancy brain imaging changes.
The significance of such molecular variants is discussed.
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Effect of single and dual renin-angiotensin blockade
on stroke in patients with and without diabetes in
VALIANT
A H Abdul-Rahim1, K Docherty2, E J Velazquez3, R M Califf3,
M A Pfeffer4, S D Solomon4, K R Lees1, J J V McMurray1
1Institute of Cardiovascular and Medical Sciences, University
of Glasgow, Glasgow, United Kingdom
2Department of Cardiology, Western Infirmary, Glasgow,
United Kingdom
3Medicine – Cardiology, Duke University Medical Center,
Durham, USA
4Department of Medicine, Brigham & Women’s Hospital,
Boston, USA
Background: Concern has been raised about a possible increase in risk of
stroke in patients with diabetes treated with the combination of the renin-
inhibitor aliskiren and an angiotensin converting enzyme (ACE) inhibitor
or angiotensin receptor blocker (ARB). We compared the rate of stroke in
patients with and without diabetes treated with single or dual renin-
angiotensin system (RAS) blockade after acute myocardial infarction
(AMI).
Methods: We performed a post-hoc analysis of the Valsartan in Acute
Myocardial Infarction trial (VALIANT) in which 14,703 patients with
heart failure, left ventricular systolic dysfunction or both, were random-
ized to captopril (C), valsartan (V) or both (C + V) after 0.5–10 days after
AMI and followed for a median of 2.1 years. We used Cox proportional-
hazard regression to estimate the hazard ratios [HR (95% confidence
intervals)] of stroke in each treatment group.
Results: Among patients with diabetes, 60/1303 (4.6%) receiving capto-
pril, 60/1337 (4.5%) valsartan and 41/1340 (3.1%) valsartan plus capto-
pril suffered a stroke: V + C vs. V or C HR 0.68 (0.47–0.96), p = 0.03. The
corresponding numbers in patients without diabetes were 106/3606
(2.9%), 97/3572 (2.7%) and 99/3545 (2.8%): V + C vs. V or C HR 0.99
(0.78–1.26), p = 0.92 (interaction p = 0.08).
Conclusions: The risk of stroke after myocardial infarction in patients
with diabetes was lower in patients treated with both an ACE inhibitor and
ARB than in patients receiving either monotherapy.
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Prehospital blood pressure differentiates stroke
etiology
L C Gioia1, R T Zewude1, M P Kate1, K Liss2, B Rowe3, K Butcher1
1Medicine, University of Alberta, Edmonton, Canada
2EMS, Alberta Health Services, Edmonton, Canada
3Emergency Medicine, University of Alberta, Edmonton,
Canada
Introduction: Elevated admission blood pressure (BP) in acute stroke is
common, and differs among stroke etiologies. The relationship between
prehospital BP and stroke etiology is unknown. We tested the hypothesis
that higher prehospital BP values are associated with intracerebral hem-
orrhage (ICH) and lacunar stroke relative to other stroke etiologies.
Methods: A retrospective analysis of an Emergency Medical Services
(EMS) centralized database of electronic patient health care reports
(including serial BP measurements) of all patients with an EMS dispatch
code for suspected stroke transported to the Emergency Department (ED)
of a single hospital during an 18-month period. Stroke etiology was clas-
sified according to TOAST criteria.
Results: A total of 877 patients were transported by EMS to the ED with
suspected stroke. Of these, 514 patients were diagnosed with acute stroke
(360 ischemic, 103 TIA, 51 ICH). In ischemic stroke patients, etiology was
large-artery atherosclerosis (14.4%), cardioembolic (37.5%), lacunar
(12.8%), other determined etiology (4.7%), and cryptogenic (30.6%).
Mean prehospital SBP was higher in ICH (172 ± 32 mmHg, p = 0.047)
than large-artery atherosclerosis (157 ± 27), cardioembolic (151 ± 27),
other determined etiology (134 ± 19), and cryptogenic stroke (157 ± 24).
Mean prehospital SBP in lacunar stroke was higher (169 ± 32 mmHg,
p = 0.002) than cardioembolic and other determined etiology. Higher
rates of mean prehospital SBP ≥180 mmHg were found in ICH (43.1%)
and lacunar stroke (41.3%) when compared to other etiologies
(p < 0.001).
Conclusion: Higher prehospital BP, particularly ≥180 mmHg, is associ-
ated with ICH and lacunar stroke. Elevated prehospital BP may represent
an acute prehospital treatment target in acute stroke patients.
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Temperature change, short- and long-term mortality in
acute ischemic stroke
N Kakaletsis1, V Papavasileiou2, D Lambrou3, G Ntaios2, P Michel3
1Department of Clinical Neurosciences and Preventive
Medicine, Danube University in Krems, Krems, Austria
2Department of Medicine, University of Thessaly, Larissa,
Greece
3Stroke Center Neurology Service, Centre Hospitalier
Universitaire Vaudois and University of Lausanne, Lausanne,
Switzerland
Aim: The aim of the study is to explore the association between baseline
temperature (T) levels, T change during the first 24 hours, and mortality
in a representative acute ischemic stroke (AIS) population.
Methods: All patients registered in the Acute Stroke Registry and Analysis
of Lausanne (ASTRAL) between 2003 and 2013 were analyzed
(n = 2,555). The outcome was mortality at 7 days, 3 and 12 months. A
local polynomial surface algorithm was used to assess the effect of T values
on the three outcomes.
Results: Hypo- and hyperthermic admission T values were associated
with more unfavorable outcomes in the short- and long-term. This asso-
ciation disappeared with subacute hypothermia but strengthened with
hyperthermia. T < 37°C that increased over 24 hours was associated with
a higher, and T > 37°C that decreased with a lower mortality.
Conclusions: Both hypo-and hyperthermia on admission are associated
with increased short- and long-term mortality after AIS. A T decrease of
initially elevated body temperatures over 24 hours reduced mortality. We
found little evidence that spontaneous hypothermia in the acute stage of
stroke was associated with short- or long-term benefits.
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The blood pressure variability increases only the day
of neurologic deterioration in ischemic stroke
J Kang1, M S Jang2, M H Yang2, H J Baek3, T Kim3, K S Yum4,
J H Hong5, M K Han4, H J Bae4
1Department of Neurology, Samsung Changwon
HospitalSungkyunkwan University of Medicine, Changwon,
Korea
2Department of Neurology, Cerebrovascular Center Seoul
National University Bundang Hospitalc, Seongnam, Korea
3College of Medine, Seoul National University, Seoul, Korea
4Department of Neurology, Cerebrovascular Center Seoul
National University Bundang Hospital, Seongnam, Korea
5Department of Neurology, Dongsan Medical Center
Keimyung University, Daegu, Korea
Introduction: Blood pressure (BP) of the day and a day before early neu-
rologic deterioration (END) was evaluated in patients with symptomatic
cerebral artery occlusion.
Method: Patients who arrived within 24 h of onset, were not treated by
recanalization therapy or failed to make a successful recanalization and
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had a symptomatic occlusion at internal carotid artery and middle cere-
bral artery, were consecutively identified. In patients with END, the mean
and standard deviation (SD) of systolic BP at the day and one-day before
of END were estimated. In those without END, they were presumed
according to the day of and one-day before median value of END.
Results: Of enrolled 131 subjects (age, 69.3 ± 12.4; median baseline
NIHSS, 14), END were occurred in 41.2%. END occurred at median 2nd
day (interquartile range, 1st–3rd day) of symptom onset. At the day of
END, patients with END were showed significantly higher SD and mean
of SBP compared to those without END (Table). At one day before END,
mean of SBP was significantly associated with END (P = 0.05). In multi-
variable analysis, one-SD increase of SBPSD at day of END independently
increased 2.18 odds (95% confidence interval, 1.37–3.47) of END.
Conclusion: In acute ischemic stroke, daily assessment of BP variability
would be helpful in predicting the onset of END.
Table. Daily BP parameters and END
END (+) END (-) P
1day before END
SBPmean 142.5 ± 17.1 132.8 ± 15.7 <0.001
SBPSD 15.1 ± 5.6 14.4 ± 5.6 0.52
At day of END
SBPmean 137.9 ± 18.2 131.7 ± 18.2 0.04
SBPSD 16.6 ± 7.9 12.1 ± 4.0 0.01
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Blood pressure lowering with transdermal glyceryl
trinitrate is not associated with improvement in
cerebral perfusion
M Kate1, N Asdaghi2, L Gioia1, B Buck1, T Jeerakathil1, A Shuaib1,
K Butcher1
1Medicine, University of Alberta, Edmonton, Canada
2Neurology, University of Miami, Miami, USA
Background: Hyper-acute treatment with the vasodilator glyceryl trini-
trate (GTN) has been hypothesized to be beneficial in acute ischemic
stroke, potentially via an increase in cerebral blood flow. We tested this
hypothesis with serial perfusion-weighted MRI (PWI) in acute stroke
patients.
Methods: Thirty-five patients underwent PWI immediately before and
72 h after BP management. Patients with mean baseline arterial blood
pressure (MAP) >100 mmHg (n = 20) were treated with transdermal glyc-
eryl trinitrate (GTN) (0.2 mg/h) for 72 hours without a nitrate-free inter-
val. Patients with MAP ≤ 100 mmHg (n = 15) were not treated. The
primary endpoint was the mean relative delay time (rDT) within the
hypoperfused region.
Results: Mean ± SD baseline MAP was 112.5 ± 12 mmHg and
92 ± 7.5 mmHg in the GTN-treated and untreated groups (p < 0.0001).
Baseline PWI was performed 22.9 ± 15 h after symptom onset. The mean
baseline rDT was similar in the GTN-treated (3.9 ± 1.7 s) and untreated
(4.3 ± 1 s, p = 0.4) groups. The median(IQR) baseline infarct volume was
7.2(49) ml in the GTN-treated group and 32.6(49.5) ml in untreated
patients (p = 0.2). MAP in GTN-treated patients decreased by 11.4 ± 12.2
and 15.8 ± 23 mmHg at 2 h and 72 h respectively. Repeat PWI was per-
formed at 72 ± 18 h. Mean rDT was unchanged in the GTN-treated
(0 ± 1.2 sec) and untreated patients (0.2 ± 1.8 sec) and did not differ
between groups (p = 0.9). Infarct growth was similar in both groups
(3(13.9) ml vs. 15.5(45) ml, p = 0.1).
Conclusion: GTN is associated with a fall in BP in acute ischemic stroke
patients, but there is no improvement in cerebral perfusion.
Fig. 1 Temporal profile of mean arterial blood pressure (MAP) in glyceryl
trinitrate (GTN) treated and untreated patients. *p < 0.05
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Blood pressure reduction with labetalol/glyerine
trinitrate does not affect cerebral blood flow in acute
ischemic stroke
M Kate1, N Asdaghi2, L Gioia1, T Jeerakathil1, B Buck1, A Shuaib1,
K Butcher1
1Medicine, University of Alberta, Edmonton, Canada
2Neurology, University of Miami, Miami, USA
Background: Blood pressure (BP) reduction in acute ischemic stroke has
been postulated to be harmful via reduced cerebral blood flow (CBF). We
tested this hypothesis with stratified BP reduction in a 3-group non-
randomized prospective study of serial CBF measurements.
Methods: Fifty-two patients underwent perfusion-weighted MRI(PWI)
pre and 15 minutes following antihypertensive therapy. Treatment was
stratified by mean arterial pressure (MAP); >120 mmHg (n = 14
patients): intravenous labetalol (5–20 mg) and sublingual (SL) glyceryl
trinitrate (0.3 mg); MAP 100–120 mmHg (n = 19): SL glyceryl trini-
trate(0.3 mg); MAP < 100 mmHg(n = 19): no antihypertensive drugs.
Results: Baseline PWI was performed at a mean ± SD 23.4 ± 15 h from
symptom onset. Baseline mean relative CBF (rCBF) in hypoperfused
tissue was 0.84 ± 0.17 in the MAP >120 group, 0.7 ± 0.2 in the MAP
100–120 group and 0.84 ± 0.17 in MAP < 100 group (p = 0.07). Median
(IQR) hypoperfused tissue volume (CBF < 18 ml/min/100 g):
MAP > 120:6(17.3) ml; MAP100–120: 8.9(70) ml, and MAP < 100:
32(41.4)ml(p = 0.05). The time between pre and post-treatment PWI was
26.3 ± 9.8 min. Median post-treatment MAP reduction was 12.5(12.9)
mmHg in the MAP > 120 group, 6(16.4) mmHg in MAP100–120 group
and 0.3(10) mmHg in the MAP < 100 group (p = 0.04). The mean post-
treatment change in rCBF was similar in all 3 groups (MAP > 120:
0.03 ± 0.12, MAP 100–120: −0.06 ± 0.19, and MAP < 100: 0.01 ± 0.11,
p = 0.5). Also, there was no difference in hypoperfused tissue volume after
MAP reduction, between groups (MAP > 120: −0.2 ± 13.8 ml, MAP 100–
120: −2 ± 17 ml, and MAP < 100: −1.9 ± 16.5 ml, p = 0.5).
Conclusion: Acute BP reduction in ischemic stroke does not exacerbate
acute hypoperfusion severity or volume. The stability of CBF following
antihypertensive therapy suggests these drugs may be safer acutely than
has been assumed
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Chronic hyperglycemia is related to poor clinical
outcome in acute ischemic stroke
M J A Luitse1, B K Velthuis2, L J Kappelle1, Y van der Graaf3,
G J Biessels1, D.U.S.T. Study Group2
1Neurology and Neurosurgery, University Medical Center
Utrecht, Utrecht, Netherlands
2Radiology, University Medical Center Utrecht, Utrecht,
Netherlands
3Julius Center for Health Sciences and Primary Care,
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Background and purpose: Acute hyperglycemia (HG) is clearly associated
with poor clinical outcome after ischemic stroke, but the relation between
chronic antecedent HG and outcome is less clear. The aim of our study
was to determine if chronic HG, measured by hemoglobin A1c (HbA1c),
is associated with poor outcome in patients with acute ischemic stroke
and to determine the role of acute HG in this context.
Methods: We included 812 patients participating in the Dutch Acute
Stroke study (DUST) (mean age 66 ± 14 years; 61.5% male). Patients were
categorized into 3 groups based on HbA1c level: no (<39 mmol/mol),
moderate (39–42 mmol/mol) or severe chronic HG (>42 mmol/mol).
Study outcome was poor clinical outcome after 3 months (Modified
Rankin Scale >2). A subgroup analysis for patients with and without
known diabetes was performed in the group with severe chronic HG.
Results: Severe chronic HG was associated with poor outcome (RR 1.40;
95% CI 1.09–1.79). After adjustment for admission glucose levels the RR
was 1.27 (95% CI 0.96–1.67). Adjustments for vascular risk factors and
stroke severity did not influence this association. The RR for poor
outcome was higher in patients with severe chronic HG and known dia-
betes (1.52; 95% CI 1.12–2.07) than in patients with chronic HG without
known diabetes (1.30; 95% CI 0.97–1.76). Moderate chronic HG was not
associated with poor outcome (RR 1.12; 95% CI 0.87–1.44).
Conclusion: Severe chronic HG is related to poor clinical outcome in
patients with acute ischemic stroke. This relation is only partially medi-
ated by admission glucose levels.
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Measurement of blood pressure variability (BPV) in
acute stroke: feasibility and patient satisfaction and
acceptability of casual cuff, finometer and ambulatory
blood pressure monitoring (ABPM)
L S Manning1, P M Rothwell2, J Potter3, T G Robinson1
1Cardiovascular Sciences, University of Leicester, Leicester,
United Kingdom
2University Department of Clinical Neurology, John Radcliffe
Hospital, Oxford, United Kingdom
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Introduction: BPV measured within 24 hours of stroke onset may predict
outcome. How best to measure BPV and associated patient acceptability
in the acute stroke period is uncertain.
Methods: Acute stroke patients were asked to complete a questionnaire
relating to patient satisfaction on a range of BPV measurement devices
(Figure 1); rating predetermined criteria on a visual Likert scale (0 to 10).
Number of complete measurements obtained, and reasons for incomplete
measures were recorded.
Results: Forty-five participants returned questionnaires. Survey results
are shown (Figure 2). 22%, 10%, and 4% of participants reported pain,
skin irritation and bruising with ABPM, respectively; only bruising (4%)
was reported with the Finometer. Recording protocol was completed in
40% of 24 hour ABPM (mean duration 14 hours), 74% of Finometer
recordings (mean duration 18 minutes), and 100% of casual BPs. Partici-
pant intolerance was the cause of incomplete recording in 77% of cases for
ABPM, and 28% Finometer measures.
Discussion: Casual cuff, and Finometer monitoring was well tolerated,
with few side effects. ABPM was often incomplete, and less acceptable to
patients. These findings should inform the design of future studies assess-
ing BPV in acute stroke.
Fig. 1 BP monitoring procedures.
Fig. 2 Results of the patient survey for ABPM and beat to beat BP
monitors.
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Prognostic significance of short-term acute stroke
blood pressure variability (BPV): Post-hoc analysis of
CHHIPS and COSSACS trials
L Manning1, A K Mistri1, J Potter2, P Rothwell3, T G Robinson1
1Cardiovascular Sciences, University of Leicester, Leicester,
United Kingdom
2Faculty of Medicine and Health Sciences, Norwich Medical
School, Norwich, United Kingdom
3Department of Clinical Neurology, John Radcliffe Hospital,
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Introduction: Short-term BPV may predict acute stroke outcome. We
undertook post-hoc data analysis from two RCTs to determine effect of
short-term BPV on two-week outcome.
Methods: CHHIPS was de novo BP-lowering RCT of 179 patients within
36 h stroke onset. COSSACS was continue/ stop pre-existing antihyper-
tensive therapy RCT in 763 patients <48 h stroke onset. Baseline BPV
parameters (defined as standard deviation, coefficient of variation, varia-
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tion independent of the mean, and average real variability) were derived
from six standardised BPs (casual cuff BP measures over <30 minutes).
Logistic regression models, adjusted for age, sex, stroke severity and mean
BP, assessed relation between BPV and death/ disability (mRS > 3) at two
weeks.
Results: Seven hundred six COSSACS and 171 CHHIPS participants were
included. No BPV parameters were significantly associated with primary
outcome (Table).
Conclusion: When derived from casual BP measures, short-term BPV is
not a useful predictor of two-week outcome following acute stroke.
However, BPV is not a single parameter, and differing methodology may
account for the discordance with previous studies indicating longer-term
(casual BPV) and short-term (beat-to-beat BPV) prognostic value.
Table: Effects of 1 SD increment in systolic BPV parameters on 2-week
death/ major disability
COSSACS CHHIPS
OR (95%CI) OR (95%CI)
Mean 0.97 (0.89 to 1.03) 1.06 (0.78 to 1.12)
Standard Deviation 0.98 (0.78 to 1.23) 0.97 (0.90 to 1.11)
Coefficient of Variation 0.98 (0.78 to 1.23) 0.89 (0.82 to 1.18)
Variation Independent of
Mean
0.98 (0.78 to 1.22) 0.98 (0.85 to 1.12)
Average Real Variability 1.00 (0.80 to 1.26) 0.93 (0.90 to 1.12)
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Newly-diagnosed diabetes and impaired fasting
glucose are associated with unfavorable outcome in
ischemic stroke patients treated with intravenous
thrombolysis
E Osei1, S Fonville2, A A M Zandbergen3, P J Koudstaal2,
D W J Dippel2, H M den Hertog1
1Neurology, Medisch Spectrum Twente, Enschede,
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Objectives: Previously established type 2 diabetes is associated with worse
outcome after intravenous stroke thrombolysis. We studied whether pre-
diabetes and newly diagnosed diabetes are associated with unfavorable
outcome in ischemic stroke patients treated with intravenous recombi-
nant tissue plasminogen activator (IV-rtPA).
Methods: We studied 246 consecutive patients with ischemic stroke
treated with IV-rtPA. In all nondiabetic patients, fasting glucose, 2-hour
post-load glucose and HbA1c levels were determined on day 2–5. Predia-
betes (classified as either impaired glucose tolerance, impaired fasting
glucose or impaired HbA1c) and newly diagnosed diabetes mellitus were
diagnosed according to current guidelines. Pre-existent diabetes was
defined as the use of anti-diabetic medication prior to admission.
Outcome measures were unfavorable outcome defined as a modified
Rankin Scale score >2 at 3 months. We determined adjusted associations
of prediabetes, newly diagnosed diabetes and pre-existent diabetes (versus
normal glucose metabolism) with unfavorable outcome.
Results: Based on all three glucose tests combined, 81 patients (37%) were
classified as prediabetics, 78 (35%) as newly diagnosed diabetics and 32
(15%) as pre-existent diabetics.
Newly diagnosed diabetes was independently associated with unfavorable
outcome (aOR 2.9, 95%CI 1.0–8.3, p = 0.049). Prediabetes was only asso-
ciated with unfavorable outcome based on impaired fasting glucose (aOR
2.6, 95%CI 1.2–5.7). Pre-existent diabetes was also an independent prog-
nostic factor of unfavorable outcome (aOR 2.8, 95%CI 1.1–6.9).
Conclusions: Newly diagnosed diabetes and impaired fasting glucose are
associated with unfavorable outcome after intravenous stroke thromboly-
sis. This underlines the importance of further research on detection and
glycemic control of these patients.
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High blood pressure increases the risk of poor
outcome for symptomatic intracranial large artery
stenosis and occlusions: subgroup analysis of the
CICAS Study
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Purpose: We went on this study aimed to reveal how blood pressure
influences on prognosis of stroke at different severity of stenosis.
Methods: Data on 2426 patients in the Chinese Intracranial Atheroscle-
rosis (CICAS) Study were analyzed. According to JNC 7, we classified
blood pressure as four subgroups: normal, pre-hypertension, hyperten-
sion stage I, hypertension stage II. Poor outcome were defined as death
and dependence (MRS 3–5) at discharge or 1 year. According to the
severity of stenosis, we classified patients into <50% or no stenosis, 50% to
69% stenosis, 70% to 99% stenosis, and occlusion.
Results: During the follow-up period, there were 652(26.88%) poor out-
comes at discharge and 436 (17.97%) poor outcomes at 12-month. For
patients with intracranial stenosis 70% to 99%, the rate of poor outcome
at discharge were 19.25%, 23.53%, 26.67%, and 39.66% (P = 0.001) for
each blood pressure subgroup (from pre-hypertension to Hypertension
Stage II). For patients with intracranial large artery occlusion, the rates
were 17.59%, 22.11%, 29.53%, and 49.75% respectively (P < 0.0001). Poor
outcome rate at 12-month were 12.56%, 15.30%, 28.50%, 27.90%
(P = 0.0038) in patients with stenosis 70% to 99% for each blood pressure
subgroup and 11.60%, 21.50%, 23.90%, 35.08% (P < 0.0001) in patients
with occlusion. For patients with stenosis of 50%-69%, the rate of poor
outcome had no significant difference among blood pressure subgroup.
Conclusions: For patients with severe intracranial stenosis and occlusion,
higher hypertension stage is associated with increased risk of poor
outcome at discharge and 12-month. This results support lowering blood
pressure therapy for those patients.
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No relation between body temperature and arterial
recanalization in patients with acute ischaemic stroke
M Geurts1, H B van der Worp1, A D Horsch2, L J Kappelle1,
G J Biessels1, B K Velthuis2
1Department of Neurology and Neurosurgery, University
Medical Center Utrecht, Utrecht, Netherlands
2Department of Radiology, University Medical Center Utrecht,
Utrecht, Netherlands
Background: Recanalization of an occluded intracranial artery is influ-
enced by temperature-dependent enzymes. Lower temperatures reduce in
vitro activity of alteplase, but whether it also affects in vivo recanalization
is uncertain. We assessed the relation between body temperature on
admission and recanalization of an occluded intracranial artery in
patients with acute ischemic stroke, treated with or without intravenous
alteplase.
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Methods: Patients with acute ischemic stroke admitted within nine hours
after symptom onset underwent non-contrast CT and CT angiography
(CTA) in a multi-center cohort study. This substudy included all patients
with a visible intracranial arterial occlusion on admission CTA and
follow-up vascular imaging at 3 (± 2) days. The relation per 0.1°Celsius
increase in admission body temperature and recanalization at three days
was calculated using logistic regression, and expressed as odds ratios (OR)
with corresponding confidence interval (CI). Subgroup analysis was per-
formed with regard to treatment with alteplase.
Results: Two hundred seventy-eight patients with 288 occluded intracra-
nial arteries were included in this study. Recanalization occurred in 73%
of occluded arteries. There was no relation between body temperature on
admission and recanalization of the occluded artery observed at day 3
(crude OR per 0.1°C, 0.98; 95%CI, 0.93–1.03; P = 0.37), or after adjust-
ment for age, NIHSS score and treatment with alteplase (aOR, 0.99; 95%
CI, 0.94–1.05; P = 0.70). Results for patients treated or not treated with
alteplase were essentially the same.
Conclusion: In patients with acute ischemic stroke and intracranial artery
occlusion, body temperature on admission has no effect on arterial reca-
nalization, irrespective of treatment with intravenous alteplase.
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15. Risk Factors for Stroke/Prognosis
Ramadan fasting in patients with ischemic
cerebrovascular disorder
A M Abdou1, A M El Fatatry1, H S Saadallah1, D E Gaber1
1Neuropsychiatry, Faculty of Medicine – Alexandria University,
Alexandria, Egypt
Objective: To investigate the effect of Ramadan fasting in patients with
ischemic cerebrovascular stroke.
Background: Ramadan is the holy month in Islam during which time
millions of adult Muslims abstain from intake of food and drink from
sunrise to sunset, Ramadan has fallen during the longest and hottest days
of the year in the Northern Hemisphere which adds to the challenge of
observing the fast.
Methods: Descriptive cross sectional approach was selected for conduct-
ing this study during Ramadan and one month following Ramadan for 2
consecutive years 2012–2013, a total of 392 patients were studied over 4
months.
Results: There was no significant difference regarding overall stroke fre-
quency or severity in Ramadan. The age was significantly higher among
the non fasting, the duration of diabetes and hypertension was also sig-
nificantly higher among the non fasting contrary to smoking which was
higher among the fasting group. 72.7% of the fasting group were advised
not to fast, while 93.4% in the non fasting group were advised not to fast.
the most common location for the stroke in the fasting group was anterior
circulation with a statistically significant difference between fasting and
non fasting groups. There was no statistically significant difference regard-
ing vital signs and laboratory results except for serum sodium level which
was higher among the non fasting. There was a significant shift of circa-
dian rhythm, of stroke onset from 6 am–12 pm to 12 pm–6 pm.
Conclusion: That Ramadan fasting has no significant effect on ischemic
strokes frequency and severity.
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15. Risk Factors for Stroke/Prognosis
Mortality associated with intracranial parenchymal
hemorrhage in anticoagulated patients
J Afonso Ribeiro1, F Alves-Silva1, J Sargento-Freitas1, O Galego2,
H Temido3, B Rodrigues1, C Machado1, G Cordeiro1, L Cunha1
1Neurology, Centro Hospitalar e Universitário de Coimbra,
Coimbra, Portugal
2Radiology, Centro Hospitalar e Universitário de Coimbra,
Coimbra, Portugal
3Internal Medicine, Centro Hospitalar e Universitário de
Coimbra, Coimbra, Portugal
Introduction: Non-traumatic intracranial parenchymal hemorrhage
(ICH) is associated with high mortality, especially in anticoagulated
patients. Clinical data comparing vitamin K antagonists (VKA)-related
ICH and non-vitamin K antagonists (NOAC)-related ICH are still
missing. The absence of validated therapies to revert anti-thrombotic
effect in NOAC-related ICH is still a matter of discussion.
Objectives: Survival analyses of patients suffering from acute ICH accord-
ing to previous anti-thrombotic therapies.
Methods: We retrospectively included consecutive patients admitted to a
tertiary center, from August 2012 to August 2014, with the diagnosis of
ICH and at least 3 months follow-up. Demographic, clinical, analytic and
imagiologic data were obtained by consultation of clinical and national
obit records. We used Cox Regression for survival analysis, adjusted for
age. Statistical significance was defined for p < 0.05.
Results: We included 250 patients, mean age 72.18 (SD 12.12) years, 149
(59.6%) males. In this sample, 31 patients were anticoagulated – 23 with
VKA and 8 with NOAC. Fourteen (60.1%) of the VKA-related ICH
received coagulation reversal. Anticoagulated patients presented higher
mortality when compared with non-anticoagulated patients: hazard ratio
(HR) 1.056 (95% CI: 1.031–1.082, p < 0.001) in VKA-related ICH and HR
1.05 (95% CI: 1.025 – 1.075, p < 0.001) in NOAC-related ICH. There was
no significant difference between VKA and NOAC-related ICH (HR
1.048, 95% CI 0.982–1.119; p = 0.155).
Conclusion: Mortality is similar between ICH patients pretreated with
NOAC or VKA, despite anticoagulation reversal in VKA-related ICH.
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15. Risk Factors for Stroke/Prognosis
Impact of organized stroke care in a tertiary care
setting
N Akhtar1, S Kamran1, P Bourke1, S Joseph1, M Santos1, A Shuaib1
1Neurology, Hamad Medical Corporation, Doha, Qatar
Background and aim: Organized stroke care essentially improves progno-
sis and reduces complications in Acute Stroke. Our aim is to determine the
impact of establishing an organized stroke service at a tertiary hospital on
patient’s outcome.
Methods: Organization of stroke service started in April 2014, with for-
mation of Stroke ward, stroke registry, hiring stroke coordinators & nurse
specialist, & setting protocols for thrombolysis, care pathways & investi-
gations. A dedicated multidisciplinary team formed for patient care,
evaluating performance measures & coordinating consultations. Outcome
measures were mortality, thrombolysis rate, disposition, length of stay
(LOS), & complications.
Results: Thrombolysis rate increased from 5% to 9%, with mean door-
CT time of 21 mins, & mean door-needle time of 51 minutes. Even 17.6%
patients got tPA within 30 minutes of arrival. About 66% admitted
directly to stroke ward compared to other wards (p = 0.001). ICU admis-
sions reduced from 17.4% to 11% (p = 0.001). Mean investigation time
(echo, carotid US, neuroimaging) was 3.1 days. Complications reduced
from 43.5% to 10% (p = 0.001), especially aspiration pneumonia (38.5%
to 6.3%, p = 0.001), UTI (14% to 3.8%, p = 0.001), & bedsores (33.3% to
3.0). LOS (<4 days) improved from 45.5% to 57% (p = 0.001), while 19%
transferred to rehabilitation. Significantly improved mRS (≤2) at
3-months follow-up (from 57% to 81.5%, p = 0.002).
Conclusions: Establishing an organized stroke care in a tertiary hospital
not only improves care of stroke patients, but also increases proportion of
patients discharged home to live independently. This also reduces health
costs spent in overall care of stroke patients.
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15. Risk Factors for Stroke/Prognosis
Newly diagnosed diabetes and prediabetes adversely
effects outcome following acute ischemic stroke
N Akhtar1, P Bourke1, S Kamran1, J Butler2, S Joseph2, M Santos2,
D Deleu2, A SHUAIB2
1Neurology, Hamad Medical Corporation, Doha, Qatar
2Diabetes, Hamad Medical Corporation, Doha, Qatar
Background and aims: To describe the clinical characteristics and prog-
nosis of ischemic stroke (IS) in patients with newly diagnosed diabetes
(NDM) and pre-diabetes (PDM) compared to patients with DM and
non-DM patient.
Methods: We analyzed our prospective stroke registry for diabetes.
Patients were classified as non-DM (HbA1c < 5.7%), PDM (HbA1c 5.7 to
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6.4%), and known DM. Demographics and clinical characteristics
(admission NIHSS) and outcome were compared in all three groups.
Results: Of 894 patients in our stroke registry, 402 (45%) had DM, while
8.5% had NDM and 15.8% PDM. Of 15.8%, PDM was significantly more
common in less than 50 years of age (47% vs 43.5%, p = 0.001). Smoking
was more common in PDM patients (26.8%) vs NDM (22%) and known
DM (16%) (p = 0.01). Hypertension was more common in patients with
PMN (p = 0.001). PDM was more common in Asians (110/141- 78%) vs
Arabs (27/141- 19%), p = 0.001, along with NDM −57/76 vs 17/76(75%
vs22.4%, p = 0.001). Stroke was more severe in PDM and NDM (55.4%)
vs known DM (48%) p = 0.001. PDM and NDM are more likely to be
disposed to rehabilitation vs DM (25.5% vs 16.2%, p = 0.01). At discharge
known DM were significantly better (mRS ≤ 2) as compared to PDM and
NDM (45% vs 16.4% vs 9.0%, p = 0.06)
Conclusion: PDM and NDM are prevalent at an alarming level in an early
age in this population with ischemic stroke. The poor outcome in such
patients suggests that aggressive stroke prevention strategies need to be
implemented early to prevent vascular events in the community.
ESOC-0511
15. Risk Factors for Stroke/Prognosis
Clinical characteristics of acute intracerebral
hemorrhage patients with progressively worsening
symptoms during aggressive antihypertensive therapy:
The SAMURAI-ICH Study
H Akiyama1, Y Hasegawa1, M Koga2, K Todo3, S Okuda4,
Y Okada5, K Kimura6, Y Shiokawa7, K Kamiyama8, E Furui9,
H Yamagami2, K Kario10, K Toyoda2
1Department of Neurology, St. Marianna University School of
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4Department of Neurology, National Hospital Organization
Nagoya Medical Center, Nagoya, Japan
5Department of Cerebrovascular Diseases, National Hospital
Organization Kyushu Medical Center, Fukuoka, Japan
6Department of Stroke Medicine, Kawasaki Medical School,
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7Department of Neurosurgery and Neurology Stroke Center,
Kyorin University School of Medicine, Mitaka, Japan
8Neurosurgery and Stroke Center, Nakamura Memorial
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9Department of Stroke Neurology, Kohnan Hospital, Sendai,
Japan
10Division of Cardiovascular Medicine Department of
Medicine, Jichi Medical University School of Medicine,
Shimotsuke, Japan
Objectives: Antihypertensive therapy for acute intracerebral hemorrhage
(ICH) may reduce the risk of hematoma expansion and recurrent hem-
orrhage. However, appropriate blood pressure levels have not been clari-
fied because of concerns about ischemic damage in the periclot area
resulting from aggressive blood pressure lowering. We aimed to elucidate
the clinical characteristics of acute ICH patients whose symptoms pro-
gressively worsened during aggressive antihypertensive therapy.
Subjects and methods: A total of 211 patients with acute supratentorial
ICH were enrolled in the SAMURAI-ICH study. All patients received a
continuous nicardipine infusion within 3 h of onset (target systolic blood
pressure, 120–160 mmHg). Characteristics of patients with marked exac-
erbation of neurological symptoms (National Institutes of Health Stroke
Scale [NIHSS] score progression ≥4 points) within 72 h after admission
were retrospectively investigated.
Results: Of the 211 patients, 5 experienced marked exacerbation of neu-
rological symptoms and 206 did not. Clinical characteristics such as
underlying disease and initial hematoma volume on admission (exacer-
bation group, 16.5 ± 13.9 ml; non-exacerbation group, 14.8 ± 13.1 ml)
were not significantly different between the groups. In the exacerbation
group, follow-up hematoma volume (56.7 ± 59.5 ml vs. 17.2 ± 15.7 ml)
and hematoma expansion after 24 h (volume, 40.2 ± 56.0 ml vs.
2.3 ± 6.6 ml; percentage, 226.3 ± 286.1% vs. 17.6 ± 49.9%) were signifi-
cantly greater (p = 0.000) and total NIHSS score including level of con-
sciousness, best gaze, facial, and leg motor palsy up to 72 h was
significantly worsened (p
Conclusion: Hematoma growth rather than brain ischemia caused early
progression in patients with acute ICH under the aggressive blood pres-
sure lowering in the SAMURAI-ICH study.
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15. Risk Factors for Stroke/Prognosis
Door-to-stroke unit time and post-stroke complications
rate of stroke patients admitted during month of
Ramadan: A single center experience
N Alotaibi1, A El-Metwall2, A L I Al Kathaami1
1Neurology, King Saud bin-Abdulaziz University for Health
Sciences, Riyadh, Saudi Arabia
2The Research Unit CPPHI KSAU-HS, King Saud bin-Abdulaziz
University for Health Sciences, Riyadh, Saudi Arabia
Objectives: Little is known about the impact of admission during month
Ramadan on acute stroke patients. We examine the relation between
admission during month of Ramadan on boarding time from
emergency department to the stroke unit and occurrence of in-hospital
complications.
Methods: Data was collected prospectively as part of local hospital regis-
try and for quality purpose at king Abdulaziz Medical City in Riyadh from
December 2011 till December 2013. Independent sample t test and Chi-
squared were used to investigate whether the mean door-to-stroke unit
time and in-hospital-post stroke complications significantly differed
between Ramadan/non-Ramadan months. Stroke complications was
defined as composite variable of any of the multiple stroke-related com-
plications and death.
Results: A total of 604 stroke cases were admitted to the ER and subse-
quently to the stroke unit of which 41 cases (8.1%) were admitted during
the Muslim holy month of Ramadan). A total of 93 patients (15.4%)
developed one or more of the stroke-related complication. Door to stroke
unit time ranged from 1.2 to 754 hours, with a median of 33.8 hours (IQR:
20.5 to 67.3). Door-to-stroke unit time did not significantly differ between
Ramadan (64.2 hrs) non-ramadan (61.4 hrs) admission time (t = 0.22,
P = 0.81) The incidence of post- stroke-related complication did not sig-
nificantly differ between Ramadan 79.6%) non-Ramadan (85.0%) admis-
sion time (x2 = 1.03, P = 0.31).
Conclusion: our study suggest that admission of acute stroke patients
during month of Ramadan has no impact on boarding time and post-
stroke in-hospital complications.
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15. Risk Factors for Stroke/Prognosis
Risk factors for stroke in symptomatic vertebrobasilar
disease: Results of the prospective international
multicenter VERiTAS Study
S Amin-Hanjani1, D K Pandey2, L Rose-Finnell1, X Du1,
D Richardson2, K R Thulborn3, M S V Elkind4, G J Zipfel5,
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5Department of Neusurgery and Neurology, Washington
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7Department of Neurology, University of Toronto, Toronto,
Canada
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St. Louis, St. Louis, USA
11Hauenstein Neuroscience Center, Michigan State University,
Grand Rapids, USA
12., ., ., USA
Introduction: Atherosclerotic vertebrobasilar disease (VBD) is the most
important cause of posterior circulation stroke. Risk factors for recurrent
stroke were examined in the prospective multicenter Vertebrobasilar Flow
Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS)
Study.
Methods: Patients with recent vertebrobasilar (VB) TIA or stroke and
≥50% atherosclerotic stenosis or occlusion in vertebral and/or basilar
arteries were enrolled. In addition to demographic, clinical and angio-
graphic risk factors, hemodynamic status using large vessel flow in the VB
territory measured with quantitative MRA was evaluated. All patients had
standard medical management and follow-up assessment for primary
outcome event of VB territory stroke. Hazard ratios (HR) and corre-
sponding CI were calculated with Cox proportional hazard models.
Results: The cohort (n = 72, 44% female) had a mean age of 66 (range 40
to 90) years. Ten VB strokes occurred during median follow-up of 23
months. On univariate analysis, younger age (≤65 years), low distal flow
status, diabetes, and coronary disease were significant predictors of sub-
sequent VB stroke (p0.25). On multivariate analysis age and flow status
remained the strongest predictors.
Variables HR (95%CI) P value
Flow status, low 9.4 (2.4–37.6) <.01
Age, ≤65 21.8 (2.4–196.4) <.01
CAD 4.8 (1.2–18.6) .02
DM 4.4 (1.1–17.8) .04
Conclusions: Risk of subsequent VB stroke in patients with symptomatic
VBD is highest in younger patients and those with distal flow
compromise.
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15. Risk Factors for Stroke/Prognosis
Risk of stroke in migraine patients using triptans
K Andersen1, V Albieri1, L Ravnskjær1, T S Olsen2
1Statistics, Danish Cancer Society, Copenhagen Ø, Denmark
2Stroke Unit, Frederiksberg Hospital, Frederiksberg, Denmark
Background: Stroke is associated with migraine in recent meta-analyses.
There is no information, however, on the association between stroke and
the migraine sub-group using triptans known for their effect on contrac-
tile 5-HT1B receptors. We studied risk of stroke in migraine patients
having used triptans for migraine headaches.
Methods and material: The study is based on the entire Danish popula-
tion (18–80 years) during 2003–2012 (329.1 mill. person years). Users of
triptans within 5 years prior to stroke were identified using the Danish
Registry of Prescriptions covering all prescriptions by physicians in
Denmark. Hospital admissions for stroke were obtained from the Danish
Stroke Registry covering all admissions for stroke in Denmark. Informa-
tion on age, gender and, income/education was obtained from Statistics
Denmark. Multivariate regression statistics were used.
Results: During 2003–2012, 49711 hospital admissions for stroke were
identified. Among these 1084 strokes were identified among users of trip-
tans (2.3 mill. person years). Adjusting for age, gender, income and edu-
cation risk of stroke was significantly higher among users of triptans. All
(RR 1.08;1.01–1.14); females (RR 1.10 CI 1.02–1.18); males (RR 1.07 CI
0.96–1.19). Risk was increased for ischemic strokes (RR 1.07 CI 1.00–1.14)
but not for hemorrhagic strokes (RR 1.18 CI 0.95–1.5). Risk was age
dependent: RR 1.6–1.7 for women (25–40 years); RR 1.3–1.5 for men
(35–45 years) (p < 0.001). At ages > 55 years RR was ≤1.0 (p > 0.05).
Conclusions: Risk of ischemic stroke is increased in migraine patients
using triptans primarily at ages 25–45 years. Most probably the result of
migraine rather than using triptans.
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15. Risk Factors for Stroke/Prognosis
Adherence to Mediterranean Diet in patients with
acute ischemic stroke: relationships between
Mediterranean Diet score and diagnostic subtype and
stroke severity indexes
V Arnao1, A Tuttolomondo2, A Casuccio3, D Di Raimondo4,
C Buttà4, R Percoraro4, G Clemente4, C Maida4, I Simonetta4,
G Miceli4, A Cirrincione4, A Pinto4
1BIONEC, University of Palermo, Palermo, Italy
2Internal Medicine and Cardio-Angiology Ward University of
Palermo Italy., University of Palermo, Palermo, Italy
3Maternal and Infant Health Department University of
Palermo Italy., University of Palermo, Palermo, Italy
4Internal Medicine and Cardio-Angiology Ward University of
Palermo Italy. 2Maternal and Infant Health Department
University of Palermo Italy, University of Palermo, Palermo,
Italy
Background: Mediterranean Diet has become the standard for healthy
eating.
Aim of the study: We conducted a retrospective study to evaluate the
association between Mediterranean Diet adherence, TOAST subtype and
stroke outcome.
Methods: The type of acute ischemic stroke was classified according to the
TOAST classification. At admission to our ward we administered to all
patients admitted with acute ischemic stroke or to their relatives a 137-
item validated food-frequency questionnaire adapted to Sicilian popula-
tion. A scale indicating the degree of adherence to the traditional
Mediterranean diet was used (range 0–9).
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Results: We enrolled 198 subjects with acute ischemic stroke and 100
control subjects without acute ischemic stroke. Among stroke patients,
lacunar subtype showed a higher mean Mediterranean diet score com-
pared to LAAS subtype. Multinomial logistic regression analysis in mul-
tiple model showed that mean Mediterranean Score resulted predictive of
SSS (p = 0.0001) , NIHSS (p = 0.0001) and rankin (p = 0.0001) scores.
Conclusions: Our study show as a low adherence to a Mediterranean diet
style is associated with stroke prevalence and how a low adherence to this
type of dietary pattern is associated to LAAS stroke subtype and a worse
stroke clinical profile evaluated by means NIHSS and rankin score. We
reported that patients with lower adherence to a Mediterranean Diet
profile are more likely to have an atherosclerotic (LAAS) subtype of
stroke, a worse clinical presentation of ischemic stroke with a higher mean
NIHSS and a dependency with higher rankin score at admission.
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15. Risk Factors for Stroke/Prognosis
Vessel wall imaging at 3.0-Tesla MRI in patients with
intracranial vessel disease and in healthy controls
D A Daniel Arteaga1, J S Jeroen Siero2, M S Megan Strother1,
C F Carlos Faraco1, J H Jeroen Hendrikse2, M D Manus Donahue1
1Radiology, Vanderbilt University, Nashville, USA
2Radiology, University Medical Center Utrecht, Utrecht,
Netherlands
Purpose: To translate a recently-proposed ultra-high field (7 Tesla) MRI
protocol for assessing intracranial (IC) vessel wall morphology to the
clinically available field strength of 3T to enable vessel wall imaging (VWI)
routinely without contrast agent administration.
Methods: Following protocol development, IC stenosis patients (n = 16)
and healthy volunteers (n = 16) provided informed, written consent and
underwent FLAIR, angiography, and a custom VWI protocol (3D turbo
spin echo, TR = 1500 ms; spatial resolution = 0.5 mm isotropic, and anti-
driven +90 equilibrium pulse). A board-certified neuroradiologist
reviewed all images.
Results: Vessel wall abnormalities were detected in all (12/16) participants
with significant (>50%) flow-limiting stenosis on angiography. Fig. 1
demonstrates changes for two individuals with VWI lesions. Two partici-
pants had advanced moyamoya disease and extensive collateralization on
DSA, both of whom had corresponding findings on VWI.
Discussion: We show that it is possible to perform VWI without contrast
at 3T and still retain an acceptable image quality for discerning IC vessel
abnormalities. Parallel work is focused on characterizing relationships
between vessel wall disease and parenchymal reactivity.
Fig. 1 (a) 57 yr/M with basilar artery stenosis. VWI (left) in the coronal
plane shows hyperintense signal of a vessel wall lesion in the basilar artery
(red arrow). AP projection from left vertebral injection during DSA (right)
shows corresponding stenosis (red arrow). (b) 53 yr/M following L MCA
territory stroke. VWI (left) demonstrates wall thickening (red arrow) of left
distal ICA continuous in the left proximal MCA which corresponds to
stenosis on DSA (right, AP view from L ICA injection).
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Relationship between blood pressure control and
arterial stiffness, carotid artery and retinal damage in
hypertensive patients with and without type 2
diabetes mellitus
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1Neurology, Faculty of Medicine – University of Porto, Porto,
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Portugal
Background: Complex interactions between several vascular risk factors
are often present in the genesis of stroke. Better understanding the weight
of each player in causing macrovascular and microvasculature disease
could help delineating more effective stroke preventive strategies.
Aim: In an arterial hypertensive population we aimed to compare the
effect of associated Diabetes Mellitus (DM) on macro and microvascular
disease.
Methods: We compared type 2 DM and non-DM hypertensive subjects,
regarding macrovascular damage markers – aortic stiffness by pulse wave
velocity (PWV) and carotid plaques and IMT by duplex ultrasound – and
microvascular disease as assessed by retinal microvascular signs (RMS) on
fundus photograph
Results: Hypertensive patients with DM (n = 71) were more frequently
male (60 vs 40%, p = 0.020), older (62 ± 8 vs 57 ± 13, p = 0.007), had
higher 24 h Systolic BP (p = 0.003), HgA1c (p < 0.001) and lower HDL
(p = 0.014) and LDL (p = 0.010) values than non-DM (n = 84). DM
group presented higher PWV (11.5 ± 1.8 vs 10.5 ± 1.7 m/s, p = 0.001),
mean IMT (0.78 ± 0.16 vs 0.70 ± 0.19 mm, p = 0.003), presence of carotid
plaques (68 vs 38%, p < 0.001), any retinopathy (62 vs 42%, p = 0.009)
and RMS score (2.3 ± 2.8 vs 1.4 ± 2.1, p = 0.026). Systolic BP more
strongly associated with PWV (p < 0.001) and IMT (p = 0.001), and
HgA1c values more strongly associated with IMT (p < 0.001) with RMS
higher score (p = 0.009).
Conclusion: In hypertensive patients, DM contributes to both macro and
microvascular disease. Whereas aortic stiffness depends mainly of BP
control, DM glycaemic control concurs in determine cerebrovascular risk.
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15. Risk Factors for Stroke/Prognosis
Long-term survival of the first-ever stroke – an
hospital-based study
V Barbosa1, G Lopes2
1Mestrado Integrado em Medicina, Instituto de Ciências
Biomédicas Abel Salazar, Porto, Portugal
2Serviço de Neurologia, Centro Hospitalar do Porto, Porto,
Portugal
Background: Long-term prognosis of cerebrovascular disease isn’t com-
pletely known. This study aims to determine the survival after the first-
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ever transient ischemic attack (TIA) or stroke and ascertain whether there
are significant differences in survival depending on pathological type.
Methods: Retrospective analysis of patients that attended to Centro Hos-
pitalar do Porto, in 2004, with a first-ever TIA/stroke. The patients’ char-
acteristics were registered according to stroke type. They were followed for
9,4 years through hospital and primary care records. The overall survival
was calculated by the Kaplan-Meier method. A Cox regression model was
used to estimate the effect of potential predictors of survival.
Results: From the 504 patients admitted with TIA/stroke, 181 were
excluded because a previous TIA/stroke and for 61 there wasn’t
enough information available. We included 262 patients, with an equal
gender distribution and a mean age of 67,7 ± 15,1 years. The mean
follow-up time was 5,0 ± 3,6 years, in which 132 patients (52,8%) died,
with a mean survival rate of 7,2 years (CI95%:6,6–7,7). Survival is signifi-
cantly better for TIA (8,5 years;CI95%:7,8–9,2) than for ischemic
(7,0 years;CI95%:6,5–7,6) or hemorrhagic strokes (6,9 years; CI95%:
5,8–7,9). Univariate analysis showed that significant predictors
of death were age (HR:1,03;CI95%:1,01–1,05), acute kidney injury
(AKI) (HR:3,21;CI95%:1,23–8,01) and chronic kidney disease
(CKD) (HR:3,49;CI95%:1,09–11,2), atrial fibrillation (AF)
(HR:1.90;CI95%:1,01–3,33) and dementia (HR:3,41;CI95%:1,24–9,38).
In multivariate analysis this relationship was found for age
(HR:1,03;CI95%:1,01–1,05), CKD (HR:4,09, CI95%:1,26–13,3) and AKI
(HR:3,39, CI95%:1,32–8,71).
Conclusions: TIA patients had a better long-term survival compared with
stoke. Globally, patients with worse survival were the elderly and those
with kidney disease, AF or dementia.
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Functional outcome and recurrence between embolic
stroke of undetermined source (ESUS) and
cardioembolic stroke in a Mexican cohort
A Arauz1, E Morelos-Figaredo1, M A Barboza1, J Colin-Luna1
1Stroke Department, National Institute of Neurology and
Neurosurgery, Mexico City, Mexico
Background: The term embolic stroke of undetermined source (ESUS)
has been recently introduced. Our aim is to analyse early and long-term
functional outcome, recurrence and death, between patients with ESUS
and Cardioembolic Stroke (CS).
Methods: We recruited Mexican mestizo patients from our institutional
database, classified as cryptogenic and CS according to ASCOD etiologic
criteria, with the qualifying event from 2003 to 2013. The criteria
proposed by the Cryptogenic Stroke/ESUS International Working Group
were applied to identify all ESUS patients. Demographic, clinical, labora-
tory, imaging and functional outcome characteristics were collected. The
endpoints were bad outcome (Modified Rankin Score 3–6), recurrence
and mortality at discharge, 6 months and final follow-up. Adjusted Mul-
tivariated Cox proportional hazard analysis, and Kaplan Meier curves
were used to estimate the probability of recurrence and death.
Results: One hundred eighty-five consecutive patients were included (103
CS [median age 59.1 years, IQR 44–73], vs. 82 ESUS [median age 34.0,
IQR 27–44]), with a median follow-up of 27 months (IQR 9.5–70). More
prevalent risk factors were hypertension (ESUS 8.5% vs. CS 46.6%;
p < 0.001), and smoking (ESUS 28% vs. CS 21.4%; p = 0.29). Bad prog-
nosis between ESUS and CS was present in 37.8% vs. 52.4% (p = 0.04) at
discharge, and 26.8% vs. 43.7% (p = 0.02) at final follow-up respectively.
Recurrence was present in 1.2% ESUS and 8.8% CS patients (p = 0.02),
with a Hazard ratio = 0.07 (CI 95% 0.007–0.76; p = 0.03) for CS. Death
was present only in 3 CS patients (p = 0.07).
Conclusion: Recurrence, bad functional outcome and mortality are more
frequent in CS than ESUS patients.
ESOC-0358
15. Risk Factors for Stroke/Prognosis
Predictors of cognitive decline after intracerebral
hemorrhage
M Benedictus1, A Hochart2, C Rossi2, G Boulouis2, H Hénon2,
W M van der Flier1, C Cordonnier2
1Neurology Alzheimer Center, VU University Medical Center,
Amsterdam, Netherlands
2Neurology, Lille University Hospital, Lille, France
Objective: We aimed to determine predictors of cognitive decline in
patients with intracerebral hemorrhage (ICH).
Methods: We prospectively included 167 consecutive ICH survivors
without pre-existing dementia. Follow-up was 4 years (interquartile range
[IQR] 2.3–5.4). We determined factors associated with cognitive decline
in the total cohort and in patients without pre-existing cognitive impair-
ment, using linear mixed models. First, we investigated each predictor
separately in univariate models. Next, we constructed a clinical and a
radiological multivariate model, including variables with a univariate
p-value < 0.1. Cognitive decline was determined based on repeated mini-
mental state examination (MMSE).
Results: Median age was 64 years (IQR 53–75), 69 (41%) patients were
female and median MMSE at baseline was 27 (IQR 23–29). Factors asso-
ciated with cognitive decline in univariate analyses were previous stroke or
TIA (β[SE]-0.50[0.21], p < 0.05), pre-existing cognitive impairment
(β[SE]-0.76[0.22], p < 0.05), microbleeds presence (β[SE]-0.24[0.11],
p < 0.05), white matter hyperintensities (β[SE]-0.24[0.11], p < 0.01) and
cortical atrophy (β[SE]-0.48[0.13], p < 0.01). In multivariate analysis, pre-
vious stroke or TIA (β[SE]-0.55[0.23], p < 0.05), pre-existing cognitive
impairment (β[SE]-0.56[0.25], p < 0.01) and cortical atrophy (β[SE]-
0.50[0.19], p < 0.01) remained independently associated. In patients
without pre-existing cognitive impairment (n = 139), previous stroke or
TIA (β[SE]-0.42[0.23], p = 0.06), new stroke or TIA (β[SE]-0.42[0.22],
p = 0.06) and cortical atrophy (β[SE]-0.28 (0.14), p < 0.05) were associ-
ated with cognitive decline in univariate analyses. In these patients, only
cortical atrophy (β[SE]-0.38[0.17], p < 0.05) was associated with cogni-
tive decline in multivariate analysis.
Interpretation: Pre-existing cognitive impairment, cortical atrophy and
vascular burden are associated with faster rate of cognitive decline after an
ICH.
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15. Risk Factors for Stroke/Prognosis
Age and “rich club” status affect the vulnerability of
the structural connectome to stroke: A study of
simulated lesions in older adults
R Berlot1, M J O’Sullivan2
1Department of Neurology, University Medical Centre
Ljubljana, Ljubljana, Slovenia
2Department of Basic and Clinical Neuroscience, King’s
College London, London, United Kingdom
Strategic infarction describes how lesions in particular locations have
profound effects on brain function. One hypothesis to explain the strate-
gic effect is that such lesions disrupt global properties of the brain’s
connectome. To test this, we generated simulated lesions of the “rich club”,
a network of highly interconnected hubs that mediate long-distance con-
nectivity in the brain, and subcortical nuclei often invoked in strategic
infarction.
Thirty-nine healthy volunteers aged 53–93 years underwent diffusion-
weighted MRI. Whole-brain tractograms were represented as network
graphs. Lesions were simulated by removing a node and its connections
from the graph. The proportional change in global efficiency due to lesion
was calculated. Comparison was made with remaining non-rich club cor-
tical nodes. All participants provided informed, written consent.
Lesions of rich-club nodes led to larger reductions in global efficiency
(t = 21.0, p < .001) than lesions outside the rich club. Lesions of a left
middle occipital node and the precunei produced largest effect. Subcorti-
cal lesions were less damaging to global efficiency compared with non-
rich club cortical nodes (t = 11.4, p < .001). Among subcortical nodes,
vulnerability was highest for thalamic lesions. Age was positively corre-
lated with vulnerability to lesions in the thalamus (right, r = .463,
p = .003; left, r = .337, p = .036).
The structural connectome of older people is vulnerable to strategic
lesions of rich-club nodes, though some of the key hubs are in sites rarely
affected by stroke. Thalamic lesions have a large global impact that
increases with age. The vulnerability of the underlying connectome could
account for poorer outcome of thalamic stroke in older patients.
ESOC-0976
15. Risk Factors for Stroke/Prognosis
In hospital prospective stroke registry-risk factor
survey
M Bhattacharjee1, P M Dalal1, J Vairale1, A Shenoy1
1Research, Lilavati Hospital & Research Centre, Mumbai, India
Introduction: Stroke is a major public health problem. Rapid urbaniza-
tion and changing patterns in lifestyle have led to rising behavioral risk
factor levels in the population.
Aim: To understand burden of stroke it is essential to assess the risk factor
profile of stroke cases.
Methodology: Prospective hospital based case control study was under-
taken. All first-ever-stroke patients enrolled in Lilavati Hospital during the
period Jan 2012-July 2013, were cases. Controls had no history of stroke
and were matched for age and sex with cases. Data of cases and controls
were entered in proforma approved by the Ethics Committee. We calcu-
lated Odds Ratio for developing stroke with selected risk factors.
Results: Data on 125 cases and 201controls were analyzed. History of
hypertension (OR 4.09; 95% CI 2.13–7.84), ischaemic heart disease (OR
1.54; 95 % CI 0.82–2.90), raised serum cholesterol (OR 1.51; 95% CI 1.26-
1.81), alcohol intake (OR 3.05; 95% CI 1.75–5.30), tobacco consumption
(OR 1.97; 95% CI 1.10- 3.52) significantly contributed to the risk of
developing stroke. However dietary preferences of vegetarian or non-
vegetarian diet (OR 0.92; 95% CI 0.55–1.54) and history of diabetes
mellitus (OR 0.69; 95% CI 0.38–1.23) was surprisingly not a significant
contributor. 23% of cases led a sedentary lifestyle and 59% of cases had a
BMI of 25 and above.
Interpretation: Our findings suggest that conventional risk factors signifi-
cantly contribute to the risk of stroke. Aggressive interventions to reduce
hypertension, promoting healthier lifestyle and community awareness, is
urgently needed to reduce the burden of stroke.
ESOC-0268
15. Risk Factors for Stroke/Prognosis
Added value of acute multimodal CT-based imaging
(MCTI): A comprehensive analysis of 1994 consecutive
stroke patients
O Bill1, M F Faouzi2, P M Michel1
1Neurology Dept. CHUV, Stroke Unit, Lausanne, Switzerland
2IUMSP, UNIL, Lausanne, Switzerland
Introduction: MCTI is used to assess acute ischemic stroke (AIS) patients.
We postulated that use of MCTI improves patient outcome regarding
independence and mortality.
Methods: From the ASTRAL registry, all patients with an AIS and a non-
contrast-CT (NCCT), angio-CT (CTA) or perfusion-CT (CTP) within
24 h from onset were included. Demographic, clinical, biological, radio-
logical, and follow-up caracteristics were collected. Significant predictors
of MCTI use were fitted in a multivariate analysis. Patients undergoing
CTA or CTA&CTP were compared with NCCT patients with regards to
favourable outcome (mRS ≤ 2) at 3 months, 12 months mortality, stroke
mechanism, short-term renal function, use of ancillary diagnostic tests,
duration of hospitalization and 12 months stroke recurrence.
Results: Among the 1’994 AIS patients with acute CT-based imaging,
factors independently associated with MCTI were young age, low pre-
stroke mRS, low creatinine , known stroke onset, anterior circulation
stroke, anticoagulation (CTA only), anti-hypertensive therapy (CTA
only), and higher admission NIHSS (CTP only). After adjustement, we
found no independent association between MCTI and 3 months favorable
outcome, risk of early renal failure, hospitalization length, number of
exams during the stay or 12 months stroke recurrency. However, 12
months mortality was reduced for patients undergoing CTA and
CTA&CTP and likelihood of having an unknown stroke mechanism for
both groups.
Conclusion: Our study showed that MCTI reduces mortality in stroke
patients, but not handicap at 3 months, suggesting that CTA and CTP
don’t harm the patient: no delay in patient management, no difference in
stroke treatment, and no renal impairment. MCTI is thus a safe, reliable
examination.
ESOC-0522
15. Risk Factors for Stroke/Prognosis
Heart rate variability: An early predictor of post-stroke
infection? The ongoing study PRED-SEP
D Brämer1, S Nowack1, D Hoyer1, H Hoyer1, F M Brunkhorst1,
O W Witte1, A Günther1
1Center for Sepsis Control and Care, University of Jena, Jena,
Germany
Introduction: Early detection of stroke-associated infections could sub-
stantially shorten treatment time, improve outcome and decrease mortal-
ity. Post-stroke infections can, amongst other mechanisms, be mainly
attributable to a stroke-induced immunosuppression mediated by the
autonomous nervous system (ANS). ANS activity can be determined from
heart rate variability (HRV) parameters. Predictive value of HRV param-
eters regarding development of infections and/or sepsis is also relevant for
different underlying diseases without stroke. In the current PRED-SEP
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study, predictive value of HRV parameters for development of infections
is examined in patients after acute ischemic stroke for the first time.
Study description: PRED-SEP is a monocentric, prospective, observa-
tional study in patients with acute ischemic infarction in the middle
cerebral artery territory suffering severe neurological deficits (NIH stroke
score ≥8). We investigate development of infection, SIRS, and severe sepsis
in the subacute phase at days 3–5 following stroke and the functional
outcome at 3 months. Infection is defined according to the PANTHERIS
study comprising pneumonia, urinary tract infection and infections
without determined focus. Data analyses include evaluation of the pre-
dictive value of HRV indices (calculated from 24 h-ECG-measurements
within the first 48 hours after stroke) adjusted to clinical factors by means
of logistic regression models (primary endpoint is infection) and exami-
nation of correlations between HRV indices, anamnestic data and pro-
and anti-inflammatory blood markers (CRP, leukocytes, Copeptine, PCT,
IL-6, IL-10, TNF-Alpha, m-HLA-DR).
Current status: Since 25-Feb-2012, 272 patients have been recruited. We
plan to recruit 280 patients until 31-Jan-2015. Statistical analyses will
begin once recruitment is complete.
ESOC-1097
15. Risk Factors for Stroke/Prognosis
Predictors of recurrent neurovascular events at one
year in patients with mild ischaemic stroke
F Chappell1, M C Valdés Hernández1, S Makin1, K Shuler1,
E Sakka1, A Heye1, M Thrippleton1, P A Armitage2,
S Muñoz Maniega1, M Dennis3, J M Wardlaw1
1Neuroimaging Sciences, University of Edinburgh, Edinburgh,
United Kingdom
2Academic Unit of Radiology, University of Sheffield,
Sheffield, United Kingdom
3Clinical Neurosciences, University of Edinburgh, Edinburgh,
United Kingdom
Background: Mild stroke patients can experience further neurological
events, leading to significant morbidity and mortality. Identification of
patients at high risk would help target secondary prevention.
Methods: We recruited 264 mild ischaemic stroke patients. We used base-
line age, Fazekas score, blood pressure, smoking status, lacunar or cortical
stroke subtype, and blood-brain barrier (BBB) permeability measured
one month post-stroke in normal white matter, grey matter, cerebrospinal
fluid, and white matter hyperintensities as predictors. We assessed recur-
rent neurovascular events (transient ischaemic attack (TIA), further
stroke, or new infarct on brain scan) at one year. We used multiple logistic
regression to assess the relationship between neurovascular events and the
predictors in each brain tissue. Ethics approval and informed consent
were obtained.
Results: Of the 264 recruited, 181 had complete data and were used in the
analysis. Sixteen patients had a further stroke, 5 a TIA, and 19 a new lesion
– 33 patients in total had a neurovascular event at one year. Fazekas score,
not age, risk factors or BBB permeability, was the only predictor consis-
tently associated with neurovascular events. In normal white matter, the
odds ratio for Fazekas score was 1.323 (95% confidence interval 1.011 to
1.730, p = 0.041). Results for the other tissues were near identical, i.e. the
odds of a neurovascular event increase by 30% per point increase in
Fazekas score.
Conclusions: Fazekas is a remarkably consistent predictor of recurrent
stroke or TIA with an odds ratio of around 1.3. Use of Fazekas score could
help target secondary prevention.
ESOC-0769
15. Risk Factors for Stroke/Prognosis
Embolic stroke of undetermined source (ESUS) has
different baseline characteristics and recurrence rate
compared to other stroke subtypes
B Chavarria Cano1, A García Pastor1, F Díaz Otero1,
P Sobrino García1, E Luque Buzo1, M Vales Montero1,
P Vázquez Alén1, Y Férnandez Bullido1, J A Villanueva Osorio1,
A Gil Núñez1
1Neurology, Hospital General Universitario Gregorio
Marañón, Madrid, Spain
Background: Embolic stroke of undetermined source (ESUS) is a recent
clinical entity proposed for the optimization of preventive treatment in
cryptogenic stroke. Our objective is to describe baseline characteristics
and stroke recurrence rate of an ESUS population derived from a pro-
spective ischemic stroke registry.
Methods: We analyzed patients with ischemic stroke admitted to our
stroke unit in 2010. Demographic, vascular risk factors and baseline data
were recorded prospectively. Stroke etiology was determined according to
TOAST classification. Patients meeting ESUS criteria were identified ret-
rospectively. Stroke recurrence was defined as any new ischemic stroke or
TIA occurring during follow-up.
Results: Among 492 included patients, 144 (29.3%) were classified as
cryptogenic stroke, 133 (92.4%) of which met ESUS criteria. Hyperten-
sion was less frequently detected in ESUS patients (60.2% Vs 71.3%;
p = 0.018), non-stenotic plaques in cerebral arteries and minor cardioem-
bolic sources were more frequently observed in ESUS group (61.7% Vs
39.6%; p < 0.001 and 74.4% Vs 47.6%; p < 0.001). Oral anticoagulants
were prescribed in 17.3% of ESUS patients at discharge. Median follow-up
was 30 months (IQR: 18–40). Global 2 year-cumulative recurrence rate
was 11.2% (15.6% for ESUS group and 9.4% for non-ESUS patients, Log
rank p = 0.006). Covert atrial fibrillation was detected during follow up in
13.8% of ESUS patients.
Conclusion: About 27% of our patients met criteria for ESUS. ESUS base-
line characteristics, diagnostic findings and recurrence rate were different
to other stroke subtypes. Covert atrial fibrillation seems to be a common
finding in these patients.
ESOC-1039
15. Risk Factors for Stroke/Prognosis
The prevalence of carotid artery stenosis remains high
in patients with ischaemic stroke despite prior
secondary prevention therapy
S F Cheng1, M M Brown1, R J Simister1, T Solbach1, T Richards1
1Division of Surgery and Interventional Science, University
College Hospitals, London, United Kingdom
Introduction: The prevalence of carotid stenosis in patients presenting
with TIA or stroke is reported at 10–20%, but the prevalence in a modern
population in which antiplatelet therapy and statins are widely used is
unknown. We therefore studied the prevalence in patients attending a
Hyper-Acute Stroke Unit (HASU).
Methods: A prospective observational study was performed over a five
month period in 2014 at a central London HASU. Consecutive patients
with suspected stroke or TIA underwent CT angiography or contrast-
enhanced MRA including the extracranial vessels. Carotid stenosis was
defined as stenosis measuring >50% confirmed by consultant neuroradi-
ology review at a joint neurovascular MDT. Patient demographics and
treatment prior to admission were collected. The cause of the stroke was
confirmed by a consultant stroke physician or neurologist, who reviewed
all patients.
Results: Carotid imaging studies was performed in 507 out of 564 patients
diagnosed with ischaemic stroke or TIA, the remainder being too unwell.
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The prevalence of carotid artery disease was 15.4% (n = 78). Carotid
disease was symptomatic in 40 patients (7.9%), of which 10 (2.0%) had
occlusion and 30 (5.9%) carotid stenosis. 16 had endarterectomy, one
stenting and 1 was included in the medical arm of ECST-2. 38 patients
(48.7%) presented on a statin, 47 (60.3%) on anti-hypertensive therapy
and 33 (42.3%) on antiplatelets. Patients with carotid stenosis (mean 74.7
years) were older than patients without stenosis (p = 0.011).
Conclusion: The prevalence of carotid artery stenosis in patients present-
ing to HASU remains high despite increased use of prior secondary pre-
vention treatments.
ESOC-1424
15. Risk Factors for Stroke/Prognosis
Correlation between Carotid Artery Risk (CAR) score
and microembolic signals in carotid stenosis
K R Czuriga-Kovács1, D Calvet1, A K Emira2, L Fisch1, F Kennedy1,
H R Jäger2, L Csiba3, T Richards4, M M Brown1
1Department of Brain Repair and Rehabilitation, Stroke
Research Group UCL Institute of Neurology, London, United
Kingdom
2Lysholm Department of Neuroradiology, UCL Institute of
Neurology, London, United Kingdom
3Department of Neurology, University of Debrecen Clinical
Center, Debrecen, Hungary
4Division of Surgical and Interventional Sciences, UCL,
London, United Kingdom
Background: Microemboli detection and various plaque characteristics
have been shown to predict future or recurrent stroke risk in patients with
carotid stenosis. However, microemboli detection is not widely used in
clinical practice due to its time consuming nature. Based on original ECST
data, the Carotid Artery Risk (CAR) score is a clinical score predicting the
5-year risk of ipsilateral stroke of patients with carotid stenosis. We
hypothesize that CAR score would predict the presence of microembolic
signals on transcranial Doppler (TCD).
Methods: Twenty-seven patients (mean age ± standard deviation:
72.04 ± 10.32 year, male/female ratio: 2) with carotid stenosis have been
examined. Based on CAR score, patients were stratified as low (<7.5%),
intermediate (<15%) or high (≥15%) risk of future stroke. TCD exami-
nation for microemboli detection was performed over the middle cerebral
arteries. Duration of monitoring lasted over 60 minutes in the majority of
patients, while in few cases it lasted for 45–50 minutes. The following
settings were used during the examination: 45–55 mm insonation depth,
lowest gain possible and minimal sample volume. Microemboli were iden-
tified from Doppler spectra according to consensus criteria.
Results: Thirteen (48%) patients had low, 10 (37%) patients had interme-
diate, while 4 (15%) patients had high CAR score. Microemboli were
detected in 6 (22%) patients, all of them having low (n = 3) or interme-
diate (n = 3) CAR score. There was no correlation between CAR score and
presence of microemboli (Fisher’s exact test p = 0.54).
Conclusion: The CAR score cannot be used to predict the presence of
microembolic signals in patients with carotid stenosis.
ESOC-1484
15. Risk Factors for Stroke/Prognosis
Minor care leads to worse prognosis in minor stroke
P de la Riva1, N Díez1, M T Martínez1, F González1, N Gonzalo1,
M Tainta1, N de Andrés1, A M De Arce1
1Neurología, H.U.Donostia, San Sebastián, Spain
Objectives: The purpose of this study was to identify modifiable risk
factors contributing to unfavorable outcomes in patients suffering from
minor strokes.
Methods: Data was obtained from the propective registry of patients hos-
pitalized in the stroke unit between Jaunary 2013 and June 2014. Medical
urgent care was analyzed in patients having a minor stroke (NIH <= 4)
compared to moderate-severe stroke (NIH > 4). Variables predicting
longterm prognosis in patients with a minor stroke were evaluated in
univariate and multivariate analysis.
Results: A total of 495 ischemic stroke patients with previous modified
Rankin Scale ≤ 2 were included in the registry. Of them, 237 had a minor
stroke. In patients with a minor stroke, Stroke code was less often activated
(p = 3). On multivariate analysis women(OR 2.37,95%CI 1.11–5.07) and
not receiving urgent intensive care (stroke code activation, neuroimaging
2 at 3 months).
Conclusions: Minor stroke receives less attention than moderate-severe
stroke and not receiving urgent intensive care is associated with unfavor-
able outcome.
ESOC-0237
15. Risk Factors for Stroke/Prognosis
Elevated pulse pressure in the subacute stage of
ischemic stroke is associated with poor outcome
M Dell’Acqua1, E Casali2, M Tondelli3, A Zini1, P Nichelli3
1Neurology, Nuovo Ospedale Civile Sant’Agostino Estense,
Modena, Italy
2Igene, Università di Modena e Reggio Emilia, Modena, Italy
3Neurology, Università di Modena e Reggio Emilia, Modena,
Italy
Background and purpose: Despite extensive scientific evidence supporting
the crucial role of blood pressure (BP) on the prognosis of acute ischemic
stroke, there are contrasting findings in literature. We aimed to identify BP
components measured during the acute and subacute stage of ischemic
stroke possibly influencing its long-term functional outcome.
Materials and methods: A daily BP monitoring was carried out for each of
95 patients with acute ischemic stroke, from a minimum of 2 days to a
maximum of 10 days after stroke onset. The following daily BP parameters
were obtained for each patient: mean systolic BP, mean diastolic BP, mean
pulse pressure and coefficient of variation of systolic BP. The average
values of these BP parameters were calculated for the acute and the sub-
acute phase of ischemic stroke. Functional outcome at three months after
stroke onset was assessed using a responder analysis, which took into
account modified Ranking scale score (mRS) and baseline severity of
stroke (NIHSS).
Results: Multivariate logistic regression analysis showed a significant cor-
relation between high mean pulse pressure measured during the subacute
phase of ischemic stroke and worse prognosis at three months after the
stroke onset. The statistical significance of this correlation was maintained
even after correction for age, history of hypertension, mean systolic BP
measured in the acute phase and thrombolysis.
Conclusion: Elevated levels of mean pulse pressure during the subacute
stage of ischemic stroke might be an independent predictor of long-term
functional outcome.
ESOC-1342
15. Risk Factors for Stroke/Prognosis
A comparison of junior and senior clinicians in
comparing patient outcomes following stroke
S Delmonte1, J M Reid2, M MacLeod2
1School of Medicine and Dentistry, University of Aberdeen,
Aberdeen, United Kingdom
2Department of Neurology, Aberdeen Royal Infirmary,
Aberdeen, United Kingdom
Introduction: Predicting outcomes following stroke is useful for advising
patients and caregivers. This study compared the accuracy of junior and
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senior clinicians in predicting patient outcomes six months post-stroke
(independence, severe dependence or death, and residence).
Methods: Our local ethics committee approved this study for audit pur-
poses. 570 stroke patients were assessed by 15 different clinicians. At the
initial assessment, clinicians were asked to predict six month modified
Rankin Score (mRS) and residence (home, residential care or death). Six
month mRS and residency status were compared with the predictions.
Clinicians were divided into two groups based on their clinical experience:
junior clinicians (0–4 years) and senior clinicians (7–40 years).
Results: The sensitivity for predicting residing at home was high for both
groups (>0.87), but specificity lower (0.54 and 0.67) for junior and senior
clinicians, respectively. Predicting residential care was similar for both
groups: sensitivity <0.39, specificity >0.83. When predicting death, junior
clinicians had a lower sensitivity than senior clinicians (0.13 vs. 0.45), with
specificity high for both groups (>0.95). Sensitivity for predicting an
independent outcome (mRS 0–2) was not significantly different. When
predicting severe dependence or death (mRS 5–6), sensitivity was lower
for junior clinicians compared to senior clinicians (0.28 vs. 0.50), although
specificities were similar (>0.94).
Conclusion: Both junior and senior clinicians demonstrated accuracy
when predicting good outcomes (home or independence). Prediction of
poor outcomes (severe dependence or death) was less accurate, particu-
larly for junior clinicians. Outcome predictions may be assisted by pre-
diction scores or models.
ESOC-0460
15. Risk Factors for Stroke/Prognosis
Guidance on flying post stroke
A Edwards1, R Bathula1
1Stroke Unit, Northwick Park Hospital – London North West
Healthcare NHS Trust, London, United Kingdom
Background: Northwick Park Stroke Unit in London is close to Heathrow
airport and serves many domestic and foreign travellers suffering recent
strokes. The team is often asked to advise patients on their fitness to fly
post stroke. However, there is no clear national or international guidance
for doctors on assessing fitness to fly.
Flying post stroke is often not practical and poses risks from the reduced
PaO2 in pressurised aircrafts and the risk of post stroke complications.
Method: We reviewed physiological factors that may contribute to flying
risk, performed a PubMed search and reviewed current aviation authori-
ties and airline medical guidelines, including the ‘UK Civil Aviation
Authority’, ‘International Air Transport Association’ and ‘Aerospace
Medical Association’.
Results: Current guidelines and PubMed search gave varying timescales of
fitness to fly, ranging from 3 days to 3 months. These guidelines were
generally based on unreferenced ‘expert’ opinion and physiological data
with limited clinical research. With evidence of relative hypoxia and
impaired cerebral autoregulation post stroke, patients are less able to
compensate for the reduced oxygen partial pressure in pressurised cabins,
leading to worsening brain tissue hypoxia as well as seizure risk.
Recommendations: Current theoretical data suggests that the risk of flying
and subsequent complications reduces after 2 weeks post stroke. However,
there is a need for more evidence to produce clear guidance. We are
currently surveying patients who have flown post stroke from our unit in
the past 4 years to retrospectively assess the clinical risk and consequences
of flying post stroke.
ESOC-1051
15. Risk Factors for Stroke/Prognosis
Premorbid frailty prior to stroke leads to a longer
length of hospital stay and higher 30-day mortality
N R Evans1, J Wall2, S J Wallis3, R Romero-Ortuno3,
E A Warburton1
1Department of Clinical Neurosciences, University of
Cambridge, Cambridge, United Kingdom
2School of Clinical Medicine, University of Cambridge,
Cambridge, United Kingdom
3Department of Medicine for the Elderly, Cambridge
University Hospitals NHS Foundation Trust, Cambridge,
United Kingdom
Introduction: Frailty is characterised by the loss of physiological reserves
with increased vulnerability to hospitalisation, institutionalisation and
death in response to stressors. The effects of premorbid frailty upon the
length of hospital stay (LOS) and 30-day mortality after stroke are
unknown.
Methods: All individuals aged 75 years and over presenting to Cambridge
University Hospitals following an ischaemic stroke, haemorrhagic stroke
or transient ischaemic attack with a recorded premorbid Canadian Study
of Health and Aging Clinical Frailty Scale (CFS) were included in the
study. LOS and 30-day mortality were collected and patients allocated into
one of two cohorts: ‘non-frail’ (CFS scores 1–4) and ‘frail’ (scores 5–8).
Individuals with the highest frailty score (terminal phase of life) were
excluded.
Results: Two hundred fifty-seven individuals were included in the study:
111 non-frail and 146 frail individuals. Mean age in years was 83.3 (SD
5.2) and 86.7 (SD 5.9) respectively. Median LOS in days was 9.9 (IQR 16)
for non-frail and 16.5 (IQR 21.9) for frail cohorts (p < 0.05). Infarcts
accounted for 95 (85.6%) of strokes in the non-frail cohort and 119
(81.5%) of the frail cohort. Following infarcts, 30-day mortality was
increased in the frail cohort (22, 18.5%) versus the non-frail cohort (4,
4.2%) (p < 0.05). There was no significant difference between cohorts in
30-day mortality following other types of cerebrovascular event.
Discussion: These results demonstrate premorbid frailty leads to longer
hospital admissions and increased 30-day mortality after infarcts. The
introduction of routine frailty assessment for acute strokes should be
considered to aid prognosis in clinical practice.
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15. Risk Factors for Stroke/Prognosis
Incidence of diabetes mellitus among vascular and
non-vascular patients in a neurology-stroke
department
A Folyovich1, N Al-Muhanna1, A Deák1, T Jarecsny1,
K A Béres-Molnár1
1Neurology and Stroke, St John’s Hospital, Budapest, Hungary
Introduction: Diabetes mellitus (DM) is a basic risk factor for stroke
(STR). Our previous studies proved, that high number of patients with
atrial fibrillation (AF), hyperlipidemia (HL) and hypertension (HT) is
revealed during neurological hospitalization, including those persons,
whose history or reason for hospitalization do not include cerebrovascular
disease. Now patients with DM were analyzed.
Patients and methods: We reviewed the history of all patients treated at
our department in 2010. The diagnosis of DM was based on control
laboratory tests. In the case of 4 patients blood glucose sample was not
valuable because of technical problem. The 337 DM patients were divided
into five groups: G1) patients admitted for first acute STR, G2) patients
with previous stroke admitted for a recurrent STR, G3) patients with a
history of STR, but admitted for a different reason, G4) TIA, neuroimag-
ing did not prove relevant lesion (9.5%), G5) patient history and reason
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for hospitalization did not include STR. Patients were classified into
further groups (previously known/not known DM).
Results: DM was present in 14.6 % of 2311 patients. The distribution of
patients was the following: G1) 21.4%, G2) 5.3%, G3) 15.7%, G4) 9.5%,
G5) 48.1%. In 7.4% of patients DM was revealed during neurological care.
G1 included 9.7%, G2 11.1%, G3 only 1.9% and the STR-negative (G5)
9.3% of patients.
Conclusion: The proportion of patients newly diagnosed with DM is high,
as with other vascular risk factors. In patients with previous STR, the DM
care seems to be relatively successful.
ESOC-0924
15. Risk Factors for Stroke/Prognosis
An intracranial petri dish? Formation of abscess in
prior large stroke after decompressive
hemicraniectomy
J Fraser1, J Wang1
1Neurological Surgery, University of Kentucky, Lexington, USA
Development of brain abscess following an infarction is rare. There have
been 11 cases in the literature. Because of this uncommon complication
following large stroke, many patients were treated with antibiotics only
and did not survive. We present two cases in which patients received
aggressive surgical resection of brain abscess and survived. The analysis in
the literature in the context of our cases confirmed our finding that
surgical intervention of brain abscess in post- stroke patients offers the
most benefit. We present two cases of patients with large hemispheric
strokes that underwent decompressive hemicraniectomy for malignant
infarct and edema. Each re-presented prior to cranioplasty with swollen
fontanelle and was found on MRI to have an intracranial abscess within
the infarcted tissue. Both underwent surgical evacuation/debridement,
followed by antibiotics, and delayed cranioplasty. In this setting, we
reviewed the literature, identifying only 11 other cases of this phenom-
enon. In reviewing ours and other published cases, several trends became
clear. The interval from stroke to abscess identification ranged from 12 to
58 weeks. Of the 13 total patients, only 3 had undergone surgical decom-
pression for the stroke. Overall mortality among the cases was 38.5%. All
but one of patients treated medically (without surgical evacuation of
abscess) died. Secondary abscess formation after significant ischemic
stroke is a rare condition that carries potential for high morbidity/
mortality. The limited body of literature with the addition of our two
cases supports aggressive management with surgical drainage of brain
abscess to increase survival.
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15. Risk Factors for Stroke/Prognosis
Impact of risk factors on pre-hospital delay in stroke
patients. Is it time to focus awareness campaigns?
R García Ruiz1, R M García Ruiz2, J Silva Fernández3,
A García Chiclano1, A Mateu Mateu1, M C Blanco Valero4,
S Navarro Muñoz1, A Vadillo Bermejo1, R Piñar Morales1,
S Valenzuela Alvarado5, E Botia Paniagua1
1Neurology, La Mancha Centro General Hospital, Alcázar de
San Juan, Spain
2Primary Care, Pedreguer Primary Care Centre, Pedreguer,
Spain
3Endocrinology, La Mancha Centro General Hospital, Alcázar
de San Juan, Spain
4Neurology, Neuroclínica Berenguer, Badajoz, Spain
5Neurology, Hospital Univeritario Reina Sofía, Córdoba, Spain
Background: Early management of stroke has a key role in reducing mor-
tality and dependence, but only half of stroke patients arrive in the first
three hours. In addition, most strokes happen in patients with known
major risk factors. This study investigates the prevalence of risk factors in
stroke patients at our hospital and their impact on pre-hospital delay.
Methods: An observational study was conducted on a sample of consecu-
tive stroke patients diagnosed by a neurologist in our Emergency
Department between 15th November 2013 and 14th April 2014. Suba-
rachnoidal haemorrage and in-hospital stroke patients were excluded.
Descriptive, bivariate and multivariate analyses were performed.
Results: One hundred thirty-eight patients (52.2% male) were included
(mean age 73.97 years). 90.6% patients carried at least one major stroke
risk factor. Most prevalent risk factors were hypertension (76.8%), a famil-
ial history of stroke (45.7%), dyslipidemia (42.8%), and Diabetes Mellitus
(37.7%). 23.2% had suffered a previous stroke or TIA. Median delay for
patients with and without known major risk factors for stroke was 180 and
79 minutes respectively (p < 0.05). Only patients with known atrial fibril-
lation or a familial history of stroke were significantly more prone to be
managed within the first three hours.
Conclusions: Prevalence of major risk factors is high in stroke patients.
Hypertensive, diabetic and dyslipemic patients, smokers, or even those
with a previous stroke or TIA didn’t arrive the hospital earlier than
patients without such conditions. Educational strategies may focus on
these groups, most when global strategies have failed reducing pre-
hospital delay in the long term.
ESOC-1229
15. Risk Factors for Stroke/Prognosis
Prognosis in Oxfordshire TACIs patients treated with
intravenous thrombolysis according to intracraneal
arterial status
E Giralt-Steinhauer1, A Ois1, P Cardona-Portela2, M Gomis3,
M Castellanos4, C Molina5, J Martí-Fàbregas6, X Urra7, R Mares8,
D Cànovas9, M Gómez-Choco10, J Kuprinski11, L Cocho12,
E Cuadrado-Godia1, A Rodríguez-Campello1, J Jiménez-Conde1,
S Abilleira13, J Roquer1
1Neurology, Hospital del Mar, Barcelona, Spain
2Neurology, Hospital Universitari de Bellvitge, Barcelona,
Spain
3Neurology, Hospital Universitari Germans Trias i Pujol,
Badalona, Spain
4Neurology, Hospital Universitari Josep Trueta, Girona, Spain
5Neurology, Hospital Universitari dela Vall d’Hebró,
Barcelona, Spain
6Neurology, Hospital Universitari de la Santa Creu i sant Pau,
Barcelona, Spain
7Neurology, Hospital Clínic, Barcelona, Spain
8Neurology, Hospital Joan XXIII, Tarragona, Spain
9Neurology, Hospital Parc Taulí, Sabadell, Spain
10Neurology, Hospital de Sant Joan Despí Moises Broggi, Sant
Joan Despí, Spain
11Neurology, Hospital Mútua de Terrassa, Terrassa, Spain
12Neurology, Hospital de Granollers, Granollers, Spain
13Stroke Programme, Catalan Agency for Health Information
Assessment and Quality, Barcelona, Spain
Aims: Total Anterior Circulation Infarct syndromes (TACIs) are associ-
ated with worse prognosis, and are more likely to have proximal intrac-
ranial arterial occlusions (IAO).
Our aim is to assess the proportion of patients with clinical TACIs without
IAO (presumable better outcome) in a cohort of IV thrombolysed (IVT)
patients, and determine their outcome.
Methods: The Catalan Stroke Code & Reperfusion registry is a region-
wide, prospective, web-based and externally monitored database that
includes data from all patients treated with IVT and/or endovascular
treatment (EVT). We selected TACIs patients treated with IVT < 4.5 hours
Abstracts
© 2015 The Authors.
International Journal of Stroke © 2015 World Stroke Organization Vol 10 (Suppl. 2); April 2015; 77–438 239
between Jan-2011 to Dec-2013 for whom a vascular study prior to IVT
was available. EVT patients were excluded (n = 465). Dichotomized
outcome was assessed using mRS at three-months (good prognosis
defined as mRS 0–2 or returning to previous functional situation).
Results: The cohort included 564 IVT-treated TACIs. After excluding 6
stroke-mimics, we found 118 (21.1%) patients without IAO. No signifi-
cant differences regarding age, sex, and previous functional status were
found between groups. IAO-patients had more severe strokes (median
NIHSS 18 vs. 16; p < 0.001), and worse outcome compared to non-IAO
(68.4% vs. 54.2%; p = 0.004). In IAO-patients more cardioembolic strokes
were detected (p = 0.049). There were no differences in onset-to-
treatment time, vascular study performed, extracranial internal carotid
occlusion, symptomatic haemorrhagic transformation, and recurrence.
Conclusions: One fifth of TACIs treated with IV-rtpa did not have IAO at
hospital arrival. Absence of IAO is associated to slightly better outcomes
but still more than half of these patients do not reach functional
independence.
ESOC-0283
15. Risk Factors for Stroke/Prognosis
Stroke subtype and recanalization rate after
endovascular treatment
M Gomis1, M Millan1, N Perez de la Ossa1, L Dorado1,
E Lopez-Cancio1, M Hernandez1, C Castaño1, S Remollo1,
L Muñoz1, A Davalos1
1Neurosciences, Hospital Germans Trias i Pujol, Barcelona,
Spain
Higher recanalization rate has been reported in cardioembolic stroke after
intravenous tPA. Our aim was to evaluate if stroke subtypes and in par-
ticular the recently described ESUS (embolic stroke of undetermined
source) are associated with different rates of revascularization after endo-
vascular treatment (EVT).
Methods: Retrospective analysis of a prospective registry of 266 patients
with anterior cerebral arterial occlusion and EVT (primary or with pre-
vious intravenous tPA) during 5 years. Stroke subtype was classified as
cardioembolic (CE), atherothrombotic (AT) and ESUS. We excluded 13
patients with undetermined source due to incomplete work-up or double
cause and 13 with infrequent causes. The independent association of
stroke subtype with complete revascularization (final TICI 2b/3) was
evaluated by logistic regression analysis adjusting for baseline, clinical and
neuroimaging variables.
Results: Fifty-four patients were AT (mean age 65, median NIHSS 18), 138
CE (mean age 69, median NIHSS 19) and 46 ESUS (mean age 57, median
NIHSS 17). TICI 2b/3 was achieved in 63%, 74% and 87%, respectively.
Time from onset to groin puncture was comparable between groups but
the procedure duration was 96,7 ± 79, 68,3 ± 55 and 66 ± 56, respectively.
ESUS (OR:3.63 CI 1.27 to 10.38) but not CE (OR:1.8 CI 0.92 to 3.72)
using AT stroke subtype as reference category, and previous treatment
with intravenous tPA (OR:1.85 CI 1.01 to 3.41), but neither age nor
baseline NIHSS were associated with TICI 2b/3.
Conclusions: These findings suggest that ESUS subtype and previous
treatment with tPA are associated with a higher probability of complete
revascularization after TEV.
ESOC-0190
15. Risk Factors for Stroke/Prognosis
Palliative care issues in inpatients dying following
stroke
O Ntlholang1, S Walsh1, D Bradley2, J Harbison1
1Dept. of Medical Gerontology, Trinity Centre for Health
Sciences, Dublin, Ireland
2Dept. of Neurology, Trinity Centre for Health Sciences,
Dublin, Ireland
Published guidance on palliative care of dying stroke patients contains
little data on symptom prevalence and management. We determined the
palliative care needs of dying patients our unit with a low overall mortality
rate (1-month: 8.8%, Inpatient: 12.9%) in a University Teaching Hospital
with both specialist stroke and palliative care services on-site.
Methods: Clinical records of consecutive stroke patients who died over 2
years were evaluated as part of a quality improvement/ audit exercise.
Notes were reviewed by physicians with training in stroke and palliative
care.
Results: Fifty-four deaths were identified, (33 (61.1%) female, mean age
79.3 yrs), median Stroke-Death interval was 20 days (range 0–389). Do
Not Attempt Resuscitation (DNAR) orders were in place in 86.8% of
patients. The median DNAR-Death interval was 7 days (range 0–311). 41
patients (75.9%) died after first stroke, 9 (16.7%) were inpatient strokes
and 7 (13.0%) were thrombolysed, 4 (7.4%) subjects underwent cardiac
arrest calls and 9 (16.7%) deaths occurred in ICU/HDU. There were clear
statements recorded in 26 (48.1%) that patients were dying and death was
thought to be due primarily to extent of brain injury in 24 (44.4%).
Palliative needs identified included dyspnoea 21 (38.9%), pain 17
(31.5%), respiratory secretions 17 (31.5%), agitation 14 (25.9%) and psy-
chological distress 1 (1.9%). Symptoms were predominantly due to pre-
morbid diseases in 6 (11.1%).
Conclusions: Dyspnoea, pain and respiratory secretions were identified
as main palliative care needs. Palliative needs are complex following
stroke and skills in assessing appropriateness and delivering such care are
essential.
ESOC-0277
15. Risk Factors for Stroke/Prognosis
Is intracranial arterial stenosis found in cannabis
related stroke due to intimal hyperplasia?
O Ntlholang1, R McDonagh1, S Donnelly2, F Brett2, D Bradley3,
J Harbison1
1Dept. of Medical Gerontology, Trinity Centre for Health
Sciences, Dublin, Ireland
2Dept. of Pathology, Trinity Centre for Health Sciences,
Dublin, Ireland
3Dept. of Neurology, Trinity Centre for Health Sciences,
Dublin, Ireland
There is now considerable evidence that habitual cannabis smoking is
associated with stroke and intracranial stenosis on angiography is a
common associated finding. Histological evidence of the nature of intrac-
ranial stenosis in these subjects is lacking. It has been reported that in
Giant Cell Arteritis, hyperplasia of the intima is associated with increased
neuro-opthalmologic events.
Methods: We present three cases of cryptogenic cerebral infarction in
regular, longstanding cannabis smokers where arterial biopsy confirmed
evidence of intimal hyperplasia.
Results: A 37 year old woman with a history of recurrent stroke and
cannabis related psychosis. Initial investigation revealed areas of arterial
stenosis on duplex ultrasound, including in her right internal carotid
artery (ICA). Temporal artery biopsy (TAB) revealed extensive arterial
intimal hypertrophy. She continued to smoke cannabis and suffered a
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large right middle cerebral artery distribution infarct. Angiogram showed
progression of flow limitation and stenosis in her right ICA.
A 32 year old man suffered a right M1 distribution haemorrhagic infarct.
Angiography revealed stenosis of his left ICA. He died at 14 days of a large
pulmonary embolism and necropsy revealed that the stenosis was caused
by a grossly hypertrophic arterial intima without evidence of dissection,
cardiac thrombus or significant arteriosclerosis.
A 28 year old man was admitted with a right M1 occlusion with evidence
of occlusion on angiogram. TAB performed after other investigations
proved unrevealing showed intimal hypertrophy.
Conclusion: Intracranial stenosis in cannabis related stroke may result
from intimal hypertrophy. TAB may be a useful investigation in cannabis
smokers with cryptogenic stroke.
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15. Risk Factors for Stroke/Prognosis
Prevalence of dysnatremias and their implication on
outcome during acute ischemic stroke and transient
ischemic attack: A cross-sectional analysis
G Lindner1, M R Heldner2, C Bernasconi2, G C Funk3, M Arnold2,
C Schwarz4, A B Leichtle5, G M Fiedler5, J Gralla6, H P Mattle2,
A K Exadaktylos1, U Fischer2
1Department of Emergency Medicine, University Hospital
Inselspital, Bern, Switzerland
2Department of Neurology, University Hospital Inselspital,
Bern, Switzerland
3Department of Respiratory and Critical Care Medicine and
Ludwig Boltzmann Institute, Otto Wagner Spital, Wien,
Austria
4Department of Nephrology, Medical University of Graz, Graz,
Austria
5Center for Laboratory Medicine, University Hospital
Inselspital, Bern, Switzerland
6Department of Diagnostic and Interventional
Neuroradiology, University Hospital Inselspital, Bern,
Switzerland
Aim: Hypo- and hypernatremia are the most common electrolyte disor-
ders in hospitalized patients. Their impact on outcome has been described
in patients with cerebral hemorrhage. However, data in patients with
ischemic stroke and transient ischemic attacks (TIA) are scarce. We aimed
to assess the prevalence of dysnatremias in stroke and TIA patients and to
investigate the impact of dysnatremias on outcome.
Methods: In this cross-sectional analysis we included all patients with
acute ischemic stroke (1807) and TIA (157) admitted to the department of
Neurology between 01 January 2004 and 31 March 2012 with a measure-
ment of serum sodium at baseline. Clinical data on admission (NIHSS
score, Charlson comorbidity index, etiology, cardiovascular risk factors),
data on therapy (conservative versus thrombolysis) and outcome at 3
months were assessed prospectively.
Results: One hundred sixty-one of 1964 patients (8%) included in the
study had hyponatremia and 56 (3%) hypernatremia. Median serum
sodium concentration on admission was 140 mmol/L (138 to 141). 219
patients (11%) died during the observation period. Patients with dysna-
tremias had higher mortality rates. Patients with serum sodium
<140 mmol/L had a significantly lower survival probability (85% vs. 90%,
p = 0.0022). Moreover, in specific multivariate logistic regression models,
serum sodium <140 mmol/L, higher age and higher NIHSS score on
admission were predictors of an increased mortality.
Conclusions: Hypo- and hypernatremia are common in patients with an
acute ischemic stroke or TIA, with associated higher mortality rates in
these patients. Serum sodium <140 mmol/L was predicting mortality 3
months after acute ischemic stroke or TIA.
ESOC-1274
15. Risk Factors for Stroke/Prognosis
Prediction models for the risk of intracranial
haemorrhage or major bleeding in patients on
antiplatelet therapy: A systematic review of the
literature
N A Hilkens1, J P Greving1, A Algra1
1Julius Center for Health Sciences and Primary Care, UMC
Utrecht, Utrecht, Netherlands
Background and purpose: Antiplatelet therapy is widely used in secondary
prevention after TIA or ischaemic stroke. Bleeding is the main adverse
effect of antiplatelet therapy and is potentially life-threatening. Identifi-
cation of patients at increased bleeding risk may target antiplatelet
therapy. This study sought to identify existing prediction models that
predict the risk of intracranial haemorrhage or major bleeding in patients
on antiplatelet therapy.
Methods: We systematically searched PubMed and Embase for existing
prediction models up to December 2014. Methodological quality of the
included studies was assessed with the CHARMS checklist. We investi-
gated model performance and predictors used in the included models.
Results: Five prediction models were identified, of which two were devel-
oped in patients with previous cerebral ischaemia. One study assessed
intracerebral haemorrhage, all others studied major bleeding. None of the
studies met criteria of good quality, three were of moderate quality, one of
low quality, one was only published as an abstract and provided insuffi-
cient information for proper quality assessment. External validation was
performed in three studies with an area under the curve (AUC) ranging
from 0.64 to 0.72. Frequently used predictors were age, hypertension,
renal failure and use of anticoagulants.
Conclusion: A limited number of prediction models is available that
predict intracranial haemorrhage or major bleeding in patients with a
previous stroke. Methodological quality of the studies varied, but was
generally low. In order to reliably predict the risk of bleeding in patients
on antiplatelet therapy, development of a prediction model according to
current methodological standards is needed.
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15. Risk Factors for Stroke/Prognosis
Drops in barometric pressure is a risk factor for deep
but not lobar interacerebral hemorrhage
A Honig1, R Eliahou2, R R Leker3
1Nerology, Hadassah-Hebrow University Medical Center,
Jerusalem, Israel
2Radiology, Hadassah-Hebrow University Medical Center,
Jerusalem, Israel
3Neurology, Hadassah-Hebrow University Medical Center,
Jerusalem, Israel
Background: The effects of changes in barometric pressure on the inci-
dence of intracerebral hemorrhage (ICH) remain unclear.
Methods: Primary ICH patients admitted over the last 5 years were
included. Patients transferred from other geographical regions and
patients with cerebellar ICH were excluded. We analyzed the relationship
between the incidence of spontaneous ICH and averaged daily atmo-
spheric air pressures and outdoor temperatures.
Results: Of 219 cases of ICH included, 147 had a deep ICH, 59 patients
had a lobar ICH and 13 had a cerebellar ICH. Patients with deep ICH were
younger (mean age 76.6 and 70.3, p = 0.001) and more often had diabetes
mellitus, smoking and previous lacunar strokes (P < 0.01 for all). We
identified high-risk ICH days as days on which 2 or more patients with
ICH were admitted. On multivariate analysis a drop in the mean recorded
air pressure 2 days prior to the ictus was a significant predictor of high risk
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(P < 0.04) in the deep ICH patients but was found to have no impact on
lobar ICH patients.
Conclusions: Lobar and deep ICH are differently affected by changes in
barometric pressure. A drop in the daily atmospheric pressure may be a
trigger for deep ICH but not for lobar ICH.
ESOC-1527
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MIDNOR TIA – a prospective cohort study of 586
patients, baseline data from a subgroup of 363
patients examined with mr diffusion-weighted
imaging
F Ildstad1, H Ellekjær2, H Fjærtoft3, B Indredavik1
1Department of Neuroscience, Norwegian University of
Science and Technology, Trondheim, Norway
2Stroke Unit, St. Olavs Hospital – Trondheim University
Hospital, Trondheim, Norway
3Norwegian Stroke Registry, St. Olavs Hospital – Trondheim
University Hospital, Trondheim, Norway
Background: MR diffusion-weighted imaging (DWI) is sensitive to isch-
emic changes. The aim of this part of the study was to evaluate risk factors
and clinical characteristics in DWI positive versus negative patients with
TIA (transient ischemic attack).
Method: DWI was performed in 363 patients (61,9%). Chi-square test
was performed for significance levels. All study subjects have signed
written informed consent.
Results: Acute ischemic lesions on DWI were found in 86 patients
(23,7%). Baseline characteristics of the DWI positive and negative
patients, respectively, were: Mean age 69,3 vs 68,4. Men 50% vs 58,7%
(p = 0,15). A former diagnosis of TIA, stroke and myocardial infarction
12,8% vs 15,9% (p = 0,56), 12,8% vs 13,4% (p = 0,84) and 16,3% vs 9,0
(p = 0,13), respectively. Known or currently diagnosed atrial fibrillation
14,0% vs 7,6% (p = 0,15). Diabetes mellitus 7,0% vs 11,2% (p = 0,11).
40,7% vs 44,8% (p = 0,51) received blood pressure lowering medication
and 36% vs 35,4% (p = 0,91) lipid lowering medication prior to the
current TIA. 16,3% vs 17,3% (p = 0,84) were current smokers. Aphasia
and/or dysartria was reported by 46,5% vs 44% (p = 0,69), hemiparesis of
arm 40,7% vs 30,7% (p = 0,09), hemiparesis of leg 23,3% vs 18,1%
(p = 0,29), hemisensory loss 15,1% vs 25,6% (p = 0,04), hemiparesis of
face 26,7% vs 15,9% (p = 0,02), hemianopsia 3,5% vs 8,7% (p = 0,11),
amaurosis fugax 3,5% vs 4,0% (p = 0,84), diplopia 3,5% vs 4,3%
(p = 0,73).
Conclusion: There were significantly more reports of hemiparesis of face
and significantly fewer of hemisensory loss in DWI positive versus nega-
tive patients. No other significant differences in clinical characteristics or
risk factors were found.
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15. Risk Factors for Stroke/Prognosis
Current control status of dyslipidemia and the
prevalence of residual risk in patients with ischemic
stroke
J M Park1, K Song2, J Lee3, J Koo2
1Neurology, Eulji General Hospital Eulji University, Seoul,
Korea
2Neurology, Seoul Saint Mary Hospital Catholic University,
Seoul, Korea
3Biostatistical Consulting Unit, Asan Medical Center, Seoul,
Korea
Objectives: We investigated the control status of dyslipidemia and the
prevalence of residual risk in patients with ischemic stroke.
Methods: Patients who were hospitalized due to acute ischemic stroke
within 7 days in two referral hospitals were enrolled retrospectively.
Patients without follow-up lipid battery between 1 month and 1 year after
discharge were excluded. Individual target LDL level was determined
using fasting lipid battery and risk factors during admission according to
2011 AHA/ASA guideline for secondary prevention. Residual risk was
determined as 1) high TG (>200 mg/dL) or 2) low HDL (<40 mg/dL) or
3) high Non-HDL (≥130 mg/dL) in follow-up lipid battery between 1
month and 1 year after discharge.
Results: Among the 1919 patients, a total of 951 (49.6%) patients had
follow-up lipid battery. Target LDL goal was achieved in 664 (69.8%)
patients. Diabetes mellitus, hyperlipidemia and atherothrombotic subtype
were more frequent in not achieved 287 patients, while atrial fibrillation
and discharge statin prescription were less prevalent. Residual risk was
observed in 507 (53.3%) patients. Male gender, diabetes mellitus, hyper-
lipidemia, smoking, fasting blood glucose and initial NIHSS score were
more frequent or higher in patients with residual risk, while discharge
statin prescription was less prevalent. Among target LDL goal achieved
population, 319 (48.0%) patients showed residual risk.
Conclusions: Target LDL goal achievement rates in ischemic stroke
patients needs to be improved. Residual risk was observed almost half of
the ischemic stroke patients irrespective of LDL goal achievement.
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15. Risk Factors for Stroke/Prognosis
Temperature change, short- and long-term handicap in
acute ischemic stroke
N Kakaletsis1, V Papavasileiou2, D Lambrou3, G Ntaios2, P Michel3
1Department of Clinical Neurosciences and Preventive
Medicine, Danube University in Krems, Krems, Austria
2Department of Medicine, University of Thessaly, Larissa,
Greece
3Stroke Center Neurology Service, Centre Hospitalier
Universitaire Vaudois and University of Lausanne, Lausanne,
Switzerland
Aim: The aim of the study is to explore the association between baseline
temperature (T) levels, T change during the first 24 hours, and functional
outcome in a representative acute ischemic stroke (AIS) population.
Methods: All patients registered in the Acute Stroke Registry and
Analysis of Lausanne (ASTRAL) between 2003 and 2013 were analyzed
(n = 2,555). Unfavorable outcomes at 7 days, 3 and 6 months were defined
as modified Rankin scores > 2. A local polynomial surface algorithm was
used to assess the effect of T values on the three outcomes.
Results: Acute and sub-acute normothermia, but not hypothermia, was
associated with less unfavorable short- and long-term outcome. Low or
normal admission temperatures followed by a T increase over 24 hours
were associated with a worse prognosis, whereas a mild baseline T increase
followed by a decrease was associated with better outcome at 7 days. These
dynamic associations with handicap disappeared after 3 and 12 months.
Conclusions: Elevated body temperature in AIS is associated with a worse
functional outcome, but initial hypothermia does not seem to be protec-
tive. These insights may help to adapt individual treatment decisions and
to plan future therapeutic studies.
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15. Risk Factors for Stroke/Prognosis
Class I recommendations for secondary prevention of
stroke
H A Kamal1
1Department of Neurology, Ain Shams University, Cairo, Egypt
Background: Worldwide, Stroke is the second most common cause of
death. The risk of recurrent stroke among the patients who survived
previous stroke is about nine times the risk of stroke in the general
population. Many studies were conducted on the secondary prevention of
stroke.
Methods: The literature on Evidence-based recommendations for the sec-
ondary prevention of stroke was reviewed to get to Class I recommenda-
tions. According to the AHA/ASA estimate of certainty, the Class I
recommendations are the procedures/treatments that should be
performed/administered as they have the evidence and/or general agree-
ment for their beneficial effect.
Results and conclusions: Class I recommendations include procedures/
treatments for blood pressure reduction, glycemic control and adjustment
of the lipid profile along with proper management of the metabolic syn-
drome, symptomatic extracranial carotid disease, extracranial verte-
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brobasilar disease, intracranial atherosclerosis, atrial fibrillation, acute
myocardial infarction , prothetic heart valves, inherited thrombophilias
and fabry disease. Also, the stroke patients are recommended to stop
smoking, reduce their alcohol consumption and take antiplatelet agents
and/or oral anticoagulants.
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Early post-stroke infections and their impact on
hospital mortality: Changes from 1995 to 2013
M A Karlinski1, J P Bembenek1, A Kobayashi2, A Czlonkowska1
12nd Department of Neurology, Institute of Psychiatry and
Neurology, Warsaw, Poland
2Interventional Stroke Treatment Cetre, Institute of Psychiatry
and Neurology, Warsaw, Poland
Background: Infectious complications of stroke are considered to associ-
ate with poor outcome. Our aim was to investigate changes in the occur-
rence of early post-stroke infections and their impact on hospital
mortality in Poland from 1995 to 2013.
Material and methods: It is a retrospective registry-based analysis of con-
secutive acute stroke patients from a highly urbanized area (Warsaw,
Poland) admitted to a single stroke centre between 1995 and 2013. A total
of 4770 patients were divided to four time periods: 1995–1999 (n = 637),
2000–2004 (n = 1501), 2005–2009 (n = 1575) and 2010–2013 (n = 1057).
Odds ratios (OR) for hospital death were calculated after adjustment for
pre-existing disability, stroke type, age and baseline neurological deficit.
Results: Over time there was a clear decrease in occurrence of pneumonia
(19%, 21%, 11% and 11%, respectively), urinary tract infection (31%,
20%, 25% and 18%) and fever (20%, 19%, 15%, 11%). There was no
significant change in the use of antibiotics (34% to 39%). Pneumonia and
fever strongly predicted hospital death in years 1995–1999 (OR 5.5 and
3.2, respectively) and 2000–2004 (OR 5.2 and 2.8), to lesser extent in
2005–2009 (OR 3.5 and 1.7), and lost significance in 2010–2013 (OR 1.5,
p = 0.39 and OR 2.1, p = 0.14). Risk of death was increased in patients
requiring antibiotics until 2005 and never by urinary tract infection.
Conclusion: Over the last 20 years infectious complications of acute stroke
became less frequent and their impact on hospital mortality was signifi-
cantly reduced. It may be an indirect marker of gradual improvement in
stroke unit care.
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The relationship between the size of patent foramen
ovale and the risk of paradoxical cerebral embolism
M Kouchi1, A Mizuma1, S Netsu1, C Kijima1, S Takizawa1
1Neurology, Tokai University School of Medicine, Isehara,
Japan
Background and objectives: Patent foramen ovale (PFO) is known to be a
risk of paradoxical embolism. We have also accidentally experienced cryp-
togenic stroke (CS) patients who have PFO. We clarify the relationship
between the size of PFO and the risk in the cryptogenic stroke patients.
Methods: We ascertained the presence and measured the size of PFO
using transesophageal echocardiography in 119 patients with acute isch-
emic stroke. We also divided PFO size into three groups by the number of
micro bubbles; small size group (≦5), moderate size group (5∼25) and
large size group (≧26). We compared with clinical features (age, gender,
subtype of stroke, size of stroke, the risks of paradoxical embolism [RoPE]
score) and embolic risk factors; atrial fibrillation, smoke-like echo, atrial
septal aneurysm (ASA), left atrial thrombus, and aortic plaque lesion.
Result: PFO was presented in 56 patients (47.0%). Embolic stroke events
were more frequently seen in the large size PFO group than in the small
size PFO group (72.0% vs 83.3%, p < 0.05). In the paradoxical embolism
patients, large size PFO (OR 6.00. 95% CI 1.21–29.74 : p < 0.05), RoPE
scores < 6 (OR 5.31. 95% CI 1.06–26.49 : p < 0.05) were independent risk
factors for paradoxical embolism by multivariable logistic regression.
Conclusions: The large size PFO and lower RoPE score (<6) are indepen-
dent risks of paradoxical embolism, and these are meaningful to deter-
mine the treatment of anticoagulation and PFO closure.
ESOC-0173
15. Risk Factors for Stroke/Prognosis
Acute ischemic stroke associated with nephrotic
syndrome: Prevalence and significance
M Kuriyama1, H Iwaki1, S Neshige1, S Takeshima1, T Himeno1,
T Yoshimoto1, K Takamatsu1, M Nomoto2, H Kobayashi3, A Tanaka3
1Neurology, Brain Attack Center Ota Memorial Hospital,
Fukuyama, Japan
2Neurology and Clinical Pharmacology, Ehime University
Graduate School of Medicine, Ehime, Japan
3Radiology, Brain Attack Center Ota Memorial Hospital,
Fukuyama, Japan
Background: Ten cases of Arterial ischemic stroke (AIS) with with neph-
rotic syndrome (NS) are reported, and the prevalence and clinical char-
acteristics of this combination are discussed.
Methods: Patients having both albumin <3 g/dL and serum cholesterol
>250 mg/dL were retrospectively identified from 11,161 cases of stroke.
From among these patients, furthermore, ischemic stroke patients
showing heavy proteinuria were selected. The extent of atherosclerosis was
evaluated by magnetic resonance angiography of intracranial and
extracranial arteries, by ultrasonography for carotid arteries and lower
extremity arteries, and by measurement of the ankle-brachial index.
Clinical characteristics, laboratory findings, and pathogenesis of NS were
investigated.
Results: Ten cases (3 definite and 7 probable cases) were diagnosed as
having AIS with NS, accounting for 0.09% of all kinds of stroke and 0.12%
of AIS cases. This was also 5 times more common than cerebral venous
thrombosis (CVT), because we experienced 2 cases having CVT with NS
during the same period. Their subtypes were 6 large-artery atherosclero-
sis, 3 small-vessel occlusion, and 1 cardioembolism. Overall, 80% of cases
showed severe stenosis and/or occlusion of intracranial and extracranial
arteries. Peripheral arterial disease was suspected in 63% of the cases
examined. The pathogenesis of NS was due to diabetic nephropathy in 8
cases (80%).
Conclusions: AIS with NS accounted for 0.12% of all cases of AIS and was
5 times more common than CVT with NS. Type 2 diabetes mellitus might
be the most important risk factor for AIS with NS, especially in the
Japanese population.
ESOC-1144
15. Risk Factors for Stroke/Prognosis
The inflammatory serum markers in patients with a
recent history of stroke and myocardial infarction
I Kurkowska-Jastrze˛bska1, B Błaz˙ejewska-Hyz˙orek1,
I Sarzyn´ska-Długosz1, M Karlin´ski1, M Kiliszek2, R Główczyn´ska2,
K Filipiak2, A Członkowska1
12nd Department of Neurology, Institute of Psychiatry and
Neurology, Warsaw, Poland
2Department of Internal Medicine and Hypertension, Clinical
Hospital of Medical University in Warsaw, Warsaw, Poland
Background: Current evidence strongly supports the role of inflamma-
tion in the process of atherosclerosis. It has been also suggested that
infection with common pathogens and the initiation of immune complex
formation may be involved.
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Methods: This is a prospective study of inflammatory markers in patients
with clinical signs of atherosclerosis. It includes 96 patients with the
history of ischaemic stroke and 41 patients with documented myocardial
infarction (3–12 months before the study), and 111 control patients with
no cardiovascular events (matched for sex and age). Serum concentrations
of conventional inflammatory markers, such as C-reactive protein (CRP),
erythrocyte sedimentation rate (ESR), white blood count (WBC) and
marker of bacterial infections – procalcitonin (PCT), immune complexes
(IC), endothelial markers (ICAM-1, von Willebrand factor, E-selectin)
were measured and correlated with atherosclerotic changes in carotid
arteries (intima media thickness, IMT; the presence of plaques and the
degree of stenosis).
Results: Patients with the history of stroke and myocardial infarction had
increased CRP, ESR, WBC, ICAM-1, E-selectin levels and IC level com-
pared with the control group. The levels of CRP and IC correlated with
IMT >1 mm and with the presence of plaques in patients with stroke and
myocardial infarction. We also found that increased expression of Herpex
simplex virus-1 and Helicobacter pylori antigens in IC of both study groups
correlated with the presence of unstable plaques.
Conclusion: Our study shows that active inflammation is present during
the process of atherogenesis and suggests that ICs might be involved in
unstable plaque formation.
ESOC-0134
15. Risk Factors for Stroke/Prognosis
Renal dysfunction is associated with deep cerebral
microbleeds but not white matter hyperintensities in
patients with acute intracerebral hemorrhage
M Laible1, S Horstmann1, M Möhlenbruch2, C Wegele3, T Rizos1,
S Schüler4, M Zorn5, R Veltkamp3
1Department of Neurology, University Hospital Heidelberg,
Heidelberg, Germany
2Department of Neuroradiology, University of Heidelberg,
Heidelberg, Germany
3Department of Neurology, University of Heidelberg,
Heidelberg, Germany
4Institute of Medical Biometry and Informatics, University of
Heidelberg, Heidelberg, Germany
5Department of Internal Medicine-I, University of Heidelberg,
Heidelberg, Germany
Background and purpose: Kidney disease is a risk factor for cerebral
microangiopathy and spontaneous intracerebral hemorrhage (ICH). We
aimed to determine the association of renal dysfunction (RD) with MRI
correlates of different cerebral microangiopathies including cerebral
microbleeds (CMB) and white matter lesions (WML) in patients with
ICH.
Methods: In a prospectively collected, single center cohort of ICH
patients, glomerular filtration rate (eGFR) was estimated using the Modi-
fication of Diet in Renal Disease equation. We classified the renal function
in five categories: category 1 (eGFR ≥ 90 mL/min/1.73 m2), category 2
(eGFR 60–89), category 3 (eGFR 30–59), category 4 (eGFR 15–29), and
category 5 (eGFR < 15) and dichotomized at an eGFR of 60. Number,
location, and extent of CMB and WML were measured on MRI. ICH and
CMB locations were classified as lobar or deep.
Results: Ninety-seven ICH patients with MRI (mean age 65.9 ± 13.9
years) were included. Intracerebral hemorrhage was lobar in 52.6%.
Median eGFR was 85.8 mL/min/1.73 m2 (IQR 34.3). Renal dysfunction
was present in 12.4% of the patients. At least one CMB was present in
57.7% of patients, WML were even more frequent (97.7%). Age and
impaired renal function were factors independently associated with the
presence of CMB. The presence of CMB was independently associated
with the number and extent of WML.
Conclusion: RD is a frequent comorbidity in patients with ICH. Associa-
tions of RD with hypertension and with CMB in deep location suggest a
predominant impact of renal dysfunction on deep arteriolar lipohyalino-
sis rather than on cerebral amyloid angiopathy.
ESOC-1235
15. Risk Factors for Stroke/Prognosis
Prevalence of arterial and venous thrombophilia in TIA
or ischaemic stroke patients with a patent foramen
ovale, with or without an inter-atrial septal aneurysm
S Lim1, C A Coughlan1, D R Smith1, J Williams1, S G Navarro1,
J McCabe1, S J X Murphy1, D P Moore2, D J H McCabe2
1Neurology, The Adelaide and Meath Hospital, Dublin,
Ireland
2Cardiology, The Adelaide and Meath Hospital, Dublin,
Ireland
Introduction: Data are limited on the prevalence of abnormalities on
comprehensive, simultaneous arterial and venous thrombophilia
screening in TIA/stroke patients with patent foramen ovale (PFO) +/- an
inter-atrial septal aneurysm (IASA).
Methods: Prospectively-collected data on TIA/ischaemic stroke patients
with a PFO, IASA or both who attended our Vascular Neurology Service
were analysed. All patients underwent trans-oesophageal echocardiogra-
phy, and testing for anti-nuclear, anti-cardiolipin and anti-beta-2 glyco-
protein I antibodies; rheumatoid factor, lupus anticoagulant, protein C&S,
anti-thrombin, factor VIII activity, activated protein C resistance, Factor V
Leiden, prothrombin gene and MTHFR-C677T mutation screening. ENA
and homocysteine were assessed in the latter part of the study. Abnormal
‘non-genetic’ thrombophilia tests were repeated >12 weeks later.
Results: Eighty-two patients were recruited. Mean follow-up was 47.3
months (maximum: 6 years). Twenty-five patients (30.5%) had ≥1 abnor-
mality on thrombophilia screening. Three patients (3.7%) had primary
anti-phospholipid syndrome with positive anti-cardiolipin/anti-beta 2
glycoprotein I antibodies, two of whom had recurrent TIAs necessitating
anti-coagulation with warfarin. Six patients (7.3%) had elevated Factor
VIII activity, three had protein S deficiency (3.7%; one developed a DVT);
one (1.2%) had a Factor V Leiden mutation, and three (3.7%) had dual
abnormalities on thrombophilia screening. Six (7.3%) had elevated
homocysteine levels, and four (4.9%) a C677T-MTHFR mutation. The
incidence of recurrent TIA/stroke was similar in patients with and
without underlying thrombophilia (12% vs. 7%; P = 0.67).
Discussion: Comprehensive thrombophilia screening is positive in an
important proportion of TIA/stroke patients with a PFO, facilitates indi-
vidualized anti-thrombotic therapy, and may help select patients warrant-
ing endovascular closure.
ESOC-1589
15. Risk Factors for Stroke/Prognosis
Hyperacute levels of high sensitivity C-reactive protein
and changes of metalloproteinase 2 improve the
accuracy of outcome prediction in acute ischemic
stroke
S Lorenzano1, N S Rost1, K L Furie1
1Department of Neurology, Massachusetts General Hospital –
Harvard Medical School, Boston, USA
Objectives: Complex biochemical processes occur as part of the early
response to cerebral ischemia. We sought to evaluate whether hyperacute
plasma concentration of biomarkers of inflammation, tissue damage, and
oxidative stress predict short-/long-term functional outcome and mortal-
ity in patients with acute ischemic stroke (AIS).
Methods: We prospectively and serially measured plasma
F2-isoprostanes, urinary 8-oxo-7,8-dihydro-2’-deoxyguoanosine, plasma
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Oxygen Radical Absorbance Capacity assay (ORACTOT, ORACPCA),
high sensitivity-C reactive protein (hs-CRP), MMP-2 and 9, homocysteine
in AIS patients presenting within 9h of symptom onset. Outcome mea-
sures were early neurological deterioration (END) (worsening of present-
ing symptom with an increase of ≥4 points at NIHSS or death) at 48
hours, 90-day modified Rankin Scale (0–2 and 3–6 as favorable and unfa-
vorable outcome, respectively), and death.
Results: We enrolled 489 subjects, mean age 70 (SD 15), median NIHSS 6
(IQR 3–13), 43% female, 41% underwent IV t-PA. After adjustment for all
the confounding variables in multivariate binary logistic regression
models, baseline MMP-2 were an independent predictor of END (OR
1.005, 95%CI 1.001–1.009; p = 0.013). Elevated 48 h hs-CRP indepen-
dently predicted death (1.014, 1.002–1.027; p = 0.026), whereas hs-CRP
level at baseline was an independent predictor of 90-day mRS (1.043,
1.004–1.084; p = 0.032). Change in MMP-2 from baseline to 48 h showed
a trend towards statistical significance (0.995, 0.990–1.0, p = 0.038).
Adding hs-CRP and MMP-2 changes to NIHSS improved accuracy of
90-day outcome prediction increasing the Nagelkerke pseudo R square
from 0.480 to 0.515 and 0.542 respectively.
Discussion: Hyperacute levels of hs-CRP and changes of MMP-2 improve
the accuracy of outcome prediction in AIS.
ESOC-1590
15. Risk Factors for Stroke/Prognosis
Mismatch salvage volume up to 24 h from stroke
onset predicts favorable outcome in acute ischemic
stroke
S Lorenzano1, N S Rost1, K L Furie1
1Department of Neurology, Massachusetts General Hospital –
Harvard Medical School, Boston, USA
Objectives: Advanced neuroimaging techniques may provide fundamen-
tal data with regard to brain tissue viability in acute ischemic stroke (AIS).
We sought to evaluate whether the volume of mismatch salvaged ischemic
tissue was predictive of clinical outcome.
Methods: Patients enrolled in a multicenter biomarker study with at least
a baseline magnetic resonance imaging (MRI) and a follow-up MRI or CT
performed within 24 h and 24–96 h of symptom onset, respectively, were
included in the analysis. Imaging were analyzed using semi-automated
volumetric method. Mismatch was defined as baseline mean transit time
(MTT) volume on PWI minus DWI volume. A percent mismatch cut-off
of 20% was considered clinically significant. Mismatch salvaged volume
was the region not overlapped by final infarction and calculated according
to the following formula [(mismatch volume – final infarct volume)].
Outcome was the dichotomized 90-day modified Rankin Scale (0–2 and
3–6 as favorable and unfavorable outcome, respectively).
Results: One hundred forty-three patients [mean age 68.8 (SD 15),
median NIHSS 8 (IQR 4–14), 43% female, 53.5% underwent IV t-PA]
were included in the analysis. After adjustment for all the confounding
variables in multivariate binary logistic regression models, NIHSS (OR
0.781, 95% CI 0.701–0.871; p < 0.001), and mismatch salvaged volume
(OR 1.012, 95% CI 1.001–1.022; p = 0.026) were independently associated
with 90-day favorable outcome. Adding mismatch salvage volume to
NIHSS improved accuracy of 90-day outcome prediction increasing the
Nagelkerke pseudo R square from 0.434 to 0.497.
Discussion: Salvage of mismatch up to 24 h from symptom onset is inde-
pendently associated with improved clinical outcome, although the effect
is small.
ESOC-1163
15. Risk Factors for Stroke/Prognosis
Dyslipidemia as the possible risk factor for arterial
ischemic stroke in young
V Gusev1, O Lvova2, M Votty1
1Stroke Unit, Clinic City Hospital 23, Yekaterinburg, Russia
2Child neurology and neonatology, Ural State Medical
University, Yekaterinburg, Russia
Background: Huge number of diseases can cause arterial ischemic stroke
(AIS) in young. Dyslipidemia seems to be the risk factors of AIS in this age
group.
Methods: Type of study: case series. Inclusion criteria: 66 male or female
under the age of 45 y.o. with AIS’s debut confirmed by brain CT(MRI)
scan; slavic origin; informed consent form. We identified cholesterol,
HDL, Triglycerides, LDL, VLDL and KA in AIS acute period (during first
2 days).
Results: Half of patients had deviations of lipid metabolism. The most
common findings were the high level of cholesterol and the low level of
HDL (table). In 9 cases we identified isolated hypo-α-cholesterolemia, in
8 – IIa, in 17 patients – IIb, in 8 – IV Fredrickson phenotype. Only 8
patients had stenosis of the brachiocephalic vessels more than 70% (ultra-
sound data). There were no correlations between any lipids level and those
stenosis’ degree.
Conclusion: We assume dyslipidemias to have diagnostic value in early life
AIS’s debut. The maximum possible set of lipid and lipoproteins must be
assigned. Detection of dyslipidemia and their reasons may become a start-
ing point for therapy and secondary prevention in those patients.
Table. Average level of lipid and lipoproteins in young patients with AIS
Triglycerides Cholesterol HDL LDL VLDL KA
without dyslipidemia
M ± m, mmol/l 1,22 ± 0,07 4,14 ± 0,13 1,88 ± 0,07 2,91 ± 0,11 0,60 ± 0,03 2,1 ± 0,10
Cases, n 52 48 17 59 53 33
with lipid metabolism deviations
M ± m, mmol/l 3,28 ± 0,27 6,10 ± 0,22 0,98 ± 0,04 4,65 ± 0,23 1,58 ± 0,12 4,48 ± 0,19
Cases, n 14 18 49 7 13 33
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15. Risk Factors for Stroke/Prognosis
TIA clinic diagnoses and subsequent mortality:
Data from the Scottish Stroke Care Audit
M Turner1, M Barber2, M Dennis3, P Langhorne4, M Macleod1
1Division of Applied Medicine, University of Aberdeen,
Aberdeen, United Kingdom
2Department of Medicine, NHS Lanarkshire, Lanarkshire,
United Kingdom
3Centre for Clinical Brain Sciences, University of Edinburgh,
Edinburgh, United Kingdom
4Institute of Cardiovascular and Medical Sciences, University
of Glasgow, Glasgow, United Kingdom
Early specialist review of suspected stroke or TIA outpatients is recom-
mended, and results in a broad range of patients being seen with many
having another diagnosis.
Aims: Using data from the Scottish Stroke Care Audit linked to routinely
collected mortality data, to look at recurrent in patient or outpatient
stroke events and death based on initial clinic diagnosis.
Methods: SSCA data were linked to SMR01 and General Records Office
mortality data.
Results: Of 27369 outpatients (mean age 67.4 ± 13.2 years, 49.6% males),
23042 (84.2%) had one outpatient entry in the stroke audit, while 2626
(9.6%) had a recurrent inpatient (5%) or outpatient (4%) stroke or TIA
event, or both (0.6%) within one year. Of those with just one recorded
event, 927 (4%) had died by one year.
Diagnosis at clinic
Stroke
(5554)
TIA
(7454)
Other
(6869)
Retinal/
SAH/SDH
(1515)
Primary cause
of death
Cerebrovascular 40 (0.7%) 26 (0.3%) 21 (0.3%) 6 (0.3%)
Cardiovascular 48 (0.8%) 56 (0.7%) 35 (0.5%) 11 (0.7%)
Cancer 78 (1.4%) 93 (1.2%) 121 (1.7%) 13 (0.8%)
Brain cancer 10 (0.1%) 7 (0.09%) 54 (0.7%) 0 (0%)
Conclusions: In this population, mortality rates at one year are similar
regardless of the clinic diagnosis. There are as many deaths recorded from
cardiovascular causes as stroke related causes, and cancer deaths are com-
moner in all groups. Further exploration of these data is warranted.
ESOC-1395
15. Risk Factors for Stroke/Prognosis
Understanding stroke and cancer relationship:
A challenge
C Marques-Matos1, A Costa1, G Moreira1, E Azevedo1,
M Carvalho1
1Cerebrovascular Diseases Study Group, Centro Hospitalar São
João, Porto, Portugal
Background: While cancer and its treatment might increase stroke risk,
the nature of the “hipercoagulable state” of cancer remains elusive.
Finding imaging and laboratory markers to predict occult cancer in stroke
patients is pressing. The aim of this study was to investigate risk factors,
stroke pattern, aetiology and outcome measures in stroke patients with
and without active cancer and assess the ability of imaging and laboratory
markers to identify cancer-related stroke.
Methods: Retrospective review of stroke patients with active cancer
admitted to our stroke unit during a 5-year period compared with age and
gender-matched non-cancer stroke patients.
Results: The distribution of tumour types in our stroke population
(n = 43) was not proportional to its prevalence in the general population.
The prevalence of vascular risk factors and stroke aetiologies was not
different between groups. Time between cancer diagnosis and stroke
showed a median of 3 months and death within 30 days of stroke was
higher in the cancer group (78,6% vs. 44,4%, p = 0,019). In non-
hematologic cancer patients with ischemic stroke, the odds of a conven-
tional stroke aetiology were 50% that of non-cancer patients (OR 0,510).
For the cancer population, the RR of a C-reactive protein (CRP) level
>20,6 mg/dl was 2,512.
Discussion: Given the distribution of tumour type and timing of stroke,
our study suggests the existence of cancer-specific mechanisms of stroke.
The relative risk of non-conventional stroke aetiology in our cancer group
advocates for the search for occult cancer in these patients. CRP level
might play a role in raising the suspicion.
ESOC-0747
15. Risk Factors for Stroke/Prognosis
Fibrinogen concentration and factor X activity –
predictors of cognitive function in 14 day disease in
ischemic stroke patients
V Melnyk1, L I Sokolova1, O M Savchuk2
1Neurology, National O.O. Bogomoletz Medical University,
Kiev, Ukraine
2Biochemistri, T.Shevchenko National University, Kiev, Ukraine
Introduction: Recently appeared on the hemostasis factors in the patho-
genesis of dementia and cognitive disorders.
Aims: We hypothesized that the fibrinogen concentration and X factor
activity in first hours of ischemic stroke was determine cognitive function
level on 14th day.
Methods: We included 72 patients with first-ever ischemic stroke in
whom plasma fibrinogen level and factor X activity was measured at
admission.
Results: On admission concentration of fibrinogen was 2,98 ± 0,1 g / l, the
activity of factor X – 102,44 ± 3,35%. On the 14th day of treatment
average on the MMSE was 22,4 ± 4,9 points. Cognitive functions were not
violated in 27 (37.5%) patients (26,4 ± 2,4 points) in 17 (23.6%) –
reported cognitive decline (23,5 ± 2,4 points), 8 (11.1%) – light, in 17
(23.6%) moderate, and 3 (4.2%) – post-stroke dementia expressed
(21,2 ± 1,3 points, 17,7 ± 1,9 points and 8,7 ± 2,5 points, respectively).
Cognitive functions better recovery responded significantly lower initial
fibrinogen levels (p = 0.001) and a lower activity of factor X (p = 0.024). It
was established that 39.4% of patients predictor MMSE score is the con-
centration of fibrinogen (R = −0,639 D = 39,4% p < 0,001) and 12.3% of
patients – factor X activity (R = −0,313 D = 12,3% p < 0,001).
Conclusion: We have shown that fibrinogen concentration and activity of
coagulation factor X was measured at admission may be predictors of
MMSE score on the 14th day of the ischemic stroke.
ESOC-0126
15. Risk Factors for Stroke/Prognosis
Insulin resistance in asymptomatic carotid stenosis
and atherotrombotic stroke
M Mijajlovic1, A Jotic2, N Lalic2, N Sternic1
1Department for Cerenrovascular Disorders and Headaches,
Neurology Clinic Clinical Center of Serbia, Belgrade, Serbia
2Department for diabetes, Clinic for Endocrinology, Belgrade,
Serbia
Background/aims: Decreased insulin sensitivity (IS) with compensatory
hyperinsulinemia plays a crucial role in the pathogenesis of atherosclero-
sis, but their role in ischemic stroke (IST) has not yet been elucidated.
Study was aimed to analyze IS and plasma insulin (PI) levels and dyslipi-
demia pattern in 100 patients with atherothrombotic IST- (group A), 100
patients with asymptomatic carotid stenosis ≥50%- (group B), 60 patients
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with lacunar stroke (Group C) and 50 healthy controls- (group D).
Patients with diabetes mellitus and ischemic heart disease were excluded.
Methods: IS was determined by Homeostasis Assessment Model (HOMA-
IR), PI levels by Radioimmunoassay. Total- , LDL- and HDL-cholesterol
and triglyceride levels were measured in all groups. Central obesity was
determined by waist circumference and hypercoagulable state was mea-
sured by plasminogen activator inhibitor (PAI-1) levels.
Results: IS was significantly lower in group A compared to group B, C and
D (4.82 +/- 0.27 vs. 3.69 +/- 0.22, p < 0.05; 4.82 +/- 0.27 vs. 2.71 +/- 0.21,
p < 0.01, 4.82 +/- 0.27 vs. 1.50 +/- 0.19, p < 0.01). PI levels were signifi-
cantly higher in group A in comparison to group B, C and D (19.00 +/- 1.2
vs. 15.95 +/- 0.88, p < 0.05; 19.00 +/- 1.2 vs. 11.12 +/- 0.19, p < 0.01,
19.00 +/- 1.2 vs. 7.12 +/- 1.08). Different patterns of dyslipidemia were
observed in ACAS in comparison to IST. PAI-1 levels, and waist circum-
ference were significantly higher in group A, B, and C in comparison to
healthy controls (P < 0.01, respectively).
Conclusion: Our results indicate that all subtypes of ischemic stroke as
well as ACAS are strongly associated with decreased IS and increased PI
and PAI-1 levels. Different patterns of dyslipidemia between ACAS and
IST were observed.
ESOC-0943
15. Risk Factors for Stroke/Prognosis
The relationship between polyunsaturated fatty acids
status and platelet activating markers in patients with
ischemic stroke
A Mizuma1, S Kohara1, T Uesugi1, Y Ohnuki1, S Takizawa1
1Neurology, Tokai university school of medicine, Isehara,
Japan
Purpose: Lower ω-3/6 polyunsaturated fatty acids (PUFAs) balance is
considered as a residual atherosclerotic risk factor. On the other hand, the
effects of PUFAs balance on pathological condition of atherosclerotic
thrombosis. The purpose of this study is investigation of the relation
between platelet activating markers as an indicator of atherosclerosis and
ω-3/6 PUFAs balance.
Subjects and methods: We enrolled 30 patients with asymptomatic or
chronic ischemic stroke (mean age; 68 years old, male; 16 patients), under-
going anti-platelet therapy and adequate risk reduction therapy. We mea-
sured platelet activating markers (PAC-1, CD62P, leukocyte agglutination
and platelet clump) and PUFAs (eicosapentaenoic acid [EPA], docosa-
hexaenoic acid, arachidonic acid [AA], and α-linolenic acid). We also
divided these patients into two groups on the basis of EPA/AA ratio (high
risk group [H group]; EPA/AA ratio <0.60, low risk group [L group];
EPA/AA ratio ≧0.60) and made a comparison between two groups for
platelet activating markers. In some cases, we followed EPA/AA ratio and
platelet activating markers after ω-3 supplementation.
Results: PAC-1 (H group: 13.76 vs L group: 21.77, P < 0.05) and CD62P
(H: 1.84 vs L: 4.02, P < 0.05) were significantly lower in H group than L
group. On the other hand, leukocyte agglutination and platelet clump
were not significantly different among three groups. In H group,
PAC1 was significantly reduced with ω-3 supplementation (pre-
supplementation: 29.67 vs post-supplementation: 12.05, P < 0.05).
Conclusion: Treatment with ω-3 supplementation or maintaining high
level EPA/AA ratio may be effected the inhabitation of platelet activation.
ESOC-0746
15. Risk Factors for Stroke/Prognosis
Platelet biomarkers in asymptomatic and symptomatic
atherosclerotic carotid stenosis: An updated detailed
systematic review of the literature
S J X Murphy1, J A Kinsella2, C A Coughlan1, G Hamilton3,
D J H Mc Cabe4
1Department of Neurology, The Adelaide and Meath
Hospital, Dublin, Ireland
2Dementia Research Centre, University College London UK,
London, United Kingdom
3Department of Vascular Surgery, Royal Free Hampstead NHS
Trust, London, United Kingdom
4Departments of Neurology and Stroke Service, Adelaide and
Meath Hospital, Dublin, Ireland
Introduction: Platelet biomarkers have the potential to improve our
understanding of the pathogenesis of TIA or stroke and optimise outcome
in patients with atherosclerotic carotid stenosis.
Methods: A detailed systematic review of the literature was performed
(Pubmed, Medline, Ovid, Embase and Web of Science) to collate available
data on ex-vivo platelet activation and platelet function/reactivity in
patients with asymptomatic and symptomatic moderate to severe (50–
99%) carotid stenosis or occlusion.
Results: 261 potentially relevant articles were identified; 41 met inclusion
criteria for review. There are no clinically informative data from urinary
or soluble blood markers of platelet activation in patients with symptom-
atic moderate to severe carotid stenosis or occlusion who might warrant
intervention. Flow cytometry studies revealed increased platelet activation
in the early, subacute or late phases after TIA or stroke in association with
50–99% carotid stenosis or occlusion (5 studies, P < 0.05), and in asymp-
tomatic 50–99% carotid stenosis patients vs. controls (3 studies, P < 0.05).
Furthermore, pilot data indicate that platelet activation is increased in
recently symptomatic compared with asymptomatic moderate to severe
carotid stenosis (4 studies, P < 0.05), and ‘high-on-treatment platelet reac-
tivity on clopidogrel’ may predict the risk of new MR-DWI lesions after
carotid stenting (2 studies, P ≤ 0.045).
Discussion: There is increasing evidence of excessive platelet activation/
hyper-reactivity that may contribute to the pathogenesis of first or recur-
rent TIA or stroke in patients with carotid stenosis. Larger longitudinal
studies are warranted to assess the ability of platelet biomarkers to facili-
tate enhanced stroke prevention in asymptomatic and symptomatic
carotid stenosis and to help risk-stratify patients undergoing carotid
intervention.
ESOC-1049
15. Risk Factors for Stroke/Prognosis
Adherence to initially-prescribed intensive secondary
prevention therapy at a rapid access stroke prevention
clinic in Ireland
S J X Murphy1, C A Coughlan1, O Tobin2, R Lonergan1,
M Gutkin1, J A Kinsella3, D J H McCabe4
1Neurology, The Adelaide and Meath Hospital, Dublin,
Ireland
2College of Medicine, Mayo Clinic, Rochester, USA
3Dementia Research Centre, University College London,
London, United Kingdom
4Departments of Neurology and Stroke Service, The Adelaide
and Meath Hospital, Dublin, Ireland
Introduction: Consistent adherence to prescribed treatment is essential
for effective secondary prevention following TIA/stroke. Representative
data on treatment-adherence rates are lacking in Ireland.
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Methods: Eligible TIA or ischaemic stroke patients attending our Rapid-
Access Stroke Prevention (RASP) Clinic were recruited. Demographic and
clinical data, and prescribed medication at the last clinic assessment were
recorded from prospectively-collected electronic records. All patients
received copies of letters containing treatment advice sent to their general
practitioners. Patients were subsequently contacted by phone or inter-
viewed in-person during clinic follow-up using a standardised pro forma
to assess continuation rates, and overall adherence to antiplatelet therapy,
statins and anti-hypertensives with a validated self-reporting tool
(Morisky Scale). Recurrent vascular events during follow-up were
recorded. Verbal informed consent/assent was obtained, and study
approval secured from the Local Research Ethics Committee.
Results: One hundred fourteen patients were recruited; mean follow-up:
670 days (range: 165–1326 days). Patients were prescribed aspirin (69.3%)
alone or in combination with dipyridamole MR (51.8%), clopidogrel
(18.2%), warfarin (16.7%) statins (76.3%), or anti-hypertensives (51.8%).
During follow-up, 93.7% were still taking their prescribed aspirin, 82.9%
dipyridamole MR, 81% clopidogrel, 94.7% warfarin; 88.5% statins and
89.8% anti-hypertensives. Overall, 99.1% reported taking their medica-
tion the preceding day;11.4% missed at least one medication over the
preceding fortnight. Two patients (1.8%) had recurrent cerebrovascular
events, and two (1.8%) had myocardial infarction during follow up.
Discussion: Data from this novel TIA/ischaemic stroke population in
Ireland show high rates of medication-continuation and self-reported
adherence with prescribed treatment, associated with a low incidence of
recurrent vascular events.
ESOC-0592
15. Risk Factors for Stroke/Prognosis
State of cytokine status and the neurological deficit in
ischemic hemispheric stroke
Y Musayeva1, S Kuranbaeva1, F Saidvaliev1, E Giyazitdinova1,
S Musaev1
1Neurological department, Tashkent medical academy,
Tashkent, Uzbekistan
Background and purpose: The aim of our research is to study the patho-
logical state of microglial cells, which are not recovered to the condition of
functional rest and continued to support phlogosis reactions, producing
one of toxic proinflammatory mediator-cytokines in ischemic hemi-
spheric stroke (IHS) at different times of the acute period of the disease.
Methods: In our observation were 35 patient with IHS, and aged were 34
to 94 years. Spontaneous produce of cytokines in the cerebrospinal fluid
from patients determined using monoclonal antibodies.
Results: In patients with IHS on the first day of the disease showed a
significant increase in tumor necrosis factor (TNF-α) to 32,8 ± 5,2 pg /
ml, which is 356% of the benchmark.
By the third day of illness content TNF-α decreases slightly, amounting to
25,5 ± 3,7 pg / ml (less than the first day of 28.7%).
By the tenth day of the disease the content of TNF-α is somewhat reduced,
but still has not reached the level of individuals in the control group-
17,9 ± 2,5 pg / ml. In 5 patients with IHS the third day of the disease level
of TNF-α remained at the same level, and by the tenth day declined
slightly.
Conclusion: The study of cytokines IHS showed the prevalence of the
disease in the first day of the inflammatory cytokine TNF-α, which indi-
cates the presence of an inflammatory response in the brain ischemic
injury. Dynamic increase in proinflammatory cytokines indicates an
increase in neurological deficit and worsening prognosis.
ESOC-1104
15. Risk Factors for Stroke/Prognosis
Family history of CVD is associated with higher
internal carotid IMT in the Norwegian Stroke in the
Young Study (NORSYS)
H Øygarden1, A Fromm1, G E Eide2, H Naess3, L Thomassen3,
U Waje-Andreassen3
1Neurology, University of Bergen, Bergen, Norway
2Statistics, University of Bergen, Bergen, Norway
3Neurology, Haukeland University Hospital, Bergen, Norway
Objectives: Family history (FH) is a risk factor for cardiovascular disease
(CVD). We aim to analyze the effect of FH on carotid intima-media
thickness (cIMT) in young ischemic stroke patients.
Methods: FH of CVD in first-degree relatives (FDRs) was assessed using a
standardized interview in patients ≤60 yrs with documented ischemic
stroke. Using B-mode ultrasound, cIMT was measured in the common
carotid artery (CCA), carotid bifurcation (BIF) and internal carotid artery
(ICA). IMT measurements were compared between FH+ and FH- groups
and regression analyses were performed to identify factors associated with
IMT thickening. Analysis at age 30–45 excluded the youngest patients with
little FH of CVD and the middle-aged patients with old parents and very
high FH of CVD.
Results: During the study period 333 young stroke patients were enrolled,
228 (68%) were males and 206 (62%) reported FH of CVD in ≥1 FDRs.
Mean age was 52.7 y and 43.8 y in the FH+ and FH- groups respectively.
Mean IMT in the FH+ group was higher in all carotid segments (all
p < 0.01). Regression analyses adjusting for risk factors known to be asso-
ciated with atherosclerosis revealed age as the most important predictor of
IMT. Analyses within age categories showed FH of stroke (Coef: 0.39;
SE0.1; p < 0.001), was associated with higher ICA-IMT in patients aged
30–45 y (N = 51).
Conclusions: FH+ is associated with higher ICA-IMT in the age group
aged 30–45 y. FH+ of stroke is not associated with increased IMT in the
CCA or BIF in any age group in this study.
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15. Risk Factors for Stroke/Prognosis
Main predictors of prosthetic valve thrombosis in the
acute phase of the stroke
J Sala I Padro1, J Pagola1, T Gonzalez2, L Sero1, S Boned1,
D Rodriguez-Luna1, M Rubiera1, M Ribo1, M Muchada1,
C A Molina1
1STROKE UNIT, Vall d’Hebrón hospital, Barcelona, Spain
2CARDIOLOGY ECHOCARDIOGRAPHY LABORATORY, Vall
d’Hebrón hospital, Barcelona, Spain
Background: Prosthetic valve thrombosis (PVT) is a serious complication
and rapid diagnosis and therapy is critical. The aim of our study is to
evaluate the prevalence and main predictors of PVT in the acute phase of
the stroke.
Methods: We studied consecutive acute stroke patients with prosthetic
heart valve who underwent emergent (<72 h) TEE in order to detect PVT
in a 4 years period. Two groups were created depending on the presence of
valve thrombosis (confirmed PVT or non PVT). The age, sex, risk factor
profile and stroke severity were recorded. TEE findings as the presence of
left atria thrombosis, spontaneous echo contrast and mean valve gradient
were analyzed. The international normalized ratio at stroke event (base-
line INR) was compared as well. Follow up clinical visits and TEE control
examinations were performed during 1 year.
Results: A total of 62 ischemic strokes from 56 patients were registered.
PVT was diagnosed in 42% (n = 25). There were no differences in the
main baseline characteristics, the echocardiographic findings and the
baseline INR between the groups. Most PVT occurred on the mitral valve
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(76%, n = 13) vs 23%, n = 4) (p = 0.006). The stroke recurrence was 9%
(n = 5), more frequently in the confirmed PVT group 18% (n = 4) vs 3%
(n = 1) (p = 0.061). Twenty-one percent of patients with confirmed PVT
died.
Conclusions: PVT occurs in nearly half of acute stroke and prosthetic
heart valve. Therefore, emergent TEE should be performed independent
of the INR level or the stroke severity. Those with mitral prosthetic valve
are at higher risk of PVT.
ESOC-1493
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Predictors of recurrence in ESUS patients with
complex aortic arch atherosclerosis
L Sero1, J Pagola1, T Gonzalez2, J Sala I Padro1, S Boned1,
D Rodriguez-Luna1, M Rubiera1, M Ribo1, M Muchada1,
C A Molina1
1Stroke Unit, Vall d’Hebrón Hospital, Barcelona, Spain
2Cardiology. Echocardiography Laboratory, Vall d’Hebrón
Hospital, Barcelona, Spain
Introduction: The presence of complex atherosclerotic plaques in the
aortic arch (cAA) is the occult etiology in almost 20% of patients with
ESUS stroke. Arch trial described the prevalence and incidence of the
stroke caused by cAA but the rate of recurrence was lower than expected.
We aimed to describe the recurrence of CAA in our cohort of patients.
Methods: We studied patients from our prospective database of ischemic
stroke patients who were studied with transthoracic echocardiography
(TTEco) in the acute phase of the stroke. All patients with large plaques
images (≥4 mm) in aortic arch were selected. Two years follow up control
visits and control TTEco were performed in order to evaluate the stroke
recurrence and the evolution of the plaques. Two groups were created
according the clinical recurrence event (Rec group and non-rec group).
Echocardiographic findings as the grade of plaque calcification, the proxi-
mal or distal location to left common carotid artery and the number of
plaques were compared.
Results: We selected 110 patients with CAA. The global rate of recurrence
in our series was 19% (n = 21). The rate of recurrence related to CAA was
12.7% (n = 14). There were no differences in the baseline clinical charac-
teristics (age, gender and vascular risk factors) between Rec group and
Non- Rec group. We did not detect difference in the Echocardiographic
findings.
Conclusions: The rate of recurrence in ESUS related CAA was remarkable.
Predictors of recurrence are needed to improve the treatment prevention.
ESOC-0362
15. Risk Factors for Stroke/Prognosis
Heme oxygenase-1 gene promoter microsatellite
polymorphism is associated with progressive
atherosclerosis and incident cardiovascular disease
R Pechlaner1, P Willeit1, M Summerer2, P Santer3, G Egger4,
F Kronenberg2, E Demetz5, G Weiss5, S Tsimikas6, J Witztum6,
K Willeit1, B Iglseder7, B Paulweber8, L Kedenko8, M Haun2,
C Gieger9, M Müller-Nurasyid9, A Peters10, J Willeit1, S Kiechl1
1Department of Neurology, Medical University of Innsbruck,
Innsbruck, Austria
2Division of Genetic Epidemiology, Medical University of
Innsbruck, Innsbruck, Austria
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Bruneck, Italy
4Department of Internal Medicine, Hospital of Bruneck,
Bruneck, Italy
5Department of Internal Medicine VI, Medical University of
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6Department of Medicine, University of California San Diego,
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7Department of Geriatric Medicine, Paracelsus Medical
University/Salzburger Landeskliniken, Salzburg, Austria
8First Department of Internal Medicine, Paracelsus Medical
University/Salzburger Landeskliniken, Salzburg, Austria
9Institute of Genetic Epidemiology, Helmholtz Zentrum
München – German Research Center for Environmental
Health, Neuherberg, Germany
10Institute of Epidemiology II, Helmholtz Zentrum München –
German Research Center for Environmental Health,
Neuherberg, Germany
Objective: The enzyme heme oxygenase-1 (HO-1) exerts cytoprotective
effects in response to various cellular stressors. A variable number tandem
repeat (VNTR) polymorphism in the HO-1 gene promoter region has
previously been linked to cardiovascular disease. We examined this asso-
ciation prospectively in the general population.
Approach and results: Incidence of stroke, myocardial infarction, or vas-
cular death was registered between 1995 and 2010 in 812 participants of
the Bruneck Study aged 45 to 84 years (49.4% males). Carotid atheroscle-
rosis progression was quantified by high-resolution ultrasound. HO-1
VNTR length was determined by polymerase chain reaction. Subjects with
≥32 repeats on both HO-1 alleles compared with the rest of the popula-
tion (recessive trait) featured substantially increased cardiovascular
disease risk (hazard ratio [95% confidence interval], 5.45 [2.39, 12.42];
P < 0.0001), enhanced atherosclerosis progression (median difference in
atherosclerosis score [interquartile range], 2.1 [0.8, 5.6] versus 0.0 [0.0,
2.2] mm; P = 0.0012), and a trend toward higher levels of oxidized
phospholipids on apolipoprotein B-100 (median oxidized phospholipids/
apolipoprotein B level [interquartile range], 11364 [4160, 18330] versus
4844 [3174, 12284] relative light units; P = 0.0554). Increased risk in those
homozygous for ≥32 repeats was also detected in a pooled analysis of 7848
participants of the Bruneck, SAPHIR, and KORA prospective studies
(hazard ratio [95% confidence interval], 3.26 [1.50, 7.33]; P = 0.0043).
Conclusions: This study found a strong association between the HO-1
VNTR polymorphism and cardiovascular risk confined to subjects with
high repeat numbers on both HO-1 alleles and provides evidence for
accelerated atherogenesis and decreased antioxidant defense in this vas-
cular high-risk group.
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Prognosis after embolic stroke of undetermined source
(ESUS): Comparative survival analysis
L Pereira1, M Rodrigues1
1Neurology, Hospital Garcia de Orta, Almada, Portugal
Introduction: Embolic stroke of undetermined source (ESUS) is a sub-
group within cryptogenic stroke, with unknown recurrence risk. We
report event-free survival comparing with other etiologies.
Methods: In a hospital-based stroke cohort, we conducted a prospective
study, recording vascular events/death. ESUS was defined by Cryptogenic
Stroke/ESUS International Working Group, and etiologies by ASCOD
grade1. We present rates and recurrence risk by Kaplan-Meyer curves with
LogRank (LR) and Cox regression with Hazard Ratio (HR), along with
95% confidence intervals (95%CI).
Results: In 460 patients (64.3% male, median age 66), 16.3% fulfilled
ESUS criteria. Main etiologies were: atherothrombosis 26.8%, small-vessel
disease 22.2%, cardioembolism 31.7%.
In a median follow-up of 2.6 years, stroke recurrence was ESUS 6.7%,
atherothrombosis 10.2%, small-vessel disease (SVD) 3.3%, and cardiac
pathology 7.4%. ESUS and SVD had no fatal vascular events, athero-
thrombosis had 1.0%, and cardioembolism 9.8%. We didn’t identify pre-
dictors of ESUS recurrence.
ESUS had fewer vascular events but event-free survival was comparable. A
composite vascular events/deaths endpoint favoured ESUS against cardio-
embolism (LR p = 0.0161; adjusted HR 5.9, 95%CI 2.5–14.1). Survival
until vascular death is higher in ESUS (LR p = 0.005).
ESUS have lower overall mortality than atherothrombosis (LR p = 0.025)
and cardioembolism (LR p < 0.001). Events/deaths were similar in ESUS
and SVD.
Atrial fibrillation was further diagnosed in 9.3% ESUS, without different
outcome.
Conclusion: Stroke recurrence after ESUS was similar to previous crypto-
genic stroke studies.
Analysis including vascular death discloses a 6-fold risk in cardioembo-
lism versus ESUS, clearly separating their prognosis.
Ongoing clinical trials will define the anticoagulation’s role on ESUS
recurrence.
ESOC-0880
15. Risk Factors for Stroke/Prognosis
Long-term predictors of stroke in middle-aged, healthy
Norwegian men. Results from Oslo Ischaemia Study
(OIS)
E Prestgaard1, I Grundvold1, S Kjeldsen1, J Bodegard1, E Berge1
1Cardiology, Oslo University Hospital, Oslo, Norway
Background: The incidence and determinants of stroke in healthy,
middle-aged people are not well known. We report results from long-term
follow-up in the Oslo Ischaemia Study.
Methods: From 1972 to 1975, 2014 healthy Norwegian men aged 40–59
years underwent cardiovascular screening including a symptom-limited
bicycle exercise test. Stroke was documented by scrutiny of medical
records in all Norwegian hospitals. We used Cox regression analysis to
identify baseline variables associated with long-term risk of stroke.
Results: During a median of 30 years of follow-up, 276 men (13.7%) had
a stroke (Table 1). Age, systolic blood pressure, maximal systolic blood
pressure during exercise and PQ interval in ECG were identified as pre-
dictors of stroke in multivariable analyses (p-values < 0.01).
Conclusion: Age, systolic blood pressure, maximal systolic blood pressure
during exercise and PQ interval were significant predictors of stroke
during 35 year’s follow-up of middle-aged healthy men.
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15. Risk Factors for Stroke/Prognosis
Copeptin improves the prognostic models of early
subsequent stroke after a transient ischemic attack
F Purroy1, I Suarez1, S Cambray1, J Farre1, J Sanahuja1,
I Benabdelhak1
1Stroke Unit, Clinical Neurosciences Group, Hospital
Universitari Arnau de Vilanova, IRBLleida, Lleida, Spain
Background: Although large artery atherosclerosis (LAA) and some clini-
cal characteristics are associated with stroke recurrence (SR) among tran-
sient ischemic attack (TIA) patients, some biomarkers have been
suggested to improve the prognosis of these patients. This study analyses
the prognosis value of different biomarkers to be used in addition to
ABCD2 score and TIA aetiology to predict SR.
Methods: Serum levels of copeptin, adiponectin, neopterin, neuron-
specific enolase, high-sensitivity C-reactive protein, IL-6, N-terminal
pro-B type natriuretic peptide, S100ß, tumor necrosis factor-alpha and
IL-1α as well as clinical characteristics were assessed on TIA patients
during the first 24 h of the onset of symptoms. The etiologic subtype was
established in all patients. Recurrence end points were at 7 and 90 days.
Results: Two hundred thirty-seven consecutive TIA patients were
included. 12 patients (5%) had a stroke within 7 days and 15 (6%) within
90 days. Among all candidate biomarkers analysed only copeptin was
significantly increased in patients with SR within 7 days (p = 0.026).
When added to LAA aetiology, copeptin levels >= 13.8 pmol/L presented
the best SR prediction at 7 and 90 days (Hazard Ratio 7.8, 2.5–24.7,
p = 0.002 and HR 5.6, 1.9–16.5, p = 0.006). Moreover, this cutoff was
associated with a great negative value (97.4%) and the association with a
diagnostic accuracy of 90.3%
Conclusions: Serum copeptin levels could be an important prognostic
biomarker to guide management decisions among TIA patients. There-
fore, TIA patients with copeptin levels below 13.8 pg/L have an insignifi-
cant risk of stroke recurrence and could be manage as outpatient basis.
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Acute pontine infarction with development of
progressive motor deficits is associated with worse
functional outcome
J Ramirez-Moreno1, D Ceberino1, A Constantino-Silva1,
O Romaskevych-Krivulya1, D Villa2, A Roa1, P Muñoz-Vega1,
L Fernández2, M Martínez Acevedo1, B Palacios2
1Neurology Department, Hospital Universitario Infanta
Cristina., Badajoz, Spain
2Radiology Department, Hospital Universitario Infanta
Cristina., Badajoz, Spain
Background: The study aimed to prospectively observe the prognosis at
three months of unilateral pontine infarction (figure) with and without
progressive motor deficit (PMD).
Methods: We studied a cohort of patients with unilateral pontine base
infarction. Neurologic progression was defined as increased NIHSS score
by >2 during hospital stay. Clinical outcome was dichotomized as good
and poor according to the modified Rankin Scale (mRS) and Index
Barthel (IB) at 3 month after stroke onset. To define the predictors of
PMD in these patients, clinical and neuroimaging variables were
investigated.
Results: A total of 51 patients (32 men and 19 women; age, 67.8 SD 11.1
years) were studied prospectively. Fifteen patients (29.4%) had PMD, and
36 patients were assigned to the stable motor deficit group without PMD.
In the PMD group, 13 patients deteriorated within the first 4 days
(median, 3; range, 1–7 days) (figure). There was no difference in admis-
sion NIHSS between the 2 groups (mean 4.1 vs. 4.4;p = 0.662). The NIH
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maximum (mean, SD) in PMD group was 9.5, 1.6. The mean length of
hospital stay was significantly longer in the PMD group than without
PMD group (14.9 versus 9.7 days;p = 0.016). And more PMD patients
were transferred to the Department of Rehabilitation than the non-PMD
group (100% versus 33.3%, p < 0.001). Functional outcome after three
months was worse in PMD group (IB < 90: 93.3 vs. 48.6, p = 0.003;
mRS > 2: 86.7% vs. 20.0%, p < 0.001) (figure).
Conclusions: The motor weakness progression is relatively common in
acute unilateral pontine infarction and associated with increased func-
tional disability.
ESOC-0260
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Simple prediction scores predict good and devastating
outcomes after stroke more accurately than physicians
J M Reid1, S Delmonte1, D Dai2, C E Counsell3, S J Phillips4,
M J MacLeod1
1Acute Stroke Unit, NHS Grampian, Aberdeen, United
Kingdom
2Center for Paediatric Clinical Effectiveness (CPCE) and
PolicyLab, The Children’s Hospital of Philadelphia,
Philadelphia, USA
3Division of Applied Health Sciences, University of Aberdeen,
Aberdeen, United Kingdom
4Queen Elizabeth II Health Sciences Centre and Faculty of
Medicine, Dalhousie University, Halifax, Canada
Introduction: There is growing evidence of the utility of the five simple
variables (FSV) score and models to predict outcome after stroke. This
study aimed to test the FSV and also PLAN scores compared to physician
informal prediction for predicting good (modified Rankin [mRS] score
0–2) and devastating outcome (mRS 5–6) following stroke.
Methods: Data were collected on consecutive patients with ischaemic or
haemorrhagic stroke between November 2012 and December 2013 at our
hospital. Demographic and clinical variables were collected with
follow-up at 6 months using mRS. Area under the receiver operator curve
(AUC) was used to establish performance of prediction scores.
Results: Five hundred seventy-five patients were included; 46% female,
median age 76 years, and 88% ischaemic stroke. Six months post stroke
47% of patients had a good outcome, 26% a devastating outcome and
19% had died. FSV based scores and the PLAN score was superior to
physician prediction (AUCs of 0.823–0.863 vs. 0.773–0.805, p < 0.0001)
for good and devastating outcomes (mRS 5–6). The FSV score was slightly
superior to the PLAN score to predict good outcomes and vice versa for
devastating outcomes. Clinical variables 24 hour post thrombolysis
improved prediction of good, but not devastating outcomes, compared to
baseline variables. The FSV score was superior to physician estimation of
outcome, particularly for less experienced physicians.
Conclusion: The FSV and PLAN scores are validated in this population for
outcome prediction post stroke, including thrombolysed patients. The
FSV score is the most parsimonious of score and can inform physician
prediction.
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Fatal stroke – an analysis of the early predictive
elements for the poor outcome in stroke
D REISZ1, V MOGA1, A MUSET2, R VELCEAN2
1Neurology, UMFT, Timisoara, Romania
2Neurology, SCJUT, Timisoara, Romania
The stroke remain one of the first four causes of all deaths in the world. In
eastern European countries, the stroke is even more aggressive keeping the
third′s place for general mortality. The actual study is aimed to find
potential predictor factors for poor outcome in the first 24 hours after
admission in hospital.
Material and method: We analyse all fatalities from 2013 and 2014 in
Neurology department – personal cases – and compare them with a
control group formed by successive stroke patients from the same clinic,
between 2013 and 2014. The study is an observational, retrospective, case
controlled. We mostly use descriptive statistics.
Results: In the SCJUT (Emergency General Hospital), the general mor-
tality rate is 3.73%. In Neurology department, the general mortality rate is
9.13%. In two years we registered 49 deceased patients from 530 (9.24%).
From all cases of death, 81.63% are stroke cases (40/49). Between stroke
causalities, 25% are haemorrhagic stroke (4/40).
Conclusions: The main risk factor for poor outcome apart from GSC,
stroke dimensions and stroke aetiology is presence of the Atrial Fibrilla-
tion, high heart rate, presence from the beginning of an infectious context
(leucocytosis) and high glycaemia. Even if the patient develop in an ulte-
rior stage a kidney failure, the values of the basal BUN and creatinine are
not relevant for poor outcome in the first 24 hours.
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15. Risk Factors for Stroke/Prognosis
Correlation between laboratory markers and
occurrence of new brain ischemic lesions in patients
undergoing carotid stenting – prospective study
M Roubec1, M Kuliha1, D Skoloudik1, R Herzig2, A Goldirova1,
V Prochazka3, T Jonszta3, J Krajca3, D Czerny3, K Langova4,
E Hurtikova1
1Neurological, University hospital Ostrava, Ostrava, Czech
Republic
2Neurological, Charles University and University Hospital
Hradec Kralove, Hradec Kralove, Czech Republic
3Radiological, University hospital Ostrava, Ostrava, Czech
Republic
4Department of Biophysics, Palacky University Olomouc,
Olomouc, Czech Republic
Background: New brain ischemic lesions can be detected in about 50% of
patients undergoing carotid artery stenting (CAS). Aim was to assess
correlation between selected laboratory markers and new brain infarc-
tions occurrence after CAS.
Methods: All consecutive patients 1) with internal carotid artery stenosis
>70%, 2) indicated to CAS, 3) with signed informed consent were enrolled
to the prospective study during 25 months. All patients used dual anti-
platelet therapy (acetylsalicylic acid [ASA] 100 mg + clopidogrel 75 mg
per day) at least 7 days before CAS. Neurological examination and brain
magnetic resonance imaging (MRI) were performed before and 24 h after
CAS in all patients. Blood samples were collected within 24 h before CAS
in all patients: hematology + reticulocytes, selected coagulation and
genetic markers, Multiplate (ASA and clopidogrel resistance test). Blood
samples for anti-Xa assessment were collected during CAS. Mann-
Whitney U-test, Fisher test and Kruskal-Wallis test were used for statistical
evaluation.
Results: The set consisted of 81 patients (53 males; mean age 67.3 ± 7.2
years). New ischemic brain infarctions on follow-up MRI were found in
35 (43.2%) patients. No statistically significant correlation was found
between laboratory markers and occurrence of new brain infarctions.
Only 1 (1%) patient with resistance to ASA and 6 (11.6%) patients with
resistance to clopidogrel were detected.
Conclusion: In the presented study, no correlation was found between
selected laboratory markers and occurrence of new brain ischemic lesions
in patients undergoing CAS.
Supported by grants IGA MH CR NT/11046-6/2010, NT/11386-5/2010,
NT/13498-4/2012, MH CZ – DRO – FNOs/2012.
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Microembolic signals detected with transcranial
doppler sonography as a predictors of acute stroke
and TIA
N Rybalko1, O Vinogradov1, A Kuznetsov1
1Neurological, National Pirogov Centre of Therapy and
Surgery, Moscow, Russia
Background: Cerebral embolism is the common stroke etiological mecha-
nism and microembolus monitoring has been widely used for ischemic
cerebrovascular disease and heart sources of embolism. Although the
presents of microemboli in the cerebral blood flow correlates with the
potential stroke risk the real clinical significance of microembolic signals
(MES) remains unclear.
The aim of our research was to evaluate of MES in predicting ischemic
stroke and TIA in patients with arterial and cardiogenic sources of
embolism.
Methods: Cerebral microemboli were detected from 145 asymptomatic
and 122 symptomatic patients. The cohort was divided into three groups:
the st patients group (n = 89) with atherosclerotic stenosis of extracranial
arteries; the 2nd patients group (n = 95) with atrial fibrillation; and the 3d
group (n = 83) with prosthetic heart valves. TCD monitoring was per-
formed at the baseline, after 10 days, 6 months and 1 year period to find
out whether the presence of embolic signals predicted risk of TIA and
stroke.
Results: The frequency of MES was significantly higher in the symptom-
atic group than in the asymptomatic group (49/122 vs 10/145, p < 0.01).
However, the frequency of MES was correlated with TIA and stroke only
in patients group with atrial fibrillation and prosthetic heart valves
(p < 0.05); the value of MES as the predictor of acute cerebrovascular
complications in the carotid stenosis patients group was not statistically
confirmed.
Conclusion: MES detection by TCD is a sensitive technique and may be
used to access the potential risk of cardiogenic sources of embolism such
as atrial fibrillation and prosthetic heart valves.
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Aortic dissection causing embolic stroke – a difficult
case
S Saber1, P Ravji1, M Hanif1, G Zachariah1, V Umachandran1
1STROKE MEDICINE, BROOMFIELD HOSPITAL, Chelmsford,
United Kingdom
Introduction: Aortic dissection is a rare and potentially fatal disease,
which produce a wide range of symptoms . Typical symptoms are chest or
back pain and hypotension.
Neurological symptoms occur due to occlusion of carotid, vertebral and
spinal arteries.
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Case Report: 78 yrs old patient with a background of hypertension and
peripheral vascular disease presenting with left sided facial and limb weak-
ness with incidental findings of blood pressure difference in both arms
CT Angiogram of Aorta- Dissection extends into all three branches of
aortic arch with occlusion of left renal artery , dissection extends into both
iliac common arteries.
CT Head: Multiple areas of low attenuation involving right parietal and
frontal lobes .
Conclusion: The case demonstrates the diagnostic challenges of differen-
tiating stroke from aortic dissection, especially when thrombolytic agents
are being considered in a narrow time frame but at a risk of haemorrhagic
complications.
The case reveals a patient with a dual diagnosis of an extensive aortic
dissection from the left carotids to iliac arteries as well as an acute isch-
emic stroke.
Cerebral ischemic events are reported to occur in up to 30% cases of aortic
dissection whilst neurological symptoms have been reported to occur in
up to 40% as a result of vessel occlusion or hypotension. The case high-
lights the importance of having a high index of suspicion of aortic dis-
section in those who present with variable neurology and being mindful
of a possible accompanying diagnosis of ischemic stroke.
ESOC-0556
15. Risk Factors for Stroke/Prognosis
The complex relationship between cancer and cerebral
vascular accidents
S Saber1, M Liewelyn1, G Zachariah1, V Umachandran1
1STROKE MEDICINE, BROOMFIELD HOSPITAL, Chelmsford,
United Kingdom
Introduction: Cancer and Stroke both carry a high burden of morbidity
and mortality in the United Kingdom. Malignancy can predispose a
patient for stroke via mechanisms unique to the disease; in particularly
hypercoaguable state, venous-to-arterial embolism, non-bacterial throm-
botic endocarditis, direct tumour compression of a vessel, tumour embo-
lism, hyperviscosity, angioinvasion leading to arterial embolism, post-
radiation vasculopathy and chemotherapy.
Case report: A 37-year-old lady who presented with profound expressive
dysphasia. Her medical history included a hysterectomy 2 years previously
for menorrhagia, with previous endometrial ablation. She was non smoke
and to family history of stroke or venous thromboembolism.
CT Head on admission confirmed an acute left middle cerebral artery
infarct.
ECG and carotid dopplers were unremarkable.
The patient re-presented on three subsequent occasions over the next 11
months with focal neurological symptoms. At each admission a new
infarct was confirmed. She was extensively investigated for thrombo-
embolic causes of stroke including thrombophilia, infection , auto-
immune screen, test for fabry’s disease, homocystin level- all negative.7
day ECG, Trans-oesophageal ECHO, bubble study, CSF study MRV, MRA
were negative.
Later that year she developed a right leg deep vein thrombosis. A CT
abdomen demonstrated an 8 cm solid mass in the right ovary, subsequent
pathology demonstrated ovarian adenocarinoma.
In our discussion we recognise occult cancer is an important missed
diagnosis in cryptogenic stroke. We recommend screening for malignancy
for the sub-group of patients where no cause is accounted for. This allows
for rapid detection and treatment for both the malignancy and secondary
stroke prevention.
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Infectious complications in critically ill stroke patients
D V Sergeev1, D S Gorbatyuk2, P R Prokazova1, Y V Ryabinkina1,
M A Piradov1
1Intensive Care Unit, Research Center of Neurology, Moscow,
Russia
2Faculty of Basic Medicine, Moscow State University, Moscow,
Russia
Infections have significant impact on outcome in critically ill neurological
patients. To estimate the structure of nosocomial infections in stroke
patients in intensive care setting we analyzed 47 cases of severe stroke (20
males, 27 females, median age 42 years).
Results: nosocomial infections were identified in 55.3% patients. The
most common nosology was pneumonia followed by urinary tract infec-
tions and catheter-associated bloodstream infections, and sinusitis
(96.2%, 50.0%, 50.0% and 26.9%, respectively). Combination of at least
two infections was found in 65.4% patients. Nosocomial infections were
associated with increased duration of ICU stay from median 14 days in
patients without infection to 27 days in patients with at least one infec-
tion, and to 113 days in 4 infections. Similar results were shown for
mechanical ventilation: patients with 0 or 1 complication were ventilated
for median 8 or 9 days, respectively, while patients with 2 or more infec-
tions required respiratory support for median 50 days. Mortality was
similar for no or one or two types of nosocomial infections (14.3% vs.
22.7% and 16.7%, respectively, p > 0.05), while all patients with 3 types of
infection survived and among patients with 4 infections 50% died.
However, infectious complication was never considered as an immediate
cause of death.
Conclusion: about half of ICU stroke patients are at risk of infectious
complications that may double the length of stay and aggravate the need
for mechanical ventilation. The most harmful effect has the often seen
combination of several types of infections.
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Carotid plaque lipid content on MRI is associated with
plaque instability
K Skagen1, K Evensen2, H Scott3, K Krohg-Sørensen4, S Vatnehol5,
P Hol6, M Skjelland7, D Russell7
1Neurology, Oslo University Hospital Rikshospitalet, Oslo,
Norway
2Neurology, Oslo University Hospital Rikshospitalet og
Drammen Hospital Vestre viken, Oslo, Norway
3Pathology, Oslo University Hospital and Institute of Clinical
Medicine University of Oslo, Oslo, Norway
4Thoracic Surgery, Oslo University Hospital Rikshospitalet,
Oslo, Norway
5The Intervention Centre, Oslo University Hospital
Rikshospitalet, Oslo, Norway
6The Intervention Centre, Oslo University Hospital
Rikshospitalet and Insitute of Clinical Medicine University of
Oslo, Oslo, Norway
7Neurology, Oslo University Hospital Rikshospitalet and
Insitute of Clinical Medicine University of Oslo, Oslo, Norway
Background and aim: The composition of a carotid plaque is thought to
be important for plaque vulnerability and stroke risk. The main aim of
this study was to assess the level of agreement between MRI assessment of
plaque components with cerebrovascular symptoms, carotid plaque ultra-
sound echogenicity and histological assessments of plaques removed at
endarterectomy.
Methods: Thirty-four consecutive patients with ≥70% carotid stenosis
scheduled for carotid endarterectomy underwent a clinical neurological
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examination, Colour Duplex ultrasound, 3T MRI with an 8 channel
carotid coil and blood tests. All examinations were performed less than 24
hours prior to surgery. Plaques were assessed histologically following
endarterectomy. Plaques were defined as symptomatic when associated
with ipsilateral cerebral ischemic symptoms within 30 days prior to inclu-
sion. The level of agreement between the size of the lipid-rich necrotic
core (LRNC) and calcification on MRI to the histological estimation of
the same tissue components, plaque echolucency and symptoms was
assessed.
Results: In this study we found an inverse correlation between time from
last symptom and the size of LRNC on MRI. The size of the LRNC
increased as the interval (days) from the last symptom got shorter
(p = 0.013). The LRNC size on MRI was correlated to the percentage of
lipid on histological assessment (p = 0.001) and to the echogenicity on
ultrasound (p = 0.004).
Conclusion: Shorter time intervals from last symptom correlated to
prevalence of a larger lipid-rich necrotic core on MRI supporting a role for
MRI in the assessment of carotid plaque instability and stroke risk.
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15. Risk Factors for Stroke/Prognosis
Molecular and clinical markers for personalized
diagnostics of atherothrombotic stroke
L N Soloveva1, A A Shmonin1, Y V Emanuel2, E A Bondareva1,
N M Lazareva2, A V Mazing2, S V Lapin2, V L Emanuel2,
E V Melnikova1
1Department of Neurology and Neurosurgery, First
Saint-Petersburg Pavlov State Medical University,
Saint-Petersburg, Russia
2Department of Laboratory Diagnostics, First Saint-Petersburg
Pavlov State Medical University, Saint-Petersburg, Russia
Background: Nowadays there are no established criteria of advanced ath-
erosclerosis. Our study aimed to investigate molecular and clinical
markers in patients with atherosclerotic carotid artery stenosis (ACAS) in
the ischemic stroke acute phase to influence treatment decisions in these
patients with high stroke risk.
Methods: Thirty patients in the acute phase of atherothrombotic stroke or
TIAs with 50–99% ACAS comprised group 1. 51 patients with ACAS
without history of vascular events during one month before enrollment
were included for group 2, including symptomatic and asymptomatic
subgroups according to history of previous vascular events. 16 healthy
volunteers comprised the control group. All participants were aged
between 50–80 years and didn’t have any non-atherothrombotic stroke
risk factors (atrial fibrillation). Examination of patients included history
taking, duplex ultrasound, biomarkers serum level measurement
(Erythropoietin(EPO), CiliaryNeurotrophicFactor(CNTF), Brain-
derivedNeurotrophicFactor(BDNF), Insulin-likeGrowthFactor(IGF) 1
and 2, Insulin-likeGrowthFactorBindingProtein-3(IGFBP-3), Glial-
FibrillaryAcidicProtein(GFAP), PhosphorylatedAxonalNeurofilament
(PNF-H), Lipoprotein-associatedPhospholipaseA2(LP-PL-A2),
Pregnancy-associatedPlasmaProteinA(PAPP-A), AsymmetricDimethyl-
arginine(ADMA), highsensitivityC-reactiveProtein(hsCRP) and blood
lipid profile). Differences between groups were accessed by Mann-
Whitney, Kruskal-Wallis tests and Data Mining.
Results: ADMA and hsCRP levels were significantly higher in acute stroke
phase compared with other groups. IGF-1 and IGFBP-3 levels in symp-
tomatic ACAS subgroup were significantly smaller than in control and
asymptomatic ACAS subgroups. Other biomarkers didn’t show any sig-
nificant differences between groups. Data Mining has found that neither
stenosis degree nor a vascular events history were associated with stroke.
Conclusion: ADMA and hsCRP serum levels increase during the acute
phase of atherothrombotic stroke. Low IGF-1 and IGFBP-3 levels in ACAS
patients might be expected to indicate an additional stoke risk.
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Is elevated mean platelet volume associated with
large artery atherosclerosis in acute ischemic stroke
patients?
V Yilmaz1, S Rızayev1, Y Baykara1, M K Altınok1, M Kuzu1,
C Ulukan1, S Tezcan1, H Cotur1, I S Gul1, A Rawandi1,
M H Sorgun1, C Togay Isıkay1
1Neurology, Ankara Univesity Medical School, Ankara, Turkey
Introduction: Platelets are involved in atherosclerosis. Previous studies
suggested that mean platelet volume (MPV) could be a marker of platelet
activation in stoke patients. The aim of this study was to investigate if
there was a correlation between MPV levels and large artery atheroscle-
rosis (LAA) with acute ischemic stroke.
Methods: We reviewed the charts of 554 patients who were admitted with
acute ischemic stroke between the dates January 2011 and August 2014.
LAA was defined as any large artery stenosis > 50% on cerebrovascular
imaging. The demographic data, NIHSS scores, platelet counts, MPV at
admission and mRS scores in follow-up period were recorded. We deter-
mined etiologic stroke subtypes using the automated Causative Classifi-
cation System (CCS).
Results: A total of 162 (29.2%) patients with LAA (106 males [65.4%] and
56 females [34.6%]; mean age, 68.41 ± 12.37 (38–98) years) were included
in the study. Male was more prevelant in LAA (p < 0.001). The mean
NIHSS score was 5.49 ± 4.22 (0–26) at admission. The etiologic stroke
subtypes was LAA (n = 140, 86.4%) and undetermined-unclassified
(n = 22, 13.6%). The median mRS was 2 (0–6) in follow up period and it
was significantly lower than other (p < 0.001). The mean platelet account
was 241.9 ± 76.0 (93–466) and the MPV was 8.85 ± 1.08 (7–12). There
were not any significant difference for platelet account and MPV between
LAA and others. Recurrent stroke was higher in LAA group, but not
significantly (p = 0.6).
Conclusion: In the present study, we did not find a significant association
between MPV and LAA with acute ischemic stroke.
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Smoking cessation and quality of life 6 years after
stroke
R Suñer-Soler1, J Serena2, Y Silva2, M Terceno2, A Grau1,
M E Gras1, S Font-Mayolas1, J M Sanchez3
1University of Girona, Quality of Life Research Institute,
Girona, Spain
2Neurology Department, Joseph Trueta Hospital, Girona,
Spain
3University of Girona, Chemistry Department, Girona, Spain
Background: Tobacco is a stroke risk factor that diminishes on stopping
smoking after stroke. Nevertheless, more than half of patients continue
smoking after suffering a stroke. Stopping smoking is associated with
better perceived health.
Objective: To reveal the perception of health in a cohort of smokers
depending on whether they had given up smoking 6 years after suffering
a stroke.
Methodology: A longitudinal observational study of a cohort of smokers
diagnosed with stroke between 2005 and 2007 who were followed for 6
years. Sociodemographic variables, stroke characteristics, tobacco cessa-
tion and quality of life (EuroQol-5D scale) were studied. Bivariate statis-
tical analysis was performed using the Chi-squared test and the Mann-
Whitney U test.
Results: The cohort consisted of 88 people, 84.1% men, average age 60.9
(SD 10.9), median NIH scale 0 (0–1), median Rankin scale 0 (0–2),
median Barthel Index 100 (100–100). Six years after stroke, 33 subjects
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(37.5%) had given up smoking, 41.9% of the men and 14.3% of the
women (p = 0.05). No differences were observed with respect to age,
neurological scales and functions depending on tobacco cessation.
Patients who stopped smoking had a better perception of health (median
80 (60–85)) than active smokers (median 62.5 (50–80)) (p = 0.021). No
differences were found between the two groups with regards to mobility
problems, self-care, daily living activities, the presence of pain and of
anxiety or depression (p > 0.05).
Conclusions: Patients who did not stop smoking had a worse perception
of health than those who did manage to give up after suffering from
stroke.
ESOC-0347
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Coexistent large-artery disease can not aggravate
dynamic cerebral autoregulation impairment in
patients with small-vessel disease
G Tian1, X Y Chen1, J Liu2, W Wang3, L J Wang4, W H Lin1,
L Xiong1, W H Leung1, C T Mok1, K S Wong1
1Medicine & Therapeutics, Chinese University of Hong Kong,
Shatin, Hong Kong China
2Integration, Shenzhen Institutes of Advanced Technology
Chinese Academy of Sciences, Shenzhen, China
3Neurology, Nanfang Hospital, Guangzhou, China
4Neurology, the First Norman Bethune Hospital of Jilin
University, Changchun, China
Background: Cerebral autoregulation may become impaired after stroke.
However, the underlying mechanisms of how these cerebrovascular dis-
eases affect dCA still be controversy. And it might be different among
different subtypes of stroke. In this study, we aim to explore the difference
pattern of dCA among large-artery disease (LAD), small-vessel disease
(SVD) and small-vessel disease accompanied by large-artery disease using
transfer function analysis (TFA).
Methods: Consecutive ischemic stroke patients within 7 days of symptom
onset were enrolled. Non-invasive continuous cerebral blood flow velocity
and arterial blood pressure were recorded simultaneously from each
subject. TFA was applied to derive autoregulatory parameters, gain, phase
difference (PD).
Results: Forty-one patients and 12 nonstroke controls were enrolled. In
patients with LAD, PD in affected hemisphere was 22.00 ± 34.93, which is
significantly lower than the unaffected hemisphere (41.00 ± 34.52,
P < 0.05), and the control (66.75 ± 30.20, P < 0.05). However, PD is
similar in the unaffected hemisphere and control (P > 0.05). In the SVD,
no difference of PD between two hemisphere (27.67 ± 36.31 vs
27.62 ± 39.31, P > 0.5), and both sides were significantly lower than the
control (all P < 0.05). In patients with coexistent LAD and SVD, no dif-
ference between two hemisphere (P > 0.05). And both sides were signifi-
cantly lower than the control (all P < 0.05). PD of affected side is
significantly lower in the group which pulsatility index is larger than 1.20
(10.56 ± 42.29, P < 0.05).
Conclusion: The impairment of dCA is different among subtypes of
stroke. And patients with large artery disease can not aggravate dCA
impairment in patients coexistent with small-vessel disease.
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15. Risk Factors for Stroke/Prognosis
Clinical features of patients with multiple transient
ischemic attacks: The PROMISE-TIA registry
N Tokuda1, T Uehara1, T Ohara1, S Sato1, M Hayakawa1, R Suzuki1,
K Toyoda1, K Minematsu1
1Cerebrovascular Medicine, National Cerebral and
Cardiovascular Center, Suita, Japan
Purpose: In a subanalysis of the PROspective Multicenter registry to iden-
tify Subsequent cardiovascular Events after TIA (PROMISE-TIA registry),
we clarified the features of patients with multiple transient ischemic
attacks (TIAs).
Methods: The study subjects were 1353 patients (873 men, 69.5 ± 12.4
years) within 7 days of TIA onset between June 2011 and December 2013
from a prospective register in 58 hospitals. The subjects were classified
into two groups; the multiple TIA (mTIA) and single TIA (sTIA) group
based on the presence or absence of TIA within 90 days before index TIA.
Results: Out of 1353 patients, 318 patients (23.5%) were included in the
mTIA group. In regard to characteristics of multiple TIAs in the mTIA
group, 228 patients (71.7%) had same symptoms, 195 patients (61.7%)
had same severity and 191 patients (60.3%) had same durations of symp-
toms. As compared to sTIA patients, mTIA patients were younger (66 ± 13
years vs. 71 ± 12 years, p < 0.001), and more frequently had extracranial
stenosis (19.7% vs. 14.5%, p = 0.037) and intracranial stenosis (42.8% vs.
29.7%, p < 0.001), and less frequently had atrial fibrillation (7.9%
vs. 18.9%, p < 0.001) and index TIA of duration ≥60 minutes (22.6% vs.
44.4%, p < 0.001). There was no difference in incidence of subsequent
ischemic stroke within 90 days after index TIA between the mTIA and
sTIA group (7.3% vs 5.0%, p = 0.138, log-rank).
Conclusions: One-fourth of TIA patients presented multiple TIAs. As
compared to sTIA patients, mTIA patients were younger, more likely to
have stenotic lesions in cervicocephalic arteries and less likely to have
atrial fibrillation.
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Incidence and predictors of subsequent ischemic
stroke after transient ischemic attack by 1-year
follow-up data of a multicenter prospective study
K Minematsu1, T Uehara1, T Ohara1, M Hayakawa1, S Sato1,
R Suzuki1, K Toyoda1
1Cerebrovascular Medicine, National Cerebral and
Cardiovascular Center, Suita Osaka, Japan
Background and purpose: Data were scare on the incidence and predictors
of ischemic stroke for 1 year after transient ischemic attack (TIA) onset.
The present study was carried out to clarify them by using data of a
prospective multicenter registration.
Methods: The study subjects were TIA patients within 7 days of TIA onset
from a prospective register in 57 hospitals. The primary endpoint was
ischemic stroke after registration.
Results: Of consecutive 1353 patients, 1158 (86%) patients (747 men,
69.4 ± 12.2 years) were followed for 1 year after TIA onset. Ninety-eight
patients (8.5%) had ischemic strokes during the follow-up, although the
90-day risk was 6.3%. The 1-year risk of ischemic stroke increased signifi-
cantly with the increase in ABCD2 score (p = 0.005); being 5.8% in 0–3
points of ABCD2 score, 7.6% in 4–5 points, and 12.9% in 6–7 points. Cox
hazard model showed that men (HR: 1.62; 95%CI: 1.05–2.59, p = 0.016),
hemiparesis (HR: 1.83; 95%CI: 1.11–3.20, p = 0.044), and systolic blood
pressure at presentation (HR: 1.10; 95%CI: 1.02–1.19, per 10 mmHg,
p = 0.014) were independently associated with the primary endpoint
events. The leading subtype of ischemic strokes after the 90 days of TIA
onset was cardioembolic stroke (36%) followed by atherothrombotic
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brain infarction (ATBI) attributable to intracranial artery disease (IAD)
(28%), whereas that within the 90 days was small-vessel disease (44%)
followed by ATBI attributable to IAD (21%).
Conclusions: We clarified the incidence and predictors, and etiology of
ischemic stroke for 1 year after TIA onset.
ESOC-1410
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Is urea : creatinine ratio a predictor of outcome in
ischaemic stroke?
L Van der Poel1, D Day1, E O’Brien1, N Hannon1
1Stroke Unit, Addenbrookes Hospital, Cambridge, United
Kingdom
Background: Dehydration during admission is common in stroke
patients. It is associated with an increased risk of venous thromboembo-
lism and poor outcomes on discharge. It can be detected biochemically by
calculating the urea:creatinine ratio (UCR).
Aim: We hypothesise that dehydration on admission is a factor in deter-
mining post-stroke mortality and functional outcome.
Methods: A retrospective chart review was performed using a random
sample of patients, where blood results were available, admitted with
ischaemic stroke between September 2012 and August 2014. Dehydration
was defined as UCR > 80.
Results: Of 289 patients (54.5% males), 34 (11.7%) died. Median age was
75.9 years, 33.5% were aged 85 or older. 160 (55.2%) were discharged
home and 67 (23.1%) were transferred to inpatient rehabilitation facili-
ties. Older age did not associate with discharge destination or mortality. In
patients with a UCR > 80 the median age was 82, versus 78 years with a
UCR < 80 (p < 0.001). 55.7% of patients aged ≥85 had a UCR > 80
(p = 0.002). Of the 34 that died, 23.5% had UCR of >80. Patients dis-
charged to further inpatient rehabilitation (n = 67) had a mean UCR 83.6
compared to 71.4 in patients discharged home (p = 0.006).
Conclusion: In this population of stroke patients, admission bloods indi-
cating dehydrated state were associated with longer inpatient stays. Older
patients (≥85) did not experience higher mortality or worse functional
outcome despite having higher UCR.
Dehydration was a factor in predicting discharge destination after stroke
and further exploration of the predictive value of UCR in patients of all
age groups is needed.
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Prognostic significance of a clinical diagnosis of stroke
or TIA in patients with acute neurological symptoms:
Long-term follow up of ∼6,000 patients
W N Whiteley1, C Graham2, D Bailey3, S Hart4,
P A G Sandercock1, C Sudlow1, F Doubal1, J Wardlaw1, M Dennis1
1Centre for Clinical Brain Sciences, University of Edinburgh,
Edinburgh, United Kingdom
2Wellcome Trust Clinical Research Facility, University of
Edinburgh, Edinburgh, United Kingdom
3Information Services Division, NHS National Services
Scotland, Edinburgh, United Kingdom
4Medicine of the Elderly Department, NHS Lothian,
Edinburgh, United Kingdom
Background: The ability of the clinical diagnosis of TIA or minor stroke to
stratify patients with neurological symptoms into high and low risk of
future ischaemic stroke or MI is unclear in routine practice, and confi-
dence may be wavering.
Methods: We recorded diagnoses made prior to investigation in patients
with suspected TIA or minor stroke presenting to a rapid access clinic. We
used three overlapping sources to ascertain subsequent ischaemic stroke
or MI. We estimated the ability of clinical diagnosis to identify patients at
high and low risk with hazard ratios.
Results: Between 2004 and 2013, we saw 5,997 patients. From 0–90 days
after symptoms, patients with a clinical diagnosis of TIA or minor stroke
had three times the hazard of stroke or MI relative to patients with a
diagnosis of mimic (HR 2.83 95%CI: 2.13–3.76); from 90 days to 8 years,
this hazard ratio declined (1.52,1.25–1.86). There was no evidence that
this hazard ratio varied with clinician, the patient’s gender, presenting
symptom, or atrial fibrillation, though the hazard ratio from 90 days to 8
years was greater in patients who were younger, and less in patients with a
history of previous MI or stroke.
Conclusions: The clinical diagnosis of stroke or TIA in patients presenting
with minor or transient neurological symptoms identified high and low
risk of recurrent vascular events up to 90 days, though was less discrimi-
nating in the longer term. The clinical diagnosis, even without advanced
technology, is an effective means of identifying patients at risk of MI or
stroke.
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Migraine prevalence in patients with unruptured
intracranial aneurysms: A case control study
E Witvoet1, N Pelzer1, G M Terwindt1, G J E Rinkel2, M H M Vlak3,
M J H Wermer1
1Neurology, Leiden University Medical Center, Leiden,
Netherlands
2Neurology and Neurosurgery, Brain Center Rudolf Magnus
University Medical Center Utrecht, Utrecht, Netherlands
3Neurology, Slotervaart Hospital, Amsterdam, Netherlands
Background and purpose: Migraine is a suggested risk factor for aneurys-
mal subarachnoid hemorrhage (aSAH). An increased risk of aSAH in
migraineurs may be explained by an increased rupture risk or an increased
prevalence of unruptured intracranial aneurysms (UIA). We performed a
case-control study to compare lifetime migraine prevalence in patients
with UIA, patients with a history of TIA or stroke and controls.
Methods: Patients with UIA were recruited from two university hospitals.
Data on patients with TIA/stroke were retrieved from a previous study.
Partners of patients with UIA or TIA/stroke were included as controls.
Migraine history was assessed via a telephone interview based on the
ICHD 3 beta criteria. We calculated odds ratios (OR) for migraine with
univariable and multivariable logistic regression analyses, adjusted for
age, sex, hypertension and smoking.
Results: We included 172 patients with UIA, 221 patients with TIA or
stroke and 164 controls. In UIA patients, migraine prevalence was 24.4%
compared with 14.6% in controls (UIA versus controls; OR 1.9; 95% CI
1.1–3.5) and 22.2% in TIA/stroke patients (UIA versus TIA/stroke; OR
1.1; 95% CI 0.7–1.8). After adjustments, the OR for migraine in UIA
patients versus controls was 1.7 (95% CI 1.0–3.1) and 0.9 (95%CI 0.5–1.0)
versus TIA/stroke. Results were comparable for migraine with and
without aura.
Conclusions: Migraine prevalence seems to be increased in patients with
UIA compared with controls and comparable with the prevalence in
patients with TIA or stroke. Further studies are needed to confirm our
findings and to investigate the underlying pathophysiology
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Essential thrombocytosis and ischemic stroke
M Xifaras1, E Poulimenou1, A Pasioti1, A Kostourou2,
K Kontokostas1, E Kerezoudi1
1Neurology, Pammakaristos Hospital, Athens, Greece
2Hematology, Pammakaristos Hospital, Athens, Greece
Essential thrombocytosis is a rare myeloproliferative disorder of unknown
etiology, which is characterized by hyperplasia of the bone marrow mega-
karyocytes. Their excessive proliferation leads to increased platelet counts.
Its incidence is approximately 2–3 cases/100,000/year and mainly affects
adults 50–60 years old. The most common symptoms accompanying
essential thrombocytosis are thrombotic (usually from the CNS) or hem-
orrhagic events.
In the report two patient cases are described; both are male, aged 49 and
65, with no cardiovascular disease history. They were admitted to our
department with left-sided hemiparesis due to recent ischemic infarcts, in
the lower part of the left segment of the medulla and in the right tempo-
roparietal area, respectively. Increased platelet counts were observed
(>450,000 for the 49-years-old and >600,000 for the 65-years-old) and
both were diagnosed with splenomegaly. Bone marrow tissue was col-
lected via biopsy from both patients. Examination of the tissue taken from
the 49-years-old showed large megakaryocytes with multilobular nuclei.
Histological study of both samples revealed the occurrence of primary
myelofibrosis. Both were heterozygous for the JAK2 V617F mutation.
None of the other tests conducted (brain MRA, carotid ultrasound etc.)
yielded abnormal results.
Essential thrombocytosis is a rare hematological disorder often associated
with manifestations of the CNS, such as signs and symptoms of headache,
TIA, transient amaurosis, stroke etc. The systematic and thorough inves-
tigation of the causes of ischemic stroke among middle-aged adults, with
no risk factors for cardiovascular events, can reveal diseases which signifi-
cantly affect the welfare of the patients, but are amenable to continuous
treating.
ESOC-0427
15. Risk Factors for Stroke/Prognosis
Autonomic dysfunction as measured by Ewing’s
battery test predicts poor outcome after acute
ischemic stroke
L Xiong1, G Tian1, H Leung1, X Chen1, T Leung1, Y Soo1,
K S Wong1
1Medicine & Therapeutics, The Chinese University of Hong
Kong, Shatin N.T., Hong Kong China
Background and objectives: Central autonomic dysfunction is frequent in
ischemic stroke. Its presence increases the risk of mortality after stroke. We
aimed to investigate whether the severity of autonomic dysfunction as
classified by Ewing’s battery test can predict poor outcome after acute
ischemic stroke.
Methods and patients: Consecutive ischemic stroke patients within 7 days
of symptom onset were enrolled. Autonomic function was assessed by
Ewing’s battery tests. We dichotomized the severity of autonomic dys-
function into two groups: severe (definite, severe or atypical) and minor
(normal or early). Modified Rankin Scale (mRS) (good outcome: mRS
0∼2; poor outcome: mRS 3∼6) was evaluated 3 months after index stroke.
Results: Forty-nine patients were recruited (mean age, 63.8 ± 10.7 years;
87.5% males). From Ewing’s battery of autonomic function tests, minor
autonomic dysfunction was identified in 14 patients (28.6%) and severe
autonomic dysfunction was identified in 35 patients (71.4%), respectively.
There were no significant differences in baseline characteristics and
current drugs use between the minor and severe autonomic dysfunction
groups (all P > 0.05). At month 3, a poor functional outcome was found in
37.1% of severe group patients compared to 7.1% in the minor group
(P = 0.042).
Conclusions: The severity of autonomic dysfunction as measured by
Ewing’s battery test predicts poor clinical functional outcome after acute
ischemic stroke.
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Which parameters of beat-to-beat blood pressure
variability predict clinical outcome after acute
ischemic stroke?
L Xiong1, G Tian1, X Chen1, H Leung1, T Leung1, Y Soo1,
K S Wong1
1Medicine & Therapeutics, The Chinese University of Hong
Kong, Shatin N.T., Hong Kong China
Background and objectives: Visit-to-visit and day-to-day variability in sys-
tolic blood pressure (SBP) are associated with an increased risk of stroke.
However, it is uncertain whether ultrashort-term BP recording assessing
BP variability (BPV) has a similar predictive role. We aimed to study
beat-to-beat measure of BPV in the acute phase of ischemic stroke to
determine whether any of them predicted clinical outcome.
Methods and patients: Consecutive ischemic stroke patients within 7 days
of symptom onset were enrolled. The frequency components of BPV by
means of power spectral analysis [very low frequency (VLF; <0.04 Hz);
low frequency (LF; 0.04–0.15 Hz); high frequency (HF; 0.15–0.40 Hz);
power spectral density (PSD; <0.40 Hz) and LF/HF ratio] were used as
parameters of BPV from 10-minute recordings of beat-to-beat BP on
admission. Outcome was assessed at 3 months after stroke onset as good
or poor by modified Rankin Scale (mRS) (good outcome, mRS ≤ 2).
Results: Seventy-five patients were recruited (mean age, 64.6 ± 9.9 years;
89.3% males). Univariate analysis showed that HF-SBP and PSD-SBP
were significantly higher in poor group compared with those in good
group [2.97 (1.35–6.59) vs 1.59 (0.92–2.62) mmHg2, P = 0.005; 20.69
(10.08–45.90) vs 13.61 (6.12–28.65) mmHg2, P = 0.045]. After adjusting
for confounding factors, multivariate logistic regression showed that only
HF-SBP (OR 1.338; 95% CI, 1.062–1.685; P = 0.013) was independently
correlated with poor functional outcome.
Conclusions: This study shows that ultrashort-term highly variable SBP
on admission in the acute stage of ischemic stroke may predict poor
functional outcome at 3 months after stroke onset.
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15. Risk Factors for Stroke/Prognosis
Management of antithrombotic agents during surgery
or other kind of medical procedures with bleeding
(MARK study)
M Yasaka1, Y Mima1, Y Wakugawa1, T Kuwashiro1, A Nakamura1,
Y Tsurusaki1, Y Okada1
1Cerebrovascular Medicine and Neurology, Kyushu Medical
Center, Fukuoka, Japan
Background: Management of antithrombotic agents during surgery has
not been etablished yet. We performed a prospective, multicenter, obser-
vational study regarding management of antithrombotic agents during
surgery or kinds of medical procedures with bleeding (MARK study).
Methods: We conducted the study at 58 National Hospital Organization
institutions in Japan and enrolled 9,992 patients (72.9 +- 9.7 years old,
men 68.8%), in whom medical procedure with bleeding was thereafter
conducted in 9,783. We analyzed for the 9,783 patients, the details of the
procedure, method of perioperative management of antithrombotic
agents, and occurrence of thrombosis, embolism, bleeding complications,
and death between two weeks before and four weeks after the procedure.
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Results: With respect to perioperative management of antithrombotic
agents, they were continued in 3,584 (36.6%, continuation group) and
discontinued in the other 6,199 (63.4%, discontinuation group). Throm-
boembolic events and death in the continuation group were more fre-
quently observed in the discontinuation group than in the continuation
group (17.9% vs. 6.5%, p < 0.01 and 0.81% vs. 0.42%, p < 0.05, respec-
tively). Hemorrhagic events were also more frequently recorded in the
discontinuation group than in the continuation group (5.65% vs. 1.70%,
p < 0.01). Heparin bridge was performed in 1,953 patients in the discon-
tinuation group, being related to hemorrhagic complication more than in
other 4,246 patients without (6.9% vs. 5.1%, p < 0.01).
Conclusion: It seems that discontinuation of antithrombotic agents is a
risk for thromboembolic events and death, that the discontinuation group
has higher risk of hemorrhagic complication than the continuation group,
and that heparin bridge is related to hemorrhagic events.
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15. Risk Factors for Stroke/Prognosis
Aspirin resistance in patients with ischemic stroke
A Bulut1, S Cagirici1, V Yayla1, M Cabalar1, S Senadim1,
A Bajrami1, F Azman1
1Neurology, Bakirkoy Dr Sadi Konuk Research & Training
Hospital, Istanbul, Turkey
Objectives: Ischemic stroke is one of the most common causes of disabil-
ity and death all over the world. Aspirin is the basic agent in antithrom-
botic treatment. However several patients do not respond to treatment
and due to these patients aspirin resistance term has been used recently.
Recent studies have shown that aspirin resistance incidence is between
3–85% among cerebrovascular disease patients. In this study, we aimed to
determine the frequency of aspirin resistance in cerebrovascular disease
patients and their relationship with demographic characteristics, risk
factors, and stroke types were evaluated.
Method: In a 6 months period, 163 (106M-57F; mean age: 64.51 ± 13.85
years) acute ischemic stroke patients followed-up in our clinics and
treated with aspirin (100 mg–300 mg daily) were evaluated. Aspirin resis-
tance was measured by a Multiplate® platelet analyser. Etiology of cere-
brovascular disease was determined according to the TOAST
classification. Correlation between aspirin resistance and age, sex, hyper-
tension, diabetes mellitus, hyperlipidemia, height, weight, fasting blood
glucose level, history of cerebrovascular disease, smoking and alcohol were
analyzed.
Results: Aspirin resistance was found in 25 (15,34%) of 163 patients. No
statistically significant relationship was observed between aspirin resis-
tance and any of the clinical parameters investigated.
Discussion: Since aspirin is an important agent in stroke, to predict
aspirin resistance will develop in which patients would help us. We could
not find any relationship with demographic findings or risk factors. The
wide range of aspirin resistance incidence makes us to think the personal
or genetic predisposing factors. This shows a need for further studies.
ESOC-1180
15. Risk Factors for Stroke/Prognosis
Evaluation of inflammatory markers (neutrophil to
lymphocyte ratio and other markers) in ischemic
cerebrovascular diseases
F Azman1, S Cagirici1, M Cabalar1, A Bajrami1, S Senadim1,
A Bulut1, V Yayla1
1Neurology, Bakirkoy Dr Sadi Konuk Research & Training
Hospital, Istanbul, Turkey
Objectives: Neutrophil lymphocyte ratio (NLR) is a marker of systemic
inflammation that can be easily measured. In this study, the relationship
between NLR to stroke subtypes, risk factors, other markers of inflamma-
tion and prognosis in patients with stroke or TIA was evaluated.
Material-methods: Data of 464 stroke or TIA patients, followed-up in
2013, were evaluated retrospectively. Patients (n = 172) with diseases that
might affect the values of NLR were excluded. Patients were classified in
three subgroups; hemorrhagic (HS), ischemic stroke (IS) and TIA. NLR,
leukocyte, neutrophil, lymphocyte, platelet count, mean platelet volume,
GGT, sedimentation rate, CRP values were compared between subgroups.
Results: The mean age of 292 patients (114F:178M) was 66.3 ± 13.3 years.
There was no significant differences of lymphocytes, platelets, MPV, CRP,
sedimentation rate, GGT levels between subgroups, in the HS subgroup
the mean leukocyte, neutrophil counts and NLR was significantly high
(p = 0.001, p = 0.006). There were significant differences of mean NLR
between HS subgroup and IS and TIA subgroups, respectively (p = 0.038,
p = 0.005), but not between IS and TIA subgroups (p = 0.180).
Conclusion: Many studies have shown increased leukocytes, neutrophil
and NLR values in stroke patients. In this study, NLR was significantly
higher in the HS subgroup. This might be an indicator of the inflamma-
tory response following the damaged cerebrovascular autoregulation sec-
ondary to bleeding. Another explanation might be related to the lack of a
control group and comparison of the values only between subgroups. Still
there is need for larger studies, to investigate the relationship between NLR
and other inflammatory markers in stroke.
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Effect of statin on symptomatic basilar artery disease
K S Yum1, S H Lee1, J H Jeong1, J Y Jang1, J H Kang2, J H Hong3,
B J Kim1, H J Bae1, M K Han1
1Neurology, Seoul National University Bundang Hospital,
Seongnam-si Gyeonggi-do, Korea
2Neurology, Samsung changwon hospital, Changwon, Korea
3Neurology, Stroke and Neurocritical care Dongsan Medical
Center Keimyung Universit, Daegu, Korea
Patients with symptomatic basilar artery stenosis are at risk for recurrence
of stroke. There are limited data on appropriate medical therapy to this.
We aimed to examine the influence of statin therapy on natural history of
basilar artery stenosis with acute ischemic stroke. We retrospectively
studied 153 patients with acute ischemic stroke with basilar artery stenosis
between April 1, 2003 and December 31, 2013. All patients were per-
formed MR angiography on first hospital day, and the day of clinical event
or 1 year later. The extent of stenosis of basilar artery was divided to
mild(signal reduction <50%) and severe stenosis(signal reduction >50%).
The clinical endpoint was recurrent ischemic stroke and other composite
vascular events. Mean follow-up time was 14.597 ± 5.825 months.
114(74.5%) patients were treated by statin after index stroke and
56(36.6%) patients were administrated high-dose statin. During the
follow-up period, there were 31(20.3%) ischemic strokes and 38(24.8%)
composite cardiovascular outcomes. Stroke recurrence(14.9% vs 35.9%)
and composite vascular event(18.4% vs 43.6%) were more common in
patients who were not administrated statin. The patients who took high-
dose statin were shown good mRS after 3 months. Stroke recur-
rence(10.7% vs 25.8%) and composite vascular events(14.3% vs 30.9%)
were lesser than who were not treated. Among the patients with admin-
istration of statin, 26(22.8%) were regressed and 8(7.0%) were progressed
while untreated patients were observed 6(15.4%) of regression and
11(28.2%) of progression. Our study suggests statin can improve progno-
sis and degree of stenosis in patients with symptomatic basilar artery
disease.
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The Norwegian Atrial Fibrillation and Stroke Study
(the NOR-FIB Study)
A Aamodt1, H Johansen1, B Ratajczak-Tretel2, D Atar3,
E C Sandset4, B Halvorsen5, H Næss6, P M Sandset7, O M Rønning8,
D Russell1
1Neurology, Oslo University Hospital Rikshospitalet, Oslo,
Norway
2Neurology, Østfold Hospital Trust, Fredrikstad, Norway
3Cardiology, Oslo University Hospital Ullevål, Oslo, Norway
4Neurology, Oslo University Hospital Ullevål, Oslo, Norway
5Institute of Clinical Medicine, University of Oslo, Oslo,
Norway
6Neurology, Haukeland University Hospital, Bergen, Norway
7the Center of Thrombosis and Hemostasis Research,
University of Oslo, Oslo, Norway
8Neurology, Akershus University Hospital, Lørenskog, Norway
Approximately 1 in 5 of all ischemic strokes with known etiology are
caused by atrial fibrillation (AF), which is also often suspected in crypto-
genic strokes. The clinical significance of very brief episodes of AF is,
however, uncertain.
Information regarding acute revascularization treatment in patients with
anticoagulation and secondary prevention with direct oral anticoagulants
is limited.
The NOR-FIB Study is an on-going trial, which involves six principal
fields of investigation:
(1) To assess sex differences and clinical risk factors in ischemic stroke
due to AF.
(2) Acute revascularization treatment and outcomes in patients with
ischemic stroke due to AF compared with findings in patients with isch-
emic stroke due to carotid atherosclerosis.
(3) Secondary stroke prevention with anticoagulation: safety, efficacy and
compliance
(4) Biomarkers, which can be used to assess stroke risk and etiology.
(5) Arrhythmia-detection in patients who present with cryptogenic
strokes.
(6) Assessment of the significance of very brief episodes of AF.
NOR-FIB is a prospective observational multi-center national study,
which is collecting data from patients admitted with cardioembolic stroke
due to AF, atherosclerotic or cryptogenic stroke. Estimated numbers of
enrollment are: 500 patients with AF related stroke and 500 patients with
cryptogenic stroke. The control group with atherosclerotic stroke is
already included in the NORSTROKE Study in ECRI – a large thematic
cerebrovascular study containing several multi-center studies.
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Pre-event CHA2DS2-VASc score and severity of acute
stroke in patients with atrial fibrillation: Findings from
the RAF study
M Acciarresi1, M Paciaroni1, G Agnelli1,
. on Behalf of RAF investigators2
1Stroke Unit and Division of Internal and Vascular Medicine,
University of Perugia, PERUGIA, Italy
2, Italy
Background: Current guidelines recommend CHA2DS2-VASc score to
assess the risk of stroke in patients with atrial fibrillation (AF). The asso-
ciation between pre-event CHA2DS2-VASc score and the severity of acute
stroke has never been defined.
Aim: We investigated the association between CHA2DS2-VASc score and
the severity of acute stroke in a prospective multicentre study which
enrolled consecutive patients with acute stroke and AF (RAF study).
Methods: Severity of stroke was evaluated on admission by the National
Institute of Health Stroke Scale (NIHSS) score, that was considered both
as a continuous and dichotomized variable (severe stroke = NIHSS > 10).
Correlations between severity of stroke and pre-event CHA2DS2-VASc
were evaluated using multiple logistic regression after adjustment for
other risk factors.
Results: Of the consecutive patients enrolled in the study, 598 patients had
an admission NIHSS score greater than 10 and 399 patients lower than 10.
The median NIHSS scores for CHA2DS2-VASc score of 0–8/9 were: 5.18,
8.30, 8.31, 8.86, 9.12, 9.67, 9.70, 10.30, 12.09, respectively. A linear corre-
lation was found between severity of stroke and CHA2DS2-VASc score (r2
0.010, p = 0.001). On multivariate analysis, CHA2DS2-VASc score corre-
lated with the severity of stroke (OR 1.084, p = 0.041, for each point
increase).
Conclusions: In patients with AF, CHA2DS2-VASc score is a predictor of
severity of stroke in addition to be a predictor of risk of stroke. This
observation increases the value of the assessment of CHA2DS2-VASc
score when considering the use of anticoagulant treatment.
ESOC-0895
16. AF & Cardioembolism
Occult atrial fibrillation detected by auto-triggered
loop recorder screening in a community-based
population
A Albilali1, A Shuaib1, T Jeerakathil1, B Buck1, K Butcher1,
S Gulamhusain1, M Abbasi2, P Kivi2, S Khera2
1Medicine Division of Neurology, University of Alberta
Hospital, Edmonton, Canada
2Family Medicine, University of Alberta Hospital, Edmonton,
Canada
Introduction: Atrial fibrillation is the most frequent source of cardiac
emboli in patients with ischemic stroke. The majority of atrial fibrillation
events are underdiagnosed, as it is often asymptomatic or intermittent
and, therefore, may not be detected on standard 12-lead ECG or even
24-hour ECG recording (Holter). We have evaluated the frequency of
atrial fibrillation (AF) by using an auto-triggered external loop recorder
(ELR) in a community-based population.
Methods: We enrolled 48 participants, 65 years of age or older, with no
history of AF (normal ECG), stroke or transient ischemic attack (TIA)
from 3 retirement facilities and 1 community clinics in Edmonton city.
The primary outcome was to detect any AF event (≥3 seconds) during the
monitoring period.
Results: The median ELR monitoring duration was 19 (IQR 15.5–20)
resulting in an AF detection rate of 27% (13/48), of which 77% (10/13)
were <30 seconds but >3 seconds, and the remaining 23%(3/13) were ≥30
seconds. Paroxysmal atrial tachycardia was detected in 50% (24/48) of
participants, of which 37.5% (9/24) occurred with the same participants
who have atrial fibrillation.
Conclusion: There is a high rate of occult atrial fibrillation (mostly <30
seconds) detected by auto-triggered external loop recorder in the com-
munity population. The use of external loop recorders to evaluate for AF
or PAT may be considered in patients at high risk for stroke.
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Left atrium enlargement predictive of paroxysmal
atrial fibrillation detected by continuous
electrocardiographic monitoring after acute ischemic
stroke
F Alemseged1, A Attanasio2, F Sallustio3, B Rizzato3, A Rocco1,
M Diomedi3, P Stanzione3
1Neurological Clinic Department of Systems Medicine,
University of Rome Tor Vergata, Rome, Italy
2Internal Medicine Department of Systems Medicine,
University of Rome Tor Vergata, Rome, Italy
3Stroke Unit Department of Systems Medicine, University of
Rome Tor Vergata, Rome, Italy
Introduction: Paroxysmal atrial fibrillation (PAF) is a common cause of
ischemic stroke, often undetected and challenging to diagnose. The aim of
this study was to investigate the relationship between left atrial size and
PAF, diagnosed using continuous stroke unit electrocardiographic moni-
toring (CEM), in patients with acute cerebral ischemia.
Material and methods: All transient ischemic attack and stroke consecu-
tive patients admitted in our stroke unit department without any history
of atrial fibrillation were considered. Patients with determined cause of
stroke as dissection or known cardioembolism were excluded. During
hospitalization patients underwent CEM and transthoracic echocardiog-
raphy. PAF was defined as an AF period of at least 30 seconds.
Results: Fifty-five out of 515 patients (10, 7%) had a new-onset PAF
during hospitalization. Median time of CEM duration was 6 days. Patients
with PAF during CEM were more likely female (p = 0.04), older (76, 2 vs.
63, 9 years; p < 0.05), presented a higher NIHSS score (12, 1 vs. 6, 9; p < 0,
05) and higher levels of CRP (p < 0, 05) at onset. An enlarged left atrium
at echocardiographic examination was found in 81, 8% of PAF patients
with respect to 26.1% of non PAF patients (p < 0.05).
Conclusions: In accordance with previous studies our data emphasize the
utility of morphological echocardiographic characteristics in stratifying
the risk of new-onset PAF in acute ischemic stroke patients. The identifi-
cation of risk markers for atrial fibrillation during hospitalization may
help to identify patients who may benefit from a prolonged ECG moni-
toring during and after hospitalization.
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Observation of cardiac rhythm in TIA patients:
Evaluation of prolonged rhythm monitoring in TIA
patients at a community based hospital
H W Versteeg1, N van Velzen- Oorsprong1, H Bienfait1
1Neurology, Gelre Hospitals, Apeldoorn, Netherlands
Background: Atrial fibrillation (AF) is considered as a strong risk factor in
the development of cerebral ischemia. Prolonged ECG monitoring may
lead to improved detection of paroxysmal AF. Therefore, since March 2013
TIA screening at a community based hospital in Apeldoorn, The Nether-
lands (160.000 inhabitants) has been extended from 9 to 24 hours of
observation. Objective of this analysis was to evaluate the effect of pro-
longed observation.
Methods: By means of nursing recordings of the TIA screening was deter-
mined how often AF de novo was caught on ECG/ monitor before and
after the introduction of the 24 hours registration period.
Results: From December 2010 until March 2013 277 patients with a defi-
nite TIA were screened. No AF de novo was seen during a 9 hours regis-
tration period.
From March 2013 up to December 2014 237 TIA patients were admitted
for 24 hours. In 3 patients AF de novo was discovered at admission. In
another 2 patients AF revealed itself on the monitor later on (0.84% of all
TIA patients). One patient was transferred to the cardiology ward because
of an unknown cardiac arrythmia on the monitor. No other types of
arrhythmia were detected. Possible impact on health care costs will be
discussed.
Conclusion: Prolonged rhythm observation has lead to an increased
detection of AF de novo, although to a small extend. A registration period
in a larger group of TIA but also minor stroke patients is required before
concrete statements concerning (cost) effectiveness can be made.
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Clinical practice with rivaroxaban in secondary stroke
prevention
A De Felipe Mimbrera1, M C Matute Lozano1,
A Alonso-Cánovas1, R Vera1, A Cruz Culebras1, J Masjuan1
1Neurology, Hospital Ramon y Cajal, Madrid, Spain
Background: Rivaroxaban has been approved for stroke prevention in
nonvalvular atrial fibrillation. Most data regarding efficacy and safety is
driven from clinical trials; information from clinical practice in secondary
stroke prevention is lacking.
Methods: We prospectively included patients starting rivaroxaban for sec-
ondary stroke prevention at our hospital from October 2012 to July 2014.
Clinical, efficacy, and safety variables were registered.
Results: Eighty-one patients were included, mean follow-up of 10 months
(range 1–24). Forty-one were female (50.6%), mean age 79.5 (range
54–96, SD 9.3), median CHADS2 4 (range 2–6), CHA2DS2-VASc 5 (range
3–8), and HAS-BLED 2 (range 1–4). Indication for rivaroxaban was isch-
emic stroke in 77 patients (45.5% anticoagulation naïve and 54.5% pre-
viously on warfarin), and intracranial hemorrhage (IH) due to warfarin in
4 (4.9%). Rivaroxaban 20 mg was prescribed in 56 cases (69.1%), and
15 mg in the remaining. Two patients received concomitant antiaggrega-
tion due to vascular disease. Seven patients (8.6%) suffered events during
follow-up. Ischemic events (4), one transient ischemic attack, and 3 isch-
emic strokes (1 disabling). Hemorrhagic events (3) lead to rivaroxaban
discontinuation in 1 patient, and were lower gastrointestinal bleeding (1),
and haematuria(2), none required blood transfusion. No IH were detected
during follow-up. All patients with history of IH remained uneventful.
Three patients died (pneumonia and sepsis in two cases) and 4 were lost
during follow-up.
Conclusions: In our cohort most ischemic events were non-disabling.
During follow-up there were no IH. Rivaroxaban was safe and efficacious
in an unselected cohort of old patients with high CHADS score.
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Are direct oral anticoagulants safe in patients with
previous intracranial hemorrhage?
A De Felipe Mimbrera1, M C Matute Lozano1,
A Alonso-Cánovas1, R Vera1, A Cruz Culebras1, J Masjuan1
1Neurology, Hospital Ramon y Cajal, Madrid, Spain
Background: Direct oral anticoagulants (DOACs) have demonstrated a
50% reduction in intracranial hemorrhage (IH) compared to warfarin in
patients with non valvular atrial fibrillation (NVAF) at high risk of stroke.
However, data regarding safety in patients with previous history of IH are
lacking as this type of patients were excluded from DOACs pivotal trials.
Methods: We prospectively included since 3/2010 to 9/2014, NVAF
patients (CHADS2 > 1) with a previous history of IH, in which treatment
with DOACs was initiated. Age, time of follow-up, CHADS2, CHA2DS2-
VASc, HAS-BLED, type of IH, embolic and hemorrhagic complications
were recorded during follow-up.
Results: Twenty-five patients were included, 13 (52%) had previous isch-
emic stroke. Eighteen were male (72%), mean age 77.9 (range 59–89, SD
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7.3), median CHADS2 4 (range 2–5), CHA2DS2-VASc 5 (range 3–7), and
HAS-BLED 3 (range 2–4). Fifteen (60%) received acenocumarol. IH was
classified as intracerebral hemorrhage (20), subarachnoid hemorrhage (3)
and subdural hematoma (2). Seventeen patients were treated with dab-
igatran, 4 with rivaroxaban and 4 with apixaban. Time from IH to DOACs
was >2 years in eight patients (32%), in the remaining median time was
2.5 months (range 0.23–9). Mean follow-up was 17.9 months (range
3–55). None were lost in follow-up. Only 2 patients suffered events, one
gastrointestinal hemorrhage which required transfusion and the other
suffered an intracerebral hemorrhage after 3 years of treatment, which
lead to death. No embolic events were recorded
Conclusions: DOACs seem safe in patients with NVAF at high risk of
stroke with a previous history of IH.
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Factors associated with paroxysmal atrial fibrillation
diagnosis in embolic stroke of undetermined source
with serial 24-hours holter monitoring
J Pérez-Lucas1, P Martínez-Sánchez1, B E Sanz-Cuesta1,
J Rodríguez-Pardo1, J Díaz de Terán1, I Illán-Gala1,
C Calle de Miguel1, E Alba-Suárez1, B Fuentes1, E Díez-Tejedor1
1NEUROLOGY, UNIVERSITY HOSPITAL LA PAZ, Madrid, Spain
Objective: To assess the utility serial 24-hours ECG Holter Monitoring
(24 h-HM) for the diagnosis of paroxysmal atrial fibrillation (PAF) in
patients with an embolic stroke/transient ischemic attack of undeter-
mined source (ESUS).
Methods: Observational study of patients with ESUS admitted at a Stroke
Center (2009–2013). A first 24 h-HM was performed in all cases and, if it
was negative, a second or even a third HM was performed. Variables
analysed: demographic data, vascular risk factors (VRF), clinical data,
presence of carotid plaques by duplex ultrasound, left atrial enlargement
by echocardiography. Multivariate models were preformed to identify
those factors associated with the PAF detection.
Results: Overall 507 patients were diagnosed with an ESUS, mean age
70.28 years old (SD 12.8), 58% of them male. The 24 h-HM results are
shown in Figure 1. Multivariate analysis showed that, for the first 24hHM,
older age (OR 1.033, CI 95% 1.013–1,054) and left atrial enlargement (OR
2.012; CI 95% 1.289–3.143) were the factors associated to the presence of
PAF. For the second and third 24hHM, the multivariate analysis showed
that left atrial enlargement (OR 13.333; CI 95% 1.539–115.548) was the
only factor related to the PAF diagnosis.
Conclusions: Serial 24hHM detect PAF in more than 25% of patients with
ESUS. Age and left atrial enlargement are the factors more strongly asso-
ciated with the PAF diagnosis.
Fig. 1 PAF diagnosis by serial 24 h holter monitoring.
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Proposal of a score to predict paroxysmal atrial
fibrillation in patients with ischemic stroke based on
clinical and echocardiographic findings
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Objective: To identify clinical and echocardiographic conditions associ-
ated to atrial fibrillation (AF) in patients with ischemic stroke (IS) and to
develop a score to predict the diagnosis of paroxysmal atrial fibrillation
(PAF) in these patients.
Methods: Retrospective observational cohort study of IS patients admit-
ted to a Stroke Unit between 2010 and 2014, selecting patients with cere-
bral infarction and without previously known AF. An urgent ECG, first
24–48 h ECG monitoring was performed in all patients, and additional
24 h Holter ECG in selected patients. An echocardiogram was performed
in all patients, including left atrial area or diameter, and measures for left
atrial filling pressure. Demographic data, vascular risk factors, clinical
variables and PAF diagnosis were recorded for analysis. Multivariate
models were built to evaluate the impact of these parameters on the
presence of PAF.
Results: Three hundred thirty patients were included in the study. 58,5%
men, mean age (SD) 67,7 (14,6) years. 132 Holter-ECG were performed.
77 (23%) patients were diagnosed with AF, 31 (28%) of them by Holter.
Age ≥75 years, severe stroke, left atrial dilation, and elevated left atrial
filling pressure were independently associated with underlying PAF. PAF
risk scale scores for these factors were built, showing high sensibility
(92%) and negative predictive value (94%) for diagnosis of PAF in pres-
ence of any these factors.
Conclusions: A PAF risk score based on age, stroke severity, left atrial
filling pressure and left atrial dilation has high sensitivity and negative
predictive value. Future studies are needed to demonstrate its external
validity.
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Extended automatic analysis of continuous ECG
monitoring (ACEM) substantially improves the
identification of patients with newly diagnosed atrial
fibrillation during hospitalization for acute ischemic
stroke
C Garcia Esperon1, T Betz1, M Steiner2, D Zumstein2,
A G Vuilliomenet2, K Nedeltchev1, T Kahles1
1Neurology, Kantonsspital Aarau, Aarau, Switzerland
2Cardiology, Kantonsspital Aarau, Aarau, Switzerland
Background and purpose: Atrial fibrillation accounts for approximately
20% of all ischemic strokes. Anticoagulation is highly effective in stroke
prevention in these patients. However, early detection of AF after stroke
remains challenging. Recent observational studies and RCTs promote pro-
longed ECG-monitoring for the detection of AF. The present study aimed
at estimating the role of extended automatic analysis of continuous ECG
monitoring (aCEM) for detecting AF already during hospitalization.
Methods: Six hundred and eighty consecutive patients with ischemic
stroke or TIA admitted to our Stroke Center in 2014 were included in this
analysis. Generally, they received an ECG on admission, followed by stan-
dard continuous ECG monitoring (CEM) during their stay on our stroke
unit (SU), and finally portable aCEM (Apoplex medical, SRAclinic) on the
early rehabilitation unit. Out of these 680 patients, 105 did not undergo
CEM but received portable aCEM directly.
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Results: A total of 151 patients were discharged with the diagnosis of AF,
which was already known on admission in 97 (64%) and newly diagnosed
in 54 (36%). From the latter group, ECG on admission identified 27 with
AF (18% from total of 151), CEM 14 (9%) and portable aCEM detected
an additional 11 patiens (7%). One patient with implanted ECG-recorder
showed AF-episodes at read-out and another patient fainted during hos-
pitalization and demonstrated AF on the concomittantly written ECG.
Conclusions: Portable aCEM considerably contributed to identifying
stroke patients with paroxysmal AF, most likely due to an extended moni-
toring period. It might serve to reduce stroke recurrence by optimizing
secondary stroke prevention.
ESOC-0832
16. AF & Cardioembolism
Predictive value of copeptin after atrial
fibrillation-related TIA or stroke: population-based
study
S Greisenegger1, H Segal1, A Burgess1, D Poole1, Z Mehta1,
P M Rothwell1
1Nuffield Department of Clinical Neurosciences, University of
Oxford, Oxford, United Kingdom
Background: Despite proven effectiveness of Warfarin in secondary pre-
vention after TIA/ischemic stroke with atrial fibrillation, many patients
are untreated. Copeptin, the c-terminal-portion of pro-vasopressin, is a
useful prognostic marker in patients after myocardial infarction and heart
failure and might enable better risk prediction after TIA/stroke. We ana-
lysed the predictive value of Copeptin in relation to warfarin treatment.
Methods: We measured Copeptin-levels in consecutive patients with
AF-related TIA/stroke in a population-based study (Oxford Vascular
Study) recruited from 2002–7 and followed-up to 2014. A raised
Copeptin-level was defined as above the 90th percentile of levels measured
in 401 age-and sex-matched controls. Associations with risk of recurrent
vascular events (stroke, myocardial infarction, systemic embolism and
vascular death) on follow-up were determined by Kaplan-Meier curves
and by Cox regression stratified according to Warfarin treatment.
Results: During about 1300 patient-years follow-up in 365 patients with
cardioembolic TIA/stroke there were 155 recurrent vascular events. In
those not treated with Warfarin, risk of recurrent vascular events at one
year was 42% (95%CI 34–51) for those with high Copeptin levels
(n = 132) and 14% (9–22;n = 107) for those with normal levels. In
Warfarin-treated patients, these risks were 10% (6–16;n = 60) and 6%
(2–15;n = 66) respectively. After age/sex adjustment, the relative predictive
value of high Copeptin for long-term risk of vascular events was similar
for patients on Warfarin (HR = 2.64, 1.40–4.96, p = 0.003) and without
Warfarin (2.84, 1.85–4.37, p < 0.0001).
Conclusions: A raised Copeptin level predicts risk of vascular events in
patients with AF-related TIA/stroke and might be useful for patient coun-
seling about oral anticoagulation.
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16. AF & Cardioembolism
Predictive features for detection of embolic arrhytmia
by holter-ecg 24 h monitoring after acute ischemic
stroke or transient ischemic attack
B Gutierrez Ruano1, F Diaz Otero1, N Bravo Quelle1,
A García Pastor1, P Vázquez Alen1, P Sobrino García1,
A García Arratibel1, G Vicente Peracho1, Y Fernández Bullido1,
J A Villanueva Osorio1, M P Martín Torres1, A C Gil Núñez1
1Neurology Service Hospital Gregorio Marañon, Stroke Unit,
Madrid, Spain
Objectives: Atrial fibrillation (AF) is the major cause of brain ischemic
events. Our objective is to identify the patient’s features associated with
higher probability of targetting embolic arrhythmia (EA) by Holter-ECG
24 h monitoring.
Patients and methods: Retrospective study over a prospective database of
patients submitted in our Stroke Unit during the period January 1st
2011–June 30th 2012. We monitored patients with cryptogenic stroke or
under the neurologist in charge criteria. We considered two groups of
patients, those with AF or Flutter detected during Holter-ECG 24 h moni-
toring – embolic arryhtmia (EA) – and non embolic arryhtmia (NEA)
patients.
Results: We included 581 patients with acute ischemic stroke (IS) and 197
with transient ischemic attack (TIA). 247 patients (31.7%) were moni-
tored by Holter-ECG 24 h. EA was detected in 28 patients (11.3%): 23 AF,
2 Flutter and 3 patients with both. Statistical differences were found
between the two groups for age (EA 79.04 +/- 6.32, NEA 71.04 +/- 13.1,
p = 0.001), hypertension (EA 82.1%, NEA 59.4%, p = 0.022) and left atrial
dilatation (LAD) (EA 64.3%, NEA 32.4%, p = 0.001). No differences were
found for previous history of stroke (EA 7.1%, NEA 21%, p = 0.125). The
multivariate study showed that age (OR 1.068, CI 95% 1.007–1.133),
hypertension (OR 3.183, CI 95% 1.101–9.201) and LAD (OR 2.639, CI
95% 1.093–6.372) were independent predictors of EA.
Conclusions: Our detection rate is slightly higher than previously
described. Age, hypertension and LAD are associated with higher
probability of targetting EA by Holter-ECG 24 h monitoring. Further
studies are needed to improve the diagnostic yield of Holter-ECG 24 h
monitoring.
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Prevalence of renal dysfunction and chronic kidney
disease in ischaemic stroke and TIA:
A population-based study
D Hayden1, C McCarthy1, N Hannon2, E Callally1, D Ni Chroinin1,
O Sheehan3, M Marnane4, G Horgan5, E Fallon5, L Kyne6,
J Duggan6, K O’Rourke1, E Dolan7, D Williams8, Y O’Meara9,
S Murphy1, P J Kelly1
1Stroke, Mater Hospital, Dublin, Ireland
2Stroke, Addenbrooke’s Hospital, Cambridge, United
Kingdom
3Stroke, Johns Hopkins University, Baltimore, USA
4Stroke, Mater, Dublin, Ireland
5Neuovascular Unit for applied translational research and
therapeutics, Mater, Dublin, Ireland
6Medicine for the Older Person, Mater Hospital, Dublin,
Ireland
7Medicine for the Older Person, Connolly Hospital, Dublin,
Ireland
8Stroke, Beaumont, Dublin, Ireland
9Nephrology, Mater Hospital, Dublin, Ireland
Objectives: Renal dysfunction has important implications for selection
and dosing of Direct Oral Anticoagulants in stroke associated with Atrial
fibrillation (AF-Stroke). We aimed to determine the prevalence of
impaired renal function in ischaemic stroke and TIA patients within the
North-Dublin Population-Based Stroke Study(NDPSS).
Methods: NDPSS is a prospective population-based, cohort study of fre-
quency and outcome of stroke and TIA in North-Dublin city (population
294,529). Ascertainment included “hot” and “cold” pursuit with multiple
overlapping sources according to Gold standard Criteria.
Estimated Glomerular Filtration rates (eGFR) at presentation and 3
months were calculated using the Modification of Diet in Renal Disease
(MDRD) and Chronic Kidney Diseases Epidemiology (CKD-EPI)
method. Renal dysfunction was defined as eGFR < 60 mL/min/1.73 m2
and Chronic Kidney Disease (CKD) was defined as persistent renal dys-
function ≥3 months.
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Results: In 639 patients (mean age 71.4, 71% Stroke, 29% TIA) renal
dysfunction was present in 48.2% by CKD EPI and 41% by MDRD
method, while CKD was present in 34.5% (CKD EPI) and 27.8%
(MDRD).
Renal dysfunction at presentation was more common in AF-patients,
OR = 1.8; P = 0.005 (55.2 vs. 40.7%)(CKD EPI) and OR = 1.7; P = 0.014
(46.9 vs. 34.5%)(MDRD). A trend towards higher rates of CKD was also
observed in patients with AF, OR = 1.6; P = 0.07 (32.3 vs. 23.5%) (MDRD)
and OR = 1.5; P = 0.08 (39.2 vs. 30.2%) (CKD EPI).
Conclusions: In a population based study of unselected ischaemic stroke
and TIA patients we found high rates of both renal dysfunction and CKD,
with highest rates among AF-Stroke. Our findings may have implications
for choice and dosing of renally-excreted anticoagulants for AF.
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Renal dysfunction in mild-to-moderate ischaemic
stroke patients with and without atrial fibrillation:
A prospective cohort study
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5Neurovascular Unit for Applied Translational Research and
theapeutics, Mater Hospital, Dubllin, Ireland
6Neurovascular Unit for Applied Translational Research and
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Background: Renal dysfunction is a key factor in the selection and dosing
of direct oral anticoagulants (DOAC) in secondary prevention of stroke
associated with atrial fibrillation (AF-Stroke). We aimed to determine the
prevalence of impaired renal function in those most likely eligible for
secondary prevention with DOACs.
Methods: In BIOSTROKE, a multi-centre prospective biomarker study of
patients with mild-to-moderate ischaemic stroke (Rankin ≤ 3), we mea-
sured estimated Glomerular Filtration rates (eGFR) using the Modifica-
tion of Diet in Renal Disease (MDRD), CKD EPI and Cockroft-Gault
method. Renal dysfunction was defined as eGFR
Results: In 493 patients (mean age 67.4, mean NIHSS 2.5) renal dysfunc-
tion was present in 25.7% (CKD-EPI), 21.4% (MDRD) and 30.4%
(Cockroft-Gault) at presentation, while CKD at ≥3 months was present in
19.2% (CKD-EPI), 15% (MDRD) and 22.2% (Cockroft-Gault).
Resolution of renal dysfunction during follow up was observed in 19.2%
(CKD-EPI), 21.7% (MDRD) and 15.7% (Cockroft-Gault).
Compared with non-AF stroke, patients with AF-Stroke were more likely
to have renal dysfunction at presentation; OR = 3.1; P
Conclusion: We found high rates of impaired renal function in mild-
moderate ischaemic stroke patients, with highest rates in those with
AF-Stroke. Renal dysfunction resolved at follow-up in approximately one
fifth of patients overall. Our findings may have important implications for
the selection and dosing of renally-excreted anticoagulants after
AF-Stroke.
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Background: Chronic Kidney Disease is associated with increased risk of
ischaemic stroke. Renal dysfunction is a key factor in the selection and
dosing of direct oral anticoagulants (DOAC) in stroke prevention after
atrial fibrillation-related TIA (AF-TIA). We aimed to determine the preva-
lence of impaired renal function in AF-TIA patients, the group most likely
eligible for DOAC use.
Methods: In BIOTIA, a multi-centre prospective study of patients with
Stroke-physician confirmed first-ever TIA, within 72 hours of onset we
measured estimated glomerular Filtration rates (eGFR) using the Modi-
fication of Diet in Renal Disease (MDRD), CKD-EPI and Cockroft-Gault
method. Renal dysfunction was defined as eGFR < 60 mL/min/1.73 m2
and Chronic Kidney Disease (CKD) was defined as persistent renal dys-
function ≥3 months.
Results: In 329 patients (mean ABCD2 4.2, mean ABCD3i 4.9) renal
dysfunction was present in 24.4% (Cockroft-Gault), 23.9% (CKD-EPI)
and 17.9% (MDRD) of patients, while CKD at ≥3 months was present in
18.5% (Cockroft-Gault), 16.2% (CKD-EPI) and 12.8% (MDRD).
Resolution of renal dysfunction during follow up was observed in 4.8%
(Cockroft-Gault), 20% (CKD-EPI) and 16.7% (MDRD) of patients.
Compared with non-AF TIA, patients with AF-TIA were more likely to
have renal dysfunction at presentation, OR = 2.9; P = 0.024 (34 vs.
15%)(Cockroft-Gault), OR = 2.1; P = 0.035 (33.3 vs. 19.2%)(CKD-EPI),
but not by MDRD OR = 1.8; P = 0.15 (23.3 vs. 14.7%).
Conclusion: We found high rates of impaired renal function in patients
with TIA, with highest rates in those with AF-TIA. Renal dysfunction
resolved at follow-up in up to one-fifth of patients overall. Our findings
may have important implications for the selection and dosing of renally-
excreted anticoagulants after AF-TIA.
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Temporal trends in anticoagulant prescribing in
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Background: International guidelines recommend anticoagulation for
prevention of stroke in Atrial Fibrillation (AF). Despite this anticoagula-
tion rates remain suboptimal. We aim to determine temporal changes in
anticoagulation prescribing in those patients most likely eligible for anti-
coagulation post AF-Stroke.
Methods: NDPSS is a prospective population-based, cohort study of fre-
quency and outcome of stroke and TIA in North-Dublin city from 2005–
2006 (population 294,529). Ascertainment included “hot” and “cold”
pursuit with multiple overlapping sources according to Gold standard
Criteria. BIOSTROKE, a multi-centre prospective biomarker study of
patients with mild-to-moderate ischaemic stroke (Rankin ≤ 3) from
2007–2012.
Results: 173 patients with mild-to-moderate AF-Stroke were recruited
across both studies (31.2% NDPSS and 68.8% BIOSTROKE). There were
no significant differences in mean age 72 years vs 74.2; P = 0.2, female sex
54.6% vs 47.1%; P = 0.1, renal dysfunction 35.9% vs. 43% (CKD-EPI) and
32.1% vs. 35.5% (MDRD) or pre-event rankin; ranksum P = 0.7 between
patients in NDPSS and BIOSTROKE studies. NIHSS scores were higher
for those patients from NDPSS 3.5 vs 2.4; P = 0.002.
There were no differences in pre-event prescribing of antiplatelet agents
48.2% vs. 52.9%; P = 0.6, anticoagulants 20.4% vs 20.2%, antihyperten-
sives 64.8% vs. 76.5%; P = 0.1 or statins 42.6% vs. 39.5%; P = 0.7.
Post-event anticoagulant prescribing was higher in BIOSTROKE 76.1%
vs. 48%; P < 0.0001. Patients in NDPSS remained less likely to receive
anticoagulation after adjusting for stroke severity OR = 0.30; P = 0.002.
Conclusion: Allowing for differences in study methodology, our results
suggest significant improvements over time in anticoagulation prescribing
in mild-to-moderate AF-Stroke patients.
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Predicting atrial fibrillation in cryptogenic stroke
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1Geriatric and Stroke Medicine, Beaumont Hospital Dublin
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Introduction: Atrial fibrillation (AF) is a well-recognised risk factor for
stroke. Studies have shown that early diagnosis and anticoagulation in
patients with subclinical AF can reduce stroke risk. Prolonged ECG moni-
toring increases the detection and diagnosis of subclinical AF and facili-
tates early anticoagulation. The aims of this research study were to identify
rates of subclinical AF on 3 and 5 day ECG holter monitors in a popula-
tion with cryptogenic stroke and scrutinise relevant risk factor profiles.
Methods: A retrospective study (from 01/08/2011 to 31/08/2014) of 3 and
5 day ECG holter monitors from the Beaumont Hospital Stroke and
Cardiology Services was conducted.
Results: A total of 103 ECG holter monitors were reviewed. Male patients
predominated (n = 56, 54%). Median age was 70 years. 16% of holters
detected AF (n = 16). 75% of these detection were in males (n = 56). Data
for 86 patients with no AF detected was available for analysis. 56%
(n = 48) had hypertension, 53% (n = 46) dyslipidaemia, 8% (n = 7) Dia-
betes Mellitus, 19% (n = 16) ischaemic heart disease (IHD), 30% (n = 26)
were active or ex-smokers, and 9% (n = 8) had left atrial enlargement
(LAE). In the AF positive group 56% (n = 9) had hypertension, 69%
(n = 11) dyslipidaemia, 25% (n = 4) Diabetes Mellitus, 63% (n = 10) IHD,
56% (n = 9) active or ex-smoker, and 38% (n = 6) LAE.
Conclusion: Prolonged ECG holter monitoring in a cryptogenic stroke
population had a 16% detection rate for subclinical AF. Male gender,
IHD, LAE, and smoking had the strongest positive predictive value. This
may help identify those patients who may benefit from prolonged ECG
monitoring.
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Determinants of intracranial hemorrhage in patients
with atrial fibrillation
C Marini1, F Crosta1, G Desideri1
1MeSVA, University of L’AQUILA, L’AQUILA, Italy
Background: Available tools to predict the risk of intracranial hemor-
rhage in patients with atrial fibrillation on antithrombotic therapy are
largely criticized for the lack of sensitivity, specificity, and validity. We
evaluated the predictive value of several clinical, radiological and labora-
tory parameters.
Methods: We conducted a case-control study on all patients with atrial
fibrillation and intracerebral hemorrhage admitted to the Avezzano Hos-
pital, Central Italy, between January 2012 and December 2013. A random
sample of subjects with atrial fibrillation without ischemic or hemor-
rhagic stroke that were admitted to the same hospital in the same period
was selected for the control group, with a ratio of two controls per case. All
patients underwent the same evaluation protocol. Patients without neu-
roimaging exams were excluded.
Results: During the period of the study we identified 37 subjects with
atrial fibrillation and intracerebral hemorrhage and 74 controls. Among
cases 57.3% were female and the mean age was of 83.3 years. Patients with
intracerebral hemorrhage were more often on anticoagulant therapy
(75.7%), compared with controls (45.9%; P = 0.0002). On CT scans, cases
had a greater severity of leukoaraiosis at the Blennow scale (P < 0.0001),
and a higher frequency of lacunar infarcts (P = 0.006). No significant
association was found between MRI parameters or the HASBLED score
and the occurrence of intracerebral hemorrhage.
Conclusion: CT scan, but not MRI, is more useful than the HASBLED
score to predict intracerebral hemorrhage in patients with atrial fibrilla-
tion on antithrombotic therapy.
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Embolic strokes of undetermined sources: Data from a
stroke unit registry
M Masina1, A Cicognani1, C Lofiego2, S Malservisi1, R Parlangeli2,
A Lombardi2
1Stroke Care Area Geriatric Ward, Bentivoglio Hospital,
Bentivoglio, Italy
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About 25% of all ischaemic strokes are cryptogenic. Most of them can be
embolic stroke of undetermined source and a new clinical construct
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(ESUS) related to minor-risk covert cardiac sources or non-occlusive
plaques in the aortic arch or in the cerebral arteries has been proposed.
In our SU precordial echocardiography, 72 hs cardiac monitoring and
cervical duplex ultrasonography are routinely performed. Transcranial
doppler ultrasonography and/or CT angiography follow when indicated.
We retrospectively reassessed 372 patients admitted to our SU in 30
months from May 2010. Out of them 102 (27.6%) had cardioembolic
stroke and 91 (24,5%) were discharged as cryptogenic. 74 (81.3%) of
cryptogenic strokes had in-patient precordial echocardiography and con-
ditions compatible with minor-risk cardiac sources were found in about
35%. About 70% of cardioembolic where prescribed VKA. All patients
with cryptogenic stroke were discharged with antiplatelet therapy.
In a 2 years follow-up (mean 25,13 months), 5 new cerebrovascular events
occurred both in cardioembolic and cryptogenic strokes (incidence
respectively of 2.5% and 2,62% per year). In cryptogenic strokes the
recurrences were embolic in 2 patient, both without minor-risk cardio-
embolic sources at index time, and depended on paroxysmal AF+auricular
thrombus (1) and on myocardial infarction (1). Two patients with slight-
to-moderate atrial enlargement had a recurrence of cryptogenic stroke. A
patient with mitral-annular-calcification and moderate atrial enlargement
had a vertebral-basilar TIA while assuming double antiplatelet therapy.
Only large clinical trials or the analysis of large SU registries can evaluate
the cost-effectiveness of extensive diagnostic research and of anticoagula-
tion in ESUS.
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Distribution of CHADS2 and CHAD2S2VASc scores in
nonvalvular atrial fibrillation-associated ischemic
stroke: A population-based study
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Background: CHADS2 and CHAD2S2VASc scores predict stroke risk in
patients with nonvalvular atrial fibrillation (NVAF). Most NVAF patients
have low CHADS2/CHAD2S2VASc scores. Despite lower stroke risk, this
group may predominate amongst stroke patients because of its demo-
graphic weight. Anticoagulation is recommended in NVAF patients with a
score ≥2.
Methods: We retrospectively reviewed the Ontario Stroke Registry’s
database (2003–07 to 2008–03) to determine the CHADS2 and
CHAD2S2VASc scores from baseline characteristics of NVAF patients
hospitalized for ischemic stroke. Antithrombotic therapy at presentation
was documented.
Results: Tables 1 shows the proportion of CHADS2 scores among 2577
study subjects.
CHADS2
Number
(proportion) with
NVAF known
prior to stroke
Number
(proportion) with
NVAF diagnosed
follo-wing stroke
Total number
(proportion)
0 83 (4.2%) 45 (7.6%) 128 (5.0%)
1 289 (14.6%) 155 (26.1%) 444 (17.2%)
2 601 (30.3%) 192 (32.4%) 793 (30.8%)
3 375 (18.9%) 92 (15.5%) 467 (18.1%)
4 391 (19.7%) 72 (12.1%) 463 (18.0%)
5 203 (10.2%) 32 (5.4%) 235 (9.1%)
6 42 (2.1%) 5 (0.8%) 47 (1.8%)
18.8% of patients with known NVAF had a CHADS2 score <2 (4.2%
CHAD2S2VASc <2) and only 28.2% had preadmission anticoagulation.
Of those with known NVAF and CHADS2 ≥2, 46.8% were anticoagulated
prior to admission.
Conclusion: An important proportion of NVAF patients have CHADS2
scores <2 prior to ischemic stroke. This is less marked with
CHAD2S2VASc. Anticoagulation based on CHAD2S2VASc rather than
CHADS2 scores ≥2 may help preventing stroke in NVAF patients.
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dynamnics of plasma level and correlation to atrial
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Introduction: Atrial fibrillation (AF) is the underlying cause of stroke in 1
of 4 patients. Failure to detect AF results in inadequate therapy. A plas-
matic biomarker for AF would help to select patients for early introduc-
tion of anticoagulation. Our aim was to further investigate the correlation
of Brain Natriuretic Peptide (BNP) and AF in stroke.
Methods: Acute stroke patients were included. Serial measurements of
BNP was done on day 1, 3 and 5. Exclusion criteria were cardiac
insufficiency and severe renal impairment. Patients had a complete
workup (MRI, angiography, echocardiography and long-duration ECG
recording).
Results: Eighty-three patients were included. Eighteen had stroke from
cardio-embolic etiology with documented AF and 65 from other origines
according to TOAST. The baseline BNP was significantly higher in AF
patients (321 vs. 96 ng/l, p < 0.0001). Respectively, high BNP values iden-
tified AF patients very well in a ROC curve analysis (best-criterion >151,
sensitivity 89%, specificity 86%, AUC 0.896, p < 0.0001).
Analysis of serial measurements revealed that AF patients reduced their
BNP values by 47% from day 1 to 5 vs. 2.8% in patients with other
determined etiologies (p = 0.05). Of all patients with abnormal BNP
values (>100, N = 38) at baseline, 22 normalized their levels by day 5
(58%). The latter were patients with AF (N = 5) or unknown etiology
(N = 17).
Discussion: This study further helps to validate measurement of BNP as
an biomarker for AF. Dynamics of plasmatic BNP suggest that the peak
level is near stroke onset. BNP should be measured in all stroke patients
and early.
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Early outcomes of stroke patients associated with
atrial fibrillation in Vietnam
T Nguyen1, C Do1, N Dao1, L Le1, H Nguyen1, B Pham1, P Cao1
1Cerebrovascular Disease, the People’s 115 hospital, Ho Chi
Minh, Vietnam
Background: To provide information on the outcomes of people with
first-ever stroke associated with atrial fibrillation in Viet Nam, mortality
and functional status was assessed 3 months after stroke among a cohort
of patients discharged from a stroke unit in Ho Chi Minh City, Vietnam.
Method: Consecutive stroke patients were diagnosed with atrial fibrilla-
tion by electrocardiogram when admitted to a stroke unit from May to
December 2013 and were assessed for socio-demographic information,
co-morbidity, lifestyle risk factors and functional status. Face-to-face
interviews were conducted in patient’s homes 3 months after stroke, and
functional status was again assessed by modified Rankin Scale.
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Result: Among the patients with acute ischemic stroke (n = 3561) admit-
ted to the People’s 115 hospital in Vietnam, there were 236 (6.63%) (mean
age 67.93 years, 54.3% female) with documented atrial fibrillation. The
oral anticoagulation use was varied from 17.3% prestroke and 62.1%
poststroke and to 68.2% at three-months respectively. Three-month case-
fatality was 33.8%. At 3-month follow-up, 7% had least severe disability
(mRS = 0–1), 32% had intermediate disability (mRS = 2–3) and 27.2%
had most severe disability (mRS = 4–5).
Conclusion: These data indicate oral anticoagulation use is suboptimal in
stroke patients with atrial fibrillation in Vietnam. Strokes that occur in
patients with atrial fibrillation are generally severe and are associated with
high mortality and morbidity. The dependency burden was providing
evidence for pressure on the healthcare system and society.
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Introduction: Atrial fibrillation (AF) is a major cause of embolic stroke
and its prevalence increases with age. In stroke patients, newly diagnosed
AF in the follow-up raises the question of non-thorough initial evaluation
versus new incidental AF. Recently, embolic stroke of undetermined eti-
ology (ESUS) was defined. We investigated the risk of new AF after ESUS.
Methods: In a hospital-based stroke cohort, we conducted a prospective
observational study, analysing newly diagnosed AF after complete
workup. ESUS was defined as by the Cryptogenic Stroke/ESUS Interna-
tional Working Group. Stroke etiology was ascertained by ASCOD grades
1–2. We present rates and recurrence risk by Kaplan-Meyer curves with
LogRank (LR) and Cox regression with Hazard Ratio (HR), along with
95% confidence intervals (95%CI).
Results: We included 460 patients (64.3% male, median age 66), 20.9%
thrombolysed, with median NIHSS 5 (interquartile range 7).
Stroke etiology was 26.8% atherothrombosis, 22.2% small-vessel disease,
31.7% cardiac pathology, 2.4% other causes, and 2.8% dissection. 26.5%
remained without determined etiology. ESUS criteria were fulfilled in
16.3%.
Prior to index stroke 12.0% had known AF and on discharge 22.7%.
In a median follow-up of 2.6 years there were 10 (2.2%) new AF, with
higher rate in ESUS than other non-AF patients (9.3% vs 0.9%, LR
p < 0.001; adjusted HR = 8.0, 95%CI 2.0–31.5%). Among undetermined
strokes, AF was higher in ESUS (9.3% vs 0%, LR p = 0.08).
Conclusion: Even without intensive search, new AF diagnosis on
follow-up isn’t uncommon. Its higher occurrence in ESUS justifies their
inclusion in clinical trials of anticoagulation as secondary stroke
prophylaxis.
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Global survey of the frequency of AF-associated stroke
and its detection
K S Perera1, M Giruparajah2, B Swaminathan3, J Bosch4,
S C Connolly5, R G Hart1
1Medicine (Neurology), Population Health Research Institute
McMaster University, Hamilton, Canada
2Research, Population Health Research Institute, Hamilton,
Canada
3Statistics, Population Health Research Institute, Hamilton,
Canada
4School of Rehabilitation Sciences, Population Health
Research Institute McMaster University, Hamilton, Canada
5Medicine (Cardiology), Population Health Research Institute
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Background: Atrial Fibrillation (AF) is recognized to be a frequent cause
of ischemic strokes that is likely to increase as populations age. We under-
took an international survey to characterize the frequency of
AF-associated strokes and methods of its detection.
Methods: Consecutive patients with recent ischemic stroke were retro-
spectively surveyed at 19 stroke research centers in 19 different countries
to identify those with AF-associated stroke. Countries were separated into
World Bank global regions.
Results: We identified a total of 2145 consecutive ischemic stroke patients
among which 28% had AF. Among those with AF only 9% was detected by
cardiac rhythm monitoring, which is only 3% of 1606 of ischemic stroke
patients without known AF or AF on ECG.
Ischemic stroke patients in Latin America and East Asia/Pacific and sig-
nificantly younger (p =< 0.001) than those in other 2 regions.
Conclusion: The fraction of ischemic stroke associated with AF is substan-
tial through out the world, averaging about 30% and, varying with the
mean age of the stroke population. The older the mean age of the ischemic
stroke cohort, the higher the frequency of AF. Most AF(90%) is evident by
history or captured by ECG’s. The yield of conventional cardiac rhythm
monitoring for detection of AF is about 2%.
Recent studies support that more extensive monitoring is likely to increase
the fraction of AF-associated stroke further.
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Cryptogenic stroke with embolic pattern: Common
phenotype with high risk of restroke
J Putaala1, T Nieminen2, E Haapaniemi1, A Meretoja3,
K Rantanen1, D Strbian1, S Curtze1, S Pakarinen2, M Lehto2,
T Tatlisumak1
1Department of Neurology, Helsinki University Central
Hospital, Helsinki, Finland
2Heart and Lung Center, Helsinki University Central Hospital,
Helsinki, Finland
3Department of Medicine/Department of Neurology,
University of Melbourne/The Royal Melbourne Hospital,
Melbourne, Australia
Background: Cryptogenic stroke with embolic pattern (CSEP) in neuro-
imaging is a common phenotype. Among those are patients meeting the
diagnostic criteria for embolic stroke of undetermined source (ESUS):
nonlacunar stroke, no cervical atherosclerosis causing relevant ≥50%
stenosis, no atrial fibrillation in ≥24 h continuous ECG, no intracardiac
thrombus, and no other specific cause. We compared CSEP with cardio-
embolism from known source (CEKS) and non-cardioembolic stroke
(NCES). Within CSEP, comparison was done between ESUS(-) and
ESUS(+).
Methods: Consecutive ischemic stroke patients admitted to Helsinki Uni-
versity Central Hospital (6-month inclusion period, follow-up 21
months). Primary endpoint was nonfatal/fatal restroke. Cox proportional
hazards model adjusted for CHA2DS2VASc score was constructed to
assess whether CSEP stands for prognostically relevant characteristic (ref-
erence: NCES).
Results: Of the 540 patients, 229 (42.4%) had NCES, 184 (34.1%) had
CEKS, and 127 (23.5%) were classified as CSEP (79.9% of all cryptogenic
strokes). Compared with NCES, CSEP patients had less often diabetes
mellitus and prior TIA, but more severe symptoms. Compared with
CEKS, CSEP cases were younger, had less frequently heart failure and
lower CHA2DS2VASc, and less severe symptoms. In Cox regression, CSEP
associated with higher risk of restroke (HR 2.36, 95% CI 1.02–5.49;
P = 0.046). ESUS(+) patients (n = 46/8.5%) were younger, had less often
hypertension and cancer, and lower CHA2DS2VASc than ESUS(-) cases
(n = 81/15%), but restroke occurred in similar proportions for both
(9.9% and 8.7%; P = 0.659).
Conclusions: Despite their younger age and more favorable risk factor
profile compared with other phenotypes, CSEP – including cases meeting
the ESUS criteria – experienced poor early prognosis.
ESOC-1166
16. AF & Cardioembolism
Impact of patent foramen ovale in the pathogenesis of
stroke recurrence: A cohort study
E Rigoni1, D Strambo1, G Giacalone1, R Chieffo1, G Comi1,
L Roveri1
1Neurology and Neurophysiology, IRCCS Ospedale San
Raffaele via Olgettina 48, 20132 Milano, Italy
Introduction: although the prevalence of patent foramen ovale (PFO) is
greater in cryptogenic stroke and AHA guidelines suggest antiplatelet
therapy for secondary stroke prevention in patients with PFO, the thera-
peutic indications in these patients are still controversial.
Materials and methods: from our stroke database we selected a cohort of
364 patients who underwent trans-esophageal echocardiography. Demo-
graphic and clinical features of index stroke were analysed according to
PFO presence. Etiopathogenesis of index and recurrent stroke were clas-
sified with TOAST.
Results: etiopathogenetic groups of index stroke had a similar proportion
of PFO (p = 0.12). Overall the annual rate of stroke recurrence was 3.2%
(2.6% in patients with PFO and 3.5% in patient without PFO). Etiopatho-
genesis of recurrent stroke was similarly distributed regardless of PFO
status (p = 0.837). While the proportion of cardioembolic stroke signifi-
cantly increased in recurrent stroke by 18.8% (p = 0.02), the proportion of
cryptogenic stroke decreased by 11.9% (p = 0.12). Patients with crypto-
genic index stroke had the greatest proportion of different etiology at
recurrent stroke (Fig. 1).
Conclusion: these data suggest that at least some cryptogenic stroke might
be cardioembolic and anticoagulant therapy should be considered in sec-
ondary prevention.
ESOC-1467
16. AF & Cardioembolism
Early detection of atrial fibrillation in embolic stroke
of unknown origin (ESUS)
A Rodríguez-Campello1, E Cuadrado-Godia1, A Ois1,
E Giralt-Steinhauer1, J Jiménez-Conde1, A Puig-Pijoan1,
A Gómez-González1, B Benito2, E Vallés2, J Martí2, J Roquer1
1Neurology, Hospital Del Mar, Barcelona, Spain
2Cardiology, Hospital Del Mar, Barcelona, Spain
Background: Since most cryptogenic strokes are of thromboembolic
origin the concept of ESUS has recently been introduced. Atrial fibrilla-
tion (AF) is the most prevalent cause of this stroke subtype. Current
guidelines recommend at least 24 h-ECG monitoring to rule out under-
lying AF and longer monitoring for patients with high suspicion and
negative findings. The CRYSTAL-AF trial detected AF in 8.9% of patients
after 6 months of monitoring with an insertable cardiac monitor (ICM).
The aim of our study is to analyze the rate of FA detection in current
clinical practice after the availability of ICM
Material and methods: Descriptive, prospective study of patients ≥60
years admitted in our stroke unit fulfilling ESUS criteria after complete
study: 12-lead ECG, 48 hours of ECG monitoring, transthoracic echocar-
diography, and arterial study of the aorta, cervical and intracranial arter-
ies. Demographic data and vascular risk factors were recorded. An ICM
with home monitoring was implanted between 5–7th day after the stroke.
Results: Since October 2013 to December 2014, 28 patients were included.
Mean age was 75.4 ± 8.9 years, 60.7% were men. Main associated vascular
risk factors were hypertension (64.3%) and dyslipidemia (53.6%). Median
time (IQR) of follow-up was 6(2–12) months. The rate of AF detection
was 46.4%. The median time between implantation and FA detection was
12(10–21) days.
Conclusion: In daily clinical practice we achieved a higher rate of AF
detection than previously reported in patients with ESUS using ICM with
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home monitoring. Time to FA detection was very short outlaying the
importance of early ICM implantation.
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16. AF & Cardioembolism
prolonged monitoring of cardiac rythm with wireless
cardiophone for real time detection of atrial
fibrillation after cerebral ischemic event (PEAACE
Study). The Edmonton Alberta experience
S Hasan1, A Pervez1, H Manosalva1, A Mohammad1, D Hussain1,
H Kalashyan1, M Saqqur1, K Khan1, W Tarhuni3, B Brian1,
K Butcher1, Y Hasan1, S Hussain2, A Shuaib1
1Neurology, University of Alberta Hospital, Edmonton,
Canada
2Cardiology, Canadian Cardiac Centre, Windsor, Canada
3Cardiology, Grey nuns Hospital, Edmonton, Canada
Introduction: Stroke is the leading cause of acquired disability. Strokes
associated with atrial fibrillation (AF) tend to be more severe; however can
be prevented.
Objective: Primary objective is to assess incidence of AF using wireless
Cardiophone for 15 days in patients with stroke/TIA.
Secondary objective is to determine the reduction of time of AF diagnosis
resulting in a prompt change in clinical management.
Method: This is an ongoing Cohort/Prospective study at the University of
Alberta Hospital. Patients ≥40 years of age (without known AF on ECG/
Holter) who had ischemic stroke or TIA within ≤90 days were eligible.
Patients with symptomatic carotid artery disease or pacemaker devices
were excluded. The signals from cardiophone were analyzed in real time at
Canadian cardiac center in Windsor, Ontario. The incidence and time of
onset of AF and change in medical treatment (anti-coagulation) was
recorded.
Results: Out of 72 patients, 66 completed monitoring for more than 48
hours. Thirteen out of these 66 subjects (≈ 20 %) were shown positive for
AF. When compared with the incidence of 5% reported in historical
controls wearing 24 hour holter, the difference was significant (chi square
p = 0.004) Mean time from onset of arrhythmia to report was ≈48 hours;
shorter than the time for report with holter (10 days in Alberta). All 13
subjects were started on anti-coagulation therapies.
Conclusion: Prolonged cardiac monitoring increased the detection of AF
4 fold as compared to 24 hour holter. Cardiophone device also allowed
faster detection of AF, and prompt change in medical treatment.
Correction added on 6 July 2015, after first online publication. The
primary author’s order list H Manosalva1, S Hasan1, A Mohammad1,
D Hussain1, A Pervez1, W Tarhuni2, K Khan1, B Buck1, M Saqqur1,
K Butcher1, S Hussain3, A Shuaib1 has been changed to S Hasan1,
A Pervez1, H Manosalva1, A Mohammad1, D Hussain1, H Kalashyan1,
M Saqqur1, K Khan1, W Tarhuni3, B Brian1, K Butcher1, Y Hasan1,
S Hussain2, A Shuaib1.
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The role of patent forame ovale in cryptogenic stroke
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Raffaele, Milano, Italy
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Background: Although patent foramen ovale (PFO) is found in approxi-
mately 40% of Cryptogenic Stroke (CS) compared with 25% of adult
population, the causal relationship between PFO and the occurrence of
ischemic stroke has to be established.
Aims: Assess clinico-radiological features of patients with CS with and
without PFO.
Materials and methods: From our stroke database we selected all patients
with CS who underwent transesophageal echocardiography, admitted to
our Stroke Unit from January 1st 2005 to January 1st 2013. We outlined a
cardioembolic (CE) pattern assessing the acute lesions in 100 patients
with ischemic stroke of known cause (60 CE stroke, 20 large vessels stroke
and 20 small vessels stroke).
Results: PFO was detected in 70 (41.6%) of 168 CS patients. Lesions in
multiple arterial territories, single cortical or cortico-subcortical lesions or
lesion larger than 15 mm predicted a CE etiology (OR 3.5 [95%IC 1.9–
6.5], p 0.000; sensitivity 86.7%, specificity 67.5%). The prevalence of CE
pattern was comparable between CS with PFO and CS without PFO
(67.1% in vs. 75.3% p = 0.250). The proportion of CE pattern was higher
in CS with PFO and atrial septal aneurism (ASA) (87.0% vs. 57.4% of PFO
without ASA, p = 0.014), but comparable to CS patients without PFO
(p = 0.153).
Conclusions: Our data shows that in 70% of CS patients the acute lesion
fits a CE pattern regardless of PFO detection. On this ground it’s reason-
able to consider other CE sources. We suggest that CS patients may deserve
prolonged ECG monitoring to disclose potential occult atrial fibrillation.
ESOC-1448
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The correlation of CES1 genotype and minimal
plasmatic concentration of dabigatran in stroke
patients
A Tomek1, P Kesnerova1, I Sarbochova1, H Magerova1,
J Paulas-Schwabova1, T Ruzickova1, Z Lacinova2, V Kaplan2,
J Klima3, V Matoska2
1Neurology, 2nd Medical School Charles University Prague,
Prague 5, Czech Republic
2Molecular Genetics Laboratory, Hospital Na Homolce, Prague
5, Czech Republic
3Pharmacology, Pharmakl, Prague 5, Czech Republic
Introduction: Dabigatran is direct thrombin inhibitor approved in the
prevention of stroke in patients with atrial fibrillation. It was proven that
genetic variants could contribute to interindividual variability in concen-
trations of the active metabolite of dabigatran and influence the safety and
efficacy of treatment. Carriage of the CES1 rs2244613 minor allele is
associated with lower exposure to active metabolite and with a lower
bleeding risk.
Aim: To determine the influence of gene CES1 polymorphism rs2244613
on minimal plasmatic concentration (Cmin) of dabigatran in stroke
patients.
Methods: DNA analysis of CES1 gene was done with RFLP analysis. Cmin
of dabigatran was quantified with liquid chromatography-tandem mass
spectrometry (LC-MS/MS).
Results: Forty-one patients, mean age 71,5 (24–85), were enrolled. 13
(31.7%) were treated with 110 mg and 28 (68.3%) with 150 mg. 20
(48.8%) patients were in therapeutical range (50–200 ng/ml), their mean
Cmin was 107.8 (63.8–177.6) ng/ml; 13 (31.7%) were subtherapeutical
(mean 29.4, 6.5–44.3) and 8 (19.5%) supratherapeutical (mean 298.1,
205.5–402.9). There was a statistically nonsignificant trend in minor allele
carriers for subtherapeutical level compared to wildtype patients (46,2%
vs. 30,8%). LC-MS/MS correlated with creatinine clearance (r = 0,468,
p = 0,003) and with Hemoclot assay (r = 0,97, p < 0,001). There was no
significant correlation with APTT, Quick or TT.
Conclusion: Minor allele carriers had only statistically nonsignificant
trend for having subtherapeutical dabigatran level. Nevertheless 52.2% of
our patients had dabigatran level outside the published range. Personal-
ized dabigatran dosing based on pharmacogenetics and monitoring cmin
should be studied in future trials.
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Diagnostic yield of repeat 24-hour holter
electrocardiography for detection of paroxysmal atrial
fibrillation in patients with embolic stroke of
undetermined source
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A Roussopoulou3, A H Katsanos1, A Safouris1, K Voumvourakis1,
J Parissis2, G Tsivgoulis1
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Background and purpose: A new clinical construct termed embolic stroke
of undetermined source (ESUS) was recently introduced as a potential
therapeutic relevant entity with a potential indication for anticoagulation
Specific criteria were proposed for the diagnosis of ESUS (including
cardiac monitoring for ≥24 hours with automated rhythm detection) in
contrast to the absence of standard diagnostic criteria for the definition of
cryptogenic stroke. We sought to prospectively evaluate the diagnostic
utility of repeat 24-hour electrocardiography for detecting paroxysmal
(PAF) in patients with ESUS in a single-center pilot study.
Subjects and methods: The criteria proposed by the Cryptogenic Stroke/
ESUS International Working Group were applied to consecutive acute
ischemic stroke patients admitted to our tertiary care stroke center over
the last 24 months to identify all cases with ESUS diagnosis. All ESUS
patients underwent repeat (≥.1) 24-hour Holter electrocardiography. ECG
recordings were analyzed by two blinded investigators using dedicated
analysis software.
Results: A total of 81 patients were classified as ESUS (mean age 57 ± 13
years, 73% men, median NIHSS-score 3 points, interquartile range 2–5).
PAF during repeat 24-hour Holter electrocardiography (median number
of repeat 24-hour Holter recordings 2, interquartile range 1–3) was
detected in 9 cases (11%, 95%CI calculated by the adjusted Wald method:
6%-20%). Oral anticoagulation was initiated in all ESUS cases with PAF
documentation on repeat 24-hour Holter monitoring.
Conclusions: Our preliminary findings underline the potential utility of
repeat 24-hour Holter electrocardiography for the detection of PAF and
confirming an indication for anticoagulation in patients with ESUS.
ESOC-1124
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Plasma levels of dabigatran in acute cerebrovascular
events
B Volbers1, M Köhrmann1, L Breuer1, J Ringwald2, S Schwab1
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Objective: Oral anticoagulation with dabigatran was shown to be effective
for secondary prevention of stroke in patients with atrial fibrillation
without the need of laboratory monitoring. However, a recent additional
publication of RE-LY data reported, that ischemic stroke and bleeding
outcomes are correlated with dabigatran plasma concentrations (DPC).
Here, DPC was determined at a pre-specified time point and correlated
with a cardiovascular event at any time during follow up. This might
be problematic due to the known large variability of DPC inter alia
depending on renal function. We now report on plasma levels of dabiga-
tran in temporal proximity to acute cerebrovascular events.
Methods: Patients with acute ischemic stroke (AIS) or acute intracerebral
hemorrhage (ICH) while on dabigatran therapy and available DPC at
admission were identified retrospectively. DPC was determined using the
diluted thrombin time (HemoclotTM). Creatinine clearance was deter-
mined by measuring creatinine in plasma and 24-hour urine.
Results: Eleven patients suffering AIS and three patients suffering ICH
were included. Mean DPC at admission was significantly higher when
ICH occurred than at patients suffering AIS (170 ng/ml and 64.07 ng/ml
respectively, p = 0.01). Increased creatinine clearance was correlated with
lower mean dose normalized DPC (0.40 ng/ml/mg vs. 1.45 ng/ml/mg at
patients with normal creatinine clearance, p = 0.02).
Conclusions: We found a notably higher DPC in patients with acute ICH
than in patients with AIS in temporal proximity to the event. Not only
decreased but also increased renal function seems to have an important
influence on DPC.
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Prevalence of subdiaphragmatic visceral infarct in
ischemic stroke and atrial fibrillation
D W Weisenburger1, D L Lopez1, J P D Decroix1, A W Wang1,
S E Evrard1, P G Graveleau1, A S Scherrer1, F M Mellot1,
F B Bourdain1, B L Lapergue1
192151, Hôpital Foch, Suresnes, France
Background: Occult atrial fibrillation (AF) may explain a part of crypto-
genetic stroke. A prevalence of 22% of subdiaphragmatic visceral infarctus
(SDVI) has been reported among patients with stroke due to AF.
Methods: To assess the impact of abdominal MRI for determining etiol-
ogy of strokes and the prevalence of SDVI, we compared magnetic reso-
nance abdominal imaging (diffusion and T2-weighted imaging) in three
groups : patients with atrial fibrillation and stroke (group A), patients
with stroke of an other determined cause (Group B) and patients with
atrial fibrillation without stroke (Group C).
Results: A total of 112 consecutive patients was included (45 in group A,
30 in group B and 34 in group C). The median time between the inclusion
and abdominal MRI was 12,5 days.
SDVI was more frequent in group A (n = 10 ; 22.2%), than in group B
(n = 1 ; 3.2%) and in group C (n = 2 ; 5.9%), p = 0.03). The most frequent
localisation was the kidney (50% in group A, 100% in groups B and C).
Conclusion: The prevalence of SDVI is more frequent among patients
with stroke of cardioembolic cause. Further studies should assess the
prevalence of SDVI among cryptogenic stroke and occult atrial
fibrillation.
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Vascular cell adhesion molecule-1 and atrial fibrillation
– results from the Bruneck and Saphir Study
K Willeit1, R Pechlaner1, E Bonora2, B Iglseder3, B Paulweber4,
G Egger5, J Willeit1, S Kiechl1
1Neurology, Medical University Innsbruck, Innsbruck, Austria
2Endocrinology and Metabolic Diseases, University of Verona
Medical School, Verona, Italy
3Geriatric Medicine, Paracelsus Medical University/Salzburger
Landeskliniken, Salzburg, Austria
4First Department of Internal Medicine, Paracelsus Medical
University/Salzburger Landeskliniken, Salzburg, Austria
5Internal Medicine, Bruneck Hospital, Bruneck, Italy
Background: There is accumulating evidence suggesting a link between
inflammation and the manifestation of atrial fibrillation (AF). Vascular
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cell adhesion molecule-1 (VCAM-1), a biomarker for endothelial activa-
tion, has been implicated in the pathogenesis of several heart diseases, but
its role in AF remains unclear.
Methods: This study uses data from the Bruneck Study, a prospective
population-based survey with a 20 year follow-up and thorough ascer-
tainment of AF. The study population comprised 909 men and women
between 40–79 years old at the 1990 baseline examination. The Saphir
Study from Salzburg served as a replication cohort.
Results: At baseline, 29 subjects (3.2%) had AF. Compared to subjects in
sinus rhythm, subjects with paroxysmal and persistent AF had higher
baseline soluble VCAM-1 levels (median [interquartile range], 609.6
[493.4–789.7] versus 813.3 [713.9–871.1] and 843.6 [677.2–1301.9];
P < 0.001). All subjects with low soluble VCAM-1 (bottom tertile group)
were free of AF. During follow-up, 117 participants developed AF. The
incidence rate (95%CI) of AF was 4.4 (2.7–6.3) in the lowest tertile com-
pared to 9.5 (7.0–12.4) and 11.4 (8.5–14.5) in the middle and highest
tertile of soluble VCAM-1 (P < 0.001). In age/sex-adjusted and multivari-
able models, soluble VCAM-1 predicted an increased risk of future AF
(hazard ratio for a 1-SD higher soluble VCAM-1 level (95%CI), 1.4 (1.1–
1.6) and 1.4 (1.1–1.6); P = 0.0014 and P = 0.0016). The association was
externally consistent in an independent population-derived cohort.
Conclusion: Level of soluble VCAM-1, a putative marker of atrial activa-
tion and inflammation, is a significant risk predictor of new-onset AF in
the general community.
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Underuse of oral anticoagulants (OAC) in atrial
fibrilation (AF) in primary care in South Wales
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Background: Atrial fibrillation (AF) is associated with significant mortal-
ity and morbidity from Stroke. Many patients who are in AF are still not
receiving the highly effective oral anticoagulant therapy (OAC) for stroke
prevention.
The aim of this study was to estimate the percentage of people with AF in
the community who are and are not on OAC therapy and to establish the
reasons for not being offered the treatment.
Methods: We included 775 patients with AF from six primary care prac-
tices in South Wales. CHADS2 score was used to identify patients who
were eligible for OAC therapy. The reasons for underuse of OAC in eligible
patients were explored.
Results: The mean age was 76 [range 47–95 years] & 353 were females
[45.5%]. 57.2% (443/775) were on OAC. The median TTR was 79.6%
(range 73.4–85.5%; 18 patients had TTR < 60%). 5/443 (1.1%) had major
haemorrhages requiring hospitalisation (none fatal). 42.8% patients in AF
(332/775) were not on OAC (169/332 [50.9%] were high-risk on CHADS2
score). Reasons for not using OAC in eligible patients were previous
haemorrhages, malignancy, patient refusal, poor compliance, low plate-
lets, erratic INR. 96 eligible patients were denied OAC due to falsely
perceived contraindications (e.g. old age, falls risk, dementia, active life
style).
Conclusions: Our study confirms the underuse of OAC therapy for stroke
prevention in AF & the results are comparable to previously reported
studies1,2. There is a clear need for educating patients and clinicians to
encourage appropriate use of OAC therapy to reduce the burden of stroke.
ESOC-0499
16. AF & Cardioembolism
Quality of anticoagulation control with acenocoumarol
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Background: The influence of the quality of previous anticoagulation control
with vitamin K antagonists (VKAs) over the risk of transient ischemic attack
(TIA), ischemic stroke (IS) or intracranial hemorrhage (ICH) remains
unestablished.We decided to evaluate the quality of previous anticoagulation
through the time in therapeutic range (TTR) and individual measurements
of previous international normalized ratios (INR) in patients that suffered a
cerebrovascular event.
Methods: We prospectively analyzed every consecutive patient admitted
to our stroke unit (SU) while treated with VKAs to prevent thromboem-
bolic events. We analyzed clinical and demographic variables, INR on
admission, 7 previous INRs and TTR during the 6 months before the
event.
Results: During one year 136 patients were admitted to our SU with the
diagnosis of TIA (27), IS (85), ICH (24) while they were treated with
VKAs. There were no statistically significant differences between the three
groups in any of the 7 INR’s previous to the event. Global TTR was 57 %
(TIA: 62,7%, IS: 53,7 %, ICH: 66,3 %). There were statistically significant
differences on INR on admission with infratherapeutic values in patients
admitted due to TIA or IS and supratherapeutic in patients with ICH in
patients anticoagulated because of atrial fibrillation (TIA: 1,96; IS: 1,7;
ICH: 3,1) as well as in patients with mechanical prosthetic heart valves
(TIA: 2,3; IS: 2,1; ICH: 4,15).
Conclusion: The risk of having a cerebrovascular event in our patients was
not related to the quality of the chronic anticoagulation control but only
to the INR on admission.
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Long-term follow up of patients with cryptogenic
stroke: NT-proBNP levels and diagnosis of atrial
fibrillation or stroke/TIA recurrence
A C Fonseca1, T Pinho e Melo1, R Geraldes1, J M Ferro1
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Background: NT-proBNP showed good accuracy for the diagnosis of
atrial fibrillation (AF) in the first six months after ischemic stroke initially
considered cryptogenic. The cut-off point of 265.5 pg/mL showed high
sensitivity (88.2%) and negative predictive value (95.1%). However, there
is no data regarding its accuracy for AF diagnosis in the long-term.
Aim: To determine NT-proBNP accuracy to predict AF or stroke/TIA
recurrence in patients with cryptogenic stroke during long-term
follow-up (>6 months).
Methods: Consecutive patients that maintained the diagnosis of crypto-
genic stroke after 6 months were prospectively followed during 48
months. NT-proBNP levels were determined immediately after ischemic
stroke. To look for AF, 24 hour Holter monitoring was performed yearly.
Annual appointments evaluated stroke/TIA recurrence. The National
Platform of Health was also searched to look for these endpoints. The area
under the curve (AUC) of NT-proBNP for the diagnosis of AF and/or
stroke/TIA recurrence was determined.
Results: Seventy-one patients were included (median age 68 years).
Patients were followed during a median time of 35 months. In 7 patients
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(9.9%, 95%CI – 4.9–19%) AF was found and in 3 other patients there was
a stroke recurrence. Median time for AF diagnosis was 24 months. The
AUC for the diagnosis of AF was 0.55. The sensitivity of the cut-off point
was 43% and negative predictive value was 91%. The AUC for the diag-
nosis of AF of stroke recurrence was 0.61.
Conclusion: NT-proBNP showed a low accuracy for the diagnosis of AF or
prediction of stroke TIA recurrence in the long-term follow-up of patients
with cryptogenic stroke.
ESOC-0269
16. AF & Cardioembolism
Opportunistic screening for atrial fibrillation in
primary care in a rural area
B Smyth1, P Marsden2, R Corcoran1, R Walsh3, C Brennan2,
K McSharry4, J Clarke5, P Kelly6, J Harbison7
1Dept. of Public Health, National Clinical Programme for
Stroke, Galway, Ireland
2Dept. of Public Health, National Clinical Programme for
Stroke, Tullamore, Ireland
3Cardiology University College Hospital, National Clinical
Programme for Stroke, Galway, Ireland
4Centre for Nurse Education, National Clinical Programme for
Stroke, Castlebar, Ireland
5Health Service Executive, National Clinical Programme for
Primary Care, Summerhill Meath, Ireland
6Dept. of Neurology UCD, National Clinical Programme for
Primary Care, Dublin, Ireland
7Dept. of Medical Gerontology Trinity College Dublin,
National Clinical Programme for Stroke, Dublin, Ireland
Atrial Fibrillation (AF) is a cause for up to 30% of strokes. There is debate
as to whether opportunistic or organised screening is more effective in
identifying cases. Previous studies of screening have typically been carried
out in highly populated areas. In rural areas, organised screening and
management of AF is more challenging because of reduced proximity and
access to primary and secondary care resources and difficulty accessing
specialist coagulation services. We performed a study of feasibility of AF
screening in three predominantly rural counties in the West of Ireland.
Methods: Following a training course, 89 doctors in 37 General Practices
participated in screening consecutive subjects >64 years over a 6-month
period using pulse measurement supported with 12-lead ECG where
arrhythmia was suspected. Screening was supported with an information
package and management algorithm and a computerised data collection
tool.
Results: Seven thousand two hundred sixty-two individuals were screened
(male 45.3%, mean age 75.1 yrs). 916 (12.6%) had an irregular pulse. 55
(0.8%) had previously undiagnosed AF (49.1%% male, mean 76.6 yrs)
identified by pulse and confirmed on ECG. 17(32.1%) had uncontrolled
AF (HR > 110/min) and 27 (49.1%) were asymptomatic. CHA2DS2VASc
score was recorded for 39 subjects (70.9%), Median score was 3 and 37
(94.9%) had a score >1. 40 patients were referred to secondary care for
follow up either acutely or to outpatients. 33 (60%) were eventually anti-
coagulated, 20 (60.1%) using a NOAC.
Conclusion: Opportunistic screening for AF is feasible and worthwhile in
rural areas. 40% of subjects were not anticoagulated despite availability of
NOACs.
ESOC-0304
16. AF & Cardioembolism
Stroke prevention: extended, intermittent monitoring
using a handheld ECG significantly increases the
diagnosis of paroxysmal atrial fibrillation
PJ Howlett1, M Mahmoudi1, J Morritt2, L Greswell2, R Jabr1,
C H Fry3, E W Leatham2
1School of Biosciences and Medicine, University of Surrey,
Guildford, United Kingdom
2Cardiology, Royal Surrey County Hospital, Guildford, United
Kingdom
3School of Physiology and Pharmacology, University of Bristol,
Bristol, United Kingdom
Purpose: Atrial fibrillation (AF) is the most common cardiac arrhythmia.
Paroxysmal AF (PAF) comprises half of AF cases and confers an equivalent
risk of stroke to sustained AF. However, PAF poses a diagnostic challenge
given its variable frequency, potential brevity and frequent lack of symp-
toms. We aim to determine whether the extended, intermittent use of a
handheld ECG monitor improves the diagnosis of PAF.
Methods: Patients meeting these criteria entered into the study: suspected
PAF (palpitations or irregular pulse); aged ≥ 40 years; no previously docu-
mented AF. Participants wore an automated cardiac event recorder for
1-week (R Test Evolution 4, Novacor). They also used a handheld ECG
monitor (OMRON® Portable ECG Monitor), recording 30-second seg-
ments twice-daily for 12 weeks.
Results: We recruited 143 participants (mean age 66 years; 63% female).
83% presented with palpitations and 17% with an irregular pulse. 90% of
participants completed the study. Atrial arrhythmias were detected in 33
patients (23%): 27 were diagnosed with PAF, 5 with atrial flutter and 1
with atrial tachycardia. 24% of cases were identified using the cardiac
event recorder, 45% using the handheld ECG and 30% with both
(p = 0.32). Significantly more PAF cases were detected over 12-weeks
compared to 24-hours (n = 33 vs 6; p = 0.0001, Fisher’s exact test) and
1-week (n = 33 vs 18; p = 0.015).
Conclusions: The intermittent use of a handheld ECG monitor over
12-weeks significantly increases the diagnosis of PAF compared to stan-
dard investigations. We suggest that the duration of monitoring used in
current practice is accordingly extended.
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Atrial fibrillation and stroke in Qatar insight from a
1-year prospective nation-wide registry
Y Z Imam1, P Bourke1, N Akhtar1, R Singh2, S Kamran1,
A D’Souza1, M Santos1, S Joseph1, A Shuaib1
1Stroke service, Hamad Medical Corporation, Doha, Qatar
2Cardiac Research Center, Hamad Medical Corporation, Doha,
Qatar
Background: Atrial fibrillation (AF) related stroke is associated with
increased morbidity and mortality. There is very limited data on AF
related stroke from non-western regions of the world.
Methods: A prospective national stroke registry in Hamad Medical Cor-
poration from 1st of January 2014 was searched for all case admitted with
stroke and the diagnosis of AF. Demographic data, stroke-type, stroke
severity, length of stay, and outcome were noted.
Results: Out of 852 entries, 57 cases (6.6%) had a diagnosis of AF. Twenty
(35%) were new AF. Thirty-four (61%)were males. Mean age was
64.0 ± 16.6 years. Thirty-one (54%) were Arabs, 19(33%) Asians, 3 (5%)
Africans and 4 (7%) Caucasian.
Strokes subtypes were: TACI 10(18 %), PACI 16 (28%), LACI 12(21%),
POCI 14 (24%) and 5(9%) TIAs. Nine (15.8%) received thrombolysis vs.
41 (5.2%) for non-AF stroke (p = 0.004)
The mean NIHSS score was 7.79 ± 6.8 vs. 6.3 ± 5.6 for non-AF stroke. Age,
stroke-type and severity did not show statistical significant difference
between AF and non-AF strokes. Mean length of stay was 15 ± 27 days
(8 ± 15 days for non-AF). Mean modified Rankin scale (mRs) was
2.8 + 1.8 for AF stroke vs. 1.9 + 1.7 for non-AF stroke (p = 0.001). Good
outcome (mRs 0–3) was 61% vs. 82%; poor outcome (mRs 4–5) was 34%
vs. 15% and death 5% vs. 4%. (All p = 0.001)
Conclusion: Prevalence and incidence of AF in patients presenting with
stroke in Qatar is 6.6% and 2.4% consecutively. AF related stroke is asso-
ciated with significantly higher percentages of thrombolysis, prolonged
length of stay and poorer outcomes.
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16. AF & Cardioembolism
Atrial fibrillation detection in patients with an
implantable loop recorder after acute embolic stroke
of unknown source (ESUS)
A Kitsiou1, M Kalyani2, L Ekosso Ejangue2, C Hagemeister1,
J Manegold2, C Israel2, W Schäbitz1
1Neurology, Protestant Hospital, Bielefeld, Germany
2Kardiology, Protestant Hospital, Bielefeld, Germany
Introduction: The embolic stroke of unknown source (ESUS) concept was
introduced as a more rigid analysis of patients with cryptogenic stroke
representing a superselection of patients with cardioembolic stroke. Typi-
cally these patients are particularly candidates for intermittent atrial fibril-
lation (AF). Implantable loop recorders (ILR) in patients with ESUS may
detect AF and establish the indication for oral anticoagulation. The aim of
this study was to prospectively assess and predict AF occurrence in
patients with ILR after ESUS.
Methods: In patients with ESUS (MR imaging , exclusion of structural
cardiac stroke source by TEE, no AFdetected by 72 h SU nmonitoring and
24 h holter ECG, exclusion of other causes such as SCAS) an ILR was
implanted. We then analyzed the predictive value of different clinical and
imaging characteristics for AF detection in ESUS.
Results: By daily remote monitoring over a period of 8 ± 5 months, AF
was documented and manually confirmed in 19 of 115 patients (17%). In
19 patients (17%) first AF detection occurred on average after 88 ± 122
days of monitoring. Characteristics of patients are shown in the table.
Conclusions: Patients with ESUS and asymptomatic AF detected only by
long-term continuous monitoring with an ILR were on average older and
had a higher CHA2DS2-VASc score. Other clinical parameters and fea-
tures of cerebral imaging in ESUS did not increase the probability of AF
detection in these preselected patients with ESUS. Importantly, ESUS
selection almost doubled AF detection rate compared to recent studies
such as the ILR group of the Crystal-AF trial (17% compared to 10%).
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16. AF & Cardioembolism
Local hemostatic abnormalities in the fibrillating
atrium
K Kovács1, N K Tóth2, Z Bagoly2, L Muszbek2, Z Bereczky2,
Z Csanádi3, A Kiss3, E Nagy-Baló3, L Csiba1
1Department of Neurology, University of Debrecen Faculty of
Medicine, Debrecen, Hungary
2Division of Clinical Laboratory Science Department of
Laboratory Medicine, University of Debrecen Faculty of
Medicine, Debrecen, Hungary
3Department of Cardiology, University of Debrecen Faculty of
Medicine, Debrecen, Hungary
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia
associated with a high risk of stroke. The latest American guideline on
secondary stroke prevention considers the usefulness of closing the left
atrial appendage with the Watchmans device uncertain. We intended to
identify coagulation and fibrinolytic abnormalities associated with AF by
presenting local differences using venous and arterial blood samples of
patients sufferring from AF (n = 22) and controls having other types of
supraventricular tachycardia (n = 10) undergoing transcatheter radiofre-
quency ablation. Blood samples were drawn from femoral vein, left atrium
and left atrial appendage. All medications influencing coagulation were
discontinued at least 5 days before the procedure. The following tests were
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carried out from all blood samples: blood count, hemostasis screening
tests, fibrinogen, factor VIII activity, von Willebrand factor antigen levels,
factor XIII activity, thrombin-antithrombin complex, quantitative fibrin
monomer test, activated factor VII-antithrombin complex, thrombin gen-
eration assay, D-dimer, plasminogen-activator inhibitor-1 activity and
antigen concentration, plasmin-antiplasmin complex. C-reactive protein
was measured from venous blood samples. Clinical data of patients and
controls (BMI, smoking habit, previous cardiovascular events, medica-
tions) were registered. We have not found difference between the left
atrium and left appendage concerning hemostatic parameters and no
difference was found between intracardial and femoral vein samples was
specific to AF itself.
ESOC-0258
16. AF & Cardioembolism
Detection of right-to-left shunt in young ischemic
stroke patients – pilot study
M Kuliha1, D Skoloudik1, M Roubec1, A Goldirova1, E Hurtikova1,
J Krajca2, V Prochazka2, M Kolek3, R Herzig4
1Neurology, Comprehensive stroke center, Ostrava, Czech
Republic
2Radiology, Comprehensive stroke center, Ostrava, Czech
Republic
3Cardiosurgery, University Hospital Ostrava, Ostrava, Czech
Republic
4Neurology, Comprehensive stroke center, Hradec Kralove,
Czech Republic
Objective: Right-to-left shunt is associated with a number of clinically
important syndromes including paradoxical thromboembolism causing
stroke or other systemic infarct, mainly in young patients. Flow detection
system CardioxTM (FDS) represents a new, comfortable method for
right-to-left shunt detection independent on examiner experience with
exact measurement of Valsalva maneuver. The aim was to assess the cor-
relation between FDS, contrast transcranial Doppler ultrasound (cTCD)
and transesophageal echocardiography (TEE) in right-to-left shunt detec-
tion in young ischemic stroke patients.
Methods: All consecutive patients presenting with acute ischemic stroke/
transient ischemic attack aged 18–55 years and able to perform sufficient
Valsalva maneuver were enrolled to the pilot study during 5 months. TEE,
FDS, cTCD and brain MRI/CT were performed in all patients. Correla-
tions in right-to-left shunt detection were statistically evaluated using
Spearman′s and interclass correlation coefficient.
Results: Totally 30 patients (21 males, mean age 46.2 ± 8.5 years) were
included. Right-to-left shunt was detected in the same 8 (26.7%) patients
using TEE and cTCD, and in one more patient (totally 9, 30.0%) using
FDS. Spearman′s coefficients for FDS and cTCD were 0.92 and 1.00, resp.
Interclass correlation coefficient was 0.975. Sensitivity, specificity, positive
and negative predictive values were 100%, 95.5%, 88.9%, 100% for FDS
and 100%, 100%, 100%, 100% for cTCD, resp.
Conclusions: Correlations between FDS and cTCD, and TEE as a gold
standard in right-to-left shunt detection were almost perfect with 100%
sensitivity. Both FDS and cTCD seem to be sufficient as a screening
method.
Supported by the internal grant of University Hospital Ostrava
RVO-FNOs/2014.
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Detection of silent atrial fibrillation after ischemic
stroke (SAFFO) guided by implantable loop recorder.
A multicentre Italian trial based on neurocardiology
unit network
D Toni1, S Lorenzano1, S Strano2
1Department of Neurology and Psychiatry – Policlinico
Umberto I Hospital, Sapienza University of Rome, Rome, Italy
2Department of Heart and Great Vessels – Policlinico Umberto
I Hospital, Sapienza University of Rome, Rome, Italy
Background: Atrial fibrillation (AF) is associated with a high risk of stroke
and its prevalence increases in subjects aged ≥ 65 years. After an ischemic
stroke, the use of standard monitoring methods may underestimate the
detection rate of AF. Hence, it is very likely that even patients having a first
atherothrombotic or lacunar stroke with high burden of vascular risk
factors are exposed to increased risk of developing AF in the subsequent
years and AF may be the cause underlying possible recurrent strokes.
Objectives: The Silent Atrial Fibrillation aFter Ischemic StrOke (SAFFO)
trial has the objective to evaluate the incidence of AF or atrial flutter (AFL)
as first diagnosis detected by implantable loop recorder (ILR) in patients
with first-ever atherothrombotic or lacunar stroke. We hypothesize that
the incidence will be higher than that found by using standard cardiac
monitoring.
Methods: SAFFO is a prospective, multicenter, randomized, controlled,
open-label trial with blinded assessment of outcome measures. Patients
who fulfill inclusion criteria will be randomized to either continuous
monitoring using ILR plus standard monitoring (intervention arm) or
standard heart rhythm monitoring alone (control arm) with a ratio of 1:1.
The primary endpoint is the incidence of AF/AFL as first diagnosis in the
first 12 months of the study period. The study has been approved by Ethic
Committee.
Discussion: If positive, SAFFO trial could have important clinical impli-
cations in terms of changing standard diagnostic protocols in patients
with atherothrombotic or lacunar stroke and of increasing the shift of
secondary prevention treatment from antiplatelet to anticoagulant
therapy.
ESOC-0320
16. AF & Cardioembolism
Are new anticoagulants really as safe as it is said?
M Monteagudo1, E Fernández-Díaz1, I Díaz-Maroto1,
O Ayo-Martín1, J García-García1, S Segura1
1Neurology, Hospital General Universitario Albacete,
Albacete, Spain
Introduction: NOACs have drawn much attention in Medicine, particu-
larly in secondary prevention of stroke (SPS). In addition to advantages in
use, they have proven to be safer than warfarin in clinical trials. However,
it remains unclear if this safety profile is reproducible in routine clinical
practice.
Material and methods: We conducted a prospective descriptive study
including patients on Rivaroxaban in SPS admitted at our Stroke Unit in
the last 24 months with at least of 3 months of follow-up. Demographic
characteristics, HASBLED score and clinically significant bleeding were
recorded. Results were compared to those in the SPS subgroup of
ROCKET-AF study: clinically significant bleeding (CSB) (13.31%/year),
major bleeding (3.13%/year) and intracranial hemorrhage (ICH)
(0.59%/year).
Results: Eighty-nine cases were enrolled -median follow-up: 15 months
(IQR 9–21), median age: 77 yo (IQR 72–82), 52.8% females, median
HASBLED 3 (IQR 2–3), median time to initiation NOAC after stroke: 4
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days (IQR 1- 90). We observed 8 CSB (6.58%/year), 1 major bleeding
(0,82%/year) and 1 ICH (0.82%/year).
Conclusions: Despite Rivaroxaban was used in higher bleeding risk
patients (older than 80 years, lower delay of initiation after stroke and
higher HASBLED score) than the ROCKET-AF post-stroke population, in
our experience it appears to be as safe as it has been shown in the clinical
trial. We found a lower rate of CSB or major bleedings and a similar rate
of ICH. Current multicenter registries are conducted to confirm these
data.
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16. AF & Cardioembolism
Correlation between prothrombin fragment 1 + 2 and
routine coagulation tests in NVAF patients treated
with dabigatran and rivaroxaban
T Nagao1, M Yamazaki1, T Shiga2, K Kitagawa1
1Neurology, Tokyo Women’s Medical University School of
Medicine, Tokyo, Japan
2Cardiology, Tokyo Women’s Medical University School of
Medicine, Tokyo, Japan
Background: In non-valvular atrial fibrillation (NVAF) patients treated
with non-vitamin K antagonist oral anticoagulant (NOAC), no reliable
method for coagulation monitoring is established. We have reported the
usefulness of prothrombin fragment 1 + 2 (PF1 + 2) which is hemostatic
molecular marker indicating thrombin generation in NVAF patients
under warfarin anticoagulation. In this report, we evaluated the utility of
PF1 + 2 among NVAF patients taking NOACs.
Subjects and methods: We recruited 35 NVAF patients treated with either
dabigatran or rivaroxaban more than three months. Activated partial
thrombin time (aPTT), prothrombin time (PT) and PF1 + 2 were mea-
sured simultaneously from serial blood specimens. We evaluated the cor-
relation between PF1 + 2 value and aPTT ratio or PT ratio. Both ratios
were calculated as “patient value / control value”.
Results: Sixty-five specimens from 18 dabigatran patients (three females,
average 70.3 y/o) and 37 specimens from 17 rivaroxaban patients (five
females, average 65.5 y/o) were assessed. Whereas we found a statistically
significant correlation between PF1 + 2 and aPTT ratio (r = −0.67,
p < 0.0001) in patients treated with dabigatran, there was no correlation
between PF1 + 2 and PT ratio nor PT-INR in those with rivaroxaban.
Conclusion: The correlation between PF1 + 2 and routine coagulation test
differed between two NOACs. Difference of dosing time and coagulation
factor which both drugs are inhibiting may affect our results.
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16. AF & Cardioembolism
The efficacy of novel oral anticoagulants for the
secondary stroke prevention in the real world
T Nakase1, M Sasaki1
1Department of Stroke Science, Research Institute for Brain
and Blood Vessels -Akita, Akita, Japan
Novel oral anticoagulants (NOACs) have been recently released for the
prevention of embolic stroke recurrence. However, the benefits and safety
of NOACs in the real clinical world have not been fully understood. In this
study, for exploring whether there are any difference of outcome in stroke
patients between warfarin and NOACs, the embolic stroke patients with
newly prescribed anticoagulants were prospectively investigated.
Between July 2012 and June 2013, acute ischemic stroke patients who
started anticoagulant therapy were consecutively enrolled. All patients
were classified into warfarin, dabigatran and rivaroxaban treated groups
(W: n = 37, D: n = 33 and R: n = 42, respectively). The outcome in one
year was investigated at outpatient clinic or telephone interview. Recur-
rence of stroke and death were considered as the major outcome.
As the results, mRS at discharge was significantly lower in the D group
compared with W and R groups (p < 0.01: 1.2, 3.1 and 3.0, respectively).
Risk factors and renal function were not significantly different among 3
groups. The incidence of major outcome in one year was 29.9%, 12.6%
and 12.8% in W, D and R groups, respectively. Recurrence rate of ischemic
stroke in one year was 13.6%, 9.7% and 8.1% in W, D and R groups,
respectively. Most of stroke recurrence was the embolic stroke. However,
one lacunar infarction was observed in the D group and one intracerebral
hemorrhage was observed in the W group.
According to our data reflecting the real clinical world, both dabigatran
and rivaroxaban showed the better outcome and safety compared with
warfarin.
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Statin treatment is associated with improved
prognosis in patients with af-related stroke
G Ntaios1, V Papavasileiou1, K Makaritsis1, H Milionis2, E Manios3,
P Michel4, G Y H Lip5, K Vemmos6
1Department of Medicine, University of Thessaly, Larissa,
Greece
2Department of Internal Medicine, University of Ioannina,
Ioannina, Greece
3Department of Medicine, University of Athens, Athens,
Greece
4Service of Neurology, University of Lausanne, Lausanne,
Switzerland
5Centre for Cardiovascular Sciences, University of
Birmingham, Birmingham, United Kingdom
6Department of Internal Medicine, University of Athens,
Athens, Greece
Background/objectives: The most recent ACC/AHA guidelines recom-
mend high-intensity statin therapy in ischemic stroke patients of presum-
ably atherosclerotic origin. On the contrary, there is no specific
recommendation for the use of statin in patients with non-atherosclerotic
stroke, e.g. strokes related to atrial fibrillation (AF). We investigated
whether statin treatment in patientswith AF-related stroke is associated
with improved survival and reduced risk for stroke recurrence and future
cardiovascular events.
Methods: All consecutive patients registered in the Athens Stroke Registry
with AF-related stroke and no history of coronary artery disease nor
clinically manifest peripheral artery disease were included in the analysis
and categorized in two groups depending on whether statin was pre-
scribed at discharge. The primary outcome was overall mortality; the
secondary outcomes were stroke recurrence and a composite cardiovas-
cular endpoint comprising of recurrent stroke, myocardial infarction,
aortic aneurysm rupture or sudden cardiac death during the 5-year
follow-up.
Results: Among 1602 stroke patients, 404 (25.2%) with AF-related stroke
were included in the analysis, of whom 102 (25.2%) were discharged on
statin. On multivariate Cox-proportional-hazards model, statin treatment
was independently associated with a lower mortality (hazard-ratio
(HR): 0.49, 95%CI:0.26–0.92) and lower risk for the composite cardio-
vascular endpoint during the median 22 months follow-up (HR: 0.44,
95%CI:0.22–0.88), but not with stroke recurrence (HR: 0.47, 95%CI:0.22–
1.01, p: 0.053).
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Conclusions: In this long-term registry of patients with AF-related stroke,
statin treatment was associated with improved survival and reduced risk
for future cardiovascular events.
ESOC-0458
16. AF & Cardioembolism
Atrial fibrillation is associated with disturbed glucose
metabolism in patients with ischemic stroke and TIA
E Osei1, A A M Zandbergen2, G J J Plas1, P J A M Brouwers1,
P J Koudstaal3, D W J Dippel3, H M den Hertog1
1Neurology, Medisch Spectrum Twente, Enschede, Netherlands
2Internal Medicine, Ikazia Ziekenhuis, Rotterdam, Netherlands
3Neurology, Erasmus Medisch Centrum, Rotterdam, Netherlands
Objectives: The prevalence of atrial fibrillation (AF) is increased in type 2
diabetes. Whether prediabetes and newly-diagnosed diabetes are risk
factors for AF is controversial. We aimed to assess the prevalence of AF in
patients with ischemic stroke or TIA with prediabetes, newly-diagnosed
diabetes and pre-existent diabetes compared with normal glucose
metabolism.
Methods: We included 1380 patients with TIA or ischemic stroke. In all
nondiabetic patients, 2-hour post-load glucose levels were determined on
day 2–5. We defined prediabetes and newly-diagnosed diabetes according
to current guidelines. Pre-existent diabetes was defined as the use of oral
or parenteral anti-diabetic medication prior to admission. AF was defined
as a combination of known AF prior to admission and registered AF
during admission on an electrocardiogram or on 24-hour cardiac rhythm
observation. We studied the occurrence of AF in groups with different
glucose metabolism. Multiple logistic regression was applied to study the
associations between the glucose groups and AF.
Results: One hundred sixteen patients (8%) were known to have AF, and
38 (3%) had de novo AF. 372 patients (27%) had prediabetes, 277 (20%)
newly-diagnosed diabetes, and 301 (22%) pre-existent diabetes. AF was
more often present in patients with prediabetes (10%, p = 0.010), newly-
diagnosed diabetes (15%, p < 0.001), and pre-existent diabetes (12%,
p = 0.001) than in those with normal glucose metabolism (5%). Predia-
betes (aOR 1.7; 95% CI 0.8–3.6), newly-diagnosed diabetes (aOR 2.4; 95%
CI 1.2–5.0), and pre-existent diabetes (aOR 1.9; 95%CI 0.9–4.0) were
associated with AF.
Conclusion: Prediabetes and newly-diagnosed diabetes are risk factors for
AF.
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Early recurrence and cerebral bleeding in patients with
acute ischemic stroke and atrial fibrillation: Effect of
anticoagulation and its timing. The (RAF) study
M Paciaroni1
1Cardiovascular Medicine, Stroke Unit, Perugia, Italy for the
RAF Investigators
Background: Anticoagulation timing in acute cardioembolic stroke
remains controversial. In a prospective cohort of patients with acute
stroke and atrial fibrillation (AF), we evaluated: 1) the risk of recurrent
ischemic event and severe bleeding; 2) the risk factors for recurrence and
bleeding; 3) the risk of recurrence and bleeding associated with antico-
agulant therapy and its starting time after the acute stroke.
Methods: The primary outcome of this multicenter study was the com-
posite of stroke, transient ischemic attack (TIA), symptomatic systemic
embolism, symptomatic cerebral bleeding and major extra-cranial bleed-
ing within 90 days from acute stroke.
Results: Of the 1,029 patients enrolled, 123 had 128 events (12.6%): 77
(7.6%) ischemic stroke or TIA or systemic embolism, 37 (3.6%) symp-
tomatic cerebral bleeding and 14 (1.4%) major extra-cranial bleeding.
High CHA2DS2-VASc score, high NIHSS, large ischemic lesion and type
of anticoagulant were predictive factors for primary study outcome.
Patients treated with oral anticoagulants alone had a better prognosis
compared to those treated with low molecular weight heparins (LMWHs)
alone or followed by oral anticoagulants. At adjusted Cox regression
analysis, initiating anticoagulants 4 to 14 days from stroke onset was
associated with a significant reduction in primary study outcome, com-
pared to initiating treatment before 4 or after 14 days: Hazard Ratio 0.53
(95% CI 0.30–0.93).
Conclusions: Acute stroke in AF patients is associated with high rates of
ischemic recurrence and major bleeding at 90 days. Anticoagulant treat-
ment administered between 4 and 14 days from the acute event was
associated with improved functional outcome.
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Predicting the outcomes of acute ischemic stroke in
atrial fibrillation: The role of baseline CHADS2,
CHA2DS2-VASc and HAS-BLED score values
V Padjen1, D R Jovanovic2, I I Berisavac2, M D Ercegovac2,
P Stanarcevic1, M Stefanovic Budimkic1, L Beslac Bumbasirevic1
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Belgrade, Belgrade, Serbia
Objective: Atrial fibrillation (AF) related risk of stroke is commonly
assessed using the CHADS2 or CHA2DS2-VASc score, whilst the oral
anticoagulation-related bleeding risk can be estimated by the HAS-BLED
score. We investigated the association of these scores with outcomes of
AF-associated strokes, defined as symptomatic intracranial haemorrhage
(sICH), favourable outcome (modified Rankin Scale [mRS] 0–2) or death.
Methods: Analyses of prospective data on stroke patients with non-
valvular AF treated in the Stroke Unit from January 2009 to June 2012
were performed.
Results: Of 787 patients with an acute ischemic stroke, 131 had AF
(16.6%, median age 70, range 62–76 years). Of those, 6 patients (4.6%)
had sICH, 49 (37.4%) died and 55 (42.0%) had a favourable 90-day
outcome. HAS-BLED score of ≥3 was associated with sICH both in the
univariate analysis (OR 15.13;95%CI, 2.11–108.25, p = 0.007) and in the
multivariable model (OR 19.96;95%CI, 2.23–178.81, p = 0.007), which
also included the baseline neurological deficit score (NIHSS), intravenous
thrombolysis or the use of antiplatelet/anticoagulant therapy. The
CHADS2 and CHA2DS2-VASc scores were associated with 90-day mor-
tality in the univariate analyses (OR 1.47;95%CI, 1.11–1.95 and OR
1.36;95%CI, 1.08–1.69, respectively, both p = 0.008). The CHA2DS2-
VASc score was inversely related to the favourable outcome in the univari-
ate analysis (OR 0.80;95%CI, 0.65–0.99, p = 0.042).
Conclusion: HAS-BLED was found to have an independent predictive
value on the occurrence of sICH regardless of the treatment (thrombolysis
or conservative therapy). A trend toward statistical relation to the influ-
ence of the CHA2DS2-VASc values on the favourable outcome was
registered.
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Adherence to oral anticoagulant therapy in secondary
stroke prevention – impact of the novel oral
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Background: Oral anticoagulant therapy (OAT) potently prevents stroke
in patients with atrial fibrillation. After vitamin K antagonists (VKA) have
been the only OAT for decades, novel non-VKA oral anticoagulants
(NOAC) have entered the market during the last few years and stirred up
many questions, among them their influence on medication adherence.
We assessed the adherence to VKA and NOAC in secondary stroke
prevention.
Methods: We entered all patients treated for ischemic stroke or transient
ischemic attack from 10/2011–09/2012 at three academic centers with a
subsequent indication for OAT into a prospective registry and recorded
baseline data and antithrombotic treatment at discharge. At one-year
follow-up, we assessed current OAT to determine the adherence to differ-
ent OAT strategies. We noted OAT changes, reasons to change treatment
and factors that influence medication adherence.
Results: In patients discharged on OAT, we achieved a fatality-corrected
response rate of 73.3 % (n = 209). 92 % of these patients received OAT at
one-year follow-up. We observed good adherence to all three therapies
(VKA: 80.9 %; dabigatran: 70.9%; rivaroxaban: 83.3 %) with a statistically
non-significant tendency towards a weaker adherence to dabigatran. Dis-
ability at one-year follow-up was an independent predictor of lower
adherence to any OAT after multivariate analysis whereas the choice of
OAT did not have a relevant influence.
Conclusions: One-year adherence to OAT after stroke is strong (>90%)
and patients who switch therapy most commonly switch towards another
OAT. The one-year adherence rates to VKA and NOAC in secondary
stroke prevention do not differ significantly.
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Spontaneous hyperdense M1 sign is predictive of
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Introduction: Spontaneous hyperdense M1 middle cerebral artery sign
(HM1S) in non-contrast CT (NCCT) in patients with acute ischemic
stroke (AIS) has a high specificity for middle cerebral artery occlusion.
“Red” thrombi produce a higher attenuation in NCCT than “white”
thrombi, but there is no consensus regarding their most likely source. Our
aim was to study the association of HM1S with stroke etiology.
Methods: Retrospective study of all patients admitted in our hospital for
anterior circulation AIS during 2013. Review of clinical records and
admission NCCT images. Identification of HM1S, quantification of
Hounsfield Units (HU) of HM1S and HM1S / contralateral MCA HU
ratio. Patients with incomplete etiological investigation were excluded.
Results: Among 322 patients with anterior circulation AIS, 78 had HM1S
on admission NCCT. Patients with HM1S were more frequently female
(p = 0.003), diabetic (p = 0.036), had higher NIHSS scores (p < 0.001) and
higher in-hospital mortality (p = 0.006). Cardioembolic etiology was
found in 60 patients (76.9%) with HM1S and in 136 patients (55.7%)
without HM1S (OR = 2.65, 95%CI = 1.47–4.78, p = 0.001). Logistic
regression adjusted for NIHSS and age showed that presence of HM1S was
independently associated with cardioembolic etiology (OR = 2.30,
95%CI = 1.01–5.25, p = 0.047).
Conclusion: Patients with HM1S present more severe deficits and have
higher in-hospital mortality, similar to what is reported in the literature.
This study suggests that HM1S in NCCT is a predictive sign of cardioem-
bolic etiology of stroke, which is independent of stroke severity and age.
Main limitations of this study are its retrospective design and absence of
systematic confirmation of large vessel occlusion using other methods.
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Background: Multiple methods to detect paroxysmal atrial fibrillation
(pAF) in acute stroke patients are available. However, it is unknown which
approaches are performed in daily clinical routine to unveil pAF and
recommendations by guidelines remain vague to the extent of recom-
mended cardiac monitoring. We aimed to characterize the current diag-
nostic efforts for pAF detection on Stroke Units (SU) in Germany.
Methods: A standardized anonymous questionnaire was sent to all clinical
leads of 250 certified SUs. The questionnaire focused on basic character-
istics of SUs, procedures to detect AF and estimates on AF detection.
Results: 179 SU leads participated (response rate 72%). All patients
underwent mandatory continuous bedside ECG monitoring (CEM), and
78% of SUs initiated additional 24 h Holter ECG in >50% of patients
without known AF. Monitoring of TIA patients was significantly shorter
compared to patients with ischemic stroke. Independent of stroke unit
type or size, 68% of leads assumed to fail detecting pAF in 5–20% of
patients. In cryptogenic stroke, additional ECG monitoring was recom-
mended by 90% but only 14% of all SUs performed routine ECG
follow-up visits for these patients. The use of implanted event recorders
was low (1–10 patients/year by 61% of SUs), 28% did not use implanted
event recorders, and 84% did not use external event recorders.
Conclusions: Our survey demonstrates substantial heterogeneity among
German SUs with regard to diagnostic work-up for pAF detection. Future
multicenter studies should focus on systematic evaluation of different
methods to uncover pAF during inpatient management and thereafter.
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young acute ischemic stroke patients can be
associated with presence of relevant cardiac source of
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Background and purpose: In young ischemic stroke (IS) patients, the cause
of IS remains often unclear. An extensive and time-consuming diagnostic
setting is needed for reliable exclusion of relevant cardiac abnormities as
the source of emboli. The aim was to evaluate whether the admission
elevation of specific serum cardiac markers (CM) in young acute IS
patients may be associated with the presence of relevant cardiac source of
emboli.
Methods: The study set consisted of acute IS patients <50 years enrolled in
the prospective HISTORY (Heart and Ischemic STrOke Relationship
studY) study. In all patients, brain ischemia was confirmed on CT/MRI.
Admission ECG, serum CM (N-terminal pro-brain natriuretic peptide
and high sensitive Troponin T), transoesophageal echocardiography
(TEE), 24-hour and 3 week ECG-Holter were performed in all patients.
Results: Out of 695 patients enrolled in the HISTORY study, 112 (58
males, mean age 40 ± 7.9 years) were <50 years. In total, 21 (19%) patients
had elevated serum CM at admission. Relevant cardiac abnormities were
detected in 12 (57%) patients with elevation of serum CM and in 2 (2%)
with normal level of serum CM (p < 0.0001). Atrial fibrillation including
paroxysmal was detected in 10 (71%) patients, other three patients had
ischemic coronary disease and one patient had severe valve defect.
Conclusion: Young acute IS patients with elevated serum CM had more
frequently relevant cardiac abnormities with embolic potential. Study
was supported by the IGA MH CR grants NT11046-6/2010 and
NT14288-3/2013.
Clinical Trial Registration: http://www.clinicaltrials.gov. Unique identi-
fier: NCT01541163.
Abstracts
© 2015 The Authors.
International Journal of Stroke © 2015 World Stroke Organization Vol 10 (Suppl. 2); April 2015; 77–438278
ESOC-0148
16. AF & Cardioembolism
Predictors of previously unknown atrial fibrillation in
acute ischemic stroke – a substudy of the Troponin
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Background: Detection rates of paroxysmal atrial fibrillation (AF) after
acute ischemic stroke increase with duration of ECG monitoring. Until
now, it is unknown which patient group may benefit most from intensive
monitoring strategies. Therefore, we aimed to identify predictors of pre-
viously unknown AF during in-hospital ECG monitoring.
Methods: All consecutive patients with imaging-confirmed ischemic
stroke admitted to our tertiary care hospital from February 2011 to
December 2013 were registered prospectively. Patients received continu-
ous bedside ECG monitoring for at least 24 h. Detection of previously
unknown AF during in-hospital ECG monitoring was obtained from
medical records. Patients with AF on admission ECG or known history of
AF were excluded from analysis.
Results: Among 1228 patients (median age 73, median NIHSS 4, 43.4%
female), previously unknown AF was detected in 114 (9.3%) during a
median time of continuous ECG monitoring of 3 days (IQR2–4). Dura-
tion of monitoring (p < 0.01), older age (p < 0.01), history of hyperten-
sion (p = 0.03), insular cortex involvement (p < 0.01) and higher high-
sensitivity cardiac troponin T (hs-cTnT, p = 0.04) on admission were
independently associated with subsequent detection of AF in a multiple
regression analysis. Addition of hs-cTnT, insular cortex stroke or both to
the CHADS2-score significantly improved c-statistics from 0.63 to 0.68
(p = 0.01), 0.70 (p < 0.01) and 0.72 (p < 0.001), respectively.
Conclusions: Insular cortex involvement, higher admission hs-cTnT, older
age, hypertension, and longer monitoring are associated with new detec-
tion of AF during in-hospital ECG monitoring. Patients with higher
hs-cTnT or insular cortex involvement may be candidates for prolonged
ECG monitoring.
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Background: It is important to prophylactically treat cardioembolic
stroke, which can arise from non-valvular atrial fibrillation (NVAF), with
oral anticoagulants. However, dozens of acute cardioembolic stroke
patients are admitted to our hospital each year, without stroke prevention.
In 2011, the novel oral anticoagulant (NOAC) was approved, which was
expected to improve the prevention of cardioembolic stroke from NVAF.
Methods: We investigated acute cardioembolic stroke patients from April
2008 to September 2014, in two groups: 1) the before NOAC group: BN,
from April 2008 to March 2011, before NOAC was approved and 2) the
after NOAC group: AN, from October 2011 to September 2014, after
NOAC was approved. We investigated the number of patients, CHADS2
score, anticoagulant usage, NIHSS score on admission, mRS on discharge
and ischemic dimension on MRI between the two groups.
Results: There were 325 and 352 patients in the BN and AN groups,
respectively. High-risk NVAF patients (CHADS2 score ≥2) represented
67.6% and 87.5% of the BN and AN groups. The proportions of high-risk
NVAF patients treated with appropriate anticoagulation were 6.8% and
12.6% in the BN and AN groups, respectively (p = 0.028). The patients
who took appropriate anticoagulants exhibited lower NIHSS on admis-
sion (3.5 vs.14: p < 0.001), lower mRS on discharge (2 vs.4: p < 0.001) and
smaller ischemic dimension on MRI (28.4 ± 39.3 mm vs. 54.8 ± 42.4 mm:
p < 0.001).
Conclusions: We concluded that anticoagulant therapies for stroke pre-
vention had spread since NOAC was approved in our hospital. Further-
more, cardioembolic stroke patients who took appropriate anticoagulants
tended to exhibit a less severe illness.
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anticoagulation for atrial fibrillation in a district
general hospital
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Introduction: There has been increased publicity in the UK regarding the
importance of anticoagulation of AF patients as a stroke prevention
measure even if they are at risk of falls. Our audit assessed the anticoagu-
lation practice for AF patients in Scarborough General Hospital- a district
general hospital.
Methods: A “snapshot” audit conducted in September 2014 identified all
the AF patients on admission in the general medical and rehabilitation
wards over a 24 hour period. Data collected and analysed include age,
stroke risk and bleeding risk scores, anticoagulants prescribed, contrain-
dications to anticoagulants, falls and discharge instruction with respect to
anticoagulation.
Results: Forty-nine patients recruited of which 35 (71,42%) were elderly.
21 patients were on anticoagulants- 14 on warfarin and 7 on Novel Oral
Anticoagulants (NOAC). 10 of the 28 not anticoagulated had a valid
contraindication to anticoagulation and 2 of these patients were later
commenced on NOAC. 18 patients were not anticoagulated with no valid
reason. 13 of these patients were not anticoagulated because of history of
falls. Only 5 patients had their CHA2DS2-VASC score documented and
none had HAS-BLED score documented.
Conclusion: Our audit results conform to previous studies and shows
most of the patients in AF are elderly with a significant percentage being
at risk of falls. The audit suggests falls is still taken as a contraindication to
anticoagulation by many physicians in our hospital even though recent
guidelines such as the NICE AF guidelines suggest otherwise. There was
poor documentation of stroke and bleeding risk scores.
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Background: Anticoagulation has been underused in primary prevention
of stroke in older individuals with atrial fibrillation (AF). Publication of
the Birmingham Atrial Fibrillation Treatment of the Aged (BAFTA) Trial
in 2007 provided strong evidence of safety and effectiveness of warfarin at
age ≥ 80 years, but the impact on incidence of AF-related ischaemic stroke
and peripheral embolic vascular events is uncertain.
Methods: We studied age-specific incidence and outcome of all AF-related
strokes and systemic emboli from 2002–2012 in a population-based study
of all acute vascular events (Oxford Vascular Study).
Results: Of 3096 acute cerebral or peripheral vascular events, 748 (24.2%)
were AF-related. Of the 597 disabling or fatal incident ischaemic strokes,
262 (43.9%) were AF-related. There was no reduction in number of
AF-related incident events between 2002–2007 and 2007–2012 at all ages
(n = 223 vs 231; adjusted RR 1.11, 0.91–1.36, p = 0.29) or at age ≥80 (137
vs 135, adjusted RR 1.15, 0.94–1.40, p = 0.17). Scope for improved pre-
vention at older ages was considerable. Among 208 patients with incident
AF-related events at age ≥80 and known prior AF, only 19 (9.1%) were
anticoagulated prior to their event. Of the 189 patients not anticoagulated,
166 (87.8%) had no major disability prior to the event and 167 (88·4%)
had an embolism risk score favouring treatment, of whom 139 (83.2%)
were also at low risk of complications. Yet, 125/167 (74.9%) were dead or
institutionalised after the event.
Conclusion: There had been no reduction in the incidence of AF-related
vascular events since publication of the BAFTA trial.
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Background: Atrial fibrillation (AF) is common and associated with
increased stroke risk. Anticoagulation is an effective therapy, but fear of
hemorrhagic complications leads to under treatment of AF in the com-
munity. We investigated population rates of ischemic and hemorrhagic
strokes as well as mortality in newly diagnosed AF patients in the province
of Alberta, Canada.
Methods: We used administrative data to conduct a population-based
cohort study of chronic non-valvular AF. We included new-onset AF
patients in 2009–2010 with follow-up through December 31 2013. We
assessed anticoagulation status as a predictor on stroke and death, using
time-to-event analysis and adjusted for sex and CHADS2 score using Cox
proportional hazards modeling.
Results: Ten thousand seven hundred forty-five patients were identified.
68.5% received anticoagulation. Amongst the 747 patients with prior
ischemic stroke, 28.5% were diagnosed with AF at the time of stroke.
Multivariable analysis confirmed that anticoagulation is associated with
significantly decreased ischemic stroke (HR 0.38, 95%CI [0.32–0.46], all
stroke (HR 0.42, 95%CI [0.35–0.50]), and all stroke and death (HR 0.14,
95%CI [0.13–0.16]). Anticoagulation was associated with significantly
lower hemorrhagic events (HR 0.58, 95%CI [0.63–0.92]) but was neutral
in the subgroup of patients without prior stroke (HR 0.67, 95% CI
[0.40–1.12]).
Conclusions: Anticoagulation is an effective and safe stroke prevention
strategy and decreases mortality in AF patients in a real-world practice.
Further studies to evaluate AF screening in stroke prevention and to
determine the optimal therapy in patients at high risk of intracerebral
hemorrhage would be of interest.
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Cardiac diseases are known risk factors of ischemic stroke (IS). Con-
versely, there is increasing evidence that brain ischemia can cause cardiac
dysfunction, in particular during the acute phase. In contrast, little is
known about the delayed consequences of IS on cardiovascular function.
We hypothesized that IS can induce long term systolic dysfunction (SD) in
mice and men that might be modifiable by therapeutic interventions.
In the experimental part of the study, focal cerebral ischemia will be
induced in mice by middle cerebral artery occlusion (MCAO). Cardiac
function will be monitored by serial echocardiography until week 8 after
stroke and correlated with neurological outcomes. In addition, hemody-
namic measurements, determination of sympathetic activity and bio-
marker studies will be performed. In the clinical part, we will estimate the
prevalence of SD after IS in acute stroke patients. Furthermore the natural
course of SD up to 6 months after IS will be determined.
Our initial investigations revealed that cardiac ejection fraction was sig-
nificantly reduced 8 weeks after MCAO while heart blood volume, BNP-
and TNFα-gene expression levels were elevated, thereby reflecting features
of chronic SD. In the first year of the clinical study, about 250 IS patients
were recruited, 89% underwent echocardiography. SD was observed in
14% during the acute phase.
Our preliminary results suggest that IS can foster the development of SD.
Additional experiments in aged and comorbid mice as well as interven-
tional studies are currently ongoing. The clinical study continues to enroll
patients and the first patients already underwent follow-up examinations.
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assessment in transient global amnesia
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Transient global amnesia (TGA) is a syndrome defined by the sudden
onset of an isolated anterograde and retrograde amnesia, spontaneously
resolved within less than 24 hours. Its aetiological mechanisms are still
open to question. The aim of this study was to describe the MRI charac-
teristics and the vascular assessment of a prospective cohort of patients
presenting with TGA at the Besançon emergency services. This analysis
involved 11 prospectively included patients, with a mean age of 63 (50–76)
and a sex ratio of 1:10. The TGA diagnosis was given on the basis of the
clinical criteria. The parameters studied were the demographic and clini-
cal data, the brain MRI and the vascular assessment. Seven patients had a
cardiovascular risk factor. The MRI was abnormal in 10 patients. There
were hippocampal hyperintense lesions on diffusion-weighted imaging in
eight patients, including one bilateral and one with an extra-hippocampal
hyperintensity. Atrial fibrillation was diagnosed in two patients, leu-
koaraiosis in six, and carotid atheroma in three. The MRIs at 48 hours and
at one month respectively showed five and two new lesions. If age, ictal
onset and MRI anomalies during the TGA’s acute phase are arguments in
favour of a vascular mechanism, then there is no such evidence today.
Despite its small population size, this study challenges the relevance of the
completion of a systematic cardiovascular assessment after a TGA. It is no
longer acknowledged as purely functional. It should perhaps be consid-
ered as a sign whose vascular aetiology must be urgently explored.
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Aims: To determine whether atrial fibrillation (AF) is associated with
impaired cognition and to determine the correlation between thrombo-
embolic risk and the cognitive impairment.
Methods: One hundred ninety patients with atrial fibrillation and no
history of stroke were consecutively examined. All cases underwent physi-
cal examination, blood chemistry, ECG, echocardiography. To investigate
the cognitive status, subjects underwent the neuro-psychological rating
scale Mini Mental State Examination (MMSE).
Results: The subjects (190) (mean age 70.1 ± 0.65 years; 56% Women)
were stratified according to ECG features into 3 groups: (1) those with de
novo AF(2.8%), (2) those with paroxysmal AF (18.4%), and (3) with
chronic AF (78.9%). Cognitive status was found to be different in the 3
groups: group 1- 28.1 ± 1.9; group 2–25.9 ± 2.9; and group 3–24.9 ± 2.9
(P < 0.01). Thromboembolic risk (according to CHA2DS2-VASc) was
similar between groups (3.1 ± 0.6 in chronic AF vs. 2.9 ± 0.8 in paroxys-
mal AF and 1.9 ± 0.2 in de novo AF, p = 0.05). There was a association
between thromboembolic risk and the presence of cognitive disturbances
(MMSE < 26) (8.7% low risk, 21.4 % moderate risk, and 48% high risk,
p < 0.05). Brain CT has shown lacunar changes or multiple cerebral isch-
emic areas in 52% of patients with cognitive disturbances. Among 56
patients with CHA2DS2-VASc score = 1 twelve of them (21.4%) have had
MMSE – 26/30, with lacunar in 3/12 (25%).
Conclusions: Cognitive dysfunction is common in elderly patients with
atrial fibrillation. The MMSE additionally to CHA2DS2-VASc identifies
patients with atrial fibrillation who need oral anticoagulation and also
extra efforts to maintain it effective and improve outcomes.
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Incidence and risk factors for recurrent stroke after
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Objective: Preventing stroke after CABG remains a therapeutic goal. The
aim of this study was to identify incidence and risk factors for recurrent
stroke in elderly CABG patients with a previous history of stroke.
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Methods: Between October 2001 and December 2011, 418 elderly patients
(age >/ = 65 years) with history of stroke, underwent CABG at our center
and divided into two groups according to the occurrence of recurrent
postoperative stroke. Pre-operative and post-operative data were retro-
spectively collected and analyzed by univariate and multivariate logistic
regression analysis.
Results: Fifty-two patients (12.44%) suffered post-operative recurrent
stroke. Univariate analysis identified several statistically significant risk
factors in the post-operative recurrent stroke group, including on-pump
surgery, post-operative AF, and hypertension. Multivariate analysis iden-
tified several independent risk factors for recurrent stroke: unstable
angina (odds ratio (OR) = 2.79, 95% CI: 1.13–7.28), use of cardiopulmo-
nary bypass , (OR = 2.77, 95% CI: 1, 35–9,62), atrial fibrillation
(OR = 4.69, 95% CI: 1.89–11.63), and systemic inflammatory response
(OR = 2.55, 95% CI: 1.07–6.04)
Conclusion: Unstable angina, use of cardiopulmonary bypass, post-
operative AF and systemic inflammatory response are independent risk
factors of recurrent stroke in CABG patients (age >/ = 65 years) with a
previous history of stroke.
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Haematological and urinary parameters are useful in monitoring clinical
conditions and predict prognosis in cerebrovascular diseases. However,
they reflect more the chronicity than the acuity (Fiori P. et al, 2014).
The aim of our study is to assess the predictive values and the correlations
between such parameters, clinical, echocardiographic and radiological
findings.
So far we recruited 264 patients affected with Acute Stroke (AS), 177 with
Chronic Cerebrovascular Disease (CCVD), 59 with Other Neurological
Disease (OND). We classified them in subgroups according to the
severity of neurological and heart dysfunctions, evaluated by Glasgow
Coma (GCS) , Glasgow Outcomes (GOS), Modified Rankin (MRS),
CHAD2DS2VAsc, HAS BLED, Hachinski scales, New York Heart
Association (NYHA) and American Cardiology Association (ACA) scales.
Moreover, within the AS group, we identified patients without or with
concomitant CCVD at Computerized Tomography and/or Magnetic
Resonance Imaging.
Preliminary results show higher levels of Erythrosedimentation Rate, C
Reactive Protein, Troponin ths, NT-Pro-Brain Natriuretic Peptide, urea,
creatinaemia, proteinuria, urinary polyclonal light chains, ejection frac-
tion, pulmonary arterial pressure and left atrial dilatation in AS and
CCVD, especially in patients affected with both conditions and severe
cardiac dysfunctions (class III/C, IV/D). The most significant correlations
were found among cardiac markers and CHAD2DS2VAsc, Hachinski and
Modified Rankin scales, urinary parameters, GCS and GOS.
In conclusions, the acuity in the chronicity of brain/heart dysfunctions is
an extreme challenge neurology has to win.
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Feasibility and diagnostic accuracy of point-of-care
handheld echocardiography in ischemic stroke patients
treated at an acute stroke unit
A Fleischer1, S Wiedmann1, P Kraft2, S Störk3, U Malzahn1,
S Hillmann1, D Mackenrodt2, C Kleinschnitz2, P Heuschmann1
1University of Würzburg, Institute of Clinical Epidemiology
and Biometry, Würzburg, Germany
2University Hospital Würzburg, Department of Neurology,
Würzburg, Germany
3University Hospital Würzburg, Comprehensive Heart Failure
Center, Würzburg, Germany
Background: Guidelines recommend echocardiography for patients with
suspected cardiac embolic stroke as part of diagnostic work-up. However,
access to adequate echocardiography is often limited. We investigated
diagnostic performance of a bedside point-of-care ultrasound device
(“hand-held-echo”) compared to a state-of-the-art transthoracic
echocardiography.
Methods: Hand-held-echo was performed at an acute stroke unit within
72 hours after ischemic stroke onset by a technician who had received an
intensive structured echocardiographical training. Basic cardiac param-
eters were assessed focussing on left heart dimensions, wall thickness,
ejection fraction (EF), major valve abnormality, and pericardial effusion.
Within 48 hours of hand-held-echo, patients received a standardized tran-
sthoracic echocardiography by an experienced echo-technician as refer-
ence standard. The test performance of the results of both examinations
was compared.
Results: Seventy-eight consecutive ischemic stroke patients were
included. Investigation was performed with sufficient imaging quality and
without any other problems in 83% of hand-held and 86% of standard
echocardiography. Intraclass-correlation coefficient of interrater reliabil-
ity between hand-held and standardized echocardiography was for: EF
0.78 (95% 0.67–0.86); septal left-ventricular wall thickness (LVWT) 0.84
(0.76–0.89); posterior LVWT 0.88 (0.81–0.92); systolic LV diameter (LVD)
0.93 (0.89–0.96); diastolic LVD 0.85 (0.77–0.90). Sensitivity of hand-held-
echo for detecting an EF < 55% was 100%, specificity 84.4%, area-under-
the-ROC-curve 0.98 (95%CI 0.96–1.00). One pericardial effusion was not
detected by hand-held-echo. No other major differences were found
between hand-held and standard echo results.
Conclusion: Hand-held-echocardiography was demonstrated to be a reli-
able screening tool for the detection of clinically relevant cardiac dysfunc-
tion in stroke patients potentially benefitting from a more detailed
cardiologic examination.
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Relationship between insular cortex infarction and
newly diagnosed atrial fibrillation
E Alba-Suárez1, P Martínez-Sánchez1, B E Sanz-Cuesta1,
C Calle de Miguel1, J Rodríguez-Pardo1, J Pérez-Lucas1, I Illán-Gala1,
FJ Díaz de Terán1, B Fuentes1, E Díez-Tejedor1
1NEUROLOGY, UNIVERSITY HOSPITAL LA PAZ, Madrid, Spain
Introduction and objective: Newly diagnosed atrial fibrillation (NDAF)
after a cerebral infarction (CI) could be a consequence of the insular
injury and not previous to the CI. Our aim was to analyse whether the
insula is affected more frequently when the atrial fibrillation (AF) is
diagnosed after the CI than when it is previously known.
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Methods: Observational study of stroke patients admitted to a Stroke
Centre (2010–2014). Variables: basal and clinical data, prior or newly
diagnosed AF, stroke severity (NIHSS), CI with insular involvement in
neuroimaging and stroke subtypes. Multivariate models were performed
to evaluate the association between AF and insular involvement.
Results: 1004 patients were included, 58.2% male, mean age 70.65 years.
The involvement of the insula was similar in patients with prior AF vs.
NDAF (34.8 vs. 33.5%) and greater than in those without AF (17.6%)
(P < 0.0001). Left atrial enlargement was more frequent in patients with
known AF and NDAF than in those without AF (74.6%, 60.6% and 38.6%,
P < 0.0001). Multivariate analysis showed that AF (both, known and
newly) was associated with insular infarction (OR 1.472; 95% CI 1.016–
2.131) as well as diabetes mellitus (OR 1.863; 95% CI 1.243–2.792), and
NIHSS on admission (OR 1.121; 95% CI 1.095–1.146).
Conclusion: The insular involvement in patients with CI is similar in
those with known and newly diagnosed AF. This suggests that NDAF is
probably previous and not a consequence of CI.
ESOC-0840
17. Brain-Heart Interactions
Frequency of left ventricular dysfunction in stroke
patients and its impact on outcome
B E Sanz-Cuesta1, B Fuentes1, P Martínez-Sánchez1,
T López-Fernández2, J J Arévalo-Manso1, F J Díaz de Terán1,
I Illán-Gala1, J J Rodríguez-Pardo1, E M Alba-Suárez1,
C Calle de Miguel1, J J Pérez-Lucas1, J U Mañez-Miró1,
E Miñano-Guillamón1, E Díez-Tejedor1
1Neurology, University Hospital La Paz, Madrid, Spain
2Cardiology, University Hospital La Paz, Madrid, Spain
Background: Severe left ventricular systolic dysfunction (LVSD) is associ-
ated with increased morbidity and mortality in ischemic stroke (IS).
However, it’s unknown whether the left ventricular dysfunction (LVD)
including mild to moderate LVSD and left ventricular diastolic dysfunc-
tion (LVDD) could influence IS outcome. Increasing left ventricular filling
pressure (LVFP) is an echocardiographic finding which is present in both
types of LVD of any severity. Our objective was to analyse the frequency of
LVD in IS patients and its impact on outcome.
Methods: Retrospective observational study. Study period: 2010–2014.
Demographics, vascular risk factors, results of diagnostic tests, reperfu-
sion treatments and outcome at 3 months (unfavourable if mRS > 2) were
prospectively collected. The results of transthoracic echocardiography
(TTE) including left atrial enlargement (LAE), increasing left ventricular
filling pressure (LVFP) and left ventricular ejection fraction (LVEF) were
recorded. A predictive model of factors associated with unfavourable
outcome was generated.
Results: Four hundred fifty-nine IS patients with complete LVD param-
eters measured by TTE were included. Mean age 67.8 years, 60.3% male.
TTE showed data of LVD in up to 211 patients (46%), LVSD in 38 (8.3%)
and LVDD in 191 (41.6%). Overall, 70 patients (15.2%) had mRS > 2 at 3
months being increased LVFP associated with unfavourable outcome (OR
2.209, 95% CI 1.135- 4.299, p < 0.020) after adjustment for diabetes mel-
litus, stroke severity and in-hospital complications.
Conclusion: LVD is present in almost half of the ischemic stroke and it is
associated with poor outcome at 3 months. Increased LVFP could be a
marker of poor outcome in IS patients.
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Percutaneous closure of patent foramen ovale in
cryptogenic cerebral ischemia: The data of the Turin
Molinette Registry
D Giobbe1, A Balducci1, G Paglia1, P Scacciatella2, G L Alunni2,
M Giorgi2, I Meynet2, S Marra2
1Neuroscienze e Salute mentale, AOU Città della Salute e
della Scienza Torino, Turin, Italy
2Cardiotoracico, AOU Città della Salute e della Scienza Torino,
Turin, Italy
Objective: To describe the results of the endovascular treatment in
patients affected by cryptogenic cerebral ischemic events (CCIE), Patent
Foramen Ovale (PFO) and associated high risk conditions such as intera-
trial septal aneurysm, hypercogulable state, multiple ischemic events, large
shunt or shunt at rest.
Patients and methods: Two hundred six patients were studied; protocol
included clinical and lab examinations, neuroimaging, duplex scanner,
transthoracic (TTE) and transesophageal echocardiography (TEE). Anti-
platelet agents were employed before and after closure. An Amplatzer
PFO-occluder was positioned in 95% of cases. The follow up included a
cardiological and neurological reevaluation at 1 and 6 months and sub-
sequently every 6 months, a TTE at 1 month, a TEE at 6 months.
Results: The success rate was 100%. In the periprocedural time a transient
paroxistic atrial arrythmia was observed in 4 pts and 1 TIA occurred; no
residual large shunts or hemorrhagic events were identified. During a
mean follow up of 32,6 months 9 small and 3 severe residual shunts were
identified, 1 stroke and 1 TIA, 5 transient arrhythmias and an interatrial
sept erosion occurred, 3 pts underwent surgery.
Conclusions: According to recent metanalyses (Rengifo-Moreno, Pickett,
Stortecky) in our group endovascular closure of PFO proved safe and
effective in the short and mid term. It seems promising the TIA-Stroke
annual Recurrence Rate (RR) resulted 0,36% and the stroke annual RR
0,18%, considerably lower than reported in previous literature. (Mas 4,8
and 3,8%, Nedeltchev 9,9% CCIE, Anzola 8,2% CCIE, Almekhlafi 4 and
1,6%, the FORI Study 4,2 and 3,4%, Furlan 3%).
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Vascular risk factors as predictors of pathological
biomarkers in cerebrospinal fluid 1 year post-stroke
H Ihle-Hansen1, G Hagberg1, M Ursin1, A R Øksengård1, B Fure2
1Bærum Hpspital Medical dep, Vestre Viken HT, Drammen,
Norway
2Research dep, The Norwegian Knowledge Centre for the
Health Services, Oslo, Norway
Background: Post-stroke cognitive impairments may be related to vascu-
lar, degenerative or mixed disease. Pathological values of total-tau,
phosphorylated-tau and β-amyloid in the cerebrospinal fluid (CSF) indi-
cate neurodegenerative disease mechanisms. Vascular factors are thought
to contribute to vascular dementia, and in the cascade of degenerative
pathology. We aimed to evaluate if vascular risk factors present at onset of
stroke symptoms predict pathological CSF biomarkers one year post-
stroke, adjusted for possible effects of genetic risk and stroke severity.
Method: We included patients with first-ever stroke and TIA. Baseline
examination included assessment of exposure to vascular risk factors
(hypertension, hyperlipidemia, diabetes, body mass index, smoking and
atrial fibrillation). After 12 months, biomarkers in CSF were assessed. The
main outcome was pathological biomarkers, defined as pathological
values in one or more of the CSF-biomarkers. The association between
vascular risk, age, gender, education, stroke severity and Apolipoprotein
E4 (ApoE4) and the outcome was studied using logistic regression.
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Results: One hundred ninety-eightpatients completed the follow-up. 56
had a lumbar puncture. In the univariate analyses, age (p = 0.018) and
ApoE4 (p = 0.044) were significantly associated with pathological bio-
markers, but in the multivariate analyses, there were no significant asso-
ciations between the risk factors and the outcome (p = 0.061–0.147).
Discussion: One year post-stroke, there was no association between vas-
cular risk factors and pathological biomarkers in CSF. We could not
confirm the hypothesis that vascular risk factors are related to neurode-
generative processes with pathology in CSF after stroke.
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Left ventricular hypertrophy is associated with
cerebral white matter hyperintensity in patients with
acute ischemic stroke and transient cerebral ischemic
attack
J Lee1, H Noh1, N Kim1, J Kwon1
1Neurology, Yeungnam UniversitySchool of Medicine, Daegu,
Korea
Objectives: We aim to investigate whether WMHs on MRI are indepen-
dently associated with LVH in patients with acute ischemic stroke or
transient cerebral ischemic attack (TIA).
Methods: We included consecutive acute ischemic stroke or TIA patients
who were admitted within 7 days after onset of symptoms and underwent
MRI and transthoracic echocardiography (TTE). LVH was defined as a
left ventricular mass index (LVMI) on TTE of >115 g/m2 for men and
>95 g/m2 for women. WMHs were rated according to the modified
Fazekas scale (grade 0, 1, 2, and 3) on the baseline MRI.
Results: A total of 841 patients was analyzed. LVH and 4th quartile of
LVMI were associated with grade 2 (OR 2.3, 95% CI 1.1 to 5.0 and OR 3.2,
95% CI 1.4 to 7.2) and grade 3 (OR 2.5, 95% CI 1.1 to 5.9 and OR 2.7, 95%
CI 1.1 to 6.6). Binary logistic regression analysis (WMH grade 0–1 versus
grade 2–3) showed that age per year (OR 1.09, 95% CI 1.07 to 1.12,
p < 0.001), hypertension (OR 1.8, 95% CI 1.2 to 2.7, p = 0.004), previous
stroke or TIA history (OR 2.3, 95% CI 1.5 to 3.4, p < 0.001) and increased
LVMI per 10 g/m2 (OR 1.15; 95% CI 1.06 to 1.24, p < 0.001) were inde-
pendently associated with grade 2–3 WMH.
Conclusions: These findings demonstrate that higher LVMI or LVH are
independently associated with moderate to severe WMHs in acute isch-
emic stroke and TIA patients regardless of the presence of established
cardiovascular risk factors.
ESOC-0966
17. Brain-Heart Interactions
Comparison of risk factors for stroke subtypes versus
acute coronary syndrome: A population-based study
C Mettananda1, L Li1, L M Bull1, E McCulloch1, S J Welch1,
L E Silver1, S Gutnikov1, Z Mehta1, P M Rothwell1
1Nuffield Department of Clinical Neurosciences, University of
Oxford, Oxford, United Kingdom
Background: Stroke and acute coronary syndromes (ACS) share risk
factors, but population-based data on differential associations with stroke
subtype and ACS are limited. We studied pre-morbid risk factors in stroke
subtypes and acute coronary syndrome.
Methods: We studied all first-ever TIA/strokes and ACS from 2002–2012
in a population-based cohort (Oxford Vascular Study). Risk associations
were compared by logistic regression, adjusted for age and sex, for
hypertension, diabetes mellitus, hyperlipidaemia, atrial fibrillation,
current smoking and over-weight (BMI > 25).
Results: One thousand nine hundred thirteen TIA/ischaemic strokes
(mean age 71.6 years, women 53.9%), 112 intracerebral haemorrhages
(ICH) (mean age 71.0 years, 51.8% women) and 1191 ACS (mean age
71.35 years, 35.4% women) were studied. Compared to ACS, hypertension
(adjusted OR = 1.34, 95%CI = 1.15–1.56, p < 0.001), hyperlipidaemia
(1.27, 1.07–1.50, p = 0.006) and atrial fibrillation (1.40, 1.12–1.76,
p = 0.004) were more strongly associated with TIA/ischemic stroke than
with ACS. However diabetes mellitus (0.71, 0.57–0.88, p = 0.002), current
smoking (0.62, 0.51–0.75, p =< 0.001) and over-weight (0.78, 0.65–0.93,
p = 0.007) were negatively associated with TIA/ischemic stroke compared
with ACS. For ICH, hypertension (1.85, 1.22–2.81, p = 0.004) was more
strongly associated than with ACS, whereas hyperlipidaemia (0.56, 0.32–
0.97, p = 0.039), current smoking (0.40, 0.21–0.74, p = 0.004) and over-
weight (0.64, 0.42–0.99, p = 0.045) were negatively associated. When ICH
was compared with TIA/ischemic stroke, the negative associations with
hyperlipidaemia (0.43, 0.25–0.74, p = 0.002) remained. Results were
unchanged after exclusion of TIA.
Conclusions: Diabetes mellitus, current smoking and obesity are more
strongly associated with ACS than with stroke, whereas hypertension is a
stronger risk factor for ischaemic and haemorrhagic stroke. Hyperlipidae-
mia is negatively associated with ICH.
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Baroreflex predicts prognosis in aneurysmal
subarachnoid hemorrhage
N Nasr1, M Sykora2, K Budohoski3, M Czosnyka3, V Larrue4,
P Smielewski3
1Neurology, University of Cambridge and University of
Toulouse, TOULOUSE, France
2Neurology, University of Heidelberg, Heidelberg, Germany
3Neurosurgery, University of Cambridge, Cambridge, United
Kingdom
4Neurology, University of Toulouse, Toulouse, France
Background: Aneurysmal subarachnoid hemorrhage (SAH) is character-
ized by a strong activation of the sympathetic system The baroreflex is a
key parameter of the cardiovascular autonomic nervous system. Its prog-
nostic role in SAH is not known. In this study, we assessed the prognostic
value at 3 months of the baroreflex measured at the acute phase of SAH.
Methods: We assessed data prospectively collected in 50 patients hospi-
talized for acute SAH. Baroreflex sensitivity (BRS, in ms/mmHg) was
measured in time-domain, using the cross-correlation method, during the
7 days that followed SAH. Bad prognosis was defined as a modified
Rankin scale (mRS) above 2 at 3 months.
Results: Median age was 60.5 (36 to 81); F/M: 36/14. Median WFNS grade
was 2 (1 to 5). Initial BRS, mean BRS and lowest BRS during the 7 days
following SAH were correlated with bad prognosis (P = 0.001; P < 0.001;
P < 0.001, Mann-Whitney U test). Lowest BRS during the first 7 days was
associated with bad prognosis independently of age, WFNS and Fisher
grades (P = 0.015).
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Conclusion: BRS impairment, more specifically the “nadir” of BRS (lowest
BRS) at the acute phase of SAH, was associated with bad prognosis at 3
months.
The “nadir” of BRS may be jointly affected by: 1) poor prior cardiovas-
cular health, 2) the severity of SAH and 3) the capacity of the patient to
thrive against early complications.
These data point to baroreflex as a potential therapeutic target in SAH.
They first need to be confirmed in a multicenter study.
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Study of hemomicrocirculatory bed among newborns
with congenital heart anomalies
R Petrosyan1
1Basic Medical Science, Beirut Arab University, Beirut,
Lebanon
The aim of the research was pathomorphological investigation of changes
of the hemomicrocirculatory bed of the heart in newborns dying within
the first 7 days of postnatal life from congenital heart disease.
Within the framework of research the dissection material (autopsy) of 48
infants was studied who had died in the neonatal period from congenital
heart anomalies. The control group included the archive dissection mate-
rial of 20 infants who died from other causes.
It was revealed that the newborns with congenital heart anomalies have
deficiency of true capillaries in the hemomicrocirculatory system. This
deficiency is observed in all newborns that died from congenital heart
anomalies, but mostly was found in the premature newborns with the
same anomalies. Pathology of development of microcirculatory system is
determined not only by reducing the activity, and then blocking forma-
tion of new portion of terminal part of vascular system, but also by
collapse, progressive reduction and sclerosis of already developed
microvessels. There was also morphological (dystrophic, atrophic and
sclerotic) alteration of myocardium.
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Coronary angiographic findings in ischemic stroke
patients with elevated cardiac troponin
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Background: Frequency of coronary causes of elevated cardiac troponins
(cTn) in patients presenting with acute ischemic stroke (AIS) is unknown.
The aim of our study was to analyze coronary vessel status in AIS patients
with elevated cTn compared to patients presenting with Non-ST-
elevation acute coronary syndrome (NSTE-ACS).
Methods: Consecutive AIS patients at two tertiary hospitals were prospec-
tively screened for cTn elevation (>50 ng/l, high-sensitivity cTnT). The
primary outcome was presence of coronary culprit lesions indicating
instable coronary artery disease (CAD). Age- and gender-matched
patients presenting with NSTE-ACS served as a control. Diagnostic coro-
nary angiograms were analyzed independently by two interventional car-
diologists blinded for clinical data and diagnoses.
Results: A total of 29 AIS patients (median age 76 [interquartile range,
IQR 70–82], 51.7% male) underwent coronary angiography within a
median of 48 h after hospital admission (IQR 28–71 h). Median cTn on
presentation was not significantly different in patients with AIS or NSTE-
ACS (95 ng/l versus 94 ng/l, p = 0.70). Compared to patients with NSTE-
ACS, AIS patients were less likely to have instable coronary lesions (24.1%
versus 79.3%, p < 0.001) or to have evidence of any obstructive CAD
(51.7% versus 86.2%, p = 0.01, median number of vessels diseased 1 [IQR
0–2] versus 2 [IQR1–3], p < 0.01). Presence of tako-tsubo cardiomyopa-
thy on LV angiography was not different between the two groups (6.9%
versus 6.9%, p = 1.0).
Conclusions: Coronary causes of cTn elevation in AIS patients are present
in approximately one out of four patients. In the majority of patients,
alternative causes (i.e. demand ischemia or non-coronary causes) should
be considered.
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Elevated troponin levels in acute stroke patients
predict long-term mortality
C Thalin1, A S Rudberg1, A C Laska1, M von Arbin1, H Wallén1,
S Aspberg1
1Department of Clinical Sciences Danderyd Hospital,
Karolinska Institutet, Stockholm, Sweden
Background: Elevated plasma levels of troponin in acute stroke patients
are common and have in several studies been shown to predict in-hospital
and short-term mortality. Little is, however, known about the long-term
prognosis of these patients. The aim of this study was to determine patient
characteristics and five-year mortality in patients with acute stroke and
troponin elevation on admission.
Methods: A retrospective cohort study of all consecutive patients with
acute stroke and a plasma troponin I (TnI) analyzed on admission to
Danderyd Hospital between January 1, 2005, and January 1, 2006
(n = 247). Patient characteristics were obtained from the Swedish national
stroke register, Riks-Stroke, as well as hospital records. Mortality data was
obtained from the Swedish Cause of Death Register.
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Results: There were 133 patients (54%) with TnI < 0.03 μg/L (normal), 74
patients (30%) with TnI 0.03–0.11 μg/L (low elevation) and 40 patients
(16%) with TnI > 0.11 μg/L (high elevation). TnI elevations were associ-
ated with a higher age, prior ischemic stroke, chronic heart failure, renal
insufficiency, stroke severity and ST segment elevation or depression on
admission. The rate of hyperlipidemia decreased with increasing TnI.
Adjusted for age and comorbidity, elevated TnI values on admission had
a significantly and sustained increased mortality over the five-year follow-
up, with a HR of 1.90 (95% CI 1.33–2.70).
Conclusion: Troponin elevation in patients with acute stroke, even when
adjusted for several possible confounders, is associated with an almost
twofold increased risk of five-year mortality.
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Functional outcome of out-of-hospital cardiac arrest
survivors. Data from the prospective FINNRESUSCI
study
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Purpose: To study the one-year functional outcome of out-of-hospital
cardiac arrest (OHCA) survivors treated in Finnish ICUs.
Methods: All OHCA patients treated in 21 Finnish ICUs between March
2010 and February 2011 were followed. Patients alive one year after the
cardiac arrest were contacted by phone. A structured interview performed
by trained neurologist included assessment of Barthel Index, questions
about activities of daily living (ADL), accommodation, help received from
family members or health care personnel, rehabilitation, occupation and
return to work, car driving and self-experienced cognitive deficits. Addi-
tionally patients received EQ-5D and Extended ADL query forms by mail,
to evaluate the self-assessed quality of life and ADL-functions.
Results: FINNRESUSCI cohort included 504 unconscious cardiac arrest
patients. Of 213 one-year survivors, 206 (96.7%) could be contacted.
Mean age of the survivors was 60 years, and 79% were male. Good
outcome, defined as Cerebral Performance Categories 1 or 2, had been
reached by 90.3% of survivors. Median Barthel Index score was 100 (IQR
100–100), and 91.3% of survivors were independent in ADL-functions.
The great majority of survivors had been able to return to their home, and
only 8.7% lived in a sheltered home or needed institutionalized care.
23.8% of survivors lived alone. Of those working before the CA, 72.6%
had returned to work. 74.8% of survivors had not noticed any permanent
cognitive deficits. Median EQ-5D VAS was 80 (IQR 70–90).
Conclusions: In this nationwide cohort study the functional outcome of
OHCA one-year survivors was good in over 90% of patients.
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Prognostic timing and testing after cardiac arrest (CA)
and return of spontaneous circulation (ROSC) in
patients with eventual withdrawal of life support
(WOLS)
D L Tirschwell1, G B Schubert1, W T Longstreth1, S P Khot1,
M Olsufka2, F Kim2
1Neurology, University of Washington, Seattle, USA
2Medicine, University of Washington, Seattle, USA
Introduction: Guidelines regarding neurologic prognosis after CA suggest
delaying testing to 72 hours or later and that multimodal testing (physical
exam (PE) plus ancillary tests) should be performed.
Methods/results: Adults with out-of-hospital CA were randomized in
2007–2012 to standard care with or without prehospital cooling with IV
4°C normal saline following ROSC; the main trial results were neutral.
There was no standardized protocol for establishing neurologic prognosis.
Possible ancillary tests included EEG, SSEPs, MRI and CSF creatine kinase
BB isoenzyme (CKBB) levels. In 908 patients, mean age was 65, 38% were
female, 42% had initial ventricular fibrillation, and 34% mild or no neu-
rologic impairment at hospital discharge. Overall, 331 patients (36%) had
WOLS, a subgroup where prognostic patience, and testing, should be
maximized. In this WOLS subgroup, at least 46% of patients had their last
documented PE at < 72 hours from ROSC; EEG was done in 39%, SSEPs
16%, MRI 11% and CKBB 8%. At least 1 ancillary test was done in 44% of
WOLS patients. Documentation described PE findings were a factor in the
WOLS decision in 59%, and ancillary testing was a factor in 26%; overall,
documentation of any factors in the WOLS decision was present in 73%.
Conclusions: In this cohort with ROSC after CA, almost half of patients
with WOLS had prognostic decisions made prior to 72 hours and less than
half had any ancillary prognostic testing. These findings may suggest the
need for professional education on guideline based best practices for
neurologic prognostication.
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ICH and IVH
ESOC-0686
18. ICH and IVH
Can baseline imaging identify patients likely to need
subsequent external ventricular drainage after
spontaneous intracerebral haemorrhage?
S Y Acharya1, H C Patel1,2, J Wilkinson3, A Vail3, A Parry-Jones2,4
1Department of Neurosurgery, Salford Royal NHS Foundation
Trust Salford M6 8HD, Manchester, United Kingdom
2The University of Manchester, Manchester Academic Health
Sciences Centre, Salford Royal NHS Foundation Trust, Salford
M6 8HD
3Centre for Biostatistics, University of Manchester
4Greater Manchester Comprehensive Stroke Centre, Salford
Royal NHS Foundation Trust, Salford M6 8HD
Introduction: ICH may be complicated by hydrocephalus requiring exter-
nal ventricular drain (EVD) placement. Reliable identification of acute
patients at high risk of developing subsequent hydrocephalus may help
divert limited neurosurgical resources towards such patients.
Aim: Identify baseline clinical and imaging factors predictive of subse-
quent need for EVD in acute ICH patients.
Methods: We identified all ICH patients referred to our regional neuro-
surgical centre between January 2008 and October 2010 who underwent
EVD insertion and/or repeat brain imaging. Baseline GCS, ICH location,
ICH volume, modified Graeb score, Evans index, Hemphill score and
midline shift were derived. Primary outcome was a composite of EVD
insertion and/or ‘EVD indicated’, based on blinded review of repeat
imaging by an experienced Neurosurgeon. Logistic regression was used to
calculate areas under receiver operating characteristic curves (AuROC).
Results: One hundred ninety-nine patients were included in the final
analysis. 44 (22.1%) patients had the primary outcome of EVD inserted/
indicated. GCS (AUROC 0.798, 95% CI 0.721–0.874), modified Graeb
score (0.732, 0.637–0.826), Evans index (0.656, 0.562–0.750), Hemphill
score (0.749, 0.673–0.825) and midline shift (0.714, 0.621–0.807) were
predictive of the primary outcome. ICH location (0.565, 0.466–0.668) and
volume (0.672, 0.585–0.759) were less predictive. A multifactorial model
including GCS, modified Graeb score and midline shift was most predic-
tive of the primary outcome (0.848, 0.779–0.917).
Conclusion: Patients likely to require an EVD after ICH may be objectively
identified by combining GCS, midline shift and modified Graeb score but
this requires validation in a large, unselected, prospective cohort of ICH
patients.
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Controversies in treatment of anticoagulation
associated intracerebral haemorrhage
S Andole1, M Krommyda1, K Myint1
1Neurosciences, Barking Havering and Redbridge Hospitals
NHS Trust, Romford, United Kingdom
Introduction and background: Use of anticoagulant therapy increases the
risk of developing ICH by 7 to 10-fold, and anticoagulation-associated
ICH(AAICH) accounts for up to 19% of all ICH patients. On the back-
ground of variable guidelines and no consensus treatment, we at our
Hospital want to know the outcomes compared to others even if our
management guidelines may slightly differ from others.
Methodology: Patients’ data who were admitted with anticoagulant asso-
ciated ICH (AAICH) were retrospectively collected from SSNAP database
from 01/01/2014 to 19/09/2014. There were total 8 cases of AAICH out of
62 ICH cases.
Conclusions and results: All our patients with Anticoagulation associated
Intracerebral haemorrhage were treated with Fresh Frozen Plasma and
Vitamin K as per our trust guidelines.
1. Mortality was significantly higher in these patients compared to
patients with spontaneous Intracerebral haemorrhage (30 day stroke mor-
tality was 37.5%) against 43–62% nationally.
2. Although we have started using newer anticoagulants as first line treat-
ment for secondary prevention of stroke since 2013, none of these patients
were on newer anticoagulants. Should this be the standard now?
3. Measuring second INR following FFP was not done because of no
clinical implication against few guidelines.
4. Although one patient had thrombocytopenia, we did not give platelet
transfusions nor Desmopressin (DDAVP) as a part of treatment.
5. We did not use either Prothrombin complex concentrates (PCC) or
rFVIIa as a part of treatment although some guidelines seem to suggest
that these may be useful.
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Anticoagulation associated intracerebral bleeding –
what does influence the outcome?
S Andole1, M Krommyda1, K Myint1
1Neurosciences, Barking Havering and Redbridge Hospitals
NHS Trust, Romford, United Kingdom
Background: Vitamin K antagonist (VKA)-associated intracranial hem-
orrhage (ICH) exhibits higher risk of hematoma expansion and larger
hematoma volumes and is commonly related to worse outcome than
spontaneous ICH1. Prothrombin complex concentrates (PCCs) and Fresh
Frozen plasma (FFP) are indicated for urgent reversal of anticoagulation
after VKA-associated ICH, however in the absence of randomized con-
trolled trials strong evidence is lacking with regards to the timing, efficacy,
and ways of normalizing coagulation in these patients2.
Methods: We conducted a retrospective study of patients treated with FFP
for VKA-associated ICH at our hospital from 01/01/2014 to 19/09/2014.
Primary outcomes included INR correction, modified Rankin scale
scoring at discharge and in-hospital mortality.
Results and conclusions: INR was corrected with help of Vit K and FFP in
100% patients within 6 hours, mRs was greater than 3 in all but one
patient and mortality was 37.5%. The reversal of anticoagulation after
VKA-associated ICH along with time taken for effective INR correction
and standard treatment have no influence on clinical outcome.
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Background and purpose: Growth of an intracranial aneurysm occurs in
around 10% of patients at 2-year follow-up imaging and may be associ-
ated with aneurysm rupture. We investigated whether PHASES, a score
providing absolute risks of aneurysm rupture based on six easily retriev-
able risk factors also predicts aneurysm growth.
Methods: In a multicenter cohort of patients with unruptured intracra-
nial aneurysms and follow-up imaging with computed tomography
angiography or magnetic resonance angiography, we performed univari-
able and multivariable Cox regression analysis for the predictors of the
PHASES score, with aneurysm growth as outcome. We calculated hazard
ratios (HR) and corresponding 95% confidence intervals (CI), with the
PHASES score as continuous variable and after division into quartiles.
Results: We included 557 patients with 734 unruptured aneurysms.
Eighty-nine (12%) aneurysms in 87 patients showed growth during a
median follow-up of 2.7 patient-years (range 0.5–10.8). Per point increase
in PHASES score HR for aneurysm growth was 1.32 (95% CI: 1.22–1.43).
With the lowest quartile of the PHASES score (0–1) as reference, HRs were
for the second [PHASES 2–3] 1.07 (95% CI: 0.49–2.32), the third
[PHASES 4] 2.29 (95% CI: 1.05–4.95), and the fourth quartile [PHASES
5–14] 2.85 (95% CI: 1.43–5.67).
Conclusions: Since higher PHASES scores were associated with an
increased risk of aneurysm growth, our findings show that aneurysm
growth can be used as surrogate outcome measure of aneurysm rupture in
follow-up studies on risk prediction or interventions aimed to reduce the
risk of rupture.
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Association between diabetes mellitus and risk of
spontaneous (non-traumatic) intracerebral
haemorrhage (ICH): Systematic review and
meta-analysis
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R A S S Al-Shahi Salman1
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3Centre for Population Health Sciences, University of
Edinburgh, Edinburgh, United Kingdom
Background: Whether diabetes mellitus (DM) is a risk factor for the
development of spontaneous intracerebral haemorrhage (ICH) remains
unclear. We performed a systematic review to investigate this possible
association.
Methods: We registered our protocol (PROSPERO CRD42014015039).
One reviewer searched OVID Medline and Embase 1980–2014 inclusive
for case-control or cohort studies investigating the association between
DM and the incidence of first-ever, spontaneous, primary ICH at any age.
Two reviewers independently confirmed each study’s eligibility, charac-
terised its methods to assess risk of bias, and extracted data to calculate the
relative risk (RR) in cohort studies or odds ratio (OR) in case-control
studies.
Results: We analysed summary data from 18 case-control studies
(15hospital-based, 3population-based, 696 cases and 5,439 controls) and
found that DM was associated with ICH in all studies (crude OR 1.35,
95% CI 1.02 to 1.79; I-squared 62%) and in studies that controlled for age
and sex (crude OR 1.94, 95% CI 1.16 to 3.26; I-squared 65%) . There was
no difference in the association in hospital-based (OR 1.31, 95% CI 0.95
to 1.81) and population-based studies (OR 1.57, 95% CI 0.96 to 2.58). We
did not find an association in 5 population-based cohort studies in which
ICH occurred in 80 (1.65%) of 4,837 diabetic and 786 (0.87%) of 90,539
non-diabetic patients during un-quantified periods of follow-up (crude
RR 1.35, 95% CI 0.74 to 2.47; I-squared 81%).
Conclusion: DM may be a risk factor for ICH, but further large,
population-based studies that adequately control for major confounders
are needed.
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Clinicoradiological pattern of convexal subarachnoid
hemorrage: Differences between cerebral amyloid
angiopathy and other causes
L Calviere1, V Cuvinciuc2, N Raposo3, V Larrue1, F Bonneville2,
A Viguier1
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Background: Cerebral amyloid angiopathy (CAA) is a common cause of
convexal subarachnoid hemorrage (cSAH) specially in the elderly. The
aim of this study was to compare the pattern of cSAH related to CAA and
other causes.
Methods: Retrospective review of clinical and radiological data of con-
secutive patients admitted in our institution with a cSAH revealed by
neurological symptoms.
Results: Sixty-two patients (37 women; mean age 66.2 ± 14.1 years) were
included. CAA accounted for 50 %. The main other etiologies were revers-
ible vasoconstriction syndrome (13 %), endocarditis (11 %), and severe
intracranial or cervical arterial stenoses (8 %). CAA patients were older
(mean age: 74 vs 58 years; p = 0.02) and presented essentially with tran-
sient focal neurological episodes (TFNE) (80.6 vs 19.3 %; p < 0.001)
without headache (18 % vs 58 %; p = 0.002). CAA-related cSAH was
strongly associated with superficial siderosis (SS) (77 vs 0 %; p < 0.001)
and cortical microbleeds (63 vs 9 %; p < 0.001). Follow up data were
available in 55 patients (88.7%). New subarachnoid bleedings in CAA vs
other causes occurred in 68 % vs 13 % (p < 0.001). Among 39 patients
with MRI follow-up, evolution from acute cSAH to SS was observed in
91.7 % of CAA patients and 66.7 % of patients with other origins
(p = 0.08).
Conclusions: CAA-related cSAH has a specific pattern defined by TFNE,
high risk of recurrence and superficial siderosis. However, evolution from
cSAH to SS does not seem specific of CAA.
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A prospective study of intracerebral haemorrhage over
a 12 year period
M Cooney1, S O’Callaghan1, I Noone1, S O’Kelly1, M Crowe1
1Medicine for the Elderly, St. Vincent’s University Hospital,
Dublin, Ireland
Background: Intracerebral haemorrhage (ICH) typically accounts a
minority of strokes. However, a high case fatality rate means that ICH
accounts for a substantially higher proportion of stroke deaths. This
underscores the need for continued monitoring of trends in ICH inci-
dence rates and associated factors.
Methods: St Vincent’s University hospital is a tertiary referral hospital
serving a population of 300,000 in Dublin, Ireland. All stroke patients are
reviewed by the stroke team prospectively. We analysed the percentages of
all strokes accounted for by intracerebral haemorrhage across three time
periods from 2003 to 2014, subdivided by age group. We excluded ICH
associated with trauma or other secondary causes. Fisher’s exact test was
used to assess for significant differences between percentages.
Results: Three thousand five hundred forty-seven stroke patients pre-
sented between 2003 and 2014; 11.1% (394) were due to ICH. The per-
centage of strokes accounted for by ICH increased from 9% in 2002–2006
to 11% in 2007–2010 to 12% in 2010–2014, p = 0.019. We also noted a 2.5
fold increase in the number of all strokes accounted for by ICH in the
group aged 80 and over, p = 0.016. In parallel with this, anticoagulant use
increased, particularly in the older age group, with an increase from 10%
in 2003–2006 to 24% in 2010–2014 in those 85 years and over.
Conclusion: Intracerebral haemorrhage rates have increased over this 12
year period. Possible explanations include the aging population and
increased use of antithrombotic and statin therapy. Examination of hae-
morrhage location and medication usage may advance our understanding
of these relationships further.
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Treatment of spontaneous intraventricular hemorrhage
with endoscope-assisted aspiration and
intraventricular tpa – early experience
J Fraser1, S Grupke1
1Neurological Surgery, University of Kentucky, Lexington, USA
Spontaneous intraventricular hemorrhage (IVH) as a result of hyperten-
sive hemorrhagic stroke can cause neurologic deficits as a result of local
mass effect and obstruction of normal cerebral spinal fluid (CSF) circu-
lation. Patients frequently require permanent diversion of CSF with
shunting. Current neurosurgical literature does not support treatment of
deep-seated hemorrhage with open surgery. The ApolloTM System (Pen-
umbra Inc, California USA) is a recently FDA-approved tool that allows
for minimally invasive aspiration of intracerebral hematomas through a
small craniotomy using an endoscope-assisted and neuronavigation-
guided aspiration and irrigation probe. We describe our early experience
with this device, noting technical considerations for evacuation of intra-
ventricular hemorrhage. We also describe, our concomitant use of the
procedure followed by a single dose of intraventricular t-PA to clear
completely casted ventricular systems. Our early experience supports such
intervention, as none of our patients required permanent CSF diversion
with shunting compared to the high rate reported in the literature.
Fig. 1 Representative CT images through the 4th, 3rd, and lateral ven-
tricles of a patient treated with the Apollo System. Preoperative (a),
12-hours post-aspiration (b), and 12-hour post t-PA (c) images are shown.
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Spontaneus isolated convexity subarachnoid
hemorrhage: A report of 3 cases associated with
cerebral amyloid angiopathy
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Introduction: Isolated, non-traumatic, convexity subarachnoid hemor-
rhage (cSAH) is a rare type of nonaneurysmal SAH characterized by
blood collections in one or a few cortical sulci at the convexity of the
brain. Etiology depends on age, so in patients under 60-years-old is asso-
ciated with a reversible vasoconstriction syndrome, while in older patients
the main cause of the bleeding is due to cerebral amyloid angiopathy
(CAA). We report a clinical series of 3 patients with cSAH associated with
probably CAA.
Cases: The age and sex of the patients were: 67 years-old man, 79 years-
old man and 72 years-old woman. All patients had recurrent tingling
paresthesias (cheiro-oral symptoms) and two had dysarthria and one had
motor dysphasia. Nobody had headache or clinical dementia.
Results: Brain CT scan detected acute cSAH as an isolated hyperintensity
intrasucal of the frontal brain convexity and brain gradient echo
T2-weighted sequences MRI showed meningeal hemosiderosis and
microbleeds. However, no atrophy was identified in medial temporal lobes
incluiding the hyppocampal formation. Sacular aneurysm were ruled out
with a MR angiography. All patients had low levels of beta-amyloid
peptide in their CSF (287 pg/mL, 466 pg/mL and 358 pg/mL, respectively)
and high level of phosphorylated-Tau protein (104 pg/mL, 73 pg/mL and
95 pg/mL, respectively). The APO-E status was: E2/E3, E3/E4 and E3/E3,
respectively. The outcome of the patients was good after treating them
with prednisone and levetiracetam.
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Conclusions: In our series, cSAH associated with CAA was characterized
by focal sensory seizures, but both headache and dementia were not
clinical features.
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Decompressive hemicraniectomy for supratentorial
spontaneous intracerebral hemorrhage: A retrospective
case-control study using propensity score matching
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Background: Spontaneous intracerebral hemorrhage (ICH) contributes
disproportionately to stroke mortality. Retrospective studies suggest that
decompressive hemicraniectomy (HC) in ICH patients is safe but evi-
dence of efficacy is lacking without a control population. We hypothesized
that HC would be associated with improved outcomes compared to no
HC by performing a propensity score analysis.
Methods: HC patients were identified from the University of Texas-
Houston’s prospectively collected stroke registry from 2011–2014; con-
current control ICH patients were identified from the multi-center,
prospective, Ethnic/Racial Variations of Intracerebral Hemorrhage study.
Exclusion criteria included infratentorial ICH, secondary cause of ICH,
and care directed toward comfort measures. A propensity score model
consisting of ICH volume, age, antiplatelet use, and GCS was combined
with race, sex, and ICH location to perform 3:1 matching. Primary out-
comes were in-hospital mortality and poor outcome defined as modified
Rankin scale ≥5 at 3 months.
Results: We identified 38 cases with ICH and HC and matched by pro-
pensity score variables to 114 control cases of ICH. In-hospital mortality
was 31.6% vs 15.8% for controls and cases, respectively (p = 0.06); 55.3%
of controls compared to 34.2% of cases had poor outcome at 3 months
(p = 0.02). Additional analysis is on-going and final results will be
reported.
Conclusion: HC showed a benefit on poor outcome at 3 months and a
trend towards improved in-hospital mortality. Although retrospective in
nature, this study represents the largest case-control study of HC in ICH
patients to date and provides the foundation for a clinical trial of HC in
ICH.
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Outcome after intracranial haemorrhage from dural
arteriovenous fistulae: A systematic review and
case-series
W Jolink1, J M C van Dijk2, C J J van Asch1, G A P de Kort3,
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Background: Dural arteriovenous fistulae (DAVFs) are a rare cause of
intracranial haemorrhage. We aimed to investigate outcome of patients
with intracranial haemorrhage from a DAVF.
Methods: We performed a systematic literature search in PubMed and
Embase for studies reporting outcome after intracranial haemorrhage
caused by a DAVF. We used predefined selection criteria and assessed the
quality of the studies. In addition, we studied outcome in all patients with
DAVF who had presented with intracranial haemorrhage at two university
centers in the Netherlands, between January 2007 and April 2012. We
calculated case-fatality and proportions of patients with poor outcome
(defined as modified Rankin Scale ≥3 or Glasgow Outcome Scale ≤3)
during follow-up with 95% confidence intervals (CIs). We investigated
mean age, sex and mid-year of study as determinants of case-fatality and
poor outcome.
Results: The literature search yielded 12 studies, all but one retrospective
and all hospital-based. Combined with our cohort of 29 patients the total
number of patients with DAVF related intracranial haemorrhage was 236
(55% intraparenchymal haemorrhage). At a median follow-up of 10
months case-fatality was 6.0% (95%CI:3.4–9.7; 13 cohorts) and the pro-
portion of patients with poor outcome 7.4% (95% CI: 2.0–15.9; 8
cohorts). We found no effect of mean age, sex or mid-year of the cohorts
on either outcome measure.
Conclusions: Hospital based case-series suggest a relatively low risk of
death and poor outcome in patients with intracranial haemorrhage due to
rupture of a DAVF. These risks may be underestimated because of bias.
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An analysis of cerebral amyloid angiopathy by the
Boston Criteria in the Ethnic/Racial Variations of
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Background: Cerebral amyloid angiopathy (CAA) is known to cause lobar
intracerebral hemorrhages (ICH) in older adults. We examined risk
factors and imaging characteristics of ERICH cases with and without CAA
defined by the Boston Criteria.
Methods: ERICH is a multi-center, prospective, case-control study of
ICH. At least every 5th ICH case enrolled undergoes a baseline MRI per
study design.
Results: Of 636 patients with MRI data, 407 (64.0%) were age ≥55. Of
these, 9.6% met criteria for probable CAA and 20.6% met criteria for
possible CAA. The frequency of CAA varied by race/ethnicity (Table).
Patients with possible/probable CAA were older, had less hypertension,
larger hemorrhage volumes, and greater rates of superficial siderosis.
Microbleeds were more common in probable CAA cases.
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No CAA
n = 284
Possible
CAA
n = 84
Probable
CAA
n = 39 p value
Mean Age (SD) 66.4(9.6) 71.1(9.5) 70.2(10.3) <0.0001
Race/Ethnicity 0.026
White 60.8% 27.5% 11.8%
Black 77.8% 13.9% 8.3%
Hispanic 71.8% 20.0% 8.2%
Hypertension 84.9% 72.6% 79.5% 0.023
Mean ICH Volume
(SD)
11.7 (14.5) 26.1 (22.8) 27.1 (27.9) <0.0001
Presence of
Microbleeds
62.7% 0%* 79.5% <0.0001†
Superficial Siderosis 4.6% 8.3% 20.5% <0.0001
*Defined by Boston Criteria
†Probable vs. no CAA
Conclusions: Previously, CAA had been considered an infrequent cause of
spontaneous ICH. Our study finds that 1/3 of spontaneous ICH cases age
≥55 meet Boston Criteria for possible/probable CAA. Superficial siderosis
was 4x more common in probable vs. no CAA. The higher proportion of
possible/probable CAA among whites with ICH may reflect a higher fre-
quency of hypertensive hemorrhage in minority populations.
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Predictors of early mortality in young adults after
intracerebral hemorrhage
R J Koivunen1, J Satopää2, E Haapaniemi1, D Strbian1,
A Meretoja1, S Mustanoja1, H Silvennoinen1, O Salonen1,
M Niemelä2, T Tatlisumak1, J Putaala1
1Department of Neurology, Helsinki University Central
Hospital, Helsinki, Finland
2Department of Neurosurgery, Helsinki University Central
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Background and Purpose: Patient and radiological characteristics of
intracerebral hemorrhage (ICH), surgical treatment, and outcome after
ICH are interrelated. Our purpose was to define whether these character-
istics, or surgical treatment correlate with mortality among young adults.
Methods: We retrospectively reviewed clinical and imaging data of all
first-ever non-traumatic ICH patients between 16 and 49 years of age
treated in our hospital between January 2000 and March 2010, and linked
these data with national causes-of-death registry. A logistic regression
analysis of factors associated with 3-month mortality, and a propensity
score comparison between patients treated conservatively and operatively
was performed.
Results: Among the 325 eligible patients (59.4% males) factors associated
with 3-month mortality included higher National Institutes of Health
Stroke Scale score, infratentorial location, hydrocephalus, herniation, and
multiple hemorrhages. Adjusted for these factors as well as demographics,
ICH volume, and the underlying cause, surgical evacuation was associated
with lower 3-month mortality (OR 0.06; 95% CI 0.02–0.21). In
propensity-score matched analysis, 3-month case-fatality rates were three-
fold in those treated conservatively (27.5% vs. 7.8%, p < 0.001).
Conclusions: The predictors of short-term case-fatality are alike in young
and elderly ICH patients. However, initial hematoma evacuation was asso-
ciated with lower 3-month case-fatality in our young ICH patients.
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Medical acute complications of intracerebral
hemorrhage in young adults
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Background and Purpose: Medical complications are frequent among
patients with intracerebral hemorrhage (ICH) and are a significant cause
of mortality. We investigated their frequency and impact on short-term
mortality in young ICH patients.
Methods: We retrospectively reviewed clinical, imaging, and laboratory
data of all first-ever non-traumatic ICH patients between 16 and 49 years
of age treated in our hospital between January 2000 and March 2010 to
identify medical complications suffered in the acute phase, and linked
these data with national causes-of-death registry. Univariable compari-
sons and logistic regression analysis were performed to identify compli-
cations associated with increased 3-month mortality.
Results: Among the 325 eligible patients (59% males), infections were
discovered in 90 (28%), venous thrombotic events in 13 (4%), cardiac
complications in 4 (1%), renal failure in 59 (18%), hypoglycemia in 15
(5%), hyperglycemia in 165 (51%), hyponatremia in 146 (45%), hyper-
natremia in 91 (28%), hypopotassemia in 104 (32%), and hyperpotas-
semia in 27 (8%). Adjusted for gender, hematoma volume, infratentorial
hematoma location, presence of intraventricular extension, National
Institutes of Health Stroke Scale score at arrival, and hematoma evacua-
tion, the only independent complication associated with 3-month mor-
tality was plasma glucose >8.0 mmol/L (odds ratio 5.96, 95% confidential
interval 2.34–15.19, p < 0.001). Three or more separate complications
suffered also associated with increased mortality (odds ratio 6.57, 95%
confidential interval 1.28–33.59, p = 0.024).
Conclusions: Hyperglycemia is a frequent complication of intracerebral
hemorrhage in young adults and associates with increased short-term
mortality. Multiple complications increase mortality even further.
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Clinical correlates and prognostic implications of
cerebral microbleeds detected by susceptibility
weighted imaging in Chinese with ischaemic stroke
K K Lau1, K C Teo1, Y K Wong1, K H Chan1, R H K Cheung1,
J C Y Chan1, E K M Wong1, S O L Chan1, E Wong1, R T F Cheung1,
C W Siu1, P M Rothwell2, S L Ho1, H K F Mak3
1Department of Medicine, The University of Hong Kong,
Hong Kong, Hong Kong China
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Background: Compared with gradient-recalled echo imaging,
susceptibility-weighted imaging (SWI) has been shown to have superior
sensitivity in detection of cerebral microbleeds (CMB). However, litera-
ture on the prognostic implications of CMBs detected using SWI amongst
patients with ischaemic stroke (ISS) remains uncertain.
Methods: We retrospectively reviewed 1556 patients who received a MRI
stroke protocol at The University of Hong Kong during 2008–2012. CMBs
were detected using SWI and graded using the Microbleed Anatomical
Rating Scale. Clinical characteristics, cardiovascular risk factors and sub-
sequent clinical outcome of study subjects were retrieved.
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Results: Amongst 726 Chinese ISS patients (mean age 68 years, 61%
males), 44% had CMBs detected (34%, 6% and 4% with CMBs of grade 1,
2 and 3 respectively). Burden of CMBs were strongly associated with
increasing age, underlying hypertension, history of TIA or stroke and
glomerular filtration rate (p < 0.05). Burden of CMBs were also signifi-
cantly associated with periventricular and subcortical white matter hyper-
intensities (p < 0.01). After a mean follow-up of 35 ± 15 months, 75
patients (10%) developed a recurrent stroke and 71 patients (10%) died.
Compared to patients without CMBs, those who had deep-seated CMBs
of grade 3 severity had the greatest risk of developing a recurrent stroke
(adjusted hazard ratio (HR) 5.75, 95% confidence interval (CI) 1.75–
18.94, p < 0.01) and in particular, haemorrhagic stroke (adjusted HR
70.45, 95% CI 2.70–187.2, p < 0.01). CMBs were not predictive of recur-
rent ISS or mortality.
Conclusions: Amongst Chinese with ISS, those with deep-seated CMBs
are at greatest risk of developing a recurrent stroke, in particular intrac-
erebral haemorrhage.
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18. ICH and IVH
Uric acid in subarachnoid hemorrhage patients:
Temporal profile and its association to neurological
complications
L Llull1, A Renú1, C Laredo1, J Codas1, S Rudilosso1, X Urra1,
S Amaro1, N Macías2, A Planas3, A Chamorro1
1Neurology, Hospital Clinic Barcelona, Barcelona, Spain
2Neuroradiology, Hospital Clinic Barcelona, Barcelona, Spain
3Department of Brain Ischemia and Neurodegeneration,
Institute for Biomedical Research of Barcelona, Barcelona,
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Objectives: Uric acid (UA) is the most important endogenous antioxidant
in humans. Its role in subarachnoid hemorrhage (SAH) has not been
previously studied. We aimed to describe the temporal profile of UA
concentration and its relationship to neurological complications in
patients with spontaneous SAH.
Methods: Forty-seven patients and twenty-three healthy volunteers were
included in a prospective observational study. Clinical, radiological and
laboratory variables were collected. UA concentration was measured in
serial blood samples at admission and on days 1, 4, 10 and 90. The
development of angiographic vasospasm (VS) was monitored daily and
new cerebral infarction was defined as the appearance of new lesions in
successive neuroimages suggesting arterial cerebral ischemia.
Results: After SAH, 60% of patients presented angiographic VS and 50%
developed new ischemic lesions. We observed a progressive decrease of UA
concentration between admission and day 10. UA levels were significantly
lower in cases compared to controls on day 1, 4 and 10 (p < 0.001). Lower
concentrations of UA on day 10 were significantly associated to the devel-
opment of angiographic VS (3.81 ± 1.54 vs 2.88 ± 0.97; p = 0.037) and
new cerebral infarction (3.63 ± 1.15 vs 2.56 ± 1.01; p = 0.021).
Conclusions: Decrease of UA concentration is related to ischemic cerebral
damage after SAH. The pathophysiological role and outcome implications
of this serum biomarker should be studied in more extensive samples of
patients.
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18. ICH and IVH
H-ATOMIC criteria for the etiologic classification of
patients with intracerebral hemorrhage
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Background: There are no accepted criteria for the etiologic classification
of Intracerebral Hemorrhage (ICH). We have developed a set of etiologic
criteria and have applied them to a large number of patients.
Methods: A multicenter and prospective study of consecutive patients
with spontaneous ICH. A prerequisite was to perform a basic study (neu-
roimaging -CT or MR-, blood tests -platelet count, liver function,
coagulation-, and CT-angio or other angiographic modalities when a
predefined score suggested an underlying structural abnormality). This
basic study was extended at the discretion of the treating neurologist.
The H-ATOMIC classification includes 7 subtypes: Hypertension,
Amyloid angiopathy, Tumor, Oral anticoagulants, arterio-venous
Malformation/cavernoma), Infrequent diseases and Cryptogenic. For
each category, the definition is graded as possible(= 3), probable(= 2) and
definite(= 1). Combinations of >1 etiologic subtype for the same patient
are accepted. In a random sample (n = 29), percentage of agreement (PA)
among 5 stroke neurologists was calculated.
Results: We included 387 patients (age 70.7 ± 14, 61% were men). A defi-
nite adjudication was achieved in 41.6% of the patients (H1 28.1%, A1
0.2%, T 0.2%, O 2.4%, M 4.3%, I 4.5%, C 1.9%); In the remaining patients
ICH was attributable to a single (14%) or the combination of ≥2 (44.4%)
possible/probable etiologies. H was the most frequent category
(H1 + 2 + 3 79.5%) followed by A (A1 + 2 + 3 32%). PA ranged
75.8–96.8%.
Conclusions: According to the H-ATOMIC criteria for ICH, only 41.6% of
patients receive a definite diagnosis, while up to 44.4% are attributable to
more than one possible or probable etiology. Percentage of agreement is
high.
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Clinical and diagnostic findings in patients with
elevated cerebrospinal bilirubin
M O McCarron1, P M Lynch2, P McCarron3, G McCluskey4,
J McKee5, F McVerry1, M J O’Kane2
1Neurology, Altnagelvin Area Hospital, Derry, United
Kingdom
2Clinical Chemistry, Altnagelvin Area Hospital, Derry, United
Kingdom
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Kingdom
5Acute Stroke Service, Altnagelvin Area Hospital, Derry,
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Background: Acute severe headache is a presenting feature of subarach-
noid haemorrhage (SAH). When a computerized tomograph (CT) does
not demonstrate blood in patients with a thunderclap headache, guide-
lines recommend investigation of cerebrospinal fluid (CSF) to look for
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SAH. In a retrospective study we evaluated the clinical utility, diagnoses
and CSF findings in patients with an elevated spectrophotometric CSF
bilirubin level.
Methods: Over a ten year period consecutive patients with elevated CSF
bilirubin admitted to two hospitals were studied. Clinical demographics,
delays to investigation and final diagnoses were recorded. Patients with an
identified intracranial vascular abnormality (avSAH) were compared with
patients without such vascular abnormality (non-avSAH).
Results: Fifty-six patients had an elevated CSF bilirubin. Ten (17.9%) had
an avSAH, of which eight (14.3%) had aneurysmal SAH. CSF spectropho-
tometry requests increased more than threefold during the study (test for
linear trend, P < 0.001), while detection of aneurysmal SAH remained
stable (2.5 persons/million population/year). Delays from headache onset
to admission, CT scan and lumbar puncture were not significantly differ-
ent for avSAH and non-avSAH patients. CSF red cell counts were higher
among av-SAH patients than non-avSAH patients (P = 0.005). Recording
of clinical history, neurological examination, lumbar puncture and accu-
racy of CT brain reporting had potential for improvement. Non-vascular
causes of elevated CSF bilirubin included meningitis, spontaneous intrac-
ranial hypotension and carcinomatous meningitis.
Conclusions: CSF spectrophotometry has an important role in identifying
avSAH in CT-negative patients presenting with a thunderclap headache.
Careful clinical utility of CSF spectrophotometry could improve the posi-
tive predictive value of this investigation.
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Prognostic significance of delayed intraventricular
haemorrhage in the interact studies
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Background and purpose: Intraventricular extension of intracerebral hae-
morrhage (ICH) predicts poor outcome but the significance of delayed
intraventricular haemorrhage (dIVH) is less well defined. We determined
the prognostic significance of dIVH in the Intensive Blood Pressure
Reduction in Acute Cerebral Hemorrhage Trials (INTERACT 1 and 2).
Methods: Pooled analyses of the INTERACT CT substudies – interna-
tional, multicenter, prospective, open, blinded endpoint, randomized con-
trolled trials of patients with acute spontaneous ICH and elevated systolic
blood pressure (SBP), randomly assigned to intensive (<140 mmHg) or
guideline-based (<180 mmHg) SBP management. Participants had
blinded central analyses of baseline and 24-hr CTs, with dIVH defined as
new IVH on the latter scan. Outcomes of death and major disability were
defined by modified Rankin scale scores at 90 days.
Results: There were 349 (27%) of 1,310 patients with baseline IVH, and
107 (11%) of 961 IVH-free patients who developed dIVH. Significant
associations of dIVH were prior warfarin anticoagulation, high (≥15)
baseline National Institutes of Health stroke scale score, larger (≥15 mL)
haematoma volume, and greater haematoma growth and higher achieved
SBP over 24 hrs. Compared to those IVH-free, dIVH had greater odds of
90-day death or major disability versus initial IVH (adjusted odds ratios
2.89 [95% CI 1.55–5.38] and 1.86 [95% CI 1.36–2.54], respectively [P
trend < 0.0001]).
Conclusion: Although linked to factors determining greater haematoma
growth including poor SBP control, dIVH is independently associated
with poor outcome in acute ICH.
Clinical Trial Registration Information – URL: http://www.clinicaltrials
.gov. Unique identifier: NCT00226096 and NCT00716079.
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Relation of prior cerebral microbleeds to clinical
characteristics of patients presenting with acute
intracerebral hemorrhage
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Background: Microbleeds (MBs) on MRI scanning is an important risk
factor for subsequent hemorrhagic stroke. It remains unclear on the fre-
quency and characteristics of acute ICH occurring at the same location as
the previously identified MBs.
Methods: We enrolled 54 consecutive acute ICH patients (mean age 71;
63% male) who had undergone 1.5T gradient-echo T2*-weighted MR
imaging before the ICH onset for previous neurological disorders. We
investigated clinical features, site and numbers of MBs and whether the
site of acute ICH co-localised to the presence of MBs.
Results: The location of the acute ICH was at the thalamus in 16 patients
(30%), basal ganglia in 14 (26%), other sites in 24 (44%). The median
number of MBs was 5 (IQR 3–13). Hematoma corresponded to prior MBs
in 24 patients (‘co-localised group’, 44%) and not in the other 30 (‘non
co-localised’ group). Co-localisation rate was the highest in the thalamus
(75%). MBs were more common in the co-localised group (median 10)
than in the ‘non co-localised’ group (median 3, P = 0.002). Age, sex, vas-
cular risk factors, hematoma volume were similar between both groups.
The rates of antiplatelet therapy (42% vs.43%, anticoagulation therapy
(25% vs.20%, and dual antithrombotic therapy (4% vs.7%) before onset
of the ICH were also similar.
Conclusion: ICH co-localisation with prior MBs tended to occur in thala-
mus and have high number of prior MBs, but was unrelated to other
clinical features, including previous antithrombotic therapy.
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18. ICH and IVH
The first week constitudes the primary critical period
in intracerebral hemorrhage – is neurological
deterioration the real culprit?
C Ovesen1, A F Christensen2, I Havsteen2, C K Hansen1,
S Rosenbaum1, E Kurt2, H Christensen1
1Department of Neurology, Bispebjerg Hospital, Copenhagen,
Denmark
2Department of Radiology, Bispebjerg Hospital, Copenhagen,
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Background: Patients with intracerebral haemorrhage (ICH) are at high
risk of neurological deterioration (ND). We aimed at establishing predic-
tors of early as well as late neurological deterioration and to explore the
impact of neurological stability during the first week on long-term
prognosis.
Method: We included 283 acute ICH-patients (≤4.5 hours from
symptom-onset) admitted to our institution from March 2009 to July
2014. ND was evaluated based on consciousness and severity of neuro-
logical symptoms. ND during the first 24 hours after admission was
defined as early ND (END) and from 24 hours to 7 days as late ND (LND).
Patients were followed up until October 2014.
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Results: We found that the spot sign on CT-angiography (OR 9.63 CI:
4.22–22.0) and extensive degree of intraventricular haemorrhage (IVH)
(OR 9.63 CI: 2.91–31.9) were independent predictors of END. Whereas
degree of comorbidity (Charlton Index), admission stroke severity, and
degree of IVH predicted LND. On follow-up imaging, hematoma expan-
sion was independently associated with END (OR 7.1 CI: 2.3–21.8), and
expansion of IVH was independently associated with both END (OR 4.8
CI: 1.3–18.0) and LND (OR 12.1 CI: 1.3–111.5). ND during first week was
associated with a one-year mortality of 61%, compared to 8% among the
patients who remained stable (Log-Rank test p < 0.0001).
Conclusion: The first week constitutes a very critical period and the results
of this study suggest that stability during the first week entails an opti-
mistic prognosis. Relatively easy and effective risk-stratification of END
and LND is possible on admission.
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18. ICH and IVH
The CT-angiographic spot-sign predicts expansion of
the intraventricular haematoma in patients with
intracerebral haemorrhage
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Background: Expansion of the intraventricular haemorrhage (IVH) is a
relatively undescribed but likely malicious consequence of on-going
bleeding in intracerebral haemorrhage. We aimed at describing the rela-
tionship between haematoma expansion, the spot-sign and IVH-
expansion along with its affect on mortality.
Method: We included 158 acute ICH-patients (≤4.5 hours from
symptom-onset) admitted from March 2009 to December 2014 with
admission and follow-up CT. CT-angiography on admission was available
in 128 (81%). Haematoma volume was calculated as ABC/2 and extent of
the IVH using the GRAEB-score. IVH on follow-up, but not on admission
imaging, was considered delayed IVH. An increase of above 2 GRAEB-
points was considered a significant IVH-expansion and 12.5 mL a signifi-
cant intraparenchymal haematoma expansion (SHE).
Results: Of the 158 patients, 53 (33.5%) had IVH on admission. Signifi-
cant IVH-expansion was observed in 30 (19.0%) during the first 24 hours.
Of the 30 patients, 12 (40.0%) had IVH on admission scan and 18 (60%)
suffered delayed IVH – all above 2 GRAEB-point increase. In multivariate
analysis, SHE (OR 3.95 CI: 1.21–12.9) and the spot-sign (OR 7.11 CI:
1.68–30.1) emerged as independent predictors adjusted for admission
haematoma volume. Within the first 90 days, 32 (20.3%) died. Adjusted
for age, admission neurological severity, admission haematoma volume,
and admission GRAEB score – haematoma expansion (HR 1.01 CI: 1.00–
1.02 per mL) and IVH-expansion (HR 1.2 CI: 1.01–1.40 per point) were
independently associated with mortality.
Conclusion: The spot-sign predicts IVH-expansion beyond what can be
attributed to intraparenchymal haematoma expansion. IVH-expansion is
an independent predictor of mortality.
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microbleeds: Results from an observational cohort
study
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Background: In patients with intracerebral haemorrhage (ICH), brain
microbleeds (BMB) may interact with antithrombotic drugs and increase
the risk of future ICH recurrence. We aimed to identify predictors of new
BMB in ICH patients.
Methods: Observational prospective cohort of 168 ICH survivors who
underwent 1.5T MRI after admission and during follow-up [median delay
between first and last MRIs 3.4 (IQR 1.4–4.7) years]. We used multivari-
able logistic regression in overall population, and then stratified by the
index ICH location (58 lobar ICH vs 103 non lobar ICH, excluding
patients with multiple ICH or unclassifiable ICH location).
Results: Eighty-nine (53%) patients had BMB at baseline, and 80 (48%)
exhibited new BMB during follow-up. The use of antiplatelet agents
during follow-up was associated with the appearance of new BMB (OR
2.16; 95%CI 1.07–4.28). When stratifying by index ICH location, this
association was only found in non-lobar ICH (OR 2.84; 95%CI 1.06–
7.61). Radiological independent predictors of new BMB were: presence of
old macro-haemorrhagic lesions (outside the index ICH) on the first MRI
(OR 6.87; 95%CI 2.10–22.48), and progression of cortical atrophy (OR
2.36; 95%CI 1.04–5.35). In the subgroup of lobar ICH, new BMB were
associated with the appearance of new macro-haemorrhagic lesions (OR
13.46; 95%CI 1.37–132.48).
Conclusions: New BMB frequently appeared during follow-up and anti-
thrombotic drugs were especially relevant in non lobar ICH. Interestingly,
new BMB were markers of an underlying evolving process (new macro-
haemorrhagic lesions and progression of cortical atrophy) suggesting
their impact on functional outcome including cognition.
ESOC-1343
18. ICH and IVH
Antithrombotic treatment following intracerebral
hemorrhage in patients with and without atrial
fibrillation. A nationwide study based on Riksstroke
J Pennlert1, K Asplund1, B Carlberg1, P G Wiklund1, A Wisten2,
S Åsberg3, M Eriksson4
1Dept of Public Health and Clinical Medicine, Umea
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Background: Patients who survive an intracerebral hemorrhage (ICH)
often have compelling indications for anticoagulant and antiplatelet
medication. We studied predictors, extent and timing of antithrombotic
treatment following ICH in patients with and without atrial fibrillation
(AF).
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Methods: We included 14045 patients with a first ICH who were dis-
charged alive and registered in the Swedish Stroke Register (Riksstroke) in
2005 through 2012. Personal identification numbers were used to link
Riksstroke data with other national registers to find comorbid conditions
and date of first dispensed prescriptions of antiplatelet (AP) and antico-
agulant (AC) agents after discharge.
Results: Among the 2777 (19.8%) patients with AF, the proportion with
dispensed prescription of antithrombotic agents was 8.5% (AC) and
36.6% (AP) within 6 months, and 11.1% (AC) and 43.6% (AP) within 1
year. Among the 11268 (80.2%) non-AF patients, the corresponding
figures were 1.6% (AC) and 13.8% (AP) within 6 months, and 2.0% (AC)
and 17.5% (AP) within 1 year. In AF-patients, less severe ICH, younger
age, previous AC-treatment, valvular disease, and previous ischemic
stroke were predictors of AC-treatment. High CHA2DS2-VASc scores did
not correlate with prescription of AC; rather the inversed relationship was
seen. There was a positive correlation between high CHA2DS2-VASc and
HAS-BLED scores (rs = .0.590, p < 0.001).
Conclusions: In a majority of patients who subsequently receive anti-
thrombotic agents, treatment is initiated within 6 months from ICH.
Other factors than high risk of embolic stroke by CHA2DS2-VASc are
used to guide the anticoagulant treatment decision in clinical practice.
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Reliability of spontaneous intracerebral haemorrhage
classification systems: A systematic review
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Objective: Distinguishing spontaneous ICH (sICH) subtypes accurately is
important since they have different risk factors, causal pathways, manage-
ment and prognosis. We systematically assessed the reliability of sICH
classification systems.
Methods: We sought all available assessments of reliability of an anatomi-
cal or mechanistic sICH classification system from electronic databases
(Medline, Embase) and through personal contact with researchers until
October 2014. We assessed included studies’ characteristics, including
quality and bias; performed meta-analyses of the proportion of cases
classified into each subtype; and summarised reliability with kappa value
forest plots, assessing visually the factors that may affect it.
Results: We included 20 of 2152 studies initially identified. In pooled
analyses: of anatomical systems, 35% of sICHs were lobar, 91% supraten-
torial, and 47% had intraventricular haemorrhage present; of mechanistic
systems, hypertension-related ICH accounted for 51%, CAA 16%, and
undetermined causes 13%. Reliability (range of kappa values) was sub-
stantial to almost perfect for both anatomical and mechanistic classifica-
tion systems (inter-rater reliability 0.78–0.97 anatomical [6 studies], 0.89–
0.93 mechanistic [3 studies]; intra-rater reliability 0.80–1 anatomical [3
studies], 0.92–0.93 mechanistic [2 studies]). Smaller numbers of raters
and categories improved reliability, but there were insufficient data to
assess all potential factors influencing reliability. Included studies were
performed mainly in highly specialised settings with experienced raters,
and had moderate reporting quality.
Conclusions: Existing classification systems perform very well in the set-
tings in which they have been tested, but their reliability is unknown in
other than highly specialised centres with experienced readers. Future
studies of reliability should follow published reporting guidelines.
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Intracerebral hemorrhage evacuation by MIN
techniques
K Resch1, R Bauer1
1Neurosurgery, Vivit-Institute, Feldkirch, Austria
Introduction: STICH I and II trials examined a situation that actually is
not representing today’s reality regarding MIN strategies and techniques.
EndoSTICH trial and MISTIE trial are studying two minimally invasive
techniques (endoscopic evacuation and katheter-lysis) which however do
not compete the needs of the majority of hemorrhages. We elaborated a
MIN technique with high effectiveness.
Material and method: This MIN concept combined several techniques to
assist microsurgery: High-end neurosonography with small probes (burr-
hole-probe/ALOKA) and mouth tracking of the microscope, both man-
datory. Additionally we added endoscopy (Wolf, Aesculap, Storz) and
LASER (Th-YAG Revolix).
165 patients underwent this application, the approaches varied from burr-
hole to 1€ or 2€ in size depending from the imaging findings and expected
difficulties.
Results: In nearly all cases it was possible to evacuate the hematoma
within 1 hour and the hematoma evacuation decreased the ICP to normal
levels. Clinical results were excellent in lobar bleedings with isochoric
before surgery. Large and deep-seated hemorrhages needed longer recov-
ery time but in all cases postop CT showed fast reduction of perifocal
edema.
Conclusion: Combination of ultrasound, mouth tracking, endoscopy and
LASER enabled evacuation of all type of hematoma minimal invasively
and very effectively in less than one hour. Ultrasound real-time control
detected all types and locations of bleeding causes.
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Necrosectomy by MIN techniques versus craniectomy
in stroke
K Resch1
1Neurosurgery, Vivit-Institute, Feldkirch, Austria
Objective: In the series of 165 hematoma evacuations some cases were
hamorrhagic infarctions. In these cases additional to the hematoma the
center oft he necrosis was evacuated also. As these patients made a much
better recovery than craniectomy cases we developed a novel concept.
Methods: Hemorrhagic infarctions were operated through key-holes
under ultrasound control (burr-hole probe, Alpha 7, ALOKA) and by
mouth-switch tracked microscope. Before surgery CTA or Duplex Sonog-
raphy was made to see if the Infarction showed reperfusion, because in the
latter condition the operation may be more difficult. Perfusion CT deter-
mined the center oft he necrosis.
Result: In all cases we saw a much better course of recovery than in
craniectomy cases. The patient were not disabled additionally by stigmata
like craniectomy defect, big scarf, loss of hair and psychological trauma.
The beginning of rehabilitation therapy could start within one week only,
the wound of 3 cm was not visible and during rehabilitation there was no
fear by the rehabilitation clinics to soon start the full training program. We
did not see any complication due to the MIN strategy.
Conclusion: The first promising results of MIN concept application in
stroke decompression seam logical regarding pathophysiology. It is worth-
while to study this novel concept by trials. The operative technique,
however is much more sophisticated than a simple craniectomy but also
much faster and economic.
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Brief consent sheets are effective: Data from the
on-going Tranexamic acid for hyperacute primary
IntraCerebral Haemorrhage (TICH-2) trial
N Sprigg1, KS Robson1, K Krishnan1, PM Bath1
1Stroke Division of Clinical Neuroscience, University of
Nottingham, Nottingham, United Kingdom
Background: Obtaining consent in the ongoing TICH-2 trial is challeng-
ing since a large proportion of patients lack capacity and relatives are often
unavailable.
Methods: Ethical approval was obtained to allow either verbal consent
(using a brief information sheet) followed by full written consent, when
full written consent was not possible or where patients lack capacity,
permission can be sort from a relative acting as legal representative. If no
relative was available, permission could be obtained if two clinicians (one
unconnected with the trial) agreed. Permission from legal representatives
could be given using a full or brief information sheet, followed by full
written consent.
Results: Of 721 patients enrolled, 161 (22.3%) gave full informed consent,
89 (12.3%) gave brief verbal consent. The majority of patients (65.3%)
were enrolled after proxy consent from a legal representative; full
informed relative consent 292 (40.5%), brief relative consent 134 (18.6%),
independent physician consent 45 (6.2 %). The majority of patients
enrolled after brief consent went on to give full consent, but some died or
were discharged without full written consent (Fig. 1). No patients or
relatives who initially gave brief consent went on to withdraw consent, and
no patients were lost to follow up.
Conclusion: Abbreviated information sheets and proxy consent can
ensure patients are enrolled rapidly into emergency clinical trials, avoiding
delays or exclusion.
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Blood pressure (BP) treatment after an intracerebral
haemorrhage (ICH): Data from the on-going
Tranexamic acid for hyperacute primary IntraCerebral
Haemorrhage (TICH-2) trial
N Sprigg1, K S Robson1, K Krishnan1, P M Bath1
1Stroke Division of Clinical Neuroscience, University of
Nottingham, Nottingham, United Kingdom
Background: Few treatment options exist for ICH patients. INTERACT-2
found that lowering BP non-significantly improved functional outcome.
The ongoing TICH-2 trial is testing whether tranexamic acid is effective at
improving outcome in ICH. We assessed whether use of BP lowering
treatment in TICH-2 increased after publication of INTERACT-2 results.
Methods: TICH-2 prospectively records BP and use of BP lowering drugs
2 and 7 days after randomisation. The percentage of participants on BP
lowering treatment was examined over time to see if a relationship could
be seen between the use of BP lowering and publication of INTERACT-2.
Results: By December 2014, 700 patients had been enrolled into TICH-2
and had day 7 follow-up. Figure 1 shows use of BP lowering drugs plotted
against time; the number of patients on BP treatment at day 2 increased
from 26 (47.3%) before INTERACT-2 to 420 (65.1%) afterwards (chi-
square, p = 0.008). No significant difference was seen at day 7; 37 (67.3%)
before and 503 (78.0%) after (p = 0.069). The number of patients using IV
BP treatment saw a significant increase after INTERACT-2 publication at
day 2 (p = 0.001) and day 7 (p = 0.0003). No difference was seen in BP
levels at day 2, before or after the INTERACT-2 results: 153.3/81.4 mmHg
versus 151.6/80.5 (ANCOVA, p = 0.2835).
Conclusion: Use of BP lowering medication has increased since publica-
tion of INTERACT-2.
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Minimum detectable difference for hematoma volume
measurement in acute intracerebral hemorrhage
D Rodriguez-Luna1, M Boyko2, S Subramaniam2, E Klourfeld2,
P Jo2, D Diederichs2, D Dowlatshahi3, M D Hill2, C A Molina1,
A M Demchuk2
1Stroke Unit – Department of Neurology, Vall d’Hebron
University Hospital and Vall d’Hebron Research Institute,
Barcelona, Spain
2Calgary Stroke Program – Department of Clinical
Neurosciences and Radiology, Hotchkiss Brain Institute and
University of Calgary, Calgary, Canada
3Department of Medicine – Neurology, The Ottawa Hospital –
University of Ottawa and Ottawa Hospital Research Institute,
Ottawa, Canada
Background: Limiting intracerebral (ICH) and intraventricular (IVH)
hemorrhage expansion is a common target for acute ICH studies. We
investigate the amount of hematoma volume difference between CT scans
that can be considered as measurement error.
Methods: Five raters performed baseline (<6 h) and 24-hour total hema-
toma (ICH + IVH) volumetric analysis from 40 randomly selected ICH
patients from the PREDICT study cohort. Estimates of intrarater and
interrater reliability are expressed as intraclass correlation coefficients
(ICC [95% CI]) and minimum detectable difference (MDD).
Results: Total hematoma volumetric analyses had excellent agreements
(Table). MDD was higher the larger total hematoma volume was and in
patients with subarachnoid hemorrhage (SAH) or IVH (Table).
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Conclusions: Larger hematomas and those with SAH or IVH are suscep-
tible to higher measurement error. >33% hematoma expansion definition
appears well above MDD (∼10% of hematoma volume) but >6 mL defi-
nition may be within the measurement error when assessing large hema-
tomas. Larger absolute expansion thresholds are more suitable to defining
hematoma expansion in large hematomas.
n Intrarater ICC
Intrarater
MDD (mL) Interrater ICC
Interrater
MDD (mL)
All 40 0.994 (0.991–0.996) 6.68 0.992 (0.990–0.993) 7.72
Volume (mL) ≤10 10 0.992 (0.978–0.996) 0.79 0.996 (0.993–0.998) 0.56
>10–30 10 0.979 (0.929–0.992) 2.52 0.986 (0.978–0.991) 2.06
>30–50 10 0.939 (0.872–0.969) 4.30 0.919 (0.878–0.945) 4.96
>50 10 0.976 (0.950–0.988) 8.22 0.962 (0.943–0.974) 10.35
SAH No 20 0.995 (0.990–0.998) 3.12 0.998 (0.996–0.999) 1.97
Yes 20 0.988 (0.979–0.993) 8.21 0.981 (0.974–0.985) 10.34
IVH No 29 0.997 (0.994–0.998) 3.82 0.993 (0.991–0.994) 5.83
Yes 11 0.985 (0.971–0.992) 8.79 0.979 (0.969–0.985) 10.40
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Intracranial hemorrhage caused by non-vitamin K
antagonist oral anticoagulants (NOACS): A multicenter
retrospective cohort study in Japan
N Saji1, K Kimura2, J Aoki2, J Uemura1
1Department of Stroke Medicine, Kawasaki Medical School,
Kurashiki, Japan
2Department of Neurological Science, Nippon Medical School
Graduate School of Medicine, Tokyo, Japan
Background: We conducted a multicenter retrospective cohort study to
elucidate the characteristics of intracranial hemorrhage in patients with
atrial fibrillation treated with non-vitamin K antagonist oral anticoagu-
lants (NOACs).
Methods: We sent a questionnaire to the directors of the 241 stroke
centers in Japan to establish the clinical characteristics of NOAC-
associated cerebral hemorrhage, including hematoma size, hematoma
enlargement (HE) and in-hospital mortality of patients treated in their
institutions. We undertook a literature review to establish the clinical
characteristics of warfarin-associated cerebral hemorrhage and compared
these with our data. The Institutional Review Board at the Kawasaki
Medical School Hospital approved this study and waived the need for
informed consent. This study was registered with the UMIN Clinical
Trials Registry (UMIN000014230).
Results: We received 174 responses (72.2%), of which 67 (38.5%) gave
anonymous details of 130 eligible patients (male, 67.7%; mean age,
77.3 ± 8.3 years, in-hospital mortality rate, 11.5%). We judged that 87 of
the 130 patients had presented with cerebral hemorrhage: one-fifth had
taken antiplatelet drugs. We found that the incidences of HE and mortal-
ity in the 87 patients presenting with NOAC-associated cerebral
hemorrhage were lower than would have been expected in those with
warfarin-associated cerebral hemorrhage (17% vs. 26%, and 16% vs. 35%,
respectively).
Conclusions: More than half the stroke center directors who responded
had not experienced cases of NOAC-associated intracranial hemorrhage.
Compared with warfarin, NOACs appear to present a lower risk of HE
and mortality in patients with atrial fibrillation who develop cerebral
hemorrhage.
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18. ICH and IVH
Local delivery of neural progenitor cells and
nanomaterial improves functional outcome in a rat
model of intracerebral hemorrhage
L Y H Sang1, X Y Yang2, H X Su3, G K K Leung1, W T Wu2,
R T F Cheung4
1Surgery, The University of Hong Kong, Hong Kong, China
2Anatomy, The University of Hong Kong, Hong Kong, China
3Institute of Chinese Medical Sciences, University of Macau,
Macau, China
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Hematoma aspiration reduces hematoma volume and decreases perihe-
matoma edema. The hemorrhagic cavity provides space for local delivery
of potential therapeutic agents. A nanomaterial RADA 16-I has been
shown to replace the hematoma and reduce ICH-related injury. In this
study, the effect of local delivery of neural progenitor cells (NPC) plus the
nanomaterial in a rat model of ICH was studied.
NPCs were derived from day 13.5 embryos of green fluorescent protein
(GFP) transgenic SD rats. ICH was induced by intrastriatal injection of
bacterial collagenase IV. Hematoma aspiration was performed at 3.5 h
after ICH. The RADA 16-I solution was injected into the cavity immedi-
ately following hematoma aspiration. The NPCs were transplanted
embedded in the nanomaterial at 3.5 h after ICH or at 2 weeks after ICH.
The functional outcome was assessed. The survival and differentiation of
the survived NPCs and the underlying mechanism were evaluated.
The cells group exhibited better functional performance than the control
group. NPCs survived in the brain cavity. More than half of the survived
cells remained undifferentiated, while a quarter of the cells differentiated
into GFAP positive astrocytes. Only a very small proportion of GFP cells
were NeuN positive neurons. The cells group showed a trend toward
increased secretion of neurotrophic factors.
Local delivery of neural progenitor cells and nanomaterial improves func-
tional outcome. This study may provide evidence for a new therapeutic
strategy for ICH.
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Higher mortality in patients with right hemispheric
intracerebral haemorrhage: INTERACT1 AND 2
S Sato1, E Heeley1, H Arima1, V Pamidimukkala2, Z Li3, Q Tao4,
Y Xu5, T Robinson6, R I Lindley1, C S Anderson1
1The George Institute for Global Health, Neurological &
Mental Health Division 2050 Camperdown, Australia
2Department of Neurology, Lalitha Super Specialities Hospital,
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3Department of Neurology, The Fifth Affiliated Hospital Sun
Yat-Sen University, Guangdong, China
4Department of Neurology, Chang Ning District Central
Hospital, Shanghai, China
5Department of Neurology, Shijiazhuang 260 Hospital, Hebei,
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6Department of Cardiovascular Sciences and NIHR Biomedical
Research Unit for Cardiovascular Diseases, University of
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Background and purpose: Controversy exists over the prognostic signifi-
cance of affected hemisphere in stroke. We aimed to determine the rela-
tionship between laterality of acute intracerebral haemorrhage (ICH) and
poor clinical outcomes.
Methods: A subsidiary analysis of the INTERACT Pilot and INTERACT2
studies – randomised controlled trials of patients with spontaneous acute
ICH with elevated systolic blood pressure (BP), randomly assigned
to intensive (target systolic BP < 140 mmHg) or guideline-based
(<180 mmHg) BP management. Outcomes were the combined and sepa-
rate endpoints of death and major disability (modified Rankin scale
[mRS] scores of 3–6, 6, and 3–5, respectively) at 90 days.
Results: A total of 2708 patients had supratentorial/hemispheric ICH and
information on mRS at 90 days. Patients with right hemispheric ICH
(1327, 49%) had a higher risk of death at 90 days compared to those with
left hemispheric ICH after adjustment for potential confounding variables
(odds ratio, 1.77 [95% confidence interval, 1.33–2.37]). There were no
differences between patients with right and left hemispheric ICH regard-
ing the combined endpoint of death or major disability or major disability
in the multivariable-adjusted models (1.07 [0.89–1.29] and 0.85 [0.72–
1.01], respectively).
Conclusions: Right hemispheric lesion was associated with increased risk
of death in patients with acute ICH. The laterality of the ICH does not
appear to affect the level of disability in survivors.
Fig. Kaplan–Meier curves for death in patients with right and left ICH.
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Off-hour admission and outcomes in patients with
acute intracerebral hemorrhage in the INTERACT2 trial
S Sato1, H Arima1, E Heeley1, Y Hirakawa1, C Delcourt1,
R I Lindley1, T Robinson2, Y Huang3, C Stapf4, C S Anderson1
1The George Institute for Global Health, Neurological &
Mental Health Division 2050 Camperdown, Australia
2Department of Cardiovascular Sciences and NIHR Biomedical
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3Department of Neurology, Peking University First Hospital,
Beijing, China
4Assistance Publique–Hôpitaux de Paris–Hôpital Lariboisière
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Background: Conflicting data exist of an association between off-hour
(weekend, holiday, or night-time) hospital admission and adverse
outcome in intracerebral hemorrhage (ICH).
Aims: We determined the association between off-hour admissions and
poor clinical outcome, and of any differential effect of early intensive
blood pressure (BP) lowering treatment between off- and on-hour admis-
sions, among participants of the Intensive Blood Pressure Reduction in
Acute Cerebral Hemorrhage Trial (INTERACT2).
Methods: Subsidiary analysis of INTERACT2, a multinational, multi-
center, clinical trial of patients with spontaneous ICH with elevated sys-
tolic BP, randomly assigned to intensive (target systolic BP < 140 mmHg)
or guideline-based (<180 mmHg) BP management. Primary outcome was
death or major disability (modified Rankin scale of 3–6) at 90 days.
Off-hour admission was defined as night-time (4:30 pm to 8:30 am) on
weekdays, weekends (Saturday and Sunday), and public holidays in each
participating country.
Results: Of 2794 patients with information on the primary outcome, 1770
(63%) were admitted to study centers during off-hours. Off-hour admis-
sion was not associated with risk of poor outcome at 90 days (53%
off-hour vs. 55% on-hour; P = 0.49), even after adjustment for co-morbid
Abstracts
© 2015 The Authors.
International Journal of Stroke © 2015 World Stroke Organization Vol 10 (Suppl. 2); April 2015; 77–438298
risk factors (odds ratio 0.92; 95% CI 0.76–1.12). Consistency exists in the
effects of intensive BP lowering between off- and on-hour admission
(P = 0.85 for homogeneity).
Conclusions: Off-hour admission was not associated with increased risks
of death or major disability among trial protocol participants with acute
ICH. Intensive BP lowering is broadly beneficial irrespective of admission
hours.
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Diagnostic yield and accuracy of CT angiography, MR
angiography and digital subtraction angiography for
detection of macrovascular causes of intracerebral
haemorrhage – a prospective, multicentre cohort study
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Background: In patients with intracerebral haemorrhage (ICH), we
assessed the diagnostic value for finding a macrovascular cause of early CT
angiography (CTA), and additional MR angiography (MRA) and digital
subtraction angiography (DSA) after 4–8 weeks.
Methods: We prospectively enrolled 301 patients with non-traumatic
ICH, aged 18–70, excluding those >45 years with hypertension and ICH in
basal ganglia, thalamus or posterior fossa. For yield and positive predictive
value (PPV) of CTA, and of additional MRA and DSA, we calculated
proportions with corresponding 95% confidence intervals (CI). We inves-
tigated determinants of finding a macrovascular cause with logistic regres-
sion, and constructed prediction charts for the probability of finding a
macrovascular cause.
Results: In 70 of 301 patients a macrovascular cause was found; in 51/298
by CTA (yield 17%, 95%CI:13–22), in 55/283 by CTA + MRA (yield 19%,
95%CI:15–24), and 70/174 by CTA + MRA + DSA (yield 40%, 95%CI:33–
48). PPV of CTA was 72% (95%CI:60–82), of additional MRI/A 35%
(95%CI:14–62), and of additional DSA 94% (95%CI:70–99). Predictors
for a macrovascular cause were age ≤50, <4 units alcohol intake/day, lobar
or posterior fossa ICH location, and absence of signs of small vessel
disease on CT. The prediction score showed good discriminative ability
(c-statistic 0.84, 95%CI:0.79–0.90).
Conclusions: CTA is an appropriate initial investigation to detect macro-
vascular causes in patients with ICH but accuracy is modest. Additional
MRI/A may find cavernomas or alternative diagnoses but DSA is needed
to diagnose macrovascular causes undetected by CTA or MRA. The pre-
diction score identifies patients with low, intermediate and high risk of a
macrovascular cause.
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Recurrent hemorrhage risk and long-term mortality
after a first intracerebral hemorrhage in hereditary
and sporadic cerebral amyloid angiopathy
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Background: Hereditary Cerebral Hemorrhage With Amyloidosis–Dutch
type (HCHWA-D) is considered a model for sporadic Cerebral Amyloid
Angiopathy (sCAA), but it is unclear whether the disease courses are
comparable. We compared recurrent ICH risk and long-term mortality in
HCHWA-D and sCAA-patients.
Methods: We included HCHWA-D-patients from Leiden University
Medical Center and sCAA-patients from Massachusetts General Hospital
with a first symptomatic ICH. Baseline characteristics, hemorrhage recur-
rence, and mortality during follow-up were compared in patients who
survived 90 days after the presenting ICH. Hazard ratio’s (HR), adjusted
for age and sex, were calculated with a Cox regression analysis.
Results: We included 54 HCHWA-D and 316 sCAA-patients. HCHWA-
D-patients less often had one or more cardiovascular risk factors (24%
versus 70% in sCAA) and were younger (mean age 54 ± 8 versus 72 ± 9 in
sCAA) at time of presenting ICH. Forty-six (85%) HCHWA-D-patients
survived 90 days after their first ICH compared with 240 (76%) sCAA-
patients. During mean follow-up of 5 ± 4 years (total 1585 person-years),
HCHWA-D-patients had higher risk of recurrent ICH (20.5 per 100
versus 8.9 per 100 person-years in sCAA; HR:2.6;95%CI:1.5–4.8) and a
higher mortality rate (9 per 100 versus 8 per 100 person-years in sCAA;
HR:3.3;95%CI:1.7–6.1).
Conclusion: HCHWA-D-patients have a higher risk of recurrent ICH and
a higher long-term mortality than sCAA-patients. Absence of cardiovas-
cular risk factors in the majority of HCHWA-D-patients suggests that
vascular amyloid is mostly responsible for the recurrent events.
HCHWA-D is a pure CAA form with an accelerated clinical course and
provides a good cohort for trials targeting vascular amyloid.
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Thrombelastometry (ROTEM®) as instrument for study
of coagulative mechanism in patients with
spontaneous intracerebral hemorrhage: a pilot study
L Vandelli1, F Rosafio1, G Bigliardi1, M L Dell’Acqua1, F Barbi1,
L Picchetto1, R Pentore1, P F Nichelli1, A Zini1
1Neuroscience, Stroke Unit Nuovo Ospedale Civile
Sant’Agostino Estense, Modena, Italy
Background: Spontaneous intracerebral hemorrhage (ICH) is linked with
high morbidity and mortality and at present there are not evidences for
use of any hemostatic drugs. Thrombelastometry (ROTEM®) gives a
qualitative and dynamic evaluation of coagulative mechanism and it
might be useful to give rapid information in ICH patients for assessing
risk of hematoma expansion.
Methods: We performed a prospective pilot study including 11 patients
with spontaneous ICH admitted in Stroke Unit. ROTEM® was performed
within 8 hours of symptom onset. CT brain imaging was obtained at
baseline and 24 hours. We evaluate if patients with major hematoma
(defined as a total volume >25 ml) show different ROTEM® parameters
than patients with minor hematoma (< 25 ml).
Results: In our sample three ICH experienced major hematoma. This
group shows a trend toward longer CFT main values and minor MCF
amplitude, α-angle and G values, than patients with minor hematoma.
These data could suggest that ICH patients with major volume present
reduced speed and strenght of clot formation. On the contrary, patient
with minor hematoma have stronger and faster clot formation, that could
hypothetically reflect a more effective adaptive response to bleeding,
resulting in a minor expansion of hemorrhage.
Conclusions: ROTEM® may rapidly show coagulation changes in patients
with acute ICH. Clotting process may be different in immediate response
to ICH, according to our preliminary data that suggest a weaker and
slower pro-coagulative response linked to the formation of larger hema-
tomas. Further wider studies are needed to confirm this hypothesis.
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Impact of perihemorrhagic edema on outcome after
intracerebral hemorrhage
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Objectives: Intracerebral hemorrhage (ICH) is a devastating disease with
a bad outcome. Initial hematoma volume and presence of intraventricular
hemorrhage (IVH) could be established as main prognostic outcome
factors. However, beside its possible effect on mortality the role of peri-
hemorrhagic edema (PHE) and its natural course remains unclear. Aim of
the present study was to elucidate the impact of the natural course of ICH
and PHE on functional outcome.
Methods: Patients were identified from our institutional ICH database.
Subjects with spontaneous supratentorial ICH who received >1 computed
tomography (CT) scans were included. PHE volume was calculated using
a semiautomatic threshold based volumetric algorithm. CT scans per-
formed on days 1, 2–3, 4–6, 7–9 and 10–12 were analyzed. Dichotomized
Modified Rankin Scale at discharge (0–3 = favorable vs. 4–6 = poor
outcome) was used as outcome parameter.
Results: The selection algorithm resulted in 250 patients for final analysis.
Mean ICH volume on admission was 20.7 ± 23.8 cm3. Mean absolute PHE
volume on admission was 20.4 ± 20.4 cm3 and increased to a mean peak
volume of 34.6 ± 31 cm3 during 6.5 ± 4.1 days on average. Besides GCS at
admission, baseline modified Rankin scale before ICH, mechanical ven-
tilation and frequency of elevated intracranial pressure, high peak PHE
volume significantly predicted poor outcome (Exp(B) 0.980 (95% CI 0.96
to 0.99)).
Conclusions: In summary we found that absolute PHE may have a nega-
tive impact on functional outcome after ICH. Therefore, PHE may repre-
sent a possible treatment target.
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Spontaneous intracerebral hemorrhage in Tibetan
plateau: How different from Han Chinese in Chengdu
Plain
D Wang1, R Yuan1, M Liu1, Y He2, Y Deng2, J Chen2, Y Silang2,
X Chang1, Q Wang1
1Neurology, West China Hospital of Sichuan University,
Chengdu, China
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Background and purpose: The patterns of spontaneous intracerebral hem-
orrhage (ICH) in the Tibetans, who lived in the Tibet plateau with their
unique natural geographical environment and dietary habit, are little
known. We investigated the patterns of those patients, compared with Han
Chinese patients in Chengdu Plain.
Methods: We enrolled consecutive patients with ICH who were admitted
to West China Hospital and People’ hospital of Garzê within 1 month of
stroke onset from January 2013 to December 2013, respectively. Basic
characteristics and functional outcomes for ICH were compared between
Tibetan and Han Chinsese.
Results: Of the 863 cases included, 105 (12.2%) patients were from
Tibetan plateau and 758 (87.8%) patients were from Chengdu Plain.
Patients from Tibetan plateau, compared with those from Chengdu Plain,
were older, and more often had experienced hypertension, and less often
had experienced diabetes and current smoking (all P ≤ 0.014). On admis-
sion due to ICH, they also had higher Glasgow coma scale (GCS) score,
higher Systolic blood pressure and diastolic blood pressure, higher level of
blood Hemoglobin and platelets, and lower lever of serum albumin (all
P ≤ 0.009). In patients from Tibetan plateau, the 3-month death rate was
25.8%, which were similar to that in patients from Chengdu Plain
(P = 0.917).
Conclusions: The mortality of ICH patients from Tibetan plateau is
similar to that from Chengdu plain and high blood pressure may be the
main etiology for Tibetan ICH patients, which need to be verified by larger
epidemiologic studies.
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MISTIE, CLEAR-IVH and CLEAR III trials
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Background: The ABC/2 score estimates intracerebral hemorrhage (ICH)
volume, yet validations have been limited by small samples and inappro-
priate outcome measures. We determined accuracy of the ABC/2 score
calculated at a specialized Reading Center (RC-ABC) or local site (site-
ABC) versus the reference-standard, CT-based planimetry (CTP).
Methods: In the MISTIE-II, CLEAR-IVH and CLEAR-III trials, ICH
volume was prospectively calculated by CTP, RC-ABC and site-ABC.
Agreement between CTP and ABC/2 was defined as an absolute difference
of at most 5 ml and as a relative difference within 20%. Determinants of
ABC/2 score accuracy were assessed by logistic regression.
Results: In 4369 scans from 507 patients, CTP was more strongly
correlated with RC-ABC (r2 = 0.93) than site-ABC (r2 = 0.87).
Although RC-ABC overestimated CTP-based volume on average (RC-
ABC = 15.2 cm3, CTP = 12.7 cm3), agreement was reasonable when cat-
egorised into mild, moderate and severe ICH volume (kappa 0.75,
p < 0.001). This was consistent with overestimation of ICH volume by
ABC/2 in 6/8 previous studies. Agreement with CTP was greater for
RC-ABC (84% within 5 ml; 48% of scans within 20%) than for site-ABC
(81% within 5 ml; 41% within 20%). RC-ABC had moderate accuracy for
detecting ≥5 ml change in CTP volume between consecutive scans (sen-
sitivity 0.76, specificity 0.86) and was more accurate with smaller ICH,
thalamic haemorrhage and homogeneous clots.
Conclusions: ABC/2 scores are sufficiently accurate to assess ICH volume
and also to determine eligibility for the CLEAR III and MISTIE III studies,
and moderately accurate for change in ICH volume. However, accuracy
decreases with large, irregular or lobar clots.
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Background: Asymmetric dimethylarginine (ADMA) – an endogenous
NO-synthase inhibitor has been regarded as mediator of endothelial dys-
function and oxidative stress. Experimental data suggest an involvement
in intracerebral hemorrhage (ICH). We hypothesized that levels of ADMA
and its analogon symmetric dimethylarginine (SDMA) are elevated after
ICH and are associated with adverse clinical outcome.
Methods: Blood samples from 20 patients with acute ICH treated at Han-
nover Medical School were taken at ≤24 h, 3 d and 7 d after the event.
Dimethylarginines were determined in serum using high-performance
liquid chromatography–tandem mass spectrometry. Levels were com-
pared with those in 30 control subjects without ICH not differing in
regard to baseline characteristics and cardiovascular risk factors. Accord-
ing to the modified Rankin Scale (mRS) score at 90 d, 9 patients had
favorable (mRS 0–2) and 11 patients unfavorable outcome (mRS 3–6).
Results: Levels of ADMA – but not SDMA – were significantly elevated in
ICH patients at any time point compared to controls (ADMA ≤24 h:
p < 0.001; 3 d: p = 0.001; 7 d: p < 0.001). While ADMA levels increased
from ≤24 h to day 7 (p = 0.030), SDMA levels decreased from ≤24 h to day
3 (p = 0.029). Dimethylarginine levels were significantly increased in
patients with unfavorable outcome compared to those with favorable
outcome (ADMA ≤24 h: p = 0.031; SDMA ≤24 h: p = 0.016; SDMA 3 d:
p = 0.004; SDMA 7 d: p = 0.031). Outcome groups did not differ in regard
to baseline characteristics and cardiovascular risk factors.
Conclusion: Our data show that dimethylarginine levels are increased
after the acute event of ICH in relation to outcome. Further studies are
needed to investigate the mechanisms behind.
ESOC-1165
18. ICH and IVH
Intracranial hemorrhage: 4 years experience
S Senadim1, M Cabalar1, V Yayla1, A Bulut1, A Bajrami1, F Azman1
1Neurology, Bakirkoy Dr Sadi Konuk Research & Training
Hospital, Istanbul, Turkey
Objective: Patients with spontaneous intracerebral haemorrhage (ICH)
were evaluated in terms of risk factors, hematoma size, localization and
their effects over mortality and morbidity and post-stroke depression.
Materials-methods: Between 1/January/2010–1/March/2014, 216 ICH
patients (142M:74F) were evaluated, demographic findings, risk factors
and neurological examinations were recorded. Diagnosis, volume and
localization of hematoma, its ventricular extension were evaluated by CT.
First 30-days mortality rate was evaluated by ICH score and ICH grading
scale. Modified Rankin Scale (mRS) was used to evaluate the dependency
status and functional recovery. Hamilton Depression Rating Scale was
applied for psychosocial determination.
Results: The mean age was 65.3 ± 14.5 years. In 80.6% of patients HT, in
18.5% DM, in 15,3% hyperlipidemia and in 8.3% of patients CRF were
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determined. The locations of ICH were lobar(28.3%), thalamus(26.4%),
basal ganglia(24.0%), cerebellum(13.9%) and brainstem(7.4%) respec-
tively. Hematoma volume average was 15.8 ± 23.8 cm3. Ventricular exten-
sion of hemorrhage developed in 34.4%, midline shift in 28.7%,
perihematomal edema in 27.8% were the most frequent complications.
Six months follow-up showed (mRS: <3 good-≥3 poor) poor prognosis in
57.9% and good in 42.1%. The mean age of poor prognosis group was
significantly higher (p = 0.003). The first 30-day mortality rate was sig-
nificantly more frequent in patients with low GCS on admission, large
volumes of hematoma, ventricular extension of hemorrhage (p = 0.0001).
In poor prognosis group, the presence of moderate depression (39.13%)
was significantly higher (p = 0.0001).
Conclusion: Evaluation and distinguishing the factors that may affect
prognosis and mortality is crucial in achieving more effective manage-
ment in patients with ICH.
Abstracts
© 2015 The Authors.
International Journal of Stroke © 2015 World Stroke Organization Vol 10 (Suppl. 2); April 2015; 77–438302
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19. Imaging
Diagnostic accuracy of CT-angiography for internal
carotid artery stenosis – comparison with a revisited
multiparametric ultrasound approach
K Barlinn1, T Floegel1, H Kitzler2, T Siepmann1, L P Pallesen1,
U Bodechtel1, V Puetz1
1Neurology, University Hospital Dresden, Dresden, Germany
2Neuroradiology, University Hospital Dresden, Dresden,
Germany
Background: We aimed to determine the accuracy of CT-angiography
(CTA) compared with the novel multiparametric duplex ultrasound
(DUS) approach from the Neurosonology Research Group (NSRG) for
extracranial ICA stenosis diagnosis.
Methods: We studied consecutive acute ischemic stroke patients who were
admitted from 01/2012 to 12/2012 and underwent CTA and DUS. On
DUS, ICA stenosis and complete occlusion were graded according to the
published NSRG criteria. Axial CTA source images were independently
assessed and NASCET–type measurements were manually performed for
each extracranial ICA. We calculated accuracy parameters of CTA for
identification of 50–99% and 70–99% ICA stenosis, and complete ICA
occlusion using DUS as reference.
Results: A total of 339 patients (age 72 ± 12 yrs, 58% men, median NIHSS
4, interquartile range 8) provided 651 DUS and CTA measurement pairs.
On DUS, 50–99% stenosis was found in 28, 70–99% stenosis in 16, and
complete occlusion in 29 ICAs. The sensitivity of CTA against DUS was
low for both 50–99% and 70–99% ICA stenosis (64% and 31%, respec-
tively). Further accuracy parameters of CTA were as follows: specificity
97%, PPV 49%, NPV 98% and overall accuracy 96%, and 99%, 56%, 98%
and 98%, respectively. The highest accuracy of CTA was obtained for
discriminating between complete ICA occlusion and non-occlusion:
100%, 96%, 91%, 100% and 99%.
Conclusions: In comparison with the widely used NSRG criteria, CTA
seem to underestimate the degree of extracranial ICA stenosis. The valid-
ity of the NSRG criteria is currently evaluated in a prospective multicenter
validation study utilizing invasive angiography as gold standard.
ESOC-1178
19. Imaging
Brain atrophy as assessed by baseline clinical
computed tomography scans predicts post-stroke
delirium
A J Barugh1, A Farrall2, S D Shenkin1, A M J MacLullich1,
G E Mead1
1Edinburgh Delirium Research Group Geriatric Medicine,
University of Edinburgh, Edinburgh, United Kingdom
2Center for Clinical Brain Sciences, University of Edinburgh,
Edinburgh, United Kingdom
Background: Delirium affects ∼25% of stroke patients in hospital, and is
associated with adverse outcomes. It is unclear whether acute (stroke
lesion) and chronic (cerebral atrophy and white matter lesions (WMLs))
brain changes on routine computed tomography (CT) brain imaging
predict delirium. We aimed to identify whether CT features predicted
delirium at up to four months post-stroke.
Methods: Ninety-five participants (aged > 60, median 77) with acute
stroke were assessed for delirium, using the Confusion Assessment
Method-ICU and the Delirium Rating Scale-Revised-98 on alternate days
for one week after stroke, then at 14 days, 28 days and 4 months. Baseline
CT scans were rated for acute stroke lesions and presence and severity
of cerebral atrophy and WMLs (0 = none, 1 = mild, 2 = moderate,
3 = severe). Relationships between CT features and delirium diagnosis
(binary outcome, based on at least one positive screening test) were exam-
ined with Chi-square.
Results: 26 (27%) participants developed delirium. Greater severity of
brain atrophy predicted delirium after stroke. Neither WMLs nor a visible
acute stroke lesion predicted delirium (see table).
CT feature
Delirium
(n = 26)
n(%)
No delirium
(n = 69)
n(%) p
Atrophy present 24 (92) 54 (78) .026*
WMLs present 21 (81) 42 (61) .296*
Visible acute stroke lesion 13 (50) 26 (38) .281
*Chi-squared test of severity of atrophy/WMLs (0,1,2,3) and delirium
(yes/no)
Discussion: Greater severity of brain atrophy as assessed by CT predicted
development of delirium in the four months after stroke. CT parameters
derived from routine clinical scans may aid prediction of those most at
risk of delirium.
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Continuing versus stopping pre-stroke
antihypertensive therapy and neuroimaging findings
and outcomes following acute ischaemic stroke:
Results from the Efficacy of Nitric Oxide in Stroke trial
L Beishon1, N Sprigg1, A Adami1, J Becker1, L Cala1, A Casado1,
R Dineen1, P Koumellis1, S Phillips2, S Szatmari3, H Christensen4,
S Osturk5, J M Wardlaw6, P M Bath1
1Stroke Trials Unit, University of Nottingham, Nottingham,
United Kingdom
2Acute Stroke, Queen Elizabeth II Health Sciences Centre,
Halifax Nova Scotia, Canada
3Department of Neurology, Mures County Emergency
Hospital, Targu Mures, Romania
4Department of Neurology, University of Copenhagen,
Copenhagen, Denmark
5Department of Neurology, Seluck University, Konya, Turkey
6Centre for Clinical Brain Sciences, University of Edinburgh,
Edinburgh, United Kingdom
Introduction: Around 50% of patients with acute stroke are on antihyper-
tensive therapy at presentation. It remains unclear whether this medica-
tion should be continued or stopped temporarily.
Methods: ENOS randomised 2097 participants to continue or stop pre-
stroke antihypertensive therapy for 7 days. We assessed the relationship
between baseline imaging and outcome at day 90 (modified Rankin scale,
Barthel Index), and the effect of continuing antihypertensives on
follow-up neuroimaging at day 7. Data are adjusted odds ratio (95%
confidence intervals).
Results: Baseline imaging variables associated with worse mRS scores at
day 90 were; previous stroke lesion (OR 1.38, 95% CI 1.14–1.67,
p = 0.001), acute stroke change (OR 1.31, 1.10–1.57, p = 0.003), lobar
infarction (OR 1.45, 1.06–1.97, p = 0.019), ASPECTS score <= 7 (OR 0.95,
95% CI 0.91–0.98, p = 0.001), and mass effect (OR 1.40, 1.16–1.69,
p < 0.001). In subgroup analyses, patients with cerebral atrophy at base-
line were more likely to benefit from stopping therapy (interaction
p = 0.044). There were no significant differences between treatment
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groups in the 26.8% of patients with neuroimaging at day 7: lesion site,
size, ASPECTS score, mass effect, ischaemic characteristics, and haemor-
rhagic transformation.
Discussion: Baseline imaging variables can contribute to early prognosti-
cation of patients with acute ischaemic stroke. Patients with cerebral
atrophy on imaging may particularly benefit from stopping therapy short
term, perhaps because it reflects dehydration. Continuation or stopping
pre-existing antihypertensive treatment does not affect early neuroimag-
ing findings.
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19. Imaging
Hemodynamic determinants of effective reperfusion in
patients with acute ischemic stroke as assessed by CT
perfusion
A Bernardoni1, M Padroni2, C Tamborino2, C D’Esterre3, C Azzini4,
A De Vito4, A Saletti5, T Y Lee6, B Menon3, E Fainardi5
1Department of Morphology Surgery and Experimental
Medicine University of Ferrara, Radiology Section, Ferrara,
Italy
2Department of Biological Psychiatric and Psychological
Science University of Ferrara, Section of Neurology, Ferrara,
Italy
3Department of Clinical Neuroscience University of Calgary,
Calgary Stroke Program, Calgary, Canada
4Department of Neuroscience and Rehabilitation Azienda
Ospedaliera Universitaria, Neurology Unit, Ferrara, Italy
5Department of Neuroscience and Rehabilitation Azienda
Ospedaliera Universitaria, Neuroradiology Unit, Ferrara, Italy
6Robarts Research Institute, Imaging Research Lab, London,
Canada
Background: We sought to identify CTP parameters at stroke onset and at
follow-up associated with reperfusion at 24 hours and good clinical
outcome at 90 days.
Methods: We retrospectively investigated 80 patients with anterior circu-
lation acute ischemic stroke (11 untreated and 69 treated with either
intravenous thrombolysis or endovascular therapy) who were imaged <6
hours from stroke symptom onset with non-enhanced CT, CT Angiogra-
phy (CTA) and CT perfusion (CTP) at admission and at 24 hours. Cere-
bral blood flow (CBF), cerebral blood volume (CBV) and Tmax were
measured in total hypoperfused area as outlined on baseline Tmax maps.
Recanalization was assessed on 24 hour CTA according to TICI criteria
modified for CTA. Successful reperfusion was defined as ≥59% reduction
in size of baseline Tmax lesion at follow-up CTP. Good outcome was
defined as 90 day-modified Rankin scale (mRS) ≤ 2.
Results: Recanalization and reperfusion occurred in 82.5% and 51.2% of
cases, respectively. A good outcome was present in 68.3% of reperfusers.
Admission CBF, CBV and Tmax were similar between reperfused and non
reperfused patients and between good and poor outcome reperfusers.
24-hour CBF was higher (p < 0.01) and Tmax was lower (p < 0.00001) in
reperfused than nonreperfused patients but 24-hour CBF and CBV were
higher (p < 0.05 and p < 0.01, respectively) in poor than good outcome
reperfusers. Successful recanalization was equally distributed between
good and poor outcome reperfusers.
Conclusions: Our findings suggest that CBF and CBV values detected in
ischemic brain at 24 hours after stroke may be determinants of the efficacy
of reperfusion (i.e. good outcome in reperfusers).
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Extension of ischemic lesions differs between grey and
white matter
L P Berner1, T H Cho2, J Bouvier3, J Haesebaert4, T Ritzenthaler2,
N Nighoghossian2, Y Berthezène1
1Service de neuroradiologie, Hospices Civils de Lyon – Hôpital
Pierre Wertheimer, Bron, France
2Service de neurologie vasculaire, Hospices Civils de Lyon –
Hôpital Pierre Wertheimer, Bron, France
3CREATIS CNRS UMR 5220 – INSERM U1044, INSA-Lyon
Université de Lyon Lyon 1, Lyon, France
4Pôle Information Médicale Evaluation Recherche, Hospices
Civils de Lyon, Lyon, France
Purpose: In acute ischemic stroke (AIS), white matter (WM) is considered
to be more resistant to infarction than grey matter (GM). We compared
the evolution of ischemic lesions within WM and GM using magnetic
resonance imaging (MRI).
Methods: From a multicenter prospective database (I-KNOW), 50
patients presenting an anterior AIS with (1) a perfusion (PWI) / diffusion-
weighted imaging (DWI) mismatch ratio of 1.2 or more; and (2) available
T1-weighted images were identified.
Five tissue compartments were outlined: (1) initial DWI lesion; (2) initial
PWI-DWI mismatch (Tmax > 4 s and DWI-negative); (3) final infarct
mapped on 1-month FLAIR; (4) lesion growth (between acute DWI and
1-month FLAIR); (5) DWI lesion reversal at 1-month.
WM and GM were segmented on T1-weighted images and corresponding
volumes were calculated for each compartment. All images were coregis-
tered within subjects to the baseline MRI.
Results: Median delay between symptom onset and baseline MRI was 140
minutes.
Volume of WM was significantly greater in the following compartments:
initial mismatch (16.08 versus 12.40 mL, p = 0.003), final infarct (8.28 ver-
sus 5.74 mL, p < 0.001) and lesion growth (5.18 versus 2.72 mL, p < 0.001).
There was no significant difference between GM and WM volumes within
the initial DWI lesion or tissue showing DWI lesion reversal.
Conclusion: These results suggest that ischemic lesions may extend pref-
erentially within the WM. Therapeutic strategies that are effective within
the WM should be developed.
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Comparison between the “DWI B0-DWI B1000”
mismatch and the DWI-FLAIR mismatch to identify
patients with acute ischemic stroke within 4.5 hours:
A preliminary study
L P Berner1, A F Geraldo1, J Haesebaert2, T H Cho3, A Chabrol1,
T Ritzenthaler3, N Nighoghossian3, Y Berthezène1
1Service de neuroradiologie, Hospices Civils de Lyon – Hôpital
Pierre Wertheimer, Bron, France
2Pôle Information Médicale Evaluation Recherche, Hospices
Civils de Lyon, Lyon, France
3Service de neurologie vasculaire, Hospices Civils de Lyon –
Hôpital Pierre Wertheimer, Bron, France
Purpose: The diffusion-weighted imaging–fluid-attenuated inversion
recovery (DWI-FLAIR) mismatch can be used to identify patients within
4.5 hours after stroke onset.
DWI includes b = 0 sec/mm2 images that are T2-weighted but not
diffusion-weighted, unlike b = 1000 sec/mm2.
We compared the accuracy of the b0–b1000 mismatch (lesion absent on
b0, hyperintense on b1000) and the DWI-FLAIR mismatch (FLAIR nega-
tive, b1000 positive) to identify patients presenting within 4.5 hours.
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Methods: Patients were included in an European multicenter database
(I-KNOW) and presented an anterior acute ischemic stroke (AIS) lesion
hyperintense on DWI b1000, with known time of onset.
Two readers independently evaluated lesion conspicuity on FLAIR images
(absent, subtle or frank). Absent and subtle signal changes were classified
in the “FLAIR negative” group.
Lesion visibility on b0 images was independently evaluated by two other
readers, who considered the lesion either absent (b0 negative) or present
(b0 positive).
Results: Among 122 patients analysed, 85 (75.89%) were within 4.5 hours
after stroke onset.
“b0-b1000” mismatch identified patients within 4.5 hours with 72.94%
[95%CI 63.50–82.39] sensitivity, 70.37% [53.15–87.59] specificity,
88.57% [81.12–96.02] PPV and 45.24% [30.19–60.29] NPV.
DWI-FLAIR mismatch identified patients within 4.5 hours with 80.00%
[95%CI 71.50–88.50] sensitivity, 62.96% [44.75–81.18] specificity,
87.18% [79.76–94.60] PPV and 50.00% [33.19–66.81] NPV.
Interrater agreement for lesion visibility on b0 was excellent (κ = 0.826;
95%CI 0.718–0.934, p < 0.001), better for deep MCA territory lesions
(κ = 0.910). Interrater agreement on FLAIR was good (κ = 0.719; 95%CI
0.577–0.861, p < 0,001).
Conclusion: The “b0-b1000 mismatch” could be considered as an alterna-
tive for the diffusion-FLAIR mismatch in situations that have to be deter-
mined more precisely.
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Digital probability atlas of cerebral ischemic
infarctions after acute ischemic stroke
A M M Boers1, H A Marquering1, O A Berkhemer2, D W Dippel3,
Y Roos4, A van der Lugt3, R J Oostenbrugge5, W H van Zwam5,
C H Slump6, C B L M Majoie2
1Biomedical Physics & Engineering / Radiology, Academic
Medical Center University of Amsterdam, Amsterdam,
Netherlands
2Radiology, Academic Medical Center University of
Amsterdam, Amsterdam, Netherlands
3Radiology, Erasmus MC, Rotterdam, Netherlands
4Acute Neurology, Academic Medical Center University of
Amsterdam, Amsterdam, Netherlands
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6Robotics and Megatronics, University of Twente, Enschede,
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Background: The location and volume of cerebral infarction after acute
ischemic stroke is strongly related with patient outcome. A probabilistic
atlas of cerebral infarctions represents the likelihood of finding infarcted
tissue at a specific position for each subject. Knowledge of this topo-
graphic distribution of ischemic infarctions has the potential to provide
insight in the patient’s outcome, progression of the disease, and may guide
treatment decisions.
Methods: We describe the creation of a digital probability atlas of infarc-
tion location and volume, associated with patient specific characteristics
and vessel branch occlusion territory using NCCT images. Infarctions
were automatically segmented on follow-up NCCTs and registered into a
coordinate space of a healthy subject’s brain.
Results: We included 361 follow-up NCCTs of acute ischemic stroke
patients who were enrolled in the MRCLEAN study. This resulted in a
3D-representation of the probability of infarction after an acute ischemic
stroke due to thromboembolic occlusion of the anterior circulation. The
atlas can dynamically be changed to determine the relation with patient’s
characteristics and probability of ischemic core.
Conclusion: We have created a novel digital probability atlas of ischemic
infarctions using CT imaging techniques. This approach is a paradigm
shift in studying the relation between baseline characteristics and radio-
logical outcome and has the potential to establish the distribution of
arterial territories and their role in patient outcome.
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Severe hypoperfusion in the absence of a large
ischemic core should not exclude patients from
reperfusion therapies
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Background: Optimal imaging selection for endovascular therapy for
ischemic stroke remains controversial with a range of criteria used in the
recent positive trials. Large volume severe hypoperfusion (Tmax > 10 s) is
one such criterion, with optimal threshold > 82 mL (‘malignant profile’),
in a previous study. We examined whether this was associated with poor
response to reperfusion in the EXTEND-IA randomized trial, which did
not exclude patients on this basis.
Methods: Patients receiving tPA < 4.5 h with major vessel occlusion and
favourable CT-perfusion (CTP) were randomised (after written informed
consent, IRB-approved) to thrombectomy after tPA versus tPA-alone.
CTP eligibility required mismatch ratio > 1.2 between hypoperfused
tissue (Tmax > 6 s) and irreversibly injured ischemic core (relative cere-
bral blood flow <30%), absolute mismatch > 10 mL, ischemic core
<70 mL (RAPID software, Stanford University). Tmax > 10 s volume was
calculated and effect on clinical outcomes examined.
Results: There were 70 patients, 35 in each arm, mean age = 69, median
NIHSS = 15. In these patients with ischemic core <70 mL, median
Tmax > 10 s volume was 41 mL with 12/70(17%) > 82 mL,
6/70(8.6%) > 100 mL. Of the ‘malignant’ patients(Tmax10s > 82 mL),
6/12(50%) had >90% reperfusion at 24 h (4 endovascular and 2 tPA-
only), all of whom had ‘early neurological recovery’ (≥8 point NIHSS
reduction or 0–1 by day 3) and 5/6(83%) had 90 day mRS0–1. No patient
with <90% reperfusion had day 90 mRS < 3.
Conclusions: In ischemic stroke patients <4.5 h after onset, large
Tmax > 10 s volume in the absence of a large ischemic core was uncom-
mon. Although the numbers in this study were small, the 83% rate of
excellent functional outcome after reperfusion suggests that excluding
such patients from therapy may not be justified.
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Does penumbral volume decrease over time?
B Cheripelli1, X Huang1, K W Muir1
1Institute of Neuroscience & Psychology, University of
Glasgow, Glasgow, United Kingdom
Introduction: Human imaging studies show significant penumbral
volumes for many hours after stroke onset, yet loss of benefit from rep-
erfusion within 6 h implies diminishing volumes of penumbra. We inves-
tigated core and penumbra volumes and collateral status in relation to
time after stroke.
Methods: Using data from three CTP and CTA studies in acute ischaemic
stroke <6 h after onset we measured core (rDT > 2 s and rCBF < 40%) and
penumbra (rDT > 2 s) volumes and graded collaterals using Miteff’s
classification (good – vessels reconstitute distal to the occlusion;
moderate – vessels seen at the Sylvian fissure; poor – opacification
restricted to distal superficial branches). We defined target mismatch as
core volume < 70 ml, perfusion volume > 15 ml, mismatch ratio > 1.8.
Patients were grouped by onset-to-imaging time (<3, 3–4.5, 4.5–6 h).
Results: Analysis included 144 patients. Across time epochs, proportions
of penumbra (59%, 64%, 75% at <3, 3–4.5, >4.5 h respectively, p = 0.4),
poor collaterals (15/56 [27%], 14/47 [30%], 4/15 [27%], p = 0.9) and
target mismatch (56%, 74%, 67%, p = 0.09) were not different. Penumbra
proportion was 45% with poor collaterals versus 72% with good-
moderate collaterals (P < 0.001); penumbra proportion was not related to
time to imaging (R2 = 0.003; P = 0.5) but a trend for divergent effects by
collateral status was seen (slight increase in penumbra over time with
good collaterals versus reduced with poor, p = 0.08 for interaction).
Conclusion: Penumbra proportion did not vary over the first 6 hours after
stroke. There was a trend for divergent effects of collateral status on
penumbra proportion over time. Reduced penumbra proportion does not
seem to account for loss of reperfusion efficacy.
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Relationship of cerebral haemorrhage and oedema
with recanalisation after iv thrombolysis
B Cheripelli1, X Huang1, KW Muir1, KW Muir1
1Institute of Neuroscience & Psychology, University of
Glasgow, Glasgow, United Kingdom
Introduction: We investigated the associations of brain oedema, haemor-
rhage, and recanalisation after IV thrombolysis.
Methods: Data on patients treated with IV rtPA < 4.5 h were extracted
from three multimodal CT studies, obtaining volumes of core (r DT > 2 s,
r CBF < 40%) and penumbra (r DT > 2 s). We defined large core as
>50 ml. On 24 h CT, we classified intracerebral haemorrhage (ICH) by
ECASS-2 and brain oedema as, no swelling (0), effacement of lateral
ventricle (1), effacement of lateral & 3rd ventricle (2), midline shift (3).
Significant Brain Swelling (SBS) was defined as edema types 2 or 3.
Recanalisation was defined as TIMI 2–3 on 24 h CTA. Raters blinded to
outcome read CTA and CTP independently.
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Results: Of 123 subjects (median age 74 yrs, median NIHSS 15, median
time to treatment 179 min, ICA or M1 occlusion 30/123 (25%), recanali-
sation 80/123 (66%)); ICH was more frequent with recanalisation (28/80,
35% vs. 8/43, 19%; p = 0.057), but not PH1 or PH2 (6/80, 7% vs. 2/43, 4%;
p = 0.5), oedema (32/78, 41% vs. 23/43, 53.5%; p = 0.18) or SBS (12/78,
15% vs. 6/43, 14%; p = 0.8). ICA or M1 occlusion (19/23(82%) vs.
68/105(65%); p = 0.09), poor collaterals (9/18 (50%) vs. 17/86 (20%);
p = 0.007) were more frequent in SBS. SBS was associated with large core
(OR 15.8, 95% CI 4.4–56; p < 0.01). SBS (OR 0.8, 95% CI 0.3–3; p = 0.8)
and PH1 or PH2 (OR 1.7, 95% CI 0.33–8; p = 0.5) were not associated
with recanalisation.
Conclusion: SBS, but not PH1 or PH2 is associated with large core; both
are not associated with recanalisation.
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Predictors of focal perfusion abnormalities in CT
perfusion for supratentorial transient ischemic attacks
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Background: Acute non-contrast CT (NCCT) for patients with TIA has
poor sensitivity when compared with diffusion-weighted MRI (DWI). We
investigated the frequency and predictors of focal perfusion deficits
(FPD), i.e. hypo- or hyperperfusion, on acute CT perfusion (CTP) in
patients with supratentorial TIA.
Methods: We prospectively collected data of consecutive patients with
TIA clinically attributable to supratentorial territories who underwent
CTP within 24 h of symptom onset from 06/2002 to 08/2014: demograph-
ics, risk factors, clinical symptoms and NIHSS, duration of TIA, symptom
onset to CTP delay, and symptom persistence at CTP. We also recorded
different ABCD scores, vascular territories and significant arterial pathol-
ogy (≥50% stenosis or occlusion in arteries leading to the ischemic terri-
tory). Variables were compared in uni- and multivariate analyses between
patients with and without FPD.
Results: Of 223 supratentorial TIA patients, 98 (44%) had an early isch-
emic lesion on NCCT, and 98 (44%) had FPD, 97% of which had hypop-
erfusion. FPD was positively associated with significant intracranial
arterial pathology (OR = 40.24, p < 0.001), early ischemic changes on
NCCT (OR = 8.34, p = 0.008), CTP during symptoms (OR = 4.16,
p = 0.003), right hemispheric TIAs (OR = 3.42, p = 0.002), preceding
recent TIAs (OR = 2.53, p = 0.059), NIHSS (OR = 1.24, p = 0.014), and
negatively with duration of the TIA (OR = 0.92, p = 0.022). There was no
significant association with different ABCD scores.
Conclusions: Our data suggest that the frequency of lesions detected on
CTP for supratentorial TIAs may be similar to that known of DWI.
Predictors of FPD include intracranial arterial pathology (most likely a
source of emboli), and clinical symptom severity.
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Cerebral infarct core estimation using aspects on plain
CT and perfusion CT: Interregional variability
M De Lera1, E Cortijo1, AI Calleja1, P García Bermejo1,
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Background: We aimed to compare the sensitivity and specificity of
ASPECTS-score on plain-CT to predict the infarct core in each regions of
ASPECTS-score and to identify those ASPECTS cerebral regions in which
the estimation of infarct core using plain-CT is less reliable.
Methods: We prospectively studied consecutive acute middle cerebral-
artery (MCA) stroke patients who underwent plain-CT and perfusion-CT
(CTP). CTP source-images were postprocesessed and quantitative maps
were obtained by means Olea-Perfscape software. Two readers blinded to
CTP-data. Infarct core was defined according to CTP by a relative Cerebral
Blood Flow (CBF) map < 0.4. ASPECTS-score were analyzed on both
plain-CT and CTP. Sensitivity and specificity and positive and negative
predictive values (PPV/NPV) on plain-CT as compared to CTP.
Results: One hundred and twenty patients with MCA ischemic stroke
were included (43.3% women, mean-age 73.06, median-NIHSS 15).
Median-ASPECTS was 8 (7–10) on plain-CT vs 9 (7–10) on CTP. PPV-
ranged from 41.9%–77.3% for each region of ASPECTS-score; whereas
NPV-ranged from 80%-94.9%. PPV/NPV were M1 77.3%/87.2%, M2
57.1%/92%, M3 57.1%/92.2%, Lenticular 50%/94.9%, Caudate 61.1%/
91.8%, internal capsule 54.5%/86.7%, Insula 41.9%/88.9%, M4 66.7%/
80%, M5 58.3%/80.6%, M6 45.5%/94.6% respectively. Sensitivity/
Specificity were M1 51.5%/94.2%, M2 59.2%/87%, M3 40%/94%,
Lenticular 72%/78.9%, Caudate 50%/91.8%, internal capsule 25%/
94.79%, Insula 74.28%/56.47%, M4 25.64%/93.82%, M5 20%/92.94%,
M6 25%/94% respectively.
Conclusions: The reliability of cerebral infarct core estimation using
ASPECTS-score on plain-CT varies between different regions analyzed.
The sensibility is lower than 0.5 in M4, M5 and M6 regions whereas the
only regions with a specificity < 0.9 are insula and lenticular nucleus.
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Multi-phase CTA: A new tool for the imaging triage of
patients with acute ischemic stroke
B K Menon1, C D d’Esterre2, E Qazi2, M Almekhlafi3, L Hahn4,
A Demchuk1, M Goyal2
1Neurology, University of Calgary Calgary Stroke Program,
Calgary, Canada
2Radiology, University of Calgary Calgary Stroke Program,
Calgary, Canada
3Internal Medicine, King Abdulaziz University, Jeddah, Saudi
Arabia
4Radiology, University of Calgary, Calgary, Canada
Purpose: To describe an imaging selection tool, multi-phase CTA (mCTA)
for use in acute ischemic stroke (AIS), and to demonstrate its inter-rater
reliability, and ability to determine clinical outcome.
Methods: The local ethics board has approved the study. Data is from the
pilot phase of PRoveIT, a prospective observational study analyzing utility
of multi-modal imaging in the triage of AIS patients. Patients had baseline
non-contrast CT (NCCT), single-phase CTA head/neck, mCTA, and per-
fusion CT (PCT). mCTA generates time-resolved images of pial arteries.
Pial arterial filling was scored on a 6-point ordinal scale and inter-rater
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reliability tested. Clinical outcomes included ≥50% drop in NIHSS over 24
hours and 90 day mRS 0–2. Ability to predict clinical outcomes were
compared between sCTA, mCTA and PCT using receiver operating curve
(ROC) analysis, Akaike Information Criterion (AIC) and Bayesian Infor-
mation Criterion (BIC).
Results: One hundred forty-seven patients were included. Inter-rater reli-
ability for mCTA is excellent (n = 30, kappa = 0.81, p < 0.001). On ROC
analysis, ability to predict clinical outcome is modest (c-statistic 0.56, 95%
CI:0.52–0.63 for ≥50% drop in NIHSS over 24 hours and 0.6,95%,
CI:0.53–0.68 for 90 day mRS 0–2), but better than models using sCTA and
PCT..p < 0.05 overall) Using AIC and BIC, models using mCTA are better
than models using sCTA and PCT for ≥50% drop in NIHSS over 24 hours
(AIC = 166 and BIC = 171.7; values least for mCTA) and 90 day mRS 0–2
(AIC = 132.1 and BIC = 137.4; values least for mCTA).
Conclusion: mCTA is a reliable tool for imaging selection in patients with
acute ischemic stroke.
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Stability of SWI acute ischaemic signs during transient
hyperoxia
K A Dani1, F Moreton1, C Santosh2, D Brennan2, X Huang1,
B Cheripelli1, D Kalladka1, S El Tawil1, K W Muir1
1Institute of Neuroscience and Psychology, University of
Glasgow, Glasgow, United Kingdom
2Department of Neuroradiology, Southern General Hospital,
Glasgow, United Kingdom
Background: Hyperoxia precipitates increases in T2*-weighted signal,
thereby reducing conspicuousness of vessels on MRI. Using data from an
ongoing study, we determined if early ischemic signs on Susceptibility
Weighted Imaging (SWI) persist during hyperoxia.
Methods: Subjects within 48 h of onset of ischemic stroke underwent
MRI including SWI before and during hyperoxia. We performed a side-
by-side analysis of SWI acquired before and during hyperoxia and evalu-
ated the following; susceptibility-vessel sign (SVS), cortical vessel sign
(CVS), and the brush sign (BS).
Results: Nine consecutive subjects were analysed, of whom 8 had a final
diagnosis of stroke. One subject did not complete baseline imaging. MRI
was repeated after 5 days in 5 subjects. Of the 8 stroke subjects, clinical
and demographic data (median, range) are: age = 67 y (59–84 y),
NIHSS = 11(3–26), median time to MRI = 11 h (4–26 h). The SVS was
seen in 4 subjects, BS in one (also seen on DWI) and CVS in 5 subjects. All
signs remained visible during hyperoxia. Figure 1 shows persistence of a
CVS (*) after hyperoxia, and a suggestion of relative parenchymal hypoin-
tensity after hyperoxia in the DWI lesion region.
Conclusions: Important signs on SWI are not abolished by hyperoxia. The
brush sign can also be seen on DWI in addition to SWI. Hyperoxia may
highlight the relative hypointensity in regions of infarct core.
ESOC-0809
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Cerebellar cortical cavities: Prevalence and association
with risk factors and markers of cerebrovascular
disease
L J L De Cocker1, R P Kloppenborg2, Y van der Graaf3,
J Hendrikse1, M I Geerlings3
1Radiology, University Medical Center Utrecht, Utrecht,
Netherlands
2Neurology, University Medical Center Utrecht, Utrecht,
Netherlands
3Julius Center for Health Sciences and Primary Care,
University Medical Center Utrecht, Utrecht, Netherlands
Purpose: Cerebellar ischaemic cavities preferentially involve the cerebellar
cortex and may present as an incidental finding on MRI. We aimed to
investigate the occurrence, risk factor profiles, and MRI correlates of cer-
ebellar cortical cavities (CCC’s) on brain MRI in a cohort of patients with
underlying vascular disease.
Methods: Within 636 patients (62 ± 9 years) from the SMART-Medea
study, CCC’s were visually determined on 1.5T 3D-T1-weighted images
and were correlated with vascular risk factors and MRI markers of cere-
brovascular disease, intracranial atrophy, and cerebral blood flow using
logistic regression analyses.
Results: CCC’s were observed in 9.6% of patients and were significantly
associated with increasing age, history of cerebrovascular disease, athero-
sclerosis (IMT) and hyperhomocysteinemia. CCC’s were significantly
associated with supratentorial infarcts, brainstem infarcts, gray matter
lacunes and atrophy, while no significant associations were found with
white matter hyperintensities, white matter lacunes, or cerebral blood
flow, after correction for age and sex.
Conclusion: CCC’s are common in patients with arterial disease and are
associated with other manifestations of cerebrovascular disease.
Odds Ratio 95% CI
Vascular Risk Factors
Smoking 1.0 1.0–1.0
Alcohol consumption 1.0 0.7–1.5
Arterial hypertension 1.6 0.9–2.8
Diabetes Mellitus 1.4 0.7–2.8
Cholesterol 0.8 0.6–1.1
Hyperhomocysteinaemia 1.8 1.01–3.3
IMT 2 1.1–3.7
Cerebrovascular Markers on MRI
Supratentorial infarct 2.9 1.6–5.3
Brainstem infarct 5.1 1.9–13.6
Gray and White Matter Lacunes 2.4 1.3–4.2
Gray Matter Lacunes 3.0 1.6–5.8
White Matter Lacunes 1.1 0.5–2.5
White Matter Hyperintensities 1.2 0.8–1.8
Brain Parenchymal Fraction 0.8 0.7–0.9
Peak Blood Flow Total 1.0 1.0–1.0
Peak Blood Flow Basilar Artery 1.0 0.9–1.1
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Cerebellar cortical cavities and posterior circulation
stroke
L J L De Cocker1, A Compter2, L J Kappelle2, J Hendrikse1,
H B van der Worp2
1Radiology, University Medical Center Utrecht, Utrecht,
Netherlands
2Neurology, University Medical Center Utrecht, Utrecht,
Netherlands
Purpose: Cerebellar ischaemic cavities preferentially involve the cerebellar
cortex and may present as an incidental finding on MRI. We aimed to
investigate the relationship between cerebellar cortical cavities (CCC’s)
and vertebrobasilar TIA or stroke.
Methods: We retrospectively evaluated 46 patients with a recent verte-
brobasilar TIA or stroke and symptomatic vertebral artery stenosis >50%
from the Vertebral Artery Stenting Trial (VAST). We evaluated the pres-
ence of CCC’s and acute posterior circulation infarcts on MRI. CCC’s
found at presentation were correlated with previous history of TIA or
stroke, and were statistically correlated with cerebrovascular risk factors
using Poisson regression analyses, before and after correction for age and
sex. Available follow-up MRI scans were evaluated to document the evo-
lution of acute cerebellar infarcts over time.
Results: Sixteen out of 46 (35%) patients showed CCC’s on the initial
MRI of patients presenting with vertebrobasilar TIA/stroke, while 73% of
patients showed acute posterior circulation infarction(s). Of the 16
patients with CCC’s, only one showed a positive history of prior stroke
while only two showed a positive history of prior TIA. No significant
associations independent from vertebrobasilar stenosis were found
between CCC’s and cerebrovascular risk factors. Three patients with evi-
dence of acute – DWI positive – cerebellar infarction at presentation
received follow-up MRI after an interval exceeding six months, and all
three developed CCC’s replacing the initial infarctions (Fig. 1).
Conclusion: CCC’s are common in patients with recently symptomatic
vertebral artery stenosis and may result from prior infarction of athero-
thrombo-embolic origin, usually without prior history of TIA or stroke.
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7-Tesla MRI relaxometry shows heterogeneity of white
matter hyperintensities and correlates with clinical
severity at the early stage of CADASIL
F De Guio1, A Vignaud2, S Reyes3, H Chabriat3, E Jouvent3
1University Paris 7, Inserm UMR 1161, Paris, France
2UNIRS, NeuroSpin, Gif-sur-Yvette, France
3Department of Neurology, AP-HP Lariboisière Hosp, Paris,
France
White matter hyperintensities (WMH) are the first MRI marker to appear
in cerebral small vessel disease (SVD), but their relationships to the clini-
cal status early in the disease are unclear.
The aim of the present work was to compare CADASIL (Cerebral Auto-
somal Dominant Arteriopathy with Subcortical Infarcts and Leukoen-
cephalopathy) patients without severe cognitive impairment and without
disability (MMSE > 24 and modified Rankin’s scale ≤1) and age and sex
matched controls to: 1) demonstrate WMH heterogeneity using T2* and
T1 relaxometry obtained at ultra-high field; 2) evaluate whether relax-
ation times are related to early clinical symptoms.
Whole brain high-resolution T1 and T2* maps were performed on a
7-Tesla scanner in 20 CADASIL patients (age 56.7 ± 11.1 years) and 17
controls (age 57.2 ± 12.3). All underwent a comprehensive neuropsycho-
logical and behavioral evaluation, including computerized tests of pro-
cessing speed and executive functions, depression and apathy.
T2* and T1 maps revealed strong heterogeneities in white matter com-
pared to controls (for T2*, SD/mean = 154% in patients vs. 26% in con-
trols), left undetected by conventional MRI. This heterogeneity was
represented by local variations of myelin content estimated from T1 and
T2* using a model recently demonstrated neuropathologically. In
patients, myelin content was related to flexibility (p = 0.04), planning task
(p = 0.04), scales of depression (p = 0.001) and apathy (p = 0.04). By con-
trast, other major conventional markers of SVD (volume of WMH,
volume of lacunar lesions, brain atrophy) were not related to any
cognitive/behavioral measure.
Our results support the hypothesis that WMH originate from various
mechanisms that impact differently the clinical status at the early stage of
SVD.
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Real-time transcranial optical monitoring of cerebral
blood flow in acute ischemic stroke during and after
thrombolysis
R Delgado-Mederos1, P Zirak2, I Blanco Nuñez2, C Gregori Pla2,
J Martí-Fábregas3, L Dinia3, R Marin Bueno3, T Durduran2
1Neurology, Hospital Santa Creu i Sant Pau, BARCELONA,
Spain
2Medical Optics, Institut de Ciencies Fotoniques, Castelldefels,
Spain
3Neurology, Hospital Santa Creu i Sant Pau, Barcelona, Spain
Background: Recent clinical evidence suggests that tissue reperfusion is a
better predictor of outcome than recanalization in acute ischemic stroke
(AIS) after thrombolysis. Diffuse correlation spectroscopy (DCS) is a
promising non-invasive tool for optical bedside monitoring of microcir-
culatory cerebral blood flow (CBF). We tested whether the effect of
thrombolysis on cerebral perfusion can be assessed by real-time diffuse
optical monitoring of CBF in patients with AIS.
Methods: In a sample of five patients with an acute MCA occlusion, we
performed bilateral DCS monitoring to measure relative CBF in the
frontal lobes continuously during the first 2,5 hours after rtPA bolus. We
evaluated the CBF temporal profile by analyzing a 6-minutes-averaged
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CBF value every 15 minutes in both hemispheres. We evaluated the results
in relation to presence of recanalization on follow-up transcranial
Doppler and early clinical outcome.
Results: Three men and 2 women (mean age 80 ± 14, median NIHSS 19)
were monitored by DCS. Globally, a significant CBF increase was observed
from 90 minutes after rtPA bolus in the ipsilateral stroke side (median
33%, range 23–71%), but not in the contralateral (median 8%, range
−3–49%). At 24 hours, all patients improved by 8 or more points in the
NIHSS (median NIHSS 3). Complete arterial recanalization was docu-
mented in all but one patient (due to insufficient acoustic window).
Conclusions: Bedside optical monitoring showed capability for real-time
detection of the effect of reperfusion therapy on CBF after AIS. Continu-
ous CBF monitoring may offer new therapeutic and prognostic insights in
the management of acute stroke patients.
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Intracranial atherosclerotic lesion characteristics
correlate with cerebrovascular lesion load after TIA or
ischemic stroke: A 7.0 Tesla MRI study
N Dieleman1, A G van der Kolk1, J J M Zwanenburg2, M Brundel3,
A A Harteveld1, G J Biessels3, F Visser1, P R Luijten1, J Hendrikse1
1Radiology, University Medical Center Utrecht, Utrecht,
Netherlands
2Radiology & Image Science Institute, University Medical
Center Utrecht, Utrecht, Netherlands
3Neurology, University Medical Center Utrecht, Utrecht,
Netherlands
Purpose: To explore the presence of cortical microinfarcts (CMIs) at 7T
MRI in patients with TIA or ischemic stroke of the anterior circulation,
and their relationship with intracranial atherosclerosis (ICAS) and
macroinfarcts.
Methods: Eighteen patients presenting with ischemic stroke (n = 12) or
TIA (n = 6) underwent FLAIR- and MPIR-TSE1 intracranial vessel wall
imaging at 7T MRI. ICAS lesions and their characteristics,2 as well as
infarcts (CMIs and macroinfarcts) (Fig. 1), were scored by two raters. The
relationship between ICAS lesions, calculated ratios of characteristics and
infarcts were examined using linear regression analyses.
Results: 101 CMIs, 31 macroinfarcts and 75 ICAS lesions were found. 76%
and 65% of CMIs and macroinfarcts, respectively, were found in the same
vascular territory of ICAS lesions. A positive correlation existed between
macroinfarcts and CMIs (p < 0.05) and concentric configuration and
macroinfarcts (p < 0.01); for CMIs no correlation was found. A diffuse
thickening pattern was positively correlated to macroinfarcts (p < 0.05); a
weak trend was found for CMIs (p = 0.09).
Fig. 1 A 75-year-old female patient presented with ischemic stroke of the
right MCA territory. (A) Transverse 7T T2-weighted FLAIR image shows
and infarct of the right MCA territory with three CMIs (white arrowheads);
(B) shows a zoomed view of the box drawn in A. (C–E) Transverse 7T
T2-weighted intracranial vessel wall images before (C and D) and after
contrast administration (E) show thickening of the right MI (C) and M2 (D)
segments of the MCA, and enhancement of the M2 vessel wall segment
after contrast administration (E) (black arrowheads).
Conclusion: This study shows that in patients with TIA or ischemic stroke
CMIs represent a relevant portion of the total cerebrovascular lesion load
and coexist with macroinfarcts. These results demonstrate that the spec-
trum of parenchymal damage caused by ICAS is not restricted to macro-
infarcts, but also include CMIs.
Referens
1 Van der Kolk et al., Stroke 2011
2 Dieleman et al., Neurology 2014
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Plaque characteristics, burden and distribution
assessment in an Asian population with
high-resolution intracranial vessel wall imaging at 3
Tesla MRI
N Dieleman1, W Yang2, J Abrigo3, K L Lee3, C W Chu3,
A G van der Kolk1, J C W Siero1, K S Wong2, J Hendrikse1,
X Y Chen2
1Radiology, University Medical Center Utrecht, Utrecht,
Netherlands
2Medicine, Chinese University of Hong Kong, Hong Kong,
China
3Imaging and Interventional Radiology, Chinese University of
Hong Kong, Hong Kong, China
Purpose: To qualitatively evaluate intracranial plaque characteristics
(contrast enhancement, thickening and configuration (1), total plaque
burden and distribution in patients with an middle cerebral artery (MCA)
stenosis, using a 3D T1-weighted volumetric isotropic turbo spin-echo
acquisition (VISTA) vessel wall sequence at 3T.
Methods: Nineteen Chinese ischemic stroke and TIA patients presenting
with a symptomatic MCA stenosis underwent 3T MR imaging; the pro-
tocol included a Time-of-Flight Magnetic Resonance Angiography (TOF-
MRA) and the T1w VISTA sequence before and after (83%) contrast
administration. One observer reviewed the plaque characteristics.
Results: Vessel wall lesions were identified in 18 patients (95%), totaling
57 lesions in 494 segments (12% of segments). Most of the lesions were
present in the anterior circulation. 75% of the lesions were eccentric
(Fig. 1), 44% enhanced after contrast administration and 74% of the
lesions were focal. Plaque burden and distribution are presented in
Table 1.
Fig. 1 A 57-year-old male patient with a left MCA stenosis. (A) Transverse
TOF-MRA shows a stenosis of the right MCA (arrow). Transverse T1w
VISTA images show a left MCA plaque (arrows in B) before contrast
admiration. The plaque enhances after contrast admiration (arrow in C).
Zoom box shows sagittal view of the eccentric plaque (black arrow).
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Table 1 Plaque burden in 18 patients with MCA stenosis
Conclusion: Intracranial vessel wall imaging using a 3D T1w VISTA vessel
wall sequence at 3T was able to identify basic intracranial plaque charac-
teristics and assess total plaque burden and distribution. Most of the
lesions were found in the anterior circulation, corresponding to similar
distributions found for ischemic strokes (2).
Referens
1 Dieleman et al., Neurology 2014
2 Bogousslavsky et al., Stroke 1988
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Sodium fluoride-positron emission tomography
provides a non-invasive method for identifying
vulnerable plaques in carotid artery stenosis
N R Evans1, J R Buscombe2, J H Rudd3, E A Warburton1
1Department of Clinical Neurosciences, University of
Cambridge, Cambridge, United Kingdom
2Department of Nuclear Medicine, Cambridge University
Hospitals NHS Foundation Trust, Cambridge, United Kingdom
3Department of Medicine, University of Cambridge,
Cambridge, United Kingdom
Introduction: Microcalcification is a histopathological feature of athero-
sclerotic plaques at risk of rupture, so-called “vulnerable plaques.” Posi-
tron emission tomography (PET) using 18F-sodium fluoride (NaF) to
detect microcalcification has been shown to be an effective non-invasive
method to identify vulnerable and ruptured coronary artery plaques.
However, use of NaF-PET to assess carotid disease has been limited and
mainly focused on asymptomatic disease.
Methods: An 89 year-old male with a left hemisphere ischemic stroke was
found to have a symptomatic left internal carotid artery (ICA) stenosis of
greater than 90% on Doppler ultrasound. The asymptomatic ICA showed
near-occlusion. NaF-PET was performed four days after stroke. NaF dose
was 125 MBq with 60 minute uptake on a GE Discovery 690 with 64 slice
computed tomography. Uptake was measured using standardized uptake
values for mean (SUVmean) and maximum (SUVmax) uptake. Written
consent was gained in accordance with research ethics committee and
local approvals.
Results: The symptomatic ICA mean SUVmean was 2.37 (SD 0.22)
MBq/kg and mean SUVmax was 3.35 (SD 0.48) MBq/kg. The asymptom-
atic ICA mean SUVmean was 2.05 (SD 0.08) MBq/kg and mean SUVmax
was 2.54 (SD 0.05) MBq/kg. SUVmean and SUVmax were significantly
higher for the symptomatic than asymptomatic ICA (both p < 0.05).
Discussion: Our results act as proof of principle that NaF uptake varies
between symptomatic and asymptomatic carotid atheroma in the setting
of an acute infarct secondary to carotid plaque rupture. Further trials of
NaF-PET are needed to evaluate its clinical application in the assessment
of carotid plaque vulnerability and rupture.
ESOC-0941
19. Imaging
Patterns of collateral flow in stroke patients with
unilateral and bilateral internal carotid artery (ICA)
stenosis
H Fang1, B O Cheng1, K Wong1, S Ho1, X Chen1
1Department of Medicine and Therapeutics, Prince of Wales
Hospital, Hong Kong, China
Background and purpose: Current over-emphasis on anatomical identifi-
cation of luminal stenosis may be insufficient and misleading because
collateral circulation are not considered. By using color velocity imaging
quantification ultrasound (CVIQ) to measure extracranial arterial blood
flow volume (BFV), the objective of this study was to evaluate the hemo-
dynamic patterns in acute stroke patients.
Patients and methods: It was a hospital based cohort study including
consecutive stroke patients admitted to the Prince of Wales Hospital from
January 5 to December 28, 2000. Within the first week after stroke onset,
carotid duplex was performed to determine the presence of ICA stenosis
(≥50%) and CVIQ technique was performed to measure BFV in bilateral
common carotid arteries (CCAs) and bilateral vertebral arteries (VAs).
Results: Of the 335 acute ischemic stroke patients (age 67.9 ± 12.5 y),
unilateral ICA stenosis was detected in 43 (12.8%) patients and bilateral
ICA stenosis in 16 (4.8%) patients. In patients with unilateral carotid
stenosis, the BFV of contralateral CCA was significantly higher than that
in ipsilateral CCA (325.4 ± 100.1 mL/min vs. 244.8 ± 121.3 mL/min,
P = 0.001). The sum of BFV in bilateral VAs increased significantly
(P < 0.001) to 159.0 ± 88.5 mL/min in patients with bilateral ICA
stenosis, compared to that in patients with unilateral ICA stenosis
(108.1 ± 64.8 mL/min) and that in patients without ICA stenosis
(101.8 ± 45.3 mL/min).
Conclusions: The present study demonstrates the different patterns of
collateral flow from contralateral ICA and posterior circulation in stroke
patients with carotid stenosis.
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The impact of lesion location on post-stroke sleep
apnea frequency
A Fisse1, A Kemmling2, P Young3, R Dziewas1, J Minnerup1
1Departement of Neurology, University of Münster, Münster,
Germany
2Departement of Neuroradiology, University of Lübeck,
Lübeck, Germany
3Department of Sleep Medicine and Neuromuscular
Disorders, University of Münster, Münster, Germany
Background: Sleep apnea (SA) is common in patients with stroke and
significantly affects outcome. Relevant risk factors for SA are age, gender
and obesity. SA after stroke was assumed to be a direct consequence of the
injury of specific central nervous system structures. However, conclusive
results regarding post-stroke SA and lesion location are lacking. We there-
fore investigated whether specific infarct locations are associated with SA.
Methods: Overall, 142 patients with acute ischemic stroke from our stroke
unit were included in a prospective observational study. All patients
underwent magnetic resonance imaging (MRI) and polysomnography in
the acute phase after stroke. The endpoint SA was defined by an apnea–
hypopnea index (AHI) >10. For each group (AHI > or <10), standardized
maps were generated to depict voxel-wise probability distribution of
infarction.
Results: Of 142 patients, 86 (59%) developed a SA. Age and NIHSS were
significantly different between both groups. The voxel-based probability
map of ischemic lesions demonstrates a higher probability of infarcts in
patients with SA in the left-sided brainstem compared to patients without
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SA (Fig.). Further analyses are ongoing to identify other factors associated
with the occurrence of SA after stroke.
Conclusion: In this study, infarcts within the left-sided brainstem were
associated with SA in the early phase after stroke. This finding might be
considered in further studies targeting post-stroke SA.
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Sparing of the hippocampus indicates better collateral
blood flow in acute posterior cerebral artery occlusion
A Förster1, B Mürle1, H U Kerl1, H Wenz1, M Al-Zghloul1,
S Habich1, C Groden1
1Neuroradiology, University Hospital Mannheim, Mannheim,
Germany
Background: In acute posterior cerebral artery (PCA) occlusion involve-
ment of the hippocampus is a common finding. Nevertheless, infarction
and ischemic lesion evolution in the hippocampus has not been studied
systematically.
Methods: In 29 patients (mean age 70.5 ± 14.1 years, 19 (65.5%) males, 10
(34.5%) females) with proximal PCA occlusion, MRI findings were ana-
lyzed, with emphasis on hippocampal infarction patterns on diffusion-
weighted images (DWI) and collateralization on dynamic 4D angiograms
generated and analyzed by use of Signal Processing In NMR-Software.
Results: On initial DWI, we identified all known hippocampal infarction
patterns: type 1 (complete) in 6/20 (30.0%), type 2 (lateral) in 12/20
(60.0%) patients, type 3 (dorsal) and type 4 (circumscribed) in 1/20
(5.0%) patient respectively. On dynamic 4D angiograms, the grade of
collateralization was classified 1 in 10 (33.3%, see Fig. 1A), 2 in 2 (6.7%),
3 in 10 (33.3%), and 4 in 8 (26.7%, see Fig.1B) patients. On follow-up
DWI, we found new ischemic lesions in 3 and infarction growth in the
hippocampus in 6 patients. Patients with better collateralization (grade
3/4) less often had hippocampal infarctions on initial (p = 0.002)/fol-
low-up DWI (p = 0.027) as well as type 1 on initial (p = 0.017)/follow-up
DWI (p = 0.006).
Conclusions: Involvement of the hippocampus in proximal PCA occlu-
sion is dependent on the extent of collateralization. The same holds true
for hippocampal infarction patterns.
Fig. 1
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Dynamic 4D angiograms for the estimation of blood
flow in lacunar infarction
A Förster1, B Mürle1, H U Kerl1, H Wenz1, J Böhme1,
M Al-Zghloul1, C Groden1
1Neuroradiology, University Hospital Mannheim, Mannheim,
Germany
Background: Blood flow through anastomoses in lacunar infarction (LI)
is not well evaluated.
Methods: In 101 LI patients who underwent MRI within 24 hours after
symptom onset MRI findings were analyzed with special emphasis on
DWI and PWI findings as well as blood flow on dynamic 4D angiograms
derived from PWI raw images generated by use of Signal Processing In
NMR-Software (SPIN). Classification of blood flow in LI is shown in
Fig. 1.
Results: On DWI, LI was found in the basal ganglia (12.5%), internal
capsule (25.8%), corona radiata (34.2%), and thalamus (27.5%). In 44
(43.6%) PWI was unremarkable, in 2 (2.0%) an area of hyperperfusion,
and in 55 (54.5%) an area of hypoperfusion was found. In 45 (44.6%) a
larger perfusion deficit (>7 mm) was observed. In these, blood flow was
classified type 1 in 4 (8.9%), 2 in 8 (17.8%, see Fig. 2A), 3 in 17 (37.8%, see
Fig. 2B), and 4 in 5 (11.1%) patients on dynamic 4D angiograms. The
remainder (24.4%) was not classifiable.
Conclusions: Dynamic 4D angiograms are a novel, useful method for a
detailed examination and graduation of blood flow in LI.
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Fig. 1
Fig. 2
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Quantitative measurements of relative flair signal
intensities in brainstem stroke for estimation of lesion
age
A Förster1, P Felefeli1, H U Kerl1, H Wenz1, M Al-Zghloul1,
C Groden1
1Neuroradiology, University Hospital Mannheim, Mannheim,
Germany
Background: A mismatch between DWI and FLAIR lesion may be useful
to identify acute ischemic stroke patients within a 4.5 hour time window.
Recently, relative FLAIR signal intensity (rSI) has been proposed for quan-
titative measurement. However, this may be difficult in small ischemic
lesion such as brainstem stroke.
Methods: In 34 patients with brainstem infarction, MRI findings were
analyzed with emphasis on the rSI by use of Signal Processing In
NMR-Software.
Results: Regarding baseline characteristics patients (17 (50%) males/
females) had a median age of 70 (IQR 58.5–74.5) years, a median time
from symptom onset to MRI of 212 (IQR 137–409.5) minutes, and a
median DWI lesion volume of 0.28 (IQR 0.17–0.3725) ml. The rSI of
FLAIR lesions showed a moderate correlation with time from symptom
onset (r = 0.356, P = 0.039, see Fig. 1). The ROC analysis identified a rSI of
1.11 as the best cutoff value for predicting the symptom onset ≤4.5 hours
with a sensitivity of 47% and a specificity of 47%. The rSI of FLAIR lesions
showed no significant correlation to age (r = 0.110, p = 0.54) nor lesion
volume (r = −0.116, p = 0.51).
Conclusions: Quantitative rSI measurements do not reliably identify
patients within 4.5 h of symptom onset in acute ischemic brainstem
stroke. Consequently, therapeutical decisions should not be based on
quantitative rSI measurements in patients with brainstem stroke.
Fig. 1
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19. Imaging
Distance to thrombus on magnetic resonance
angiography predicts outcome of middle cerebral
artery occlusion treated by IV thrombolysis
M Gawlitza1, B Friedrich2, U Quäschling1, D Fritzsch1, S Schob1,
A Schaudinn2, C Hobohm3, K T Hoffmann1, D Lobsien1
1Department of Neuroradiology, University Hospital Leipzig,
Leipzig, Germany
2Department of Diagnostic and Interventional Radiology,
University Hospital Leipzig, Leipzig, Germany
3Department of Neurology, University Hospital Leipzig,
Leipzig, Germany
Background and purpose: Our group recently proposed that the distance
to thrombus (DT) on CT angiography might be a predictor of outcome in
patients treated by intravenous thrombolysis (IVT) for stroke due to acute
occlusion of the middle cerebral artery (MCA). The purpose of the
present study was to validate its use and prognostic value on contrast-
enhanced magnetic resonance angiography (CE-MRA).
Methods: Patients with acute MCA occlusions treated by IVT with recom-
binant tissue plasminogen activator and diagnosed with magnetic reso-
nance imaging (MRI) were included. DT was defined as the distance from
the carotid T to the thrombus in the MCA. Infarct volumes were calcu-
lated semiautomatically. Clinical status was determined using the initial
NIH stroke scale (NIHSS) and 90-day modified Rankin Scale (90d mRS).
Results: Of 605 patients with acute stroke, 61 showed a lesion on a
diffusion-weighted magnetic resonance image and an occlusion of the
MCA on CE-MRA. We found a significant inverse correlation between DT
and NIHSS scores at admission (r = −0.29; P = 0.02) and between DT and
mRS at 90 days (r = −0.29; P = 0.04). For a DT 50% (see Fig.). The initial
lesion volumes showed no significant correlation with the outcome.
Conclusions: DT on CE-MRA may predict clinical outcome in patients
with acute MCA occlusion treated by IVT. It might therefore serve as a
marker to triage patients into different treatment strategies.
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19. Imaging
CT perfusion – Follow-up CT false positive infarct core
mismatch in acute ischemic stroke
R R E G Geuskens1, J Borst2, M Lucas1, A M M Boers1,
O A Berkhemer2, M A A van Walderveen3, S F M Jenniskens4,
D Dippel5, C B L M Majoie2, H A Marquering1
1Biomedical Engineering and Physics (BMEP), Academic
Medical Center University of Amsterdam, Amsterdam,
Netherlands
2Radiology, Academic Medical Center University of
Amsterdam, Amsterdam, Netherlands
3Radiology, Leiden University Medical Centre, Leiden, he
Netherlands
4Radiology, Radboud Medical Centre Nijmegen, Nijmegen,
Netherlands
5Radiology, Erasmus Medical Centre Rotterdam, Rotterdam,
Netherlands
Introduction: CT perfusion software analyses the hemodynamic charac-
teristics to estimate ischemic core and penumbra on baseline CTP. The
aim of this study is to identify mismatch between CTP derived ischemic
core and final NCCT infarct core, and investigate possible causes of
mismatch.
Materials and methods: This study included 17 full brain coverage, stan-
dard (53 sec.) and extended (205 sec.) acquisition time CTP. Final infarct
core volume was calculated on 5–7 day follow-up NCCT (FUCT) datasets.
CTP processing was performed using Philips software (IntelliSpace 7.0).
FUCT infarct core was automatically segmented. CTP and FUCT ischemic
core were registered yielding false-positive ROIs. False-positive rate was
defined as false-positive ROI divided by total CTP ischemic core. Absolute
and relative CBV, CBF, and MTT were calculated for true and false positive
CTP ischemic core and compared with rank-sum tests. CTP ischemic core
is defined as rMTT > 145% and aCBV < 2.0 ml/100g.
Results: Average false-positive rate was 75%. Median rMTT (in %) false-
positive core was 253 (IQR:157–398) (P < 0.001), 357 for true-positive
core (IQR:202–552) (P < 0.001). Median aCBV (in ml/100g) false-positive
core was 1.7 (IQR:0.82–3.16) (P < 0.001), 1.24 for true-positive core
(IQR:0.56–2.56) (P < 0.001). Median rCBV (in %) false-positive core was
52.8 (IQR:21.7–108) (P < 0.001), 32.2 for true-positive core (IQR:11.8–
71.6) (P < 0.001).
Discussion: Average false-positive rate is high. Although absolute thresh-
olds can differ significantly between patients, a significant difference in all
parameter values between true-positive and false-positive core exists for
all patients. To increase CTP sensitivity, thresholds for CTP ischemic core
definition therefore need revision.
ESOC-1520
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Cerebral blood flow within the ischemic penumbra is
unrelated to prehospital blood pressure
L Gioia1, M P Kate1, K Butcher1
1Medicine, University of Alberta, Edmonton, Canada
Introduction: Resistance to treating elevated prehospital blood pressure
(BP) in acute stroke is based on fear of exacerbating cerebral blood flow
(CBF) decreases within the penumbra, despite an absence of available
data. We tested the hypotheses that prehospital SBP is correlated with
severity and volume of hypoperfusion.
Methods: Acute stroke patients who underwent CT perfusion (CTP) at
admission and prior to antihypertensive or thrombolytic therapy were
included. Ischemic penumbra was defined as tissue with a relative delay
time (rDT) >2 sec, and core was defined as rDT >2 sec and rCBF < 30%.
Pre-hospital SBP was obtained from EMS electronic records.
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Results: Ninety-four patients (64.2 ± 17.0 years) with a median(IQR)
NIHSS of 12(11) were included. The mean prehospital SBP was
149.7 ± 27 mmHg. Median time from symptom onset to CTP was 4.8(7.4)
hours. Median penumbral volume was 32.9 (46) mL with a mean rCBF of
0.83 ± 0.18. Median ischemic core volume was 21.3 (31.9) mL, with a
mean rCBF of 0.34 ± 0.18. Prehospital SBP was not correlated with pen-
umbral rCBF (r = −0.65, p = 0.63) or core rCBF (r = −0.03, p = 0.8). Pre-
hospital SBP was inversely correlated with penumbral tissue volume
(r = −0.29, p = 0.008). However, the correlation no longer existed after
adjusting for the presence of large vessel occlusion (r2 = 0.19, p = 0.48).
Prehospital SBP was not correlated with core volumes (r = −0.19, p = 0.1).
Conclusion: We found no relationship between admission CBF and pre-
hospital SBP in untreated acute ischemic stroke patients. Although acute
penumbral perfusion values and volumes are variable, this is likely related
to other factors, including large vessel occlusion, and cannot be explained
by prehospital BP.
ESOC-1488
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Analysis of collateral circulation in proximal cerebral
vessel occlusions based on digital subtraction
angiography (DSA)
P Gruber1, B Menze2, M Pfeiffer3, G Baltsavias4, S Wegener1,
R Steffen1, A Luft1
1Neurology, University Hospital Zurich, Zurich, Switzerland
2Computer Science, Technical University Munich, Munich,
Germany
3Radiology, Kantonsspital Luzern, Lucerne, Switzerland
4Neuroradiology, University Hospital Zurich, Zurich,
Switzerland
Introduction: In stroke due to proximal vessel occlusion (PVO), collaterals
are essential for outcome. Different classification schemes for the assess-
ment of collaterals exist, but most are not quantitative. We developed a
semi-automated post-processing algorithm (sPPS) based on DSA, to
obtain a more reliable and inter-observer independent method.
Methods: Data of patients with stroke due to acute PVO admitted to our
institution for endovascular intervention between 2011–14, were ana-
lyzed. Cerebral anteroposterior time series from pre-/post-interventional
DSA were compared. Using MatLab (MatLab R2013b (8.2.701), Math-
Works), regions of interest (ROI) in the following territories (VTs) were
analyzed: middle cerebral artery (MCA), anterior cerebral artery (ACA),
lenticulostriate arteries (LSA). Time-intensity-curves (TIC) from these
ROIs were plotted. Statistical analysis was done using Excel (Windows,
version 14.3.9, Excel for Mac 2011).
Results: Application of this new sPPS resulted in different TICs according
to the territory and interventional result. Recanalization led to a steeper
slope and higher amplitude of the TIC within the MCA-ROI; whereas a
post-intervention flattening of the TIC was observed in the VT of the
ACA.
Conclusion: Our preliminary results show that it is feasible to assess the
quality of the collaterals by DSA with this new sPPS. This method will be
further elaborated and correlated to other imaging techniques, aiming to
a reliable quantification of the collaterals.
ESOC-1417
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Spontaneous and traumatic vertebral artery dissection:
Imaging and clinical findings of a single tertiary stroke
center
A Günther1, O W Witte1, M Freesmeyer2, T E Mayer3, R Drescher4
1Neurology, University of Jena, Jena, Germany
2Nuclear Medicine, University of Jena, Jena, Germany
3Neuroradiology Section, University of Jena, Jena, Germany
4Nuclear Medicine Neuroradiology Section, University of Jena,
Jena, Germany
Background: Vertebral artery dissection (VAD) is a potentially severe
illness with significant morbidity. We present clinical presentation,
imaging findings and course of patients diagnosed with VAD from a single
tertiary stroke center.
Methods: 47 patients (33 male, 14 female, age 25–76 years) were included
in this study. Initially, all patients underwent clinical evaluation and
Duplex ultrasound imaging. Head and neck MR imaging, including TOF-
and CE-MRA, was performed within 12 hours after admission.
Results: Diagnoses consisted of 34 spontaneous (72%) and 13 traumatic
VAD (28%). Patients presented with focal neurological deficits (64%),
headache (54%) and vertigo (50%). MRI revealed ischemic lesions in 36
patients (77%). Lesions occurred in cerebellar and medullar branches of
PICA (51% of patients), PCA (19%), AICA (11%), SCA (8,5%) and
basilar artery territories (15%).
Most frequent MRI/MRA findings indicative for VAD were vessel irregu-
larity (87% of patients), vessel wall hyperintensity (81%), and loss of flow
void (70%). The “classical” crescent-shaped wall hematoma was found
more commonly in patients without ischemia (64%) than in those with
ischemia (33%). Duplex sonography revealed VA occlusion in 56% and a
dissection membrane in 26% of patients.
Patients underwent treatment with anti-platelet drugs and/or anticoagu-
lation. 7 patients (15%) suffered recurrent dissection and/or stroke.
Conclusion: The data presented demonstrate the clinical diversity and the
variability of MR and ultrasound imaging findings in patients with VAD.
The algorithm of management of these patients should be based on a
multi-modality approach.
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19. Imaging
Our experience including a routine 3D TOF imaging in
patients with stroke or TIA
F Jose1, A Ana2, G Marta1, B Natalia1
1Neurology, Hospital Universitario Rey Juan Carlos, Madrid,
Spain
2Neurorradiology, Hospital Universitario Rey Juan Carlos,
Madrid, Spain
Introduction: There is no consensus on the best vessel-imaging for routine
work up in stroke. The 3D TOF-MRA showed a sensitivity of 93% and a
specificity of 88% for detection of high-grade stenosis against cerebral
angiography. We wanted to test the benefits of including a 3D TOF-MRA
routinely in the work up of stroke/TIA patients.
Patients and methods: An eight minute-long 3T MRI (including T1, T2,
gradient echo, FLAIR, DWI and ADC sequences) + 3D TOF-MRA proto-
col was designed and applied indiscriminately upon clinical decision. We
retrospectively reviewed the MRA of patients with cerebral infarction
(excluding those classified as cardioembolic by the TOAST) or TIA in the
period October 1 2013–September 31 2014. The histories of those patients
with any abnormal findings were reviewed to analyze coherence and rel-
evance of the findings.
Results: The MRI/MRA protocol was performed in 79/162 patients
(48%). In 34/79 (43%) abnormal findings were informed. In 22 of these
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(64%) a second/confirmatory technique was considered, and coherence
between both techniques was met in 17/22 patients (77%). In 26/34
patients (76%) the finding was relevant to the clinical picture and
explained or contribute to do it, the possible underlying process of the
stroke. In this group, 18 patients (69%) had a second/confirmatory tech-
nique, and in 16 patients (89%) coherence was met.
Conclusions: We consider that including a TOF-MRA in the routine work
up of noncardiomebolic stroke/TIA patients at a minimum time expense
definitively contribute to a better study of the disease underlying the
clinical event.
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19. Imaging
Aspects on CT-angiography source images is a strong
predictor of futile recanalization in acute ischemic
stroke
M Kawiorski1, P Martinez-Sanchez2, A García-Pastor3, P Calleja4,
B Fuentes2, B E Sanz-Cuesta2, E Fandiño5, F Díaz-Otero3, F Sierra6,
G Ruiz-Ares7, A Cruz-Culebras1, A Gil-Nuñez3,
M Alonso de Leciñana1
1Neurology, Hospital Ramon y Cajal, Madrid, Spain
2Neurology, Hospital La Paz, Madrid, Spain
3Neurology, Hospital Gregorio Marañon, Madrid, Spain
4Neurology, Hospital 12 de Octubre, Madrid, Spain
5Radiology, Hospital Ramon y Cajal, Madrid, Spain
6Radiology, Hospital 12 de Octubre, Madrid, Spain
7Radiology, Hospital La Paz, Madrid, Spain
Aim: CT angiography source images (CTA-SI) Alberta Stroke Pro-
gramme Early CT Score (ASPECTS) predicts final infarct volume and
neurological outcome after an ischemic stroke. We aimed to determine if
baseline CTA-SI ASPECTS predicts futile recanalization after reperfusion
therapies.
Methods: Data are from the prospective observational study FUN-TPA.
Included were acute ischemic stroke patients with identified proximal
arterial occlusion in anterior circulation, undergoing reperfusion thera-
pies. Clinical characteristics, baseline non-contrast CT and CTA-SI
ASPECTS, time-lapse to image acquisition, occurrence and timing of
recanalization, were recorded. Outcome measures were NIHSS, mRS score
and mortality at 90 days. Recanalization was considered as futile when it
was associated with mRS > 3.
Results: 113 patients, baseline NIHSS 17 (11; 22) [median (IQR)], treated
with iv thrombolysis (IVT) (46%), primary endovascular treatment
(EVT) (16%) or combined IVT + EVT (38%). Recanalización rate in the
whole sample was 70.5% with a median delay of 285 minutes (215; 355).
In 23% of cases recanalization was futile. In an adjusted model, baseline
CTA-SI ASPECTS was inversely related with futile recanalization with
odds ratio (OR: 0.3; 95% CI: 0.15 to 0.7; p = 0.002), whereas non-contrast
CT ASPECTS was not (OR: 0.7; 95% CI: 0.3 to 1.69; p = 0.4). Our data
defines a score ≤5 in CTA-SI ASPECTS as the best cut-off to predict futile
recanalization (S 94%, E 67%).
Conclusions: CTA-SI ASPECTS strongly predicts futile recanalization. It
may be useful to assign patients to conservative treatment in cases of
uncertain risk/benefit ratio of reperfusion therapies.
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Aspects on CT-angiography source images correlates
with final infarct volume and clinical improvement
after reperfusion in ischemic stroke
M Kawiorski1, D Lourido2, E Viedma1, A Vicente-Bártulos2,
A Muriel3, M J López-Martínez1, R Álvarez-Velasco1, E Fandiño2,
M J Alonso de Leciñana1
1Neurology, Hospital Ramon y Cajal, Madrid, Spain
2Radiology, Hospital Ramon y Cajal, Madrid, Spain
3Biostatistics, Hospital Ramon y Cajal, Madrid, Spain
Aim: To assess if CT-angiography source images ASPECTS (CTA-SI
ASPECTS) may predict response to reperfusion in ischemic stroke, inves-
tigating its relationship with infarct volume and clinical improvement at
24-h follow-up.
Methods: Retrospective study of anterior circulation stroke patients
undergoing reperfusion therapies that had CT-perfusion (CTP) and CTA
pre-treatment, and assessment of vessel recanalization post-treatment.
Clinical characteristics and baseline CTA-SI ASPECTS were registered.
Tissue-at-risk was considered as that with reduced cerebral blood flow
(CBF), infarct core was the region of reduced cerebral blood volume
(CBV), the mismatch region being salvageable tissue. Volumes of core and
mismatch region were measured. Outcome variables were the volume of
the hypodensity in the NCCT and the NIHSS score at 24 hours.
Results: Forty-two consecutive patients, age 68 (60; 76), baseline NIHSS
score 17 (12; 22) [median (IQR)]. Sixteen underwent iv thrombolysis
(IVT), eight mechanical thrombectomy (MT) and eighteen IVT + MT.
Core volume was 10 cc (2; 18); mismatch 88% (76; 95); lesion volume in
24-h NCCT 14 cc (8, 56). CTA-SI ASPECTS correlates with the core
volume (r = −0.71, p = 0.0001) and mismatch volume (r = 0.73,
p = 0.0001) and predicts the final lesion extent and the neurological
improvement at 24-h if recanalization occurred, i. e. the lesion at 24-h was
12 cc smaller for every point of CTA-SI ASPECTS (95% CI = −16.6 to
−7.9) p = 0.0001, and NIHSS at 24-h 1.3 points lower for every point of
CTA-SI ASPECTS (95% IC = −2.5 to −0.13), p = 0.031.
Conclusions: CTA-SI ASPECTS could help predict the degree of improve-
ment following successful reperfusion.
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Diagnostic and volumetric agreement between bold
signal delay and bolus-tracking MRI on perfusion
deficits in acute ischemic stroke
A Khalil1, A C Ostwaldt1, T Nierhaus2, H J Audebert1, K Villringer1,
A Villringer3, J B Fiebach1
1Center for Stroke Research, Charité Universitätsmedizin,
Berlin, Germany
2Berlin Neuroimaging Center, Berlin School of Mind and
Brain, Berlin, Germany
3Department of Neurology, Max Planck Institute for Human
Cognitive and Brain Sciences, Leipzig, Germany
Aims: In this study, we assessed the agreement between dynamic suscep-
tibility contrast MRI (DSC-MRI) and the Time Shift Analysis (TSA) of
resting-state functional MRI (rsfMRI) data for the assessment of perfu-
sion deficits in acute ischemic stroke patients.
Methods: Maps of Tmax (>6 seconds) and TSA (relative delay in local
versus average BOLD signal), derived from DSC-MRI and rsfMRI data
respectively, were generated for 52 patients scanned within 24 hours of
acute ischemic stroke onset. The maps were independently evaluated for
perfusion deficits by two raters.
Results: TSA and Tmax maps agreed on the presence or absence of per-
fusion deficits in 63.5% (rater 1) and 65.4% (rater 2) of cases. In 36.5%
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(rater 1) and 32.7% (rater 2), TSA maps showed a BOLD delay lesion in
the absence of a Tmax lesion. BOLD delay lesions were on average 61 ml
(rater 1, 95% limits of agreement = −70 to 192 ml) and 51 ml (rater 2,
95% limits of agreement = −82 to 184 ml) larger than Tmax lesions. We
found moderate agreement between raters on the presence of BOLD delay
(Cohen’s kappa = 0.466, p = 0.001) and hypoperfusion (Cohen’s
kappa = 0.618, p < 0.0001). Lesion volumes between raters were similar
(intraclass correlation coefficient = 0.966 for TSA maps, p < 0.0001 and
0.985 for Tmax maps, p < 0.0001).
Conclusion: BOLD delay consistently coexists with hypoperfusion in
acute stroke patients, but also often occurs without substantial perfusion
delay. BOLD delay lesions tend to be considerably larger than Tmax per-
fusion lesions. Diagnostic and volumetric agreement between observers is
moderate for TSA maps.
ESOC-1218
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Early reversible and late inflammatory blood–brain
barrier disruption in human acute ischemic stroke
R Leigh1, C Dias1, Z Nadareishvili2, A W Hsia3, J K Lynch1,
R T Benson3, L L Latour1
1Intramural Stroke Branch, National Institute of Neurological
Disorders and Stroke, Bethesda, MD, USA
2Neurology, Johns Hopkins Community Physicians, Bethesda,
MD, USA
3Neurology, Medstar Washington Hospital Center,
Washington, DC, USA
Background: Animal models of acute ischemia have revealed two distinct
patterns of blood–brain barrier (BBB) disruption. An early reversible BBB
disruption takes place within minutes of ischemia onset, while a late
inflammatory BBB disruption is typically seen days after the acute isch-
emia. This biphasic BBB disruption has not previously been demonstrated
in human acute stroke.
Methods: A case report of a patient who demonstrated early reversible and
late inflammatory BBB disruption is presented (Fig.).A 77-year-old gentle-
man presented to our institution with an acute right middle cerebral artery
syndrome. MRI was performed 70 minutes after onset of symptoms dem-
onstrating occlusion of the M1 segment of the MCA with a large severe
perfusion deficit. Post processing of the PWI source images revealed
leakage of gadolinium into the DWI lesion consistent with BBB disruption.
The patient received IV tPA 97 minutes after the onset of symptoms. Repeat
MRI 171 minutes after onset revealed recanalization of the MCA with
resolution of the PWI deficit and reversal of the BBB disruption. MRI
performed 24 hours later began to show a secondary inflammatory BBB
disruption and MRI a week later demonstrated frank BBB disruption.
Conclusion: Biphasic BBB disruption as described in animal models can
also be seen in human stroke.
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Earlier serial MR imaging is associated with a greater
rate of T2 signal change in acute stroke
C Dias1, A W Hsia2, Z Nadareishvili3, R T Benson2, J K Lynch1,
L L Latour1, R Leigh1
1Intramural Stroke Branch, National Institute of Neurological
Disorders and Stroke, Bethesda, MD, USA
2Neurology, Medstar Washington Hospital Center,
Washington, DC, USA
3Neurology, Johns Hopkins Community Physicians, Bethesda,
MD, USA
Background: Qualitative T2 signal change on FLAIR imaging of acute
stroke is currently being tested as a way to select patients with an unknown
time of onset for treatment. While there is a presumed time dependence of
T2 signal change, a quantitative analysis using multiple time points has
been lacking.
Hypothesis: T2 signal change in an acute stroke imaged at two early time
points will be significantly associated with the time between MRI scans.
Methods: MRIs were co-registered. ROIs were defined by ADC < 600 and
TTP > 6 seconds. Mean T2 signal was calculated within the ROI at both
time points on FLAIR. Linear regression was used to compare variables.
Results: 24 patients enrolled in our natural history study in 2013 had the
necessary clinical and imaging data to perform the analysis and were
included in this study. All patients received IV tPA in between the two MRI
scans. Mean time from onset to first MRI was 101 minutes and the mean
time between MRIs was 135 minutes. The amount of time between MRIs
was not significantly associated with the amount (p = 0.46) or rate
(p = 0.34) of T2 signal change. However the time from onset to the first
MRI was significantly associated with both amount (p = 0.033) and rate
(p = 0.032) of T2 signal change, with earlier MRI scanning resulting in
larger and faster changes in T2.
Conclusions: Quantitative change in T2 signal in acute stroke may be
greater at earlier time points. The relationship between T2 signal change
and time may be nonlinear.
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Blood–brain barrier breakdown after acute ischemic
stroke: Does permeability imaging add to clinical
evaluation and multimodal CT?
B Little1, K Muir1, X Huang1, K Dani1, N MacDougall1, F McVerry2
1Institute of Neuroscience and Psychology, University of
Glasgow, Glasgow, United Kingdom
2Neurology Department, Altnagelvin Hospital, Derry, United
Kingdom
Background: Hemorrhagic transformation (HT) after IV thrombolysis is
associated with poorer functional outcomes and blood–brain barrier
compromise. We investigated the predictive value of permeability mea-
sures derived from CT perfusion (CTP) for HT.
Methods: We undertook retrospective analysis of all IV rtPA-treated
patients from 3 acute ischemic stroke studies that acquired CTP < 6 h
after onset and repeat CT at 24–72 h, including the ATTEST trial that
compared alteplase with tenecteplase. Permeability maps for five perme-
ability parameters were generated using MiStar software (Melbourne,
Australia). The extent of permeability abnormalities was graded using a
modified ASPECTS score, deducting 1 point for each abnormal region on
visual analysis, and a grade of severity of impaired permeability assigned
(0 = no abnormality, 3 = severe). CT at 24 h was graded for HT using
ECASS-2 criteria by raters blind to permeability analyses. The relationship
between permeability and HT was assessed by binary logistic regression.
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Results: We included 158 patients of whom 20.3% (n = 32) had HT of any
kind and 4.4% (n = 7) had PH2. Of the 5 permeability parameters
assessed, only total ASPECTS score for VE (extravascular and extracellular
volume in a certain volume of tissue) was related to HT in univariate
analysis (p = 0.001), but none was significant in a multivariate model.
Admission blood glucose (p = 0.044), core (r DT > 2 s, r CBF < 40%,)
volume (p = <0.0001)and which tPA received(p = 0.008)were indepen-
dent associations in a multivariate model for any hemorrhage. Prior dual
antiplatelet therapy (p = 0.004) was associated in a multivariate model for
PH2 only.
Conclusion: CTP-derived permeability abnormalities were not indepen-
dently associated with subsequent HT.
ESOC-1390
19. Imaging
Cluster-based arterial input functions improve
penumbral flow detection in acute stroke
M Livne1, P Brunecker1, V Madai1, O Zaro-Weber2,
W Moeller-Hartmann3, W D Heiss2, K Mouridsen4, J Sobesky1
1CSB, Center for Stroke Research Berlin (CSB), Berlin,
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2Max-Planck-Institute for Metabolism Research, Cologne,
Germany
3Department of Radiology, Ludmillenstift Meppen, Meppen,
Germany
4Neuroinformatics, Center of Functionally Integrative
Neuroscience, Aarhus, Denmark
Introduction: Dynamic susceptibility-weighted contrast-enhanced
magnetic-resonance-imaging (DSC-MRI) is used to assess penumbral
flow in acute ischemic stroke. However, validated automated post-
processing methods are lacking. For these, the choice of the arterial input
function (AIF) is a major confounder, and has not been validated so far by
an imaging gold-standard.
Materials and methods: In 18 (sub)acute stroke patients with MRI and
H2O15 positron-emission-tomography (PET) performed at the Max-
Planck-Institute in Cologne, the optimal AIFs were calculated based on
the kinetic model of DSC-MRI customly adapted to individual PET and
MRI data. Cerebral-blood-flow (CBF), cerebral-blood-volume (CBV),
mean-transit-time (MTT) and time-to-maximum (Tmax) were com-
puted applying 3 methodologies: 1) GLOBAL AIF: One median AIF. 2)
CLUSTER AIF: A cluster analysis approach identified voxels with similar
AIFs. 3) MANUAL AIF selection. Non-deconvolved Time-to-peak (TTP)
maps were created. All maps were tested for their performance in penum-
bral flow detection (<20 ml/100 g/min) on a voxel level by receiver oper-
ating characteristics (ROC) curve analysis.
Results: Optimal PET validated AIF curves showed a wide distribution,
suggesting that one single AIF for all voxels of one patient might not be
adequate. Accordingly, the GLOBAL AIF methodology performed simi-
larly (AUC 0.72–0.85) to MANUAL AIF (AUC 0.73–0.85). CLUSTER AIF,
however, as a multiple-AIF approach, showed significantly better perfor-
mance (AUC 0.82–0.90), surpassing even the high performance of TTP
(AUC 0.87).
Discussion: Our results challenge the widely used Global AIF approach.
The CLUSTER AIF concept was superior over single voxel approaches and
over TTP. The findings support multiple-AIF approaches and might
enhance the performance of deconvolved parameters.
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Decreased volume of subcortical structures in minor
stroke patients
M S Stringer1, O Varsou1, C Dinis Fernandes1, C Schwarzbauer1,
M J Macleod2
1Aberdeen Biomedical Imaging Centre, University of
Aberdeen, Aberdeen, United Kingdom
2Department of Medicine and Therapeutics, University of
Aberdeen, Aberdeen, United Kingdom
Introduction: Transient neurological events provide a diagnostic chal-
lenge in the clinic setting, but accurate diagnosis of TIA or minor stroke is
important to prevent serious recurrent ischemic events. Neuroimaging
provides a promising means of seeking potential biomarkers and prog-
nostic indicators. In this study we compare the volume of subcortical
structures in minor stroke patients relative to healthy controls.
Methods: Recruitment was approved by the relevant ethics committee, all
participants provided written informed consent after the experimental
procedures were explained. High-resolution T1-weighted scans were
obtained as part of a diagnostic protocol from 22 patients with a final
diagnosis of minor stroke (mean age: 54 ± 14, 25–82) and 22 healthy
controls with no known history of ischemic events (mean age: 35 ± 8,
21–47). Automatic subcortical segmentation was performed using Free-
surfer. SPSS 22 was used to perform an ANCOVA with age and total
intracranial volume included as covariates.
Results: Significant differences (p < 0.05) were found between the control
and patient groups. Specifically the volumes of the left hippocampus
(F = 6.5526, p = 0.015), right thalamus (F = 4.199, p = 0.047), right hip-
pocampus (F = 5.246, p = 0.027), cortex volume (F = 4.949, p = 0.032),
and total grey matter volume (F = 4.927, p = 0.032) were significantly
lower in the minor stroke group relative to the healthy controls.
Conclusion: The results accord well with previous research showing lower
hippocampal volumes in minor stroke patients compared to healthy con-
trols, while the thalamus is known to be associated with regulating motor
function and sensory perception. Further work is required to investigate
these changes more fully, in particular whether the differences in the
thalamus correlate with clinical data.
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Intra-aneurysmal thrombus: Morphology, behavior, and
contribution to aneurysm hemodynamics and behavior;
extrapolation from CFD models
O. Mansour1
1Stroke and Neurovascular Department, Faculty of Medicine,
Alexandria, Egypt
Background: Review of the literature suggests that complete thrombosis
of intracranial aneurysms is uncommon. It most frequently occurs after
subarachnoid hemorrhage and in fusiform or giant saccular aneurysms.
In autopsy series thrombosis of intracranial aneurysms has been found in
9% to 13% of cases. Aneurysm thrombosis after subarachnoid hemor-
rhage has a reported incidence of 1–2%. This may be as high as 3% in
patients treated with antifibrinolytic agents or may be a delayed event after
subarachnoid hemorrhage. Spontaneous thrombosis of giant intracranial
aneurysms may be evident in up to 55% of lesions demonstrated on CT
scans. Thrombosis is usually partial, with complete thrombosis occurring
in 13% to 20% of cases.
Aim: of the current work is to extrapolate different predictive scenario by
using different flow analysis models simulating the intra-aneurysmal
thrombus – aneurysm relationship. And to try to predict the thrombus
genesis , behavior , contribution to aneurysm hemodynamics and growth
or regress behavior
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Materials and results: By using “pipe to-fro box” model and usage of this
model as prototype simulating for the thrombus-aneurysm. We could
extrapolate 8 scenario predicting these possible contribution of the intra-
aneurysmal thrombus to the aneurysm hemodynamics and behavior of
growth and regress.
Conclusion: this simple 3d model simulation shed a new focus on the
importance of intra-aneurysmal thrombus and its contribution for the
behavior of the aneurysm itself.
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Temporal evolution of symptomatic intracranial
atherosclerotic plaque post-contrast enhancement:
A serial high-resolution MRI study
E Martínez-Velasco1, M Margarita Rodríguez-Velasco2,
A I Calleja1, E C Elisa Cortijo1, L Luis López-Mesonero1,
P Pablo García-Bermejo1, M María Hernández3, J Josep Munuera4,
J F Arenillas1
1Neurology, Hospital Clínico Universitario de Valladolid,
Valladolid, Spain
2Radiology, Hospital Clínico Universitario de Valladolid,
Valladolid, Spain
3Neurology, Hospital German Trias I Pujol, Barcelona, Spain
4Radiology, Hospital German Trias I Pujol, Barcelona, Spain
Objectives: Post-contrast enhancement (PCE) in high-resolution mag-
netic resonance imaging (HR-MRI) has been proposed as a marker of
intracranial atherosclerotic plaque activity. We aimed to describe the tem-
poral evolution of PCE and other structural parameters in symptomatic
intracranial plaques under aggressive medical therapy.
Methods: We prospectively studied consecutive patients with a first-ever
ischemic stroke attributable to a symptomatic intracranial atherostenosis.
Symptomatic intracranial plaques were studied with 3Tesla HR-MRI
during admission and three months thereafter, using 2mm-slices and the
following sequences: proton-density, T1, T2 and post-contrast (PC) T1.
Atherosclerotic plaque area was calculated on T2 images. The plaque was
then demarcated as a region of interest where mean and maximal signal
intensities were calculated on T1 and PC-T1 sequences. Intraplaque signal
intensity was compared to adjacent white matter’s intensity.
Results: We studied four stroke patients (two women, mean age 60).
Symptomatic plaques were located in M1 segment of middle cerebral
artery (2), intracranial vertebral (1) and basilar (1) arteries. PCE was
visible in all patients on initial PC-T1, with a relative mean intensity
ranging from 1.3 to 1.8. Mean plaque signal intensity on PC-T1 decreased
during follow-up, showing a wide interindividual variation ranging from
a 4% to a 62% intensity reduction. Both plaque area and mean plaque
signal intensity on non-contrast T1 diminished also in all patients,
showing mean reductions of 29% and 11% respectively.
Conclusion: Intracranial atherosclerotic plaque’s PCE on PC-T1, signal
intensity on non-contrast-T1 and area decreased during the first three
months after stroke. The clinical implication of these findings warrants
further study.
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19. Imaging
CT angiography in acute ischemic stroke: A validated
case archive based on an audit of local practice
E A Cora1, A M Mohamed2, P White1, G Ford3
1Institute of Neuroscience, Newcastle University, Newcastle
upon Tyne, United Kingdom
2Neuroradiology, The Newcastle Upon Tyne Hospitals NHS
Foundation Trust, Newcastle upon Tyne, United Kingdom
3Academic Health Science Network, University of Oxford,
Oxford, United Kingdom
Introduction: Recently there have been a few positive thrombectomy
trials. CT angiograms (CTA) are mostly performed in tertiary centers. In
light of the new thrombectomy trials, there is a need for patients present-
ing with acute ischemic stroke (AIS) to obtain a CTA at the presenting
hospital. Depending on the findings, further management could be done
locally or the patient can be referred to a tertiary center.
Purpose: We developed a validated case archive of CTAs to help with
teaching and training of the regions radiologists with the aim that this will
drive clinical practice change in the management of AIS across the north
east of England. There is an emerging need for CTAs to be performed and
interpreted in a district general hospital setting.
Methods: A retrospective review of 364 patients presenting over a period
of 7 months was performed. From this audit data 100 CTA cases were
collected and these scans are being reviewed by 3 neuroradiologists for a
validated case archive.
Results: From the audit data, CTA was indicated in 153/364 (43%)
patients and performed in 115/153 (69%) patients. Reasons behind failure
to obtain CTA’s in remaining 38/153 patients were evaluated. 40 (11%)
patients underwent thrombolysis, 6 (2%) underwent thrombectomy and
carotid endarterectomy was performed in 7 (2%) patients.
Conclusion: A validated case archive of CTA’s used for training will hope-
fully result in a positive clinical practice change in hyperacute manage-
ment of stroke. Illustrative teaching cases from the archive will be
presented.
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Quantitative MR imaging of white matter
hyperintensities shows a prevailing role of increased
water content at all ages with increased BBB leakage
at older age
S Muñoz Maniega1, M C Valdés Hernández1, P A Armitage2,
A K Heye1, M J Thrippleton1, S D Makin1, F M Chappell1,
K Shuler1, M S Dennis1, J M Wardlaw1
1Neuroimaging Sciences, University of Edinburgh, Edinburgh,
United Kingdom
2Department of Cardiovascular Science, University of
Sheffield, Sheffield, United Kingdom
White matter hyperintensities (WMH), commonly seen in brain images
of stroke patients, were characterized at different age ranges using quan-
titative MRI.
We recruited patients with mild stroke, performed brain MRI, classified
WMH, normal-appearing white matter (NAWM), and markers of white
matter integrity (diffusion fractional anisotropy (FA), mean diffusivi-
ty(MD)), water content (T1 relaxation time), and a potential marker of
blood–brain barrier (BBB) leakage (uptake slope of dynamic contrast-
enhanced MRI). We divided the patients into age groups (Fig. 1) and
analyzed variation in MRI parameters by tissue type and age using
ANCOVA and ROC analysis.
Amongst 204 patients (age 34.3–90.9 y), all parameters differed signifi-
cantly between tissues across all age groups (p < 0.001 for FA, MD and T1;
p = 0.003 for slope). There was a significant age effect on MD,
T1(p < 0.001) and slope (p = 0.022) in both tissues; age and tissue inter-
acted for FA (p < 0.001), Fig. 1. MD best discriminated WMH from
NAWM. The discriminant ability of FA and T1 decreased with age, but
increased for BBB leakage, Fig. 2.
NAWM deteriorates diffusely with age not just in WMH. ROC analysis
suggests increased tissue water is the primary pathology in WMH, with
BBB leakage being more obvious at older age.
Fig. 1
Abstracts
© 2015 The Authors.
International Journal of Stroke © 2015 World Stroke Organization Vol 10 (Suppl. 2); April 2015; 77–438320
Fig. 2
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Prevalence of acute silent brain infarction in retinal
artery occlusion and amaurosis fugax
H Neugebauer1, F Lauda1, L Reiber1, E Jüttler1
1Neurology, University of Ulm, Ulm, Germany
Objective: There is some evidence that acute monocular visual loss of
presumed ischemic origin (MVL) is accompanied by acute ischemic
stroke. We sought to determine the prevalence of acute silent brain infarc-
tion in unselected patients with branch and central retinal artery occlu-
sion (BRAO/CRAO) and amaurosis fugax (AF).
Methods: Due to local conditions, within a radius of approximately 50 km
all patients with acute MVL are admitted to our stroke unit and receive
MRI after emergency examination by an ophthalmologist. We retrospec-
tively analyzed 227 consecutive patients with AF (31.7%), BRAO (19.8%)
and CRAO (48.5%) who were treated between 2008 and 2013.
Results: DWI was obtained after 34.9 (+/−80.6) hours from symptom
onset. Acute ischemic stroke was detected in 48 (21.1%) of patients. Of
these only 5 (10.4%) patients presented with additional neurologic symp-
toms, whereas silent brain infarctions were seen in 43 (89.6%) patients.
Higher age (p < 0.001), additional stroke symptoms (p = 0.002), atrial
fibrillation (p = 0.05), hypertension (p < 0.02), and type of retinal artery
occlusion (AF 9.7%, CRAO 22.7%, BRAO 35.6%, p = 0.003) were associ-
ated with DWI lesion. In multivariate analysis only age and type of occlu-
sion remained positive predictors for silent brain infarction. Etiology was
undetermined in most cases (43.2%) followed by large artery atheroscle-
rosis (35.7%) and cardioembolism (18.5%).
Conclusion: Acute silent brain infarction on DWI is a frequent finding in
unselected patients with RAO and AF. Because silent brain infarctions
bear a high risk of future stroke, these patients should be treated on stroke
unit and effort should be made to identify underlying etiology.
ESOC-0942
19. Imaging
Neuroimaging of hyperacute ischemic stroke:
Post-thrombolysis
R Renganathan1, N Moussa1, K A Siddiqui1
1Department of Neurology, Al Ain Hospital, AL AIN, United
Arab Emirates
Background: CT brain is done in hyperacute ischemic stroke patients
post-thrombolysis to rule out hemorrhage and also to decide on further
anti-thrombotic and/or anticoagulant therapy. In this study we observed
neuroimaging findings on MRI Brain done in hyperacute ischemic stroke
patients within 24 hours post-IV thrombolysis.
Methods: We retrospectively analyzed data from our Stroke registry over
a two-year period. All stroke patients who were thrombolysed were
included. Demographics, clinical presentation, NIHSS pre-thrombolysis
and findings on brain imaging were analyzed. CT Brain, MRI-DWI/ADC,
FLAIR, GRE sequences and MR Angiogram of Circle of Willis (MRA-
COW) were reviewed. Stroke subtypes viz. infarcts were identified based
on location: cortical-subcortical, deep-subcortical and brainstem.
Results: 68 patients with ischemic stroke had IV-thrombolysis. 24 of these
patients had MRI brain done within 24 hours post-thrombolysis. There
were 20 males and 4 females. Mean age was 54 years. Eleven patients had
dense hemiplegia, 8 had hemiparesis, 3 had hemiataxia and 2 had aphasia.
Mean NIHSS score was 9 on admission. MRI brain (DWI/ADC and
FLAIR) showed cortical-subcortical infarcts in 8, deep-subcortical infarcts
in 12 and brainstem infarcts in 4 patients.
MRI brain (GRE sequence) showed microbleeds in lentiform nucleus in 3
patients.
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MRA-COW showed MCA-M1 occlusion in 4 patients.
MRA-COW showed MCA-M2 occlusion in 5 patients.
Conclusion: In hyperacute ischemic stroke post-thrombolysis, MRI brain
done within 24 hours identifies the extent and location of stroke, detects
microbleeds and provides information about cerebral vasculature early
on.
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Diagnosing extracranial vertebral artery stenosis:
Duplex ultrasonography versus CT angiography
A D Rozeman1, H Hund2, M Westein3, M J H Wermer4,
G.J. Lycklama a Nijeholt2, J. Boiten1, R.J. Schimsheimer3, A. Algra5
1Neurology, MC Haaglanden, The Hague, Netherlands
2Radiology, MC Haaglanden, The Hague, Netherlands
3Clinical Neurophysiology, MC Haaglanden, The Hague,
Netherlands
4Neurology, LUMC, Leiden, Netherlands
5Clinical Epidemiology, LUMC, Leiden, Netherlands
Introduction: Vertebrobasilar stenosis is often found in patients with pos-
terior circulation stroke and it increases risk of stroke recurrence. We
investigated feasibility and accuracy of duplex ultrasonography (DUS) as
a screening tool for the detection of proximal vertebral artery (VA) steno-
sis compared with CT angiography (CTA).
Methods: We gathered data on all patients who had to undergo DUS
because of a posterior circulation stroke or TIA. Matching CTA studies
were retrieved and used as “gold standard.” VA stenosis of ≥50% on CTA
was considered significant. For each segment of the VA, Receiver Operat-
ing Characteristic (ROC) curves were drawn and the area under the ROC
curve (AUROC) was determined. We also calculated which DUS Peak
Systolic Velocity (PSV) cut-off value resulted in highest sensitivity with
acceptable specificity.
Results: We included 338 patients with 676 V1- and 676 V2-segments. Of
the 619 adequate measurements with CTA at the V1-segment, only 370
corresponding measurements with DUS were adequately made. DUS
detected a stenosis in 49 V1-segments (13%, PSV cut-off 140 cm/s). CTA
showed corresponding significant stenosis in 11 (22%) of these segments
(AUROC 0.76; 95% CI 0.67–0.86). A PSV cut-off value of 90 cm/s resulted
in best sensitivity (89%) with acceptable specificity (47%). For the
V2-segment there were too few stenoses to allow reliable assessment of
diagnostic characteristics of DUS.
Conclusion: Given the technical difficulties in proper assessment of the
proximal VA and the modest accuracy, we think that usefulness of DUS as
a screening tool for proximal VA stenosis is limited.
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Comparison of multi- versus single-phase CTA for
collateral circulation evaluation on acute stroke
M Rubiera1, V Carvalho1, S Boned1, P Coscojuela2, A Flores1,
D Rodriguez-Luna1, J Pagola1, M Muchada1, L Sero1, R Ponciano2,
D Bonadona2, P Meler1, E Sanjuan1, C A Molina1, B Menon3,
M Goyal3, A Tomasello2, M Ribo1
1Stroke Unit, Hospital Vall d’Hebron, Barcelona, Spain
2Neurorradiology Department, Hospital Vall d’Hebron,
Barcelona, Spain
3Neurorradiology Department, University of Calgary, Calgary,
Canada
Good collateral circulation (CC) associates favorable outcomes on acute
stroke. Single-phase CTA (sCTA) is widely used, but lacks temporal reso-
lution, and may mislabel CC. We aim to evaluate a new-not post
processing-time resolved technique to evaluate CC:multiphase CTA
(mCTA).
Methods: Consecutive <4.5 h stroke patients with confirmed M1-MCA or
TICA occlusion by sCTA were included. Additional cerebral CTA acqui-
sitions with 10- and 20s-delay were performed for mCTA. CC evaluation
is described in the Fig. sCTA and mCTA were compared as outcome
predictors. Recanalization (REC) was assessed by TCD at 24 h.
Results: 78 patients were included. Mean age: 66.3 ± 13.6 y, median
NIHSS 17.5 (IQR 6.3), 52(66.7%) M1- and 26 (33.3%) TICA-occlusions.
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Mean time from onset to CTA: 2:32 ± 1:31 h. On sCTA, 61.8% patients
presented good CC whereas on mCTA, 54.7%.
Only on mCTA good CC was an independent predictor of low infarct
volume at 24 h (OR 3.6, CI 95% 1.3–10.5, p = 0.017). Only on mCTA, CC
status was associated with lower 24 h median NIHSS (good CC: 5 vs poor
CC: 17, p < 0.001), and 3 mo favorable outcome (mRS 0–2: good CC
57.1% vs poor CC 11.5%, p < 0.001).
Poor mCTA-CC status was especially significant in patients without REC,
with 0% of mRS 0–2 (mRS 0–2 = 50% in REC with poor CC) (p < 0.01).
In a logistic regression model including age, NIHSS, ASPECTS and REC,
only good CC on mCTA predicted favorable outcome (OR 6.8, CI 95%
1.6–29.2, p = 0.009).
Conclusion: CC evaluation on mCTA improves outcome prediction as
compared with sCTA. CC on mCTA is an independent predictor of infarct
volume and functional outcome, especially if REC is not achieved.
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Difference of thrombus attenuation between CT and
CT angiography measured in patients with acute
ischemic stroke: An expression of thrombus porosity?
E M M Santos1, A J Yoo2, L F Beenen3, M B den Blanken1,
O A Berkhemer3, W J Niessen4, C B Majoie3, H A Marquering1
1BMEP – Biomedical Engineering and Physics, AMC –
Academisch Medisch Centrum Amsterdam, Amsterdam,
Netherlands
2Radiology, Massachusetts General Hospital, Boston, USA
3Radiology, AMC – Academisch Medisch Centrum Amsterdam,
Amsterdam, Netherlands
4BIGR – Biomedical Imaging Group, Erasmus University
Medical Center, Rotterdam, Netherlands
Background: It has been demonstrated that a thrombus could be porous
rather than fully compact, and that porosity is associated with the speed of
fibrinolysis such as it may improve intravenous treatment success in acute
ischemic stroke. We hypothesize that CT contrast agent may penetrate a
porous thrombus, ensuing that the porosity could be measured by assess-
ing thrombus attenuation differences between ncCT and CTA imaging.
Objective: We aim to characterize thrombus attenuation changes between
ncCT and CTA images as a potential imaging biomarker of thrombus
porosity.
Methods: From the MR CLEAN trial database, 125 consecutive acute
ischemic stroke patients with good quality admission thin-slice ncCT and
CTA imaging were included. The ncCT and CTA images were
co-registered, and independent observers placed 3 small standardized
regions of interest in each thrombus such that the attenuation on ncCT
and CTA was simultaneously measured. CTA-based thrombus density
measurement larger than 1.96 times the standard deviation of the corre-
sponding ncCT measurement was classified as porous.
Results: Thirty-seven out of 125 thrombi (29.6%) were classified as
porous with a paired average increase of +27.7 (+/−12.9) HU on CTA. The
overall mean thrombus attenuation was 50.1(+/−7.4) for ncCT and was
60.7(+/−13.4) for CTA images. Six patients (4.8%) had an increase in
thrombus density of more than 40 HU.
Conclusion: CTA-based measurements can demonstrate quantifiable
increases in attenuation value compared to ncCT assessments. This con-
trast penetration in CTA likely reflects thrombus porosity, and could be
investigated as a potential imaging biomarker for treatment response to
fibrinolysis.
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Absolute thrombus density measurement on
non-contrast CT in patients with acute ischemic stroke
has superior interobserver agreement than relative
ratio
E M M Santos1, A J Yoo2, L F Beenen3, M B den Blanken4,
O A Berkhemer3, W J Niessen1, C B Majoie3, H A Marquering4
1BIGR – Biomedical Imaging Group, Erasmus University
Medical Center, Rotterdam, Netherlands
2Radiology, Massachusetts General Hospital, Boston, USA
3Radiology, Academisch Medisch Centrum, Amsterdam,
Netherlands
4BMEP – Biomedical Engineering and Physics, Academisch
Medisch Centrum, Amsterdam, Netherlands
Background: Thrombus density is increasingly considered as predictive
characteristic for acute ischemic stroke (AIS) treatment success. However,
its value is still under debate since the published studies are not exclusive.
The used thrombus density measurement method varies widely between
studies, which could explain the variations in associations with outcome
success.
Aim: This study compares the observer variability of four common
thrombus density manual measurements: absolute HU and relative HU
using either one or three measures.
Method: From the MR CLEAN trial database, for 104 consecutive AIS
patients with thin-slice ncCT, three expert observers and a trained observer
placed three small standardized regions of interest (ROI) in the thrombus
and in the contralateral vessel. The middle ROI was used as the reference
single measure. Based on these measurements the average absolutes (aHU)
and average relatives (rHU) thrombus densities were determined aHU1,
rHU1 and aHU3, rHU3 for single and triple measure respectively. The
interobserver variations were evaluated by the calculation of the intraclass
correlation coefficient (ICC) and performing Bland & Altman analysis.
Results: The results for the Bland & Altman analysis showed and the ICCs
are showed in the table below.
Table Bland & Altman analysis and intraclass correlation coefficients
Conclusions: The interobserver variability for absolute density measure-
ment is superior to relative ratio. We therefore advise researchers to use
relative ratio measurement with care when studying imaging biomarker in
non-contrast CT images.
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Permeable thrombi on CT perfusion have shorter
thrombus length and recanalize early with IV TPA
A Seong Hwan1, D D Christopher2, Q M Emmad2, H Lisa2,
G Mayank3, D M Andrew4, H D Michael4, L Y Ting5, R Marta6,
F Enrico7, M K Bijoy4
1Neurology, Chosun University, Gwangju, Korea
2Clinical Neurosciences, Calgary Stroke Program University of
Calgary, Calgary, Canada
3Radiology, University of Calgary, Calgary, Canada
4Clinical Neurosciences, University of Calgary, Calgary, Canada
5Diagnostic Radiology & Nuclear Medicine, Lawson Health
Research Institute and Robarts Research Institute, London,
Canada
6Neurology, Hospital Vall d’Hebron, Barcelona, Spain
7Neurosciences and Rehabilitation, Arcispedale Sant’Anna,
Ferrara, Italy
Introduction: In middle cerebral artery (MCA) occlusions, we have pre-
viously shown that thrombus permeability is a robust determinant of
early recanalization with IV tPA. In this project, we seek to test if perme-
able thrombi are shorter in length.
Methods: From the PROVE-IT stroke image database, MCA M1 occlu-
sions treated with intravenous tPA were analyzed. Using perfusion CT and
a delay insensitive algorithm (T0 map), a “positive sloped regression line
of T0 values” measured along artery silhouette distal to thrombus was
defined as marker of permeable thrombus. Length of thrombus was
measured on axial CT angiography images (thickness 0.625 mm)
co-registered on CT perfusion average maps. Early recanalization was
assessed on first angiography of subsequent IA procedure or on 4-hour
CTA.
Results: In 38 MCA M1 stroke patients (intravenous tPA: 19, additional
IA: 19), early recanalization was achieved in 11 (28.9%). Measured
median thrombus length was 17 mm (IQR 11–25). Thrombus length in
those who recanalized early was shorter vs. those who did not (10 mm vs.
20 mm, p = 0.04). Patients with permeable thrombus (n = 11) had higher
early recanalization rates vs. without (54.5 vs. 18.5%, p = 0.02). Patients
with permeable thrombus had shorter thrombus length (10 mm vs.
21 mm, p = 0.002). Thrombus length threshold that best discriminates
permeable thrombi was 13 mm (sensitivity: 0.91, specificity: 0.81, AUC:
0.82).
Conclusions: In MCA stroke, permeable thrombi are associated with short
thrombi length and recanalize early with IV tPA.
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Subclinical ischemic lesions in patients with
intracranial hemorrhage
S Singhal1, J V Ly1, R V Chandra1, J Zhou1, C Soufan1, H Ma1,
B Clissold1, V Srikanth1, T G Phan1
1Stroke Department, Monash Medical Centre, Melbourne,
Australia
Background and purpose: Subclinical ischemic lesions on diffusion
weighted MR imaging (MRI-DWI) have been recently described in
patients with spontaneous intracerebral hemorrhage (ICH) and convexity
subarachnoid hemorrhage (cSAH). Such lesions are postulated to be part
of the amyloid angiopathy spectrum. We hypothesized that the frequency
of these MRI-DWI lesions may differ between patients presenting with
cSAH, lobar ICH and basal ganglia ICH.
Methods: Retrospective study of patients presenting between 2011–2014
with cSAH and/or ICH and subsequent MRI. Patients with an aneurysm,
arteriovenous malformation, or hemorrhagic infarct were excluded. ICH
topography was classified as lobar or basal ganglia; MRI-DWI lesions were
classified as subclinical if there were no associated symptoms; contrast
enhanced scans were assessed for leptomeningeal contrast enhancement.
Results: Of 115 eligible patients, 56 patients had MRI within 14 days of
hemorrhage (mean age 69.4 ± 11.5 years; 48% male). Overall, 21%
(n = 12/56) patients with cSAH and/or ICH had subclinical MRI-DWI
lesions. MRI-DWI lesions occurred more frequently in patients with
cSAH than basal ganglia ICH (n = 5/12 vs 2/30; p = 0.006) and in patients
with lobar ICH than basal ganglia ICH (n = 5/18 vs 2/30; p = 0.04). There
was no significant difference in MRI-DWI lesions between cSAH and
lobar ICH. Patients with MRI-DWI lesions had more frequent adjacent
leptomeningeal contrast enhancement (p < 0.001).
Conclusion: Subclinical ischemic lesions occur more frequently in
patients with cSAH and lobar ICH than basal ganglia ICH. More frequent
leptomeningeal contrast enhancement in these patients may point to a
common underlying amyloid-related small vessel vasculopathy.
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Added dietary salt intake is associated with increased
white matter hyperintensity volume
M J Thrippleton1, A K Heye1, F M Chappell1,
M Valdes Hernandez1, P A Armitage1, S D Makin1,
S Munoz Maniega1, E Sakka1, P W Flatman2, M S Dennis1,
J M Wardlaw1
1Centre for Clinical Brain Sciences, University of Edinburgh,
Edinburgh, United Kingdom
2Centre for Integrative Physiology, University of Edinburgh,
Edinburgh, United Kingdom
Dietary salt intake and hypertension are associated with increased risk of
cardiovascular disease including stroke. We aimed to explore the influence
of these factors in cerebral small vessel disease. 264 patients with non-
disabling cortical or lacunar stroke were recruited. Patients answered
questions regarding their salt intake from which a semi-quantitative score
was derived, and plasma sodium concentration was measured; brain tissue
volume and white matter hyperintensity volume were measured using
MRI. Multiple linear regression with correction for age, stroke subtype
and vascular risk factors revealed that salt intake score (p = 0.021), bra-
chial pulse pressure (p = 0.036) and diagnosis of hypertension
(p = 0.0093) were all associated with increased white matter hyperinten-
sity volume. Plasma sodium concentration did not predict white matter
hyperintensity volume but was negatively associated with brain tissue
volume (p = 0.019). Our results confirm previous findings that raised
blood pressure and pulse pressure are associated with white matter hyper-
intensities and raise the possibility of an independent role for dietary salt
in the development of cerebral small vessel disease.
Fig. 1 Relationship of white matter hyperintensity volume with pulse
pressure, diagnosis of hypertension and salt intake score (range: 1–5, with
5 indicating maximum added salt).
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Perfusion CT-derived blood–brain barrier permeability
strongly predicts low risk of hemorrhagic
transformation after intravenous thrombolysis in acute
stroke
V Cecile1, J Puig2, G Blasco2, J Daunis i Estadella3, J Serena1,
Y Silva1, M Terceño1, M Wintermark4, S Pedraza2, M Castellanos1
1Neurology, Hospital Dr. Josep Trueta Girona Biomedical
Research Institute, Girona, Spain
2Radiology, Institut Diagnòstic Imatge Girona Biomedical
Research Institute, Girona, Spain
3Statistics, Universitat de Girona, Girona, Spain
4Department of Radiology Neuroradiology Division, Stanford
University, Stanford, USA
Background and purpose: Blood–brain barrier (BBB) permeability has
been proposed as an imaging predictor of hemorrhagic transformation
(HT) after tissue plasminogen activator (tPA) administration; however,
perfusion computed tomography (PCT) permeability imaging has not yet
been established as a reliable technique for stroke treatment. We aimed to
determine the performance of PCT-derived BBB permeability surface
using different volume thresholds in predicting HT after intravenous tPA
administration in patients with acute stroke.
Materials and methods: We retrospectively studied consecutive patients
with acute middle cerebral artery stroke treated with tPA. We used
delayed-acquisition to calculate admission PCT-derived BBB permeability
surface. Nine volume thresholds were applied (from 3 to 7 mL/100 g/min,
every 0.5 units). HT was graded according to the European-Australasian
Acute Stroke Study II criteria. ROC curves selected optimal volume
threshold, and multivariate logistic regression analysis identified indepen-
dent predictors of HT.
Results: Of 68 patients, 18 (26.4%) developed HT (4 PH1 and 9 PH2).
None of the permeability surface volume thresholds was better than the
others at predicting HT. Permeability surface >618.958 mm2 at 3-mL
threshold yielded sensitivity, specificity, and positive and negative predic-
tive values 44.4%, 94.0%, 72.7% and 82.5%, respectively, for HT (AUC
0.686, CI 0.526–0.845) and 55.6%, 89.8%, 45.5% and 93%, respectively,
for PH2 (AUC 0.718, CI 0.503–0.932). The volume threshold of 3-mL was
the only independent predictor of PH2 (OR 1.30; AUC 0.72, CI 1.04–1.63,
P = 0.016).
Conclusions: Lower PCT-derived BBB permeability surface predicts lower
risk of HT after thrombolysis in acute stroke patients.
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Background: Several studies using different CTP parameters provide
varying results in terms of malignant brain edema prediction. We explore
the predictive ability of multiphase CT angiography (mCTA) and CT
perfusion (CTP) at admission in development of malignant brain edema
in patients with acute proximal occlusion of middle cerebral artery
(MCA).
Methods: Patients from multicenter prospective study PROVE-IT with
proximal MCA+-terminal ICA occlusion were analyzed. Admission CTA
was evaluated for clot localization, leptomeningeal collaterals and dural
sinuses morphology. Admission CTP parameters were calculated (perme-
ability, cerebral blood flow, cerebral blood volume) within the ischemic
territory and contralateral mirror regions and tested using ROC. Reca-
nalization was evaluated by TICI score in patients undergoing mechanical
thrombectomy or CTA in IV-tPA group. Outcome was evaluated by
midline shift and final volume of infarction on follow-up CT/MRI within
24–32 hours.
Results: Of 200 patients, 7 patients (3.5%) had midline shift ≥5 mm (2
were excluded for poor-quality imaging). Five patients with midline shift
≥5 mm and 5 matched patients without shift were analyzed. Six patients
were treated by IV tPA (0% recanalization) and 4 were treated by
mechanical thrombectomy (100% TICI2b). Three of 5 (60%) with
midline shift ≥5 mm had ipsilesional hypoplasia of dural sinuses vs. 0/5
without shift. Mean CBF, CBV, PS within ischemic and contralateral
regions were not different. CBV threshold of 1.7 ml/100 g had the highest
AUC (0.72) with sensitivity and specificity of 0.83 and 0.67 respectively for
midline shift.
Conclusion: Our data did not show significant difference in analyzed CTP
parameters between both groups.
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TTP versus TMAX to define the PWI/DWI mismatch
profile
A Wouters1, S Christensen2, J Leggins2, M Mlynash2, G W Albers2,
M G Lansberg2
1Experimental neurology, KU Leuven, Leuven, Belgium
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Background: Perfusion MRI (PWI) together with diffusion (DWI)-maps,
are widely used to select stroke-patients for endovascular therapy. The
time to maximum of the residue function (Tmax) perfusion measure,
with delays of >6 seconds(s), has been shown to be a good predictor of
critically hypoperfused tissue. Theoretically, since Tmax is a measure of
hemodynamic delay, a time to peak (TTP)-map should contain similar
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properties with potentially being less sensitive to artifacts related to the
arterial input function (AIF). We aimed to compare the observed response
to reperfusion in subgroups selected by TTP and Tmax.
Methods: In this retrospective analysis of the DEFUSE 2-trial, Tmax-maps
were automatically calculated using RAPID-software and relative TTP
(rTTP)-maps were calculated using the concentration-time-curve, nor-
malized to the contralateral hemisphere. The rTTP-threshold was
adjusted by maximizing the lesion volume correspondence between Tmax
>6 s and >10 s and rTTP. For both perfusion parameters the effect of
reperfusion and presence of the PWI/DWI mismatch-profile on favorable
clinical response (FCR) was assessed.
Results: rTTP thresholds of >4.5 s and >9 s corresponded best with Tmax
thresholds of >6 s and >10 s. The rTTP-maps required removal of imaging
artifacts in 18 patients(16%), compared to 24(22%) for the Tmax-maps.
The odds ratio (OR) for FCR in patients with reperfusion was 7.4 (95% CI
2.3–24.1) and 6.0 (95% CI 2.0–18.4) for the TMM-profile for Tmax and
rTTP respectively.
Conclusion: rTTP-maps appear to be comparable to Tmax-maps for
selecting stroke patients who respond favorably to endovascular reperfu-
sion and may be less prone to imaging artifacts.
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Background and purpose: Perfusion weighted (PW) magnetic resonance
imaging (MRI) is used to identify penumbral flow in acute stroke but its
validity remains a matter of debate. One issue is the choice of the best
singular value decomposition (SVD) deconvolution method to calculate
PW maps. Two major SVD procedures exist: the standard (sSVD) and the
block-circulant (bSVD) method. By comparative positron emission
tomography (PET), we evaluated the influence of the SVD methods on
penumbral flow detection.
Methods: PW-MRI and 15O-water-PET was performed in acute stroke
patients. Maps of time to maximum (Tmax), cerebral blood flow (CBF),
cerebral blood volume (CBV) and mean transit time (MTT) were created
using sSVD and bSVD deconvolution and analyzed in a region-of-interest
(ROI) and voxel-of-interest (VOI) based analysis. We compared the per-
formance of both deconvolution methods to detect penumbral flow with
a receiver-operating-characteristics (ROC) curve analysis.
Results: 20 patients were included (ROI: n = 10 and VOI: n = 20); time
MRI to PET: 62/79 min. Tmax and CBF performed best in detecting
penumbral flow (median highest area under the curve [AUC] of sSVD/
bSVD): Tmax (ROI: 90/92 and VOI: 86/82), CBF (89/91 and 80/81) and
MTT (82/88 and 65/75). Only MTT penumbral flow detection improved
significantly (p < 0.01) with bSVD deconvolution.
Conclusion: The good performance of Tmax and CBF to detect penum-
bral flow did not differ between the underlying SVD methods. The use of
the faster sSVD method seems justified in acute stroke.
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Dual source CT-angiography (DSCTA) for non-invasive
and more accurate imaging following intracranial
aneurysm repair
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Objective: The invasiveness and risk of thromboembolic complications of
catheter angiography underline the role of non-invasive imaging modali-
ties, but especially for patients following intracranial aneurysm (IA) repair
image quality is often low due to superimposed clip or coil artifacts. We
prospectively investigated the potential role of dual-source CT angiogra-
phy (DSCTA) for the more accurate assessment of aneurysm occlusion
degree and parent vessel integrity in this respect.
Methods: Thirteen patients underwent DSCTA imaging following rup-
tured or unruptured IA repair. These datasets were matched for 13
patients, who underwent single source CT angiography (SSCTA) imaging
for similar IAs following aneurysm repair. Image quality was objectively
rated by quantifying beam hardening artifacts as the volume of a prolate
ellipsoid. Subjective image quality at the site of aneurysms and corre-
sponding parent vessels was rated by 2 independent neuroradiologists on
a scale from 4 (excellent, no artifacts) to 1 (poor, severe artifacts).
Results: Patients undergoing surgical (8) or endovascular (5) aneurysm
repair received DSCTA imaging. The beam hardening artifact volumes
were significantly lower for DSCTA (mean: 2.55 vs.135.1 ml; p < 0.0023),
compared to SSCTA images in the matched IA patient cohort. Subjective
image quality was good or excellent in 11 out of 13 patients in the DSCTA
cohort, compared to 1 out of 13 patients in the SSCTA cohort.
Conclusion: DSCTA imaging quality is markedly superior to SSCTA and
should be considered as an alternative, non-invasive imaging modality in
patients treated for their IA and who have an increased cardiovascular risk
profile.
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Extent and pattern of thrombosis as predictors of
parenchymal lesions in patients with cerebral venous
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Background and purpose: Parenchymal lesions in patients with cerebral
venous thrombosis (CVT) are associated with a worse prognosis. There
are no established imaging predictors of brain lesion in CVT. We aim to
determine if the extent(1) or topographical pattern(2) of venous throm-
bosis are associated with parenchymal lesions in a large sample of patients
with CVT.
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Methods: Data from the “International Study on Cerebral Vein and Dural
Sinus Thrombosis,” a prospective cohort with 624 patients. Numerical
scoring of the extent of thrombosis. Classification of lesions as non-
hemorrhagic or hemorrhagic (ICH). Descriptive analysis and testing for
an association between the presence of brain lesion, type, size and number
of lesions, and extent or topographical pattern of venous thrombosis.
Results:
1) Extent of thrombosis
Significant association of the thrombosis extent with: parenchymal
lesion (Rho = 0.9; p = 0.034); multiple lesions (Rho = 1; p = 0.0); ICH
(Rho = 0.9; p = 0.037).
2) Topographical pattern of thrombosis
Topographical patterns most strongly associated with brain lesion: deep
venous system- 88%; cortical veins- 87%; straight sinus- 67%, combined
thrombosis of superior sagittal and both lateral sinus- 52%.
Presence of multiple lesions: thrombosis of the deep venous system- 39%;
combined thrombosis of superior sagittal and both lateral sinus- 19%.
Presence of brain lesions with >5 cm: thrombosis of the deep venous
system- 39%, cortical veins –30%, straight sinus –25% and combined
thrombosis of superior sagittal and both lateral sinus- 13%.
Conclusion: The extent of thrombosis is an imaging feature associated
with brain lesions in CVT. Some patterns of thrombosis are associated
with higher risk of parenchymal lesion.
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Cortical atrophy as demonstrated by measurement of cortical thickness is
a hallmark of various neurodegenerative diseases. In the wake of an acute
ischemic stroke, brain architecture undergoes dynamic changes that can
be tracked by structural and functional magnetic resonance imaging
studies in the early chronic stage. Although few studies of cortical plastic-
ity post-stroke exist, it remains largely unknown how these changes are
related to the primary ischemic lesion in space and time.
In this study, we prospectively measured changes of cortical thickness in
cortical areas connected to subcortical stroke lesions in fifteen patients with
upper extremity paresis combining white matter probabilistic tractography
and semi-automatic measurement of cortical thickness using Freesurfer
software. In addition, reference surfaces connected to a mirrored subcor-
tical region on the contralesional hemisphere were constructed.
Three months post-stroke, significant cortical thinning of 2.4% (median,
upper / lower boundary of 95% confidence interval 4.1% / 0.7%) was
detected in areas connected to ischemic lesions, whereas cortical thickness
in unconnected cortical surface areas remained largely unchanged. In
addition, regional increases of cortical thickness were observed in the
contralesional hemisphere surrounding the hand area on the precentral-
gyrus. There was no significant correlation of changes in cortical thickness
with clinical outcome parameters.
Our results demonstrate a specific impact of subcorticallesions on remote,
yet connected cortical areas explainable by secondary neuro-axonal
degeneration of distant areas. In addition, findings of increased cortical
thickness in functionally relevant cortical areas point towards mecha-
nisms of structural plasticity after stroke.
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Do multimodal CT scans change clinicians initial
decisions to thrombolyse acute stroke patients?
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Background: Time is brain and thrombolysis decisions in acute ischemic
stroke should be made without delay. Multimodal (MMCT) scans includ-
ing CT angiogram (CTA) and CT perfusion (CTP) are becoming increas-
ingly common to guide thrombolysis decision making, but image
acquisition and analysis may significantly and unnecessarily delay throm-
bolysis initiation.
Aim: To examine whether MMCT scans change the clinicians initial deci-
sion to thrombolyse acute stroke patients.
Methods: This prospective study examined clinicians initial thrombolysis
treatment decisions based on primary patient assessment and non-
contrast CT scans, and compared this to the final decision made following
MMCT scans.
Results: Ninety-two cases were examined. There was a high correlation
between the initial and final treatment decision (r = 0.77). Eight patients
(9%) had a treatment change recorded following the use of MMCT scans:
seven patients initially not for thrombolysis had a CTP deficit and received
alteplase, and one patient initially for treatment had a large core on CTP
and was subsequently not treated. NIHSS scores were significantly lower
in those patients with an initial decision not to treat (median NIHSS 2
(IQR = 4) vs. 10 (IQR = 11), p = 0.009). Of the twenty-nine thrombolysed
patients, twenty-eight had a discharge diagnosis of stroke.
Conclusions: Despite rapid door-to-decision times, clinicians initial
thrombolysis decisions correlate highly with the final decision made fol-
lowing MMCT scans. However, these advanced images may act to reassure
clinical decision making.
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High-resolution intracranial vessel wall MR imaging in
angiogram-negative subarachnoid hemorrhage: A pilot
study
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Introduction: In 10% of patients with an aneurysmal-type subarachnoid
hemorrhage (SAH), the cause of hemorrhage is not apparent. Our aim
was to determine feasibility and potential utility of high-resolution intrac-
ranial vessel wall MR imaging (VW-MRI) in these patients.
Methods: From 2012–2014, we performed VW-MRI in patients with a
spontaneous aneurysmal-type SAH and no identifiable cause on minimally
3 angiographies, including at least CT-angiography and 6-vessel catheter
angiography. We excluded patients with a perimesencephalic pattern. We
performed VW-MRI of the circle of Willis on a 3-Tesla system using T1-,
T2-, and gadolinium-enhanced T1-weighted two-dimensional black-
blood sequences in multiple planes (voxel size 2.0 × 0.4 × 0.4 mm). Two
neuroradiologists independently scored abnormalities of the arterial wall.
Results: Eleven patients (mean age 59 years) underwent VW-MRI. 8/11
patients had WFNS grade 1 SAH and 3/11 grade 2. One patient had a
2 mm focus of T1-hyperintensity (Fig. A) and T2-hypointensity (Fig. B)
contiguous with the outer margin of the basilar artery wall (*) which
disappeared at follow-up. Diagnostic possibilities were dissection, throm-
bosed or blood blister-like aneurysm, or conceivably extramural blood
from elsewhere. A similar abnormality was found in a second patient. Two
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patients had concentric wall enhancement of multiple arteries, possibly
secondary to SAH.
Conclusion: Our preliminary study suggests VW-MRI is feasible and
potentially useful in patients with an angiogram-negative SAH. Further
investigation is warranted.
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Objective: Cerebral white matter lesions (WMLs) are typically evaluated
from magnetic resonance images. There are, however, several computed
tomography (CT)-based rating scales. Since no consensus exists on supe-
riority of any of the CT rating scale, we aimed to compare their interclass
correlation.
Methods: We included 50 random patients out of 2485 consecutive pre-
thrombolysis CT scans treated at the Helsinki University Central Hospital.
WMLs were scored according to five previously published CT visual rating
scales: The Gorter, the van Swieten, the Blennow, and the Wahlund rating
scales. Single measure (SM) and average-measures (AM) interclass corre-
lation (ICC) for consistency in a two-way mixed model with fully crossed
design and eight raters were calculated for all used four visual rating scales
at different cutoffs.
Results:
SM ICC (CI) AM ICC (CI)
Any WMLs 0.67 (0.59–0.78) 0.95 (0.92–0.97)
Gorter WMLs 0.78 (0.70–0.85) 0.97 (0.95–0.98)
Gorter WMLs 2 0.80 (0.72–0.86) 0.96 (0.95–0.98)
van Swieten anterior 0.76 (0.68–0.84) 0.96 (0.94–0.98)
van Swieten posterior 0.77 (0.69–0.84) 0.96 (0.95–0.98)
van Swieten 0.82 (0.75–0.88) 0.97 (0.96–0.98)
van Swieten 3 or 4 0.75 (0.66–0.83) 0.95 (0.93–0.97)
Blennow extension 0.82 (0.75–0.88) 0.97 (0.96–0.98)
Blennow intension 0.76 (0.68–0.83) 0.96 (0.95–0.98)
Blennow 0.81 (0.74–0.87) 0.97 (0.96–0.98)
Blennow over 2 0.66 (0.56–0.76) 0.94 (0.91–0.96)
Wahlund sum 0.87 (0.82–0.92) 0.98 (0.97–0.99)
Wahlund any WMLs 0.69 (0.60–0.78) 0.95 (0.92–0.97)
Wahlund any site score >1 0.69 (0.60–0.78) 0.95 (0.92–0.97)
Interpretation: The inter-rater agreement for the visual rating scales of
WMLs ranged from substantial to perfect (0.66–0.87).
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Visual rating of white matter lesions and atrophy in
research studies: CT versus MRI
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Introduction: In research, MRI is the preferred modality for analysis of
structural age-related brain changes. However, feasibility and cost may
render this impractical in large clinical studies. Here, we compared CT
and MRI white matter hyperintensity (WMH) and atrophy ratings, and
also examined inter-rater reliabilities of CT measures.
Method: Two raters independently completed visual rating scales in
paired CT and MRI scans from a stroke trial (n = 70, median age 80).
WMHs were scored according to the Fazekas, van Swieten and the Age-
Related White Matter Changes (ARWMC) scales. Superficial and deep
atrophy were scored on a five-point validated scale. Inter-rater reliability
of CT measures was also assessed.
Results: Kappa statistics for intra-rater (CT-MRI) agreement indicated
moderate to substantial CT-MRI agreement for most WMH scales (0.55–
0.75). Relatively poor CT-MRI agreement in ARWMC scale basal ganglia
ratings (0.18 and 0.44) was due to differences in the interpretation of the
scale with regard to whether lesions were confluent and the presence of
clusters of enlarged perivascular spaces appearing as focal lesions on CT.
Atrophy scales also showed moderate to substantial CT-MRI agreement
(0.44–0.70). Inter-rater (CT only) reliability results were similar to intra-
rater scores with frontal and parieto-occipital ratings from the ARWMC
scale producing the best agreement (0.74 and 0.75, respectively). McNe-
mar’s tests showed some differences between raters reflecting systematic
higher rating by one rater compared to the other.
Discussion: Use of these scales to assess WMHs and atrophy for research
is feasible in CT. Periventricular WMH rating was more reliable than deep
lesion scoring.
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Comparison of CT and MRI for detection of old
infarcts
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Introduction: Old infarcts may indicate risk for stroke. The preferred
method for classifying these in research studies is on MRI. However, in
clinical cohorts, feasibility and cost may make this modality impractical.
Methods: We compared detection of old infarcts in paired CT and MRI
scans from a large stroke trial (n = 70, median age 80) using a scheme for
coding cortical and lacunar infarcts based on location and size. For
lacunar infarcts, cavitation and volume estimations were recorded.
Results: Cortical infarcts were correctly identified more frequently (48%)
than cavitated (33%) or non-cavitated lacunar infarcts (12%). Old
infarcts were missed on CT primarily because they fell below the size
criteria for inclusion (cortical 26%; cavitated lacunar 35%, non-cavitated
lacunar 31%). The average volume of lacunar infarcts coded only on MRI
was 107 mm3 while lacunar infarcts detected in both modalities were
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smaller when measured on CT than MRI (240 mm3 versus 314 mm3)
reflecting signal changes in the surrounding tissue visible on MRI but not
CT and making MRI lesions appear larger. Some small cortical lesions
were apparent as signal changes on MRI without structural changes and
were therefore not visible on CT. Some lacunar lesions were detected but
attributed to different locations. Non-cavitated lacunar lesions in particu-
lar were confused with white matter hyperintensities, enlarged periven-
tricular spaces or acute lesions.
Discussion: Detection of larger cortical infarcts and cavitated lacunar
lesions on CT was good and would be expected to be better in cohorts
without acute lesions. Classification of small and non-cavitated lesions
was not reliable.
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Linear measurements on CT as an alternative to visual
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Introduction: Quantitative methods may be preferable to subjective
atrophy rating scales in clinical research. We aimed to validate linear
measurements in CT and to examine correlations between those and
qualitative atrophy ratings.
Methods: Anonymized scans from a large stroke trial (n = 103) were ana-
lyzed using a DICOM reader. Superficial and deep atrophy were scored
separately on a 5-point validated scale. Linear measurements were made
blind to atrophy ratings and included right-to-left and anterior-to-
posterior intracranial dimensions (for ratios), maximal frontal horn, third
ventricle and frontal subarachnoid dimensions, minimal intercaudate and
lateral ventricular body dimensions and the sums of the widths of the
central sulci and Sylvian fissures.
Results: Most linear measures were very highly correlated when repeated
within CT (Spearman’s rho’s 0.72–0.98, p < 0.001). The maximal frontal
subarachnoid dimension was unreliable (Spearman’s rho = 0.37, ns);
better defined methodology may improve the reliability of this measure-
ment. All ratios were significantly correlated with atrophy ratings (Spear-
man’s rho = 0.34–0.76; all p < 0.01) with the exception of the frontal
subarachnoid ratio with deep atrophy scores (Spearman’s rho = 0.15, ns).
Generally, linear measures relating to ventricular size correlated higher
with deep atrophy ratings and measurements of sulcal width correlated
better with superficial atrophy ratings (e.g. for central sulci ratio: Spear-
man’s rho = 0.76 with superficial atrophy and 0.34 with deep atrophy).
Discussion: Linear measurements correlate highly with regionally specific
visual ratings, and show high intra-rater reliabilities. Such measurements
can therefore be reliably used for the assessment of deep and superficial
atrophy in CT scans.
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Sample size estimates for modifiers of white matter
hyperintensities in ageing and stroke
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Introduction: White matter hyperintensities (WMH) are common and
are associated with increased risk of stroke. Sample size estimates are
required for clinical trials in ageing and stroke that use WMH progression
as an intermediary outcome.
Methods: 459 community-dwelling subjects from the Lothian Birth
Cohort 1936 had baseline brain magnetic resonance imaging (MRI) at
mean age 72.7 ± 0.7 years and follow-up at 76.4 ± 0.6 years. 197 patients
had brain MRI at presentation with stroke (mean age 66.9 ± 11.8 years)
and at follow-up (mean age 67.0 ± 11.1 years). All subjects gave approved
written-informed consent and were scanned on the same scanner. WMH
volumes were measured using a validated multispectral segmentation
method, masking out index stroke lesions. Sample sizes were calculated
(alpha 0.05, power 0.9) to detect a 20% reduction in WMH progression.
Results: Mean WMH volume increased from 11.92 ± 11.70 ml to
15.92 ± 14.62 ml over three years in the community-dwelling subjects
(mean change 4.00 ± 4.32 ml), and from 21.96 ± 24.84 ml to
23.23 ± 23.28 ml over one year in stroke patients (mean change
1.27 ± 8.46 ml). The sample size per arm to detect a 20% reduction in
WMH progression was 293 for community-dwelling subjects (over 3
years) and 23420 for stroke patients (over 1 year). The large sample size for
stroke patients reflected the wide variance in WMH progression.
Discussion: Variability in WMH in stroke patients versus community-
dwelling older subjects may limit their use as an intermediary end point to
reduce sample sizes for clinical trials. High power may be achieved in
clinical trials of modifiers of WMH progression in ageing with relatively
modest sample sizes.
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The role of microvascular dysfunction in CADASIL
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3University of Glasgow, Institute of Health and Wellbeing,
Glasgow, United Kingdom
Objectives: Cerebral autosomal dominant arteriopathy with subcortical
infarctions and leucoencephalopathy (CADASIL) is associated with
microvascular dysfunction. We hypothesized that physiological shunting
of oxygenated blood caused by capillary flow disturbances might result in
tissue hypoxia in CADASIL patients. We used MRI to compare microvas-
cular perfusion in healthy controls and CADASIL patients.
Methods: Dynamic susceptibility contrast MRI was acquired in 15
CADASIL patients and 22 healthy controls. Subject-wise whole-brain per-
fusion characteristics were derived to evaluate microvascular flow. Capil-
lary transit time heterogeneity (CTH) was introduced as the standard
deviation of intra-voxel transit times, and the coefficient of variance
(COV) as the ratio between CTH and the mean transit time. Clinical
characteristics were obtained in CADASIL patients.
Results: Mean CTH was higher in CADASIL patients vs controls (5.0 vs
3.2, p < 0.001). As COV values were distinctly right-skewed only in
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CADASIL patients, the 95th percentile was selected as a possible bio-
marker of capillary dysfunction. Combined, CTH and COV were highly
predictive of CADASIL (Fig.). Within CADASIL patients, CTHmean was
correlated with high age, number of lacunar infarcts, and increased pro-
cessing speed.
Conclusions: We observed evidence of disturbed microvascular flow pat-
terns in CADASIL patients. Additionally, perfusion markers correlated
with disease severity and clearly discriminated CADASIL patients and
controls. We propose that microvascular dysfunction leads to hypoxia,
tissue damage, and ultimately disabling cognitive impairment in these
patients.
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Effect of thin-section diffusion-weighted imaging on
the detection of acute ischemic lesion in transient
ischemic attack patients
J Fujinami1, T Ohara1, J Matsuura2, A Fujii2, Y Tomii3,
M Nakagawa4, T Mizuno1
1Neurology, Kyoto Prefectural University of Medicine, Kyoto,
Japan
2Neurology, Saiseikai Shiga Hospital, Ritto, Japan
3Neurology, Kyoto Katsura Hospital, Katsura, Japan
4Neurology, North Medical Center Kyoto Prefectural
University of Medicine, Yosano, Japan
Background and purpose: Diffusion-weighted image (DWI) thin-section
method was reported to be more sensitive to small acute ischemic lesions
in stroke patients than conventional method. Thin-section method may
increase DWI positive rate in TIA and affect the diagnosis of tissue-based
TIA. We examined the influence of thin-section method on DWI positiv-
ity in time-based TIA patients.
Methods: We retrospectively enrolled consecutive 110 TIA patients (61
men, mean age 74 years) hospitalized to university hospital of Kyoto
prefectural university of medicine (K group) and Saiseikai Shiga hospital
(S group) within 7 days of onset, from 2010 to 2014. TIA was defined as
focal neurologic symptoms ascribable to a vascular etiology lasting less
than 24 hours. Thin-section method (3 mm section thickness, 0 mm
intersection gaps) was performed in K group, and conventional method
(5 mm thickness, 1 mm gaps) was performed in S group.
Results: DWI positive rate of all patients was 28.2%, and it was signifi-
cantly higher in K group (41.0% vs 21.1%, p = 0.028). Smoking habits,
NIHSS at admission, and onset to MRI time also showed the significant
difference between two groups. After adjustment for age, sex, and these
factors, multivariable analysis showed that thin-section method was inde-
pendently associated with DWI positivity (OR: 3.24; 95% CI: 1.26–8.56).
Of the DWI positive 16 cases in thin-section method, six cases exhibited
small ischemic lesions (<5 mm diameter).
Conclusions: Thin-section method increased DWI positive rate in time-
based TIA patients. When using the diagnostic criteria for tissue-based
TIA, the diagnosis may be affected by imaging methods of DWI.
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Bilateral carotid artery dissection following an
exercise boot camp: The role of CT for detection
L Grunsell1, I Kane1, N Gainsborough1
1Stroke Medicine, Birghton & Sussex Universities Hospital NHS
Trust, Brighton, United Kingdom
It is well understood that early detection and treatment of stroke reduces
the associated morbidity and mortality. The etiology of stroke caused by
carotid artery dissection can be explained by several mechanisms, occlu-
sion of the true lumen by thrombus or the expanding vessel itself causes
distal hypo-perfusion. Most commonly, embolism from thrombus within
the lumen can cause infarction; therefore early detection of carotid artery
dissection is imperative for successful early treatment or intervention.
We present a 43 year old gentleman, who came to the emergency depart-
ment with headache, paresthesia of both the left arm and face, accompa-
nying a left-sided Horner’s syndrome. The day before he had attended an
exercise boot camp, undertaking extreme physical activity which was
unusual for him. The left-sided dissection was confirmed with MRA
imaging after initial CT scanning revealed no abnormality, treatment with
300 mg of aspirin was started. The bilateral dissection was discovered two
weeks later on further MRI imaging. Retrospective analysis of the CT head
revealed a clear image of the bilateral carotid artery dissections.
This case, which provides us with typical symptoms and signs of carotid
artery dissection, emphasizes the importance of CT scanning. We have
learnt that thorough review of CT images can lead to early diagnosis and
encourage swift progression to further imaging and treatment. This case
highlights the value of analyzing both carotid arteries routinely even if the
clinical symptoms do not suggest bilateral pathology.
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CT or MRI in evaluation for I.V. thrombolysis:
A single-center quasi randomized trial
C K Hansen1, A Christensen2, I Havsteen2, H Christensen1
1Department of Neurology, Bispebjerg University Hospital,
Copenhagen K, Denmark
2Department of Radiology, Bispebjerg University Hospital,
Copenhagen K, Denmark
Background: The issue if Computer Tomography (CT) or Magnetic Reso-
nance Imaging (MRI) is the ‘best’ primary image modality in evaluation of
patients with symptoms of acute stroke has been discussed by stroke
scientists for more than a decade. Access to primary acute MRI evaluation
is frequently regarded as a token of high treatment quality; nevertheless,
few centers worldwide are really primarily MRI based. MRI is superior in
detecting acute ischemia and CT is faster and has no contraindications. As
the efficacy of thrombolysis decreases with time to treatment one must ask
if use of MRI is only of academic interest.
Aim: The aim of this ongoing study is to determine if choice of primary
imaging modality (CT versus MRI) affects efficacy and safety of i.v
thrombolysis.
Method: An open quasi-randomized design, where imaging allocation is
based on the date of admission. The 3 following items will be compared:
Safety; Exclusion of other causes of symptoms than acute cerebral isch-
emia and contraindications to scanning method. Effect; Delay to treat-
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ment, acquisition of imaging in diagnostic quality and identification of
stroke mechanism. Applicability; Patient experience, experience of deci-
sion support for treating physician, deviation from radiological Standard
Operational Plan (SOP) and use of resources.
Inclusion and exclusion criteria: Clinical suspicion of stroke <4.5 hours,
NIHSS ≥ 1, admission in the daytime and informed consent by patient or
proxy.
Time schedule: The project was initiated in December 2013 and is
expected to comprise 600 patients. By December 2014 298 patients had so
far been evaluated.
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Assessment of collateral blood flow with 4-dimension
3t-MR imaging in acute stroke patients
M Hernandez-Perez1, J Puig2, G Blasco2, N Pérez de la Ossa3,
L Dorado3, A Dávalos3, J Munuera4
1Neurosciencies, Health Sciences Research Institute of the
“Germans Trias i Pujol” Foundation (IG), Badalona, Spain
2Radiology, IDIBGI Diagnostic Imaging Institute Dr Josep
Trueta University Hospital, Girona, Spain
3Neurosciences, Stroke Unit Germans Trias i Pujol Hospital,
Badalona, Spain
4MR, Diagnostic Imaging Institute (IDI), Badalona, Spain
Purpose: Four-dimensional MR angiography (4D-MRA) is a time-
resolved sequence that enables the hemodynamic study of cerebral blood
vessels. We evaluated the ability of 4D-MRA to determine the grade of
occlusion and collateral blood flow in acute ischemic stroke patients.
Methods: 21 consecutive patients (mean age, 63; mean NIHSS, 17) under-
went 3T-MR within 12 h of anterior arterial occlusion defined as TIMI
0–1 on TOF-MRA. Two independent readers evaluated grade of occlusion
(mTICI) and arterial collateral grade (ACG) on 4D-MRA. Collateral
status was dichotomized into incomplete (ACG 0–2) or complete (ACG
3–4) filling. We measured DWI and PWI (Tmax > 6 s) lesion volumes and
calculated the collateral circulation deficit index: TMax > 2 s volume x
(TMax > 6 s volume/volume of tissue with TMax > 2 s and TMax < 6 s).
Results: Inter-reader agreement for mTICI and ACG was k = 1 and
k = 0.93. Site of occlusion according to 4D-MRA was M1 in 14 patients,
tandem ICA-M1 in 2, tandem ICA-terminal ICA in 2, and isolated
extracranial ICA in 3. TOF-MRA was unable to detect 3 of 4 tandem
occlusions. Despite all patients had TIMI 0–1 on TOF-MRA, 4D-MRA
showed mTICI 2a in 2, and mTICI 2b in 1. Complete collateral filling,
observed in 9 patients (42.9%), was associated with smaller DWI lesion
volume (p = 0.012), smaller hypoperfused brain volume (p = 0.028), and
less collateral circulation deficit (p = 0.009).
Conclusion: 4D-MRA seems more sensitive detecting tandem occlusions
and determining grade of occlusion than TOF-MRA. This technique is a
fast, direct, feasible, noninvasive, reliable way to assess collateral circula-
tion. It provides profound insights into hemodynamic alterations in acute
stroke.
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Characteristics of transient ischemic attack patients
with positive lesions on diffusion-weighted imaging:
Promise-TIA registry
T Ishihara1, T Uehara1, T Ohara1, M Hayakawa1, S Sato1,
R Suzuki1, K Toyoda1, K Minematsu1
1Department of Cerebrovascular Medicine, National Cerebral
and Cardiovascular Center, Suita Osaka, Japan
Background: The purpose of this study was to clarify factors associated
with the presence of acute ischemic lesions on diffusion-weighted imaging
(DWI) in transient ischemic attack (TIA) patients, using data of a multi-
center prospective TIA registry.
Methods: Subjects of this registry were TIA patients within 7 days of onset
between June 2011 and December 2013 from a prospective register in 57
hospitals. A total of 1414 patients were consecutively enrolled. Of these,
103 patients were excluded as a result of either final diagnoses of diseases
other than TIA (n = 42), incomplete data (n = 19), or no magnetic reso-
nance imaging (MRI) examination (n = 42). We analyzed the associations
of DWI lesions with baseline characteristics.
Results: We studied 1311 patients with TIA (848 men, mean age of
69.3 ± 12.3 years). DWI lesions were found in 429 patients (32.7%), and
divided into single lesion (286 patients, 21.8%) or multiple lesions (143
patients, 10.9%). Multivariate analyses revealed that lower body mass
index (BMI), atrial fibrillation (AF), hemiparesis, speech disturbance,
symptom duration ≥10 minutes, intracranial arterial stenosis were asso-
ciated with patients having DWI lesions. When considered single and
multiple DWI lesion separately, AF, speech disturbance, symptom dura-
tion ≥10 minutes, higher diastolic blood pressure were associated with
patients having single DWI lesion. Lower BMI, history of myocardial
infarction, AF, smoking, alcohol, hemiparesis, MRI examination over 24
hours from onset, and intracranial arterial stenosis were associated with
patients having multiple DWI lesions.
Conclusion: We identified some differences in relating factors between
TIA patients with single and multiple DWI lesions.
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Emissary vein thrombosis-clinical and neuroimagistic
features
D C Jianu1, S N Jianu2, L Petrica3, S M Deme4, M Serpe1, F Dan1,
C Falup Pecurariu5, D F Muresanu6
1Department of Neurology, University of Medicine and
Pharmacy “Victor Babes,” Timisoara, Romania
2Department of Ophthalmology, Military Emergency Hospital,
Timisoara, Romania
3Department of Internal Medicine-Nephrology, University of
Medicine and Pharmacy “Victor Babes,” Timisoara, Romania
4Department of Neurology, West University “Vasile Goldis,”
Arad, Romania
5Department of Neurology, University of Brasov, Brasov,
Romania
6Department of Neurology, University of Medicine and
Pharmacy “Iuliu Hateganu,” Cluj-Napoca, Romania
Introduction: Emissary veins are remains of fetal life, which are rarely
accounted in adulthood, causing non-specific clinical manifestations.
Purpose: To assess the clinical features and neuroimaging data in patients
with an emissary vein thrombosis.
Patients andmethods: Cerebral venous and sinus thrombosis were defined
in five patients according to the EFNS Guidelines (2011); the diagnosis
was confirmed on the basis of history, neurological evaluation, cerebral
CT scan/CT-Angiography (Aura Philips spiral single slice), MRI/MR-
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Angiography (Signa Horizont Lx 1.0T), and laboratory data. They were
examined at admission and after three months, using the mRS scores.
Results: Clinical aspects were represented by recent headache due to
intracranial hypertension, associated with a peculiar sensibility of the
temporo-mandibular joint. Laboratory findings consisted in signs of non-
specific inflammation, without thrombophilia. CT and MRI detected an
exterior convex channel situated at the level of the premeatic squamae,
which ended at the superior part of the temporo-mandibular joint. We
used mannitol and steroids (for reducing the intracranial pressure), and
antithrombotic therapy (low molecular weight heparin), with a favorable
outcome (mRS score = 0, at 90 days) for all five patients.
Conclusions: The prompt diagnosis of emissary veins thrombosis is essen-
tial, because the early initialization of an efficient therapy has a great
impact on the evolution of this disease.
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Focal grey matter atrophy after subcortical infarct of
pyramidal tract: A longitudinal study of 21 patients
M Lafuma1, N Chauveau2, J F Albucher1, N Raposo1, J M Olivot1,
I Loubinoux2, M Planton2, F Chollet1
1Purpan, PPR stroke center, Toulouse, France
2Purpan, INSERM 825, Toulouse, France
Introduction: Subcortical infarcts are associated with cortical atrophy
which mechanism remains unknown. This remote consequence on gray
matter may be explained by two phenomena. First by a retrograde degen-
eration of injured neurons, and secondly by a coexistence of microcortical
lesions occurring in parallel of subcortical ones.
In order to highlight a retrograde degeneration of motor pathway after its
injury and determine its onset time, we longitudinally studied grey matter
volume after subcortical stroke of the pyramidal tract.
Method: Consecutive patients with subcortical infarct of pyramidal tract
and NIHSS ≥ 2 were recruited from the Purpan’s stroke center (Toulouse,
France). They underwent clinical examination and MRI right after stroke
and three months (M3) later. Our primary aim was to find focal atrophy
of ipsilesional (i) primary motor cortex (M1) at M3. We used voxel-based
morphometry (VBM) to determine grey matter density.
Results: 21 subjects were included. At 3 months, there was no significant
atrophy of M1 (FWE, p ≤ 0,05, k ≥ 100) but there was significant atrophy
of Caudate and Thalamus (i).
There also was significant hypertrophy of Premotor and Insular cortices
(i), Cingular anterior and Cingular middle cortices (i and c), and Precu-
neus (i and c).
Discussion: Our study highlights remote consequences induced by sub-
cortical infarct of pyramidal tract, in regions directly related to it such as
Premotor cortex and in associative cortices such as Cingular and Insular.
These cortical hypertrophy may be a compensatory mechanism. We
couldn’t confirm precocious retrograde degeneration of pyramidal tract.
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Fluid-attenuated inversion recovery (FLAIR) signal
intensity as a proxy for lesion age in acute stroke
J Legge1, A Graham1, D Copeland1, R Lee1, R Zand1
1Neurology, University of Tennessee Health Science Center,
Memphis, USA
Background: In many centers, patients with wake-up stroke or unknown
time of onset stroke are excluded from thrombolytic treatment. However,
current studies indicate that some magnetic resonance (MR) sequences
can help predict time from symptom onset. Our goal was to assess the
value of FLAIR signal intensity ratio (SIR) as a surrogate for stroke time of
onset.
Materials and methods: We studied 95 acute stroke patients with known
time of onset who underwent MR imaging within 48 hours of symptom
onset. The SIR was calculated as the value of the FLAIR signal intensity of
the visible lesion or the identified area of infarction corresponding to the
diffusion weighted images divided by the FLAIR signal intensity in the
homologous contralateral side of the brain.
Results: Fifty-seven patients (60%) had MRI within 4.5 hours of stroke
onset. We found a positive correlation between FLAIR SIR and time from
symptom onset (Pearson correlation coefficient, 0.34). The FLAIR SIR
showed a negative correlation with the NIH Stroke Scale (NIHSS) when
controlling for stroke duration. Receiver operating characteristic curves
indicated that FLAIR SIR ≤ 1.11 could identify patients within 4.5 hours
of symptom onset with 76% sensitivity (95%, CI: 62–86%) and 67%
specificity (95%, CI: 52–79%). Visualization of FLAIR hyperintensity can
predict the lesion outside of 4.5-hour treatment window with a sensitivity
of 84% (95%, CI: 66–94%).
Conclusion: Qualitative and quantitative assessment of FLAIR sequence
can be used as a proxy for lesion age among patients with wake-up stroke
or unknown time of onset stroke.
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Features of symptomatic intracranial stenosis
correlated with functional outcome of affected
patients at 1 year: Clinical application of the
computational fluid dynamics modeling technique
X Leng1, F Scalzo2, H L Ip1, Y O Y Soo1, T W H Leung1, L Liu3,
D S Liebeskind4, K S Wong1
1Medicine & Therapeutics, The Chinese University of Hong
Kong, Hong Kong, China
2Neurology & Computer Science, University of California Los
Angeles, Los Angeles, USA
3Neurology, Beijing Tiantan Hospital Capital Medical
University, Beijing, China
4Stroke Center Neurology, University of California Los
Angeles, Los Angeles, USA
Background: We aimed to investigate the correlations between features of
symptomatic intracranial atherosclerotic stenosis (ICAS) and functional
outcome of affected stroke patients, using routine CT angiography (CTA)
and computational fluid dynamics (CFD) modeling technique.
Methods: Ischemic stroke patients with symptomatic ICAS of 50–99%
luminal stenosis, revealed by CTA performed within 1 month of ictus,
were recruited. CFD models of the index ICAS lesions were built based on
CTA source images. Anatomic and hemodynamic features of the index
ICAS lesions were respectively evaluated on CTA and CFD models. The
correlations between these features of the ICAS lesions and improved
functional outcome at 1 year, defined as reduced modified Rankin Scale
(mRS) at 1 year compared as that at baseline, were assessed.
Results: In total, 32 patients were recruited (median age 65; male 59.4%),
with 6 (18.8%) having improved functional outcome at 1 year, and 26
(81.2%) having stable or worse functional outcome at 1 year. In univariate
analysis, the index ICAS lesions in patients with improved functional
outcome at 1 year had less severe luminal stenosis on CTA (median: 53%
versus 70%; P = 0.014), and less severe pressure drop across the lesions as
measured on the CFD models (median distal to proximal pressure ratio:
0.8 versus 0.4; P = 0.029).
Conclusions: Not only the anatomic but also the hemodynamic features of
symptomatic ICAS lesions might be correlated with the functional
outcome of affected stroke patients at 1 year. Future studies are needed
to further validate these findings, and to uncover the underlying
mechanisms.
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How often does multimodality imaging change the
diagnosis in patients presenting with stroke like
symptoms?
C McInnes1, L Shennan1
1Department of Stroke and Elderly Care, Monklands Hospital,
Airdrie, United Kingdom
Introduction: Stroke is common, however 1/3 of patients presenting with
stroke-like symptoms have stroke mimics. Use of multimodality imaging
in assessing stroke patients is increasing. Both non-contrast computed
tomography (NCCT) and magnetic resonance imaging (MRI) have roles.
Patients who have an uncertain clinical diagnosis and a non-diagnostic
NCCT often require further imaging with MRI. We sought to determine
how often diagnosis/management of patients was changed when they had
multimodality imaging to investigate stroke-like symptoms.
Methods: We retrospectively evaluated inpatients from within the Acute
Stroke Unit at Monklands Hospital, Lanarkshire, who had dual imaging
performed and who had a clinical suspicion of acute stroke over a 6 month
period in 2014. Information was gathered from clinical letters, electronic
records and radiology reporting systems.
Results: Mean age was 56.6, 62% were female. 25 inpatients had both
NCCT and MRI. Of these, 18 (72%) had NCCT which did not show acute
ischemic stroke. The remainder (7) had NCCT findings of alternative
pathology. Of these 18 patients with non-diagnostic NCCT , 12 (67%) had
normal MR imaging, and stroke was ruled out as a diagnosis, 5 had a
stroke diagnosis confirmed (28%), and 2 had alternative pathology found
on MR. 78% of patients had their diagnoses and treatment changed
following multimodality imaging.
Conclusion: MR in addition to NCCT in patients with stroke like presen-
tation changes clinical diagnosis in three quarters of patients. This has
implications for cost, quality of life and avoidance of unnecessary
investigations.
ESOC-0377
19. Imaging
Biased visualization of hypoperfused tissue by
computed tomography due to short imaging duration:
Improved classification by vascular models
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5Stroke Unit, Cambridge University Hospitals Addenbrooke,
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Objectives: Lesion detection in acute stroke by computed-tomography
perfusion (CTP) can be impaired by incomplete bolus coverage in veins
and hypoperfused tissue, so-called bolus truncation (BT)1, see Fig. 1. We
examined the BT-frequency and hypothesize that a vascular model (VM)
for perfusion calculation improves classification of normo- and hypoper-
fused tissue under bolus truncation.
Fig. 1 Contrast concentration-time-curves (CTC) in vessels and hypoper-
fused tissue. Imaging may have ended before CTCs reach the down-slope
point.
Methods: CTP datasets from 40 acute stroke patients were retrospectively
analyzed for BT. In 16 patients with hypoperfused tissue but no BT,
reduced scan duration was simulated, and the minimum scan-duration, at
which the estimated lesion volumes came within 10% of their true
volume, was compared for VM2 and state-of-the-art perfusion
algorithms.3–4
Results: BT in veins and hypoperfused tissue were observed in 9/40
(22.5%) and 17/40 patients (42.5%), respectively.
VM reduced minimum scan-duration, providing reliable maps of cerebral
blood-flow and mean transit-time, by 5 s (p = 0.03) and 7 s (p < 0.0001),
respectively. See Fig. 2
Fig. 2 The estimated lesion volume depends in imaging duration. Here
mean transit-time (MTT) for VM and two state-of-the-art algorithms. VM
detects lesions at shorter scan duration than SVD methods.
Conclusions: BT is not uncommon in stroke CTP with 40 s scan duration.
Using VM improves tissue classification under BT.
Referens
1 Copen et al (2011) Neuroimaging Clin N Am 21:259–83
2 Mouridsen et al (2006) Neuroimage 33:570–79
3 Wu et al (2003) MRM 50:164–74
4 Ostergaard et al (1996) MRM 36:715–25
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CT perfusion imaging in wake-up stroke
N Morelli1, E Rota1, P Immovilli1, M Giorgi Pierfranceschi2,
A Magnacavallo3, E Michieletti4, D Guidetti5
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Italy
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Background and purpose: Wake-up stroke (WUS) patients are typically
excluded from reperfusion treatment, as the time of symptom onset is
unknown. The purpose of this study is to evaluate the efficacy and safety
of intravenous thrombolysis with rt-PA in patients with WUS eligible for
therapy using computed tomography perfusion criteria (CTP), in com-
parison with patients treated with rt-PA within 4.5 h of symptom onset
(non-WUS).
Methods: This is an experimental, open label trial, controlled against the
best therapy currently in use. Primary endpoints were functional indepen-
dence after 3-months (mRS ≤ 1) for efficacy and symptomatic intracere-
bral hemorrhage (SICH) for safety. Secondary endpoints were no or only
mild disability after 3-months (mRS ≤ 2) for efficacy, total intracerebral
hemorrhage (TICH) and contrast-induced-nephropathy (CIN) for safety.
Results: 170 patients were treated, 143 non-WUS patients and 27 patients
with WUS. Strokes of cardioembolic origin were most common in WUS
patients (p < 0.001). Primary endpoints: mRS ≤ 1 was found in 35.8%
(non-WUS: 36.2% vs WUS 34.2%; p = 0.62) and SICH was observed in
3.4% of non-WUS patients and in no WUS patients (p = 0.32). Secondary
endpoints: mRS ≤ 2 was observed in 66.4% of patients (non-WUS: 67.8%
vs WUS 65.5%; p = 0.67,), TICH in 13.5% of patients (13.9% non-WUS
vs 11.1% WUS – p = 0.69). CIN was documented in 3.7% of WUS
patients.
Conclusion: rt-PA treatment carried out in WUS patients selected on the
basis of CTP data demonstrated comparable safety and efficacy with
respect to non-WUS patients. The study supports the hypothesis that a
selected group of WUS patients may be suitable for thrombolysis.
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Clinical application of arterial spine labeling MR
imaging
D Park1
1Radiology, Hanyang University Guri Hospital, Guri, Korea
Purpose: Arterial spine labeling (ASL) MR imaging sequence enables
cerebral blood flow (CBF) evaluation with magnetically labeled blood
water. The purpose of this study is to present the clinical application of
ASL MRI.
Methods: ASL MRI using a pseudocontinuous ASL pulse sequence con-
ducted for suspected ischemic stroke. We categorized ASL abnormalities
into decreased, increased, and mixed CBF disorders and demonstrated the
specific examples in addition to ASL artifacts.
Results: ASL abnormalities due to decreased CBF include stroke,
vasospasm, hydrocephalus, and neurodegeration, but those due to
increased CBF include hypercapnea, vascular shunts, and aggressive
tumors. Mixed CBF disorders include seizure and migraine.
ASL using magnetically labeled arterial blood protons enables initial and
follow-up evaluation of tumors. Vascular artifacts in acute ischemic stroke
due to long transit time, facilitate the detection of arterial occlusion. ASL
could detect vascular shunt lesions because of venous signals with short
transit time. Localized hyperperfusion is seen in the occipital region by
visual activation, and in the internal frontal region, residual vascular
signal. Localized hypoperfusion from the frontal and occipital horns to
the frontal and parieto-occipital cortex, corresponds to arterial border-
zones. Susceptibility artifacts may be seen at skull base, hematomas, cal-
cifications and metals. Hemispheric perfusion defect could be developed
due to saturation failure from carotid stent. Movement artifacts may
produce strips at the periphery of the brain.
Conclusions: In conclusion, ASL MRI could provide a specific diagnosis
or functional information critical to patient. Clinical application of ASL
MRI in brain imaging is presented with specific examples.
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Hyperintense vessel signal on arterial spin labeling MR
image in acute ischemic stroke, comparing with
susceptibility vessel sign on susceptibility weighted
image
D Park1
1Radiology, Hanyang University Guri Hospital, Guri, Korea
Purpose: Susceptibility vessel sign by the susceptibility effect of intravas-
cular clot on susceptibility weighted image (SWI) depends on the clot
composition, which is significantly more common in RBC dominant and
mixed clots than fibrin-dominant clots. Meanwhile, the hyperintense
vessel signal on arterial spin labeling (ASL) depends on the delayed arte-
rial transit time of magnetically labeled blood water. The purpose of this
study is to evaluate the hyperintense vessel signal on ASL in acute ischemic
stroke, comparing with susceptibility vessel sign on SWI.
Methods: All images of patients who performed MRI for suspected acute
ischemic stroke were analyzed with the respect to followings: hyperintense
vessel signal on ASL, susceptibility vessel sign on SWI, arterial occlusion
on time-of-flight MR angiography, and diffusion restricted area on diffu-
sion weighted image.
Results: Hyperintense vessel signal on ASL was significantly more identi-
fied in groups with arterial occlusion and territorial-pattern diffusion
restricted area than in groups without arterial occlusion and cortical-
pattern small diffusion restricted area (79% [22/28] versus 31% [16/51],
64% [30/47] versus 38% [21/55], respectively; P < 0.05). Hyperintense
vessel signal on ASL had a significantly higher sensitivity for the detection
of occlusion than the susceptibility vessel sign (79% [22 of 28] versus 57%
[16 of 28], P < 0.05).
Conclusions: Hyperintense vessel signal on ASL could identify arterial
occlusion and acute territorial-pattern infarct in patients with acute isch-
emic stroke, which may be associated with stagnant flow at occlusion sites.
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High resolution molecular magnetic resonance imaging
of the endothelial adhesion molecule, P-selectin for
the diagnosis of transient ischemic attack
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Transient ischemic attack (TIA) is a transient episode of neurologic dys-
function due to brain ischemia without infarction on imaging. TIA is a
risk factor for ischemic stroke. Thus, failure to diagnose TIA is a wasted
opportunity to prevent permanent disability. Unfortunately, diagnosing
TIA remains challenging.
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We first developed an original model of TIA in mice displaying all the
features of TIA in humans, as measured by laser doppler, somatosensory
evoked potentials and 7T MRI.
Then, an analysis of endothelial adhesion molecules identified P-selectin
as a putative biomarker for TIA. However, ELISA assays for plasmatic
P-selectin proved to be not sensitive enough to diagnose TIA in both mice
and humans. By contrast, molecular MRI with antibody-based particles of
iron oxide targeting P-Selectin appeared as an excellent and highly sensi-
tive tool to diagnose TIA (Fig.), and even discriminate this disease from
ischemic stroke and stroke mimics in experimental models. High resolu-
tion molecular magnetic imaging is thus a powerful technic to diagnose
discrete pathogenic events during diagnostically challenged brain diseases
like TIA.
Fig. High-resolution molecular imaging of P-selectin identifies sequelae
inflammatory areas after TIA, while regular MRI evidences no brain lesion
Representative images of brain infarction (T2 images), and molecular
imaging of P-selectin 24 hours post-surgery in mice and corresponding
quantifications (n = 5 mice per group; Mann-Whitney’s U-test, * p < 0.05
versus sham).
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Hyperacute prediction of stroke outcome using
diffusion tensor imaging
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S Crozier1, D Dormont3, Y Samson1
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Background: Fractional anisotropy (FA) is known to be an effective
marker of motor prediction at the sub-acute and chronic stage of stroke,
yet proves to be less efficient at early time points. The present study aims
to determine which diffusion metric is the best marker by assessing isch-
emic damage in different levels of the corticospinal tract (CST) with DTI
at 24 h post-stroke.
Methods and materials: 28 thrombolysed patients underwent DTI at 24
hours post-stroke onset. Ipsilesional and contralesional FA, mean (MD),
axial (AD), and radial diffusivities were calculated in regions of interest
(ROIs) of the corticospinal tract: (1) The white matter of the precentral
gyrus (M1), (2) the corona radiata (CR), (3) the posterior limb of the
internal capsule (PLIC), and (4) the cerebral peduncles. NIHSS scores
were acquired at the time of scanning (day one) and at day 7 as well as
modified Rankin Scores (mRS) at 3 months.
Results: Significant differences were found in FA, MD and AD of the
PLIC, CR, and M1. The ratio of axial diffusivity (rAD) correlated strongly
with motor items of the NIHSS at day 7, as well as with the mRS. A
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Receiver-Operator Curve analysis yielded an accurate model for the rAD
of the corona radiata to predict “good” and “poor” outcome based on
upper limb NIHSS motor scores and mRS scores. FA values were not
correlated with clinical outcome.
Conclusion: Axial diffusivity from clinical DTI at 24 h post-stroke is the
most appropriate diffusion metric for quantifying stroke damage related
to outcome.
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B-mode ultrasonography of carotid artery plaque can
be used to select patients eligible for carotid
magnetic resonance imaging
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Objective: To explore whether carotid artery ultrasonography can select
patients eligible for carotid artery MRI.
Methods: B-mode ultrasonography and 3T-MRI of the carotid plaque
were performed in patients with recent TIA/stroke and 30–99% ipsilateral
carotid stenosis. Ultrasonography assessed plaque morphology using the
normalized grey-scale median (GSM, ranging from 0 (echolucent) to 255
(echointense)). MRI evaluated vulnerable plaque components (i.e. lipid-
rich necrotic core (LRNC), intraplaque hemorrhage (IPH) and presence
of a thin/ruptured fibrous cap (TRFC)).1 Median GSM (interquartile
range) was compared for different plaque components using the Mann-
Whitney-test. Since IPH and TRFC can only be scored if LRNC is present,
the ROC-curve was drawn to determine area-under-curve (AUC) for
GSM to distinguish between plaques with and without LRNC.
Results: We included 55 patients (67 ± 8 year, 41 males). Median GSM was
significantly smaller in plaques with LRNC versus without LRNC (31
(19–51) vs. 63 (43–78), p = 0.017). Median GSM was also smaller in
plaques with TRFC versus a thick fibrous cap (29 (19–46) vs. 58 (28–70),
p = 0.045), but it failed to discriminate plaques with and without IPH (32
(19–61) vs. 42 (21–66), p = 0.437).
AUC for detecting stable plaques with LRNCC was 0.74 (95% CI 0.59–
0.89, p = 0.007). A GSM cut-off of ≤40 to refer patients for subsequent
MRI results in a sensitivity and specificity of 80% and 65%, respectively.
Conclusion: Carotid ultrasonography can identify patients with LRNC
plaques with good sensitivity and reasonable specificity, which require
subsequent carotid MRI to identify vulnerable plaque features.
Referen
1 Truijman et al. Int J Stroke 2014 (9); 747–54.
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Validity of acute stroke lesion volume estimation by
DWI-ASPECTS depends on lesion location in 496 MCA
stroke patients
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Background: There have been several attempts to use Alberta Stroke
Program Early CT Score (ASPECTS) to estimate diffusion weighted
imaging (DWI) lesion volume in acute stroke. We aimed to assess corre-
lations of DWI-ASPECTS with lesion volume in different MCA subre-
gions and reproduce existing ASPECTS thresholds for a lesion volume
≥100 ml.
Methods: We analyzed data of patients with middle cerebral artery
(MCA) stroke from a prospective observational study of DWI and FLAIR
in acute stroke (PRE-FLAIR). DWI-ASPECTS and lesion volume were
calculated. The population was divided into subgroups based on lesion
localization (superficial MCA territory, deep MCA territory, or both).
Correlation of ASPECTS and infarct volume was calculated and receiver-
operating characteristics (ROC) curve analysis was performed to identify
the optimal ASPECTS threshold for ≥100 ml lesion volume.
Results: 496 patients were included. There was a significant negative
correlation between ASPECTS and DWI lesion volume (r = −0.78,
p < 0.0001). With regards to lesion localization, correlation was weaker in
deep MCA region (r = −0.19, p = 0,038) as compared to superficial
(r = −0.72, p < 0.001) or combined superficial and deep MCA lesions
(r = −0.72, p < 0.001). ROC analysis revealed ASPECTS ≤ 6 as best cut-off
to identify ≥100 ml DWI lesion volume, however positive predictive value
was low (0.35).
Conclusion: ASPECTS has limitations when lesion location is not consid-
ered. Identification of patients with “malignant profile” by DWI-
ASPECTS seems to be unreliable. ASPECTS may be a useful tool for the
evaluation of non-contrast CT. However, if MRI is used ASPECTS appears
dispensable as lesion volume can easily be quantified on DWI maps.
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Headache in acute ischemic stroke – A lesion mapping
study
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Background: Headache occurs frequently in acute ischemic stroke, but the
underlying mechanisms are incompletely understood. The aim of this
lesion mapping study was to identify brain regions, which are associated
with the development of headache in acute ischemic stroke.
Methods: 100 patients with ischemic stroke underwent cerebral MRI
including diffusion weighted imaging. 50 patients with stroke suffered
from headache at the time of symptom onset and 50 patients reported no
headache. Infarcts were manually outlined and the according regions of
interest were transformed into standard stereotaxic space. Voxel-wise
overlap and subtraction analysis of lesions and non-parametric statistics
(MRIcron) were conducted. All analyses were carried out with and
without flipping of left-sided lesions.
Results: The headache group as well as the non-headache group did not
differ in infarct volumes, in the distribution of affected vascular beds nor
in clinical severity. The headache phenotype was mostly tension type-like.
Subtraction analysis revealed more frequent infarction within two areas of
the central pain matrix, namely in the insula and the somatosensory
cortex, which was confirmed in the flipped analysis. This was also con-
firmed by non-parametric statistical testing (whole brain corrected
P-value < 0.05).
Conclusion: To our knowledge, this is the first lesion mapping study inves-
tigating the association between acute headache and ischemic stroke.
Insular infarcts turned out to be strongly associated with the occurrence of
headache. The insular cortex is a well-established region in pain process-
ing and our results suggest that at least in a subgroup of patients, acute
stroke-headache may be centrally driven.
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18FDG-PET-CT predicts occurrence of stroke, TIA or
and/or need for revascularization in patients with
carotid stenosis
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Background and purpose: We investigated whether uptake of (18) fluoro-
2-deoxy-d-glucose (18FDG)positron emission tomography-computed
tomography (PET-CT) and presence of microembolic signals (MES)
detected by transcranial Doppler (DTC) predicted the occurrence of
stroke, TIA and/or need for revascularization inpatients with carotid
stenoses.
Methods: 18FDG-PET-CT and MES detection were performed in con-
secutive patients with 50% to 99% carotid stenoses. Uptake index was
defined by a target to background ratio (TBR) between maximum stan-
dardized uptake value of the carotid plaque and the mean standardized
uptake value of the jugular veins. All patients were followed every 3
months. Outcome endpoints were occurrence of stroke, TIA and/or need
for revascularization during the follow-up period.
Results: We included 117 stenosis derived from 106 patients, 56 symp-
tomatic and 61 asymptomatic. Of these 43 were operated within the first
month and 74 were followed during a mean period of 24 months. Seven
patients(10%) presented at least one of the three outcome endpoints.
Median TBR value was of 2.4 in the event positive(+) and of 1.79 in the
event negative (−) group (p < 0.01). MES were present in one of the
7(14%) event + (14%) and in 8 (12%) of the event- patients (p < 0.9). Ina
logistic regression model including age, degree of stenosis, presence of
MES and TBR, only TBR resulted to be an independent predictive factor
(OR 18,4 95% CI 2.11 to 161, p = 0.008).
Conclusions: In patients with carotid stenoses,18FDG-PET-CT predicted
the occurrence of stroke, TIA and/or need for revascularization during
follow-up
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disease imaging markers is the ipsilateral hemisphere
after a lacunar ischemic stroke?
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Background: In structural Magnetic Resonance Imaging (MRI) of
patients with a recent small subcortical infarct (RSSI), white matter hyper-
intensities (WMH), lacunes, remnants of previous micro-/macro-
hemorrhages and, previous cortical stroke lesions may coexist with the
acute lesion. The distribution and prevalence of these small vessel disease
(SVD) imaging markers with respect to the location of the RSSI is not yet
known.
Methods: From brain MRI from 187 patients with an acute lacunar isch-
emic stroke clinical syndrome and a relevant DWI-positive lesion, we
semi-automatically extracted the RSSI, micro-/macro-hemorrhages,
lacunes, old cortical infarcts and WMH using optimized thresholding in
the relevant sequences. We used Wilcoxon and χ2 tests to compare the
volumes and frequencies of occurrence, respectively, of the SVD markers
in both hemispheres throughout the sample.
Results: 51.9% patients (n = 97) had the RSSI in the left hemisphere,
41.7%(n = 78) in the right, 2.7%(n = 5) in both and 3.7%(n = 7) in the
cerebellum or brainstem. There was no significant difference in RSSI
frequency between left and right hemispheres (p = 0.10). The median
percentage volume of the RSSI in intracranial volume was 5.33 × 10–4
(IQR = 2.7 × 10–4–8.9 × 10–4). There was no inter-hemispheric differ-
ences on the volumes of the RSSIs(p = 0.16). Neither was there a signifi-
cant difference between hemispheres in the volume of any of the SVD
markers assessed.
Conclusions: The load of SVD imaging markers was balanced between
both hemispheres regardless of the location of the RSSI. Therefore, assess-
ment of SVD imaging markers only on the contralateral hemisphere could
be used as a proxy for the SVD load in the whole brain.
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Blood–brain barrier assessment in stroke using T1
dynamics: A pilot study
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Objective: Blood–brain barrier (BBB) dysfunction is believed to be a pre-
cursor of hemorrhage and worse outcome after stroke. HARM sign
reflects BBB dysfunction though only qualitatively. However, it would be
preferable to assess BBB function quantitatively and thus enabling the
monitoring of drug delivery to the infarction. We aimed to assess BBB
function in stroke patients using dynamic quantitative T1 measurements.
Methods: We included 28 patients with ischemic strokes and a median
delay of 35 hours between symptom onset and MRI examination. Thir-
teen patients received rt-PA, 10 showed hemorrhagic transformation. T1
weighted images at different flip angles were acquired for quantification
purposes, followed by T1 measurements after contrast agent application.
After preprocessing linear fit maps were generated resulting in median
slopes characterizing Gadolinium wash-in/wash-out for each voxel. Values
within the infarction were compared to the contralateral side.
Results: Median slope and median subtraction values were significantly
different between infarction and contralateral regions (p < 0.001). No
correlation was found between median slope and T1 post contrast values
(r = 0.078), time of onset (r = 0.277), lesion size (r = 0.078). Six patients
with repetitive measurements demonstrated significantly higher median
slopes (p = 0.028) at follow-up. There was no significant difference
between patients with hemorrhagic transformation and ischemic stroke
(median slope: p = 0.175).
Conclusion: BBB dysfunction in infarcted tissue can be visualized and
quantified with dynamic T1 measurements.
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Can advanced CT imaging predict the high-risk carotid
plaque?
A C Webb1, L M J Best1, T Richards1
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Introduction: 20–30% of ischemic strokes are caused by carotid athero-
sclerosis. Currently, the severity of stenosis is the determining factor for
surgical intervention. Histology has identified a number of plaque fea-
tures that are associated with an increased risk of stroke and contribute to
the ‘vulnerable’ plaque. Other plaque characteristics available for analysis
on CTA 3D visualization software may correlate with these and help
identify patients at high risk of stroke.
Materials andmethod: Nineteen symptomatic patients (14 men, 5 women)
were selected. Computed Tomography Angiography (CTA) images were
analyzed for carotid plaque features using TeraRecon 3D visualization
software. Results were validated by interobserver agreement, comparison
with Duplex Ultrasound (DUS) recordings and ex vivo measurements.
Carotid plaques were histologically processed, classified and high-risk
features were detected. A CTA risk score was produced based on the degree
of each characteristic analyzed and compared to a histology risk score.
Results: CTA measurements for degree of stenosis, plaque length and
irregularity correlated well with DUS and ex vivo results. However, there
was no correlation between the high-risk plaques identified by each risk
score (χ2 = 0.059, p < 0.8). Irregularity on CT correlated with plaque his-
tology, no other clear correlations were seen.
Conclusion: Currently, the use of routinely available imaging software is
insufficient to identify the high-risk carotid plaque. There is a need to
continue research specific plaque scans.
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Greater transmission of aortic pulsatility to the brain
on propranolol versus amlodipine: Novel MRI method
to measure concurrent beat-to-beat brachial and
cerebral arterial pulsatility
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Background: Cerebral arterial pulsatility is dependent upon aortic pulsa-
tility and is associated with leukoaraiosis, stroke and dementia. The effect
of antihypertensive drugs on aortic pulsatility and its transmission to the
cerebral circulation is unknown due to limited methods of assessment.
Methods: In a randomized cross-over study in 10 healthy volunteers,
aortic (Sphygmocor) and middle cerebral artery pulsatility (DWL-
transcranial ultrasound) were measured during sequential treatment with
amlodipine and propranolol. On each drug, 3-tesla multiband BOLD
MRI (32 channel, MB factor 6) was performed with whole brain coverage
every 0.43 s and concurrent continuous non-invasive brachial BP moni-
toring, to simultaneously assess systemic and parenchymal cerebral arte-
rial pulsatility. Differences in drug effects on the strength of association
between cardiac cycle oscillations in BP and BOLD signal were deter-
mined by general linear modeling (FMRIB Software Library-FEAT).
Results: Despite no significant difference in aortic pulsatility between
amlodipine (27.3 mmHg) and propranolol (27.9 mmHg, p-diff = 0.33),
MCA pulsatility was increased from baseline on propranolol (+6%, 95%
CI 0.2–11.7%, p = 0.04) but not on amlodipine (+2.7%, −3.0–8.7%,
p = 0.21). On MRI, there was a significantly stronger association between
systemic arterial pulsatility and parenchymal cerebral pulsation on pro-
pranolol than amlodipine (Fig.).
Conclusions: Novel methods of high-frequency BOLD MRI and concur-
rent non-invasive BP monitoring demonstrated enhanced transmission of
systemic arterial pulsation to the cerebral circulation with beta-blockers,
potentially explaining differences in effect on stroke risk.
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Fig. Strenth of association (red voxels indicate significant associations)
between systemic arterial pulsatility and cerebral pulsatility by drug, and
the difference between the two drugs.
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The DWI/FLAIR imaging mismatch, i.e. the presence of a hyperintense
signal in MR DWI without a relevant change in FLAIR is a potential
marker for the timing of stroke onset. The aim of the study was to assess
if it can identify patients with lacunar and nonlacunar acute ischemic
stroke within 4.5 h of onset. The authors analyzed admission MR imaging
data from 86 ischemic stroke patients with a known time of symptom
onset. The presence of lesions was correlated with the duration and type
of the stroke.
The time from stroke onset to neuroimaging was significantly shorter in
patients with lesion visible only in the DWI (mean 2.78 h, n = 24) as
compared to patients with radiological signs of ischemia in DWI + FLAIR,
(mean 8.6 h, n = 62) (p = 0.0001, Kruskal-Wallis ANOVA).
The sensitivity, specificity, PPV and NPV of DWI/FLAIR imaging in deter-
mining whether the patients remained within the 4.5 h thrombolysis time
window was presented in the table:
Sensitivity Specificity PPV NPV
General population 58% 94% 87.5% 76%
(95% CI: 40,7 to 74,4%) (95% CI: 83,4% to 98,6%) (95% CI: 67,6% to 97,2%) (95% CI: 63,2% to 85,7%)
Nonlacunar stroke 58% 94% 90% 72%
(95% CI: 39% to 75.4%) (95% CI: 80.8% to 99.1%) (95% CI: 68.2% to 98.4%) (95% CI: 56.5% to 84%)
Lacunar stroke 50% 92.8% 75% 81.2%
(95% CI: 12,4% to 87%) (95% CI: 66% to 98,8%) (95% CI: 20,3% to 95,9%) (95% CI: 54,3% to 95,7%)
The presence of acute ischemic lesions only in DWI help identify both lacunar and nonlacunar stroke patients in the 4.5 h time window for intravenous
thrombolysis with high specificity and PPV.
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Clinical spectrum, underlying etiologies and
radiological characteristics of cortical superficial
siderosis
F A Wollenweber1, N Lummel2, C Opherk3, J Linn2
1Neurology, Institute for stroke and dementia (ISD), Munich,
Germany
2Neuroradiology, University Hospital Munich, Munich,
Germany
3Neurology, SLK-Kliniken Heilbronn GmbH Heilbronn
Germany, Munich, Germany
Background: Cortical superficial siderosis (cSS) is an increasingly recog-
nized MR-imaging marker most probably caused by focal convexity suba-
rachnoid hemorrhage (SAH). There is accumulating evidence that cSS
represents an important risk factor for previous and subsequent intracra-
nial hemorrhages. Here we aimed to determine clinical symptoms, under-
lying etiologies, and radiological characteristics of cSS in a large patient
cohort.
Methods: We performed an electronic database search on all patients who
presented between 2002 and 2013 to the university hospital Munich with
non-traumatic and non-aneurysmal cSS. T2*-weighted gradient-echo
sequences were analyzed regarding localization and extent of cSS as well as
of acute SAH, intracerebral hemorrhages (ICH) and microbleeds. Besides,
all available clinical, laboratory, imaging and histological data was
analyzed.
Results: 113 subjects matched the inclusion criteria. cSS was focal in 56
(50%) and disseminated in 57 (50%) patients. The following etiologies for
cSS were identified: cerebral amyloid angiopathy (CAA): 109 (97%);
reversible cerebral vasoconstriction syndrome: 2 (2%); central nervous
system vasculitis: 1; and hyperperfusion syndrome: 1. Acute ICH was
evident in 55 (49%) cases. Other clinical manifestations were: transient
focal neurological episodes (TFNE): 38 (34%); cognitive impairment: 14
(12%); generalized seizure: 4 (4%); and headache: 2 (2%). Cognitive
impairment was more frequent in disseminated cSS while TFNE was more
often found in focal cSS (p = 0.042).
Conclusion: Our data indicates CAA to be the most common etiology of
cSS. In absence of symptomatic ICH, patients with focal cSS frequently
present with TFNE, while those with disseminated cSS commonly mani-
fest clinically with cognitive impairment.
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Background: Remote structural and functional changes have been
described after stroke and may have an impact on clinical outcome. We
aimed to use multimodal MRI to investigate contralesional subcortical
structural and functional changes 3 months after anterior circulation
ischemic stroke.
Methods: Fifteen patients with acute ischemic stroke had multimodal
MRI imaging (including high resolution structural T1-MPRAGE and
resting state fMRI) within 1 week of onset and at 1 and 3-months. Con-
tralesional subcortical structural change was assessed using an automated
segmentation algorithm in FMRIB’s Integrated Registration and Segmen-
tation Tool (FIRST). Functional connectivity changes were assessed using
the intrinsic connectivity contrast (ICC), which was calculated using the
functional connectivity toolbox for correlated and anticorrelated net-
works (Conn).
Results: Mean patient age was 70.8 years (range 51–83 years). Median
baseline NIHSS was 9 (interquartile range [IQR] 5–13). Contralesional
thalamic volume was significantly reduced at 3 months compared to
baseline (median change −2.1%, IQR −3.4–0.4, p < 0.05), with the pre-
dominant areas demonstrating atrophy geometrically appearing to be the
superior and inferior surface. The degree of longitudinal thalamic atrophy
was correlated with baseline stroke severity (Spearman’s rho −0.54,
p < 0.05). Concurrently, there was a significant linear reduction in the
mean ICC of the contralesional thalamus over the imaging time points
(F(1,14) = 10.85, p < 0.01, η2 = 0.44), indicating reduced connectivity to
the remainder of the brain.
Conclusions: This study has demonstrated longitudinal atrophy and func-
tional disconnection in the contralesional thalamus after ischemic stroke.
Similar methods have the potential to be used as imaging biomarkers of
stroke recovery.
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Association between cerebrovascular reactivity and
severity of diabetic retinopathy in patients with
diabetes mellitus
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Objective: To investigate the association between severity of diabetic ret-
inopathy and alterations in cerebral vasomotor reactivity in patients with
diabetes by using Transcranial Doppler and breath-holding index
Methods: 43 patients with diabetic retinopathy who applied Bezmi Alem
Vakıf University Neurology clinic between Jan 2013–Jan 2014 were
enrolled. Patients were classified into three categories according to grade
of diabetic retinopathy and all patients underwent Transcranial Doppler
examination during voluntary breath holding. Physical examination and
laboratory findings were recorded for each patient and breath-holding
index was calculated.
Results: The mean age of patient population was 56,51 ± 9,34 years and
the mean time from diabetes diagnosis to study enrollment was
14.49 ± 8.06 years. 12 out of 43 patients (27.9%) had mild retinopathy, 15
patients (34.9%) had moderate and 16 (37.2%) patients had severe dia-
betic retinopathy at the enrollment. Both calculated right and left breath-
holding indexes were significantly lower in patients with severe
retinopathy compared to the patients with mild or moderate disease
(right; p < 0,01, left; p < 0,05). Both right and left breath holding indexes
were significantly lower in patients with moderate retinopathy compared
to the patients with mild retinopathy (p < 0,01).
Conclusion: This study has shown an association between severity of dia-
betic retinopathy and the magnitude of cerebral vascular reactivity altera-
tions in patients with diabetes mellitus
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Association between cerebrovascular reactivity and
white matter changes in patients with diabetes
mellitus
H Duruyen1, A Yaman1, S Tokdemir2, A Aralasmak2, T Asil1
1Neurology, Bezmialem Vakif University, Istanbul, Turkey
2Radiology, Bezmialem Vakif University, Istanbul, Turkey
Objective: The aim of this study was to evaluate cerebral autoregulation in
patients with DM using transcranial doppler (breath-holding test) and
analyzing their correlation to cerebrovascular reactivity and white matter
lesions in MRI.
Methods: 38 patients had consulted our clinic who had been diagnosed
with Diabetes Mellitus were included the study. The sociodemographic
characteristics, physical examination symptoms and laboratory results of
the individuals were recorded. The breath-holding test was done using
TCD and the breath-holding index (BHI) was calculated. The Fazekas
scale was used to evaluate the white matter lesions in the cranial MRI.
Results: The BHI evaluated using TCD was found to be in correlation
with age (p = 0,019), DM duration (p = 0,016) and periventricular white
matter lesions (p = 0,019). The prevalence of white matter lesions in MRI
was 71,1% (27 patients). The prevalence of periventricular white matter
lesions in different locations (grade 1–3 Fazekas scale) was 60,5%, the
prevalence of deep white matter lesions (grade 1–3 Fazekas scale) was
50%. A relation between periventricular white matter lesions and age
(p < 0,001), blood glucose (p = 0,004), history of hyperlipidemia
(p = 0,039) and BHI (p = 0,012) was found. The deep white matter lesions
were found to have relations to age (p < 0,001), fasting blood glucose
(p = 0,006), HbA1c (p = 0,006) and a history of hypertension (p = 0,022).
No statistical relationship was determined between deep white matter
lesions and the BHI (p = 0,35).
Conclusion: This study has shown the connection between impairment of
cerebral autoregulation and periventricular white matter lesions in
patients with DM using transcranial doppler ultrasonography.
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Transcranial color-coded duplex for the noninvasive
monitoring of patients with acute intracerebral
hemorrhage
P Camps-Renom1, J Eliecer2, F Casoni1, E Granell2,
L Prats-Sánchez1, A Martínez-Domeño1, J Martí-Fàbregas1,
R Delgado-Mederos1
1Neurology, Hospital De La Santa Creu I Sant Pau, Barcelona,
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Background: Spontaneous Intracerebral Hemorrhage (sICH) is related to
high mortality within the first hours due to progressive mass effect and
increase of intracranial pressure. We sought to determine the prognostic
value of bedside monitoring with transcranial color-coded duplex
(TCCD) in patients with acute sICH.
Methods: Prospective study of patients with sICH presenting within 24
hours from symptoms onset. Serial TCCD exams were performed at
admission, 24 and 48 hours. The following neurosonological variables
were recorded: hematoma volume (HV), midline shift (MLS), third ven-
tricle diameter (IIIVD), lateral ventricles diameter and pulsatility index
(PI) in both middle cerebral arteries. We correlated these data with the
radiological information from the CT scans, the early clinical course and
the functional outcome at 3 months. Early Neurological Deterioration
(END) was defined as an increase in the NIHSS ≥ 4 and poor functional
outcome as mRS ≥ 3.
Results: We included 34 patients with a mean age of 71.8 ± 12.7 years.
Median baseline ICH volume was 10.2 mL (IQR = 5.5–77.2). We found an
excellent correlation between TCCD and CT scan in HV (r = 0.79;
p < 0.01), IIIVD (r = 0.86; p < 0.01) and MLS (r = 0.84; p < 0.01). HV and
MLS at baseline measured with TCCD were significantly associated with
END and mortality (p < 0.05). Additionally, HV (baseline and 24 h), MLS
(baseline), ipsilateral PI (baseline and 24 h) and contralateral PI (24 h)
were associated with poor functional outcome (p < 0.05).
Conclusions: In patients with acute sICH, HV, MLS and PI measured with
TCCD are associated with END and poor outcome. TCCD is a promising
tool for the noninvasive monitoring of these patients.
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Duplex ultrasound is not sufficient to detect high-risk
patient prior to carotid endarterectomy
L Fisch1, P Kamalathevan1, M Rodriguez-Justo1, F Kennedy1,
M M Brown1, R Jager1, T Richards1
1Neurology, UCL institute of Neurology, London, United
Kingdom
Introduction: Prophylactic carotid endarterectomy in patients with
carotid stenosis can prevent long-term stroke. Indication for operation is
Abstracts
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based on clinical judgment and severity of stenosis. The benefit of the
operation could be increased if one could identify high-risk plaque prior
to surgery, especially in case of moderate stenosis (50–69%) which endar-
terectomy is subject to debate. Plaque ulceration is associated with high-
risk plaque, may be identified on routine non-invasive imaging.
Methods: A prospective observational study over a one year period in a
central London HASU. All patients underwent preoperative Duplex and
all plaques removed underwent routine AHA grading that includes histo-
logical analysis for intra-plaque hemorrhage and ulceration.
Results: 82 consecutive patients with histology available for analysis were
included. Median age was 74 years old (50–91). 70 had recent symptoms
and 12 had asymptomatic carotid stenosis. On Duplex, median stenosis
was 70% (40–95) and 34 patients had moderate carotid stenosis (50–
69%). Preoperative Duplex showing ulceration or irregularity was present
in 32 patients (44%). There was no overall difference in terms of ulcer-
ation on histology or presence of symptoms in respect to ulceration/
irregularity status on Duplex. Predictive positive (PPV) and negative
values (PNV) of Duplex for histology ulceration prediction was 44% and
54% respectively. For patients with moderate carotid stenosis, results were
similar (no difference in term of histology or presence of symptoms
considering Duplex results; VPP was 36%, VPN was 56%)
Conclusion: Duplex ultrasound alone is not sufficient to assess patient
likely to have high-risk plaque.
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Carotid artery intima-media thickness as a marker of
small or large vessel disease in ischemic stroke
F J Díaz de Terán1, P Martínez-Sanchez1, I Illán Gala1,
J Rodríguez-Pardo1, C Calle de Miguel1, J Pérez-Lucas1,
E Alba-Suárez1, G Ruiz-Ares1, B E Sanz-Cuesta1, M Lara1,
J U Mañez-Miró1, S Calcedo1, B Fuentes1, E Díez-Tejedor1
1Neurology, University Hospital La Paz, Madrid, Spain
Objectives: Some studies relate the carotid intima media thickness (IMT)
to small vessel disease (SVD) whilst others relate it to atheromatous large
vessel disease (LVD). Our objective was to study the impact that has IMT
in each of these entities, analyzing their relationship in patients with
cerebral infarction (CI)
Methods: Observational cohort study including CI patients. Study period:
2010–2014. Duplex carotid ultrasonography was performed in all patients
during the first 48 hours after admission and mean IMT as well as the
presence of atheroma plaques were recorded. SVD was defined as the
presence of lacunar infarcts or moderate-important leukoaraiosis in neu-
roimaging, and LVD as extra/ intracranial brain arteries atheromatosis.
Patients were classified into 4 groups: 1) SVD, 2) LVD, 3) SVD + LVD and
4) not SVD nor LVD. Multiple linear regression analyses were conducted
to evaluate the association between SVD/LVD and IMT.
Results: Overall, 823 patients were included, 57,2% male, mean age
70.9 years. Multivariate analysis showed that SVD (beta coefficient
[ET] = 0.050 [0.0197]) as well as LVD (Beta coefficient [SE] = 0.048
[0.0167]) were related to mean IMT, being this association higher in case
of SVD + LVD group (beta coefficient [SE] = 0.065 [0.0171]). Bonferroni
test showed that the greatest difference was between the SVD + LVD and
the group without SVD or LVD.
Conclusion: Both SVD and LVD are associated with mean IMT and this
association is greater when they coexist. This non-invasive and easily
reproducible measure is a useful tool to estimate vascular damage what
could contribute to a more effective prevention.
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Assessment of clinical hands-on training in carotid and
vertebral duplex and transcranial Doppler: Impact of
experience on diagnostic inter-observer agreement
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4Unidad de Apoyo a la Investigación, Universidad
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Background: Diagnostic tests performed in Neurosonology laboratories
are observer-dependent. We sought to evaluate the required number of
examinations to be performed during the training to reach a kappa index
of 0.8, while assessing if the prevalence of pathological studies influences
the learning curve.
Methods: Prospective cohort study. Ultrasound scans were done in con-
secutive patients referred to our Laboratory over three years. Trainees were
assessed at baseline and after a period of supervised training. Interstage
experience studies were counted for every trainee. Statistical analyses
included linear and exponential general estimating equation models.
Results: Number of patients assessed during training, 1527; in stage 1:
136, in stage 2: 150. It was considered a normal study in 81 carotid duplex
(28,32%), in 249 vertebral duplex (87,06%), and in 112 TCD (39,16%).
The most frequent pathological categories were carotid atherosclerosis,
vertebral hypoplasia and intracranial microangiopathy.
At stage 2, kappa index achieved in the relevant categories in carotid
duplex and TCD was 0.80, and 0.60 in vertebral duplex.
The minimum number of required examinations to be done under super-
vision to achieve a kappa index of 0.80 is, for our Neurosonology Labo-
ratory, according to the linear model 66, above 102 and 102 for carotid
duplex, vertebral duplex and TCD, respectively; according to the expo-
nential model 76, above 102 and higher than 102.
Conclusions: With the training, the concordance index improves in all the
modalities.
Neurosonology training places should report their pathology prevalence
to calculate the required number of studies to achieve a 0.80 kappa index.
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Risk reduction of brain infarction during
cardiovascular surgery using sonolysis – A pilot study
E Hurtikova1, M Roubec1, D Skoloudik1, M Kuliha1, A Goldirova1,
J Havelka2, R Brat3, R Mikoviny3, K Langova4
1Department of Neurology, University Hospital Ostrava,
Ostrava, Czech Republic
2Department of Radiology, University Hospital Ostrava,
Ostrava, Czech Republic
3Department of Cardiosurgery, University hospital Ostrava,
Ostrava, Czech Republic
4Department of Biophysics, University Hospital Olomouc,
Olomouc, Czech Republic
Background: Heart surgery is burdened with significant risk of ischemic
stroke. Moreover, asymptomatic brain infarctions can be detected in up to
32% patients after heart surgery. Aim of the study is to examine if
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intraoperative sonolysis alters the risk of new brain infarction during
open heart surgery.
Methods: Patients indicated to isolated coronary artery bypass graft or
heart valve surgery were included into the study. Patients were random-
ized 1:1 to sonolysis group (right middle cerebral artery was continually
monitored by continual transcranial Doppler using 2-MHz diagnostic
probe during the procedure) and to control group without sonolysis. All
patients underwent brain magnetic resonance (MR) before and 24 hours
after surgery and number of new ischemic lesions, their location and
volume were evaluated.
Results: Totally 87 patients were enrolled to the study (62 males, mean age
63.0 ± 15.8 years); 44 patients were randomized to sonolysis group and 46
patients to control group. New brain infarctions on control MR were
found in 11 (25.0%) patients in sonolysis group; 6 (13.6%) patients had
infarction in the right MCA territory and only 2 (4.5%) patients had new
ischemic lesion >0.5 mL. In control group, new brain infarctions were
found in 12 (27.3%) patients; 9 (19.6%) had infarction in the right MCA
territory and 5 (10.9%) patients had new ischemic lesion >0.5 mL
(P > 0.05 in all cases).
Conclusion: Pilot study results showed a trend in reduction of number
and volume of new ischemic infarctions in patients treated using sonolysis
during heart surgery.
Supported by IGAMHCR grant NT13498–4/2012.
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Clinical and ultrasonographic features in anterior
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5Department of Neurology, University of Brasov, Brasov,
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Introduction: Anterior ischemic optic neuropathies (AIONs) represent a
segmental infarction of the optic nerve head (ONH) supplied by the
posterior ciliary arteries (PCAs).
Purpose: To investigate the characteristic clinical features and ultrasound
findings of the orbital vessels and of the superficial temporal and the
carotid arteries, which help differentiate newly diagnosed non-arteritic
(NA)-AIONs from arteritic forms (A-AIONs), which require immediate
steroid treatment.
Patients and methods: In this prospective comparative observational
study, 62 consecutive patients with clinical suspicion of unilateral AION
were examined at admission, and at each follow-up visit, following a
complex protocol including color Doppler imaging (CDI) of orbital
vessels.
Results: The final diagnoses were A-AION due to giant cell arteritis in 12
patients, and 50 patients with NA-AION. A combination of a history of
amaurosis fugax before abrupt, painless, and severe vision loss in the
involved eye, and a diffuse pale optic disc edema was extremely suggestive
of A-AION. However, none of these symptoms were ever found in
NA-AION. CDI of the orbital vessels in A-AION revealed undetectable or
diminished blood flow velocities in the PCAs, (especially on the affected
side, and high resistance index (RI) in all retrobulbar vessels, in both
orbits). By contrast, in NA-AION, blood velocities and RI in PCAs were
preserved.
Conclusions: CDI data of retrobulbar vessels supported the evidence of
involvement of the entire PCA trunk in A-AION. By contrast, impaired
flow to the ONH was distal to the PCAs themselves, possibly at the level of
the paraoptic branches in NA-AION cases.
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Ultrasonographic features in central retinal artery
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5Department of Neurology, University of Brasov, Brasov,
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Introduction: Central Retinal Artery Obstruction (CRAO) represents an
abrupt diminution of blood flow through the CRA that is severe enough
to cause ischemia of the inner retina with permanent unilateral visual loss.
Purpose: To assess the role of Color Doppler Imaging (CDI) of orbital
vessels and Extracranial Duplex Sonography in the etiological diagnosis of
CRAO.
Patients and methods: Three patients with clinical suspicion of unilateral
right CRAO were examined following a protocol including CDI of orbital
vessels.
Results: All patients had no emboli visible on ophthalmoscopy. The
B-scan ultrasound (US) evaluation of the first two patients found a small
round, moderate reflective echo within the right optic nerve, 3 millimeters
behind the optic disc. Both had normal right ophthalmic artery hemody-
namic parameters, but no arterial flow signal on CDI on a distance of 3
millimeters behind the right optic disc (embol of cholesterol). By contrast,
their left eye had a normal aspect on CDI of retrobulbar vessels. Right
internal carotid artery US revealed in both cases an ulcerated ateromatous
plaque, as emboli source. The third patient had characteristic CDI find-
ings for giant cell arteritis (GCA) with eye involvement: high resistance
index in all retrobulbar vessels (with severe diminished blood flow veloci-
ties in the affected CRA). She had no systemic symptoms or signs of GCA.
Conclusions: Ultrasound investigation enables prompt differentiation
between CRAO of embolic mechanism and CRAO caused by vasculitis
from GCA. The second group requires immediate steroid treatment in
order to protect the fellow eye from going blind.
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Accuracy of transcranial duplex sonography, compared
with CT angiography, for detection of intracranial
arterial occlusions in acute stroke
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Objective: To analyze the accuracy of the transcranial color-coded duplex
sonography (TCCD) for the detection of the middle cerebral artery occlu-
sions, according to TIBI criteria, in patients with ischemic stroke, com-
paring it with CT angiography (CTA).
Methods: Multicenter retrospective cross-sectional study including acute
stroke patients (<8 h) that underwent a TCCD and a CTA (<60 minutes
apart) (2010–2013). Variables: clinical data; TCCD results: M1 complete
occlusion if TIBI 0–1, (0–2 for M2), M1 incomplete occlusion if TIBI 2–3
(3 for M2); and results of brain CTA establishing three degrees of
obstruction: no obstruction or mild (0–50%), moderate-severe (50–99%)
and occlusion (100%). The sensitivity, specificity, positive predictive
value (PPV) and negative predictive value (NPV) of TCCD were
analyzed, comparing with CTA, for detecting complete/incomplete MCA
occlusions.
Results: 65 patients, 60% men, mean age 63.8 years. TCCD showed
complete/incomplete occlusion of the MCA in 90.7% (59/65) of cases: 8 T
obstructions T (ICA + MCA), 42 M1 (with / without M2) and 9 M2
isolated. CTA showed complete/incomplete occlusion of the MCA in
90.7% (59/65) of cases: 10 T obstructions, 37 M1 (with/without M2) and
13 M2 isolated. The sensitivity, specificity, PPV and NPV (95% CI) of
TCCD for detection of complete/incomplete MCA occlusion was 100%
(93.9–100%), 100% (61–100%), 100% (93.9–100%) and 100% (61–
100%), respectively
Conclusions: TCCD accuracy for the detection of MCA occlusions, com-
pared with CTA, is very high and seems to be an excellent tool for the
screening of arterial obstructions in acute stroke.
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Hemodynamic correlates of transient cognitive
impairment after TIA and minor stroke: A transcranial
Doppler study
S Mazzucco1, L Li1, M Tuna1, S T Pendlebury1, R Wharton1,
P M Rothwell1
1Nuffield Department of Clinical Neurosciences, University of
Oxford, Oxford, United Kingdom
Background: Transient cognitive impairment (TCI), previously defined as
a transient decline in Mini Mental State Evaluation (MMSE) score, is
common early after a TIA/minor stroke, and is associated with increased
risk of dementia on subsequent follow-up. We aimed to validate TCI using
the Montreal Cognitive Assessment (MoCA), which is more sensitive to
vascular cognitive impairment, and to determine any associated changes
in cerebral hemodynamics.
Methods: Consecutive TIA/minor stroke (NIHSS ≤ 3) patients attending
an emergency clinic were enrolled from 2011–2014 and underwent tran-
scranial Doppler sonography (TCD) with bilateral MCA flow velocities,
BP recording and cognitive testing with MoCA acutely and at 1-month
follow-up visits, together with MRI/MRA at baseline. TCI was defined as
MoCA score increase of ≥2 points at 1-month in patients scoring <26 at
baseline.
Results: Of 226 patients undergoing repeated TCD and cognitive assess-
ments, 74 (33%) had TCI by the MoCA definition. The TCI group was
older (mean age/SD 72.3/11.8 vs 65.5/13.1, p < 0.001), but did not differ
from the non-TCI one in terms of BP, DWI positive lesions on acute MRI,
or type of event (TIAs in 45/74 TCI patients vs 103/152 non-TCI patients,
p = 0.18). After age correction, cerebral blood flow velocities were not
significantly different between the 2 groups at either time-points.
Conclusions: We validated the concept of TCI with the MoCA, but we did
not find any acute cerebral hemodynamic correlates to explain the
phenomenon.
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Micro-embolic signals (MES) detection by means of
transcranial Doppler in acute stroke patients: TCDX
versus standard recording
L Piccolo1, H Müller2, G Toledo Sotomayor2, R Sztajzel2
1Department of Bio-Medical and Specialized Surgical Sciences,
Section of Neurology, Ferrara, Italy
2Department of Clinical Neurosciences, Vascular Neurology
Unit, Geneva, Switzerland
Background: Previous studies reported a low prevalence of MES among
acute stroke patients, with an overall low sensitivity (31%) and a good
specificity (95%).
Aim: To compare a new TCDX system, allowing a longer recording time,
with the standard method using a DWL (TCD) machine in acute stroke/
TIA patients.
Methods: We performed sequential recordings of MCA Doppler-signal: a
45 minutes bilateral recording by means of the standard machine (DWL)
and two 60 minutes unilateral recordings (one for each side) using the
non-validated TCDX.
Results: We included 31 patients; ten of them (32%) were MES+. The
recordings were performed 44 ± 28 hours after stroke onset. There were: 3
(30%) large-artery, 2 (20%) cardio-embolic; 0 (0%) small-vessels and 5
(50%) of other etiology (2 carotid dissections, 1 anti-phospholipid syn-
drome, 1 hemochromatosis; 1 protein S deficiency). In 2 cases the detec-
tion was positive during both standard and TCDX recording; the other
positive cases were detected by TCDX only (80%).
Conclusions: The prevalence of MES in our study was high and situated
among Literature’s extremes of 9.3% and 71%. This wide variability may
be explained by differences in the time interval between stroke onset and
TCD recording as well as in the duration of recording.
TCDX was not inferior to the conventional system in detecting MES; it
was more easily tolerate for long-lasting recordings and less prone to
displacement.
More extensive studies and larger number of patients are needed in order
to confirm our preliminary results.
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Intracranial collaterals in cases of chronic symptomatic
carotid occlusion: A TCCD-based novel grading system
H Rizk1, F Abd Allah1, H Khalil2, A Hegazy3, A Ismaiel4, M Allam1
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Objectives: To establish a novel TCCD-based grading system for collateral
circulation in cases of symptomatic chronic total carotid occlusion
(TCO). Also to correlate this new grading system to cerebrovascular
reserve capacity measured by SPECT.
Methods: 34 patients with symptomatic chronic TCO diagnosed by color-
coded duplex were subjected to: clinical assessment, grading of cerebral
using a new TCD criteria (table 1), SPECT brain with dipyridamole stress.
Results: The new grading system for cerebral collateral circulation showed
a significant positive correlation with CVR (P value < 0.001 & Spearman
correlation coefficient 0.686) (Fig. 1).
Conclusion: The current study showed that this new TCCD grading
system for cerebral collaterals may be a good index for cerebral perfusion
and reserve capacity in cases of chronic symptomatic TCO.
Table 1 Grading of cerebral collaterals
Grade Description
5 Primary collateral flow + 2 secondary
4 Primary collateral flow + 1 secondary
3 Primary collateral flow only
2 Two secondary collaterals
1 One secondary collateral
0 No collaterals
Fig. 1 Relation between collateral grading and cerebrovascular reserve.
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Background: Neurovascular study is essential in defining stroke etiology
and therapy. In order to define the better cost-effective diagnostic work-
up, we measured concordance between I and II level tests for vessels
assessment and the impact on direct hospital cost.
Materials and methods: We selected ischemic stroke patients who under-
went both Ultrasounds (I level) and CTA and MRA (II level) and mea-
sured the unweight Cohen’s k in according to the presence and grade of
extracranial and intracranial vessels stenosis. Cost analysis was performed
accounting for direct cost of I and II level neurovascular study.
Results: 692 patients out of 1287 stroke patients fulfilled the inclusion
criteria. The agreement between DUS and II level for ICA was moderate
(DUS-CTA k = 0,578; DUS-MRA k = 0,528), fair for VA (DUS-CTA
k = 0,067; DUS-MRA k = 0,158) for MCA (DUS-CTA k = 0,385; DUS-
MRA k = 0,267) and for BA (DUS-CTA k = 0,382; DUS-MRA k = −0,02).
I level neurovascular studies with cervical vessels DUS was performed on
692 patients and transcranial DUS in 229, yielding a total cost of € 42.532.
II level neurovascular study was performed on 485 patients for a total cost
of € 107.507, accounting for 16% of global diagnostic costs. Overall 25%
of II level tests added new information with respect to Ultrasound, while
4% had a therapeutic yield.
Conclusions: Ultrasound appeared to remain the first line neurovascular
study, while II level tests should target intracranial vessels. Cost-effective
diagnostic work-up might include both cervical Ultrasound and Intrac-
ranial MRA or CTA only unless X-RAY exposure is not a concern.
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Transcranial ultrasound predictors of recurrent
ischemic stroke in symptomatic internal carotid artery
occlusion
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Introduction: Occlusion of the internal carotid artery (ICA) puts patients
at risk of recurrent ischemic events due to hemodynamic compromise.
Our goal was to characterize duplex parameters that could indicate
patients at risk of recurrent ipsilateral ischemia.
Methods: We screened our clinical database for patients with symptom-
atic proximal ICA occlusions. Collateral networks as well as flow velocities
in extra- and intracranial vessels were analyzed along with clinical and
epidemiological characteristics.
Results: Of 69 patients, 16 (23.2%) experienced a recurrent ischemic
event such as transient ischemic attack (TIA), retinal ischemia or stroke
within the same vascular territory during the mean follow up of 16
months (range 1–138). Smoking, female sex and previous TIA were asso-
ciated with a recurrent event; while stroke etiology or severity of initial
stroke symptoms was not. Flow within the ipsilateral MCA tended to be
smaller in patients with a recurrent event (74.8 ± 29.5 cm/s vs.
93.7 ± 35.7 cm/d; 70% vs. 87% of contralateral M1), which was, however,
not significant. Flow in the posterior cerebral arteries was higher in
patients who experienced a recurrent event at a later time point (p = 0.017
for contralateral P2), as was flow in the ipsilateral external carotid artery
(ECA; p = 0.015 for PDV).
Conclusion: Increases in contralateral P2 and ipsilateral ECA flow suggest
compensatory efforts through vertebrobasilar and ECA-collaterals.
Further refinement of these predictors in conjunction with clinical and
imaging information has the potential to identify patients at risk of hemo-
dynamic failure.
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ESOC-0431
20. Neurosonology
Correlation of severity of autonomic dysfunction with
dynamic cerebral autoregulation after acute ischemic
stroke
L Xiong1, J Liu2, G Tian1, H Leung1, X Chen1, T Leung1, Y Soo1,
K S Wong1
1Medicine & Therapeutics, The Chinese University of Hong
Kong, Shatin N.T., Hong Kong, China
2Chinese Academy of Sciences, Shenzhen Institutes of
Advanced Technology, Shen zhen, China
Background and objectives: Ischemic stroke may lead to impaired dynamic
cerebral autoregulation (CA) and autonomic dysfunction, and both are
related with unfavorable clinical outcomes. However, the correlation
between them after acute ischemic stroke is unknown.
Methods and patients: Consecutive acute ischemic stroke patients were
enrolled. Autonomic function was assessed by Ewing’s battery tests. We
dichotomized the severity of autonomic dysfunction into two groups:
severe (definite, severe or atypical) and minor (normal or early). CA was
assessed by autoregulatory parameters (autoregulation index (ARI)/
phase/gain) using transfer function analysis from spontaneous oscilla-
tions of cerebral blood flow velocities (CBFV) in bilateral middle cerebral
arteries (MCAs) by transcranial Doppler (TCD) and mean arterial blood
pressure (ABP).
Results: 12 acute ischemic stroke patients (6 patients with anterior circu-
lation infarct and 6 patients with posterior circulation infarct) were
recruited. In patients with anterior circulation infarct, only ARI in affected
hemisphere was borderline significantly lower in severe autonomic dys-
function group (n = 2 patients) than that in minor group (n = 4)
(4.25 ± 0.33 vs. 6.70 ± 1.21, P = 0.064). In patients with posterior circula-
tion infarct, ARI in both sides was similar in severe group (n = 4) to that
in minor group (n = 2) (left side, 3.82 ± 2.72 vs. 4.77 ± 0.08; right side,
4.27 ± 3.11 vs. 5.15 ± 0.52; all P > 0.05).
Conclusions: This pilot study showed a trend that severe autonomic dys-
function is related to worse dynamic CA in affected infarct side in patients
with anterior circulation infarct.
ESOC-0843
20. Neurosonology
The assessment of neovascularization in carotid artery
plaques and ischemic stroke risk using superb
microvascular imaging
M Zamani1, K Ryeng Skagen1, M Skjelland1, D Russell1
1Neurology, Oslo University Hospital Rikshospitalet, Oslo,
Norway
Introduction: Carotid plaque neovascularization is associated with plaque
instability and increased ischemic stroke risk. Conventional Doppler
examinations filter out low-flow signals preventing the visualization of
small blood vessels but this may be improved using contrast-enhanced
ultrasound (CEUS). Superb Microvascular Imaging (SMI) is a new
Doppler technique that allows the visualization of very small low-flow
vessels without the use of contrast agents. The aim of this study is to assess
level of agreement between the quantification of neovascularization using
Doppler ultrasound with CEUS and SMI and to compare these findings
with carotid MRI and histological assessments and ischemic symptoms.
Methods: 30 consecutive patients with symptomatic and 30 with asymp-
tomatic >50% carotid stenosis will undergo a neurological examination.
Color Doplex ultrasound investigation with CEUS, SMI and carotid MRI
will be carried out to quantify neovascularization. Plaques removed at
endarterectomy will also be assessed histologically with regard to amount
of neovascularization. The level of agreement between the ultrasound
examinations using CEUS, SMI, carotid MRI and histological assessments
will be evaluated and correlated to clinical symptoms prior to inclusion
and following a two-years follow-up.
Results: The results of this on-going study will firstly enable a comparison
of the different methods used to assess neovascularization (Ultrasound
examination using CEUS, SMI, carotid MRI and histological assess-
ments). Secondly to determine their correlation to ischemic events prior
to inclusion and during a 2 years follow-up.
Discussion: This study will hopefully advance the possibility for identify-
ing unstable carotid artery plaque non-invasively using carotid ultrasound
and Superb Microvascular Imaging.
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21. Nursing and Carers
Dietary knowledge, compliance, and educational needs
of stroke patients in Korea
S Choi-Kwon1, J Back1, B W Yoon2
1College of Nursing, Seoul National University, Seoul, Korea
2Department of Neurology College of Medicine, Seoul
National University Hospital, Seoul, Korea
Background: Many stroke patients do not meet recommended dietary
guidelines for secondary prevention and often have misconceptions about
dietary therapy. The purpose of this study was to examine dietary knowl-
edge, compliance, and educational needs of stroke patients and to analyze
the related factors that affect the level of dietary knowledge.
Methods: This was a cross-sectional descriptive study. The patients were
recruited from Seoul National University Hospital visiting outpatient
stroke clinic between Apri and June 2014. The data were collected using
questionnaires and patients’ medical records. Dietary compliance, dietary
knowledge and educational needs were also measured. Data were analyzed
using Windows SPSS 21.0.
Results: The level of dietary knowledge was different according to sub-
jects’ BMI (p = 0.006) and exercise status (p = 0.007). Thirty-seven
percent of the participants did not follow dietary therapy and 36% mod-
erately met the guidelines. There were significant differences in mini
dietary assessment(MDA) score according to age (p = 0.003), exercise
status (p = 0.013), and smoking (p = 0.028). Dietary educational needs
had positive correlation with the level of dietary knowledge (r = 0.415,
p < 0.001) and had negative correlation with MDA (r = −.172, p = 0.038).
Conclusion: Our results indicated that the level of dietary knowledge was
relatively high although dietary compliance were low, suggesting there
were discprepancies between dietary knowledge and compliance in some
items. Since dietary compliance was different among the patients with
different characteristics, patient-specific dietary educational program to
enhance compliance should be developed.
ESOC-0020
21. Nursing and Carers
Incorporating stroke rehabilitation techniques in
routine nursing practice: What can be achieved?
findings from case study research
D Clarke1
1Academic Unit of Elderly Care and Rehabilitation, Institute
of Health Sciences, Bradford, United Kingdom
Introduction: Recent focus on hyper-acute care and reductions in length
of stay mean it is particularly important all staff adopt consistent
approaches to post-stroke rehabilitation, provide the same advice and
teach the same techniques to enable patients to ameliorate or overcome
impairments. Research indicates nurses and therapists believe stroke reha-
bilitation techniques can and should be routinely incorporated in nurses’
practice. However, few nurses receive structured competency-based train-
ing in rehabilitation techniques. Case study methods were used to explore
and characterize ways nurses and therapists in two stroke units were
working to integrate rehabilitation techniques in nurses’ practice.
Method: In-depth qualitative case studies in an integrated and rehabilita-
tion stroke unit.
Results: Ninety-six hours of observations of nursing and therapy practice
and thirty-nine interviews were completed. Planned joint working in
which nurses, healthcare assistants and therapists routinely completed
patient activities together, including washing and dressing practice, trans-
fers from bed to chair, and mobility practice, increased nurses’ rehabili-
tation knowledge and skills. A shared understanding of how to facilitate
and enable activity using structured therapeutic approaches developed.
There was consistent evidence of carryover of rehabilitation techniques
and an increase in confidence in stroke specific skills, particularly amongst
healthcare assistants who provided most patient support. Inconsistency in
carryover was most evident in inexperienced nurses’ practice and was
related to difficulties in establishing and sustaining routine joint working
activities.
Conclusion: Planned, routine joint working with therapists enabled
nurses and healthcare assistants develop competence in and to consis-
tently employ rehabilitation techniques in integrated and rehabilitation
stroke units.
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21. Nursing and Carers
Poor stroke risk perception despite moderate public
stroke awareness: Insight from a cross-sectional
national survey in Greece
A Karagiannaki1, V Melikoki1, G Perifanos1, K Perlepe1,
F Gioulekas2, I Tsantzali1, E Poulianiti1, M Poulikakou1,
K Makaritsis1, G Ntaios1
1Medicine, University of Thessaly Medical School, Larissa,
Greece
2General University Hospital of Larissa, Sub-Directorate of
Informatics, Larissa, Greece
Background and purpose: Although stroke is the fourth cause of death in
western societies, public stroke awareness remains suboptimal. The aim of
this study is to estimate stroke risk perception and stroke awareness in
Greece through a cross-sectional telephone survey.
Methods: A trained interview team conducted this cross-sectional tele-
phone survey between February and April 2014 using an online structured
questionnaire. Participants were selected using random digit dialing of
landline and mobile telephone numbers with quota sampling weighted
for geographical region based on the most recent General Population
Census (2011).
Results: Between February and April 2014, 723 individuals [418 (58%)
females, 47.4 ± 17.8 years] agreed to respond. Among all respondents, 642
(88.8%) were able to provide at least one stroke risk factor. 673 (93.08%)
respondents were able to provide correctly at least one stroke symptom or
sign. When asked what would they do in case of acute onset of stroke
symptoms, 497 (68.7%) responded that they would either call the ambu-
lance or visit the closest emergency department. Only 35.3%, 18.9%,
17.2%, 20.7%, 15.0% of respondents with atrial fibrillation, arterial
hypertension, dyslipidemia, diabetes mellitus and current smoking
respectively considered themselves as being in high risk for stroke
Conclusions: Stroke risk perception in Greece is low despite moderate
public stroke awareness.
ESOC-1186
21. Nursing and Carers
How well do we communicate?
M Makinde1, S Dawson1, D Kondova1, M Misty1
1Stroke Department, University Hospitals of Leicester NHS
Trust, Leicester, United Kingdom
Introduction: It is a duty of NHS trusts and stroke services to ensure that
people who have suffered a stroke and their families are kept well
informed’. The National Sentinel Audit for Stroke highlighted poor
communication as the foremost cause of dissatisfaction and reason for
complaint.
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We therefore audited our department to see if we were meeting the gold
standard of ‘100% of all families should be informed of diagnosis, man-
agement and prognosis after a stroke within 72 hours’ (National Clinical
Guideline for Stroke recommendation 7.6.1).
Method: We reviewed 50 consecutive acute admissions. The time from
admission to first documented discussion, grade of doctor, and nature of
discussion were recorded. We also looked at whether there was any rela-
tionship between NIHSS score, (a surrogate of stroke severity), and grade
of doctor.
Results: Percentage with documented discussion <72 hours = 62%
Most common themes documented = diagnosis (21%), mortality and
morbidity (18.5%).
Initial discussions by FY1 (31%) and consultant (28%). This was not
affected by NIHSS score. However, consultants were more likely to discuss
DNAR.
Discussion: Is it appropriate for FY1 doctors to have initial discussions?
Are they prepared to discuss DNAR?
With faster transfer of patients between units it is increasingly important
that documentation is clear to aid clarity for clinicians as well as patients
/ relatives.
We have introduced a new communication form and review its impact. In
the longer term we will see if this affects patient / carer satisfaction.
ESOC-1010
21. Nursing and Carers
The stroke clinical nurse specialist role – The Irish
experience
P McElwaine1, I Noone2, J Harbison1
1Medical Gerontology, St James’s Hospital, Dublin, Ireland
2Geriatrics and Stroke Medicine, St Vincent’s University
Hospital, Dublin, Ireland
Background: Following the Irish National Audit of Stroke Care 2008 and
the development of the National Stroke Programme, the recruitment of
specialized staff including Stroke Clinical Nurse Specialists (CNS) was a
key element in improving stroke care in Ireland. We surveyed the Stroke
CNS to see how the role works in practical terms and what challenges are
evident.
Method: A survey was administered to Stroke CNS attenders of a study
day in late 2014. The survey was based on the framework of the original
job description for the specialist nursing role. The survey was self-
administered.
Results: Of the 22 respondents, which represented 82% of the CNS cur-
rently in position in Ireland, the average time in position was 3.8 years,
with a combined total of 84 years’ experience in Stroke Medicine.
The majority of their time (>50%) was spent on ward based clinical role
including patient assessment and education, and 95% of respondents were
involved in at least monthly staff education.
Protected time for their training was available to 23% of respondents. 8/22
(36%) were in involved in non-Stroke related commitments in their
working week.
They identified low staffing rates in the stroke service and a lack of clarity
in the CNS role as the greatest challenges they face.
Discussion: The responses show that the specialist nurses are providing
essential services to stroke patients, that there are significant challenges the
role, but that there is a knowledgeable and experienced group of people to
draw from when developing the role into the future.
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21. Nursing and Carers
Understanding the burden of care during early
supported discharge on spouses of people with stroke
C Meagher1, S Demain1, L Anderson1, C Toogood1
1Health Sciences, University of Southampton, Southampton,
United Kingdom
Background and aims: Despite the clearly documented benefits of Early
Supported Discharge (ESD) there is limited research about the impact on
caregivers. This research aimed to quantify the perceived workload and
impact on well-being of caregiving during ESD.
Objectives: To determine i) the type and perceived duration of ESD care
and rehabilitation tasks undertaken by informal caregivers ii) the impact
of ESD work on caregiver wellbeing and iii) the relationship between the
perceived duration and impact of ESD work and patient disability and
quality of life and carer strain.
Methods: A structured interview was carried out with 18 caregivers after
the first week of ESD. Using a researcher administered questionnaire we
collected data measuring the time spent per day performing care tasks and
the perceived impact of each task. Data were correlated with routinely
collected measures; Barthel Index, EQ5D and Carer Strain index.
Findings: Tasks associated with health and safety, emotional manage-
ment, exercise/ mobility, and new domestic responsibilities generated
greatest workload. Tasks associated with health/safety, emotional manage-
ment and new domestic responsibilities also generated the greatest impact
on well-being. Duration of workload and impact on carers were strongly
correlated for many of the tasks addressed by the questionnaire (r = 0.6–
0.9). A strong positive correlation was found between the carer strain
index and data collected during ESD (r = 0.8).
Conclusion: Carers report a substantial workload during the second week
after a patient is discharged home which has a negative impact on well-
being and associated high levels of carer strain.
ESOC-1462
21. Nursing and Carers
A qualitative investigation into the burden of care
during early supported discharge on spouses of
people with stroke
C Meagher1, S Demain1
1Health Sciences, University of Southampton, Southampton,
United Kingdom
Background and aims: The benefits to patients of Early Supported Dis-
charge (ESD) following stroke are well-documented but research investi-
gating the impact of ESD pathways on care-givers is limited. This study
aimed to describe the experience of caregiving during ESD, the conse-
quences on carer well-being and to identify solutions to reduce the impact
of caring.
Objectives: To explore caregivers experiences of managing the work of
caring and identify how ESD pathways could better support people to
care.
Methods: 14 purposively selected primary carers were recruited from one
ESD service. In-depth semi-structured interviews with caregivers were
conducted 3–8 weeks after ESD services ended. Data were audio-recorded
and transcribed verbatim. A framework analysis approach was used.
Findings: Carers valued the support of the ESD team. However, all carers
reported emotional strain (anxiety, sadness, anger, guilt and isolation);
some reported physical symptoms (difficulty sleeping, fatigue and lack of
appetite); some sought medical support for their own mental health. The
intensity and causes of emotional strain varied as did the timing of great-
est strain. Strain was associated with inadequately planned discharges,
insufficient equipment or care provision, limited consideration of carer’s
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other commitments, worries about patient safety, and coping with
patients’ cognitive, language and mood impairments.
Conclusion: There is a need to routinely assess carer’s needs including
their willingness and ability to provide support. ESD services could reduce
caregiver strain by reviewing discharge systems, providing tailored infor-
mation and addressing the emotional needs and safety concerns of
patients and caregivers.
ESOC-1012
21. Nursing and Carers
Implications of stroke for caregiver outcomes: Findings
from the ASPIRE-S study
S Atteih1, L Mellon2, P Hall3, L Brewer4, F Horgan5, D Williams6,
A Hickey2
1Medical Student, Royal College of Surgeons in Ireland,
Dublin, Ireland
2Psychology, Royal College of Surgeons in Ireland, Dublin,
Ireland
3Emergency Department, Mater Hospital, Dublin, Ireland
4Geriatric Medicine, Beaumont Hospital, Dublin, Ireland
5Physiotherapy, Royal College of Surgeons in Ireland, Dublin,
Ireland
6Stroke and Geriatric Medicine, Royal College of Surgeons in
Ireland, Dublin, Ireland
Background: Informal caregivers are vital to long-term care and rehabili-
tation of stroke survivors worldwide. However, caregiving has been asso-
ciated with negative psychological outcomes such as anxiety and
depression, leading to concerns about caregiver in addition to stroke
survivor well-being. Furthermore, caregivers may not receive the support
and service provision they require from the hospitals and community.
Aims: This study examines caregiver psychological well-being and satis-
faction with service provision in the context of stroke.
Methods: Caregiver data was collected as part of the ASPIRE-S study, a
prospective study of secondary prevention and rehabilitation which
assessed stroke patients and their carers at 6-months post stroke. Carer
assessment included measurement of demographics, satisfaction with care
(UK Healthcare Commission National Patient Survey of Stroke Care),
psychological distress (Hospital Anxiety and Depression Scale), and vul-
nerability (Vulnerable Elders Scale). Logistic regression analyses were per-
formed using STATA Version 12.
Results: Analyses from 162 carers showed substantial levels of dissatisfac-
tion (37.9%) with community and hospital services, as well as notable
levels of anxiety (31.3%) and depressive symptoms (18.8%) amongst
caregivers. Caregiver anxiety was predicted by stroke survivor anxiety
(OR = 3.47, 95% CI 1.35–8.93), depression (OR = 5.17, 95% CI 1.83–
14.58) and stroke survivor cognitive impairment (OR 2.35, 95% CI 1.00–
5.31). Caregiver depression was predicted by stroke survivor anxiety
(OR = 4.41, 95% CI 1.53–12.72), and stroke survivor depression
(OR = 6.91, 95% CI 2.26–21.17).
Conclusion: Findings indicate that caregiver and stroke survivor well-
being are interdependent. Early interventions, including increased train-
ing and support programs that include caregivers are likely to reduce risk
of negative emotional outcomes.
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Reducing door to needle time: Impact of the
“fastroke” protocol implementation on intra hospital
delay and functional outcome of patients treated with
intravenous RTPA
L Muñoz-Narbona1, C Casanovas2, G Lucente2,
N Pérez de la Ossa2, M Gomis2, L Dorado2, E López-Cancio2,
M Hernández2, C Molinos2, R López2, D Santos3, F Arasa3,
M Millán2
1Neuroscience, Health Sciences Research Institute “Germans
Trias i Pujol,” Barcelona, Spain
2Neuroscience, Germans Trias i Pujol Hospital, Barcelona,
Spain
3Emergency, Germans Trias i Pujol Hospital, Barcelona, Spain
Background: Reduction of door-to-needle (DTN) time is an indicator of
the quality of healthcare systems, being <45 min recommended in ESO
guidelines. Our aim is to analyze DTN time and functional outcome of
acute ischemic stroke patients treated with iv rtPA within 4.5 hours in our
center after the implementation of a new in hospital protocol
Methods: The FASTROKE protocol was implemented in March 2014;
main organizational changes were checkout medical history prior to
arrival, point-of-care systems to determine the INR and starting iv rtPA at
emergency room instead of transferring patients to the stroke unit. We
studied patients treated 9 months before and after the FASTROKE imple-
mentation. Functional outcome was prospectively evaluated using the
Barthel Index at discharge and Rankin Score at 90 days
Results: 70 patients in the pre-FASTROKE phase (68 years, median
NIHSS 10) and 72 patients in the post-FASTROKE phase (67 years,
median NIHSS 7) were included. A reduction of 30% was observed in the
DTN (median 50 min [40–70] vs. 35 min [30–54], p < 0.001). The Euro-
pean quality standard was achieved in 41% and 72% (p < 0.001) of
patients in the pre and post-FASTROKE phase. The Barthel Index at
discharge was 50 vs. 65 (p = 0.28) and good outcome at 3 months (mRS
0–2) was achieved in 59% vs. 60% patients (p = 0.92)
Conclusion: The implementation of a fast intervention protocol for the
acute stroke patients has allowed a reduction of 30% in the door-to-needle
time; nevertheless, an impact on clinical outcome was not observed in our
limited sample
ESOC-1267
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Stroke team members’ experiences of strategies to
handle ethical problems in unexpected sudden death –
Obstacles and possibilities
Å Rejnö1, L Berg2
1Skaraborg Hospital, Stroke Unit, Skövde, Sweden
2Institute of Health and Care Sciences, Sahlgrenska Academy
University of Gothenburg, Göteborg, Sweden
In end-of-life ethical problems often come to the fore. Little research is
performed on strategies for handling ethical problems and on obstacles
and possibilities for using such strategies. A previous study illuminated
stroke team members’ experiences of ethical problems and how the teams
managed the situation when caring for patients faced with sudden and
unexpected death from stroke. The aim of the study of this study was to
illuminate obstacles and possibilities perceived by stroke team members in
using strategies for handling of ethical problems when caring for patients
afflicted by sudden and unexpected death caused by stroke. A qualitative
method with combined deductive and inductive content analysis was
utilized. Data were collected through individual interviews with 15 stroke
team members working in stroke units of two associated county hospitals
in western Sweden. All the studied strategies for handling of ethical prob-
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lems were found to have both obstacles and possibilities. Uncertainty is
shown as a major obstacle and unanimity as a possibility in the use of the
strategies. The findings also illuminate the value “the patient’s best” as a
starting-point for the carers’ ethical reasoning. The concept “the patient’s
best interests” used as a starting point for ethical reasoning among the
carers is not explicitly defined yet, and its possible different cultural
aspects are likewise not explored. These make this value difficult to use
both as a universal concept and an argument for decisions. Carers need
reflect on and use ethically-grounded arguments and defined ethical
values in their clinical work.
ESOC-1094
21. Nursing and Carers
Does quality of stroke nursing care improve in
Catalonia after four audit editions?
M Salvat-Plana1, R Suñer-Soler2, A Ribera3, S Abilleira1,
P Ramírez-García4, M Gallofré1
1Stroke Programme, Agency for Health Quality and
Assessment of Catalonia, Barcelona, Spain
2Faculty of Nursing, Universitat de Girona, Girona, Spain
3Cardiovascular Epidemiology Unit, Hospital Universitari Vall
d’Hebron, Barcelona, Spain
4Faculty of Nursing, Université de Montréal, Montreal,
Canada
Background: After publishing/making available Catalan stroke guidelines
in 2006, four biennial clinical audits have been carried out to assess the
compliance of evidence-based recommendations. Need of improvement
of some indicators led the Stroke Program to propose specific actions
related to nursing care. The aim is to analyze the evolution of adherence to
specific nursing care recommendations across four stroke audits con-
ducted between 2005 and 2013.
Method: We assessed compliance with four quality indicators focusing at
stroke nursing care across consecutive stroke audits for comparison pur-
poses. Stroke Audits studied consecutive patients admitted to 46 of the 49
public hospitals in Catalonia for acute stroke. Data were obtained from a
retrospective medical record review in the first three audits and prospec-
tively in the 4th edition.
Results: 1.791 cases were evaluated in 2005, 1.767 in 2007, 2.190 in 2010
and 1.916 in 2013 representing 17%, 16%, 21.3% and 17.5%, respectively,
of the annual stroke admissions in Catalonia. ‘Dysphagia screening’
improved gradually and significantly through the four Audits (from 30%
to 68.2%). ‘Early mobilization’, stabilized between 2nd and 3rd audit
improved in the 4th (from 78.6 in the 3rd to 85.1% in the 4th). Compli-
ance with ‘mood assessment’ worsened between the 2nd (51.8%) and 3rd
editions (46.1%) but improved in the 4th (67.6%) even though persisted
sub-optimal. ‘Patient/family education’ showed a high increase (from
34.2% to 74.1).
Discussion: Quality of nursing stroke care improves gradually in Catalo-
nia. While, the improvement of some recommendations is possible, use-
fulness of specific interventions carried out it is demonstrated.
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21. Nursing and Carers
Incidence, risk factors and nursing of poststroke
bladder and bowel dysfunction: A prospective,
multicenter study of 310 patients in Western China
J Yang1, L H Zhao1, Y P Zeng1, R Yang1
1Department of Neurology, West China Hospital Sichuan
University, Chengdu, China
Objectives: To describe the clinical features of the four types of bladder
and bowel dysfunction (BBD) after stroke in West China and to compare
nursing methods between West China and other countries.
Methods: Patients with stroke hospitalized from September 2010 to Feb-
ruary 2012 were prospectively observed. Data were analyzed using
descriptive statistics, chi-square test and Logistic regression.
Results: 310 patients were recruited. 190 patients suffered from BBD. The
prevalence of urinary incontinence (UI) + fecal incontinence (FI), urinary
retention (UR) + FI, UR + constipation, and UI + constipation were
4.52%, 2.26%, 6.13% and 4.52%, respectively. The risk factors for UI were
disturbance of consciousness, a history of heart diseases and higher
NIHSS scores. Hemorrhagic stroke and higher NIHSS scores were related
to UR. Higher NIHSS scores was the risk factor for FI. The disturbance of
consciousness and higher NIHSS scores were the risk factors for UI + FI.
A history of heart diseases was the risk factors for UR + FI. Hemorrhagic
stroke was related to UR + constipation. Some nursing methods of BBD in
West China were inconsistent with the guidelines in developed countries.
Conclusion: Co-existed types of BBD after stroke are also common in
stroke patients. There is a large gap of nursing methods for BBD between
West China and other countries. We should also pay attention to patients
who suffer from co-existed types of BBD after stroke. Some nursing
methods of BBD should be improved in West China.
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Prolonged stay in emergency room results in more
complications in acute stroke patients
N Akhtar1, S Kamran1, P Bourke1, S Joseph1, M Santos1, A Shuaib1
1Neurology, Hamad Medical Corporation, Doha, Qatar
Background and aim: Complications in acute stroke (AS) effects patient
outcome, but the settings causing these complications are not well under-
stood. We aim to identify whether prolonged staying in emergency depart-
ment (ED) has any effect on risk of increased complications in patients
with AS.
Methods: We analyzed data from our stroke registry of patients admitted
with AS during 2014. Data regarding demographics, stroke types, ED stay
duration (in hours), length of stay (LOS) in hospital, number and types of
complications and prognosis were collected. Stay in ED divided into three
groups- , <8 hours, 8–24 hours, and >24 hours.
Results: Mean age was 55 years, and 79% were males (total n = 894).
Twenty three percent (n = 202) remained in ED for <8 hours, 49%
(n = 416) b/w 8–24 hours, and 27% (n = 233) >24 hours. Moderate to
severe strokes (NIHSS > 4) were found in 46% in 1st, 47% in 2nd and 65%
in 3rd group (p = 0.02). Patients staying <8 hours in ED (24%) were
associated with reduced LOS in hospital (<4 days, p = 0.001), and better
prognosis at discharge (62% had mRS of ≤2, p = 0.004). Prolonged stay
was associated with increased risk of complications (15% vs 21%,
p = 0.001), and increased aspiration pneumonia (9.3% vs 15.8%,
p = 0.002).
Conclusion: Delay in transferring AS patients from ED results in more
complications, which affects prognosis and increases LOS, causing burden
on available resources. Priority transfer of these patients to stroke ward
will improve their outcome, and reduction in health costs.
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The outcome following acute stroke is significantly
better in patients admitted to a stroke ward compare
to medical wards
N Akhtar1, S Kamran1, P Bourke1, S Joseph1, M Santos1, A Shuaib1
1Neurology, Hamad Medical Corporation, Doha, Qatar
Background and aim: A number of studies have shown that patients
admitted to multidisciplinary stroke ward (SW) have better outcome
compared to general medical wards. The objective of this study is to
compare outcome between patients admitted to stroke ward versus
general medical wards (MW).
Methods: An 8 bed SW was established at the Hamad General Hospital,
Qatar in April 2014, with multidisciplinary team & care pathways & pro-
tocols. This small unit was not sufficient to admit all stroke patients
allowing an opportunity to compare outcome in admission to SW versus
MW. Outcomes measured were mortality, discharge disposition, length of
stay, and complications.
Results: 894 patients admitted in 2014, with 55.3% (n = 495) in SW,
29.5% (n = 264) in MW and 12.5% (n = 111) in intensive care (ICU).
Investigations were completed faster in SW vs MW; neuroimaging (80%
vs 67%), carotid Dopplers (89% vs 82%), echo (93% vs 72%,) and Holter
monitoring (37% vs 23%), p = 0.001. Patients managed in SW showed
reduced deaths (2.8% vs 4.5%, p = 0.001), & fewer long-term care trans-
fers (1.2% vs 2.2%). Medical complications were 3.8% in SW vs 16.2% in
MW; aspiration pneumonia (2.3% vs 9.7%, p = 0.001), UTI (1.5% vs
6.8%,) and bed sores (1.06% vs 8.4%, p = 0.001). Length of stay (≤4 days)
was found in 63% in SW vs 54% in MW (p = 0.001). At 3 months mRS ≤ 2
was 93.4% in SW vs 76% in MW (p = 0.001).
Conclusion: Establishment of a SW significantly decreased complications,
improved survival and increased home discharges.
ESOC-0060
22. Service Organisation
A comparison of remote and bedside assessment of
the NIH stroke scale in acute stroke patients
A M Alasheev1, Y V Gonysheva1, G I Lipin1, A A Belkin1
1Regional Stroke Center, Sverdlovsk Regional Clinical Hospital
#1, Yekaterinburg, Russia
Background: Telestroke videoconference for conducting the National
Institute of Health Stroke Scale (NIHSS) is recommended when direct
bedside evaluation by a stroke specialist is not immediately available for
hyperacute stroke assessment. However, some NIHSS-telestroke studies
inherit systematic bias due to subjectivity of NIHSS administration. We
aimed to evaluate NIHSS telestroke assessment, while implementing mea-
sures to minimize subjectivity bias.
Methods: Ninety acute stroke patients within 48 hours of onset were
assessed by 6 stroke neurologists grouped in 15 pairs. Each pair of physi-
cians assessed 6 patients. Patients were allocated through block random-
ization to a physician pair and order of bedside or remote assessment.
Every patient was assessed once at the bedside and once remotely. Remote
examination was performed by a neurologist through high-quality video-
conferencing, assisted by a nurse at the patient’s bedside. The Institutional
Review Board waived the need for informed consent.
Results: Cumulative difference of ≤3 NIHSS points was observed in
85.6% (95% CI 76.6%; 92.1%) cases. Therefore, every fifth remote exami-
nation may have been inaccurate. Quadratically weighted kappa (k) for
total NIHSS score was 0.91 (95% CI 0.87; 0.95). Fair agreements were for
commands (k = 0.40), facial palsy (k = 0.27), and ataxia (k = 0.30).
Remote assessments were longer than bedside: 8 minutes (IQR 7; 9) versus
6 (IQR 5; 8), p < 0.001.
Conclusions: NIHSS-telestroke assessment using high-quality videocon-
ferencing in the acute stroke settings is closely matched with NIHSS-
bedside assessment but it’s credibility for clinical use needs further
evaluation.
ESOC-0059
22. Service Organisation
Distinctive features of the prevalence of risk factors of
stroke among urban and rural residents
R Aliyev1, R Shiraliyeva1, A Mammadbayli1
1Neurology, Azerbaijan State Advanced Training Institute for
Doctors Named after A. Aliyev, Baku, Azerbaijan
One of the most pressing problems of the modern neurology is a stroke.
Aim: The purpose of the research was to study the prevalence of risk
factors of stroke among urban and rural residents of the north-east of
Azerbaijan.
Materials and methods: The object of the study was 40–49 year old popu-
lation. With the special survey form the prevalence of risk factors of stroke
has been investigated (2008–2010).
Results: 1821 people have been involved in the study, 657 (348 females,
309 males) urban and 1164 (575 females, 589 males) rural residents.
The most frequent risk factor was physical inactivity 37.3 ± 1.1%. Among
rural population who have physically active lifestyle (76.4 ± 1.3%) was in
majority compared to urban residents (38.5 ± 1.9%).
Although no sexual difference has been found in hypertension among
rural residents (males 14.4 ± 1.5% and females 15.1 ± 1.5%), in urban
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population among males hypertension was higher (22.3 ± 2.4% and
15.8 ± 2.0%). Ischemic heart disease (IHD) among urban (10.5 ± 1.2%)
and rural residents (10.4 ± 0.9%) had the same share. Obesity was more
common in rural females (11.5 ± 1.4%) than in rural males (7.6 ± 1.1%).
Prevalence of transient ischemic attack/stroke and diabetes among urban
(0.5 ± 0.1%/1.5 ± 0.5%and 6.4 ± 1.0%) and rural (0.4 ± 0.2%/0.8 ± 0.3
and 4.8 ± 0.6%) residents was without significant difference. The share of
smokers among urban population (19.9 ± 1.6%) was higher than rural
population (13.3 ± 1.0%).
Discussion: Prevalence of some risk factors is the case depending on rural
and urban settlements. The results show the importance of launching new
studies in region, expanding the scope of preventive measures and
awareness-raising among population about risk factors and their
correction.
ESOC-0908
22. Service Organisation
Does the quality of discharge planning following acute
stroke influence long-term quality of life and unmet
needs?
N E Andrew1, M F Kilkenny1, N A Lannin2, D A Cadilhac1
1Stroke and Ageing Research School of Clinical Sciences at
Monash Health, Monash University, Clayton, Australia
2Faculty of Health Sciences, La Trobe University, Melbourne,
Australia
Background: Comprehensive discharge planning is important for success-
ful community integration following stroke. How this influences out-
comes has not been previously reported.
Aim: To investigate the association between the quality of discharge plan-
ning following acute stroke and reported Health Related Quality of Life
(HRQoL) at 90–180 days and unmet needs at 6–9 months post-stroke.
Method: Patients discharged to the community and registered in the Aus-
tralian Stroke Clinical Registry (AuSCR) participated. Discharge quality
was retrospectively measured using validated questionnaires (PREPARED,
Grimmer et al 2001). Domain scores for information exchange, medica-
tion management, coping preparation, and discharge control were calcu-
lated. Unmet needs were measured using the LUNS questionnaire (LoTS
care 2011). AuSCR data, including HRQoL information, were merged
with survey responses. Quantile regression adjusting for demographics,
stroke variables and patient clustering were used. Dependent variables
were HRQoL (EQ-5D Visual Analogue Scale (VAS) 0–100) and number of
unmet needs.
Results: 207/446 eligible registrants responded (median age 72 years, 69%
male; 63% ischemic stroke). Responders and non-responders were
similar. PREPARED scores were lowest for: discharge control (65%); and
medications (71%). Approximately half (59%) reported feeling well pre-
pared. Better information exchange (coefficient: 0.1, 95% CI: 0.03, 0.2
p = 0.008) and coping scores (coefficient: 0.1, 95% CI: 0.04, 0.2, p = 0.003)
were associated with higher VAS scores. Lower medication (coefficient:
−0.009, 95% CI: −0.02, −0.002, p = 0.02) and information exchange scores
(coefficient: −0.02, 95% CI: −0.03, −0.005, p = 0.009) were associated with
increased unmet needs.
Conclusion: We provide new information demonstrating that the quality
of discharge planning received by stroke patients is sub-optimal, with
long-term implications.
ESOC-0369
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Lone transient ischemic attack – Analysis of the
application of the tissue-based diagnosis in the
Budapest Districts 8–12 Project
D Bereczki1, A Ajtay1, I Vastagh1, I Szo˝cs1, A Folyovich2
1Depatment of Neurology, Semmelweis University, Budapest,
Hungary
2Department of Neurology and Stroke, Szent János Hospital,
Budapest, Hungary
Background: although the current diagnosis of TIA involves the revers-
ibility of focal neurological signs without tissue damage since 2002, in
routine practice TIA is frequently diagnosed without neuroimaging based
only on clinical features. We analyzed the rate of neurological evaluation
and imaging of patients diagnosed with TIA.
Methods: the database of the National Health Insurance Fund was ana-
lyzed for patients living in 2 districts (about 130,000 inhabitants) of the
Hungarian capital Budapest city with an exclusive ICD-10 diagnosis of
G45 assigned by any specialists both in the inpatient and outpatient set-
tings in the period of 2002–2007, i.e. the first years after the introduction
of the tissue-based TIA definition.
Results: overall 4667 patients were diagnosed with TIA in the study
period, of these 1960 (42%) had TIA as an exclusive diagnosis. The diag-
nosis was given in the outpatient setting in 93% of the cases. Of the 1960
patients the diagnosis of TIA was established by neurologists in 1562
cases, and the rest were not seen by a neurologist in the 6 years of the
study. Cranial CT or MRI was performed in only 11.3% of the cases and
90% of the cases were not hospitalized during the 6 years.
Conclusions: in the Hungarian healthcare system TIA as a lone diagnosis
is given by non-neurologists in 20%, and is not confirmed by neuroim-
aging in the majority of the cases. The current diagnostic standard of TIA
requiring preferably MR imaging is not feasible in the outpatient setting
in middle income countries.
ESOC-1542
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Triage of TIA clinic referrals using clinical features
identifies true vascular events
S Blayney1, M D Hill1, P A Barber1, A M Demchuk1, J D Engbers1,
S B Coutts1
1Clinical Neurosciences, University of Calgary, Calgary, Canada
Introduction: Rapid specialist assessment of patients with TIA is essential
in preventing further stroke. However an increasing number of referrals to
a fixed capacity service requires safe triaging to prioritize those at highest
risk. We use clinical symptoms and time from event to triage patients into
high, medium and low-risk categories. We hypothesized that we would
identify more true vascular events in higher risk categories.
Method: We reviewed new clinic attendances over 12 months, triaged
using the algorithm below. “A” referrals were targeted to be seen within 2
days, “B” within 7 days and “C” routine. Analysis looked at final diagnoses
made by the treating neurologist.
Clinical features
Symptom onset to
referral timing Triage
Motor weakness or speech deficit
≥5 mins
Within 7 days
8–14 days
A
B
Amaurosis fugax
Central retinal artery occlusion
Within 14 days B
All other referrals – e.g. numbess, ataxia,
late presentation motor or speech, etc.
C
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Results: Amongst 1600 new patients, 652 (40.8%) had a final diagnosis of
TIA (27.4%) or stroke (13.4%). Over 80% of TIA/stroke patients were
seen urgently using this system. More patients were diagnosed with TIA/
stroke in higher risk categories (p < 0.0001, 52.5% as ‘A’,31.0% as ‘B’ and
16.7% as ‘C’. There was no difference in vascular risk factors between
triage groups. Recurrent stroke rates and hospitalization numbers will be
available at the conference.
Discussion: TIA/stroke rates vary within triage categories. We saw more
TIA/stroke patients urgently or semi-urgently.
ESOC-1253
22. Service Organisation
Cost-effectiveness of telestroke in five organizational
scenarios in Franche-Comté (France)
B Bouamra1, E Medeiros de Bustos1, F Vuillier1, P Montiel1,
L Bonnet1, T Moulin1
1Neurology, CHRU de Besançon, Besançon, France
Medical and economical evaluation of five different organizational sce-
narios for telestroke in the Franche-Comté region: the current model,
comprised of three stroke units and eight emergency services, all equipped
with telemedicine tools; the model with alternating hubs; the stroke ward
model (local units dedicated to stroke care and equipped with telemedi-
cine tools); the model without telemedicine; and the model with eight
stroke units.
Establishment of a model that takes into account the patient management
costs during the initial phase (from the onset of clinical signs to the
discharge from hospital) according to the different financial sectors
(transport, hospital personnel time, telemedicine tools, etc.).
Comparison of the different models according to three criteria: economi-
cal, thrombolysis rates, and hospitalization in a dedicated unit.
In conclusion, the scenarios with telemedicine, in particular those with
the stroke ward model, reduce management costs whilst promoting care
quality for all patients, including non-thrombolysed patients.
ESOC-0231
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The quality of acute stroke care received by renal
replacement therapy recipients in England: A National
linkage study
B D Bray1, F Caskey2, A Power3, T Evans4, J Medcalf5, L Paley6,
A Hoffman6, C D A Wolfe1, A G Rudd1
1Division of Health and Social Care Research, King’s College
London, London, United Kingdom
2UK Renal Registry, UK Renal Registry, Bristol, United
Kingdom
3Renal Unit, North Bristol NHS Trust, Bristol, United Kingdom
4National Cardiovascular Intelligence Network, Public Health
England, London, United Kingdom
5Renal Unit, Leicester Royal Infirmary, Leicester, United
Kingdom
6Stroke Programme, Royal College of Physicians, London,
United Kingdom
Background: The requirement for renal replacement therapy (RRT) may
make it harder to provide good quality acute stroke care for patients. We
aimed to identify if inequalities existed in the quality of acute stroke care
provided to RRT recipients in England.
Methods: Retrospective linked cohort study using data from the UK Renal
Registry and SINAP (a national quality register of stroke care), of patients
admitted with stroke to hospitals in England from April 2010 to December
2012. Pseudonymized person level data linkage was carried out.
Results: 84,330 patients with acute stroke were admitted to 96 hospitals in
England. 439 of these were RRT recipients: 292 (67%) hemodialysis, 41
(9%) peritoneal dialysis and 105 (24%) transplant. There were no signifi-
cant differences in the proportion of patients admitted to a stroke unit
within 4 hours between RRT and other patients (54% vs 56%; p = 0.23), in
having a brain scan within 24 hours (89% vs 92%; p = 0.05), antiplatelet
therapy if applicable within 24 hours (89% vs 86%; p = 0.14) or in having
a swallow assessment within 24 hours (85% vs 87%; p = 0.22). RRT
patients were less likely to have thrombolysis (7% vs 10% of ischemic
stroke; p = 0.04) or access to occupational therapy (80% vs 85%, p = 0.02),
physiotherapy (89% vs 93%; p = 0.005) and speech and language therapy
(59% vs 69%; p = 0.001).
Conclusion: In patients reported to the national quality register for stroke
in England, inequalities in stroke care quality in RRT patients largely relate
to access to post stroke rehabilitation, which may reduce the chance of
recovery.
ESOC-0698
22. Service Organisation
Beliefs and opinions regarding telemedicine: A survey
of the broad public and professional caregivers
R Brouns1, A Valenzuela Espinoza1, K Guldolf2, F Vandervorst2,
R J Van Hooff1, H Fernandez1, S Desmaele3, M Cambron1,
I Hubloue4, A De Smedt1
1Center for Neurosciences (C4N), Vrije Universiteit Brussel,
Brussels, Belgium
2Neurology, Universitair Ziekenhuis Brussel, Brussels, Belgium
3Research group Clinical Pharmacology and Clinical Pharmacy
(KFAR), Vrije Universiteit Brussel, Brussels, Belgium
4Research Group on Emergency and Disaster Medicine
(ReGEDiM), Vrije Universiteit Brussel, Brussels, Belgium
Introduction: Telemedicine can be a reliable alternative for face-to-face
patient care, yet its adoption remains slow and fragmented. Many barriers
for broad application of this technology have been suggested, among
which patient and caregiver acceptance.
Methods: We designed a survey to evaluate the opinions and beliefs of the
broad public regarding telemedicine for emergency and chronic care.
In-ambulance telemedicine for stroke was presented as a live showcase for
emergency telemedicine. The survey was obtained via face-to-face inter-
views of visitors at the Universitair Ziekenhuis Brussel (UZB) on World
Stroke Day 2014. The online questionnaire was distributed among pro-
fessional caregivers the UZB and among the broad public using social
media.
Results: 642 respondents accessed the survey, of which 607 were aged ≥18
years and provided at least one answer. 20.3% of respondents were pro-
fessional caregivers, 38.6% were visitors of the UZB at World Stroke Day
and 41.2% were responders via social media. The questions and results are
presented in the Table.
Conclusion: The results of this survey indicate that the broad public is
ready to adopt telemedicine for emergency treatment (i.e. in-ambulance
telestroke) and for chronic care at home. Possible issues with privacy are
not perceived as a major objection and the majority of respondents is
willing to participate in future teleconsultations.
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Alcohol habits and awareness in stroke patients
attending a nurse-led stroke clinic for outpatients
I De Sousa1
1Stroke, Imperial College Healthcare NHS Trust, London,
United Kingdom
Background: Excessive alcohol intake is a risk factor for stroke. Guidelines
in the United Kingdom recommend that stroke patients are advised on
maximum alcohol intake per day. The aim of this study is to understand
alcohol habits and awareness of patients attending a new nurse-led stroke
clinic in hospital.
Methods: Patients that attended an outpatient nurse-led stroke clinic at 1
month following discharge from a Hyper-acute stroke unit were included.
Patients were seen by a Clinical nurse specialist in stroke during the month
of December 2014 and the first week of January 2015. An audit tool was
developed to facilitate a retrospective audit of the clinic’s proforma.
Results: Fourteen patients were included. Six of 14 patients (42,9%)
denied alcohol consumption before and after the stroke, while only 1 of 14
patients (7,1%) reported alcohol consumption prior to the stroke. Seven
of 14 patients (50%) were identified with having drinking habits and wine
was mentioned by 5 of 7 patients (71,3%) as their preferred drink. All
patients drinking alcohol were unaware of maximum unit consumption,
nor their usual unit intake. Four of 7 patients (57,1%) consumed alcohol
above the recommended prior to their stroke.
Conclusion: Alcohol consumption was present in 50% of patients that
attended an outpatient nurse-led stroke clinic. Stroke patients are unaware
of their maximum recommended intake of alcohol per day and usual
intake of alcohol (in units). Information tailored to patient’s gender and
preferred drink should be provided. An outpatient nurse-led stroke clinic
enhanced secondary stroke prevention.
ESOC-0788
22. Service Organisation
Time is brain: The Sheffield straight to scan audit
G Dunn1, S Bell1, K Harkness1, A Majid1
1Department of neurology, Sheffield Teaching Hospitals NHS
Trust, Sheffield, United Kingdom
Introduction: UK Stroke teams have had to develop thrombolysis services
in an environment not originally set up to deal with an acute service. To
try and reduce the door to needle time (DNT) in Sheffield we developed
a ‘straight to CT’ approach. Analysis of our thrombolysis pathway showed
delays in obtaining a CT scan prolonged DNT.
Method: The ‘straight to CT’ approach involves patients going directly to
CT scan on hospital arrival. Previously, patients went to the ward and then
CT scan. Between 9am–5pm paramedics pre-alert the stroke team (who
then meet the paramedics in CT) of a potential thrombolysis case.
Data collection: 3 months before and after this change.
Results: 21 patients were thrombolysed prior to the start of ‘straight to
CT’, DNT was 64 minutes, median Door to CT scan time was 14 minutes
(IQR 8–18.5).
Seven patients were thrombolysed after the start of ‘straight to CT.’ DNT
was 30 minutes (IQR 28–37), median door to CT scan time was 3 minutes
(IQR 2–5).
Sixteen patients were taken straight to CT, but not thrombolysed due to
contraindications. Median Door to CT time was 4 minutes (IQR 0–5.5)
for 13 of the 16 (1 refused CT,2 currently missing data). No serious
complications occurred by going straight to scan.
Conclusion: Straight to scan can substantially reduce DNT times; in our
case by 34 minutes. Many UK stroke centers may face similar logistical
problems. With adaptation of the thrombolysis pathway, substantial
reductions can be safely made to the DNT.
ESOC-1189
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Integration of dedicated mri into acute stroke services
is cost-effective in reducing length of hospital
admission and expediting clinical decision-making for
atypical stroke presentations
N R Evans1, D J Day2, M Spillane1, N M Hannon2
1Department of Clinical Neurosciences, University of
Cambridge, Cambridge, United Kingdom
2Department of Stroke Medicine, Cambridge University
Hospitals NHS Foundation Trust, Cambridge, United Kingdom
Introduction: Atypical stroke presentations constitute a large proportion
of stroke unit workloads. Magnetic resonance imaging (MRI) may differ-
entiate stroke and non-stroke presentations and guide management.
However, MRI availability is often limited and delays waiting for scans
result in increased lengths of hospital stay (LOS). We assessed how
increased availability of MRI affected LOS and its cost implications.
Methods: The expedited MRI protocol involved a dedicated daily MRI
slot for stroke unit use. Patients requiring MRI for diagnosis or to deter-
mine management were identified from all acute stroke admissions to
Cambridge University Hospitals between November 2013 and May 2014.
MRI sequences included T1, T2, diffusion-weighted imaging (DWI), gra-
dient echo, and angiography.
Results: 93 individuals underwent expedited MRI scanning. 36 (38.7%)
were discharged within 24 hours of admission. Median time from admis-
sion to MRI was 1 (IQR 1.5) day. Median MRI to discharge was 3.5 (IQR
9) days for confirmed stroke and 0 (IQR 2.5) days for stroke mimics
(p < 0.01). 50 had DWI lesions, 31 had normal MRI scans, 12 had abnor-
mal but DWI negative findings (such as tumors).
Discussion: Before expedited MRI scanning, four to five bed days were
taken up every week by individuals awaiting MRI. Timely MRI
Abstracts
© 2015 The Authors.
International Journal of Stroke © 2015 World Stroke Organization Vol 10 (Suppl. 2); April 2015; 77–438354
investigation facilitates early stroke mimic discharge and improves clinical
decision-making in the acute setting. For patients discharged within 24
hours, there is an estimated cost saving of £546 per patient, representing
potential savings of £88,450 per annum. These results have important
implications for hospital capacity, service costs, patient satisfaction and
clinical care.
ESOC-0344
22. Service Organisation
Developing a state-wide acute stroke protocol for
public hospitals
K Goldsmith1, J Luker2, J Jannes3, S L Hillier2
1Stroke Clinical Network, SA Health, Adelaide, Australia
2International Centre for Allied Health Evidence, University of
South Australia, Adelaide, Australia
3Stroke Unit Head, The Queen Elizabeth Hospital, Adelaide,
Australia
Objectives: The Stroke Clinical Network (Network) used a participatory
process to develop state-wide procedures and protocols for acute stroke
care in South Australia (SA).
Setting: SA has a small population of 1.7 million, but large land area
(983,000 km2), with four metropolitan stroke units (52 beds), three rural
services and around 3,000 acute stroke admissions per year.
Background: Despite having Australian guidelines for acute stroke man-
agement since 1999, a 2013 national audit reported: access to stroke unit
care in SA is low (43%); 13% of patients with ischemic stroke received
thrombolysis; 64% of eligible patients were swallow screened or assessed
before food or drink; and 56% were seen by a physiotherapist within 48
hours.
Methods: A number of work groups, comprising in total 98 people, from
different disciplines (doctors, nurses, allied health) and consumers, were
tasked with developing different sections of the procedures and protocols.
Two clinical leads provided leadership in the development and writing of
the document. Iterative feedback/consultation sessions were held, culmi-
nating in a forum attended by around 80 people. The process was inclusive
and consensus based with choices provided, such as where more than one
evidence based assessment/screening tool was identified, final selections
were by consensus. The 94 page document operationalizes Australian
guidelines and provides a pathway to ensure our stroke units provide best
practice, safe, effective and efficient care.
Next steps: The Network will lead an implementation process in conjunc-
tion with the state Safety & Quality Unit and includes targeted data
collection, consumer and clinician feedback.
ESOC-0737
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Differences in standardized thrombolysis rates
according to stroke service level are mainly explained
by restriction of thrombolysis to patients >80 years
and with preexisting disabilities
C Gumbinger1, B Reuter2, T Sauer2, W Hacke1, R Peter1
1Department of Neurology, University Hospital Heidelberg,
Heidelberg, Germany
2Department of Neurology, University Hospital Mannheim,
Mannheim, Germany
Background: Intravenous thrombolysis (IVT) is a well-reviewed treat-
ment of proven benefit for selected patients with acute ischemic stroke,
but in everyday clinical practice thrombolysis remains underused. We
analyzed the proportion of patients receiving IVT in a state with 10.4
million inhabitants using uniform reporting and interpretation instruc-
tion to describe differences between stroke service levels and to explore
reasons for possible underuse of IVT.
Methods: Data from 2008 to 2012 of the Baden-Württemberg stroke reg-
istry was analyzed for the proportion of patients admitted within the 4.5 h
time-window receiving IVT. We used a Poisson-model to identify predic-
tors of IVT and reasons for differences between stroke service levels.
Potential IVT rates were estimated using stroke centers as reference. We
adjusted for comorbidities stroke severity.
Results: 10,499 of 36,901 patients were treated with IVT; the rate was
28.5% and decreased with service levels from 44.0% (stroke centers) to
13.1% (hospitals without a stroke unit). For patients >80 years and with
preexisting disabilities IVT rates decreased from 43.5% to 2.8%. Potential
thrombolysis rates differed between 41.9% (regional stroke units) and
44.4% (hospitals without a stroke unit) leading to a potential relative
increase of 52.7% of the IVT rate.
Conclusion: Standardized IVT rate may improve comparability of IVT
rates between stroke service providers. Differences in IVT rates between
stroke service levels were mainly explained by differences in use of IVT in
patients >80 years and with preexisting disabilities. The potential relative
increase of 52.7% of the IVT rate underlines the importance of optimizing
stroke service organization.
ESOC-0245
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Differences in vascular investigations in the setting of
transient ischemic attacks
R Milo1, A Y Gur1, D Tanne2, N M Bornstein3, S Koton4
1Neurology, Barzilai Medical Center, Ashkelon, Israel
2Neurology, Sheba Medical Center, Ramat Gan, Israel
3Neurology, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel
4Epidemiology, Stanley Steyer School of Health Professions,
Tel Aviv, Israel
Background: Recent studies suggest that rapid evaluation of patients with
transient ischemic attack (TIA) is critical. Quality of in-hospital care
strongly depends on a complex package of vascular investigations. Rates of
diagnostic tests may vary between wards. We used data from the National
Acute Stroke Israeli (NASIS 2004, 2007 and 2010) prospective hospital-
based registry for comparing vascular investigation in TIA patients admit-
ted at different departments.
Methods: Odds Ratios (ORs, 95% CI) by admission ward (neurological
departments with stroke units – NDSU, neurological departments
without stroke units – ND and other departments-Other) were produced
using logistic regression models for brain computed tomography or mag-
netic resonance imaging (CT/MRI), CT/MRI angiography, carotid
duplex, transcranial Doppler (TCD), transthoracic or transesophagial
echocardiography (TTE/TEE) and Holter electrocardiography in TIA
patients adjusting for age, gender, prior stroke, prior disability, cancer and
dementia.
Results: Overall, 1245 patients were admitted (NDSU: 137 patients; ND:
309; Other: 799). OR (95% CI) for NDSU and ND compared to other
wards were: 20.03 (2.76–145.21) and 3.42 (1.83–6.41) respectively for
CT/MRI angiography; 2.60 (1.77–3.82) and 5.43 (4.00–7.39) for carotid
duplex; 3.53(1.81–6.88) and 2.21 (1.21–4.03) for TCD; 1.57 (0.99–2.51)
and 1.55 (1.08–2.22) for TTE; 0.34 (0.04–2.66) and 3.13 (1.52–6.46) for
TEE; 2.94 (1.36–6.33) and 4.78 (2.69–8.49) respectively for Holter elec-
trocardiography. Findings were generally consistent in all NASIS periods.
Conclusions: Our data suggest that TIA patients are best evaluated in
NDSUs. Findings may partially be related to availability and awareness of
tests in the various wards, as well as differences in patients characteristics
not accounted for in this study.
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The Irish National Stroke Programme 2010–2014:
Evaluation of results
J Harbison1, C Brennan2, P Marsden2, P Kelly3
1Department of Medical Gerontology, Trinity Centre for
Health Sciences, Dublin, Ireland
2Department of Public Health, Health Service Executive,
Tullamore, Ireland
3Department of Neurology, University College Dublin, Dublin,
Ireland
The National Audit of Stroke Care (INASC) published in 2007 showed
that stroke services in Ireland were s underdeveloped with only one stroke
unit in the country and a thrombolysis rate of 1%. In response a clinician
led, National Stroke Programme was established in 2009 to improve stroke
care and develop multiple areas of stroke care from prevention to reha-
bilitation. In the interim, Ireland suffered a banking collapse and conse-
quent economic crisis that severely restricted resources available for the
program.
Methods: The program undertook several initiatives, notably the reorga-
nization of stroke services including redirection of acute patients to orga-
nized stroke services, the opening of 7 new stroke units and the
appointment of 49 new specialist nursing and therapy staff to units across
the country. We appointed a number of new stroke trained physicians
(neurologists and geriatricians) and established a training program for
thrombolysis. We established early supported discharge teams in three
urban areas and a national electronic stroke register. Most recently, a
national telemedicine network has been established to support stroke and
other specialties.
Results: Between 2009 and 2013 there was a 2.9% reduction in stroke
admissions but a 10.5% reduction in stroke deaths (p = 0.06). Discharge
direct to nursing homes reduced by 22.9% (p < 0.001). Average length of
stay for dropped by 2.1 days (10.2%), median length of stay by 1 day.
National thrombolysis rate increased from 3.5% in 2009 to 10.5% in 2013.
Conclusions: With limited resources, reorganization of stroke services has
significantly improved care of stroke in Ireland.
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Quality of stroke unit care in Germany 2010–2012:
The German Stroke Registers Study Group (ADSR)
S Hillmann1, S Wiedmann1, K Berger2, D G Nabavi3, I Bruder4,
H C Koennecke5, G Seidel6, B Misselwitz7, A Janssen8,
C Burmeister9, C Matthis10, P Hermanek11, P U Heuschmann1
1Institute of Clinical Epidemiology and Biometry (ICE-B),
University of Würzburg, Würzburg, Germany
2Institute of Epidemiology and Social Medicine University of
Münster, Quality Assurance Project ”Stroke Register
Northwest Germany,” Münster, Germany
3Department of Neurology, Vivantes Klinikum Neukölln,
Berlin, Germany
4Office for Quality Assurance in Hospitals (GeQiK),
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Background: Evaluations of the quality of stroke unit (SU) care in
Germany are scarce. We investigated characteristics of patients admitted
to a SU as well as adherence to evidence-based quality indicators among
hospitals providing SU care between 2010 and 2012.
Methods: Data were derived from the German Stroke Registers Study
Group (ADSR), a network of 9 regional registers for monitoring quality of
acute stroke care in Germany. Analyses were restricted to hospitals with a
certified SU according to the criteria of the German Stroke Society, the
German Stroke Foundation or to regional criteria with available informa-
tion on SU admission. Adherence of these hospitals to a set of 11 evidence-
based quality indicators (QIs) including aspects of early prevention,
management, rehabilitation and diagnosis with predefined target ranges
for good quality of acute stroke care was calculated. Multivariate logistic
regression analyses were performed.
Results: Between 2010 and 2012 more than 490,000 patients were treated
in 259 hospitals providing SU care; of those 76.8% were admitted on a SU.
Patients younger than 85 y (p < 0.0001), with a symptom admission time
of less than 24 hours (p < 0.0001), without disturbances of consciousness
(p < 0.0001), and with an ischemic stroke or TIA (p < 0.0001) were more
likely to be admitted directly to a SU. Overall, in hospitals providing SU
care a median of 8 (inter-quartile range 7–10) out of a maximum of 11
QIs was found to be within or above the defined target ranges.
Conclusions: Data indicate high quality of acute SU care in Germany.
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stroke management
N Kakaletsis1, H Milionis2, G Ntaios3, I A Panagopoulou2,
A Karagiannaki3, K Makaritsis3, T Tegos4, K Tziomalos1,
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Background: Delays during acute ischemic stroke (AIS) management may
be identified at population, emergency services and hospital level. The
purpose of this study is to evaluate the duration of “stroke-onset to
hospital-arrival” time and of “hospital-arrival to computerized tomogra-
phy (CT) initiation” time, in three University Hospitals of Northern and
Central Greece.
Methods: We used data derived from the multicenter observational
PREVISE study (11/2013–11/2014) concerning the prognostic value of
blood pressure variability in AIS. Age, gender, NIHSS on admission and
the exact time of stroke onset, arrival at hospital and CT initiation were
recorded.
Results: A total of 163 AIS patients with mean NIHSS 9.9, mean age 80.6
years, male 43.8%, consisted the material of our study. The mean “onset-
to-door” time was 5 hours and 36 minutes and the mean “door-to-CT
initiation” time was 2 hours and 15 minutes. The observed frequency of
intravenous thrombolytic therapy was only 2.5%, but the potential
frequency according to age, NIHSS and time was 8.6% for thrombolysis at
3 hours and 14.7% at 4.5 hours, and by excluding the delayed time of
arrival the frequency of potential candidates for thrombolysis increased to
29.4%.
Discussion: The long mean “onset-to-door” time may reflect the unaware-
ness concerning the recognition of stroke by population or delay of trans-
portation to hospital. The long mean “door-to-CT initiation” time
constituted another barrier to timely intravenous thrombolytic therapy
which was not implemented widely compared to the threefold potential
frequency of its application at 3 hours or fivefold potential frequency at
4.5 hours.
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Purpose: Stroke is one of the leading causes for morbidity and mortality
worldwide. Yet, ischemic stroke can effectively be treated within the first
hours after symptom onset. Despite of this effective treatment available,
most patients arrive too late in hospital and thus cannot be treated. Many
patients wait too long before calling the medical emergency phone. Thus,
in order to increase the number of acute stroke patients coming early to
hospital, we conducted a multi media stroke campaign in Western
Norway. We present the effect of this campaign.
Material and methods: A multimedia stroke campaign was run for one
month (May 2014). Stroke awareness in the population was assessed
before and after the campaign. The number of thrombolysed patients was
registered in all participating hospitals before and after the campaign.
Additionally, in one health region the number of calls to the medical
emergency phone suspecting a stroke was registered.
Results: Stroke awareness in the general population increased from 66%
to 75%. The number of patients thrombolysed increased in all participat-
ing hospitals varying from 5% to 43%. The number of calls to the medical
emergency phone suspecting a stroke increased by 37.4%. The effect of the
stroke awareness campaign persisted for more than five month.
Conclusion: The stroke awareness campaign in Western Norway increased
both stroke awareness in the population and the number of thrombolysed
patients. The results of this campaign encourage the planning of new and
nationwide awareness campaigns.
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Background: Hypertension is a major modifiable risk factor for recurrent
stroke, but is often under-diagnosed by occasional clinic BP readings.
Home BP-monitoring could improve accuracy of diagnosis of hyperten-
sion and BP-variability and allow more appropriately-informed titration
of treatment. We determined the opinion of patients on centralized tele-
metric home monitoring of BP to diagnose and treat hypertension after
TIA or stroke.
Methods: Consecutive consenting patients with a recent TIA or non-
disabling stroke in a population-based study (Oxford Vascular Study)
were taught to use a Bluetooth-equipped BP-monitor (t + Medical, Abing-
don, UK). BP was measured 3 times over 10 minutes on 3 occasions each
day at home for at least 1-month, depending on control. Measurements
transmitted automatically using mobile phone technology were checked
daily on a secure web-page. If BP was consistently above 130/80 mmHg or
below 100/60 antihypertensive therapy was adjusted. Patients’ views were
assessed by anonymized questionnaire at 1-month.
Results: Of 1000 patients recruited, 576 (57.6%) returned the question-
naire. 533 (90.8%) approved of the intensive monitoring, 522 (89%) felt
reassured by the central surveillance, and 500 (85.2%) thought it helpful
to be able to discuss their BP readings over the phone. However, 72
(12.3%) patients reported that monitoring their BP made them anxious
and 83 (14.1%) felt it was time consuming. Mean/SD overall satisfaction
(0% extremely dissatisfied to 100% extremely satisfied) was 89/15.58%.
Conclusion: Centrally-observed telemetric home BP-monitoring was well
received by the majority of patients as a method of diagnosing residual
hypertension and titrating treatment after TIA and stroke.
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Introduction: It is hoped that as stroke care improves case fatality will fall,
but there are few reliable data confirming this.
Aims: To investigate the impact of case mix, hospital of admission and
stroke unit care on changing 30 day and one year case fatality after stroke.
Methods: Routinely collected Scottish Stroke Care Audit data (2005–
2011) were linked to national mortality data. Using 2011 as the index year,
odds ratios (OR) for death within 30 days were calculated, and adjusted
for case mix [six simple variables (SSV)] in three models which included
variations of: admitting hospital, stroke subtype (infarct/hemorrhage)
and stroke unit admission.
30-day mortality according to year of admission (Adjusted OR (95% CI))
Year of
admission Model 11 Model 22 Model 33
2011 1.00 1.00 1.00
2010 1.15 (1.01–1.32) 1.14 (0.98–1.32) 1.10 (0.95–1.28)
2009 1.17 (1.02–1.35) 1.18 (1.01–1.37) 1.12 (0.96–1.32)
2008 1.38 (1.21–1.58) 1.41 (1.21–1.64) 1.31 (1.13–1.53)
2007 1.25 (1.08–1.43) 1.32 (1.13–1.53) 1.24 (1.06–1.45)
2006 1.22 (1.06–1.41) 1.23 (1.05–1.44) 1.12 (0.95–1.31)
2005 1.25 (1.09–1.44) 1.29 (1.11–1.51) 1.11 (0.95–1.30)
1 Adjusted for SSV and hospital; 2 Adjusted for SSV, hospital, stroke type;
3 Adjusted for SSV, hospital, stroke type, stroke unit.
Results: Thirty day mortality adjusted for SSV and hospital (model 1)
showed that the likelihood of dying after stroke fell after 2008. Including
stroke type (model 2) showed a similar pattern. Adding stroke unit care
(model 3) attenuated the risk of death for all years except 2007 and 2008.
Findings were broadly similar at one year.
Conclusions: Case mix, stroke type, admitting hospital and more strik-
ingly stroke unit admission may partly explain changes in case fatality over
time
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Background: Endovascular therapy for the management of acute ischemic
stroke due to large vessel occlusion is offered to select groups of patients at
some tertiary centers. A pathway has been introduced at our district
general hospital to transfer patients, who may benefit from intervention,
to a tertiary center. Results of patients entering the pathway over the first
9 months are presented here.
Methods: Patients entering the pathway were entered into a prospective
register, recording baseline demographic, clinical data, National Institutes
for Health Stroke Scale (NIHSS) and imaging results. Mortality and modi-
fied Rankin score (mRS) were assessed at 3 months for those receiving
intervention (intra-arterial thrombolysis, mechanical thrombectomy or
both).
Results: From February to October 2014, 19 patients entered the pathway
and 11 patients (58%) were transferred to the tertiary center. Of the group
transferred 10 (91%) received intravenous bridging thrombolysis and 9
(82%) underwent endovascular therapy. The median NIHSS was 21 (11–
25) and mean age 62 years (31–79). The median time from stroke onset to
groin puncture was 225 minutes (155–335). At 3 months, 5 patients (55%)
had a MRS ≤ 3, 3 patients (33%) achieved functional independence
(MRS ≤ 2) and 2 patients died (mortality 22%). For all patients, median
time from admission to intravenous thrombolysis was 31 minutes (20–
120) and 38 minutes (11–160) for CT angiogram acquisition.
Conclusions: Patients at District General Hospitals can potentially benefit
from Endovascular Therapy. A multidisciplinary agreed pathway should
be in place in centers providing hyperacute care for the transfer of select
patients to a tertiary unit.
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Outpatient TIA care bundle – An exploration of
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Introduction: Inpatient acute stroke care in Scotland is audited against
evidenced based standards using a “stroke bundle.” Improving adherence
to the care bundle is associated with improved outcome. Outpatient stan-
dards concentrate on rapid access to assessment, but without appropriate
investigations and treatment this will not meet patients’ needs. We inves-
tigated the potential utility of a “TIA bundle” to improve outpatient care.
Methods: We collected data for new patient appointments during one
month in a teaching hospital with six TIA clinics/week. Limited dedicated
imaging slots are available for each clinic but no direct access to cardiac
investigations. Standards set were: clinic review within 4 days of receipt of
referral; same day brain imaging; carotid imaging within 48 hours; cardiac
investigations within one month; treatment advice on the day of clinic
attendance.
Results: 59 urgent TIA referrals were received. 61%(n = 36) were offered
an appointment within the target of 4 days. In 15 the diagnosis after clinic
review was not TIA. Of those with a diagnosis of possible or definite
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TIA(n = 44) none achieved all five elements of the bundle. 7%(n = 3)
achieved four elements; 34%(n = 15) three elements; 54%(n = 24) two
elements and 5%(n = 2) one element. Treatment advice was offered in
98%(n = 43). Poorest performance was in cardiac investigation, where
there is no dedicated service; only 16%(n = 7) met the bundle standard.
Discussion: Presentation of the data in bundle format made assessment of
service deficiencies clearer. A national “outpatient bundle” for TIA clinics
could highlight areas of deficiency and improve access to rapid specialist
assessment and also timely investigation and treatment.
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Background: NHS organizations have are required to involve patients and
the public when redesigning healthcare services. Little is known about
what such involvement contributes to service improvement. Recent
reconfiguration of acute stroke services in London and Manchester sought
to involve patients, carers and the public.
Aim: To understand how lay people were involved in stroke service recon-
figurations and the perceived impact of this.
Methods: Thematic analysis of qualitative interviews with 41 stakeholders
working on the reconfigurations.
Results: Lay people were informed about but did not actively contribute
to reconfiguration planning. Lay people were asked to help to prepare
information delivery strategies, including how to frame ‘scripts’ about the
planned changes. Considerable efforts, using a range of methods, went
into seeking lay views on the reconfiguration plans. Stakeholder consul-
tations collected evidence that lay people largely supported the planned
changes to acute services. In one area, total consultation costs were esti-
mated at £1.2 million. Interviewees raised concerns about the representa-
tiveness of lay people who were ‘involved’. They considered that consulting
the public was a necessary political exercise but felt it had little or no
influence on reconfiguration plans. Lay people were reported to use con-
sultation to express their greater concern about a need to improve reha-
bilitation services.
Conclusion: In these cases, lay involvement served a symbolic function,
asserting the centrality of the patient, and demonstrating that political
legitimacy had been sought and obtained. Both reconfigurations
improved patient outcomes, raising questions about what kinds of
involvement are required for specific circumstances.
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Background: In-hospital strokes are associated with slower referral than
those which occur outside the hospital, which results in contraindication
for thrombolysis treatment. It may be that knowledge deficits in stroke
response amongst hospital staff may contribute to delays in referral,
assessment and treatment of in-hospital stroke.
Method: A hospital survey was conducted with all hospital staff members
operating at ward level including doctors, nurses, allied health profession-
als, support staff, porters and students. The Stroke Awareness Question-
naire was adapted for use with hospital staff to assess knowledge of stroke
symptoms, stroke impairments, acute treatments, and hospital protocol
for treatment of stroke.
Results: Ninety-six staff members were interviewed, 81% of whom were
clinical staff (medical, nursing, allied health professionals). Ninety-two
percent were found to have adequate knowledge of stroke symptoms (i.e.
name three or more symptoms), however only 49% of staff were aware of
thrombolysis treatment and only 48% could identify the treatment
window for thrombolysis administration. Staff on neurology wards were
found to be more likely to name more symptoms than staff on general
medical and surgical wards (5.1 vs. 3.7 [p < 0.001]) Post-stroke depression
was poorly recognized as a long-term impairment of stroke (6.3%, n = 6).
Conclusion: Hospital staff were found to have adequate stroke knowledge.
Of concern was the low awareness of thrombolysis therapy amongst hos-
pital. Only half of the sample could identify the time restrictions for
thrombolysis administration. If inpatient staff do not activate stroke pro-
tocols immediately when in-hospital stroke occurs, opportunities for
treatment with thrombolysis may be missed.
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Background and purpose: Implementation of TeleStroke Units is one way
to organize acute stroke care in underserved, mostly rural, areas. The
Telemedical Project for Integrative Stroke Care (TEMPiS) is a TeleStroke
Unit network in Bavaria, Germany. We aimed to determine quality of
acute stroke care in TEMPiS TeleStroke Units.
Methods: All TEMPiS TeleStroke Units report quality data to the Bavarian
Stroke Registry. Predefined national quality indicators are analyzed.
Results for the year 2013 are reported. Results of quality indicators of
TEMPiS TeleStroke Units were looked at regarding fulfillment of pre-
defined national targets and compared to statewide and national results.
Results: In 2013, 15 TEMPiS TeleStroke Units treated 7,386 patients with
stroke and TIA (hospital range 240 to 892; mean 492; median 452).
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Documentation rate was 99.3%. In 12 of 13 indicators predefined targets
were fulfilled. In comparison to all 154 hospitals participating in the
Bavarian Stroke Registry, TeleStroke Units had higher percentage points in
14, lower in 3 and equal percentage level in one quality indicator.
Conclusion: Registry data of the TeleStroke network TEMPiS suggest a
convincing acute care quality in TeleStroke Units.
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Background: Previous research has shown the importance of urgent ini-
tiation of secondary prevention after transient ischemic attack (TIA) to
reduce the risk of recurrent stroke. Many hospitals in the Netherlands
have therefore implemented rapid care pathways for TIA patients, here-
after TIA screening. Dutch stroke guidelines lack clear directives for orga-
nization of the TIA screening and thus allow for variation.
Aim: The aim of this study was to investigate variation in organization of
TIA care in Dutch hospitals.
Methods: In 88 Dutch hospitals a neurologist was invited to participate in
a web-based survey. The survey primarily focused on the organization and
content of TIA care. Timeliness of TIA care was also addressed.
Results: A total of 70 (80%) neurologists completed the survey, all of
whom reported having a TIA screening in their hospital. There was con-
siderable variation in the method of application and the location where
the screening is conducted. In 10,2% of the hospitals TIA patients are
admitted to the ward. The content of the screenings is similar, although
hospitals vary in the extent of cardiological assessment and young stroke
protocol. Almost all hospitals aim for timeliness as directed by guidelines,
however registration of timeliness is often lacking. 85,7% of respondents
reported that secondary prevention is initiated prior to screening.
Conclusions: As was hypothesized, this study found variation in organi-
zation of rapid TIA care in Dutch hospitals, especially regarding location,
method of application and cardiological assessment. Further research is
needed to investigate implications of this variation for quality of care.
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Aims: National guidance promotes early identification of carotid stenosis
in patients with TIA and non-disabling stroke so that surgery can be
contemplated early. We aim to image vessels within 24 hours and refer for
endarterectomy by 48 hours. Ultrasound provides quick and safe diagno-
sis. Limited vascular ultrasound expertise in our Trust leads to reliance on
other modalities. We aimed to assess whether clearer pathways for carotid
ultrasound across the Trust could facilitate rapid access scans for TIA.
Method: We analyzed all carotid ultrasounds performed over 6 months,
waiting times, requesting speciality, indications and results.
Results: 104 scans were performed between May and November 2014.
Mean waiting time was 6.49 days. Scans were requested from 14 speciali-
ties – mainly stroke physicians (52.9%), general practitioners (13.5%) and
cardiologists (6.7%). In 22 (21.2%) no clear indication was given. Bar one,
these were from non-stroke specialists. 33 (32%) scans were for suspected
stroke or TIA, mean waiting time 4.24 days. 7 of these were from
non-stroke specialists. Flow limiting stenosis (>50%) was identified on 15
(14.4%) scans, of which 8 had seen the stroke team beforehand. By exclud-
ing requests with insufficient detail or non-standard indications we esti-
mate mean waiting time reduces to 5.12 days.
Conclusion: A significant proportion (68%) of carotid ultrasound
requests do not aim to assess high-risk carotid stenosis which might
benefit from early surgery. Closer evaluation of request form information
or policing of referrals might improve identification of these patients and
allow more rapid assessment for this group.
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Background: Since 2013, seven Swedish county councils collaborate
within the project Sveus to develop value-based monitoring and reim-
bursement systems for eight patient groups including stroke. Research
topics (approved by Ethical Review Board):
• Are there differences in the value of health care between care
givers/counties?
• How can a value-based monitoring system and reimbursement
system be designed?
Aim of substudy: To compare resource use during one year following a
stroke between county councils, adjusted for patient characteristics.
Method: Identification of key resources and factors influencing outcome
(casemix-variables) were based on available literature and clinical exper-
tise of the research group, representing county councils, patient organi-
zation, specialists, quality registries and Ivbar (RnD company). The
research database consists of data from patients suffering a stroke 2007–
2012 retrieved from several registries; county councils’ administrative
systems, national quality registries for stroke (Riks-Stroke) and rehabili-
tation (WebRehab), the National Board of Health and Welfare, Swedish
Social Insurance Agency, and Statistics Sweden. Data were linked on
patient level, anonymized, and statistical analyses were performed,
primarily using mixed-effects models, to allow for casemix-adjusted
comparisons.
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Results:
Generally, county councils averaging longer inpatient stay have less out-
patient visits.
Conclusions: In this sub-study within Sveus we show that there were, after
casemix-adjustments, significant differences in resource use between
counties in the care of stroke patients. How this is associated with
outcome will be explored.
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Background: Severe complications following an acute stroke adversely
impacts outcomes. Little is known about the factors that contribute to, or
ameliorate, the risk of severe complications in hospital after stroke.
Aims: To describe the factors associated with the occurrence of severe
complications following acute stroke in public hospital patients in New
South Wales, Australia.
Methods: A medical record audit of eligible acute stroke admissions from
2000–2014, was carried out using a standardized and validated data col-
lection tool. Severe complication was defined as a new condition that was
incapacitating, life threatening and prolonged hospital admission. Factors,
including gender, admission stroke severity/type, and stroke unit (SU)
care were included in a multilevel logistic regression model if p < 0.15,
with hospital defined as the level.
Results: Among 5,413 patients from 43 hospitals (22 metropolitan, 21
rural), 448 (8%) experienced a severe complication (53% female, median
age 81, 85% ischemic stroke). Multilevel model factors included: indepen-
dence prior to stroke, hemorrhagic stroke, more severe stroke, use of care
plans (all p < 0.001), SU care (p = 0.03), and team meetings (p < 0.01).
Patients with a clinical care plan during their admission were less likely to
experience a severe complication (aOR: 0.64 95% CI 0.46, 0.90). Patients
who experienced a severe complication were more likely to have a team
meeting within 7 days (aOR: 1.6 95% CI 1.2, 2.2).
Conclusion: In a large sample of acute stroke patients, those with a clinical
care plan during their admission had fewer severe in-hospital complica-
tions and therefore, potentially improved patient outcomes.
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Background: Transient ischemic attacks and minor strokes (TIAMS)
require urgent diagnosis and management.
While a proportion of people with TIAMS in Australia present to an
emergency department (ED), many are managed in general practice (GP).
We aimed to establish and compare the demographics and presentation
patterns of ED-presenting and GP-presenting TIAMS.
Methods: Ethics approval was obtained. InSiST – an inception cohort
study of patients of 17 general practices in the Hunter and Manning Valley
regions of Australia. Possible TIAMS were ascertained by multiple over-
lapping methods including searching of GP and hospital databases. Data
is extracted from participants’ GP and hospital medical records and from
structured interviews conducted at baseline, 3-months and 12-months. A
three-clinician panel adjudicates cases as TIAMS or TIAMS-mimic based
on this data plus vascular- and neuro-imaging.
Differences in ED-presenting and GP-presenting TIAMS were tested with
logistic regression, adjusting for age and sex (and ABCD2-score for pro-
cesses of care and management parameters) within Generalized Estimat-
ing Equations to account for clustering within practices.
Results: Of 171 panel-adjudicated TIAMS, 97 were GP-presenting.
GP-presenters had a significantly lower (ABCD2-determined) stroke risk,
lower systolic BP, consumed less alcohol and higher educational attain-
ment than ED-presenters. Following the TIAMS, GP-presenters delayed
contacting medical help longer, and waited longer to see a doctor, com-
pared with ED-presenters. GP-presenters were less likely to have an ECG
performed or have appropriate pharmacotherapy (anti-platelet or antico-
agulant) initiated or increased.
Conclusions: Many TIAMS are GP-presenting, but may receive less appro-
priate investigation and management compared to ED-presenting
TIAMS.
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A comparison of rural and urban health-seeking
behaviour and processes of care in patients with
transient ischemic attack and minor stroke
P Magin1, N Najib2, A Tapley3, D Lasserson4, D Quain1, H Dewey5,
M Parsons6, D Cadilhac7, A P Barber8, C Levi6
1Discipline of General Practice, University of Newcastle,
Newcastle, Australia
2School of Medicine and Public Health, University of
Newcastle, Newcastle, Australia
3Data Management, General Practice Training Valley to Coast,
Newcastle, Australia
4Nuffield Department of Primary Care Health Sciences,
University of Oxford, Oxford, United Kingdom
5Eastern Clinical School Faculty of Medicine Nursing and
Health Sciences, Monash University, Melbourne, Australia
6Centre for Translational Neuroscience, University of
Newcastle, Newcastle, Australia
7Faculty of Medicine Nursing and Health Sciences, Monash
University, Melbourne, Australia
8Centre for Brain Research Faculty of Medical and Health
Sciences, The University of Auckland, Auckland, New Zealand
Background: Transient ischemic attacks and minor strokes (TIAMS)
require urgent diagnosis and management. Distance is a barrier to health-
care access in rural Australia. We sought to determine if community-based
TIAMS patients were disadvantaged by rurality. We aimed to compare
help-seeking and process-of-care between rural and urban TIAMS
patients
Methods: An inception cohort study of patients of 17 general practices in
the Hunter and Manning Valley regions of Australia. Ethics approval and
patient consent were obtained. Possible TIAMS are ascertained by over-
lapping methods including searching of GP and hospital databases. Data
is extracted from participants’ GP and hospital medical records and from
structured interviews conducted at baseline, 3-months and 12-months. A
three-clinician panel adjudicates cases as TIAMS or TIAMS-mimic based
on this data plus vascular and neuro-imaging.
‘Major city’ was classified ‘urban’, and ‘inner and outer regional’ as ‘rural’.
Differences in rural and urban help-seeking behaviour and process-of-
care were tested with logistic regression, adjusting for age and sex within
Generalized Estimating Equations to account for clustering within
practices.
Results: Of 171 adjudicated TIAMS, 83 were rural, 88 were urban. There
were no significant demographic differences between rural and urban
patients (including ABCD2-determined stroke-risk).
Time from seeking to receiving medical care was slightly, but significantly,
longer for rural patients. There was a non-significant trend for longer time
to receiving brain-imaging. Otherwise there were no significant
differences.
Conclusions: Accessing initial healthcare and neuro-imaging post-TIAMS
was not greatly compromised for rural patients. But results may not
generalize to ‘remote’ and ‘very remote’ areas.
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Presentation patterns of patients with transient
ischemic attack (TIA) and minor stroke, compared with
those of stroke/TIA mimics
C Levi1, A Davey2, D Lasserson3, M Parsons1, A P Barber4,
H Dewey5, D Cadilhac6, D Quain2, P Rothwell7, P Magin2
1Centre for Translational Neuroscience, University of
Newcastle, Newcastle, Australia
2Discipline of General Practice, University of Newcastle,
Newcastle, Australia
3Nuffield Department of Primary Care Health Sciences,
University of Oxford, Oxford, United Kingdom
4Centre for Brain Research Faculty of Medical and Health
Sciences, The University of Auckland, Auckland, New Zealand
5Eastern Clinical School Faculty of medicine Nursing and
Health Sciences, Monash University, Melbourne, Australia
6Faculty of Medicine Nursing and Health Sciences, Monash
University, Melbourne, Australia
7University Department of Clinical Neurology, University of
Oxford, Oxford, United Kingdom
Background: In many health systems a majority of TIAs and minor
strokes (TIAMS) present to general practice and often managed without
onward referral. Distinguishing from TIAMS from TIAMS-mimics is
often challenging for the general practitioner (GP) or Emergency Depart-
ment physician (EDP). We aimed to establish and compare the demo-
graphics and presentation patterns of TIAMS and TIAMS-mimics.
Methods: Ethics approval and patient consent were obtained. An incep-
tion cohort study of patients of 17 general practices in the Hunter and
Manning Valley regions of Australia. Possible TIAMS were ascertained by
multiple overlapping methods including searching of general practice and
hospital databases. Data is extracted from participants’ GP and hospital
medical records and from structured interviews conducted at baseline,
3-months and 12-months. A three-clinician panel adjudicates cases
as TIAMS or TIAMS-mimic based on this data plus vascular- and
neuro-imaging.
Differences in characteristics of TIAMS and TIAMS-mimics were tested
with logistic regression, adjusting for age and sex and within Generalized
Estimating Equations to account for clustering within practices.
Results: Of the first 311 adjudicated cases, 171 (55.0%) were TIAMS. Most
common TIAMS-mimics were migraine, vestibular disturbance and
syncope/pre-syncope.
TIAMS adjudication was significantly associated with male sex, age, BMI,
hypertension, smoking-history, lower educational attainment, living
alone and a higher ABCD2 score. TIAMS were significantly more likely to
have motor, speech or ataxic (but not visual or sensory) symptoms.
Conclusions: Presentations of TIAMS and TIAMS-mimics differ on mul-
tiple parameters. This will inform decision-support tools for GP diagnosis
of TIA and minor stroke.
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Effectiveness and safety of endovascular treatment in
acute stroke by a mobile neurointerventional team
H Quesada1, N Perez-Ossa2, M Ribó3, S Abilleira4, L Aja5,
A Tomasello6, C Castaño7, A Martínez-Yélamos1, A Dávalos2,
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1Neurology Department, Hospital Universitary de Bellvitge,
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4Pla Director Malaltia Vascular Cerebral, Agència de Qualitat i
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5Radiology Department, Hospital Universitary de Bellvitge,
Barcelona, Spain
6Radiology Department, Hospital Universitary Vall d’Hebron ,
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7Radiology Department, Hospital Universitary Germans Trias i
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Stroke endovascular treatment (EVT) off-hours in our health area is
performed by staff on call that may attend patients in their own
comprehensive stroke center (CSC) or in a different CSC. Our aim was to
compare effectiveness and safety of EVT between the two models of inter-
vention, local and visiting team.
We studied all patients treated off-hours with EVT from Oct-2012 to
Aug-2014 in three CSC, prospectively recorded in the Catalan Stroke Code
and Reperfusion Consortium Registry. 216 consecutive patients received
off-hours EVT, 154 by local and 65 by visiting teams. Age, NIHSS, vascular
risk factors, stroke subtype, ASPECTS, vessel occlusion site and IV tPA use
were comparable between the two groups. Safety data, outcome variables
at 90 days and time from door to groin puncture and end of procedure are
shown in table.
Our findings suggest that treating patients in CSC by visiting staff is not
associated with poorer outcome, regardless of longer door-to-groin times.
Local team
n = 154
Visiting team
n = 62 P value
Outcome Revascularization (mTICI 2b,3) 117 (76%) 50 (81%) 0.45
Dramatic recovery at 24 hours (improvement ≥8 or NIHSS ≤ 2) 67 (43%) 25 (40%) 0.78
Good outcome (mRS 0–2)* 65 (42%) 25 (40%) 0.87
Safety Symptomatic ICH (SITS-MOST definition) 4 (2.6%) 0 0.50
Procedural complications 23 (15%) 10 (16%) 0.78
Mortality* 36 (23%) 12 (19%) 0.59
Quality Door-to-groin, median[IQR] 125 [85,168] min 141 [111,193] min 0.015
Groin-to-end, median[IQR] 86 [60,127] min 70 [50,120] min 0.22
*Available in 147 patients of local and 57 of visiting groups; missing values are considered as failures and deaths
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Northwick park hospital inter-disciplinary task-based
learning in stroke medicine
R Licenik1, S Davis1, M Ngwako2, P Parmar1, D Ubalde1,
M Dzvene1, L Alwis1, R Bathula1, J Devine1, D Cohen1
1Hyper Acute Stroke Unit, London North West Healthcare
Northwick Park Hospital, London, United Kingdom
2Radcliffe Department of Medicine – Investigative Medicine,
University of Oxford, Oxford, United Kingdom
Background: The Northwick Park Hospital Stroke unit in London is one
of the busiest in the United Kingdom. It was crucial for further healthcare
quality improvement and professional development to develop a compre-
hensive educational program focused on stroke medicine. The program
had to be implemented into the busy hectic hyper acute stroke service. For
successful implementation it was important it is comprehensive, inter-
disciplinary, highly relevant to day-to-day clinical practice and not
time-consuming.
Methods: Between July 2013 and January 2015 has been developed, imple-
mented and evaluated an inter-disciplinary educational program focused
on stroke medicine.
Results: The program development started in 2013 with needs assess-
ment, and set up the goals and learning outcomes. As the educational
strategies, inter-disciplinary education and task-based learning were
decided. The program is designed for ten months in total and consists of
basic and advanced modules. The 60-minute plenary sessions of study
groups, tutors and super-tutors are held once weekly. After piloting in
summer 2014, the program was fully implemented in September 2014.
The members of four study groups are junior and senior doctors, stroke
nurses, pharmacists, research nurses, and stroke unit managers. Multiple
systematic evaluation strategies have been used.
Conclusions: The educational program has been developed, piloted and
implemented in 2013. It was design as a continuing medical education
inter-disciplinary program in stroke medicine as well as very powerful
managerial tool. The program is generic and is transferable to different
healthcare settings and specialties. It can be used both in undergraduate
and postgraduate continuing medical education.
Abstracts
© 2015 The Authors.
International Journal of Stroke © 2015 World Stroke Organization Vol 10 (Suppl. 2); April 2015; 77–438 363
ESOC-1278
22. Service Organisation
The effect of pre-hospital alert and out of hours
services on stroke thrombolysis timing
M X Khor1, A Bown1, A Barret1, M Dale1, M J MacLeod1,
J M Reid1
1Acute Stroke Unit, NHS Grampian, Aberdeen, United
Kingdom
Introduction: Intravenous thrombolysis given within 4.5 hours of
symptom onset increases independent survival rates in ischemic stroke
patients. Pre-hospital notification (PHN) by ambulance services (AS) can
improve timing and increase the proportion of patients eligible for throm-
bolysis within 4.5 hours. We aimed to determine whether PHN and treat-
ing out of hours (OOH) impact on thrombolysis timings.
Methods: The stroke thrombolysis proforma collects information on
timing of CT scan, thrombolysis and whether there was PHN or patient
presented OOH. Data were collected between May 2012 and June 2014.
This study was approved by our local ethics committee.
Results: 182 patients were identified (88 females; mean age of 74; median
NIHSS score of 12). PHN patients were significantly (p < 0.0001) more
likely to have a CT head scan within 25 minutes (60% vs. 24%), be assessed
earlier by stroke physician (mean time of 10 vs. 33 min) and to receive
thrombolysis within 60 minutes (89% vs. 49%). PHN did not affect pre-
hospital timing. Being treated OOH did not significantly influence timing
of AS response, stroke physician assessment, CT imaging or thrombolysis.
Introduction of a near sited CT scanner to the emergency department
improved the proportion of patients receiving a CT scan within 25
minutes (15% vs. 35%; p = 0.042), but did not significantly alter throm-
bolysis timing.
Conclusion: PHN improves timely delivery of thrombolysis and reassur-
ingly there was no difference in timing OOH. Increased usage of PHN and
continuing audit amongst other measures will likely further improve
timing.
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Using the Sentinel Stroke National Audit Programme
benchmarks to improve hyper-acute stroke care at a
district general hospital
S Alam1, D Singh1, E Stebbings1, J Imam1, A Nicolson1, A Azim1,
A L A M Sajid1
1Stroke Medicine, West Suffolk Hospital, Bury St Edmunds,
United Kingdom
Background: The Sentinel Stroke National Audit Programme (SSNAP) in
the United Kingdom is a platform for collecting data regarding stroke care
and auditing stroke services against nationally set benchmarks. SSNAP
collects various data sets for every stroke patient, including acute care,
rehabilitation, 6-month follow-up, and outcome measures in England,
Wales and Northern Ireland. On a local level it allows stroke services a real
time process mapping opportunity to improve their services to provide
the quality of care set by the benchmark.
Method: SSNAP being a prospective audit allows us to continuously make
improvements in problem areas aiming to meeting the benchmark targets.
SSNAP includes ten domains; process mapping each domain as a multi-
disciplinary team allows us to concentrate resources in more innovative
ways.
Results: We present data over four consecutive audit cycles July 2013 to
June 2014. Performances against the benchmarks have consistently
improved.
July–
September
2013
October–
December
2013
January–
March
2014
April–
June
Scanning A A A A
Stroke unit B B B B
Thrombolysis C D D B
Specialist assessment B B B A
Occupational therapy D B A A
Physiotherapy D B A A
Speech and language E E C C
MDT working D C B B
Standards by discharge C B B A
Conclusion: Our service has consistently improved. Targeted approaches,
continuous process mapping and innovative multi-disciplinary working
have all helped in improving our stroke service. Our efforts were rewarded
with the stroke service winning a national award for patient care in 2014.
This poster will explore the individual strategies we have employed for
other European hyper-acute stroke units to learn from and replicate.
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UNWELL S
Troke mimics in the HASU – Who are they, what are
their diagnoses and what happens to them?
D Turner1, R Simister1
1Stroke, UCLH NHS Foundation Trust, London, United
Kingdom
Introduction: The introduction of the Hyperacute Stroke Unit (HASU)
model has meant that many stroke mimics present to the stroke team.
Some of these patients cannot be immediately discharged, and need refer-
ral to another speciality.
Methods: Using the ward lists generated from collecting Stroke Sentinel
National Audit Programme data we identified patients over a 7 month
period (February–August 2014) who had been transferred to the care of
another medical speciality. We recorded diagnosis at discharge, length of
stay, and mortality. We reviewed the case notes of 19 patients and recorded
discharge destination, time spent on HASU, time to referral and the
number of therapy sessions they received.
Results: 42 patients transferred to another team. The average age was 81.
Their average length of stay was 20.6 days. Mortality was high – 6 died in
hospital. At least 5 more died by the time of audit (November 2014) with
an overall mortality of 26%. Diagnoses were varied, the top three being
seizures, metastatic disease and community acquired pneumonia. Of the
19 patients with case note review the average time on HASU was 7 days,
11/19 were discharged home, 6/19 to rehab or nursing home, and 2 died.
Their average number of therapy sessions required pre discharge was 9.
Conclusion: These patients are elderly, require a long length of stay and
large therapy input. They stay on HASU longer than the expected stay of
3 days. Mortality is high. Their care is a significant challenge for the HASU
team.
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Care needs and functional impairment after stroke in
England and Wales
L Paley1, S Kavanagh1, B D Bray1, A Hoffman1, P Tyrrell1,
E Vestesson1, A G Rudd1
1Sentinel Stroke National Audit Programme, Royal College of
Physicians, London, United Kingdom
Background: While acute care in hospital has improved significantly over
the last decade, the transition from hospital to the community remains
problematic. The failure to provide joined-up services after discharge is a
principal area of concern raised by patients.
Methods: Data were extracted from the Sentinel Stroke National Audit
Programme, the national register of stroke care in England and Wales. The
sample included 66,798 patients with acute stroke, aged over 18, dis-
charged from 266 stroke services from April 2013 to March 2014. Data
were collected by clinical teams and entered into the database using an
online web tool.
Results: 54.6% of patients (36,490/66,798) were discharged home, 26.1%
of these (9,515/36,490) to a place where they lived alone. 10.9% of patients
(7,262/66,798) were discharged to a care home, 63.7% (4,627/7,262) of
these for the first time. 32.8% (21,890/66,798) left hospital with moderate
to severe disability (modified Rankin scale score 3–5). 51.6% (11,307/
21,890) of patients leaving hospital with moderate to severe disability
were over 80 years old at the time of stroke.
36.7% of patients (20,747/56,605) discharged from hospital required help
with activities of daily living. Of these, 19.4% (4,025/20,747) did not have
paid carers.
Conclusion: Despite improvements in acute stroke care, many stroke sur-
vivors are discharged home with significant functional impairments and
care needs. Health services need to ensure that stroke survivors and carers
have effective long-term support.
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Inequalities in the management of the psychological
symptoms of stroke
B D Bray1, S Kavanagh1, A Hoffman1, L Paley1, P Tyrrell1,
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1Sentinel Stroke National Audit Programme, Royal College of
Physicians, London, United Kingdom
Background: Many patients will have significant psychological symptoms
following stroke. We describe access to and provision of psychological
screening and support in a national sample of stroke patients during their
inpatient stay.
Methods: Data for 66,798 stroke patients treated in 266 stroke services
between April 2013 and March 2014 were extracted from the Sentinel
Stroke National Audit Programme, the national register of stroke care in
England and Wales. Data on organizational characteristics of 183 acute
hospitals (100%) were collected via survey. Data were collected by clinical
teams and entered into the database using an online web tool.
Results: Of 34,390 patients with a stay of longer than 7 days, 85.6% were
reported as being applicable for mood screening and 84% for cognition
screening. Of these, 27.1% were not screened for mood prior to discharge
from inpatient care. 16.2% were not screened for cognition. 39% of hos-
pitals do not have access to a clinical psychologist and 19% of hospitals
with access have waiting times longer than 5 days. Psychological support is
provided on a median of 5.9% of inpatient days. Fig. 1 shows wide varia-
tion of access.
Conclusion: Not all stroke patients in England and Wales have adequate
access to psychology services in hospital. Early diagnosis of mood and
memory problems is vital to identify and meet psychological support
needs.
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Provision and use of domiciliary stroke services in a
national cohort of contemporary stroke patients
M Kavanagh1, S Kavanagh1, B D Bray1, A Hoffman1, L Paley1,
P Tyrrell1, E Vestesson1, A G Rudd1
1Sentinel Stroke National Audit Programme, Royal College of
Physicians, London, United Kingdom
Background: After inpatient care, many stroke patients need further reha-
bilitation in the community, ideally in their own homes. Previous studies
have shown that early supported discharge (ESD) for stroke reduced
length of stay and improved patient outcomes.
Methods: Data for 66,798 stroke patients discharged from 266 stroke units
between April 2013 and March 2014 were extracted from the Sentinel
Stroke Audit Programme, the national register of stroke care in England
and Wales. Data on the organization of services in 183 acute hospitals
(100%) were collected via a snapshot organizational audit in July 2014.
Data were collected by clinical teams and entered into the database using
an online web tool.
Results: Of 56,605 patients discharged alive from inpatient care 24.7%
were discharged with plans for on-going rehabilitation from a specialist
ESD team and 22.8% from a specialist community rehabilitation team
(CRT). 74% of acute hospitals (135/183) have access to specialist ESD
services and 72% (131/183) to specialist CRT, an increase from 44% and
55% respectively in 2010.
Conclusion: While there is greater access to domiciliary stroke services,
there is an inequality of access across England and Wales. As length of stay
in hospital decreases access to specialist domiciliary care is increasingly
important to good outcome after stroke.
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Time trends in quality of acute stroke care in Germany
2003–2012: The German Stroke Registers Study Group
(ADSR)
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5Department of Neurology, Vivantes-Klinikum Spandau,
Berlin, Germany
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Rhine–Westphalia, Medical Association North Rhine,
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Background: Analyses of variations in appropriate stroke care over time
are scarce. We analyzed adherence to evidence-based quality indicators
over a time period from 2003–2012 in Germany
Methods: Data were derived from 9 regional acute stroke care registers
collaborating within the German Registers Study Group (ADSR). Tempo-
ral changes in evidence-based quality indicators in appropriate patients
(antithrombotic therapy, vascular imaging, anticoagulant therapy, brain
imaging, early physiotherapy therapy, speech and language therapy,
thrombolytic therapy) for which comparable information was available
over a 10-year time period were assessed. Logistic regression models were
performed to estimate time trends.
Results: Between 2003 and 2012 (without 2006), individual data from
more than 780,000 patients treated in more than 300 hospitals with con-
tinuous documentation of quality indicators since the start of the indi-
vidual registers were documented. A continuous increase in adherence to
predefined quality indicators was seen for all indicators. In some indica-
tors a constant increase across the whole study period was observed:
anticoagulant therapy (p < 0.0001), vascular imaging (p < 0.0001), and
speech and language therapy (p < 0.0001). In other indicators, an initial
increase was followed by a stable plateau of high-level adherence (throm-
bolytic therapy [p < 0.0001], antithrombotic therapy [p < 0.0001], brain
imaging [p < 0.0001], physiotherapy [p < 0.0001]).
Conclusion: An increasing quality of stroke care defined by standardized
quality indicators was observed over time in Germany. In some indicators,
high level of adherence might indicate that best practice is already
reached.
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Influence of intravenous low-intensity laser irradiation
of blood on the level of circulating endothelial
progenitor cells in acute lacunar stroke
L Anatskaia1, N Goncharova2, I Seviaryn2, G Khulup3
1Clinical Neurology, Republican Research and Practical Centre
of Neurology and Neurosurgery, Minsk, Belarus
2Stem Cells, The Republic Research & Production Center for
Transfusiology and Medical Biotechnologies, Minsk, Belarus
3The Republic Research & Production Center for
Transfusiology and Medical Biotechnologies, Minsk, Belarus
Background and purpose: The purpose of our study was to determine
influence of low-intensity intravenous laser irradiation of blood ILIB on
the levels of circulating endothelial progenitor cells (EPCs) and adult
vascular endothelial stem cells (ESCs) CD117+ (c-kit+) in patients with
acute lacunar stroke (LS) resulting from CSVD.
Methods: The level of circulating EPCs (CD34+, CD133+, KDR+, CD31+,
CD144+, CD146+, vWF+) and CD117 + (c- Kit+) were examined in
patients at 48 hours of LS (n = 20, a mean age of 59 ± 4,3 years) and after
7 days of standard therapy and ILIB by the semi-conductor laser at wave
length 0,67 μm, and radiation power at the end of the light guide –
2,0–3,0 mW and time of application 20 minutes, 7 procedures per course
using flow cytometry; once in 10 healthy volunteers.
Results: Significant increased CD133+CD34− (from 0,51 ± 0,07%
to 0,92 ± 0,13%, p < 0,01), CD133–CD34+ (from 0,38 ± 0,05% to
1,34 ± 0,18%, p < 0,001), CD117+CD34− (from 0,83 ± 0,06% to 1,54 ±
0,24%, p < 0,01), CD117–CD34+ (from 0,52 ± 0,09% to 1,16 ± 0,16%,
p < 0,01) levels after 7 days of treatment were reviled. The increase in the
proportion of CD133+CD34+, CD45+CD117+ and CD45+CD34+,
p < 0.05, after ILIB application may indicate an increase in the degree of
functional activity of the EPCs. A significant increase in CD31+CD144+
and CD31+CD71+ level (p < 0.05) after treatment reflected blood–brain
barrier (BBB) stabilization.
Conclusions: Our data suggest that application of ILIB from the first days
LS allows significantly increase the functional and proliferative activity
and the level of circulating EPCs; CD117 + ESCs and pluripotent
CD34+CD45+, CD45+CD117+ cells and stabilize BBB.
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Small vessel disease after stroke at young age: The
future study
R Arntz1, S van den Broek1, L Rutten-Jacobs1, N Maaijwee1,
I van Uden1, M Ghafoorian2, B Platel2, E van Dijk1, F E de Leeuw1
1Neurology, Radboudumc Donders institute for Brain
Cognition and Behaviour, Nijmegen, Netherlands
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Objective: To investigate the prevalence of small vessel disease (SVD) in
patients with an ischemic stroke or TIA at young age.
Methods: Prospective cohort study among 337 patients with a first-ever
TIA or ischemic stroke, aged 18–50 years and 90 healthy, age and sex
matched controls. At follow-up blood pressure, diabetes and smoking
were assessed and all participants underwent a cerebral MRI. White
matter hyperintensity (WMH) volume was assessed and lacunes and
microbleeds were rated. Linear regression was used to quantify the rela-
tion between risk factors and SVD.
Results: There were 110 patients with a TIA and 227 patients with an
ischemic stroke, 45.4% of the patients were male and 45.6% of the con-
trols. After mean follow-up of 9.9 (SD 8.1) years, mean age for patients
was 49.7 (SD 10.3) years and 48.7 (SD 11.8) for controls. At follow-up, 81
(24.0%) patients and 4 (4.5%) controls had at least 1 lacune (p < 0.001).
There was no difference in prevalence of microbleeds (13.6% versus
6.7%). Median WMH-volume was 1.9 ml (IQR 0.6–4.6) for patients and
0.34 ml (IQR 0.03–1.2) for controls, which differed significantly after
adjustment for hypertension, DM, age and sex (p < 0.001). In the young
TIA and stroke group, age (β = 0.19, p = 0.001), smoking (β = 0.19,
p < 0.001), DM (β = 0.13, p = 0.023) and systolic blood pressure (β = 0.18
per mmHG, p = 0.002) were independently associated with WMH-
volume, adjusted for sex.
Conclusion: Patients with a young stroke have a higher prevalence of SVD
than control subjects. This might give us more insight in pathophysiologi-
cal mechanisms of the development of SVD.
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Absence of cortical superficial siderosis in CADASIL
E Baykara1, F A Wollenweber1, B Gesierich1, E Jouvent2,
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4Klinikum der Universität München, Department of
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Cortical superficial siderosis (cSS) recently emerged as a novel neuroim-
aging marker for cerebral amyloid angiopathy (CAA). CAA patients with
cSS are at much higher risk of intracranial hemorrhage, indicating a high
clinical relevance. However, there are other known causes of cSS such as
reversible cerebral vasoconstriction syndrome or vasculitis, and therefore
the specificity of cSS as a marker for CAA remains unclear. In particular,
it is not known whether severe non-amyloidogenic small vessel disease
(SVD) can also present with cSS.
We therefore investigated the prevalence of cSS in cerebral autosomal-
dominant arteriopathy with subcortical infarcts and leukoencephalopahty
(CADASIL), a hereditary non-amyloidogenic SVD with early-onset and
severe clinical manifestation. 367 CADASIL patients were drawn from a
two-center cohort study. As a control group, we included elderly subjects
from population-based study (Austrian Stroke Prevention Study,
n = 372). Ethics committees approved the study and written informed
consent was obtained from every subject. We studied the pattern of SVD-
related lesions, in particular hemorrhagic manifestations: cSS and cerebral
microbleeds on T2-star-weighted gradient echo images.
The amount of white matter hyperintensities and lacunes confirmed the
presence of severe SVD in the CADASIL group. Similar to CAA, we found
a significant number of lobar cerebral microbleeds in CADASIL patients.
Importantly, cSS was absent in CADASIL, indicating a prevalence below
0.3% (population-based sample: 0.8%).
Our results suggest that cSS is not part of the neuroimaging spectrum of
severe non-amyloidogenic SVD. The presence of cSS together with other
signs of SVD should therefore be regarded as highly suspicious for CAA.
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Use of blood oxygen level dependent MRI to assess
cerebrovascular reactivity in cerebral small vessel
disease: A systematic review
G W Blair1, F N Doubal1, M J Thrippleton1, I Marshall1,
J M Wardlaw1
1Centre for Clinical Brain Sciences, University of Edinburgh,
Edinburgh, United Kingdom
Introduction: The pathophysiology of cerebral small vessel disease (SVD)
is poorly understood. Cerebrovascular reactivity (CVR) impairment may
play a role, but evidence for this is indirect. Blood oxygen level dependent
(BOLD) MRI can investigate CVR directly in tissues affected by SVD. We
performed a systematic review to assess data on its use in SVD.
Method: We searched MEDLINE and EMBASE for articles assessing CVR
using BOLD MRI in humans with SVD published between 1990 and
September 2014. We extracted data from relevant articles on patient and
control demographics, study quality, methods, technical factors and
results using standardized forms.
Results: Of 263 potentially relevant articles, 3 provided data on CVR
using BOLD MRI in patients with SVD (total n = 71). Reporting of
patient and control demographics was incomplete, the MR protocol
varied significantly, each study used different stimuli and method of cal-
culating CVR, only one study reported safety and tolerability and did so
only partially. CVR decreased with age in two studies, was lower in females
than males and with increasing diastolic blood pressure in another study.
Each study reported CVR impairment associated with at least one imaging
feature of SVD, but not with others and did not mention adjustment for
other factors known to affect CVR.
Conclusion: Despite the perception that CVR declines in SVD, little objec-
tive evidence exists to support or quantify SVD-specific changes in CVR,
there is considerable variation in methodology, and inadequate control-
ling for potentially confounding factors. CVR changes in SVD requires
considerable clarification in larger, well-controlled studies.
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Cerebral hemodynamics in patients with large vessel
disease stroke and lacunar stroke
S Elyas1, D Adingupu2, K Aizawa2, A C Shore2, W D Strain2,
P E Gates2
1Acute Stroke Unit, Royal Devon & Exeter Hospital, Exeter,
United Kingdom
2Diabetes and Vascular Research Centre, University of Exeter
Medical School, Exeter, United Kingdom
Background: Large vessel disease stroke(LVDS) and lacunar stroke(LS)
are two different subtypes of ischemic stroke. They have a different risk
factor profile, outcome and etiopathological cause with atherosclerosis
being more important in LVDS and hypertension in LS. It is not clear
whether cerebral blood flow dynamics are different in both subtypes. We
studied the cerebral blood flow patterns in patients with LVDS and LS.
Methods: Transcranial Doppler(TCD) was performed on 47 patients with
LVDS(33 males, age 67 ± 10 yrs) and 43 patients with LS (33 males,
age68 ± 9 yrs) within 3 months of diagnosis. All patients underwent
CT/MRI head to confirm the stroke subtype. Cerebral blood flow
parameters (Peak systolic(PSV), End diastolic(EDV) and Mean flow
velocities (MSF)) and cerebral vascular resistance parameters(Pulsatility
index(PI), Resistive index(RI) and Adjusted Cerebral Resistance Index-
(ACRI = MAP/MFV)) of the middle cerebral arteries were obtained.
Results: Patients with LS had a higher prevalence of hypertension, drank
more alcohol and had a larger waist compared to LVD stroke. There was
no difference in MFV (49(95% CI 45–50) vs. 49(46–52), p = 0.38) and no
difference in cerebral PI and RI between LVDS and LS patients (p = 0.6).
ACRI was higher in LS patients compared to LVDS patients (2.1 (95% CI
2–2.2) vs. 1.9 (95% CI 1.8–2), p = 0.02).
Discussion: We demonstrated a higher ACRI in patients with LS com-
pared to LVDS. Given this increased resistance one would expect a higher
cerebral blood flow in LS in order to maintain cerebral perfusion; however
cerebral flow velocities were similar in LVDS and LS. This may support the
notion of a state of chronic cerebral hypoperfusion in patients with LS.
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APOE ε2 increases white matter hyperintensity burden
in pure small vessel disease
B Gesierich1, C Opherk1, J Rosand2, M Gonik1, R Malik1,
M Dichgans1, M Ewers1, M Düring1,
for the CADASIL-GEWAS consortium3
1Institute for Stroke and Dementia Research, Klinikum der
Universität München Ludwig-Maximilians-University, Munich,
Germany
2Center for Human Genetic Research & Department of
Neurology, Massachusetts General Hospital, Boston, USA
3This includes the many coauthors who cannot be listed in
person, from France, Italy, Netherlands, UK, USA, Germany
Cerebral small vessel disease (SVD) is the most common cause of vascular
cognitive impairment, with white matter hyperintensities (WMH) being
one of its neuroimaging hallmarks. A strong genetic contribution to
WMH has been demonstrated, and an association between APOE and
increased WMH volumes (WMHV) was established. However, this asso-
ciation was found mostly in the elderly population and might be
explained by the co-occurrence of other APOE related diseases, like
Alzheimer’s disease (AD) and cerebral amyloid angiopathy (CAA).
In order to decrease the likelihood of concomitant age-related diseases, we
studied Cerebral Autosomal Dominant Arteriopathy with Subcortical
Infarcts and Leukoencephalopathy (CADASIL), an inherited, early-onset
SVD. We recruited 488 CADASIL patients through an international, mul-
ticenter consortium. Median age was 51 years (inter-quartile range 44 to
60 years). Institutional Review Boards approved the study. Subjects signed
written informed consent. WMH were segmented and corrected centrally
by two raters (intraclass-correlation coefficient of 0.996). Regression
analysis was used to determine the effect of APOE status on WMHV. Age,
sex and hypertension were entered as covariates. In a second analysis, we
also controlled for genetic background using principal components
derived from a genome-wide set of 466 single nucleotide polymorphism
markers.
Carriers of APOE ε2 (β = 0.031, t = 2.4, p = 0.0186) but not APOE ε4
(β = 0.017, t = 1.7, p = 0.0902) showed increased WMHV, compared to
the reference genotype ε3/ε3. When further controlling for genetic back-
ground variation, the results remained largely unchanged. Our findings
suggest a modifying influence of APOE ε2 on WMHV in pure SVD and
motivate future studies investigating the underlying mechanisms.
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Recurrent intracerebral hemorrhage in a young adult
caused by COL4A2 mutation
B Gunda1, T Kovács1, C Hornyák1, D Bereczki1, G Várallyay2,
G Rudas2, M Mine3, E Tournier-Lasserve3
1Department of Neurology, Semmelweis University, Budapest,
Hungary
2MRI Research Centre, Semmelweis University, Budapest,
Hungary
3Laboratory of Molecular Genetics, Hôpital Lariboisière
Université Paris VII, Paris, France
Background: Type IV collagen α1 and α2 chains form heterotrimers that
constitute an essential component of basement membranes. Mutations in
COL4A1, encoding the α1 chain, cause porencephaly, bleeding prone
cerebral small vessel disease (cSVD), intracranial aneurysms and variable
abnormalities of the eyes, kidneys and muscles. Mutations in COL4A2
have recently been reported in a few porencephaly families, members of
whom also harbored white matter abnormalities and intracranial aneu-
rysms.
Objective: Herein, we report on a young adult patient with recurrent
intracerebral hemorrhage, leukoencephalopathy, intracranial aneurysms,
nephropathy and myopathy associated with a de novo COL4A2 mutation.
Methods: We examined a 29-year-old male patient with recurrent intrac-
erebral hemorrhages. Brain MRI, abdominal ultrasound, ophthalmologi-
cal examination, laboratory tests (including biochemical, hematological,
clotting, autoimmune and inflammatory studies, urine analysis) and
molecular genetic analysis of COL4A1, COL4A2, PKD1 and PKD2 genes
were performed. Several family members have also been investigated.
Results: MRI showed deep ICHs of different age, multiple cerebral
microbleeds, diffuse leukoencephalopathy and small carotid siphon aneu-
rysms. Laboratory workup revealed microscopic hematuria and elevated
CK. Autoimmune, inflammatory and hemostasis studies were normal.
Genetic testing found a novel glycine mutation within the COL4A2 triple
helical domain (c.2821G > A, p.G941R) not present in parents and other
family members without this phenotype.
Conclusions: This study reports the first COL4A2 mutated adult patient
with a phenotype very close to the spectrum of manifestations in COL4A1
mutations, and emphasizes the importance of screening both COL4A1
and COL4A2 in patients showing recurrent ICH of unknown etiology
particularly if associated with leukoencephalopathy.
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Amyloid spells related to cortical siderosis
misdiagnosed as TIA
A Martínez-Domeño1, J Sotoca1, I Aracil1, P Camps-Renom1,
L Prats-Sánchez1, R Marín1, R Delgado-Mederos1, J Martí-Fàbregas1
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Background: Cortical superficial siderosis(CSS) is related to cerebral
amyloid angiopathy(CAA), and increases the risk of symptomatic intrac-
erebral hemorrhage(ICH). The clinical presentation as amyloid spells can
be confused with transient ischemic attacks(TIA) and antithrombotic
agents are not indicated. We analyzed the frequency of CSS in patients
with suspected TIA.
Methods: We conducted a retrospective review of consecutive patients
diagnosed with TIA at our center. All patients underwent MRI study,
including T2*gradient-recalled echo sequences. We collected the follow-
ing variables: demographics(age, sex), relevant medical history(head
trauma, brain surgery, etc), clinical features of the episodes(positive/
negative symptoms, duration, recurrence) and MRI data(CSS, microb-
leeds, acute/chronic ischemic lesions). We used bivariate analyses to
compare patients with CSS(CSS+) and without CSS(CSS-).
Results: We included 160 patients(age 71.5 ± 11.7 years), 48% were men.
Thirty-eight(23.8%) patients had prior stroke/TIA, 4(2.5%) previous
ICH, 3(1.9%) severe head trauma, and 2(1.3%) brain surgery. 81
patients(51%) were on antithrombotic therapy at TIA onset. CSS was
detected in 10(6.3%) patients, that was focal in 9 and disseminated in 1.
Also, acute ischemic stroke in DWI sequences were found in 9(5.6%)
patients, while old vascular lesions were observed in 29(18.1%).
We did not observe differences between groups(CSS+ vs CSS−) regarding
demographics, medical history, antithrombotic therapy, presence of
acute/chronic ischemic lesions, or clinical features of episodes.
Conclusions: In our cohort, CSS is present in 6.3% of patients initially
diagnosed as TIA. Further studies are needed to better define the clinical
characteristics of these patients that will help to select which patient needs
antithrombotic therapy for secondary prevention.
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Arterial spin labeling MRI in CADASIL: Impaired
cerebrovascular reactivity is associated with an
increased number of lacunes
F Moreton1, B Cullen2, M R Lopez-Gonzalez3, C Santosh4,
C Schwarzbauer5, K W Muir6
1Institute of Neuroscience & Psychology, University of
Glasgow, Glasgow, United Kingdom
2Institute of Health and Wellbeing, University of Glasgow,
Glasgow, United Kingdom
3Clinical Physics, NHS Greater Glasgow and Clyde, Glasgow,
United Kingdom
4Department of Neuroradiology, NHS Greater Glasgow and
Clyde, Glasgow, United Kingdom
5Aberdeen Biomedical Imaging Centre, University of
Aberdeen, Glasgow, United Kingdom
6Institute of Neuroscience and Psychology, University of
Glasgow, Glasgow, United Kingdom
Objectives: Radiological manifestations of CADASIL such as white matter
hyperintensities (WMH) are well defined, but offer limited insight into
natural history and progression. We aimed to examine cerebral blood flow
(CBF) and cerebrovascular reactivity (CVR) in CADASIL using arterial
spin labeling (ASL) MRI and a hypercapnic challenge, as a first step in
investigating them as potential biomarkers of disease progression.
Methods: Subjects underwent standard brain MRI plus normocapnic and
hypercapnic ASL. Region of interest and segmented tissue analysis of CBF
and CVR was performed. The normalized volume of lacunes and WMH
were calculated. Subjects were categorized into those with 0–4 or ≥5
lacunes. Neuropsychological testing was performed in all subjects with
test results normalized and grouped into cognitive domains.
Results: We investigated 22 CADASIL patients (median age 53). CBF in
grey matter (58 ml/100g/min ± 12), normal appearing white matter
(26 ± 5) and WMH (19 ± 4) were significantly different. Age did not cor-
relate with CBF, CVR or neuropsychological tests. Subjects with ≥5
lacunes had lower CVR in NAWM (14% ± 9 v 3% ± 4) and WMH
(13% ± 8 v 3% ± 3). Lacune count and volume correlated with executive
function and processing speed but not other neuropsychological indices.
Conclusions: ASL offers non-invasive insight into cerebral hemodynamics
in CADASIL. Impaired CVR is associated with increased lacunes, which
are in turn associated with impaired executive function. If impairment of
CVR precedes the development of lacunes, it has potential as a biomarker
for disease progression which warrants investigation in longitudinal
studies.
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Dimensions of lacunar infarcts associated with the
lenticular artery territory in CADASIL
F Moreton1, R Beare2, X Huang1, V Srikanth2, K W Muir1, T Phan2
1Institute of Neuroscience & Psychology, University of
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Objectives: Axial diameter is proposed to define lacunar infarcts and
suggest etiology, but the size of artery involved is more relevant when
investigating disease mechanisms. CADASIL, an inherited vasculopathy, is
proposed as a model for sporadic small vessel disease. We studied basal
ganglia infarcts in CADASIL using MRI with overlaid microangiographic
templates, to determine their relationship to arterial branching order.
Methods: Infarcts identified by seed-based thresholding on T1-weighted
scans were registered to a standard brain template. Microangiographic
templates of the lenticulostriate arteries (LSA) were overlaid onto coronal
slices and 4 raters estimated the branching order of arteries related to the
infarct (Fig.). Lacunar infarct dimensions and volume were measured.
Results: 22 CADASIL patients (median age 53) underwent MRI. None
had hypertension, AF, carotid disease or diabetes. Ten had one or more
infarcts in LSA territory, with 13 infarcts suitable for analysis. Three were
associated with secondary branches (coronal height 14 mm ± 3, volume
0.48 ml ± 0.16), and 10 with tertiary branches (height 5 mm ± 2, volume
0.04 ml ± 0.04). The groups were significantly different in all dimensions.
Conclusions: Basal ganglia lacunar infarcts in CADASIL were predomi-
nantly small and associated with tertiary branch lenticulostriate arteries.
This observation is consistent with lacunar infarct dimensions providing
insight into stroke etiology. Replication in non-CADASIL sporadic small
vessel disease would further strengthen the findings.
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Depressive symptoms in cerebral small vessel disease
are associated with white matter microstructural
damage: The VMCI-TUSCANY Study
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2“Mario Serio” Department of Experimental and Clinical
Biomedical Sciences, University of Florence, Florence, Italy
3Medical Physics Section Department of Biomedicine and
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Background and purpose: It has been suggested that disruption of
cortical-subcortical circuits related to small vessel disease (SVD) may
predispose to depression. Our objective was to determine the independent
association between white matter (WM) microstructural damage, evalu-
ated with diffusion tensor imaging (DTI), and depressive symptoms in a
cohort of elderly subjects with mild cognitive impairment (MCI) and
SVD.
Methods: The VMCI Tuscany study is an observational multicentric lon-
gitudinal ongoing study that enrolled patients with MCI (Winblad et al.
criteria) and moderate to severe degrees of WM hyperintensities on MRI.
Lacunar infarcts, cortical atrophy, medial temporal lobe atrophy, microb-
leeds and DTI derived-indices (mean diffusivity, MD and fractional
anisotropy, FA) were evaluated on baseline MRI. Geriatric depression
scale (GDS) (score 0–15) was used to assess depressive symptoms. An
extensive neuropsychological battery, instrumental activities of daily
living scale, and short physical performance battery were used for cogni-
tive, functional and motor assessments, respectively.
Results: Seventy-six patients (mean age: 75.1 ± 6.8) were included. Uni-
variate analyses showed a significant association between GDS score and
both DTI derived-indices (MD: r = 0.366, p = 0.002; FA: r = −0.258;
p = 0.031). The significant association remained after adjustment for age,
WM hyperintensities severity, global cognitive, functional and motor per-
formances, and antidepressant therapy (MD: r = 0.307, p = 0.007; FA:
r = −0.245; p = 0.033).
Conclusions: These results confirm the presence of an association between
WM microstructural damage and depressive symptoms in our cohort of
MCI patients with SVD. This relationship does not seem to be mediated
by disability, cognitive, and motor impairment, thus supporting the vas-
cular depression hypothesis.
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White matter hyperintensities may be related to brain
swelling in early cerebral small vessel disease
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E Duchesnay3, M Duering4, M Dichgans4, H Chabriat1, E Jouvent1
1INSERM 1161, Paris Diderot University, Paris, France
2Department of Neurology, Medical University of Graz, Graz,
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3LNAO, Neurospin CEA, Saclay, France
4Insitute for Stroke and Dementia Research,
Ludwig-Maximilians University, Munich, Germany
Objectives: Experimental data suggest that white matter edema without
structural loss may be involved in the early development of white matter
hyperintensities (WMH) in cerebral small vessel disease (SVD). To test
this hypothesis in vivo with MRI, the relationships between brain volume
and WMH volume (WMHV) were analyzed in a large cohort of healthy
subjects.
Methods: 302 healthy individuals from the ASPS family study were
included. Volumes of whole brain parenchyma, of white matter, of cortical
gray matter, and of WMH were determined using validated methods.
Sulcal depth and width were obtained as another independent marker of
brain morphology. Associations between brain volumes or sulcal depth
and width with WMHV were tested after adjustment for age, gender,
presence of lacunar lesions and intracranial cavity volume.
Results: Mean age was 64.3 ± 10.6 years. Whole brain volume was posi-
tively related to WMHV (β = 0.74, s.e. = 0.32, p = 0.02). White matter
volume was positively related to WMHV with a trend towards significance
(β = 0.47, s.e. = 0.26, p = 0.06). Sulcal depth was also positively related to
WMHV (β = 1.5 10–5, s.e. = 3.3 10–6, p
Conclusion: In middle-aged community dwelling subjects with moderate
extent of WMH, WMHV are associated with larger brains and larger white
matter volumes. Additionally, sulcal depth, by contrast to the effect of age,
also increases with WMHV. Our results support the hypothesis that the
early development of WMH in SVD is related to white matter edema
without structural loss.
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Peripheral vasoreactivity in CADASIL (cerebral
autosomal dominant arteriopathy with subcortical
infarcts and leukoencephalopathy)
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Background: CADASIL is an inherited small vessel disease pathologically
characterized by degeneration of vascular smooth muscle cells (VSMC).
Data are arising about a possible role of endothelial dysfunction in
modulating phenotype. Altered vasoreactivity has been proposed as a
possible pathogenic mechanism.
Methods: We assessed vasoreactive response to hyperemia in CADASIL
patients with respect to controls by non invasive pletismographic method
of pulse arterial volume at the fingertips (EndoPAT2000, Itamar, Israel).
The ratio between the average post-occlusion and baseline signal ampli-
tude (PAT score) was assumed as RH index (RHI). A cut-off 1.67 was used
to define abnormal RHI values. Normalized augmentation index (NAI),
measuring arterial elasticity, and PAT score after administration of nitro-
glycerin (NVI), an endothelium-independent vasodilatation index, were
also assessed.
Results: We enrolled 74 consecutive CADASIL pts and 55 age and sex-
matched controls among patients’ partners. Mean RHI was 2.050 ± 0.70
in CADASIL pts and 2.128 ± 0.55 in controls (p = 0.50). RHI was more
frequently abnormal in CADASIL pts than controls (37.3 vs 18.2%,
p = 0.019). Mean NAI was significantly higher in CADASIL pts
(14.66 ± 15.4 vs 6.25 ± 15.3; p = 0.003), while mean NVI was almost the
same (1.59 ± 1.08 vs 1.45 ± 0.59, respectively in CADASIL pts and con-
trols; p = 0.415). The differences remained significant in multivariate
logistic regression models adjusting for age, hypercholesterolemia, hyper-
tension, diabetes, statins and antiaggregants use.
Conclusion: Our findings support the presence of functional alterations
in endothelium and other vascular components in CADASIL patients.
These alterations could be a consequence of both the mutation and the
co-existing vascular risk factors.
ESOC-1129
23. Small Vessel Disease
Impairment of ubiquitin-mediated proteolysis in
cerebral small vessel disease
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Objective: Both, sporadic and hereditary cerebral small vessel disease
(SVD) lead to vascular cognitive impairment (VCI) and subcortical
ischemic vascular dementia. To date, the mechanisms linking SVD and
neuronal damage, eventually leading to VCI are incompletely understood.
Methods: Aim of this project was to further elucidate the molecular
mechanisms underlying neuronal damage in SVD. We compared gene
expression in snap-frozen post-mortem brain specimens from the frontal
and occipital cortex and white matter of 5 sporadic SVD and 2 CADASIL
patients with samples from 5 non-neurologically affected controls, using
oligonucleotide-based microarray technology (Affymetrix® Genechips).
Gene annotation and statistical analysis were performed using Partek®
Genomics Suite. Genes with fold expression changes F > 1.2 in both direc-
tions (P < 0.05) were considered differently expressed between diseased
and control groups. Biological functions enriched with these up- and
down-regulated genes were identified using DAVID® bioinformatics
resources.
Results: Functional classification revealed various cellular pathways
affected in sporadic and hereditary SVD. One interesting common
pathway involving many under-expressed genes in several brain regions
was ubiquitin-mediated proteolysis. We confirmed these results by immu-
nohistochemistry on brains sections, showing accumulation of mono-
and poly-ubiquitinated proteins, such as p62 or P-Tau.
Conclusions: Our findings emphasize that, on a molecular level, besides
ischemia, SVD follows patterns of neurodegeneration with deregulation
of the ubiquitin-mediated proteolysis, inducing formation of protein
aggregates. This suggests that the ubiquitin proteasome system plays a
potential role in neuronal damage in SVD and may thus represent a
possible therapeutic target in subjects with VCI related to SVD.
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Cerebral microbleeds and late-life depressive
symptoms in the Framingham Heart Study
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Background: The ‘vascular depression’ hypothesis dictates that disruption
of cerebral circuits secondary to cerebrovascular lesions drives the
occurrence/progression of late-life depressive symptoms (DS). We aimed
to assess the relationship between cerebral microvascular lesions, in par-
ticular cerebral microbleeds (CMBs), and late-life DS in a community-
dwelling population.
Methods: We evaluated stroke and dementia-free Framingham Offspring
Cohort participants who underwent brain MRI allowing for CMB detec-
tion and assessment for DS with the Center for Epidemiological Studies
Depression Scale (CES-D). MRI markers of interest were covert brain
infarcts (CBIs), extensive white matter hyperintensity volume (eWMHV),
and CMB presence, as well as CMB count (≥2 vs. 1) and topography
(strictly lobar, deep or mixed). Presence of DS was defined as a CES-D
score ≥16 and/or antidepressant medication use.
Results: In 1598 participants (mean age: 65), 320 (20%) had DS. DS were
more frequent in male participants (p < 0.001), current smokers
(p = 0.04) and those with diabetes (p < 0.01). In multivariable logistic
regression adjusting for vascular risk factors (including sex, diabetes mel-
litus, and current smoking), mixed CMBs were associated with DS (OR
4.03, 95% CI 1.35–12.05). The association remained robust after addition-
ally adjusting for CBIs and eWMHV. There was no notable association
between DS and other CMB topographic patterns, CBIs or eWMHV.
Conclusion: In the community, late-life DS is associated with vascular risk
factors and mixed CMBs. Our cross-sectional study cannot establish
causality or direction of effect, but supports the ‘vascular depression’
hypothesis that diffuse disruption of cortico-subcortical networks by
microvascular lesions may potentiate late-life DS.
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Severe cerebral white matter lesions in ischemic
stroke patients are associated with less time spent at
home and early institutionalization
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Background and purpose: Cerebral white matter lesions (WMLs) are a
surrogate for cerebral small-vessel disease. These WMLs are associated
with increased morbidity and mortality in both the general population
and ischemic stroke patients. We aimed to investigate whether severe
WMLs in a cohort of ischemic stroke patients are associated with fewer
days spent at home and earlier permanent institutionalization.
Methods: We included 391 consecutive patients aged 55 to 85 years with
ischemic stroke admitted to the Helsinki University Central Hospital (The
SAM cohort) with a 12-year follow-up. Hospitalization and nursing home
admissions were reviewed from national registers.
WMLs were rated using MRI performed 3 months post-stroke, dichoto-
mized as none-to-moderate and severe. Kaplan-Meier plots log-rank and
binary logistic regression (odds ratio, OR) and Cox multivariable propor-
tional hazards model were used to study the association of WMLs with
days spent at home and the time of permanent institutionalization. HR
and OR with their 95% confidence intervals (CI) are reported.
Results: Severe WMLs were associated with fewer days spent at home,
more frequent, and earlier permanent institutionalization (1487 versus
2354 days; log-rank p < 0.001).
After adjusting for significant covariates from univariable analyses, severe
WMLs were associated with fewer days spent at home (OR 1.78; CI 1.13–
2.80), permanent institutionalization within 5 years (OR 2.61; CI 1.54–
4.42), and increased hazards ratio of permanent institutionalization
during 12 years of follow-up (1.41; CI 1.10–1.81).
Conclusions: After ischemic stroke, patients with severe WMLs spend
fewer days at home and become earlier permanently institutionalized,
especially within the first 5 years.
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23. Small Vessel Disease
A re-evaluation of the lacunar concept through
perfusion imaging
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Background: Lacunar infarct is postulated to be the result of intrinsic
small vessel disease based on early clinico-pathological works from the
1960s. Based on this mechanism, we hypothesized that hyperacute lacunar
infarcts should not have perfusion deficits or vessel occlusions. The aim of
this study is to compare the perfusion and vessel status between subcor-
tical and cortical strokes in the hyperacute phase.
Method: Patients undergoing CT Perfusion/angiography within 6 hours
of symptom onset and follow-up MRI for ischemic stroke were included
(2009–2013). Perfusion deficit was defined from mean transit time map;
and MRI for infarct topography and dimensions. Lacunar infarct on MRI
was defined as single subcortical infarct < 20 mm. Vascular risk factors
and other patient characteristics were obtained from medical records.
Results: Two hundred and ninety-two patients were included (mean age
66.4 ± 15.3 years, 66% male); follow-up MRI occurred at median 15 days
post symptom onset (IQR 5.0–34.8 days). Lacunar infarct occurred in 31
(17%) of 182 patients. Approximately 40% (n = 12/31) of patients with
lacunar infarct had a perfusion deficit. The smallest lacunar infarct
dimension with a perfusion deficit had diameter ≤5 mm. Large artery
occlusion was present in 6 of these 12 patients.
Conclusion: A small subcortical stroke at outcome MRI may be associated
with perfusion deficits and relevant vessel occlusion in the hyperacute
phase. The assignment of ‘lacunar’ or intrinsic small vessel disease mecha-
nism requires evaluation of the acute CTP to avoid misclassifying cases of
embolic occlusion.
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23. Small Vessel Disease
Associations between structural network connectivity,
gait and cognition in small vessel disease
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3Department of Neurology, Radboudumc Donders Institute
for Brain Cognition and Behaviour, Nijmegen, Netherlands
4Department of Neurology, HagaZiekenhuis, Nijmegen,
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5Department of Neurology, Amphia Ziekenhuis, Nijmegen,
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Cerebral small vessel disease (SVD), including white matter hyperinten-
sities (WMH) and lacunes of presumed vascular origin, affects gait by
disrupting important white matter tracks. However, little is known about
the relationship between the structural network connectivity and gait in
subjects with cerebral SVD, and the interaction with cognitive function.
We assessed gait characteristics (stride length, cadence and stride width, as
well as Tinetti and Timed-Up-and-Go test) of 423 subjects with cerebral
SVD. The structural network was constructed using diffusion tensor
imaging and tractography. We applied graph-theory to calculate network
efficiency from the undirected weighted network. Associations between
network measures, conventional MRI markers for SVD, gait performances
and cognitive index as global cognitive function were tested. Network
measures were associated with conventional MRI markers for SVD
(WMH and lacunes) and with gait performances. Stride length, Tinetti
and Timed-Up-and-Go test were associated with network measures, inde-
pendent of WMH or lacunes. However, after adjusting for cognitive index,
these associations diminished and were not significant anymore. In the
mediation analyses, cognitive index mediated the association between
global efficiency and stride length, Tinetti and Timed-Up-and-go test.
Regional analysis showed widespread involvement of cortical regions in
gait performance, including frontal motor, cingulate and visuospatial
regions, which diminished after adjusting for cognitive index. These
results suggest that measures for network disruption were associated with
gait performance, possibly indirectly by disrupting brain network respon-
sible for cognitive function and hereby impairing gait performance.
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Predictors of mortality in cerebral small vessel disease
patients: The RUN DMC Study
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Background: Information about life expectancy is very important in
medical decision making. Recent attention has been drawn to gait speed,
cognitive function and diverse cerebral imaging parameters as reliable and
easily obtainable markers of mortality. However, prediction models com-
bining these different markers are currently lacking and these markers
have never been investigated in specific groups of elderly, including older
adults with cerebral small vessel disease (SVD).
Objective: to investigate the relationship between clinical and imaging
parameters and all-cause mortality in elderly with SVD.
Methods: 503 independently living elderly participants with SVD on MRI
were included (2006). Vital status and cause of death were collected
through November, 2014. Cox regression analysis was used to identify
baseline clinical and imaging predictors of all-cause mortality, adjusted
for age, sex and vascular risk factors. Prediction models of all-cause mor-
tality were constructed to study which parameters were most predictive.
Results: 80 participants died. Mean follow-up duration was 7.8 years and
cumulative 7.5-year risk of mortality was 13.2%. In the prediction of
all-cause mortality, gait speed (HR1.13 per 0.1 m/s slower gait,95%
CI:1.04–1.22), gray matter volume (HR0.75 per standard deviation (SD)
increase,95% CI:0.56–0.99) and structural integrity of the white matter,
assessed by diffusion tensor imaging using mean diffusivity (HR1.53 per
SD increase,95% CI:1.19–1.96) had the best predictive ability, next to age,
sex and vascular risk factors.
Conclusion: Gait speed, gray matter volume and structural integrity of the
white matter are the main predictors of mortality at 7.5-years follow-up in
elderly with SVD and could possibly be targets for preventive
interventions.
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Decreased kidney function is associated with
progression of cerebral microbleeds in lacunar stroke
patients
E van Overbeek1, J Staals1, R van Oostenbrugge1
1Neurology, Maastricht University Medical Center, Maastricht,
Netherlands
Introduction: Cross-sectional studies found impaired kidney function to
be associated with the presence of cerebral microbleeds in stroke patients.
It is hypothesized that both impaired kidney function and cerebral
microbleeds represent small vessel disease in different organs. Our aim
was to determine whether kidney function is related to progression of
cerebral microbleeds to further confirm the association in a longitudinal
study design.
Methods: In 117 lacunar stroke patients, in whom baseline brain MRI
(including gradient echo images) and estimated glomerular filtration rate
(eGFR) were available, we obtained a follow-up brain MRI after 2 years.
eGFR was calculated using the Cockcroft-Gault equation. Presence of
cerebral microbleeds on baseline and follow-up MRI was scored visually
and progression of microbleeds was defined as the presence of any new
microbleed on follow-up MRI. The relationship between progression of
cerebral microbleeds (dependent variable) and eGFR (independent vari-
able) was assessed by logistic regression analysis adjusting for age, sex and
24-hour ambulatory mean arterial pressure (MAP).
Results: Progression of cerebral microbleeds was present in 21 patients
(17.9%). In binary logistic regression analysis lower eGFR was associated
with progression of cerebral microbleeds (OR 1.37 per 10 ml/min/
1.73 m2, 95% CI 1.03–1.82, with correction for age, sex and MAP).
Conclusion: We found an association between lower eGFR and progres-
sion of cerebral microbleeds. Cerebral microbleeds and chronic kidney
disease are both seen as manifestations of microvascular organ damage
and our findings support the assumption that small vessel disease should
be considered as a multi-system disorder.
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Plasma markers of inflammation, endothelial function
and hemostasis in cerebral small vessel disease
S Wiseman1, F N Doubal1, F M Chappell1,
M C Hernandez Valdes1, X Wang1, A Rumley2, G D O Lowe2,
M S Dennis1, J M Wardlaw1
1Centre for Clinical Brain Sciences, University of Edinburgh,
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2Division of Cardiovascular and Medical Sciences, University
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Background and purpose: The cause of cerebral small vessel disease is
unknown. Inflammation and endothelial dysfunction have been impli-
cated. Plasma biomarkers could provide mechanistic insights but current
data are conflicting. Imaging biomarkers such as white matter hyperin-
tensities (WMH) are common. It is unknown if plasma biomarkers add
predictive capacity beyond age and vascular risk factors in explaining
WMH.
Methods: We prospectively recruited patients presenting with mild isch-
emic stroke, classifying them clinically and with magnetic resonance
imaging as lacunar or cortical. We measured biomarkers of inflammation,
endothelial dysfunction and hemostasis and compared biomarker levels
between stroke subtypes. We quantitatively calculated WMH. We used
multiple linear regression to model WMH as a function of age, sex, hyper-
tension and smoking (the baseline model). We fitted exploratory models
using plasma biomarkers as predictor variables to assess model improve-
ment over baseline.
Results: We recruited 125 patients. The lacunar group (n = 65) had lower
t-PA levels in unadjusted (7.39 v 8.59 ng/mL, p = 0.029) and adjusted
(p = 0.031) analyses compared with the cortical group (n = 60). There
were no significant differences in the other plasma biomarkers. The base-
line regression model explained 29% of the variance in quantitative WMH
(R2 0.289). Inflammatory biomarkers showed minor improvement over
baseline (R2 0.291) but the other plasma biomarkers did not improve the
baseline model.
Conclusion: t-PA is lower in lacunar stroke compared with mild cortical
stroke, independent of age, sex and risk factors. Inflammatory biomarkers
explain WMH beyond age and risk factors, but model improvement is
somewhat minor.
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Intravoxel incoherent motion MR imaging reveals
abnormal parenchyma and microvasculature in
cerebral small vessel disease
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Introduction: Cerebral small vessel disease (cSVD) is an age and vascular
risk factor related microvascular disease. The pathophysiology of cSVD
remains to be elucidated. Previous MRI studies have showed that early
changes in cSVD include microstructural alterations in the normal
appearing white matter (NAWM) and a possible association with hypop-
erfusion. However, no distinction between the contributions of parenchy-
mal or vascular microstructure could be made, leaving the more precise
nature of the damage undetermined. To examine both the parenchymal
microstructure and microvasculature, we performed intravoxel incoher-
ent motion (IVIM) diffusion MRI.
Methods: Sixty-five cSVD patients (age 68 ± 11 y) and thirty-five healthy
controls (age 69 ± 12 y) underwent IVIM imaging(3.0T MRI). The IVIM
measures f (perfusion fraction), D (parenchymal diffusivity), D* (intra-
vascular diffusivity) and the perfusion-related measure fD* were calculated
using a diffusion model in the NAWM, deep gray matter (DGM), cortex
and white matter hyperintensities (WMH).
Results: For patients a larger f and D were found than controls (pD* and
fD* or other regions.
Discussion and conclusion: In contrast to previous studies, no signs of
hypoperfusion were found for these patients. Instead, we found a larger
blood volume (f), suggesting alterations in microvasculature, which may
be due to vasodilatative responses or increased tortuosity. The observed
higher D may imply degeneration of parenchymal microstructure and can
provide evidence of early parenchymal changes preceding WMH forma-
tion. We demonstrated that IVIM imaging can provide novel pathophysi-
ological information of the normal appearing brain tissue in patients with
cSVD.
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The concept of “total small vessel disease score” in
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Background: Recently, the concept of total small vessel disease (SVD)
score, composed of four major MRI makers of SVD, has been proposed as
a comprehensive index of SVD severity in the brain. However, little is
known about the construct validity of this score in healthy populations.
Methods: We analyzed baseline data of an ongoing Japanese population-
based study. Lacunes, cerebral microbleeds, periventricular and white
matter hyperintensities, and perivascular spaces in basal ganglia were
rated independently on appropriate MRI sequences. The presence of each
SVD feature was summed in an ordinal “total SVD score” (range 0–4). The
associations with vascular risk factors, %cerebral parenchyma (an index of
cerebral atrophy = [cerebral parenchyma area / intracranial space] x 100),
and global cognitive function (MMSE) were investigated.
Results: We included 1451 neurologically healthy adults (mean
age ± standard deviation [SD] 57.1 ± 9.7, 47% male). In multivariable
ordinal regression analyses, age (per 10 years increase) (OR 1.56, 95% CI
1.32–1.85), hypertension (OR 2.44, 95% CI 1.91–3.12), diabetes mellitus
(OR1.56, 95% CI 1.09–2.24) and %cerebral parenchyma (OR 0.86, 95%
CI 0.74–0.98) were significantly associated with the total SVD score.
MMSE < 27 (OR 1.67, 95% CI 1.05–2.65) and MMSE < age-education
related mean-1.5SD (OR 1.50, 95% CI 1.00–2.25) were associated with
SVD score.
Conclusions: In a neurologically healthy cohort, the SVD score showed
good correlation with vascular risk factors. Associations of SVD score with
cerebral atrophy and global cognitive function provide additional con-
struct validity. The total SVD score might be useful for future observa-
tional or interventional clinical studies of stroke or dementia prevention
in SVD.
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Lower cerebral microvascular perfusion is associated
with lower cognitive function in patients with cerebral
small vessel disease
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Background: Cerebral small vessel disease (cSVD) may cause vascular
cognitive impairment. Earlier studies have shown that a decreased micro-
vascular perfusion is associated with cSVD. It is unknown whether
decreased microvascular perfusion is also associated with decreased cog-
nitive function. Intravoxel Incoherent Motion (IVIM) imaging is a
diffusion-based MRI technique designed to determine microstructural
integrity and microvascular perfusion. The aim of the present study was to
determine the relationship between microvascular perfusion and cogni-
tive function in cSVD patients using IVIM.
Methods: Thirty-nine cSVD patients underwent IVIM imaging. The
IVIM parameters D(parenchymal diffusivity), f(perfusion fraction),
D*(intravascular diffusivity) and the perfusion-related parameter fD* were
calculated using a two-compartment diffusion model. This was per-
formed for the normal appearing white matter (NAWM), white matter
hyperintensities (WMH), cortex and deep grey matter. All patients had an
extensive neuropsychological assessment. The relationship between the
IVIM parameters and cognition was examined, corrected for patient char-
acteristics and WMH volumes.
Results: A lower fD* in the NAWM and cortex is significantly associated
with a lower score in overall cognitive function (p = 0.011 resp p = 0.007),
executive function (p = 0.044 resp p = 0.048) and information processing
speed (p = 0.045 resp p = 0.027), but not with memory. There were no sig-
nificant associations between cognition and the other IVIM parameters.
Conclusion: Our findings suggest that a lower cognitive function is asso-
ciated with a lower microvascular perfusion in the NAWM and cortex in
patients with cSVD. Longitudinal studies are needed to examine the
nature of this relationship and whether microvascular perfusion can be
used to predict future cognitive decline.
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Baseline stroke symptoms as predictors of cognitive
impairment after stroke
F Arba1, M Ali1, T Quinn2, D Inzitari3, G J Hankey4, K R Lees1
1Western Infirmary, Institute of Cardiovascular and Medical
Sciences, Glasgow, United Kingdom
2Glasgow Royal Infirmary, Institute of Cardiovascular and
Medical Sciences, Glasgow, United Kingdom
3NEUROFARBA, University of Florence, Florence, Italy
4Department of Neurology, University of Western Australia,
Perth, Australia
Background: Post stroke cognitive impairment (PSCI) is a frequent com-
plication of stroke, and is linked with development of dementia. We
investigated the relationship between baseline stroke symptoms and pres-
ence of PSCI at 1 and 3 years after ischemic stroke.
Methods: Anonymized data were accessed from the Virtual International
Stroke Trial Archive (VISTA). PSCI was defined as a Mini Mental State
Examination (MMSE) score of ≤26 at 1 and 3 years after stroke. We
conducted univariate analyses, assessing the relationship between baseline
stroke symptoms, medical history and MMSE at 1 and 3 years following
stroke, retaining the significant and relevant clinical factors as covariates
in a final adjusted logistic regression model.
Results: Data were available for 2172 (Median age = 65, median OHS = 1)
and 1324 patients (Median age = 65, median OHS = 1) at 1 and 3 years
respectively, after stroke. At one year, presence of aphasia (p = 0.005,
OR = 1.43; 95% CI = 1.12–2.83), and leg paralysis (p = 0.003, OR = 1.60;
95% CI = 1.17–2.17) at baseline were associated with MMSE ≤ 26. At
three years, presence of aphasia (p = 0.014, OR = 1.55; 95% CI = 1.09–
2.21), and leg paralysis (p = 0.003; OR = 1.69, 95% CI = 1.20–2.39) at
baseline were associated with MMSE ≤ 26.
Conclusions: Aphasia and leg weakness are known to affect up to 30% and
72% of stroke survivors respectively; our results suggest that these impair-
ments are associated with the development of PSCI up to 3 years after
stroke, as described by MMSE ≤ 26. Further validation work is required
using a robust PSCI measure; findings may help to identify those at risk to
develop post-stroke cognitive impairment.
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Overnight memory, attention, speech disruption:
Disconnection syndromes
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Introduction: Small, single infarcts in thalamus can cause a clinical picture
which is characterized by abrupt onset of confusion, impairment of
attention and memory. The above may often be misdiagnosed as CNS
inflammation.
Case report: A 63-year old woman with medical history of POEMS syn-
drome and autologous marrow transplant, hypertension, hyperlipidemia
and mastectomy presented with sudden onset of higher mental functions
disturbance less than 2 weeks prior to her admission.
The neurological examination revealed disorientation in space and time,
profound memory and attention deficits (MMSE = 11/30 and MoCA = 6/
30), speech disorder with difficulty in naming objects and no motor or
sensory pathology.
Routine blood, immunology, viral and CSF testing were normal.
Brain MRI depicted T2 and FLAIR-hyperintense lesion in the anatomic
area of left anterior thalamus that was not enhanced with contrast admin-
istration, congruous with a subacute ischemic vascular event.
On her follow-up a month later she re-appeared slightly improved
(MMSE = 15/30 and MoCA = 6/30) and 3 months later her MMSE score
was 22/30 and the patient was functional for basic activities of daily living.
Conclusion: Frontotemporal cortices have extensive connections with
ipsilateral anterior thalamic nuclei via the anterior and inferior thalamic
penducles which are formed by corticothalamic and thalamocortical
fibres. Previous studies have confirmed that in the case of an infarct in the
thalamus, the disruption of the thalamic projection fibers determines a
functional deactivation of the ipsilateral frontal cortex (thalamocortical
disconnection syndrome).
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The occurrence of a cognitive impairment after a stroke is a well known
phenomenon that can affect about 30% of the patients. The aim of this
work was to explore the potential cerebral alterations behind these impair-
ments, by focusing on the hippocampus and entorhinal cortex according
to the cognitive profile of patients after a stroke.
92 subjects free of dementia were scanned on 3T MR scanner (Achieva,
Philips) 6 months after a stroke. Two groups were defined: 52 subjects
with cognitive impairments at 6 months and 40 without. Hippocampus
and entorhinal cortex were automatically segmented from 3D
T1-weighted images using Freesurfer. Hippocampal volumes and entorhi-
nal cortex surfaces were compared between groups. Furthermore, a shape
analysis using SPHARM-PDM was done to assess potential focal altera-
tions of the hippocampus. Statistical comparisons between groups were
assessed using two-sample t-test corrected by age and gender. In shape
analysis, p-values were adjusted by the FDR p-value adjustment
procedure.
Shape analysis revealed a significant shrink of the left hippocampus
(p < 0.05), mainly in posterior part in subjects with cognitive impair-
ments. However, this was not corroborated with a reduction of the left and
right hippocampal volume (p = 0.19). Furthermore, this alteration of the
hippocampus integrity was associated with a significant reduction of the
entorhinal cortex surface (left: p < 0.001, right: p < 0.05).
Cognitive impairments following the stroke seem to be associated with
alterations of the hippocampus and entorhinal cortex surface. Then, the
next step is to follow these alterations and corroborate with a potential
dementia that could further appear.
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with vascular risk factors in neurology unit – A
challenging etiology
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Background: The aim of this study was to evaluate the prevalence of ACS
in neurological service, to describe the etiology, risk factors, investigation,
possible recovery and ACS outcome.
Method: we reviewed the clinical data of 86 aged (>65, median age, 70
years) patients hospitalized in our neurological service (2 years long) for
sudden confusional state, vascular risk factors (>2) and no preexisting
cognitive decline history. Patients were diagnosed for ACS using DSM-IV
criteria, “Confusion assessment method” and the Delirium Rating Scale
with a cut off of 12. Also by clinical examination, brain computed tomog-
raphy, vascular related blood tests, EEG, angio IRM in selected cases.
Results: we find 28(33%), hyperactive 40 (46%), hypoactive, and 18
(21%) mixed types of delirium and no correlation with the etiology. The
final causes of ACS were: subarachnoid hemorrhage 8 cases (9%), non-
dominant temporal lobe stroke 26 cases (30%), silent viral encephalitis 4
cases (5%), frontal lobe lacunars stroke 12 cases (14%), occipital ischemic
stroke 18 cases (21%), dementia onset 6 cases (6%), metabolic disorders 4
cases (5%), bilateral thalamic small hemorrhage 4 cases (5%), silent
urinary tract infection in women 4 cases (5%). 18 (21%) patients with no
stroke etiology.
After 2 weeks the psychological outcome was good for 56 (65%), patients
poor for 22 (25%) patients and partial recovery for 8 (10%) patients. In
stroke etiology patients, thalamic and non dominant temporal lesions
were poor recovery.
Conclusions: Acute confusional state etiology is always a challenging diag-
nosis in elderly even vascular risk factors is present.
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Hippocampal volume early after stroke lower than
controls
T Cumming1, E Werden1, Q Li1, A Brodtmann1
1Stroke, Florey Institute of Neuroscience and Mental Health,
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Background: Structural brain volume is an important marker of neuro-
degeneration. Quantifying regional brain volume early after stroke allows
us to establish a baseline for longitudinal change measurement.
Methods: The Cognition And Neocortical Volume After Stroke
(CANVAS) study is an ongoing longitudinal investigation. Ischemic stroke
patients without dementia are recruited and assessed within a month of
stroke, and are compared to healthy age-matched controls. All partici-
pants undergo high-resolution 3T MPRAGE MRI to evaluate regional
brain volume. Cognitive assessments include the Montreal Cognitive
Assessment (MoCA), the Hopkins Verbal Learning Test-Revised
(HVLT-R) and a test of working memory (CogState one-back task).
Results: We recruited 80 stroke patients (57 male, age 67.3 ± 12.9 years,
education 13.0 ± 3.8 years; days post-stroke 25.4 ± 10.2) and 30 controls
(17 male, age 68.8 ± 7.6 years, education 15.0 ± 5.0 years). Adjusting for
age and intracranial volume, regional analysis indicated smaller hip-
pocampi (p = 0.025) and amygdalae (p = 0.005) in stroke patients than
controls, but no difference in the thalami or caudate nuclei. In stroke
patients, hippocampal volume was significantly correlated with MoCA
(r = 0.72, p < 0.001; Fig. 1), HVLT-R immediate recall (r = 0.39,
p = 0.001) and working memory (r = 0.36, p = 0.002).
Fig. 1 Correlation between stroke patients’ hippocampal volume and
MoCA score.
Conclusions: Stroke patients have smaller-than-expected hippocampi and
amygdalae early after stroke, and these differences have important impli-
cations for cognitive function.
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The relationship between premorbid IQ, education
level and post-stroke cognitive functioning in patients
with mild stroke
C McHutchison1, V Cvoro1, K Shuler1, S Makin1, M Dennis1,
J Wardlaw1
1Centre for Clinical Brain Sciences, University of Edinburgh,
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Background: Those with better cognitive functioning in childhood appear
to be more likely to achieve a higher level of education and experience and
fewer cognitive difficulties in older adulthood. More recent research has
suggested that these early life variables may act as protective factors
against cognitive dysfunction following neurological incidents including
stroke. The purpose of this study was to examine the relationship between
premorbid IQ, educational level and post-stroke cognitive functioning in
patients with mild stroke.
Methods: Participants from the Mild Stroke Study completed measures of
current cognitive functioning, including Addenbrooke’s Cognitive Exami-
nation (ACE-R) and Montreal Cognitive Assessment (MoCA), at three to
four years after ischemic stroke. Premorbid IQ was assessed using the
National Adult Reading Test (NART) and socio-economic data were also
collected.
Results: Amongst 89 participants (mean age 70.4, range 51–94), perfor-
mance on the NART positively correlated with scores on both the ACE-R
(r = 0.49) and MoCA (r = 0.50, both at p < 0.001). In addition, a logistic
regression showed that those with further education beyond completion
of secondary school were significantly less likely to have mild (ACE-
R = 82–87) or severe (ACE-R < 82) cognitive impairment at three to four
years post stroke than those with less education (b = −0–0.2, p < 0.001
and b = −0.17, p < 0.001 respectively). Similar trends were found on
performance on the MoCA, however this did not reach statistical
significance.
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Conclusions: Higher performance on the NART late after stroke is related
to both a higher education level and better post stroke cognitive function-
ing in patients with mild stroke.
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S Hilal1, X Xu1, M K Ikram2, H Vrooman3, N Venketasubramanian4,
C Chen1
1Pharmacology, National University of Singapore, Singapore,
Singapore
2Clinical Sciences, Academic Medicine Research Institute
Duke-NUS Graduate Medical School, Singapore, Singapore
3Departments of Radiology & Medical Informatics, Erasmus
University Medical Center, Rotterdam, Netherlands
4Raffles Neuroscience Centre, Raffles Hospital, Singapore,
Netherlands
Introduction: Subcortical volume reduction is conventionally considered
a sensitive marker of neurodegeneration. However, its association with
cerebrovascular disease, particularly in vascular cognitive impairment no
dementia (VCIND) and vascular dementia (VaD) has not been explored
previously.
Methods: A case-control study was performed, with cases (VCIND and
VaD) recruited from memory clinics and controls from memory clinics
and the community. All subjects underwent detailed neuropsychological
assessment and 3T MRI. Subcortical volumes of the accumbens,
amygdala, caudate, pallidum, putamen and thalamus were measured
using FreeSurfer. VCIND was defined as impairment in at least one cog-
nitive domain associated with a history of ischemic stroke and neuroim-
aging evidence of infarct. VaD was diagnosed using the NINDS-AIREN
criteria. Logistic regression models were constructed for age2 initially and
subsequently for gender and hypertension.
Results: A total of 90 controls (mean age:67.6 years), 64 VCIND (mean
age:68.2 years) and 22 VaD (mean age:72.1 years) were included. In mul-
tivariate adjusted models, smaller volumes of accumbens, amygdala, pal-
lidum, putamen and thalamus were significantly associated with VCIND
compared to controls. In VaD, significant reduction was observed in the
volumes of accumbens [OR:3.67; 95% CI (1.68–7.99)], pallidum
[OR:4.29; 95% CI (1.78–10.33) and putamen [OR:2.26; 95% CI
(1.27–3.99)].
Conclusion: These findings suggest that the amygdala and thalamus have
reduced volume in the early stages of vascular cognitive impairment
whereas the accumbens, pallidum and putamen are more severely affected
by volume reductions in the later stages of vascular cognitive impairment.
The mechanisms underlying this specific pattern of subcortical volume
reductions requires further elucidation.
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24. Vascular Cognitive Impairment
Asymptomatic carotid artery stenosis and cognitive
function: A systematic review
N Hunter1, J Lau2, A Lee2, S Shenkin2
1Medicine of Elderly, Western General Hospital, Edinburgh,
United Kingdom
2Medicine of Elderly, Royal Infirmary of Edinburgh,
Edinburgh, United Kingdom
Scope: Symptomatic carotid artery stenosis (CAS) is associated with cog-
nitive impairment, but it is unclear whether asymptomatic CAS is asso-
ciated with cognitive function. We performed a systematic review to assess
whether asymptomatic CAS was an independent risk factor for cognitive
decline.
Search methods: Two independent researchers searched Medline, Embase
and PsychINFO using terms for (i) CAS and (ii) cognition. The inclusion
criteria were: published full-text primary research in English, adult sub-
jects over 18 years old with asymptomatic CAS and use of validated
neuropsychological tests. Data including study design, participant char-
acteristics, exclusion criteria, method of assessing CAS, neuropsychologi-
cal tests, statistical analysis, result summary and conclusions were
extracted for analysis.
Results: We included 11 studies consisting 5 case-control, 4 prospective
and 2 cross-sectional studies. These included a total of 15805 participants
(range 12 to 4371) with mean age of 62.5 years studied in 10 centers
within 6 countries. 38 different neuropsychological tests were used. 10
studies concluded that cognitive impairment is present in people with
asymptomatic CAS. The strength of the association and whether
increasing degree of CAS causes increasing cognitive impairment is
undetermined.
Conclusion: Asymptomatic CAS is associated with cognitive impairment.
However, more analysis is needs to be done to gauge the degree of stenosis
at which cognitive impairment becomes significant. Furthermore, studies
are needed to explore the options and benefits of treatment and whether
population screening would be appropriate.
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24. Vascular Cognitive Impairment
White matter hyperintensities and cognition in MCI
and dementia: A domain-specific analysis
E van den Berg1, M I Geerlings2, G J Biessels3, P J Nederkoorn4,
R P Kloppenborg5
1Experimental Psychology, Utrecht University, Utrecht,
Netherlands
2Julius Center for Health Sciences and Primary Care,
University Medical Center Utrecht, Utrecht, Netherlands
3Rudol Magnus Brain Center, Department of Neurology,
University Medical Center Utrecht, Utrecht, Netherlands
4Academic Medical Center, Department of Neurology,
Amsterdam, Netherlands
5Rudolf Magnus Brain Center Department of Neurology,
University Medical Center Utrecht, Utrecht, Netherlands
Background: White matter hyperintensities (WMHs) are related to cog-
nition in the general population. WMHs and cognition are also linked in
patients with dementia, but the clinical relevance is not well-defined. We
aimed to quantify the effects of WMHs on specific cognitive functions in
patients with MCI and dementia.
Methods: PubMed (January 1990–May 2014) was searched for studies
that used MRI to quantify WMHs, and measured cognitive functioning
(≥1 predefined cognitive domains with ≥1 test) in a well-defined popula-
tion of persons with cognitive dysfunctioning. Correlation coefficients
(transformed to Fischer’s Z) were extracted/calculated and used as the
common metric for effect size.
Results: Twenty-one cross-sectional studies on dementia (total n = 2974,
median age 75 y) and 9 studies on MCI (8 cross-sectional, 1 longitudinal;
total n = 2258, median age 73 y) were included. Presence of WMHs was
associated with overall cognition (Fischer’s Z: −0.14, 95% CI–0.19 to
−0.09). This effect was significantly larger for MCI (−0.23, −0.36 to −0.09)
than for dementia (−0.11, −0.16 to −0.06; QM 4.7, p < 0.05). WMHs were
specifically associated with attention & executive functions (−0.26, −0.40
to −0.12), processing speed (−0.20, −0.37 to −0.02) and visuoconstruction
(trend: −0.21, −0.48, −0.48 to 0.08), but were unrelated to memory (−0.05,
−0.14 to 0.04) and language (−0.03, −0.28 to 0.22).
Conclusion: WMHs have a small but consistent effect on cognition in
persons with MCI and dementia, particularly with regard to attention &
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executive functioning and processing speed. These results underscore the
important role of vascular brain damage in the clinical presentation of
dementia.
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24. Vascular Cognitive Impairment
Methodological factors in determining rates of
dementia in TIA and stroke: Impact of baseline
selection bias
S T Pendlebury1, P J Chen1, L Bull1, L Silver1, Z Mehta1,
P M Rothwell1
1Nuffield Department of Clinical Neurosciences, Stroke
Prevention Research Unit, Oxford, United Kingdom
Introduction: Many previous studies on dementia in stroke have restric-
tive inclusion criteria which may result in under-estimation of dementia
rates. We undertook a large prospective population-based study of all TIA
and stroke to determine the impact of study entry criteria on measured
rates of pre- and post-event dementia.
Methods: All patients with acute TIA or stroke from a defined population
of 92 728 are referred from primary care or at hospital admission to the
Oxford Vascular Study (2002–2007) and have baseline clinical and cogni-
tive assessment and follow-up. We examined the impact of early death,
other non-availability, and commonly-used selection criteria, on mea-
sured rates of dementia.
Results: Among 1236 patients (mean age/SD 75.2/12.1 years, 582 male,
403 TIA), 139 died or were otherwise unavailable for baseline assessment,
224 were dysphasic, 319 had prior dependency, 425 had co-morbidity, 512
were aged ≥80 years and 502 were hospitalized. Pre-event dementia was
threefold higher in patients dying pre-ascertainment (10/47, 21%) and
twice as high in other non-assessed (14/92,15%) vs assessed patients (69/
1097, 6%; p = 0.0006, p = 0.002) and was several-fold higher in those with
prior functional impairment (24% vs 3%, p < 0.0001), age >80 years (13%
vs 3%, p < 0.0001), dysphasia (11% vs 7%, p < 0.0001) and co-morbidity
(10% vs 6%, p = 0.04). Findings for post-event dementia were similar:
prior functional impairment (40% vs 13%, p < 0.0001), age >80 years
(28% vs 10%, p < 0.0001), dysphasia (22% vs 15%, p = 0.02) and
co-morbidity (25% vs 15%, p = 0.005).
Conclusions: Exclusion of patients unavailable for assessment, and other
widely used selection criteria, results in underestimation of the measured
rate of dementia associated with TIA and stroke.
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Methodological factors in determining rates of
dementia after TIA and stroke: Impact of loss to
face-to-face study clinic follow-up
S T Pendlebury1, P J Chen1, S J V Welch1, F C Cuthbertson1,
Z Mehta1, P M Rothwell1
1Nuffield Department of Clinical Neurosciences, Stroke
Prevention Research Unit, Oxford, United Kingdom
Introduction: Cognitive assessment in cohorts and trials is often based
only on face-to-face clinic testing. However, cognitive impairment is
strongly associated with increased morbidity and mortality potentially
leading to substantial loss to face-to-face follow-up assessment. In the
absence of previous population-based data, we determined the impact of
such attrition on measured rates of dementia after TIA and stroke.
Methods: Patients with TIA or stroke prospectively recruited (2002–2007)
into the Oxford Vascular Study (OXVASC) had baseline clinical and cog-
nitive assessment and follow-up to 2014. Dementia was diagnosed
through face-to-face clinic interview, supplemented by home-visits and
telephone-assessment in patients unable to attend clinic and by hand-
searching of primary care records in uncontactable patients.
Results: Of 1236 patients (mean/SD age 75.2/12.1 years, 582 male), 527
(43%) died by 5-year follow-up. Follow-up assessment rates (study clinic,
home visit or telephone) of survivors were high at 947/1026 (92%), 857/
958 (89%), 792/915 (87%), and 567/673 (84%) at 1, 6, 12 months and 5
years. Dementia developed in 260 patients, of whom 87 (33%) had not
been available for face-to-face study clinic follow-up. The 5-year cumula-
tive incidence of post-event dementia was 19.0% (95% CI 17–22) in study
clinic assessed patients but 29% (26–32%) overall (p-difference = 0.012).
Conclusions: Exclusion of patients unavailable for clinic follow-up sub-
stantially reduces the measured rate of post-event dementia. Use of mul-
tiple other follow-up methods including home visits, telephone
assessments and consent to access primary care records increases ascer-
tainment of dementia outcomes by about a third.
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Executive function in stroke patients with ipsilateral
internal carotid artery stenosis: The impact of clinical
variables
S Pires-Barata1, R García2, V Ladera2, M V Perea2, L Azinheiro3,
S Mateus4, C Corzo1, L Rebocho1
1Stroke Unit, Hospital Espírito Santo de Évora EPE, Évora,
Portugal
2Departamento de Psicología Básica Psicobiología y
Metodología de las Ciencias del Comportamiento,
Universidad de Salamanca, Salamanca, Spain
3Department of Physical Medicine and Rehabilitation,
Hospital Espírito Santo de Évora EPE, Évora, Portugal
4LUSCAN, Hospital Espírito Santo de Évora EPE, Évora,
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Purpose: The association between stroke, vascular risk factors and cogni-
tive impairment is well documented. However, few studies report the
cognitive performance of ischemic stroke patients with ipsilateral internal
carotid artery stenosis (ICAS), before being subjected to revascularization
treatments, and considering clinical variables like hemispheric lateraliza-
tion, degree of stenosis or presence of collateral circulation. The aim of the
present study is to understand the impact of these variables on executive
function.
Methods: 74 participants were eligible for inclusion and were divided in
three groups, matched by gender, age and scholar grade: 14 ischemic
stroke with ICAS and 30 ischemic stroke without stenosis, and 30 partici-
pants without either neurological or cognitive disorders. A neuropsycho-
logical evaluation was performed, during the first two weeks after the
vascular event, before being subjected to carotid revascularization
treatment.
Results: ischemic stroke patients with ICAS showed lower results when
compared to the other groups, in most of the executive function tests
applied. Higher education is considered good predictors for executive
function performance. However, having a right stroke and stenosis, hyper-
triglyceridemia and anxiety, were considered predictors for poorer perfor-
mance in executive function.
Conclusions: Poor performance in specific executive domains was associ-
ated to stroke patients and ICAS, when compared to stroke patients
without stenosis. Having a higher education grade seems to have a positive
impact in executive function. The presence of a right hemispheric stroke,
hypertriglyceridemia and anxiety seems to have a negative impact. There
for more research is needed to clarify the mechanisms implied in this
process.
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Basal ganglia enlarged perivascular spaces and other
MRI markers are associated with mild cognitive
impairment in hypertensives
Y Riba Llena1, C Nafría2, X Mundet3, A López-Rueda4,
J Jiménez-Balado5, C Ioana Jarca6, J L Fernández7, J L Tovar8,
I Fernández-Cortiñas4, F Orfila9, O Maisterra10, M Domingo11,
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Background: The relation of mild cognitive impairment (MCI) with
enlarged perivascular spaces (EPVS) is not completely established. Our
objectives are to describe the presence of EPVS at basal ganglia (BG) and
centrum semiovale (CSO) in a hypertensive cohort and determine how
their presence (either individually or combined with other imaging
markers) and location relate to cognitive status (–MCI- or normal cogni-
tive aging –NCA-).
Methods: Cross-sectional study on 798 non-demented and stroke-free
hypertensives, diagnosed of MCI or NCA. EPVS and other MRI (magnetic
resonance imaging) markers (brain infarcts, white matter hyperintensities
and microbleeds) were rated in brain MRI. Multivariate analysis were
performed to relate the presence of extensive (>11 lesions) EPVS (alone or
combined with other MRI markers) with MCI, after adjustment by poten-
tial confounders (age, sex, education and vascular risk factors).
Results: 76 participants were diagnosed of MCI and 658 of NCA. 40.2% of
the participants had extensive CSO EPVS and 23.3% had extensive BG
EPVS. MCI was associated with extensive BG EPVS, particularly when
they were jointly found with either brain infarcts (OR 2.99, CI 95%
1.25;7.15), extensive subcortical (OR 5.86, CI 95% 2.15;15.95) or periven-
tricular (OR 7.95, CI 95% 1.69;37.11) white matter hyperintensities after
correcting for confounders. However, extensive CSO EPVS were not asso-
ciated with cognitive status.
Conclusions: Extensive BG EPVS and particularly their combined effect
with other brain MRI markers might contribute to MCI. Besides, our
results support the need to relate cognition to the burden of MRI markers,
rather than focus on individual lesions.
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Cardiovascular health and subsequent cognitive
decline in patients with pre-existing coronary heart
disease
D Tanne1, M Lutski2, U Goldbourt2
1Stroke Center Neurology, Chaim Sheba Medical Center, Tel
Hashomer, Israel
2Department of Epidemiology and Preventive Medicine,
School of Public Health, Sackler Faculty of Medicine, Tel Aviv
University, Ramat Aviv, Israel
Background: Cardiovascular (CV) health factors are associated with lower
risk of CV disease and stroke. We used a CV health metric to examine
association with subsequent cognitive decline in coronary heart disease
(CHD) patients.
Methods: A subset of 203 surviving patients (95.9% males; age at baseline
57 ± 6.0 yrs.) with chronic CHD who had previously participated in a
clinical trial (BIP;1990–1997) underwent cognitive evaluations after
median follow-ups of 14 yrs and 20 yrs. Cognitive performance was
assessed using the NeuroTrax Computerized Cognitive Battery. A CV
health metric at baseline was calculated including 3 health factors
(glucose, LDL-cholesterol, blood-pressure), 4 health behaviors (physical-
activity, adherence to Mediterranean diet, smoking, BMI), and body-
height assessing, in-part, early life environment, categorizing each into
ideal (0-points), intermediate (1-point), and poor levels (2-points). To
examine the association between CV health metric and rate of cognitive
decline, we used linear mixed effects models.
Results: Controlling for potential confounders, increment in the overall
CV health score (per 1-point) was associated with an increased rate of
cognitive decline in a global cognitive score (Standardized β coefficient
(β) = −0.04 ± SE 0.02;P = 0.008) and in specific cognitive domains:
executive function (β = −0.05 ± 0.02;P = 0.036) and visual spatial
(β = −0.09 ± 0.03;P = 0.002). Increment (per 1-point) in the health
behavior component was associated with a decline in the global cognitive
score (β = −0.04 ± 0.02;P = 0.057) and in the visual spatial domain
(β = −0.11 ± 0.04;P = 0.007). Lower height score was associated with a
decline in the global cognitive score (β = −0.18 ± 0.08;P = 0.037). The
health factors component was not associated with subsequent cognitive
scores.
Conclusion: Among patients with pre-existing CHD, worse CV health is
associated with subsequent cognitive decline.
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Cerebral microbleeds and cognitive function in
ischemic stroke or transient ischemic attack patients
Z Wang1, A Wong1, W Liu1, J Yang2, W Chu3, L Au1, A Lau1,
Y Xiong4, Y Soo1, V Mok1
1Division of Neurology, Department of Medicine and
Therapeutics, The Chinese University of Hong Kong, Hong
Kong, China
2Institute of Neuroscience and the Second Affiliated Hospital,
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Background: We explored the association between cerebral microbleeds
(CMBs) and cognitive impairment in patients with ischemic stroke/
transient ischemic attack (TIA).
Methods: A total of 218 acute ischemic stroke/TIA subjects received mag-
netic resonance imaging with sensitivity weighted imaging sequence.
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Montreal Cognitive Assessment (MoCA) was used to evaluate global cog-
nitive function and cognitive domains. The association of CMBs quantity
with cognitive function and the impact of CMBs locations (“strictly
lobar” region; “strictly deep” region; “mixed” region) on cognitive impair-
ment were examined in regression models after adjusting for confounders,
including brain atrophy, white matter hyperintensities, lacunes and
volume of acute infarction. This study was approved by New-Territories
clinical research committee.
Results: A total of 71 subjects (32.6%) had ≥1 CMB, with 28 having 1
CMB, 22 having 2–4 CMBs, 21 having ≥5 CMBs. Strictly lobar, strictly
deep and mixed CMBs were identified in 23, 22 and 26 patients, respec-
tively. Presence of ≥5 CMBs in the whole brain or strictly deep CMBs was
associated with MoCA total score (β = 0.279, 95% CI 0.008–0.551,
P = 0.044; β = 0.234, 95% CI 0.012–0.456, P = 0.039, respectively. Table).
Of all the MoCA domains tested, lower score in attention domain was
related to presence of ≥5 CMBs (OR = 10.632, 95% CI 1.638–68.998,
P = 0.013) and strictly deep CMBs (OR = 3.359, 95% CI 0.924–12.212,
P = 0.066).
Conclusion: CMBs was associated with cognitive dysfunction especially in
attention domain in stroke/TIA patients. This association was mainly
driven by CMBs in the “deep” region, underlining the role of hypertensive
microangiopathy in stroke-related cognitive impairment in Chinese.
Table Association of CMBs with MoCA total score (reflect and log trans-
formed. linear regression)
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Association between macroscopic and microstructural
white matter damage and cognition in vascular
cognitive impairment
G Zamboni1, L Griffanti1, G Bonifacio1, S Mazzucco1, A Khan1,
S T Pendlebury1, U Schulz1, W Kuker1, M Jenkinson1,
P M Rothwell1
1NDCN, Oxford University, Oxford, United Kingdom
Background: White matter hyperintensities (WMH) detectable on MRI
provide a measure of macroscopic white matter damage and have been
associated with increased risk of cognitive impairment. Diffusion MRI
provides more sensitive, fine-grained measures of the microstructural
integrity of white matter. We investigated the association between degree
and localization of macro- and micro-structural white matter damage and
cognitive performance in patients with recent TIA or non-disabling
stroke.
Methods: We studied 306 consecutive eligible patients with TIA or non-
disabling-stroke (Oxford Vascular Study) who underwent MRI and cog-
nitive assessment with MMSE and MoCA. WMH were automatically
segmented on FLAIR images. Voxel-based correlational analyses were per-
formed with FSL tools to evaluate associations with MoCA and MMSE
scores. Diffusion-weighted images were acquired on a subsample of 242
subjects and the same voxel-based correlational analyses were performed
on fractional anisotropy (FA) images using TBSS.
Results: After correction for age, lower MoCA scores were associated with
higher likelihood of having WMH in the left frontal periventricular white
matter and in the genu and splenium of corpus callosum (voxel-corrected
p < 0.05, tpeak-voxel = 5.6). Less involvement of WMH in the left frontal
white matter was found for MMSE. After correction for age, lower MoCA
and MMSE scores were associated with lower FA values in almost all the
white matter tracts (TFCE-corrected p < 0.01, tpeak-voxel = 5.6).
Conclusion: Vascular cognitive impairment is associated with diffuse
microstructural white matter damage and more focal frontal and callosal
WMH, suggesting that silent microstructural injury occurs early and is
already widespread by the time WMH and cognitive impairment are
manifest.
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Vascular Neurosurgery
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25. Vascular Neurosurgery
4'-O-B-D-Glucosyl-5-o-methylvisamminol, an active
ingredient of Saposhnikovia divaricata, attenuates
high-mobility group box 1 and subarachnoid
hemorrhage-induced vasospasm in a rat model
C Chang1, S Wu2, A Kwan3
1Neurosurgery, Kaohsiung Municipal Ta-Tung Hospital,
Kaohsiung, Taiwan
2Neurosurgery, Kaohsiung Medical university Hospital,
Kaohsiung, Taiwan
3Surgery, Kaohsiung Medical University, Kaohsiung, Taiwan
Abstract: High-mobility group box 1 (HMGB1) was observed to be an
important extracellular mediator involved in vascular inflammation asso-
ciated with subarachnoid hemorrhage (SAH). This study is of interest to
examine the efficacy of 4′-O-β-D-glucosyl-5-O-methylvisamminol,
C22H28O10, on the alternation of cytokines and HMGB1 in a animal
model.
Methods: A rodent double hemorrhage SAH model was employed.
Administration with 4′-O-β-D-glucosyl-5-O-methylvisamminol was ini-
tiated 1 hr after animals subject to SAH. Basilar arteries (BAs) were har-
vested and cortex to examine HMGB1 mRNA, protein expression
(Western blot) and monocyte chemoattractant protein-1 (MCP-1) immu-
nostaining. CSF samples were collected to examine IL-1β, IL-6, IL-8 and
MCP-1 (rt-PCR).
Results: Morphological findings reveal endothelial cell deformity, intra-
vascular elastic lamina torture, and smooth muscle necrosis in the vessels
of SAH groups. Correspondently, IL-1β, IL-6 and MCP-1 in the SAH only
and SAH plus vehicle groups was also elevated. 4′-O-β-D-glucosyl-5-O-
methylvisamminol dose-dependently reduced HMGB1 protein expres-
sion when compared with the SAH groups.(p < 0.01) Likewise, 400 ug/kg
4′-O-β-D-glucosyl-5-O-methylvisamminol reduced IL-1β, MCP-1 and
HMGB1 mRNA levels as well as MCP-1(+) monocytes when compared
with the SAH groups.
Conclusion: 4′-O-β-D-glucosyl-5-O-methylvisamminol exerts its neuro-
inflammation effect through the dual effect of inhibiting IL-6 and MCP-1
activation and also reduced HMGB1 protein, mRNA and MCP-1(+) leu-
kocytes translocation. This study lends credence to support 4′-O-β-D-
glucosyl-5-O-methylvisamminol could attenuate pro-inflammatory
cytokine mRNA, late-onset inflamosome and cellular basis in SAH-
induced vasospasm.
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The influence of neurovascular multidisciplinary team
on the carotid management in ischemic stroke
patients with carotid artery stenosis
S F Cheng1, M M Brown1, R J Simister1, T Solbach1, T Richards1
1Division of Surgery and Interventional Science, University
College Hospitals, London, United Kingdom
Introduction: Discussion of patients with carotid stenosis at a neurovas-
cular multidisciplinary team (MDT) meeting allows consensus decisions
to take account of cerebrovascular imaging, medical management, and the
impact of comorbidities with ageing; but might delay surgery beyond the
guideline of a maximum of two weeks from symptoms. We therefore
studied the impact of an MDT on carotid management.
Methods: A prospective observational study was performed over a five
month period. All patients with stroke or TIA underwent extracranial CT
angiography or contrast enhanced MRA. Patients with carotid stenosis
>50% were discussed at a joint neurovascular MDT attended by a neu-
rologist, neuroradiologist and vascular surgeon twice weekly. Patient
demographics and results of carotid imaging techniques were collected.
Proposed management plans were recorded before and after the MDT
discussion. The impact of the MDT was documented as a change in plan
or request for further imaging.
Results: 78 patients had significant carotid stenosis of >50%. The MDT
meeting discussed 35 of the 78 patients; 25 had symptomatic and 10
asymptomatic stenosis or occlusion. MDT discussion resulted in no
change in 7 patients, 7 had a change in diagnosis on imaging review, 9 a
change in management and 5 both; a further 7 underwent further review.
Carotid endarterectomy was performed in 16 patients and 1 was included
in the medical arm of ESCT-2, all within 14 days of symptoms.
Conclusion: A neurovascular MDT impacts on clinical management
without unduly delaying surgery and is necessary for clinical governance
in patients with carotid artery disease.
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Clipping versus coiling in the management of
posterior communicating artery aneurysms with third
nerve palsy: A Systematic review and meta-analysis
T Gaberel1, A Borha1, C di Palma1, E Emery1
1Neurosurgery, Caen University Hospital, Caen, France
Object: To compare surgical clipping to endovascular coiling in terms of
recovery from oculomotor nerve palsy (ONP) in the management of
posterior communicating artery (PCoA) aneurysms causing third nerve
palsy.
Methods: The authors conducted a systematic review of the literature and
meta-analysis.
Results: 10 relevant studies involving a total of 205 patients with third
nerve palsy due to PCoA aneurysms at baseline, of which 123 (60.0%)
were treated by clipping and 82 by coiling (40.0%), were included in a
meta-analysis. Pooled Odds Ratios of the impact of clipping or coiling on
complete ONP recovery, lack of ONP recovery and procedure-related
death were calculated. The overall complete ONP recovery rate was 47.6%
in the coiling group compared to 73.1% in the clipping group, corre-
sponding to an overall pooled Peto odds ratio of 2.97 (95% CI 1.54–5.71).
Subgroup analysis revealed a clear benefit of clipping over coiling in
patients with ruptured aneurysms, but not in unruptured aneurysms.
None of the ten studies reported any procedure-related death.
Conclusions: Surgical clipping of PCoA aneurysms causing third nerve
palsy achieves better outcome than endovascular coiling. This result could
be particularly true in the case of ruptured aneurysms. In view of the small
number of cases and purely observational data, statements about this
effect should be made with great caution. A randomized trial would better
respond to the therapeutic dilemma raised, but while awaiting the results
of such a trial, we recommend managing PCoA artery aneurysms causing
ONP with surgery.
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The role of vasa vasorum activities in carotid
atherosclerosis are associated with plaque
development and vulnerability
S Joo1, T Kim1, S Jeong1
1Neurosurgery, Chonnam National University Hospital,
Gwangju, Korea
Background: The aim of this study was to investigate the correlation
between the activities of carotid vasa vasorum and carotid plaque vulner-
ability by indocyanine green (ICG) angiography during CEA, focusing on
how the vasa vasorum of carotid artery is depicted.
Methods: Sixty-five patients (mean age: 68.8 ± 2.5, mean degree of steno-
sis 78.9 ± 3.8) who underwent a CEA were enrolled prospectively. ICG was
injected intravenously as a bolus before and after the arterectomy during
CEA. We also performed an immunohistochemistry study using CD68
(macrophage), CD117 (mast cell), CD4 (T-cell), and CD8 (B-cell) anti-
body for resected plaque specimens.
Results: In the ICG angiographic series (n = 65), the active vasa vasorum
density was observed in all patients. The vasa vasorum externa (VVE) and
interna (VVI) were seen in 10 patients (15.4%) and 55 patient (84.6%),
respectively. The types of VVE were strongly associated with preoperative
angiographic instability (90.0%, p = 0.001) and carotid plaque vulnerabil-
ity (100%, P = 0.003) microscopically. In contrast, the types of VVI were
less associated with angiographic instability (36.1%) and plaque vulner-
ability (49.1%,). Macrophages and mast cells stained by CD86 and CD117
were more frequently observed in unstable plaque, compared to stable
plaque (P < 0.0001, P = 0.002, respectively), However, there were no sig-
nificant differences in T-cell and B-cell
Conclusion: The early appearance of VVE in ICG angiography is strongly
associated with carotid unstable plaque. Macrophage and mast cell are
involved in the formation of microvessel in the atherogenic plaque and
accelerate plaque progression into an unstable phenotype.
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The results and perioperative complications of
revascularization surgery for the ischemic
cerebrovascular disease
S Joo1, S Jeong1, T Kim1
1Neurosurgery, Chonnam National University Hospital,
Gwangju, Korea
Background: We evaluate the outcome of our patients of ischemic cere-
brovascular disease who underwent revascularization surgery.
Methods: We retrospectively reviewed the medical records and results of
follow up imaging studies on 80 cases in 63 patients with moyamoya
disease and 144 patients with occlusive vascular disease who received
bypass surgery at our institution over a 10-year period.
Results: In 80 cases of moyamoya disease, transient ischemic attack was
presented on 11 cases (13.8%); focal infarction on 2 cases (2.5%); sub-
dural hemorrhage (SDH) on 2 (2.5%); intracerebral hemorrhage (ICH)
on 2 (2.5%) postoperatively. All cases of TIA were recovered without
permanent deficit. In 6 patients with postoperative ICH or SDH or infarc-
tion, 2 patients had moderate or severe neurological deficit and one
patients was expired (mortality 1.3%). Others were discharged without
any neurological deficit after conservative treatment. In occlusive vascular
disease, TIA was developed on 7 patients (4.8%); postoperative infarction
was developed on 5 patients (3.4%); small sized ICH at previous infarc-
tion site on 2 (1.4%); SDH required revision on 1 (0.7%); wound infec-
tion on 1. Although 4 patients with postoperative infarction or ICH had
neurological deficit, others were recovered without neurological deficit.
Conclusion: Cerebral revascularization procedures are effective for symp-
tomatic patients with moyamoya or occlusive vascular disease. However,
Half of the cause of poor outcome is postoperative complication. There-
fore the prevention and adequate treatment of perioperative complica-
tions of revascularization surgery can be a one important factor that
improve the outcome.
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Have outcomes improved in patients with
subarachnoid hemorrhage (sah) related delayed
cerebral ischemia (DCI)? A single-center sequential
cohort study
A Khan1, L Dulhanty1, A Vail2, P Tyrrell3, J Galea3, H C Patel1
1Department of Neurosurgery, Salford Royal NHS Foundation
Trust, Salford, United Kingdom
2Institute for Population Health, University of Manchester,
Manchester, United Kingdom
3Institute for Cardiovascular Sciences, University of
Manchester, Manchester, United Kingdom
Introduction: Delayed cerebral ischemia (DCI) is a well-accepted negative
prognostic predictor of outcome in patients that have had a SAH. Overall
outcomes following SAH have improved over time, but it is unclear if
outcomes have improved in patients that have developed DCI.
Methods: We retrospectively compared outcomes (mortality, discharge
destination, GOS (Glasgow outcome scale)) in patients documented to
have DCI treated before (2004–2007 Epoch A) and after (2009–2011
Epoch B) the introduction of a specialized SAH service. Patients were
identified from a departmental SAH database, the relevant notes and scans
were scrutinized for confirmation of DCI. Multi-factorial logistic regres-
sion analysis was performed to determine the injury and age adjusted
odds survival at discharge, discharge home, good recovery (GOS 5) and
favorable outcome (GOS 4–5) at 3 months.
Results: Seventeen percent of patients were documented to have DCI
(82/495 in Epoch A and 81/485 in epoch B). DCI was an independent
predictor of unfavorable outcome (OR 0.468, p < 0.001, 95% CI 0.316–
0.694). There was no significant difference in the odds of discharge home
(48% vs. 48%, p = 0.251, OR 0.654, 95% CI 0.316–1.351), hospital mor-
tality (16% vs. 14%, p = 0.207, OR 1.910 95% CI 0.699–5.218) good
recovery (46% vs. 52%, p = 0.127, OR 1.740, 95% CI 0.852–3.552) or
favorable recovery (71% vs. 73%, p = 0.323, OR 1.510, 95% CI 0.658–
3.559) between the two epochs.
Conclusions: Our data suggests that outcomes in patients with DCI have
not significantly improved over time in our experience, and strategies to
address this clinical problem continue to be important.
ESOC-0376
25. Vascular Neurosurgery
Decompressive hemicraniectomy for malignant
hemispheric infarction-a review of practice at a
comprehensive stroke center (CSC)
A Kishore1, M Elmi1, D Sen1, J Molloy1
1Stroke Medicine, Salford Royal Foundation Trust, Salford,
United Kingdom
Introduction: Recent societal guidelines (UK) for stroke suggest that
decompressive hemicraniectomy should be offered in selected patients for
malignant hemispheric infarction. However intervention is often depen-
dent on the referring stroke and treating neurosurgical teams. As a first
step to creating a consensus based protocol and a prospective database for
patients referred for hemicraniectomy, we audited our recent practice at
Salford Royal NHS Foundation Trust.
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Methods: This was a retrospective audit (5 year) involving data collection
from electronic patient records, neurosurgical referral database, inpatient
elective and emergency theatre lists (1 Jan 2009–31 Dec 2014).
Results: 15 patients were included in final analysis. Median age was 45 y
(range 29 y–65 y); majority were male (75% M vs 25% F). Information on
time to hemicraniectomy (median = 37 hrs) was available in 80% of
patients with 33% of patients undergoing surgery after 48 hrs (range from
50% of MCA territory with mass effect at time of referral. 93% of patients
were alive at 1 year with limited morbidity data.
Conclusions: There appeared to be substantial variation in documenta-
tion of essential criteria when deciding on hemicraniectomy. A large
number of patients underwent hemicraniectomy outside of national
guidance, although with good survival rates at 1 year. A robust local
hemicraniectomy protocol with a prospective database is thus likely to
have utility in both clinical research and practice.
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Efficacy of adenosine-induced transient cardiac arrest
for cerebral aneurysm surgery
Y. Niiya1, H. Itosaka1, M. Kawabori1, M. Iwasaki1, S. Mabuchi1,
K. Houkin2
1Neurosurgery, Otaru General Hospital, Otaru, Japan
2Neurosurgery, Hokkaido University, Sapporo, Japan
Introduction: Cerebral aneurysm surgery occasionally requires transient
deflation of the aneurysm to prevent its rupture or to manage premature
rupture. Temporary occlusion of the parent artery is an effective method
to reduce the pressure of the aneurysm. However, in some case, blocking
the parent artery may not be feasible. Transient cardiac arrest (TCA)
induced by adenosine triphosphate (ATP) is an effective alternative in
such cases. Adenosine is a purine nucleoside that suppresses atrioventricu-
lar conduction. A bolus dose of ATP provokes short duration of cardiac
arrest. Aims: We present the efficiency of TCA to the clipping process.
Methods: 290 consecutive patients with aneurysms (ruptured aneurysm:
140, unruptured aneurysm: 150) were surgically treated between 2007 and
2014. Of these, 12 patients underwent TCA-inclusive surgery. Bolus intra-
venous injection of ATP was administered. Microsurgery was performed
during the short period of cardiac arrest. Results: We observed 3–40 s of
cardiac arrest and noted remarkable softening or collapse of the aneu-
rysms in all cases. In every case, the aneurysms were successfully obliter-
ated. TCA also served to control the bleeding in one case with premature
rupture of the aneurysm. Complications associated with TCA were not
observed in any of these patients.
Conclusions: TCA facilitated safe and quick dissection of the aneurysm
and clip application during the clipping operation. This approach is useful
when temporary occlusion of the parent artery is difficult. ATP-induced
TCA is a quite useful and safe method, although the former requires close
monitoring by an experienced anesthesiologist.
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Women and Stroke
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26. Women and Stroke
Functional recovery after stroke: Does being a woman
make the difference?
E Andrenelli1, M Capecci1, M Coccia1, M Millevolte1,
M G Ceravolo1
1Experimental and Clinical Medicine – Politecnica delle
Marche University, Neurorehabilitation Clinic, ANCONA, Italy
Study aim: To investigate if women show different recovery rates, from
men, after a first-ever stroke, across age groups.
Study design: Retrospective cohort study.
Methods: The data was extracted from a multicenter study on subjects,
admitted to intensive rehabilitation after a first-ever stroke. Recovery rate
was measured through the Effectiveness Index [(Barthel Index (BI) score
at discharge – BI score at admission)/(100-BI at discharge) x100], and
used as a dependent variable in the prognostic equation. The explanatory
variables, collected at rehabilitation admission, were: age, sex, pre-stroke
Rankin score, lesion side, interval from stroke to rehabilitation, comor-
bidities, CNS score, trunk control test, motricity index, functional ambu-
lation category, aphasia, neglect, cognitive impairment (MMSE score),
urinary incontinence, dysphagia.
Results: The studied sample consisted of 246 men and 174 women aged
66.6 ± 10.1 years and 67.8 ± 10.7 years, respectively. An inverse relation-
ship between age and the Effectiveness Index was observed (p < 0.0001),
in both sexes, with a faster decline of observed/expected recovery in
women, after 60 s (p < 0.04). Bladder incontinence, severe trunk control
and gait dysfunctions were more frequent in women, on admission, inde-
pendent of age. Cognitive ability declined with age (p < 0.008), though
faster in women over 60 s (p < 0.0001). The multivariate analysis indi-
cated that both advanced age and cognitive impairment, though not sex,
increased the risk of poor recovery (p < 0.001).
Conclusion: Age and cognitive impairment predict functional recovery in
stroke subjects admitted to intensive rehabilitation. Women may exhibit a
worse prognosis, than men, only after 60 s, likely due to the impairment of
their cognitive reserve.
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26. Women and Stroke
Cerebral venous thrombosis with
levonorgestrel-releasing intrauterine system in a
low-risk patient with essential thrombocythemia
A Cruz Culebras1, R Vera1, A De Felipe1, C Matute1, J Masjuan1
1Neurology, Stroke Unit, Hospital Universitario Ramón y Cajal,
Madrid, Spain
Introduction: Essential thrombocythemia (ET) is a myeloproliferative
syndrome and cerebral venous thrombosis (CVT) is a rare complication.
Common cardiovascular risk factors contribute to the pathogenesis of
arterial events, whereas circumstantial risk factors to that of venous
events.
History: A 39 year old woman with a seven year history of ET with no
vascular event until hospitalization (low-risk ET). Four weeks before
admission she began to use a low dose levonorgestrel-releasing intrauter-
ine system as a contraceptive. The brain MRI and the venous MRA
showed a thrombosis involving the right sigmoid sinus, the lateral sinus
and the jugular vein. CT body scan showed splancnic vein thrombosis as
well. Proteins S and C activities and anti-thrombin III levels were within
the normal range. Lupus anticoagulant and anti-cardiolipin antibody
were negative. Treatment was initiated with enoxaparin and patient was
discharged asymptomatic on oral anticoagulation.
Discussion: According to large series, risk of venous thrombosis has not
been high in women using levonorgestrel intrauterine systems. Concomi-
tant conditions such as ET might increase thrombogenic risk
Conclusion: ET is a rare cause of CVT but circumstantial conditions like
hormonal contraceptives (even those with low thrombogenic risk) might
trigger it
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26. Women and Stroke
The gender gap: Effect of intravenous fibrinolysis in
stroke outcome
J Fernández-Domínguez1, P Martínez-Sánchez1,
B Fuentes-Gimeno1, E Díez-Tejedor1
1Neurology, La Paz University Hospital, Madrid, Spain
Background: Analyze if women benefit more than men, in terms of out-
comes, from the use of intravenous thrombolysis (IVT) in acute ischemic
stroke.
Methods: observational prospective study of patients admitted in the
Stroke Center since the introduction of IVT over the first eight years
(2002–2010). Non-treated group: 2262 consecutive stroke patients (939
women). Treated (IVT) group: 330 consecutive patients (143 women).
Both groups were not homogenous, so propensity analysis was performed
and after, a case control, which comprised 1980 patients, was done. 330
IVT and 1650 non treated. We examined outcomes (by the modified
Rankin scale-mRS, defining poor outcome as a score >2) after hospital
discharge in both groups (treated and non-treated) by sex.
Results: IVT was used in the 13% of the patients, without gender differ-
ence between treated and non treated group. IVT group was younger and
have more severe strokes than non-treated group. These differences dis-
appeared after propensity analysis. There were no sex-differences in both
groups (IVT and non IVT). Women untreated were more likely than men
to have a modified Rankin Score >2 (64,9% vs. 45.7%, P < 0.0001) in the
first 15 days after stroke whereas there was no outcome sex differences in
the IVT group (45.5% vs 40.6%, P = 0.207) Logistic regression analysis
pointed women as an independent unfavorable outcome factor in the not
treated group (OR 2.195; 95% CI 1.655–2,911) adjusted by confounders,
but not in the IVT group.
Conclusions: In this observational study women benefited more IVT than
men.
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26. Women and Stroke
Validating the hypothesis that the interaction
sex-by-hemisphere influences functional outcome
using data from the Virtual International Stroke Trials
Archive (VISTA)
C Hametner1, R L Fulton2, L Kellert3, A H Abdul-Rahim2,
P Ringleb4, K R Lees2
1Neurology (Im Neuenheimer Feld 400), University of
Heidelberg, Heidelberg, Germany
2Cardiovascular and Medical Sciences, University of Glasgow,
Glasgow, United Kingdom
3Ludwig-Maximilians-University, Neurology, Munich, Germany
4Neurology, University of Heidelberg, Heidelberg, Germany
Background: In many neurosciences researcher consider sex differences
between the hemispheres highly relevant. In acute ischemic stroke this
matter is under-investigated.
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Methods: We analyze rtPA-treated and control patients by sex from an
international collection of clinical trial data: The Virtual International
Stroke Trials Archive (VISTA). Because baseline characteristics differ sub-
stantially between the sexes, analysis may be biased. Coarsened exact
matching, a new matching method tries finding better balance within the
covariate distribution between groups, which may help overcome this
potential bias. After this pre-processing step, we evaluate functional
outcome at day 90 after stroke (measured by modified Rankin Scale) with
an proportional odds model and meaningful dichotomizations (mRS 0–1
for excellent, mRS 0–2 for good outcome). We present the results in
side-by-side comparison with traditional analyses.
Results: Abbreviated results from our single center study that served as
groundwork for this analysis are given – upon acceptance of this paper the
authors may present the final analysis at the conference: Between-sex
analysis revealed that right hemispheric strokes in men were 1.54 (risk
ratio) times (95% confidence interval 1.15–2.01) more likely than in
women predicting good outcome. Within-sex analysis revealed that
women with right hemispheric strokes were 0.72 times (CI 0.54–0.92) less
likely to achieve good outcome than women with left hemispheric strokes;
conversely, men with right hemispheric strokes were 1.35 times (CI 1.06–
1.70) more likely to achieve good outcome than men with left hemispheric
strokes.
Conclusion: The relationship of sex and hemisphere may determine func-
tional stroke outcome more profoundly than expected.
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26. Women and Stroke
Analyzing sex differences in response to intravenous
thrombolysis: Evidence from the Virtual International
Stroke Trials Archive (VISTA)
C Hametner1, R L Fulton2, L Kellert3, A H Abdul-Rahim2,
P Ringleb4, K R Lees5
1Neurology (Im Neuenheimer Feld 400), University of
Heidelberg, Heidelberg, Germany
2Cardiovascular and Medical Sciences, University of Glasgow,
Glasgow, United Kingdom
3Neurology, Ludwig-Maximilians-University, Munich, Germany
4University of Heidelberg, Neurology, Heidelberg, Germany
5Cardiovascular and Medical Sciences, University of Glasgow,
Glasgow, United Kingdom
Background: Few studies exist that investigate the sex-related effect on
intravenous thrombolysis. Some suggest that women–doing worse in their
natural course of disease–reach equal outcomes when given intravenous
thrombolysis and that this may be because of a greater treatment effect as
compared with men (nullifying hypothesis). We sought confirmation of
this hypothesis.
Methods: We analyze rtPA-treated and control patients by sex from an
international collection of independent clinical trial data: The Virtual
International Stroke Trials Archive (VISTA).
We perform two steps: First, we pre-processed data by coarsened exact
matching, a new matching methods that gains a better multidimensional
covariate balance. Second, we deploy Cochran-Mantel-Haenszel test and
multiple regression analysis (adjusted for confounders of age, National
Institutes of Health Stroke Scale and multiple risk factors). We present
outcomes at day 90 after stroke for ordinal outcomes and meaningful
dichotomizations (mRS 0–1: excellent; mRS 0–2: good) as measured by
the modified Rankin scale–an outcome scale ranging from 0 (no disabil-
ity) to 6 (death).
Preliminary results and conclusion: 8313 cases were analyzed, 3785 woman
(36.3% rtPA) and 4528 men (44.5% rtPA).
Upon acceptance of this paper, the author may present the full analysis at
the conference and may put results into context of previous studies.
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Difference between males and females in the outcome
of thrombolytic treatment
M Haršány1, P Kadlecová2, A Kobayashi3, Z Gdovinová4, J Kõrv5,
K Fekete6, V B Kes7, V Švigelj8, D Jatuzis9, R Mikulík1
1Department of Neurology, St. Annés University Hospital and
Medical Faculty of Masaryk University, Brno, Czech Republic
2Department of Clinical Development and Technology
Transfer, International Clinical Research Center, Brno, Czech
Republic
3Department of Neurology, Institute of Psychiatry and
Neurology, Warsaw, Poland
4Department of Neurology, Faculty of Medicine P.J. Safarik
University Kosice and University Hospital L. Pasteur, Kosice,
Slovakia
5Department of Neurology and Neurosurgery, University of
Tartu, Tartu, Estonia
6Department of Neurology, University of Debrecen, Debrecen,
Hungary
7Department of Neurology, Sestre Milosrdnice University
Hospital Centre, Zagreb, Croatia
8Department of Vascular Neurology and Neurological
Intensive Care, University Medical Centre Ljubljana and
Zdravstveni Nasveti, Ljubljana, Slovenia
9Department of Neurology and Neurosurgery, Vilnius
University and Vilnius University Hospital Santariskiu Clinics,
Vilnius, Lithuania
Introduction: Recently, it has been shown in animal models that there is a
variability in X-chromosome inactivation. Thus, in some brains a moth-
er’s X chromosome may dominate to one hemisphere and the father’s
dominate to the other one. Hence, response of brain to ischemia may
differ in men and women. Our goal was to determine if there are differ-
ences in the outcomes between males and females after the thrombolytic
treatment.
Methods: Prospectively collected data from the Safe Implementation of
Treatments in Stroke – EAST (12 Central/Eastern European countries)
registry between January 2000 and April 2014 were analyzed. Baseline
patient characteristics and the outcomes (defined as NIHSS at 2 h, 24 h, 7
days, and mRS at 3 months) were analyzed descriptively. Generalized
linear model and logistic regression methods were used to identify differ-
ences between sex and the outcomes.
Results: Altogether, all 15167 patients treated with thrombolysis within
4.5 hours of symptom onset between January 2000 and April 2014 were
analyzed. Of these, 6651 (43.9%) were females. Males and females signifi-
cantly differed in age, baseline NIHSS, hypertension, hyperlipidemia,
atrial fibrillation, history of stroke, pre-stroke mRS 0–1, and smoking
status. Overall, males had less severe strokes and also better outcomes
compared to females (median NIHSS at baseline, 2 h, 24 h, 7 days, and
mRS 0–1 at 3 months was 11, 8, 6, 4, and 41.4% vs. 12, 9, 7, 4, and 35.9%,
respectively). However, difference in outcome disappeared after the
adjustment.
Conclusions: Despite the genetic differences between males and females
we could not demonstrate that sex influences outcome after stroke.
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Iatrogenic intracranial hypotension and sinus vein
thrombosis
A Honig1, R Eliahou2, R R Leker3
1Nerology, Hadassah-Hebrow University Medical Center,
Jerusalem, Israel
2Radiology, Hadassah-Hebrow University Medical Center,
Jerusalem, Israel
3Neurology, Hadassah-Hebrow University Medical Center,
Jerusalem, Israel
Background: Intracranial hypotension (IH) is characterized by venous
distention and sluggish flow associated with sinus vein thrombosis (SVT).
Lumbar punctures (LP) and spinal anesthesia (SA) are common iatro-
genic causes of IH but their attributes remain unclear.
Methods: Patients aged ≥18 years, diagnosed with acute SVT were iden-
tified. Patients with SVT and IH were compared to those with SVT
without IH.
Results: Overall, 41 patients met inclusion criteria and 10/41 had under-
gone LP, EA, or SA within ≤10 days before the diagnosis (9/10 women
mean age 30). Patients with IH presented earlier after symptom onset
(6 ± 2.2 days vs. 15.6 ± 14 days; p = 0.002), had higher mean National
Institutes of Health Stroke Scores (NIHSS) at presentation (4.5 ± 2.0 vs.
0.5 ± 0.5; p < 0.01), and higher rates of venous infarction (6/10, 60% vs.
6/31, 19%; p = 0.014) and seizures (4/10, 40% vs. 3/31, 10%; p = 0.026). In
patients with IH after labor (5/10) no or mild hypercoagulability was
found while in patients with IH after elective procedures (5/10) substan-
tial factors of hypercoagulability were found. On imaging studies patients
with IH more often had superior saggital sinus thrombi and cortical vein
thrombosis with infarction (6/10, 60% vs. 4/31, 13%; p = 0.0025). All pts
were treated conservatively with anti-coagulants. AED were used in pts
with seizures. 9/10 pts had mRS90 of 0–1.
Conclusions: Patients with SVT associated with IH typically affects young
women with pre-existing coagulation abnormalities and presents with a
more severe clinical course with frequent seizures and venous infarcts.
However, the outcome seems to be relatively benign.
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Gender differences in patients with craniocervical
artery dissection
Y Kablan1, O Kamıslı1, S Altinayar1, C Ozcan1
1Neurology, Inonu University, Malatya, Turkey
Objectives: Dissection of the carotid (CAD) or vertebral (VAD) artery is a
major cause of ischemic stroke in young adults. We aimed to elucidate the
impact of gender-based differences of patients with dissection on risk
factors, demographical, clinical and etiological characteristics.
Methods: We reviewed retrospectively all patients diagnosed with CAD or
VAD admitted to our clinic between January 2000 and December 2014
and enrolled 74 such patients (27 females, 47 males) in the study. We
compared age, modified Rankin Scale prestroke and at time of admission,
clinical presentation of dissection, location of dissection, vascular risk
factors (hypertension, hypercholesterolemia, diabetes mellitus, history of
regular smoking at the time of the event), other risk factors known to be
associated with artery dissections, nature of dissection (spontaneous or
associated with minor trauma), and the rate of mortality between gender.
Results: The mean ages were 52,00 ± 15,15 and 61,96 ± 14,36 for female
and male patients, respectively. The mean ages were significantly different
between two genders (p < 0.05). The frequency of VAD was much higher
in men than women (59.6% and 40.7% respectively, p < 0.05). Although
there was no statistically significant difference for disability prestroke and
at admission, clinical presentation, vascular risk factors, and mortality
rate, men have significantly more spontaneous dissection (26% for
women vs. 91% for men; p < 0.05 and have more other risk factors than
women (11% for women vs. 36% for men; p < 0.05).
Conclusion: Identifying factors related to clinical outcome may be impor-
tant for starting appropriate treatment and setting targets in the manage-
ment of patients with dissection.
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Pregnancy loss and risk of ischemic stroke and
myocardial infarction in the Risk of Arterial
Thrombosis in Relation to Oral Contraceptives (RATIO)
study
A Maino1, B Siegerink2, A Algra3, I Martinelli4, F Peyvandi4,
F Rosendaal2
1Angelo Bianchi Bonomi Haemostasis and Thrombosis Centre,
Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico,
Milan, Italy
2Department of Clinical Epidemiology, Leiden University
Medical Center, Leiden, Netherlands
3Julius Center for Health Sciences and Primary Care,
University Medical Center Utrecht, Utrecht, Netherlands
4Angelo Bianchi Bonomi Haemostasis and Thrombosis Centre,
IRCCS Fondazione Ca’ Granda – Ospedale Maggiore
Policlinico, Milano, Italy
Objective: To investigate whether pregnancy loss is associated with the
risk of ischemic stroke (IS) or myocardial infarction (MI).
Methods: The RATIO is a case-control study of women (age 18 to 50
years) with IS or MI. For this analysis, we included women who previously
had at least one pregnancy. Odds ratios (OR) with 95% confidence inter-
vals (CI) were calculated, indicating the association between pregnancy
loss and risk of IS or MI. ORs were adjusted for matching variables and
other potential confounders (smoking, hypertension, alcohol consump-
tion, diabetes, hyperlipidemia, body mass index), and calculated for the
number of pregnancy losses as well as the gestational week of unsuccessful
pregnancies (<13, 13–20 and >20 weeks).
Results: 165 IS cases, 218 MI cases and 743 controls were included, with
an average of 2.7, 2.5 and 2.5 pregnancies per woman, respectively. 59
(36%) women with IS and 63 (29%) with MI experienced at least one
pregnancy loss compared with 234 (32%) controls. Women with ≥1 preg-
nancy loss had no increased risk of IS nor MI compared with women
without pregnancy loss (OR 1.0, 95% CI 0.7–1.6 for IS; OR 0.7, 95% CI
0.5–1.1 for MI). However, women with recurrent (>3) or late (>20 weeks)
pregnancy loss had a moderately increased risk of any arterial thrombosis
(recurrent, OR 1.9, 95% CI 0.8–4.5; late, OR 1.5, 95% CI 0.7–3.2).
Conclusion: The association between pregnancy loss and IS or MI might
be present only for women with recurrent or late pregnancy loss.
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Stress at work is a significant predictor of
hypertension and stroke in female population 25–64
years in Russia: WHO Epidemiological Program
Monica-Psychosocial Study
V Gafarov1, D Panov1, E Gromova1, I Gagulin1, A Gafarova1
1Collaborative Laboratory of Cardiovascular Diseases
Epidemiology SB RAMS, FSBI Institute of Internal and
Preventive Medicine SB RAMS, Novosibirsk, Russia
Objective: To explore the job stress effect on risk of stroke and arterial
hypertension (AH) in female population of 25–64 y in Russia over 16
years of follow-up.
Methods: Under the third screening of the WHO “MONICA-
psychosocial” program random representative sample of women aged
25–64 years (n = 870) were surveyed in Novosibirsk. Levels of job stress
were estimated by questionnaire based on Karasek’s job demands-control
model. From 1995 to 2010 women were followed for the incidence of AH,
stroke. Cox regression model was used for risk assessment (HR).
Results: The prevalence of high job stress level in women aged 25–64 years
was 31.6%.
HR of stroke over 16 years of follow-up was 1.96-fold higher
(95.0%CI:1.01–3.79, p < 0.05) in women with job stress, HR of AH was
1.39-fold higher (95.0%CI:1.08–1.78, p = 0.01) compared to those
without stress. There were tendencies of increasing stroke and AH rates in
married women experienced stress at work. Stroke developed in women
with lower educational level and AH significantly higher developed in
women with higher educational level (p for all <0.05) having job stress.
AH and stroke rates was found higher for physical workers with job stress
(χ2 = 5.47 df = 1 p < 0.05) and AH rates were tend to be higher in man-
agers experienced stress at work.
Conclusions: There is high prevalence of stress at work in female popula-
tion aged 25–64 y in Russia. Women with job stress have significantly
higher risk of stroke and AH over 16-th years of follow-up, especially in
married ones and in physical workers with job stress.
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Outcome of acute ischemic stroke after stent based
thrombectomy: Are there gender differences?
F Perren1, V Mendes Pereira2
1Neurology, HUG University Hospital and Medical Faculty
Department of Clinical Neurosciences, Geneva, Switzerland
2Interventional Neuroradiology, University Health
Network/University of Toronto, Toronto Ontario, Canada
Background: The natural course of stroke has been shown to be worse in
women than in men. Several recent studies suggested no gender differ-
ences in the outcome among patients treated with systemic thrombolysis.
Because the latter achieves recanalization in only about one-third of
patients with MCA occlusion, endovascular therapy with stent-based
thrombectomy is an alternative for these cases.
Methods: Retrospective analysis of patients with major ischemic stroke
due to acute proximal MCA occlusion ineligible for systemic thrombolysis
who had been treated with stent retrievers’ thrombectomy. We studied
whether gender differences in the efficacy and safety outcomes of stent
based mechanical thrombectomy were present.
Results: 18 patients (9 women, mean age of 63.0 ± 16.6 years; 9 men
67.2 ± 16.6 years (t = 0.449;p > 0.05) were studied. NIHSS at admission
was 16.89 ± 3.95 in women, 15.0 ± 5.45 in men (t = 0.841;p > 0.05). Reca-
nalization was complete in 8/9 women and 8/9 men. NIHSS after reca-
nalization in women was 4.78 ± 4.87, in men 6.33 ± 8.14 (t = 0.4914;p >
0.05). NIHSS improvement before and after recanalization was significant
in women (t = 5.3947;p = 0.0007) and in men (t = 4.14;p = 0.0043).
Improvements did not differ significantly between women and men
(t = 1.2301;p > 0.05). Good functional outcome at 90 days (mRS 0–2)
showed no gender difference (Fisher exact p > 0.05). Asymptomatic hem-
orrhagic transformation occurred in 4/9 women and in 5/9 men.
Conclusions: Stent-based thrombectomy for acute MCA occlusions seems
relatively safe, recanalyzes very efficiently, and improve neurological
outcome. This small study shows no gender differences in the outcome
among patients treated with stent retrievers’ thrombectomy thus nullify-
ing the usual gender differences in functional outcomes after stroke.
ESOC-0193
26. Women and Stroke
Acute large vessel occlusion varies with age and
gender
J Ravn Hansen1, L Bentsen1, C Ovesen1, C Krarup Hansen1,
I Havsteen2, A Christensen2, H Christensen1
1Neurology, Bispebjerg University Hospital Copenhagen,
Copenhagen, Denmark
2Radiology, Bispebjerg University Hospital Copenhagen,
Copenhagen, Denmark
Background: The influences of gender and age on the occurrence of acute
large vessel occlusions (LVO) in hyperacute ischemic stoke remains
unclear. The aim of this study was to explore the prevalence of acute LVO
in relation to gender and age.
Method: This analysis was based on 758 consecutive stroke patients with
symptom onset within 4.5 hours. Admission cerebral CT and CT angiog-
raphy was evaluated blinded to clinical findings. Presence and location of
LVO’s were calculated in 10-year age ranges and stratified for gender.
Results: In the age ranges 55–64 and 65–74 acute LVO were significantly
predominant in males as opposed to the age ranges 75–84 and 85–99
where occlusions were significantly more frequent in females, Fig. 1.
Overall, 14.9% of male patients had a LVO vs. 12.9% of female patients.
Males had significantly higher prevalence of acute LVO in the
M2-segment (MCA) (p = 0.027), vertebral artery (p = 0.012), basilar
artery (p = 0.046), extra-cranial ICA (p = 0.027), dissection of a. vertebra-
lis (p > 0.001) as well as occlusions affecting both the intra and extra
cranial part of ICA (p = 0.040).
Conclusion: Occurrence of LVO occlusion co-varies with age and gender.
Increased focus on gender differences in stroke may help individualize
patient care.
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26. Women and Stroke
Gender difference in atherosclerotic stroke
C. Yoon1, S J Kim1, H K Park1, J H Rha1
1Neurology, Inha University School of Medicine, Incheon,
Korea
Background and purpose: The aim of this study was to investigate the
gender difference in cerebral atherosclerosis (intracranial atherosclerosis
[ICAS] vs. extracranial atherosclerosis [ECAS]).
Methods: A total of 703 consecutive patients with acute ischemic stroke
that was considered to be caused by symptomatic ICAS or ECAS were
enrolled.
Results: Compared with males, females tended to have more ICAS than
ECAS after controlling age, hypertension, hyperlipidemia, diabetes,
smoking and body mass index (odds ratio [OR], 2.121; 95% confidence
interval [CI], 1.272–3.538; p = 0.004). After stratification by gender, the
risk factors for ICAS or ECAS differed between sexes. In males, age (OR,
1.052; 95% CI, 1.025–1.079; p < 0.001) was a factor favoring ECAS (vs
ICAS), whereas hypertension (OR, 2.235; 95% CI, 1.202–4.156; p = 0.011)
was a factor related to ICAS (vs ECAS). However, the association was only
significant in males.
Conclusions: There are gender differences in distribution and risk factors
of cerebral atherosclerosis.
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Reports
Aneurysms of the cavernous segment of the internal
carotid artery with a carotid cavernous fistula and
endovascular stent/coil treatment: Case report
V Arnao1, V Caso1, M Acciarresi1, G Agnelli1, A Alberti1,
C D’Amore1, M Venti1, M Paciaroni1
1Vascolar Medicine and Stroke Unit, University of Perugia,
PERUGIA, Italy
Aneurysms of the cavernous segment of the internal carotid artery is a
diagnostic challenge for neurologists. This type of intracranial aneurysm
accounts 2% to 9% of all intracranial aneurysms. The risk of subarach-
noid hemorrhage is extremely low (0.2–0,4% per year). However, symp-
toms include progressive cranial nerve deficits, visual symptoms, retro-
orbital pain, carotid-cavernous fistula (CCF), subarachnoid hemorrhage,
recurrent transient ischemic attacks, spontaneous thrombosis and
epistaxis.
Objectives: To describe a case of aneurysms of the cavernous segment of
the internal carotid with CCF treated by endovascular stent/coil
treatment.
Case report: An 81 year-old woman was admitted to our hospital for a loss
of consciousness. A CT-scan showed a small right frontal ribbon hyper-
density and irregular aspect of right ophthalmic vein. The neurological
examination showed: drowsiness, right exophthalmos and headache and
vision impairment were noted. Electrographic Examination (EEG)
recordings showed bifrontal PLEDS suggesting a possible critic nature of
patient’s loss of consciousness. A MRI reported a frontal right CCF. Con-
versely, the angiography showed a left carotid siphon aneurysm and
rupture of aneurysm of the cavernous segment of the internal carotid with
a carotid cavernous fistula. Endovascular stent assisted coil treatment has
been placed with the resolution of the clinical picture
Conclusions: this is an unusual clinic presentation of aneurysms of the
cavernous segment of the internal carotid which benefited from endovas-
cular treatment.
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Reports
Alpha-galactosidase deficiency and cerebral venous
thrombosis: A case report
R Barbosa1, S Calado1, S Ferreira2, J P Oliveira2, M Viana-Baptista1
1Neurology Department, Hospital Egas Moniz, Lisboa,
Portugal
2Medical Genetics, Hospital de São João Faculdade de
Medicina da Universidade do Porto, Porto, Portugal
Background: Fabry disease (FD) is an X-linked lysossomal storage disor-
der, associated with mutations in the GLA gene that cause deficiency of
alpha-Galactosidase enzyme. Mutations associated with relatively high
residual enzyme activity have been reported in young patients with stroke,
without other features of FD. Vascular abnormalities in FD do not seem to
be exclusive of the arterial system, nevertheless cerebral venous thrombo-
sis (CVT) has been reported only once in a FD survey.
Case Report: A previously healthy 44 year-old male, was admitted in July
2014 with headache, photophobia, nausea and vomiting. He was on
Azythromicin for an upper respiratory infection and one week before he
had run 18 kilometers. Family history was negative. General and neuro-
logic examination were normal. Veno-CT scan revealed thrombosis of the
straight and left transverse and sigmoid sinuses. The patient was started
on heparin and subsequently discharged, at day 9, on oral anticoagulation.
Genetic study of thrombophilias showed a homozigotic MTHFFR
677C > T and PAI-146146 mutation. The alpha-Galactosidase activity was
slightly reduced in dried blood spot assay (8.04, Ref Val 8.75–15.6) and
molecular analysis of GLA gene revealed the variant Asp313Tyr.
Conclusions: Although there is a lot of debate on the pathogenicity of
p.D313Y GLA gene mutation, an association with cerebrovascular disease
has been repeatedly suggested. The role of alpha-Galactosidase deficiency
in CVT, alone or in combination with other prothrombotic conditions,
probably deserves to be further elucidated.
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Reports
First diagnosis of polycythemia rubra vera in a general
hospital stroke unit
T R Bates1, A C Boudville1, L K Kho1, S P’Ng2
1Comprehensive Stroke Unit, Swan District Hospital, Perth,
Australia
2Haemostasis and Thrombosis, Royal Perth Hospital, Perth,
Australia
Introduction: Identifying the cause of ischemic stroke (IS) guides man-
agement. Polycythemia rubra vera (PRV) is a well described although,
uncommon cause of stroke that may be easily overlooked.
Aim: In this study we aim to report the clinical and radiological charac-
teristics of patients who presented to a general hospital stroke unit who
were subsequently diagnosed with PRV.
Methods: all 165 patients with confirmed stroke who presented to our
hospital in 2014 were included; 3 patients with PRV were identified.
Stroke was confirmed on neurological imaging. PRV was diagnosed by the
presence of an elevated hemoglobin, low serum erythropoietin level
and/or the presence of a JAK-2 mutation.
Results: Of the 3 patients who were identified, 2 were male and mean age
was 69 years (range 60–79). None were hypoxic on room air at presenta-
tion. Mean hemoglobin at presentation was 194.7 g/L (range 177–210,
normal 135–180 g/L), hematocrit 0.56 (range 0.51–0.58, normal 0.4–
0.54), EPO level 2.3 U/L (range 1.7–26, normal 4.3–29.4 U/L), 2 of 3
patients were JAK-2 mutation positive. 2 of 3 patients had multiple terri-
tory cerebral infarctions, with one patient presenting with small vessel
disease. All patients made a good recovery with venesection, hydration
and antithrombotic medication.
Conclusion: PRV may be a not uncommon cause of stroke. Multiple ter-
ritory infarction was more common, although small vessel occlusive
stroke may also occur. Clinicians should be aware of the possibility of PRV
being the cause of stroke.
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Multiple embolic stroke during vaginal delivery in a
patient with patent foramen ovale
D Chang1, S H Heo1
1Department of Neurology, Kyung Hee University Hospital,
Seoul, Korea
Aim: We report a case of cerebral infarction associated with patent
foramen ovale (PFO) during vaginal delivery.
Background: Ischemic stroke during the pregnancy or puerperium is rare
but associated with high risk of mortality and residual neurological
deficits.
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Case report: A 38-year-old woman was referred to the emergency depart-
ment with loss of consciousness with generalized tonic-clonic seizure
during vaginal delivery. She had three parturitions on the full-term of
pregnancy and had no obstetric complications during gestational period
of previous pregnancy. On a neurologic exam, she had stuporous mental-
ity and weakness of all four limbs, mainly in the left side. The serologic
tests including autoimmune antibodies and thrombosis panel were within
normal range. Chest CT showed pulmonary thromboemboli in the left
lower lobar artery and these branches, and abdominal CT showed filling
defect in the left renal and ovarian veins that were considered thrombo-
emboli. Brain MRI revealed multiple infarctions on the both cerebral
hemispheres, but no stenoocclusion was seen on MRA. TCD monitoring
with agitated-saline contrast revealed curtain-type microembolic signals
during a valsalva maneuver. TTE was normal, but TEE showed large sized
PFO. She was treated with anticoagulation. Three weeks later, she was
discharged with neurological improvement except mild dysarthria and
clumsiness in the left side. Her modified Rankin scale score after three
months was zero.
Conclusion: PFO is an important cause of cryptogenic stoke, particularly
in younger patients. To our knowledge, this is the first case of multiple
embolic stroke related with PFO during vaginal delivery.
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Sneddon’s syndrome – Diagnosis, thrombolysis and
secondary prevention
D Collas1, M Dani1
1Stroke Medicine, Watford General Hospital, Watford, United
Kingdom
A 37 year old female smoker with migraine with aura, asthma, hyperten-
sion, obesity and mild anxiety presented with dysphasia, dysarthria, facial
droop and numb R arm, NIH 6. After thrombolysis this fell to NIH 1 at 4
hours, with mild persisting right hand paresthesia, mRS 1. CT showed old
right parietal and left frontal infarcts and on MRI DWI an acute left
frontal cortical infarct. FLAIR showed bilateral ischemia in the centrum
semiovale.
She had suffered a stroke 4 years earlier, with right-sided numbness and
clumsiness, left posterior parietal infarct and multiple small sub-cortical
infarcts. She displayed livedo reticularis and was diagnosed Sneddon’s
syndrome (Sneddon, 1965) based on lack of cardio-embolic or large
artery sources, negative antiphospholipid and vasculitis screen, and a skin
biopsy showing non-vasculitic arteriopathy. The only other abnormality
was a raised homocysteine level, 36. She had remained stroke-free on
aspirin, but suffered migraines, mild untreated hypertension and contin-
ued to smoke.
Only one other case of thrombolysis in Sneddon’s syndrome is reported
(Sun, 2012), also with a good outcome, supporting its use in this rare
condition. The presence of fibrinous thrombi, presumably amenable to
thrombolysis, in the skin biopsy along with perivascular lymphocytic
infiltrate, suggests a mechanism. The migraines and hypertension are
frequent associated features but might divert attention from the true
diagnosis, unless the livedo is recognized.
The best secondary prevention is unknown, but this early recurrence and
new lesions, with risk of progression to cognitive impairment, prompts us
to change from anti-platelet to anti-coagulation therapy.
ESOC-0978
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A case of Anderson-Fabry disease with cerebrovascular
manifestations
F Corea1, S Micheli2, P Brustenghi1, G Savarese3, F Crusco4,
F Scarponi1, A Proietti1, M Zampolini1
1Stroke and Brain Injury Units, Usl Umbria 2, Foligno, Italy
2Neurology, Usl Umbria 2, Spoleto, Italy
3Cardiology, Usl Umbria 2, Foligno, Italy
4Radiology, Usl Umbria 2, Foligno, Italy
We describe a patient with isolated neurological manifestation from an
Italian family later diagnosed with Anderson-Fabry disease. Clinical
examination, neuroimaging (MRI), biochemical and genetic analyses
were carried out in all the family. Alpha-galactosidase A activity was
detected by fluorimetric assay and genetic analysis was performed by DNA
sequencing.
Case: A male patient of 50 years with history of fatigue and TIAs presented
an ischemic vertebrobasilar stroke, retinopathy and cardiomiopathy The
cardiac imaging showed Left Ventricular Hypetrhophy with patchy mid-
wall abnormalities.
In patients with Anderson-Fabry disease, stroke-like manifestations are
frequent complication, and may be the first threatening clinical event. In
young people with undefined stroke or neurological stroke-like condi-
tions, even without signs of renal involvement, it is important to consider
the diagnosis of Anderson-Fabry disease and so to perform clinical exami-
nation and biochemical analysis to avoid misdiagnosis.
ESOC-1411
27. Rare Causes, Stroke in the Young, and Case
Reports
Think twice: Two cases of bilateral carotid artery
dissection
L Grunsell1, I Kane1, N Gainsborough1
1Stroke Medicine, Birghton & Sussex Universities Hospital NHS
Trust, Brighton, United Kingdom
Carotid artery dissection is a well-known cause of stroke in younger
patients; it is unclear from the literature how many cases are bilateral. We
discuss the presentation and cause of two cases of bilateral carotid artery
dissection and suggest that its prevalence may be under estimated.
A 43 year old male presented with headache, paresthesia of his left arm
and face with left-sided Horner’s syndrome following a session of vigor-
ous exercise at a charity boot camp. Despite only presenting with left-
sided neurology his MRA confirmed bilateral carotid dissections. After
thorough investigation his diagnosis was attributed to his excessive
exercise.
Secondly, a 41 year old male was found to have bilateral carotid artery
dissections five days after a whiplash injury. He presented with headache
and signs of right hand dyspraxia, left-sided Horner’s syndrome and a
hoarse voice. Interestingly, he had been diagnosed with a unilateral dis-
section two years previous, then presenting with sudden onset headache
and right-sided Horner’s syndrome with no preceding trauma or sudden
neck movements. Extensive investigations revealed a diagnosis of Ehlers
Danlos type 4.
Headache combined with neurological signs and symptoms should
prompt investigations for carotid artery dissections. We urge physicians to
analyze both carotid arteries despite unilateral signs and symptoms. We
have learnt the importance of searching for underlying pathology, con-
nective tissue disorders in particular, especially in cases where no obvious
trigger is evident or repeat presentations occur.
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A case of brain tumor masquerading as stroke – In
post-MRI era
A Harris1, M Bhogle1, L Sekaran1, D Phiri1, N Mohammed1,
S Sethuraman1
1Stroke medicine, Luton and Dunstable Hospital, Luton,
United Kingdom
Brain tumors masquerading as stroke were common in the pre CT/MRI
imaging era. Brain tumors with imaging suggestive of stroke constitute
about 5% of stroke presentations. The delay in diagnosis affects the
management.
Our patient presented with right arm weakness and dysphasia 10 months
ago. The CT brain and Carotid Doppler was normal then. In spite of
starting him on anticoagulation for atrial fibrillation, he presented to
different specialities due to ongoing episodes of dysphasia and seizures. His
MRI Brain at 7 and 9 months showed a hyperintense lesion on T2 weighted
sequences with no restricted diffusion. Further investigation in view of
ongoing symptoms 10 months later led to a diagnosis of glioblastoma.
It requires high index of suspicion when patients present with recurrent
symptoms of stroke despite treatment. Potential delays are still possible
despite better imaging. Further studies and research are required to avoid
delays in the diagnosis and management.
ESOC-1173
27. Rare Causes, Stroke in the Young, and Case
Reports
Monocular diplopia after left posterior cerebral artery
territory infarction
R Hourez1, B Capron1, G Bruninx2
1Neurology, Hôpital Civil Marie Curie, Charleroi, Belgium
2Radiology, Hôpital Civil Marie Curie, Charleroi, Belgium
Background: Monocular diplopia is typically considered as an “eye disor-
der” but can be exceptionally present in central nervous disorders.
Methods: We report a 78 year-old man presenting acutely a « blurred
vision » on his right side and episodes of right monocular diplopia. The
next day, bedside examination of the visual fields by confrontation showed
a right homonymous hemianopia. Three days after the event, the patient
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complained of a disturbing right monocular diplopia. Examination of the
visual fields by confrontation at that time appeared normal and the
patient described a right monocular diplopia increasing when looking
upside and to his right. Pinhole test did not improve the diplopia. Color
vision, reading, object and faces recognition were spared.
Results: CT and MRI showed a left posterior cerebral artery infarction.
EEG was normal. Ophtalmologic examination was normal. Formal visual
field assessment with Goldman perimetry demonstrated right homony-
mous hemianopia.
Conclusion: True monocular diplopia can be observed in left posterior
cerebral artery infarction and therefore does not exclude a central neuro-
logical disorder.
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Pituitary apoplexy: An unusual complication of carotid
endarterectomy
R Hourez1, D Bataille2, G Bruninx3, C Chaskis4, A Mendili4,
S Jeangette1
1Neurology, Hôpital Civil Marie Curie, Charleroi, Belgium
2Vascular Surgery, Hôpital Civil Marie Curie, Charleroi,
Belgium
3Radiology, Hôpital Civil Marie Curie, Charleroi, Belgium
4Neurosurgery, Hôpital Civil Marie Curie, Charleroi, Belgium
Background: Pituitary apoplexy is a well-described complication of the
post-partum period. It rarely occurs in association with other facilitating
factors and has been reported after major cardiac surgery. To our knowl-
edge, this is the first report of pituitary apoplexy following carotid
endarterectomy.
Methods: We present a 76-year-old male with a past medical history of
hypertension, right MCA minor strokes and a known pituitary adenoma
with invasion of the cavernous sinus space. US and MRA follow up dem-
onstrated a progressive stenosis of the right carotid artery (>70%). A right
carotid endarterectomy was performed under general anesthesia. The
patient was confused and agitated in the immediate postoperative period.
The next day, he presented a bilateral and symmetric ptosis, areflectic
pupils and divergent strabismus. Only adduction eye movements were
possible, voluntary and reflex vertical movements were abolished. The rest
of the neurological examination was unremarkable.
Results: MRI demonstrated pituitary apoplexy. Biological evaluation
demonstrated pituitary insufficiency. The patient was treated with thyroid
hormones and hydrocortisone. There was no improvement in his eye
movements.
Conclusion: To our knowledge, this is the first report of a case of pituitary
apoplexy following carotid endarterectomy.
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Coma and cerebral venous thrombosis associated with
meningitis and posterior fossa empyema in an
18-year-old patient with familial cholesteatoma
R Hourez1, A Mendili2, C Chaskis2, G Bruninx3, H Von Engelhardt1
1Neurology, Hôpital Civil Marie Curie, Charleroi, Belgium
2Neurosurgery, Hôpital Civil Marie Curie, Charleroi, Belgium
3Radiology, Hôpital Civil Marie Curie, Charleroi, Belgium
Background: Cholesteatoma are generally considered as benign condi-
tions. We describe a young patient with multiple life-threatening compli-
cations of a cholesteatoma.
Methods: We present an 18-year-old male with a known familial cho-
lesteatoma who developed bacterial meningitis. Despite broad-spectrum
antibiotics, he rapidly developed high fever, increased neck stiffness
and altered consciousness. His neurological exam was otherwise
unremarkable.
Results: Urgent MRI demonstrated a right cholesteatoma with intracra-
nial extension, a right epidural posterior fossa empyema with mass effect
on the cerebellum and the brainstem, compression of the right lateral
sinus; the ipsilateral right sigmoid sinus was thrombosed and hypersignal
lesions of the right occipital and external temporal lobes (DWI) were
observed. The patient underwent urgent neurosurgery (burr hole and
catheter drainage) and treated with anticoagulants. The patient experi-
enced a rapid and complete clinical and radiological recovery.
Conclusion: We describe a young patient with a known familial cholestea-
toma who developed meningitis and, despite treatment with broad spec-
trum antibiotics, an epidural posterior fossa empyema causing
compression of the cerebellum, the brainstem, the lateral sinus – causing
sigmoid sinus thrombosis and temporo-occipital ischemic lesions. Urgent
surgical treatment of the empyema was needed with anticoagulants,
allowing a full recovery.
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Varicella-associated angiitis in pediatric stroke: A case
report
M Impellizzeri1, M G Natali Sora2, L Roveri2, M Comola1,
G Comi1, R Chieffo1
1Neurology and Neurorehabilitation, San Raffaele Hospital,
Milan, Italy
2Neurology, San Raffaele Hospital, Milan, Italy
Background: Varicella-associated arteritis is one of the most frequent
causes of pediatric stroke, but in many cases it is difficult to diagnose
because of the late onset of manifestations after the acute infectious
episode.
Case report: an 8-year-old boy presented at the emergency room of our
hospital after the sudden onset of speech difficulties and severe right hand
weakness, 3 months after a systemic varicella infection with pharyngeal
involvement. The neurologic examination revealed right facial palsy,
dysarthria and right distal upper limb plegia. MRI scan revealed an acute
ischemic lesion in the left posterior lenticulo-capsular region, character-
ized by restricted diffusivity in DWI sequences and hyperintensity in T2
sequences. MRI-angiography showed narrowing at the upper-posterior
branch of the left middle cerebral artery. Routine blood tests analysis,
autoimmune and thrombophilic screening were normal. In relation to the
history of recent varicella infection, a lumbar puncture for the cerebro-
spinal fluid (CSF) analysis was performed. CSF proteins and glucose were
normal and cell count resulted increased. Polymerase chain reaction
(PCR) for VZV-DNA was negative but intrathecal CSF synthesis of Vari-
cella IgG antibodies was detected. Diagnosis of varicella-zoster virus
arteritis was therefore made and antiviral therapy with acyclovir iv and
acetylsalicylic acid were administered.
Discussion: the diagnosis of varicella-associated arteritis always need to be
considered in pediatric patients with recent VZV systemic infection
history. A negative VZV DNA PCR does not exclude the diagnosis of VZV
vasculopathy whereas the detection of anti-VZV IgG antibody in CSF was
a more sensitive indicator of VZV vasculopathy.
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Subdural hematoma: A capsular warning syndrome
mimic
K Mahawish1
1Elderly Care, Warrington Hospital, Warrington, United
Kingdom
Capsular warning syndrome (CWS) is rare, accounting for 1.5% of tran-
sient ischemic attacks and carries a poor prognosis, with a 7-day stroke
risk of 60% without prompt antithrombotic treatment.
I present the case of a 69 year old gentleman with a past medical history of
hypertension and radical nephrectomy for renal cell carcinoma. He pre-
sented with a 48 hour history of recurrent episodes of dysarthria associ-
ated with left facial and arm weakness, each episode lasting 10 – 15
minutes followed by full resolution; features typical of CWS.
A contrast enhanced CT brain scan demonstrated a low density 5 mm
subdural overlying the right cerebral convexity with localized mass effect.
MR brain imaging demonstrated a small right subdural, however no
restricted diffusion on DWI, excluding acute ischemia. The patient was
managed non-operatively, and lamotrigine commenced for presumed sei-
zures. The symptoms resolved within a few days and the patient
discharged.
There are a number of reports of recurrent transient neurological features
associated with subdural hematoma in the literature. Cortical features,
mainly dysphasia, tend to predominate. The pathophysiology remains
unclear and hypothesized to be due to; compression of adjacent cortical
blood vessels; seizure activity; cortical depression due to mechanical
stimulation of the cortex; fluctuations in intracranial pressure; and small,
repeated hemorrhages into the subdural space. Factors precipitating neu-
rological deterioration within the literature include periods of relative
hypotension and changes in posture, with symptoms uniformly resolving
following hematoma evacuation. Here, the termination of symptoms fol-
lowing anticonvulsant treatment strongly suggests seizures as a cause.
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Urgent decisions and a tight spot: Cardioembolic
infarction of a herniated cerebellar tonsil
R Mc Donagh1, J A Harbison1
1Medicine for the Elderly, St James’s Hospital, Dublin, Ireland
We present the case of a previously well 30 year old woman presenting
with a sudden onset of dizziness and headache. She was initially investi-
gated with a CT Brain and lumbar puncture, which yielded no diagnosis.
Subsequent MR scan revealed multiple posterior circulation infarcts,
along with a previously undiagnosed Arnold-Chiari malformation and
syringomyelia. Edema of an infarct in the herniated tonsils caused pro-
gressive neurology. This occurred between 48 and 72 hours after the stroke
when edema would be expected to be maximal, and necessitated cervical
decompression surgery. The etiology of her stroke was a paradoxical
embolus via a patent foramen ovale (PFO). There are no cases found on
review of literature that link PFO or stroke with syringomyelia. Although
her syringomyelia had not caused our patient any symptoms prior to this
admission, it clearly complicated the management of her stroke.
This case also highlights issues surrounding brain imaging in acute neu-
rological presentations. CT brain is generally the investigation performed
to outrule contraindication to lumbar puncture. CT imaging may not
clearly identify an Arnold-Chiari malformation, particularly when limited
to axial views. The finding may influence the decision to perform a lumbar
puncture, although it is not an absolute contraindication, particularly
where the purpose is to out rule subarachnoid hemorrhage in the context
of a normal CT brain.
MR is the scan of choice in this case, where a patient presents with acute
neurological signs suggestive of a potential posterior circulation stroke.
However, MR is not widely available outside working hours.
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Bihemispheric stroke in eosinophilic granulomatosis
and polyangiitis
M O McCarron1, M Kelly2
1Neurology, Altnagelvin Area Hospital, Derry, United
Kingdom
2Respiratory Medicine, Altnagelvin Area Hospital, Derry,
United Kingdom
Background: Stroke can be more difficult to diagnose in patients under 50
years, in the presence of other organ disease and fluctuating agitation. We
present a 49 year old man who had bihemispheric infarction in the context
of emerging eosinophilic granulomatosis with polyangiitis (EGPA).
Case report: A 49 year old man presented with diarrhoea and vomiting
and subsequently had an epileptic seizure. He became hypoxic and
required intubation and ventilation. Skin bruises were noticed. Subse-
quently he became intermittently very agitated with episodes of tachyp-
noeic and apparent apnoea. He had no obvious lateralizing neurology.
Results: Cerebrospinal fluid was normal. EEG revealed an encephalopa-
thy. Hematology demonstrated increasing eosinophilia, peaking at
15.1 × 109. CT scan of chest showed extensive bilateral interstitial thick-
ening with interlobar fluid and bibasal consolidation. There were multiple
watershed areas of restricted diffusion in both hemispheres on MRI of
brain. There was proteinuria.
Empirical steroid therapy correlated with gradual clinical improvement.
The eosinophilia resolved. One year on he is stable on mycophenylate.
Conclusions: EGPA is a systemic vasculitis of small to medium sized arter-
ies with lung, skin, brain and kidney features. As stroke in EGPA may not
be clinically obvious, early neuroimaging is important.
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Cerebrovascular events as presenting manifestations
of myeloproliferative neoplasm
E Ong1, F Barraco2, A Paire2, V Desestret1, N Nighoghossian1,
L Derex1, A Vighetto1, D Biotti1
1Neurology, Hopital Wertheimer, LYON, France
2Neurology, Hopital Lyon Sud, LYON, France
Objective: To determine the incidence and main characteristics of cere-
brovascular events as presenting manifestation of Myeloproliferative Neo-
plasm (MPN).
Materials and methods: The Hematology in Lyon registry (HEMILY) is a
prospective database (763 patients) collecting all MPN diagnosed since
2005 in the Rhône-Alpes district (France). MPN were divided into 4
groups: polycythemia Vera (PV), essential thrombocythemia (ET),
myelofribrosis (MF) and atypical MPN. The ischemic stroke subtype was
classified according to the TOAST criteria.
Results: A stroke history revealed MPN in 35 patients (4,3%). Twenty-two
patients (63%) had an ischemic stroke, eight patients (23%) a transient
ischemic attack, four patients (11%) a cerebral venous thrombosis and
one patient (3%) a hemorrhagic stroke. All patients had hemoglobin
count and/or platelets count abnormalities. Twelve patients (34%) had
PV, twenty-one patients (60%) had ET, one patient (3%) had MF and one
patient (3%) an atypical/unclassified MPN. The JAK2V617F mutation
was found in 83% of patients. In eighteen patients (51%), an additional
mechanism of stroke was present (atherosclerosis in ten patients, atrial
fibrillation in one patient and dissection in one patient). The median
NIHSS at entrance was 2. The median modified Rankin Scale at 3 months
was 0. Compared to the global MPN population, stroke MPN patients
presented a significantly higher level of hemoglobin (p < 0,001) and were
more frequently positive for the JAK2 V617F mutation (p = 0,044).
Conclusion: Stroke revealing MPN is rare. However careful attention
should be paid to the blood count even in patients with an obvious stroke
etiology.
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Unusual CT head findings in a stroke patient
S Ponnambath1, L Gbadamoshi1, L Shaw1
1Department of Geriatric Medicine, Royal United Hospital,
Bath, United Kingdom
Case report: A 63 year old lady presented with right-sided weakness and
aphasia while she was abroad on holidays. Past history included hyper-
tension, diabetes mellitus, implantable cardioverter defibrillator inserted
for cardiomyopathy, hypothyroidism, cognitive impairment, hearing loss
in left ear and vitamin D deficiency. Examination revealed facial weakness
and decreased power on right side and dysphasia. CT head scan did not
show any bleed and she received emergency thrombolysis. Following
treatment her weakness improved but expressive dysphasia persisted. She
returned to UK for further management. Repeat CT showed small area of
acute left MCA territory infarction and extensive bilateral basal ganglia
calcification and further calcification in occiput and cerebellum. This
raised the possibility of Fahr’s disease (FD). Bloods were unremarkable.
She had declining memory over 3 years which got worse over past 6
months. She was reviewed by psychiatrist and was diagnosed with fronto-
temporal dementia. The findings as a whole is most likely secondary to
FD.
Conclusion: FD is a rare neurological disorder characterized by abnormal
deposits of calcium in basal ganglia and cerebral cortex. It may
present with seizures, parkinsonian features, speech disturbance and
neuropsychiatric symptoms. We should keep an open mind when we see
calcifications on CT scan. It could be secondary to a rare cause. It is
relevant as the affected individual and their families could benefit from
genetic counselling.
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A rare choroid plexus infarct in a patient with
vertebral artery dissection
J Stapleton1, L Valenzuela1, M Ibrahim1, L Sekaran1, D Phiri1,
S Sethuraman1
1Medicine, Luton & Dunstable University Hospital, Luton,
United Kingdom
Infarcts of choroid plexus are rare, usually unilateral, and clinically silent
on its own. Our patient aged 51 with background of epilepsy presented
with sudden onset left-sided ataxia, left facial paresthesia, and dizziness.
He was found to have bilateral rotatory nystagmus, left-sided Horner’s
syndrome, dysmetria, dysdiadochokinesia and unsteadiness of his feet.
Motor power was normal in both upper and lower limbs. He had reduced
sensitivity to pain and temperature on the right side and reduced sensi-
tivity to touch on the left side of his face.
Examination of other systems was unremarkable
MRI brain showed restricted diffusion in DWI and ADC map on the right
choroid plexus with multiple infarcts involving left medulla, and cerebel-
lum. MR carotid angiogram confirmed left vertebral artery dissection. He
was started on anticoagulation and improved with rehabilitation.
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Bilateral paramedian thalamic stroke due to artery of
Percheron occlusion in a patient with atrial fibrillation
and newly diagnosed kidney cancer
H Sienkiewicz-Jarosz1, P Jezierski1, A Graban1, D Ryglewicz1
11st Department of Neurology, Institute of Psychiatry and
Neurology, Warsaw, Poland
Bilateral thalamic infarct is a rare presentation of stroke. Usually, it occurs
as a consequence of anatomical predisposition combined with stroke risk
factors such as embolic diseases.
We report a case of a 61-year-old man who is an active smoker with
untreated hypertension. The patient was found unconscious by his wife in
the early morning. The exact time of the onset was unknown. In Emer-
gency Room, his Glasgow Coma Scale score was 10. The left pupil was
dilated and showed no reaction to light. His vertical gaze was paralyzed
and the left eye was deviated downwards and outwards. Moreover, he had
left-sided hemiparesis. Although CT scan gave negative results, the isch-
emic changes, that were consistent with acute infarction in bilateral
thalami, were observed in magnetic resonance imaging (diffusion
weighted imaging).
Patient was treated conservatively. The diagnostic workup showed the
presence of hyperlipidemia and paroxysmal atrial fibrillation. Moreover
the patient was diagnosed with renal cancer with hepatic metastases. The
routine MRI showed subacute bilateral paramedian thalamic and antero-
medial midbrain infarction suggesting occlusion of the artery of Perche-
ron. The functional outcome, which was pure, might have been influenced
by comorbidity.
The presented case is an example of a bilateral paramedian thalamic and
rostral midbrain stroke from the spectrum of bilateral thalamic infarcts.
The presenting author has been supported by National Science Center
(grant UMO-2011/01/B/NZ7/05402).
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Strokes related to suicide attempts: Frequency,
mechanisms and outcome
M Silva1, L Michaud2, P Michel1
1Stroke Center Neurology Service, CHUV – University of
Lausanne, Lausanne, Switzerland
2Psychiatric Liaison Service, CHUV – University of Lausanne,
Lausanne, Switzerland
Background: Suicide attempts (SA) are frequent, but only few patients
with strokes related to suicide attempts (SRSA) are described. We aimed at
determining frequency, mechanisms and outcome of such patients
through systematic observation.
Methods: We prospectively collected data on patients with ischemic SRSA
admitted to our university hospital over 10 years. We calculated the pro-
portion of SRSA among every strokes and the proportion of SA immedi-
ately before stroke among all SA. Medical history, psychiatric
co-morbidity, and stroke severity were reviewed and stroke severity were
measured. A thorough etiological work-up for stroke was performed.
Outcome was measured at 12 months using the modified Rankin scale
(mRS). Known completed suicides were examined.
Results: We identified five SRSA among 6′278 strokes (0.08%) and among
3′701 SA (0.14%) arriving at our institution. SRSA were younger (median
52 years) and less severe than usual stroke patients. Multiple mechanisms
were present: hanging with carotid artery dissections, hypovolemic from
multi-site venosection, coagulation activation from self stabbing and
atrial fibrillation during drowning. Psychiatric comorbidity included
acute depressive episodes, recurrent psychotic depression, and bipolar
disorder. At 12 months, neurological outcome was good with a median
mRS of zero, but one patient committed suicide 6 days after his SA.
Conclusion: SRSA is rare and may be missed without appropriate neuro-
imaging in patients with neurological signs after SA. Stroke mechanisms
are heterogeneous and result from various suicidal methods. A good neu-
rological outcome was observed and was likely related to younger age and
low initial stroke severity.
Abstracts
© 2015 The Authors.
International Journal of Stroke © 2015 World Stroke Organization Vol 10 (Suppl. 2); April 2015; 77–438396
ESOC-1308
27. Rare Causes, Stroke in the Young, and Case
Reports
An unusual cause of carotid-occlusion and stroke in a
young woman
A Grisold1, P Sommer2, M Krichmayr2, E Fertl2, S Greisenegger1,
W Serles1
1Neurology, Medical University of Vienna, Vienna, Austria
2Neurology, Krankenanstalt Rudolfstiftung, Vienna, Austria
Background: Takayasu arteritis (TA) is a rare chronic systemic disease
affecting predominantly young women with an age of onset between 10
and 40 years. While pathogenesis is still not fully understood, several
etiological factors have been proposed, including genetic predisposition.
Active inflammation is mainly found in large- and medium-sized arteries
with predilection for the aorta and its branches.
In the early phase unspecific systemic symptoms may appear, whereas
vascular symptoms are commonly seen as the disease progresses.
Case: A 26-year old female student of Finnish origin experienced acute
onset of speech disturbance and right hemiparesis. The medical history
revealed colitis ulcerosa. Neurologically she presented with forced conju-
gate gaze to the left, global aphasia and right-sided hemiplegia. The
NIHSS was 21 points.
MRI demonstrated an occlusion of the left carotid artery and the
M1-segment. The CT-angiography suggested an acute dissection of the
aortic arch (Stanford Type I).
Thoracotomy revealed no dissection of the aortic arch. After reviewing the
MRI-/ CT-images the initially suspected dissection of aorta were inter-
preted as narrowing due to inflammation as seen in vasculitis. Further-
more, wall thickening of other aortic branches was shown. Later, the
diagnosis of TA was made according to the American College of Rheu-
matology guidelines, supported by FDG-PET demonstrating active vas-
cular inflammation. Steroid treatment was initiated while the patient
recovered from stroke.
Discussion: Stroke as a first clinical symptom in TA is rare, specifically in
non-Asian populations. However, our case report suggests that TA should
be considered as differential diagnosis in young women with stroke.
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Delayed hyperperfusion syndrome after
extra-intracranial bypass: A case report
J Sotoca Fernandez1, P Camps-Renom1, L Prats-Sanchez1,
F Muñoz-Hernandez2, J Marti-Fabregas1
1Neurology, Santa Creu i Sant Pau Hospital, Barcelona, Spain
2Neurosurgery, Santa Creu i Sant Pau Hospital, Barcelona,
Spain
Introduction: Extra-intracranial bypass is a therapeutic option for
patients with chronic occlusion of the internal carotid artery (ICA) and
recurrent ischemic cerebrovascular events. This procedure has no proven
benefit in clinical trials but can be considered an option in selected
patients. We report one patient who suffered an intracerebral hemorrhage
due to hyperperfusion syndrome after the procedure.
Materials and methods: A 64 year-old patient with a past medical history
of Arterial hypertension, smoking, hyperlipidemia, ischemic heart disease
and chronic left ICA occlusion, who presented four minor strokes in a
period of 6 months involving the left ICA territory without significant
sequelae, despite optimized medical treatment.
Results: Cerebral MRI showed multiple borderline ischemic lesions in the
left MCA-ACA and MCA-PCA territories. Cerebral angiography con-
firmed complete left ICA occlusion and compensation by anterior and
posterior communicating arteries. Cerebrovascular reactivity measured
by Transcranial Doppler and perfusion SPECT before and after the Aceta-
zolamide test showed and exhausted reserve.
Extra-intracranial bypass (superficial temporal artery with MCA) was
performed, and a follow-up cerebral angiography showed significant
hemodynamic improvement and reduction of collateral circulation.
Blood pressure (BP) was difficult to control during the postoperative
period and the patient suffered new ischemic events. Antiplatelet therapy
was initiated. Three weeks after the procedure, the patient suffered a left
fronto-parietal intracerebral hemorrhage.
Conclusions: Delayed intracerebral hemorrhage due to a reperfusion syn-
drome is a rare complication after extra-intracranial bypass. Poor BP
control, previous stroke and antiplatelet therapy may have contributed to
its occurrence in this case.
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Breaking age limits – Successful stroke thrombolysis in
the oldest old, a 102-year-old gentleman
K Stadler1, D Oel1, S Einsiedler1, W Sperl2, H Lugmayr3,
R Topakian1
1Department of Neurology, Klinikum Wels-Grieskirchen, Wels,
Austria
2Akute Zentralversorgung, Klinikum Wels-Grieskirchen, Wels,
Austria
3Institute of Radiology, Klinikum Wels-Grieskirchen, Wels,
Austria
Objective: For very old patients with acute ischemic stroke, IV thromboly-
sis remains a controversially debated off-label treatment option despite
recent evidence from the International Stroke Trial-3 indicating that
benefit may not be diminished in elderly patients. We report successful
stroke thrombolysis in a 102-year-old gentleman.
Case: The patient was admitted to our emergency room with acute right-
sided hemiparesis resulting in a National Institute of Health Stroke Scale
(NIHSS) score of 6. Prior to the actual event he only had mild cognitive
impairment, ambulated with a wheeled walker, and needed little help with
activities of daily living. His past medical history was remarkable for
hypertension, diabetes, pace-maker implantation due to AV block, and
two prior cerebrovascular ischemic events without residual symptoms.
Preexisting medication included aspirin, lansoprazole, bisoprolole,
spironolactone, and insulin. Because of the patient’s relative fitness prior
to the actual event, the admission non-contrast CT scan (showing only
moderate leukoaraiosis) and favorable time window, we decided to carry
out off-label treatment following informed consent with 50 mg alteplase
starting 90 minutes after symptom onset. IV thrombolysis was followed by
complete resolution of symptoms. Further work-up suggested microan-
giopathy as stroke etiology. He was put on clopidogrel and discharged 5
days after admission.
Conclusion: To our knowledge, this is the oldest reported stroke patient
treated with IV thrombolysis, 22 years beyond the product information’s
age limit (80 years). In selected centenarians with acute stroke, IV throm-
bolysis may be an off-label treatment option.
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Record door-to-needle time in stroke thrombolysis –
Doing it in 3 minutes
S Einsiedler1, B Hörmanseder1, G Schustereder1, W Sperl2,
G Huemer3, H Lugmayr4, R Topakian1
1Department of Neurology, Klinikum Wels-Grieskirchen, Wels,
Austria
2Zentrale Akutversorgung, Klinikum Wels-Grieskirchen, Wels,
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3Institute of Anesthesiology and Critical Care Medicine I,
Klinikum Wels-Grieskirchen, Wels, Austria
4Institute of Radiology, Klinikum Wels-Grieskirchen, Wels,
Austria
Objective: In stroke patients receiving IV thrombolysis, in-hospital delays
should be kept as short as possible. We report on a patient with a record
door-to-needle time (DNT) of 3 minutes achieved by applying a stroke
care protocol inspired by the Helsinki model.
Case: After ambulance prenotification with patient details (name; sex –
male; age – 83 years; date of birth; symptoms – acute right-sided brachio-
facial hemiparesis and dysarthria; onset time; past history – longstanding
hypertension, 2 transient ischemic attacks 13 and 4 years ago; medication
– clopidogrel, enalaprile, amlodipine, escitaloprame; weight) the stroke
neurologist alerted the administrative, emergency, laboratory, and radio-
logical personnel involved in hyperacute stroke care to meet the patient,
who was transferred on the ambulance stretcher directly onto the CT table
bypassing the emergency room. After a rapid clinical evaluation and a CT
scan (showing confluent leukoaraiosis), a pre-prepared IV bolus of
alteplase was given immediately following the neurologist’s scan interpre-
tation. DNT and onset-to-treatment time were kept to 3 and 51 minutes,
respectively. IV thrombolysis was followed by near-complete resolution of
symptoms, the National Institute of Health Stroke Scale score improved
from 6 to 1 (residual slight dysarthria). Repeat CT exam did not depict
infarct demarcation. Further work-up suggested microangiopathy as
stroke etiology.
Conclusion: This is the first stroke patient with a reported record DNT as
short as 3 minutes. In selected patients, dedicated stroke care and appli-
cation of the Helsinki model may enable very short DNTs by organizing
in-hospital management while the patient is being transported.
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Cancer in young adults with ischemic stroke
K Aarnio1, H Joensuu2, E Haapaniemi1, S Melkas1, M Kaste1,
T Tatlisumak1, J Putaala1
1Department of Neurology, Helsinki University Central
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2Department of Oncology, Helsinki University Central
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Background: Cancer is a risk factor for ischemic stroke. However, little is
known about cancer among young patients with ischemic stroke. We
studied the frequency of cancer and its relation with long-term risk of
death among young patients with first-ever ischemic stroke.
Methods: 1002 patients aged 15 to 49, registered in the Helsinki Young
Stroke Registry and with a median follow-up of 10.0 years (IQ range
6.5–13.8) after stroke were included. Historical and follow-up data were
derived from the Finnish Care Register and Statistics Finland. Survival
between groups was compared with the Kaplan-Meier life-table method,
and Cox proportional hazard models were used to identify factors
associated with mortality. The study protocol was approved by an insti-
tutional Ethics Committee.
Results: Cancer diagnosis was made in 77 (7.7%) patients, of whom 39
(3.9%) had cancer diagnosed prestroke. During the poststroke follow-up,
41 (53.2%) of the cancer patients died. Median time from prestroke cancer
to stroke was 4.9 (1.0–9.5) years and from stroke to poststroke cancer 6.7
(2.7–10.9) years. Poststroke cancer was associated with age >40 years,
heavy drinking and cigarette smoking. The cumulative mortality was sig-
nificantly higher among the cancer patients (68.6%, 95% CI 52.0–85.3%)
compared with patients without cancer (19.7%, 95% CI 16.3–23.2%).
Active cancer at index stroke, melanoma, and lung/respiratory tract cancer
had the strongest independent association with death during the follow-up
when adjusted for known poststroke mortality prognosticators.
Conclusions: Cancer is common in the patient population with stroke at a
young age, and is generally associated with unfavorable survival.
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Fatal stroke mimic
B Aweid1, M Venter1
1Stroke Medicine, Imperial College Healthcare NHS trust,
London, United Kingdom
Acute Fulminating Haemorrhagic Leukoenchephalitis (AHLE) or Hurst’s
disease is a hyperacute and fatal form of ADEM (Acute Disseminating
Encephalomyelitis). It has a similar presentation as acute Stroke and
radio-logically it can mimic a tumor or an abscess. The infrequency with
which this is encountered makes it a formidable diagnostic challenge.
A 73 year old gentleman was admitted with sepsis on a background of
Myelodysplasia. He was managed under the hematology team with broad
spectrum IV antibiotics, blood transfusions and G-CSF. Within a week of
admission he developed acute delirium with a normal CT head. The next
day he woke up with a dense right hemiplegia, aphasia and reduced GCS
(E2, V4, M5). The Stroke team were contacted and he had a 12 hour
interval CT head that showed extensive hypo-attenuation in the left hemi-
sphere with cortical sparing. This was followed by a CT head with contrast
that showed aggressive expansion of this area of hypo-attenuation but no
evidence of an abscess or tumor. Within 24 hours he deteriorated further
and required intubation. He had an MRI scan that revealed an aggressive
lesion thought to be ADEM. This diagnosis was confirmed to be Hurst’s
disease after a consensus between the Stroke, Neurology and Neuroradi-
ology teams.
This case identifies an extremely rare condition that can present as a stroke
mimic.
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Moyamoya disease (case report)
M Azhermacheva1, K I Burkova2, D M Plotnikov1,
N V Pugachenko1, T A Valikova1, E S Koroleva1, V M Alifirova1,
N A Zautner2, L N Alexeyeva2
1Neurology and Neurosurgery, Siberian State Medical
University, Tomsk, Russia
2Vascular Center for the Treatment of stroke, Regional
Hospital in Tomsk, Tomsk, Russia
Moyamoya disease is a rare chronic progressive disease of brain vessels in
which certain arteries in the brain are constricted. During the disease a
collateral circulation develops around the blocked vessels to compensate
for the blockage, and on angiography these collateral vessels have the
appearance of a “puff of smoke.” Moyamoya is extremely rare disease,
especially outside of Japan.
The article presents case report of Moyamoya disease in patient 27-year-
old from Tomsk, Russia. The diagnosis of moyamoya is suggested by
MRI-angiogram results and an aspect of the disease in accordance to the
diagnostic criteria The clinical features is an acute stroke in right middle
cerebral artery with dysarthria and paralysis of VII and XII cranial nerves.
MR angiography (Pic. 1) was revealed stenosis of the main vessels circle of
Willis (stenosis of the internal carotid artery, anterior and middle cerebral
artery, anterior communicating artery on both sides) with the formation
of collaterals vessels. Inadequate blood supply caused the development of
multiple ischemic brain damage with different degrees of limitation:
lacunar infarctions in right and left hemispheres, post ischemic cyst in
region vascularization of left middle cerebral artery.
Pic. 1 The patient was treated by vascular and metabolic therapy. On
discharge the patient’s condition improved significantly: decreased facial
asymmetry, completely recovered speech articulation. Recommendations
were made for planned specialized high-tech surgical treatment.
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Prevalence of Fabry disease in a cryptogenic ischemic
stroke young patients cohort in Mexico
A Arauz1, M A Barboza1, J Colin-Luna1, A Ruiz-Franco1,
A Quiroz-Compean1, J C Vargas1
1Stroke Department, National Institute of Neurology and
Neurosurgery, Mexico City, Mexico
Background: although Fabry disease is a rare lysosomal disease related to
α-galactosidase deficiency, ischemic stroke could be the first manifesta-
tion in young patients, even before kidney disease. Our aim was to estab-
lish the prevalence of Fabry disease in a young patients cohort (<50 years)
classified as cryptogenic ischemic stroke.
Methods: we recruited Mexican mestizo patients younger than 50 years
from our institutional database, classified as cryptogenic stroke according
to ASCOD etiologic criteria, with the qualifying event from 1991 to 2004.
Demographic, clinical, laboratory, imaging and functional outcome char-
acteristics were collected. All male patients were screened with
α-galactosidase activity levels, and mutations in the α-galactosidase gene
was performed in female patients.
Results: A total of 58 patients were included (31 men; median age 35
years, interquartile range 26–44), with a median follow-up of 59 months
(interquartile range 14–141). Main risk factors documented were smoking
(17.2%), hypertension (8.6%) and hyperlipidemia (6,9%). Partial anterior
circulation (46.6%) and posterior circulation (32.8%) infarctions were the
clinical features more frequently observed. Modified Rankin score of good
prognosis (0–2) was present in 62.1% patients at discharge and 75.9% at
final follow-up; no deaths were recorded. Mean α-galactosidase activity
levels in men were 3.88 μmol/L/h. Only one female case was reported as
definite Fabry disease in our sample (1,72%, CI 95% 0.96–1.11; p = 0.28)
and none in men.
Conclusion: In our cohort of young patients with ischemic stroke classi-
fied as cryptogenic, uncommon metabolic and genetic conditions should
be screened as possible targets for additional therapy.
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Persistent trigeminal artery and valsalva maneuver –
Risky combination for transient ischemic attack
C Brunner1, W Struhal1, C Scherer1, T Lukas2, G Ransmayr1,
M R Vosko1
1Medical Faculty Neurology AKH, Johannes Kepler University
of Linz, Linz, Austria
2Medical Faculty Radiology Institute AKH, Johannes Kepler
University of Linz, Linz, Austria
The persistent trigeminal artery (PTA) represents the most frequently
reported persistent carotid-basilar anastomosis between the carotid and
vertebro-basilar circulation with incidence of 0,1 to 1.0% in adult popu-
lation. The PTA ist the biggest of the four known embryonic anastomoses.
It’s natural obliteration occurs normally between 11.5 to 14 mm embry-
onic period. If not, the vessel persists open. The Saltzman Classification
differentiate three Types.
We present a 48 years old male with acute onset of persistent linear
horizontal nystagmus to the right, rotatory vertigo and ataxia of the right
upper extremity. The symptoms occurred after massive vomiting due to
endoscopically verified gastritis. Acute stroke MRI showed no diffusion
lesion but a perfusion reduction over the right cerebellar hemisphere. The
functional transcranial colour-coded duplex sonography showed PTA and
hypoplastic basilar artery. The vomiting was simulated by valsalva maneu-
ver and caused reproducible reduction of blood flow velocity in the PTA.
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We supposed an insufficient autoregulatory function (embryonic vessel)
and / or an incomplete steal phenomenon in combination with an addi-
tional poor anterograde flow from BA.
We present an overview about embryonal development of the brain arter-
ies and a detailed case report with rare hemodynamic cause of TIA in the
posterior circulation.
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Giant cell arteriitis and stroke
F de Courbiere1, P Michels1, B Eckert2, J Röther1
1Neurology, Asklepios Klinik Altona, Hamburg, Germany
2Neuroradiology, Asklepios Klinik Altona, Hamburg, Germany
Stroke due to giant cell arteriitis (GCA) of brain-supplying vessels is rare.
We report 6 patients that were admitted with acute neurological deficits
due to cerebral infarction. In addition to typical symptoms (blurred
vision, jaw claudication and headache), the diagnosis was supported by
elevated C-reactive-protein, leucocytes and erythrocyte-sedimentation-
rate. A positive biopsy of the external temporal artery (n = 3) or a halo-
sign in ultrasound confirmed the diagnosis. All patients had multi-
segmental stenosis (MRA) with hypoechogenic thickening of the vertebral
artery (ultrasound) or contrast enhancement in high resolution MRI of
the intracranial carotid artery.
Therapeutic management: High-dose oral steroids, simvastatin, ASA and
clopidogrel were initiated. Additionally, 5 patients received cyclophosph-
amide according to the CYCLOPS-scheme. In one patient, tocilizumab
was applied as option to avoid progression. Patient outcome varied con-
siderably. While 3 patients could complete 6 courses of CYCLOPS with a
stable clinical outcome and with an adverse effect of pneumonia in only
one case, 3 other patients died within a few weeks after diagnosis. These
patients showed a rapid deterioration with progressive strokes due to
inflammatory vessel occlusions. In two patients, an endovascular angio-
plasty was performed as ultima ratio but did not prevent further progres-
sion and lethal outcome.
Discussion: Therapeutic options for the management of GCA patients
with cerebral involvement frequently fail to prevent further progressive
disease. New therapeutic interventions need to be validated to improve
GCA patient care.
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Steno-occlusive lesion of the intracranian internal
carotid artery: One vascular occlusion site, two
pathogenic mechanisms in two very young
patient-cases report
B Dumitriu1, A R Cheffneux2, B Oprea2
1Neurovascular Emergency, National Institute of Neurological
and Neurovascular Diseases, Bucharest, Romania
2Radiology, Bagdasar Emergency Hospital, Bucharest,
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Background: Ischemic stroke in the young patient has multiple causes.
Many times we have to assess , all the vascular aspects of the artery wall,
the blood constituents and the possibility of cardioembolism. In this
presentation I show two rare, but important to consider, mechanisms of
ischemic strokes in two very young women (25 and 27 years old) with
obstruction of the intracranian ICA with consecutive cerebral infarcts.
Methods: Both cases have had the same clinical presentation with sudden
right-sided limb weakness and speech disorder. The CT scan show left
middle cerebral artery infarct predominantly in the capsulo-lenticulo-
striatal area. In both cases the echocardiography was normal. Doppler
ultrasound revealed an high resistance flow pattern in left comune and
internal carotid arteries. Doppler transcranian in one case showed a spec-
tral alteration of velocimetric curve of left distal ICA and M1 suggestive
for tight stenosis. DSA indicated a classic “string of beads” appearance of
left carotidian “T” and of M1 diagnostic for medial fibrodysplasia. The
other case had an occlusion of terminal left ICA with poststenotic flow in
MCA at transcranian Doppler and DSA confirm the occlusion of left “T”
carotidian with no fill of A1 and minimal fill of M1 and, very important,
with impressive left fronto-temporal collateral circulation suggestive for
unilateral left moyamoya disease.
Results: Two young female patient with an ischemic MCA stroke that are
carriers of a two serious chronic conditions: fibromuscular dysplasia and
unilateral moyamoya disease.
Conclusions: Even if, is only diagnostic, DSA has to be perform in young
people with ischemic stroke without dissection, cardioembolism and
thrombophilia.
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Post-thrombolysis intracerebral hemorrhage in stroke
mimic: Two cases and review of literature
N Goyal1, S Male1, T Georgios1, R Zand1
1Neurology, University of Tennessee Health Science Center,
Memphis, USA
Background and purpose: Symptomatic-intracerebral-hemorrhage
(sICH) is a potential life-threatening complication associated with IV-tPA
treatment of acute-stroke. There are however several-studies confirming
the safety of IV-tPA in stroke-mimic. Here we present two-cases of stroke-
mimic, who had sICH after IV-tPA administration.
Case reports: Case 1: A-77-year-old-man with history of hypertension
presented with dysarthria and confusion (NIHSS-3). CT-scan-head did
not show any acute-abnormality. Pre-thrombolysis-Diffusion-Weighted-
only-imaging showed a small area of diffusion-restriction in the left-
thalamus. The patient received IV-tPA and the MRI was completed after
the infusion. Unexpectedly, the complete MRI was consistent with a late-
subacute-thalamic-hemorrhage (extracellular-methemoglobin). Despite
thrombolysis-reversal attempts, the patient developed a catastrophic-
intracerebral-hemorrhage. Later it was concluded that the etiology of
patient’s initial presentation was possibly alcohol-withdrawal-seizure
versus metabolic-encephalopathy.
Case 2: A-66-year-old-man with history of hypertension presented with
confusion, dysarthria and right-sided-gaze-preference (NIHSS-6).
CT-scan-head did not show any acute-abnormality and subsequently he
received IV-tPA. Immediate-post-thrombolysis-MRI demonstrated
numerous chronic-micro-hemorrhages and a small hyperacute-ICH, but
did not show any diffusion-lesion corresponding with an acute-infarction.
Although the patient experienced worsening of his neurological status, the
ICH was controlled with thrombolysis-reversal and strict blood-pressure
control. The 24-hour CT-head showed multiple hemorrhagic foci in both
hemispheres.
Conclusion: On literature-review, we did not find any case of stroke-
mimic with post-thrombolysis ICH. Although these two-cases do not
undermine the safety of IV-tPA in patients with stroke-mimic, it high-
lights the fact that the risk of sICH is more than zero among stroke-mimic
patients.
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Multimodal imaging follow-up of stroke-like episodes
in MELAS: Pseudonormalization?
B Gunda1, C Ertsey1, G Várallyay2, T Györke3, D Bereczki1
1Department of Neurology, Semmelweis University, Budapest,
Hungary
2MRI Research Centre, Semmelweis University, Budapest,
Hungary
3Department of Radiology, Semmelweis University, Budapest,
Hungary
Background: The pathogenesis of stroke-like episodes (SLEs) in MELAS
(mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like
episodes) is still poorly understood. Recent serial MRI studies showed a
characteristic evolution of lesions suggesting a metabolic cytopathy: i. The
acute phase is usually characterized by anatomically progressive restricted
diffusion and high T2 signal. ii. The subacute lesions usually show normal
or slightly increased diffusivity, while the T2 hyperintensity becomes less
prominent. iii. In the chronic phase both diffusivity and T2 signal seem to
return to normal.
Objective: We followed up two SLEs in a MELAS patient with 3T MRI
(T2, FLAIR, DWI and MRA) and regional cerebral perfusion SPECT
(HM-PAO Tc-99m) to further characterize imaging abnormalities.
Results: Serial MRI confirmed the above described evolution of signal
changes from low to high and then normal diffusivity together with the
regression of T2/FLAIR hypersignal. It showed a progressive spread of
lesions through vascular territories followed by a slow regression of signal
abnormalities. However brain tissue involved in a previous SLE with
apparently normal signal showed marked volume loss. SPECT detected a
significantly decreased cortical perfusion both in the previously affected
areas and the acute lesion.
Conclusion: Our findings confirm the non-vascular nature of SLEs and
suggest that the regression of T2 and DWI abnormalities is only a pseudo-
normalization. Although the microstructural density of affected brain
tissue may be similar to normal in the chronic phase, the integrity and
metabolism are not as indicated by atrophy and decreased perfusion.
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Tobacco use and cryptogenic stroke in young adults:
A Population-based case-control study
A Jaffre1, J B Ruidavets2, N Nasr1, B Guidolin1, J Ferrieres2,
V Larrue1
1Neurology, Hôpital Pierre Paul Riquet University Hospital,
Toulouse, France
2Epidemiology, Hôpital Rangueil University Hospital,
Toulouse, France
Objective: Cryptogenic stroke is the leading subtype of ischemic stroke in
the young. We sought to evaluate the association of traditional cardiovas-
cular risk factors with cryptogenic stroke by use of a case-control study.
Methods: Patients aged 16–54 years, consecutively treated for first-ever
cryptogenic ischemic stroke in an academic stroke unit were compared
with subjects from the general population living in the same geographic
area. Patients without ASCOD (A: atherothrombosis, S: small vessel
disease, C: cardiac source, O: other cause, D: dissection) grade 1 (poten-
tially causal) cause of stroke were classified as cryptogenic. Control sub-
jects were 1:1 matched for age and sex with patients. We further evaluated
the association of significant risk factors with non-obstructive (<50%
stenosis) carotid plaque and intraluminal thrombus among patients.
Odds ratios were calculated using logistic regression analysis.
Results: A total of 155 patients with cryptogenic stroke (66.4% men;
mean age [SD], 43.5 [8.4] years) were included. Cryptogenic stroke was
associated with current tobacco use (42.6% in patients versus 23.9% in
control subjects, odds ratio 2.38, 95% confidence interval 1.40 to 4.05,
P = 0.002). Current tobacco use was associated with non-obstructive
carotid plaque (odds ratio 6.22, 95% confidence interval 2.43 to 15.9,
P = 0.001) and intraluminal thrombus (odds ratio 13.7, 95% confidence
interval 1.42 to 132.7, P = 0.03) among patients.
Conclusion: Our case-control study showed a strong association of
current tobacco use with cryptogenic stroke in young adults. Our findings
suggest that current tobacco use may be responsible for a substantial
number of cryptogenic strokes in young adults.
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Delay in diagnosis of arterial ischemic stroke in
children
I Komarova1, V P Zykov1, L S Mamedova1
1Child Neurology, Russian Medical Academy of Postgraduate
Education, Moscow, Russia
Aims: The aims were to identify the time of diagnosis arterial ischemic
stroke (AIS) in children and to investigate the features, which influence
the diagnostic delay.
Methods: 67 stroke pts with a median age of 5,28 ± 4,28 years were
included. Time to diagnosis, time/modality of neuroimaging and its
results, risk factors and prior diagnoses were analyzed.
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Results: The time to diagnosis was >24 hours in 38 (56,7%) children. 30
(44,8%) pts had an initial CT scan, 11 (16,4%) pts had an initial MRI and
7 (10,4%) pts underwent both procedures. On the first day CT was per-
formed in 15 out of 30 pts, it led to AIS diagnosis in only 3 pts. MRI was
done on the first day in 5 out of 11 pts; it led to the correct diagnosis in all
5 pts. The most often misdiagnoses were encephalitis (n = 10), epilepsy
(n = 6) and craniocerebral trauma (n = 7). Encephalitis correlated with
gradual symptoms onset, infectious signs and no neuroimaging in the first
week (R = 0,47; p = 0,001). Epilepsy correlated with gradual symptoms
onset, seizures and no neuroimaging in the first week (R = 0,45;
p = 0,003). Craniocerebral trauma correlated only with any head injury
(R = 0,48, p = 0,000035). Any misdiagnosis correlated to gradual onset of
symptoms, diffuse cerebral signs and neuroimaging >1 week (R = 0,59;
p = 0,000005).
Conclusion: The diagnosis AIS was delayed for more than 24 hours in
56,7% pts. The delayed diagnosis is usually related to gradual onset of
symptoms, no acute neuroimaging, using CT scan instead of MRI on the
first day, and erroneous interpretation of symptoms.
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Arterial ischemic stroke after mild head trauma in
children
I B Komarova1, V P Zykov1, O V Shuleshko2, L S Mamedova1
1Child Neurology, Russian Medical Academy of Postgraduate
Education, Moscow, Russia
2Outpatient Department, Children’s City Clinical Hospital
n.a.Z.A.Buslaeva, Moscow, Russia
Aim: The aim was to evaluate the importance of mild head trauma
(MHT) for arterial ischemic stroke in children.
Methods: 81 stroke pts (aged 4,93 ± 4,13 years) were included. All pts were
divided into two groups. The main group (n = 24) consisted of patients
within 1 month prior to stroke was observed MHT. The other pts formed
the comparison group, n = 57. The demographic data, clinical course and
neuroimaging were analyzed.
Results: The average age of the patients of the main group was two times
lower than patients in the comparison group: 2,43 ± 2,9 years vs
5,98 ± 4,14 years, p = 0,0003. The median Pediatric National Institutes of
Health Stroke score in MHT pts was lower than in other pts: 10,5 ± 3, vs
13,86 ± 6,84; p = 0,026. The period until the neurological symptoms tends
to be resolved was shorter in the main group than in the comparison
group: 5,125 ± 4,44 days vs 8,19 ± 6,39 days, p = 0,038. There were the
prevalence of basal ganglia infarcts (83,3% vs 19,3%, p = 0,0007), lenticu-
lostriate arteries mineralization (72,2% vs 7,14%, p = 0,0014), and the
rarity of cerebral arteriopathy (25% vs 81%, p = 0,009) in MHT pts in
compare with other pts. The predictors for stroke associated with MHT
are age up to 2 years and mineralization in the lenticulostriate arteries
(RR ± S = 8,357 ± 0,67).
Conclusion: The mild head trauma is an important cause of arterial isch-
emic stroke in infants and toddlers. The condition for the stroke devel-
opment is mineralization of lenticulostriate arteries. The middle severity
in the acute period, short unstable period, subcortical infarcts, and no
cerebral arteriopathy are typical for stroke after MHT.
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Multiple cerebral infarcts in a young patient with
heroin-induced hypereosinophilic syndrome
J Bolz1, S H Meves1, A Reinacher-Schick2, K Kara3, R Gold1,
C Krogias1
1Neurology St. Josef-Hospital, Ruhr University Bochum,
Bochum, Germany
2Hematology/Oncology St. Josef-Hospital, Ruhr University
Bochum, Bochum, Germany
3Cardiology St. Josef-Hospital, Ruhr University Bochum,
Bochum, Germany
Background: Hypereosinophilic syndrome (HES) is as a primary or sec-
ondary leukoproliferative disorder characterized by sustained eosino-
philia (>1,500/μL) with consecutive eosinophilic infiltration and
mediator release leading to target organ dysfunction. Neurological
involvements in form of polyneuropathy, encephalopathy and cerebral
infarctions have rarely been described. Local hypercoagulability and direct
endothelial damage by the “Eosinophil major basic protein“ have been
discussed as underlying pathophysiologies of microvascular alteration. In
addition, Loeffler endocarditis leading to thromboembolism has been
associated to HES.
Case report of a young heroin consumer with multiple cerebral infarc-
tions in the setting of HES:
A 29-year-old male presented with mild right-sided hemiparesis. Addi-
tionally, he complained a subacute left-sided hemihypesthesia. Both CT
and MRI showed multiple small cerebral and cerebellar infarctions.
MR-angiography as well as neurosonological examination revealed no
evidence for cerebral vasoconstriction. Echocardiography findings were
normal. White blood cell (WBC) count showed elevated levels of
40,880/μl (27,860/μl eosinophilic granulocytes). The patients reported
transnasal heroin abuse for several years. After exclusion of primary clonal
and other reactive causes of eosinophilia (such as lymphoproliferative,
infectious or autoimmune diseases) heroin remained the only possible
trigger. Under corticosteroid therapy and cessation of heroin the WBC
and particularly the eosinophilic granulocytes count dropped within few
weeks to almost normal values.
Conclusion: Hypereosinophilic syndrome is a heterogenous disease and it
represents a rare cause of cerebral infarctions. To our knowledge, this is
the first description of stroke in the setting of heroin-induced hypere-
osinophilia. Thus, besides vasoconstriction, HES should be considered in
drug-induced cerebral infarctions.
ESOC-0669
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A case of probable post-irradiation subclavian,
vertebral and carotid arteriopathy
C J Lavery1, A J Fulton2
1Medical Student, Queen’s University Belfast, Belfast, United
Kingdom
2Stroke Unit, Royal Victoria Hospital, Belfast, United Kingdom
A 46 year old right handed lady was admitted with a three day history of
migrainous type features, neck pain and, on the morning of admission,
sudden numbness and weakness of the left side of the body lasting ten
minutes before resolving. On examination, the right upper limb appeared
weaker than the left and there was left lower limb ataxia.
Past medical history included Hodgkin’s lymphoma twenty-nine years
previously, treated by chemotherapy, an autologous bone marrow trans-
plant and radiotherapy to the left side of her neck.
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Imaging demonstrated occlusive arterial disease involving the left verte-
bral, subclavian and internal carotid arteries, as well as calcification at the
right vertebral artery origin.
It would be rare for typical atherosclerotic disease to affect this pattern of
vessels. Moreover, as the patient has no conventional risk factors for ath-
erosclerosis (normotensive, non-smoker, normal lipid profile, no family
history of cerebrovascular or cardiovascular disease) and received radio-
therapy to the left side of her neck, radiation-induced stenosis of these
major vessels seems the most plausible explanation.
Clinically, the patient poses a significant management challenge. Aged 46,
despite dual anti-platelet therapy, she has had two further symptomatic
episodes, one right-sided and one left-sided. Symptomatic patients with
carotid artery stenosis >50–70% require either carotid endarterectomy or
carotid angioplasty and stenting. Technically, this may be difficult with the
extent of the arteriopathy and fibrotic tissue formation.
This case highlights radiation-induced arteriopathy as a potential cause of
stroke in young patients presenting with unusual patterns of atheroscle-
rotic disease.
ESOC-0143
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Hyponatremic encephalopathy: An unusual stroke
mimic
K Mahawish1, W Wareing1, B Dhatore1
1Elderly Care, Warrington Hospital, Warrington, United
Kingdom
Acute stroke is a common presentation to hospital requiring prompt
assessment, investigation and management. Stroke mimics, including
space occupying lesions, sepsis, seizures and hypoglycemia are well docu-
mented in the literature.
We present the case of a 74 year old gentleman admitted with subacute
expressive and receptive dysphasia with subsequent development of a
right homonymous hemianopia and mild right hemiparesis. NIHSS
(National Institute of Stroke Score) was 10, indicative of a moderately
severe stroke. Admission CT brain imaging excluded acute pathology and
antiplatelets commenced for suspected ischemic stroke.
This diagnosis was not supported by subsequent brain MR imaging using
standard and DWI sequences (Figs 1 and 2). Severe hyponatremia was
noted (i.e. Na ≤ 120 mmol/L) with investigations in keeping with Syn-
drome of Inappropriate Anti-Diuretic Hormone (SIADH). Following
fluid restriction and cessation of omeprazole (a PPI well documented to
cause hyponatremia) the neurological features resolved, corresponding
with a correction in the plasma sodium (Fig. 3) over the subsequent seven
days.
Hyponatremia is the most common electrolyte abnormality encountered
in clinical practice but is frequently under-diagnosed and undertreated.
Neurological features manifest in one-fifth of patients with severe
hyponatremia, with an equal proportion of such patients presenting with
focal neurological signs. Patients presenting with focal neurological signs
should be treated with standard stroke therapy including thrombolysis as
the risk of complications in mimics is exceedingly small, unless the phy-
sician is convinced to the contrary.
Hyponatremia as a stroke mimic is recognized in the literature and carries
an excellent prognosis with prompt treatment.
Fig. 1
Fig. 2
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Fig. 3
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Evolution of risk factors and phenotype between
first-ever and recurrent young-onset ischemic stroke
N Martinez-Majander1, E Haapaniemi1, M Kaste1, J Putaala1,
T Tatlisumak1, E Vuoristo1
1Department of Neurology, University of Helsinki Division of
Neurosciences, Helsinki, Finland
Background: Etiological diversity makes diagnosis and secondary preven-
tion of ischemic stroke (IS) at young age challenging. We studied whether
risk factors and patient phenotype change in between first-ever and first
recurrent young IS (restroke).
Methods: Of the 1008 first-ever IS patients in the Helsinki Young Stroke
Registry, we included 110 patients (age 44.1 ± 5.5 years) experiencing a
restroke during mean follow-up of 9.3 (±4.1) years, phenotyped with
ASCO classification, and rated for 3-month modified Rankin Scale (mRS)
after first-ever and restroke. Related-samples statistics were applied: Fried-
man’s 2-way analysis of variance, Wilcoxon signed ranked test, and
McNemar test.
Results: Compared with first-ever stroke, hypertension (51% vs. 75%,
P < 0.001), type 2 diabetes mellitus (14% vs. 21%, P = 0.021), and cardio-
vascular disease (15% vs. 24%, P = 0.021) were more common at restroke,
while cholesterol level (5.2 ± 1.1 vs. 4.6 ± 1.1 mmol/L, P < 0.001) and
prevalence of smoking (56% vs. 35%, P < 0.001) had declined. No differ-
ence emerged in vascular territories or symptom severity, but mean
3-month mRS leveled higher after restroke (1.6 ± 1.2 vs. 2.3 ± 1.5,
P < 0.001). Between first-ever and restroke, no significant differences
existed in proportions of definite atherosclerosis (16% vs. 15%), small-
vessel occlusion (16% vs. 23%), cardioembolism (11% vs. 13%), or other
determined etiology (14% vs. 13%). Furthermore, proportions without
definite or probable cause (ASCO 1 or 2) were similar (27% vs. 24%).
Conclusions: Despite favorable trends in some risk factors—including
smoking and cholesterol levels—these young patients were more diseased
and disabled after restroke. However, underlying causes remained unal-
tered and initially cryptogenic cases remained cryptogenic by ASCO
classification.
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Vertebral artery dissection mimicking cervical
radiculopathy
P Methil1, C Ramakrishnan1
1Neurology, Kg Hospital & Post Graduate Medical Institute,
Coimbatore, India
Background and purpose: Vertebral artery dissection may produce the
clinical picture of a cervical radiculopathy.
Method: Case reports of 2 case with cervical pain radiating down the arm
occurring subsequent to prolonged neck hyperextension for dental extrac-
tion. Both occurred in male patients aged 62 and 58 yrs respectively.
Results: Neurological examination showed very sluggish ipsilateral
C5–C6 deep tendon reflexes with a normal sensory examination without
significant motor weakness. DSA ( Digital Subtraction Angiography)
done showed vertebral artery dissection affecting V2 segment in one
patient & V3 segment in the other patient.
Conclusion: Even though ipsilateral cervical pain is a common manifes-
tation of vertebral artery dissection , radicular pain is rare. An ipsilateral
cervical radiculopathy has been reported in 7% of extra cranial vertebral
artery dissections. Pain & Weakness in the C5–C6 distribution associated
with V2 dissection has been attributed to direct mechanical compression
& stretch of the nerve root from extra luminal hematoma. In V3 dissection
the role of central mechanisms with C1–C2 afferents results in the referred
pain.
Cervical Artery dissection should be considered in other wise unexplained
head & neck pain syndromes.
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Transient locked in syndrome due to basilar artery
occlusion
P Methil1, C Ramakrishnan1
1Neurology, Kg Hospital & Post Graduate Medical Institute,
Palakkad, India
Introduction: The locked in syndrome is characterized by quadriplegia
and anarthria without loss of consciousness. Basilar occlusion has been
described as a cause of locked in syndrome and has typically been
described as carrying a high mortality rate.
We present a case of basilar thrombosis which manifested with a transient
locked in syndrome.
Maternal and methods: A 65 yrs old male with a history of hypertension
& Diabetes presented with a 20 minutes episode of circum-oral numbness
and tingling in both extremities. Transcranial Doppler & CTAngiogram
(CTA) of brain revealed high grade proximal basilar stenosis.
He experienced ongoing episodes of transient double vision. Approxi-
mately 1 month after the initial presentation he developed acute onset of
dysphagia and inability to speak followed by quadriplegia. The patient had
intact memory of all events at that time and he recovered the motor power
over the next 3 hours. He made a complete recovery. Patient had to be
intubated during the episode.
Results: MRI of the brain did not show any Diffusion weighted imaging
(DWI) abnormalities. MRA showed a loss of flow void in the proximal
basilar artery. Trans cranial Doppler (TCD) was suggestive of proximal
basilar occlusion. CTA confirmed the proximal basilar occlusion.
Conclusion: This case illustrates a unique presentation of basilar artery
occlusion. Transient locked in syndrome is a rare condition and when
present points to non vascular etiologies. However, our case illustrates the
significant variability in presentation of locked in syndrome and also of
Transient Ischemic attack(TIA).
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Non-vitamin K oral anticoagulants for treating cervical
artery dissection
S Mustanoja1, T M Metso1, J Putaala1, E Haapaniemi1, O Salonen1,
T Tatlisumak1
1Neurology, Helsinki University Central Hospital, Helsinki,
Finland
Background: Cervical artery dissection (CeAD) patients with or without
stroke are frequently treated with either antiplatelet agents or vitamin K
antagonists (VKAs), but no data are reported on the use of non-vitamin K
oral anticoagulants (NOACs).
Materials and methods: Between November 2011 and January 2014, we
recorded data from our stroke patients with vertebral (VAD) or internal
carotid artery dissection (ICAD). Patients using oral anticoagulants were
included in the study and were divided into 2 treatment groups: patients
using NOACs and those using VKAs. Excellent outcome was defined on
modified Rankin Scale (mRS) ≤1 at 6 months.
Results: Out of 68 stroke patients (67% male; median age 45 [39–53]), six
(8.8%; 2 with VAD and 4 with ICAD) were treated with NOACs: three
with direct thrombin inhibitor dabigatran and three with direct factor Xa
inhibitor rivaroxaban. National Institutes of Health Stroke Scale score at
baseline was 4 (3–7) in the NOAC vs. 2 (1–7) in the VKA groups. Com-
plete recanalization at 6 months was seen in most patients in the NOAC
(n = 5; 83%) and VKA (n = 34; 55%) groups. All the patients using
NOACs had mRS ≤ 1 at 6 months and none had an intracerebral hemor-
rhage (ICH). In the VKA group most patients (n = 48; 77%) had mRS ≤ 1,
one patient (1.7%) had an ICH and one died.
Conclusions: Treatment of ischemic stroke patients with CeAD with
NOACs did not bring up safety concerns and resulted in similarly good
outcomes in this small consecutive single-center patient sample.
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A case of genuine paradoxical embolism causing
stroke after valsalva maneuver
T Pain1, K Pasco1, A Blight1
1Stroke and Geriatric Medicine, Royal Surrey County Hospital
NHS Trust, Guildford, United Kingdom
A 63 year old female smoker with a pleural effusion presented with sudden
onset isolated aphasia during pulmonary function testing. Brain imaging
with computed tomography (CT) showed subtle increased density in a
branch of the left middle cerebral artery in the sylvian fissure (Fig. 1)
suggestive of thrombus. Thrombolysis was not administered as symptoms
were resolving, leaving mild aphasia. Magnetic resonance brain imaging
showed areas of restricted diffusion in the left insula and foci within the
grey matter of the left parietal lobe suggesting embolic etiology (Fig. 2).
CT of the whole body showed evidence of bilateral pulmonary embolic
disease (Fig. 3) but not malignancy. Echocardiography showed an aneu-
rysmal intra-atrial septum with resting left to right shunt consistent with
a patent foramen ovale (PFO), and an unexpected finding of a severe
dilated cardiomyopathy. We postulate her stroke was caused by genuine
paradoxical embolism across a PFO during Valsalva maneuver with
proven unprovoked venous thromboembolism, and lifelong anticoagula-
tion is therefore indicated.
Fig. 1
Fig. 2
Fig. 3
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Stroke and cerebral vasculitis: A 10-year clinical
experience
P Kempster1, C McLean2, T Phan1
1Neurosciences, Monash Health, Clayton, Australia
2Pathology, Alfred Health, Melbourne, Australia
Background: Angiitis of the central nervous system (CNS) is difficult to
diagnose but potentially fatal. It usually causes infarction of brain tissue.
When stroke occurs in a younger individual or is associated multiple
infarcts on imaging, clinicians must decide how far to pursue a possible
diagnosis of vasculitis. The aim of this study is to establish the prevalence
of primary and secondary cerebral angiitis among patients presenting
with stroke.
Methods: Hospital attendances over a 10-year period were surveyed by
searching for diagnostic codes and key words specific for cerebral
vasculitis/angiitis. Case notes were reviewed by the authors using 2 sets of
criteria for angiitis of the CNS.
Results: Thirty-two patients were initially considered likely to have cere-
bral angiitis by treating physicians. Thirteen had been admitted to hospital
with stroke. During this period, there were 7475 admissions for ischemic
and hemorrhagic stroke. Six patients had a final diagnosis of vasculitic
stroke but only one had definite CNS angiitis with a first presentation as
ischemic stroke (0.02%). Most patients who did have cerebral vasculitis
developed multifocal or subacute neurological deficits, or already had an
immunological disorder known to be associated with secondary CNS
angiitis. Of 19 patients given an alternative final diagnosis, the commonest
were atherosclerotic/ embolic cerebrovascular disease (9) and reversible
cerebral vasoconstriction syndrome (7).
Conclusions: Stroke is rarely the first manifestation of cerebral vasculitis.
Our findings suggest that routine screening for angiitis in stroke patients
may not be warranted.
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Stroke among centenarians in Denmark
L Ravnskjær1, T S Olsen2, K K Andersen1
1Statistics Bioinformatics and Registry, Danish Cancer Society,
Copenhagen Ø, Denmark
2Department of Neurology, Bispebjerg University Hospital,
Copenhagen, Denmark
Background: The oldest old is the fastest growing segment of the total
population. The projected increase of centenarians being 400% by 2030.
We studied incidence, risk profile and mortality of centenarians with
stroke in Denmark.
Methods: We identified all hospital admissions for stroke in the adult
Danish population 2003–2012 (23.5 million person-years). Demographic
data on the Danish background population was obtained from Statistics
Denmark. Age, sex, risk profile, stroke severity (Scandinavian Stroke Scale,
SSS 0 (worst)-58 (best)), subtype and 1-month mortality was obtained
from the Danish Stroke Register covering all admissions for stroke in
Denmark (n = 82 081).
Results: In total 95 patients (1.1/1000) were ≥100 years (range 100–108);
83% women; 94% infarcts; 80% single living; 62% living in own home.
Incidence of hospitalization for stroke for a100 year old person in the
Danish population was 21.1 per 1000/year. Risk factor prevalence was
generally lower among centenarians. Using 70–79 year-olds as reference:
diabetes 3.2% vs. 15.5%; previous myocardial infarction 5.3% vs.11%;
smoking 5.3% vs. 31.2%; high alcohol consumption 0% vs. 6.3%. Preva-
lence of atrial fibrillation (AF) was higher 28.4% vs. 16.4%; prevalence of
hypertension was the same 54.7% vs. 54.6%. Strokes were more severe in
centenarians: SSS 28.8 vs. 42.8 in 70–79 year-olds. Among centenarians
1-month mortality was 31.6% compared to 8.6% in 70–79 year-olds.
Conclusion: Centenarians with stroke were predominantly women 2/3
living in own home. Except for AF and hypertension the risk profile was
more favorable in centenarians. However, incidence and case-fatality was
high and strokes were severe.
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Familial paraganglioma syndrome: A rare cause of
carotid artery occlusion
F Rosafio1, M L Dell’Acqua1, S Vallone2, B Madeo3, G Bigliardi1,
L Vandelli1, L Picchetto1, R Pentore1, F Barbi1, A Zini1
1Stroke Unit – Department of Neuroscience, S.
Agostino-Estense Hospital and University of Modena and
Reggio Emilia, Modena, Italy
2Departement of Neuroradiology, S. Agostino-Estense
Hospital, Modena, Italy
3Departement of Endocrinology, S. Agostino-Estense Hospital
and University of Modena and Reggio Emilia, Modena, Italy
Background: Head and neck paragangliomas (HNPs) are rare tumors
arising from chromaffin cells of the autonomic paraganglia, most
frequently within the covering of the carotid artery. Carotid body
paraganglioma are often clinically silent, typically presenting as slowly
enlarging mass in lateral neck. Approximately 30% of all HNPs are
hereditary, frequently bilateral and can associate with secreting thorax
and abdominal paraganglioma (pheocromocitoma-paraganglioma
syndrome).
Case report: A 45-year-old man, with history of occasional bilateral tin-
nitus and scintillanting scotoma in the last 5 years, was admitted for
sudden-onset of headache and visual loss. Neurologic examination
showed an inferior altitudinal visual field impairment in the left eye.
Familial history was positive for laterocervical space-occupying masses in
paternal family. Neuroimaging (CTA, Angiography and brain MRI)
showed complete occlusion of the left carotid artery, bilateral HNPs, more
extended on the left side, and no brain parenchymal lesion. Laboratory
tests showed increased levels of normetanephrines. Whole body Ga68-
DOTA-NOC-PET detected tracer accumulation in the laterocervical area
bilaterally, in the left adrenal gland and in one left para-aortic lymph node.
Conclusion: We describe a case of acute retinal ischemia secondary to left
carotid artery occlusion, likely due to an aggressive carotid HNP, in a
patient with a familial pheochromocytoma paraganglioma syndrome.
Although HNPs are usually indolent lesions, we report a case of cerebro-
vascular disease caused by an aggressive paraganglioma. We suggest to
follow-up and treat HNPs, in order to avoid not only symptoms due to
mass and secreting effects, but also possible thrombotic complications.
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Early pregnancy cerebral venous thrombosis and
status epilepticus treated with enoxaparin,
levetiracetam and lacosamide throughout pregnancy
J Ruuskanen1, R A Ketola2, S Timonen3, H Malm4, P Ylikotila1
1Clinical Neurosciences, Turku University Hospital, Turku,
Finland
2Forensic Medicine, University of Helsinki, Helsinki, Finland
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4Teratology Information Service, Helsinki University Central
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Cerebral venous thrombosis (CVT) accounts for less than 1% of all
strokes. Pregnancy predisposes to CVT, with most cases occurring during
the third trimester or post-partum. Mortality for CVT has been reported
to be as high as 15%. Seizures and status epilepticus associate with poor
prognosis, further justifying aggressive treatment also during pregnancy.
A rare case of a massive CVT in early pregnancy, complicated by multiple
intracranial hemorrhages and status epilepticus was successfully treated
with heparinoids, benzodiazepines, propofol, fosphenytoin, levetiracetam
and lacosamide. Enoxaparin, levetiracetam and lacosamide were contin-
ued throughout pregnancy. The infant was delivered at pregnancy week 36
by cesarean section, showed no structural anomalies but was sleepy and
feeding poorly during the first weeks after the delivery. Lacosamide and
levetiracetam concentrations in cord blood corresponded to those in the
maternal blood. Levetiracetam was undetectable and lacosamide was
present in very low levels in breast-milk and in the infant blood five days
after the delivery.
This is the first report of a pregnancy outcome after in utero lacosamide
exposure, and of lacosamide levels in cord blood, breast milk and breast-
fed infant. Levetiracetam is compatible with breast-feeding. For lacos-
amide, the estimated relative infant dose for a fully breast-fed infant is
1.2% of the maternal daily dose. It is therefore likely that the transient
neonatal symptoms were due to the in utero exposure to these drugs
rather than exposure via breast-milk. The infant showed normal develop-
mental milestones at 6 months of age. The mother has recovered remark-
ably well.
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Let’s not forget basic investigations in the era of
magnet, how a chest X ray helped our gentleman
D Shah1, H Brown2
1Stroke Unit, Princess Alexandra Hospital, Brisbane, Australia
2Department of Neurology, Princess Alexandra Hospital,
Brisbane, Australia
We describe the case of a 58 year-old male who presented with facial
droop and slurring of speech on a background of recent episodes of
amaurosis fugax. Diffusion weighted Magnetic Resonance Imaging (MRI)
confirmed acute right basal ganglia stroke. Further diagnostic work up
including Chest X Ray showed left upper lobe abnormality. Carotid
Ultrasonography showed very minor plaques bilaterally (<10% stenosis).
Transthoracic echocardiogram (TTE) revealed large amount of transpul-
monary shunting with agitated saline injection with no evident atrial
septal defect or patent foramen ovale. There was no other structural heart
disease. Given these results, Computerized tomography pulmonary angio-
gram was performed which showed an isolated complex pulmonary ate-
riovenous malformation (PAVM) in the left apex. Two shunt (venous
admixture) studies showed a calculated shunt of 17% and 15.6%. Pulmo-
nary arteriography of the left main pulmonary artery confirmed complex
AVM with multiple feeding arteries and a single draining vein. Amplatzer
coils were percutaneously inserted. Post coiling shunt study showed cal-
culated shunt of 2.9%. At the follow up, more than 12 months later,
patient didn’t have any further embolic events. In this case, a simple Chest
X Ray helped with further evaluation and management. PAVMs should be
considered in all patients with cryptogenic stroke and CXR should be
performed in all patients.
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Cerebral venous thrombosis in Behçet’s disease and
long-term follow-up of 21 cases
M H Sorgun1, S Rızayev1, A Kural1, C Yucesan1
1Neurology, Ankara University Medical School, Ankara, Turkey
Introduction: Behcet’s disease (BD) is one of the most common causes of
cerebral venous thrombosis (CVT) in the countries along the ancient Silk
Route. We present a study showing clinical features and follow up results
in patients with cerebral venous thrombosis due to Behçet’s disease
(CVTBD).
Material and methods: The files of CVTBD patients who had admitted to
our clinic between January 2007 and November 2014 were reviewed.
Onset ages of BD and NBD, functional system involvement, EDSS, neu-
roimaging findings and medications were recorded.
Results: Twenty-one patients with CVTBD were included to the study
(female = 12; (57.1%), male = 9; (42.9%)). The mean age was 47.0 ± 12
(range 27–69) years (48.0 ± 14 in male, 46.25 ± 10 in female). Sixteen
patients had only intracranial hypertension due to CVT. Five patients
(23.8%) had parenchymal involvement beside CVT; they had parenchy-
mal involvement signs in addition to intracranial hypertension signs. The
course was monophasic except one patient (4.8%) who had parenchymal
involvement had relapsing course. The median EDSS score was 0 (range
0–1) at the beginning and at the end of the study. Sixteen patients had a
single sinus occlusion and 5 patients had multiple occlusions. The trans-
verse sinus thrombosis was seen in 14 patients. All patients were treated
with prednisolone. After the treatment, recanalization was seen in the
occluded sinuses.
Discussion: Occlusion of a single sinus, especially transverse sinus, is more
frequent than multiple sinus occlusions in patients with CVTBD in our
study. Moreover, the prognosis is good after the treatment with steroid.
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Etiologic subtypes of acute ischemic stroke with
young patients
H Cotur1, M Kuzu1, A Rawandi1, S Rızayev1, C Ulukan1, S Tezcan1,
I S Gul1, V Yilmaz1, M H Sorgun1, C Togay Isıkay1
1Neurology, Ankara University Medical School, Ankara, Turkey
Introduction: Stroke in people under 45 years of age is less frequent than
in older population. The aim of this study was to determine the etiologic
subtypes of ischemic stroke in the young patients in our acute stroke
registry.
Methods: We reviewed the charts of 554 patients who were admitted with
acute ischemic stroke between the dates January 2011 and August 2014.
The patients under 45 years of age were included into the study. The
demographic data, admission NIHSS scores and mRS scores in follow-up
period were recorded. We determined etiologic stroke subtypes using the
automated Causative Classification System (CCS).
Results: A total of 29 (5.2%) young patients with acute ischemic stroke
(11 males [37.9%] and 18 females [62.1%]; mean age, 38.1 ± 6.24 (25–45)
years) were included. The mean NIHSS score was 4.32 ± 3.39 at admission
and it was significantly lower than in the elderly population (p = 0.027).
The rates of hypertension, diabetes, atrial fibrillation and coronary artery
disease were significantly lower in the young patients compared to others
(p < 0.05). Otherwise, patent foramen ovale was significantly higher in the
youngs (p < 0.001). Etiologic stroke subtypes were large-artery atheroscle-
rosis (n = 7, 24.1%), cardioaortic embolism (n = 9, 31%), small vessel
disease (n = 2, 6.9%), other causes (n = 5, 17.2%) and undetermined
causes (n = 6, 20.7%). The median mRS was 1 (0–4) in follow-up period
and it was significantly lower than in the elderly (p = 0.002).
Conclusion: In our registry, young patients with acute ischemic stroke was
found 5.2%. Cardioaortic embolism was the most common cause of
stroke in young patients.
ESOC-0271
27. Rare Causes, Stroke in the Young, and Case
Reports
Renal dysfunction: A new cause for stroke in young
adults
N E Synhaeve1, M E van Alebeek1, R A Arntz1, N A M Maaijwee1,
L C A Rutten-Jacobs1, P L M de Kort2, E van Dijk1, J F M Wetzels3,
F E de Leeuw1
1Department of Neurology, Radboud University Medical
Center, Nijmegen, Netherlands
2Department of Neurology, St. Elisabeth Hospital, Tilburg,
Netherlands
3Department of Nephrology, Radboud University Medical
Center, Nijmegen, Netherlands
Background: In about 30% of young ischemic stroke patients no cause
can be identified. In elderly patients renal dysfunction has been suggested
as a possible contributing risk factor for stroke. Our objective is to inves-
tigate the influence of renal dysfunction on long-term incident vascular
events after stroke in young adults aged 18 through 50 years.
Methods: This study is a prospective cohort study among 464 young
stroke patients with an ischemic stroke or transient ischemic attack
between January 1, 1980 and November 1, 2010. Estimated glomerular
filtration rate (eGFR) was calculated from baseline creatinine levels using
the chronic kidney disease epidemiology collaboration (CKD-EPI) equa-
tion and was divided in eGFR < 60, 60–120 and >120 ml/min/1.73 m2.
Cox proportional hazard models were used to determine the effect of
renal dysfunction on incident vascular events, adjusting for cardiovascular
risk factors.
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Results: eGFR < 60 ml/min/1.73 m2 was associated with an increased risk
of incident stroke (HR4.0 (95% CI:1.8–8.9)), but was not associated with
an increased risk of other arterial events (cardial disease and/or peripheral
artery disease) after adjustment for cardiovascular risk factors. eGFR
>120 ml/min/1.73 m2 was not associated with incident events.
Conclusions: Renal dysfunction is related to long-term stroke recurrence,
but not to incident cardiovascular disease, on average almost 8 years after
young stroke. Our findings might be a first step in the recognition of renal
dysfunction as a new risk factor for the development of stroke at young
age.
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Stroke due to severe cardiomyopathy in bevacizumab
treatment
R Tamazyan1, P Garçon2, M Al Hammad3, M Zuber1
1Neurology, Groupe Hospitalier Paris Saint Joseph and Paris
Descartes University, Paris, France
2Cardiology, Groupe Hospitalier Paris Saint Joseph, Paris,
France
3Neurology, Groupe Hospitalier Paris Saint Joseph, Paris,
France
Cerebrovascular events complications of bevacizumab treatment include
hemorrhagic and – more rarely – ischemic strokes.
We report on a 40 year old man with no previous vascular history who
developed an acute right hemiparesis and aphasia (NIHSS = 8) due to
ischemic stroke in the left MCA territory, with M2 occlusion. Time of
onset was unknown and the patient did not undergo IV thrombolysis. He
had a 2 year history of rectal cancer with hepatic and pulmonary metas-
tases, treated with surgery completed by radio- and chemotherapy:
FOLFIRI protocol (irinotecan, 5FU, folic acid) associated with bevaci-
zumab (5 mg/kg) every 15 days since 18 months. Last dose of bevaci-
zumab was given 10 days prior to stroke. Echocardiography performed six
months earlier was normal. Routine lab tests and cardiac monitoring were
normal, so was neck and intracranial CT-angiography except for persis-
tence of the left M2 occlusion.
Transthoracic echocardiography revealed a very severe low flow dilated
cardiomyopathy with an ejection fraction of 18% and multiple, volumi-
nous and mobile thrombi in the left ventricle. Anticoagulation was started
and the patient was referred to the oncology department one week later
with NIHSS 3 and Rankin 2.
Although limited information is available on the effects of bevacizumab
on the cerebral vasculature, distal arterial thrombi is the usual suspected
mechanism of the ischemic strokes previously reported. Bevacizumab
treatment otherwise increases the risk of developing high-grade cardiac
heart failure in cancer patients and this could lead, in the most severe cases
such as the present one, to stroke of cardioembolic origin.
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Denmark
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Background: Reports have indicated that stroke incidence in young adults
may be increasing, however updated population-based data remain
sparse. We studied the temporal trends (1994–2012) in incidence of stroke
in Denmark among young adults aged 15 to 30 years.
Methods: We identified all individuals 15 to 30 years of age admitted to a
hospital with a first-ever stroke in Denmark between 1994–2012 from the
Danish Patient Registry, a national registry which holds information on all
admissions to Danish hospitals. Incidence rates and corresponding 95%
confidence intervals (95% CI) were estimated by the approximate boot-
strap method. The estimated annual percentage change (EAPC) was com-
puted using Poisson regression. Possible non-linearities were tested by
means of restricted cubic splines.
Results: We identified 3431 individuals with admitted with first-time
stroke in the 18-year long study period. The age-standardized incidence
rate of stroke increased from 11.97/100.000 person-years in 1994 to 16.77/
100.000 person-years in 2012. This corresponded to an EAPC of 1.8% per
year (CI: 1.1–2.6). The incidence rate of ischemic stroke increased from
1.92/100.000 person-years in 1994 to 4.42/100.000 person-years in 2012.
The EAPC for ischemic stroke was 2.6% per year (CI: 0.6–4.6) between
1994–2006 and increased to 11.8% (CI 7.4;16.4) in the period between
2006–2012.
Conclusion: The incidence rate of first-time hospitalizations with stroke
and in particular ischemic stroke in young Danish adults has increased
substantially since the mid 1990’s. The increase has been particularly
strong in the most recent years.
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JAK2-V617F mutation as an underlying
hypercoagulable state in a case of recurrent and
therapy resistant venous and arterial thrombosis
T Toell1, M Knoflach1, K Willeit1, R Pechlaner1, S Kiechl1, J Willeit1
1Neurology, Innsbruck Medical University, Innsbruck, Austria
Introduction: Hypercoagulable states due to acquired or inherited abnor-
malities of coagulation are suspected in patients experiencing thrombotic
events without obvious associated risk factors, at early age, positive family
history and recurrent or multifocal events.
Case presentation: A 48-year-old Caucasian man with history of
treatment-resistant recurrent venous and arterial thrombotic events
(fibular vein thrombosis, pulmonary embolism, thrombotic ulnar artery
occlusion) presented to our department with symptoms of a transient
ischemic attack due to an unstable thrombus formation of the left internal
carotid artery (ICA). Two hours after carotid-endarterectomy the patient
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developed a thrombotic re-occlusion of the left ICA, which resulted in
territorial middle cerebral artery infarction.
Evaluations of an underlying hypercoagulable state yielded negative
results and no overt hematologic disease was present at that time. Within
the next few months the patient presented to our department again with
cerebral vein thrombosis and a Budd-Chiari syndrome. A positive test for
the JAK2-V617F mutation and the subsequent bone marrow biopsy
revealed an underlying myeloproliferative disorder (MPD) contributing
to the prothrombotic state.
Conclusion: An acquired single gain-of-function point mutation (V617F)
in the JAK2-gene is highly prevalent in polycythemia vera (95%) and
essential thrombocythemia (50%). Major thrombotic events, especially
splanchnic vein thrombosis also occur in JAK2+ patients (27–44%) who
otherwise have few or no clinical and laboratory features of MPD.
Subclinical MPD identified by molecular testing for the JAK2-V617F
mutation might be an underrecognized prothrombotic state in patients
with stroke and recurrent thrombotic events that strongly affects further
diagnostic and therapeutic strategies.
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Apixaban-associated interstitial lung disease
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Background: Post-marketing reports of interstitial lung disease (ILD) in
users of dabigatran or rivaroxaban have been identified. However, asso-
ciation of apixaban, a factor Xa inhibitor, with ILD has not been clarified.
Methods: A single-center observational study on patients developing
respiratory failure after initiation of apixaban medication was performed
between February 2013 (sales release in Japan) and December 2014.
Results: Three patients (#1–3) were registered. All were Japanese men,
high-aged (91, 87, 79 years old, respectively), and had renal dysfunction
with a creatinine clearance around 35 ml/min. One had a history of ILD
(#1) and another had emphysema (#3). One began to take apixaban as an
initial anticoagulant for primary prevention (#1), and the other two
changed from warfarin to apixaban for primary (#3) or secondary (#2)
prevention. All developed acute respiratory failure 3 or 4 days after initia-
tion of apixaban and ceased the medication soon. ILD was the final
diagnosis for all. All underwent methylprednisolone pulse therapy and
two received mechanical ventilation (#1, #3). One returned to normal
within a week (#2), one repeated aspiration pneumonia and recovered
(#3), and the other died of respiratory failure (#1).
Discussion and conclusion: Since ILD occurred soon after initiation of
apixaban, there seems to be a strong association between ILD and apixa-
ban for these three patients. In addition, all had multiple risk factors for
ILD, including advanced age, renal dysfunction, and history of lung dis-
eases. ILD is a possible early complication of apixaban for aged patients
with multiple risk factors.
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Neurofilament light chain serum levels in cervical
artery dissection patients – An exploratory analysis
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Background: Cervical Artery Dissection (CeAD) is a major cause of stroke
in young, otherwise healthy subjects. Serum neurofilament-light-chain
(sNfL) levels are a marker of axonal injury. SNfL-levels correlate with
clinical disease severity in several neurological disorders, but their impor-
tance in cerebrovascular disease remain unclear. In a proof-of-concept
study we compared sNfL-levels with clinical features in patients with
CeAD, which is a form of acute cerebrovascular disease with little con-
founding comorbidity.
Methods: This observational study included 49 consecutive non-
traumatic CeAD-patients. SNfL-levels were measured by high-sensitivity
electrochemiluminescence–immunoassay. Levels were compared with
regard to (i) type of presenting symptoms: local symptoms alone (LS,
n = 8), TIA, (n = 10), or ischemic stroke (n = 31); (ii) stroke severity at
baseline quantified by NIHSS; and (iii) 3-month-outcome. Univariate and
multivariate analyses adjusted for age, sex, NIHSS, and time to sNfL-
measurement were done.
Results: CeAD-patients presenting with stroke had significantly higher
sNfL-levels (median 108.9 pg/ml [Interquartile Range IQR 37.8–427.7])
than TIA patients (16.4 pg/ml [8.7–36.3], p = 0.009) or LS patients
(23.4 pg/ml [17.8–30.8], p = 0.005) respectively. Among stroke patients,
sNfL-levels were associated with NIHSS (r = 0.402, p = 0.025). SNfL-levels
were associated with 3-month outcome (r = 0.403; p = 0.004). However
this association was reduced to a non-significant trend after adjustment
for age, sex, stroke severity, and time to sNfL-measurement (p = 0.096
(adjusted)).
Conclusion: In CeAD-patients, sNfL-levels differed with the type of pre-
senting symptom. In stroke patients, sNfL concentrations reflected stroke
severity as measured clinically. The prognostic meaning of sNfL in CeAD
deserves further testing.
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Acute ischemic stroke as trigger of non-convulsive
status epilepticus: A case series
C Traenka1, G M De Marchis1, L Hert1, D Seiffge1, N Peters1,
L H Bonati1, S T Engelter1, P Lyrer1, S Rueegg1, R Sutter2
1Neurology and Stroke Center, University Hospital Basel,
Basel, Switzerland
2Department of Intensive Care Medicine, University Hospital
Basel, Basel, Switzerland
Background: Acute ischemic stroke (AIS) can trigger non-convulsive
status epilepticus (NCSE). In this study, we sought to assess the frequency
and clinical characteristics of patients with an acute ischemic stroke as
cause of NCSE.
Methods: From January 2005 to December 2012, we prospectively regis-
tered all consecutive patients who had at least 1 EEG > 30 minutes or
continuous video-EEG monitoring confirming status epilepticus. We
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describe clinical and imaging characteristics of all NSCE patients who
suffered AIS as detected on diffusion-weighted magnetic resonance
imaging (MRI) as trigger of NCSE.
Results: Out of 335 consecutive patients with confirmed NCSE, we iden-
tified 9 patients (2.7%) who had both AIS and NCSE; four (44%) were
women. The median age was 70 years (interquartile range: 67–82.5 years).
Three patients (33%) presented with pure left-hemispheric ischemic
lesions, 6 patients (66%) showed bilateral AIS. Ischemic lesions were
located in the anterior circulation (n = 4, 44%), posterior circulation
(n = 2, 22%), or both (n = 3, 33%). Prior to MRI, computed tomography
(CT) was done in 8/9 patients (89%). On CT-scans, 2 patients (25%) had
signs suggesting early cerebral ischemia, while in 6/8 such signs were
absent. Median delay between symptom onset leading to admission and
diffusion weighted-MRI was 3 days (interquartile range: 1.5–6.5 days).
Conclusion: Acute ischemic stroke is a rare but important cause of NCSE.
On CT-scans culprit ischemic lesions can frequently be missed. MRI with
diffusion weighted imaging should be performed shortly after NCSE-
onset to identify its etiology.
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I Vastagh1, C Hornyák1, R Debreczeni1, S Ilniczky1, P Orosz1,
I Kalina2, G Várallyay3, G Rudas3, D Bereczki1
1Department of Neurology, Semmelweis University, Budapest,
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2Department of Radiology, Semmelweis University, Budapest,
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Background: Free-floating thrombus in the carotid artery (FFT-CA) is an
uncommon cause of embolic stroke. The most common etiology is a
complication of an unstable atheromatous plaque, but several other con-
ditions can be responsible. The preferred diagnostic technique depends on
local facilities. There is no guideline recommendation for the treatment of
FFT. We retrospectively analyze the features of 7 patients with FFT in the
last two years in our department.
Method: Patients with FFT were identified prospectively in our Neuro-
sonology Laboratory during 2013 and 2014. Patient demographics, car-
diovascular risk factors, clinical features, diagnostic modalities, treatment
regimes, and outcomes were recorded.
Results: In the study period 6.396 duplex sonography examinations of
extracranial arteries were performed and 7 cases were diagnosed with
FFT-CA. CT angiograms confirmed the ultrasonic diagnosis in three of
the 7 cases. One patient with transient neurological signs caused by sig-
nificant internal carotid artery stenosis and FFT was treated with anti-
platelet therapy and statin, followed by endarterectomy. Three patients
with minor or moderate stroke without significant stenosis were antico-
agulated. The outcomes were favorable in these 4 patients. Three patients
were admitted with severe stroke. They were treated with low dose
LMWH, antiplatelet drug and statin. These 3 patients died due to systemic
complications.
Conclusions: These cases support the theory that plaque morphology may
be more important in causing stroke than severity of stenosis. Medical and
surgical management have been used and careful evaluation of risk-
benefit can help in the final individual decision.
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Young Stroke Physicians: Research Design Workshop for Studies
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Comparison of rehabilitation outcomes for persons
after stroke in Latvia and Sweden: A PhD Project
G Berzina1, A Vetra1, K S Sunnerhagen2
1Department of Rehabilitation, Riga Stradins University, Riga,
Latvia
2Institute of Neuroscience and Physiology/Rehabilitation
Medicine, University of Gothenburg, Gothenburg, Sweden
The ultimate goal of this project is to identify strengths and weaknesses of
Latvian rehabilitation system to improve care for patients with stroke. The
way towards this, will be by comparing outcomes for persons after stroke,
in Latvia and Sweden, using the bio-psycho-social model of the World
Health Organization.
Specific aims:
1. Study 1: To compare Latvian and Swedish in-patient rehabilitation
systems and explore the impact of possible differences on functional inde-
pendence for persons after stroke – comparative cohort study; data from
retrospective chart reading and registry data;
2. Study 2: To investigate whether functional limitations in the post-acute
phase of stroke (at the time of inpatient rehabilitation) have an influence
on self-perceived level of disability in the chronic phase of stroke in a
Latvian population living in the society (at home) – concurrent cohort
study;
3. Study 3: To investigate whether personal factors, such as age, gender,
place of residence and time since onset of stroke, can influence self-
perceived functioning and predict barriers and facilitators perceived in
dealing with environmental factors for persons in the chronic stage of
stroke living in Sweden – cross-sectional study;
4. Study 4: To explore if personal factors identified as important in a
Swedish population, are relevant for a Latvian population of stroke sur-
vivors – cross-sectional study.
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Neuropsychological computer training versus
entertaining computer games in patients with
post-stroke cognitive impairments: Randomized
clinical study
A Bezdenezhnykh1, S Prokopenko1, E Mozheiko1, M Petrova1,
E Grippa1, S Lipatnikova1, O Gricenko1
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Background: Complex of computer neuropsychological programs, elabo-
rated in the KSMU, has shown effectiveness for cognitive training in
patients with vascular cognitive impairments in several pilot studies.
Some studies have found that computer activity can influence mental
ability positively in elderly.
Aim: comparing changes in cognitive status in patients with post-stroke
VCI, who worked with neuropsychological computer programs, with
those in a similar group of patients, who played entertaining games.
Methods: Patients after hemispheric stroke in recovery period with VCI
without dementia (N = 55, age 37–67) were randomized into three
groups. All patients received conventional treatment. Patients in the inter-
vention group had 10 daily training sessions with neuropsychological
computer programs of 40 min duration. Participants in the active control
group played entertaining games keeping the identical regimen. The
passive control group patients received standard treatment. Cognitive,
neurological, affective and functional states were assessed before and after
training period.
Results: After training course there were significant improvements in the
intervention and the active control group on all cognitive scales (MMSE,
MoCA, FAB, CDT, Shulte’s test). Improvements of functional state were
observed in the intervention group (IADL, p = 0.008). We found signifi-
cant score increasing comparing cognitive states of patients from both
training groups with the control group. But there were no differences on
cognitive scales between the intervention and the active control groups.
Conclusions: Neuropsychological computer programs and entertaining
computer games enhance cognitive status in patients with post-stroke
VCI. But only neuropsychological computer training impacts functional
state.
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Effect of RTMS on serum vascular endothelial growth
factor (VEGF) in chronic stroke: Does that indicate
neuroplasticity?
A Bhasin1, N Kuthiala1, R Sharma1, N Kumar2, R Moganty3,
M P Srivastava4
1Department of Neurology, All India Institute of Medical
Sciences, Delhi, India
2Department of Psychiatry, All India Institute of Medical
Sciences, Delhi, India
3Department of Biochemistry, All India Institute of Medical
Sciences, Delhi, India
4Department of neurology, All India Institute of Medical
Sciences, Delhi, India
Background and purpose: Repetitive transcranial magnetic stimulation
(rTMS) has been known to stimulate neurotrophins like vascular
endothelial growth factor (VEGF) aiding in neuroplasticity post stroke.
The purpose of the study was to investigate the effect of rTMS with
intensive physiotherapy on serum VEGF in chronic stroke patients with
upper extremity motor deficits.
Methods: This ongoing randomized controlled trial recruited fifteen
(n = 15) chronic stroke patients from 3 to 18 months of index event with
at least 10° of wrist extension, 10° of thumb abduction, Brunnstorm stage
2–4; NIHSS 4–20. Patients were randomized to rTMS with intensive phys-
iotherapy (n = 7) and physiotherapy only (n = 8). Serum venous sample
for VEGF along with assessment with Fugl Meyer (FM), Barthel Index,
modified Rankin Scale was done at baseline, 2 & 6 months. rTMS (1 Hz,
750 pulses with 110%RMT) was administered for 3 weeks (5 days/week).
Results: Significant improvement was seen in patients treated with rTMS
& physiotherapy on FM score (53.5 vs 42.7, p = 0.001) unlike modified
Rankin scale (1.2 vs 1.8, p = 0.3) and Barthel Index (90.7 vs 83.7, p = 0.34)
at 2 months. A high mean VEGF (1097.3 vs 803.5 pg/ml) with 35.4%
increase after rTMS as compared to 24.4% in physiotherapy group alone.
A weak positive correlation of VEGF with FM score (r = 0.56, p = 0.09)
was observed in rTMS group (Fig. 1).
Conclusion: Increased serum VEGF after rTMS may help in neuroplasti-
city leading to significant improvement in upper extremity in chronic
stroke. Future trials are needed to authenticate the results.
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Fig. 1 Correlation between serum VEGF and FM score in rTMS group (7
patients).
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Evolution of resting-state network activity reflects
functional recovery following acute lacunar stroke
D Carone1, G W Harston1, S Thandeswaran1, M Ngwako1,
R Dwivedi2, F Sheerin2, N Filippini3, J Kennedy1
1Acute Stroke Programme Radcliffe Department of Medicine,
University of Oxford, Oxford, United Kingdom
2Department of Neuroradiology, Oxford University Hospitals
NHS Trust, Oxford, United Kingdom
3Oxford Centre of Functional MRI of the Brain, Nuffield
Department of Clinical Neurosciences, University of Oxford,
Oxford, United Kingdom
Objective: Individual prediction of functional recovery after acute stroke
remains imprecise. Improving this could help with stratification for post-
stroke recovery intervention trials. Resting-state fMRI (rs-fMRI) has been
used in chronic stroke, but there is little understanding of its utility in
acute stroke patients. The aim of this study was to evaluate the evolution
of resting-state network (RSN) activity in the recovery from acute lacunar
stroke.
Methods: Eleven consecutive patients with acute lacunar stroke
(onset < 6 h) underwent rs-fMRI (TE 40 ms, TR 3000 ms, time of scan:
6 min) alongside clinical assessments (NIHSS, modified Rankin Scale
(mRS)) at 4 time points: at presentation, 24 hours, 1 week, and 1 month.
Functional connectivity within and between RSNs was evaluated and
correlated with clinical changes. Validated statistical methods were used
for each analysis; p values <0.05 were considered significant.
Results: Median NIHSS at onset was 4 and at 1 month was 0. Median mRS
at 3 months was 1. Significant dynamic changes were seen in the func-
tional connectivity both within and between the motor, visual, and
executive-control networks. Acute changes in intra-network connectivity
were characterized by a higher variance affecting a more limited number
of voxels when compared with week/month scans. Intra-network connec-
tivity was significantly correlated with improvement in NIHSS (p = 0.04).
Conclusions: The evolution of RSN activity closely tracked clinical
changes with acute network disruption in the immediate aftermath of
lacunar stroke and subsequent connectivity changes representing likely
brain plasticity. Further work is ongoing to validate RSN as a prognostic
measure.
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Long-term stroke outcomes following inpatient
rehabilitation
R Davidson1, F Anderson1, F Jeddi1
1Neurorehabilitation, Royal Berkshire Hospital, Reading,
United Kingdom
Background: Many studies have been performed looking at outcomes
after stroke but few have reported on whether patients get back to work.
Other outcomes, for example the percentage of those with depression
often have great variation within them depending on the study. Patients
attending rehabilitation units following strokes often have more disabling
symptoms and there has not been much work looking at this group
particularly. We plan to clarify levels of residual disability in this patient
cohort, as well as add to the literature describing the rates of getting back
to work.
Methods: All patients who have previously had an inpatient stay on our
rehabilitation ward will be given a questionnaire one year on in our
outpatient clinic asking them specifically about symptoms including
depression, bladder and bowel incontinence, place of living, mobility and
continence of the bladder and bowels. We will conduct this over a year
period in all of our clinics therefore hopefully recruiting approximately 40
patients. We will then look up their initial Barthel scores on arrival to the
rehabilitation unit and their final scores on discharge.
Hypothesis: We anticipate that our initial Barthel scores will be lower than
those published in other studies of all strokes but that they will have a
greater subsequent improvement in those scores. One year on the percent-
age of those with motility and bladder and bowel problems will be slightly
greater than the averages published due to the increased severity in this
group.
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Very early cognitive rehabilitation: A proposed
algorithm to detect, assess and treat cognitive deficits
in a stroke unit
D Dinacci1, P Rossi1, F Zanchi1, E Borghi1, S Rossi2, C Städler2,
G Ruggieri1, V Stojanova2, L Sacco2, C Cereda2
1Clinica Hildebrand, Centro Riabilitazione Brissago, Brissago,
Switzerland
2Department of Neurology, Neurocenter (EOC) of Italian
Switzerland Civic Hospital, Lugano, Switzerland
Background: Neuronal plasticity is a process that appears early after
stroke. Early rehabilitation, by supporting motor learning and cognitive
functions implied in learning processes, could enhance functional
improvement early after stroke. A consistent and widely shared algorithm
for early cognitive assessment and rehabilitation is needed.
Aims: we created and propose here an algorithm to detect, assess and treat
cognitive impairment early after stroke. We first tested the feasibility in
our comprehensive Stroke Center.
Methods: an interdisciplinary stroke and rehabilitation experts team pro-
duced the algorithm here presented. This algorithm is modulated taking
into account the specificity of early stroke patients (level of cognitive
functioning, behavioral disturbances, typical stroke side determined cog-
nitive syndromes, individual cognitive profile) and the specificity of envi-
ronment and setting in stroke units.
Results: In our Stroke Centre, during a period of 12 months, 113 patients
have been studied and 25 started a very early cognitive rehabilitation. All
patients were included in the algorithm in the first 2 weeks after stroke.
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Discussion: Our preliminary experience showed that this tool is feasible
and suitable for early stroke patients. It seems to be a promising tool to
early detect cognitive deficit, in orienting cognitive rehabilitation and
planning the post acute rehabilitation. All this points will be addressed in
a prospective study planned to test the efficacy of this new rehabilitation
strategy.
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Clot structure/function, hemostasis and hemorheology
– Underlying causes for IV thrombolysis failure?
M Domashenko1, M Gafarova1, M Maximova1, M Tanashian2,
M Piradov3
1Stroke Unit, Research Center of Neurology, Moscow, Russia
2Angioneurology, Research Center of Neurology, Moscow,
Russia
3ICU, Research Center of Neurology, Moscow, Russia
Introduction: Extracerebral (ECA) or intracerebral artery (ICA) occlu-
sions respond for majority of ischemic stroke (IS). Clot properties may
differ depending on source, comorbidity and fibrinolytic ability of plasma
which lead to different efficacy of intravenous thrombolysis (IVT). Rate of
recanalization, neurological deficit and functional outcome in IS have
been shown to be related to some hemostatic and hemorheological dis-
turbances. The aim of the planning study is to evaluate the association
between IVT efficacy with clot structure/function and blood properties
which are the possible factors of IVT failure.
Design: prospective non-randomized clinical trial should include 200
patients with IS (eligible for IVT and with confirmed occlusion of ECA or
ICA). Based on the IVT effect (recanalization or not) they might be
selected for mechanical thrombectomy (MT). After that clot properties
will be studied (histopathology method, scanning electron microscopy).
All patients will undergo detailed neurological examination, standard
neuroimaging (brain CT, CT-angiography and CT-perfusion), extended
evaluation of blood properties at admission, after IVT, after MT (if done),
at 1st, 7th, 21st and 90th day after admission. Blood properties evaluation
is supposed to include detailed hemostatic, hematological and hemorheo-
logical analyses, platelet function, endothelial dysfunction, markers of
inflammation and immune response, NET formation, recruitment and
interactions between different leucocytes types, erythrocytes and platelets.
That multidimensional study is able to be conducted on the multicenter
basis with institutions collaboration.
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Evaluation of the efficacy of a simple educational
strategy in reducing pre-hospital delay and improving
prognosis in stroke patients
R García Ruiz1, J Silva Fernández2, R M García Ruiz3,
M Recio Bermejo1, A García Chiclano1, A Mateu Mateu1,
M C Blanco Valero4, E Botia Paniagua1
1Neurology, La Mancha Centro General Hospital, Alcázar de
San Juan, Spain
2Endocrinology, La Mancha Centro General Hospital, Alcázar
de San Juan, Spain
3Primary care, Denia General Hospital, Denia, Spain
4Neurology, Neuroclínica Berenguer, Badajoz, Spain
Background and purpose: In recent years, the need for an early manage-
ment of stroke patients has attracted increasing attention. A time-
dependent effect has been observed with best prognosis in patients
attended in the first 60 min (‘the golden hour’) after onset of symptoms.
On the other hand, in the vast majority of studies evaluating pre-hospital
delay, only 50–60% of patients arrive within the first 180 minutes, and a
small proportion within the first 60 minutes. Global strategies and media
campaigns (e.g. the FAST strategy) have only shown some effect on aware-
ness of stroke in the short term. These global approaches are both
expensive and ineffective in the long-term. Our aim is to evaluate a strat-
egy targeting patients with risk factors, as most strokes happen in such
patients (>90% in our series). The low cost of our strategy may allow its
use as an everyday tool in primary care.
Methods: We want to evaluate the efficacy of a simple educational inter-
vention (consisting of delivering a leaflet with graphic information on
stroke symptoms and an advice to call the emergency services) for
primary-care patients at risk of stroke in reducing the median pre-
hospital delay after the onset of stroke symptoms. Our previous series will
be used as a comparator. Secondary outcomes are a reduction of morbid-
ity, dependence and mortality, and an increase in the use of the ‘112
Emergency Services’ and in the rate of thrombolysis. No other interven-
tions for patients or healthcare professionals will take place within the
study period.
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Stroke team rhine main – A multicenter approach to
structured, team-based management of acute ischemic
stroke
D Gürzoglu1, W Pfeilschifter1
1Neurology, University of Frankfurt, Frankfurt am Main,
Germany
Background: The benefit of thrombolytic therapy for acute ischemic
stroke is highly time-dependent. Endovascular stroke therapy has shown
efficiency in experienced stroke centers and its wider implementation
requires new forms of interdisciplinary organization. We implemented a
new team-based stroke algorithm based on the principles of acute trauma
life support (ATLS) in our hospital, bringing down our average DNT to 23
minutes and significantly reducing periprocedural delays in patients
selected for endovascular stroke therapy.
Aim of the project: We plan to extend the STROKE TEAM algorithm to
five participating Stroke Units of a regional stroke network in Hesse,
Germany and evaluate its transferability to other hospital settings. End-
points of a successful transfer will be a reduction of the DNT and an
increase in staff satisfaction. Data on Patient safety will be reported, but
our sample size will not permit meaningful statistical analysis.
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Project description: In a first observation phase (3 months) DNT of
patients receiving thrombolysis and data on staff satisfaction regarding the
current state of acute stroke care will be collected at all participating
hospitals.
In the following intervention phase we plan to communicate these find-
ings to the participating hospitals, evaluate the individual stroke algo-
rithms in group meetings, collect suggestions from the plenary for an
individually tailored STROKE TEAM algorithm at each hospital and offer
“train the trainer-workshops“ including teaching materials for the
simulator-based team trainings.
In the second observation phase (6 months) we will reevaluate DNT and
staff satisfaction after the implementation of the STROKE TEAM
algorithm.
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External validation of a score to predict the presence
of asymptomatic carotid artery stenosis in people
older than 59 years: A population study
A Mattioni1, S Cenciarelli1, T Mazzoli2, L M Greco2, E Gallinella1,
I Sicilia1, R Condurso1, C Padiglioni1, S Mastrocola1, C Marando1
1Department of Neurology-Stroke Unit, Ospedale Città di
Castello USLUmbria1, Citta di Castello, Italy
2Department of Neurology-Stroke Unit, Ospedale Branca
USLUmbria1, Branca, Italy
Background: Asymptomatic carotid artery stenosis (ACAS) is related to a
higher risk of stroke. Because of the improvement in drug therapy, the
annual rate of ipsilateral stroke associated with asymptomatic carotid
stenosis has fallen from 2% to 4% to <1% in the past 20 years.
Population screening for ACAS are expensive and time consuming but
could help to identify individuals at high risk of stroke who should be
considered for best medical treatment.
Aim: We aim to determine the external validation of a prediction model
(stroke 2014) for the identification of subgroups with relatively high
prevalence of moderate or severe ACAS in the general population. Appli-
cation of the prediction model may lead to a reduction in the number
needed to screen for ACAS.
Methods: From the population registry of Citerna town, Umbria, Italy, we
will include a random sample of inhabitants aged 60 years or more. We
will include only participants without symptoms 6 months before the
examination. Assuming a prevalence of moderate and severe ACAS
(> 50%) around 10% (IC 7–13%) we will need a sample size of 276
individuals.
A trained neurologist will perform ultrasound examination of the carotid
arteries. When both carotid arteries has a stenosis, we will register the
most severe stenosis grade observed. An independent neurologist will
calculate the score for each participant and will define the risk (from very
low to high). We will calculate sensibility, specificity, PPV and NPV for
each cut off.
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The influence of time of stroke onset on the utility of
alberta stroke program early ct score
J Naylor1, L Churilov2, N Rane3, P Mitchell3, R Dowling3, B Yan1
1Melbourne Brain Centre, Royal Melbourne Hospital,
Melbourne, Australia
2Statistics and Decision Analysis, The Florey Institute of
Neuroscience and Mental Health, Melbourne, Australia
3Neurology, Royal Melbourne Hospital, Melbourne, Australia
Background: The efficacy of intravenous tissue plasminogen activator
(tPA) diminishes in the setting of increased ischemic tissue burden, which
can be assessed by the Alberta Stroke Program Early CT Score (ASPECTS).
However, ASPECTS is dependent on the visibility of evolving ischemic
changes on CT, and timing may critically impact on the reliability of
ASPECTS. We hypothesize that the predictive capacity of ASPECTS on
functional outcome is associated with time from acute ischemic stroke
onset.
Methods: Acute ischemic stroke patients treated with tPA between 2007
and 2014 were included in a retrospective study. Patient demographics,
vascular risk factors, baseline NIHSS, stroke subtype, time of onset and
imaging and treatment, and 3 month mRS were collected. ASPECTS was
assessed by 2 independent raters. We used generalized odds ratio analysis
to assess onset time with the predictive capacity of ASPECTS.
Results: Three hundred and sixty-eighty patients were included. Median
(IQR) age was 74 years (64–81), 167 (45.38%) were female and median
(IQR) baseline NIHSS was 12 (6–18). Inter-rater agreeability was 0.59
(weighted kappa, 95% CI: 0.293–0.835). We categorized time from stroke
onset to CT scan into quartiles: Q1 (11 to 100.5 minutes), Q2 (100.5 to
190 minutes), Q3 (190 to 279.5 minutes) and Q4 (279.5 to 369 minutes).
There was significant association between a high ASPECTS (>7) and low
mRS (<2) in Q3 (p = 0.02) and Q4 (p = 0.006), but not in Q1 and Q2.
Conclusion: We showed that ASPECTS beyond 190 minutes from stroke
onset was significantly associated with mRS at 3 months.
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Clinical and surgical features associated with stroke in
patients undergoing coronary artery bypass grafting
(CABG) surgery: A retrospective cohort study of 798
patients
E P Pacheco1, G W Kuster1, R B Domingues1, D L Ramos1,
P G M Barros1, V Furlan1, A R Massaro1
1Amil Stroke Network, Total Cor Hospital PIAVEN, São Paulo,
Brazil
Background and objective: Postoperative stroke (POS) is one of the most
feared complications of cardiac surgery due to its high morbidity and
mortality consuming disproportionate amount of available resources.
Our aim was to describe the major clinical and surgical features associated
with stroke in patients undergoing CABG.
Methods: We reviewed all cases submitted to CABG surgery in our insti-
tution from January 2011 to June 2014. Their clinical and surgical char-
acteristics were recorded. Mortality between patients with and without
stroke was compared using Fisher’s exact two-tailed test.
Results: Of 798 patients submitted to CABG surgery, only 1.62% (n = 12)
experienced POS. The majority of patients were male (76%) with a mean
age of 63,5 years old. One quarter of them presented with an asymptom-
atic carotid stenosis. All cases were ischemic stroke occurring predomi-
natly during the first week (76%). One third awoke from anesthesia with
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neurological deficit. The majority of POS after CABG surgery occur in the
anterior circulation due to embolic mechanism. New onset postoperative
atrial fibrillation (NOAF) was found in 23% of patients. POS usually
needed vasoactive drugs (76%) and blood transfusion (61%) during
surgery. Mechanical thrombectomy was performed in 15% of the POS.
POS had a higher mortality rate (30% – p = 0.0002) and a worse outcome
after hospital discharge.
Conclusions: Stroke is a devastating postoperative complication of CABG
surgery, however there are new opportunities to prevent and treat them.
NOAF may increase the risk of stroke if they were not detected and rapidly
treated.
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Atrial strain plus NT-ProBNP for atrial fibrillation
detection in ESUS stroke patients
J Pagola1, L Sero1, A Bustamante2, T Gonzalez3,
D Rodriguez-Luna1, M Rubiera1, J Sala I Padro1, M Muchada1,
J Montaner1, C A Molina1
1Stroke Unit, Vall d’Hebrón hospital, Barcelona, Spain
2Neurovascular Research Lab Vall d’Hebrón Research Institute,
Vall d’Hebrón hospital, Barcelona, Spain
3cardiology, Echocardiography Laboratory, Vall d’Hebrón
Hospital, Barcelona, Spain
Abstract: Subclinical atrial fibrillation (AF) is the main cause of ESUS
(embolic stroke of undetermined source). The left atria strain (LAS) is
decreased in patients with AF. The level of N-terminal pro brain natri-
uretic peptide (NT-ProBNP) is a cardioembolic stroke marker. We studied
the relationship between these surrogates to improve the AF detection in
ESUS patients.
Methods: All patients with non-lacunar stroke in a 3 years period were
included. Those with prosthetic heart valves of previous AF were
excluded. ECG monitoring for AF detection was performed by 72 hours
telemetry. The left atria deformability was analyzed by the percentage of
LAS. Blood samples were drawn to measure the serum NT ProBNP con-
centration. The patients were classified in High-risk group for AF detec-
tion: (LAS < 25.83%&NT-ProBNP > 148 pg/ml) and Low-risk group
(LAS < 25.83%&NT-ProBNP > 148 pg/ml).
Results: A total of 88 patients were included. The percentage of LAS and
the value of NT- ProBNP showed an inverse correlation (Spearman’s Rho
−0.5) (p < 0.001). The High-risk group showed higher percentage of AF
detection (34.5% vs 8.5%) (p = 0.002 and the Low-risk group had the
most percentage of aterothrombotic strokes (35.5% vs 17.5%) (p = 0.059)
and stroke by PFO (19.4%vs3.5%) (p = 0.014). High-risk group was an
independent predictor of AF when the age, (OR 0.18 [95% CI, 0.05–
0.65]; p = 0.008), the CHADSVASC score (OR 0.13 [95% CI, 0.03–0.49];
p = 0.002) and the stroke etiology OR 0.15 [95% CI, 0.04–0.56];
p = 0.005) were considered.
Conclusions: The percentage of LAS and NT- ProBNP may help to classify
the risk of AF detection in ESUS.
ESOC-0979
28. Young Stroke Physicians: Research Design
Workshop for Studies in Development
RISCLON – Risk of recurrent stroke in Clopidogrel
non-responders
C Rath1, T Wienecke1
1Neurology, Region Sjaelland Sygehus Nord Roskilde,
Roskilde, Denmark
Background: Antiplatelet treatment with Clopidogrel is a cornerstone in
secondary stroke prevention. Studies in patients with cardiovascular
disease indicate that some individuals (4–34%) have a poor response to
Clopidogrel and have a higher risk of new cardiovascular events. This is
never studied in ischemic stroke patients. We aim to evaluate if Clopi-
dogrel non-responders have an increased risk of recurrent stroke.
Method: 196 patients with first-ever ischemic stroke on Clopidogrel
75 mg/day is tested for their Clopidogrel response (PRU, Platelet Reaction
Units) using the VerifyNow P2Y12 assay (Accumetrics, California) 2–4
weeks after treatment initiation. Included patients must have stroke
lesions on CTC/MRI, perfusion deficit or clinically high suspicion of
stroke.
Follow-up every 3 months for 2 years in the outpatient clinic by a stroke
physician to determine whether a new stroke has occurred. Both stroke
physician and patients are blinded for the PRU result. At end of follow-up
the PRU results are revealed and the number of non-responders
(PRU > 208) with a recurrent stroke or TIA (Transitoric Ischemic Attack)
is compared to those without.
Progress: 35% of patients have been enrolled.
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Tasdevil: Demographics and predictors of epilepsy
following vascular insult, a longitudinal
population-based study in northwestern Tasmania,
Australia
L Sanders1
1Neurosciences, St Vincent’s Hospital, East Melbourne,
Australia
Background: Increasing data indicate epilepsy in the elderly is rising with
substantial potential consequences, including injury and loss of indepen-
dence. Although Cerebrovascular Disease (CVD) is the most common
cause of seizures in this demographic, etiology remains largely unknown
in the modern neuroimaging era. Epilepsy prevalence in Australia is an
estimated 7.5 per 1000. However, there have been no community-based
studies to determine epilepsy incidence outside the hospital setting in
Australia, with CVD risk a potentially modifiable cause and consequence
of epilepsy.
Aims: To evaluate association between CVD and development of epilepsy
in elderly Tasmanians. Specifically:
i. incidence of silent CVD in new-onset seizures
ii. incidence of post-stroke seizures,
iii. predictors of further seizure (i.e. potentially modifiable risk factors).
Methods: Design: component of a prospective, population-based study to
determine seizure and epilepsy incidence, their associated risk factors and
health service use over 5 years.
Setting: Northwest Tasmania (22,500 km2). Population 112,000, 18.2%
≥65 years.
Case identification: All patients presenting with stroke, seizure or their
mimickers.
i. Hot pursuit: hospital presentations, general practitioner visits, radiol-
ogy and electroencephalogram (EEG) requests, general physician and
neurologist referrals.
ii. Cold pursuit: emergency department attendances, hospital discharge
lists.
Primary outcomes: Incidence of stroke, seizures and CVD risk factors.
Risk of seizure (incidence and recurrence).
Secondary outcomes: Incidence of EEG and cerebral imaging abnormali-
ties, anti-epileptic drug prescription patterns, hospital re-admission rates.
Statistics: Power of 80% to evaluate primary outcome, based on published
Australian stroke rates and predicted rates of post-stroke seizure. Cox
proportional hazard models for seizure risk analysis.
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Novel oral anticoagulants in stroke patients (NOACISP)
– A prospective registry
D Seiffge1, L Hert1, C Traenka1, G M De Marchis1, H Gensicke1,
N Peters1, L Bonati1, P Lyrer1, S Engelter1
1Neurology and Stroke Center, University Hospital Basel,
Basel, Switzerland
Background: New direct oral anticoagulants (NOAC) are approved for
prevention of stroke in patients with atrial fibrillation. These agents
inhibit selected players in the coagulation cascade such as the direct
thrombin inhibitor dabigatran or the factor Xa-inhibitors apixaban, riva-
roxaban and edoxaban. Little is known how patients should be cared for if
they have an acute ischemic stroke or an intracranial hemorrhage (ICH)
while under NOAC treatment.
Aim: To systematically evaluate (i) current management strategies and
(ii) 3-month outcome and complication of patients with either (a) acute
ischemic stroke or (b) ICH occurring under NOAC treatment (i.e., last
intake
Design: We set up a prospective, web-based multi-center registry. The
following items are systematically ascertained: Demographic variables,
stroke/ICH characteristics, routine laboratory tests including clotting
tests/drug specific coagulation tests; type, agent, and dosage of anticoagu-
lant, use and type of acute recanalization therapy or hemostatic therapies;
3-month functional outcome, presence or absence of ischemic/
hemorrhagic complications. Patients taking vitamin K antagonists will
serve as comparison group.
Potential significance: A multi-center cooperation with other stroke
centers is intended. The present study will explore important aspects of
current management of patients with ICH or acute ischemic stroke while
under NOAC treatment. A special interest is focused on the use of acute
recanalization therapies for acute ischemic stroke and hemostatic thera-
pies in ICH.
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Effects of mannitol on the clinical outcomes in acute
intracerebral hemorrhage: Analysis in INTERACT2
X Wang1, H Arima1, J Yang2, S Zhang3, G Wu4, M Woodward5,
E Heeley1, C Delcourt1, J Chalmers1, T Robinson6, C Stapf7,
P Muñoz-Venturelli8, C Anderson1
1Neurological & Mental Health Division, The George Institute
for Global Health, Sydney, Australia
2Department of Neurology, Nanjing First Hospital Nanjing
Medical University, Nanjing, China
3Stroke Clinical Research Unit Department of Neurology, West
China Hospital Sichuan University, Chengdu, China
4Department of Neurology, Hebei Yutian Hospital, Yutian,
China
5Professorial Unit, The George Institute for Global Health,
Sydney, Australia
6Department of Cardiovascular Sciences and NIHR Biomedical
Research Unit in Cardiovascular Disease, University of
Leicester, Leicester, United Kingdom
7Department of Neurology APHP, Hôpital Lariboisière and
DHU NeuroVasc Paris – Sorbonne Univ Paris Diderot –
Sorbonne Paris Cité, Paris, France
8Servicio de Neurología Departamento de Medicina, Clínica
Alemana, Universidad del Desarrollo, Santiago, Chile
Background: Mannitol is frequently used in the management of acute
stroke without clear supporting evidence of benefit. We aimed to
determine whether mannitol improved clinical outcomes independent of
other factors among participants of INTERACT2.
Methods: INTERACT2 was an open, blinded endpoint, randomized con-
trolled trial of 2839 patients with spontaneous intracerebral hemorrhage
(ICH) (<6 hrs) and elevated systolic blood pressure (SBP, 150–
220 mmHg) allocated to intensive (target SBP < 140 mmHg within 1 hr)
or guideline-recommended (target SBP < 180 mmHg) BP lowering treat-
ment. Multivariable and propensity score (PS) analyses were used to assess
the relationship of mannitol use (<7 days) and 90-day clinical outcomes
(death or major disability, mRS scores 3–6).
Results: There was no significant difference in death or major disability
between mannitol and non-mannitol users (multivariable adjusted odds
ratio [OR] 0.89, 95% CI 0.73–1.08; p = 0.22 and PS analyses OR 0.86, 95%
CI 0.72–1.04; p = 0.12). However, mannitol significantly reduced the risk
of death at 90 days (multivariable adjusted OR = 0.78, 95% CI 0.59–1.03;
p = 0.08 and PS analyses OR = 0.71, 95% CI: 0.54–0.95; p = 0.02).
Conclusions: Mannitol appears to improve the chances of survival but not
in overall better functional outcome in ICH.
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Development and evaluation of a complex
intervention for post-stroke fatigue
S Wu1, T Chalder2, K E Anderson3, D C Gillespie4, M R Macleod1,
G E Mead1
1Centre for Clinical Brain Sciences, University of Edinburgh,
Edinburgh, United Kingdom
2Department of Psychological Medicine, King’s College
London, London, United Kingdom
3Department of Geriatric Medicine, University of Edinburgh,
Edinburgh, United Kingdom
4Division of Clinical Neurosciences, University of Edinburgh,
Edinburgh, United Kingdom
Introduction: Post-stroke fatigue (PSF) is common and distressing but
there is no effective treatment. PSF is associated with psycho-behavioral
factors and complex interventions targeting these factors are effective in
treating fatigue in other conditions. This study aims to develop and evalu-
ate the feasibility of an intervention for PSF.
Methods: Based on a comprehensive literature review, the views of service
users, and expert input from stroke physicians, clinical psychologists and
a psychotherapist, a psychological therapy was developed. This is a
complex intervention which comprises an educational approach to reas-
sure patients that PSF is often reversible, and a behavioral approach to
encourage patients to achieve a balance between daily activities, rest and
sleep. The intervention is being tested in a feasibility study, which is
delivered by a clinical psychologist through six face-to-face sessions and
one telephone session. Feasibility outcomes include recruitment rate,
completion rate, and participants’ feedback.
Results: We sent out 120 invitation letters and 12 people consented to
participate. Eight of the enrolled participants completed the treatment
and another four participants withdrew for reasons not directly relevant
to the intervention (Fig. 1). All eight participants reported their fatigue
‘improved’ following the intervention and rated this intervention ‘helpful’
in reducing their fatigue. Further feedback will be obtained from a focus
group with all participants.
Conclusion: This intervention is acceptable to stroke survivors. In the next
phase, we will adapt it for delivery by stroke nurses and test it in a
randomized controlled trial to obtain further evidence on feasibility and
efficacy.
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28. Young Stroke Physicians: Research Design
Workshop for Studies in Development
Magnetic resonance vessel wall imaging in young
stroke
E Zock1, J Hendrikse2, J Bakker3, H Kerkhoff4
1Neurology, Albert Schweitzer Hospital, Dordrecht,
Netherlands
2Radiology, University Medical Centre Utrecht, Utrecht,
Netherlands
3Radiology, Albert Schweitzer hospital, Dordrecht,
Netherlands
4Neurology, Albert Schweitzer hospital, Dordrecht,
Netherlands
Background: Current stroke analysis in young stroke patients often fails to
determine the exact cause. Magnetic Resonance – Vessel Wall Imaging
(MR-VWI) of intracranial vessels, being a step beyond imaging luminal
stenosis, may detect and characterize vessel wall alterations as a cause of
young stroke. The presence of vessel wall abnormalities in young stroke
may point to causes of stroke with possibly more often rare causes of
stroke in this population (intracranial dissections, vasculitis, vasoconstric-
tion). As a result, individual treatment or on the other hand further
diagnostic efforts can be adjusted.
Objective:
1) To study vessel wall alterations of intracranial vessels in young stroke
patients with a cryptogenic stroke,
2) To study the presence of contrast-enhancement in vessel walls as a sign
of inflammation
Methods: We will perform a prospective study in 50 patients with isch-
emic stroke, aged between 18–50 years and 25 age matched controls. We
will exclude patients with known cardiovascular risk factors, known
coagulation disorders, known carotid stenosis or a suspected cardiogenic
cause. We will use high resolution VWI in combination with a standard
young stroke MR protocol (MRA, DWI, FLAIR). The presence of vessel
wall abnormalities will be assessed in patients and controls.
ESOC-0334
29. Ongoing Trials
The REstart or STop Antithrombotics Randomised Trial
(RESTART): baseline characteristics of the first 100
participants
R. Al-Shahi Salman1, J. Stephen2, J. Drever1,
RESTART trial steering committee1, RESTART trial collaborators1
1Centre for Clinical Brain Sciences, University of Edinburgh,
Edinburgh, United Kingdom
2Centre for Population Health Sciences, University of
Edinburgh, Edinburgh, United Kingdom
Background: In high-income countries, 40% of adults with spontaneous
intracerebral haemorrhage (ICH) are prescribed an antithrombotic drug
before ICH onset. In previous observational studies, adults with
antithrombotic-associated ICH were mean age 75 years, 56% male, 40%
had lobar ICH, 73% had hypertension, and 3% had a prior history of ICH;
antithrombotic drugs before ICH included antiplatelet drugs (59%), anti-
coagulants (35%), or both (6%).
Methods: The REstart or STop Antithrombotics Randomised Trial
(www.RESTARTtrial.org, ISRCTN71907627) aims to recruit >720 adult
survivors of antithrombotic-associated ICH to test whether starting
antiplatelet drugs causes a beneficial net reduction of all serious vascular
events over two years compared with avoiding antiplatelet drugs.
We performed descriptive analyses of trial participants to assess
generalisability.
Results: At randomisation, the first 100 participants were mean age 76
years, 61% male, and 50% had lobar ICH. Co-morbidities before ran-
domisation included hypertension (83%), ICH (6%), ischaemic heart
disease (54%), atrial fibrillation/flutter (36%), ischaemic stroke (25%),
and transient ischaemic attack (17%). Before ICH onset, participants had
taken aspirin (57%), clopidogrel (20%), dipyridamole (6%), warfarin
(30%) or rivaroxaban (2%). Median delay from ICH onset to randomi-
sation was 56 days (inter-quartile range 21–98). These characteristics were
similar in the 60 participants in the brain magnetic resonance imaging
sub-study.
Conclusion: The characteristics of the first 100 participants in RESTART
are similar to the characteristics of adults with antithrombotic-associated
ICH in previous observational studies, suggesting there is no evidence of
selection bias and that, if maintained, the trial findings should be
generalisable.
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29. Ongoing Trials
Combined lysis of thrombus with ultrasound and
systemic tissue plasminogen activator for emergent
revascularization in acute ischemic stroke
(CLOTBUSTER)
A.V. Alexandrov1, P.D. Schellinger2, A.D. Barreto3,
A.M. Demchuk4, L. Soinne5, M. Köhrmann6, G. Howard7
1Neurology, University of Tennessee Health Sciences Center,
Memphis, USA
2Neurology, Johannes Wesling Klinikum, Minden, Germany
3Neurology, University of Texas Medical School, Houston, USA
4Neurology, University of Calgary Foothills Medical Center,
Calgary, Canada
5Neurology, Helsinki University Central Hopsital, Helsinki,
Finland
6Neurology, Universitatsklinkum Erlangen, Erlangen, Germany
7Biostatistics, University of Alabama Birmingham,
Birmingham, USA
Background: Continuous exposure of intracranial arterial occlusions to
pulsed wave ultrasound enhances tPA-induced recanalization.
Hypothesis: Sonothrombolysis improves functional outcomes of stroke
patients receiving tPA therapy.
Objectives: Assess efficacy of combined treatment with a novel transcra-
nial ultrasound device and systemic tPA (Target) compared to systemic
tPA alone (Control) in subjects with acute ischemic stroke.
Methods: Subjects with acute ischemic stroke, pre-morbid mRS of 0–1
and NIHSS ≥ 10 will be randomized (1:1) to the Target and Control
groups. Active and sham ultrasound will be delivered via the Clotbust ER
device for 2 hours with the first hour overlapping with IV-tPA adminis-
tration. Subjects are followed for adverse events through day 7 or hospital
discharge, whichever is first and return for 90-day mRS evaluation.
Primary endpoint analysis of 90-day mRS will be assessed utilizing ordinal
logistic regression. A total of 824 patients will be enrolled with interim
analyses at 1⁄3 and 2⁄3 of enrollment.
Current Status: As of February 18, 2015 CLOTBUSTER is ongoing with
639 of 824 planned subjects enrolled to date. The DSMB recommended
continuation of the trial as planned without modification after the first
interim analysis. The second interim analysis is planned for the end of
March, 2015. Enrollment is expected to complete by the end of June 2015
with follow up of the last patient projected at the end of the third quarter
of 2015.
Conclusions: CLOTBUSTER enrollment is projected to continue into the
third quarter of 2015.
Sponsored by Cerevast Therapeutics Inc. ClinicalTrials.gov Trial Registry
ID: NCT01098981.
ESOC-1376
29. Ongoing Trials
Life after stroke – the LAST study
T. Askim1, B. Langhammer2, M. Gunnes1, H. Ihle-Hansen3,
B. Indredavik4
1Faculty of Medicine Department of Neuroscience, Norwegian
University of Science and Technology, Trondheim, Norway
2Department of Physiotherapy, Oslo and Akershus University
Collage, Oslo, Norway
3Department of Medicine, Vestre Viken Hospital Trust Bærum
Hospital, Bærum, Norway
4Department of Medicine, Trondheim University Hospital,
Trondheim, Norway
Purpose: The primary aim of the LAST study is to assess the effect of a
long term follow-up program on motor function after stroke.
Methods: This is a prospective, multi-site randomised controlled trial,
with blinded assessment 18 months after inclusion. A total of 390
informed consenting patients will be recruited and randomised to a
control group or to an intervention group. The recruitment will be con-
ducted at the outpatient clinic at the participating hospitals, 10 to 16
weeks after onset of stroke. Patients will be stratified according to stroke
severity, age above 80 and recruitment site. Every month, patients ran-
domised to the intervention group will be encouraged by a physiothera-
pist to do 30 minutes of daily physical activity and 60 minutes of motor
training every week. The control group will receive standard care accord-
ing to the Norwegian guidelines. All patients will be followed for 18
consecutive months. The primary outcome is motor function (Motor
Assessment Scale) at 18 months follow-up. Secondary outcomes are;
dependency, balance, endurance, health related quality of life, fatigue,
anxiety and depression, cognitive function, burden on caregivers and
health costs.
Results/Discussion: The recruitment was ended by June 2014. A total, 384
patients were included. Out of these, 279 (73%) were <80 years and 305
(79%) suffered from mild/moderate stroke. So fare, 188 patients have
completed the intervention. The drop-out rate is 17% which is in accor-
dance with the power calculation. The intervention will be concluded
bythe end of 2015.
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29. Ongoing Trials
Lumina-study: Gadolinium-enhanced aneurysm wall
imaging of non-ruptured intracranial aneurysms
D. Backes1, M.D.I. Vergouwen1, J. Hendrikse2, I.C. van der Schaaf2,
B.H. Verweij1, G.J.E. Rinkel1
1Neurology and Neurosurgery, University Utrecht, Utrecht,
Netherlands
2Radiology, University Utrecht, Utrecht, Netherlands
Background: Current models to assess the rupture risk of intracranial
aneurysms are inaccurate and fail to identify small aneurysms with a high
risk of rupture. Therefore, new risk factors for aneurysm rupture need to
be identified. Inflammation may be a key modulator in aneurysm rupture.
Gadolinium-enhanced magnetic resonance imaging (MRI) with vessel
wall imaging (VWI) can identify sites of inflammation in other vascu-
lopathies such as vasculitis and intracranial atherosclerosis. Recent studies
suggest that contrast enhancement of the aneurysm wall is associated with
aneurysm growth or rupture.
Design: Prospective single center cross-sectional study.
Objectives: To assess the prevalence of contrast enhancement of the aneu-
rysm wall and its predictors in patients with small unruptured intracranial
aneurysms.
Population: 80 patients ≥18 years with ≥1 small unruptured intracranial
aneurysm(s).
Outcome: Contrast enhancement of the aneurysm wall on 3 Tesla MRI
with VWI.
Statistical analyses: We will assess the proportion and corresponding 95%
confidence interval (CI) of aneurysms with contrast enhancement. With
univariable and multivariable conditional logistic regression analysis we
will calculate odds ratios and 95%CI for the association between contrast
enhancement and the use of anti-inflammatory drugs, aneurysm size,
hypertension, and tobacco use.
Yield: This study gives insight in the prevalence of contrast enhancement
and its predictors in patients with small unruptured intracranial aneu-
rysms. The results of this study will be used to design a prospective
multicenter cohort study to investigate whether contrast enhancement of
the aneurysm wall predicts aneurysm growth in small aneurysms that are
left untreated.
Status: 38 patients have been included.
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29. Ongoing Trials
Patch: platelet transfusion in cerebral haemorrhage
M.I. Baharoglu1, K. De Gans1, Y.B. Roos1
1neurology, Academic Medical Center University of
Amsterdam, Amsterdam, Netherlands
Background: Haematoma volume is one of the most important outcome
predictors in intracerebral hemorrhage (ICH). Several studies showed that
haematoma volume increases during the first 6 hours after onset of ICH.
Reduction of this haematoma growth provides a promising target to
improve outcome. Patients using antiplatelet treatment (APT) are at risk
for haematoma growth. In these patients platelet transfusion (PT) is the
best way to restore coagulation.
Objective: The objective is to investigate whether platelet transfusion
within 6 hours after onset of ICH can improve functional outcome by
limiting haematoma growth in ICH patients using APT.
Study Design: PROBE: Prospective, randomised, open treatment, blind
end-point evaluation study
Study Population: Patients with spontaneous ICH using APT (aspirin,
dipirydamole and / or clopidogrel) at time of haemorrhage. For full inclu-
sion and exclusion criteria please visit ww.strokeamc.nl.
Intervention: Patients are randomised to receive either 1) single platelet
transfusion (1 or 2 units) or 2) standard care without platelet transfusion
Outcome: Primary endpoint is poor functional outcome (modified
Rankin Scale score 4–6) three months after ICH.
Secondary endpoints are safety of platelet transfusion and haematoma
growth within 24 hours on CT imaging.
Trial Progress: 162 patients of the targeted 190 patients have been
included. The trial is including in 36 centres in the Netherland, 13 centres
in Scotland, and 11 centres in France.
Contact: Please visit www.strokeamc.nl. Study nurse Nadine Fleitour:
n.m.fleitour@amc.uva.nl, +315664564 or PhD student Irem Baharoglu:
m.i.baharoglu@amc.uva.nl
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29. Ongoing Trials
ARTSS-2: A pilot, phase IIb, randomised, multi-center
trial of argatroban in combination with recombinant
tissue plasminogen activator for acute stroke
A. Barreto1, G. Ford2, L. Shen1, M. Rahbar3, R. Delgado4,
C. Pedroza5, J. Grotta6, on behalf of the ARTSS-2 Investigators7
1Neurology, University of Texas at Houston Health Science
Center, Houston, USA
2Pharmacology, Oxford Academic Health Science Network,
Oxford, United Kingdom
3Center for Clinical and Translational Sciences, University of
Texas at Houston Health Science Center, Houston, USA
4Health Economics, University of Texas School of Public
Health, Houston, USA
5Center for Clinical Research & Evidence-Based Medicine,
University of Texas Health Science Center at Houston,
Houston, USA
6Memorial Hermann Hospital-Texas Medical Center, Clinical
Innovation and Research Institute, Houston, USA
7., ., ., USA
Trial Registry Numbers: NCT01464788; ISRCTN51505768
Background: Recombinant tissue plasminogen activator (rt-PA), fails to
reperfuse most large thrombi strokes. In our Phase IIa low-dose safety
study (n = 65), the two drugs appear safe when delivered concomitantly
and recanalization rates were greater than with historical controls. This
study will provide evidence-based data needed to design a definitive trial.
Objectives: Estimate overall benefit among stroke patients treated with
rt-PA who are randomised to also receive either low-dose Argatroban,
high-dose Argatroban, or neither; Verify the safety of low-dose Arga-
troban and rt-PA and test the safety of high-dose combination treatment;
Assess rates of early recanalization.
Study Population: 105 total ischaemic stroke patients treated with IV-rt-
PA; age ≥ 18 years; proximal intracranial artery occlusion (imaged by TCD
or CTA), or NIHSS ≥ 10.
Intervention: Patients are randomized 1:1:1:
1) Low-dose Argatroban 1.0 μg/kg/min 48-hr infusion, preceded by a
100 μg/kg bolus. Titrated to 1.75 times baseline aPTT + IV-rt-PA;
2) High-dose Argatroban 3.0 μg/kg/min 48-hr infusion, preceded by a
100 μg/kg bolus. Titrated to 2.25 times baseline aPTT + IV-rt-PA;
3) Intravenous-rt-PA alone.
Outcome Measures: Excellent functional outcome (0–1 mRS) at Day 90 as
assessed by blinded personnel; Safety as measured by the incidence of
symptomatic intracranial haemorrhage; Rates of arterial recanalisation;
NIHSS improvement at 2/24/48 hours, day 7 and day 90; Quality of Life
and Cost Utility Analysis.
Trial Status: Ongoing. 89 of 105 patients enrolled. Mean age: 69.3 ± 14.8
and median (range) NIHSS: 14.5 (2–33).
Trial Sponsors: NIH; The University of Texas Health Science Center-
Houston
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29. Ongoing Trials
Rapid intervention with glyceryl trinitrate in
hypertensive stroke Trial-2 (RIGHT-2)
P. Bath1, T. England1, M. Jarvis2, A. Montgomery1, S. Pocock3,
J. Potter4, C. Price5, T. Robinson6, C. Roffe7, N. Siriwardena8,
N. Sprigg1, J. Wardlaw9, H. Foster1
1Stroke Division of Clinical Neuroscience, University of
Nottingham, Nottingham, United Kingdom
2Private, Private, Nottingham, United Kingdom
3Department of Medical Statistics, London School of Hygiene
and Tropical Medicine, London, United Kingdom
4Norwich Medical School, University of East Anglia, Norwich,
United Kingdom
5The Medical School, University of Newcastle, Newcastle,
United Kingdom
6Department of Cardiovascular Sciences, University Hospital
of Leicester, Leicester, United Kingdom
7Institute for Science and Technology in Medicine, Keele
University, Keele, United Kingdom
8School of Health and Social Care, University of Lincoln,
Lincoln, United Kingdom
9Centre for Clinical Brain Sciences, University of Edinburgh,
Edinburgh, United Kingdom
Rationale: High blood pressure (BP) is common in acute stroke and is
associated with poor outcome. Previous hospital-based trials testing the
effects of BP lowering on functional outcome have been inconclusive. The
PIL-FAST and RIGHT pilot trials confirmed the feasibility of performing
single centre UK ambulance-based stroke trials. In both RIGHT and in a
subgroup of patients recruited within 6 hours into the large ENOS trial,
transdermal glyceryl trinitrate (GTN), a nitric oxide donor, lowered BP
and reduced death or disability. Based on these results, RIGHT-2 aims to
test the safety and efficacy of transdermal GTN in the pre-hospital setting.
Methods: Paramedics from 5 UK ambulance services serving 30 compre-
hensive or primary stroke care centres will screen, consent, randomise and
treat 850 patients presenting within 4 hours of FAST-positive stroke and
with systolic BP >120 mmHg. Treatment will comprise GTN or similar
sham patch, and will be continued in hospital for 3 days. The primary
outcome will be the modified Rankin Scale at day 90. Secondary outcomes
include vascular events, disability, quality of life, mood and cognition.
Neuroimaging and biomarkers will examine potential mechanisms of
action. Recruitment will commence in quarter 1/2 2015.
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Contact Information:
Website: http://www.right2-trial.org
E-mail: right-2@nottingham.ac.uk or philip.bath@nottingham.ac.uk
Telephone: +44 115 823 1770
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29. Ongoing Trials
Triple Antiplatelets for Reducing Dependency after
Ischaemic Stroke (TARDIS). A randomised controlled
trial
P. Bath1, K. Krishnan1, N. Sprigg1, T. Payne1, M. Adrian1,
J. Keeling1, H. Howard1, M. Stringer1, K. Robson1, L. Woodhouse1
1Stroke Division of Clinicial Neuroscience, University of
Nottingham, Nottingham, United Kingdom
Rationale: The risk of recurrence is greatest immediately after stroke or
TIA. Existing prevention strategies (antithrombotic, lipid/blood pressure
lowering, endarterectomy) reduce, not abolish, further events. Dual anti-
platelet therapy – aspirin & clopidogrel (AC) for ischaemic heart disease,
aspirin & dipyridamole (AD) for stroke, is superior to aspirin mono-
therapy. We hypothesise that triple antiplatelet therapy (ACD) will be
superior to current guideline therapy (AD or C) in patients at high-risk of
recurrence, providing bleeding does not become excessive.
Design: TARDIS is a multicentre, parallel-group, prospective, ran-
domised, open-label, blinded-endpoint, controlled trial. In the start-up (3
years) phase, we assessed the safety, tolerability and feasibility of intensive
antiplatelet therapy (ACD) versus guideline therapy given for 1 month in
902 patients with acute stroke/TIA. The main 5 year phase will assess the
safety and efficacy of intensive or guideline therapy in up to 4,100 patients.
The primary outcome is ordinal stroke severity (fatal/severe non-fatal/
mild/TIA/none) at 90 days. Secondary outcomes include death, myocar-
dial infarction (MI), vascular events, function, bleeding, serious adverse
events; sub-studies will assess cerebral emboli and platelet function.
Trial status: The main phase of the trial commenced on 1st October, 2012,
and will run for 5 years. As of 8th January, 2285 patients have been
recruited from 102 centres (UK, Denmark, Georgia, New Zealand).
Funding: The National Institute of Health Research, Health and Technol-
ogy Assessment Programme
Contact Information:
Website: http://www.tardistrial.org/
E-mail: tardis@nottingham.ac.uk
Telephone: +44 (0)115 8231770
ISRCTN47823388
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Tenecteplase versus alteplase for stroke thrombolysis
evaluation trial
M. Parsons1, A. Bivard1, B. Campbell2, P. McElduff1, C. Hsu3,
K. Butcher4, C. Bladin5, R. Lindley6, W. Hacke7, G. Albers8, H. Ma5,
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2Medicine, University of Melbourne, Melbourne, Australia
3Division of Geriatrics and Gerontology, Institute of
Population Health Sciences, Zhunan, Taiwan
4Neurology, University of Alberta, Alberta, Canada
5Stroke, Florey Institute of Neuroscience and Mental
HealthUniversity of Alberta, Melbourne, Australia
6Sydney Medical School-Westmead Hospital, The George
Institute for Global Health, Sydney, Australia
7Neurology, Heidelberg University Hospital, Heidelberg,
Germany
8Stanford Stroke Center, Stanford University Medical Center,
San Fransisco, USA
9Neurology, Hospital Vall d’Hebron-Barcelona, Barcelona,
Spain
10Neurology, University Hospital Leuven, Leuven, Belgium
In phase II studies, tenecteplase has been shown to result in more com-
plete reperfusion. We have now begun a phase III trial compare Tenect-
eplase with Alteplase in acute ischemic stroke with onset <4.5 hours in
patients clinically eligible for intravenous alteplase who fulfil additional
imaging criteria.
Design: Multicentre, prospective, randomised, open-label, blinded end-
point (PROBE) phase III study. Patients will be randomised 1:1 to stan-
dard dose intravenous alteplase (0.9 mg/kg) or tenecteplase (0.25 mg/kg
as a single bolus). There will be two randomisation strata: first, randomi-
sation will be stratified by the presence or absence of internal carotid
artery occlusion (ICAO) on baseline CT or MR angiography; second,
randomisation will be stratified by size of infarct core (above or below
25 mL) on baseline CTP or diffusion-weighted MRI (DWI). Patients with
ICAO will be capped at a maximum of 25% of the sample size.
Population Studied: Patients aged ≥ 18 years presenting with acute hemi-
spheric ischemic stroke within 4.5 hours of stroke onset who are clinically
eligible for IV alteplase. Mutlimodal CT or MRI including perfusion
imaging must be performed before randomization.
Primary Outcome: Modified Rankin Scale (mRS) 0–1 at 3 months (no
disability).
Secondary Outcomes: Reperfusion at 24 hours post stroke
Early clinical improvement (reduction in acute – 24 hour NIHSS score)
Modified Rankin Scale 0–2 at 3 months
Recanalisation at 24 hours post stroke.
Trial Status: Commenced August 2014 with 6 centres now open in Aus-
tralia and a further 17 sites planned to open across Taiwan, Canada and
Europe.
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Robot Assisted Training for the Upper Limb after
Stroke (RATULS)
H. Bosomworth1, L. Shaw1, H. Rodgers1
1Stroke Research Group, Newcastle University, Newcastle
upon Tyne, United Kingdom
Introduction Loss of the ability to use the arm is a common and distress-
ing consequence of stroke. Currently it is unclear how best to provide
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therapy to improve arm recovery and function. Research suggests that
robot-assisted training may be beneficial but this is not yet proven and
further research is needed.
Methods:
Study design: A pragmatic multicentre randomised controlled trial, cost
analysis and process evaluation.
Study setting: Four study centres, each consisting of a hub hospital with
an InMotion robotic gym system and adjacent primary and secondary
care spoke sites.
Study participants: Adults with acute or chronic first ever stroke (1 week
to 5 years post stroke) causing moderate to severe upper limb functional
limitation.
Study treatments: There are three randomisation groups:
i. Robot assisted training using the InMotion robotic gym system deliv-
ered for 45 minutes, three times per week for 12 weeks.
ii. Enhanced upper limb therapy delivered for 45 minutes, three times
per week for 12 weeks.
iii. Usual NHS care.
Randomisation: Central independent web based service.
Primary outcome: Upper limb function measured by the Action Research
Arm Test at 3 months.
Secondary outcomes: Upper limb impairment, activities of daily living,
quality of life, resource use and adverse events measured at 3 and 6
months.
Blinding: Outcomes assessments by blinded assessor.
Parallel process evaluation: Semi-structured interviews with a sub-sample
of participants and staff.
Sample size: 720 participants.
Current study progress: RATULS opened to recruitment in April 2014.
Current recruitment (16.02.2015) is 146 participants.
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The NIH strokenet: Maximizing efficiencies for
conducting high quality clinical trials in stroke
prevention, treatment and recovery
J. Broderick1, Y. Palesch2, W. Zhao2,
for the NIH StrokeNet Investigators
1Neurology Physical Medicine and Rehabilitation, University
of Cincinnati, Cincinnati, USA
2Public Health Sciences, Medical University of South Carolina,
Charleston, USA
Background: The 2012 Stroke Progress Review Group and National Insti-
tute of Neurological Disorders and Stroke (NINDS) identified the need
for a multi-center stroke trial network that would provide a robust, stan-
dardized, and accessible infrastructure to facilitate rapid development and
implementation of NINDS-funded stroke trials in stroke prevention,
treatment, and recovery.
Objective: The network is designed to increase efficiency of stroke trials
by facilitating patient recruitment and retention, supporting novel meth-
odologies, and streamlining approaches to develop stroke therapies.
Design: In 2013, NINDS awarded 25 Regional Coordinating Centers, a
National Coordinating Center at the University of Cincinnati, and a
National Data Management Center at the Medical University of South
Carolina, to form the NIH StrokeNet. Efficiencies of the network include
master trial agreements, central IRB, central pharmacy and investigational
product distribution, common data elements, standard operating proce-
dures, web-based Clinical Trial Management System, and statistical exper-
tise. The StrokeNet will collaborate with other consortia and includes a
training program for stroke research.
Investigators should contact NINDS to determine whether a proposal is
appropriate for the network. Concepts approved by NINDS are referred to
StrokeNet to assess feasibility. If feasible, Investigators may submit a grant
application in response to one of the StrokeNet Funding Opportunity
Announcements for review by NINDS.
Funding: NINDS Award Number U01NS086872 and NS087748. The
content is solely the responsibility of the authors and does not necessarily
represent the official views of the NIH. NCC PI: J. Broderick, MD, Uni-
versity of Cincinnati. Contact: J. Spilker, RN, Administrative Director.
judith.spilker@uc.edu (513) 558–5430
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Prehospital stroke study at the universitair ziekenhuis
brussel: Preliminary data on 24/7 in-ambulance
telemedicine for emergency stroke care
R. Brouns1, A. Valenzuela Espinoza1, A. De Smedt1, M. Moens1,
I. Hubloue2, S. Neyrinck2, K. Nieboer3, A. Convents1, J. De Keyser1,
R.J. Van Hooff1
1Center for Neurosciences (C4N), Vrije Universiteit Brussel,
Brussels, Belgium
2Research Group on Emergency and Disaster Medicine
(ReGEDiM), Vrije Universiteit Brussel, Brussels, Belgium
3Department of Radiology, Universitair Ziekenhuis Brussel,
Brussels, Belgium
In-ambulance telemedicine for stroke (telestroke) is a promising concept.
Real-time bidirectional audiovisual communication between a patient in
a moving ambulance and a remote stroke expert can facilitate specialized
care at a very early stage. We have developed several prototypes for
in-ambulance telemedicine and we have created a telemedicine platform
encompassing standardized assessment of stroke severity using the Unas-
sisted TeleStroke Scale (UTSS), clinical decision support software for
stroke physicians and reporting functionality for the in-hospital team
awaiting the patient. Feasibility studies using this system in healthy vol-
unteers and in patients during paramedic emergency missions have
shown that this approach is safe, feasible and well-accepted by all
stakeholders.
We have completed a pilot study on 24/7 in-ambulance telestroke support,
confirming the safety, feasibility and reliability of this concept. We present
a video fragment of an in-ambulance teleconsultation from this trial.
Already during patient evacuation to the ambulance, vital data was
exchanged between the general practitioner present at the location and the
remote stroke physician. During emergency transportation to the hospi-
tal, the teleconsultant examined the patient, alarmed the in-hospital team
and communicated critical information to the in-hospital team (patient
identification and date of birth, vital parameters, glycaemia, time of
symptom onset, stroke severity based on the UTSS, Glasgow Coma Scale
score, medical history, concomitant medication, suspected diagnosis,
checklist for treatment with intravenous thrombolysis, family contact
information, premorbid modified Rankin Scale score).
A single-center randomized clinical trial evaluating the efficacy, safety,
feasibility, reliability, and cost-effectiveness of in-ambulance telestroke is
currently ongoing.
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29. Ongoing Trials
Stroke: An evaluation of thrombectomy in the ageing
brain – [including] where IV thrombolysis fails or is
contraindicated (STABILISE)
E. Cora1, P. White1, G. Ford2
1Institute of Neuroscience, Newcastle University, Newcastle
upon Tyne, United Kingdom
2Academic Health Science Network, University of Oxford,
Oxford, United Kingdom
Introduction: Patients with acute ischaemic stroke (AIS) due to a large
vessel occlusion (LVO) have very poor outcomes. Only one randomised
controlled trial (RCT), MR CLEAN, has evaluated the efficacy of throm-
bectomy in a heterogeneous population. Published thrombectomy studies
typically exclude patients ≥75 years or patients with a contraindication to
intravenous thrombolysis (IVT).
Thrombectomy devices have limitations because they were initially
designed as stents for intracranial aneurysm coiling. Although modified
for endovascular acute stroke treatment, they have limitations especially
for accessing distal and tortuous vessels. Longer clots are more common in
patients not responding to IVT.
STABILISE evaluates a new thrombectomy device (ERIC™) designed with
features allowing longer clot retrieval and access to distal and tortuous
vessels.
Method: Multicentre, prospective, phase II, single blinded RCT compar-
ing the ERIC™ device with standard thrombectomy devices in female and
male patients ≥50 years with AIS due to a LVO. Patients will be ran-
domised in a 2:1 ratio to the ERIC device preferentially or to a standard
thrombectomy device. A total of 120 patients will be enrolled over a
period of 2 years.
The feasibility, safety and technical efficacy of the ERIC™ device will be
assessed in a truly heterogeneous population. Early MRI after thrombec-
tomy will be used as biomarker of clinical outcome. The trial is currently
open to enrolment at the Royal Victoria Infirmary in Newcastle and the
early progress results will be presented. The final trial results will be used
to devise a definitive phase III clinical trial of the ERIC™ device.
ESOC-1620
29. Ongoing Trials
Practise trial: Penumbra and recanalisation acute
computed tomography in ischaemic stroke evaluation
S. El Tawil1, J. Wardlaw2, L. Kalra3, I. Ford4, K. Muir1
1Institute of Neuroscience and Psychology, University of
Glasgow, Glasgow, United Kingdom
2Clinical Neurosciences, University of Edinburgh, Edinburgh,
United Kingdom
3Clinical Neurosciences, King’s College London, London,
United Kingdom
4Robertson Centre of Biostatistics, University of Glasgow,
Glasgow, United Kingdom
Background: IV rtPA is used in less than half of patients with acute isch-
emic stroke eligible for thrombolysis. The use of multimodal imaging,
such as CTP and CTA provide additional information on tissue viability,
brain perfusion and vascular anatomy that might be helpful in patient
stratification for therapy. It is currently unknown whether these addi-
tional benefits will outweigh the disadvantages of additional resource
utilisation, radiation and contrast exposure, and treatment delay associ-
ated with their use.
Aim: To evaluate the utility of additional multimodal CT imaging in
acute ischaemic stroke patients clinically eligible for IV rtPA, compared to
NCCT. The primary endpoint is the proportion of patients treated with IV
rtPA in the 2 groups. Secondary end-points include diagnostic accuracy
and clinical outcomes at 3 months.
Methods: The study isa prospective, multicentre RCT. Patients eligible for
rt-PA will be randomised to NCCT alone or CT+CTP+CTA. The decision
on IV rtPA based on allocated imaging will be documented. Total imaging
time in both arms, and time to initiation of treatment delivery in those
treated with IV rtPA, will be recorded. Follow up will include brain
imaging at 24 h to document infarct size, presence of oedema and the
presence of intra-cerebral haemorrhage. Clinical evaluations will include
NIHSS score at baseline, 24 hours and 7 days, and mRS at day 90 to define
functional outcomes.
Progress: The first centre was opened for patient recruitment, with seven
other centres to be opened in March and April of 2015.
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29. Ongoing Trials
On the road towards prehospital stroke diagnosis
using microwave technology
J. Karlsson1, Z. Fekete2, B. Cederin3, E. Bertholds3, S. Candefjord4,
A. Fhager4, T. McKelvey4, M. Persson4, M. Elam5
1Stroke Unit, Sahlgrenska Univ Hospital, Gothenburg, Sweden
2Stroke Unit, County Hospital of Borås, Borås, Sweden
3Stroke Unit, County Hospital of Skövde, Skövde, Sweden
4Signals & Systems, Chalmers Univ of Technology,
Gothenburg, Sweden
5Clin Neurophysiology, Inst of Neuroscience & Physiology,
Gothenburg, Sweden
In 2014 we reported “proof-of principle” results showing that microwave-
based brain measurements on patients hospitalized for stroke were
capable of differentiating hemorrhagic (HS) from ischemic strokes (IS)
(Persson et al, 2014). From start, one major aim of this project has been to
develop a system suitable for prehospital use. This calls for a small, low
weight, user-friendly and mechanically robust instrument. Here we
present early data from an ongoing study using a recently developed
device, which is battery-powered and weighs less than 6 kg.
After ethical/regulatory review, stroke alert chain patients hospitalized at
three stroke units in the West Sweden region are recruited. Currently 23
patients, whereof 13 diagnosed with HS and 10 with IS, have been
included. The classification algorithm was trained on measurements from
patients with confirmed diagnosis, using a leave-one-out procedure with
Monte Carlo-based bootstrap step (Persson et al, 2014). The classification
accuracy was evaluated using the area under receiver operating character-
istic curve (AUC). For selected parameter settings an AUC of 0.96 ± 0.02
within ten nearby frequency intervals around 0.45–1.50 GHz was
obtained. These parameter settings as well as the high AUC value needs to
be confirmed on larger patient populations.
Compared to our previous studies on stroke patients, using two consecu-
tive generations of microwave devices, preliminary findings with the
present 4th generation device show higher sensitivity and specificity, prob-
ably due to an improved antenna positioning system. We are presently
planning prehospital trials with this device.
Persson, Fhager, Trefna, Yu, McKelvey, Pegenius, Karlsson & Elam (2014)
IEEE TBME 61(11)2806–2817
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29. Ongoing Trials
Targeting sedentary behaviour and sitting time in
stroke survivors. A new paradigm for addressing
recurrent stroke risk
C. English1, G. Healy2, A. Coates1, T. Olds1, J. Bernhardt3
1Alliance for Research in Exercise Nutrition and Activity,
University of South Australia, Adelaide, Australia
2School of Population Health, University of Queensland,
Brisbane, Australia
3Stroke Division, Florey Institute of Neuroscience and Mental
Health, Melbourne, Australia
High levels of sitting time can have serious health consequences, including
increased risk of cardiovascular disease. Targeting sitting reduction in
stroke survivors may reduce recurrent stroke risk. Our research program,
comprising to date an observational study and pilot randomized con-
trolled trial (RCT), investigates sitting time in people living in the com-
munity after disabling stroke. All studies use objective measures of sitting
time (activPAL3 activity monitor) and activity (Actigraph GT3X+). In our
observational study (n = 63), stroke survivors spent, on average, 2.7 (95%
confidence interval [CI] 1.6 to 3.7) hours more each day sitting down, 156
(95% CI 105.5 to 205.6) minutes less in light intensity physical activity
and 33 (95% CI 22.7 to 43.6) minutes less in activity of at least moderate
intensity compared to healthy age-matched controls. In the pilot RCT to
investigate the safety and feasibility of reducing sitting time in people with
stroke, 35 participants were randomly allocated to receive a series of
counselling sessions based on a message to either ‘sit less move more’
(intervention group) or ‘calcium for bone health’ (control group). To date,
sitting time data are available for n = 21. Intervention participants
(n = 11) reduced their daily sitting time by 63 (95% CI 27 to 100) minutes.
Control participants (n10) showed smaller sitting time reductions (53
minutes, 95% CI 3 to 104 minutes). These data show that changes in
sitting time are safe and feasible in this population. Preliminary work on
markers of recurrent stroke risk indicates positive effects on blood pres-
sure and glucose metabolism.
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29. Ongoing Trials
Platelet-oriented inhibition in new TIA and minor
ischemic stroke (POINT) trial
M. Farrant1, J.D. Easton1, A. Kim1, S.C. Johnston2
1Neurology, University of California San Francisco, San
Francisco, USA
2Neurology, University of Texas Austin, Austin, USA
Platelet-Oriented Inhibition in New TIA and minor ischemic stroke is a
prospective, randomized, double-blind, multicenter trial with the primary
null hypothesis that, in patients with TIA or minor ischemic stroke treated
with aspirin 50–325 mg/day, there is no difference in survival free of
ischemic stroke, myocardial infarction, and ischemic vascular death at 90
days in those treated with clopidogrel (600 mg loading dose then 75 mg/
day) compared to placebo when therapy is initiated within 12 hours of the
time last known free of new ischemic symptoms.
Subjects are 18 years of age or older with high-risk TIA (ABCD2 score > 4)
or minor ischemic stroke (NIHSS < 3) followed for 90 days from random-
ization. 5,840 patients will be recruited; international sites joined the
POINT trial in August of 2013.
Principal Investigator: S. Claiborne Johnston, MD, PhD, University of
Texas, Austin
Co-Principal Investigators: J. Donald Easton, MD, University of Califor-
nia, San Francisco
Anthony S. Kim, MD, MAS, University of California, San Francisco
Contact: Mary Farrant, MBA, BSN, RN, University of California, San
Francisco; Director, POINT Trial Clinical Coordinating Center (CCC),
San Francisco, California, United States, 94158; Phone 1-415-502-7304;
Email: mary.farrant@ucsfmedctr.org
Planned Number of Centers: 350; Present Number: 245
Planned Number of Subjects: 5,840; Present Number: 2,522
Sponsor: University of California, San Francisco (UCSF); National Insti-
tute of Neurological Disorders and Stroke (NINDS)
Collaborators: Neurological Emergencies Treatment Trials Network
(NETT); Medical University of South Carolina (MUSC); POINT Clinical
Research Collaboration EMMES Corporation
Dates of Study: October 2009–September 2016
ClinicalTrials.gov Identifier: NCT00991029; http://clinicaltrials.gov/ct2/
show/NCT00991029?term=POINT&rank=1
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29. Ongoing Trials
Assessment of therapy fidelity processes in the very
early rehabilitation in speech (VERSE) clinical trial
E. Godecke1, E. Armstrong1, S. Middleton2, T. Rai3, D. Cadilhac4,
N. Ciccone1, A. Whitworth5, M. Rose6, G.J. Hankey7, A. Holland8,
J. Bernhardt9
1Psychology and Social Science, Edith Cowan University, Perth,
Australia
2Faculty of Health Sciences, St Vincent’s & Mater Health and
Australian Catholic University, Sydney, Australia
3School of Mathematical Sciences, University of Technology
Sydney, Sydney, Australia
4Stroke and Ageing Research Group, Monash University,
Melbourne, Australia
5School of Psychology and Speech Pathology, Curtin
University of Technology, Perth, Australia
6Human Communication Sciences, La Trobe University,
Melbourne, Australia
7School of Medicine and Pharmacology, University of Western
Australia, Perth, Australia
8Speech Language and Hearing Sciences, University of
Arizona, Arizona, USA
9Stroke, The Florey Institute of Neuroscience and Mental
Health, Melbourne, Australia
Background: The benefits of intensive, standardised aphasia therapy after
stroke are unclear. VERSE is a randomised, open-label, blinded endpoint
evaluation trial designed to test whether two forms of daily, prescribed
aphasia therapy for 20 sessions, beginning within 14 days of acute stroke,
is more effective than usual care in promoting recovery from post-stroke
aphasia in 246 eligible patients. Efficacy is determined by between group
differences in the Aphasia Quotient of the Western Aphasia Battery at 3
months.
This substudy will describe the process of evaluating therapy fidelity in the
three-arm trial: usual care (UC); usual care-plus (UC-Plus); or VERSE
therapy. UC therapy is usual ward-based therapy; UC-Plus is usual ward-
based therapy but provided daily, and VERSE therapy is a prescribed
aphasia therapy provided daily.
Methods: All speech pathology services are being documented in the
REDCapTM online database system. The primary outcome is adherence to
the prescribed amount of therapy time. Secondary outcomes include
adherence measures of therapy task, task instructions, cueing and produc-
tion of verbal output as contracted to the intervention protocol for
UC-Plus and VERSE therapy. An independent evaluator will assess
therapy fidelity from 4–5 video-recorded sessions (per participant) in
UC-Plus and VERSE groups. UC sessions will be video-recorded and
evaluated as completed. Logistic regression will be used to compare group
differences.
Results: This trial is currently running in 10 centres as of 9th January 2015.
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Discussion: This methodological process will produce data that will
enable the active ingredients of very early aphasia therapy to be
determined.
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29. Ongoing Trials
Mistie III: Update on the international trial of
minimally invasive surgery plus RT-PA for spontaneous
intracerebral haemorrhage
B.A. Gregson1, A.D. Mendelow1, K. Lane2, N. McBee2,
R. Thompson3, M. Zuccarello4, I. Awad5, K. Lees6, J. Dawson6,
C. Anderson7, D. Hanley2
1Neurosurgical Trials Group, Newcastle University, Newcastle
upon Tyne, United Kingdom
2Department of Neurology, Johns Hopkins University School
of Medicine, Baltimore, USA
3Department of Biostatistics, JJohns Hopkins University
Bloomberg School of Public Health, Baltimore, USA
4Department of Neurosurgery, University of Cincinnati,
Cincinnati, USA
5Department of Neurosurgery, University of Chicago, Chicago,
USA
6Department of Cardiovascular & Medical Sciences, University
of Glasgow, Glasgow, United Kingdom
7Department of Neurology, University of Sydney, Sydney,
Australia
Background and Aims: Pilot studies of minimally invasive surgery (MIS)
for spontaneous supratentorial intracerebral haemorrhage (ICH) have
suggested that when combined with recombinant tissue plasminogen acti-
vator (rt-PA) applied directly to the clot improved recovery is seen.
MISTIE III aims to establish whether MIS plus rt-PA in selected patients
with ICH improves outcome compared with conventional medical
management.
Design: MISTIE III is an international multicentre randomised open label
trial coordinated by the BIOS group at Johns Hopkins University and
funded by US NIH. It will recruit 500 patients and will evaluate primary
outcome by a 12% increase in modified Rankin Scale score (mRS) of 0–3
at 180 days compared to medical management.
Patients and methods: Patients must have a stable ICH of >30 ml with a
GCS ≤ 14 or an NIHSS ≥ 6, and SBP <180 for six hours prior to randomi-
sation. Randomisation should occur within 72 hours of the diagnostic CT.
Outcome will be measured at 30, 180 and 365 days using video recorded
mRS assessment. Patients randomised to surgery will have a CT to
confirm correct location of the drainage catheter prior to dosing and 1 mg
of rt-PA will be administered every 8 hours for up to 9 doses. All
patients will have daily CT scans during the acute period to monitor for
rebleeding.
Progress: To date 102 patients have been recruited in the US and Israel.
About 30 sites have been recruited in UK, Germany, Hungary, and Spain.
Patient recruitment opened in Europe in December 2014.
ESOC-1512
29. Ongoing Trials
Higher stroke risk patients with previous symptoms
and cerebral infarction in the ACST-2 trial
A. Halliday1, G. ACST-2 Collaborators1
1Nuffield Department of Surgery, University of Oxford,
Oxford, United Kingdom
The Asymptomatic Carotid Surgery Trial-2, ACST-2, is an international
randomised trial comparing surgery with stenting for treatment of tight
carotid stenosis. Patients entered have not had recent ipsilateral symp-
toms, but are thought to require intervention to prevent stroke. They
should be on appropriate drug treatments with a life expectancy of at least
5 years. Over 1700 patients of a planned 3600 have been recruited. Patient
medicines are recorded by the participating physician at entry and at one
month after treatment and are reported by patients themselves at yearly
follow up. Early hazards of intervention (30-day stroke, myocardial infarc-
tion and death rates) and long-term risk of stroke will be compared
between treatment groups using Kaplan Meier analyses.Interim Results
Participants’ mean age is 72 years and median stenosis of the artery being
treated is 80%. Many patients (43%) had previous symptoms or cerebral
infarction prior to trial entry. The early (30-day) risk of serious compli-
cations, disabling stroke and death for both patient groups is 1.0%.
Patients have now been followed for up to 6 years. Almost all (98%) are
taking antithrombotic ( platelet or anticoagulant) treatment, 85% are on
statins (type and dose recorded) and over 80% are on blood pressure
lowering treatments.Conclusions Almost half of patients being recruited
to ACST-2 for stroke prevention interventions have had symptoms or
evidence of previous cerebral infarction(43%). Their long-term risk of
stroke is significantly higher than for others with no history or evidence of
previous cerebral ischaemia. The early risk of serious hazards from trial
interventions is low and we continue to monitor stroke prevention drug
therapy yearly. ACST-2 is not a trial confined to low risk patients who have
never had stroke or TIA and we continue to recruit patients thought to
require intervention because of significant future risk of stroke from their
severe carotid stenosis.
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29. Ongoing Trials
Prevention of cerebral ischaemia in stent treatment
for carotid artery stenosis – design of a randomised
trial of optimised antiplatelet therapy with outcome
assessment on MRI (PRECISE-MRI)
L. Hert1, P. Lyrer1, L. Bonati1
1Neurology, University Hospital Basel, Basel, Switzerland
Background and Aim: Carotid artery stenting (CAS) prevents stroke in
patients with carotid artery stenosis but carries a risk of peri-procedural
stroke. Ticagrelor is a novel reversible inhibitor of the platelet adenosine
diphosphate receptor P2Y12 which was superior to clopidogrel as add-on
to aspirin in preventing stent thrombosis, cardiovascular outcome events,
and death in patients undergoing coronary artery stenting, without
causing an increase in major bleeding events. The primary aim is to test
the hypothesis that ticagrelor is superior to clopidogrel as add-on to
aspirin in preventing peri-procedural ischaemic brain lesions occurring
during CAS without increasing the risk for intracerebral haemorrhage.
Study Design: Randomised placebo controlled double-bind trial. 370
patients with symptomatic or asymptomatic carotid stenosis undergoing
CAS according to local and national guidelines will be randomly assigned
to ticagrelor (180 mg loading dose prior to the procedure followed by
90 mg twice daily) or clopidogrel (300 mg loading dose followed by 75 mg
once daily). All patients will receive 100 mg aspirin per day throughout the
study period. Dual antiplatelet therapy (study drug plus aspirin) will be
continued for 28 days after stent placement. Brain MRI including
diffusion-weighted and susceptibility-weighted imaging will be per-
formed 1–3 days before CAS; 1–3 days after CAS; and 28–32 days after
CAS. The primary composite imaging study endpoint is the presence of at
least one new ischaemic or haemorrhagic brain lesion on the MRI scan
done 1–3 days or 28–32 days after CAS, which had not been present on the
MRI before the procedure.
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29. Ongoing Trials
Telstar – treatment of electroencephalographic status
epilepticus after cardiopulmonary resuscitation
B. Ruijter1, J. Horn2, M.J. Blans3, A. Beishuizen4,
A.F. van Rootselaar5, M.J.A.M. van Putten1, J. Hofmeijer1
1clinical neurophysiology, University of Twente, Enschede,
Netherlands
2intensive care, Academic Medical Center, Amsterdam,
Netherlands
3intensive care, Rijnstate Hospital, Arnhem, Netherlands
4intensive care, Medisch Spectrum Twente, Enschede,
Netherlands
5clinical neurophysiology, Academic Medical Center,
Amsterdam, Netherlands
Background: Electrographic status epilepticus is observed in 9–35% of
patients with postanoxic encephalopathy after cardiac arrest and is asso-
ciated with poor outcome. It is unclear whether these EEG patterns rep-
resent a condition to be treated with antiepileptic drugs to improve
outcome, or severe ischemic damage, in which treatment is futile. We
study the effect of early treatment with antiepileptic drugs on neurological
outcome.
Design: Multicenter clinical trial with randomised treatment allocation,
open label treatment, blinded endpoint evaluation (PROBE design).
Population: Adult patients with postanoxic encephalopathy after cardiac
arrest, admitted to an intensive care unit, with electrographic status epi-
lepticus on continuous EEG.
Intervention: Treatment of electrographic status epilepticus is based on
recommendations for treatment of status epilepticus and consists of step-
wise treatment up to thiopental, if necessary. The objective is to suppress
all epileptiform activity in the EEG during at least 24 hours. If the status
returns after 2 x 24 hours, it will be considered refractory. In the control
group, electrographic status epilepticus will be left untreated.
Endpoints: The primary outcome measure is neurological outcome
defined as the score on the Cerebral Performance Category (CPC) at 3
months, dichotomised as good (CPC 1–2 = no or moderate neurological
disability) or poor (CPC 3–5 = severe disability, coma, or death).
Sample size: The projected sample size is 172, based on a presumed reduc-
tion of poor outcome of 7%.
Trial status: Inclusion started March 1, 2014. Interested centres are invited
to participate.
clinicaltrials.gov, identifier NCT02056236
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REstart or STop Antithrombotics Randomised Trial
(RESTART)
R. Al-Shahi Salman1, K. Innes1, O. RESTART Trial Collaboration1
1Centre for Clinical Brain Sciences, University of Edinburgh,
Edinburgh, United Kingdom
Question: For adults surviving spontaneous (non-traumatic) intracere-
bral haemorrhage (ICH) who had taken an antithrombotic (i.e. antico-
agulant or antiplatelet) drug for the prevention of vaso-occlusive disease
before the ICH, does a policy of starting antiplatelets result in a beneficial
net reduction of all serious vascular events compared with a policy of
avoiding antiplatelets?
Design: Investigator-led, multicentre, open, randomised, parallel group,
assessor-masked.
Eligibility: Adults with spontaneous primary or secondary ICH who had
taken antithrombotic drugs for the prevention of vaso-occlusive disease
before ICH onset. Brain magnetic resonance imaging (MRI) performed
after ICH but before randomisation (if in MRI sub-study).
Randomisation: Central, web-based system using a minimisation algo-
rithm, with 1:1 treatment allocation to which central research staff are
masked.
Interventions: Avoid versus start antiplatelet drugs (aspirin, clopidogrel or
dipyridamole; chosen at investigator’s discretion).
Primary outcome: recurrent symptomatic ICH.
Secondary outcomes: symptomatic haemorrhagic and vaso-occlusive
events; symptomatic stroke of uncertain type; other fatal events; modified
Rankin Scale score; adherence to antiplatelets.
Power: Given the annual recurrence rate of ICH may be 1.8–7.4% and
there may be a 1–4-fold relative increase in this risk on antiplatelet
therapy, 720 participants will have 90% power to detect a doubling of an
annual ICH rate of 4.5% or 93% power to detect a quadrupling of an
annual rate of 1% over two years at the 5% level. This trial will also
provide adequately precise estimates of the rates of all serious vascular
events to inform the design of a trial with the power to assess net clinical
benefit.
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Reversal of neurological deficit in acute stroke with
signal-of-efficacy trial of auto-BPAP to limit damage
from suspected sleep apnea (REVERSE-STEAL):
A multicenter randomized trial update
J. Kepplinger1, K. Barlinn1, S. Kolieskova2, O. Chernyshev3,
X. Graehlert4, L.P. Pallesen1, V. Puetz1, A.W. Alexandrov5,
M. Vosko6, R. Mikulik2, U. Bodechtel1, A.V. Alexandrov5
1Neurology, University Hospital Dresden, Dresden, Germany
2Neurology, St. Anne’s University Hospital, Brno, Czech
Republic
3Neurology, LSU Health Shreveport, Shreveport, USA
4Coordination Center for Clinical Studies, University Hospital
Dresden, Dresden, Germany
5Neurology, University of Tennessee Health Science Center,
Memphis, USA
6Neurology, General Hospital Linz, Linz, Austria
Background: With evidence emerging, treatment with non-invasive ven-
tilation in patients with acute ischemic stroke (AIS) and sleep apnea has
been recently added as Class IIb recommendation to the updated AHA/
ASA stroke guidelines. However, most evidence originated from sub-acute
and rehabilitation phases of stroke and efficacy data for non-invasive
ventilation in the acute phase is lacking.
Methods: We conduct a multicenter randomized controlled third-rater
blinded parallel-group trial. AIS patients with symptomatic proximal
arterial obstruction and clinically suspected sleep apnea are randomized
to standard stroke care alone or standard stroke care plus auto-titrating
bilevel positive airway pressure (auto-BPAP). Auto-BPAP is initiated
within 24 hours from stroke onset and performed for a maximum of 48
hours during diurnal and nocturnal sleep. Patients undergo cardiorespi-
ratory polygraphy between days 3 and 5 to assess sleep apnea. Primary
endpoint is any early neurological improvement on the NIHSS score at 72
hours. Safety, tolerability, short-term and 3-months functional outcomes
are assessed as secondary endpoints by un-blinded and blinded observers.
Results: To date, sixteen AIS patients have been enrolled: 69% men, 68 ± 8
years, median NIHSS 12 (IQR 5–18) points. Thirteen (81%) patients had
symptomatic M1- or M2- MCA-occlusions, 2 (13%) PCA- and 1 (6%)
ICA-occlusions. Mean apnea-hypopnea-index was 12.8 ± 11.5/h sugges-
tive of sleep apnea in 11/16 (69%) patients.
Discussion: We expect that this study will further define the clinical
potential of early treatment with non-invasive ventilation in the acute
phase of ischemic stroke. The study will provide data to power a subse-
quent phase III trial.
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Thrombolysis for acute wake-up and unclear-onset
stroke trial with alteplase at 0.6 mg/kg (THAWS).
Protocol and update
M. Koga1, K. Toyoda2, K. Kimura3, H. Yamamoto4, M. Sasaki5,
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1Division of Stroke Care Unit, National Cerebral and
Cardiovascular Center, Suita, Japan
2Department of Cerebrovascular Medicine, National Cerebral
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3Department of Neurology, Nippon Medical School, Tokyo,
Japan
4Advanced Medical Technology Development, National
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5Advanced Medical Research Center, Iwate Medical University,
Morioka, Japan
6Department of Clinical Science and Medicine Graduate
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Japan
Purpose: Stroke patients with unclear-onset time have a potential to
recover with intravenous thrombolysis. MRI findings with positive DWI
and negative FLAIR (negative FLAIR pattern) can identify ischemic stroke
patients within 4.5 h from symptom onset. We aim to test the efficacy and
safety of intravenous thrombolysis with alteplase at 0.6 mg/kg (officially
approved dosage in Japan) in ischemic stroke patients with unclear-onset
time and a negative FLAIR pattern.
Design: The THAWS (ClinicalTrials.gov identifier: NCT02002325) is an
investigator initiated, multicenter (35 hospitals in Japan), prospective,
randomized, open label, blinded-endpoint assessment clinical trial. Trial
protocol was published in International Journal of Stroke (2014;9:1117–
1124). Patients with unclear-onset time will be evaluated with a multi-
modal MRI. Three hundred patients with a negative FLAIR pattern will be
randomized 1:1 to either intravenous thrombolysis with alteplase
(n = 150) or standard treatment (n = 150) within 4.5 h after symptom
recognition. We generally follow the trial design of the WAKE-UP (Clini-
calTrials.gov Identifier: NCT01525290). Intracranial hemorrhage will be
assessed on follow-up MRI after 22–36 h. Primary outcome will be
assessed at 90 days.
Study outcomes: The primary efficacy endpoint is favorable outcome
defined by 90-day mRS 0–1. The safety outcome measures are 24-h symp-
tomatic intracranial hemorrhage, serious bleeding during study period
and 90-day mortality.
Update: Patient enrollment was started in May 2014. Initial safety assess-
ment was approved from the Ministry of Health, Labour and Welfare in
Oct 2014.
Discussion: This trial may help determine whether low-dose alteplase
should be recommended for ischemic stroke patients with unclear-onset
time using MRI-based selection.
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TALOS: A multicenter, randomized, double-blind,
placebo-controlled trial to test the effects of
citalopram in patients with acute stroke – ongoing
trial
K.L. Kraglund1, G.A. Andersen1
1Neurology, Aarhus University Hospital, Aarhus C, Denmark
Rationale: Selective Serotonin Reuptake Inhibitors (SSRI) are effective in
the treatment of post-stroke depression and may have potential neuro-
protective and vascular effects. A possible neuroprotective effect was sug-
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gested to be the mechanism of an enhanced motor recovery with early
prescription of fluoxetine post stroke (Chollet et al., Lancet, 2011).
Human studies have shown a 80–90% decrease in platelet serotonin after
treatment with SSRI, and this potentially results in platelet inhibition.
SSRI treatment may thus protect against ischemic vascular events as
shown in registry data on ischemic stroke patients (Mortensen et al.,
Stroke, 2013).
Prospective studies are needed to determine the effects of SSRI treatment
after acute ischemic stroke.
Aims and design: TALOS is an ongoing investigator-initiated, national
multicenter randomized- and placebo-controlled, double-blind trial
testing citalopram in acute ischemic stroke. We hypothesize that citalo-
pram treatment initiated in the acute phase after ischemic stroke will
improve outcome assessed by the modified Rankin Score (mRS) and
reduce the risk of vascular death, TIA/stroke or myocardial infarction
during 6 months of follow-up.
Study population planned: 600 patients
Inclusion period: August 2013 – August 2015 (ongoing)
Study outcomes: There are two co-primary effect variables
1. Functional status at 6-months, (mRS), and
2. Vascular death, TIA/stroke or myocardial infarction
Secondary effect variables include
• Single primary outcomes
• Performance in activities of daily living (Barthel Index)
• Cognitive impairment (Mini Mental State Examination)
• Prevention of Post-stroke depression
Discussion: SSRI treatment may be neuroprotective and prevent new vas-
cular events, well tolerated and overall beneficial in the wake of stroke.
ESOC-1610
29. Ongoing Trials
The Norwegian Sonothrombolysis in Acute Stroke
Study (NOR-SASS)
C. Kvistad1, A. Nacu1, U. Waje-Andreassen1, H. Naess1,
L. Thomassen1
1Dep. of Neurology, Haukeland University Hospital, Bergen,
Norway
Background: Sonothrombolysis augments intravenous thrombolysis by
promoting fluid motion around the thrombus, weakening fibrin cross-
links and increasing tPA concentration within the thrombus. Contrast
enhanced sonothrombolysis (CEST), adding iv gaseous microspheres
(Sonovue), may potentiate the effect of ultrasound. When exposed to
ultrasound, microspheres oscillate, expand and collapse, agitate surround-
ing fluid, erode thrombus surface and increase the surface area for throm-
bolytic action. As yet, there are no randomized studies of CEST in
ischemic stroke patients without arterial occlusion, patients treated with
iv tenecteplase or patients ineligible for iv thrombolysis.
Methods: Unselected patients ≥18 years with acute ischaemic stroke with/
without visible arterial occlusion on admission CTA are randomized 1:1
within <41⁄2h to CEST (2 MHz TCD for 60 min + 10 ml Sonovue) or
placebo in a single center PROBE (Prospective Randomised Open-label
Blinded Endpoint) trial. Both patients receiving either alteplase or tenect-
eplase (NOR-SASS A+B) and patients ineligible for iv thrombolysis
(NOR-SASS C) are included. Primary endpoints are early clinical
outcome at 24 h and functional handicap at 90 days.
Results: Approximately 200 patients have been included so far. To date,
data and safety committee has not found any safety issues and the study is
still recruiting patients (18 February 2015).
Discussion: If a positive effect can be proven, CEST may become a thera-
peutic option for a broader acute ischemic stroke population, including
patients without arterial occlusion, patients treated with tenecteplase and
patients ineligible for iv thrombolysis.
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29. Ongoing Trials
The Norwegian Tenecteplase Stroke Trial (NOR-TEST):
Randomised controlled trial of tenecteplase vs.
alteplase in acute ischaemic stroke
N. Logallo1, L. Thomassen1
1Neurology, Haukeland University Hospital, Bergen, Norway
Background: Alteplase is the only approved thrombolytic agent for acute
ischaemic stroke. Tenecteplase may be more effective and less harmfull
than alteplase, but large randomised controlled phase 3 trials are lacking.
The Norwegian Tenecteplase Stroke Trial (NOR-TEST) aims to compare
efficacy and safety of tenecteplase vs. alteplase.
Methods/Design: NOR-TEST is a multi-centre PROBE (prospective ran-
domised, open-label, blinded endpoint) trial designed to establish supe-
riority of tenecteplase 0.4 mg/kg (single bolus) as compared with alteplase
0.9 mg/kg (10% bolus + 90% infusion/60 minutes) for consecutively
admitted patients with acute ischaemic stroke eligible for thrombolytic
therapy, i.e. patients a) admitted <41⁄2 hours after symptoms onset; b)
admitted <41⁄2 hours after awakening with stroke symptoms c) receiving
bridging therapy before embolectomy.
Randomisation tenecteplase:alteplase is 1:1. The primary study endpoint
is favourable functional outcome defined as modified Rankin Scale 0–1 at
90 days. Secondary study endpoints are: 1) haemorrhagic transformation
(haemorrhagic infarct/haematoma); 2) symptomatic cerebral haemor-
rhage on CT 24–48 hours; 3) major neurological improvement at 24
hours; 4) recanalisation at 24–36 hours; 5) death.
Results: To date, data and safety monitoring committee has not found any
safety issue and the study is still recruiting patients. Approximately 400
patients have been so far included (1st March 2015).
Discussion: NOR-TEST may establish a novel approach to acute ischae-
mic stroke treatment. A positive result will lead to a more effective, safer
and easier treatment for all acute ischaemic stroke pasients.
NOR-TEST is registered with EudraCT No 2011-005793-33 and in Clini-
calTrials.gov (NCT01949948).
ESOC-1608
29. Ongoing Trials
Fluoxetine Or Control Under Supervision (FOCUS)
C. Williams1, K. Innes1, M.S. Dennis1, G.E. Mead1,
f. FOCUS Trial Collaborators1
1Centre for Clinical Brain Sciences, University of Edinburgh,
Edinburgh, United Kingdom
Introduction: Recent small trials suggest that selective serotonin reuptake
inhibitors improve neurological and overall recovery after stroke. Our
aims are to determine whether fluoxetine 20 mg daily for 6 months,
started at 2–15 days after stroke onset in patients with persisting neuro-
logical deficits, reduces dependency at 6 months and whether any benefits
persist to 12 months.
Methods: This UK wide, multicentre, randomised placebo-controlled
trial aims to recruit 3000 patients. Eligible patients providing informed
consent are randomised by a central web-based system. Patients’ progress
in-hospital and early adherence are collected by local follow-up at hospital
discharge (for inpatients) and central follow-up at one month (for out-
patients). Other secondary outcomes (survival, health related quality of
life, mood, fatigue, Stroke Impact Scale, new clinical diagnosis of depres-
sion and resource use) are collected at 6 and 12 months via postal, or
telephone questionnaires to patients and general practitioners. Based on a
sample size for a binary outcome, a trial of 3000 (1500 per group) will
provide greater than 90% power (alpha = 0.05) to detect a 5.5% absolute
increase in proportion of patients with a modified Rankin score of 0–2
(i.e. independent) (odds ratio = 1.30). Using an ordinal sample size
method, we will detect a common odds ratio of 1.23. We have harmonised
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assessments with the Australian AFFINITY (Assessment of fluoxetine in
stroke recovery) and Swedish EFFECTS (Efficacy oF Fluoxetine – a ran-
domisEd Controlled Trial in Stroke) trial.
Conclusion: FOCUS will show whether fluoxetine improves overall recov-
ery in a broad range of stroke patients.
ESOC-0410
29. Ongoing Trials
Pragmatic Ischaemic Stroke Thrombectomy Evaluation:
PISTE
A. Murray1, K.W. Muir2, P. White3
1Glasgow Clinical Research Facility, NHS Greater Glasgow
Clyde, Glasgow, United Kingdom
2University of Glasgow, Institute of Neuroscience &
Psychology, Glasgow, United Kingdom
3Newcastle University, Institute of Neuroscience, Newcastle,
United Kingdom
Intravenous thrombolytic treatment (IVT) within 4.5 hours of onset
improves the probability of recovery to independence after acute ischae-
mic stroke, but is much less effective in patients with large artery occlusion
(LAO). Outcomes in this group of patients (up to two thirds of those
eligible for IVT) remain particularly poor, with high mortality (around
25%) and likelihood of disability (>45%). Since recanalisation of the
occluded artery is strongly associated with the likelihood of good recovery,
treatment that can more effectively open the occluded artery may benefit
this group.
Devices for endovascular mechanical thrombectomy are known to
increase recanalisation rates. Recent clinical trials indicate superiority of
endovascular thrombectomy over medical treatment alone in the setting
of persistent LAO despite IVT and have demonstrated encouraging safety
data with their use. However, the effect of endovascular treatment as
adjunctive care in all LAO patients when initiated as early as possible after
starting IVT remains to be fully determined.
PISTE is a pragmatic RCT comparing standard IV thrombolysis (rtPA)
with IV lysis and additional mechanical thrombectomy in patients with
ischaemic stroke eligible for thrombolysis who have a relevant anterior
circulation large vessel occlusion. Any approved device can be used.
The full scale trial follows on from the nearly completed pilot phase. It
involves the hyperacute stroke research centre network and other
UK/Norwegian centres with neurointerventional expertise in stroke.
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29. Ongoing Trials
Head Position in Stroke Trial (HeadPoST): Challenges of
setting up of a large international stroke nursing care
trial
C. Watkins1, P. Munoz Venturelli2, T. Robinson3, H. Arima4, J. Lim4,
M. Hackett4, S. Middleton5, V. Olavarría2, A. Brunser2, P. Lavados2,
B. Peng6, L. Cui6, R.T. Lin7, T.H. Lee8, O. Pontes9, L. Natsagdorj10,
C. Anderson4
1Lancashire Clinical Trials Unit, University of Central
Lancashire, Preston, United Kingdom
2Neurology, Clinica Alemana de Santiago – Universidad del
Desarrollo, Santiago, Chile
3Department of Cardiovascular Sciences, University of
Leicester, Leicester, United Kingdom
4NMH, The George Institute for Global Health Royal Prince
Alfred Hospital and University of Sydney, Sydney, Australia
5National Centre for Clinical Outcomes Research (NaCCOR),
Australian Catholic University & St Vincent’s Health, Sydney,
Australia
6Department of Neurology, Peking Union Medical College
Hospital Chinese Academic Medical Science, Beijing, China
7Stroke Centre, Kaohsiung Medical University Chung-Ho
Memorial Hospital, Taiwan, Taiwan
8Department of Neurology, Linkou Chang Gung Memorial
Hospital, Taiwan, Taiwan
9Department of Neuroscience and Behavior, Ribeirão Preto
School of Medicine University of Sao Paulo, Ribeirão Preto,
Brazil
10Department of Neuroscience and Behavior, State Third
Hospital, Ulanbaatar, Mongolia
Background: There is insufficient evidence to recommend a specific head
position in patients with acute ischemic stroke (AIS) or intracerebral
hemorrhage (ICH). Potential benefits of lying flat in AIS and conversely
sitting up in ICH may be offset by increased risk of aspiration pneumonia
and cardiac-respiratory failure.
Aims: To compare the effects of lying flat (0°) with sitting-up (≥30°) head
position applied in the first 24 hours of admission for patients presenting
with acute stroke on poor outcome (death or disability) at 90 days. Key
secondary aim is to determine if sitting up is superior to lying flat in acute
ICH.
Methods: A multicenter, prospective, cluster randomized, crossover,
blinded outcome assessed, clinical trial through a 140 hospitals in Austra-
lia, China, Taiwan, Mongolia, Chile, Brazil, and United Kingdom. Key
aspects of the study to avoid bias include consecutive recruitment (selec-
tion bias), thorough preparation and training of site staff (compliance and
overcome local barriers) and central blinded outcome assessment
(observer bias). Sample size is calculated on each hospital recruiting 140
consecutive patients. Funded by the National Health and Medical
Research Council (NHMRC) of Australia.
Results: Set-up of the study was performed during 2014 in 7 countries
and more than 100 hospitals, addressing compliance and other key aspects
of consecutive recruitment, thorough training and overcoming local bar-
riers. Patient recruitment will occur during 2015–2016.
Conclusions: Cooperation, training and communications are essential to
setting up and conducting the study. Given uncertainty over benefits/risks,
reliable randomized evidence is required to standardize clinical and
nursing practice.
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29. Ongoing Trials
Establishment of a research and training network for
aphasia after stroke
M. Ali1, K. VandenBerg1, A. Bowen2,
M. Brady On behalf of the Collaboration of Aphasia Trialists1
1NMAHP Research Unit, Glasgow Caledonian Unversity,
Glasgow, United Kingdom
2School of Psychological Sciences, Manchester University,
Manchester, United Kingdom
Introduction: Aphasia research faces methodological and infrastructural
challenges, often remaining language, region, and discipline-specific, lim-
iting the efficiency, strength, and broader relevance of individual research.
Funded by the European Cooperation in Science and Technology (COST),
the Collaboration of Aphasia Trialists (CATs) enhances knowledge, skills
and methodology in aphasia research on an international level.
Methods: We established a memorandum of understanding; two indi-
viduals represent each participating country on a management commit-
tee. We established working groups to investigate (i) assessment and
outcome measures for aphasia research, (ii) prognosis and predictors of
recovery, (iii) effectiveness of interventions, and (iv) societal impact and
re-integration. We collated aphasia trial datasets to facilitate novel explor-
atory and secondary analyses to address gaps in knowledge and inform
trial design. We facilitated knowledge exchange across our network
through training visits at participating institutions within CATs.
Results: Our network includes >85 multidisciplinary members, across 22
European countries, Australia, New Zealand and South Africa. Our active
research programmes include systematic reviews, meta-analyses, improve-
ments in the quality of aphasia research methodology and reporting and
translation of language assessment tools across multiple languages. We
have also facilitated 8 research training visits across the collaboration,
developed and informed international aphasia research grant applications
and established annual training schools for early stage aphasia researchers.
Conclusions: Expansion and integration of trial networks is essential to
facilitate research translation. CATs facilitates high-quality, synergistic
international research, dissemination and training opportunities. We
welcome additional participation in this Collaboration by the aphasia
research community. Information can be found at www.aphasiatrials.org
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29. Ongoing Trials
Head Position in Stroke Trial (HeadPoST) pilot phase
V. Olavarria1, P.M. Lavados1, P.M. Muñoz-Venturelli1, S. Gaete2,
S. Martins3, H. Arima4, S. Heiritier4, C.S. Anderson4, A.M. Brunser1
1Internal Medicine, Clinica Alemana Universidad del
Desarrollo Instituto de Neurociencias, Santiago, Chile
2Internal Medicine, Hospital Dr. Lautaro Navarro Avaria,
Punta Arenas, Chile
3Neurology, Hospital de Clinicas de Porto Alegre, Porto
Alegre, Brazil
4Neurology, The George Institute for Global Health University
of Sydney, Sydney, Australia
Background: Controversy exists over the optimal head position in acute
ischemic stroke (AIS) patients in the first 24–48 hours. Interventions that
augment cerebral blood flow (CBF) could be beneficial. The simplest way
to do this could be to place the head in “lying flat” rather than “sitting up”
position. Potential benefits may be offset by an increased risk of pneumo-
nia or cardiac failure. Aims: HeadPoST Pilot will determine the safety,
feasibility and potential efficacy of the “lying flat” compared to the
standard “sitting up” head position in AIS patients. Methods: Cluster
randomized, open, blinded endpoint assessment, active-comparative
international clinical trial. Patient are included if within 12 hours from
symptom onset, anterior circulation infarction, NIHSS > 1 and adequate
sonographic window. Main efficacy outcome is mean CBF velocity in the
“lying flat” compared to the “sitting up” head position assessed by Tran-
scranial Doppler (TCD) to the middle cerebral arteries. Secondary objec-
tives are safety and neurological status at 7 days and disability at 90 days.
A sample size of 32 clusters (mean 3 patients) was calculated to detect an
8.3 cm/s increase in CBF velocity (IC 95% 4.82 a 12.03) with 90% power,
5% significance. Results: The study has included 76 patients (16 clusters)
as of January 2015 in 3 centres. No safety concerns have been raised by the
DSMB. Conclusions: This pilot phase is recruiting on schedule. The lying
flat head position is a potential low cost, widely applicable, nursing inter-
vention to increase CBF in AIS and may improve clinical outcomes.
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29. Ongoing Trials
A randomized controlled trial of nature-based
post-stroke fatigue rehabilitation (“the nature stroke
study” (NASTRU)): study design and progress report
A. Pálsdóttir1, G. Andersson2, P. Grahn1, B. Norrving3,
S. Kyrö Wissler1, I.F. Petersson4, H. Pessah-Rasmussen5
1Dept. Work Science Business Economics and Environmental
Psychology (AEM), Swedish University of Agricultural Sciences
(SLU), Alnarp, Sweden
2VO Neurology and Rehabilitation Medicine, Skånes
University Hospital, Malmö, Sweden
3Dept. of clinical sciences Neurology & VO Neurology and
rehabilitation medicine Skånes University Hospital, Lunds
University, Lund, Sweden
4Orthopaedics Dept. of clinical sciences & Epidemiology and
Register Centre South Skåne, Lunds University, Lund, Sweden
5Department of Neurology and Rehabilitation medicine
Skåne University Hospital Dept health science, Lund
University, Lund, Sweden
Fatigue is common after stroke and contributes to disability, impaired
quality of life, and reduced work ability. Currently, there is no evidence-
based intervention for post-stroke fatigue but idiopathic chronic fatigue
and burnt-out syndromes may benefit from nature-based rehabilitation.
The aim of NASTRU was to examine whether ten weeks of nature-based
rehabilitation, as add-on to standard management, could influence post-
stroke fatigue (primary outcome), depression, work ability or functional
outcome (secondary outcomes), compared to controls.
Inclusion criteria were patients with stroke living in the catchment area of
the Skåne University Hospital, 50–80 years old, independent in ADL, and
reporting fatigue at 3 months (sub-acute subgroup) or >one year (chronic
sub-group) after the index stroke. Patients randomized to the intervention
underwent a rehabilitation program in groups up to 8 patients in an
especially designed garden at the Swedish University of Agricultural Sci-
ences, Alnarp. The intervention was grounded in environmental psychol-
ogy and occupational therapy, supported by a multimodal rehabilitation
team that utilized the garden/nature for sensory stimulation, body aware-
ness, meaningful occupations and nature experiences.
The enrollment of 101 patients (51 intervention; 50 control) was com-
pleted on August 2014. Follow-up is on-going, with assessments by exam-
iner blinded to treatment group, at end of intervention period, 8 months,
and 14 months after randomization. A parallel study with qualitative
in-depth interviews in a subset of patients, who were randomized to the
intervention group, as well as the staff, is also on going.
Abstracts
© 2015 The Authors.
International Journal of Stroke © 2015 World Stroke Organization Vol 10 (Suppl. 2); April 2015; 77–438430
ESOC-1605
29. Ongoing Trials
An audit of prevalence of obstructive sleep apnoea in
a cohort of patients attending tia clinics within
william harvey hospital
A. Saxena1, D. Hargroves2
1School of Medicine, King’s College London, London, United
Kingdom
2Stroke Medicine, William Harvey Hospital, Ashford, United
Kingdom
Introduction: An on-going audit to assess prevalence of obstructive sleep
apnoea (OSA) in a cohort of patients attending TIA clinics at William
Harvey Hospital (WHH) with complaints of both transient focal neuro-
logical symptoms and disturbed sleep.
Method: An on-going case review of patients seen in the TIA clinics at
WHH and referred to overnight sleep studies if they have evidence of
increased day time sleepiness and/or nocturnal sympathetic over-activity.
Information recorded included results categorized by AHI.
Results: 460 patients have been referred to sleep studies.
Based on their sleep study results:
• 117 (25.4%) had mild OSA
• 68 (14.8%) had moderate OSA,
• 32 (7.0%) had severe OSA,
• 22 (4.8%) required a repeat study,
• 221 (48%) had no significant OSA
• Therefore, 217 out of 460 patients (47.2%) were diagnosed with
OSA.
Discussion: The prevalence of OSA in the cohort of TIA and stroke
patients at William Harvey Hospital was 47.2% compared to the average
prevalence of 2–9% in the general population. Therefore, the study dem-
onstrates the positive correlation between neurovascular diseases and
OSA similar to emerging evidence. The clinical importance is physicians
in neurovascular clinics should use the screening questions and Epworth
sleeping scale in order to identify and manage OSA earlier. The benefits of
treating OSA are improved blood pressure control, decreased cardiovas-
cular morbidity and mortality, reduced healthcare costs and improvement
in clinical symptoms. Furthermore, treating OSA in patients with known
cardiovascular disease can decrease risk of further events and increase
time to such events.
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29. Ongoing Trials
Optimising the analysis of cognition collaboration
(OA-Cog)
P. Scutt1, P.M.W. Bath1, A.A. Montgomery2
1Stroke Division of Clinical Neuroscience, University of
Nottingham, Nottingham, United Kingdom
2Nottingham Clinical Trials Unit, University of Nottingham,
Nottingham, United Kingdom
Rationale: Over 800,000 people suffer with dementia in the UK. The
evidence base for the treatment of cognitive decline and dementia is small.
One reason for this may be that the measures used to assess cognition in
clinical trials are not sensitive to change and/or the analyses used are
suboptimal. OA-Cog aims to identify the most efficient cognitive mea-
surement and analysis technique for cognition data and dementia in ran-
domised controlled trials.
Design: Chief investigators of randomised controlled trials with cognitive
outcome assessments are asked to share individual patient data from their
trials. Variables requested include baseline prognostic factors, treatment
group, cognitive measures (e.g. Mini Mental State Examination (MMSE),
Alzheimer’s Disease Assessment Scale cognitive sub-score (ADAS-cog))
and other outcome measures (e.g. death, dementia).
Data are then analysed using various endpoints (e.g. mean MMSE score at
end of trial, MMSE score as a gradient over time) and statistical methods
(e.g. Wilcoxon rank-sum test, repeated measures ANOVA) in order to
identify which is the most efficient.
Trial Status: As of 15th December 2014, data from 28 clinical trials, with a
total of 82,668 patients, have been shared. The OA-Cog project is currently
seeking further clinical trial data.
ESOC-1403
29. Ongoing Trials
Navigate ESUS: Multicenter, randomized, double-blind,
phase III study of prevention of recurrent stroke and
systemic embolism in patients with recent embolic
stroke of undetermined source
R. Veltkamp1, A. Dávalos2, D. Toni3, L. Cunha4, R. Brouns5, K. Muir6,
H. Mundl7, S.D. Berkowitz8, A. Shoamanesh9, S.J. Connolly10
1Medicine (Division of Brain Sciences), Imperial College
London, London, United Kingdom
2Neurosciences, Autonomous University of Barcelona,
Barcelona, Spain
3Neurology and Psychiatry, Sapienza University of Rome,
Rome, Italy
4Neurology, Coimbra University, Coimbra, Portugal
5Neurology, Vrije Universiteit Brussel, Brussels, Belgium
6Neurology, University of Glasgow, Glasgow, United Kingdom
7Global Clinical Development (Cardiovascular – Thrombosis),
Bayer Healthcare, Wuppertal, Germany
8Global Clinical Development (Cardiovascular – Thrombosis),
Bayer Healthcare, Whippany, USA
9Medicine (Division of Neurology), Population Health
Research Institute – McMaster University, Hamilton, Canada
10Medicine (Division of Cardiology), Population Health
Research Institute – McMaster University, Hamilton, Canada
Rationale: Embolic stroke of undetermined source (ESUS) has been
defined as a non-lacunar infarction without proximal arterial stenosis or
identified high risk source of cardioembolism. The risk of recurrent stroke
in older ESUS patients is substantial despite current standard of care.
Objective: To determine whether rivaroxaban is superior to aspirin for
reducing the risk of recurrent stroke and systemic embolism after recent
ESUS.
Design: Multicenter, multinational, double-blind, double-dummy, active-
controlled randomized clinical trial.
Population: Seven thousand patients aged ≥18 years randomized within 6
months of their qualifying stroke. Main eligibility criteria are outlined in
the Table.
Table. Main Eligibility Criteria
Inclusion criteria Definition
Embolic stroke of
undetermined
source
Non-lacunar ischemic stroke visualized by
neuroimaging
Absence of relevant extracranial arterial
occlusion/atherosclerotic stenosis ≥50%
No history/evidence of atrial fibrillation after at
least 24 hours of cardiac monitoring
Absence of intracardiac thrombus
Absence of other specific cause of stroke
Exclusion criteria
Specific contraindications to aspirin or rivaroxaban
Indication for chronic anticoagulation or
antiplatelet therapy
GFR
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Intervention: Rivaroxaban 15 mg daily or aspirin 100 mg daily (1:1
blinded randomization).
Primary outcome: Time to recurrent stroke or systemic embolism.
Secondary outcomes: Time to the composite of cardiovascular death,
recurrent stroke, systemic embolism, and myocardial infarction, the indi-
vidual components of the composite, and all-cause mortality. The
primary safety outcome is major bleeding (ISTH criteria).
Statistical analysis: The primary efficacy intention-to-treat analyses will
compare rivaroxaban to aspirin using an age-stratified log-rank test.
Current Status: First participant randomized in December, 2014. Target of
400 recruitment sites in 27 countries.
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29. Ongoing Trials
Interference of blood pressure control within 24 h in
acute ischemic stroke. Systematic review and
meta-analysis. Protocol
A.A. da Silva1, G.J.M. Porfirio2, M.R. Pedrosa2, G.S. Silva3,
A.N. Atallah2
1Brazilian Cochrane Center, Universidade Federal de São
Paulo/ Hosp. Israelita Albert Einstein, Sao Paulo, Brazil
2Brazilian Cochrane Center, Universidade Federal de São
Paulo, Sao Paulo, Brazil
3Neurology, Universidade Federal de São Paulo / Hosp.
Israelita Albert Eisntein, Sao Paulo, Brazil
Introduction: Review the evidence on how acute variation in blood pres-
sure (BP) during first 24 hours of acute ischemic stroke (AIS) can influ-
ence outcome.
Methods: Searched the Cochrane Central Register of Controlled Trials
(CENTRAL) (The Cochrane Library 2015, Issue 12); MEDLINE (1954 to
feb 2015); EMBASE (1980 to feb 2015); CINAHL (1982 to feb 2015),
database of Research in Stroke (DORIS) (2008 to 2013), Latin American
and Caribbean Health Sciences Literature (LILACS) (1982 to feb 2015)
and reference lists of articles. We contacted researchers in the field. We also
searched Dissertation Abstracts International via Dissertation Express,
and the meta-Register of Controlled Trials. In an effort to identify further
published, unpublished, ongoing trials and SCOPUS.
Objectives: Primary: Death or dependency at the end of scheduled follow-
up. Dependency is defined as being severely dependent on others in activi-
ties of daily living, or being significantly disabled; this corresponds to a
Barthel Index score or a modified Rankin Scale grade 3 to 6 at three
months follow-up.
Secundary: 1. Standardized non-disease-specific instrument for describ-
ing and valuating health-related quality of life. EQ-5D (EuroQol) ques-
tionnaire. 2. The NIH Stroke Scale measure of neurologic deficit; the
Barthel Index measure of activities of daily living; the Modified Rankin
Scale measure of the degree of disability or dependence in daily activities
90 days follow-up. 3. Average time of hospital discharge. 4. Time to dis-
charge from the Neuro ICU or Neurocritical Care Unit. 5. Assessment of
systolic and diastolic blood pressure control. 6. Causality assessment of
adverse events following blood pressure reduction within 24 h of AIS.
ESOC-0995
29. Ongoing Trials
TICH-2 Trial – tranexamic acid for intracerebral
haemorrhage 2
N. Sprigg1, P.M.W. Bath1, K. Krishnan1, H. Foster1, T. Payne1,
M. Adrian1, J. Keeling1, H. Howard1, M. Stringer1, K.S. Robson1
1Stroke – Division of Clinical Neuroscience, University of
Nottingham, Nottingham, United Kingdom
Rationale: To assess in a pragmatic phase III prospective double blind
randomised placebo-controlled trial whether tranexamic acid is safe and
reduces death or dependency after primary intracerebral haemorrhage
(PICH). The results will determine whether tranexamic acid should be
used to treat PICH, which currently has no proven therapy.
Design: Patients will be randomised (1:1) to receive either tranexamic
acid or placebo (0.9 % saline) within 8 hours of acute primary intracere-
bral haemorrhagic stroke.
Randomisation will be computerised and minimised on key prognostics
age; sex; time since onset; systolic blood pressure; stroke severity (NIHSS);
presence of intraventricular haemorrhage and known history of antiplate-
let treatment. Patients randomised to placebo will receive intravenous
normal saline. Patients, investigators and outcome assessors will be blind
to treatment allocation. The primary outcome is death or dependency
(modified Rankin Scale, mRS) and telephone follow-up is at day 90.
Trial status: The start-up phase of the trial commenced on 1 March 2013
and ran for 1 year and the main phase commenced 1st April 2014. The
recruitment target was 300 participants in the start-up phase and 2,000 in
the main phase. As at 6th January, 2015 754 patients have been recruited
from 78 centres (UK, Georgia, Italy). The objective is to have 80 UK
centres and 40 international centres.
Funding: The National Institute of Health Research, Health and Technol-
ogy Assessment Programme
Contact information: http://tich-2.org, E-mail: tich-2@nottingham.ac.uk,
Telephone: +44 (0)115 823 1770
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29. Ongoing Trials
A European, multicentre, phase III, clinical trial of
hypothermia for acute ischaemic stroke: EuroHYP-1
N. Sprigg1, P.M.W. Bath1, K. Lees2, M. Macleod3
1Stroke – Division of Clinical Neuroscience, University of
Nottingham, Nottingham, United Kingdom
2Institute of Cardiovascular and Medical Sciences, University
of Glasgow, Glasgow, United Kingdom
3Centre for Clinical Brain Sciences, University of Edinburgh,
Edinburgh, United Kingdom
Background: Cooling is a promising neuroprotective intervention in
experimental ischaemic stroke; cooling to 35°C reduced infarct size by
about one third. Cooling awake ischaemic stroke patients to 35°C has been
shown feasible and safe, but whether this is safe and effective has not been
tested in a large clinical trial.2
Aims: To determine whether systemic cooling to target temperature of 34
to 35°C, started within 6 hours of symptom onset and maintained for 24
hours, improves functional outcome at 3 months in patients with acute
ischaemic stroke.
Methods: Open, randomised, phase III, multicentre, international clinical
trial with masked outcome assessment testing the safety and efficacy of
therapeutic cooling in 1500 awake adult patients with acute ischaemic
stroke. Cooling will be initiated within 6 hours of symptom onset with an
intravenous infusion of 20 ml/kg cooled normal saline (4°C) over 30 to 60
minutes, followed by either surface or endovascular cooling to 34 to 35°C,
maintained for 24 hours. Shivering and discomfort will be prevented and
treated with anti-shivering drugs. All patients will receive best medical
treatment, including alteplase, if indicated. The primary outcome is cen-
trally adjudicated modified Rankin Scale (mRS) at 90 days (shift analysis).
A trial with 750 patients per arm has 90% power to detect a 7% absolute
improvement in the mRS at the 5% significance level.
Conclusion: EuroHYP-1 is ongoing, and funded by the European Com-
mission within the 7th Framework Programme (FP7/2007–2013) grant
agreement number 278709.
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29. Ongoing Trials
A multicentre, randomized, double-blind,
placebo-controlled trial to test efficacy and safety of
MRI-based thrombolysis in wake-up stroke (WAKE-UP)
G. Thomalla1, J.B. Fiebach2, S. Pedraza3, V. Thijs4,
N. Nighoghossian5, P. Roy6, K. Muir7, M. Ebinger2, J. Puig3,
F. Boutitie6, C.Z. Simonsen8, M. Endres2, J. Fiehler9, C. Gerloff1
1Neurology, University Medical Center Hamburg-Eppendorf,
Hamburg, Germany
2Neurology, Charité, Berlin, Germany
3Neuroradiology, IDIBGi, Girona, Spain
4Neurology, KU Leven, Leuven, Belgium
5Neurology, HCL, Lyon, France
6Biostatistics, HCL, Lyon, France
7Neurology, University of Glasgow, Glasgow, United Kingdom
8Neurology, Arhus University Hospital, Arhus, Denmark
9Neuroradiology, University Medical Center
Hamburg-Eppendorf, Hamburg, Germany
Background: In about 20% of acute ischemic stroke patients symptoms
occur during sleep. These patients are generally excluded from intrave-
nous thrombolysis. Recently, it was shown that MRI can identify patients
within the time-window for thrombolysis (≤4.5 h from symptom onset)
by a mismatch between the acute ischemic lesion visible on diffusion
weighted imaging (DWI) but not visible on fluid-attenuated inversion
recovery (FLAIR) imaging. WAKE-UP (Efficacy and safety of MRI-based
thrombolysis in wake-up stroke: a randomised, double-blind, placebo-
controlled trial) aims to test the efficacy and safety of MRI-guided throm-
bolysis with tissue plasminogen activator (rtPA) in ischemic stroke
patients with unknown time of symptom onset.
Methods: WAKE-UP is an investigator initiated, European, multicentre,
randomized, double-blind, placebo-controlled clinical trial. Patients with
unknown time of symptom onset who otherwise comply with clinical
inclusion and exclusion criteria for thrombolysis will be studied by MRI.
Patients with MRI findings of a DWI-FLAIR-mismatch will be ran-
domised to either treatment with rtPA or placebo. The primary efficacy
endpoint will be favourable outcome as defined by modified Rankin Scale
0–1 at day 90. The primary safety outcome measures will be mortality and
death or dependency as defined by modified Rankin Scale 4–6 at 90 days.
WAKE-UP is registered with the EU Clinical Trials Register (EudraCT No.
2011-005906-32) and ClinicalTrials.gov (ClinicalTrials.gov Identifier
NCT01525290).
Results: The trial has started in October 2012 and is currently recruiting
patients in 6 European countries. A first interim safety analysis was per-
formed after 100 patients had completed the trial. No safety concerns have
been raised as of yet. An update on the number of active sites and enroll-
ment status will be given.
Conclusion: WAKE-UP is an innovative clinical trial applying novel MRI
criteria to identify stroke patients with unknown time of symptom onset
likely to benefit from thrombolysis based on the estimation of lesion age.
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29. Ongoing Trials
APACHE-AF: Apixaban versus antiplatelet drugs or no
antithrombotic treatment after
anticoagulation-associated intracerebral haemorrhage
in patients with atrial fibrillation. A randomized phase
II clinical trial
K.M. van Nieuwenhuizen1, H.B. van der Worp1, A. Algra2,
I.C. van Gelder3, L.J. Kappelle1, G.J.E. Rinkel1, R.E.G. Schutgens4,
C.J.M. Klijn1, on behalf of the APACHE-AF investigators5
1Neurology and Neurosurgery Brain Center Rudolf Magnus,
University Medical Center Utrecht, Utrecht, Netherlands
2Neurology and Neurosurgery Brain Center Rudolf Magnus
and Julius Center for Health Sciences and Primary Care,
University Medical Center Utrecht, Utrecht, Netherlands
3Cardiology, University Medical Center Groningen, Groningen,
Netherlands
4Van Creveldkliniek, University Medical Center Utrecht,
Utrecht, Netherlands
5, Netherlands
Background: There is a lack of evidence on the optimal prevention of
ischaemic stroke in patients with atrial fibrillation and a recent intracere-
bral haemorrhage (ICH) during treatment with oral anticoagulation.
These patients are currently treated with vitamin K antagonists, antiplate-
let drugs, or no antithrombotic treatment, depending on personal and
institutional preferences. Treatment with a direct oral anticoagulant like
apixaban might be an attractive alternative in terms of a low risk of
recurrent ICH, while at the same time being effective for the prevention of
ischaemic stroke.
Objective: To obtain reliable estimates of the rates of vascular death or
non-fatal stroke in patients with atrial fibrillation and a recent
anticoagulation-associated ICH who are treated with apixaban versus
those who are treated with antiplatelet drugs or no antithrombotic drug at
all.
Study design: Multi-centre, phase II, randomised, open-label clinical trial
with blinded outcome assessment.
Study population: 100 adults with a history of atrial fibrillation and a ICH
during treatment with oral anticoagulation in whom clinical equipoise
exists on the optimal stroke prevention therapy.
Intervention: Patients will be randomized to apixaban 5 mg twice daily or
to avoiding anticoagulation. Patients will be randomized between 7–90
days after the index haemorrhage.
Primary outcome: Vascular death or non-fatal stroke.
Sample size: Ten primary outcome events in 100 patient-years of follow
up will yield a 95% confidence interval of 4.9 to 17.6.
Funding: The Netherlands Organisation for Health Research and Devel-
opment, Dutch Heart Foundation.
Status: Recruitment started, first patients randomised.
Registration: NTR4526
Trial website: http://www.apache-af.com
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29. Ongoing Trials
The optimising the analysis of vascular prevention
trials project (OA-PREVENTION)
L.J. Woodhouse1, A. Montgomery2, P.M.W. Bath1
1Stroke Division of Clinical Neuroscience, University of
Nottingham, Nottingham, United Kingdom
2Nottingham Clinical Trials Unit, University of Nottingham,
Nottingham, United Kingdom
Rationale: Due to major advances being made in primary and secondary
vascular prevention and the risk of recurrence of vascular events falling,
vascular prevention trials are increasing in size. Since the number of trials
has also increased, it is increasingly difficult to recruit patients into new
trials. Therefore new strategies are needed to reduce trial sample sizes and
to amplify the potential to demonstrate benefit. OA-Prevention aims to
identify the most efficient type of outcome measure and analysis tech-
nique for vascular prevention data in randomised controlled trials.
Methods: Prevention trials typically count outcomes as dichotomous
events although this is inefficient statistically and gives no indication on
the severity of recurrent events. Vascular events could therefore be poly-
chotomised with ordering determined by severity. It is planned to test this
concept by using data from vascular prevention trials.
Design: Chief investigators of randomised controlled trials in vascular
prevention are asked to share individual patient data from their trials.
Requested data includes baseline prognostic factors, treatment group and
vascular event outcome data (including information on severity).
Status: As of 8th January 2015, data from 17 clinical trials (7 primary
prevention, 9 secondary and 1 acute) with a total of 91,721 participants
have been shared with the collaboration. The OA-Prevention project is
currently seeking further clinical trial data.
Contact Information:
E-mail: L.Woodhouse@nottingham.ac.uk
Telephone: +44 (0) 115 823 1670
Postal Address: Stroke, Division of Clinical Neuroscience
University of Nottingham
Room B48, Clinical Sciences Building
North Road, City Hospital Campus
Nottingham NG5 1PB, United Kingdom
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29. Ongoing Trials
The thrombolysis in uncontrolled hypertension (TRUTH)
study: An observational study on treatment strategy of
elevated blood pressure in stroke patients eligible for
IVT
T.P. Zonneveld1, A. Algra2, D.W.J. Dippel3, L.J. Kappelle4,
R.J. van Oostenbrugge5, Y. Roos1, M.J. Wermer6,
H.B. van der Worp4, P.J. Nederkoorn1, N.D. Kruyt6
1Department of neurology, Academic Medical Center,
Amsterdam, Netherlands
2Department of clinical epidemiology, Leiden UMC, Leiden,
Netherlands
3Department of neurology, Erasmus MC, Rotterdam,
Netherlands
4Department of neurology, UMC Utrecht, Utrecht,
Netherlands
5Department of neurology, Maastricht UMC+, Maastricht,
Netherlands
6Department of neurology, Leiden UMC, Leiden, Netherlands
Intravenous thrombolysis (IVT) with recombinant tissue plasminogen
activator is an effective treatment in acute ischemic stroke. However, IVT
is contraindicated when blood pressure (BP) is above 185/110 mm Hg. In
Dutch clinical practice, two distinct strategies are used in this situation.
The active strategy comprises lowering BP with antihypertensive agents
below these thresholds to allow start of IVT. In the conservative strategy,
IVT is administered only when BP drops spontaneously below protocolled
thresholds.
We hypothesize that the active strategy leads to a better functional
outcome three months after acute ischemic stroke. Secondary hypotheses
are that this effect occurs despite increasing the number of sICHs, and
could be attributable to a higher rate of IVT treatments and a shorter
door-to-needle time.
The TRUTH is a prospective, observational, cluster-based, parallel group
follow-up study; in which participating centers continue their current
local treatment guidelines. Outcomes of patients admitted to centers with
an active will be compared to those admitted to centers with a conserva-
tive strategy.
Our sample size estimate of 1235 was based on an ordinal analysis of the
modified Rankin Scale, with corrections for expected imbalance in group
size and clustering effects.
The TRUTH is the first large prospective study specifically studying IVT-
candidates with elevated BP, and has the potential to change clinical prac-
tice and optimize acute stroke care in these patients.
Study proceedings as of March 3rd, 2015:
Approval medical ethical committee September 2014
Start date January 2015
Estimated end date December 2018
Centers participating 11
Centers starting up 15
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29. Ongoing Trials
Thrombolysis or anticoagulation for cerebral venous
thrombosis (TO-ACT trial)
J.M. Coutinho1, J.M. Ferro2, S.M. Zuurbier1, P. Canhao2,
I. Crassard3, C.B. Majoie4, J. Reekers4, E. Houdart5, R.J. de Haan6,
M.G. Bousser3, J. Stam1
1Neurology, Academic Medical Center University of
Amsterdam, Amsterdam, Netherlands
2Neurology, Hospital Santa Maria University of Lisbon, Lisbon,
Portugal
3Neurology, Hopital Lariboisiere, Paris, France
4Radiologie, Academic Medical Center University of
Amsterdam, Amsterdam, Netherlands
5Radiologie, Hopital Lariboisiere, Paris, France
6Clinical Research Unit, Academic Medical Center, Amsterdam,
Netherlands
Background: Endovascular thrombolysis (ET), with or without mechani-
cal clot removal, may be beneficial for a subgroup of patients with cerebral
venous sinus thrombosis (CVT), who have a poor prognosis despite treat-
ment with heparin. Published experience with ET is promising, but only
based on uncontrolled studies.
Objective: The objective of the TO-ACT trial is to determine if ET
improves the functional outcome of patients with CVT.
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Methods: Multi-centre, prospective, randomized, open-label, blinded
endpoint (PROBE) trial. Patients are eligible if they have a radiologically
proven CVT, a high probability of poor outcome (defined by presence of
one or more of the following risk factors: mental status disorder, coma,
intracranial hemorrhagic lesion, or thrombosis of the deep cerebral
venous system) and if the responsible physician is uncertain whether ET
or standard anticoagulant treatment is better. 164 patients will be
included.
Intervention: Patients are randomized to receive either ET or standard
treatment (therapeutic doses of heparin). ET consists of local application
of rt-PA or urokinase within the thrombosed sinuses, mechanical throm-
bectomy, or a combination of both.
Outcomes: The primary endpoint is the modified Rankin score (mRS) at
12 months. Secondary outcomes are 6 months mRS, mortality and reca-
nalization rate. Principal safety outcomes are major intra- and extracra-
nial hemorrhagic complications.
Further information: The first patient was randomized in September
2011. Currently, 50 patients are included by a total of 13 hospitals in four
countries. Investigators who are interested in participation can contact us
at j.coutinho@amc.uva.nl
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30. Late-breaking abstracts
Epidemiology of childhood stroke
T. Aprasidze1
1Pediatric Neurology and Neurosurgery, M. Iashvili Children’s
Central Hospital, Tbilisi, Georgia
The purpose of this study is to report on our experience of epidemiologi-
cal data of childhood stroke.32 patients under the age of 15 years were
investigated.18 (56.25%) of these patients were males and 14 (43.75%)
were females.Diagnoses of stroke were confirmed by MRI/MRA scan.The
most – 12 (37.5%) childhood stroke cases were obtained in patients aged
6–24 months,5 (15.62%) patients were in the age group of 2–5 years, 9
(28.13%) were aged 5–10 years and 6 (18.75%) – above 10 years of age.
AIS was reported in 21 (65.62%) patients,among which 12 (37.5%) were
males; followed by hemorrhagic stroke in 7 (21.88%) patients and CSVT
in 4 (12.5%) cases. Focal signs occurred in all cases of AIS, in 3 of hem-
orrhagic stroke cases and in 2 patients with CSVT. Risk factors were
identified in 11 (34.37%) children.
Age
AIS n = 21
n (%)
CSVT n = 4
n (%)
Hemorrhage n = 7
n (%)
6–24 months 9 (28.12%) 1 (3.12%) 2 (6.25%)
2–5 years 4 (12.5%) 1 (3.12%) 0 (0%)
5–10 years 5 (15.62%) 2 (6.25%) 2 (6.25%)
>10 years 3 (9.37%) 0 (0%) 3 (9.37%)
Males (n = 18)
N (%)
Females (n = 14)
N (%)
Total (n = 32)
N (%)
AIS 12 (37.5%) 9 (28.12%) 21 (65.62%)
CSVT 3 (9.37%) 1 (3.12%) 4 (12.5%)
Hemorrhagic 3 (9.37%) 4 (12.5%) 7 (21.87%)
Other
Risk factors N, %
Factor VIII deficiency 2 (6.25%)
Encephalitis 2 (6.25%)
Moya moya disease 1 (3.12%)
ALL 2 (6.25%
Bacterial meningitis 1 (3.12%)
AVM 1 (3.12%)
Head trauma 1 (3.12%)
Hypertension 1 (3.12%)
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30. Late-breaking abstracts
Where time is not of the essence – stroke treatment
and care in an Ebola treatment centre
P. Dhillon1, S. McCarthy2, M. Gibbs3
1Family Medicine, University of Saskatchewan, Regina,
Canada
2Emergency Medicine, St. Vincent’s Hospital Dublin, Dublin,
Ireland
3Trainee Advanced Clinical Practitioner, Heart of England
Foundation Trust, United Kingdom
Stroke care has advanced in the western world by leaps and bounds over
the past century. Recently, in West Africa, declining Ebola mortality rates
in the Ebola epidemic have raised questions and issues about standards of
care and in terms of non-Ebola disease management. Patients now may
present with Ebola disease manifestations but then acquire new diagnoses
which require treatment and possible interventions.
Neurological sequelae of Ebola are known but not well described in the
literature. They include encephalitis, meningitis, and stroke. No studies
are available that differentiate between the different neurological diagno-
ses as there is no imaging support and limited laboratory access; diagnosis
is clinical.
Through a case discussion we explore the difficulties and challenges of
providing a low resource post-stroke care in an Ebola Treatment Centre.
The patient was Ebola positive on PCR testing, suffered a stroke which left
her with a right sided hemi-paresis, and then consequently cleared the
virus from her system. Providing stroke care not only in a low resource
environment but while also wearing full Personal Protective Equipment
(PPE), in tropical heat with limited patient time is explored and docu-
mented for the first time in the literature.
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30. Late-breaking abstracts
Experience in mechanical thrombectomy in acute
ischemic stroke: How close are the results of the real
clinical practice to those obtained in the lasts trials?
C. Fernandez1, A. Luna1, T. Pérez Concha1, A. Gil2,
E.M. González2, I. Labayen2, J.J. Fondevila2, J.J. Zarranz1
1Neurology, Hospital Universitario Cruces, Barakaldo, Spain
2Neuroradiology, Hospital Universitario Cruces, Barakaldo,
Spain
Background: In the last weeks two important trials on endovascular treat-
ment for ischemic stroke have beem published, showing that early throm-
bectomy with the stent retriever in selected patients can improve their
functional outcome. Mechanical thrombectomy for acute treatment of
ischemic stroke was stablished at the University Hospital of Cruces in
October 2012. We below show our experience and results with this
technique.
Methods: Since endovascular treatment was implemented in our hospital,
we have treated 181 patients with acute ischaemic stroke. We selected
patients with a carotid territory stroke of less than 6 hours from onset,
with a previous mRs ≤ 2, that present an arterial stop in the angio-CT,
ASPECT score >7 in the CT-scan and a favorable perfusion study.
Those patients elegible for r-TPA recieved treatment before endovascular
procedure.
Results: This group of 181 patients has a mean age of 70.9 (± 12.83,
27–91), there are 97 males and 87 females, with a previos mRs of 0 in
84.21%,1 in 4.09% and 2 in 8.18%. The mean NIHSS at admission was
15.7 (± 6.37, 3–28). 34.16% of patients recieved previous treatment with
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r-TPA. Complete recanalization (TICI 2b, 3) was obtained in 91.16%.
Mean NIHSS at discharge was 3.8.Symptomatic cerebral hemorrage
ocurred in 4.97% patients. 64.23% of patients are independet (mRs ≤ 2) at
90 days.
Conclusions: Mechanical thrombectomy is a safe and efficient therapy in
acute stroke when it is performed in experienced centres under strict
selection criteria. A proper stroke treatment strategy is needed in our
country in the pursuit of equity.
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30. Late-breaking abstracts
Epidermal growth factor and growth
hormone-releasing peptide-6: Combined therapeutic
approach in experimental stroke
D. Garcia-del-Barco1, N. Subirós1, H. Pérez-Saad1
1Biomedical Research Neuroprotection, Center for Genetic
Engineering and Biotechnology, Havana, Cuba
Stroke is the world’s second leading cause of mortality, with a high inci-
dence of disability in survivors. Promising preclinical studies on neuro-
protection have failed in stroke trials. Combined therapy is a compelling
promissory strategy, as it simultaneously targets different nodes of the
complex ischemic cascade. The aim of this work is to evaluate the possible
neuroprotective effects of the combined therapy of Epidermal Growth
Factor (EGF) and Growth Hormone-Releasing Peptide-6 (GHRP6) in
focal brain ischemia experimental stroke. The neuroprotective effect of
the EGF+GHRP6-combined therapy, which has been previously assessed
in global brain ischemia experimental models, were compared with one of
the most relevant strategies to reach neuroprotection: Hypothermia.
The brain focal ischemia model were generated using one intracerebral
administration of endothelin-1 in rats. Two hours after reperfusion EGF,
GHRP6 or EGF+GHRP6 were intraperitoneally administered. Clinical
manifestations were registered daily. Three days after reperfusion, animals
were anesthetized and perfused with saline. Infarct volume was analyzed
with TTC staining.
EGF+GHRP6 co-administration reduced clinical manifestations, and
infarct size. Additionally animals treated with EGF+GHRP6 had a neuro-
logical grade and infarct volume, similar to those that were treated with
hypothermia.
Thus EGF and GHRP6 co-administration had an impact in both clinical
and pathological outcomes, showing the promising therapeutic potential
of this combined treatment approach for stroke patients.
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Randomized clinical trial of the effectiveness of
nutritional assessment in adult patients with prior
stroke
M. Medeiros1, J.P.U. Ferreira2, P.F. Sablewski3, D.G. Barbosa4,
F.A.G. Teixeira3, A.L.S. Arantes4, K.P. Ilidio3, L.F.M. Pereira1,
K.N. Freitas1, G.A.G. Silva5
1Santa Casa de São José dos Campos Hospital, Camilo Castelo
Branco University, São José dos Campos, Brazil
2Intensive Care, São Francisco Hospital, Ribeirão Preto, Brazil
3Santa Casa de Fernandópolis Hospital School, Camilo Castelo
Branco University, Fernandópolis, Brazil
4Medicine School, Centro Universitário Barão de Mauá,
Ribeirão Preto, Brazil
5Medicine School, University of the Region of Joinville,
Joinville, Brazil
Background: Chronic noncommunicable diseases (NCDs) account for
about 60% of global mortality Stroke becomes more important as it is the
leading cause of disability and the second cause of mortality worldwide,
with 6.15 million deaths worldwide. Hypertension is a major risk for
stroke, several studies have shown that various nutritional aspects are
associated with the risk of stroke, reducing it.
Objectives: To evaluate the effectiveness of nutritional counseling with a
DASH-style in improving the control of stroke risk factors compared to
the usual diet in adult patients with a history of stroke.
Patients and Methods: Patients with previous stroke were randomized to
receive nutritional guidance with a DASH diet (intervention group GI), or
follow usual diet (control group GII). Clinical and biographical charac-
teristics were evaluated and visits were conducted anthropometric and
blood pressure measurements, biochemical tests, and 24-hour recall of
food intake. Pacient follow-up was three months (December/2014 to
February/2015).
Results: This study evaluated 43 patients (21 GI and GII 22) with a mean
age of 58 years. There were no significant differences between groups.
There is a tendency for reduction of diastolic blood pressure with increas-
ing calcium intake (p < 0.05) and an increase of the same with increased
sodium intake (p < 0.0055) in both groups.
Conclusions: The results of the research were negative, showing no differ-
ences between groups. Possibly the low compliance of patients influence
the results and therefore a greater number of people in groups and longer
follow-up may bring us a more accurate perception of this relationship.
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Clinical significance of biochemical markers in the
recovery period of ischemic stroke in children
N. Nechaeva1, L.M. Kuzenkova1, I.E. Smirnov2, A.G. Kucherenko2,
O.V. Globa1
1psychoneurology, Scientific Centre of children health of
Russian Academy of medical science, Moscow, Russia
2pathophysiology, Scientific Centre of children health of
Russian Academy of medical science, Moscow, Russia
The causes and risk factors of stroke in children differ significantly from
those of adults: infections, cardiac arrhythmias, heart diseases, prothrom-
botic mutations, migraine, etc. Biochemical markers, well studied in
adults, are unknown for peadiatric neurology: nitric oxide, endothelin-1,
von Willebrand factor, homocysteine.
Methods: 50 children from 10 months to 17 years after ischemic stroke
and control group of 50 healthy children, comparable by gender and age,
underwent clinical assessment of neurologic deficit by the scale PSALM
(Pediatric Stroke Activity Limitation Measure). Blood levels of von Wille-
brand factor (vWF), homocysteine, nitric oxide, endothelin-1 were evalu-
ated in all children.
Results: Significant increase in levels of vWF (p = 0.005), endothelin-1
(p < 0.001) and homocysteine (p = 0.02), as well as the reduction of nitro-
gen oxide (p < 0.001) were found in children after ischemic stroke com-
pared to the control group. In a stroke group strong positive correlation
(r = 0,63; p < 0,001) between vWF and PSALM score, as well as a moder-
ate negative correlation (r = -0,48; p < 0.001) between ratio NO /
endothelin-1 and PSALM score were observed.
Based on this independent correlations, with the linear regression analysis
we have calculated the mathematical model, predicting the outcome of
ischemic stroke in children on the base of vWF, nitric oxide and
endothelin-1 blood levels.
Conclusion: Changing of vWF, nitric oxide and endothelin-1 blood levels
can be considered not only as a risk factor of ischemic stroke, but also as
an outcome measure.
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Poor leptomeningeal collateral status is associated
with abysmal outcome in consecutive patients with
acute MCA occlusion
C. Ovesen1, C. Trampedach2, A. Christensen2, I. Havsteen2,
C.K. Hansen1, H. Christensen1
1Department of Neurology, Bispebjerg Hospital, Copenhagen,
Denmark
2Department of Radiology, Bispebjerg Hospital, Copenhagen,
Denmark
Background: Poor collateral blood flow through leptomeningeal vessels is
likely a pivotal factor in the outcome of stroke patients, but the effect lacks
to be documented in unselected and consecutive stroke patients.
Method: We included 185 consecutive patients with middle cerebral
artery occlusion (MCA) undergoing thrombolysis (and endovascular
treatment – EVT) from May 2009 to February 2014. All patients received
acute CT-angiography followed by intravenous thrombolysis treatment
(and transferal for EVT). Poor collateral status was defined as contrast
filling of only distal superficial vessels in the ischemic area. Modified
Rankin Scale (mRS) was assessed after 3 months. Mortality-status was
followed for one year after stroke.
Results: Patients underwent CTA with a median delay of 87 minutes
(70–117 minutes). Median (IQR) NIHSS on admission was 15 (9.5–19).
All patients underwent intravenous thrombolysis, and 56 (30%) under-
went additional EVT. Median (IQR) 3 months outcome in patients with
poor collaterals was 4 (3–6) compared to 2 (1–4) in the remaining popu-
lation (p < 0.0001). Patients with poor collaterals were less prone to good
3 months outcome (mRS 0–2) (OR 0.31 CI: 0.12–0.80) after adjustment
for age, time-to-scan, EVT, NIHSS, and thrombus burden. During the first
year after stroke, patients with poor collaterals suffered a cumulative mor-
tality of 41.9% compared to 18.3% of the remaining population
(p = 0.001). Adjusted for age, time-to-scan, EVT, NIHSS, and thrombus
burden, poor collateral status was associated with morality during the first
year (HR 2.1 CI: 1.01–4.15).
Conclusion: Poor collateral status predicts poor long-term outcome after
stroke in consecutively treated stroke patients.
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EuroSCORE risk model as predictor of mace after
carotid artery stenting and carotid endarterectomy in
patients with carotid stenosis and concomitant
coronary artery disease
B. Rudenko1, A. Shanoyan1, S. Boytcov2, T. Tvorogova1,
A. Okshina1
1cath lab, National Research Center for Preventive medicine,
Moscow, Russia
2principal, National Research Center for Preventive medicine,
Moscow, Russia
Purpose: To study outcomes of carotid artery stenting (CAS) and carotid
endarterectomy (CEA) in patients with carotid stenosis and multivessel
coronary disease according to EuroSCORE risk model.
Methods: We reviewed 312 patients who were treated for carotid stenosis
(142 carotid artery stentings and 170 carotid endarterectomies).
Results: Depending on comorbidities all patient were divided in two
groups: EuroSCORE ≤ 5 (n – 181) and EuroSCORE > 5 (n – 131). In
EuroSCORE ≤ 5 group CAS was performed in 75 patients, CEA – in 106
patients. The 30-days stroke rate did not differ between CAS and CEA.
The 1-year freedom from stroke were 93.4% in CAS subgroup and 94.3%
in CEA subgroup (p > 0.05). There was no difference in the all-cause
death rate (stroke-related, coronary, other) at 1-year follow-up. In Euro-
SCORE > 5 group CAS was performed in 73 patients, CEA – in 58
patients. There was no difference in the incidence of 30-days stroke
between CAS and CEA. The 1-year freedom from stroke were 93.2% in
CAS subgroup and 94.9% in CEA subgroup (p > 0.05). The all-cause
death rate among CAS patients was lower (1.4%) compared to CEA
patients (12%, p = 0.044).
Conclusion: In the low-risk patients (EuroSCORE ≤ 5) the incidence of
neurological complications and all-cause death rate did not differ between
CAS and CEA subgroups. In high-risk patients (EuroSCORE > 5) there
was no significant difference in the incidence between subgroups, but
patients after CEA are at higher risk for any-cause related death.
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